PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Brugger, A; Morton, TA; Dessai, S				Bruegger, Adrian; Morton, Thomas A.; Dessai, Suraje			Hand in Hand: Public Endorsement of Climate Change Mitigation and Adaptation	PLOS ONE			English	Article							RISK PERCEPTIONS; CHANGE POLICY; WILLINGNESS; MOTIVATION; ATTITUDES; BELIEFS; SUPPORT; ACT	This research investigated how an individual's endorsements of mitigation and adaptation relate to each other, and how well each of these can be accounted for by relevant social psychological factors. Based on survey data from two European convenience samples (N = 616/309) we found that public endorsements of mitigation and adaptation are strongly associated: Someone who is willing to reduce greenhouse gas emissions (mitigation) is also willing to prepare for climate change impacts (adaptation). Moreover, people endorsed the two response strategies for similar reasons: People who believe that climate change is real and dangerous, who have positive attitudes about protecting the environment and the climate, and who perceive climate change as a risk, are willing to respond to climate change. Furthermore, distinguishing between (spatially) proximal and distant risk perceptions suggested that the idea of portraying climate change as a proximal (i.e., local) threat might indeed be effective in promoting personal actions. However, to gain endorsement of broader societal initiatives such as policy support, it seems advisable to turn to the distant risks of climate change. The notion that "localising" climate change might not be the panacea for engaging people in this domain is discussed in regard to previous theory and research.	[Bruegger, Adrian] Univ Bern, Fac Business Econ & Social Sci, Bern, Switzerland; [Bruegger, Adrian; Morton, Thomas A.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Dessai, Suraje] Univ Leeds, Sustainabil Res Inst, Leeds, W Yorkshire, England; [Dessai, Suraje] Univ Leeds, ESRC Ctr Climate Change Econ & Policy, Sch Earth & Environm, Leeds, W Yorkshire, England; [Dessai, Suraje] Univ Lisbon, Fac Sci, Climate Change Impacts Adaptat & Mitigat Res Grp, P-1699 Lisbon, Portugal	University of Bern; University of Exeter; University of Leeds; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of Leeds; Universidade de Lisboa	Brugger, A (corresponding author), Univ Bern, Fac Business Econ & Social Sci, Bern, Switzerland.	adrian.bruegger@imu.unibe.ch	Brügger, Adrian/E-4252-2014; Dessai, Suraje/D-4219-2009	Brügger, Adrian/0000-0003-0026-3153; Dessai, Suraje/0000-0002-7879-9364; /0000-0002-7577-7047	Social Psychology Division of the Otto-von-Guericke University at Magdeburg, Germany; Climate Change and Sustainable Futures theme at the University of Exeter; European Research Council under the 7th Framework Programme/ERC Grant [284369]; UK Economic and Social Research Council (ESRC); Economic and Social Research Council [ES/K006576/1] Funding Source: researchfish; ESRC [ES/K006576/1] Funding Source: UKRI	Social Psychology Division of the Otto-von-Guericke University at Magdeburg, Germany; Climate Change and Sustainable Futures theme at the University of Exeter; European Research Council under the 7th Framework Programme/ERC Grant; UK Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The study conducted in Switzerland was partly supported by the Social Psychology Division of the Otto-von-Guericke University at Magdeburg, Germany. Adrian Brugger was supported by a doctoral fellowship from the Climate Change and Sustainable Futures theme at the University of Exeter. Suraje Dessai is supported by the European Research Council under the 7th Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 284369 and by the UK Economic and Social Research Council (ESRC) for the Centre for Climate Change Economics and Policy (CCCEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger W. N., 2001, Journal of International Development, V13, P921, DOI 10.1002/jid.833; [Anonymous], 2002, AM PSYCHOL, V57, P1060, DOI DOI 10.1037/0003-066X.57.12.1060; [Anonymous], 2006, RECIEL REV EUROPEAN, DOI [10.1111/j.1467-9388.2006.00501.x, DOI 10.1111/J.1467-9388.2006.00501.X, DOI 10.1177/0306312715620061]; Arbuckle JG, 2013, CLIMATIC CHANGE, V117, P943, DOI 10.1007/s10584-013-0707-6; Barnett J, 2010, WIRES CLIM CHANGE, V1, P314, DOI 10.1002/wcc.28; Bichard E, 2012, CLIMATIC CHANGE, V112, P633, DOI 10.1007/s10584-011-0257-8; Blennow K, 2009, GLOBAL ENVIRON CHANG, V19, P100, DOI 10.1016/j.gloenvcha.2008.10.003; Brody S, 2012, CLIM POLICY, V12, P1, DOI 10.1080/14693062.2011.579261; Brugger A, 2011, EUR PSYCHOL, V16, P324, DOI 10.1027/1016-9040/a000032; Bubeck P, 2012, RISK ANAL, V32, P1481, DOI 10.1111/j.1539-6924.2011.01783.x; City of London Corporation, 2007, RISING TO THE CHALLE; CRED, 2009, THE PSYCHOLOGY OF CL; Devine-Wright P, 2013, GLOBAL ENVIRON CHANG, V23, P61, DOI 10.1016/j.gloenvcha.2012.08.003; Dietz T, 2007, RURAL SOCIOL, V72, P185, DOI 10.1526/003601107781170026; Esham M, 2013, MITIG ADAPT STRAT GL, V18, P535, DOI 10.1007/s11027-012-9374-6; Field C. B., 2014, CONTRIBUTION OF WORK; Floyd DL, 2000, J APPL SOC PSYCHOL, V30, P407, DOI 10.1111/j.1559-1816.2000.tb02323.x; Fussel HM, 2006, CLIMATIC CHANGE, V75, P301, DOI 10.1007/s10584-006-0329-3; Gardner GT, 2008, ENVIRONMENT, V50, P12, DOI 10.3200/ENVT.50.5.12-25; Grothmann T, 2005, GLOBAL ENVIRON CHANG, V15, P199, DOI 10.1016/j.gloenvcha.2005.01.002; Haden V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052882; Hayward SF, 2006, ACCLIMATIZING HOW TO; IPCC, 2014, WORKING GROUP III CO; IPCC (Intergovernmental Panel on Climate Change), 2007, CONTRIBUTION WORKING, P793; Kaiser FG, 2004, PERS INDIV DIFFER, V36, P1531, DOI 10.1016/j.paid.2003.06.003; Kim HY, 2009, J CONSUM RES, V35, P877, DOI 10.1086/593700; Klein RJT, 2005, ENVIRON SCI POLICY, V8, P579, DOI 10.1016/j.envsci.2005.06.010; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; Lindell MK, 2000, ENVIRON BEHAV, V32, P461, DOI 10.1177/00139160021972621; Lorenzoni I, 2007, GLOBAL ENVIRON CHANG, V17, P445, DOI 10.1016/j.gloenvcha.2007.01.004; Marx SM, 2007, GLOBAL ENVIRON CHANG, V17, P47, DOI 10.1016/j.gloenvcha.2006.10.004; McCrann T, 2011, THE AUSTRALIAN BUSIN; Monbiot G, 2006, NEW INT MAG; Monckton C, 2010, WAS THE WARMEST YEAR; Nilsson A, 2004, J ENVIRON PSYCHOL, V24, P267, DOI 10.1016/j.jenvp.2004.06.002; O'Connor RE, 1999, RISK ANAL, V19, P461, DOI 10.1111/j.1539-6924.1999.tb00421.x; Olausson U, 2009, PUBLIC UNDERST SCI, V18, P421, DOI 10.1177/0963662507081242; Prillwitz J, 2011, J TRANSP GEOGR, V19, P1590, DOI 10.1016/j.jtrangeo.2011.06.011; Semenza JC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-46; Shwom R, 2008, CLIMATIC CHANGE, V90, P343, DOI 10.1007/s10584-008-9428-7; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Smith N, 2012, RISK ANAL, V32, P1021, DOI 10.1111/j.1539-6924.2012.01801.x; Spence A, 2011, NAT CLIM CHANGE, V1, P46, DOI [10.1038/NCLIMATE1059, 10.1038/nclimate1059]; Spence A, 2012, RISK ANAL, V32, P957, DOI 10.1111/j.1539-6924.2011.01695.x; Spence A, 2010, GLOBAL ENVIRON CHANG, V20, P656, DOI 10.1016/j.gloenvcha.2010.07.002; Tabachnick B.G., 2013, USING MULTIVARIATE S, V6th ed; Tobler C, 2012, J ENVIRON PSYCHOL, V32, P197, DOI 10.1016/j.jenvp.2012.02.001; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Tucker CM, 2010, GLOBAL ENVIRON CHANG, V20, P23, DOI 10.1016/j.gloenvcha.2009.07.006; WEINSTEIN ND, 1980, J PERS SOC PSYCHOL, V39, P806, DOI 10.1037/0022-3514.39.5.806; Whitmarsh L, 2010, J ENVIRON PSYCHOL, V30, P305, DOI 10.1016/j.jenvp.2010.01.003; Whitmarsh L, 2009, PUBLIC UNDERST SCI, V18, P401, DOI 10.1177/0963662506073088	52	33	33	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124843	10.1371/journal.pone.0124843	http://dx.doi.org/10.1371/journal.pone.0124843			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25922938	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600106
J	Herrera, MS; Kuhn, WR; Lorenzo-Carballa, MO; Harding, KM; Ankrom, N; Sherratt, TN; Hoffmann, J; Van Gossum, H; Ware, JL; Cordero-Rivera, A; Beatty, CD				Herrera, Melissa Sanchez; Kuhn, William R.; Olalla Lorenzo-Carballa, Maria; Harding, Kathleen M.; Ankrom, Nikole; Sherratt, Thomas N.; Hoffmann, Joachim; Van Gossum, Hans; Ware, Jessica L.; Cordero-Rivera, Adolfo; Beatty, Christopher D.			Mixed Signals? Morphological and Molecular Evidence Suggest a Color Polymorphism in Some Neotropical Polythore Damselflies	PLOS ONE			English	Article							SEXUALLY SELECTED TRAIT; PARASITE RESISTANCE; PREMATING ISOLATION; NEURAL-NETWORKS; GENE FLOW; SELECTION; HYBRIDIZATION; SPECIATION; EXPRESSION; ORNAMENT	The study of color polymorphisms (CP) has provided profound insights into the maintenance of genetic variation in natural populations. We here offer the first evidence for an elaborate wing polymorphism in the Neotropical damselfly genus Polythore, which consists of 21 described species, distributed along the eastern slopes of the Andes in South America. These damselflies display highly complex wing colors and patterning, incorporating black, white, yellow, and orange in multiple wing bands. Wing colors, along with some components of the male genitalia, have been the primary characters used in species description; few other morphological traits vary within the group, and so there are few useful diagnostic characters. Previous research has indicated the possibility of a cryptic species existing in P. procera in Colombia, despite there being no significant differences in wing color and pattern between the populations of the two putative species. Here we analyze the complexity and diversity of wing color patterns of individuals from five described Polythore species in the Central Amazon Basin of Peru using a novel suite of morphological analyses to quantify wing color and pattern: geometric morphometrics, chromaticity analysis, and Gabor wavelet transformation. We then test whether these color patterns are good predictors of species by recovering the phylogenetic relationships among the 5 species using the barcode gene (COI). Our results suggest that, while highly distinct and discrete wing patterns exist in Polythore, these "wingforms" do not represent monophyletic clades in the recovered topology. The wingforms identified as P. victoria and P. ornata are both involved in a polymorphism with P. neopicta; also, cryptic speciation may have taking place among individuals with the P. victoria wingform. Only P. aurora and P. spateri represent monophyletic species with a single wingform in our molecular phylogeny. We discuss the implications of this polymorphism, and the potential evolutionary mechanisms that could maintain it.	[Herrera, Melissa Sanchez; Kuhn, William R.; Ware, Jessica L.] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA; [Olalla Lorenzo-Carballa, Maria; Harding, Kathleen M.; Cordero-Rivera, Adolfo; Beatty, Christopher D.] Univ Vigo, Dept Ecol & Biol Anim, Grp Ecol Evolut & Conservac, Galiza, Spain; [Olalla Lorenzo-Carballa, Maria] Univ Liverpool, Inst Integrat Biol, Dept Evolut Ecol & Behav, Liverpool L69 3BX, Merseyside, England; [Ankrom, Nikole; Beatty, Christopher D.] Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA; [Sherratt, Thomas N.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Hoffmann, Joachim] ALAUDA Arbeitsgemeinschaft Landschaftsokol Unters, Hamburg, Germany; [Van Gossum, Hans] Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium	Rutgers State University Newark; Rutgers State University New Brunswick; Universidade de Vigo; University of Liverpool; Santa Clara University; Carleton University; University of Antwerp	Beatty, CD (corresponding author), Univ Vigo, Dept Ecol & Biol Anim, Grp Ecol Evolut & Conservac, Galiza, Spain.	cbeatty@scu.edu	Beatty, Christopher/ABE-6438-2020; Lorenzo-Carballa, M. Olalla/B-2624-2017; Sanchez-Herrera, Melissa/AAL-3270-2021; Cordero-Rivera, Adolfo/K-4182-2014	Beatty, Christopher/0000-0003-2641-0000; Lorenzo-Carballa, M. Olalla/0000-0003-4570-2594; Sanchez-Herrera, Melissa/0000-0001-5144-4996; Cordero-Rivera, Adolfo/0000-0002-5087-3550; Ware, Jessica/0000-0002-4066-7681; Kuhn, William/0000-0002-5506-6379	Spanish Ministry of Science and Innovation [PCI2006-A7-0639, CGL2008-02799]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Funding was provided by grants from the Spanish Ministry of Science and Innovation with competences in Science to CDB (Grant PCI2006-A7-0639) and ACR (Grant CGL2008-02799). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beccaloni George W., 1997, Tropical Lepidoptera, V8, P103; BICK G H, 1985, Odonatologica, V14, P1; BICK G H, 1986, Odonatologica, V15, P245; Brower AVZ, 2011, GENETICA, V139, P589, DOI 10.1007/s10709-010-9530-4; Brower AVZ, 1996, ZOOL J LINN SOC-LOND, V116, P317; CAIN AJ, 1954, GENETICS, V39, P89; Chapman RF, 1998, THE INSECTS STRUCTUR; Contreras-Garduno J, 2007, J INSECT PHYSIOL, V53, P612, DOI 10.1016/j.jinsphys.2007.03.003; Corbet PS, 1999, DRAGONFLIES BEHAVIOU; Cordoba-Aguilar A, 2002, ANIM BEHAV, V63, P759, DOI 10.1006/anbe.2001.1974; Cordoba-Aguilar A, 2008, DRAGONFLIES AND DAMS; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; DAUGMAN JG, 1980, VISION RES, V20, P847, DOI 10.1016/0042-6989(80)90065-6; DAUGMAN JG, 1988, IEEE T ACOUST SPEECH, V36, P1169, DOI 10.1109/29.1644; Davison A, 2000, P ROY SOC B-BIOL SCI, V267, P1399, DOI 10.1098/rspb.2000.1156; de Marmels J., 1982, Advances in Odonatology, V1, P39; Doyle J. J., 1987, PHYTOCHEM B, P11; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feder JL, 2012, PHILOS T R SOC B, V367, P461, DOI 10.1098/rstb.2011.0256; Fitzstephens DM, 2000, ANIM BEHAV, V60, P851, DOI 10.1006/anbe.2000.1548; Ford E. B., 1940, P493; Franks DW, 2009, EVOLUTION, V63, P2697, DOI 10.1111/j.1558-5646.2009.00748.x; Garrison RW, 2010, DAMSELFLY GENERA OF; GILLESPIE AR, 1987, REMOTE SENS ENVIRON, V22, P343, DOI 10.1016/0034-4257(87)90088-5; Goloboff P, 2008, CLADISTICS, V24, P91; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; Grether GF, 1997, P ROY SOC B-BIOL SCI, V264, P207, DOI 10.1098/rspb.1997.0029; Grether GF, 1996, EVOLUTION, V50, P1939, DOI 10.1111/j.1558-5646.1996.tb03581.x; Grether GF, 1996, EVOLUTION, V50, P1949, DOI 10.1111/j.1558-5646.1996.tb03582.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hassall C, 2014, PEERJ, V2, DOI 10.7717/peerj.438; Hill RI, 2012, BIOL J LINN SOC, V106, P540, DOI 10.1111/j.1095-8312.2012.01874.x; Honkavaara J, 2011, J EVOLUTION BIOL, V24, P139, DOI 10.1111/j.1420-9101.2010.02146.x; Hooper RE, 1999, PHYSIOL ENTOMOL, V24, P364, DOI 10.1046/j.1365-3032.1999.00152.x; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Joop G, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-19; Joron M, 2006, HEREDITY, V97, P157, DOI 10.1038/sj.hdy.6800873; Joron M, 2006, PLOS BIOL, V4, P1831, DOI 10.1371/journal.pbio.0040303; Kronforst MR, 2006, P NATL ACAD SCI USA, V103, P6575, DOI 10.1073/pnas.0509685103; LEES DR, 1975, J ANIM ECOL, V44, P67, DOI 10.2307/3852; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOUTON J.A., 1996, MANU BIODIVERSITY SE, P431; Maddison WP, 2011, MESQUITE A MODULAR S; MALLET J, 1989, PROC R SOC SER B-BIO, V236, P163, DOI 10.1098/rspb.1989.0019; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; Martin SH, 2013, GENOME RES, V23, P1817, DOI 10.1101/gr.159426.113; Mavarez J, 2006, NATURE, V441, P868, DOI 10.1038/nature04738; Mullen SP, 2014, ANNU REV ENTOMOL, V59, P339, DOI 10.1146/annurev-ento-120710-100621; Lorenzo-Carballa MO, 2014, INT J ODONATOL, V17, P149, DOI 10.1080/13887890.2014.951696; Polly P. D., 2014, GEOMETRIC MORPHOMETR; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Rambaut A, 2014, FIGTREE V 1 4 1 A TR; Rambaut A., 2014, TRACER V1 6; RIEK EF, 1984, CAN J ZOOL, V62, P1150, DOI 10.1139/z84-166; ROBERTSON HM, 1982, EVOLUTION, V36, P243, DOI 10.1111/j.1558-5646.1982.tb05037.x; Rohlf F. J., 2005, TPSDIG DIGITIZE LAND; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Russell KN, 2007, SYST ASSOC SPEC VOL, V74, P131; Salazar C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-132; Herrera MS, 2010, MOL PHYLOGENET EVOL, V57, P912, DOI 10.1016/j.ympev.2010.08.016; Sanchez-Herrera M, 2010, INT J ODONATOL, V13, P27, DOI 10.1080/13887890.2010.9748358; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Siva-Jothy MT, 2000, P ROY SOC B-BIOL SCI, V267, P2523, DOI 10.1098/rspb.2000.1315; Sonnentag O, 2012, AGR FOREST METEOROL, V152, P159, DOI 10.1016/j.agrformet.2011.09.009; Sukumaran J., 2008, SUMTREES SUMMARIZATI; Svensson EI, 2004, AM NAT, V163, P726, DOI 10.1086/383592; Svensson EI, 2007, AM NAT, V170, P101, DOI 10.1086/518181; Svensson EI, 2006, EVOLUTION, V60, P1242; Szeliski R., 2010, COMPUTER VISION ALGO, DOI DOI 10.1007/978-3-030-34372-9; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tynkkynen K, 2008, ANIM BEHAV, V75, P1431, DOI 10.1016/j.anbehav.2007.09.017; Tynkkynen Katja, 2008, P139; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Weldon TP, 1996, PATTERN RECOGN, V29, P2005, DOI 10.1016/S0031-3203(96)00047-7; Wellenreuther M, 2010, BIOL J LINN SOC, V100, P506, DOI 10.1111/j.1095-8312.2010.01464.x; Wellenreuther M, 2010, EVOLUTION, V64, P242, DOI 10.1111/j.1558-5646.2009.00815.x; WOEBBECKE DM, 1995, T ASAE, V38, P259, DOI 10.13031/2013.27838; Wolfram Research, 2010, MATHEMATICA EDITION; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zwickl DJ., 2006, THESIS	87	7	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125074	10.1371/journal.pone.0125074	http://dx.doi.org/10.1371/journal.pone.0125074			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923455	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600122
J	Garcia, NW; Pfennig, KS; Burmeister, SS				Garcia, Nicholas W.; Pfennig, Karin S.; Burmeister, Sabrina S.			Leptin Manipulation Reduces Appetite and Causes a Switch in Mating Preference in the Plains Spadefoot Toad (Spea bombifrons)	PLOS ONE			English	Article							MATE CHOICE; WEIGHT; ADIPOSITY; OBESE; GROWTH	Condition- or context-dependent mate choice occurs when females modify their mate preferences depending on their internal or external environment. While the ecological and evolutionary factors that favor the evolution of such plasticity are emerging, relatively little is known of the mechanisms underlying such choice. Here we evaluated whether leptin, a protein hormone involved in the regulation of appetite, might affect the expression of conditiondependent mate choice decisions. To do so, we administered leptin to spadefoot toads, Spea bombifrons, which exhibit condition-dependent mate choice for males of their own species versus congeneric males of S. multiplicata. In particular, poor-condition S. bombifrons are more likely than are good-condition S. bombifrons to prefer S. multiplicata males, but only in environments where hybridization between the two species is beneficial. We found that our leptin treatment reduced appetite in S. bombifrons adults, as was expected from leptin's known effects on appetite. However, although we predicted that leptin would reduce female preferences for heterospecific males, we found the opposite. In particular, our leptin treatment generated a consistent, repeatable preference for heterospecifics in an environment where females generally prefer conspecifics regardless of condition. These results indicate that leptin has the potential to affect female mate choice, but that it might do so in non-intuitive ways.	[Garcia, Nicholas W.; Pfennig, Karin S.; Burmeister, Sabrina S.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Burmeister, Sabrina S.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Burmeister, SS (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	sburmeister@unc.edu		Burmeister, Sabrina/0000-0001-5612-692X	New Innovator Award from the Office of the Director of the National Institutes of Health [1 DP2 OD004436-01]; University of North Carolina Research Council Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004436] Funding Source: NIH RePORTER	New Innovator Award from the Office of the Director of the National Institutes of Health; University of North Carolina Research Council Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The research was supported by a New Innovator Award from the Office of the Director of the National Institutes of Health (1 DP2 OD004436-01) to KSP and by a University of North Carolina Research Council Award to SSB. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Bragg AN, 1965, GNOMES NIGHT SPADEFO; Caprio M, 2001, TRENDS ENDOCRIN MET, V12, P65, DOI 10.1016/S1043-2760(00)00352-0; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Crespi EJ, 2006, P NATL ACAD SCI USA, V103, P10092, DOI 10.1073/pnas.0507519103; Denver RJ, 2011, NEUROENDOCRINOLOGY, V94, P21, DOI 10.1159/000328435; Drazen DL, 2001, ENDOCRINOLOGY, V142, P2768, DOI 10.1210/en.142.7.2768; French SS, 2011, INTEGR COMP BIOL, V51, P505, DOI 10.1093/icb/icr019; Froiland E, 2012, GEN COMP ENDOCR, V178, P330, DOI 10.1016/j.ygcen.2012.06.017; Gorissen M, 2012, GEN COMP ENDOCR, V178, P75, DOI 10.1016/j.ygcen.2012.04.004; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Kronfeld-Schor N, 2000, AM J PHYSIOL-REG I, V279, pR1277, DOI 10.1152/ajpregu.2000.279.4.R1277; Londraville RL, 2014, GEN COMP ENDOCR, V203, P146, DOI 10.1016/j.ygcen.2014.02.002; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Nieminen P, 2002, J BIOL RHYTHM, V17, P155, DOI 10.1177/074873002129002447; Oomura Y, 2006, PEPTIDES, V27, P2738, DOI 10.1016/j.peptides.2006.07.001; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; Pfennig KS, 2000, BEHAV ECOL, V11, P220, DOI 10.1093/beheco/11.2.220; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Spanovich S, 2006, COMP BIOCHEM PHYS B, V143, P507, DOI 10.1016/j.cbpb.2006.01.001; Sprent J, 2012, GEN COMP ENDOCR, V178, P372, DOI 10.1016/j.ygcen.2012.06.021; Steppan CM, 2000, REGUL PEPTIDES, V92, P73, DOI 10.1016/S0167-0115(00)00152-X	24	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125981	10.1371/journal.pone.0125981	http://dx.doi.org/10.1371/journal.pone.0125981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919309	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659400091
J	Park, MS				Park, Min-Sun			Molecular Dynamics Simulations of the Human Glucose Transporter GLUT1	PLOS ONE			English	Article							CYSTEINE-SCANNING MUTAGENESIS; FREE-ENERGY DIFFERENCES; DEFICIENCY SYNDROME; CRYSTAL-STRUCTURE; BRAIN; MECHANISM; RESIDUES; MUTATION; BINDING; FAMILY	Glucose transporters (GLUTs) provide a pathway for glucose transport across membranes. Human GLUTs are implicated in devastating diseases such as heart disease, hyper- and hypo-glycemia, type 2 diabetes and caner. The human GLUT1 has been recently crystalized in the inward-facing open conformation. However, there is no other structural information for other conformations. The X-ray structures of E. coli Xylose permease (XylE), a glucose transporter homolog, are available in multiple conformations with and without the substrates D-xylose and D-glucose. XylE has high sequence homology to human GLUT1 and key residues in the sugar-binding pocket are conserved. Here we construct a homology model for human GLUT1 based on the available XylE crystal structure in the partially occluded outward-facing conformation. A long unbiased all atom molecular dynamics simulation starting from the model can capture a new fully opened outward-facing conformation. Our investigation of molecular interactions at the interface between the transmembrane (TM) domains and the intracellular helices (ICH) domain in the outward- and inward-facing conformation supports that the ICH domain likely stabilizes the outward-facing conformation in GLUT1. Furthermore, inducing a conformational transition, our simulations manifest a global asymmetric rocker switch motion and detailed molecular interactions between the substrate and residues through the water-filled selective pore along a pathway from the extracellular to the intracellular side. The results presented here are consistent with previously published biochemical, mutagenesis and functional studies. Together, this study shed light on the structure and functional relationships of GLUT1 in multiple conformational states.	Howard Hughes Med Inst, Ashburn, VA USA	Howard Hughes Medical Institute	Park, MS (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA.	parkm10@janelia.hhmi.org			Howard Hughes Medical Institute (HHMI)	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute)	This work was supported by the Howard Hughes Medical Institute (HHMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; ASANO T, 1991, J BIOL CHEM, V266, P24632; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784; Brockmann K, 2001, ANN NEUROL, V50, P476, DOI 10.1002/ana.1222; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Doege H, 1998, BIOCHEM J, V329, P289, DOI 10.1042/bj3290289; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; HASHIRAMOTO M, 1992, J BIOL CHEM, V267, P17502; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hruz PW, 2000, BIOCHEMISTRY-US, V39, P9367, DOI 10.1021/bi000821g; Hruz PW, 1999, J BIOL CHEM, V274, P36176, DOI 10.1074/jbc.274.51.36176; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; INUKAI K, 1994, BIOCHEM J, V302, P355, DOI 10.1042/bj3020355; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jarzynski C, 1997, PHYS REV E, V56, P5018, DOI 10.1103/PhysRevE.56.5018; Jojart B, 2007, J COMPUT CHEM, V28, P2051, DOI 10.1002/jcc.20748; Klepper J, 2002, EUR J PEDIATR, V161, P295, DOI 10.1007/s00431-002-0939-3; Klepper J, 1999, NEUROCHEM RES, V24, P587, DOI 10.1023/A:1022544131826; Klepper J, 2001, FEBS LETT, V498, P104, DOI 10.1016/S0014-5793(01)02463-2; Klepper J, 2001, HUM MOL GENET, V10, P63, DOI 10.1093/hmg/10.1.63; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; LAM VMS, 1980, J BACTERIOL, V143, P396, DOI 10.1128/JB.143.1.396-402.1980; Lee HS, 2006, BIOCHEM BIOPH RES CO, V342, P702, DOI 10.1016/j.bbrc.2006.01.184; Leen WG, 2010, BRAIN, V133, P655, DOI 10.1093/brain/awp336; Liu YF, 2013, STAT INTERFACE, V6, P1; LOIKE JD, 1993, J GEN PHYSIOL, V102, P897, DOI 10.1085/jgp.102.5.897; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MAIDEN MCJ, 1987, NATURE, V325, P641, DOI 10.1038/325641a0; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MORI H, 1994, J BIOL CHEM, V269, P11578; Mueckler M, 1999, J BIOL CHEM, V274, P10923, DOI 10.1074/jbc.274.16.10923; Mueckler M, 2002, J BIOL CHEM, V277, P3498, DOI 10.1074/jbc.M109157200; MUECKLER M, 1994, J BIOL CHEM, V269, P20533; Mueckler M, 2005, J BIOL CHEM, V280, P39562, DOI 10.1074/jbc.M509050200; MURAOKA A, 1995, BIOCHEM J, V311, P699, DOI 10.1042/bj3110699; Olsowski A, 2000, BIOCHEMISTRY-US, V39, P2469, DOI 10.1021/bi992160x; Overweg-Plandsoen WCG, 2003, J INHERIT METAB DIS, V26, P559, DOI 10.1023/A:1025999914822; Pantano S, 2007, PROTEINS, V66, P930, DOI 10.1002/prot.21239; Pascual JM, 2002, ANN NEUROL, V52, P458, DOI 10.1002/ana.10311; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Quistgaard EM, 2013, NAT STRUCT MOL BIOL, V20, P766, DOI 10.1038/nsmb.2569; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; Roux B, 2004, STRUCTURE, V12, P1343, DOI 10.1016/j.str.2004.06.013; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider SA, 2009, MOVEMENT DISORD, V24, P1684, DOI 10.1002/mds.22507; Schurmann A, 1997, BIOCHEMISTRY-US, V36, P12897, DOI 10.1021/bi971173c; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Seidner G, 1998, NAT GENET, V18, P188, DOI 10.1038/ng0298-188; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Tikhonova IG, 2013, BIOCHEMISTRY-US, V52, P5593, DOI 10.1021/bi400499n; Wang D, 2000, HUM MUTAT, V16, P224, DOI 10.1002/1098-1004(200009)16:3<224::AID-HUMU5>3.0.CO;2-P; Wang D, 2008, PEDIATR RES, V64, P538, DOI 10.1203/PDR.0b013e318184d2b5; WILLEJORGENSEN P, 1983, ARCH SURG-CHICAGO, V118, P926; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; Ytreberg FM, 2004, J COMPUT CHEM, V25, P1749, DOI 10.1002/jcc.20103; Zoete V, 2005, PROTEINS, V61, P79, DOI 10.1002/prot.20528	64	34	36	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125361	10.1371/journal.pone.0125361	http://dx.doi.org/10.1371/journal.pone.0125361			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919356	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659400081
J	Hanggi, J; Langer, N; Lutz, K; Birrer, K; Merillat, S; Jancke, L				Haenggi, Juergen; Langer, Nicolas; Lutz, Kai; Birrer, Karin; Merillat, Susan; Jaencke, Lutz			Structural Brain Correlates Associated with Professional Handball Playing	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; WHITE-MATTER; CORTICAL THICKNESS; MOTOR CORTEX; FIBER TRACTS; PLASTICITY; ABNORMALITIES; ASYMMETRY; VOLUME; AREAS	Background There is no doubt that good bimanual performance is very important for skilled handball playing. The control of the non-dominant hand is especially demanding since efficient catching and throwing needs both hands. Methodology/Hypotheses We investigated training-induced structural neuroplasticity in professional handball players using several structural neuroimaging techniques and analytic approaches and also provide a review of the literature about sport-induced structural neuroplastic alterations. Structural brain adaptations were expected in regions relevant for motor and somatosensory processing such as the grey matter (GM) of the primary/secondary motor (MI/supplementary motor area, SMA) and somatosensory cortex (SI/SII), basal ganglia, thalamus, and cerebellum and in the white matter (WM) of the corticospinal tract (CST) and corpus callosum, stronger in brain regions controlling the non-dominant left hand. Results Increased GM volume in handball players compared with control subjects were found in the right MI/SI, bilateral SMA/cingulate motor area, and left intraparietal sulcus. Fractional anisotropy (FA) and axial diffusivity were increased within the right CST in handball players compared with control women. Age of handball training commencement correlated inversely with GM volume in the right and left MI/SI and years of handball training experience correlated inversely with radial diffusivity in the right CST. Subcortical structures tended to be larger in handball players. The anatomical measures of the brain regions associated with handball playing were positively correlated in handball players, but not interrelated in control women. Discussion/Conclusion Training-induced structural alterations were found in the somatosensory-motor network of handball players, more pronounced in the right hemisphere controlling the non-dominant left hand. Correlations between handball training-related measures and anatomical differences suggest neuroplastic adaptations rather than a genetic predisposition for a ball playing affinity. Investigations of neuroplasticity specifically in sportsmen might help to understand the neural mechanisms of expertise in general.	[Haenggi, Juergen; Langer, Nicolas; Lutz, Kai; Birrer, Karin; Merillat, Susan; Jaencke, Lutz] Univ Zurich, Dept Psychol, Div Neuropsychol, Zurich, Switzerland; [Langer, Nicolas] CUNY, Neural Syst Lab, New York, NY 10021 USA; [Langer, Nicolas] Child Mind Inst, New York, NY USA; [Lutz, Kai] Cereneo AG, Ctr Neurol & Rehabil, Vitznau, Switzerland; [Lutz, Kai] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Birrer, Karin] Univ Childrens Hosp Zurich, Rehabil Ctr Affoltern Am Albis, Affoltern Am Albis, Switzerland; [Merillat, Susan; Jaencke, Lutz] Univ Zurich, Int Normal Aging & Plast Imaging Ctr, Zurich, Switzerland; [Jaencke, Lutz] Univ Zurich, Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Jaencke, Lutz] Univ Zurich, Dynam Hlth Aging, Univ Res Prior Program, Zurich, Switzerland; [Jaencke, Lutz] King Abdulaziz Univ, Dept Special Educ, Jeddah 21413, Saudi Arabia	University of Zurich; City University of New York (CUNY) System; University of Zurich; University Zurich Hospital; University Children's Hospital Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; King Abdulaziz University	Hanggi, J (corresponding author), Univ Zurich, Dept Psychol, Div Neuropsychol, Zurich, Switzerland.	j.haenggi@psychologie.uzh.ch	Lutz, Kai/C-1433-2011	Hanggi, Jurgen/0000-0001-8124-6018; Merillat, Susan/0000-0002-0566-088X	National Centre of Competence in Research (NCCR) on Neural Plasticity and Repair; Swiss National Science Foundation (SNF) [31003A-100109]	National Centre of Competence in Research (NCCR) on Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	The authors thank all volunteers for their participation in the study. The present work was supported by the National Centre of Competence in Research (NCCR) on Neural Plasticity and Repair and by the grant number 31003A-100109 awarded to L.J. from the Swiss National Science Foundation (SNF).	Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Amunts K, 1997, HUM BRAIN MAPP, V5, P206, DOI 10.1002/(SICI)1097-0193(1997)5:3<206::AID-HBM5>3.0.CO;2-7; Amunts K, 2000, NEUROPSYCHOLOGIA, V38, P304, DOI 10.1016/S0028-3932(99)00075-5; Andersson JLR, 2007, TECHNICAL REPORTS; Ashburner J, 2003, LANCET NEUROL, V2, P79, DOI 10.1016/S1474-4422(03)00304-1; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bailey JA, 2014, J COGNITIVE NEUROSCI, V26, P755, DOI 10.1162/jocn_a_00527; Bezzola L, 2011, J NEUROSCI, V31, P12444, DOI 10.1523/JNEUROSCI.1996-11.2011; Blankstein U, 2009, NEUROPSYCHOLOGIA, V47, P599, DOI 10.1016/j.neuropsychologia.2008.10.014; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Burciu RG, 2013, J NEUROSCI, V33, P4594, DOI 10.1523/JNEUROSCI.3381-12.2013; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Burgel U, 1999, NEUROIMAGE, V10, P489, DOI 10.1006/nimg.1999.0497; Causby R, 2014, PERCEPT MOTOR SKILL, V118, P765, DOI 10.2466/25.27.PMS.118k27w2; Chiang MC, 2009, J NEUROSCI, V29, P2212, DOI 10.1523/JNEUROSCI.4184-08.2009; Chung MK, 2003, NEUROIMAGE, V18, P198, DOI 10.1016/S1053-8119(02)00017-4; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Di Paola M, 2013, HUM BRAIN MAPP, V34, P2707, DOI 10.1002/hbm.22095; Di X, 2012, BRAIN CONNECT, V2, P225, DOI 10.1089/brain.2011.0050; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Ericsson KA, 2009, ANN NY ACAD SCI, V1172, P199, DOI 10.1196/annals.1393.001; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fjell AM, 2008, NEUROIMAGE, V42, P1654, DOI 10.1016/j.neuroimage.2008.06.005; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Friston K, 2012, NEUROIMAGE, V61, P1300, DOI 10.1016/j.neuroimage.2012.04.018; Gaser C, 2003, J NEUROSCI, V23, P9240; Geyer S, 2004, Adv Anat Embryol Cell Biol, V174, pI; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2001, REV NEUROL-FRANCE, V157, P797; Grefkes C, 2001, NEUROIMAGE, V14, P617, DOI 10.1006/nimg.2001.0858; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Huang R, 2013, BRAIN STRUCT FUNCT; Hufner K, 2011, HIPPOCAMPUS, V21, P855, DOI 10.1002/hipo.20801; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Jacini Wantuir F S, 2009, J Sci Med Sport, V12, P688, DOI 10.1016/j.jsams.2008.11.004; Jancke L, 2009, RESTOR NEUROL NEUROS, V27, P521, DOI 10.3233/RNN-2009-0519; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Jancke L, 1996, PERCEPT MOTOR SKILL, V82, P735; Jancke Lutz, 2009, F1000 Biol Rep, V1, P78, DOI 10.3410/B1-78; Johansen-Berg H, 2010, CURR OPIN NEUROL, V23, P351, DOI 10.1097/WCO.0b013e32833b7631; Johansson RS, 2006, PLOS BIOL, V4, P1025, DOI 10.1371/journal.pbio.0040158; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Langer N, 2012, NEUROLOGY, V78, P182, DOI 10.1212/WNL.0b013e31823fcd9c; Lepage JF, 2014, GENES BRAIN BEHAV, V13, P127, DOI 10.1111/gbb.12107; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Makin TR, 2013, ELIFE, V2, DOI 10.7554/eLife.01273; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; Meyer M, 2014, CEREB CORTEX, V24, P2541, DOI 10.1093/cercor/bht094; Mietchen Daniel, 2009, Front Neuroinform, V3, P25, DOI 10.3389/neuro.11.025.2009; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Park IS, 2012, CEREBELLUM, V11, P925, DOI 10.1007/s12311-012-0366-6; Park IS, 2011, HUM MOVEMENT SCI, V30, P56, DOI 10.1016/j.humov.2010.09.001; Park IS, 2009, CEREBELLUM, V8, P334, DOI 10.1007/s12311-009-0100-1; Park IS, 2006, J KOREAN MED SCI, V21, P342, DOI 10.3346/jkms.2006.21.2.342; Raznahan A, 2010, NEUROIMAGE, V49, P2915, DOI 10.1016/j.neuroimage.2009.11.057; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Schlaffke L, 2014, NEUROSCIENCE, V259, P35, DOI 10.1016/j.neuroscience.2013.11.046; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Smolker HR, 2014, BRAIN STRUCT FUNCT; Steingruber HJ, 1971, ZEITSCHRIFT FUR EXPE, V18, P337, DOI [10.1107/S0108767309007235, DOI 10.1107/S0108767309007235]; Takao H, 2013, NEUROSCIENCE, V231, P1, DOI 10.1016/j.neuroscience.2012.11.038; Taubert M, 2013, POSTER PRESENTED AT; Thompson PM, 2004, NEUROIMAGE, V23, pS2, DOI 10.1016/j.neuroimage.2004.07.071; Valko PO, 2010, EUR J NEUROL, V17, P612, DOI 10.1111/j.1468-1331.2009.02872.x; Voets NL, 2008, NEUROIMAGE, V43, P665, DOI 10.1016/j.neuroimage.2008.08.013; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Wang B, 2013, NEUROIMAGE, V65, P476, DOI 10.1016/j.neuroimage.2012.10.007; Wei GX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028309; Wei GX, 2009, PROG NAT SCI-MATER, V19, P1397, DOI 10.1016/j.pnsc.2008.12.009; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhang HY, 2012, HIGH ALT MED BIOL, V13, P118, DOI 10.1089/ham.2011.1073; Zhang YC, 2013, MED SCI SPORT EXER, V45, P1077, DOI 10.1249/MSS.0b013e31827f4370	84	30	30	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124222	10.1371/journal.pone.0124222	http://dx.doi.org/10.1371/journal.pone.0124222			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915906	Green Accepted, Green Published, gold			2022-12-27	WOS:000353659100040
J	Yamaguchi, H; Tada, S; Nakanishi, Y; Kawaminami, S; Shin, T; Tabata, R; Yuasa, S; Shimizu, N; Kohno, M; Tsuchiya, A; Tani, K				Yamaguchi, Harutaka; Tada, Saaya; Nakanishi, Yoshinori; Kawaminami, Shingo; Shin, Teruki; Tabata, Ryo; Yuasa, Shino; Shimizu, Nobuhiko; Kohno, Mitsuhiro; Tsuchiya, Atsushi; Tani, Kenji			Association between Mouth Breathing and Atopic Dermatitis in Japanese Children 2-6 years Old: A Population-Based Cross-Sectional Study	PLOS ONE			English	Article							ADENOTONSILLAR HYPERTROPHY; SCHOOL-CHILDREN; PREVALENCE; SYMPTOMS; ASTHMA; FILAGGRIN; ECZEMA; SLEEP; NASAL; SKIN	As mouth breathing is associated with asthma and otitis media, it may be associated with other diseases. Therefore, this population-based cross-sectional study evaluated the association of mouth breathing with the prevalences of various diseases in children. Preschool children older than 2 years were included. A questionnaire was given to parents/guardians at 13 nurseries in Tokushima City. There were 468 valid responses (45.2%). We defined a subject as a mouth breather in daytime (MBD) if they had 2 or more positive items among the 3 following items: "breathes with mouth ordinarily," "mouth is open ordinarily," and "mouth is open when chewing." We defined subjects as mouth breathers during sleep (MBS) if they had 2 or more positive items among the following 3 items: "snoring," "mouth is open during sleeping," and "mouth is dry when your child gets up." The prevalences of MBD and MBS were 35.5% and 45.9%, respectively. There were significant associations between MBD and atopic dermatitis (odds ratio [OR]: 2.4, 95% confidence interval [CI]: 1.4-4.2), MBS and atopic dermatitis (OR: 2.4, 95% CI: 1.3-4.2), and MBD and asthma (OR: 2.2, 95% CI: 1.2-4.0). After adjusting for history of asthma and allergic rhinitis; family history of atopic dermatitis, asthma, and allergic rhinitis; and nasal congestion; both MBD (OR: 2.6, 95% CI: 1.3-5.4) and MBS (OR: 4.1, 95% CI: 1.8-9.2) were significantly associated with atopic dermatitis. In preschool children older than 2 years, both MBD and MBS may be associated with the onset or development of atopic dermatitis.	[Yamaguchi, Harutaka; Tada, Saaya; Shin, Teruki; Tabata, Ryo; Shimizu, Nobuhiko; Kohno, Mitsuhiro; Tani, Kenji] Univ Tokushima, Dept Gen Med, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan; [Nakanishi, Yoshinori] Tokushima Prefecture Naruto Hosp, Naruto, Japan; [Kawaminami, Shingo] Outpatient Facil Kameda Clin, Tateyama, Toyama, Japan; [Tsuchiya, Atsushi] Univ Tokushima, Dept Civil & Environm Studies, Fac Integrated Arts & Sci, Grad Sch, Tokushima, Japan	Tokushima University; Tokushima University	Tani, K (corresponding author), Univ Tokushima, Dept Gen Med, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan.	taniken@tokusima-u.ac.jp						Abreu RR, 2008, J PEDIAT-BRAZIL, V84, P467, DOI 10.2223/JPED.1806; Barros Juliana R. C., 2006, J. Pediatr. (Rio J.), V82, P458; Bonuck KA, 2011, SLEEP, V34, P875, DOI 10.5665/SLEEP.1118; Camfferman D, 2010, SLEEP MED REV, V14, P359, DOI 10.1016/j.smrv.2010.01.004; Chamlin SL, 2005, ARCH PEDIAT ADOL MED, V159, P745, DOI 10.1001/archpedi.159.8.745; CHEN WY, 1982, CHEST, V81, P675, DOI 10.1378/chest.81.6.675; Costa EC, 2013, BRAZ J OTORHINOLAR, V79, P663, DOI 10.5935/1808-8694.20130123; Menezes Valdenice Aparecida De, 2006, Rev. Bras. Otorrinolaringol., V72, P394, DOI 10.1590/S0034-72992006000300017; Demir UL, 2013, AM J OTOLARYNG, V34, P501, DOI 10.1016/j.amjoto.2013.04.013; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Eichenfield LF, 2003, PEDIATRICS, V111, P608, DOI 10.1542/peds.111.3.608; Elad D, 2008, RESP PHYSIOL NEUROBI, V163, P121, DOI 10.1016/j.resp.2008.05.002; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Felcar JM, 2010, CIENC SAUDE COLETIVA, V15, P437, DOI 10.1590/S1413-81232010000200020; Garde J B, 2014, J Int Oral Health, V6, P39; Gill AI, 2012, SLEEP MED, V13, P1191, DOI 10.1016/j.sleep.2012.05.007; GRIFFIN MP, 1982, J ALLERGY CLIN IMMUN, V69, P354, DOI 10.1016/0091-6749(82)90145-2; Gudjonsson JE, 2003, BRIT J DERMATOL, V149, P530, DOI 10.1046/j.1365-2133.2003.05552.x; Hansen TE, 2013, ACTA PAEDIATR, V102, P47, DOI 10.1111/apa.12030; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Japan Health Promotion and Fitness Foundation, 2012, AD SMOK RAT NAT HLTH; Kharbanda O P, 2003, J Indian Soc Pedod Prev Dent, V21, P120; Limeira AB, 2013, EUR J PEDIATR, V172, P519, DOI 10.1007/s00431-012-1919-x; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; Okabe Y, 2012, PEDIAT ALLERG IMM-UK, V23, P550, DOI 10.1111/j.1399-3038.2011.01261.x; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Satoh T, 2003, ACTA DERM-VENEREOL, V83, P376, DOI 10.1080/00015550310003728; Satoh T, 2002, J AM ACAD DERMATOL, V46, P942, DOI 10.1067/mjd.2002.120605; Shetty S R, 1998, J Indian Soc Pedod Prev Dent, V16, P61; Sigurdardottir SL, 2013, BRIT J DERMATOL, V168, P237, DOI 10.1111/j.1365-2133.2012.11215.x; Sogut A, 2009, INT J PEDIATR OTORHI, V73, P1769, DOI 10.1016/j.ijporl.2009.09.026; Sonoda T, 2001, BRIT J DERMATOL, V145, P516, DOI 10.1046/j.1365-2133.2001.04395.x; Steinsvag SK, 2007, INT J PEDIATR OTORHI, V71, P615, DOI 10.1016/j.ijporl.2006.12.012; Stensson M, 2008, INT J PAEDIATR DENT, V18, P243, DOI 10.1111/j.1365-263X.2008.00921.x; Sue-Chu M, 2012, BRIT J SPORT MED, V46, P397, DOI 10.1136/bjsports-2011-090822; Takeuchi S, 2014, J DERMATOL, V41, P200, DOI 10.1111/1346-8138.12331; The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee, 1988, LANCET, V351, P1225; Thorleifsdottir RH, 2012, J IMMUNOL, V188, P5160, DOI 10.4049/jimmunol.1102834; Trabalon M, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/207605; Valera FCP, 2003, INT J PEDIATR OTORHI, V67, P761, DOI 10.1016/S0165-5876(03)00095-8; van den Oord RAHM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2433; VANBON MJH, 1989, INT J PEDIATR OTORHI, V17, P119, DOI 10.1016/0165-5876(89)90087-6; Verma M, 2006, J PHYSIOL-LONDON, V574, P859, DOI 10.1113/jphysiol.2005.102129; WAGAIYU EG, 1991, J CLIN PERIODONTOL, V18, P698, DOI 10.1111/j.1600-051X.1991.tb00112.x; Yamada T, 2014, J ALLERGY CLIN IMMUN, V133, P632, DOI 10.1016/j.jaci.2013.11.002; Yura A, 2011, PEDIAT ALLERG IMM-UK, V22, P631, DOI 10.1111/j.1399-3038.2011.01159.x	47	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125916	10.1371/journal.pone.0125916	http://dx.doi.org/10.1371/journal.pone.0125916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915864	gold, Green Published			2022-12-27	WOS:000353659100152
J	Li, LJ; Aris, I; Su, LL; Tint, MT; Cheung, CYL; Ikram, MK; Gluckman, P; Godfrey, KM; Tan, KH; Yeo, G; Yap, F; Kwek, K; Saw, SM; Chong, YS; Wong, TY; Lee, YS				Li, Ling-Jun; Aris, Izzuddin; Su, Lin Lin; Tint, Mya Thway; Cheung, Carol Yim-Lui; Ikram, M. Kamran; Gluckman, Peter; Godfrey, Keith M.; Tan, Kok Hian; Yeo, George; Yap, Fabian; Kwek, Kenneth; Saw, Seang-Mei; Chong, Yap-Seng; Wong, Tien-Yin; Lee, Yung Seng			Associations of Maternal Retinal Vasculature with Subsequent Fetal Growth and Birth Size	PLOS ONE			English	Article							UTERINE ARTERY DOPPLER; VELOCITY WAVE-FORMS; BLOOD-FLOW; RISK-FACTORS; MICROVASCULAR CHARACTERISTICS; HEMODYNAMIC-CHANGES; PREGNANCY; PREECLAMPSIA; WEIGHT; ULTRASOUND	Objective We aimed to study the maternal retinal microvasculature at mid-trimester and its relationship with subsequent fetal growth and birth size. Methods We recruited 732 pregnant women aged 18-46 years in the first trimester with singleton pregnancies. All had retinal photography and fetal scan performed at 26-28 weeks gestation, and subsequent fetal scan at 32-34 weeks gestation. Infant anthropometric measurements were done at birth. Retinal microvasculature was measured using computer software from the retinal photographs. Results In multiple linear regression models, each 10 mu m narrowing in maternal retinal arteriolar caliber was associated with decreases of 1.36 mm in fetal head circumference at 32-34 weeks gestation, as well as decreases of 1.50 mm and 2.30 mm in infant head circumference and birth length at delivery, respectively. Each standard deviation decrease in maternal retinal arteriolar fractal dimension was associated with decreases of 1.55 mm in fetal head circumference at 32-34 weeks gestation, as well as decreases of 1.08 mm and 46.42 g in infant head circumference and birth weight at delivery, respectively. Conclusions Narrower retinal arteriolar caliber and a sparser retinal vascular network in mothers, reflecting a suboptimal uteroplacental microvasculature during mid-pregnancy, were associated with poorer fetal growth and birth size.	[Li, Ling-Jun; Cheung, Carol Yim-Lui; Ikram, M. Kamran; Saw, Seang-Mei; Wong, Tien-Yin] Singapore Eye Res Inst, Singapore Natl Eye Ctr, Singapore, Singapore; [Aris, Izzuddin; Lee, Yung Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 117548, Singapore; [Su, Lin Lin; Tint, Mya Thway; Chong, Yap-Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynecol, Singapore 117548, Singapore; [Cheung, Carol Yim-Lui] DUKE NUS Grad Med Sch, Singapore, Singapore; [Ikram, M. Kamran] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Ikram, M. Kamran] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Ikram, M. Kamran] Natl Univ Hlth Syst, Memory Aging & Cognit Ctr, Singapore, Singapore; [Gluckman, Peter; Lee, Yung Seng] Singapore Inst Clin Sci, Agcy Sci Technol & Res, Singapore, Singapore; [Godfrey, Keith M.] Univ Southampton, Biomed Res Ctr, Med Res Council Lifecourse Epidemiol Unit, Southampton, Hants, England; [Godfrey, Keith M.] Univ Southampton, Biomed Res Ctr, NIHR Southampton, Southampton, Hants, England; [Tan, Kok Hian; Yeo, George; Yap, Fabian; Kwek, Kenneth] KK Womens & Childrens Hosp, Singapore, Singapore; [Saw, Seang-Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Wong, Tien-Yin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117548, Singapore	National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Southampton; University of Southampton; KK Women's & Children's Hospital; National University of Singapore; National University of Singapore	Wong, TY (corresponding author), Singapore Eye Res Inst, Singapore Natl Eye Ctr, Singapore, Singapore.	wong.tien.yin@snec.com.sg; yung_seng_lee@nuhs.edu.sg	Tint, Mya-Thway/HGU-1202-2022; Aris, Izzuddin/C-1855-2017; Lee, Yung Seng/F-2169-2014; Wong, Tien Yin/AAC-9724-2020; Cheung, Carol Y./G-7895-2016; Cheung, Carol/AAF-1101-2020; Tan, Kok Hian/AFS-6514-2022	Aris, Izzuddin/0000-0002-9239-7476; Lee, Yung Seng/0000-0002-1253-0557; Wong, Tien Yin/0000-0002-8448-1264; Cheung, Carol/0000-0002-9672-1819; Godfrey, Keith/0000-0002-4643-0618; Ikram, Mohammad Kamran/0000-0003-0173-9571; Yap, Fabian/0000-0003-1083-7958; Tan, Kok Hian/0000-0003-1945-0266; Cheung, Carol/0000-0003-0869-859X; TINT, Mya Thway/0000-0002-9548-7186; Chong, Yap Seng/0000-0002-7232-8473	National Research Foundation (NRF) [NMRC/TCR/004-NUS/2008]; MRC [MC_UU_12011/4, MC_UP_A620_1017] Funding Source: UKRI; Medical Research Council [MC_UU_12011/4, MC_UP_A620_1017] Funding Source: researchfish	National Research Foundation (NRF); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is under the Translational Clinical Research (TCR) Flagship Program on Developmental Pathways to Metabolic Disease, NMRC/TCR/004-NUS/2008 funded by the National Research Foundation (NRF) and administered by the National Medical Research Council (NMRC), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaiges G, 2003, ULTRASOUND OBST GYN, V21, P170, DOI 10.1002/uog.30; Amit A, 1998, ULTRASOUND OBST GYN, V11, P94, DOI 10.1046/j.1469-0705.1998.11020094.x; Aris IM, 2014, J CLIN ENDOCR METAB, V99, P240, DOI 10.1210/jc.2013-2738; Baykal Cem, 2004, Archives of Gynecology and Obstetrics, V270, P99; Belkacemi L, 2010, BIOL REPROD, V83, P325, DOI 10.1095/biolreprod.110.084517; BOWER S, 1993, BRIT J OBSTET GYNAEC, V100, P989, DOI 10.1111/j.1471-0528.1993.tb15139.x; CHANDLER KD, 1985, BRIT J NUTR, V53, P625, DOI 10.1079/BJN19850072; CHANG TC, 1993, J CLIN ULTRASOUND, V21, P515, DOI 10.1002/jcu.1870210808; Chapman AB, 1997, AM J PHYSIOL-RENAL, V273, pF777, DOI 10.1152/ajprenal.1997.273.5.F777; Cheung CY, 2012, AM J OPHTHALMOL, V154, P663, DOI 10.1016/j.ajo.2012.04.016; Cheung CY, 2011, J HYPERTENS, V29, P1380, DOI 10.1097/HJH.0b013e328347266c; Daien V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071089; Daien V, 2013, ACTA OPHTHALMOL, V91, pE283, DOI 10.1111/aos.12094; Deloison B, 2012, BJOG-INT J OBSTET GY, V119, P626, DOI 10.1111/j.1471-0528.2011.03251.x; Dudley NJ, 2005, ULTRASOUND OBST GYN, V25, P80, DOI 10.1002/uog.1751; Duvekot J J, 1994, Obstet Gynecol Surv, V49, pS1, DOI 10.1097/00006254-199412011-00001; El Assaad MA, 2002, BLOOD PRESS MONIT, V7, P237, DOI 10.1097/00126097-200208000-00006; Filly RA, 2000, ULTRASONOGRAPHY OBST, P146; Grab D, 2000, ULTRASOUND OBST GYN, V15, P19, DOI 10.1046/j.1469-0705.2000.00009.x; Greiss FC, 2008, UTERINE PLACENTAL BL, P1756; Gull I, 2002, ULTRASOUND OBST GYN, V20, P57, DOI 10.1046/j.1469-0705.2002.00742.x; HADLOCK FP, 1982, AM J ROENTGENOL, V138, P649, DOI 10.2214/ajr.138.4.649; HENDRICKS SK, 1989, AM J OBSTET GYNECOL, V161, P761, DOI 10.1016/0002-9378(89)90397-9; Heringa SM, 2013, J CEREBR BLOOD F MET, V33, P983, DOI 10.1038/jcbfm.2013.58; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Irion O, 1998, BRIT J OBSTET GYNAEC, V105, P422, DOI 10.1111/j.1471-0528.1998.tb10128.x; JACKSON MR, 1995, AM J OBSTET GYNECOL, V172, P518, DOI 10.1016/0002-9378(95)90566-9; Khan F, 2005, HYPERTENSION, V46, P1123, DOI 10.1161/01.HYP.0000186328.90667.95; Khan F, 2010, MICROCIRCULATION, V17, P608, DOI 10.1111/j.1549-8719.2010.00055.x; Kliman HJ, 2000, AM J PATHOL, V157, P1759, DOI 10.1016/S0002-9440(10)64813-4; Li LJ, 2012, OBSTET GYNECOL, V120, P627, DOI 10.1097/AOG.0b013e3182639577; Li LJ, 2012, HYPERTENSION, V60, P223, DOI 10.1161/HYPERTENSIONAHA.112.195404; Liew G, 2006, HYPERTENSION, V48, pE10, DOI 10.1161/01.HYP.0000231652.97173.4c; Liew G, 2008, CIRC-CARDIOVASC IMAG, V1, P156, DOI 10.1161/CIRCIMAGING.108.784876; Lupton SJ, 2013, HYPERTENSION, V62, P899, DOI 10.1161/HYPERTENSIONAHA.113.01890; Luther Justin S, 2005, Hum Fertil (Camb), V8, P179, DOI 10.1080/14647270500320121; MAINSTER MA, 1990, EYE, V4, P235, DOI 10.1038/eye.1990.33; Melchiorre K, 2009, ULTRASOUND OBST GYN, V33, P524, DOI 10.1002/uog.6368; METCALFE J, 1974, Progress in Cardiovascular Diseases, V16, P363, DOI 10.1016/0033-0620(74)90028-0; Neri I, 1996, ACTA OBSTET GYN SCAN, V75, P208, DOI 10.3109/00016349609047088; NORTH RA, 1994, OBSTET GYNECOL, V83, P378; NOVY MJ, 1975, AM J OBSTET GYNECOL, V122, P419, DOI 10.1016/S0002-9378(16)33533-5; Papageorghiou AT, 2001, ULTRASOUND OBST GYN, V18, P441, DOI 10.1046/j.0960-7692.2001.00572.x; Pardi G, 2006, AM J OBSTET GYNECOL, V194, P1088, DOI 10.1016/j.ajog.2005.12.056; Patton N, 2006, PROG RETIN EYE RES, V25, P99, DOI 10.1016/j.preteyeres.2005.07.001; PHIPPARD AF, 1986, J HYPERTENS, V4, P773, DOI 10.1097/00004872-198612000-00013; Predanic M, 2002, J ULTRAS MED, V21, P495, DOI 10.7863/jum.2002.21.5.495; Regnault TRH, 2002, PLACENTA, V23, pS119, DOI 10.1053/plac.2002.0792; Reynolds LP, 2005, PLACENTA, V26, P689, DOI 10.1016/j.placenta.2004.11.010; Shalev I, 2013, PSYCHOL SCI, V24, P1198, DOI 10.1177/0956797612470959; SHEPARD MJ, 1982, AM J OBSTET GYNECOL, V142, P47; Sibai BM, 1998, NEW ENGL J MED, V339, P667, DOI 10.1056/NEJM199809033391004; Soh SE, 2013, INT J EPIDEMIOL; Stosic T, 2006, IEEE T MED IMAGING, V25, P1101, DOI 10.1109/TMI.2006.879316; Sun C, 2009, SURV OPHTHALMOL, V54, P74, DOI 10.1016/j.survophthal.2008.10.003; Thornburg KL, 2000, SEMIN PERINATOL, V24, P11, DOI 10.1016/S0146-0005(00)80047-6; UELAND K, 1976, AM J OBSTET GYNECOL, V126, P671, DOI 10.1016/0002-9378(76)90517-2; VINTZILEOS AM, 1984, OBSTET GYNECOL, V64, P779; Wallace JM, 2002, AM J PHYSIOL-REG I, V282, pR1027, DOI 10.1152/ajpregu.00465.2001; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; ZAMIR M, 1976, J THEOR BIOL, V62, P227, DOI 10.1016/0022-5193(76)90058-8	61	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0118250	10.1371/journal.pone.0118250	http://dx.doi.org/10.1371/journal.pone.0118250			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909909	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000353376800003
J	Takagishi, T; Oda, M; Kabura, M; Kurosawa, M; Tominaga, K; Urano, S; Ueda, Y; Kobayashi, K; Kobayashi, T; Sakurai, J; Terao, Y; Nagahama, M				Takagishi, Teruhisa; Oda, Masataka; Kabura, Michiko; Kurosawa, Mie; Tominaga, Kaori; Urano, Shiori; Ueda, Yoshibumi; Kobayashi, Keiko; Kobayashi, Toshihide; Sakurai, Jun; Terao, Yutaka; Nagahama, Masahiro			Clostridium perfringens Alpha-Toxin Induces Gm1a Clustering and Trka Phosphorylation in the Host Cell Membrane	PLOS ONE			English	Article							PROTEIN-KINASE-C; PHOSPHOLIPASE-C; TRANSBILAYER MOVEMENT; LEUKOCYTE ADHERENCE; DIACYLGLYCEROL; METABOLISM; PATHOGENESIS; ACTIVATION; HEMOLYSIS; CERAMIDE	Clostridium perfringens alpha-toxin elicits various immune responses such as the release of cytokines, chemokines, and superoxide via the GM1a/TrkA complex. Alpha-toxin possesses phospholipase C (PLC) hydrolytic activity that contributes to signal transduction in the pathogenesis of gas gangrene. Little is known about the relationship between lipid metabolism and TrkA activation by alpha-toxin. Using live-cell fluorescence microscopy, we monitored transbilayer movement of diacylglycerol (DAG) with the yellow fluorescent protein-tagged C1AB domain of protein kinase C-gamma (EYFP-C1AB). DAG accumulated at the marginal region of the plasma membrane in alpha toxin-treated A549 cells, which also exhibited GM1a clustering and TrkA phosphorylation. Annexin V binding assays showed that alpha-toxin induced the exposure of phosphatidylserine on the outer leaflet of the plasma membrane. However, H148G, a variant toxin which binds cell membrane and has no enzymatic activity, did not induce DAG translocation, GM1a clustering, or TrkA phosphorylation. Alpha-toxin also specifically activated endogenous phospholipase C gamma-1 (PLC gamma-1), a TrkA adaptor protein, via phosphorylation. U73122, an endogenous PLC inhibitor, and siRNA for PLC gamma-1 inhibited the formation of DAG and release of IL-8. GM1a accumulation and TrkA phosphorylation in A549 cells treated with alpha-toxin were also inhibited by U73122. These results suggest that the flip-flop motion of hydrophobic lipids such as DAG leads to the accumulation of GM1a and TrkA. We conclude that the formation of DAG by alpha-toxin itself (first step) and activation of endogenous PLC gamma-1 (second step) leads to alterations in membrane dynamics, followed by strong phosphorylation of TrkA.	[Takagishi, Teruhisa; Oda, Masataka; Kabura, Michiko; Tominaga, Kaori; Urano, Shiori; Kobayashi, Keiko; Sakurai, Jun; Nagahama, Masahiro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Tokushima 7708514, Japan; [Oda, Masataka; Kurosawa, Mie; Terao, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Div Microbiol & Infect Dis, Chuo Ku, Niigata 25274, Japan; [Ueda, Yoshibumi] Kanazawa Med Univ, Hematol & Immunol, Uchinada, Ishikawa 9200293, Japan; [Kobayashi, Toshihide] RIKEN, Rikagaku Kenkyujo, Lipid Biol Lab, Wako, Saitama 3510198, Japan	Tokushima Bunri University; Niigata University; Kanazawa Medical University; RIKEN	Oda, M (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Yamashiro Cho 180, Tokushima 7708514, Japan.	masataka@dent.niigata-u.ac.jp	Oda, Masataka/ABG-6047-2020; KOBAYASHI, TOSHIHIDE/S-8313-2019; Ueda, Yoshibumi/AHA-4956-2022	KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Ueda, Yoshibumi/0000-0003-1500-3469; Terao, Yutaka/0000-0002-4450-5583	JSPS KAKENHI Grant [24590542]; Takeda Science Foundation	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This research was supported by JSPS KAKENHI Grant Number 24590542 and the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN D, 1978, NATURE, V276, P289, DOI 10.1038/276289a0; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Bryant AE, 1996, INFECT IMMUN, V64, P358, DOI 10.1128/IAI.64.1.358-362.1996; Bryant AE, 2012, EXPERT REV ANTI-INFE, V10, P1, DOI [10.1586/ERI.11.147, 10.1586/eri.11.147]; Bunting M, 1997, J CLIN INVEST, V100, P565, DOI 10.1172/JCI119566; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; CARVETH HJ, 1989, BIOCHEM BIOPH RES CO, V162, P387, DOI 10.1016/0006-291X(89)92009-3; Contreras FX, 2010, FEBS LETT, V584, P1779, DOI 10.1016/j.febslet.2009.12.049; Contreras F. -Xabier, 2009, V462, P155, DOI 10.1007/978-1-60327-115-8_10; Flores-Diaz M, 2003, TOXICON, V42, P979, DOI 10.1016/j.toxicon.2003.11.013; Goni FM, 2006, BBA-BIOMEMBRANES, V1758, P1902, DOI 10.1016/j.bbamem.2006.09.011; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; HAMILTON JA, 1991, J BIOL CHEM, V266, P1177; Ichikawa N, 2009, J CELL SCI, V122, P289, DOI 10.1242/jcs.030338; Lattanzio Rossano, 2013, Advances in Biological Regulation, V53, P309, DOI 10.1016/j.jbior.2013.07.006; Monturiol-Gross L, 2014, CELL MICROBIOL, V16, P535, DOI 10.1111/cmi.12237; Monturiol-Gross L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086475; Mukaida N, 2003, AM J PHYSIOL-LUNG C, V284, pL566, DOI 10.1152/ajplung.00233.2002; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; NAGAHAMA M, 1995, J BACTERIOL, V177, P1179, DOI 10.1128/jb.177.5.1179-1185.1995; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; OBERMEIER A, 1993, EMBO J, V12, P933, DOI 10.1002/j.1460-2075.1993.tb05734.x; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; Ochi S, 2004, J BIOL CHEM, V279, P12181, DOI 10.1074/jbc.M307046200; Ochi S, 2002, MICROBIOL-SGM, V148, P237, DOI 10.1099/00221287-148-1-237; Ochi S, 1996, INFECT IMMUN, V64, P3930, DOI 10.1128/IAI.64.9.3930-3933.1996; Oda M, 2006, INFECT IMMUN, V74, P2876, DOI 10.1128/IAI.74.5.2876-2886.2006; Oda M, 2008, J PHARMACOL EXP THER, V327, P934, DOI 10.1124/jpet.108.143677; Oda M, 2008, J LIPID RES, V49, P1039, DOI 10.1194/jlr.M700587-JLR200; Oda M, 2012, J BIOL CHEM, V287, P33070, DOI 10.1074/jbc.M112.393801; Oda M, 2012, BBA-MOL BASIS DIS, V1822, P1581, DOI 10.1016/j.bbadis.2012.06.007; Oda M, 2011, BIOCHEM BIOPH RES CO, V411, P241, DOI 10.1016/j.bbrc.2011.06.103; Ogushi F, 2012, CHEM PHYS LETT, V522, P96, DOI 10.1016/j.cplett.2011.11.057; PAGANO RE, 1985, J BIOL CHEM, V260, P1909; Sakurai J, 2004, J BIOCHEM, V136, P569, DOI 10.1093/jb/mvh161; SAKURAI J, 1994, INFECT IMMUN, V62, P717, DOI 10.1128/IAI.62.2.717-721.1994; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Songer JG, 1997, TRENDS MICROBIOL, V5, P156, DOI 10.1016/S0966-842X(97)01005-6; Stevens DL, 2012, ANAEROBE, V18, P254, DOI 10.1016/j.anaerobe.2011.11.001; Stevens DL, 1997, CLIN INFECT DIS, V25, pS160, DOI 10.1086/516249; Stonehouse MJ, 2002, MOL MICROBIOL, V46, P661, DOI 10.1046/j.1365-2958.2002.03194.x; TITBALL RW, 1993, FEMS MICROBIOL LETT, V110, P45, DOI 10.1016/0378-1097(93)90240-3; Titball RW, 1997, TRENDS MICROBIOL, V5, P265, DOI 10.1016/S0966-842X(97)88834-8; Ueda Y, 2013, FASEB J, V27, P3284, DOI 10.1096/fj.12-226548; Urbina P, 2011, BBA-BIOMEMBRANES, V1808, P2618, DOI 10.1016/j.bbamem.2011.06.008; Urbina P, 2011, BBA-BIOMEMBRANES, V1808, P279, DOI 10.1016/j.bbamem.2010.08.011; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001	50	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0120497	10.1371/journal.pone.0120497	http://dx.doi.org/10.1371/journal.pone.0120497			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910247	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800009
J	Tian, FX; Zang, JL; Wang, T; Xie, YL; Zhang, J; Hu, JJ				Tian, Feng-Xia; Zang, Jian-Lei; Wang, Tan; Xie, Yu-Li; Zhang, Jin; Hu, Jian-Jun			Aldehyde Dehydrogenase Gene Superfamily in Populus: Organization and Expression Divergence between Paralogous Gene Pairs	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; ARABIDOPSIS-THALIANA; COMPREHENSIVE ANALYSIS; TOBACCO PLANTS; STRESS; RICE; EVOLUTIONARY; POPLAR; FAMILY; TOLERANCE	Aldehyde dehydrogenases (ALDHs) constitute a superfamily of NAD(P)+-dependent enzymes that catalyze the irreversible oxidation of a wide range of reactive aldehydes to their corresponding nontoxic carboxylic acids. ALDHs have been studied in many organisms from bacteria to mammals; however, no systematic analyses incorporating genome organization, gene structure, expression profiles, and cis-acting elements have been conducted in the model tree species Populus trichocarpa thus far. In this study, a comprehensive analysis of the Populus ALDH gene superfamily was performed. A total of 26 Populus ALDH genes were found to be distributed across 12 chromosomes. Genomic organization analysis indicated that purifying selection may have played a pivotal role in the retention and maintenance of PtALDH gene families. The exon-intron organizations of PtALDHs were highly conserved within the same family, suggesting that the members of the same family also may have conserved functionalities. Microarray data and qRT-PCR analysis indicated that most PtALDHs had distinct tissue-specific expression patterns. The specificity of cis-acting elements in the promoter regions of the PtALDHs and the divergence of expression patterns between nine paralogous PtALDH gene pairs suggested that gene duplications may have freed the duplicate genes from the functional constraints. The expression levels of some ALDHs were up-or down-regulated by various abiotic stresses, implying that the products of these genes may be involved in the adaptation of Populus to abiotic stresses. Overall, the data obtained from our investigation contribute to a better understanding of the complexity of the Populus ALDH gene superfamily and provide insights into the function and evolution of ALDH gene families in vascular plants.	[Tian, Feng-Xia; Zang, Jian-Lei; Wang, Tan; Xie, Yu-Li] Nanyang Normal Univ, Coll Life Sci & Technol, Nanyang 473061, Henan, Peoples R China; [Tian, Feng-Xia; Zang, Jian-Lei; Wang, Tan; Xie, Yu-Li; Zhang, Jin; Hu, Jian-Jun] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat State Forestry A, Beijing 100091, Peoples R China; [Zhang, Jin] Chinese Acad Forestry, Res Inst Wood Ind, Beijing 100091, Peoples R China	Nanyang Normal College; Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Chinese Academy of Forestry; Research Institute of Wood Industry, CAF	Zhang, J (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat State Forestry A, Beijing 100091, Peoples R China.	Zhang007jin@163.com; Hujj@caf.ac.cn	Zhang, Jin/J-9618-2019	Zhang, Jin/0000-0002-8397-5078	National Nonprofit Institute Research Grant of CAF [CAFYBB2014ZX001-4, TGB2013009]; China Postdoctoral Science Foundation [2014M550104]	National Nonprofit Institute Research Grant of CAF; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Nonprofit Institute Research Grant of CAF [CAFYBB2014ZX001-4] and [TGB2013009] to JJH and the China Postdoctoral Science Foundation [2014M550104] to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Bartels D, 2001, TRENDS PLANT SCI, V6, P284, DOI 10.1016/S1360-1385(01)01983-5; Bosch M, 2011, J EXP BOT, V62, P3545, DOI 10.1093/jxb/err045; Brocker C, 2013, PLANTA, V237, P189, DOI 10.1007/s00425-012-1749-0; Brunner AM, 2004, TRENDS PLANT SCI, V9, P49, DOI 10.1016/j.tplants.2003.11.006; Chai GH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-253; Dharmawardhana P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-150; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Gao CX, 2009, GENE, V431, P86, DOI 10.1016/j.gene.2008.11.010; GarciaRios M, 1997, P NATL ACAD SCI USA, V94, P8249, DOI 10.1073/pnas.94.15.8249; Guillaumie S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-71; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Hofberger JA, 2015, GENOME BIOL EVOL; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Huang WZ, 2008, PLANT MOL BIOL, V68, P451, DOI 10.1007/s11103-008-9382-9; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Jimenez-Lopez JC, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-43; Kirch HH, 2005, PLANT MOL BIOL, V57, P315, DOI 10.1007/s11103-004-7796-6; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kotchoni S, 2003, BULG J PLANT PHYSL S, V2003, P37; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; Kreuzwieser J, 2009, PLANT PHYSIOL, V149, P461, DOI 10.1104/pp.108.125989; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lan T, 2009, PLANT CELL, V21, P3749, DOI 10.1105/tpc.109.070219; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Li XQ, 2013, PLANT PHYSIOL BIOCH, V71, P268, DOI 10.1016/j.plaphy.2013.07.017; LINDAHL R, 1992, CRIT REV BIOCHEM MOL, V27, P283, DOI 10.3109/10409239209082565; Liu F, 2002, PLANT PHYSIOL, V130, P1657, DOI 10.1104/pp.012336; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Moore RC, 2005, CURR OPIN PLANT BIOL, V8, P122, DOI 10.1016/j.pbi.2004.12.001; Nair RB, 2004, PLANT CELL, V16, P544, DOI 10.1105/tpc.017509; Nuruzzaman M, 2012, BIOCHEM BIOPH RES CO, V423, P417, DOI 10.1016/j.bbrc.2012.05.142; Ohno S., 1970, P1; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Rodrigues SM, 2006, J EXP BOT, V57, P1909, DOI 10.1093/jxb/erj132; Roth C, 2007, J EXP ZOOL PART B, V308B, P58, DOI 10.1002/jez.b.21124; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shin JH, 2009, PLANT PHYSIOL, V149, P905, DOI 10.1104/pp.108.130716; Skibbe David S., 2002, Plant Molecular Biology, V48, P751, DOI 10.1023/A:1014870429630; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; Sterck L, 2005, NEW PHYTOL, V167, P165, DOI 10.1111/j.1469-8137.2005.01378.x; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsuji H, 2003, GENE, V305, P195, DOI 10.1016/S0378-1119(03)00383-4; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vandepoele K, 2003, PLANT CELL, V15, P2192, DOI 10.1105/tpc.014019; Vasiliou V, 1999, PHARMACOGENETICS, V9, P421, DOI 10.1097/00008571-199910000-00004; Vasiliou V, 2000, CHEM-BIOL INTERACT, V129, P1, DOI 10.1016/S0009-2797(00)00211-8; Walsh B, 2003, GENETICA, V118, P279, DOI 10.1023/A:1024194802441; Weston DJ, 2011, PLANT CELL ENVIRON, V34, P1488, DOI 10.1111/j.1365-3040.2011.02347.x; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Wood AJ, 2009, BRYOLOGIST, V112, P1, DOI 10.1639/0007-2745-112.1.1; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; Zhang JL, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1555-8; Zhou ML, 2012, FUNCT INTEGR GENOMIC, V12, P683, DOI 10.1007/s10142-012-0290-3	63	16	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124669	10.1371/journal.pone.0124669	http://dx.doi.org/10.1371/journal.pone.0124669			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909656	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800099
J	Pukazhenthi, BS; Nagashima, J; Travis, AJ; Costa, GM; Escobar, EN; Franca, LR; Wildt, DE				Pukazhenthi, Budhan S.; Nagashima, Jennifer; Travis, Alexander J.; Costa, Guilherme M.; Escobar, Enrique N.; Franca, Luiz R.; Wildt, David E.			Slow Freezing, but Not Vitrification Supports Complete Spermatogenesis in Cryopreserved, Neonatal Sheep Testicular Xenografts	PLOS ONE			English	Article							TESTIS TISSUE; RECIPIENT MICE; SPERMATOGONIAL SURVIVAL; GENETIC MATERIAL; GONADAL TISSUES; MOUSE TESTES; SPERM; PORCINE; CELLS; TRANSPLANTATION	The ability to spur growth of early stage gametic cells recovered from neonates could lead to significant advances in rescuing the genomes of rare genotypes or endangered species that die unexpectedly. The purpose of this study was to determine, for the first time, the ability of two substantially different cryopreservation approaches, slow freezing versus vitrification, to preserve testicular tissue of the neonatal sheep and subsequently allow initiation of spermatogenesis post-xenografting. Testis tissue from four lambs (3-5 wk old) was processed and then untreated or subjected to slow freezing or vitrification. Tissue pieces (fresh, n = 214; slow freezing, then thawing, n = 196; vitrification, then warming, n = 139) were placed subcutaneously under the dorsal skin of SCID mice and then grafts recovered and evaluated 17 wk later. Grafts from fresh and slow frozen tissue contained the most advanced stages of spermatogenesis, including normal tubule architecture with elongating spermatids in similar to 1% (fresh) and similar to 10% (slow frozen) of tubules. Fewer than 2% of seminiferous tubules advanced to the primary spermatocyte stage in xenografts derived from vitrified tissue. Results demonstrate that slow freezing of neonatal lamb testes was far superior to vitrification in preserving cellular integrity and function after xenografting, including allowing similar to 10% of tubules to retain the capacity to resume spermatogenesis and yield mature spermatozoa. Although a first for any ruminant species, findings also illustrate the importance of preemptive studies that examine cryo-sensitivity of testicular tissue before attempting this type of male fertility preservation on a large scale.	[Pukazhenthi, Budhan S.; Nagashima, Jennifer; Wildt, David E.] Ctr Species Survival, Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA; [Nagashima, Jennifer; Travis, Alexander J.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Travis, Alexander J.] Cornell Univ, Atkinson Ctr Sustainable Future, Ithaca, NY USA; [Costa, Guilherme M.] Univ Fed Minas Gerais, Dept Morphol, Lab Cellular Biol, Belo Horizonte, MG, Brazil; [Escobar, Enrique N.] Univ Maryland Eastern Shore, Dept Agr Food & Resource Sci, Sch Agr & Nat Sci, Princess Anne, MD USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Cornell University; Cornell University; Universidade Federal de Minas Gerais; University System of Maryland; University of Maryland Eastern Shore	Pukazhenthi, BS (corresponding author), Ctr Species Survival, Smithsonian Conservat Biol Inst, Natl Zool Pk, Front Royal, VA 22630 USA.	pukazhenthib@si.edu	Mattos Jardim Costa, Guilherme/A-7369-2016; DE FRANCA, LUIZ/AAA-6923-2021	Mattos Jardim Costa, Guilherme/0000-0002-2907-7760; Pukazhenthi, Budhan/0000-0003-4657-2023; Nagashima, Jennifer/0000-0001-6189-0914	Sichel Endowment Fund	Sichel Endowment Fund	This study was supported with funding from the Sichel Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi S, 2012, ANIM REPROD SCI, V135, P47, DOI 10.1016/j.anireprosci.2012.09.007; Abbasi S, 2011, THERIOGENOLOGY, V76, P607, DOI 10.1016/j.theriogenology.2011.03.011; Abbasi S, 2010, REPROD FERT DEVELOP, V22, P1279, DOI 10.1071/RD10084; Abrishami M, 2010, THERIOGENOLOGY, V73, P86, DOI 10.1016/j.theriogenology.2009.08.004; Campos PHA, 2014, REPRODUCTION, V147, P291, DOI 10.1530/REP-13-0581; Arregui L, 2008, REPRODUCTION, V136, P85, DOI 10.1530/REP-07-0433; Arregui L, 2008, ANIM REPROD SCI, V106, P65, DOI 10.1016/j.anireprosci.2007.03.026; Arregui L, 2014, REPROD FERT DEVELOP, V26, P817, DOI 10.1071/RD12411; Baert Y, 2012, FERTIL STERIL, V97, P1152, DOI 10.1016/j.fertnstert.2012.02.010; Caires KC, 2008, REPROD DOMEST ANIM, V43, P280, DOI 10.1111/j.1439-0531.2008.01175.x; Comizzoli P, 2012, THERIOGENOLOGY, V78, P1666, DOI 10.1016/j.theriogenology.2012.04.008; Comizzoli P, 2014, ADV EXP MED BIOL, V753, P331, DOI 10.1007/978-1-4939-0820-2_14; Comizzoli P, 2014, REPROD FERT DEVELOP, V26, P91, DOI 10.1071/RD13259; FAHY GM, 1984, CRYOBIOLOGY, V21, P407, DOI 10.1016/0011-2240(84)90079-8; Frederickx V, 2004, HUM REPROD, V19, P948, DOI 10.1093/humrep/deh154; Gao D, 2000, ILAR J, V41, P187; GARNER DL, 1995, BIOL REPROD, V53, P276, DOI 10.1095/biolreprod53.2.276; Goossens E, 2008, FERTIL STERIL, V89, P725, DOI 10.1016/j.fertnstert.2007.03.044; Gourdon JC, 2011, COMPARATIVE MED, V61, P145; Honaramooz A, 2002, NATURE, V418, P778, DOI 10.1038/nature00918; Honaramooz A, 2004, BIOL REPROD, V70, P1500, DOI 10.1095/biolreprod.103.025536; Honaramooz A., 2005, REPROD FERT DEVELOP, V17, P247, DOI [10.1071/RDV17N2AB193, DOI 10.1071/RDV17N2AB193]; Honaramooz A, 2008, REPROD FERT DEVELOP, V20, P802, DOI 10.1071/RD08093; IUCN, IUCN RED LIST THREAT; Jahnukainen K, 2007, HUM REPROD, V22, P1060, DOI 10.1093/humrep/del471; Kagawa N, 2009, REPROD BIOMED ONLINE, V18, P568, DOI 10.1016/S1472-6483(10)60136-8; Kaneko H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070989; Kaneko H, 2012, THERIOGENOLOGY, V78, P898, DOI 10.1016/j.theriogenology.2012.04.004; Keros V, 2005, HUM REPROD, V20, P1676, DOI 10.1093/humrep/deh797; Keros V, 2007, HUM REPROD, V22, P1384, DOI 10.1093/humrep/del508; Kikuchi K, 2011, ANIM SCI J, V82, P495, DOI 10.1111/j.1740-0929.2011.00919.x; Kim Y, 2007, REPROD FERT DEVELOP, V19, P869, DOI 10.1071/RD07056; Kvist K, 2006, HUM REPROD, V21, P484, DOI 10.1093/humrep/dei331; Lees C. M., 2009, International Zoo Yearbook, V43, P6, DOI 10.1111/j.1748-1090.2008.00066.x; Leibo SP, 2002, THERIOGENOLOGY, V57, P303, DOI 10.1016/S0093-691X(01)00673-2; Leus K.L., 2011, WAZA MAGAZINE, V12, P11; Milazzo JP, 2008, HUM REPROD, V23, P17, DOI 10.1093/humrep/dem355; Mota PC, 2012, THERIOGENOLOGY, V77, P299, DOI 10.1016/j.theriogenology.2011.07.042; Nakai M, 2010, REPRODUCTION, V139, P331, DOI 10.1530/REP-09-0509; Oatley OM, 2004, BIOL REPROD, V71, P494, DOI 10.1095/biolreprod.104.027953; Petrie A., 2012, ADDRA GAZELLE NANGER, P1; Piltz J., 2012, SABLE ANTELOPE HIPPO, P1; Poels J, 2012, THERIOGENOLOGY, V77, P1008, DOI 10.1016/j.theriogenology.2011.10.015; Poels J, 2013, HUM REPROD, V28, P578, DOI 10.1093/humrep/des455; Pope CE, 2000, THERIOGENOLOGY, V53, P163, DOI 10.1016/S0093-691X(99)00249-6; Pothana L, 2015, THERIOGENOLOGY, V83, P625, DOI 10.1016/j.theriogenology.2014.10.028; Pukazhenthi B, 2006, REPROD FERT DEVELOP, V18, P77, DOI 10.1071/RD05117; Pukazhenthi Budhan, 2007, P433; Rathi R, 2005, REPRODUCTION, V130, P923, DOI 10.1530/rep.1.00912; Rathi R, 2006, REPRODUCTION, V131, P1091, DOI 10.1530/rep.1.01101; Rodriguez-Sosa Jose R, 2013, Methods Mol Biol, V927, P489; Rodriguez-Sosa JR, 2012, REPRODUCTION, V144, P37, DOI 10.1530/REP-12-0020; Rodriguez-Sosa JR, 2009, REPRODUCTION, V138, P187, DOI 10.1530/REP-09-0012; Rohrs M, 1990, GRZIMEKS ENCY MAMMAL, V4, P440; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Sato Y, 2010, HUM REPROD, V25, P1113, DOI 10.1093/humrep/deq001; Schlatt S, 2002, REPRODUCTION, V124, P339, DOI 10.1530/rep.0.1240339; Schlatt S, 2003, BIOL REPROD, V68, P2331, DOI 10.1095/biolreprod.102.014894; Schlatt S, 2009, PEDIATR BLOOD CANCER, V53, P274, DOI 10.1002/pbc.22002; Shinohara T, 2002, HUM REPROD, V17, P3039, DOI 10.1093/humrep/17.12.3039; Snedaker AK, 2004, J ANDROL, V25, P926; Song Y, 2007, POULTRY SCI, V86, P1390, DOI 10.1093/ps/86.7.1390; Thuwanut P, 2013, CRYOBIOLOGY, V67, P244, DOI 10.1016/j.cryobiol.2013.07.002; Van Saen D, 2013, REPROD BIOMED ONLINE, V26, P286, DOI 10.1016/j.rbmo.2012.11.013; Wildt DE, 2013, CONNECT MAGAZINE AUG, P10; Wowk B, 2010, CRYOBIOLOGY, V60, P11, DOI 10.1016/j.cryobiol.2009.05.007; Wyns C, 2008, HUM REPROD, V23, P2402, DOI 10.1093/humrep/den272; Wyns C, 2007, HUM REPROD, V22, P1603, DOI 10.1093/humrep/dem062; Yildiz C, 2013, CRYOBIOLOGY, V67, P70, DOI 10.1016/j.cryobiol.2013.05.004; Zeng W, 2009, REPROD FERT DEVELOP, V21, P489, DOI 10.1071/RD08235; Zeng WX, 2006, J ANDROL, V27, P527, DOI 10.2164/jandrol.05143	72	39	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123957	10.1371/journal.pone.0123957	http://dx.doi.org/10.1371/journal.pone.0123957			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923660	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600064
J	Ruggiero, MA; Gordon, DP; Orrell, TM; Bailly, N; Bourgoin, T; Brusca, RC; Cavalier-Smith, T; Guiry, MD; Kirk, PM				Ruggiero, Michael A.; Gordon, Dennis P.; Orrell, Thomas M.; Bailly, Nicolas; Bourgoin, Thierry; Brusca, Richard C.; Cavalier-Smith, Thomas; Guiry, Michael D.; Kirk, Paul M.			A Higher Level Classification of All Living Organisms	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; EVOLUTIONARY HISTORY; ANIMAL BIODIVERSITY; ACANTHOCEPHALA; PHYLOGENOMICS; DIVERSITY; TREE; GNATHOSTOMULIDA; PLATYHELMINTHES; MICROGNATHOZOA	We present a consensus classification of life to embrace the more than 1.6 million species already provided by more than 3,000 taxonomists' expert opinions in a unified and coherent, hierarchically ranked system known as the Catalogue of Life (CoL). The intent of this collaborative effort is to provide a hierarchical classification serving not only the needs of the CoL's database providers but also the diverse public-domain user community, most of whom are familiar with the Linnaean conceptual system of ordering taxon relationships. This classification is neither phylogenetic nor evolutionary but instead represents a consensus view that accommodates taxonomic choices and practical compromises among diverse expert opinions, public usages, and conflicting evidence about the boundaries between taxa and the ranks of major taxa, including kingdoms. Certain key issues, some not fully resolved, are addressed in particular. Beyond its immediate use as a management tool for the CoL and ITIS (Integrated Taxonomic Information System), it is immediately valuable as a reference for taxonomic and biodiversity research, as a tool for societal communication, and as a classificatory "backbone" for biodiversity databases, museum collections, libraries, and textbooks. Such a modern comprehensive hierarchy has not previously existed at this level of specificity.	[Ruggiero, Michael A.; Orrell, Thomas M.] Smithsonian Inst, Natl Museum Nat Hist, Integrated Taxon Informat Syst, Washington, DC 20560 USA; [Gordon, Dennis P.] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Bailly, Nicolas] WorldFish FIN, Los Banos, Philippines; [Bourgoin, Thierry] Univ Paris 04, Inst Systemat, UMR 7205 MNHN CNRS UPMC EPHE, Evolut,Biodiversite ISYEB,Museum Natl Hist Nat, F-75005 Paris, France; [Brusca, Richard C.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Cavalier-Smith, Thomas] Univ Oxford, Dept Zool, Oxford, England; [Guiry, Michael D.] Natl Univ Ireland, Ryan Inst, AlgaeBase Fdn & Irish Seaweed Res Grp, Galway, Ireland; [Kirk, Paul M.] Royal Bot Gardens, Mycol Sect, London, England	Smithsonian Institution; Smithsonian National Museum of Natural History; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; CGIAR; Worldfish; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Arizona; University of Oxford; Ollscoil na Gaillimhe-University of Galway; Royal Botanic Gardens, Kew	Ruggiero, MA (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Integrated Taxon Informat Syst, Washington, DC 20560 USA.	ruggierm@si.edu	Bourgoin, Thierry/L-5146-2019; Orrell, Thomas/R-9460-2017; Bailly, Nicolas/AID-4444-2022; Brusca, Richard/S-1673-2019	Bourgoin, Thierry/0000-0001-9277-2478; Orrell, Thomas/0000-0003-1038-3028; 	Natural Environment Research Council [NE/C510975/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Adrianov AV, 1995, ZOOSYST ROSS, V3, P181; Alrichs WH, 1995, THESIS GEORGE AUGUST; Alrichs WH, 1977, ZOOMORPHOLOGY, V117, P41; [Anonymous], 2013, LPSN LIST PROKARYOTI; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; BREMER K, 1985, Cladistics, V1, P369, DOI 10.1111/j.1096-0031.1985.tb00434.x; Brusca RC, 2003, INVERTEBRATES; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Burki F, 2009, GENOME BIOL EVOL, V1, P231, DOI 10.1093/gbe/evp022; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Cavalier-Smith T, 2000, THE MYCOTA A, VVII; Cavalier-Smith T, 1993, ORIGIN PLATIDS SYMBI; Cavalier-Smith T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016006; Cavalier-Smith T, 2014, MOL PHYLOGENET EVOL, V81, P71, DOI 10.1016/j.ympev.2014.08.012; Cavalier-Smith T, 2013, EUR J PROTISTOL, V49, P115, DOI 10.1016/j.ejop.2012.06.001; Cavalier-Smith T, 2010, PHILOS T R SOC B, V365, P111, DOI 10.1098/rstb.2009.0161; CAVALIERSMITH T, 1981, BIOSYSTEMS, V14, P461, DOI 10.1016/0303-2647(81)90050-2; Chapman A, 2009, NUMBERS LIVING SPECI, P1; Chase MW, 2009, BOT J LINN SOC, V161, P122, DOI 10.1111/j.1095-8339.2009.01002.x; David J, 2012, ZOOKEYS, P67, DOI 10.3897/zookeys.192.3347; De Smet WH, 2002, J ZOOL, V258, P381, DOI 10.1017/S095283690200153X; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Edgecombe GD, 2011, ORG DIVERS EVOL, V11, P151, DOI 10.1007/s13127-011-0044-4; Egger B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005502; Garcia-Varela M, 2006, MOL PHYLOGENET EVOL, V40, P61, DOI 10.1016/j.ympev.2006.02.010; Garey JR, 1996, J MOL EVOL, V43, P287, DOI 10.1007/BF02338837; Garrity GM, 2007, TAXONOMIC OUTLINE BA; Gazave E, 2012, HYDROBIOLOGIA, V687, P3, DOI 10.1007/s10750-011-0842-x; Gazi M, 2012, PARASITOL INT, V61, P307, DOI 10.1016/j.parint.2011.12.001; Giribet G, 2004, CLADISTICS, V20, P1, DOI 10.1111/j.1096-0031.2004.00004.x; Giribet G, 2002, MOL SYSTEMATICS EVOL; Giribet G, 2007, ZOOTAXA, P61, DOI 10.11646/zootaxa.1668.1.8; Gordon D., 2009, NZ INVENTORY BIODIVE, V1; Gordon DP, 2010, NZ INVENTORY BIODIVE, V2; Gordon DP, 2012, NZ INVENTORY BIODIVE; Gruhl A, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-10; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Hausdorf B, 2007, MOL BIOL EVOL, V24, P2723, DOI 10.1093/molbev/msm214; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Hennig W., 1966, P263; Hooper JNA, 2002, SYSTEMA PORIFERA GUI; James TY, 2013, CURR BIOL, V23, P1548, DOI 10.1016/j.cub.2013.06.057; JEFFREY C, 1971, Kew Bulletin, V25, P291, DOI 10.2307/4103226; Jenner RA, 2004, CONTRIB ZOOL, V73, P3, DOI 10.1163/18759866-0730102001; Jimenez-Guri E, 2007, SCIENCE, V317, P116, DOI 10.1126/science.1142024; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kirk P., 2008, Ainsworth and Bisby�s Dictionary of the Fungi, DOI 10.1079/9780851998268.0000; Kristensen RM, 2000, J MORPHOL, V246, P1; Lane CE, 2008, TRENDS ECOL EVOL, V23, P268, DOI 10.1016/j.tree.2008.02.004; Lemburg Christian, 1995, Microfauna Marina, V10, P7; Linnaeus C, 1753, SPECIES PLATARUM EXH; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Mabberley D. J., 2008, MABBERLEYS PLANT BOO; Mallatt J, 2002, MOL BIOL EVOL, V19, P289, DOI 10.1093/oxfordjournals.molbev.a004082; Mallatt J, 2007, MOL PHYLOGENET EVOL, V43, P1005, DOI 10.1016/j.ympev.2006.11.023; Mallatt J, 2010, MOL PHYLOGENET EVOL, V55, P1, DOI 10.1016/j.ympev.2009.09.028; Margulis L, 2001, 5 KINGDOMS ILLUSTRAT; Mayr E, 2002, J ZOOL SYST EVOL RES, V40, P169, DOI 10.1046/j.1439-0469.2002.00211.x; MAYR E., 1991, PRINCIPLES SYSTEMATI, V2nd; Monks S, 2001, SYST PARASITOL, V48, P81, DOI 10.1023/A:1006400207434; Monks Scott, 2011, Zootaxa, V3148, P234; Neuhaus B, 2002, INTEGR COMP BIOL, V42, P619, DOI 10.1093/icb/42.3.619; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Nielsen C, 2008, EVOL DEV, V10, P241, DOI 10.1111/j.1525-142X.2008.00231.x; Paps J, 2009, P ROY SOC B-BIOL SCI, V276, P1245, DOI 10.1098/rspb.2008.1574; Parfrey LW, 2006, PLOS GENET, V2, P2062, DOI 10.1371/journal.pgen.0020220; Parker SP, 1982, SYNOPSIS CLASSIFICAT; Parker SP, 1982, SYNOPSIS CLASSIFICAT, V2; Parte AC, 2014, NUCLEIC ACIDS RES, V42, pD613, DOI 10.1093/nar/gkt1111; Philippe H, 2006, TRENDS ECOL EVOL, V21, P614, DOI 10.1016/j.tree.2006.08.004; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; RIEGER RM, 1995, INVERTEBR BIOL, V114, P186, DOI 10.2307/3226891; Riutort M, 2012, INT J DEV BIOL, V56, P5, DOI 10.1387/ijdb.113441mr; Roskov Y., 2014, SPECIES 2000 ITIS CA; Ruppert EE, 1994, INVERTEBRATE ZOOLOGY; Schmidt-Lebuhn AN, 2014, CLADISTICS, V30, P229, DOI 10.1111/cla.12037; Segers H, 1998, J ZOOL, V244, P201, DOI 10.1111/j.1469-7998.1998.tb00025.x; Segers Hendrik, 2011, Zootaxa, V3148, P231; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; Sorensen MV, 2003, J MORPHOL, V255, P131, DOI 10.1002/jmor.10038; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Stech M, 2008, NOVA HEDWIGIA, V86, P1, DOI 10.1127/0029-5035/2008/0086-0001; Stevens PF, 2014, ANGIOSPERM HYLOGENY; Stuessy TF, 2014, CLADISTICS, V30, P291, DOI 10.1111/cla.12038; Tyler S, 2014, TURBELLARIAN TAXONOM; Tyler Seth, 2011, Zootaxa, V3148, P24; Vences M, 2013, ZOOTAXA, V3636, P201, DOI 10.11646/zootaxa.3636.2.1; Villarreal JC, 2010, PHYTOTAXA, V9, P150; Witek A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-345; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Zhang KY, 2008, ENTOMOL SCI, V11, P269, DOI 10.1111/j.1479-8298.2008.00271.x; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zhang ZQ, 2013, ZOOTAXA, V3703, P5; Zrzavy J, 1998, CLADISTICS, V14, P249, DOI 10.1111/j.1096-0031.1998.tb00338.x	99	74	81	3	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0119248	10.1371/journal.pone.0119248	http://dx.doi.org/10.1371/journal.pone.0119248			60	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923521	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600003
J	Charach, G; Rubalsky, O; Charach, L; Rabinovich, A; Argov, O; Rogowski, O; George, J				Charach, Gideon; Rubalsky, Olga; Charach, Lior; Rabinovich, Alexander; Argov, Ori; Rogowski, Ori; George, Jacob			Internal Thoracic Impedance - A Useful Method for Expedient Detection and Convenient Monitoring of Pleural Effusion	PLOS ONE			English	Article							ELECTRICAL-IMPEDANCE; PULMONARY-EDEMA; HEART-FAILURE; FLUID STATUS; RIGHT LUNG; BIOIMPEDANCE	Measurement of internal thoracic impedance (ITI) is sensitive and accurate in detecting acute pulmonary edema even at its preclinical stage. We evaluated the suitability of the highly sensitive and noninvasive RS-207 monitor for detecting pleural effusion and for demonstrating increased ITI during its resolution. This prospective controlled study was performed in a single department of internal medicine of a university-affiliated hospital between 2012-2013. One-hundred patients aged 25-96 years were included, of whom 50 had bilateral or right pleural effusion of any etiology (study group) and 50 had no pleural effusion (controls). ITI, the main component of which is lung impedance, was continuously measured by the RS-207 monitor. The predictive value of ITI monitoring was determined by 8 measurements taken every 8 hours. Pleural effusion was diagnosed according to well-accepted clinical and roentgenological criteria. During treatment, the ITI of the study group increased from 32.9 +/- 4.2 ohm to 42.8 +/- 3.8 ohm (p<0.0001) compared to non-significant changes in the control group (59.6 +/- 6.6 ohm, p=0.24). Prominent changes were observed in the respiratory rate of the study group: there was a decrease from 31.2 +/- 4.0 to 19.5 +/- 2.4 ohm (35.2%) compared to no change for the controls, and a mean increase from 83.6 +/- 5.3%-92.5 +/- 1.6% (13.2%) in O2 saturation compared to 94.2 +/- 1.7% for the controls. Determination of ITI for the detection and monitoring of treatment of patients with pleural effusion enables earlier diagnosis and more effective therapy, and can prevent hospitalization and serious complications, such as respiratory distress, and the need for mechanical ventilation.	[Charach, Gideon; Rubalsky, Olga; Charach, Lior; Rabinovich, Alexander; Argov, Ori; Rogowski, Ori; George, Jacob] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Dept Internal Med C, IL-69978 Tel Aviv, Israel; [George, Jacob] Hebrew Univ Jerusalem, Med Ctr, Kaplan Med Ctr, Dept Cardiol, Jerusalem, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center	Charach, G (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Dept Internal Med C, IL-69978 Tel Aviv, Israel.	drcharach@012.net.il						Anderson FA, 1980, ENCY MED DEVICES INS, P1632; CAMPBELL JH, 1994, CLIN SCI, V87, P97, DOI 10.1042/cs0870097; Charach G, 2001, CRIT CARE MED, V29, P1137, DOI 10.1097/00003246-200106000-00008; Charach G, 2012, J GERIATR CARDIOL, V9, P321, DOI 10.3724/SP.J.1263.2012.07231; FEIN A, 1979, CIRCULATION, V60, P1156, DOI 10.1161/01.CIR.60.5.1156; KUBICEK WG, 1970, ANN NY ACAD SCI, V170, P724, DOI 10.1111/j.1749-6632.1970.tb17735.x; LUEPKER RV, 1973, AM HEART J, V85, P83, DOI 10.1016/0002-8703(73)90529-2; Newell JC, 1996, IEEE T BIO-MED ENG, V43, P133, DOI 10.1109/10.481982; Quaglietti SE, 2000, PROG CARDIOVASC DIS, V43, P259, DOI 10.1053/pcad.2000.19803; Rabinovich P, 1998, US Patent No, Patent No. [5,749,369, 5749369]; SAUNDERS CE, 1988, AM J EMERG MED, V6, P337, DOI 10.1016/0735-6757(88)90151-9; Shochat M, 2004, EUR HEART J, V25, P72; Shochat M, 2003, J AM COLL CARDIOL, P1206; Shochat M, 2005, EUR J HEART FAIL S1, V4, P79; Shochat M, 2004, J AM COLL CARDIOL S, V43, P1154; Shochat M, 2006, CARDIOVASC REVASCULA, V7, P41, DOI 10.1016/j.carrev.2005.10.005; Shochat M, 2006, INTENS CARE MED, V32, P1214, DOI 10.1007/s00134-006-0237-z; Shochat M, 2012, AM J CARDIOL, V110, P190, DOI 10.1016/j.amjcard.2012.03.009; SPINALE FG, 1989, J SURG RES, V47, P535, DOI 10.1016/0022-4804(89)90132-7; Yu CM, 2005, CIRCULATION, V112, P841, DOI 10.1161/CIRCULATIONAHA.104.492207; ZELLNER JL, 1990, J SURG RES, V48, P454, DOI 10.1016/0022-4804(90)90012-Q	21	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0122576	10.1371/journal.pone.0122576	http://dx.doi.org/10.1371/journal.pone.0122576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919389	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659400015
J	Ikegami, T; Inatsugi, T; Kojima, I; Umemura, M; Hagiwara, H; Machida, M; Asai, K				Ikegami, Tsutomu; Inatsugi, Toyohiro; Kojima, Isao; Umemura, Myco; Hagiwara, Hiroko; Machida, Masayuki; Asai, Kiyoshi			Hybrid De Novo Genome Assembly Using MiSeq and SOLiD Short Read Data	PLOS ONE			English	Article							SEQUENCE DATA; GENERATION; ALIGNMENT; ORYZAE	A hybrid de novo assembly pipeline was constructed to utilize both MiSeq and SOLiD short read data in combination in the assembly. The short read data were converted to a standard format of the pipeline, and were supplied to the pipeline components such as ABySS and SOAPdenovo. The assembly pipeline proceeded through several stages, and either MiSeq paired-end data, SOLiD mate-paired data, or both of them could be specified as input data at each stage separately. The pipeline was examined on the filamentous fungus Aspergillus oryzae RIB40, by aligning the assembly results against the reference sequences. Using both the MiSeq and the SOLiD data in the hybrid assembly, the alignment length was improved by a factor of 3 to 8, compared with the assemblies using either one of the data types. The number of the reproduced gene cluster regions encoding secondary metabolite biosyntheses (SMB) was also improved by the hybrid assemblies. These results imply that the MiSeq data with long read length are essential to construct accurate nucleotide sequences, while the SOLiD mate-paired reads with long insertion length enhance long-range arrangements of the sequences. The pipeline was also tested on the actinomycete Streptomyces avermitilis MA-4680, whose gene is known to have high-GC content. Although the quality of the SOLiD reads was too low to perform any meaningful assemblies by themselves, the alignment length to the reference was improved by a factor of 2, compared with the assembly using only the MiSeq data.	[Ikegami, Tsutomu; Kojima, Isao] Natl Inst Adv Ind Sci & Technol, Informat Technol Res Inst, Tsukuba, Ibaraki, Japan; [Inatsugi, Toyohiro] Cift Corp, Tsukuba, Ibaraki, Japan; [Umemura, Myco; Hagiwara, Hiroko; Machida, Masayuki] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan; [Asai, Kiyoshi] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Ikegami, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Informat Technol Res Inst, Tsukuba, Ibaraki, Japan.	t-ikegami@aist.go.jp	Asai, Kiyoshi/AAT-8344-2020; Umemura, Maiko/M-4092-2018; IKEGAMI, TSUTOMU/N-3452-2016; Kojima, Isao/M-2845-2018	Asai, Kiyoshi/0000-0003-0909-4982; Umemura, Maiko/0000-0001-8730-1380; IKEGAMI, TSUTOMU/0000-0003-2977-6390; Kojima, Isao/0000-0001-5505-889X	Cift Corporation	Cift Corporation	Cift Corporation provided support in the form of a salary for author T. Inatsugi, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2009, NOVO ERROR CORRECTIO; [Anonymous], 2012, SOLID SYSTEM XSQ TOO; [Anonymous], 2010, APPL BIOSYSTEMS SOLI; [Anonymous], 2011, MATE PAIRED LIB PREP; Arnaud MB, 2013, ASPERGILLUS GENOME D; Breu H., 2010, THEORETICAL UNDERSTA; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Denisov G, 2008, BIOINFORMATICS, V24, P1035, DOI 10.1093/bioinformatics/btn074; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Extensible Sequence (XSQ), 2011, FIL FORM SPEC 1 0 1; Frith MC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-80; Fujii T, 2015, GENOME ANNOUNCEMENTS, V3, DOI [10.1128/genomeA.00014-15, DOI 10.1128/GEN0MEA.00014-15]; Genome Project of Streptmyces avermitilis, 2013, VERS 11022 090102 CH; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Inglis DO, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-91; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; MacCallum I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r103; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Massingham T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-145; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Oka T, 2014, GENOME ANNOUNCEMENTS, V2, DOI [10.1128/genomeA.01162-13, DOI 10.1128/GEN0MEA.01162-13]; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Ribeiro FJ, 2012, GENOME RES, V22, P2270, DOI 10.1101/gr.141515.112; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Takeda I, 2014, GENOME ANNOUNCEMENTS, V2, DOI [10.1128/genomeA.00071-14, DOI 10.1128/GEN0MEA.00071-14]; Umemura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063673; Wang J., 2009, GENOME RES; Yu J, 2014, GENOME ANNOUNCEMENTS, V2, DOI [10.1128/genomeA.00635-14, DOI 10.1128/GEN0MEA.00635-14]; Zhao G, 2014, GENOME ANNOUNCEMENTS, V2, DOI [10.1128/genomeA.00548-14, DOI 10.1128/GEN0MEA.00548-14]	34	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0126289	10.1371/journal.pone.0126289	http://dx.doi.org/10.1371/journal.pone.0126289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919614	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400094
J	Kossyvakis, A; Tao, Y; Lu, XY; Pogka, V; Tsiodras, S; Emmanouil, M; Mentis, AF; Tong, SX; Erdman, DD; Antoniadis, A				Kossyvakis, Athanasios; Tao, Ying; Lu, Xiaoyan; Pogka, Vasiliki; Tsiodras, Sotirios; Emmanouil, Mary; Mentis, Andreas F.; Tong, Suxiang; Erdman, Dean D.; Antoniadis, Antonios			Laboratory Investigation and Phylogenetic Analysis of an Imported Middle East Respiratory Syndrome Coronavirus Case in Greece	PLOS ONE			English	Article							RECEPTOR-BINDING DOMAIN; PROTEIN	Rapid and reliable laboratory diagnosis of persons suspected of Middle East respiratory syndrome coronavirus (MERS-CoV) infection is important for timely implementation of infection control practices and disease management. In addition, monitoring molecular changes in the virus can help elucidate chains of transmission and identify mutations that might influence virus transmission efficiency. This was illustrated by a recent laboratory investigation we conducted on an imported MERS-CoV case in Greece. Two oropharyngeal swab specimens were collected on the 1st and 2nd day of patient hospitalization and tested using two real-time RT-PCR (rRT-PCR) assays targeting the UpE and Orf-1a regions of the MERS-CoV genome and RT-PCR and partial sequencing of RNA-dependent RNA polymerase and nucleocapsid genes. Serum specimens were also collected and serological test were performed. Results from the first swab sample were inconclusive while the second swab was strongly positive for MERS-CoV RNA by rRT-PCR and confirmed positive by RTPCR and partial gene sequencing. Positive serologic test results further confirmed MERSCoV infection. Full-length nucleocapsid and spike gene coding sequences were later obtained from the positive swab sample. Phylogenetic analysis revealed that the virus was closely related to recent human-derived MERS-CoV strains obtained in Jeddah and Makkah, Saudi Arabia, in April 2014 and dromedary camels in Saudi Arabia and Qatar. These findings were consistent with the patient's history. We also identified a unique amino acid substitution in the spike receptor binding domain that may have implications for receptor binding efficiency. Our initial inconclusive rRT-PCR results highlight the importance of collecting multiple specimens from suspect MERS-CoV cases and particularly specimens from the lower respiratory tract.	[Kossyvakis, Athanasios; Pogka, Vasiliki; Emmanouil, Mary; Mentis, Andreas F.; Antoniadis, Antonios] Hellenic Pasteur Inst, Natl Influenza Reference Lab Southern Greece, Athens, Greece; [Tao, Ying; Lu, Xiaoyan; Tong, Suxiang; Erdman, Dean D.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA; [Tsiodras, Sotirios] Hellen Ctr Dis Control & Prevent, Dept Epidemiol Surveillance & Intervent, Athens, Greece	Centers for Disease Control & Prevention - USA	Mentis, AF (corresponding author), Hellenic Pasteur Inst, Natl Influenza Reference Lab Southern Greece, Athens, Greece.	mentis@pasteur.gr	TSIODRAS, SOTIRIOS/AAD-8273-2019; Pogka, Vasiliki/H-7602-2019	TSIODRAS, SOTIRIOS/0000-0002-0463-4321; POGKA, VASILIKI/0000-0002-1543-2418				Boheemen S, 2012, MBIO, V3; Briese T, 2014, MBIO, V5; Chen YQ, 2013, J VIROL, V87, P10777, DOI 10.1128/JVI.01756-13; Chu DKW, 2014, EMERG INFECT DIS, V20, P1049, DOI 10.3201/eid2006.140299; Corman V. M., 2012, EUROSURVEILLANCE, V17, P49, DOI DOI 10.2807/ESE.17.49.20334-EN; Cotten M, 2013, EMERG INFECT DIS, V19, P736, DOI 10.3201/eid1905.130057; Drosten C, 2013, LANCET INFECT DIS, V13, P745, DOI 10.1016/S1473-3099(13)70154-3; Du LY, 2014, J VIROL, V88, P7045, DOI 10.1128/JVI.00433-14; European CDC, 2015, SEV RESP DIS ASS MID; European Centre for Disease Prevention and Control, EP UPD MIDDL E RESP; Jayaram H, 2006, J VIROL, V80, P6612, DOI 10.1128/JVI.00157-06; LU L, 2014, NAT COMMUN, V5; Qian ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076469; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Tsiodras S, 2014, EURO SURVEILL, V19; Wang NS, 2013, CELL RES, V23, P986, DOI 10.1038/cr.2013.92	16	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125809	10.1371/journal.pone.0125809	http://dx.doi.org/10.1371/journal.pone.0125809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919137	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659400089
J	Lou, YT; Chen, CW; Fan, YC; Chang, WC; Lu, CY; Wu, IC; Hsu, WH; Huang, CW; Wang, JY				Lou, Yun-Ting; Chen, Chao-Wen; Fan, Yun-Ching; Chang, Wei-Chiao; Lu, Chien-Yu; Wu, I-Chen; Hsu, Wen-Hung; Huang, Ching-Wen; Wang, Jaw-Yuan			LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy	PLOS ONE			English	Article							COLORECTAL-CANCER; DNA METHYLATION; VASCULAR INVASION; HYPOMETHYLATION; SURVEILLANCE; PHENOTYPE; PROGNOSIS; EVENTS; BLOOD; AGE	Background Methylation levels of long interspersed nucleotide elements (LINE-1) are representative of genome-wide methylation status and crucial in maintaining genomic stability and expression. Their prognostic impact on colon cancer patients receiving adjuvant chemotherapy has not been well established. We evaluated the association between LINE-1 methylation status and clinicopathologic features and postoperative oncological outcomes in stage III colon cancer patients. Materials and Methods 129 UICC stage III colon cancer patients who had received radical resection and FOLFOX adjuvant chemotherapy were enrolled. Global methylation was estimated by analyzing tumor LINE-1 methylation status using bisulfite-polymerase chain reaction (PCR) and pyrosequencing assay. Demographics, clinicopathological data, and postoperative outcomes were recorded by trained abstractors. Outcome measurements included postoperative recurrence and disease-free survival. Univariate, multivariate, and survival analyses were conducted to identify prognostic factors of oncological outcomes. Results The LINE-1 methylation of all 129 patients was measured on a 0-100 scale (mean 63.3; median 63.7, standard deviation 7.1), LINE-1 hypomethylation was more common in patients aged 65 years and above (61.7%+/- 7.6% vs. 64.6 +/- 6.4, p=0.019) and those with post-therapeutic recurrence (61.7 +/- 7.4 vs 64.3 +/- 6.7, p=0.041). Considering risk adjustment, LINE-1 hypomethylation was found to be an independent risk factor of post-therapeutic recurrence (Adjusted OR=14.1, p=0.012). Kaplan-Meier analysis indicated that patients in the low methylation group had shorter period of disease free survival (p=0.01). In a stratified analysis that included 48 patients with post-therapeutic recurrence, it was found that those who experienced shorter period of disease free survival (<= 6 months) appeared to have lower LINE-1 methylation levels than patients who reported of recurrence after 6 months (56.68 +/- 15.75 vs. 63.55 +/- 7.57, p=0.041) Conclusion There was a significantly greater risk of early postoperative recurrence and a shorter period of disease-free survival in Stage III colon cancer patients exhibiting LINE-1 hypomethylation status after being treated with radical resection and FOLFOX chemotherapy.	[Lou, Yun-Ting; Fan, Yun-Ching; Chang, Wei-Chiao; Wang, Jaw-Yuan] Kaohsiung Med Univ, Coll Med, Grad Inst Genom Med, Kaohsiung, Taiwan; [Lou, Yun-Ting] I Shou Univ, E DA Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Chen, Chao-Wen; Wang, Jaw-Yuan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan; [Chen, Chao-Wen] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Surg, Kaohsiung, Taiwan; [Chen, Chao-Wen] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Emergency Med, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Chang, Wei-Chiao; Wang, Jaw-Yuan] Taipei Med Univ, Wanfang Hosp, Dept Pharm, Taipei, Taiwan; [Chang, Wei-Chiao] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Master Program Clin Pharmacogen & Pharmacoprote, Taipei, Taiwan; [Lu, Chien-Yu; Wu, I-Chen; Hsu, Wen-Hung] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Internal Med, Kaohsiung, Taiwan; [Lu, Chien-Yu; Wu, I-Chen; Hsu, Wen-Hung; Wang, Jaw-Yuan] Kaohsiung Med Univ, Div Gastroenterol, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Huang, Ching-Wen; Wang, Jaw-Yuan] Kaohsiung Med Univ, Dept Surg, Kaohsiung Med Univ Hosp, Div Gastrointestinal & Gen Surg, Kaohsiung, Taiwan; [Huang, Ching-Wen; Wang, Jaw-Yuan] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ, Ctr Biomarkers & Biotech Drugs, Kaohsiung, Taiwan	Kaohsiung Medical University; E-Da Hospital; I Shou University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Taipei Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Wang, JY (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Genom Med, Kaohsiung, Taiwan.	cy614112@ms14.hinet.net	Jaw-Yuan, Wang/AFS-8845-2022	Jaw-Yuan, Wang/0000-0002-7705-2621; Chen, Chao Wen/0000-0002-8405-342X; Chang, Wei-Chiao/0000-0002-8573-5924	Kaohsiung Medical University Research Foundation [KMU-1M-30]; Center for Biomarkers and Biotech Drugs, Kaohsiung Medical University [KMU-TP103C03, KMU-TP103H11]; Biosignature in Colorectal Cancers, Academia Sinica, Taiwan	Kaohsiung Medical University Research Foundation; Center for Biomarkers and Biotech Drugs, Kaohsiung Medical University; Biosignature in Colorectal Cancers, Academia Sinica, Taiwan	Funding: This study was supported by Kaohsiung Medical University Research Foundation (KMU-1M-30), Center for Biomarkers and Biotech Drugs, Kaohsiung Medical University (KMU-TP103C03, KMU-TP103H11), and the Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan. CWC and JYW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JB, 2011, CANCER-AM CANCER SOC, V117, P1847, DOI 10.1002/cncr.25737; Antelo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045357; Baba Y, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-125; Baca B, 2011, DIS COLON RECTUM, V54, P1036, DOI 10.1007/DCR.0b013e31820db364; Banaz-Yasar F, 2012, DNA CELL BIOL, V31, P1458, DOI 10.1089/dna.2012.1676; Betge J, 2011, ACTA GASTRO-ENT BELG, V74, P516; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Bosch LJW, 2011, CLIN COLORECTAL CANC, V10, P8, DOI 10.3816/CCC.2011.n.002; Brennan K, 2012, CANCER PREV RES, V5, P1345, DOI 10.1158/1940-6207.CAPR-12-0316; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Desch CE, 2005, J CLIN ONCOL, V23, P8512, DOI 10.1200/JCO.2005.04.0063; Edge S.B., 2010, AJCC CANC STAGING MA, V7th ed., P143; Goel A, 2010, GASTROENTEROLOGY, V138, P1854, DOI 10.1053/j.gastro.2010.01.035; Hahn MA, 2010, MUTAT RES-FUND MOL M, V693, P77, DOI 10.1016/j.mrfmmm.2009.10.005; Heyn H, 2013, EXPERT REV MOL DIAGN, V13, P473, DOI [10.1586/ERM.13.36, 10.1586/erm.13.36]; Horii J, 2008, CLIN BIOCHEM, V41, P1440, DOI 10.1016/j.clinbiochem.2008.08.089; Hur K, 2014, GUT, V63, P635, DOI 10.1136/gutjnl-2012-304219; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kawakami K, 2011, CANCER SCI, V102, P166, DOI 10.1111/j.1349-7006.2010.01776.x; Khare Sharad, 2012, Methods Mol Biol, V863, P177, DOI 10.1007/978-1-61779-612-8_10; Kim MS, 2010, CANCER METAST REV, V29, P181, DOI 10.1007/s10555-010-9207-6; Kozak KR, 2008, J SURG ONCOL, V98, P161, DOI 10.1002/jso.21107; Lara E, 2011, EPIGENETIC ASPECTS OF CHRONIC DISEASES, P21, DOI 10.1007/978-1-84882-644-1_2; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Nelson RL, 1997, CANCER-AM CANCER SOC, V80, P193, DOI 10.1002/(SICI)1097-0142(19970715)80:2<193::AID-CNCR4>3.0.CO;2-V; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Piyathilake CJ, 2011, NUTRITION, V27, P513, DOI 10.1016/j.nut.2010.08.018; Rodic N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003402; Rosati G, 2010, WORLD J GASTROENTERO, V16, P1427, DOI 10.3748/wjg.v16.i12.1427; Saito K, 2010, CLIN CANCER RES, V16, P2418, DOI 10.1158/1078-0432.CCR-09-2819; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Schweiger MR, 2013, BRIEF FUNCT GENOMICS, V12, P411, DOI 10.1093/bfgp/elt024; Sunami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018884; Tournier B, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-12; Tsai HL, 2008, J SURG ONCOL, V97, P383, DOI 10.1002/jso.20942; Tsai HL, 2013, INT J COLORECTAL DIS, V28, P415, DOI 10.1007/s00384-012-1570-z; van Ijzendoorn MH, 2010, BIOL PSYCHIAT, V68, P405, DOI 10.1016/j.biopsych.2010.05.008; Wangsri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045292; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812; Zhang FF, 2011, EPIGENETICS-US, V6, P293, DOI 10.4161/epi.6.3.14378	45	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123973	10.1371/journal.pone.0123973	http://dx.doi.org/10.1371/journal.pone.0123973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919688	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659400040
J	Beverborg, NG; Verweij, N; Klip, IT; van der Wal, HH; Voors, AA; van Veldhuisen, DJ; Gansevoort, RT; Bakker, SJL; van der Harst, P; van der Meer, P				Beverborg, Niels Grote; Verweij, Niek; Klip, IJsbrand T.; van der Wal, Haye H.; Voors, Adriaan A.; van Veldhuisen, Dirk J.; Gansevoort, Ron T.; Bakker, Stephan J. L.; van der Harst, Pim; van der Meer, Peter			Erythropoietin in the General Population: Reference Ranges and Clinical, Biochemical and Genetic Correlates	PLOS ONE			English	Article							SERUM ERYTHROPOIETIN; TRANSFERRIN RECEPTOR; PLASMA ERYTHROPOIETIN; STIMULATING AGENTS; DARBEPOETIN ALPHA; ANEMIA; MORTALITY; HEMOGLOBIN; HYPERTENSION; EQUATION	Background Although erythropoietin has been used for decades in the treatment of anemia, data regarding endogenous levels in the general population are scarce. Therefore, we determined erythropoietin reference ranges and its clinical, biochemical and genetic associations in the general population. Methods We used data from 6,777 subjects enrolled in the Prevention of REnal and Vascular ENd-stage Disease (PREVEND) study. Fasting venous blood samples were obtained in the morning from all participants from 2001-2003. Serum erythropoietin concentrations were measured using a fully automated chemiluminescent enzyme-labeled immunometric assay. A genome-wide association study was performed to identify genetic determinants. Results Mean age (+/- SD) was 53 +/- 12 years and 50% were female. Median (IQR) erythropoietin concentrations were 7.6 (5.8-9.9) IU/L in men and 7.9 (6.0-10.6) IU/L in women. A strong positive correlation was found between erythropoietin and waist circumference, glucose and systolic blood pressure (all P < 0.05). In subjects with normal renal function there was a strong exponential relation between hemoglobin and erythropoietin, whereas in renal impairment (eGFR < 60 mL/min/1.73m(2)) this relation was linear (men) or absent (women) (P < 0.001 for interaction). Single-nucleotide polymorphisms at the HBS1L-MYB locus were shown to be related to erythropoietin levels (P < 9x10(-21)), more significantly than other erythrocyte parameters. Conclusion We provide age-specific reference ranges for endogenous serum erythropoietin. Erythropoietin levels are positively associated with the components of the metabolic syndrome, except cholesterol. We show that even mild renal failure blunts erythropoietin production and propose the HBS1L-MYB locus as a regulator of erythropoietin.	[Beverborg, Niels Grote; Verweij, Niek; Klip, IJsbrand T.; van der Wal, Haye H.; Voors, Adriaan A.; van Veldhuisen, Dirk J.; van der Harst, Pim; van der Meer, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Gansevoort, Ron T.; Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands	University of Groningen; University of Groningen	van der Meer, P (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.	p.van.der.meer@umcg.nl	Voors, Adriaan/ABE-6784-2020; Verweij, Niek/A-4499-2017; van der Wal, Haye/AAR-4470-2020; van der Wal, Haye/V-7528-2019; Verweij, Niek/ABC-6249-2021; Bakker, Stephan J. L./J-4023-2015; Grote Beverborg, Niels/L-3809-2019	Verweij, Niek/0000-0002-4303-7685; Bakker, Stephan J. L./0000-0003-3356-6791; Grote Beverborg, Niels/0000-0003-4629-9960	Amgen Inc.; Vifor Pharma	Amgen Inc.(Amgen); Vifor Pharma	Dr. van Veldhuisen received board membership fees from Amgen Inc. Dr. Voors, Dr. van Veldhuisen and Dr. van der Meer received consultancy fees from Vifor Pharma. Dr. Voors and Dr. van der Meer received an unrestricted grant from Vifor Pharma. Dr. Klip received a speaker fee from Vifor Pharma. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	BEGUIN Y, 1993, BLOOD, V81, P1067; Benson EW, 2000, J CLIN LAB ANAL, V14, P271, DOI 10.1002/1098-2825(20001212)14:6<271::AID-JCLA4>3.0.CO;2-8; Bunn HF, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011619; CHANDRA M, 1988, J PEDIATR-US, V113, P1015, DOI 10.1016/S0022-3476(88)80573-0; Charuruks Navapun, 2000, Journal of the Medical Association of Thailand, V83, P1267; Choi D, 2010, J EXP MED, V207, P2831, DOI 10.1084/jem.20100665; Cotroneo P, 2000, DIABETES-METAB RES, V16, P172, DOI 10.1002/1520-7560(200005/06)16:3<172::AID-DMRR117>3.3.CO;2-4; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; DEKLERK G, 1981, BLOOD, V58, P1164; den Elzen WPJ, 2010, CAN MED ASSOC J, V182, P1953, DOI 10.1503/cmaj.100374; Dicato M, 2008, ONCOLOGIST, V13, P11, DOI 10.1634/theoncologist.13-S3-11; Dickson VV, 2008, EUR J CARDIOVASC NUR, V7, P171, DOI 10.1016/j.ejcnurse.2007.11.005; Ershler WB, 2005, J AM GERIATR SOC, V53, P1360, DOI 10.1111/j.1532-5415.2005.53416.x; ESCHBACH JW, 1989, KIDNEY INT, V35, P134, DOI 10.1038/ki.1989.18; Farrell JJ, 2011, BLOOD, V117, P4935, DOI 10.1182/blood-2010-11-317081; Ferrucci L, 2005, AM J MED, V118, DOI 10.1016/j.amjmed.2005.06.039; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Hamalainen P, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-116; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; KRANTZ SB, 1991, BLOOD, V77, P419; Krapf R, 2009, CLIN J AM SOC NEPHRO, V4, P470, DOI 10.2215/CJN.05040908; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Luft FC, 2000, CLIN NEPHROL, V53, pS61; Lundby C, 2007, J PHYSIOL-LONDON, V578, P309, DOI 10.1113/jphysiol.2006.122689; Mak RHK, 1998, PEDIATR NEPHROL, V12, P660, DOI 10.1007/s004670050524; Mastromarino V, 2011, CLIN SCI, V120, P51, DOI 10.1042/CS20100305; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Murphy WG, 2010, BLOOD, V116, P2861, DOI 10.1182/blood-2010-07-294595; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882; Roque ME, 2001, CLIN LAB HAEMATOL, V23, P291, DOI 10.1046/j.1365-2257.2001.00413.x; SCHAEFER RM, 1988, AM J NEPHROL, V8, P449, DOI 10.1159/000167652; Sinclair AM, 2010, BLOOD, V115, P4264, DOI 10.1182/blood-2009-10-248666; Sinkeler SJ, 2012, AM J TRANSPLANT, V12, P485, DOI 10.1111/j.1600-6143.2011.03825.x; Smilde TDJ, 2005, AM J HYPERTENS, V18, P342, DOI 10.1016/j.amjhyper.2004.09.015; Swedberg K, 2013, NEW ENGL J MED, V368, P1210, DOI 10.1056/NEJMoa1214865; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; van der Meer P, 2004, J AM COLL CARDIOL, V44, P63, DOI 10.1016/j.jacc.2004.03.052; VANBEMMEL JH, 1990, METHOD INFORM MED, V29, P346; VANDYKE D, 1961, BLOOD, V18, P187, DOI 10.1182/blood.V18.2.187.187; Wagner M, 2011, CLIN J AM SOC NEPHRO, V6, P1573, DOI 10.2215/CJN.00380111; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; WIDE L, 1989, BRIT J HAEMATOL, V72, P85, DOI 10.1111/j.1365-2141.1989.tb07657.x	43	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125215	10.1371/journal.pone.0125215	http://dx.doi.org/10.1371/journal.pone.0125215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915923	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100110
J	Chen, P; Yang, WK; Tian, YP; Sun, ST; Chen, GY; Zhang, CY; Ma, FX; Xun, YP; Shi, LL; Yang, CH; Zhao, LQ; Zhou, YB; Du, HW				Chen, Peng; Yang, Weikang; Tian, Yaping; Sun, Shutao; Chen, Guangyu; Zhang, ChunYan; Ma, Fuxin; Xun, Yiping; Shi, Lili; Yang, Chunhe; Zhao, Lanqing; Zhou, Yabin; Du, Hongwu			Electron Transfer Flavoprotein Subunit Beta Is a Candidate Endothelial Cell Autoantigen in Behcet's Disease	PLOS ONE			English	Article							FATTY ACYL COENZYME; ANTIBODIES; IDENTIFICATION; VASCULITIS; ANTIGEN	Behcet's disease (BD) is a chronic inflammatory disease with multisystem involvement, and it is listed as a rare disease in the United States but is common in the Middle East, China, and Japan. The aim of this study was to identify novel autoantigens in Chinese patients with BD. First, the candidate autoantigens were screened by Western blotting, and the sequences of putative antigens were identified by LC-MALDI-TOF/TOF mass spectrometry. Next, the screened protein was cloned, expressed and purified. Then, an optimized ELISA was developed, and the serological criteria were evaluated using a large number of confirmed patients. One antigen with a molecular weight of approximately 28 kDa was identified as electron transfer flavoprotein subunit beta (ETFB). Positive reactivity was detected in recombinant human ETFB sera from 38 of 92 BD patients (41 %) and 1 of 90 healthy controls (1%).	[Chen, Peng; Yang, Weikang; Ma, Fuxin; Xun, Yiping; Shi, Lili; Yang, Chunhe; Zhao, Lanqing; Zhou, Yabin; Du, Hongwu] Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Beijing 100083, Peoples R China; [Tian, Yaping; Zhang, ChunYan] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Biochem, Beijing 100853, Peoples R China; [Sun, Shutao] Chinese Acad Sci, Inst Microbiol, Core Facil, Beijing, Peoples R China; [Chen, Guangyu] ImmunoHunt Corp, Beijing 100071, Peoples R China	University of Science & Technology Beijing; Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; Institute of Microbiology, CAS	Du, HW (corresponding author), Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Beijing 100083, Peoples R China.	hongwudu@ustb.edu.cn		Xun, Yiping/0000-0001-6367-8407	Fundamental Research Funds for the Central universities; Program for New Century Excellent Talents in University; National Natural Science Foundation of China [31371203]; ImmunoHunt Corporation	Fundamental Research Funds for the Central universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ImmunoHunt Corporation	This work was supported by the Fundamental Research Funds for the Central universities, the Program for New Century Excellent Talents in University and the National Natural Science Foundation of China (31371203). Co-author Guangyu Chen is employed by ImmunoHunt Corporation. ImmunoHunt Corporation provided support in the form of salary for author GC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	AYDINTUG AO, 1993, CLIN IMMUNOL IMMUNOP, V67, P157, DOI 10.1006/clin.1993.1059; Bax M, 2014, SEMIN IMMUNOPATHOL, V36, P313, DOI 10.1007/s00281-014-0429-5; BEINERT H, 1962, J BIOL CHEM, V237, P2988; Bin Cho S, 2012, J INVEST DERMATOL, V132, P601, DOI 10.1038/jid.2011.397; Chen P, 2015, BIOCHEM BIOPH RES CO, V456, P866, DOI 10.1016/j.bbrc.2014.12.064; CRANE FL, 1956, J BIOL CHEM, V218, P701; de Chambrun MP, 2012, AUTOIMMUN REV, V11, P687, DOI 10.1016/j.autrev.2011.11.026; Deng CY, 2014, MOL PLANT MICROBE IN, V27, P101, DOI 10.1094/MPMI-08-13-0234-R; Dinc A, 2003, CLIN EXP RHEUMATOL, V21, pS27; Du HW, 2013, BIOANALYSIS, V5, P2269, DOI 10.4155/bio.13.195; Du HW, 2012, BIOANALYSIS, V4, P2161, DOI 10.4155/BIO.12.188; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; Karasawa R, 2011, EXPERT OPIN BIOL TH, V11, P77, DOI 10.1517/14712598.2011.540234; Lee SJ, 2006, J ALLERGY CLIN IMMUN, V117, pS445, DOI 10.1016/j.jaci.2005.06.023; LOEHR JP, 1990, PEDIATR RES, V27, P311, DOI 10.1203/00006450-199003000-00024; Mak T., 2008, PRIMER IMMUNE RESPON; Mendes D, 2009, J AUTOIMMUN, V32, P178, DOI 10.1016/j.jaut.2009.02.011; Mor F, 2002, EUR J IMMUNOL, V32, P356, DOI 10.1002/1521-4141(200202)32:2<356::AID-IMMU356>3.0.CO;2-9; Moutsopoulos HM, 2014, J AUTOIMMUN, V51, P1, DOI 10.1016/j.jaut.2014.01.001; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; Sakane T, 2011, NEW ENGL J MED, V341, P1284; Schiff M, 2006, MOL GENET METAB, V88, P153, DOI 10.1016/j.ymgme.2006.01.009; Shin SJ, 2011, DIGEST DIS SCI, V56, P812, DOI 10.1007/s10620-010-1326-y; SILMAN AJ, 1990, LANCET, V335, P1078; Verity DH, 2003, BRIT J OPHTHALMOL, V87, P1175, DOI 10.1136/bjo.87.9.1175; Verity DH, 1999, TISSUE ANTIGENS, V54, P213, DOI 10.1034/j.1399-0039.1999.540301.x; Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007; Xun YP, 2014, BIOCHEM BIOPH RES CO, V451, P389, DOI 10.1016/j.bbrc.2014.07.126	28	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124760	10.1371/journal.pone.0124760	http://dx.doi.org/10.1371/journal.pone.0124760			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915519	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100065
J	Huang, YM; Zhang, Q; Yang, ZS; Conrad, T; Liu, YJ; Zhong, GM				Huang, Yumeng; Zhang, Qi; Yang, Zhangsheng; Conrad, Turner; Liu, Yuanjun; Zhong, Guangming			Plasmid-Encoded Pgp5 Is a Significant Contributor to Chlamydia muridarum Induction of Hydrosalpinx	PLOS ONE			English	Article							TRACHOMATIS; MICE; INFECTION; TRANSFORMATION; VIRULENCE; PATHOLOGY; DEFICIENT; IMMUNITY; STRAIN; CELL	We have previously shown that the plasmid-encoded Pgp3 is a major virulence factor for C. muridarum induction of hydrosalpinx. We now report that Pgp5 also plays a significant role in the development of hydrosalpinx following C. muridarum induction. Pgp5 deficiency was introduced via either in-frame deletion (CM-Delta pgp5) or premature stop codon installation (CM-pgp5S). Mice infected with either CM-Delta pgp5 or CM-pgp5S developed hydrosalpinges at significantly reduced levels with an incidence rate of <40% and a mean severity score of 2 or less. In contrast, 80% or more mice developed hydrosalpinx with a severity score of >3 when mice were infected with Pgp5-sufficient C. muridarum (plasmid-competent wild type or plasmid-free C. muridarum transformed with a full plasmid or depleted of pgp7 gene). The attenuated pathogenicity of the Pgp5-deficient C. muridarum correlated with a significantly reduced level of ascending infection in the oviduct tissue despite the similar overall shedding courses between mice infected with Pgp5-deficeint versus sufficient C. muridarum. Furthermore, in the oviducts of mice infected with Pgp5-deficient C. muridarum, significantly lower levels of inflammatory cell infiltration and cytokine production were detected. Thus, Pgp5 is a significant plasmid-encoded virulence factor for C. muridarum pathogenicity in the upper genital tract.	[Huang, Yumeng; Zhang, Qi; Yang, Zhangsheng; Conrad, Turner; Liu, Yuanjun; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Huang, Yumeng] Cent South Univ China, Xiangya Sch Med, Xiangya Hosp 2, Dept Dermatol, Changsha 410013, Hunan, Peoples R China; [Zhang, Qi] Cent South Univ China, Xiangya Sch Med, Xiangya Hosp 3, Dept Obstet & Gynecol, Changsha 410013, Hunan, Peoples R China; [Liu, Yuanjun] Tianjin Med Univ, Gen Hosp, Dept Dermatovenereol, Tianjin 300052, Peoples R China	University of Texas System; University of Texas Health San Antonio; Central South University; Central South University; Tianjin Medical University	Liu, YJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	Liuyuanjun1980@126.com; Zhongg@UTHSCSA.EDU			US National Institutes of Health (NIH) [R01AI064537, R01AI047997]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064537, R01AI047997] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research is supported by US National Institutes of Health (NIH) grants R01AI064537 and R01AI047997. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057090; Chen JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095076; Chen LL, 2010, J IMMUNOL, V184, P2602, DOI 10.4049/jimmunol.0901593; de la Maza Luis M, 2002, Curr Opin Investig Drugs, V3, P980; Ding HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080534; Dong XH, 2014, INFECT IMMUN, V82, P1833, DOI 10.1128/IAI.01668-13; Gong SQ, 2013, J BACTERIOL, V195, P3819, DOI 10.1128/JB.00511-13; Kari L, 2011, J EXP MED, V208, P2217, DOI 10.1084/jem.20111266; Lei L, 2014, INFECT IMMUN, V82, P983, DOI 10.1128/IAI.01543-13; Li ZY, 2008, INFECT IMMUN, V76, P3415, DOI 10.1128/IAI.01377-07; Liu Y, 2014, INFECT IMMUN, V82, P5327, DOI 10.1128/IAI.02576-14; Liu YJ, 2014, J BACTERIOL, V196, P989, DOI 10.1128/JB.01161-13; Lu CX, 2012, VACCINE, V30, P475, DOI 10.1016/j.vaccine.2011.10.059; Matsumoto A, 1998, J CLIN MICROBIOL, V36, P3013, DOI 10.1128/JCM.36.10.3013-3019.1998; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; Murthy AK, 2011, INFECT IMMUN; O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027; O'Connell CM, 2006, MICROBIOL-SGM, V152, P1601, DOI 10.1099/mic.0.28658-0; Peng B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-347; Ramsey KH, 2014, INFECT IMMUN; RICCI S, 1995, GENE, V154, P93, DOI 10.1016/0378-1119(94)00825-D; Rockey DD, 2009, EXPERT REV VACCINES, V8, P1365, DOI 10.1586/ERV.09.98; Seth-Smith HMB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-239; Shah AA, 2005, SEX TRANSM DIS, V32, P49, DOI 10.1097/01.olq.0000148299.14513.11; Sigar IM, 2014, PATHOG DIS, V70, P61, DOI 10.1111/2049-632X.12086; Song LH, 2013, INFECT IMMUN, V81, P636, DOI 10.1128/IAI.01305-12; Tang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060345; Thomas NS, 1997, MICROBIOL-SGM, V143, P1847, DOI 10.1099/00221287-143-6-1847; Wang YB, 2013, PATHOG DIS, V67, P100, DOI 10.1111/2049-632X.12024; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Wickstrum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076743; Xu Shuang, 2013, BMC Res Notes, V6, P377, DOI 10.1186/1756-0500-6-377; Yang ZS, 2014, INFECT IMMUN, V82, P3154, DOI 10.1128/IAI.01833-14; Zhang HB, 2014, INFECT IMMUN, V82, P2688, DOI 10.1128/IAI.00055-14; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935	35	23	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124840	10.1371/journal.pone.0124840	http://dx.doi.org/10.1371/journal.pone.0124840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915629	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100073
J	Yang, JJ; Li, XH; Yang, RM; Yu, X; Yu, CL; Qian, YF; Yu, YQ				Yang, Jinjing; Li, Xiaohu; Yang, Renmin; Yu, Xuen; Yu, Changliang; Qian, Yinfeng; Yu, Yongqiang			Susceptibility-Weighted Imaging Manifestations in the Brain of Wilson's Disease Patients	PLOS ONE			English	Article							IRON DEPOSITION; MULTIPLE-SCLEROSIS; CLINICAL CORRELATION; CRANIAL MRI; GREY-MATTER; CERULOPLASMIN; LIVER	Purpose It is well known that patients with Wilson's disease (WD) suffer copper metabolism disorder. However, recent studies point to an additional iron metabolism disorder in WD patients. The purpose of our study was to examine susceptibility-weighted imaging (SWI) manifestations of WD in the brains of WD patients. Methods A total of 33 patients with WD and 18 normal controls underwent conventional MRI (Magnetic resonance imaging) and SWI. The phase values were measured on SWI-filtered phase images of the bilateral head of the caudate nuclei, globus pallidus, putamen, thalamus, substantia nigra, and red nucleus. Student's t-tests were used to compare the phase values between WD groups and normal controls. Results The mean phase values for the bilateral head of the caudate nuclei, globus pallidus, putamen, thalamus, substantia nigra, and red nucleus were significantly lower than those in the control group (P < 0.001), and bilateral putamen was most strongly affected. Conclusions There is paramagnetic mineralization deposition in brain gray nuclei of WD patients and SWI is an effective method to evaluate these structures.	[Yang, Jinjing; Li, Xiaohu; Yu, Changliang; Qian, Yinfeng; Yu, Yongqiang] Anhui Med Univ, Dept Radiol, Affiliated Hosp 1, Hefei, Peoples R China; [Yang, Renmin; Yu, Xuen] Anhui Coll TCM, Dept Neurol, Hosp Affiliated, Hefei, Peoples R China	Anhui Medical University	Qian, YF (corresponding author), Anhui Med Univ, Dept Radiol, Affiliated Hosp 1, Hefei, Peoples R China.	ayfyqianyinfeng@126.com; ayfyyuyongqiang@126.com		Yu, Xu-En/0000-0003-1241-6962	National Natural Science Foundation of China [813012240]; Anhui Provincial Education Department [KJ2013A144]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Education Department	This study was supported by the grant from National Natural Science Foundation of China (813012240) and Anhui Provincial Education Department (KJ2013A144).	Bruehlmeier M, 2000, J NUCL MED, V41, P781; Chen W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098303; Chen X, 2012, EUR J RADIOL, V81, pE633, DOI 10.1016/j.ejrad.2012.01.003; Duchen LW, 1992, GREENFIELDS NEUROPAT, P838; Fox PL, 2003, BIOMETALS, V16, P9, DOI 10.1023/A:1020799512190; Frazer DM, 2003, BLOOD CELL MOL DIS, V30, P288, DOI 10.1016/S1079-9796(03)00039-1; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2007, J MAGN RESON IMAGING, V26, P256, DOI 10.1002/jmri.22987; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; HITOSHI S, 1991, J NEUROL NEUROSUR PS, V54, P624, DOI 10.1136/jnnp.54.7.624; Ishida S, 2012, INTERNAL MED, V51, P1759, DOI 10.2169/internalmedicine.51.7341; Kim TJ, 2006, AM J NEURORADIOL, V27, P1373; King AD, 1996, AM J ROENTGENOL, V167, P1579, DOI 10.2214/ajr.167.6.8956601; Kozic D, 2003, EUR J NEUROL, V10, P587, DOI 10.1046/j.1468-1331.2003.00661.x; Lee JH, 2012, J NEUROL SCI, V313, P54, DOI 10.1016/j.jns.2011.09.031; Lee JH, 2012, CLIN NEUROL NEUROSUR, V114, P47, DOI 10.1016/j.clineuro.2011.07.002; Li CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073626; Merle U, 2010, J GASTROEN HEPATOL, V25, P1144, DOI 10.1111/j.1440-1746.2009.06173.x; Mukhopadhyay CK, 1998, SCIENCE, V279, P714, DOI 10.1126/science.279.5351.714; Ogg RJ, 1999, MAGN RESON IMAGING, V17, P1141, DOI 10.1016/S0730-725X(99)00017-X; Rumzan R, 2013, EUR J RADIOL, V82, pE95, DOI 10.1016/j.ejrad.2012.09.006; Sargent PJ, CURR MED CHEM, V12, P2683; Shiono Y, 2001, AM J GASTROENTEROL, V96, P3147; Sinha S, 2006, NEURORADIOLOGY, V48, P613, DOI 10.1007/s00234-006-0101-4; Wang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050706; Young SP, 1997, FEBS LETT, V411, P93, DOI 10.1016/S0014-5793(97)00478-X; Zhang JQ, 2010, BRAIN RES, V1330, P124, DOI 10.1016/j.brainres.2010.03.036; Zivadinov R, 2010, INT ANGIOL, V29, P158	28	20	21	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125100	10.1371/journal.pone.0125100	http://dx.doi.org/10.1371/journal.pone.0125100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915414	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659100099
J	Zhuang, CL; Wang, SL; Huang, DD; Pang, WY; Lou, N; Chen, BC; Chen, XL; Yu, Z; Shen, X				Zhuang, Cheng-Le; Wang, Su-Lin; Huang, Dong-Dong; Pang, Wen-Yang; Lou, Neng; Chen, Bi-Cheng; Chen, Xiao-Lei; Yu, Zhen; Shen, Xian			Risk Factors for Hospital Readmission after Radical Gastrectomy for Gastric Cancer: A Prospective Study	PLOS ONE			English	Article							AMERICAN-COLLEGE; MORTALITY; SURGERY; QUALITY; COMPLICATIONS; MANAGEMENT; MORBIDITY; PATIENT	Background Hospital readmission is gathering increasing attention as a measure of health care quality and a potential cost-saving target. The purpose of this prospective study was to determine risk factors for readmission within 30 days of discharge after gastrectomy for patients with gastric cancer. Methods We conducted a prospective study of patients undergoing radical gastrectomy for gastric cancer from October 2013 to November 2014 in our institution. The incidence, cause and risk factors for 30-day readmission were determined. Results A total of 376 patients were included in our analysis without loss in follow-up. The 30-day readmission rate after radical gastrectomy for gastric cancer was 7.2% (27of 376). The most common cause for readmission included gastrointestinal complications and postoperative infections. On the basis of multivariate logistic regression analysis, preoperative nutritional risk screening 2002 score >= 3 was an independent risk factor for 30-day readmission. Factors not associated with a higher readmission rate included a history of a major postoperative complication during the index hospitalization, prolonged primary length of hospital stay after surgery, a history of previous abdominal surgery, advanced age, body mass index, pre-existing cardiopulmonary comorbidities, American Society of Anesthesiology grade, type of resection, extent of node dissection and discharge disposition. Conclusions Readmission within 30 days of discharge after radical gastrectomy for gastric cancer is common. Patients with nutritional risk preoperatively are at high risk for 30-day readmission. Preoperative optimization of nutritional status of patients at nutritional risk may effectively decrease readmission rates.	[Zhuang, Cheng-Le; Wang, Su-Lin; Huang, Dong-Dong; Pang, Wen-Yang; Lou, Neng; Chen, Xiao-Lei; Yu, Zhen; Shen, Xian] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Wenzhou, Peoples R China; [Chen, Bi-Cheng] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou Key Lab Surg, Wenzhou, Peoples R China; [Yu, Zhen] Tongji Univ, Shanghai Peoples Hosp 10, Dept Gastrointestinal Surg, Shanghai 200092, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Tongji University	Yu, Z (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Wenzhou, Peoples R China.	yuzhen0577@gmail.com; shenxian5166@126.com			National Natural Science Foundation of China [81171857]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81171857). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2014, J AM COLL SURGEONS, V218, P1215, DOI 10.1016/j.jamcollsurg.2014.02.015; Ahmad SA, 2012, ANN SURG, V256, P529, DOI 10.1097/SLA.0b013e318265ef0b; Bartlett EK, 2014, SURGERY, V156, P298, DOI 10.1016/j.surg.2014.03.022; Braga M, 2009, CLIN NUTR, V28, P378, DOI 10.1016/j.clnu.2009.04.002; Coburn N, 2014, ANN SURG, V259, P102, DOI 10.1097/SLA.0b013e318288dd2b; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Gavazzi C, 2011, BRIT J NUTR, V106, P1773, DOI 10.1017/S0007114511002509; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jie B, 2012, NUTRITION, V28, P1022, DOI 10.1016/j.nut.2012.01.017; Kassin MT, 2012, J AM COLL SURGEONS, V215, P322, DOI 10.1016/j.jamcollsurg.2012.05.024; Kerwel TG, 2014, DIS COLON RECTUM, V57, P98, DOI 10.1097/DCR.0000000000000007; Kim MC, 2012, ANN SURG ONCOL, V19, P2459, DOI 10.1245/s10434-012-2271-0; Kimbrough CW, 2014, SURGERY, V156, P1039, DOI 10.1016/j.surg.2014.06.057; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; Kulaylat AN, 2015, J SURG RES, V193, P528, DOI 10.1016/j.jss.2014.09.029; Kwaan MR, 2013, DIS COLON RECTUM, V56, P1087, DOI 10.1097/DCR.0b013e31829aa758; Mariette C, 2012, ANN SURG ONCOL, V19, P2128, DOI 10.1245/s10434-012-2225-6; Papenfuss WA, 2014, ANN SURG ONCOL, V21, P3008, DOI 10.1245/s10434-014-3664-z; Ryu SW, 2010, WORLD J GASTROENTERO, V16, P3310, DOI 10.3748/wjg.v16.i26.3310; Schneider EB, 2012, J AM COLL SURGEONS, V215, P607, DOI 10.1016/j.jamcollsurg.2012.07.007; Sellers MM, 2013, J AM COLL SURGEONS, V216, P420, DOI 10.1016/j.jamcollsurg.2012.11.013; Sutton JM, 2014, DIS COLON RECTUM, V57, P1371, DOI 10.1097/DCR.0000000000000227; Thrumurthy SG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6367; Tsai TC, 2013, NEW ENGL J MED, V369, P1134, DOI 10.1056/NEJMsa1303118; Worhunsky DJ, 2015, J NATL COMPR CANC NE, V13, P319, DOI 10.6004/jnccn.2015.0044; Yamamoto M, 2015, J GASTROINTEST ONCOL, V6, P79, DOI 10.3978/j.issn.2078-6891.2014.097; Zhou W, 2013, SURG ENDOSC, V27, P2569, DOI 10.1007/s00464-013-2790-1	29	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125572	10.1371/journal.pone.0125572	http://dx.doi.org/10.1371/journal.pone.0125572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915547	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659100135
J	Tang, N; Deng, W; Hu, GJ; Hu, N; Li, ZG				Tang, Ning; Deng, Wei; Hu, Guojian; Hu, Nan; Li, Zhengguo			Transcriptome Profiling Reveals the Regulatory Mechanism Underlying Pollination Dependent and Parthenocarpic Fruit Set Mainly Mediated by Auxin and Gibberellin	PLOS ONE			English	Article							DOWN-REGULATION; TOMATO; ARABIDOPSIS; EXPRESSION; ETHYLENE; SEED; VISUALIZATION; SENESCENCE; METABOLITE; PROTEIN	Background Fruit set is a key process for crop production in tomato which occurs after successful pollination and fertilization naturally. However, parthenocarpic fruit development can be uncoupled from fertilization triggered by exogenous auxin or gibberellins (GAs). Global transcriptome knowledge during fruit initiation would help to characterize the molecular mechanisms by which these two hormones regulate pollination-dependent and -independent fruit set. Principal Findings In this work, digital gene expression tag profiling (DGE) technology was applied to compare the transcriptomes from pollinated and 2,4-D/GA(3)-treated ovaries. Activation of carbohydrate metabolism, cell division and expansion as well as the down-regulation of MADS-box is a comprehensive regulatory pathway during pollination-dependent and parthenocarpic fruit set. The signaling cascades of auxin and GA are significantly modulated. The feedback regulations of Aux/IAAs and DELLA genes which functioned to fine-tune auxin and GA response respectively play fundamental roles in triggering fruit initiation. In addition, auxin regulates GA synthesis via up-regulation of GA20ox1 and down-regulation of KNOX. Accordingly, the effect of auxin on fruit set is mediated by GA via ARF2 and IAA9 down-regulation, suggesting that both pollination-dependent and parthenocarpic fruit set depend on the crosstalk between auxin and GA. Significance This study characterizes the transcriptomic features of ovary development and more importantly unravels the integral roles of auxin and GA on pollination-dependent and parthenocarpic fruit set.	[Tang, Ning; Deng, Wei; Hu, Guojian; Hu, Nan; Li, Zhengguo] Chongqing Univ, Genet Engn Res Ctr, Sch Life Sci, Key Lab Funct Gene & New Regulat Technol Chongqin, Chongqing 400030, Peoples R China	Chongqing University	Li, ZG (corresponding author), Chongqing Univ, Genet Engn Res Ctr, Sch Life Sci, Key Lab Funct Gene & New Regulat Technol Chongqin, Chongqing 400030, Peoples R China.	zgli6@163.com	Li, Zhengguo/A-5572-2017; Li, Zhengguo/AAR-5191-2020	HU, Guojian/0000-0002-7358-7805; Zhengguo, Li/0000-0002-4643-9540	National High Technology Research and Development Program of China [2012AA101702]; National Basic Research Program of China [2013CB127101, 2013CB127106]; National Natural Science Foundation of China [31272166]; Committee of Science and Technology of Chongqing [2011BA1024]; Fundamental Research Funds for the Central Universities [CDJXS11232245]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology of Chongqing; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National High Technology Research and Development Program of China (2012AA101702), National Basic Research Program of China (2013CB127101, 2013CB127106), National Natural Science Foundation of China (31272166), the Committee of Science and Technology of Chongqing (2011BA1024) and Fundamental Research Funds for the Central Universities (CDJXS11232245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampomah-Dwamena C, 2002, PLANT PHYSIOL, V130, P605, DOI 10.1104/pp.005223; Benjamini Y, 2001, ANN STAT, V29, P1165; Carbonell-Bejerano P, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-84; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de Folter S, 2006, PLANT J, V47, P934, DOI 10.1111/j.1365-313X.2006.02846.x; de Jong M, 2009, PLANT J, V57, P160, DOI 10.1111/j.1365-313X.2008.03671.x; de Jong M, 2009, J EXP BOT, V60, P1523, DOI 10.1093/jxb/erp094; Ding JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070080; Do PT, 2010, PLANT PHYSIOL, V154, P1128, DOI 10.1104/pp.110.163030; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Goetz M, 2007, PLANT PHYSIOL, V145, P351, DOI 10.1104/pp.107.104174; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Hay A, 2002, CURR BIOL, V12, P1557, DOI 10.1016/S0960-9822(02)01125-9; Jin Y, 2009, PLANT CELL, V21, P2072, DOI 10.1105/tpc.108.063719; Kolotilin I, 2007, PLANT PHYSIOL, V145, P389, DOI 10.1104/pp.107.102962; Lefebvre S, 2005, PLANT PHYSIOL, V138, P451, DOI 10.1104/pp.104.055046; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Marti C, 2007, PLANT J, V52, P865, DOI 10.1111/j.1365-313X.2007.03282.x; Martinez C, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-139; Mazzucato A, 2008, PHYSIOL PLANTARUM, V132, P526, DOI 10.1111/j.1399-3054.2007.01035.x; Middleton AM, 2012, P NATL ACAD SCI USA, V109, P7571, DOI 10.1073/pnas.1113666109; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Mounet F, 2012, J EXP BOT, V63, P4901, DOI 10.1093/jxb/ers167; Odanaka S, 2002, PLANT PHYSIOL, V129, P1119, DOI 10.1104/pp.000703; Olimpieri I, 2007, PLANTA, V226, P877, DOI 10.1007/s00425-007-0533-z; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Pascual L, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-67; PIECHULLA B, 1987, PLANT PHYSIOL, V84, P911, DOI 10.1104/pp.84.3.911; PNUELI L, 1994, PLANT CELL, V6, P163, DOI 10.1105/tpc.6.2.163; Richter R, 2013, P NATL ACAD SCI USA, V110, P13192, DOI 10.1073/pnas.1304250110; Ruan YL, 2012, TRENDS PLANT SCI, V17, P656, DOI 10.1016/j.tplants.2012.06.005; Sagar M, 2013, PLANT PHYSIOL, V161, P1362, DOI 10.1104/pp.113.213843; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Serrani JC, 2007, J PLANT GROWTH REGUL, V26, P211, DOI 10.1007/s00344-007-9014-7; Serrani JC, 2008, PLANT J, V56, P922, DOI 10.1111/j.1365-313X.2008.03654.x; Switzenberg JA, 2014, TRANSGENIC RES, P1, DOI [10.1007/s11248-014-9843-7, DOI 10.1007/S11248-014-9843-7]; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Vivian-Smith A, 2000, MOL BASIS INITIATION; Vriezen WH, 2008, NEW PHYTOL, V177, P60, DOI 10.1111/j.1469-8137.2007.02254.x; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; Wang H, 2009, PLANT CELL, V21, P1428, DOI 10.1105/tpc.108.060830; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Zanor MI, 2009, PLANT PHYSIOL, V150, P1204, DOI 10.1104/pp.109.136598; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024	47	47	53	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125355	10.1371/journal.pone.0125355	http://dx.doi.org/10.1371/journal.pone.0125355			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909657	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800139
J	Tseng, CH; Li, JL				Tseng, Chia-huei; Li Jingling			A Salient and Task-Irrelevant Collinear Structure Hurts Visual Search	PLOS ONE			English	Article							DRIVEN ATTENTIONAL CAPTURE; FEATURAL SINGLETONS; COLOR; PROBABILITY; SELECTIVITY; CONTINGENT; IMPLICIT; ONSET; FORM	Salient distractors draw our attention spontaneously, even when we intentionally want to ignore them. When this occurs, the real targets close to or overlapping with the distractors benefit from attention capture and thus are detected and discriminated more quickly. However, a puzzling opposite effect was observed in a search display with a column of vertical collinear bars presented as a task-irrelevant distractor [6]. In this case, it was harder to discriminate the targets overlapping with the salient distractor. Here we examined whether this effect originated from factors known to modulate attentional capture: (a) low probabilitythe probability occurrence of target location at the collinear column was much less (14%) than the rest of the display (86%), and observers might strategically direct their attention away from the collinear distractor; (b) attentional control setting-the distractor and target task interfered with each other because they shared the same continuity set in attentional task; and/or (c) lack of time to establish the optional strategy. We tested these hypotheses by (a) increasing to 60% the trials in which targets overlapped with the same collinear distractor columns, (b) replacing the target task to be connectivity-irrelevant (i.e., luminance discrimination), and (c) having our observers practice the same search task for 10 days. Our results speak against all these hypotheses and lead us to conclude that a collinear distractor impairs search at a level that is unaffected by probabilistic information, attentional setting, and learning.	[Tseng, Chia-huei] Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Li Jingling] China Med Univ, Grad Inst Neural & Cognit Sci, Taichung, Taiwan	University of Hong Kong; China Medical University Taiwan	Li, JL (corresponding author), China Med Univ, Grad Inst Neural & Cognit Sci, Taichung, Taiwan.	jlli@mail.cmu.edu.tw		Jingling, Li/0000-0003-3843-3293	Taiwan National Science Council [NSC-100-2627-B-039-004, NSC101-2410-H-039-001-MY2]; HKU China Affair Office; Hong Kong Grant Research Council; HKU Seed Funding Programme for Basic Research	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); HKU China Affair Office; Hong Kong Grant Research Council; HKU Seed Funding Programme for Basic Research	Dr. Li Jingling was supported by Taiwan National Science Council (NSC-100-2627-B-039-004 and NSC101-2410-H-039-001-MY2) (http://www.most.gov.tw/) and a travel grant by HKU China Affair Office (http://www.als.hku.hk/hkucao/). Dr. Chia-huei Tseng was supported by the Hong Kong Grant Research Council and HKU Seed Funding Programme for Basic Research. (http://www.ugc.edu.hk and http://www.rss.hku.hk/). NTT Research Lab in Japan supported Dr. Tseng during completion of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACON WF, 1994, PERCEPT PSYCHOPHYS, V55, P485, DOI 10.3758/BF03205306; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chow HM, 2013, J VISION, V13, DOI 10.1167/13.10.24; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Chun MM, 2003, J EXP PSYCHOL LEARN, V29, P224, DOI 10.1037/0278-7393.29.2.224; Cohen A, 1999, PERCEPT PSYCHOPHYS, V61, P291, DOI 10.3758/BF03206889; Driver J, 2001, COGNITION, V80, P61, DOI 10.1016/S0010-0277(00)00151-7; Farrell S, 2010, P NATL ACAD SCI USA, V107, P929, DOI 10.1073/pnas.0906845107; Fiser J, 2002, J EXP PSYCHOL LEARN, V28, P458, DOI 10.1037//0278-7393.28.3.458; Fiser J, 2001, PSYCHOL SCI, V12, P499, DOI 10.1111/1467-9280.00392; FOLK CL, 1994, PERCEPT PSYCHOPHYS, V56, P277, DOI 10.3758/BF03209762; Folk CL, 1998, J EXP PSYCHOL HUMAN, V24, P847, DOI 10.1037/0096-1523.24.3.847; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Geng JJ, 2005, PERCEPT PSYCHOPHYS, V67, P1252, DOI 10.3758/BF03193557; Geng JJ, 2002, PSYCHOL SCI, V13, P520, DOI 10.1111/1467-9280.00491; Geyer T, 2008, VISION RES, V48, P1315, DOI 10.1016/j.visres.2008.02.006; Gibson BS, 1998, J EXP PSYCHOL HUMAN, V24, P699, DOI 10.1037/0096-1523.24.3.699; Hess RF, 1998, VISION RES, V38, P783, DOI 10.1016/S0042-6989(97)00333-7; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1987, J NEUROSCI, V7, P3378; Jingling L, 2008, PERCEPTION, V37, P197, DOI 10.1068/p5829; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; Kelley TA, 2009, J VISION, V9, DOI 10.1167/9.7.16; Kimchi R, 2007, PSYCHON B REV, V14, P166, DOI 10.3758/BF03194045; Li JL, 2007, VIS COGN, V15, P661, DOI 10.1080/13506280600926695; Li JL, 2013, J EXP PSYCHOL HUMAN, V39, P156, DOI 10.1037/a0027325; Li Zhaoping, 2005, P570; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; Liu CL, 2010, J NEUROPHYSIOL, V103, P1438, DOI 10.1152/jn.00815.2009; Liu L, 2007, VISION RES, V47, P2627, DOI 10.1016/j.visres.2007.07.001; Mortier K, 2005, J EXP PSYCHOL HUMAN, V31, P542, DOI 10.1037/0096-1523.31.3.542; Mueller HJ, 2009, J EXP PSYCHOL HUMAN, V35, P1, DOI 10.1037/0096-1523.35.1.1; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Roelfsema PR, 2011, ATTEN PERCEPT PSYCHO, V73, P2542, DOI 10.3758/s13414-011-0200-0; Sayim B, 2010, J VISION, V10, DOI 10.1167/10.3.10; SIRETEANU R, 1995, VISION RES, V35, P2037, DOI 10.1016/0042-6989(94)00295-W; Sireteanu R, 2000, VISION RES, V40, P2925, DOI 10.1016/S0042-6989(00)00145-0; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V50, P184, DOI 10.3758/BF03212219; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; Theeuwes J, 2006, VIS COGN, V14, P466, DOI 10.1080/13506280500195110; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Turatto M, 2000, VISION RES, V40, P1639, DOI 10.1016/S0042-6989(00)00061-4; Turatto M, 2001, PERCEPT PSYCHOPHYS, V63, P286, DOI 10.3758/BF03194469; Turk-Browne NB, 2005, J EXP PSYCHOL GEN, V134, P552, DOI 10.1037/0096-3445.134.4.552; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Yeshurun Y, 2009, VISION RES, V49, P1329, DOI 10.1016/j.visres.2008.01.014	46	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124190	10.1371/journal.pone.0124190	http://dx.doi.org/10.1371/journal.pone.0124190			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909986	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800065
J	Young, K; Tweedie, E; Conley, B; Ames, J; FitzSimons, M; Brooks, P; Liaw, L; Vary, CPH				Young, Kira; Tweedie, Eric; Conley, Barbara; Ames, Jacquelyn; FitzSimons, MaryLynn; Brooks, Peter; Liaw, Lucy; Vary, Calvin P. H.			BMP9 Crosstalk with the Hippo Pathway Regulates Endothelial Cell Matricellular and Chemokine Responses	PLOS ONE			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; PULMONARY ARTERIOVENOUS-MALFORMATIONS; TISSUE GROWTH-FACTOR; RECEPTOR-LIKE KINASE-1; FOCAL ADHESION KINASE; TGF-BETA; SIGNALING PATHWAYS; INTEGRIN ALPHA(6)BETA(1); VASCULAR DEVELOPMENT; ENDOGLIN EXPRESSION	Endoglin is a type III TGF beta auxiliary receptor that is upregulated in endothelial cells during angiogenesis and, when mutated in humans, results in the vascular disease hereditary hemorrhagic telangiectasia (HHT). Though endoglin has been implicated in cell adhesion, the underlying molecular mechanisms are still poorly understood. Here we show endoglin expression in endothelial cells regulates subcellular localization of zyxin in focal adhesions in response to BMP9. RNA knockdown of endoglin resulted in mislocalization of zyxin and altered formation of focal adhesions. The mechanotransduction role of focal adhesions and their ability to transmit regulatory signals through binding of the extracellular matrix are altered by endoglin deficiency. BMP/TGF beta transcription factors, SMADs, and zyxin have recently been implicated in a newly emerging signaling cascade, the Hippo pathway. The Hippo transcription coactivator, YAP1 (yes-associated protein 1), has been suggested to play a crucial role in mechanotransduction and cell-cell contact. Identification of BMP9-dependent nuclear localization of YAP1 in response to endoglin expression suggests a mechanism of crosstalk between the two pathways. Suppression of endoglin and YAP1 alters BMP9-dependent expression of YAP1 target genes CCN1 (cysteine-rich 61, CYR61) and CCN2 (connective tissue growth factor, CTGF) as well as the chemokine CCL2 (monocyte chemotactic protein 1, MCP-1). These results suggest a coordinate effect of endoglin deficiency on cell matrix remodeling and local inflammatory responses. Identification of a direct link between the Hippo pathway and endoglin may reveal novel mechanisms in the etiology of HHT.	[Young, Kira; Tweedie, Eric; Conley, Barbara; Ames, Jacquelyn; Brooks, Peter; Liaw, Lucy; Vary, Calvin P. H.] Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA; [Young, Kira; Ames, Jacquelyn; FitzSimons, MaryLynn; Brooks, Peter; Liaw, Lucy; Vary, Calvin P. H.] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME 04469 USA	Maine Medical Center; University of Maine System; University of Maine Orono	Vary, CPH (corresponding author), Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA.	varyc@mmc.org			American Heart Association [14GRNT20460045]; National Institutes of Health [HL083151, HL070865, HL109652, CA91645]; NIH / NIGMS [1P30 GM106391, P30GM103392]; NATIONAL CANCER INSTITUTE [R01CA091645] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109652, R01HL070865, R01HL083151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103392, P30GM106391] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH / NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This Research is supported in part through an American Heart Association grant 14GRNT20460045 (CV), National Institutes of Health grants HL083151 (CV), HL070865 and HL109652 (LL), and CA91645 (PB). Additional support was provided by the institute core facilities in Flow Cytometry and Progenitor Cell Analysis (as supported by NIH / NIGMS 1P30 GM106391, DM Wojchowski, PI) and Protein, Nucleic Acid and Cell Imaging (as supported by NIH / NIGMS P30GM103392, R Friesel, PI). The authors thank Ms. Sarah Coreau for help in the preparation of this manuscript.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Alt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029948; Artemenko Y, 2012, P NATL ACAD SCI USA, V109, P13632, DOI 10.1073/pnas.1211304109; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Berg JN, 1996, J MED GENET, V33, P256, DOI 10.1136/jmg.33.3.256; Bernabeu C, 2007, J CELL BIOCHEM, V102, P1375, DOI 10.1002/jcb.21594; Bianchi-Smiraglia A, 2013, CELL CYCLE, V12, DOI [10.4161/cc.26540, DOI 10.4161/CC.26540]; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Booy AT, 2005, J PROTEOME RES, V4, P325, DOI 10.1021/pr049840t; Bourdeau A, 2000, AM J PATHOL, V156, P911, DOI 10.1016/S0002-9440(10)64960-7; Bourdeau A, 2000, TRENDS CARDIOVAS MED, V10, P279, DOI 10.1016/S1050-1738(01)00062-7; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Burke JP, 2010, BRIT J SURG, V97, P892, DOI 10.1002/bjs.6996; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Chintala H, 2012, J BIOL CHEM, V287, P40570, DOI 10.1074/jbc.M112.386565; Chopra A, 2014, BIOMATERIALS, V35, P71, DOI 10.1016/j.biomaterials.2013.09.066; Conley BA, 2004, J BIOL CHEM, V279, P27440, DOI 10.1074/jbc.M312561200; Cottin V, 2007, J VASC INTERV RADIOL, V18, P938, DOI 10.1016/j.jvir.2006.12.741; Cretu A, 2007, CLIN CANCER RES, V13, P3068, DOI 10.1158/1078-0432.CCR-06-2342; Dakeishi M, 2002, HUM MUTAT, V19, P140, DOI 10.1002/humu.10026; David L, 2008, CIRC RES; David L, 2007, J CELL PHYSIOL, V213, P484, DOI 10.1002/jcp.21126; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Duarte CW, 2014, CANCER EPIDEM BIOMAR, V23, P117, DOI 10.1158/1055-9965.EPI-13-0665; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Duwel A, 2007, TUMOR BIOL, V28, P1, DOI 10.1159/000097040; Dzenko KA, 2005, MICROVASC RES, V70, P53, DOI 10.1016/j.mvr.2005.04.005; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Enderle L, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004208; Fernandez-L A, 2005, CARDIOVASC RES, V68, P235, DOI 10.1016/j.cardiores.2005.06.009; Fernandez-L A, 2006, CLIN MED RES, V4, P66, DOI 10.3121/cmr.4.1.66; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; Fujiyama S, 2003, CIRC RES; Gagne PJ, 2005, AM J PATHOL, V167, P1349, DOI 10.1016/S0002-9440(10)61222-9; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gong Y, 2013, ANGIOGENESIS, V16, P861, DOI 10.1007/s10456-013-9361-x; Grzeszkiewicz TM, 2002, ENDOCRINOLOGY, V143, P1441, DOI 10.1210/en.143.4.1441; Hall-Glenn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030562; Han JS, 2003, EUR J BIOCHEM, V270, P3408, DOI 10.1046/j.1432-1033.2003.03723.x; Herrera B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069535; Hirata Hiroaki, 2008, Commun Integr Biol, V1, P192; Hitchcock JK, 2014, J CELL COMMUN SIGNAL, V8, P125, DOI 10.1007/s12079-014-0231-0; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Hong W, 2012, SEMIN CELL DEV BIOL; Ishida Y, 2012, J CLIN INVEST, V122, P711, DOI 10.1172/JCI43027; Jerkic M, 2006, CARDIOVASC RES, V69, P845, DOI 10.1016/j.cardiores.2005.11.020; Kanellopoulou T, 2013, EXPERT OPIN BIOL TH, V13, P1315, DOI 10.1517/14712598.2013.813478; Kjeldsen A D, 2000, Ugeskr Laeger, V162, P3597; Koleva RI, 2006, J BIOL CHEM, V281, P25110, DOI 10.1074/jbc.M601288200; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lacombe P, 2009, CHEST, V135, P1031, DOI 10.1378/chest.08-1794; Laubli H, 2009, BLOOD, V114, P4583, DOI 10.1182/blood-2008-10-186585; Lamouille S, 2002, BLOOD, V100, P4495, DOI 10.1182/blood.V100.13.4495; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee NY, 2012, MOL BIOL CELL, V23, P2412, DOI 10.1091/mbc.E11-12-0993; Letteboer TGW, 2006, J MED GENET, V43, P371, DOI 10.1136/jmg.2005.035451; Leu SJ, 2003, J BIOL CHEM, V278, P33801, DOI 10.1074/jbc.M305862200; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Li S, 2002, P NATL ACAD SCI USA, V99, P3546, DOI 10.1073/pnas.052018099; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu SC, 2013, BBA-MOL CELL RES, V1833, P1114, DOI 10.1016/j.bbamcr.2012.12.014; Livandovsky YA, 2005, Z NEVROL PSIKHIATRII, P51; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Mahmoud M, 2009, LAB INVEST, V89, P15, DOI 10.1038/labinvest.2008.112; Mancini ML, 2009, DEV DYNAM, V238, P2479, DOI 10.1002/dvdy.22066; Matsubara S, 2000, STROKE, V31, P2653, DOI 10.1161/01.STR.31.11.2653; Mise N, 2012, J BIOL CHEM, V287, P31393, DOI 10.1074/jbc.M112.357624; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Pericacho M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054687; Peter MR, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/767185; Pi LY, 2011, INVEST OPHTH VIS SCI, V52, P8701, DOI 10.1167/iovs.11-7870; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Quandt J, 2004, J NEUROPATH EXP NEUR, V63, P350, DOI 10.1093/jnen/63.4.350; Raghunathan VK, 2013, INVEST OPHTH VIS SCI, V54, P378, DOI 10.1167/iovs.12-11007; Rauskolb C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000624; Reginensi A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003380; REINHARD M, 1995, P NATL ACAD SCI USA, V92, P7956, DOI 10.1073/pnas.92.17.7956; Ricard N, 2012, BLOOD; Rodriguez-Barbero A, 2006, CELL PHYSIOL BIOCHEM, V18, P135, DOI 10.1159/000095181; Romero D, 2011, CANCER RES, V71, P3482, DOI 10.1158/0008-5472.CAN-10-2665; Rossi E, 2013, BLOOD, V121, P403, DOI 10.1182/blood-2012-06-435347; Rottner K, 2001, MOL BIOL CELL, V12, P3103, DOI 10.1091/mbc.12.10.3103; Saluja S, 2004, RADIOLOGY, V230, P25, DOI 10.1148/radiol.2293031482; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Scharpfenecker M, 2012, RADIOTHER ONCOL, V105, P313, DOI 10.1016/j.radonc.2012.08.021; Shovlin CL, 1999, THORAX, V54, P714, DOI 10.1136/thx.54.8.714; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; Smerdel-Ramoya A, 2008, J BIOL CHEM, V283, P22690, DOI 10.1074/jbc.M710140200; STJACQUES S, 1994, BIOL REPROD, V51, P405, DOI 10.1095/biolreprod51.3.405; Suzuki Y, 2010, J CELL SCI, V123, P1684, DOI 10.1242/jcs.061556; Tian HY, 2012, EMBO J, V31, P3885, DOI 10.1038/emboj.2012.246; Torsney E, 2003, CIRCULATION, V107, P1653, DOI 10.1161/01.CIR.0000058170.92267.00; Torsney E, 2002, INFLAMM RES, V51, P464, DOI 10.1007/PL00012413; Turk T, 2009, J HISTOCHEM CYTOCHEM, V57, P623, DOI 10.1369/jhc.2009.953224; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Varelas X, 2012, TRENDS CELL BIOL, V22, P88, DOI 10.1016/j.tcb.2011.10.002; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang Y, 2003, BBA-MOL CELL RES, V1593, P115, DOI 10.1016/S0167-4889(02)00349-X; Weston BS, 2003, J AM SOC NEPHROL, V14, P601, DOI 10.1097/01.ASN.0000051600.53134.B9; Wolf MJ, 2012, CANCER CELL, V22, P91, DOI 10.1016/j.ccr.2012.05.023; Woo JA, 2012, FASEB J, V26, P1672, DOI 10.1096/fj.11-194423; Wu SH, 2008, GROWTH FACTORS, V26, P192, DOI 10.1080/08977190802227828; Wu XP, 2006, MICROVASC RES, V71, P12, DOI 10.1016/j.mvr.2005.11.004; Xu DJ, 2012, BMB REP, V45, P247, DOI 10.5483/BMBRep.2012.45.4.247; Ye L, 2008, MOL CANCER RES, V6, P1594, DOI 10.1158/1541-7786.MCR-08-0171; You JJ, 2014, CELL SIGNAL, V26, P133, DOI 10.1016/j.cellsig.2013.08.026; Young J'nelle S, 2012, Spermatogenesis, V2, P63; Young K, 2012, BLOOD, V120, P4263, DOI 10.1182/blood-2012-07-440784; Yu Y, 2008, EXP CELL RES, V314, P3198, DOI 10.1016/j.yexcr.2008.08.001; Yu YRA, 2013, AM J RESP CELL MOL, V48, P647, DOI 10.1165/rcmb.2012-0182OC; Yue T, 2012, DEV CELL, V22, P255, DOI 10.1016/j.devcel.2011.12.011; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043383	123	30	31	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122892	10.1371/journal.pone.0122892	http://dx.doi.org/10.1371/journal.pone.0122892			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909848	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800022
J	Andani, ME; Tinazzi, M; Corsi, N; Fiorio, M				Andani, Mehran Emadi; Tinazzi, Michele; Corsi, Nicole; Fiorio, Mirta			Modulation of Inhibitory Corticospinal Circuits Induced by a Nocebo Procedure in Motor Performance	PLOS ONE			English	Article							MAGNETIC BRAIN-STIMULATION; TASK-DEPENDENT MODULATION; PLACEBO-INDUCED CHANGES; SILENT PERIOD; INTRACORTICAL INHIBITION; CORTICAL INHIBITION; COIL ORIENTATION; HEALTHY HUMANS; SPINAL-CORD; FATIGUE	As recently demonstrated, a placebo procedure in motor performance increases force production and changes the excitability of the corticospinal system, by enhancing the amplitude of the motor evoked potentials (MEP) and reducing the duration of the cortical silent period (CSP). However, it is not clear whether these neurophysiological changes are related to the behavioural outcome (increased force) or to a general effect of expectation. To clarify this, we investigated the nocebo effect, in which the induced expectation decreases force production. Two groups of healthy volunteers (experimental and control) performed a motor task by pressing a piston with the right index finger. To induce a nocebo effect in the experimental group, low frequency transcutaneous electrical nerve stimulation (TENS) was applied over the index finger with instructions of its detrimental effects on force. To condition the subjects, the visual feedback on their force level was surreptitiously reduced after TENS. Results showed that the experimental group reduced the force, felt weaker and expected a worse performance than the control group, who was not suggested about TENS. By applying transcranial magnetic stimulation over the primary motor cortex, we found that while MEP amplitude remained stable throughout the procedure in both groups, the CSP duration was shorter in the experimental group after the nocebo procedure. The CSP reduction resembled previous findings on the placebo effect, suggesting that expectation of change in performance diminishes the inhibitory activation of the primary motor cortex, independently of the behavioural outcome.	[Andani, Mehran Emadi; Tinazzi, Michele; Corsi, Nicole; Fiorio, Mirta] Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy; [Andani, Mehran Emadi] Univ Isfahan, Dept Biomed Engn, Esfahan, Iran	University of Verona; University of Isfahan	Fiorio, M (corresponding author), Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy.	mirta.fiorio@univr.it	Corsi, Nicole/L-5001-2019; TINAZZI, Michele/J-7134-2018	TINAZZI, Michele/0000-0002-2370-7063; Corsi, Nicole/0000-0002-9577-2753; Fiorio, Mirta/0000-0002-6356-0211; EMADI ANDANI, Mehran/0000-0001-8238-9969				Alaerts K, 2010, EUR J NEUROSCI, V31, P1144, DOI 10.1111/j.1460-9568.2010.07124.x; Amanzio M, 2013, HUM BRAIN MAPP, V34, P738, DOI 10.1002/hbm.21471; Beedie CJ, 2007, INT J SPORT NUTR EXE, V17, P259, DOI 10.1123/ijsnem.17.3.259; Beedie CJ, 2009, SPORTS MED, V39, P313, DOI 10.2165/00007256-200939040-00004; Benedetti F, 2005, J NEUROSCI, V25, P10390, DOI 10.1523/JNEUROSCI.3458-05.2005; Benedetti F, 2003, J NEUROSCI, V23, P4315; Benedetti F, 2011, NEUROPSYCHOPHARMACOL, V36, P339, DOI 10.1038/npp.2010.81; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Butler JE, 2012, CLIN NEUROPHYSIOL, V123, P1409, DOI 10.1016/j.clinph.2011.11.034; CANTELLO R, 1992, NEUROLOGY, V42, P1951; Christie A, 2014, AGE, V36, P749, DOI 10.1007/s11357-013-9577-0; Colloca L, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0419-2; Conte A, 2007, EXP BRAIN RES, V182, P109, DOI 10.1007/s00221-007-0975-3; Coxon JP, 2006, J NEUROPHYSIOL, V95, P3371, DOI 10.1152/jn.01334.2005; Crupi D, 2013, J MOTOR BEHAV, V45, P127, DOI 10.1080/00222895.2012.760514; de la Fuente-Fernandez R, 2004, BIOL PSYCHIAT, V56, P67, DOI 10.1016/j.biopsych.2003.11.019; Djaldetti R, 1996, NEUROLOGY, V46, P632, DOI 10.1212/WNL.46.3.632; Eippert F, 2009, SCIENCE, V326, P404, DOI 10.1126/science.1180142; Fiorio M, 2014, J NEUROSCI, V34, P3993, DOI 10.1523/JNEUROSCI.3931-13.2014; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Geuter S, 2013, J NEUROSCI, V33, P13784, DOI 10.1523/JNEUROSCI.2191-13.2013; Hess A, 1999, EXP BRAIN RES, V124, P321, DOI 10.1007/s002210050629; Hilty L, 2011, EXP PHYSIOL, V96, P505, DOI 10.1113/expphysiol.2010.056226; INGHILLERI M, 1993, J PHYSIOL-LONDON, V466, P521; Kidgell DJ, 2010, HUM MOVEMENT SCI, V29, P631, DOI 10.1016/j.humov.2010.01.004; Klein PA, 2012, J NEUROSCI, V32, P18124, DOI 10.1523/JNEUROSCI.1701-12.2012; Kong J, 2008, J NEUROSCI, V28, P13354, DOI 10.1523/JNEUROSCI.2944-08.2008; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; Krummenacher P, 2010, PAIN, V148, P368, DOI 10.1016/j.pain.2009.09.033; Lutz K, 2012, NEUROPSYCHOLOGIA, V50, P1739, DOI 10.1016/j.neuropsychologia.2012.03.030; Mathis J, 1998, ELECTROMYOGR MOTOR C, V109, P426, DOI 10.1016/S0924-980X(98)00042-3; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Pollo A, 2008, EUR J NEUROSCI, V28, P379, DOI 10.1111/j.1460-9568.2008.06344.x; Pollo A, 2012, EUR J APPL PHYSIOL, V112, P3893, DOI 10.1007/s00421-012-2333-9; Robbins DW, 2010, J STRENGTH COND RES, V24, P2996, DOI 10.1519/JSC.0b013e3181f67474; Rosler K. M., 2008, OXFORD HDB TRANSCRAN, P77; Saisanen L, 2008, J NEUROSCI METH, V169, P231, DOI 10.1016/j.jneumeth.2007.12.005; Schutz-Bosbach S, 2009, J COGNITIVE NEUROSCI, V21, P1215, DOI 10.1162/jocn.2009.21068; Schweinhardt P, 2009, J NEUROSCI, V29, P4882, DOI 10.1523/JNEUROSCI.5634-08.2009; Scott DJ, 2008, ARCH GEN PSYCHIAT, V65, P220, DOI 10.1001/archgenpsychiatry.2007.34; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Stefan K, 2004, J NEUROPHYSIOL, V92, P66, DOI 10.1152/jn.00383.2003; Surakka J, 2005, BIOL SPORT, V22, P301; Tinazzi M, 2003, EXP BRAIN RES, V150, P222, DOI 10.1007/s00221-003-1448-y; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Werhahn KJ, 2007, J CLIN NEUROPHYSIOL, V24, P419, DOI 10.1097/WNP.0b013e3181379a69; Wolters A, 2008, OXFORD HDB TRANSCRAN, P91; Yu RJ, 2014, HUM BRAIN MAPP, V35, P4583, DOI 10.1002/hbm.22496	49	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125223	10.1371/journal.pone.0125223	http://dx.doi.org/10.1371/journal.pone.0125223			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923533	Green Submitted, gold, Green Published			2022-12-27	WOS:000353711600135
J	Gu, FF; Hou, Q; Yang, HH; Zhu, YQ; Guo, XK; Ni, YX; Han, LZ				Gu, Fei-Fei; Hou, Qi; Yang, Hai-Hui; Zhu, Yue-Qiu; Guo, Xiao-Kui; Ni, Yu-Xing; Han, Li-Zhong			Characterization of Staphylococcus aureus Isolated from Non-Native Patients with Skin and Soft Tissue Infections in Shanghai	PLOS ONE			English	Article							OUTBREAK; MRSA; USA300; MANAGEMENT; STRAINS	Background Staphylococcus aureus is one predominant cause of skin and soft-tissue infections (SSTIs), but little information exists regarding the characterization of S. aureus from non-native patients with SSTIs in China. Methods In this study, we enrolled 52 non-native patients with S. aureus SSTIs, and 65 native control patients with S. aureus SSTIs in Shanghai. 52 and 65 S. aureus isolates were collected from both groups, respectively. S. aureus isolates were characterized by antimicrobial susceptibility testing, toxin gene detection, and molecular typing with sequence type, spa type, agr group and SCCmec type. Results Methicillin-resistant S. aureus (MRSA) was detected in 8 non-native patients and 14 native patients with SSTIs. Overall, antimicrobial susceptibilities of S. aureus isolated from non-native patients were found higher than those from native patients. CC59 (ST338 and ST59) was found in a total of 14 isolates (4 from non-native patients; 10 from native patients), 9 of which were carrying lukS/F-PV (3 from non-native patients; 6 from native patients). ST7 was found in 12 isolates and all 12 isolates were found in native patients. The livestock-associated clone ST398 was found in 11 isolates (6 from non-native patients; 5 from native patients), and 5 ST398 lukS/F-PV-positive methicillin-susceptible S. aureus (MSSA) were all discovered among non-native patients. The molecular epidemiology of S. aureus isolated from non-native patients was quite different from those from native patients. lukS/F-PV was more frequent in isolates originating from non-native patients with SSTIs compared to native patients (31 vs. 7, P < 0.0001). Conclusions CC59 was the most common clonal complex among patients with SSTIs in Shanghai. The other most common sequence types were ST7 and Livestock ST398. The molecular epidemiology of S. aureus isolated from non-native patients was quite different from those from native patients. S. aureus isolated from non-native patients was more likely to carry lukS/F-PV.	[Gu, Fei-Fei; Ni, Yu-Xing; Han, Li-Zhong] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Clin Microbiol, Shanghai 200030, Peoples R China; [Hou, Qi; Zhu, Yue-Qiu] Shanghai United Family Hosp, Lab, Shanghai, Peoples R China; [Yang, Hai-Hui] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Clin Lab, Shanghai 200030, Peoples R China; [Guo, Xiao-Kui] Shanghai Jiao Tong Univ, Sch Med, Dept Microbiol & Parasitol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Han, LZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Clin Microbiol, Shanghai 200030, Peoples R China.	hanlizhong1107@163.com		Guo, Xiao-Kui/0000-0002-1595-9965	National Natural Science Foundation of China [81472010]; Research Special Fund for Public Welfare Industry of Health [201002021]; Scientific Research Program of Science and Technology Commission of Shanghai Municipality [14140900602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Special Fund for Public Welfare Industry of Health; Scientific Research Program of Science and Technology Commission of Shanghai Municipality	This study was supported by the National Natural Science Foundation of China (No. 81472010), Research Special Fund for Public Welfare Industry of Health (No. 201002021) and Scientific Research Program of Science and Technology Commission of Shanghai Municipality (No. 14140900602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud O, 2014, EUR J CLIN MICROBIOL, V33, P1757, DOI 10.1007/s10096-014-2127-6; Borgundvaag B, 2013, CAN J EMERG MED, V15, P141, DOI 10.2310/8000.2013.130798; Bourigault C, 2014, PLOS CURRENTS, V6; Chen X, 2012, BURNS, V38, P738, DOI 10.1016/j.burns.2011.12.023; Chen XZ, 2009, ACTA AGR JIANGXI, V9, P008, DOI DOI 10.1371/J0URNAL.P0NE.0072811; Cockerill III FR, 2013, M100S23 WAYN, V33; Dryden MS, 2010, J ANTIMICROB CHEMOTH, V65, piii35, DOI 10.1093/jac/dkq302; Dryden MS, 2009, INT J ANTIMICROB AG, V34, pS2, DOI 10.1016/S0924-8579(09)70541-2; Gould IM, 2009, INT J ANTIMICROB AG, V34, pS8, DOI 10.1016/S0924-8579(09)70542-4; Grant D, 2013, ANN ACAD MED SINGAP, V42, P575; Han LZ, 2010, EMERG INFECT DIS, V16, P731, DOI 10.3201/eid1604.081324; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Ito Teruyo, 2014, Methods Mol Biol, V1085, P131, DOI 10.1007/978-1-62703-664-1_8; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Kaltsas A, 2011, J CLIN MICROBIOL, V49, P2992, DOI 10.1128/JCM.00704-11; Lee H, 2014, J HOSP INFECT, V87, P145, DOI 10.1016/j.jhin.2014.04.003; Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692; Li TS, 2012, OTHER TITL APPL MATH, V126, P1; Maeda T, 2012, J INFECT CHEMOTHER, V18, P906, DOI 10.1007/s10156-012-0506-4; Merritt C, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-26; NeVille-Swensen M, 2011, J PEDIATR HEALTH CAR, V25, P308, DOI 10.1016/j.pedhc.2010.05.005; Otto M, 2013, INT J MED MICROBIOL, V303, P324, DOI 10.1016/j.ijmm.2013.02.007; Qiao YH, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0582-4; Sanchini A, 2013, J HOSP INFECT, V83, P36, DOI 10.1016/j.jhin.2012.09.017; Shore AC, 2014, J CLIN MICROBIOL, V52, P859, DOI 10.1128/JCM.02799-13; Tattevin P, 2012, CLIN INFECT DIS, V55, P781, DOI 10.1093/cid/cis527; Udo EE, 2003, J ANTIMICROB CHEMOTH, V51, P1283, DOI 10.1093/jac/dkg188; Verkade E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100823; Waldenburger S, 2014, J DTSCH DERMATOL GES, V12, P59, DOI 10.1111/ddg.12228; Wu DJ, 2010, DIAGN MICR INFEC DIS, V67, P1, DOI 10.1016/j.diagmicrobio.2009.12.006; Zhao CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038577; Zheng BW, 2015, BRAZ J INFECT DIS, V19, P85, DOI 10.1016/j.bjid.2014.07.006	32	16	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123557	10.1371/journal.pone.0123557	http://dx.doi.org/10.1371/journal.pone.0123557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923531	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600051
J	Johnson, SS; Chevrette, MG; Ehlmann, BL; Benison, KC				Johnson, Sarah Stewart; Chevrette, Marc Gerard; Ehlmann, Bethany L.; Benison, Kathleen Counter			Insights from the Metagenome of an Acid Salt Lake: The Role of Biology in an Extreme Depositional Environment	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; MICROBIAL COMMUNITIES; SALINE LAKES; REFLECTANCE SPECTROSCOPY; HALOMONAS-ELONGATA; WESTERN-AUSTRALIA; MINE DRAINAGE; GEN. NOV.; MERIDIANI; ALIGNMENT	The extremely acidic brine lakes of the Yilgarn Craton of Western Australia are home to some of the most biologically challenging waters on Earth. In this study, we employed meta-genomic shotgun sequencing to generate a microbial profile of the depositional environment associated with the sulfur-rich sediments of one such lake. Of the 1.5 M high-quality reads generated, 0.25 M were mapped to protein features, which in turn provide new insights into the metabolic function of this community. In particular, 45 diverse genes associated with sulfur metabolism were identified, the majority of which were linked to either the conversion of sulfate to adenylylsulfate and the subsequent production of sulfide from sulfite or the oxidation of sulfide, elemental sulfur, and thiosulfate via the sulfur oxidation (Sox) system. This is the first metagenomic study of an acidic, hypersaline depositional environment, and we present evidence for a surprisingly high level of microbial diversity. Our findings also illuminate the possibility that we may be meaningfully underestimating the effects of biology on the chemistry of these sulfur-rich sediments, thereby influencing our understanding of past geobiological conditions that may have been present on Earth as well as early Mars.	[Johnson, Sarah Stewart] Georgetown Univ, Sci Technol & Int Affairs, Washington, DC 20057 USA; [Chevrette, Marc Gerard] Harvard Univ Extens, Grad Program Biotechnol & Bioengn, Cambridge, MA USA; [Ehlmann, Bethany L.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Ehlmann, Bethany L.] CALTECH, Jet Prop Lab, Pasadena, CA 91125 USA; [Benison, Kathleen Counter] W Virginia Univ, Dept Geol & Geog, Morgantown, WV 26506 USA	Georgetown University; California Institute of Technology; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); West Virginia University	Johnson, SS (corresponding author), Georgetown Univ, Sci Technol & Int Affairs, Washington, DC 20057 USA.	sarah.johnson@georgetown.edu	Chevrette, Marc G/N-7895-2016	Chevrette, Marc G/0000-0002-7209-0717	William F. Milton Fund	William F. Milton Fund	This research was supported by a William F. Milton Fund grant to SSJ (http://www.faculty.harvard.edu/scholarship-and-research/grants-enabling-research/william-f-milton-fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anand RR, 2002, AUST J EARTH SCI, V49, P3, DOI 10.1046/j.1440-0952.2002.00912.x; Arahal DR, 2001, INT J SYST EVOL MICR, V51, P1443, DOI 10.1099/00207713-51-4-1443; Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Beer KD, 2014, APPL ENVIRON MICROB, V80, P1821, DOI 10.1128/AEM.03280-13; Beller HR, 2006, J BACTERIOL, V188, P1473, DOI 10.1128/JB.188.4.1473-1488.2006; Benison KC, 2008, ASTROBIOLOGY, V8, P807, DOI 10.1089/ast.2006.0034; Benison KC, 2008, PALAIOS, V23, P571, DOI 10.2110/palo.2008.S05; Benison KC, 2007, J SEDIMENT RES, V77, P366, DOI 10.2110/jsr.2007.038; Benison KC, 2006, ICARUS, V183, P225, DOI 10.1016/j.icarus.2006.02.018; Benison KC, 2013, CHEM GEOL, V351, P154, DOI 10.1016/j.chemgeo.2013.05.018; Benison KC, 1998, NATURE, V392, P911, DOI 10.1038/31917; Benison KC, 2003, ASTROBIOLOGY, V3, P609, DOI 10.1089/153110703322610690; Benison KC, 2001, SEDIMENTOLOGY, V48, P165, DOI 10.1046/j.1365-3091.2001.00362.x; Benison KC, 2014, GEOLOGY, P1; Benison KC, 2000, J SEDIMENTARY RES, V70; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Bodaker I, 2010, ISME J, V4, P399, DOI 10.1038/ismej.2009.141; Bond PL, 2000, APPL ENVIRON MICROB, V66, P4962, DOI 10.1128/AEM.66.11.4962-4971.2000; Bowen BB, 2009, APPL GEOCHEM, V24, P268, DOI 10.1016/j.apgeochem.2008.11.013; BURNS RG, 1987, J GEOPHYS RES-SOLID, V92, pE570, DOI 10.1029/JB092iB04p0E570; Canovas D, 1997, J BIOL CHEM, V272, P25794, DOI 10.1074/jbc.272.41.25794; Challacombe JF, 2013, STAND GENOMIC SCI, V8, P206, DOI 10.4056/sigs.3677284; Chen XG, 2004, LETT APPL MICROBIOL, V39, P495, DOI 10.1111/j.1472-765X.2004.01615.x; CLARK BC, 1979, J GEOPHYS RES, V84, P8395, DOI 10.1029/JB084iB14p08395; Clark DP, 2009, BROCK BIOL MICROORGA, P34; CLARK RN, 1990, J GEOPHYS RES-SOLID, V95, P12653, DOI 10.1029/JB095iB08p12653; DEANGELIS MM, 1995, NUCLEIC ACIDS RES, V23, P4742, DOI 10.1093/nar/23.22.4742; Espana JS, 2005, APPL GEOCHEM, V20, P1320, DOI 10.1016/j.apgeochem.2005.01.011; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Hallberg KB, 2011, EXTREMOPHILES, V15, P271, DOI 10.1007/s00792-011-0359-2; Hawley ER, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01212-13; Jimenez DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052069; Leon MJ, 2014, APPL ENVIRON MICROB, V80, P3850, DOI 10.1128/AEM.00430-14; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kimura S, 2006, BIODEGRADATION, V17, P57, DOI 10.1007/s10532-005-3050-4; Koren S, 2011, BIOINFORMATICS, V27, P2964, DOI 10.1093/bioinformatics/btr520; Kuever J, 2005, BERGEYS MANUAL SYSTE, V2, P988; Kunin V, 2008, MOL SYSTEMS BIOL, V4; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lay CY, 2013, APPL ENVIRON MICROB, V79, P3637, DOI 10.1128/AEM.00153-13; Liu B, 2011, GENOME BIOL, V12, P10, DOI 10.1186/1465-6906-12-S1-P11; Liu YC, 2013, BIOINFORMATICS, V29, P308, DOI [10.1093/bioinformatics/btt688, 10.1093/bioinformatics/bts690]; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Minegishi H, 2010, INT J SYST EVOL MICR, V60, P2513, DOI 10.1099/ijs.0.013722-0; Mormile MR, 2009, ASTROBIOLOGY, V9, P919, DOI 10.1089/ast.2008.0293; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Mwirichia R, 2011, CURR MICROBIOL, V62, P209, DOI 10.1007/s00284-010-9692-4; Nancucheo I, 2012, MICROB BIOTECHNOL, V5, P34, DOI 10.1111/j.1751-7915.2011.00285.x; Norlund KLI, 2010, CHEM GEOL, V275, P235, DOI 10.1016/j.chemgeo.2010.05.014; O'Connor K, 2003, APPL ENVIRON MICROB, V69, P6334, DOI 10.1128/AEM.69.10.6334-6336.2003; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Oren Aharon, 2010, Lakes & Reservoirs Research and Management, V15, P215, DOI 10.1111/j.1440-1770.2010.00435.x; Pastor JM, 2013, J BIOL CHEM, V288, P17769, DOI 10.1074/jbc.M113.470567; Ramana CV, 2009, J GEN APPL MICROBIOL, V55, P301, DOI 10.2323/jgam.55.301; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Roach L, 2007, LUNAR AND PLANETARY; Sanchez-Andrea I, 2015, EXTREMOPHILES, V19, P39, DOI 10.1007/s00792-014-0701-6; Schloss PD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-229; Schwibbert K, 2011, ENVIRON MICROBIOL, V13, P1973, DOI 10.1111/j.1462-2920.2010.02336.x; Squyres SW, 2012, SCIENCE, V336, P570, DOI 10.1126/science.1220476; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Stewart FJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00134; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tindall BJ, 2009, STAND GENOMIC SCI, V1, P270, DOI 10.4056/sigs.42644; Treangen TJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r2; Treangen TJ, 2009, IEEE ACM T COMPUT BI, V6, P180, DOI 10.1109/TCBB.2009.9; Vargas Carmen, 2008, Saline Syst, V4, P14, DOI 10.1186/1746-1448-4-14; Wiggli M, 1999, J MICROBIOL METH, V34, P173, DOI 10.1016/S0167-7012(98)00085-2; Wilke A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-141; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yin HQ, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-179	78	34	36	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122869	10.1371/journal.pone.0122869	http://dx.doi.org/10.1371/journal.pone.0122869			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923206	Green Accepted, gold, Green Published			2022-12-27	WOS:000353711600024
J	Nersisyan, L; Arakelyan, A				Nersisyan, Lilit; Arakelyan, Arsen			Computel: Computation of Mean Telomere Length from Whole-Genome Next-Generation Sequencing Data	PLOS ONE			English	Article							GENE-EXPRESSION; DNA; ALIGNMENT; DISEASE; CANCER; LONG; END	Telomeres are the ends of eukaryotic chromosomes, consisting of consecutive short repeats that protect chromosome ends from degradation. Telomeres shorten with each cell division, leading to replicative cell senescence. Deregulation of telomere length homeostasis is associated with the development of various age-related diseases and cancers. A number of experimental techniques exist for telomere length measurement; however, until recently, the absence of tools for extracting telomere lengths from high-throughput sequencing data has significantly obscured the association of telomere length with molecular processes in normal and diseased conditions. We have developed Computel, a program in R for computing mean telomere length from whole-genome next-generation sequencing data. Computel is open source, and is freely available at https://github.com/lilit-nersisyan/computel. It utilizes a short-read alignment-based approach and integrates various popular tools for sequencing data analysis. We validated it with synthetic and experimental data, and compared its performance with the previously available software. The results have shown that Computel outperforms existing software in accuracy, independence of results from sequencing conditions, stability against inherent sequencing errors, and better ability to distinguish pure telomeric sequences from interstitial telomeric repeats. By providing a highly reliable methodology for determining telomere lengths from whole-genome sequencing data, Computel should help to elucidate the role of telomeres in cellular health and disease.	[Nersisyan, Lilit; Arakelyan, Arsen] Natl Acad Sci Republ Armenia, Inst Mol Biol, Grp Bioinformat, Yerevan, Armenia	National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA	Arakelyan, A (corresponding author), Natl Acad Sci Republ Armenia, Inst Mol Biol, Grp Bioinformat, Yerevan, Armenia.	aarakelyan@sci.am		Arakelyan, Arsen/0000-0002-6851-1056; Nersisyan, Lilit/0000-0001-8525-420X				Aubert G, 2012, MUTAT RES-FUND MOL M, V730, P59, DOI 10.1016/j.mrfmmm.2011.04.003; Azzalin CM, 2001, CHROMOSOMA, V110, P75, DOI 10.1007/s004120100135; Balistreri CR, 2012, REJUV RES, V15, P170, DOI 10.1089/rej.2011.1273; Beirne C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108964; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Buermans HPJ, 2014, BBA-MOL BASIS DIS, V1842, P1932, DOI 10.1016/j.bbadis.2014.06.015; Castle JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-244; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Ding ZH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku181; Guan JZ, 2015, MOL CELL BIOCHEM, V400, P183, DOI 10.1007/s11010-014-2274-1; Hernandez-Caballero E, 2009, BMB REP, V42, P747, DOI 10.5483/BMBRep.2009.42.11.747; Holohan B, 2014, J CELL BIOL, V205, P289, DOI 10.1083/jcb.201401012; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Ishizuka T, 2013, J AM CHEM SOC, V135, P14, DOI 10.1021/ja308481c; Khan S, 2012, CARDIOVASC J AFR, V23, P563, DOI 10.5830/CVJA-2012-056; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Monaghan P, 2010, ANN NY ACAD SCI, V1206, P130, DOI 10.1111/j.1749-6632.2010.05705.x; Montpetit AJ, 2014, NURS RES, V63, P289, DOI 10.1097/NNR.0000000000000037; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; Ottaviani A, 2008, BIOCHIMIE, V90, P93, DOI 10.1016/j.biochi.2007.07.022; Parker M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r113; Pereira B, 2013, CURR OPIN ONCOL, V25, P93, DOI 10.1097/CCO.0b013e32835b6358; Riethman H, 2004, GENOME RES, V14, P18, DOI 10.1101/gr.1245004; Robin JD, 2014, GENE DEV, V28, P2464, DOI 10.1101/gad.251041.114; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Tham WH, 2002, ONCOGENE, V21, P512, DOI 10.1038/sj.onc.1205078; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Wellinger RJ, 2012, GENETICS, V191, P1073, DOI 10.1534/genetics.111.137851; Zakian VA, 2012, EXP CELL RES, V318, P1456, DOI 10.1016/j.yexcr.2012.02.015	34	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125201	10.1371/journal.pone.0125201	http://dx.doi.org/10.1371/journal.pone.0125201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923330	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600133
J	Rizzardi, K; Akerlund, T				Rizzardi, Kristina; Akerlund, Thomas			High Molecular Weight Typing with MALDI-TOF MS - A Novel Method for Rapid Typing of Clostridium difficile	PLOS ONE			English	Article							SURFACE-LAYER PROTEINS; FLIGHT MASS-SPECTROMETRY; IDENTIFICATION; BACTERIA	Clostridium difficile strains were typed by a newly developed MALDI-TOF method, high molecular weight typing, and compared to PCR ribotyping. Among 500 isolates representing 59 PCR ribotypes a total of 35 high molecular weight types could be resolved. Although less discriminatory than PCR ribotyping, the method is extremely fast and simple, and supports for cost-effective screening of isolates during outbreak situations.	[Rizzardi, Kristina; Akerlund, Thomas] Publ Hlth Agcy Sweden, Dept Microbiol, Solna, Sweden	Public Health Agency of Sweden	Akerlund, T (corresponding author), Publ Hlth Agcy Sweden, Dept Microbiol, Solna, Sweden.	thomas.akerlund@folkhalsomyndigheten.se			Swedish Civil Contingencies Agency	Swedish Civil Contingencies Agency	The study was supported by the Swedish Civil Contingencies Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlund T, 2011, EURO SURVEILL, V16; Ausiello CM, 2006, MICROBES INFECT, V8, P2640, DOI 10.1016/j.micinf.2006.07.009; Bianco M, 2011, J MED MICROBIOL, V60, P1162, DOI 10.1099/jmm.0.029694-0; Calabi E, 2002, INFECT IMMUN, V70, P5770, DOI 10.1128/IAI.70.10.5770-5778.2002; Calabi E, 2001, MOL MICROBIOL, V40, P1187, DOI 10.1046/j.1365-2958.2001.02461.x; Carbonnelle E, 2012, J MICROBIOL METH, V89, P133, DOI 10.1016/j.mimet.2012.03.003; Cerquetti M, 2000, MICROB PATHOGENESIS, V28, P363, DOI 10.1006/mpat.2000.0356; Dingle KE, 2013, J INFECT DIS, V207, P675, DOI 10.1093/infdis/jis734; Freiwald A, 2009, NAT PROTOC, V4, P732, DOI 10.1038/nprot.2009.37; Indra A, 2008, J MED MICROBIOL, V57, P1377, DOI 10.1099/jmm.0.47714-0; Knetsch CW, 2013, EUROSURVEILLANCE, V18, P57; Lo Vecchio A, 2012, CURR OPIN GASTROEN, V28, P1, DOI 10.1097/MOG.0b013e32834bc9a9; Madonna AJ, 2000, RAPID COMMUN MASS SP, V14, P2220, DOI 10.1002/1097-0231(20001215)14:23<2220::AID-RCM155>3.0.CO;2-4; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Wright A, 2008, J MED MICROBIOL, V57, P750, DOI 10.1099/jmm.0.47532-0	15	30	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122457	10.1371/journal.pone.0122457	http://dx.doi.org/10.1371/journal.pone.0122457			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923527	gold, Green Submitted, Green Published			2022-12-27	WOS:000353711600015
J	Congedo, M; Afsari, B; Barachant, A; Moakher, M				Congedo, Marco; Afsari, Bijan; Barachant, Alexandre; Moakher, Maher			Approximate Joint Diagonalization and Geometric Mean of Symmetric Positive Definite Matrices	PLOS ONE			English	Article							BLIND SOURCE SEPARATION; RIEMANNIAN GEOMETRY; ELECTROENCEPHALOGRAM; CLASSIFICATION; DISTANCES; METRICS	We explore the connection between two problems that have arisen independently in the signal processing and related fields: the estimation of the geometric mean of a set of symmetric positive definite (SPD) matrices and their approximate joint diagonalization (AJD). Today there is a considerable interest in estimating the geometric mean of a SPD matrix set in the manifold of SPD matrices endowed with the Fisher information metric. The resulting mean has several important invariance properties and has proven very useful in diverse engineering applications such as biomedical and image data processing. While for two SPD matrices the mean has an algebraic closed form solution, for a set of more than two SPD matrices it can only be estimated by iterative algorithms. However, none of the existing iterative algorithms feature at the same time fast convergence, low computational complexity per iteration and guarantee of convergence. For this reason, recently other definitions of geometric mean based on symmetric divergence measures, such as the Bhattacharyya divergence, have been considered. The resulting means, although possibly useful in practice, do not satisfy all desirable invariance properties. In this paper we consider geometric means of covariance matrices estimated on high-dimensional time-series, assuming that the data is generated according to an instantaneous mixing model, which is very common in signal processing. We show that in these circumstances we can approximate the Fisher information geometric mean by employing an efficient AJD algorithm. Our approximation is in general much closer to the Fisher information geometric mean as compared to its competitors and verifies many invariance properties. Furthermore, convergence is guaranteed, the computational complexity is low and the convergence rate is quadratic. The accuracy of this new geometric mean approximation is demonstrated by means of simulations.	[Congedo, Marco; Barachant, Alexandre] CNRS, GIPSA Lab, Grenoble, France; [Congedo, Marco; Barachant, Alexandre] Grenoble Univ, Grenoble, France; [Afsari, Bijan] Johns Hopkins Univ, Ctr Imaging Sci, Baltimore, MD USA; [Moakher, Maher] Natl Engn Sch, LAMSIN, Tunis, Tunisia	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Johns Hopkins University; Universite de Tunis-El-Manar; Ecole Nationale d'Ingenieurs de Tunis (ENIT)	Congedo, M (corresponding author), CNRS, GIPSA Lab, Grenoble, France.	marco.congedo@gmail.com	Moakher, Maher/A-6315-2010; Moakher, Maher/AAZ-3793-2021	Moakher, Maher/0000-0002-9432-0456; barachant, alexandre/0000-0001-8202-6287	 [ERC-2012-AdG-320684-CHESS]		Funding: Author MC in an investigator of the European project ERC-2012-AdG-320684-CHESS and for this research has been partially supported by it. The support consisted in the reimbursement of expenses related to a scientific mission (visit to author MM) and the payment of publication fees. No other funder has supported this research besides the employers of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afsari B, 2008, SIAM J MATRIX ANAL A, V30, P1148, DOI 10.1137/060655997; Afsari B, 2013, SIAM J CONTROL OPTIM, V51, P2230, DOI 10.1137/12086282X; Ando T, 2004, LINEAR ALGEBRA APPL, V385, P305, DOI 10.1016/j.laa.2003.11.019; Arsigny V, 2007, SIAM J MATRIX ANAL A, V29, P328, DOI 10.1137/050637996; Arsigny V, 2006, MAGN RESON MED, V56, P411, DOI 10.1002/mrm.20965; Barachant A, 2012, IEEE T BIO-MED ENG, V59, P920, DOI 10.1109/TBME.2011.2172210; Belouchrani A, 1997, IEEE T SIGNAL PROCES, V45, P434, DOI 10.1109/78.554307; Bhatia R, 2006, LINEAR ALGEBRA APPL, V413, P594, DOI 10.1016/j.laa.2005.08.025; Bhatia R, 2007, PRINC SER APPL MATH, P1; Bhatia R, 2003, LINEAR ALGEBRA APPL, V375, P211, DOI 10.1016/S0024-3795(03)00647-5; Bhatia R, 2013, MATRIX INFORM GEOMET; Bhatia R, 2011, ISIDMS201102 IND STA; Bini DA, 2013, LINEAR ALGEBRA APPL, V438, P1700, DOI 10.1016/j.laa.2011.08.052; Bini DA, 2011, ADV COMPUT MATH, V35, P175, DOI 10.1007/s10444-010-9165-0; CARDOSO JF, 1993, IEE PROC-F, V140, P362, DOI 10.1049/ip-f-2.1993.0054; Cardoso JF, 1998, P IEEE, V86, P2009, DOI 10.1109/5.720250; Charfi M, 2013, LECT NOTES COMPUTER, V8085, P551; Chebbi Z, 2012, LINEAR ALGEBRA APPL, V436, P1872, DOI 10.1016/j.laa.2011.12.003; Comon P, 2010, HANDBOOK OF BLIND SOURCE SEPARATION: INDEPENDENT COMPONENT ANALYSIS AND APPLICATIONS, P1; Congedo M, 2013, EEG SOURCE ANAL, P194; Congedo M, 2008, CLIN NEUROPHYSIOL, V119, P2677, DOI 10.1016/j.clinph.2008.09.007; Fillard P, 2005, LECT NOTES COMPUT SC, V3753, P112, DOI 10.1007/11577812_10; Fillard P, 2007, IEEE T MED IMAGING, V26, P1472, DOI 10.1109/TMI.2007.899173; FLURY BN, 1986, SIAM J SCI STAT COMP, V7, P169, DOI 10.1137/0907013; Forstner W., 1999, QUO VADIS GEODESIA, V113, P113; Georgiou TT, 2007, IEEE T SIGNAL PROCES, V55, P3995, DOI 10.1109/TSP.2007.896119; Goh A, 2008, LECT NOTES ARTIF INT, V5211, P377, DOI 10.1007/978-3-540-87479-9_43; Jeuris B, 2012, ELECTRON T NUMER ANA, V39, P379; Kleinsteuber M, 2013, IEEE T SIGNAL PROCES, V61, P1786, DOI 10.1109/TSP.2013.2242065; Li Y, 2012, IET SIGNAL PROCESS, V6, P288, DOI 10.1049/iet-spr.2011.0234; Li YL, 2013, IEEE J-STSP, V7, P655, DOI 10.1109/JSTSP.2013.2260320; Moakher M, 2006, VISUALIZATION AND PROCESSING OF TENSOR FIELDS, P285, DOI 10.1007/3-540-31272-2_17; Moakher M, 2005, SIAM J MATRIX ANAL A, V26, P735, DOI 10.1137/S0895479803436937; Moakher M., 2012, NEW DEV VISUALIZATIO, P307; Nakamura N, 2009, KYUNGPOOK MATH J, V49, P167; Pennec X, 2004, 5255 INRIA; Pham D-T, 1999, TECHNICAL REPORT; Pham DT, 2001, SIAM J MATRIX ANAL A, V22, P1136, DOI 10.1137/S089547980035689X; Pham DT, 2001, IEEE T SIGNAL PROCES, V49, P1837, DOI 10.1109/78.942614; Poloni F, 2010, ELECTRON J LINEAR AL, V20, P419; Rao C.R., 1945, B CALCUTTA MATH SOC, V37, P81, DOI DOI 10.1007/978-1-4612-0919-5_15; Rentmeesters Q, 2011, EUR SIGNAL PR CONF, P2229; Schott J. R., 1997, MATRIX ANAL STAT; Searle S. R., 1982, MATRIX ALGEBRA USEFU; SKOVGAARD LT, 1984, SCAND J STAT, V11, P211; Sra S, 2013, ARXIV11101773; Sra S, 2012, P ADV NEUR INF PROC, P1; Tichavsky P, 2009, IEEE T SIGNAL PROCES, V57, P878, DOI 10.1109/TSP.2008.2009271; Zhang T, 2014, ARXIV13124654	51	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0121423	10.1371/journal.pone.0121423	http://dx.doi.org/10.1371/journal.pone.0121423			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919667	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659400007
J	Eriksson, EM; Liegler, T; Keh, CE; Karlsson, AC; Holditch, SJ; Pilcher, CD; Loeb, L; Nixon, DF; Hecht, FM				Eriksson, Emily M.; Liegler, Teri; Keh, Chris E.; Karlsson, Annika C.; Holditch, Sara J.; Pilcher, Christopher D.; Loeb, Lisa; Nixon, Douglas F.; Hecht, Frederick M.			Newly Exerted T Cell Pressures on Mutated Epitopes following Transmission Help Maintain Consensus HIV-1 Sequences	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LYMPHOCYTE ESCAPE; VIRAL ESCAPE; INFECTION; EVOLUTION; REVERSION; SELECTION; VARIANTS; GAG; MUTATIONS	CD8(+) T cells are important for HIV-1 virus control, but are also a major contributing factor that drives HIV-1 virus sequence evolution. Although HIV-1 cytotoxic T cell (CTL) escape mutations are a common aspect during HIV-1 infection, less is known about the importance of T cell pressure in reversing HIV-1 virus back to a consensus sequences. In this study we aimed to assess the frequency with which reversion of transmitted mutations in T cell epitopes were associated with T cell responses to the mutation. This study included 14 HIV-1 transmission pairs consisting of a 'source' (virus-donor) and a 'recipient' (newly infected individual). Non-consensus B sequence amino acids (mutations) in T cell epitopes in HIV-1 gag regions p17, p24, p2 and p7 were identified in each pair and transmission of mutations to the recipient was verified with population viral sequencing. Longitudinal analyses of the recipient's viral sequence were used to identify whether reversion of mutations back to the consensus B sequence occurred. Autologous 12-mer peptides overlapping by 11 were synthesized, representing the sequence region surrounding each reversion and longitudinal analysis of T cell responses to source-derived mutated and reverted epitopes were assessed. We demonstrated that mutations in the source were frequently transmitted to the new host and on an average 17 percent of mutated epitopes reverted to consensus sequence in the recipient. T cell responses to these mutated epitopes were detected in 7 of the 14 recipients in whom reversion occurred. Overall, these findings indicate that transmitted non-consensus B epitopes are frequently immunogenic in HLA-mismatched recipients and new T cell pressures to T cell escape mutations following transmission play a significant role in maintaining consensus HIV-1 sequences.	[Eriksson, Emily M.; Keh, Chris E.; Holditch, Sara J.; Nixon, Douglas F.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Expt Med,San Francisco Posit Hlth Program, San Francisco, CA USA; [Liegler, Teri; Pilcher, Christopher D.; Loeb, Lisa; Hecht, Frederick M.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco Posit Hlth Program, San Francisco, CA USA; [Karlsson, Annika C.] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Karolinska Institutet	Eriksson, EM (corresponding author), Walter & Eliza Hall Inst Med Sci, Melbourne, Vic, Australia.	eriksson@wehi.edu.au	Karlsson, Annika/R-2255-2016; Nixon, Douglas/AAU-5734-2020	Karlsson, Annika/0000-0002-2028-8393; Nixon, Douglas/0000-0002-2801-1786; Hecht, Frederick/0000-0002-5782-1171; Loeb Stanga, Lisa/0000-0001-7471-5381; Eriksson, Emily/0000-0002-7851-973X	NIH from National Institute of Allergy and Infectious Diseases [P01 AI071713]; American-Scandinavian Foundation; National Institutes of Health, University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research [P30 AI27763]; T32 Training in HIV Translational Research [AI060530]; National Center for Complementary & Integrative Health [K24AT007827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, T32AI060530, P01AI071713] Funding Source: NIH RePORTER	NIH from National Institute of Allergy and Infectious Diseases; American-Scandinavian Foundation; National Institutes of Health, University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USAUniversity of California System); T32 Training in HIV Translational Research; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This study was supported by NIH Program Project Grant P01 AI071713 from the National Institute of Allergy and Infectious Diseases. E.M.E was supported by a fellowship from the American-Scandinavian Foundation and a grant from the National Institutes of Health, University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research, P30 AI27763. C.E.K. was supported by T32 Training in HIV Translational Research [PI: Diane Havlir, grant number AI060530]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Allen TM, 2005, J VIROL, V79, P12952, DOI 10.1128/JVI.79.20.12952-12960.2005; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Brander C, 1998, J CLIN INVEST, V101, P2559, DOI 10.1172/JCI2405; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Carlson JM, 2014, SCIENCE, V345, DOI 10.1126/science.1254031; Christie NM, 2009, VIROLOGY, V388, P137, DOI 10.1016/j.virol.2009.03.003; Crawford H, 2009, J EXP MED, V206, P909, DOI 10.1084/jem.20081984; Feeney ME, 2005, J IMMUNOL, V174, P7524, DOI 10.4049/jimmunol.174.12.7524; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Furutsuki T, 2004, J VIROL, V78, P8437, DOI 10.1128/JVI.78.16.8437-8445.2004; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Hecht FM, 2002, AIDS, V16, P1119, DOI 10.1097/00002030-200205240-00005; Hecht FM, 2010, AIDS, V24, P941, DOI 10.1097/QAD.0b013e328337b12e; Karlsson AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000225; Keane NM, 2012, IMMUNOL CELL BIOL, V90, P224, DOI 10.1038/icb.2011.34; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KOENIG S, 1995, NAT MED, V1, P330, DOI 10.1038/nm0495-330; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Li B, 2007, J VIROL, V81, P193, DOI 10.1128/JVI.01231-06; Lopez M, 2006, AIDS RES HUM RETROV, V22, P884, DOI 10.1089/aid.2006.22.884; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Milicic A, 2005, J VIROL, V79, P13953, DOI 10.1128/JVI.79.22.13953-13962.2005; Navis M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002422; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Ryland EG, 2010, J VIROL, V84, P12437, DOI 10.1128/JVI.01617-10; Schneidewind A, 2009, J VIROL, V83, P8616, DOI 10.1128/JVI.00730-09; Willberg CB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010249	32	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0120787	10.1371/journal.pone.0120787	http://dx.doi.org/10.1371/journal.pone.0120787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919393	Green Published, gold			2022-12-27	WOS:000353659400004
J	Park, CH; Jeong, YH; Lee, DK; Hwang, JY; Uh, KJ; Yeom, SC; Ahn, C; Lee, CK				Park, Chi-Hun; Jeong, Young-Hee; Lee, Dong-Kyung; Hwang, Jae Yeon; Uh, Kyung-Jun; Yeom, Su-Cheong; Ahn, Curie; Lee, Chang-Kyu			Availability of Empty Zona Pellucida for Generating Embryonic Chimeras	PLOS ONE			English	Article							MOUSE EMBRYOS; AGGREGATION; BLASTOMERES; PANCREAS; CULTURE; ABILITY; CLONES; NUMBER; CELLS; MICE	In the present study we used an empty zona pellucida derived from hatched blastocysts as an alternative source for embryo aggregation and compared results with the conventional microwell method. Denuded 4-cell stage porcine embryos were aggregated by introduction into an empty zona or placement within a concave microwell. The present study showed that although the rate of aggregate formation was similar, the blastocyst rates and allocation of more cells to the inner cell mass (ICM) in the resultant aggregates were increased significantly more in the empty zona than in the microwell. Notably, using an empty zona showed no limitations with regards to the increased number of embryos aggregated or embryonic stages for aggregation, while partial or no aggregation frequently occurred in the microwell. The discrepancy may be due to the difference of microenvironments where the embryos were placed namely, the presence/absence of zona pellucida. We hypothesize the success of the empty zona in generating aggregates is due to the physical aggregation of individual embryos allowing closer contact between the blastomeres and/or embryos compared with a concave microwell. These results indicate that aggregation conditions could influence overall production efficiency and developmental potential of aggregates, suggesting physical restraint via empty zona that provide three-dimensional pressures is an important factor for successful embryo aggregation.	[Park, Chi-Hun; Uh, Kyung-Jun; Yeom, Su-Cheong; Ahn, Curie; Lee, Chang-Kyu] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeong Chang, Kangwon Do, South Korea; [Jeong, Young-Hee] Chonnam Natl Univ, Coll Agr & Life Sci, Gwangju, South Korea; [Lee, Dong-Kyung; Hwang, Jae Yeon; Lee, Chang-Kyu] Seoul Natl Univ, Dept Agr Biotechnol, Anim Biotechnol Major, Seoul, South Korea; [Lee, Dong-Kyung; Hwang, Jae Yeon; Lee, Chang-Kyu] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Yeom, Su-Cheong] Seoul Natl Univ, Int Agr Technol Grad Sch, Pyeong Chang, Kangwon Do, South Korea; [Ahn, Curie] Seoul Natl Univ, Coll Med, Div Nephrol, Seoul, South Korea	Seoul National University (SNU); Chonnam National University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, CK (corresponding author), Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeong Chang, Kangwon Do, South Korea.	leeck@snu.ac.kr	Park, Chi-Hun/J-1258-2019	Park, Chi-Hun/0000-0002-7618-9028; Hwang, Jae Yeon/0000-0002-6493-4182; Yeom, Su Cheong/0000-0002-9491-5740	Biogreen 21 program of Rural development administration [PJ01130012015]; Ministry of Food and Drug Safety, Republic of Korea [KFDA2013-18075]	Biogreen 21 program of Rural development administration(Rural Development Administration (RDA), Republic of Korea); Ministry of Food and Drug Safety, Republic of Korea(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	Funding: This work was supported by Biogreen 21 program (PJ01130012015) of Rural development administration and the Ministry of Food and Drug Safety (KFDA2013-18075), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boiani M, 2003, EMBO J, V22, P5304, DOI 10.1093/emboj/cdg507; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; DEAN J, 1992, J CLIN INVEST, V89, P1055, DOI 10.1172/JCI115684; Eakin GS, 2006, NAT PROTOC, V1, P1145, DOI 10.1038/nprot.2006.173; Jeong YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063241; KASHIWAZAKI N, 1988, EXP ANIM TOKYO, V37, P127, DOI 10.1538/expanim1978.37.2_127; Katayama M, 2010, BIOL REPROD, V82, P1237, DOI 10.1095/biolreprod.109.082982; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Lee SG, 2007, MOL REPROD DEV, V74, P1436, DOI 10.1002/mrd.20728; LEWIS NE, 1982, J EMBRYOL EXP MORPH, V72, P169; Matsunari H, 2013, P NATL ACAD SCI USA, V110, P4557, DOI 10.1073/pnas.1222902110; Misica-Turner PA, 2007, BIOL REPROD, V76, P268, DOI 10.1095/biolreprod.106.050922; MODLINSKI JA, 1970, J EMBRYOL EXP MORPH, V23, P539; MOORE NW, 1968, J REPROD FERTIL, V17, P527, DOI 10.1530/jrf.0.0170527; Moulavi F, 2013, REPRODUCTION, V145, P345, DOI 10.1530/REP-12-0318; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakano K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061900; NIJS M, 1988, HUM REPROD, V3, P999, DOI 10.1093/oxfordjournals.humrep.a136831; Ohta H, 2008, BIOL REPROD, V79, P486, DOI 10.1095/biolreprod.107.067116; Park CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051398; Polejaeva I, 2013, REPRODUCTION, V145, pR81, DOI 10.1530/REP-12-0396; Ribas RC, 2006, BIOL REPROD, V74, P307, DOI 10.1095/biolreprod.105.046284; SAITO S, 1991, BIOL REPROD, V44, P927, DOI 10.1095/biolreprod44.5.927; Siriboon C, 2014, REPROD FERT DEVELOP, V26, P395, DOI 10.1071/RD12243; SUZUKI H, 1995, BIOL REPROD, V53, P78, DOI 10.1095/biolreprod53.1.78; Tam PPL, 2003, DEVELOPMENT, V130, P6155, DOI 10.1242/dev.00893; Tanaka Mika, 2009, V530, P287, DOI 10.1007/978-1-59745-471-1_15; TARKOWSKI AK, 1961, NATURE, V190, P857, DOI 10.1038/190857a0; Terashita Y, 2011, REPROD DOMEST ANIM, V46, P189, DOI 10.1111/j.1439-0531.2010.01614.x; Thouas G. A., 2001, Reprod Biomed Online, V3, P25; TSUNODA Y, 1983, J REPROD FERTIL, V69, P315, DOI 10.1530/jrf.0.0690315; Van Soom A, 2010, REPROD FERT DEVELOP, V22, P21, DOI 10.1071/RD09230; WILLADSEN SM, 1979, NATURE, V277, P298, DOI 10.1038/277298a0; WOOD SA, 1993, P NATL ACAD SCI USA, V90, P4582, DOI 10.1073/pnas.90.10.4582	35	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123178	10.1371/journal.pone.0123178	http://dx.doi.org/10.1371/journal.pone.0123178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919298	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400025
J	Xu, HM; Wang, HS; Xu, QQ; Lv, L; Yin, CH; Liu, XL; Du, HW; Yan, H				Xu, Huimin; Wang, Huasheng; Xu, Qianqian; Lv, Le; Yin, Chunhua; Liu, Xiaolu; Du, Hongwu; Yan, Hai			Pathway for Biodegrading Microcystin-YR by Sphingopyxis sp USTB-05	PLOS ONE			English	Article							CYANOBACTERIAL HEPATOTOXIN; DEGRADING BACTERIUM; ENZYMATIC PATHWAY; FRESH-WATERS; LR; LAKE; DEGRADATION; RR; SEDIMENTS; EXTRACTS	Harmful cyanobacterial blooms in waters have become a global environmental problem, this mainly due to the production and release of various microalgal toxins, in which microcystins (MCs) are distributed widely. Here, we focused on the study of a typical form of microcystins called microcystin-YR (MC-YR). It was found that initial 14.8 mg/L of MC-YR could be completely eliminated within 10 hr by the crude enzymes (CEs) of Sphingopyxis sp. USTB-05, a promising bacterial strain we isolated and identified in our previous study. During the enzymatic biodegradation of MC-YR with time course, the peaks of two intermediate and two final products were observed on the profiles of HPLC at the wavelengths of 238 nm and 230 nm, respectively. Based on the analysis of m/z ratios of MC-YR and its four products by LC-MS/MS, we suggested that at least four enzymes were involved in the biodegradation of MC-YR by Sphingopyxis sp. USTB-05. The first enzyme microcystinase converted cyclic MC-YR to linear MC-YR as the first product. Then the second enzyme serine protease was found to cleave the target peptide bond between alanine (Ala) and tyrosine (Tyr) of linearized MC-YR, producing a tetrapeptide and a tripeptide as second products, which were Adda-Glu-Mdha-Ala and Tyr-Masp-Arg, respectively. Next, the third enzyme peptidase converted the tetrapeptide of Adda-Glu-Mdha-Ala to Adda. And the fourth enzyme cleaved the tripeptide of Tyr-Masp-Arg to produce Tyr and dipeptide (Masp-Arg), which has never been reported. These findings will help us better understand the biodegradation pathway of MC-YR by Sphingopyxis sp. USTB-05.	[Xu, Huimin; Wang, Huasheng; Xu, Qianqian; Lv, Le; Yin, Chunhua; Liu, Xiaolu; Du, Hongwu; Yan, Hai] Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Beijing 100083, Peoples R China	University of Science & Technology Beijing	Yan, H (corresponding author), Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Beijing 100083, Peoples R China.	haiyan@ustb.edu.cn	liu, xiaolu/AAC-6908-2020		National Natural Science Foundation of China [21177009]; Specifical Foundation of Doctoral Program, Ministry of Education, P.R. China [20120006110001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specifical Foundation of Doctoral Program, Ministry of Education, P.R. China	This work was supported by the National Natural Science Foundation of China (No. 21177009) and the Specifical Foundation of Doctoral Program, Ministry of Education, P.R. China (No. 20120006110001).	Bourne DG, 2006, WATER RES, V40, P1294, DOI 10.1016/j.watres.2006.01.022; Chen XG, 2010, WATER RES, V44, P1884, DOI 10.1016/j.watres.2009.11.025; Cousins IT, 1996, WATER RES, V30, P481, DOI 10.1016/0043-1354(95)00189-1; Ding XS, 2006, TOXICON, V48, P973, DOI 10.1016/j.toxicon.2006.07.039; Edwards C, 2008, CHEMOSPHERE, V73, P1315, DOI 10.1016/j.chemosphere.2008.07.015; Eleuterio L, 2010, TOXICON, V55, P1434, DOI 10.1016/j.toxicon.2010.02.020; Harada K, 2004, TOXICON, V44, P107, DOI 10.1016/j.toxicon.2004.04.003; Ho L, 2007, WATER RES, V41, P4685, DOI 10.1016/j.watres.2007.06.057; Holst T, 2003, WATER RES, V37, P4748, DOI 10.1016/S0043-1354(03)00413-5; JONES GJ, 1994, WATER RES, V28, P871, DOI 10.1016/0043-1354(94)90093-0; Kujbida P, 2008, TOXICON, V51, P1274, DOI 10.1016/j.toxicon.2008.02.013; Lahti K, 1997, WATER RES, V31, P1005, DOI 10.1016/S0043-1354(96)00353-3; Lemes GAF, 2008, ECOTOX ENVIRON SAFE, V69, P358, DOI 10.1016/j.ecoenv.2007.03.013; Morgan M, 2014, J GREAT LAKES RES, V40, P215, DOI [10.1016/j.jglr.2013.12.012, DOI 10.1016/J.JGLR.2013.12.012]; Park HD, 2001, ENVIRON TOXICOL, V16, P337, DOI 10.1002/tox.1041; Pouria S, 1998, LANCET, V352, P111, DOI [10.1016/S0140-6736(97)12285-1, DOI 10.1016/S0140-6736(97)12285-1]; Puerto M, 2009, TOXICON, V54, P161, DOI 10.1016/j.toxicon.2009.03.030; Saito T, 2003, FEMS MICROBIOL LETT, V229, P271, DOI 10.1016/S0378-1097(03)00847-4; Shimizu K, 2012, J BIOSCI BIOENG, V114, P630, DOI 10.1016/j.jbiosc.2012.07.004; Smith EA, 2014, HARMFUL ALGAE, V35, P38, DOI 10.1016/j.hal.2014.03.008; Takenaka S, 1997, CHEMOSPHERE, V34, P749, DOI 10.1016/S0045-6535(97)00002-7; Vareli K, 2013, MAR DRUGS, V11, P2751, DOI 10.3390/md11082751; Vasconcelos VM, 2007, TOXICON, V50, P740, DOI 10.1016/j.toxicon.2007.06.010; Vasconcelos VM, 1996, WATER RES, V30, P2377, DOI 10.1016/0043-1354(96)00152-2; Wang JF, 2010, CHINESE J CHEM ENG, V18, P108, DOI 10.1016/S1004-9541(08)60330-4; Xiao CB, 2011, FRONT ENVIRON SCI EN, V5, P526, DOI 10.1007/s11783-010-0261-7; Yan H, 2012, J ENVIRON SCI-CHINA, V24, P1816, DOI 10.1016/S1001-0742(11)61016-4; Yan H, 2012, CHEMOSPHERE, V87, P12, DOI 10.1016/j.chemosphere.2011.11.030; Yang F, 2014, BIODEGRADATION, V25, P447, DOI 10.1007/s10532-013-9673-y	29	83	85	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124425	10.1371/journal.pone.0124425	http://dx.doi.org/10.1371/journal.pone.0124425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919632	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659400050
J	Atkinson, JM; Rank, KB; Zeng, Y; Capen, A; Yadav, V; Manro, JR; Engler, TA; Chedid, M				Atkinson, Jennifer M.; Rank, Kenneth B.; Zeng, Yi; Capen, Andrew; Yadav, Vipin; Manro, Jason R.; Engler, Thomas A.; Chedid, Marcio			Activating the Wnt/beta-Catenin Pathway for the Treatment of Melanoma - Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3	PLOS ONE			English	Article							BETA-CATENIN; TARGET; CANCER; EXPRESSION	It has previously been observed that a loss of beta-catenin expression occurs with melanoma progression and that nuclear beta-catenin levels are inversely proportional to cellular proliferation, suggesting that activation of the Wnt/beta-catenin pathway may provide benefit for melanoma patients. In order to further probe this concept we tested LY2090314, a potent and selective small-molecule inhibitor with activity against GSK3 alpha and GSK3 beta isoforms. In a panel of melanoma cell lines, nM concentrations of LY2090314 stimulated TCF/LEF TOP-Flash reporter activity, stabilized beta-catenin and elevated the expression of Axin2, a Wnt responsive gene and marker of pathway activation. Cytotoxicity assays revealed that melanoma cell lines are very sensitive to LY2090314 in vitro (IC50 similar to 10nM after 72hr of treatment) in contrast to other solid tumor cell lines (IC50 > 10 mu M) as evidenced by caspase activation and PARP cleavage. Cell lines harboring mutant B-RAF or N-RAS were equally sensitive to LY2090314 as were those with acquired resistance to the BRAF inhibitor Vemurafenib. shRNA studies demonstrated that beta-catenin stabilization is required for apoptosis following treatment with the GSK3 inhibitor since the sensitivity of melanoma cell lines to LY290314 could be overcome by beta-catenin knockdown. We further demonstrate that in vivo, LY2090314 elevates Axin2 gene expression after a single dose and produces tumor growth delay in A375 melanoma xenografts with repeat dosing. The activity of LY2090314 in preclinical models suggests that the role of Wnt activators for the treatment of melanoma should be further explored.	[Atkinson, Jennifer M.; Rank, Kenneth B.; Zeng, Yi; Capen, Andrew; Yadav, Vipin; Chedid, Marcio] Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA; [Manro, Jason R.] Eli Lilly & Co, Lilly Res Labs, Stat Discovery, Indianapolis, IN 46285 USA; [Engler, Thomas A.] Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly; Eli Lilly	Chedid, M (corresponding author), Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA.	chedid.marcio@lilly.com	Atkinson, Jennifer/AAE-5466-2019	Atkinson, Jennifer/0000-0001-5164-5114	Eli Lilly and Company Discovery Research	Eli Lilly and Company Discovery Research(Eli Lilly)	This work was supported by Eli Lilly and Company Discovery Research. The funder had roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Arozarena I, 2011, ONCOGENE, V30, P4531, DOI 10.1038/onc.2011.162; Bafico A, 1998, ONCOGENE, V16, P2819, DOI 10.1038/sj.onc.1201797; Biechele TL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002274; Biechele TL, 2010, CHEM BIOL, V17, P1177, DOI 10.1016/j.chembiol.2010.08.012; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Engler TA, 2004, J MED CHEM, V47, P3934, DOI 10.1021/jm049768a; Fattet S, 2009, J PATHOL, V218, P86, DOI 10.1002/path.2514; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Gallagher SJ, 2012, ONCOGENE; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Horvath LG, 2005, INT J CANCER, V113, P415, DOI 10.1002/ijc.20599; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kageshita T, 2001, BRIT J DERMATOL, V145, P210, DOI 10.1046/j.1365-2133.2001.04336.x; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Scholer-Dahirel A, 2011, P NATL ACAD SCI USA, V108, P17135, DOI 10.1073/pnas.1104182108; Sinnberg T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023429; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wang Z, 2010, CANCER CELL, V17, P597, DOI 10.1016/j.ccr.2010.04.024; Williams SP, 2011, CANCER RES, V71, P5374, DOI 10.1158/0008-5472.CAN-10-3026; Yadav V, 2012, J BIOL CHEM; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008	31	65	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125028	10.1371/journal.pone.0125028	http://dx.doi.org/10.1371/journal.pone.0125028			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915038	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100091
J	Elliott, JC; Giesbrecht, B				Elliott, James C.; Giesbrecht, Barry			Distractor Suppression When Attention Fails: Behavioral Evidence for a Flexible Selective Attention Mechanism	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; ELECTROPHYSIOLOGICAL EVIDENCE; SPATIAL ATTENTION; BLINK; LOCUS; LOAD; CORTEX	Despite consistent evidence showing that attention is a multifaceted mechanism that can operate at multiple levels of processing depending on the structure and demands of the task, investigations of the attentional blink phenomenon have consistently shown that the impairment in reporting the second of two targets typically occurs at a late, or post-perceptual, stage of processing. This suggests that the attentional blink phenomenon may represent the operation of a unique attentional mechanism that is not as flexible as other attentional mechanisms. To test whether the attentional blink is a fixed or flexible phenomenon, we manipulated first target task demands (i.e., difficulty) and measured the influence this had on processing a subsequently presented distractor and the second target. If the attentional blink represents a mechanism that is fixed and consistently fails at a single stage of processing, then manipulations of task difficulty should not affect distractor processing. However, if the attentional blink represents a more multifaceted and flexible mechanism, then task difficulty should modulate distractor processing. The results revealed that distractor processing during the AB was attenuated under high task difficulty. In addition, unlike previous studies, we failed to find a correlation between distractor processing and the severity of the attentional blink. Using a simulation, we demonstrate that the previously reported correlations may have been spurious and due to using variables that were not independent. Overall, the present results support the conclusion that the selectivity of attention during the AB is flexible and depends on the structure and demands of the task.	[Elliott, James C.; Giesbrecht, Barry] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Elliott, JC (corresponding author), Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA.	james.elliott@psych.ucsb.edu			Yoga Science Foundation; Institute for Collaborative Biotechnologies from the U.S. Army Research Office [W911NF-09-0001]	Yoga Science Foundation; Institute for Collaborative Biotechnologies from the U.S. Army Research Office	This work was supported by the Yoga Science Foundation and the Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the U.S. Army Research Office. The content of the information does not necessarily reflect the position or the policy of the U.S. Government, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Breitmeyer B.G., 1984, VISUAL MASKING INTEG; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Chua FK, 2001, J EXPT PSYCHOL; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Dell'Acqua R, 2006, PSYCHOPHYSIOLOGY, V43, P394, DOI 10.1111/j.1469-8986.2006.00411.x; Dux PE, 2009, ATTEN PERCEPT PSYCHO, V71, P1683, DOI 10.3758/APP.71.8.1683; Dux PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003330; Elliott JC, 2010, ATTEN PERCEPT PSYCHO, V72, P2106, DOI 10.3758/APP.72.8.2106; Fan J, 2002, J COGNTIVE NEUROSCIE, V14; Giesbrecht B, 2014, ANN NEW YORK ACAD SC; Giesbrecht B, 2007, J COGNITIVE NEUROSCI, V19, P2005, DOI 10.1162/jocn.2007.19.12.2005; Giesbrecht B, 2009, VISION RES, V49, P1378, DOI 10.1016/j.visres.2008.02.013; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Jolicoeur P, 2006, PSYCHOL RES-PSYCH FO, V70, P414, DOI 10.1007/s00426-005-0008-4; Kastner Sabine, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P483, DOI 10.3758/CABN.4.4.483; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; Luck SJ, 1996, NATURE; Maki WS, 1997, J EXP PSYCHOL HUMAN, V23, P1014, DOI 10.1037/0096-1523.23.4.1014; Martens S, 2010, NEUROSCI BIOBEHAV R, V34, P947, DOI 10.1016/j.neubiorev.2009.12.005; McLaughlin EN, 2001, Q J EXP PSYCHOL-A, V54, P169, DOI 10.1080/02724980042000075; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Pashler HE, 1998, PSYCHOL ATTENTION; RAYMOND JE, 1995, J EXP PSYCHOL HUMAN, V21, P653, DOI 10.1037/0096-1523.21.3.653; Serences J.T., 2014, OXFORD HDB ATTENTION, P76; Shapiro K, 1997, PSYCHOL SCI, V8, P95, DOI 10.1111/j.1467-9280.1997.tb00689.x; Shapiro KL, 1997, J EXP PSYCHOL HUMAN, V23, P504, DOI 10.1037/0096-1523.23.2.504; Shore DI, 2001, CAN J EXP PSYCHOL, V55, P318, DOI 10.1037/h0087379; Slagter HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064681; Sy JL, 2013, FRONT HUM NEUROSCI, DOI [10.3389/fnhum.2013.00627/abstract8B684A2E-1341-4E98-9468-B6B9E89D7153, DOI 10.3389/FNHUM.2013.00627/ABSTRACT8B684A2E-1341-4E98-9468-B6B9E89D7153]; Torralbo A, 2008, PSYCHOL SCI, V19, P1045, DOI 10.1111/j.1467-9280.2008.02197.x; Vachon F, 2011, PSYCHOPHYSIOLOGY, V48, P102, DOI 10.1111/j.1469-8986.2010.01040.x; VANSELST M, 1994, Q J EXP PSYCHOL-A, V47, P631, DOI 10.1080/14640749408401131; Vogel EK, 2005, J COGNITIVE NEUROSCI, V17, P1907, DOI 10.1162/089892905775008599; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Woodman GF, 1999, NATURE, V400, P867, DOI 10.1038/23698; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P135, DOI 10.1037/0096-1523.16.1.135	39	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0126203	10.1371/journal.pone.0126203	http://dx.doi.org/10.1371/journal.pone.0126203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915934	gold, Green Submitted, Green Published			2022-12-27	WOS:000353659100153
J	Fang, YX; He, M; Lin, JY; Ma, KJ; Zhao, H; Hong, Z; Li, BX				Fang, You-Xin; He, Meng; Lin, Jun-Yi; Ma, Kai-Jun; Zhao, Hai; Hong, Zhen; Li, Bei-Xu			Suicidal Drownings with Psychiatric Disorders in Shanghai: A Retrospective Study from 2010.1 to 2014.6	PLOS ONE			English	Article							SEASONAL-VARIATION; SCHIZOPHRENIA; RISK; MORTALITY; PSYCHOSIS; AUTOPSY; CHINA	Psychiatric disorders exhibited in 13% suicidal drownings in Southwestern Croatia and 63% in Milan, but in China is unknown. This study is committed to outline the feature of a suicidal drowning with psychiatric disorder, show mental status and reveal key factor to high incidence in China. Immersed corpses were handled by SPSBMPH in its jurisdiction range. Half of immersed corpses were suicidal, and nearly half of suicides had psychiatric disorders. 104 suicidal drownings with psychiatric disorders cases from 2010.1 to 2014.6 were reviewed (21.5% of all immersed corpses, 42.1% of suicides). Most victims clothed normally, and only 2 fastened attached weights. Male victims were more and younger than female. Psycho were prone to commit suicidal drowning in warm and hot season. Psycho were prone to choose familiar area to commit suicide, 45 decedents were found in their familiar areas. Suicidal drowings were occult without suicide attempts, suicide note or abnormal clothing, but showed abnormal mental or behavior changes prior to suicide. The three leading psychiatric disorders were depression (33.7%), depression status (30.8%) and schizophrenia (20.2%). Only 44.2% decedents had visited psychiatric disorder specialist, and merely less than 10% patients could adhere to regular medication. No regular medication on psychiatric disorder was the key factor contributing to high incidence of suicide in psycho. Professional psychiatric and psychological intervention should be taken as soon as possible when they had psychiatric symptoms or suffered misfortune. Guardians should be alert to patients' abnormality to detect their suicidal ideation and intervene, especially in warm season.	[Fang, You-Xin; Hong, Zhen] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [He, Meng; Lin, Jun-Yi; Li, Bei-Xu] Fudan Univ, Sch Basic Med Sci, Dept Forens Med, Shanghai 200433, Peoples R China; [Ma, Kai-Jun] Shanghai Publ Secur Bur, Inst Forens Sci, Shanghai Key Lab Crime Scene Evidence, Shanghai, Peoples R China; [Zhao, Hai] Shanghai Publ Secur Bur, Shanghai Publ Secur Bur Marine Police Headquarter, Shanghai, Peoples R China	Fudan University; Fudan University; Institute of Forensic Science Ministry of Justice PRC	Li, BX (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Forens Med, Shanghai 200433, Peoples R China.	libeixu@gmail.com			Funds for Youth in Department of Forensic Medicine, School of Basic Medical Sciences, Fudan University [FY2014-04]	Funds for Youth in Department of Forensic Medicine, School of Basic Medical Sciences, Fudan University	This study is supported by Funds for Youth in Department of Forensic Medicine, School of Basic Medical Sciences, Fudan University (FY2014-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdacic-Gross V, 2003, SOC SCI MED, V57, P1173, DOI 10.1016/S0277-9536(02)00493-8; Bando DH, 2014, CRISIS, V35, P5, DOI 10.1027/0227-5910/a000222; Brown S, 1997, BRIT J PSYCHIAT, V171, P502, DOI 10.1192/bjp.171.6.502; CALDWELL CB, 1990, SCHIZOPHRENIA BULL, V16, P571, DOI 10.1093/schbul/16.4.571; Cantor CH, 2000, PSYCHOPATHOLOGY, V33, P303, DOI 10.1159/000029162; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; Cheung YB, 2006, J AFFECT DISORDERS, V90, P193, DOI 10.1016/j.jad.2005.11.018; Dutta R, 2012, PSYCHOL MED, V42, P1649, DOI 10.1017/S0033291711002807; Grjibovski AM, 2013, MEDICINA-LITHUANIA, V49, P379, DOI 10.3390/medicina49080059; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9; Hawton K, 2003, PSYCHOL MED, V33, P987, DOI 10.1017/S0033291703007943; He M, 2014, AM J FOREN MED PATH, V35, P218, DOI 10.1097/PAF.0000000000000115; Jeon HJ, 2014, J AFFECT DISORDERS, V166, P206, DOI 10.1016/j.jad.2014.05.010; Law CK, 2013, INT J ENV RES PUB HE, V10, P2825, DOI 10.3390/ijerph10072825; Lopez-Morinigo JD, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0213-z; MILES CP, 1977, J NERV MENT DIS, V164, P231, DOI 10.1097/00005053-197704000-00002; Muccino E, 2015, INT J LEGAL MED, V129, P777, DOI 10.1007/s00414-014-1115-9; Palmer BA, 2005, ARCH GEN PSYCHIAT, V62, P247, DOI 10.1001/archpsyc.62.3.247; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Ran MS, 2003, ACTA PSYCHIAT SCAND, V107, P430, DOI 10.1034/j.1600-0447.2003.02014.x; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Shibre T, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-150; Stemberga V, 2010, AM J FOREN MED PATH, V31, P52, DOI 10.1097/PAF.0b013e3181c215c8	24	6	6	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0121050	10.1371/journal.pone.0121050	http://dx.doi.org/10.1371/journal.pone.0121050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915853	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100005
J	Ramirez, P; Mosley, SB				Ramirez, Pedro, Jr.; Mosley, Sherri Baker			Oil and Gas Wells and Pipelines on US Wildlife Refuges: Challenges for Managers	PLOS ONE			English	Article							CHRONIC ANTHROPOGENIC NOISE; WINTER HABITAT SELECTION; GREATER SAGE-GROUSE; ENERGY DEVELOPMENT; SAGEBRUSH; EMISSIONS; ABUNDANCE; SONGBIRDS; IMPACTS	The increased demand for oil and gas places a burden on lands set aside for natural resource conservation. Oil and gas development alters the environment locally and on a much broader spatial scale depending on the intensity and extent of mineral resource extraction. The current increase in oil and gas exploration and production in the United States prompted an update of the number of pipelines and wells associated with oil and gas production on National Wildlife Refuge System (NWRS) lands. We obtained geospatial data on the location of oil and gas wells and pipelines within and close to the boundaries of NWRS lands (units) acquired as fee simple (i.e. absolute title to the surface land) by the U.S. Fish and Wildlife Service. We found that 5,002 wells are located in 107 NWRS units and 595 pipelines transect 149 of the 599 NWRS units. Almost half of the wells (2,196) were inactive, one-third (1,665) were active, and the remainder of the wells were either plugged and abandoned or the status was unknown. Pipelines crossed a total of 2,155 kilometers (1,339 miles) of NWRS fee simple lands. The high level of oil and gas activity warrants follow up assessments for wells lacking information on production type or well status with emphasis on verifying the well status and identifying abandoned and unplugged wells. NWRS fee simple lands should also be assessed for impacts from brine, oil and other hydrocarbon spills, as well as habitat alteration associated with oil and gas, including the identification of abandoned oil and gas facilities requiring equipment removal and site restoration.	[Ramirez, Pedro, Jr.] US Fish & Wildlife Serv, NWRS, Div Nat Resources & Conservat, Ft Collins, CO 80525 USA; [Mosley, Sherri Baker] US Fish & Wildlife Serv, NWRS, Nat Resource Program Ctr, Ft Collins, CO USA	United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service	Ramirez, P (corresponding author), US Fish & Wildlife Serv, NWRS, Div Nat Resources & Conservat, Ft Collins, CO 80525 USA.	Pedro_Ramirez@fws.gov			U.S. Fish and Wildlife Service National Wildlife Refuge System	U.S. Fish and Wildlife Service National Wildlife Refuge System	Funding was provided by the U.S. Fish and Wildlife Service National Wildlife Refuge System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J., 2014, NUMERICAL SIMULATION; Bayne EM, 2008, CONSERV BIOL, V22, P1186, DOI 10.1111/j.1523-1739.2008.00973.x; Bentley RW, 2002, ENERG POLICY, V30, P189, DOI 10.1016/S0301-4215(01)00144-6; Blickley JL, 2012, CONSERV BIOL, V26, P461, DOI 10.1111/j.1523-1739.2012.01840.x; Boyce MS, 2011, ENERGY DEV WILDLIFE, pix; Doherty KE, 2008, J WILDLIFE MANAGE, V72, P187, DOI 10.2193/2006-454; Esmoil Brent J., 1995, Prairie Naturalist, V27, P81; Fisher J.B., 2005, ENV GEOSCIENCES, V12, P89, DOI DOI 10.1306/EG.11160404039; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; Gilbert MM, 2011, J WILDLIFE MANAGE, V75, P816, DOI 10.1002/jwmg.123; Ground Water Protection Council and ALL Consulting, 2009, MOD SHAL GAS DEV US; Harris T.M., 2005, ENV GEOSCI, V12, P101, DOI [10.1306/eg.11160404041, DOI 10.1306/EG.11160404041]; Hyne NJ., 2012, NONTECHNICAL GUIDE P, V3rd ed.; Interstate Oil and Gas Compact Commission, 2008, PROT OUR COUNTR RES; Jager HI, 2005, ENVIRONMETRICS, V16, P687, DOI 10.1002/env.730; Knick ST, 2003, CONDOR, V105, P611, DOI 10.1650/7329; Knick ST, 2011, STUD AVIAN BIOL, P203; McDonald RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006802; McKenzie LM, 2012, SCI TOTAL ENVIRON, V424, P79, DOI 10.1016/j.scitotenv.2012.02.018; Miesener Thomas O., 2006, OIL GAS PIPELINES NO; North Dakota Department of Health, N DAK DEP HLTH ENV I; Petron G, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016360; Preston TM, 2014, SCI TOTAL ENVIRON, V472, P1152, DOI 10.1016/j.scitotenv.2013.09.027; Ramirez P, 2010, ENVIRON MANAGE, V46, P820, DOI 10.1007/s00267-010-9557-4; Reeves MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077467; Riley T.Z., 2012, WILDLIFE SOC TECHNIC, V1202; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; U.S. Bureau of Land Management, 2012, OIL GAS STAT; U.S. Department of Energy, 2011, PRES OB SETS GOAL RE; U.S. Department of the Interior, US DEP INT EC REP FY; U.S. Energy Information Administration, 2011, REV EM RES US SHAL G; U.S. Energy Information Administration, INT EN OUTL 2013 PRO; U.S. Energy Information Administration, ANN EN OUTL 2013 PRO; U.S. Energy Information Administration, US TOT DISTR WELLS P; U.S. Fish and Wildlife Service, 2008, COMPR CONS PLAN UPP; U.S. Fish and Wildlife Service, ANN REP LANDS CONTR; U.S. General Accounting Office, 2003, GAO03517 US GEN ACC; Warneke C, 2014, ATMOS CHEM PHYS, V14, P10977, DOI 10.5194/acp-14-10977-2014; Williams P, 2005, PROLIFIC PROUND CENT	39	8	8	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124085	10.1371/journal.pone.0124085	http://dx.doi.org/10.1371/journal.pone.0124085			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915417	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659100036
J	Rossi, E; Basso, D; Zambon, CF; Navaglia, F; Greco, E; Pelloso, M; Artuso, S; Padoan, A; Pescarin, M; Aita, A; Bozzato, D; Moz, S; Cananzi, M; Guariso, G; Plebani, M				Rossi, Elisa; Basso, Daniela; Zambon, Carlo-Federico; Navaglia, Filippo; Greco, Eliana; Pelloso, Michela; Artuso, Serena; Padoan, Andrea; Pescarin, Matilde; Aita, Ada; Bozzato, Dania; Moz, Stefania; Cananzi, Mara; Guariso, Graziella; Plebani, Mario			TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SMALL-INTESTINAL MUCOSA; IFN-GAMMA; CYTOKINE RESPONSE; INTERFERON-GAMMA; POLYMORPHISMS; ALPHA; VARIANTS; TIME; SUSCEPTIBILITY	Background TNF-alpha and IFN-gamma play a role in the development of mucosal damage in celiac disease (CD). Polymorphisms of TNFA and IFNG genes, as well as of the TNFRSF1A gene, encoding the TNF-a receptor 1, might underlie different inter-individual disease susceptibility over a common HLA risk background. The aims of this study were to ascertain whether five SNPs in the TNFA promoter (-1031T>C,-857C>T,-376G>A,-308G>A,-238G>A), sequence variants of the TNFRSF1A gene and IFNG +874A>T polymorphism are associated with CD in a HLA independent manner. Methods 511 children (244 CD, 267 controls) were genotyped for HLA, TNFA and INFG (Real Time PCR). TNFRSF1A variants were studied (DHPLC and sequence). Results Only the rare TNFA-1031C (OR=0.65, 95% CI:0.44-0.95), -857T (OR=0.42, 95% CI: 0.27-0.65), -376A (OR= 2.25, 95% CI:1.12-4.51) and -308A (OR= 4.76, 95% CI:3.12-7.26) alleles were significantly associated with CD. One TNFRSF1A variant was identified (c.625+10A>G, rs1800693), but not associated with CD. The CD-correlated TNFA SNPs resulted in six haplotypes. Two haplotypes were control-associated (CCGG and TTGG) and three were CD-associated (CCAG, TCGA and CCGA). The seventeen inferred haplotype combinations were grouped (A to E) based on their frequencies among CD. Binary logistic regression analysis documented a strong association between CD and HLA (OR for intermediate risk haplotypes=178; 95% CI:24-1317; OR for high risk haplotypes=2752; 95% CI:287-26387), but also an HLA-independent correlation between CD and TNFA haplotype combination groups. The CD risk for patients carrying an intermediate risk HLA haplotype could be sub-stratified by TNFA haplotype combinations. Conclusion TNFA promoter haplotypes associate with CD independently from HLA. We suggest that their evaluation might enhance the accuracy in estimating the CD genetic risk.	[Rossi, Elisa; Zambon, Carlo-Federico; Greco, Eliana; Pelloso, Michela; Padoan, Andrea; Aita, Ada; Bozzato, Dania; Moz, Stefania; Plebani, Mario] Univ Padua, Dept Med DIMED, Padua, Italy; [Basso, Daniela; Navaglia, Filippo; Plebani, Mario] Univ Hosp Padova, Dept Lab Med, Padua, Italy; [Artuso, Serena; Pescarin, Matilde; Cananzi, Mara; Guariso, Graziella] Univ Hosp Padova, Dept Women & Childrens Hlth, Unit Pediat Gastroenterol, Padua, Italy	University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova	Basso, D (corresponding author), Univ Hosp Padova, Dept Lab Med, Padua, Italy.	daniela.basso@sanita.padova.it	Plebani, Mario/AAF-4953-2020; Basso, Daniela/J-7855-2016; Padoan, Andrea/J-7869-2016; Bozzato, Dania/AAA-5142-2019; Zambon, Carlo Federico/J-8187-2016; cananzi, mara/AAS-8540-2020; pelloso, michela/K-5615-2018	Basso, Daniela/0000-0001-8745-6171; Padoan, Andrea/0000-0003-1284-7885; Zambon, Carlo Federico/0000-0002-4244-879X; moz, stefania/0000-0002-7485-520X; Pelloso, Michela/0000-0002-2853-4499; Aita, Ada/0000-0001-5497-7544; Cananzi, Mara/0000-0002-7177-2847				Ahn R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036926; Anand SP, 2010, CYTOKINE, V49, P130, DOI 10.1016/j.cyto.2009.11.009; Brottveit M, 2013, AM J GASTROENTEROL, V108, P842, DOI 10.1038/ajg.2013.91; Caruso R, 2014, CLIN SCI, V126, P451, DOI 10.1042/CS20130478; Caso F, 2013, INT J RHEUMATOL, V2013, DOI 10.1155/2013/513782; Cataldo F, 2005, DIGEST LIVER DIS, V37, P923, DOI 10.1016/j.dld.2005.08.001; Catassi C, 1996, ACTA PAEDIATR, V85, P29, DOI 10.1111/j.1651-2227.1996.tb14244.x; Chernavsky AC, 2008, CYTOKINE, V42, P48, DOI 10.1016/j.cyto.2008.01.015; Comabella M, 2013, NEUROLOGY, V80, P2010, DOI 10.1212/WNL.0b013e318294b2d6; D'Osualdo A, 2006, ARTHRITIS RHEUM-US, V54, P998, DOI 10.1002/art.21657; de la Concha EG, 2000, HUM IMMUNOL, V61, P513, DOI 10.1016/S0198-8859(99)00187-1; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fasano A, 2012, NEW ENGL J MED, V367, P2419, DOI 10.1056/NEJMcp1113994; Fernandez S, 2003, EUR J IMMUNOGENET, V30, P141, DOI 10.1046/j.1365-2370.2003.00376.x; Ferstl B, 2004, GENES IMMUN, V5, P405, DOI 10.1038/sj.gene.6364108; Garrote JA, 2002, IMMUNOGENETICS, V54, P551, DOI 10.1007/s00251-002-0498-9; Hajeer AH, 2000, MICROSC RES TECHNIQ, V50, P216, DOI 10.1002/1097-0029(20000801)50:3<216::AID-JEMT5>3.0.CO;2-Q; Huang HR, 2012, GENE, V494, P96, DOI 10.1016/j.gene.2011.09.027; Huang Y, 2007, P NATL ACAD SCI USA, V104, P985, DOI 10.1073/pnas.0609954104; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Koning F, 2012, SEMIN IMMUNOPATHOL, V34, P541, DOI 10.1007/s00281-012-0321-0; Kupfer Sonia S, 2012, Gastrointest Endosc Clin N Am, V22, P639, DOI 10.1016/j.giec.2012.07.003; Lio D, 2005, DIGEST LIVER DIS, V37, P756, DOI 10.1016/j.dld.2005.04.027; Lionetti E, 2014, NEW ENGL J MED, V371, P1295, DOI 10.1056/NEJMoa1400697; Louka AS, 2003, IMMUNOGENETICS, V55, P339, DOI 10.1007/s00251-003-0586-5; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Marchenko YV, 2008, STATA J, V8, P305, DOI 10.1177/1536867X0800800301; McGonagle D, 2009, PEDIATR RES, V65, p38R, DOI 10.1203/PDR.0b013e31819dbd0a; Megiorni F, 2009, HUM IMMUNOL, V70, P55, DOI 10.1016/j.humimm.2008.10.018; Mourao AF, 2009, J RHEUMATOL, V36, P837, DOI 10.3899/jrheum.080615; Negm OH, 2014, EUR J IMMUNOL, V44, P2096, DOI 10.1002/eji.201344328; Nilsen EM, 1998, GASTROENTEROLOGY, V115, P551, DOI 10.1016/S0016-5085(98)70134-9; O'Dwyer MJ, 2008, INT J IMMUNOGENET, V35, P279, DOI 10.1111/j.1744-313X.2008.00773.x; Oberhuber G, 2000, BIOMED PHARMACOTHER, V54, P368, DOI 10.1016/S0753-3322(01)80003-2; Ottoboni L, 2013, NEUROLOGY, V81, P1891, DOI 10.1212/01.wnl.0000436612.66328.8a; Palova-Jelinkova L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062426; Romanos J, 2014, GUT, V63, P415, DOI 10.1136/gutjnl-2012-304110; Ruiz-Ortiz E, 2014, TISSUE ANTIGENS, V84, P545, DOI 10.1111/tan.12472; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Sumnik Z, 2006, DIABETES CARE, V29, P858, DOI 10.2337/diacare.29.04.06.dc05-1923; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Villanacci V, 2015, DIGEST LIVER DIS, V47, P2, DOI 10.1016/j.dld.2014.09.022; Villanacci V, 2011, DIGEST LIVER DIS, V43, pS385, DOI 10.1016/S1590-8658(11)60594-X; Westerholm-Ormio M, 2003, DIABETES, V52, P2287, DOI 10.2337/diabetes.52.9.2287; Westerholm-Ormio M, 2002, CLIN EXP IMMUNOL, V128, P94, DOI 10.1046/j.1365-2249.2002.01798.x; Zambon CF, 2005, CYTOKINE, V29, P141, DOI 10.1016/j.cyto.2004.10.013; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	48	3	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123244	10.1371/journal.pone.0123244	http://dx.doi.org/10.1371/journal.pone.0123244			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915602	Green Published, gold			2022-12-27	WOS:000353659100017
J	Salm, F; Dimitrova, V; von Bueren, AO; Cwiek, P; Rehrauer, H; Djonov, V; Anderle, P; Arcaro, A				Salm, Fabiana; Dimitrova, Valeriya; von Bueren, Andre O.; Cwiek, Paulina; Rehrauer, Hubert; Djonov, Valentin; Anderle, Pascale; Arcaro, Alexandre			The Phosphoinositide 3-Kinase p110 alpha Isoform Regulates Leukemia Inhibitory Factor Receptor Expression via c-Myc and miR-125b to Promote Cell Proliferation in Medulloblastoma	PLOS ONE			English	Article							GROWTH-FACTOR; ONCOGENIC TRANSFORMATION; CANCER; PATHWAY; PROGRESSION; MICRORNA; CHEMORESISTANCE; AMPLIFICATION; P110-GAMMA; SIGNATURES	Medulloblastoma (MB) is the most common malignant brain tumor in childhood and represents the main cause of cancer-related death in this age group. The phosphoinositide 3-kinase (PI3K) pathway has been shown to play an important role in the regulation of medulloblastoma cell survival and proliferation, but the molecular mechanisms and downstream effectors underlying PI3K signaling still remain elusive. The impact of RNA interference (RNAi)-mediated silencing of PI3K isoforms p110 alpha and p110 delta on global gene expression was investigated by DNA microarray analysis in medulloblastoma cell lines. A subset of genes with selectively altered expression upon p110 alpha silencing in comparison to silencing of the closely related p110 delta isoform was revealed. Among these genes, the leukemia inhibitory factor receptor alpha (LIFR alpha) was validated as a novel p110 alpha target in medullo-blastoma. A network involving c-Myc and miR-125b was shown to be involved in the control of LIFR alpha expression downstream of p110 alpha. Targeting the LIFR alpha by RNAi, or by using neutralizing reagents impaired medulloblastoma cell proliferation in vitro and induced a tumor volume reduction in vivo. An analysis of primary tumors revealed that LIFR alpha and p110 alpha expression were elevated in the sonic hedgehog (SHH) subgroup of medulloblastoma, indicating its clinical relevance. Together, these data reveal a novel molecular signaling network, in which PI3K isoform p110 alpha controls the expression of LIFR alpha via c-Myc and miR-125b to promote MB cell proliferation.	[Salm, Fabiana; Dimitrova, Valeriya; Cwiek, Paulina; Arcaro, Alexandre] Univ Bern, Dept Clin Res, Div Pediat Hematol Oncol, Bern, Switzerland; [von Bueren, Andre O.] Univ Gottingen, Dept Pediat, Gottingen, Germany; [von Bueren, Andre O.] Univ Gottingen, Dept Pediat Hematol & Oncol, D-37073 Gottingen, Germany; [Rehrauer, Hubert] ETH, Funct Genom Ctr Zurich, Zurich, Switzerland; [Rehrauer, Hubert] Univ Zurich, Zurich, Switzerland; [Djonov, Valentin] Univ Bern, Inst Anat, Bern, Switzerland; [Anderle, Pascale] Univ Bern, Inst Biochem & Mol Med, Swiss Natl Ctr Competence Res TransCure, Bern, Switzerland; [Anderle, Pascale] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Natl Ctr Competence Res Mol Oncol, Swiss Inst Expt Canc Res, Lausanne, Switzerland; [Anderle, Pascale] Swiss Inst Bioinformat, Lausanne, Switzerland	University of Bern; University of Gottingen; University of Gottingen; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Bern; University of Bern; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Swiss Institute of Bioinformatics	Arcaro, A (corresponding author), Univ Bern, Dept Clin Res, Div Pediat Hematol Oncol, Bern, Switzerland.	alexandre.arcaro@dkf.unibe.ch	von Bueren, Andre/AAF-2065-2020; Arcaro, Alexandre/G-1711-2010	Arcaro, Alexandre/0000-0001-9107-2947; von Bueren, Andre/0000-0003-4197-6264; Djonov, Valentin/0000-0002-5062-1169; Bronnimann, Paulina/0000-0001-7574-8214; Cwiek, Paulina/0000-0002-0964-6364	European Union's Seventh Framework Programme (FP7) [259348]; Fondation FORCE; Hartmann Muller-Stiftung; Ida de Pottere-Leupold-Fonds zur Forderung der Krebsforschung; Berner Stiftung fur krebskranke Kinder und Jugendliche	European Union's Seventh Framework Programme (FP7); Fondation FORCE; Hartmann Muller-Stiftung; Ida de Pottere-Leupold-Fonds zur Forderung der Krebsforschung; Berner Stiftung fur krebskranke Kinder und Jugendliche	This work was supported by a grant from the Fondation FORCE, Hartmann Muller-Stiftung, Ida de Pottere-Leupold-Fonds zur Forderung der Krebsforschung, Berner Stiftung fur krebskranke Kinder und Jugendliche. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 259348. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaro A, 2007, CURR GENOMICS, V8, P271, DOI 10.2174/138920207782446160; Ball S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018820; Bandopadhayay P, 2014, CLIN CANCER RES, V20, P912, DOI 10.1158/1078-0432.CCR-13-2281; Baryawno N, 2010, CANCER RES, V70, P266, DOI 10.1158/0008-5472.CAN-09-0578; Baxter EW, 2010, J NEURO-ONCOL, V97, P373, DOI 10.1007/s11060-009-0043-x; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Castelletti D, 2010, MOL CANCER THER, V9, P3145, DOI 10.1158/1535-7163.MCT-10-0539; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Corno D, 2012, CANCER DISCOV, V2, P554, DOI 10.1158/2159-8290.CD-11-0199; David E, 2012, AM J PATHOL, V181, P1782, DOI 10.1016/j.ajpath.2012.07.023; Del Valle L, 2002, CLIN CANCER RES, V8, P1822; Dhingra K, 1998, BREAST CANCER RES TR, V48, P165, DOI 10.1023/A:1005942923757; Dudu V, 2012, CELL MOL BIOENG, V5, P402, DOI 10.1007/s12195-012-0253-8; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; Fiaschetti G, 2011, ONCOGENE, V30, P2823, DOI 10.1038/onc.2011.10; FRIEDMAN HS, 1988, AM J PATHOL, V130, P472; Geoerger B, 2001, CANCER RES, V61, P1527; Gilbertson R, 2002, EUR J CANCER, V38, P675, DOI 10.1016/S0959-8049(01)00315-X; Grotzer MA, 2009, CURR CANCER DRUG TAR, V9, P176, DOI 10.2174/156800909787580962; Guerreiro AS, 2008, CLIN CANCER RES, V14, P6761, DOI 10.1158/1078-0432.CCR-08-0385; Guerreiro AS, 2011, MOL CANCER RES, V9, P925, DOI 10.1158/1541-7786.MCR-10-0200; Hagedorn M, 2005, P NATL ACAD SCI USA, V102, P1643, DOI 10.1073/pnas.0408622102; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; Henssen A, 2013, ONCOTARGET, V4, DOI 10.18632/oncotarget.1534; Hernan R, 2003, CANCER RES, V63, P140; Holand K, 2011, CURR CANCER DRUG TAR, V11, P894, DOI 10.2174/156800911797264743; Hu Y, 2011, RNA BIOL, V8, P861, DOI 10.4161/rna.8.5.16034; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kang J, 2008, ONCOGENE, V27, P3999, DOI 10.1038/onc.2008.15; Kang S, 2006, P NATL ACAD SCI USA, V103, P1289, DOI 10.1073/pnas.0510772103; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Korshunov A, 2012, ACTA NEUROPATHOL, V123, P515, DOI 10.1007/s00401-011-0918-8; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Liu J, 1999, J CANCER RES CLIN, V125, P475, DOI 10.1007/s004320050304; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Massimino M, 2011, CRIT REV ONCOL HEMAT, V79, P65, DOI 10.1016/j.critrevonc.2010.07.010; Morfouace M, 2014, CANCER CELL, V25, P516, DOI 10.1016/j.ccr.2014.02.009; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Peng SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102403; Pocza T, 2014, PATHOL ONCOL RES; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Reynolds CP, 2012, PEDIAT BLOOD CANC; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Roussel MF, 2013, COLD SPRING HARB PER, V3, DOI [10.1101/cshperspecta015552, DOI 10.1101/CSHPERSPECTA015552]; Stearns D, 2006, CANCER RES, V66, P673, DOI 10.1158/0008-5472.CAN-05-1580; Tan J, 2013, CANCER DISCOV, V3, P1156, DOI 10.1158/2159-8290.CD-12-0595; Trouillas M, 2009, EUR CYTOKINE NETW, V20, P51, DOI 10.1684/ecn.2009.0148; von Bueren AO, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-19; von Bueren AO, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-10; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wetmore C, 2001, CANCER RES, V61, P513; Wu CH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000090; Wysoczynski M, 2007, CANCER RES, V67, P2131, DOI 10.1158/0008-5472.CAN-06-1021; Yu HG, 2008, INT J CANCER, V122, P433, DOI 10.1002/ijc.23049; Zhou LM, 2010, CANCER RES, V70, P8199, DOI 10.1158/0008-5472.CAN-09-4562	64	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123958	10.1371/journal.pone.0123958	http://dx.doi.org/10.1371/journal.pone.0123958			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915540	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000353659100030
J	Bartz, KK; Ford, MJ; Beechie, TJ; Fresh, KL; Pess, GR; Kennedy, RE; Rowse, ML; Sheer, M				Bartz, Krista K.; Ford, Michael J.; Beechie, Timothy J.; Fresh, Kurt L.; Pess, George R.; Kennedy, Robert E.; Rowse, Melinda L.; Sheer, Mindi			Trends in Developed Land Cover Adjacent to Habitat for Threatened Salmon in Puget Sound, Washington, USA	PLOS ONE			English	Article							FOREST DISTURBANCE; UNITED-STATES; RIVER; PATTERNS; STREAMS; VARIABILITY; NORTHWEST; EXTENT; AREA	For widely distributed species at risk, such as Pacific salmon (Oncorhynchus spp.), habitat monitoring is both essential and challenging. Only recently have widespread monitoring programs been implemented for salmon habitat in the Pacific Northwest. Remote sensing data, such as Landsat images, are therefore a useful way to evaluate trends prior to the advent of species-specific habitat monitoring programs. We used annual (1986-2008) land cover maps created from Landsat images via automated algorithms (LandTrendr) to evaluate trends in developed (50-100% impervious) land cover in areas adjacent to five types of habitat utilized by Chinook salmon (O. tshawytscha) in the Puget Sound region of Washington State, U.S.A. For the region as a whole, we found significant increases in developed land cover adjacent to each of the habitat types evaluated (nearshore, estuary, mainstem channel, tributary channel, and floodplain), but the increases were small (<1% total increase from 1986 to 2008). For each habitat type, the increasing trend changed during the time series. In nearshore, mainstem, and floodplain areas, the rate of increase in developed land cover slowed in the latter portion of the time series, while the opposite occurred in estuary and tributary areas. Watersheds that were already highly developed in 1986 tended to have higher rates of development than initially less developed watersheds. Overall, our results suggest that developed land cover in areas adjacent to Puget Sound salmon habitat has increased only slightly since 1986 and that the rate of change has slowed near some key habitat types, although this has occurred within the context of a degraded baseline condition.	[Bartz, Krista K.; Ford, Michael J.; Rowse, Melinda L.; Sheer, Mindi] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98112 USA; [Beechie, Timothy J.; Fresh, Kurt L.; Pess, George R.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Fish Ecol Div, Seattle, WA 98112 USA; [Kennedy, Robert E.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University	Ford, MJ (corresponding author), NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98112 USA.	mike.ford@noaa.gov			National Marine Fisheries Service	National Marine Fisheries Service	This work was funded by the National Marine Fisheries Service.	Al-Chokhachy R, 2011, T AM FISH SOC, V140, P399, DOI 10.1080/00028487.2011.567865; Alberti M, 2007, LANDSCAPE URBAN PLAN, V80, P345, DOI 10.1016/j.landurbplan.2006.08.001; Anchor QEA LLC, 2009, FIN GEOSP METH US PS; Anlauf KJ, 2011, AQUAT CONSERV, V21, P704, DOI 10.1002/aqc.1221; Anlauf KJ, 2011, T AM FISH SOC, V140, P52, DOI 10.1080/00028487.2010.550496; Bagan H, 2014, ENVIRON RES LETT, V9; Beamer E, 1998, JUVENILE SALMOID USE; Beechie T, 2013, RIVER RES APPL, V29, P939, DOI 10.1002/rra.2590; Beechie T., 1994, North American Journal of Fisheries Management, V14, P797, DOI 10.1577/1548-8675(1994)014<0797:ECSRHA>2.3.CO;2; Beechie TJ, 2006, CAN J FISH AQUAT SCI, V63, P1242, DOI 10.1139/F06-015; Beechie TJ, 2001, WATER SCI APPL, V4, P37; Beechie TJ, 2003, NMFSNWFSC58 NOAA; Booth DB, 1997, J AM WATER RESOUR AS, V33, P1077, DOI 10.1111/j.1752-1688.1997.tb04126.x; Booth DB, 2002, J AM WATER RESOUR AS, V38, P835, DOI 10.1111/j.1752-1688.2002.tb01000.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Campbell SP, 2002, ECOL APPL, V12, P674, DOI 10.1890/1051-0761(2002)012[0674:AAOMEI]2.0.CO;2; Cohen WB, 2004, BIOSCIENCE, V54, P535, DOI 10.1641/0006-3568(2004)054[0535:LRIEAO]2.0.CO;2; FEMAT (Forest Ecosystem Management Assessment Team), 1993, FOR EC MAN EC EC SOC; Ford M, 2011, NOAATMNWFSC113 US DE; Fullerton AH, 2006, LANDSCAPE ECOL, V21, P1347, DOI 10.1007/s10980-006-0017-8; Gregory S, 1997, PACIFIC SALMON THEIR; Groot C., 1991, PACIFIC SALMON LIFE; Hohensinner S, 2004, RIVER RES APPL, V20, P25, DOI 10.1002/rra.719; Homer C, 2007, PHOTOGRAMM ENG REM S, V73, P337; HUDSON DJ, 1966, J AM STAT ASSOC, V61, P1097, DOI 10.2307/2283203; Jones KB, 2010, LANDSCAPE ECOL, V25, P1261, DOI 10.1007/s10980-010-9510-1; Judge M, 2011, 2011 IMPLEMENTATON S; Katz SL, 2007, RESTOR ECOL, V15, P494, DOI 10.1111/j.1526-100X.2007.00245.x; Kennedy RE, 2011, DEV YEARLY MAPS LAND; Kennedy RE, 2012, REMOTE SENS ENVIRON, V122, P117, DOI 10.1016/j.rse.2011.09.024; Kennedy RE, 2010, REMOTE SENS ENVIRON, V114, P2897, DOI 10.1016/j.rse.2010.07.008; Konrad C, GEOSPATIAL IN PRESS; Lawler JJ, 2002, ECOL APPL, V12, P663, DOI 10.2307/3060975; Morley SA, 2002, CONSERV BIOL, V16, P1498, DOI 10.1046/j.1523-1739.2002.01067.x; Muggeo V.M., 2008, R NEWS, V8, P20; Myers JM, 1998, NMFSNWFSC35; Nagendra H, 2013, ECOL INDIC, V33, P45, DOI 10.1016/j.ecolind.2012.09.014; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; NMFS, 2014, SALM STEELH SURV FCR; NOAA Fisheries Service, 2011, 2011 REP C PAC COAST; Pess GR, 2002, CAN J FISH AQUAT SCI, V59, P613, DOI 10.1139/F02-035; PFMC, 2014, REV 2013 OC SALM FIS; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Quinn Thomas P., 2005, P1; Sexton JO, 2013, REMOTE SENS ENVIRON, V129, P42, DOI 10.1016/j.rse.2012.10.025; Shared Strategy Development Committee, 2007, PUGET SOUND SALM REC, V1; Simenstad CA, 2011, 201101 US ARM CORPS; Sleeter BM, 2013, GLOBAL ENVIRON CHANG, V23, P733, DOI 10.1016/j.gloenvcha.2013.03.006; State of Washington, 2013, FORCAST STATE POPULA; State of Washington, 2014, MED HOUS INC EST COU; Treaty Indian Tribes in Western Washington, 2011, TREAT RIGHTS RISK ON; United States Geological Survey (USGS), 2009, GET NHD DAT; US Census Bureau, 1995, HIST POP COUNTS 1900; Washington State Department of Natural Resources (WDNR), 2006, WASH STAT WAT BODY H	56	11	11	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124415	10.1371/journal.pone.0124415	http://dx.doi.org/10.1371/journal.pone.0124415			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923327	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600085
J	Lim, FL; Hashim, Z; Than, LTL; Said, SM; Hashim, JH; Norback, D				Lim, Fang Lee; Hashim, Zailina; Than, Leslie Thian Lung; Said, Salmiah Md; Hashim, Jamal Hisham; Norback, Dan			Asthma, Airway Symptoms and Rhinitis in Office Workers in Malaysia: Associations with House Dust Mite (HDM) Allergy, Cat Allergy and Levels of House Dust Mite Allergens in Office Dust	PLOS ONE			English	Article							SICK BUILDING SYNDROME; RESPIRATORY SYMPTOMS; RISK-FACTORS; BRONCHIAL HYPERRESPONSIVENESS; COMMON AEROALLERGENS; INDOOR ALLERGENS; ADULT-POPULATION; LUNG-FUNCTION; PREVALENCE; SENSITIZATION	A prevalence study was conducted among office workers in Malaysia (N= 695). The aim of this study was to examine associations between asthma, airway symptoms, rhinitis and house dust mites (HDM) and cat allergy and HDM levels in office dust. Medical data was collected by a questionnaire. Skin prick tests were performed for HDM allergens (Dermatophagoides pteronyssinus, Dermatophagoides farinae) and cat allergen Felis domesticus. Indoor temperature and relative air humidity (RH) were measured in the offices and vacuumed dust samples were analyzed for HDM allergens. The prevalence of D. pteronyssinus, D. farinae and cat allergy were 50.3%, 49.0% and 25.5% respectively. Totally 9.6% had doctor-diagnosed asthma, 15.5% had current wheeze and 53.0% had current rhinitis. The Der p 1 (from D. pteronyssinus) and Der f 1 (from D. farinae) allergens levels in dust were 556 ng/g and 658 ng/g respectively. Statistical analysis was conducted by multilevel logistic regression, adjusting for age, gender, current smoking, HDM or cat allergy, home dampness and recent indoor painting at home. Office workers with HDM allergy had more wheeze (p= 0.035), any airway symptoms (p= 0.032), doctor-diagnosed asthma (p= 0.005), current asthma (p= 0.007), current rhinitis (p= 0.021) and rhinoconjuctivitis (p< 0.001). Cat allergy was associated with wheeze (p= 0.021), wheeze when not having a cold (p= 0.033), any airway symptoms (p= 0.034), doctor-diagnosed asthma (p= 0.010), current asthma (p= 0.020) and nasal allergy medication (p= 0.042). Der f 1 level in dust was associated with daytime breathlessness (p= 0.033) especially among those with HDM allergy. Der f 1 levels were correlated with indoor temperature (p< 0.001) and inversely correlated with RH (p<0.001). In conclusion, HDM and cat allergies were common and independently associated with asthma, airway symptoms and rhinitis. Der f 1 allergen can be a risk factor for daytime breathlessness.	[Lim, Fang Lee; Hashim, Zailina] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Environm & Occupat Hlth, Serdang 43400, Selangor, Malaysia; [Than, Leslie Thian Lung] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Med Microbiol & Parasitol, Serdang 43400, Selangor, Malaysia; [Said, Salmiah Md] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Community Hlth, Serdang 43400, Selangor, Malaysia; [Hashim, Jamal Hisham] UN Univ, Int Inst Global Hlth UNU IIGH, Kuala Lumpur, Malaysia; [Hashim, Jamal Hisham] Natl Univ Malaysia, Dept Community Hlth, Kuala Lumpur, Malaysia; [Norback, Dan] Uppsala Univ, Dept Med Sci Occupat & Environm Med, Univ Hosp, Uppsala, Sweden	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Kebangsaan Malaysia; Uppsala University; Uppsala University Hospital	Hashim, Z (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Environm & Occupat Hlth, Serdang 43400, Selangor, Malaysia.	zailina@upm.edu.my	Md. Said, Salmiah/ABE-6447-2021	Norback, Dan/0000-0002-5174-6668; Lim, Fang Lee/0000-0002-8253-2662; Than, Leslie/0000-0001-6956-4638; Md. Said, Salmiah/0000-0001-5865-2499	Universiti Putra Malaysia (UPM) for Research University Grant Scheme (RUGS) [9199671]; Swedish Research Council (VR) [2013-6762]	Universiti Putra Malaysia (UPM) for Research University Grant Scheme (RUGS); Swedish Research Council (VR)(Swedish Research Council)	This study was supported by grants from the Universiti Putra Malaysia (UPM) for Research University Grant Scheme (RUGS, grant number: 9199671) and the Swedish Research Council (VR) (grant number: 2013-6762). The funders supported the project financially. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Akpinar-Elci M, 2008, INDOOR AIR, V18, P125, DOI 10.1111/j.1600-0668.2007.00514.x; Andiappan AK, 2014, ALLERGY, V69, P501, DOI 10.1111/all.12364; Anto JM, 2010, ALLERGY, V65, P1021, DOI 10.1111/j.1398-9995.2009.02301.x; Arbes SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1139, DOI 10.1016/j.jaci.2007.07.056; Arbes SJ, 2004, J ALLERGY CLIN IMMUN, V114, P111, DOI 10.1016/j.jaci.2004.04.036; ARLIAN LG, 1992, EXP APPL ACAROL, V16, P15, DOI 10.1007/BF01201490; Arlian LG, 2003, IMMUNOL ALLERGY CLIN, V23, P443, DOI 10.1016/S0889-8561(03)00005-5; Asha'ari Z A, 2011, Med J Malaysia, V66, P202; Asha'ari ZA, 2010, ANN ACAD MED SINGAP, V39, P619; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Australasian Society of Clinical Immunology and Allergy, 2006, SKIN PRICK TESTING F; Bakolis I, 2015, INDOOR AIR, V25, P235, DOI 10.1111/ina.12137; Bjorksten B, 2008, PEDIAT ALLERG IMM-UK, V19, P110, DOI 10.1111/j.1399-3038.2007.00601.x; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brunetto B, 2009, ANN I SUPER SANITA, V45, P415; Brunetto B, 2009, ANN I SUPER SANITA, V45, P409; Burney P, 1997, J ALLERGY CLIN IMMUN, V99, P314, DOI 10.1016/S0091-6749(97)70048-4; Chew FT, 1999, ALLERGY, V54, P1150, DOI 10.1034/j.1398-9995.1999.00050.x; Chew GL, 2009, INDOOR AIR, V19, P193, DOI 10.1111/j.1600-0668.2008.00578.x; Cox-Ganser JM, 2005, ENVIRON HEALTH PERSP, V113, P485, DOI 10.1289/ehp.7559; Custovic A, 2002, ANN ALLERG ASTHMA IM, V88, P432, DOI 10.1016/S1081-1206(10)62378-2; Custovic A, 2012, J INVEST ALLERG CLIN, V22, P393; Daengsuwan T, 2003, ASIAN PAC J ALLERGY, V21, P199; Dejsomritrutai W, 2006, CHEST, V129, P602, DOI 10.1378/chest.129.3.602; Gehring U, 2001, EUR RESPIR J, V18, P555, DOI 10.1183/09031936.01.00096801; HO TM, 1995, ASIAN PAC J ALLERGY, V13, P11; Lam HT, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-6; Hoang TL, 2011, RESP MED, V105, P177, DOI 10.1016/j.rmed.2010.10.001; Jaakkola JJK, 2006, AM J EPIDEMIOL, V164, P742, DOI 10.1093/aje/kwj249; Jaakkola MS, 2006, J ALLERGY CLIN IMMUN, V117, P642, DOI 10.1016/j.jaci.2005.11.003; Jacquet A, 2013, ISRN ALLERGY, V2013, DOI [10.1155/2013/735031, DOI 10.1155/2013/735031]; Jacquet A, 2011, TRENDS MOL MED, V17, P604, DOI 10.1016/j.molmed.2011.05.014; Jarvis D, 2007, J ALLERGY CLIN IMMUN, V119, P697, DOI 10.1016/j.jaci.2006.10.042; John AB, 1996, ASIAN PAC J ALLERGY, V14, P9; Katelaris CH, 2011, AM J RHINOL ALLERGY, V25, pS3, DOI [10.2500/ajra.2011.25.3674, 10.2500/ajr.2011.25.3674]; Kim JS, 2008, J ALLERGY CLIN IMMUN, V122, P929, DOI 10.1016/j.jaci.2008.08.009; Konishi E, 1999, EXP APPL ACAROL, V23, P41, DOI 10.1023/A:1006121401348; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lal A, 2011, INDIAN J OTOLARYNGOL, V63, P132, DOI 10.1007/s12070-010-0064-y; Langley SJ, 2005, THORAX, V60, P17, DOI 10.1136/thx.2004.027839; Leynaert N, 2004, J ALLERGY CLIN IMMUN, V113, P86, DOI 10.1016/j.jaci.2003.10.010; Li CS, 1997, ARCH ENVIRON HEALTH, V52, P68, DOI 10.1080/00039899709603803; Li J, 2013, CLIN EXP ALLERGY, V43, P1171, DOI 10.1111/cea.12157; Li J, 2009, ALLERGY, V64, P1083, DOI 10.1111/j.1398-9995.2009.01967.x; Liam CK, 2002, RESPIROLOGY, V7, P345, DOI 10.1046/j.1440-1843.2002.00409.x; Lowe LA, 2004, ARCH PEDIAT ADOL MED, V158, P996, DOI 10.1001/archpedi.158.10.996; Lu YX, 2013, SOC PSYCH PSYCH EPID, V48, P1273, DOI 10.1007/s00127-013-0655-5; Macher JM, 2005, INDOOR AIR, V15, P82, DOI 10.1111/j.1600-0668.2005.00347.x; Mariana A, 2000, Southeast Asian J Trop Med Public Health, V31, P712; Menzies D, 1998, J ALLERGY CLIN IMMUN, V101, P38, DOI 10.1016/S0091-6749(98)70191-5; Milian Evelyn, 2004, P R Health Sci J, V23, P47; Nadchatram M., 2005, Tropical Biomedicine, V22, P23; Nam HS, 2008, KOREAN J PARASITOL, V46, P187, DOI 10.3347/kjp.2008.46.3.187; Neal JS, 2002, ANN ALLERG ASTHMA IM, V88, P410, DOI 10.1016/S1081-1206(10)62373-3; Nishihara N, 2014, BUILD ENVIRON, V71, P153, DOI 10.1016/j.buildenv.2013.09.018; Norbaeck D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088303; Olivieri M, 2012, J ALLERGY CLIN IMMUN, V129, P420, DOI 10.1016/j.jaci.2011.10.044; Ooi PL, 1998, OCCUP ENVIRON MED, V55, P188, DOI 10.1136/oem.55.3.188; Park JH, 2006, INDOOR AIR, V16, P192, DOI 10.1111/j.1600-0668.2005.00415.x; Perfetti L, 2004, SCI TOTAL ENVIRON, V328, P15, DOI 10.1016/j.scitotenv.2004.01.028; Prasarnphanich T, 2005, PEDIAT ALLERG IMM-UK, V16, P402, DOI 10.1111/j.1399-3038.2005.00297.x; Prester Ljerka, 2007, Arhiv za Higijenu Rada i Toksikologiju, V58, P413, DOI 10.2478/v10004-007-0034-2; Pumhirun P, 1997, ASIAN PAC J ALLERGY, V15, P183; Ramos JDA, 2007, PHILIPP J SCI, V136, P139; Raukas-Kivioja A, 2007, INT ARCH ALLERGY IMM, V142, P247, DOI 10.1159/000097027; Repace JL, 1982, ENVIRON INT, V8, P21; Sakashita M, 2010, INT ARCH ALLERGY IMM, V151, P255, DOI 10.1159/000242363; Samiah Yasmin A., 2013, AM J RES COMMUN, V1, P18; Shaaban R, 2008, LANCET, V372, P1049, DOI 10.1016/S0140-6736(08)61446-4; Simpson A, 2001, CLIN EXP ALLERGY, V31, P803, DOI 10.1046/j.1365-2222.2001.01110.x; Simpson BM, 2001, CLIN EXP ALLERGY, V31, P391, DOI 10.1046/j.1365-2222.2001.01050.x; SKOV P, 1987, ENVIRON INT, V13, P339, DOI 10.1016/0160-4120(87)90190-5; Song WJ, 2014, ASIA PAC ALLERGY, V4, P3, DOI [10.5415/apallergy.2014.4.1.3, 10.5415/apallergy.2014.4.2.75]; Sonomjamts M, 2014, ASIA PAC ALLERGY, V4, P25, DOI 10.5415/apallergy.2014.4.1.25; Stevens W, 2011, CLIN EXP ALLERGY, V41, P1587, DOI 10.1111/j.1365-2222.2011.03832.x; Svanes C, 1999, J ALLERGY CLIN IMMUN, V103, P415, DOI 10.1016/S0091-6749(99)70465-3; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Uthaisangsook S, 2007, ASIAN PAC J ALLERGY, V25, P127; Uthaisangsook S, 2010, ASIAN PAC J ALLERGY, V28, P23; van der Heide S, 1998, ALLERGY, V53, P104, DOI 10.1111/j.1398-9995.1998.tb05009.x; Vidal C, 2004, ALLERGY, V59, P401, DOI 10.1111/j.1398-9995.2003.00430.x; Wan GH, 1999, ARCH ENVIRON HEALTH, V54, P58, DOI 10.1080/00039899909602238; Wang JY, 2013, ALLERGY ASTHMA IMMUN, V5, P68, DOI 10.4168/aair.2013.5.2.68; Weschler CJ, 2009, ATMOS ENVIRON, V43, P153, DOI 10.1016/j.atmosenv.2008.09.044; Wickens K, 2004, PEDIAT ALLERG IMM-UK, V15, P55, DOI 10.1046/j.0905-6157.2003.00100.x; Wyon DP, 2004, INDOOR AIR, V14, P92, DOI 10.1111/j.1600-0668.2004.00278.x; Yao MS, 2009, AEROBIOLOGIA, V25, P183, DOI 10.1007/s10453-009-9123-9; Yong SB, 2013, J MICROBIOL IMMUNOL, V46, P295, DOI 10.1016/j.jmii.2012.07.002; Yuen Anthony P. W., 2007, Hong Kong Medical Journal, V13, P131; Zhang X, 2011, SCI TOTAL ENVIRON, V409, P5253, DOI 10.1016/j.scitotenv.2011.08.059; Zhao ZH, 2006, INDOOR AIR, V16, P404, DOI 10.1111/j.1600-0668.2006.00433.x; Zhao ZH, 2008, PEDIAT ALLERG IMM-UK, V19, P455, DOI 10.1111/j.1399-3038.2007.00664.x; Zock JP, 2006, J ALLERGY CLIN IMMUN, V118, P682, DOI 10.1016/j.jaci.2006.04.060	94	36	39	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124905	10.1371/journal.pone.0124905	http://dx.doi.org/10.1371/journal.pone.0124905			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923543	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000353711600111
J	Liu, QN; Trudeau, MC				Liu, Qiang-ni; Trudeau, Matthew C.			Eag Domains Regulate LQT Mutant hERG Channels in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							LONG-QT SYNDROME; GENE POTASSIUM CHANNELS; C-TERMINAL REGION; CARDIAC-ARRHYTHMIA; I-KR; DEACTIVATION; MUTATIONS; RECTIFIER; FAMILY	Human Ether a go-go Related Gene potassium channels form the rapid component of the delayed-rectifier (I-Kr) current in the heart. The N-terminal 'eag' domain, which is composed of a Per-Arnt-Sim (PAS) domain and a short PAS-cap region, is a critical regulator of hERG channel function. In previous studies, we showed that isolated eag (i-eag) domains rescued the dysfunction of long QT type-2 associated mutant hERG R56Q channels, by substituting for defective eag domains, when the channels were expressed in Xenopus oocytes or HEK 293 cells. Here, our goal was to determine whether the rescue of hERG R56Q channels by i-eag domains could be translated into the environment of cardiac myocytes. We expressed hERG R56Q channels in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) and measured electrical properties of the cells with whole-cell patch-clamp recordings. We found that, like in non-myocyte cells, hERG R56Q had defective, fast closing (deactivation) kinetics when expressed in hiPSC-CMs. We report here that i-eag domains slowed the deactivation kinetics of hERG R56Q channels in hiPSC-CMs. hERG R56Q channels prolonged the AP of hiPSCs, and the AP was shortened by co-expression of i-eag domains and hERG R56Q channels. We measured robust Forster Resonance Energy Transfer (FRET) between i-eag domains tagged with Cyan fluorescent protein (CFP) and hERG R56Q channels tagged with Citrine fluorescent proteins (Citrine), indicating their close proximity at the cell membrane in live iPSC-CMs. Together, functional regulation and FRET spectroscopy measurements indicated that i-eag domains interacted directly with hERG R56Q channels in hiPSC-CMs. These results mean that the regulatory role of i-eag domains is conserved in the cellular environment of human cardiomyocytes, indicating that i-eag domains may be useful as a biological therapeutic.	[Liu, Qiang-ni; Trudeau, Matthew C.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Trudeau, MC (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	mtrudeau@som.umaryland.edu			NIH NHLBI [R01 HL083121]; Maryland Stem Cell Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083121] Funding Source: NIH RePORTER	NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Maryland Stem Cell Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by NIH NHLBI R01 HL083121 (http://www.nhlbi.nih.gov/) and the Maryland Stem Cell Research Fund (http://www.mscrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brelidze TI, 2010, PLOS ONE, DOI [10. 1371/ journal. pone. 0012523, DOI 10.1371/J0URNAL.P0NE.0012523]; Brelidze TI, 2013, P NATL ACAD SCI USA, V110, P11648, DOI 10.1073/pnas.1306887110; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Carlson AE, 2013, J GEN PHYSIOL, V141, P347, DOI 10.1085/jgp.201210900; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Clancy CE, 2001, CARDIOVASC RES, V50, P301, DOI 10.1016/S0008-6363(00)00293-5; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Germanguz I, 2011, J CELL MOL MED, V15, P38, DOI 10.1111/j.1582-4934.2009.00996.x; Gianulis EC, 2013, J GEN PHYSIOL, V142, P351, DOI 10.1085/jgp.201310995; Gianulis EC, 2011, J BIOL CHEM, V286, P22160, DOI 10.1074/jbc.M110.205948; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Honda M, 2011, J PHARMACOL SCI, V117, P149, DOI 10.1254/jphs.11038FP; Jost N, 2009, BASIC RES CARDIOL, V104, P33, DOI 10.1007/s00395-008-0730-3; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Marques-Carvalho MJ, 2012, ACTA CRYSTALLOGR F, V68, P337, DOI [10.1107/S1744309112004216, 10.1107/S1744309112004216337]; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438	24	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123951	10.1371/journal.pone.0123951	http://dx.doi.org/10.1371/journal.pone.0123951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923442	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600062
J	Parrott, ML; Ward, SJ; Temple-Smith, PD; Selwood, L				Parrott, Marissa L.; Ward, Simon J.; Temple-Smith, Peter D.; Selwood, Lynne			Females Choose Mates Based on Genetic Relatedness in a Small Dasyurid Marsupial, the Agile Antechinus (Antechinus agilis)	PLOS ONE			English	Article							INCREASE OFFSPRING HETEROZYGOSITY; MULTIPLE PATERNITY; SEXUAL SELECTION; SPERM COMPETITION; FIELD POPULATION; MATING-BEHAVIOR; CHOICE; SUCCESS; COMPATIBILITY; EVOLUTION	Females in a variety of taxa mate with more than one male during a single oestrus and exhibit mate preferences for genetically compatible males, but the influence of female mate choice on siring success is not clearly understood. Whether females choose to mate with more than one male or endure forced copulations is also often unknown. Here, we examined the effects of genetic relatedness on female mate choice and siring success in a small semelparous carnivorous marsupial, the agile antechinus (Antechinus agilis), during two consecutive breeding seasons. Experimental trials were conducted in captivity over periods of 72 hours using interconnected enclosures in which female antechinus could choose to access any of four separated males, but males were only able to access females that entered their quarters. Females had access to two genetically similar and two genetically dissimilar males simultaneously and all behavioural interactions were observed and scored from continuous video recordings. Genetic similarity between mates and paternity of young was determined by microsatellite analyses. Some females chose to enter and mate with more than one male during a single oestrus period. Although females investigated all males, they spent significantly more time visiting, and mated more times with, genetically dissimilar males. Males that were genetically dissimilar to the female sired 88% of subsequent offspring. Whilst males mated readily with most females, they rejected the advances of some receptive females, indicating a previously unexpected level of male mate choice. The results show that genetic relatedness between mates has a significant influence on mate choice, breeding and siring success in the agile antechinus.	[Parrott, Marissa L.; Ward, Simon J.; Temple-Smith, Peter D.; Selwood, Lynne] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia; [Ward, Simon J.] NT Dept Nat Resources Environm Arts & Sport, Biodivers Conservat Div, Palmerston, NT, Australia; [Temple-Smith, Peter D.] Monash Univ, Dept Obstet & Gynaecol, Southern Clin Sch, Clayton, Vic 3168, Australia; [Parrott, Marissa L.; Temple-Smith, Peter D.] Zoos Victoria, Wildlife Conservat & Sci, Parkville, Vic, Australia	University of Melbourne; Monash University	Parrott, ML (corresponding author), Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia.	mparrott@zoo.org.au		, Peter/0000-0002-4754-369X	Melbourne Research PhD Scholarship; Holsworth Wildlife Research Endowment and Winifred Violet Scott Estate; Loftus-Hills Memorial Fund Award; David Hay Postgraduate Writing-up Award	Melbourne Research PhD Scholarship; Holsworth Wildlife Research Endowment and Winifred Violet Scott Estate; Loftus-Hills Memorial Fund Award; David Hay Postgraduate Writing-up Award	This research was funded by a Melbourne Research PhD Scholarship, grants from the Holsworth Wildlife Research Endowment and Winifred Violet Scott Estate, a Loftus-Hills Memorial Fund Award and David Hay Postgraduate Writing-up Award to M. Parrott. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Amundsen T, 2001, P NATL ACAD SCI USA, V98, P13155, DOI 10.1073/pnas.211439298; Arnqvist G, 1988, OIKOS, V54, P248; Aslin H.J., 1982, P22; BIRKHEAD T, 1993, TRENDS ECOL EVOL, V8, P100, DOI 10.1016/0169-5347(93)90060-3; Brown JL, 1997, BEHAV ECOL, V8, P60, DOI 10.1093/beheco/8.1.60; Charpentier MJE, 2010, ANIM BEHAV, V80, P101, DOI 10.1016/j.anbehav.2010.04.005; Consuegra S, 2008, P ROY SOC B-BIOL SCI, V275, P1397, DOI 10.1098/rspb.2008.0066; Craig AS, 2002, CAN J ZOOL, V80, P745, DOI 10.1139/Z02-050; Drickamer LC, 2000, ANIM BEHAV, V59, P371, DOI 10.1006/anbe.1999.1316; DUGATKIN LA, 1992, P ROY SOC B-BIOL SCI, V249, P179, DOI 10.1098/rspb.1992.0101; Edward DA, 2011, TRENDS ECOL EVOL, V26, P647, DOI 10.1016/j.tree.2011.07.012; Fisher DO, 2006, NATURE, V444, P89, DOI 10.1038/nature05206; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; Gibson RM, 1991, BEHAV ECOL, V2, P165, DOI 10.1093/beheco/2.2.165; Hill CE, 2010, AUK, V127, P300, DOI 10.1525/auk.2009.09055; HILL GE, 1993, EVOLUTION, V47, P1515, DOI 10.1111/j.1558-5646.1993.tb02172.x; Hoogland JL, 1998, ANIM BEHAV, V55, P351, DOI 10.1006/anbe.1997.0575; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jennions MD, 1997, TRENDS ECOL EVOL, V12, P251, DOI 10.1016/S0169-5347(97)01128-2; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; Jones TM, 1998, P ROY SOC B-BIOL SCI, V265, P1651, DOI 10.1098/rspb.1998.0484; KELLER L, 1995, ADV STUD BEHAV, V24, P291, DOI 10.1016/S0065-3454(08)60397-6; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; Kraaijeveld-Smit FJL, 2003, MOL ECOL, V12, P475, DOI 10.1046/j.1365-294X.2003.01745.x; Kraaijeveld-Smit FJL, 2002, J EVOLUTION BIOL, V15, P100, DOI 10.1046/j.1420-9101.2002.00367.x; Kraaijeveld-Smit FJL, 2002, BEHAV ECOL SOCIOBIOL, V52, P84, DOI 10.1007/s00265-002-0485-z; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; LAZENBYCOHEN KA, 1988, BEHAV ECOL SOCIOBIOL, V22, P195, DOI 10.1007/BF00300569; LOMAN J, 1988, OIKOS, V52, P69, DOI 10.2307/3565983; MADSEN T, 1992, NATURE, V355, P440, DOI 10.1038/355440a0; MARLOW B. J., 1961, AUSTRALIAN JOUR ZOOL, V9, P203, DOI 10.1071/ZO9610203; Mays HL, 2008, GENETICA, V134, P147, DOI 10.1007/s10709-007-9219-5; Mays HL, 2004, TRENDS ECOL EVOL, V19, P554, DOI 10.1016/j.tree.2004.07.018; Meister B, 2012, AMPHIBIA-REPTILIA, V33, P308, DOI 10.1163/156853812X634053; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; Noble DWA, 2013, BEHAV ECOL, V24, P1128, DOI 10.1093/beheco/art040; Nolan PM, 2010, ETHOLOGY, V116, P635, DOI 10.1111/j.1439-0310.2010.01775.x; Nordeide JT, 2007, AQUAC RES, V38, P1, DOI 10.1111/j.1365-2109.2006.01635.x; OLSSON M, 1994, NATURE, V369, P528, DOI 10.1038/369528b0; Orrell KS, 2002, ANIM BEHAV, V63, P1091, DOI 10.1006/anbe.2002.3013; Parker GA, 1970, BIOL REV, V45, P526, DOI DOI 10.1111/J.1469-185X.1970.TB01176.X; Parrott ML, 2007, WILDLIFE RES, V34, P437, DOI 10.1071/WR07071; Parrott ML, 2007, BEHAV ECOL SOCIOBIOL, V61, P1075, DOI 10.1007/s00265-006-0340-8; Parrott ML, 2006, AUST J ZOOL, V54, P319, DOI 10.1071/ZO06030; Parrott ML, 2005, AUST J ZOOL, V53, P79, DOI 10.1071/ZO04025; Pitcher TE, 2003, P ROY SOC B-BIOL SCI, V270, P1623, DOI 10.1098/rspb.2002.2280; Puurtinen M, 2009, AM NAT, V174, P741, DOI 10.1086/606024; Ryan KK, 2003, ANIM BEHAV, V65, P379, DOI 10.1006/anbe.2003.2040; Ryan KK, 2001, BEHAV ECOL SOCIOBIOL, V50, P436; SCOTT MP, 1985, BEHAV ECOL SOCIOBIOL, V17, P29, DOI 10.1007/BF00299424; Selwood L., 1982, P31; SELWOOD L, 1987, J REPROD FERTIL, V79, P495; SELWOOD L, 1985, Australian Mammalogy, V8, P91; Shimmin GA, 2000, J ZOOL, V252, P343, DOI 10.1017/S095283690000008X; Shimmin GA, 1999, BIOL REPROD, V60, P1353, DOI 10.1095/biolreprod60.6.1353; Shimmin GA, 2002, J ZOOL, V258, P39, DOI 10.1017/S0952836902001188; Slatyer RA, 2012, BIOL REV, V87, P1, DOI 10.1111/j.1469-185X.2011.00182.x; Stapleton MK, 2007, BEHAV ECOL SOCIOBIOL, V61, P1725, DOI 10.1007/s00265-007-0404-4; STOCKLEY P, 1993, P ROY SOC B-BIOL SCI, V254, P173, DOI 10.1098/rspb.1993.0143; Stockley P, 1997, TRENDS ECOL EVOL, V12, P154, DOI 10.1016/S0169-5347(97)01000-8; *SYSTAT, 2004, SYSTAT WIND STAT VER; TAGGART DA, 1990, J REPROD FERTIL, V88, P81; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; WOOD D H, 1970, Australian Journal of Zoology, V18, P185, DOI 10.1071/ZO9700185; WOOLLEY P., 1966, SYMP ZOOL SOC LONDON, V15, P281; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250	67	6	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122381	10.1371/journal.pone.0122381	http://dx.doi.org/10.1371/journal.pone.0122381			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923325	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600013
J	Lin, YW; Chen, CC; Lin, LC; Lee, SP				Lin, Yu-Wei; Chen, Chia-Chun; Lin, Li-Ching; Lee, Steve P.			The Impact of Reduced-Volume, Intensity-Modulated Radiation Therapy on Disease Control in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							NECK-CANCER; CLINICAL-OUTCOMES; TARGET VOLUMES; RADIOTHERAPY; HEAD; EXPERIENCE; PATTERNS; FAILURE; IRRADIATION; DELINEATION	Objective To investigate the feasibility of using intensity-modulated radiotherapy (IMRT) with reduced, high-dose target volumes for nasopharyngeal carcinoma (NPC). Methods The first 57 patients (admitted from October 2005 to May 2008) were treated with large-target-volume IMRT (LV-IMRT). For the LV-IMRT group, the CTV at 70 Gy (CTV70) was delineated as the gross target volume (GTV) plus 7mm, with or without the first-echelon lymphnode region. The next 56 patients (admitted from June 2008 to November 2011) were treated with reduced-target-volume IMRT (RV-IMRT). For the RV-IMRT group, the CTV70 was delineated as the GTV alone. Results The 4-year local recurrence-free, regional recurrence-free, distant metastasis-free, progression-free, and overall survival rates were 77.2%, 80.1%, 83.2%, 61.2%, and 74.4% for the LV-IMRT group and 83.5%, 92.6%, 89.1%, 78.5, and 91.0% for the RV-IMRT group, respectively. Late toxicity scoring of xerostomia was lesser in the RV-IMRT group than the LV-IMRT group (P < 0.001). Conclusions The use of RV-IMRT for the treatment of NPC did not negatively affect survival rates but did reduce the late xerostomia events compared to LV-IMRT.	[Lin, Yu-Wei; Lin, Li-Ching] Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan; [Lin, Yu-Wei] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Lin, Yu-Wei] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; [Chen, Chia-Chun] Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan; [Lin, Li-Ching] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Lee, Steve P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA; [Lee, Steve P.] VA Greater Los Angeles Healthcare Syst, Dept Radiat Oncol, Los Angeles, CA USA	Chi Mei Hospital; National Sun Yat Sen University; Kaohsiung Medical University; Chi Mei Hospital; Taipei Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Lin, YW (corresponding author), Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan.	marklin1108@gmail.com; splee@mednet.ucla.edu	Lee, Steve Pai-hsun/AAU-8313-2020	Lee, Steve Pai-hsun/0000-0001-7168-1542				Apisarnthanarax S, 2006, INT J RADIAT ONCOL, V64, P678, DOI 10.1016/j.ijrobp.2005.08.020; Cannon DM, 2008, INT J RADIAT ONCOL, V70, P660, DOI 10.1016/j.ijrobp.2007.09.018; Cao CN, 2013, ORAL ONCOL, V49, P175, DOI 10.1016/j.oraloncology.2012.08.013; Caudell JJ, 2010, INT J RADIAT ONCOL, V76, P164, DOI 10.1016/j.ijrobp.2009.01.037; Chao KSC, 2002, INT J RADIAT ONCOL, V53, P1174, DOI 10.1016/S0360-3016(02)02881-X; Chen JZ, 2013, INT J RADIAT ONCOL, V85, P929, DOI 10.1016/j.ijrobp.2012.07.2356; Fang FM, 2008, INT J RADIAT ONCOL, V72, P356, DOI 10.1016/j.ijrobp.2007.12.054; Gregoire Vincent, 2003, Rays, V28, P217; HO JHC, 1978, INT J RADIAT ONCOL, V4, P182; Kam MKM, 2007, J CLIN ONCOL, V25, P4873, DOI 10.1200/JCO.2007.11.5501; Kam MKM, 2004, INT J RADIAT ONCOL, V60, P1440, DOI 10.1016/j.ijrobp.2004.05.022; Kong FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091362; Lee AWM, 2013, INT J RADIAT ONCOL, V85, P902, DOI 10.1016/j.ijrobp.2012.09.010; Lee AWM, 2012, RADIOTHER ONCOL, V104, P272, DOI 10.1016/j.radonc.2012.08.001; LEE AWM, 1992, INT J RADIAT ONCOL, V23, P261, DOI 10.1016/0360-3016(92)90740-9; Lee N, 2003, INT J RADIAT ONCOL, V57, P49, DOI 10.1016/S0360-3016(03)00405-X; LEE N, 2002, MACWORLD         FEB, P15; Lee N, 2013, TARGET VOLUME DELINE, P1; Lee N, 2009, J CLIN ONCOL, V27, P3684, DOI 10.1200/JCO.2008.19.9109; Lee NY, 2012, LANCET ONCOL, V13, P172, DOI 10.1016/S1470-2045(11)70303-5; Liao XB, 2008, INT J RADIAT ONCOL, V72, P1368, DOI 10.1016/j.ijrobp.2008.03.017; Lin SJ, 2009, INT J RADIAT ONCOL, V75, P1071, DOI 10.1016/j.ijrobp.2008.12.015; Martinez-Monge R, 1999, RADIOLOGY, V211, P815, DOI 10.1148/radiology.211.3.r99jn40815; Ng WT, 2008, INT J RADIAT ONCOL, V72, P1082, DOI 10.1016/j.ijrobp.2008.02.006; Ng WT, 2011, INT J RADIAT ONCOL, V79, P420, DOI 10.1016/j.ijrobp.2009.11.024; Peng G, 2012, RADIOTHER ONCOL, V104, P286, DOI 10.1016/j.radonc.2012.08.013; Teo P, 1996, INT J RADIAT ONCOL, V36, P291, DOI 10.1016/S0360-3016(96)00323-9; Tham IWK, 2009, INT J RADIAT ONCOL, V75, P1481, DOI 10.1016/j.ijrobp.2009.01.018; Toledano I, 2012, RADIOTHER ONCOL, V103, P57, DOI 10.1016/j.radonc.2011.12.010; Vergeer MR, 2009, INT J RADIAT ONCOL, V74, P1, DOI 10.1016/j.ijrobp.2008.07.059; WITHERS HR, 1995, INT J RADIAT ONCOL, V31, P353, DOI 10.1016/0360-3016(94)00354-N; Wolden SL, 2006, INT J RADIAT ONCOL, V64, P57, DOI 10.1016/j.ijrobp.2005.03.057	32	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125283	10.1371/journal.pone.0125283	http://dx.doi.org/10.1371/journal.pone.0125283			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919285	Green Published, gold			2022-12-27	WOS:000353659400079
J	Umbers, KDL; Byatt, LJ; Hill, NJ; Bartolini, RJ; Hose, GC; Herberstein, ME; Power, ML				Umbers, Kate D. L.; Byatt, Lachlan J.; Hill, Nichola J.; Bartolini, Remo J.; Hose, Grant C.; Herberstein, Marie E.; Power, Michelle L.			Prevalence and Molecular Identification of Nematode and Dipteran Parasites in an Australian Alpine Grasshopper (Kosciuscola tristis)	PLOS ONE			English	Article							BODY-SIZE; SEX-DIFFERENCES; HOST; INFECTIONS; MERMITHIDAE; ORTHOPTERA; INSECT; COLOR; HYMENOPTERA; POPULATIONS	In alpine Australia, Orthoptera are abundant, dominant herbivores, important prey species, and hosts for parasites and parasitoids. Despite the central role of orthopterans in alpine ecosystems, the impact of parasites on orthopteran populations is under-explored. In this study we describe the relationship between parasite prevalence and host sex, body size and year of collection. We accessed an existing, preserved collection of 640 Kosciuscola tristis collected from across its range between 2007 and 2011. Upon dissection we collected juvenile parasites and used molecular tools to identify them to three families (Nematoda; Mermithidae, and Arthropoda: Diptera: Tachinidae and Sarcophagidae). The prevalence of nematodes ranged from 3.5% to 25.0% and dipterans from 2.4% to 20.0%. Contrary to predictions, we found no associations between parasite prevalence and grasshopper sex or size. Although there was an association between prevalence of both nematodes and dipterans with year of collection, this is likely driven by a small sample size in the first year. Our results provide a foundation for future studies into parasite prevalence within the alpine environment and the abiotic factors that might influence these associations.	[Umbers, Kate D. L.; Byatt, Lachlan J.; Hill, Nichola J.; Bartolini, Remo J.; Hose, Grant C.; Herberstein, Marie E.; Power, Michelle L.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Umbers, Kate D. L.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Umbers, Kate D. L.] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA, Australia; [Umbers, Kate D. L.] Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia	Macquarie University; University of Wollongong; University of Western Australia; Western Sydney University	Umbers, KDL (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	kate_umbers@uow.edu.au	; Herberstein, Marie/D-2042-2011	/0000-0003-3213-6693; Power, Michelle/0000-0003-3160-4301; Herberstein, Marie/0000-0001-5071-2952; Hose, Grant/0000-0003-2106-5543	Australia & Pacific Science Foundation; Macquarie University; Australian Biological Resources Study	Australia & Pacific Science Foundation; Macquarie University; Australian Biological Resources Study	Funding: This project was funded by the Australia & Pacific Science Foundation, Macquarie University and the Australian Biological Resources Study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Attard LM, 2008, J ZOO WILDLIFE MED, V39, P488, DOI 10.1638/2007-0179.1; BAKER G L, 1988, Revue de Nematologie, V11, P343; BAKER G L, 1986, Revue de Nematologie, V9, P125; Baker GL, 1998, AUST J ENTOMOL, V37, P80, DOI 10.1111/j.1440-6055.1998.tb01549.x; Baker GL, 1990, P 5 INT C INV PATH M; BLACKITH R. E., 1967, AUST J ZOOL, V15, P745, DOI 10.1071/ZO9670745; CADE W, 1975, SCIENCE, V190, P1312, DOI 10.1126/science.190.4221.1312; CANTRELL BK, 1980, J AUST ENTOMOL SOC, V19, P217; Civantos E, 2005, BIOL J LINN SOC, V85, P373, DOI 10.1111/j.1095-8312.2005.00494.x; Clift A., 1998, Journal of Orthoptera Research, V7, P77; Crane AL, 2011, ANIM BEHAV, V82, P817, DOI 10.1016/j.anbehav.2011.07.015; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Gray DA, 2000, CAN J ZOOL, V78, P140, DOI 10.1139/cjz-78-1-140; Green K., 1994, WILDLIFE AUSTR SNOW; Hall MD, 2012, P ROY SOC B-BIOL SCI, V279, P3176, DOI 10.1098/rspb.2012.0509; Hechinger RF, 2013, AM NAT, V182, P234, DOI 10.1086/670820; Hecker KR, 2002, CAN J ZOOL, V80, P162, DOI 10.1139/Z01-213; Huth-Schwarz A, 2012, J INVERTEBR PATHOL, V110, P48, DOI 10.1016/j.jip.2012.02.003; KEY KHL, 1954, AUST J ZOOL, V2, P309, DOI 10.1071/ZO9540309; Khokhlova IS, 2011, ANIM BEHAV, V81, P275, DOI 10.1016/j.anbehav.2010.10.018; KUKAL O, 1987, CAN J ZOOL, V65, P156, DOI 10.1139/z87-022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laws AN, 2012, B ENTOMOL RES, V102, P123, DOI 10.1017/S0007485311000472; Laws AN, 2009, CAN ENTOMOL, V141, P415, DOI 10.4039/n09-027; Lindsey E, 2009, ECOL ENTOMOL, V34, P551, DOI 10.1111/j.1365-2311.2009.01107.x; Lott MJ, 2012, EXP PARASITOL, V132, P185, DOI 10.1016/j.exppara.2012.06.013; Martin P, 2010, AQUAT ECOL, V44, P431, DOI 10.1007/s10452-009-9301-4; Miura K, 2014, APPL ENTOMOL ZOOL, V49, P171, DOI 10.1007/s13355-013-0236-9; Mongkolkiti S, 1997, J NEMATOL, V3, P356; Poinar GO, 2007, SYST PARASITOL, V68, P115, DOI 10.1007/s11230-007-9102-x; Poulin R, 1996, AM NAT, V147, P287, DOI 10.1086/285851; Poulin R, 2002, ANIM BEHAV, V63, P269, DOI 10.1006/anbe.2001.1938; Rehn JAG, 1957, FAMILY ACRIDIDAE SUB; Rentz D. C. F., 1996, GRASSHOPPER COUNTRY; Sato T, 2008, CAN J ZOOL, V86, P231, DOI 10.1139/Z07-135; Sheridan LAD, 2000, OIKOS, V88, P327, DOI 10.1034/j.1600-0706.2000.880211.x; Slatyer RA, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0204-1; STEINHAUS EA, 1958, ECOLOGY, V39, P503, DOI 10.2307/1931761; Sternberg ED, 2013, AM NAT, V182, pE235, DOI 10.1086/673442; Tatarnic NJ, 2013, INVERTEBR SYST, V27, P307, DOI 10.1071/IS12072; Umbers KDL, 2013, J INSECT PHYSIOL, V59, P81, DOI 10.1016/j.jinsphys.2012.10.016; Umbers KDL, 2013, BEHAV ECOL SOCIOBIOL, V67, P439, DOI 10.1007/s00265-012-1464-7; Umbers KDL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049600; Umbers KDL, 2011, J INSECT PHYSIOL, V57, P1198, DOI 10.1016/j.jinsphys.2011.05.010; Vance SA, 1996, P ROY SOC B-BIOL SCI, V263, P907, DOI 10.1098/rspb.1996.0134; Vance SA, 1996, CAN J ZOOL, V74, P1907, DOI 10.1139/z96-215; Ward Darren F., 1998, Journal of Orthoptera Research, V7, P99; Webster JM, 1984, PLANT INSECT NEMATOD; Wedekind C, 1998, OIKOS, V81, P458, DOI 10.2307/3546767; WHITE EG, 1991, NEW ZEAL J ECOL, V15, P139; Yang RC, 2012, EXP PARASITOL, V132, P216, DOI 10.1016/j.exppara.2012.07.003; Yeates GW, 2009, NEW ZEAL J ZOOL, V36, P35, DOI 10.1080/03014220909510137; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]; ZUK M, 1988, EVOLUTION, V42, P969, DOI 10.1111/j.1558-5646.1988.tb02515.x	56	6	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0121685	10.1371/journal.pone.0121685	http://dx.doi.org/10.1371/journal.pone.0121685			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919745	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400008
J	Zhang, XC; Xu, XP; Xu, WT; Hou, WZ; Cheng, YY; Li, CX; Ni, GX				Zhang, Xin-chang; Xu, Xiu-ping; Xu, Wen-tao; Hou, Wen-zhen; Cheng, Ying-ying; Li, Chang-xi; Ni, Guang-xia			Acupuncture Therapy for Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							MEDICINE	Objective Acupuncture has commonly been used in China, either alone or in combination with Western medicine, to treat sudden sensorineural hearing loss (SSHL). The purpose of this systematic review is to assess the efficacy and safety of acupuncture therapy for patients with SSHL. Methods We searched PubMed, the Cochrane Library, Embase, China National Knowledge Internet (CNKI), Database for Chinese Technical Periodicals (VIP), and Chinese Biomedical literature service system (SinoMed) to collect randomized controlled trials of acupuncture for SSHL published before July 2014. A meta-analysis was conducted according to the Cochrane systematic review method using RevMan 5.2 software. The evidence level for each outcome was assessed using the GRADE methodology. Results Twelve trials involving 863 patients were included. A meta-analysis showed that the effect of manual acupuncture combined with Western medicine comprehensive treatment (WMCT) was better than WMCT alone (RR 1.33, 95% CI 1.19-1.49) and the same as the effect of electroacupuncture combined with WMCT (RR 1.33, 95% CI 1.19-1.50). One study showed a better effect of electroacupuncture than of WMCT (RR 1.34, 95% CI 1.24-1.45). For mean changes in hearing over all frequencies, the meta-analysis showed a better effect with the combination of acupuncture and WMCT than with WMCT alone (MD 10.85, 95% CI 6.84-14.86). However, the evidence levels for these interventions were low or very low due to a high risk of bias and small sample sizes in the included studies. Conclusion There was not sufficient evidence showing that acupuncture therapy alone was beneficial for treating SSHL. However, interventions combining acupuncture with WMCT had more efficacious results in the treatment of SSHL than WMCT alone. Electroacupuncture alone might be a viable alternative treatment besides WMCT for SSHL. However, given that there were fewer eligible RCTs and limitations in the included trials, such as methodological drawbacks and small sample sizes, large-scale RCTs are required to confirm the current findings regarding acupuncture therapy for SSHL.	[Zhang, Xin-chang; Li, Chang-xi] Yang Zhou Univ, Subei Peoples Hosp Jiangsu Prov, Dept Pain Management, Yangzhou 225001, Jiangsu, Peoples R China; [Zhang, Xin-chang; Li, Chang-xi] Yang Zhou Univ, Sch Clin Med, Yangzhou 225001, Jiangsu, Peoples R China; [Zhang, Xin-chang; Xu, Wen-tao; Hou, Wen-zhen; Cheng, Ying-ying; Ni, Guang-xia] Nanjing Univ Chinese Med, Sch 2, Coll Med, Nanjing 210029, Jiangsu, Peoples R China; [Ni, Guang-xia] Second Chinese Med Hosp Jiangsu Prov, Nanjing 210017, Jiangsu, Peoples R China; [Xu, Xiu-ping] Southeast Univ, Sch Med, Nanjing Zhong Da Hosp, Dept Crit Care Med, Nanjing 210009, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Southeast University - China	Ni, GX (corresponding author), Nanjing Univ Chinese Med, Sch 2, Coll Med, Nanjing 210029, Jiangsu, Peoples R China.	xgn66@163.com	Xu, Xiuping/W-5865-2019	Xu, Xiuping/0000-0003-3950-3425	state administration of traditional Chinese medicine [ZYYS-2010[0044]-2]; technology project of jiangsu provincial administration of traditional Chinese medicine [LZ11074]	state administration of traditional Chinese medicine; technology project of jiangsu provincial administration of traditional Chinese medicine	This study was supported by project grant from state administration of traditional Chinese medicine (Project Number: ZYYS-2010[0044]-2) and technology project of jiangsu provincial administration of traditional Chinese medicine (Project Number: LZ11074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; BYL FM, 1984, LARYNGOSCOPE, V94, P647; Chau JK, 2012, OTOLARYNG CLIN N AM, V45, P941, DOI 10.1016/j.otc.2012.06.002; Chen XL, 2011, J NEW CHINESE MED, V42, P76; Conlin AE, 2007, ARCH OTOLARYNGOL, V133, P573, DOI 10.1001/archotol.133.6.573; Crane RA, 2015, LARYNGOSCOPE, V125, P209, DOI 10.1002/lary.24834; Dong LH, 2011, J SHANXI COLL TRADIT, V34, P70; Editorial board of Chinese Journal of Otorhinolaryngology Head and Neck Surgery Otorhinolaryngology Head and Neck Surgery of Chinese Medical Association, 2006, CHINESE J OTORHINOLA, V41, P569; Fan Xin-hua, 2010, Zhongguo Zhen Jiu, V30, P630; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Huang NB, 2012, ACUPUNCT MED, V30, P56, DOI 10.1136/aim.2010.010003; Huang W, 2014, SHANGHAI J TRADITION, V48, P50; Ji Jie, 2008, Zhongguo Zhen Jiu, V28, P353; Kim JI, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-97; Klemm E, 2009, LARYNGO RHINO OTOL, V88, P524, DOI 10.1055/s-0028-1128133; Kuhn M, 2011, TRENDS AMPLIF, V15, P91, DOI 10.1177/1084713811408349; Lazarini Paulo Roberto, 2006, Rev. Bras. Otorrinolaringol., V72, P554, DOI 10.1590/S0034-72992006000400019; Liang JG, 2012, ZHONG YI ER BI HOU K, V11, P36; Liu SC, 2011, CLIN OTOLARYNGOL, V36, P121, DOI 10.1111/j.1749-4486.2011.02303.x; LIU YH, 2011, ACTA CHINESE MED PHA, P111; Long AF, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep047; Luo Cheng-Lin, 2012, Zhongguo Zhen Jiu, V32, P981; Luo Ren-han, 2009, Zhongguo Zhen Jiu, V29, P185; MacPherson H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000261; Otorhinolaryngology of Chinese Medical Association. & editorial board of Chinese Journal of Otolaryngology, 1997, CHIN J OTORHINOLARYN, V32, P72; Plaza G, 2011, ACTA OTORRINOLAR ESP, V62, P144, DOI 10.1016/j.otorri.2010.09.001; Qiu L, 2012, WORLD J ACUPUNCT-MOX, V22, P22, DOI 10.1016/S1003-5257(12)60023-3; Schreiber BE, 2010, LANCET, V375, P1203, DOI 10.1016/S0140-6736(09)62071-7; Schunemann H, 2011, GRADE HDB GRADING QU; Stachler RJ, 2012, OTOLARYNG HEAD NECK, V146, pS1, DOI 10.1177/0194599812436449; Su CX, 2013, CLIN OTOLARYNGOL, V38, P455, DOI 10.1111/coa.12198; Suckfull M, 2009, DTSCH ARZTEBL INT, V106, P669, DOI 10.3238/arztebl.2009.0669; [王长海 Wang Changhai], 2003, [中国针灸, Chinese Acupuncture and Moxibustion], V23, P87; Wang CZ, 1998, J ASIAN NAT PROD RES, V1, P1, DOI 10.1080/10286029808039839; Wang Meiqun, 2010, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V24, P869; Wang Y, 2006, J CLIN ACUPUNCTURE M, V22, P33; Wei BPC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003998.pub3; Wu CS, 2006, AUDIOL NEURO-OTOL, V11, P151, DOI 10.1159/000091198; Xu WY, 2013, CHINA J CHINESE MED, V28, P1915; Xu YG, 2013, J NEW CHINESE MED, V45, P127; Yan QF., 2014, CHINA MODERN DOCTOR, V52, P13; Yin CS, 2010, J ALTERN COMPLEM MED, V16, P973, DOI 10.1089/acm.2009.0542; Zhang B, 2013, J NEW CHINESE MED, V45, P97; Zhang Cui-yan, 2006, Zhongguo Zhen Jiu, V26, P256; Zhang HT, 2009, GANSU SCI TECHNOLOGY, V25, P150; Zhang Xiao-Zhe, 2009, Zhongguo Zhen Jiu, V29, P525	47	9	10	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125240	10.1371/journal.pone.0125240	http://dx.doi.org/10.1371/journal.pone.0125240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919000	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400076
J	Glaring, MA; Vester, JK; Lylloff, JE; Abu Al-Soud, W; Sorensen, SJ; Stougaard, P				Glaring, Mikkel A.; Vester, Jan K.; Lylloff, Jeanette E.; Abu Al-Soud, Waleed; Sorensen, Soren J.; Stougaard, Peter			Microbial Diversity in a Permanently Cold and Alkaline Environment in Greenland	PLOS ONE			English	Article							SULFUR-OXIDIZING BACTERIA; SULFATE-REDUCING BACTERIUM; MEROMICTIC SODA LAKE; IKAITE TUFA COLUMNS; ARCTIC IKKA FJORD; SP-NOV.; MONO LAKE; PROKARYOTIC COMMUNITIES; SOUTHWEST GREENLAND; HALOALKALINE LAKE	The submarine ikaite columns located in the Ikka Fjord in Southern Greenland represent a unique, permanently cold (less than 6 degrees C) and alkaline (above pH 10) environment and are home to a microbial community adapted to these extreme conditions. The bacterial and archaeal community inhabiting the ikaite columns and surrounding fjord was characterised by high-throughput pyrosequencing of 16S rRNA genes. Analysis of the ikaite community structure revealed the presence of a diverse bacterial community, both in the column interior and at the surface, and very few archaea. A clear difference in overall taxonomic composition was observed between column interior and surface. Whereas the surface, and in particular newly formed ikaite material, was primarily dominated by Cyanobacteria and phototrophic Proteobacteria, the column interior was dominated by Proteobacteria and putative anaerobic representatives of the Firmicutes and Bacteroidetes. The results suggest a stratification of the ikaite columns similar to that of classical soda lakes, with a light-exposed surface inhabited by primary producers and an anoxic subsurface. This was further supported by identification of major taxonomic groups with close relatives in soda lake environments, including members of the genera Rhodobaca, Dethiobacter, Thioalkalivibrio and Tindallia, as well as very abundant groups related to uncharacterised environmental sequences originally isolated from Mono Lake in California.	[Glaring, Mikkel A.; Vester, Jan K.; Lylloff, Jeanette E.; Stougaard, Peter] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg, Denmark; [Abu Al-Soud, Waleed; Sorensen, Soren J.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Stougaard, P (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg, Denmark.	psg@plen.ku.dk	Abu Al-Soud, Waleed/K-4408-2014; Glaring, Mikkel/I-5789-2014; Sørensen, Søren J/J-5015-2014; Sørensen, Søren Johannes/N-2120-2019; Abu Al-Soud, Waleed/AAH-3477-2021; Stougaard, Peter/G-9978-2014; Vester, Jan/C-1631-2015	Abu Al-Soud, Waleed/0000-0002-1143-9233; Glaring, Mikkel/0000-0002-8003-4635; Sørensen, Søren J/0000-0001-6227-9906; Sørensen, Søren Johannes/0000-0001-6227-9906; Abu Al-Soud, Waleed/0000-0002-1143-9233; Stougaard, Peter/0000-0002-2796-7137; Vester, Jan/0000-0001-8272-9863	Danish Environmental Protection Agency [MST-112-00272]; Danish Council for Strategic Research; Novo Nordisk Fonden [NNF12OC0000797] Funding Source: researchfish	Danish Environmental Protection Agency; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Danish Environmental Protection Agency (grant no. MST-112-00272) and the Danish Council for Strategic Research, project NOVENIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alazard D, 2007, EXTREMOPHILES, V11, P33, DOI 10.1007/s00792-006-0006-5; [Anonymous], 2011, EXTREMOPHILES HDB, DOI DOI 10.1007/978-4-431-53898-1_3; Antony CP, 2014, GEOMICROBIOL J, V31, P519, DOI 10.1080/01490451.2013.849314; Antony CP, 2013, ISME J, V7, P468, DOI 10.1038/ismej.2012.137; Antony CP, 2012, FEMS MICROBIOL ECOL, V81, P43, DOI 10.1111/j.1574-6941.2011.01274.x; Asao M, 2011, ENVIRON MICROBIOL, V13, P2146, DOI 10.1111/j.1462-2920.2011.02449.x; BISCHOFF JL, 1993, GEOCHIM COSMOCHIM AC, V57, P3855, DOI 10.1016/0016-7037(93)90339-X; Brazelton WJ, 2013, APPL ENVIRON MICROB, V79, P3906, DOI 10.1128/AEM.00330-13; Buchardt B, 1997, NATURE, V390, P129, DOI 10.1038/36474; Buchardt B, 2001, J SEDIMENT RES, V71, P176, DOI 10.1306/042800710176; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cavicchioli R, 2011, MICROB BIOTECHNOL, V4, P449, DOI 10.1111/j.1751-7915.2011.00258.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dahl K, 2006, J SEDIMENT RES, V76, P460, DOI 10.2110/jsr.2006.035; De Maayer P, 2014, EMBO REP, V15, P508, DOI 10.1002/embr.201338170; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dieckmann GS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033540; Dirnitriu PA, 2008, APPL ENVIRON MICROB, V74, P4877, DOI 10.1128/AEM.00455-08; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Foti M, 2007, APPL ENVIRON MICROB, V73, P2093, DOI 10.1128/AEM.02622-06; Fujinami S, 2010, ENVIRON TECHNOL, V31, P845, DOI 10.1080/09593331003762807; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Hamdan LJ, 2013, ISME J, V7, P685, DOI 10.1038/ismej.2012.143; Hansen MO, 2011, J SEDIMENT RES, V81, P553, DOI 10.2110/jsr.2011.50; Hauptmann AL, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01014-13; Horikoshi K, 2004, P JPN ACAD B-PHYS, V80, P166, DOI 10.2183/pjab.80.166; Humayoun SB, 2003, APPL ENVIRON MICROB, V69, P1030, DOI 10.1128/AEM.69.2.1030-1042.2003; Jones BE, 1998, EXTREMOPHILES, V2, P191, DOI 10.1007/s007920050060; Jungblut AD, 2012, FEMS MICROBIOL ECOL, V82, P356, DOI 10.1111/j.1574-6941.2012.01380.x; Kaluzhnaya M, 2001, SYST APPL MICROBIOL, V24, P166, DOI 10.1078/0723-2020-00028; Kevbrin VV, 1998, CURR MICROBIOL, V37, P94, DOI 10.1007/s002849900345; Kirchman DL, 2010, ENV MICROBIOLOGY, V12; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Lanzen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072577; Lee DJ, 2014, APPL MICROBIOL BIOT, V98, P1301, DOI 10.1007/s00253-013-4976-9; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Margesin R, 2010, ENVIRON TECHNOL, V31, P835, DOI 10.1080/09593331003663328; Mesbah NM, 2007, INT J SYST EVOL MICR, V57, P2507, DOI 10.1099/ijs.0.65068-0; Mesbah NM, 2007, MICROB ECOL, V54, P598, DOI 10.1007/s00248-006-9193-y; Milford AD, 2000, ARCH MICROBIOL, V174, P18, DOI 10.1007/s002030000166; Mwirichia R, 2011, CURR MICROBIOL, V62, P209, DOI 10.1007/s00284-010-9692-4; Pedersen K, 2004, EXTREMOPHILES, V8, P151, DOI 10.1007/s00792-004-0374-7; Pikuta EV, 2003, INT J SYST EVOL MICR, V53, P1327, DOI 10.1099/ijs.0.02598-0; Pikuta EV, 2003, EXTREMOPHILES, V7, P327, DOI 10.1007/s00792-003-0326-7; Poser A, 2013, EXTREMOPHILES, V17, P1003, DOI 10.1007/s00792-013-0582-0; Rees HC, 2004, EXTREMOPHILES, V8, P63, DOI 10.1007/s00792-003-0361-4; Schmidt M, 2006, INT J SYST EVOL MICR, V56, P2887, DOI 10.1099/ijs.0.64450-0; Schmidt M, 2006, EXTREMOPHILES, V10, P551, DOI 10.1007/s00792-006-0529-9; Schmidt M, 2010, ENVIRON TECHNOL, V31, P1091, DOI 10.1080/09593331003770289; Schmidt M, 2010, ENVIRON TECHNOL, V31, P1107, DOI 10.1080/09593331003677872; Scholten JCM, 2005, MICROB ECOL, V50, P29, DOI 10.1007/s00248-004-0085-8; Sorensen Martin Vinther, 2000, Meddelelser om Gronland Bioscience, V51, P1; Sorokin DY, 2008, EXTREMOPHILES, V12, P431, DOI 10.1007/s00792-008-0148-8; Sorokin DY, 2007, APPL ENVIRON MICROB, V73, P451, DOI 10.1128/AEM.02087-06; Sorokin DY, 2014, EXTREMOPHILES, V18, P791, DOI 10.1007/s00792-014-0670-9; Sorokin DY, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00044; Sorokin DY, 2004, HYDROBIOLOGIA, V522, P235, DOI 10.1023/B:HYDR.0000029989.73279.e4; Sorokin DY, 2002, INT J SYST EVOL MICR, V52, P657, DOI 10.1099/00207713-52-2-657; Sorokin DY, 2001, INT J SYST EVOL MICR, V51, P565, DOI 10.1099/00207713-51-2-565; Sorokin DY, 2000, EXTREMOPHILES, V4, P145, DOI 10.1007/s007920070029; Spring S, 2003, INT J SYST EVOL MICR, V53, P1019, DOI 10.1099/ijs.0.02554-0; Stougaard P, 2002, ENVIRON MICROBIOL, V4, P487, DOI 10.1046/j.1462-2920.2002.00327.x; SUESS E, 1982, SCIENCE, V216, P1128, DOI 10.1126/science.216.4550.1128; Sundberg C, 2013, FEMS MICROBIOL ECOL, V85, P612, DOI 10.1111/1574-6941.12148; Surakasi VP, 2010, J BASIC MICROB, V50, P465, DOI 10.1002/jobm.201000001; Suzuki S, 2014, NATURE COMMUNICATION, V5; Suzuki S, 2013, P NATL ACAD SCI USA, V110, P15336, DOI 10.1073/pnas.1302426110; Takai K, 2006, INT J SYST EVOL MICR, V56, P1725, DOI 10.1099/ijs.0.64255-0; Thorbjorn L, 2003, OPHELIA, V57, P177, DOI 10.1080/00785236.2003.10409513; Tiago I, 2004, APPL ENVIRON MICROB, V70, P7378, DOI 10.1128/AEM.70.12.7378-7387.2004; Tiago I, 2013, ENVIRON MICROBIOL, V15, P1687, DOI 10.1111/1462-2920.12034; Vester JK, 2015, APPL MICROBIOL BIOT, V99, P717, DOI 10.1007/s00253-014-5931-0; Vester JK, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-72; Wand U, 2006, LIMNOL OCEANOGR, V51, P1180, DOI 10.4319/lo.2006.51.2.1180; Wani AA, 2006, RES MICROBIOL, V157, P928, DOI 10.1016/j.resmic.2006.08.005; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zhilina TN, 2009, MICROBIOLOGY+, V78, P445, DOI 10.1134/S0026261709040080; Zhilina TN, 2005, MICROBIOLOGY+, V74, P557, DOI 10.1007/s11021-005-0103-y; Zhilina TN, 2005, INT J SYST EVOL MICR, V55, P1001, DOI 10.1099/ijs.0.63490-0	82	31	32	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124863	10.1371/journal.pone.0124863	http://dx.doi.org/10.1371/journal.pone.0124863			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915866	gold, Green Submitted, Green Published			2022-12-27	WOS:000353659100075
J	Gupta, N; Vashist, P; Malhotra, S; Senjam, SS; Misra, V; Bhardwaj, A				Gupta, Noopur; Vashist, Praveen; Malhotra, Sumit; Senjam, Suraj Singh; Misra, Vasundhara; Bhardwaj, Amit			Rapid Assessment of Visual Impairment in Urban Population of Delhi, India	PLOS ONE			English	Article							AVOIDABLE BLINDNESS; CATARACT-SURGERY; PREVALENCE; DISTRICT	Purpose To determine the prevalence, causes and associated demographic factors related to visual impairment amongst the urban population of New Delhi, India. Methods A population-based, cross-sectional study was conducted in East Delhi district using cluster random sampling methodology. This Rapid Assessment of Visual Impairment (RAVI) survey involved examination of all individuals aged 40 years and above in 24 randomly selected clusters of the district. Visual acuity (VA) assessment and comprehensive ocular examination were done during the door-to-door survey. A questionnaire was used to collect personal and demographic information of the study population. Blindness and Visual Impairment was defined as presenting VA <3/60 and <6/18 in the better eye, respectively. Descriptive statistics were computed along with multivariable logistic regression analysis to determine associated factors for visual impairment. Results Of 2421 subjects enumerated, 2331 (96.3%) were available for ophthalmic examination. Among those examined, 49.3% were males. The prevalence of visual impairment (VI) in the study population, was 11.4% (95% C.I. 10.1, 12.7) and that of blindness was 1.2% (95% C.I. 0.8, 1.6). Uncorrected refractive error was the leading cause of VI accounting for 53.4% of all VI followed by cataract (33.8%). With multivariable logistic regression, the odds of having VI increased with age (OR = 24.6[95% C.I.: 14.9, 40.7]; p<0.001). Illiterate participants were more likely to have VI [OR = 1.5 (95% C.I.: 1.1,2.1)] when compared to educated participants. Conclusions The first implementation of the RAVI methodology in a North Indian population revealed that the burden of visual impairment is considerable in this region despite availability of adequate eye care facilities. Awareness generation and simple interventions like cataract surgery and provision of spectacles will help to eliminate the major causes of blindness and visual impairment in this region.	[Gupta, Noopur; Vashist, Praveen; Malhotra, Sumit; Senjam, Suraj Singh; Misra, Vasundhara; Bhardwaj, Amit] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences	Vashist, P (corresponding author), All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India.	praveenvashist@yahoo.com	GUPTA, NOOPUR/AAX-5043-2021; Senjam, Suraj Singh/GQI-1323-2022; senjam, suraj/AAL-9700-2021	GUPTA, NOOPUR/0000-0001-8022-6656; Senjam, Suraj Singh/0000-0001-8204-3669; 	Sightsavers India	Sightsavers India	Sightsavers India, a non-governmental organization funded the VISION DELHI project. The RAVI survey was conducted as part of this project to provide baseline information about the need of refractive error services in this region. PV was the principal investigator of the project and received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casson RJ, 2007, OPHTHALMOLOGY, V114, P2302, DOI 10.1016/j.ophtha.2007.02.004; CENSUS OF INDIA, 2011, PRIMARY CENSUS ABSTR; Guruprasad BS, 2013, OPHTHAL EPIDEMIOL, V20, P89, DOI 10.3109/09286586.2012.759597; Marmamula S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070120; Marmamula S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055924; Marmamula S, 2012, INDIAN J OPHTHALMOL, V60, P416, DOI 10.4103/0301-4738.100539; Marmamula S, 2011, BMC OPHTHALMOL, V11, DOI 10.1186/1471-2415-11-26; Murthy GVS, 2010, OPHTHAL EPIDEMIOL, V17, P185, DOI 10.3109/09286586.2010.483751; Neena J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002867; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Patil S, 2014, INDIAN J OPHTHALMOL, V62, P240, DOI 10.4103/0301-4738.128633; Ramke J, 2007, BRIT J OPHTHALMOL, V91, P1117, DOI 10.1136/bjo.2006.106559; Robinson B, 2013, OPHTHAL EPIDEMIOL, V20, P123, DOI 10.3109/09286586.2013.789915; Sapkota YD, 2006, BRIT J OPHTHALMOL, V90, P411, DOI 10.1136/bjo.2005.082503; Sapkota YD, 2010, OPHTHAL EPIDEMIOL, V17, P82, DOI 10.3109/09286581003624947; Sherchan A, 2010, BRIT J OPHTHALMOL, V94, P161, DOI 10.1136/bjo.2008.155408; Singh N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100644; Vijaya L, 2006, BRIT J OPHTHALMOL, V90, P407, DOI 10.1136/bjo.2005.081406; World Health Organization, CUMULATIVE OFFICIAL; Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023; Zhu MJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-311	21	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124206	10.1371/journal.pone.0124206	http://dx.doi.org/10.1371/journal.pone.0124206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915659	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100038
J	Hou, WG; Xu, ZK; Qin, NN; Xiong, DP; Ding, MY				Hou, Wenguang; Xu, Zekai; Qin, Nannan; Xiong, Dongping; Ding, Mingyue			Surface Reconstruction through Poisson Disk Sampling	PLOS ONE			English	Article							CRUST	This paper intends to generate the approximate Voronoi diagram in the geodesic metric for some unbiased samples selected from original points. The mesh model of seeds is then constructed on basis of the Voronoi diagram. Rather than constructing the Voronoi diagram for all original points, the proposed strategy is to run around the obstacle that the geodesic distances among neighboring points are sensitive to nearest neighbor definition. It is obvious that the reconstructed model is the level of detail of original points. Hence, our main motivation is to deal with the redundant scattered points. In implementation, Poisson disk sampling is taken to select seeds and helps to produce the Voronoi diagram. Adaptive reconstructions can be achieved by slightly changing the uniform strategy in selecting seeds. Behaviors of this method are investigated and accuracy evaluations are done. Experimental results show the proposed method is reliable and effective.	[Hou, Wenguang; Xu, Zekai; Xiong, Dongping; Ding, Mingyue] Huazhong Univ Sci & Technol, Dept Biomed Engn, Wuhan 430074, Peoples R China; [Qin, Nannan] Elect Power Planning & Engn Inst Beijing North St, Beijing, Peoples R China	Huazhong University of Science & Technology	Qin, NN (corresponding author), Elect Power Planning & Engn Inst Beijing North St, 65-2 Ande Rd, Beijing, Peoples R China.	nnq1989@126.com	Xiong, Dongping/GSE-4248-2022	Xiong, Dongping/0000-0002-8081-1297	Natural Science Fund of People's Republic China [41371426]; Electric Power Planning & Engineering Institute Beijing North-Star Co., Ltd.	Natural Science Fund of People's Republic China; Electric Power Planning & Engineering Institute Beijing North-Star Co., Ltd.	Natural Science Fund of People's Republic China under contract 41371426 provides supports in preparation of this manuscript about algorithm design, experiments implementation and etc. The fund is a public welfare research fund. Electric Power Planning & Engineering Institute Beijing North-Star Co., Ltd., provided support in the form of a salary for author Nannan Qin, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Alliez P, 2005, GRAPH MODELS, V67, P204, DOI 10.1016/j.gmod.2004.06.007; Alliez P, 2008, MATH VIS, P53, DOI 10.1007/978-3-540-33265-7_2; Amenta N, 1998, GRAPH MODEL IM PROC, V60, P125, DOI 10.1006/gmip.1998.0465; Amenta N, 1999, DISCRETE COMPUT GEOM, V22, P481, DOI 10.1007/PL00009475; Amenta N, 2001, COMP GEOM-THEOR APPL, V19, P127, DOI 10.1016/S0925-7721(01)00017-7; Boissonnat JD., 2006, EFFECTIVE COMPUTATIO; Bolitho M, 2009, LECT NOTES COMPUT SC, V5875, P678, DOI 10.1007/978-3-642-10331-5_63; Bowers J, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1866158.1866188; Chang DC, 2011, J GEOM PHYS, V61, P986, DOI 10.1016/j.geomphys.2011.01.011; Cline D, 2009, COMPUT GRAPH FORUM, V28, P1217, DOI 10.1111/j.1467-8659.2009.01499.x; COOK RL, 1986, ACM T GRAPHIC, V5, P51, DOI 10.1145/7529.8927; EDELSBRUNNER H, 1994, ACM T GRAPHIC, V13, P43, DOI 10.1145/174462.156635; Edelsbrunner Herbert, 2010, COMPUTATIONAL TOPOLO; Fleishman S, 2005, ACM T GRAPHIC, V24, P544, DOI 10.1145/1073204.1073227; Floater MS, 2001, COMPUT AIDED GEOM D, V18, P77, DOI 10.1016/S0167-8396(01)00013-9; Gopi M, 2000, COMPUT GRAPH FORUM, V19, pC467, DOI 10.1111/1467-8659.00439; Hoppe H., 1993, Computer Graphics Proceedings, P19, DOI 10.1145/166117.166119; Hoppe H., 1996, Computer Graphics Proceedings. SIGGRAPH '96, P99, DOI 10.1145/237170.237216; HOPPE H, 1992, COMP GRAPH, V26, P71, DOI 10.1145/142920.134011; Hou WG, 2013, INT J APPL EARTH OBS, V23, P264, DOI 10.1016/j.jag.2012.09.008; Kazhdan M., 2006, P 4 EUROGRAPHICS S G, P61; Lagae A, 2008, COMPUT GRAPH FORUM, V27, P114, DOI 10.1111/j.1467-8659.2007.01100.x; Martinez D, 2004, XVII BRAZILIAN SYMPOSIUM ON COMPUTER GRAPHICS AND IMAGE PROCESSING, PROCEEDINGS, P210, DOI 10.1109/SIBGRA.2004.1352963; Moenning C, 2003, 562 U CAMBR; Mount MD, 2010, LIB APPROXIMATE NEAR; Ohtake Y, 2005, P 2005 ACM S SOL PHY; Peyre G, 2006, INT J COMPUT VISION, V69, P145, DOI 10.1007/s11263-006-6859-3; Samuel P., COMPUTING CONSTRAINE; Schmidt R, 2012, COMPUT GRAPH-UK, V36, P488, DOI 10.1016/j.cag.2012.03.030; Stanford, 2014, STANF 3D SCANN REP; Surazhsky V., 2003, Symposium on Geometry Processing, P20; Tamal K, 2007, CURVE SURFACE RECONS; Zagorchev LG, 2012, IEEE T VIS COMPUT GR, V18, P1460, DOI 10.1109/TVCG.2011.276	33	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0120151	10.1371/journal.pone.0120151	http://dx.doi.org/10.1371/journal.pone.0120151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915744	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100004
J	Kim, M; Lee, JS; Oh, JE; Nan, J; Lee, H; Jung, HS; Chung, SS; Park, KS				Kim, Min; Lee, Ji Seon; Oh, Joo En; Nan, Jinyan; Lee, Hakmo; Jung, Hye Seung; Chung, Sung Soo; Park, Kyong Soo			SIRT3 Overexpression Attenuates Palmitate-Induced Pancreatic beta-Cell Dysfunction	PLOS ONE			English	Article							ENZYME GENE-EXPRESSION; MITOCHONDRIAL; DEACETYLASE; PGC-1-ALPHA; DEATH	Abnormally high levels of circulating free fatty acids can lead to pancreatic islet beta-cell dysfunction and apoptosis, contributing to beta-cell failure in Type 2 diabetes. The NAD(+)-dependent protein deacetylase Sirtuin-3 (SIRT3) has been implicated in Type 2 diabetes. In this study, we tested whether SIRT3 overexpression affects palmitate-induced beta-cell dysfunction in cells of line NIT1, which are derived from mouse pancreatic beta-cells. Two different lengths of SIRT3 were overexpressed: full length SIRT3 (SIRT3LF), which was preferentially targeted to mitochondria and partially to the nucleus, and its N-terminal truncated form (SIRT3SF), which was located in the nucleus and cytoplasm. Overexpression of SIRT3LF and SIRT3SF using an adenoviral system alleviated palmitate-induced lipotoxicity such as reduction of cell viability and mitogen-activated protein kinase (MAPK) activation. Chronic exposure to low concentrations of palmitate suppressed glucose-stimulated insulin secretion, but the suppression was effectively reversed by overexpression of SIRT3LF or SIRT3SF. The mRNA levels of the endoplasmic reticulum (ER) stress responsive genes ATF4, GRP94 and FKBP11 were increased by palmitate treatment, but the increases were completely inhibited by SIRT3LF overexpression and less effectively inhibited by SIRT3SF overexpression. This result suggests that overexpression of SIRT3 inhibits induction of ER stress by palmitate. Collectively, we conclude that overexpression of SIRT3 alleviates palmitate-induced beta-cell dysfunction.	[Kim, Min; Lee, Ji Seon; Oh, Joo En; Nan, Jinyan; Lee, Hakmo; Jung, Hye Seung; Chung, Sung Soo; Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Park, Kyong Soo] Seoul Natl Univ, Coll Med, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Chung, SS (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	suschung@snu.ac.kr; kspark@snu.ac.kr	Lee, Hakmo/V-8317-2019; Park, Kyong Soo/C-2265-2008	Lee, Hakmo/0000-0002-8861-4351; Park, Kyong Soo/0000-0003-3597-342X	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A062260, A110421, A120273]	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by grants of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A062260), (A110421) and (A120273). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bao JJ, 2010, J CELL BIOCHEM, V110, P238, DOI 10.1002/jcb.22531; Caton PW, 2013, DIABETOLOGIA, V56, P1068, DOI 10.1007/s00125-013-2851-y; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; Cheng K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040868; Cooper HM, 2008, BIOCHEM J, V411, P279, DOI 10.1042/BJ20071624; Cooper HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004986; Elsner M, 2011, DIABETES, V60, P200, DOI 10.2337/db09-1401; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Frigerio F, 2010, DIABETOLOGIA, V53, P331, DOI 10.1007/s00125-009-1590-6; Hellemans K, 2007, FEBS J, V274, P6094, DOI 10.1111/j.1742-4658.2007.06131.x; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lin N, 2012, ENDOCRINE, V42, P107, DOI 10.1007/s12020-012-9633-z; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wang Y, 2013, AUTOPHAGY, V9, P272, DOI 10.4161/auto.23628; Wu L, 2012, BBA-MOL BASIS DIS, V1822, P1815, DOI 10.1016/j.bbadis.2012.08.009; Zhang PX, 2005, FEBS LETT, V579, P1446, DOI 10.1016/j.febslet.2005.01.046; Zmuda EJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2096	28	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124744	10.1371/journal.pone.0124744	http://dx.doi.org/10.1371/journal.pone.0124744			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915406	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100064
J	Matusovsky, OS; Shevchenko, UV; Matusovskaya, GG; Sobieszek, A; Dobrzhanskaya, AV; Shelud'ko, NS				Matusovsky, Oleg S.; Shevchenko, Ulyana V.; Matusovskaya, Galina G.; Sobieszek, Apolinary; Dobrzhanskaya, Anna V.; Shelud'ko, Nikolay S.			Catch Muscle Myorod Modulates ATPase Activity of Myosin in a Phosphorylation-Dependent Way	PLOS ONE			English	Article							THICK-FILAMENT PROTEIN; MOLLUSCAN MUSCLES; SMOOTH MUSCLES; TWITCHIN; ACTIN; PARAMYOSIN; INTERACTS; MECHANISM; STATE; ROD	Myorod is expressed exclusively in molluscan catch muscle and localizes on the surface of thick filaments together with twitchin and myosin. Myorod is an alternatively spliced product of themyosin heavy-chain gene that contains the C-terminal rod part of myosin and a unique N-terminal domain. The unique domain is a target for phosphorylation by gizzard smooth myosin light chain kinase (smMLCK) and, perhaps, molluscan twitchin, which contains a MLCK-like domain. To elucidate the role of myorod and its phosphorylation in the catch muscle, the effect of chromatographically purified myorod on the actin-activated Mg2+-ATPase activity of myosin was studied. We found that phosphorylation at the N-terminus of myorod potentiated the actin-activated Mg2+-ATPase activity of mussel and rabbit myosins. This potentiation occurred only if myorod was phosphorylated and introduced into the ATPase assay as a co-filament with myosin. We suggest that myorod could be related to the catch state, a function specific to molluscan muscle.	[Matusovsky, Oleg S.; Shevchenko, Ulyana V.; Matusovskaya, Galina G.; Dobrzhanskaya, Anna V.; Shelud'ko, Nikolay S.] Russian Acad Sci, Far East Branch, AV Zhirmunsky Inst Marine Biol, Vladivostok 690022, Russia; [Matusovsky, Oleg S.] Far Eastern Fed Univ, Sch Biomed, Vladivostok, Russia; [Sobieszek, Apolinary] Austrian Acad Sci, Inst Biomed Aging Res, Innsbruck, Austria	Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; Far Eastern Federal University; Austrian Academy of Sciences	Matusovsky, OS (corresponding author), Russian Acad Sci, Far East Branch, AV Zhirmunsky Inst Marine Biol, Vladivostok 690022, Russia.	osmatusovsky@gmail.com; sheludko@stl.ru	Shelud'ko, Nikolay S./B-2573-2016; Dobrzhanskaya, Anna V/F-5214-2019; Shevchenko, Ulyana/U-8475-2018; Sobieszek, Apolinary/AAD-8985-2022; Matusovsky, Oleg/AAV-1062-2021	Shelud'ko, Nikolay S./0000-0002-2923-2206; Sobieszek, Apolinary/0000-0003-4915-9621; Matusovsky, Oleg/0000-0002-0824-9260	Russian Science Foundation [14-14-00080]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation (No 14-14-00080).	Andersen O, 2009, J MUSCLE RES CELL M, V30, P233, DOI 10.1007/s10974-009-9192-y; Butler TM, 2011, J MUSCLE RES CELL M, V31, P349, DOI 10.1007/s10974-011-9240-2; Butler TM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/725207; CASTELLANI L, 1987, SCIENCE, V235, P334, DOI 10.1126/science.3026049; Franke AS, 2007, BIOPHYS J, V93, P554, DOI 10.1529/biophysj.107.105577; Funabara D, 2003, J BIOL CHEM, V278, P29308, DOI 10.1074/jbc.M303272200; Funabara D, 2001, BIOCHEMISTRY-US, V40, P2087, DOI 10.1021/bi0022691; Funabara D, 2007, J EXP BIOL, V210, P4399, DOI 10.1242/jeb.008722; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Matusovskii O. S., 2005, Biophysics, V50, P63; Matusovsky OS, 2011, ARCH BIOCHEM BIOPHYS, V509, P59, DOI 10.1016/j.abb.2011.02.010; Matusovsky OS, 2010, BBA-PROTEINS PROTEOM, V1804, P884, DOI 10.1016/j.bbapap.2009.12.020; OPLATKA A, 1975, BIOCHEM BIOPH RES CO, V66, P1323, DOI 10.1016/0006-291X(75)90504-5; Shelud'ko N, 2002, COMP BIOCHEM PHYS B, V133, P69, DOI 10.1016/S1096-4959(02)00108-2; Shelud'ko N, 2001, J MUSCLE RES CELL M, V22, P91, DOI 10.1023/A:1010359718304; Shelud'ko NS, 2007, ARCH BIOCHEM BIOPHYS, V466, P125, DOI 10.1016/j.abb.2007.07.014; Shelud'ko NS, 1999, COMP BIOCHEM PHYS B, V122, P277, DOI 10.1016/S0305-0491(99)00009-7; Shelud'ko NS, 2004, ARCH BIOCHEM BIOPHYS, V432, P269, DOI 10.1016/j.abb.2004.10.006; Sheng ST, 2003, J BIOL CHEM, V278, P39892, DOI 10.1074/jbc.M306094200; Siegman MJ, 1998, P NATL ACAD SCI USA, V95, P5383, DOI 10.1073/pnas.95.9.5383; Sobieszek A, 2006, ARCH BIOCHEM BIOPHYS, V454, P197, DOI 10.1016/j.abb.2006.08.004; Sobieszek A, 2010, BIOCHEMISTRY-US, V49, P4191, DOI 10.1021/bi100143q; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; STEPKOWSKI D, 1994, BIOCHEM J, V300, P153, DOI 10.1042/bj3000153; SZENTGYORGYI AG, 1971, J MOL BIOL, V56, P239, DOI 10.1016/0022-2836(71)90462-1; VIBERT P, 1993, J MUSCLE RES CELL M, V14, P598, DOI 10.1007/BF00141557; Yamada A, 2004, J BIOL CHEM, V279, P40762, DOI 10.1074/jbc.M405191200; Yamada A, 2000, J MOL BIOL, V295, P169, DOI 10.1006/jmbi.1999.3349	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125379	10.1371/journal.pone.0125379	http://dx.doi.org/10.1371/journal.pone.0125379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915932	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100125
J	Perez-Nunez, D; Garcia-Urdiales, E; Martinez-Bonet, M; Nogal, ML; Barroso, S; Revilla, Y; Madrid, R				Perez-Nunez, Daniel; Garcia-Urdiales, Eduardo; Martinez-Bonet, Marta; Nogal, Maria L.; Barroso, Susana; Revilla, Yolanda; Madrid, Ricardo			CD2v Interacts with Adaptor Protein AP-1 during African Swine Fever Infection	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; COMPLEX CLASS-I; CELLULAR VIMENTIN; GOLGI MEMBRANES; BREFELDIN-A; VIRUS; NEF; BINDING; MOTIF; INHIBITION	African swine fever virus (ASFV) CD2v protein is believed to be involved in virulence enhancement, viral hemadsorption, and pathogenesis, although the molecular mechanisms of the function of this viral protein are still not fully understood. Here we describe that CD2v localized around viral factories during ASFV infection, suggesting a role in the generation and/or dynamics of these viral structures and hence in disturbing cellular traffic. We show that CD2v targeted the regulatory trans-Golgi network (TGN) protein complex AP-1, a key element in cellular traffic. This interaction was disrupted by brefeldin A even though the location of CD2v around the viral factory remained unchanged. CD2v-AP-1 binding was independent of CD2v glycosylation and occurred on the carboxy-terminal part of CD2v, where a canonical di-Leu motif previously reported to mediate AP-1 binding in eukaryotic cells, was identified. This motif was shown to be functionally interchangeable with the di-Leu motif present in HIV-Nef protein in an AP-1 binding assay. However, we demonstrated that it was not involved either in CD2v cellular distribution or in CD2v-AP-1 binding. Taken together, these findings shed light on CD2v function during ASFV infection by identifying AP-1 as a cellular factor targeted by CD2v and hence elucidate the cellular pathways used by the virus to enhance infectivity.	[Perez-Nunez, Daniel; Nogal, Maria L.; Barroso, Susana; Revilla, Yolanda; Madrid, Ricardo] CSIC UAM, Ctr Biol Mol Severo Ochoa, Dept Virol, Madrid, Spain; [Garcia-Urdiales, Eduardo] Univ Dublin Trinity Coll, Mol Design Grp, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Martinez-Bonet, Marta] Hosp Gen Gregorio Maranon, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Trinity College Dublin; General University Gregorio Maranon Hospital	Revilla, Y (corresponding author), CSIC UAM, Ctr Biol Mol Severo Ochoa, Dept Virol, Madrid, Spain.	yrevilla@cbm.csic.es	Pérez-Núñez, Daniel/S-4195-2018	Perez-Nunez, Daniel/0000-0002-0901-8309; Yolanda, Revilla/0000-0001-6555-6331; Madrid Gonzalez, Ricardo/0000-0002-1350-9864; Martinez Bonet, Marta/0000-0003-0715-403X	Ministerio de Ciencia e Innovacion of Spain [BFU2010-17794]; European Community's Seventh Framework Programme [KBBE.2012.1.3-02-ASFORCE]; Amarauto research program;  [FIS-641 PS09/01386]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community's Seventh Framework Programme(European Commission); Amarauto research program; 	This work was supported by Ministerio de Ciencia e Innovacion of Spain, BFU2010-17794 (YR); European Community's Seventh Framework Programme, KBBE.2012.1.3-02-ASFORCE (YR). Ricardo Madrid was funded by an Amarauto research program and by FIS-641 PS09/01386. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01813; Borca MV, 1998, J VIROL, V72, P2881, DOI 10.1128/JVI.72.4.2881-2889.1998; Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9; Canagarajah BJ, 2013, PROTEIN SCI, V22, P517, DOI 10.1002/pro.2235; CARRASCOSA AL, 1982, J VIROL METHODS, V3, P303, DOI 10.1016/0166-0934(82)90034-9; Castello A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000562; Chapman DAG, 2008, J GEN VIROL, V89, P397, DOI 10.1099/vir.0.83343-0; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Dixon LK, 2004, VET IMMUNOL IMMUNOP, V100, P117, DOI 10.1016/j.vetimm.2004.04.002; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; ENJUANES L, 1976, J GEN VIROL, V32, P471, DOI 10.1099/0022-1317-32-3-471; Fay N, 2013, VIROLOGY, V444, P181, DOI 10.1016/j.virol.2013.06.009; Galindo I, 2000, VIROLOGY, V266, P340, DOI 10.1006/viro.1999.0080; Gladue DP, 2013, J VIROL, V87, P6794, DOI 10.1128/JVI.00448-13; Goatley LC, 2011, J VIROL; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Granja AG, 2008, J IMMUNOL, V180, P2429, DOI 10.4049/jimmunol.180.4.2429; Granja AG, 2009, J VIROL, V83, P969, DOI 10.1128/JVI.01663-08; Heath CM, 2001, J CELL BIOL, V153, P449, DOI 10.1083/jcb.153.3.449; Janvier K, 2003, J BIOL CHEM, V278, P8725, DOI 10.1074/jbc.M210115200; Johnson DC, 2001, J VIROL, V75, P821, DOI 10.1128/JVI.75.2.821-833.2001; Kay-Jackson PC, 2004, J GEN VIROL, V85, P119, DOI 10.1099/vir.0.19435-0; Kulpa DA, 2013, J VIROL, V87, P8085, DOI 10.1128/JVI.00701-13; Laguette N, 2010, MOL ASPECTS MED, V31, P418, DOI 10.1016/j.mam.2010.05.003; Lanke KHW, 2009, J VIROL, V83, P11940, DOI 10.1128/JVI.01244-09; Madrid R, 2005, J BIOL CHEM, V280, P5032, DOI 10.1074/jbc.M401202200; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mori Y, 2008, TRAFFIC, V9, P1728, DOI 10.1111/j.1600-0854.2008.00796.x; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; Nakatsu F, 2003, CELL STRUCT FUNCT, V28, P419, DOI 10.1247/csf.28.419; Netherton CL, 2006, J VIROL, V80, P11385, DOI 10.1128/JVI.00439-06; Nigsch A, 2013, PREV VET MED, V108, P262, DOI 10.1016/j.prevetmed.2012.11.003; Revilla Y, 1997, VIROLOGY, V228, P400, DOI 10.1006/viro.1996.8395; ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U; RODRIGUEZ JM, 1993, J VIROL, V67, P5312; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Rowlands RJ, 2009, VIROLOGY, V393, P319, DOI 10.1016/j.virol.2009.07.040; Sanchez EG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002754; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Stefanovic S, 2005, J VIROL, V79, P11766, DOI 10.1128/JVI.79.18.11766-11775.2005; Teo CSH, 2014, J VIROL, V88, P1897, DOI 10.1128/JVI.01249-13; Tong X, 1998, J VIROL, V72, P476, DOI 10.1128/JVI.72.1.476-482.1998; Tordo N., 2012, VIRUS TAXONOMY CLASS, P153; VINUELA E, 1985, CURR TOP MICROBIOL, V116, P151; Wonderlich ER, 2008, J BIOL CHEM, V283, P3011, DOI 10.1074/jbc.M707760200; YANEZ RJ, 1995, VIROLOGY, V208, P249, DOI 10.1006/viro.1995.1149	48	27	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123714	10.1371/journal.pone.0123714	http://dx.doi.org/10.1371/journal.pone.0123714			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915900	Green Published, gold			2022-12-27	WOS:000353659100026
J	Tombolan, L; Zampini, M; Casara, S; Boldrin, E; Zin, A; Bisogno, G; Rosolen, A; De Pitta, C; Lanfranchi, G				Tombolan, Lucia; Zampini, Matteo; Casara, Silvia; Boldrin, Elena; Zin, Angelica; Bisogno, Gianni; Rosolen, Angelo; De Pitta, Cristiano; Lanfranchi, Gerolamo			MicroRNA-27a Contributes to Rhabdomyosarcoma Cell Proliferation by Suppressing RARA and RXRA	PLOS ONE			English	Article							TRANS-RETINOIC ACID; ACUTE PROMYELOCYTIC LEUKEMIA; GENE-EXPRESSION SIGNATURE; EMBRYONAL RHABDOMYOSARCOMA; TRANSCRIPTION FACTORS; ONCOGENIC MICRORNA-27A; CANCER; ALVEOLAR; DIFFERENTIATION; TARGETS	Background Rhabdomyosarcomas (RMS) are rare but very aggressive childhood tumors that arise as a consequence of a regulatory disruption in the growth and differentiation pathways of myogenic precursor cells. According to morphological criteria, there are two major RMS subtypes: embryonal RMS (ERMS) and alveolar RMS (ARMS) with the latter showing greater aggressiveness and metastatic potential with respect to the former. Efforts to unravel the complex molecular mechanisms underlying RMS pathogenesis and progression have revealed that microRNAs (miRNAs) play a key role in tumorigenesis. Methodology/Principal Findings The expression profiles of 8 different RMS cell lines were analyzed to investigate the involvement of miRNAs in RMS. The miRNA population from each cell line was compared to a reference sample consisting of a balanced pool of total RNA extracted from those 8 cell lines. Sixteen miRNAs whose expression discriminates between translocation-positive ARMS and negative RMS were identified. Attention was focused on the role of miR-27a that is up-regulated in the more aggressive RMS cell lines (translocation-positive ARMS) in which it probably acts as an oncogene. MiR-27a overexpressing cells showed a significant increase in their proliferation rate that was paralleled by a decrease in the number of cells in the G1 phase of the cell cycle. It was possible to demonstrate that miR-27a is implicated in cell cycle control by targeting the retinoic acid alpha receptor (RARA) and retinoic X receptor alpha (RXRA). Conclusions Study results have demonstrated that miRNA expression signature profiling can be used to classify different RMS subtypes and suggest that miR-27a may have a therapeutic potential in RMS by modulating the expression of retinoic acid receptors.	[Tombolan, Lucia; Zampini, Matteo; De Pitta, Cristiano; Lanfranchi, Gerolamo] Univ Padua, Dept Biol, Padua, Italy; [Tombolan, Lucia; Zampini, Matteo; Casara, Silvia; Boldrin, Elena; Lanfranchi, Gerolamo] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [Zin, Angelica] IRP, Pediat Res Inst, Padua, Italy; [Zin, Angelica; Bisogno, Gianni; Rosolen, Angelo] Univ Padua, Oncohematol Unit, Dept Womens & Childrens Hlth, Padua, Italy	University of Padua; University of Padua; Fondazione Citta della Speranza; University of Padua	De Pitta, C (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	cristiano.depitta@unipd.it; gerolamo.lanfranchi@unipd.it	De Pitta, Cristiano/AAY-7302-2020; Zampini, Matteo/L-9027-2018; Bisogno, Gianni/K-9282-2016	De Pitta, Cristiano/0000-0001-8013-8162; Zampini, Matteo/0000-0002-9952-1142; Bisogno, Gianni/0000-0003-4462-5523; Boldrin, Elena/0000-0001-6815-3060	Fondazione Citta della Speranza (the City of Hope Foundation); Associazione ltaliana per la Ricerca sul Cancro (The Italian Association for Cancer Research) [6014/2008, 13576/2012]	Fondazione Citta della Speranza (the City of Hope Foundation); Associazione ltaliana per la Ricerca sul Cancro (The Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Fondazione Citta della Speranza (the City of Hope Foundation) and the Associazione ltaliana per la Ricerca sul Cancro (The Italian Association for Cancer Research) (Grant No. 6014/2008 to AR and GL; Grant No. 13576/2012 to AR and GL). The funders played no role in designing the study, in collecting/analyzing the data, in drafting the manuscript or in the decision to submit it for publication	Ades L, 2010, BLOOD, V115, P1690, DOI 10.1182/blood-2009-07-233387; Al-Tahan A, 2012, PEDIATR BLOOD CANCER, V58, P877, DOI 10.1002/pbc.23246; Arisi MF, 2014, INT J ONCOL, V44, P1831, DOI 10.3892/ijo.2014.2354; Asou N, 2007, BLOOD, V110, P59, DOI 10.1182/blood-2006-08-043992; Barlow JW, 2006, PEDIATR BLOOD CANCER, V47, P773, DOI 10.1002/pbc.20650; Barr FG, 1997, CURR TOP MICROBIOL, V220, P113; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Biscontin A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-44; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonvini P, 2013, BRIT J CANCER, V109, P3084, DOI 10.1038/bjc.2013.653; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chen Ji-ming, 2005, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V19, P80; Chintharlapalli S, 2009, INT J CANCER, V125, P1965, DOI 10.1002/ijc.24530; Ciarapica R, 2009, CELL CYCLE, V8, P172, DOI 10.4161/cc.8.1.7292; Cimino D, 2013, FASEB J, V27, P1223, DOI 10.1096/fj.12-214692; CROUCH GD, 1991, CANCER RES, V51, P4882; Dagher SM, 1999, J ENVIRON SCI HEAL B, V34, P849, DOI 10.1080/03601239909373230; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; De Pitta C, 2006, INT J CANCER, V118, P2772, DOI 10.1002/ijc.21698; DEGIOVANNI C, 1989, ANTICANCER RES, V9, P1943; Fletcher CE, 2012, HUM MOL GENET, V21, P3112, DOI 10.1093/hmg/dds139; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Garcia-Alonso I, 2005, REV ESP ENFERM DIG, V97, P240; Gasparini P, 2014, ONCOTARGET, V5, P1174, DOI 10.18632/oncotarget.1682; Gastaldi T, 2006, CARCINOGENESIS, V27, P1758, DOI 10.1093/carcin/bgl008; Girardi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031293; Gougelet Angelique, 2011, Sarcoma, V2011, P460650, DOI 10.1155/2011/460650; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; HAZELTON BJ, 1987, CANCER RES, V47, P4501; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DZ, 2014, J CELL BIOCHEM, V115, P549, DOI 10.1002/jcb.24689; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Iolascon A, 1996, GENE CHROMOSOME CANC, V15, P217, DOI 10.1002/(SICI)1098-2264(199604)15:4<217::AID-GCC3>3.3.CO;2-X; Kouraklis G, 1999, PEDIATR RES, V45, P552, DOI 10.1203/00006450-199904010-00015; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leonardo TR, 2012, NAT CELL BIOL, V14, P1114, DOI 10.1038/ncb2613; Lerner M, 2011, CELL CYCLE, V10, P2172, DOI 10.4161/cc.10.13.16248; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li L, 2012, LAB INVEST, V92, P571, DOI 10.1038/labinvest.2012.10; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Masetti R, 2012, ADV THER, V29, P747, DOI 10.1007/s12325-012-0047-3; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Moretti A, 2002, EUR J CANCER, V38, P2290, DOI 10.1016/S0959-8049(02)00454-9; Poy MN, 2007, DIABETES OBES METAB, V9, P67, DOI 10.1111/j.1463-1326.2007.00775.x; Ricaud S, 2005, EXP CELL RES, V311, P192, DOI 10.1016/j.yexcr.2005.09.011; Risso D, 2009, BIOINFORMATICS, V25, P2685, DOI 10.1093/bioinformatics/btp443; Rocke DM, 2003, BIOINFORMATICS, V19, P966, DOI 10.1093/bioinformatics/btg107; Romualdi C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-287; Rota R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-120; Sabnis N, 2013, FRONT PEDIATR, V1, DOI 10.3389/fped.2013.00006; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Sarver AL, 2010, LAB INVEST, V90, P753, DOI 10.1038/labinvest.2010.53; SHAPIRO DN, 1993, CANCER RES, V53, P5108; Shingara J, 2005, RNA, V11, P1461, DOI 10.1261/rna.2610405; Siddikuzzaman, 2011, IMMUNOPHARM IMMUNOT, V33, P241, DOI 10.3109/08923973.2010.521507; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Subramanian S, 2008, ONCOGENE, V27, P2015, DOI 10.1038/sj.onc.1210836; Tallman MS, 2002, BLOOD, V100, P4298, DOI 10.1182/blood-2002-02-0632; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Toffolatti L, 2002, J PATHOL, V196, P450, DOI 10.1002/path.1068; Tombolan L, 2011, AM J PATHOL, V179, P2611, DOI 10.1016/j.ajpath.2011.07.018; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang S, 1999, ONCOGENE, V18, P3501, DOI 10.1038/sj.onc.1202684; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Zhang HH, 2007, WORLD J GASTROENTERO, V13, P2883, DOI 10.3748/wjg.v13.i20.2883; Zhang HW, 2010, DIGEST DIS SCI, V55, P2545, DOI 10.1007/s10620-009-1051-6; Zhu H, 2008, BIOCHEM PHARMACOL, V76, P582, DOI 10.1016/j.bcp.2008.06.007	80	19	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125171	10.1371/journal.pone.0125171	http://dx.doi.org/10.1371/journal.pone.0125171			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915942	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100104
J	Badr, G; Sayed, A; Abdel-Maksoud, MA; Mohamed, AO; El-Amir, A; Abdel-Ghaffar, FA; Al-Quraishy, S; Mahmoud, MH				Badr, Gamal; Sayed, Ayat; Abdel-Maksoud, Mostafa A.; Mohamed, Amany O.; El-Amir, Azza; Abdel-Ghaffar, Fathy A.; Al-Quraishy, Saleh; Mahmoud, Mohamed H.			Infection of Female BWF1 Lupus Mice with Malaria Parasite Attenuates B Cell Autoreactivity by Modulating the CXCL12/CXCR4 Axis and Its Downstream Signals PI3K/AKT, NF kappa B and ERK	PLOS ONE			English	Article							LYMPHOCYTE STIMULATOR LEVELS; DISEASE-ACTIVITY; CHEMOKINE RECEPTORS; AUTOIMMUNE-DISEASE; ERYTHEMATOSUS; EXPRESSION; CXCR4/CXCL12; CHEMOTAXIS; NEPHRITIS; CYTOKINE	Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by abnormal autoreactivity in B cells. Lymphocytes and their soluble mediators contribute to the disease pathogenesis. We recently demonstrated that infecting lupus mice with malaria confers protection against lupus nephritis by attenuating oxidative stress in both liver and kidney tissues. In the current study, we further investigated B cell autoreactivity in female BWF1 lupus mice after infection with either live or gamma-irradiated malaria, using ELISA, flow cytometry and Western blot analysis. The lupus mice exhibited a significant elevation in plasma levels of IL-4, IL-6, IL-7, IL-12, IL-17, IFN-alpha, IFN-gamma,TGF-beta, BAFF and APRIL and a marked elevation of IgG2a, IgG3 and ant-dsDNA autoantibodies compared with normal healthy mice. Infecting lupus mice with live but not gamma-irradiated malaria parasite partially and significantly restored the levels of the soluble mediators that contribute to the progression of lupus. Furthermore, the B cells of lupus mice exhibited an increased proliferative capacity; aberrant overexpression of the chemokine receptor CXCR4; and a marked elevation in responsiveness to their cognate ligand (CXCL12) via aberrant activation of the PI3K/AKT, NF kappa B and ERK signaling pathways. Interestingly, infecting lupus mice with live but not gamma-irradiated malaria parasite restored a normal proliferative capacity, surface expression of CXCR4 and B cell response to CXCL-12. Taken together, our data present interesting findings that clarify, for the first time, the molecular mechanisms of how infection of lupus mice with malaria parasite controls B cell autoreactivity and thus confers protection against lupus severity.	[Badr, Gamal] Assiut Univ, Fac Sci, Dept Zool, Lab Immunol & Mol Physiol, Assiut, Egypt; [Sayed, Ayat; Mohamed, Amany O.] Assiut Univ, Dept Biochem, Fac Med, Assiut, Egypt; [Abdel-Maksoud, Mostafa A.; El-Amir, Azza; Abdel-Ghaffar, Fathy A.] Cairo Univ, Fac Sci, Dept Zool, Cairo, Egypt; [Abdel-Maksoud, Mostafa A.; Al-Quraishy, Saleh] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Mahmoud, Mohamed H.] King Saud Univ, Deanship Sci Res, Riyadh, Saudi Arabia; [Mahmoud, Mohamed H.] Natl Res Ctr, Dept Food Sci & Nutr, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Cairo University; King Saud University; King Saud University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Badr, G (corresponding author), Assiut Univ, Fac Sci, Dept Zool, Lab Immunol & Mol Physiol, Assiut, Egypt.	badr73@yahoo.com	Mahmoud, Mohamed hassanein/J-4178-2015; Badr, Gamal/I-4891-2014; Alquraishy, Saleh A/R-3570-2016	Mahmoud, Mohamed hassanein/0000-0003-2928-3828; Badr, Gamal/0000-0002-6157-7319; Mahmoud, Mohamed/0000-0003-0629-9384; Abdel-Maksoud, Mostafa A./0000-0002-6964-4846; Mohamed, Amany/0000-0003-3131-3846	King Saud University [RG-1435-019]	King Saud University(King Saud University)	The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for funding this Research group NO (RG-1435-019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebajo AO, 1997, LANCET, V349, P361, DOI 10.1016/S0140-6736(05)62867-X; Al-Quraishy S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/156562; Asito AS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-238; Badot V, 2013, ANN RHEUM DIS, V72, P453, DOI 10.1136/annrheumdis-2012-202364; Badr G, 2005, J IMMUNOL, V175, P302, DOI 10.4049/jimmunol.175.1.302; Badr G, 2008, BLOOD, V111, P2744, DOI 10.1182/blood-2007-03-081232; Badr G, 2013, FREE RADICAL BIO MED, V65, P175, DOI 10.1016/j.freeradbiomed.2013.06.018; Badr G, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-236; Badr G, 2012, CELL IMMUNOL, V273, P10, DOI 10.1016/j.cellimm.2011.12.003; Badr G, 2011, CELL PHYSIOL BIOCHEM, V27, P381, DOI 10.1159/000327964; Bertsias GK, 2010, ANN RHEUM DIS, V69, P1603, DOI 10.1136/ard.2010.135186; Biajoux V, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-251; Bjorkander S, 2013, SCAND J IMMUNOL, V77, P200, DOI 10.1111/sji.12021; BLANCO F, 1992, LUPUS, V1, P391, DOI 10.1177/096120339200100609; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Chu VT, 2009, ARTHRITIS RHEUM-US, V60, P2083, DOI 10.1002/art.24628; Chun HY, 2007, J CLIN IMMUNOL, V27, P461, DOI 10.1007/s10875-007-9104-0; Criscione Lisa G, 2003, Curr Rheumatol Rep, V5, P264, DOI 10.1007/s11926-003-0004-x; Ezzat MHM, 2011, LUPUS, V20, P845, DOI 10.1177/0961203311398513; Fairhurst AM, 2008, EUR J IMMUNOL, V38, P1948, DOI 10.1002/eji.200837925; FerreiradaCruz MD, 1997, MEM I OSWALDO CRUZ, V92, P137; Garnica MR, 2002, IMMUNOL LETT, V83, P47, DOI 10.1016/S0165-2478(02)00067-6; Gomez D, 2004, SEMIN ARTHRITIS RHEU, V33, P404, DOI 10.1016/j.semarthrit.2003.11.002; Grammer AC, 2003, ARTHRITIS RES THER, V5, pS22, DOI 10.1186/ar1009; Grammer AC, 2004, ARTHRITIS RES THER, V6, P28, DOI 10.1186/ar1155; GREENWOOD BM, 1970, NATURE, V226, P266, DOI 10.1038/226266a0; Hao SL, 2005, MOL BIOL CELL, V16, P2275, DOI 10.1091/mbc.e04-10-0881; Henneken M, 2005, ARTHRITIS RES THER, V7, pR1001, DOI 10.1186/ar1776; HENTATI B, 1991, J AUTOIMMUN, V4, P341, DOI 10.1016/0896-8411(91)90029-C; HENTATI B, 1994, EUR J IMMUNOL, V24, P8, DOI 10.1002/eji.1830240103; Jacobi AM, 2003, ARTHRITIS RHEUM, V48, P1332, DOI 10.1002/art.10949; Khan Islam U, 2003, Curr Dir Autoimmun, V6, P89; Klasen C, 2014, J IMMUNOL, V192, P5273, DOI 10.4049/jimmunol.1302209; Launay O, 2013, VACCINE, V31, P3492, DOI 10.1016/j.vaccine.2013.05.095; Liu XQ, 2012, EUR J IMMUNOL, V42, P3291, DOI 10.1002/eji.201242689; Liu Z, 2011, ARTHRITIS RHEUM-US, V63, P219, DOI 10.1002/art.30087; Lourenco EV, 2009, CURR MOL MED, V9, P242, DOI 10.2174/156652409787847263; Mathian A, 2005, J IMMUNOL, V174, P2499, DOI 10.4049/jimmunol.174.5.2499; Minaur N, 2004, J RHEUMATOL, V31, P965; Munroe ME, 2014, ARTHRITIS RHEUMATOL, V66, P1888, DOI 10.1002/art.38573; Ohl K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/432595; Parrish YK, 2009, J IMMUNOL, V182, P4255, DOI 10.4049/jimmunol.0800489; Petri M, 2008, ARTHRITIS RHEUM, V58, P2453, DOI 10.1002/art.23678; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ramanujam M, 2009, ARTHRITIS RHEUM-US, V60, P1096, DOI 10.1002/art.24414; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Sen ES, 2014, ARTHRITIS RHEUMATOL, V66, pS155, DOI 10.1002/art.38539; Tobon GJ, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/827254; Tseng Jui-Cheng, 2007, Journal of Microbiology Immunology and Infection, V40, P50; Tsujimura M, 1997, Nihon Rinsho Meneki Gakkai Kaishi, V20, P8; Vadacca M, 2010, REUMATISMO, V62, P259; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wang A, 2010, ARTHRITIS RHEUM-US, V62, P3436, DOI 10.1002/art.27685; Wang A, 2009, J IMMUNOL, V182, P4448, DOI 10.4049/jimmunol.0801920; Weiss GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015983; Wong CK, 2000, LUPUS, V9, P589, DOI 10.1191/096120300678828703; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	57	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125340	10.1371/journal.pone.0125340	http://dx.doi.org/10.1371/journal.pone.0125340			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909640	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800138
J	Frykman, PK; Nordenskojld, A; Kawaguchi, A; Hui, TT; Granstrom, AL; Cheng, Z; Tang, J; Underhill, DM; Iliev, I; Funari, VA; Wester, T				Frykman, Philip K.; Nordenskojld, Agneta; Kawaguchi, Akemi; Hui, Thomas T.; Granstrom, Anna L.; Cheng, Zhi; Tang, Jie; Underhill, David M.; Iliev, Iliyan; Funari, Vince A.; Wester, Tomas		HAEC Collaborative Res Grp HCRG	Characterization of Bacterial and Fungal Microbiome in Children with Hirschsprung Disease with and without a History of Enterocolitis: A Multicenter Study	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CANDIDA-ALBICANS; PATHOGENESIS; THERAPY	Development of potentially life-threatening enterocolitis is the most frequent complication in children with Hirschsprung disease (HSCR), even after definitive corrective surgery. Intestinal microbiota likely contribute to the etiology of enterocolitis, so the aim of this study was to compare the fecal bacterial and fungal communities of children who developed Hirschsprung-associated enterocolitis (HAEC) with HSCR patients who had never had enterocolitis. Eighteen Hirschsprung patients who had completed definitive surgery were enrolled: 9 had a history of HAEC and 9 did not. Fecal DNA was isolated and 16S and ITS-1 regions sequenced using Next Generation Sequencing and data analysis for species identification. The HAEC group bacterial composition showed a modest reduction in Firmicutes and Verrucomicrobia with increased Bacteroidetes and Proteobacteria compared with the HSCR group. In contrast, the fecal fungi composition of the HAEC group showed marked reduction in diversity with increased Candida sp., and reduced Malassezia and Saccharomyces sp. compared with the HSCR group. The most striking finding within the HAEC group is that the Candida genus segregated into "high burden" patients with 97.8% C. albicans and 2.2% C. tropicalis compared with "low burden" patients 26.8% C. albicans and 73% C. tropicalis. Interestingly even the low burden HAEC group had altered Candida community structure with just two species compared to more diverse Candida populations in the HSCR patients. This is the first study to identify Candida sp. as potentially playing a role in HAEC either as expanded commensal species as a consequence of enterocolitis (or treatment), or possibly as pathobioants contributing to the pathogenesis of HAEC. These findings suggest a dysbiosis in the gut microbial ecosystem of HAEC patients, such that there may be dominance of fungi and bacteria predisposing patients to development of HAEC.	[Frykman, Philip K.; Cheng, Zhi] Cedars Sinai Med Ctr, Dept Surg, Div Pediat Surg, Los Angeles, CA 90048 USA; [Frykman, Philip K.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Nordenskojld, Agneta; Granstrom, Anna L.; Wester, Tomas] Karolinska Univ Hosp, Astrid Lindgrens Childrens Hosp, Dept Pediat Surg, Stockholm, Sweden; [Nordenskojld, Agneta; Granstrom, Anna L.; Wester, Tomas] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Nordenskojld, Agneta; Granstrom, Anna L.; Wester, Tomas] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Kawaguchi, Akemi] Childrens Hosp Los Angeles, Div Pediat Surg, Los Angeles, CA 90027 USA; [Hui, Thomas T.] Childrens Hosp Oakland, Div Pediat Surg, Oakland, CA USA; [Tang, Jie; Funari, Vince A.] Cedars Sinai Med Ctr, Inst Med Genet, Genom Core Lab, Los Angeles, CA 90048 USA; [Underhill, David M.; Iliev, Iliyan] Cedars Sinai Med Ctr, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Children's Hospital Los Angeles; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Frykman, PK (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Pediat Surg, Los Angeles, CA 90048 USA.	Philip.Frykman@cshs.org	Wester, Tomas/ABF-8303-2020; UNDERHILL, DAVID/ABE-2185-2021; Tang, Jie/D-3764-2015	Wester, Tomas/0000-0003-4878-6447; Nordenskjold, Agneta/0000-0001-6638-4631; Goodhue, Catherine/0000-0001-8833-9938; Underhill, David/0000-0002-2989-658X; Tang, Jie/0000-0002-3991-2539	National Institute of Diabetes, Digestive and Kidney Diseases [5K08 DK090281]; National Center for Advancing Translational Sciences [UL1TR000124]; Lippey Family Endowment; Walter and Shirley Wang Endowed Chair in Pediatric Surgery at Cedars-Sinai Medical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090281] Funding Source: NIH RePORTER	National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Lippey Family Endowment; Walter and Shirley Wang Endowed Chair in Pediatric Surgery at Cedars-Sinai Medical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Diabetes, Digestive and Kidney Diseases grant 5K08 DK090281 (PKF). This project was supported by the National Center for Advancing Translational Sciences, Grant UL1TR000124. Additional funding was provided by The Lippey Family Endowment and The Walter and Shirley Wang Endowed Chair in Pediatric Surgery at Cedars-Sinai Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh A, 2012, J GASTROENTEROL, V47, P1298, DOI 10.1007/s00535-012-0605-0; Austin KM, 2012, SEMIN PEDIATR SURG, V21, P319, DOI 10.1053/j.sempedsurg.2012.07.006; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Freeman JJ, 2015, PEDIATR SURG INT, V31, P77, DOI 10.1007/s00383-014-3633-4; Frykman PK, 2012, SEMIN PEDIATR SURG, V21, P328, DOI 10.1053/j.sempedsurg.2012.07.007; HARDY SP, 1993, ARCH DIS CHILD, V69, P221, DOI 10.1136/adc.69.2.221; Hirschsprung H., 1887, JB KINDERH, V27, P1; Hold GL, 2014, WORLD J GASTROENTERO, V20, P1192, DOI 10.3748/wjg.v20.i5.1192; Hsu MC, 2003, J MED MICROBIOL, V52, P1071, DOI 10.1099/jmm.0.05302-0; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Levin DN, 2012, J PEDIATR GASTR NUTR, V55, P272, DOI 10.1097/MPG.0b013e31824f617a; Mason KL, 2012, INFECT IMMUN, V80, P3371, DOI 10.1128/IAI.00449-12; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Pastor AC, 2009, J PEDIATR SURG, V44, P251, DOI 10.1016/j.jpedsurg.2008.10.052; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Rintala RJ, 2001, J PEDIATR SURG, V36, P1032, DOI 10.1053/jpsu.2001.24732; SAMONIS G, 1994, ANTIMICROB AGENTS CH, V38, P602, DOI 10.1128/AAC.38.3.602; Shen DH, 2009, WORLD J PEDIATR, V5, P201, DOI 10.1007/s12519-009-0038-x; THOMAS DFM, 1982, LANCET, V1, P78; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Yan ZL, 2014, BIOCHEM BIOPH RES CO, V445, P269, DOI 10.1016/j.bbrc.2014.01.104	23	73	79	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124172	10.1371/journal.pone.0124172	http://dx.doi.org/10.1371/journal.pone.0124172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909773	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800061
J	He, Y; Zheng, QL; Jiang, MM; Sun, S; Christiansen, TG; Kassem, M; Karsdal, MA; Bay-Jensen, AC				He, Yi; Zheng, Qinlong; Jiang, MengMeng; Sun, Shu; Christiansen, Thorbjorn G.; Kassem, Moustapha; Karsdal, Morten A.; Bay-Jensen, Anne C.			The Effect of Protease Inhibitors on the Induction of Osteoarthritis-Related Biomarkers in Bovine Full-Depth Cartilage Explants	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE; ARTICULAR-CARTILAGE; AGGRECANASE ACTIVITY; CHONDROITIN SULFATE; GENE-EXPRESSION; CELL-SURFACE; ONCOSTATIN-M; ACTIVATION; DEGRADATION; CLEAVAGE	Objective The specific degradation of type II collagen and aggrecan by matrix metalloproteinase (MMP)-9, -13 and ADAMTS-4 and -5 (aggrecanase-1 and -2) in the cartilage matrix is a critical step in pathology of osteoarthritis (OA). The aims of this study were: i) To investigate the relative contribution of ADAMTS-4 and ADAMTS-5 to cartilage degradation upon catabolic stimulation; ii) To investigate the effect of regulating the activities of key enzymes by mean of broad-spectrum inhibitors. Methods Bovine full-depth cartilage explants stimulated with tumor necrosis factor alpha (TNF-alpha) and Oncostatin M (OSM) were cultured for 21 days with or without a number of inhibitors targeting different types of proteases. Monoclonal antibodies were raised against the active sites of ADAMTS-4, -5, MMP-9 and -13, and 4 ELISAs were developed and technically validated. In addition, the established AGNxI (ADAMTS-degraded aggrecan), AGNxII (MMP-degraded aggrecan), and CTX-II (MMP-derived type II collagen) were quantified in the explants-conditioned media. Results We found that: i) Active ADAMTS-4, MMP-9, -13 were released in the late stage of TNF-alpha/OSM stimulation, whereas no significant active ADAMTS-5 was detected in either extracts or supernatants; ii) Active ADAMTS-4 was primarily responsible for E-373-(374)A bond cleavage in aggrecan in this setting; and iii) The compensatory mechanism could be triggered following the blockage of the enzyme caused by inhibitors. Conclusions ADAMTS-4 appeared to be the major protease for the generation of (374)ARGS aggrecan fragment in the TNF-alpha/OSM stimulated bovine cartilage explants. This study addresses the need to determine the roles of ADAMTS-4 and ADAMTS-5 in human articular degradation in OA and hence identify the attractive target for slowing down human cartilage breakdown.	[He, Yi; Zheng, Qinlong; Sun, Shu; Karsdal, Morten A.; Bay-Jensen, Anne C.] NordicBiosci, Herlev, Denmark; [Jiang, MengMeng] NordicBiosci China, Beijing, Peoples R China; [Christiansen, Thorbjorn G.] Gentofte Univ Hosp, Dept Orthoped, Hellerup, Denmark; [Kassem, Moustapha] Odense Univ Hosp, Mol Endocrinol Lab KMEB, DK-5000 Odense, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Southern Denmark; Odense University Hospital	Bay-Jensen, AC (corresponding author), NordicBiosci, Herlev, Denmark.	acbj@nordicbioscience.com	He, Yi/GLV-0913-2022; Bay-Jensen, Anne-Christine/AEQ-7281-2022; Kassem, Moustapha/O-3819-2019; ZHENG, Qin/T-2925-2019; Kassem, Moustapha/J-7688-2013	Bay-Jensen, Anne-Christine/0000-0001-7952-9297; Kassem, Moustapha/0000-0003-1557-0869; Kassem, Moustapha/0000-0003-1557-0869; Sun, Shu/0000-0002-2477-8904; Karsdal, Morten/0000-0001-5026-8740	Danish Research foundation; Danish High Technology fund; Danish ministry of Innovation and science; Nordic Bioscience	Danish Research foundation; Danish High Technology fund; Danish ministry of Innovation and science; Nordic Bioscience	The study was funded by the Danish Research foundation and the Danish High Technology fund, as well as the Danish ministry of Innovation and science, which supported the PhD fellowship of Shu Sun and Yi He. Nordic Bioscience provided support in the form of salaries for authors YH, QZ, MMJ, SS, MAK and ACBJ but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 1999, MON ANT PROD; Bay-Jensen AC, 2010, RHEUMATOL INT, V30, P435, DOI 10.1007/s00296-009-1183-1; Bitton Ryan, 2009, Am J Manag Care, V15, pS230; Bondeson J, 2007, J RHEUMATOL, V34, P523; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Chan PS, 2006, J RHEUMATOL, V33, P1329; Chen-An P, 2013, RHEUMATOL INT, V33, P401, DOI 10.1007/s00296-012-2368-6; Fosang AJ, 2008, EUR CELLS MATER, V15, P11, DOI 10.22203/eCM.v015a02; Fosang AJ, 2010, METHODS MOL BIOL, V622, P305, DOI 10.1007/978-1-60327-299-5_19; Galasso O, 2012, ADV ORTHOP, V2012, DOI 10.1155/2012/834208; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Garnero P, 2002, ARTHRITIS RHEUM-US, V46, P2613, DOI 10.1002/art.10576; He Y, 2013, MATRIX BIOL, V32, P143, DOI 10.1016/j.matbio.2012.12.001; Hui W, 2003, ARTHRITIS RHEUM-US, V48, P3404, DOI 10.1002/art.11333; Karsdal MA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2434; Karsdal MA, 2007, ARTHRITIS RHEUM-US, V56, P1549, DOI 10.1002/art.22599; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Malfait AM, 2008, ARCH BIOCHEM BIOPHYS, V478, P43, DOI 10.1016/j.abb.2008.07.012; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; Mercuri FA, 2000, J BIOL CHEM, V275, P33038, DOI 10.1074/jbc.275.42.33038; Milner JM, 2001, ARTHRITIS RHEUM-US, V44, P2084, DOI 10.1002/1529-0131(200109)44:9<2084::AID-ART359>3.0.CO;2-R; Mort JS, 2003, BIOCHEM SOC SYMP, V70, P107, DOI 10.1042/bss0700107; Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564; Patwari P, 2005, OSTEOARTHR CARTILAGE, V13, P269, DOI 10.1016/j.joca.2004.10.023; Powell AJ, 2007, ARTHRITIS RHEUM-US, V56, P3010, DOI 10.1002/art.22818; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Sandy JD, 2006, OSTEOARTHR CARTILAGE, V14, P95, DOI 10.1016/j.joca.2005.09.004; Sondergaard BC, 2006, OSTEOARTHR CARTILAGE, V14, P738, DOI 10.1016/j.joca.2006.01.016; Sumer EU, 2007, OSTEOARTHR CARTILAGE, V15, P212, DOI 10.1016/j.joca.2006.07.009; Tortorella MD, 2000, J BIOL CHEM, V275, P18566, DOI 10.1074/jbc.M909383199; Tortorella MD, 2002, MATRIX BIOL, V21, P499, DOI 10.1016/S0945-053X(02)00069-0; Toth M, 2003, BIOCHEM BIOPH RES CO, V308, P386, DOI 10.1016/S0006-291X(03)01405-0; Vankemmelbeke MN, 2001, EUR J BIOCHEM, V268, P1259, DOI 10.1046/j.1432-1327.2001.01990.x; Wang Bijue, 2009, BMC Res Notes, V2, P259, DOI 10.1186/1756-0500-2-259; Wang MN, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4133; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; Wang XB, 2004, OSTEOARTHR CARTILAGE, V12, P963, DOI 10.1016/j.joca.2004.08.008	39	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122700	10.1371/journal.pone.0122700	http://dx.doi.org/10.1371/journal.pone.0122700			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909781	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800021
J	Yombi, JC; Schwab, PE; Thienpont, E				Yombi, Jean Cyr; Schwab, Pierre Emmanuel; Thienpont, Emmanuel			Serum C-Reactive Protein Distribution in Minimally Invasive Total Knee Arthroplasty Do Not Differ with Distribution in Conventional Total Knee Arthroplasty	PLOS ONE			English	Article							TOTAL HIP; SURGERY; INFECTION; CRP	Minimally invasive total knee arthroplasty (MITKA) has been developed to reduce surgical trauma and facilitate rehabilitation after arthroplasty. A plausible hypothesis is that this reduced trauma results in lower concentrations of circulating inflammatory biomarkers, such as C-reactive protein (CRP). In this study, we compared CRP concentrations in patients undergoing MITKA to those undergoing conventional TKA (CTKA). Eight hundred and seven patients undergoing MITKA were prospectively recruited. CRP was measured before operation and on days 2, 4, 21, and 42 after operation. Two hundred and forty-seven patients who had CTKA were collected retrospectively, with the same inclusion and exclusion criteria as those who had MITKA. We found in both groups, that CRP values rose abruptly after operation, with peak values reached on day 2 or 4. Values then declined so that by days 21 and 42 they were only modestly above baseline values. Throughout the entire study period, mean CRP in MITKA patients did not differ significantly from those in CTKA patients. However, a significantly higher proportion of CTKA patients than of MITKA patients had peak CRP values at day 4 rather than at day 2 (76.8% vs 42.5%), a difference that was more pronounced in women. Also, by day 42, CRP values were still above baseline in 18.5% of MITKA patients and 28.8% of CTKA patients without known complications. In conclusion, CRP distribution pattern was similar in patients who received MITKA or CTKA,. CRP values remained slightly elevated in both MITKA and CTKA patients for as long 42 days after operation. These findings suggest that MITKA is no less traumatic than CTKA, as determined by CRP values, and the patterns of postoperative CRP may be useful in the management of TKA patients.	[Yombi, Jean Cyr] Clin Univ St Luc, Dept Internal Med & Perioperat Med, B-1200 Brussels, Belgium; [Yombi, Jean Cyr; Schwab, Pierre Emmanuel; Thienpont, Emmanuel] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Schwab, Pierre Emmanuel; Thienpont, Emmanuel] Clin Univ St Luc, Dept Orthopaed & Traumatol, B-1200 Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Yombi, JC (corresponding author), Clin Univ St Luc, Dept Internal Med & Perioperat Med, B-1200 Brussels, Belgium.	jean.yombi@uclouvain.be						Almeida Herrero Fernando, 2008, Acta Ortop Mex, V22, P80; Bagry H, 2008, REGION ANESTH PAIN M, V33, P17, DOI 10.1016/j.rapm.2007.06.398; Bergin PF, 2011, J BONE JOINT SURG AM, V93A, P1392, DOI 10.2106/JBJS.J.00557; Bilgen OF, 2001, J INT MED RES, V29, P7, DOI 10.1177/147323000102900102; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; CHOUDHRY RR, 1992, J BONE JOINT SURG BR, V74, P523, DOI 10.1302/0301-620X.74B4.1624508; Codine P., 2005, Annales de Readaptation et de Medecine Physique, V48, P590, DOI 10.1016/j.annrmp.2005.03.013; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; Dupont C., 2008, Annales de Readaptation et de Medecine Physique, V51, P348, DOI 10.1016/j.annrmp.2008.01.014; ELLITSGAARD N, 1991, INT ORTHOP, V15, P311; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Honsawek S, 2011, INT ORTHOP, V35, P31, DOI 10.1007/s00264-010-0973-0; LARSSON S, 1992, CLIN ORTHOP RELAT R, P237; Limpisvasti O, 2004, J PEDIATR ORTHOPED, V24, P574, DOI 10.1097/01241398-200409000-00020; Moreschini O, 2001, INT J TISSUE REACT, V23, P151; Neumaier M, 2008, ACTA ORTHOP, V79, P428, DOI 10.1080/17453670710015355; Neumaier M, 2006, ACTA ORTHOP, V77, P788, DOI 10.1080/17453670610013006; Niki Y, 2009, J ARTHROPLASTY, V24, P499, DOI 10.1016/j.arth.2008.04.002; Niskanen RO, 1996, J BONE JOINT SURG BR, V78B, P431, DOI 10.1302/0301-620X.78B3.0780431; Orrego M, 2005, REV MED CHILE, V133, P1341; Osmon DR, 2013, CLIN INFECT DIS, V56, DOI [10.1093/cid/cis803, 10.1093/cid/cis966]; Scherer MA, 2001, CLIN ORTHOP RELAT R, P287; Shah K, 2009, CLIN ORTHOP RELAT R, V467, P946, DOI 10.1007/s11999-008-0562-3; Shen H, 2009, ACTA ORTHOP, V80, P330, DOI 10.3109/17453670903066596; Thienpont E, 2013, KNEE SURG SPORT TR A, V21, P2603, DOI 10.1007/s00167-012-2345-3; Thienpont E, 2013, KNEE SURG SPORT TR A, V21, P2412, DOI 10.1007/s00167-012-1978-6; Tsuji S, 2010, J ARTHROPLASTY, V25, P970, DOI 10.1016/j.arth.2009.06.016; White J, 1998, J BONE JOINT SURG BR, V80B, P909, DOI 10.1302/0301-620X.80B5.8708	28	7	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124788	10.1371/journal.pone.0124788	http://dx.doi.org/10.1371/journal.pone.0124788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910083	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800107
J	Kandalepas, D; Blum, MJ; Van Bael, SA				Kandalepas, Demetra; Blum, Michael J.; Van Bael, Sunshine A.			Shifts in Symbiotic Endophyte Communities of a Foundational Salt Marsh Grass following Oil Exposure from the Deepwater Horizon Oil Spill	PLOS ONE			English	Article							TROPICAL FUNGAL ENDOPHYTES; BACILLUS-PUMILUS; BIODIVERSITY LOSS; DIVERSITY; MICROORGANISMS; EVOLUTION; PLANTS; STRESS; GROWTH; COLONIZATION	Symbiotic associations can be disrupted by disturbance or by changing environmental conditions. Endophytes are fungal and bacterial symbionts of plants that can affect performance. As in more widely known symbioses, acute or chronic stressor exposure might trigger disassociation of endophytes from host plants. We tested this hypothesis by examining the effects of oil exposure following the Deepwater Horizon (DWH) oil spill on endophyte diversity and abundance in Spartina alterniflora - the foundational plant in northern Gulf coast salt marshes affected by the spill. We compared bacterial and fungal endophytes isolated from plants in reference areas to isolates from plants collected in areas with residual oil that has persisted for more than three years after the DWH spill. DNA sequence-based estimates showed that oil exposure shifted endophyte diversity and community structure. Plants from oiled areas exhibited near total loss of leaf fungal endophytes. Root fungal endophytes exhibited a more modest decline and little change was observed in endophytic bacterial diversity or abundance, though a shift towards hydrocarbon metabolizers was found in plants from oiled sites. These results show that plant-endophyte symbioses can be disrupted by stressor exposure, and indicate that symbiont community disassembly in marsh plants is an enduring outcome of the DWH spill.	[Kandalepas, Demetra; Blum, Michael J.; Van Bael, Sunshine A.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Kandalepas, Demetra; Blum, Michael J.] Tulane Univ, Tulane Xavier Ctr Bioenvironm Res, New Orleans, LA 70118 USA	Tulane University; Tulane University; Xavier University of Louisiana	Van Bael, SA (corresponding author), Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA.	svanbael@tulane.edu	Van Bael, Sunshine/M-5370-2019; Van Bael, Sunshine/K-1930-2019	Van Bael, Sunshine/0000-0001-7317-3533; 	Tulane University; Gulf of Mexico Research Initiative; Tulane-Xavier Center for Bioenvironmental Research; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	Tulane University; Gulf of Mexico Research Initiative; Tulane-Xavier Center for Bioenvironmental Research; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding for this study was provided from Tulane University to SAV, the Gulf of Mexico Research Initiative to MJB from research funds provided to Louisiana State University and from the Tulane-Xavier Center for Bioenvironmental Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2014, PLANT PHYSIOL BIOCH, V80, P160, DOI 10.1016/j.plaphy.2014.04.003; Alonso-Gutierrez J, 2009, APPL ENVIRON MICROB, V75, P3407, DOI 10.1128/AEM.01776-08; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Arnold AE, 2003, MYCOLOGIA, V95, P388, DOI 10.2307/3761880; Beazley MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041305; Bharti N, 2013, WORLD J MICROB BIOT, V29, P379, DOI 10.1007/s11274-012-1192-1; Bik HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038550; Blum MJ, 2014, OIL SPILL REMEDIATION: COLLOID CHEMISTRY-BASED PRINCIPLES AND SOLUTIONS, P59; Cappello S, 2007, MICROBIOL RES, V162, P185, DOI 10.1016/j.micres.2006.05.010; Chaudhry Q, 2005, ENVIRON SCI POLLUT R, V12, P34, DOI 10.1065/espr2004.08.213; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 2015, PRIMER V7 USER MANUA; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Deivanai Subramanian, 2014, J Nat Sci Biol Med, V5, P437, DOI 10.4103/0976-9668.136233; Estrada C, 2013, NEW PHYTOL, V198, P241, DOI 10.1111/nph.12140; FRAVEL DR, 1988, ANNU REV PHYTOPATHOL, V26, P75, DOI 10.1146/annurev.py.26.090188.000451; Friesen ML, 2011, ANNU REV ECOL EVOL S, V42, P23, DOI 10.1146/annurev-ecolsys-102710-145039; GOREAU TJ, 1994, AMBIO, V23, P176; Harvey PJ, 2002, ENVIRON SCI POLLUT R, V9, P29, DOI 10.1007/BF02987315; Hassen AI, 2010, WORLD J MICROB BIOT, V26, P1837, DOI 10.1007/s11274-010-0365-z; Head IM, 2006, NAT REV MICROBIOL, V4, P173, DOI 10.1038/nrmicro1348; Hernandez JP, 2009, EUR J SOIL BIOL, V45, P88, DOI 10.1016/j.ejsobi.2008.08.004; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoffman MT, 2008, MYCOL RES, V112, P331, DOI 10.1016/j.mycres.2007.10.014; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Hubbard M, 2014, J APPL MICROBIOL, V116, P109, DOI 10.1111/jam.12311; Hubbell S.P., 2001, MG POP BIOL, V32; JOHNSON ND, 1987, OECOLOGIA, V74, P425, DOI 10.1007/BF00378940; Joye SB, 2014, BIOSCIENCE, V64, P766, DOI 10.1093/biosci/biu121; Kandalepas D, 2012, THESIS LOUISIANA STA; Kandalepas D, 2010, WETLANDS, V30, P189, DOI 10.1007/s13157-010-0017-y; Khan S, 2013, CHEMOSPHERE, V90, P1317, DOI 10.1016/j.chemosphere.2012.09.045; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Lamendella R, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00130; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Lin QX, 2012, ENVIRON SCI TECHNOL, V46, P3737, DOI 10.1021/es203552p; Manousaki E, 2011, INT J PHYTOREMEDIAT, V13, P959, DOI 10.1080/15226514.2010.532241; Marks K, 2013, THESIS GEORGIA I TEC; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; Mejia LC, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00479; Mohammed Y, 2015, GULF MEX OIL SPILL E; Morris JT, 2013, WETLANDS, V33, P975, DOI 10.1007/s13157-013-0480-3; Morris J. T., 2014, PERSPECTIVES RESTORA, P111; Mugerwa TTM, 2013, FUNGAL ECOL, V6, P70, DOI 10.1016/j.funeco.2012.08.004; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Naeem S, 2002, ECOLOGY, V83, P1537, DOI 10.1890/0012-9658(2002)083[1537:ECOBLT]2.0.CO;2; Nielsen P, 1997, FEMS MICROBIOL ECOL, V22, P183, DOI 10.1016/S0168-6496(96)00089-X; Nyman JA, 2014, ESTUAR COAST, V37, P1490, DOI 10.1007/s12237-013-9747-4; Redman RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014823; Rillig MC, 2014, OECOLOGIA, V174, P263, DOI 10.1007/s00442-013-2759-8; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Rudgers J. A., 2012, TRAIT MEDIATED INDIR, P391; Rudgers JA, 2010, J APPL ECOL, V47, P468, DOI 10.1111/j.1365-2664.2010.01788.x; Ryu CM, 2004, PLANT J, V39, P381, DOI 10.1111/j.1365-313X.2004.02142.x; Saxby T, 2003, MAR ECOL PROG SER, V248, P85, DOI 10.3354/meps248085; Shaffer GP, 2009, J COASTAL RES, P152, DOI 10.2112/SI54-006.1; Silliman BR, 2003, P NATL ACAD SCI USA, V100, P15643, DOI 10.1073/pnas.2535227100; Thomas P, 2004, J APPL MICROBIOL, V97, P114, DOI 10.1111/j.1365-2672.2004.02279.x; U'ren JM, 2009, MYCOL RES, V113, P432, DOI 10.1016/j.mycres.2008.11.015; Viswanath B., 2014, ENZYME RES, V2014, P1, DOI [DOI 10.1155/2014/163242, 10.1155/2014/163242]; Weishampel PA, 2006, MYCORRHIZA, V16, P495, DOI 10.1007/s00572-006-0064-7; Weyens N, 2009, CURR OPIN BIOTECH, V20, P248, DOI 10.1016/j.copbio.2009.02.012; WILSON D, 1995, OIKOS, V73, P274, DOI 10.2307/3545919; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yule KM, 2013, OIKOS, V122, P1512, DOI 10.1111/j.1600-0706.2012.00229.x; Zengel S, 2014, INT OIL SPILL C P, P1985, DOI DOI 10.7901/2169-3358-2014.1.1985; Zengel S, 2013, DEEPWATER HORIZON OI, P74; [Zhang Shumei 张淑梅], 2008, [微生物学通报, Microbiology], V35, P1593; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	75	34	34	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122378	10.1371/journal.pone.0122378	http://dx.doi.org/10.1371/journal.pone.0122378			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923203	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600012
J	Robertson, DA; Savva, GM; King-Kallimanis, BL; Kenny, RA				Robertson, Deirdre A.; Savva, George M.; King-Kallimanis, Bellinda L.; Kenny, Rose Anne			Negative Perceptions of Aging and Decline in Walking Speed: A Self-Fulfilling Prophecy	PLOS ONE			English	Article							OLDER-ADULTS; GAIT SPEED; LONGITUDINAL FINDINGS; PREDICT MORTALITY; BODY-COMPOSITION; POSITIVE VIEW; HEALTH; AGE; GO; INTERVENTION	Introduction Walking speed is a meaningful marker of physical function in the aging population. While it is a primarily physical measure, experimental studies have shown that merely priming older adults with negative stereotypes about aging results in immediate declines in objective walking speed. What is not clear is whether this is a temporary experimental effect or whether negative aging stereotypes have detrimental effects on long term objective health. We sought to explore the association between baseline negative perceptions of aging in the general population and objective walking speed 2 years later. Method 4,803 participations were assessed over 2 waves of The Irish Longitudinal Study on Ageing (TILDA), a prospective, population representative study of adults aged 50+ in the Republic of Ireland. Wave 1 measures - which included the Aging Perceptions Questionnaire, walking speed and all covariates - were taken between 2009 and 2011. Wave 2 measures - which included a second measurement of walking speed and covariates - were collected 2 years later between March and December 2012. Walking speed was measured as the number of seconds to complete the Timed Up-And-Go (TUG) task. Participations with a history of stroke, Parkinson's disease or an MMSE < 18 were excluded. Results After full adjustment for all covariates (age, gender, level of education, disability, chronic conditions, medications, global cognition and baseline TUG) negative perceptions of aging at baseline were associated with slower TUG speed 2 years later (B=.03, 95%CI=.01 to 05, p<.05). Conclusions Walking speed has previously been considered to be a consequence of physical decline but these results highlight the direct role of psychological state in predicting an objective aging outcome. Negative perceptions about aging are a potentially modifiable risk factor of some elements of physical decline in aging.	[Robertson, Deirdre A.; King-Kallimanis, Bellinda L.; Kenny, Rose Anne] Univ Dublin Trinity Coll, Dept Med Gerontol, TILDA Irish Longitudinal Study Ageing, Dublin 2, Ireland; [Savva, George M.] Univ E Anglia, Sch Hlth Sci, Norwich NR4 7TJ, Norfolk, England; [Kenny, Rose Anne] Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland	Trinity College Dublin; University of East Anglia; Trinity College Dublin	Robertson, DA (corresponding author), Univ Dublin Trinity Coll, Dept Med Gerontol, TILDA Irish Longitudinal Study Ageing, Dublin 2, Ireland.	droberts@tcd.ie	Robertson, Deirdre A/AAG-4990-2021; Savva, George M/E-9670-2011	Robertson, Deirdre A/0000-0002-2829-1722; Savva, George M/0000-0001-9190-124X; Kenny, Rose Anne/0000-0002-9336-8124	Atlantic Philanthropies; Irish Government; Health Research Board; Department of Health and Atlantic Philanthropies; Irish Life	Atlantic Philanthropies; Irish Government; Health Research Board; Department of Health and Atlantic Philanthropies; Irish Life	Funding was gratefully received from the Atlantic Philanthropies (www.atlanticphilanthropies.org), the Irish Government, the Health Research Board (www.hrb.ie). TILDA is funded by the Department of Health and Atlantic Philanthropies, along with support from Irish Life in the form of a charitable gift. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Barker M., 2007, BMC GERIATR, V7, P9, DOI [10.1186/1471-2318-7-9, DOI 10.1186/1471-2318-7-9]; Borsch-Supan Axel, 2005, Eur J Ageing, V2, P245, DOI 10.1007/s10433-005-0014-9; Buchner DM, 1996, J GERONTOL A-BIOL, V51, pM297, DOI 10.1093/gerona/51A.6.M297; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Demakakos P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068632; Dugravot A, 2009, J EPIDEMIOL COMMUN H, V63, P675, DOI 10.1136/jech.2008.081281; Elbaz A, 2013, AGE, V35, P943, DOI 10.1007/s11357-012-9387-9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Kearney PM, 2011, INT J EPIDEMIOL, V40, P877, DOI 10.1093/ije/dyr116; KESSLER RC, 1995, EPIDEMIOL REV, V17, P192, DOI 10.1093/oxfordjournals.epirev.a036176; Kotter-Gruhn D, 2009, PSYCHOL AGING, V24, P654, DOI 10.1037/a0016510; Lachman M. E., 2010, HDB PSYCHOL AGING, P175; Levy B, 2009, CURR DIR PSYCHOL SCI, V18, P332, DOI 10.1111/j.1467-8721.2009.01662.x; Levy BR, 2004, PREV MED, V39, P625, DOI 10.1016/j.ypmed.2004.02.029; Levy BR, 2002, J GERONTOL B-PSYCHOL, V57, pP409, DOI 10.1093/geronb/57.5.P409; Maurois A., 2007, AN ART OF LIVING; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Peeters GMEE, 2008, CLIN ENDOCRINOL, V69, P673, DOI 10.1111/j.1365-2265.2008.03212.x; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rabe-Hesketh S, 2003, STATA J, V3, P386; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sargent-Cox KA, 2014, J GERONTOL B-PSYCHOL, V69, P168, DOI 10.1093/geronb/gbt005; Sargent-Cox KA, 2012, PSYCHOL AGING, V27, P750, DOI 10.1037/a0027578; Sarkisian CA, 2007, J AM GERIATR SOC, V55, P1842, DOI 10.1111/j.1532-5415.2007.01427.x; Savva GM, 2013, J GERONTOL A-BIOL, V68, P441, DOI 10.1093/gerona/gls190; Sexton E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-44; Sneed JR, 2005, J SOC ISSUES, V61, P375, DOI 10.1111/j.1540-4560.2005.00411.x; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Stewart TL, 2012, PSYCHOL HEALTH, V27, P881, DOI 10.1080/08870446.2011.630735; Weiss D, 2013, PSYCHOL AGING, V28, P1140, DOI 10.1037/a0033811; Weiss D, 2012, PSYCHOL AGING, V27, P153, DOI 10.1037/a0024887; White DK, 2013, J GERONTOL A-BIOL, V68, P456, DOI 10.1093/gerona/gls197; Wolff JK, 2014, PSYCHOL HEALTH, V29, P915, DOI 10.1080/08870446.2014.896464; Wurm S, 2008, EUR J AGEING, V5, P117, DOI 10.1007/s10433-008-0077-5; Wurm S, 2007, J GERONTOL B-PSYCHOL, V62, pP156, DOI 10.1093/geronb/62.3.P156; Wurm S, 2014, PSYCHOL HEALTH, V29, P832, DOI 10.1080/08870446.2014.891737; Wurm S, 2010, PSYCHOL HEALTH, V25, P25, DOI 10.1080/08870440802311314	37	39	40	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123260	10.1371/journal.pone.0123260	http://dx.doi.org/10.1371/journal.pone.0123260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923334	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600037
J	Liu, G; Liu, YX; Ali, T; Ferreri, M; Gao, J; Chen, W; Yin, JH; Su, JL; Fanning, S; Han, B				Liu, Gang; Liu, Yongxia; Ali, Tariq; Ferreri, Miro; Gao, Jian; Chen, Wei; Yin, Jinhua; Su, Jingliang; Fanning, Seamus; Han, Bo			Molecular and Phenotypic Characterization of Aerococcus viridans Associated with Subclinical Bovine Mastitis	PLOS ONE			English	Article							VAR. HOMARI; SEQUENCE; IDENTIFICATION; STREPTOCOCCI; RESISTANCE	Aerococcus viridans is a wide spread bacterium in the environment and clinically this organism is associated with different diseases in animals and humans. However, the geno- and phenotypic characterization of A. viridans associated with bovine mastitis has not yet been reported. The objectives of this study were to investigate the genetic and phenotypic diversity of A. viridans isolates using three different molecular methods including 16S rRNA gene sequencing, pulsed-field gel electrophoresis and random amplified polymorphic DNA (RAPD) along with biochemical tests, including antimicrobial susceptibility test. In total, 60 A. viridans strains were cultured from dairy herds presenting with subclinical mastitis. The results of biochemical tests revealed that most of the isolates (75.0%) were accurately identified by API Rapid 20 Strep system and the majority of A. viridans strains (96.7%) were found to be catalase negative, while two (3.3%) isolates were weakly positive. All isolates were resistant to trimethoprim-sulfamethoxazole, followed by streptomycin (96.7%), tetracycline (65.0%) and clindamycin (56.7%) by minimum inhibition concentration-determining broth microdilution technique. As compared to the sequence of 16S rRNA gene, both PFGE and RAPD showed their capacities to discriminate the intra-species diversity of A. viridans. Furthermore, most of the isolates obtained from the same herd or region belonged to the same major RAPD group, which indicated that RAPD is an appropriate assay for tracking the origins of isolates and epidemiological studies of A. viridans. This is a novel approach to use three molecular techniques and to compare their efficiency regarding the genetic diversity of A. viridans. The data suggest that A. viridans associated with subclinical mastitis has a considerable phenotypic and genotypic diversity.	[Liu, Gang; Liu, Yongxia; Ali, Tariq; Ferreri, Miro; Gao, Jian; Chen, Wei; Yin, Jinhua; Su, Jingliang; Han, Bo] China Agr Univ, Coll Vet Med, Dept Clin Vet Med, Beijing 100094, Peoples R China; [Fanning, Seamus] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Ctr Food Safety, Dublin 4, Ireland	China Agricultural University; University College Dublin	Han, B (corresponding author), China Agr Univ, Coll Vet Med, Dept Clin Vet Med, Beijing 100094, Peoples R China.	hanbo@cau.edu.cn	Han, Bo/AAF-4329-2020; Liu, Yongxia/AAJ-3181-2020	Liu, Yongxia/0000-0001-6125-8599	Chinese Twelfth "Five-year" National Science and Technology Support Project [2012BAD12B03]; National Education Ministry's Major Project [313054]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) State Education Ministry [20120008110042]; China Postdoctoral Science Foundation [2014M561102]; High-end Foreign Experts Recruitment Program [GDT20141100043]	Chinese Twelfth "Five-year" National Science and Technology Support Project; National Education Ministry's Major Project; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) State Education Ministry(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); High-end Foreign Experts Recruitment Program	This research was supported by the Chinese Twelfth "Five-year" National Science and Technology Support Project (No. 2012BAD12B03) BH, National Education Ministry's Major Project (No. 313054) BH, Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) State Education Ministry (No. 20120008110042) BH, China Postdoctoral Science Foundation (No. 2014M561102) JG and High-end Foreign Experts Recruitment Program (No. GDT20141100043) BH.	[Anonymous], 2009, PERFORMANCE STANDARD, V19; Bosshard PP, 2004, J CLIN MICROBIOL, V42, P2065, DOI 10.1128/JCM.42.5.2065-2073.2004; Chen LY, 2012, J MICROBIOL IMMUNOL, V45, P158, DOI 10.1016/j.jmii.2011.09.010; CLSI, 2008, M31A2 CLSI; de Vos P., 2009, BERGEYS MANUAL SYSTE, DOI [10.1002/9781118960608, DOI 10.1002/9781118960608]; Devriese LA, 1999, VET MICROBIOL, V70, P87, DOI 10.1016/S0378-1135(99)00124-8; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; Duarte RS, 2004, J CLIN MICROBIOL, V42, P4214, DOI 10.1128/JCM.42.9.4214-4222.2004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Ghanbarpour R, 2010, RES VET SCI, V88, P6, DOI 10.1016/j.rvsc.2009.06.003; Greenwood SJ, 2005, DIS AQUAT ORGAN, V63, P237, DOI 10.3354/dao063237; Guccione J., 2013, Open Journal of Veterinary Medicine, V3, P131, DOI 10.4236/ojvm.2013.32021; Guerin-Faublee V, 2002, INT J ANTIMICROB AG, V19, P219, DOI 10.1016/S0924-8579(01)00485-X; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Ke XL, 2012, AQUACULTURE, V342, P18, DOI 10.1016/j.aquaculture.2012.02.012; KERBAUGH MA, 1968, APPL MICROBIOL, V16, P519, DOI 10.1128/AEM.16.3.519-523.1968; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu YX, 2014, RES MICROBIOL, V165, P273, DOI 10.1016/j.resmic.2014.03.007; Martin V, 2007, J CLIN MICROBIOL, V45, P3053, DOI 10.1128/JCM.00156-07; Munoz MA, 2007, J CLIN MICROBIOL, V45, P3964, DOI 10.1128/JCM.00795-07; NEI M, 1981, GENETICS, V97, P145; Olive DM, 1999, J CLIN MICROBIOL, V37, P1661, DOI 10.1128/JCM.37.6.1661-1669.1999; OWENS WE, 1990, J DAIRY SCI, V73, P1225, DOI 10.3168/jds.S0022-0302(90)78786-3; Pitkala A, 2004, J DAIRY SCI, V87, P2433, DOI 10.3168/jds.S0022-0302(04)73366-4; Rasmussen M, 2013, J INFECTION, V66, P467, DOI 10.1016/j.jinf.2012.12.006; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Spakova T, 2012, POL J VET SCI, V15, P329, DOI 10.2478/v10181-012-0051-1; Stebbing PD, 2012, DIS AQUAT ORGAN, V100, P159, DOI 10.3354/dao02491; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Torrent A, 2002, J WILDLIFE DIS, V38, P221, DOI 10.7589/0090-3558-38.1.221; Wiedmann M, 2000, APPL ENVIRON MICROB, V66, P2085, DOI 10.1128/AEM.66.5.2085-2095.2000; WILLIAMS REO, 1953, J GEN MICROBIOL, V8, P475, DOI 10.1099/00221287-8-3-475; Yang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067755; Zhou WQ, 2014, INDIAN J MED MICROBI, V32, P462, DOI 10.4103/0255-0857.142238	36	133	139	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125001	10.1371/journal.pone.0125001	http://dx.doi.org/10.1371/journal.pone.0125001			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919289	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400068
J	Ohta, Y; Nakamoto, H; Ishii, Y; Ikudome, S; Takahashi, K; Shima, N				Ohta, Yoichi; Nakamoto, Hiroki; Ishii, Yasumitsu; Ikudome, Sachi; Takahashi, Kyohei; Shima, Norihiro			Muscle Activation Characteristics of the Front Leg During Baseball Swings with Timing Correction for Sudden Velocity Decrease	PLOS ONE			English	Article							MOVEMENT CORRECTION; ELECTROMYOGRAPHIC ACTIVITY; ONSET; TIME	This study aimed to clarify the activation characteristics of the vastus lateralis muscle in the front leg during timing correction for a sudden decrease in the velocity of a target during baseball swings. Eleven male collegiate baseball players performed coincident timing tasks that comprised constant velocity of 8 m/s (unchanged) and a sudden decrease in velocity from 8 to 4 m/s (decreased velocity). Electromyography (EMG) revealed that the muscle activation was typically monophasic when responding unchanged conditions. The type of muscle activation during swings in response to decreased velocity condition was both monophasic and biphasic. When biphasic activation appeared in response to decreased velocity, the impact time and the time to peak EMG amplitude were significantly prolonged and the timing error was significantly smaller than that of monophasic activation. However, the EMG onset from the target start was consistent both monophasic and biphasic activation in response to conditions of decreased velocity. In addition, batters with small timing errors in response to decreased velocity were more likely to generate biphasic EMG activation. These findings indicated that timing correction for a sudden decrease in the velocity of an oncoming target is achieved by modifying the muscle activation characteristics of the vastus lateralis muscle of front leg from monophasic to biphasic to delay reaching peak muscle activation and thus prolong impact time. Therefore, the present findings suggests that the extent of timing errors in response to decreased velocity is influenced by the ability to correct muscle activation after its initiation rather than by delaying the initiation timing of muscle activation during baseball swings.	[Ohta, Yoichi] Aichi Shukutoku Univ, Dept Sports & Hlth Sci, Fac Hlth & Med Sci, Nagoya, Aichi, Japan; [Nakamoto, Hiroki; Ikudome, Sachi] Natl Inst Fitness & Sports Kanoya, Fac Sports Humanities & Appl Social Sci, Dept Phys Educ, Kagoshima, Japan; [Ishii, Yasumitsu] Japan Inst Sports Sci, Dept Sports Sci, Tokyo, Japan; [Takahashi, Kyohei] Natl Inst Technol, Kumamoto Coll, Fac Liberal Studies, Kumamoto, Japan; [Shima, Norihiro] Tokai Gakuen Univ, Sch Sport & Hlth Sci, Nagoya, Aichi, Japan	Aichi Shukutoku University; National Institute Fitness & Sports Kanoya	Ohta, Y (corresponding author), Aichi Shukutoku Univ, Dept Sports & Hlth Sci, Fac Hlth & Med Sci, Nagoya, Aichi, Japan.	yohta@asu.aasa.ac.jp	Shima, Norihiro/O-5113-2019	Ohta, Yoichi/0000-0002-8351-3017; Nakamoto, Hiroki/0000-0002-3778-1571	Aichi Shukutoku University	Aichi Shukutoku University	The work was supported by research grant from Aichi Shukutoku University (http://www.aasa.ac.jp/english/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benguigui N, 2003, J EXP PSYCHOL HUMAN, V29, P1083, DOI 10.1037/0096-1523.29.6.1083; Breen J. L., 1967, J HLTH PHYSICAL ED R, V38, P36; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cortina J.M., 2000, EFFECT SIZE ANOVA DE; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Fortenbaugh DM, 2011, THESIS U MIAMI; FROHLICH C, 1984, AM J PHYS, V52, P325, DOI 10.1119/1.13883; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; Hubbard AW, 1954, RES QUART, V25, P42, DOI 10.1080/10671188.1954.10624942; Ikudome S, 2013, NEUROREPORT, V24, P879, DOI 10.1097/WNR.0000000000000010; Katsumata H, 2007, HUM MOVEMENT SCI, V26, P27, DOI 10.1016/j.humov.2006.09.005; Kudo K, 1998, EXP BRAIN RES, V122, P23, DOI 10.1007/s002210050487; Le Runigo C, 2005, HUM MOVEMENT SCI, V24, P429, DOI 10.1016/j.humov.2005.06.008; Mason B.R., 1987, BIOMECHANICS XB HUMA, P749; MCLEOD P, 1987, PERCEPTION, V16, P49, DOI 10.1068/p160049; MESSIER SP, 1985, RES Q EXERCISE SPORT, V56, P138, DOI 10.1080/02701367.1985.10608448; Modenese L, 2012, MULTIBODY SYST DYN, V28, P157, DOI 10.1007/s11044-011-9274-7; Nakamoto H, 2012, HUM MOVEMENT SCI, V31, P1529, DOI 10.1016/j.humov.2012.04.005; Nakanishi H, 2008, J JPN SOC TRIBOLOGIS, V53, P39; Nakata H, 2012, J STRENGTH COND RES, V26, P1461, DOI 10.1519/JSC.0b013e318231ab12; Ohta Y, 2014, PERCEPT MOTOR SKILL, V118, P96, DOI 10.2466/23.25.PMS.118k15w8; Rosenbaum DA, 2010, HUMAN MOTOR CONTROL, 2ND EDITION, P1; Sabes PN, 2000, CURR OPIN NEUROBIOL, V10, P740, DOI 10.1016/S0959-4388(00)00149-5; SELIN C, 1959, RES QUART, V30, P232, DOI 10.1080/10671188.1959.10613029; Slater-Hammel AT, 1951, RES QUART, V22, P377, DOI 10.1080/10671188.1951.10621327; Slater-Hammel AT, 1950, RES QUART, V21, P353, DOI 10.1080/10671188.1950.10621292; Takatoku N, 2010, J ELECTROMYOGR KINES, V20, P290, DOI 10.1016/j.jelekin.2009.03.007; Vasseljen O, 2006, CLIN BIOMECH, V21, P905, DOI 10.1016/j.clinbiomech.2006.05.003; Williams T., 1986, SCI HITTING; YANG JF, 1985, ELECTROEN CLIN NEURO, V60, P485, DOI 10.1016/0013-4694(85)91108-3	30	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124113	10.1371/journal.pone.0124113	http://dx.doi.org/10.1371/journal.pone.0124113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25918848	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659400042
J	Pei, XL; Li, MH; Zhan, J; Yu, Y; Wei, XF; Guan, LZ; Aydin, H; Elson, P; Zhou, M; He, HY; Zhang, HQ				Pei, Xuelian; Li, Muhan; Zhan, Jun; Yu, Yu; Wei, Xiaofan; Guan, Lizhao; Aydin, Hakan; Elson, Paul; Zhou, Ming; He, Huiying; Zhang, Hongquan			Enhanced IMP3 Expression Activates NF-kappa B Pathway and Promotes Renal Cell Carcinoma Progression	PLOS ONE			English	Article							PREDICT METASTASIS; PROTEIN IMP3; PROGNOSIS; MARKER; BIOMARKER; ADENOCARCINOMA; PROLIFERATION; MIGRATION	Background Insulin-like growth factor 2 mRNA binding protein 3 (IMP3) is expressed in metastatic and a subset of primary renal cell carcinoma (RCC). However, the role of IMP3 in RCC progression was poorly understood. We aim to uncover the mechanism of IMP3 in regulating clear cell RCC (CCRCC) progression and validate the prognostic significance of IMP3 in localized CCRCC. Methods Caki-1 cells stably overexpressing IMP3 and Achn cells with knockdown of IMP3 were analyzed for cell migration and invasion by Transwell assay. RNA-seq was used to profile gene expression in IMP3-expressing Caki-1 cells. A cohort of 469 localized CCRCC patients were examined for IMP3 expression by immunohistochemistry using tumor tissue array. Results IMP3 promoted Caki-1 cell migration and invasion, whereas knockdown of IMP3 by RNAi inhibited Achn cell migration and invasion. Enhanced IMP3 expression activated NF-kappa B pathway and through which, it functioned in promoting the RCC cell migration. IMP3 expression in localized CCRCC was found to be associated with higher nuclear grade, higher T stage, necrosis and sarcomatoid differentiation (p < 0.001). Enhanced IMP3 expression was correlated with shorter recurrence-free and overall survivals. Multivariable analysis validated IMP3 as an independent prognostic factor for localized CCRCC patients. Conclusion IMP3 promotes RCC cell migration and invasion by activation of NF-kappa B pathway. IMP3 is validated to be an independent prognostic marker for localized CCRCC.	[Pei, Xuelian; Li, Muhan; Zhan, Jun; Yu, Yu; Wei, Xiaofan; Guan, Lizhao; He, Huiying; Zhang, Hongquan] Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Pei, Xuelian; Li, Muhan; Zhan, Jun; Yu, Yu; Wei, Xiaofan; Guan, Lizhao; He, Huiying; Zhang, Hongquan] Peking Univ, State Key Lab Nat & Biomimet Drugs, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Li, Muhan; He, Huiying] Peking Univ, Dept Pathol, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Pei, Xuelian; Zhan, Jun; Yu, Yu; Wei, Xiaofan; Guan, Lizhao; Zhang, Hongquan] Peking Univ, Dept Anat Histol & Embryol, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Aydin, Hakan; Zhou, Ming] Cleveland Clin, Inst Pathol & Lab Med, Cleveland, OH 44106 USA; [Elson, Paul] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Pei, Xuelian] Shihezi Univ, Sch Med, Dept Histol & Embryol, Minist Educ, Shihezi, Xinjiang, Peoples R China; [Pei, Xuelian] Shihezi Univ, Sch Med, Key Lab Xinjiang Endem & Ethn Dis, Minist Educ, Shihezi, Xinjiang, Peoples R China	Peking University; Peking University; Peking University; Peking University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Shihezi University; Shihezi University	He, HY (corresponding author), Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Hlth Sci Ctr, Beijing 100871, Peoples R China.	huiyinghe@bjmu.edu.cn; Hongquan.Zhang@bjmu.edu.cn	Zhan, Jun/AAH-5499-2020		Natural Science Foundation of China [81001135, 81230051, 30830048, 31170711, 81321003]; Ministry of Science and Technology of China [2013CB910501, 2010CB912203, 2010CB529402]; Ministry of Education; Beijing Natural Science Foundation [7120002]; Peking University [BMU20120314, BMU20130364]; Beijing Education Bureau	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Peking University(Peking University); Beijing Education Bureau	This work was supported by the Natural Science Foundation of China 81001135, 81230051, 30830048, 31170711 and 81321003, the Ministry of Science and Technology of China 2013CB910501, 2010CB912203 and 2010CB529402, the 111 Project of the Ministry of Education, Beijing Natural Science Foundation 7120002 and Peking University grants BMU20120314 and BMU20130364, and a Leading Academic Discipline Project of Beijing Education Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZW, 2010, INT J CANCER, V127, P1999, DOI 10.1002/ijc.25223; Cairns P, 2011, CANCER BIOMARK, V9, P461, DOI 10.3233/CBM-2011-0176; Christofakis EP, 2008, ORAL ONCOL, V44, P920, DOI 10.1016/j.oraloncology.2007.12.002; Feng W, 2011, ARCH PATHOL LAB MED, V135, P1024, DOI 10.5858/2009-0617-OAR2; Findeis-Hosey JJ, 2010, HUM PATHOL, V41, P477, DOI 10.1016/j.humpath.2009.10.004; Hoffmann NE, 2008, CANCER-AM CANCER SOC, V112, P1471, DOI 10.1002/cncr.23296; Jiang Z, 2008, CLIN CANCER RES, V14, P5579, DOI 10.1158/1078-0432.CCR-08-0504; Jiang Z, 2008, CANCER-AM CANCER SOC, V112, P2676, DOI 10.1002/cncr.23484; Jiang Z, 2006, LANCET ONCOL, V7, P556, DOI 10.1016/S1470-2045(06)70732-X; Kobel M, 2009, MODERN PATHOL, V22, P469, DOI 10.1038/modpathol.2008.206; Li DW, 2009, ANN SURG ONCOL, V16, P3499, DOI 10.1245/s10434-009-0648-5; Li HG, 2011, J CRANIOFAC SURG, V22, P2022, DOI 10.1097/SCS.0b013e3182319750; Lu D, 2011, AM J SURG PATHOL, V35, P1638, DOI 10.1097/PAS.0b013e31823272d4; Morais C, 2011, INT J BIOCHEM CELL B, V43, P1537, DOI 10.1016/j.biocel.2011.08.003; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Oya M, 2003, CARCINOGENESIS, V24, P377, DOI 10.1093/carcin/24.3.377; Parihar Jaspreet S, 2014, Rev Urol, V16, P118; Patel AR, 2012, J UROLOGY, V187, P1978, DOI 10.1016/j.juro.2012.01.121; Perak RB, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-165; Peri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076746; Pryor JG, 2008, MODERN PATHOL, V21, P431, DOI 10.1038/modpathol.3801016; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Samanta S, 2012, ONCOGENE, V31, P4689, DOI 10.1038/onc.2011.620; Schaeffer DF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-59; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sonpavde G, 2012, BRIT J CANCER, V107, P1009, DOI 10.1038/bjc.2012.399; Sung CH, 2013, TOXICOL LETT, V223, P109, DOI 10.1016/j.toxlet.2013.09.006; Vasudev NS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-112; Walter O, 2009, HUM PATHOL, V40, P1528, DOI 10.1016/j.humpath.2009.05.005; Wang L, 2010, CHINESE MED J-PEKING, V123, P3554, DOI 10.3760/cma.j.issn.0366-6999.2010.24.010; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Yoo JY, 2008, GENE THER, V15, P635, DOI 10.1038/gt.2008.3	33	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124338	10.1371/journal.pone.0124338	http://dx.doi.org/10.1371/journal.pone.0124338			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919292	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400046
J	Tate, CM; Mc Entire, J; Pallini, R; Vakana, E; Wyss, L; Blosser, W; Ricci-Vitiani, L; D'Alessandris, QG; Morgante, L; Giannetti, S; Larocca, LM; Todaro, M; Benfante, A; Colorito, ML; Stassi, G; De Maria, R; Rowlinson, S; Stancato, L				Tate, Courtney M.; Mc Entire, Jacquelyn; Pallini, Roberto; Vakana, Eliza; Wyss, Lisa; Blosser, Wayne; Ricci-Vitiani, Lucia; D'Alessandris, Quintino Giorgio; Morgante, Liliana; Giannetti, Stefano; Larocca, Luigi Maria; Todaro, Matilde; Benfante, Antonina; Colorito, Maria Luisa; Stassi, Giorgio; De Maria, Ruggero; Rowlinson, Scott; Stancato, Louis			A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology	PLOS ONE			English	Article							STEM-LIKE CELLS; MORPHOGENETIC PROTEINS; ANTIANGIOGENIC THERAPY; INITIATING CELLS; BONE; CANCER; PATHWAY; VASCULATURE; KINASE; HETEROGENEITY	Bone morphogenetic proteins (BMPs), members of the TGF-beta superfamily, have numerous biological activities including control of growth, differentiation, and vascular development. Using an in vitro co-culture endothelial cord formation assay, we investigated the role of a BMP7 variant (BMP7v) in VEGF, bFGF, and tumor-driven angiogenesis. BMP7v treatment led to disruption of neo-endothelial cord formation and regression of existing VEGF and bFGF cords in vitro. Using a series of tumor cell models capable of driving angiogenesis in vitro, BMP7v treatment completely blocked cord formation. Pre-treatment of endothelial cells with BMP7v significantly reduced their cord forming ability, indicating a direct effect on endothelial cell function. BMP7v activated the canonical SMAD signaling pathway in endothelial cells but targeted gene knockdown using shRNA directed against SMAD4 suggests this pathway is not required to mediate the anti-angiogenic effect. In contrast to SMAD activation, BMP7v selectively decreased ERK and AKT activation, significantly decreased endothelial cell migration and down-regulated expression of critical RTKs involved in VEGF and FGF angiogenic signaling, VEGFR2 and FGFR1 respectively. Importantly, in an in vivo angiogenic plug assay that serves as a measurement of angiogenesis, BMP7v significantly decreased hemoglobin content indicating inhibition of neoangiogenesis. In addition, BMP7v significantly decreased angiogenesis in glioblastoma stem-like cell (GSLC) Matrigel plugs and significantly impaired in vivo growth of a GSLC xenograft with a concomitant reduction in microvessel density. These data support BMP7v as a potent anti-angiogenic molecule that is effective in the context of tumor angiogenesis.	[Tate, Courtney M.; Mc Entire, Jacquelyn; Vakana, Eliza; Wyss, Lisa; Blosser, Wayne; Rowlinson, Scott; Stancato, Louis] Eli Lilly & Co, Discovery Res, Indianapolis, IN 46285 USA; [Pallini, Roberto; D'Alessandris, Quintino Giorgio] Univ Cattolica Sacro Cuore, Dept Neurosurg, Rome, Italy; [Ricci-Vitiani, Lucia] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Morgante, Liliana; Giannetti, Stefano] Univ Cattolica Sacro Cuore, Inst Human Anat, Rome, Italy; [Larocca, Luigi Maria] Univ Cattolica Sacro Cuore, Inst Pathol, Rome, Italy; [Todaro, Matilde; Benfante, Antonina; Colorito, Maria Luisa; Stassi, Giorgio] Univ Palermo, Surg & Oncol Sci, Palermo, Italy; [De Maria, Ruggero] Regina Elena Inst Canc Res, Rome, Italy	Eli Lilly; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Istituto Superiore di Sanita (ISS); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Palermo; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Stancato, L (corresponding author), Eli Lilly & Co, Discovery Res, Indianapolis, IN 46285 USA.	l.stancato@lilly.com	Ricci Vitiani, Lucia/J-8320-2016; Larocca, Luigi Maria/M-9590-2019; todaro, matilde/AAC-1003-2022; Pallini, Roberto/AAA-3760-2019; Larocca, Luigi M/A-1577-2008; D'Alessandris, Quintino Giorgio/J-8827-2018; Stassi, Giorgio/AAC-1175-2022; De Maria, Ruggero/S-6385-2019; PALLINI, Roberto/AAA-3747-2019	Ricci Vitiani, Lucia/0000-0001-7336-5615; Larocca, Luigi Maria/0000-0003-1739-4758; todaro, matilde/0000-0001-8686-8043; Larocca, Luigi M/0000-0003-1739-4758; D'Alessandris, Quintino Giorgio/0000-0002-2953-9291; De Maria, Ruggero/0000-0003-2255-0583; PALLINI, Roberto/0000-0002-4611-8827	Eli Lilly	Eli Lilly(Eli Lilly)	This study was supported by Eli Lilly. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Blosser W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096036; Catalano V, 2013, SEMIN CANCER BIOL, V23, P522, DOI 10.1016/j.semcancer.2013.08.007; Cunha SI, 2011, BLOOD, V117, P6999, DOI 10.1182/blood-2011-01-330142; D'Amico L, 2013, BRIT J CANCER, V108, P2525, DOI 10.1038/bjc.2013.271; Dow JK, 2000, UROLOGY, V55, P800, DOI 10.1016/S0090-4295(00)00457-X; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Falchetti ML, 2008, INT J CANCER, V122, P1236, DOI 10.1002/ijc.23193; Falcon BL, 2013, DRUG DISCOV TODAY, V18, P510, DOI 10.1016/j.drudis.2012.08.008; Gough W, 2011, J BIOMOL SCREEN, V16, P155, DOI 10.1177/1087057110393340; Heinke J, 2008, CIRC RES, V103, P804, DOI 10.1161/CIRCRESAHA.108.178434; Heinke J, 2007, CARDIOVASC RES, V76, P390, DOI 10.1016/j.cardiores.2007.08.003; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Langenfeld EM, 2005, MOL CANCER RES, V3, P679, DOI 10.1158/1541-7786.MCR-05-0124; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Levet S, 2013, BLOOD, V122, P598, DOI 10.1182/blood-2012-12-472142; Lieu C, 2011, CLIN CANCER RES, V17, P6130, DOI 10.1158/1078-0432.CCR-11-0659; Lowery JW, 2010, CYTOKINE GROWTH F R, V21, P287, DOI 10.1016/j.cytogfr.2010.06.001; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Meier T, 2011, MOL CANCER THER, V10, P2168, DOI 10.1158/1535-7163.MCT-11-0323; Miosge N, 2002, MATRIX BIOL, V21, P611, DOI 10.1016/S0945-053X(02)00070-7; Miosge N, 2001, HISTOCHEM J, V33, P523, DOI 10.1023/A:1014995523521; Nagy JA, 2012, CLIN EXP METASTAS, V29, P657, DOI 10.1007/s10585-012-9500-6; Nagy JA, 2010, SEMIN THROMB HEMOST, V36, P321, DOI 10.1055/s-0030-1253454; Pallini R, 2008, CLIN CANCER RES, V14, P8205, DOI 10.1158/1078-0432.CCR-08-0644; Perron JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008198; Piccirillo SGM, 2007, ERNST SCHERING FOUND, V5, P59, DOI 10.1007/2789_2007_044; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Rothhammer Tania, 2007, Cancer Biomarkers, V3, P111; Rush S, 2007, EXP CELL RES, V313, P121, DOI 10.1016/j.yexcr.2006.09.018; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Silinsky J, 2013, J SURG RES, V185, P113, DOI 10.1016/j.jss.2013.05.049; Sitohy B, 2011, CANCER RES, V71, P7021, DOI 10.1158/0008-5472.CAN-11-1693; Sobczak I, 2008, ONCOGENE, V27, P4779, DOI 10.1038/onc.2008.128; Tate CM, 2012, CELL DEATH DIFFER, V19, P1644, DOI 10.1038/cdd.2012.44; Tokuda H, 2003, AM J PHYSIOL-ENDOC M, V284, pE1202, DOI 10.1152/ajpendo.00300.2002; Townsend KL, 2012, FASEB J, V26, P2187, DOI 10.1096/fj.11-199067; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Wagner DO, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3107mr1; Wimmer R, 2012, DEV CELL, V22, P158, DOI 10.1016/j.devcel.2011.11.012	46	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125697	10.1371/journal.pone.0125697	http://dx.doi.org/10.1371/journal.pone.0125697			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919028	Green Published, gold			2022-12-27	WOS:000353659400088
J	Dettling, MD; Seavy, NE; Howell, CA; Gardali, T				Dettling, Mark D.; Seavy, Nathaniel E.; Howell, Christine A.; Gardali, Thomas			Current Status of Western Yellow-Billed Cuckoo along the Sacramento and Feather Rivers, California	PLOS ONE			English	Article							POPULATIONS; ABUNDANCE; PATTERNS; BIRDS	To evaluate the current status of the western population of the Yellow-billed Cuckoo (Coccyzus americanus) along the Sacramento and Feather rivers in California's Sacramento Valley, we conducted extensive call playback surveys in 2012 and 2013. We also quantified the amount and distribution of potential habitat. Our survey transects were randomly located and spatially balanced to sample representative areas of the potential habitat. We estimated that the total area of potential habitat was 8,134 ha along the Sacramento River and 2,052 ha along the Feather River, for a total of 10,186 ha. Large-scale restoration efforts have created potential habitat along both of these rivers. Despite this increase in the amount of habitat, the number of cuckoos we detected was extremely low. There were 8 detection occasions in 2012 and 10 occasions in 2013 on the Sacramento River, in both restored and remnant habitat. We had no detections on the Feather River in either year. We compared our results to 10 historic studies from as far back as 1972 and found that the Yellow-billed Cuckoo had unprecedentedly low numbers in 2010, 2012, and 2013. The current limiting factor for the Yellow-billed Cuckoo in the Sacramento Valley is likely not the amount of appropriate vegetation, as restoration has created more habitat over the last 30 years. Reasons for the cuckoo decline on the Sacramento and Feather rivers are unclear.	[Dettling, Mark D.; Seavy, Nathaniel E.; Howell, Christine A.; Gardali, Thomas] Point Blue Conservat Sci, Petaluma, CA 94954 USA		Dettling, MD (corresponding author), Point Blue Conservat Sci, Petaluma, CA 94954 USA.	mdettling@pointblue.org			California Department of Fish and Wildlife [1182002]; US Fish and Wildlife Service	California Department of Fish and Wildlife; US Fish and Wildlife Service(US Fish & Wildlife Service)	Our research was funded by California Department of Fish and Wildlife grant #1182002 (www.dfg.ca.gov). We would like to acknowledge the US Fish and Wildlife Service (www.fws.gov) Traditional Section 6 - Threatened and Endangered Wildlife Program for providing the funding to the California Department of Fish and Wildlife. Canh Nguyen and David Wright of the California Department of Fish and Wildlife reviewed the manuscript before submission.	Benton TG, 2002, J APPL ECOL, V39, P673, DOI 10.1046/j.1365-2664.2002.00745.x; Birdlife International NatureServe, 2012, BIRD SPEC DISTR MAPS; Bouvier JC, 2011, ENVIRON TOXICOL CHEM, V30, P212, DOI 10.1002/etc.377; California Department of Fish and Wildlife. State and federally listed endangered and threatened animals of California, 2013, STAT FED LIST END TH; Dettling MD, 2011, 1794 PRBO CAL DEP FI; Dybala Kristen E., 2014, Ecological Restoration, V32, P239; GAINES D, 1974, CONDOR, V76, P204, DOI 10.2307/1366731; Gaines D., 1984, Western Birds, V15, P49; Gaines D., 1973, THESIS U CALIFORNIA; Gardali T, 2006, RESTOR ECOL, V14, P391, DOI 10.1111/j.1526-100X.2006.00147.x; Gardali T, 2011, ENVIRON MANAGE, V48, P28, DOI 10.1007/s00267-011-9623-6; Geographical Information Center. Medium-Scale Central Valley Riparian Vegetation Map, 2012, MED SCAL CENTR VALL; Girvetz EH, 2007, LANDSCAPE ECOL, V22, P1131, DOI 10.1007/s10980-007-9104-8; Girvetz EH, 2009, LANDSCAPE ECOL, V24, P1315, DOI 10.1007/s10980-009-9384-2; GOLET GH, 2008, SAN FRANCISCO ESTUAR, V6, P2; Greco SE, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P183; Grinnell J, 1944, PACIFIC COAST AVIFAU; Halterman M. D, 2001, STATUS YELLOW BILLED; Halterman MD, 2011, NATURAL HIS IN PRESS; Halterman MD., 1991, THESIS CALIFORNIA ST; Halterman MD., 2009, THESIS U NEVADA RENO; Hammond JE, 2011, THESIS CALIFORNIA ST; Holl KD, 2004, J APPL ECOL, V41, P922, DOI 10.1111/j.0021-8901.2004.00949.x; Holmes RT, 2007, IBIS, V149, P2, DOI 10.1111/j.1474-919X.2007.00685.x; Hughes J.M., 2020, BIRDS OF THE WORLD, DOI [10.2173/bow.yebcuc.01, DOI 10.2173/BOW.YEBCUC.01]; Katibah E.F., 1984, CALIFORNIA RIPARIAN, P23; LAYMON S A, 1987, Western Birds, V18, P19; LAYMON SA, 1989, US FOR SERV T R PSW, V110, P272; Laymon SA., 1998, RIPARIAN BIRD CONSER; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McNeil SE., 2013, YELLOW BILLED CUCKOO; Ockendon N, 2012, BIRD STUDY, V59, P111, DOI 10.1080/00063657.2011.645798; Paquette SR, 2013, ECOL APPL, V23, P122, DOI 10.1890/12-0068.1; Penteriani V, 2008, ECOL MODEL, V213, P98, DOI [10.1016/j.ecolmodel.2007.11.009, 10.1016/j.ecolmode1.2007.11.009]; RHJV (Riparian Habitat Joint Venture), 2004, VERS 2 0 RIP BIRD CO; Rohwer S, 2009, P NATL ACAD SCI USA, V106, P19050, DOI 10.1073/pnas.0908121106; Sawyer J.O., 2009, MANUAL CALIFORNIA VE; Sechrist Juddson D., 2012, Western Birds, V43, P2; Singer MB, 2007, RIVER RES APPL, V23, P55, DOI 10.1002/rra.968; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Stevens DL, 2003, ENVIRONMETRICS, V14, P593, DOI 10.1002/env.606; U.S. Fish and Wildlife Service, 2001, FED REGISTER, V66, P38611	43	3	3	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125198	10.1371/journal.pone.0125198	http://dx.doi.org/10.1371/journal.pone.0125198			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915801	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100109
J	Greenwood, M; Greenwood, MP; Paton, JFR; Murphy, D				Greenwood, Mingkwan; Greenwood, Michael Paul; Paton, Julian F. R.; Murphy, David			Transcription Factor CREB3L1 Regulates Endoplasmic Reticulum Stress Response Genes in the Osmotically Challenged Rat Hypothalamus	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA; ER STRESS; SUBFORNICAL ORGAN; TRANSDUCER OASIS; CREB/ATF-FAMILY; EXPRESSION; ATF6; XBP1; CLEAVAGE	Arginine vasopressin (AVP) is synthesised in magnocellular neurons (MCNs) of supraoptic nucleus (SON) and paraventricular nucleus (PVN) of the hypothalamus. In response to the hyperosmotic stressors of dehydration (complete fluid deprivation, DH) or salt loading (drinking 2% salt solution, SL), AVP synthesis increases in MCNs, which over-burdens the protein folding machinery in the endoplasmic reticulum (ER). ER stress and the unfolded protein response (UPR) are signaling pathways that improve ER function in response to the accumulation of misfold/unfold protein. We asked whether an ER stress response was activated in the SON and PVN of DH and SL rats. We observed increased mRNA expression for the immunoglobulin heavy chain binding protein (BiP), activating transcription factor 4 (Atf4), C/EBP-homologous protein (Chop), and cAMP responsive element binding protein 3 like 1 (Creb3l1) in both SON and PVN of DH and SL rats. Although we found no changes in the splicing pattern of X box-binding protein 1 (Xbp1), an increase in the level of the unspliced form of Xbp1 (Xbp1U) was observed in DH and SL rats. CREB3L1, a novel ER stress inducer, has been shown to be activated by ER stress to regulate the expression of target genes. We have previously shown that CREB3L1 is a transcriptional regulator of the AVP gene; however, a role for CREB3L1 in the response to ER stress has yet to be investigated in MCNs. Here, we used lentiviral vectors to introduce a dominant negative form of CREB3L1 (CREB3L1DN) in the rat SON. Expression of CREB3L1DN in the SON decreased Chop and Xbp1U mRNA levels, but not BiPand Atf4 transcript expression. CREB3L1 is thus implicated as a transcriptional mediator of the ER stress response in the osmotically stimulated SON.	[Greenwood, Mingkwan; Greenwood, Michael Paul; Murphy, David] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Paton, Julian F. R.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Murphy, David] Univ Malaya, Dept Physiol, Kuala Lumpur, Malaysia	University of Bristol; University of Bristol; Universiti Malaya	Greenwood, M (corresponding author), Univ Bristol, Sch Clin Sci, Bristol, Avon, England.	mingkwan.greenwood@bristol.ac.uk	Paton, Julian/AAM-2121-2020; Murphy, David/C-3967-2012	Murphy, David/0000-0003-2946-0353; Paton, Julian/0000-0001-7410-2913; Greenwood, Michael/0000-0003-0565-2748; Greenwood, Mingkwan/0000-0003-0463-6615	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G006156/1, BB/J015415/1]; University of Malaya (High Impact Research Chancellery Grant) [UM.C/625/1/HIR/MOHE/MED/22 H-20001-E0000865]; BBSRC [BB/G006156/1, BB/J015415/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G006156/1, BB/J015415/1] Funding Source: researchfish; British Heart Foundation [RG/12/6/29670] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Malaya (High Impact Research Chancellery Grant); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC; www.bbsrc.ac.uk), (BB/G006156/1, MPG, JP, DM; BB/J015415/1, MG, JP, DM), and the University of Malaya (High Impact Research Chancellery Grant UM.C/625/1/HIR/MOHE/MED/22 H-20001-E0000865, DM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; [Anonymous], 2014, ENDOCRINOLOGY; Arima H, 1999, J NEUROENDOCRINOL, V11, P337; Arima H, 2010, J NEUROENDOCRINOL, DOI [10.1111/j.1365-2826.2010.02041.x, DOI 10.1111/J.1365-2826.2010.02041.X]; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Boone M, 2008, PFLUG ARCH EUR J PHY, V456, P1005, DOI 10.1007/s00424-008-0498-1; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Gainer H, 2012, J NEUROENDOCRINOL, V24, P528, DOI 10.1111/j.1365-2826.2011.02236.x; Greenwood M, 2014, J NEUROSCI, V34, P3810, DOI 10.1523/JNEUROSCI.4343-13.2014; Hagiwara D, 2012, PEPTIDES, V33, P346, DOI 10.1016/j.peptides.2011.12.011; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hindmarch C, 2006, P NATL ACAD SCI USA, V103, P1609, DOI 10.1073/pnas.0507450103; Hiramatsu N, 2011, METHOD ENZYMOL, V491, P183, DOI 10.1016/B978-0-12-385928-0.00011-0; Honma Y, 1999, MOL BRAIN RES, V69, P93, DOI 10.1016/S0169-328X(99)00102-3; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kondo S, 2011, IUBMB LIFE, V63, P233, DOI 10.1002/iub.433; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinon F, 2011, CURR OPIN IMMUNOL, V23, P35, DOI 10.1016/j.coi.2010.10.016; McKinley MJ, 2003, ADV ANAT EMBRYOL CEL, V172, P1; MISELIS RR, 1981, BRAIN RES, V230, P1, DOI 10.1016/0006-8993(81)90388-7; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Omori Y, 2002, BIOCHEM BIOPH RES CO, V293, P470, DOI 10.1016/S0006-291X(02)00253-X; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito A, 2014, ANAT SCI INT, V89, P11, DOI 10.1007/s12565-013-0214-x; Saito A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1971; Samali Afshin, 2010, Int J Cell Biol, V2010, P830307, DOI 10.1155/2010/830307; Shao DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056124; SUEMARU S, 1990, ACTA MED OKAYAMA, V44, P233; VANDENPOL AN, 1982, J COMP NEUROL, V206, P317, DOI 10.1002/cne.902060402; Yan Zhongyu, 2011, Open Neuroendocrinol J, V4, P136; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Yue CM, 2006, AM J PHYSIOL-REG I, V290, pR1233, DOI 10.1152/ajpregu.00709.2005	41	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124956	10.1371/journal.pone.0124956	http://dx.doi.org/10.1371/journal.pone.0124956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915053	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100084
J	Koutsoulidou, A; Kyriakides, TC; Papadimas, GK; Christou, Y; Kararizou, E; Papanicolaou, EZ; Phylactou, LA				Koutsoulidou, Andrie; Kyriakides, Tassos C.; Papadimas, George K.; Christou, Yiolanda; Kararizou, Evangelia; Papanicolaou, Eleni Zamba; Phylactou, Leonidas A.			Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress	PLOS ONE			English	Article							UNSTABLE CTG REPEAT; SKELETAL-MUSCLE; CIRCULATING MICRORNAS; TRINUCLEOTIDE REPEAT; SOMATIC INSTABILITY; BIOMARKERS; TYPE-1; AGE; EXPANSION; ONSET	The discovery of reliable and sensitive blood biomarkers is useful for the diagnosis, monitoring and potential future therapy of diseases. Recently, microRNAs (miRNAs) have been identified in blood circulation and might have the potential to be used as biomarkers for several diseases and clinical conditions. Myotonic Dystrophy type 1 (DM1) is the most common form of adult-onset muscular dystrophy primarily characterized by muscle myotonia, weakness and atrophy. Previous studies have shown an association between miRNAs and DM1 in muscle tissue and, recently, in plasma. The aim of this study was to detect and assess muscle-specific miRNAs as potential biomarkers of DM1 muscle wasting, an important parameter in the disease's natural history. Disease stable or progressive DM1 patients with muscle weakness and wasting were recruited and enrolled in the study. RNA isolated from participants' serum was used to assess miRNA levels. Results suggest that the levels of muscle-specific miRNAs are correlated with the progression of muscle wasting and weakness observed in the DM1 patients. Specifically, miR-1, miR-133a, miR133b and miR-206 serum levels were found elevated in DM1 patients with progressive muscle wasting compared to disease stable DM1 patients. Based on these results, we propose that muscle-specific miRNAs might be useful molecular biomarkers for monitoring the progress of muscle atrophy in DM1 patients.	[Koutsoulidou, Andrie; Phylactou, Leonidas A.] Cyprus Inst Neurol & Genet, Dept Mol Genet Funct & Therapy, CY-1683 Nicosia, Cyprus; [Kyriakides, Tassos C.] Yale Univ, Sch Publ Hlth, Yale Ctr Analyt Sci, New Haven, CT 06520 USA; [Papadimas, George K.; Kararizou, Evangelia] Eginitio Hosp, Dept Neurol, Med Sch Athens, Athens 11528, Greece; [Christou, Yiolanda; Papanicolaou, Eleni Zamba] Cyprus Inst Neurol & Genet, Neurol Clin D, CY-1683 Nicosia, Cyprus	Yale University; National & Kapodistrian University of Athens	Phylactou, LA (corresponding author), Cyprus Inst Neurol & Genet, Dept Mol Genet Funct & Therapy, POB 2346, CY-1683 Nicosia, Cyprus.	laphylac@cing.ac.cy	Kyriakides, Tassos/E-4980-2013; BOUGEA, ANASTASIA/P-8197-2017	Kyriakides, Tassos/0000-0001-8913-108X; Phylactou, Leonidas/0000-0002-1377-211X	A.G. Leventis Foundation	A.G. Leventis Foundation	This work was supported by a research grant from the A.G. Leventis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANVRET M, 1993, HUM MOL GENET, V2, P1397, DOI 10.1093/hmg/2.9.1397; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; ASHIZAWA T, 1992, NEUROLOGY, V42, P1877; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Chau CH, 2008, CLIN CANCER RES, V14, P5967, DOI 10.1158/1078-0432.CCR-07-4535; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; de Die-Smulders CEM, 1998, BRAIN, V121, P1557, DOI 10.1093/brain/121.8.1557; Fernandez-Costa JM, 2013, HUM MOL GENET, V22, P704, DOI 10.1093/hmg/dds478; Gambardella S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-48; Gharehbaghi-Schnell EB, 1998, CLIN GENET, V53, P20, DOI 10.1034/j.1399-0004.1998.531530105.x; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Hamshere MG, 1999, J MED GENET, V36, P59; Hanke Merle, 2010, Urol Oncol, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; Higham CF, 2012, HUM MOL GENET, V21, P2450, DOI 10.1093/hmg/dds059; Holmberg J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00155; HUNTER A, 1992, J MED GENET, V29, P774, DOI 10.1136/jmg.29.11.774; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; LAVEDAN C, 1993, AM J HUM GENET, V52, P875; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li XH, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.29; Machuca-Tzili L, 2005, MUSCLE NERVE, V32, P1, DOI 10.1002/mus.20301; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Malpass Katy, 2012, Nat Rev Neurol, V8, P297, DOI 10.1038/nrneurol.2012.85; Martorell L, 1997, HUM MOL GENET, V6, P877, DOI 10.1093/hmg/6.6.877; Mayeux Richard, 2004, NeuroRx, V1, P182, DOI 10.1007/BF03206601; Merlevede K, 2002, J NEUROL, V249, P693, DOI 10.1007/s00415-002-0692-6; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mizuno H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018388; Modoni A, 2004, ARCH NEUROL-CHICAGO, V61, P1943, DOI 10.1001/archneur.61.12.1943; MONCKTON DG, 1995, HUM MOL GENET, V4, P1; Morales F, 2012, HUM MOL GENET, V21, P3558, DOI 10.1093/hmg/dds185; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Pavicevic DS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/391821; Perbellini R, 2011, NEUROMUSCULAR DISORD, V21, P81, DOI 10.1016/j.nmd.2010.11.012; Perfetti A, 2014, NEUROMUSCULAR DISORD, V24, P509, DOI 10.1016/j.nmd.2014.02.005; Pineiro E, 2003, NUCLEIC ACIDS RES, V31, P6733, DOI 10.1093/nar/gkg898; REDMAN JB, 1993, JAMA-J AM MED ASSOC, V269, P1960, DOI 10.1001/jama.269.15.1960; Savic D, 2002, HUM MUTAT, V19, P131, DOI 10.1002/humu.10027; Su YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037395; THORNTON CA, 1994, ANN NEUROL, V35, P104, DOI 10.1002/ana.410350116; Tome S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000482; Turchinovich A., 2013, Frontiers in Genetics, V4, P119, DOI 10.3389/fgene.2013.00119; Turchinovich A, 2012, RNA BIOL, V9, P1066, DOI 10.4161/rna.21083; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Turner C, 2010, J NEUROL NEUROSUR PS, V81, P358, DOI 10.1136/jnnp.2008.158261; van den Broek WJAA, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-61; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wagner J, 2013, ARTERIOSCL THROM VAS, V33, P1392, DOI 10.1161/ATVBAHA.112.300741; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; WONG LJC, 1995, AM J HUM GENET, V56, P114; Yang Z, 2003, AM J HUM GENET, V73, P1092, DOI 10.1086/379523; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; ZATZ M, 1995, HUM MOL GENET, V4, P401, DOI 10.1093/hmg/4.3.401; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zubakov D, 2010, INT J LEGAL MED, V124, P217, DOI 10.1007/s00414-009-0402-3	64	47	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125341	10.1371/journal.pone.0125341	http://dx.doi.org/10.1371/journal.pone.0125341			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915631	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659100122
J	Nakahata, K; Uehara, S; Nishikawa, S; Kawatsu, M; Zenitani, M; Oue, T; Okuyama, H				Nakahata, Kengo; Uehara, Shuichiro; Nishikawa, Shimpei; Kawatsu, Miyoko; Zenitani, Masahiro; Oue, Takaharu; Okuyama, Hiroomi			Aldehyde Dehydrogenase 1 (ALDH1) Is a Potential Marker for Cancer Stem Cells in Embryonal Rhabdomyosarcoma	PLOS ONE			English	Article							CD133; POPULATION; RESISTANCE; LINES	Cancer stem cells (CSCs) are defined as a small population of cancer cells with the properties of high self-renewal, differentiation, and tumor-initiating functions. Recent studies have demonstrated that aldehyde dehydrogenase 1 (ALDH1) is a marker for CSCs in adult cancers. Although CSCs have been identified in some different types of pediatric solid tumors, there have been no studies regarding the efficacy of ALDH1 as a marker for CSCs. Therefore, in order to elucidate whether ALDH1 can be used as a marker for CSCs of pediatric sarcoma, we examined the characteristics of a population of cells with a high ALDH1 activity (ALDH1(high) cells) in rhabdomyosarcoma (RMS), the most common soft tissue sarcoma in children. We used the human embryonal RMS (eRMS) cell lines RD and KYM-1, and sorted the cells into two subpopulations of ALDH1(high) cells and cells with a low ALDH1 activity (ALDH1(low) cells). Consequently, we found that the ALDH1(high) cells comprised 3.9% and 8.2% of the total cell population, respectively, and showed a higher capacity for self-renewal and tumor formation than the ALDH1(low) cells. With regard to chemoresistance, the survival rate of the ALDH1(high) cells was found to be higher than that of the ALDH1(low) cells following treatment with chemotherapeutic agents for RMS. Furthermore, the ALDH1(high) cells exhibited a higher degree of pluripotency and gene expression of Sox2, which is one of the stem cell markers. Taken together, the ALDH1(high) cells possessed characteristics of CSCs, including colony formation, chemoresistance, differentiation and tumor initiation abilities. These results suggest that ALDH1 is a potentially useful marker of CSCs in eRMS.	[Nakahata, Kengo; Uehara, Shuichiro; Kawatsu, Miyoko; Zenitani, Masahiro; Oue, Takaharu; Okuyama, Hiroomi] Osaka Univ, Grad Sch Med, Dept Pediat Surg, Osaka, Japan; [Nishikawa, Shimpei] Osaka Univ, Grad Sch Med, Frontier Sci Canc & Chemotherapy, Osaka, Japan	Osaka University; Osaka University	Uehara, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Pediat Surg, Osaka, Japan.	uehara@pedsurg.med.osaka-u.ac.jp			JSPS KAKENHI [23592630, 25861668]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by JSPS KAKENHI Grant Number 23592630 (SU) and 25861668 (KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita M, 2013, MICROSC RES TECHNIQ, V76, P844, DOI 10.1002/jemt.22237; Awad O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013943; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Casarsa C, 2008, J ONCOL, V2008, DOI 10.1155/2008/492643; Chen Y, 2011, BIOCHEM BIOPH RES CO, V405, P173, DOI 10.1016/j.bbrc.2011.01.002; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Haji MA, 2004, ONCOGENE, V23, P7274; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; Hwang YS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072023, 10.1371/annotation/b02313dc-840f-4f03-91a2-77cb55a3a4c9]; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Komuro H, 2007, J PEDIATR SURG, V42, P2040, DOI 10.1016/j.jpedsurg.2007.08.026; Lohberger B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043664; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Marcato P, 2011, CELL CYCLE, V10, P1378, DOI 10.4161/cc.10.9.15486; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; Nishikawa S, 2013, INT J ONCOL, V42, P1437, DOI 10.3892/ijo.2013.1837; Oshima N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101735; Pressey JG, 2013, PEDIATR BLOOD CANCER, V60, P45, DOI 10.1002/pbc.24117; Rahadiani N, 2011, CANCER SCI, V102, P903, DOI 10.1111/j.1349-7006.2011.01864.x; Raney RB, 2001, J PEDIAT HEMATOL ONC, V23, P215, DOI 10.1097/00043426-200105000-00008; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Rasper M, 2010, NEURO-ONCOLOGY, V12, P1024, DOI 10.1093/neuonc/noq070; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Smith MA, 2010, J CLIN ONCOL, V28, P2635, DOI [10.1200/JCO.2009.27.2443, DOI 10.1200/JCO.2009.27.2443]; Song W, 2008, INT J CLIN PRACT, V62, P1212, DOI 10.1111/j.1742-1241.2008.01777.x; Su Y, 2010, CANCER EPIDEM BIOMAR, V19, P327, DOI 10.1158/1055-9965.EPI-09-0865; Takenobu H, 2011, ONCOGENE, V30, P97, DOI 10.1038/onc.2010.383; Walter D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019506; Yasuda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068187; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	34	39	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125454	10.1371/journal.pone.0125454	http://dx.doi.org/10.1371/journal.pone.0125454			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915760	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100130
J	Valigurova, A; Paskerova, GG; Diakin, A; Kovacikova, M; Simdyanov, TG				Valigurova, Andrea; Paskerova, Gita G.; Diakin, Andrei; Kovacikova, Magdalena; Simdyanov, Timur G.			Protococcidian Eleutheroschizon duboscqi, an Unusual Apicomplexan Interconnecting Gregarines and Cryptosporidia	PLOS ONE			English	Article							HOST-CELL INVASION; FINE-STRUCTURE; LIFE-CYCLE; PARVUM; ULTRASTRUCTURE; ATTACHMENT; CYTOSKELETON; ORGANELLES; COCCIDIA; GOUSSIA	This study focused on the attachment strategy, cell structure and the host-parasite interactions of the protococcidian Eleutheroschizon duboscqi, parasitising the polychaete Scoloplos armiger. The attached trophozoites and gamonts of E. duboscqi were detected at different development stages. The parasite develops epicellularly, covered by a host cell-derived, two-membrane parasitophorous sac forming a caudal tipped appendage. Staining with Evans blue suggests that this tail is protein-rich, supported by the presence of a fibrous substance in this area. Despite the ultrastructural evidence for long filaments in the tail, it stained only weakly for F-actin, while spectrin seemed to accumulate in this area. The attachment apparatus consists of lobes arranged in one (trophozoites) or two (gamonts) circles, crowned by a ring of filamentous fascicles. During trophozoite maturation, the internal space between the parasitophorous sac and parasite turns translucent, the parasite trilaminar pellicle seems to reorganise and is covered by a dense fibrous glycocalyx. The parasite surface is organised in broad folds with grooves in between. Micropores are situated at the bottom of the grooves. A layer of filaments organised in bands, underlying the folds and ending above the attachment fascicles, was detected just beneath the pellicle. Confocal microscopy, along with the application of cytoskeletal drugs (jasplakinolide, cytochalasin D, oryzalin) confirmed the presence of actin and tubulin polymerised forms in both the parasitophorous sac and the parasite, while myosin labelling was restricted to the sac. Despite positive tubulin labelling, no microtubules were detected in mature stages. The attachment strategy of E. duboscqi shares features with that of cryptosporidia and gregarines, i.e. the parasite itself conspicuously resembles an epicellularly located gregarine, while the parasitophorous sac develops in a similar manner to that in cryptosporidia. This study provides a re-evaluation of epicellular development in other apicomplexans and directly compares their niche with that of E. duboscqi.	[Valigurova, Andrea; Diakin, Andrei; Kovacikova, Magdalena] Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic; [Paskerova, Gita G.] St Petersburg State Univ, Fac Biol, Dept Invertebrate Zool, St Petersburg 199034, Russia; [Simdyanov, Timur G.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Invertebrate Zool, Moscow 119234, Russia	Masaryk University Brno; Saint Petersburg State University; Lomonosov Moscow State University	Valigurova, A (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, CS-61137 Brno, Czech Republic.	andreav@sci.muni.cz	Simdyanov, Timur G/H-8279-2012; Paskerova, Gita G./H-3805-2014; Valigurová, Andrea/B-4522-2012	Simdyanov, Timur G/0000-0003-2478-9301; Paskerova, Gita G./0000-0002-1026-4216; Valigurová, Andrea/0000-0001-8313-1580	Czech Science Foundation [P505/12/G112]; St. Petersburg State University [1.42.514.2013, 1.42.1277.2014]; Council of President of the Russian Federation [NSh-1801.2014.4]; Ministry of Education and Science of Russian Federation; Core Facility Centres 'Culturing of microorganisms' and 'Development of molecular and cell technologies' of St. Petersburg State University; Department of Botany and Zoology, Faculty of Science, Masaryk University	Czech Science Foundation(Grant Agency of the Czech Republic); St. Petersburg State University; Council of President of the Russian Federation; Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); Core Facility Centres 'Culturing of microorganisms' and 'Development of molecular and cell technologies' of St. Petersburg State University; Department of Botany and Zoology, Faculty of Science, Masaryk University	AV, AD and MK were supported by the Czech Science Foundation, Project no. P505/12/G112 (ECIP). GGP was supported with grants from St. Petersburg State University (1.42.514.2013, 1.42.1277.2014). TGS was supported by the grant of the Council of President of the Russian Federation NSh-1801.2014.4. A part of the electron microscopic analysis was performed at the User Facilities Center of Lomonosov Moscow State University under financial support of Ministry of Education and Science of Russian Federation and at the Core Facility Centres 'Culturing of microorganisms' and 'Development of molecular and cell technologies' of St. Petersburg State University. AV, AD and MK acknowledge support from the Department of Botany and Zoology, Faculty of Science, Masaryk University, towards the preparation of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Awerinzew S., 1908, T IMP ST PETERSBURG, V38, P1; Barta JR, 2006, TRENDS PARASITOL, V22, P463, DOI 10.1016/j.pt.2006.08.001; BAUDOIN J, 1969, Protistologica, V5, P431; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; BENAJIBA MH, 1994, J EUKARYOT MICROBIOL, V41, P215, DOI 10.1111/j.1550-7408.1994.tb01500.x; Bonnin A, 1999, EUR J CELL BIOL, V78, P794, DOI 10.1016/S0171-9335(99)80030-2; Bouzid M, 2013, CLIN MICROBIOL REV, V26, P115, DOI 10.1128/CMR.00076-12; Brasil L., 1906, ARCH ZOOL EXP GEN, V4, P17; Butaeva F, 2006, Tsitologiia, V48, P695; Carreno RA, 1999, PARASITOL RES, V85, P899, DOI 10.1007/s004360050655; Chatton E, 1936, CR HEBD ACAD SCI, V203, P833; COX FEG, 1994, INT J PARASITOL, V24, P1301, DOI 10.1016/0020-7519(94)90197-X; Desportes I., 1969, Annls Sci Nat, V11, P31; Dubremetz JF, 1998, INT J PARASITOL, V28, P1007, DOI 10.1016/S0020-7519(98)00076-9; DYKOVA I, 1981, J FISH DIS, V4, P487, DOI 10.1111/j.1365-2761.1981.tb01161.x; Eli A., 2012, Research Journal of Applied Sciences Engineering and Technology, V4, P1438; Elliott DA, 2001, INFECT IMMUN, V69, P5940, DOI 10.1128/IAI.69.9.5940-5942.2001; Elliott DA, 2000, INFECT IMMUN, V68, P2315, DOI 10.1128/IAI.68.4.2315-2322.2000; Ferguson DJP, 2008, EUKARYOT CELL, V7, P698, DOI 10.1128/EC.00021-08; Forney JR, 1999, INFECT IMMUN, V67, P844, DOI 10.1128/IAI.67.2.844-852.1999; Hashim A, 2006, INFECT IMMUN, V74, P99, DOI 10.1128/IAI.74.1.99-107.2006; HILDEBRAND HF, 1976, Z PARASITENKD, V49, P193, DOI 10.1007/BF00380590; Huang BQ, 2004, J PARASITOL, V90, P212, DOI 10.1645/GE-3204; Jirku M, 2002, PROTIST, V153, P379, DOI 10.1078/14344610260450118; KIM SH, 1992, DIS AQUAT ORGAN, V12, P191; Kudryashev M, 2010, CELL MICROBIOL, V12, P362, DOI 10.1111/j.1462-5822.2009.01399.x; LANDSBERG JH, 1986, DIS AQUAT ORGAN, V2, P13, DOI 10.3354/dao002013; Leander BS, 2008, TRENDS PARASITOL, V24, P60, DOI 10.1016/j.pt.2007.11.005; LUKES J, 1993, FOLIA PARASIT, V40, P1; LUKES J, 1992, CAN J ZOOL, V70, P2382, DOI 10.1139/z92-320; LUKES J, 1992, J PROTOZOOL, V39, P484, DOI 10.1111/j.1550-7408.1992.tb04836.x; LUMB R, 1988, PARASITOL RES, V74, P531, DOI 10.1007/BF00531630; MACMILLAN WG, 1973, PARASITOLOGY, V66, P207, DOI 10.1017/S0031182000044553; Melicherova J, 2014, PARASITOLOGY, V141, P287, DOI 10.1017/S0031182013001637; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; MOLNAR K, 1986, J FISH DIS, V9, P99, DOI 10.1111/j.1365-2761.1986.tb00988.x; Morrissette NS, 2004, MOL BIOL CELL, V15, P1960, DOI 10.1091/mbc.E03-07-0530; Morrissette NS, 2002, J CELL SCI, V115, P1017; O'Hara Steven P., 2008, V47, P92; OrtegaPierres G, 2009, GIARDIA AND CRYPTOSPORIDIUM: FROM MOLECULES TO DISEASE, P1; PAPERNA I, 1987, DIS AQUAT ORGAN, V2, P239; Paperna I, 1996, DIS AQUAT ORGAN, V27, P95, DOI 10.3354/dao027095; PAPERNA I, 1989, S AFR J ZOOL, V24, P345; Paperna I, 1999, PARASITE, V6, P359, DOI 10.1051/parasite/1999064359; Perkins F. O., 2000, ILLUSTRATED GUIDE PR, V1, P190; Reis Y, 2006, FEBS LETT, V580, P4673, DOI 10.1016/j.febslet.2006.07.050; ROBERTS WL, 1972, Z PARASITENKD, V40, P183; Scholtyseck E., 1979, FINE STRUCTURE PARAS; Schrevel J., 1966, Protistologica, V2, P17; SCHREVEL J, 1968, J MICROSC-PARIS, V7, P391; SCHREVEL J, 1971, J PROTOZOOL, V18, P448, DOI 10.1111/j.1550-7408.1971.tb03355.x; Schrevel J, 2013, GREGARINES EARLY BRA, P26; SHEFFIEL.HG, 1971, J PROTOZOOL, V18, P98, DOI 10.1111/j.1550-7408.1971.tb03289.x; Simdyanov TG, 2007, EUR J PROTISTOL, V43, P17, DOI 10.1016/j.ejop.2006.09.003; Sokolova YY, 2014, PARASITOLOGY, V141, P1108, DOI 10.1017/S0031182014000420; TRONCHIN G, 1977, J PROTOZOOL, V24, P67, DOI 10.1111/j.1550-7408.1977.tb05282.x; Umemiya R, 2005, J PARASITOL, V91, P1034, DOI 10.1645/GE-508R.1; Valigurova A, 2005, EUR J PROTISTOL, V41, P209, DOI 10.1016/j.ejop.2005.05.005; Valigurova A, 2008, EUR J PROTISTOL, V44, P197, DOI 10.1016/j.ejop.2007.11.006; Valigurova A, 2008, INT J PARASITOL, V38, P913, DOI 10.1016/j.ijpara.2007.11.003; Valigurova A, 2007, J EUKARYOT MICROBIOL, V54, P495, DOI 10.1111/j.1550-7408.2007.00291.x; Valigurova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042606; Valigurova A, 2009, INT J PARASITOL, V39, P1235, DOI 10.1016/j.ijpara.2009.04.009; YOSHIKAWA H, 1992, J PROTOZOOL, V39, P539, DOI 10.1111/j.1550-7408.1992.tb04848.x	65	12	12	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125063	10.1371/journal.pone.0125063	http://dx.doi.org/10.1371/journal.pone.0125063			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915503	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100093
J	Zhang, XD; Xie, JJ; Liao, LD; Long, L; Xie, YM; Li, EM; Xu, LY				Zhang, Xiao-Dan; Xie, Jian-Jun; Liao, Lian-Di; Long, Lin; Xie, Yang-Min; Li, En-Min; Xu, Li-Yan			12-O-Tetradecanoylphorbol-13-Acetate Induces Up-Regulated Transcription of Variant 1 but Not Variant 2 of VIL2 in Esophageal Squamous Cell Carcinoma Cells via ERK1/2/AP-1/Sp1 Signaling	PLOS ONE			English	Article							EZRIN EXPRESSION; C-JUN; PHOSPHORYLATION; GENE; METASTASIS; ACTIVATION; PROTEIN; BINDING; SP1; PROLIFERATION	The membrane-cytoskeleton link organizer ezrin may be the most "dramatic" tumor marker, being strongly over-expressed in nearly one-third of human malignancies. However, the molecular mechanisms of aberrant ezrin expression still need to be clarified. Ezrin, encoded by the VIL2 gene, has two transcript variants that differ in the transcriptional start site (TSS): V1 and V2. Both V1 and V2 encode the same protein. Here, we found that 12-O-tetradecanoylphorbol-13-acetate (TPA) induced over-expression of human VIL2 in esophageal squamous cell carcinoma (ESCC) cells. Furthermore, VIL2V1 but not V2 was up-regulated after TPA stimulation in a time-dependent manner. AP-1 and Sp1 binding sites within the promoter region of VIL2V1 acted not only as basal transcriptional elements but also as a composite TPA-responsive element (TRE) for the transcription of VIL2V1. TPA stimulation enhanced c-Jun and Sp1 binding to the TRE via activation of the ERK1/2 pathway and increased protein levels of c-Jun, c-Fos, and Sp1, resulting in over-expression of VIL2V1, whereas the MEK1/2 inhibitor U0126 blocked these events. Finally, we showed that TPA promoted the migration of ESCC cells whereas MEK1/2 inhibitor or ezrin silencing could partially inverse this alteration. Taken together, these results suggest that TPA is able to induce VIL2V1 over-expression in ESCC cells by activating MEK/ERK1/2 signaling and increasing binding of Sp1 and c-Jun to the TRE of the VIL2V1 promoter, and that VIL2 is an important TPA-induced effector.	[Zhang, Xiao-Dan; Xie, Jian-Jun; Liao, Lian-Di; Long, Lin; Li, En-Min; Xu, Li-Yan] Shantou Univ, Coll Med, High Canc Incidence Coastal Chaoshan Area, Key Lab Mol Biol, Shantou 514041, Guangdong, Peoples R China; [Zhang, Xiao-Dan; Liao, Lian-Di; Xu, Li-Yan] Shantou Univ, Coll Med, Inst Oncol Pathol, Shantou 514041, Guangdong, Peoples R China; [Xie, Jian-Jun; Long, Lin; Li, En-Min] Shantou Univ, Coll Med, Dept Biochem & Mol Biol, Shantou 514041, Guangdong, Peoples R China; [Xie, Yang-Min] Shantou Univ, Coll Med, Dept Expt Anim Ctr, Shantou 514041, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University; Shantou University	Li, EM (corresponding author), Shantou Univ, Coll Med, High Canc Incidence Coastal Chaoshan Area, Key Lab Mol Biol, Shantou 514041, Guangdong, Peoples R China.	nmli@stu.edu.cn	xu, li/GNH-3667-2022; Long, Lin/H-1917-2012	Long, Lin/0000-0002-9657-8645	National Natural Science Foundation of China [81172264, 81472613, 81472342]; Natural Science Foundation of China-Guangdong Joint Fund [U1301227]; Fok Ying-Tong Education Foundation [141034]; Science and Technology Program of Guangdong [2011B060300025, 2013B060300020]; Foundation for the Author of Excellent Doctoral Dissertation of Guangdong [sybzzxm201228]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China-Guangdong Joint Fund; Fok Ying-Tong Education Foundation(Fok Ying Tung Education Foundation); Science and Technology Program of Guangdong; Foundation for the Author of Excellent Doctoral Dissertation of Guangdong	This work was supported by grants from the National Natural Science Foundation of China (No. 81172264, No. 81472613 and No. 81472342), the Natural Science Foundation of China-Guangdong Joint Fund (No. U1301227), the Fok Ying-Tong Education Foundation (No. 141034), the Science and Technology Program of Guangdong (No. 2011B060300025, No. 2013B060300020), and the Foundation for the Author of Excellent Doctoral Dissertation of Guangdong (sybzzxm201228).	Ben-Shmuel A, 2013, ONCOGENE, V32, P3220, DOI 10.1038/onc.2012.340; Chen Y, 2011, CANCER RES, V71, P1721, DOI 10.1158/0008-5472.CAN-09-4683; Chung YW, 2011, J BIOL CHEM, V286, P29681, DOI 10.1074/jbc.M111.264945; Crish JF, 2002, ONCOGENE, V21, P738, DOI 10.1038/sj.onc.1205038; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Gao SY, 2009, J BIOL CHEM, V284, P7995, DOI 10.1074/jbc.M809734200; Garbett D, 2012, J CELL BIOL, V198, P195, DOI 10.1083/jcb.201204008; Goldhar AS, 2011, MOL CELL ENDOCRINOL, V335, P148, DOI 10.1016/j.mce.2011.01.004; Griner EM, 2013, ONCOGENE, V32, P1010, DOI 10.1038/onc.2012.124; He H, 2014, J BIOL CHEM, V289, P9089, DOI 10.1074/jbc.M113.534271; Hu LC, 2013, TUMOR BIOL, V34, P2573, DOI 10.1007/s13277-013-0803-2; Iqbal J, 2013, J BIOL CHEM, V288, P36994, DOI 10.1074/jbc.M113.492314; Jang SI, 2002, J BIOL CHEM, V277, P42268, DOI 10.1074/jbc.M205593200; Jiang WG, 1996, ANTICANCER RES, V16, P861; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kiryu-Seo S, 2008, J BIOL CHEM, V283, P6988, DOI 10.1074/jbc.M707514200; Kishore R, 2005, J CLIN INVEST, V115, P1785, DOI 10.1172/JCI22849; LaLonde DP, 2010, MOL BIOL CELL, V21, P1519, DOI 10.1091/mbc.E10-01-0008; Li QC, 2012, TUMOR BIOL, V33, P1493, DOI 10.1007/s13277-012-0400-9; MATSUI M, 1990, ONCOGENE, V5, P249; Meng YX, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-61; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Min HJ, 2014, CELL SIGNAL, V26, P398, DOI 10.1016/j.cellsig.2013.08.002; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Ohtani K, 2002, CANCER LETT, V179, P79, DOI 10.1016/S0304-3835(01)00857-6; Okamura D, 2008, MODERN PATHOL, V21, P847, DOI 10.1038/modpathol.2008.59; Park SY, 2012, J CELL BIOCHEM, V113, P3653, DOI 10.1002/jcb.24238; Ren L, 2012, CANCER RES, V72, P1001, DOI 10.1158/0008-5472.CAN-11-0210; RYSECK RP, 1991, ONCOGENE, V6, P533; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Saito S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054881; Shen ZY, 2003, WORLD J GASTROENTERO, V9, P1182, DOI 10.3748/wjg.v9.i6.1182; Shen ZY, 2000, J CANCER RES CLIN, V126, P589, DOI 10.1007/PL00008469; Teng HJ, 2009, J BIOL CHEM, V284, P26368, DOI 10.1074/jbc.M109.021360; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Velpula KK, 2013, NEOPLASIA, V15, P192, DOI 10.1593/neo.121334; Wang GF, 2008, FEBS LETT, V582, P3663, DOI 10.1016/j.febslet.2008.09.051; Xie JJ, 2011, J SURG ONCOL, V104, P538, DOI 10.1002/jso.21909; Xie JJ, 2009, INT J CANCER, V124, P2549, DOI 10.1002/ijc.24216; Xu X, 2015, MOL CARCINOGEN, V54, P134, DOI 10.1002/mc.22081; Yu YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012710; Yu YL, 2006, CANCER RES, V66, P1982, DOI 10.1158/0008-5472.CAN-05-2360; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x; Zhou JH, 2014, INT J ONCOL, V44, P2059, DOI 10.3892/ijo.2014.2381; Zhu CJ, 2012, ACTA PHARMACOL SIN, V33, P873, DOI 10.1038/aps.2012.36	47	43	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124680	10.1371/journal.pone.0124680	http://dx.doi.org/10.1371/journal.pone.0124680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915860	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100061
J	Chang, SL; Cavnar, SP; Takayama, S; Luker, GD; Linderman, JJ				Chang, S. Laura; Cavnar, Stephen P.; Takayama, Shuichi; Luker, Gary D.; Linderman, Jennifer J.			Cell, Isoform, and Environment Factors Shape Gradients and Modulate Chemotaxis	PLOS ONE			English	Article							CHEMOKINE RECEPTOR; BREAST-CANCER; TUMOR-GROWTH; BETA-ARRESTIN; SENSITIVITY-ANALYSIS; T-CELLS; CXCR4; CXCL12; DIMERIZATION; MODEL	Chemokine gradient formation requires multiple processes that include ligand secretion and diffusion, receptor binding and internalization, and immobilization of ligand to surfaces. To understand how these events dynamically shape gradients and influence ensuing cell chemotaxis, we built a multi-scale hybrid agent-based model linking gradient formation, cell responses, and receptor-level information. The CXCL12/CXCR4/CXCR7 signaling axis is highly implicated in metastasis of many cancers. We model CXCL12 gradient formation as it is impacted by CXCR4 and CXCR7, with particular focus on the three most highly expressed isoforms of CXCL12. We trained and validated our model using data from an in vitro microfluidic source-sink device. Our simulations demonstrate how isoform differences on the molecular level affect gradient formation and cell responses. We determine that ligand properties specific to CXCL12 isoforms (binding to the migration surface and to CXCR4) significantly impact migration and explain differences in in vitro chemotaxis data. We extend our model to analyze CXCL12 gradient formation in a tumor environment and find that short distance, steep gradients characteristic of the CXCL12-gamma isoform are effective at driving chemotaxis. We highlight the importance of CXCL12-gamma in cancer cell migration: its high effective affinity for both extracellular surface sites and CXCR4 strongly promote CXCR4+ cell migration. CXCL12-gamma is also more difficult to inhibit, and we predict that co-inhibition of CXCR4 and CXCR7 is necessary to effectively hinder CXCL12-gamma-induced migration. These findings support the growing importance of understanding differences in protein isoforms, and in particular their implications for cancer treatment.	[Chang, S. Laura; Linderman, Jennifer J.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Cavnar, Stephen P.; Takayama, Shuichi; Luker, Gary D.; Linderman, Jennifer J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Takayama, Shuichi] Univ Michigan, Dept Macromol Sci & Engn, Ann Arbor, MI 48109 USA; [Luker, Gary D.] Univ Michigan, Sch Med, Dept Radiol, Ctr Mol Imaging, Ann Arbor, MI 48109 USA; [Luker, Gary D.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Linderman, JJ (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	linderma@umich.edu		luker, gary/0000-0001-6832-2581	United States National Institutes of Health [R01CA136553, R01CA142750, R21CA182333, P50CA093990]; NSF Predoctoral Fellowship [DGE 0718128, F031543]; University of Michigan Rackham Merit Fellowship; Advanced Proteome informatics of Cancer Training Grant [T32 CA140044]; National Institutes of Health [EB012579, GM096040]; NATIONAL CANCER INSTITUTE [P50CA093990, T32CA140044, R01CA136553, R21CA182333, R01CA142750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096040] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Predoctoral Fellowship(National Science Foundation (NSF)); University of Michigan Rackham Merit Fellowship(University of Michigan System); Advanced Proteome informatics of Cancer Training Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the United States National Institutes of Health Grants R01CA136553, R01CA142750, R21CA182333, and P50CA093990. Both S.L.C. and S.P.C. were supported on NSF Predoctoral Fellowship Project Grants # DGE 0718128 and # F031543, respectively. S.L.C. was also supported under a University of Michigan Rackham Merit Fellowship and S.P.C. was supported under an Advanced Proteome informatics of Cancer Training Grant # T32 CA140044. J.J.L. was supported by National Institutes of Health grants EB012579 and GM096040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Altenburg JD, 2007, J VIROL, V81, P8140, DOI 10.1128/JVI.00268-07; Altenburg JD, 2010, J VIROL, V84, P2563, DOI 10.1128/JVI.00342-09; AZNAVOORIAN S, 1990, J CELL BIOL, V110, P1427, DOI 10.1083/jcb.110.4.1427; Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Bailly M, 2000, MOL BIOL CELL, V11, P3873, DOI 10.1091/mbc.11.11.3873; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bauer AL, 2007, BIOPHYS J, V92, P3105, DOI 10.1529/biophysj.106.101501; Bellmann-Sickert K, 2011, CHEMMEDCHEM, V6, P193, DOI 10.1002/cmdc.201000403; Bendall LJ, 2005, CANCER RES, V65, P3290, DOI 10.1158/0008-5472.CAN-04-3402; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423; Byrne MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085726; Cavnar SP, 2014, INTEGR BIOL-UK, V6, P564, DOI 10.1039/c4ib00015c; Checa S, 2009, ANN BIOMED ENG, V37, P129, DOI 10.1007/s10439-008-9594-9; Choi TJ, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4764108; Cilfone NA, 2015, CELL MOL BIOENG, V8, P119, DOI 10.1007/s12195-014-0363-6; Cilfone NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068680; Cleaver O, 1998, DEVELOPMENT, V125, P3905; Coggins NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098328; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; DeFea KA, 2007, ANNU REV PHYSIOL, V69, P535, DOI 10.1146/annurev.physiol.69.022405.154804; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Dubrovska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031226; Fallahi-Sichani M, 2011, J IMMUNOL, V186, P3472, DOI 10.4049/jimmunol.1003299; Fermas S, 2008, GLYCOBIOLOGY, V18, P1054, DOI 10.1093/glycob/cwn088; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Gerlee P, 2007, J THEOR BIOL, V246, P583, DOI 10.1016/j.jtbi.2007.01.027; Guo ZY, 2008, J THEOR BIOL, V255, P163, DOI 10.1016/j.jtbi.2008.08.008; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Helton JC, 2006, RELIAB ENG SYST SAFE, V91, P1175, DOI 10.1016/j.ress.2005.11.017; Herzmark P, 2007, P NATL ACAD SCI USA, V104, P13349, DOI 10.1073/pnas.0705889104; Hesselgesser J, 1998, J IMMUNOL, V160, P877; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Kirschner DE, 2014, WIRES SYST BIOL MED, V6, P225, DOI 10.1002/wsbm.1270; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P705, DOI 10.1189/jlb.1105656; Lambeir AM, 2001, J BIOL CHEM, V276, P29839, DOI 10.1074/jbc.M103106200; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lin F, 2008, J IMMUNOL, V181, P8335, DOI 10.4049/jimmunol.181.12.8335; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lucas TA, 2008, SIAM J NUMER ANAL, V46, P3113, DOI 10.1137/070701595; Lukacs NW, 2002, AM J PATHOL, V160, P1353, DOI 10.1016/S0002-9440(10)62562-X; Luker KE, 2012, ONCOGENE, V31, P4750, DOI 10.1038/onc.2011.633; Luker KE, 2012, NAT MED, V18, P172, DOI 10.1038/nm.2590; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Maksym RB, 2009, EUR J PHARMACOL, V625, P31, DOI 10.1016/j.ejphar.2009.04.071; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Mirisola V, 2009, EUR J CANCER, V45, P2579, DOI 10.1016/j.ejca.2009.06.026; Mitha F, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-6; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Nimmagadda S, 2010, CANCER RES, V70, P3935, DOI 10.1158/0008-5472.CAN-09-4396; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Paskauskas S, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-64; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Quitub AA, 2009, IEEE ENG MED BIOL, V28, P14, DOI 10.1109/MEMB.2009.931791; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Riggs T, 2008, J THEOR BIOL, V250, P732, DOI 10.1016/j.jtbi.2007.10.015; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Rueda P, 2012, CIRCULATION, V126, P1882, DOI 10.1161/CIRCULATIONAHA.112.113290; Rueda P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002543; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Schneider IC, 2006, CELL CYCLE, V5, P1130, DOI 10.4161/cc.5.11.2770; Serini G, 2003, EMBO J, V22, P1771, DOI 10.1093/emboj/cdg176; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Sundnes J, 2005, MATH BIOSCI, V194, P233, DOI 10.1016/j.mbs.2005.01.001; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Torisawa YS, 2010, INTEGR BIOL-UK, V2, P680, DOI 10.1039/c0ib00041h; TRANQUILLO RT, 1987, J MATH BIOL, V25, P229, DOI 10.1007/BF00276435; Venkiteswaran G, 2013, CELL, V155, P674, DOI 10.1016/j.cell.2013.09.046; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Walpole J, 2013, ANNU REV BIOMED ENG, V15, P137, DOI 10.1146/annurev-bioeng-071811-150104; Wang SJ, 2004, EXP CELL RES, V300, P180, DOI 10.1016/j.yexcr.2004.06.030; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wendt MK, 2008, ONCOGENE, V27, P1461, DOI 10.1038/sj.onc.1210751; Woolf PJ, 2004, J THEOR BIOL, V229, P157, DOI 10.1016/j.jtbi.2004.03.012; Yu L, 2006, GENE, V374, P174, DOI 10.1016/j.gene.2006.02.001; Zhao S, 2014, TRANSL ONCOL, V7, P429, DOI 10.1016/j.tranon.2014.04.001; ZIGMOND SH, 1981, J CELL BIOL, V88, P644, DOI 10.1083/jcb.88.3.644	90	15	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123450	10.1371/journal.pone.0123450	http://dx.doi.org/10.1371/journal.pone.0123450			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909600	Green Published, gold			2022-12-27	WOS:000353376800037
J	Elgrabli, D; Beaudouin, R; Jbilou, N; Floriani, M; Pery, A; Rogerieux, F; Lacroix, G				Elgrabli, Dan; Beaudouin, Remy; Jbilou, Nawel; Floriani, Magali; Pery, Alexandre; Rogerieux, Francoise; Lacroix, Ghislaine			Biodistribution and Clearance of TiO2 Nanoparticles in Rats after Intravenous Injection	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; TISSUE DISTRIBUTION; PHARMACOKINETIC MODELS; ULTRAFINE PARTICLES; TOXICITY; BODY; LUNG; TRANSLOCATION; EXPOSURE; SIZE	Titanium dioxide (TiO2) nanoparticles are used in many applications. Due to their small size, easy body penetration and toxicological adverse effects have been suspected. Numerous studies have tried to characterize TiO2 translocation after oral, dermal or respiratory exposure. In this study, we focused on TiO2 nanoparticle biodistribution, clearance and toxicological effects after intravenous injection, considering TiO2 translocation in the blood occurs. Using ICP-OES, transmission electron microscopy, and histological methods, we found TiO2 accumulation in liver, lungs and spleen. We estimated TiO2 nanoparticles' half life in the body to about 10 days. Clinical biomarkers were also quantified for 56 days to identify potential toxicological impact on lungs, blood, liver, spleen and kidneys. Results showed absence of toxicological effects after TiO2 intravenous injection at concentrations of 7.7 to 9.4 mg/kg.	[Elgrabli, Dan; Beaudouin, Remy; Jbilou, Nawel; Pery, Alexandre; Rogerieux, Francoise; Lacroix, Ghislaine] Inst Natl Environm Ind & Risques INERIS, Parc Technol Alata, Verneuil Halatte, Verneuil En Halatte, France; [Elgrabli, Dan] Univ Paris Diderot, Lab Matisres & Syst complexes, CNRS UMR7057, Paris, France; [Floriani, Magali] Inst Radioprotect & Surete Nucl Cadarache IRSN, St Paul Les Durance, France	Institut National de l'Environnement Industriel et des Risques (INERIS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite	Elgrabli, D (corresponding author), Inst Natl Environm Ind & Risques INERIS, Parc Technol Alata, Verneuil Halatte, Verneuil En Halatte, France.	dan.elgrabli@univ-paris-diderot.fr	Beaudouin, Rémy/H-1491-2012; Lacroix, Ghislaine/Q-8005-2018	Beaudouin, Rémy/0000-0002-2855-1571; Lacroix, Ghislaine/0000-0002-3260-8526				Bois FY, 1997, J STAT SOFTW, V2, P1, DOI [10.18637/jss.v002.i09, DOI 10.18637/JSS.V002.I09]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown RP, 1997, TOXICOL IND HEALTH, V13, P407, DOI 10.1177/074823379701300401; Fabian E, 2008, ARCH TOXICOL, V82, P151, DOI 10.1007/s00204-007-0253-y; FERIN J, 1992, AM J RESP CELL MOL, V6, P535, DOI 10.1165/ajrcmb/6.5.535; Geraets L, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-30; Gontier E, 2004, 34 ANN EUR SOC DERM; Haddad S, 1998, ENVIRON TOXICOL PHAR, V5, P245, DOI 10.1016/S1382-6689(98)00008-8; Kertesz Z, 2005, NUCL INSTRUM METH B, V231, P280, DOI 10.1016/j.nimb.2005.01.071; Kreyling WG, 2002, J TOXICOL ENV HEAL A, V65, P1513, DOI 10.1080/00984100290071649; KREYLING WG, 2000, LUNG BIOL HEALTH DIS, V143, P323; Lankveld DPK, 2010, BIOMATERIALS, V31, P8350, DOI 10.1016/j.biomaterials.2010.07.045; Lu MG, 2010, ACS NANO, V4, P6303, DOI 10.1021/nn1018818; Nemmar A, 2001, AM J RESP CRIT CARE, V164, P1665, DOI 10.1164/ajrccm.164.9.2101036; Nestorov I, 2003, CLIN PHARMACOKINET, V42, P883, DOI 10.2165/00003088-200342100-00002; Oberdorster G, 2002, J TOXICOL ENV HEAL A, V65, P1531, DOI 10.1080/00984100290071658; OBERDORSTER G, 1994, ENVIRON HEALTH PERSP, V102, P173, DOI 10.2307/3432080; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Olmedo D, 2002, J MATER SCI-MATER M, V13, P793, DOI 10.1023/A:1016131310025; Pery ARR, 2009, INHAL TOXICOL, V21, P1099, DOI 10.3109/08958370902748542; Robichaud CO, 2009, ENVIRON SCI TECHNOL, V43, P4227, DOI 10.1021/es8032549; Shelley ML, 2008, INT J TOXICOL, V27, P359, DOI 10.1080/10915810802503487; Shvedova A.A., 2007, NANOTOXICOLOGY CHARA, P225; Stone PH, 1999, AM HEART J, V138, P804, DOI 10.1016/S0002-8703(99)70002-5; Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001; Wang Y, 2013, SMALL, V9, P1742, DOI 10.1002/smll.201201185; Yang RSH, 2010, J NANOSCI NANOTECHNO, V10, P8482, DOI 10.1166/jnn.2010.2687	27	63	65	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124490	10.1371/journal.pone.0124490	http://dx.doi.org/10.1371/journal.pone.0124490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909957	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800084
J	Luo, XD; Cideciyan, AV; Iannaccone, A; Roman, AJ; Ditta, LC; Jennings, BJ; Yatsenko, SA; Sheplock, R; Sumaroka, A; Swider, M; Schwartz, SB; Wissinger, B; Kohl, S; Jacobson, SG				Luo, Xunda; Cideciyan, Artur V.; Iannaccone, Alessandro; Roman, Alejandro J.; Ditta, Lauren C.; Jennings, Barbara J.; Yatsenko, Svetlana A.; Sheplock, Rebecca; Sumaroka, Alexander; Swider, Malgorzata; Schwartz, Sharon B.; Wissinger, Bernd; Kohl, Susanne; Jacobson, Samuel G.			Blue Cone Monochromacy: Visual Function and Efficacy Outcome Measures for Clinical Trials	PLOS ONE			English	Article							GENE-THERAPY; SPECTRAL SENSITIVITY; COLOR-VISION; MOLECULAR-GENETICS; NULL MUTATION; ROD; MECHANISMS; PERIMETRY; PHOTORECEPTORS; ACHROMATOPSIA	Background Blue Cone Monochromacy (BCM) is an X-linked retinopathy caused by mutations in the OPN1LW / OPN1MW gene cluster, encoding long (L)- and middle (M)-wavelength sensitive cone opsins. Recent evidence shows sufficient structural integrity of cone photoreceptors in BCM to warrant consideration of a gene therapy approach to the disease. In the present study, the vision in BCM is examined, specifically seeking clinically-feasible outcomes for a future clinical trial. Methods BCM patients (n = 25, ages 5-72) were studied with kinetic and static chromatic perimetry, full-field sensitivity testing, and eye movement recordings. Vision at the fovea and parafovea was probed with chromatic microperimetry. Results Kinetic fields with a Goldmann size V target were generally full. Short-wavelength (S-) sensitive cone function was normal or near normal in most patients. Light-adapted perimetry results on conventional background lights were abnormally reduced; 600-nm stimuli were seen by rods whereas white stimuli were seen by both rods and S-cones. Under dark-adapted conditions, 500-nm stimuli were seen by rods in both BCM and normals. Spectral sensitivity functions in the superior retina showed retained rod and S-cone functions in BCM under dark-adapted and light-adapted conditions. In the fovea, normal subjects showed L/M-cone mediation using a 650-nm stimulus under dark-adapted conditions, whereas BCM patients had reduced sensitivity driven by rod vision. Full-field red stimuli on bright blue backgrounds were seen by L/M-cones in normal subjects whereas BCM patients had abnormally reduced and rod-mediated sensitivities. Fixation location could vary from fovea to parafovea. Chromatic microperimetry demonstrated a large loss of sensitivity to red stimuli presented on a cyan adapting background at the anatomical fovea and surrounding parafovea. Conclusions BCM rods continue to signal vision under conditions normally associated with daylight vision. Localized and retina-wide outcome measures were examined to evaluate possible improvement of L/M-cone-based vision in a clinical trial.	[Luo, Xunda; Cideciyan, Artur V.; Roman, Alejandro J.; Sheplock, Rebecca; Sumaroka, Alexander; Swider, Malgorzata; Schwartz, Sharon B.; Jacobson, Samuel G.] Univ Penn, Dept Ophthalmol, Perelman Sch Med, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Iannaccone, Alessandro; Ditta, Lauren C.; Jennings, Barbara J.] Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Hamilton Eye Inst, Memphis, TN 38163 USA; [Yatsenko, Svetlana A.] Univ Pittsburgh, Sch Med, Ctr Med Genet & Genom, Pittsburgh Cytogenet Lab, Pittsburgh, PA USA; [Wissinger, Bernd; Kohl, Susanne] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Mol Genet Lab, Tubingen, Germany	University of Pennsylvania; Pennsylvania Medicine; University of Tennessee System; University of Tennessee Health Science Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Cideciyan, AV (corresponding author), Univ Penn, Dept Ophthalmol, Perelman Sch Med, Scheie Eye Inst, Philadelphia, PA 19104 USA.	cideciya@mail.med.upenn.edu; jacobsos@mail.med.upenn.edu	Cideciyan, Artur V/A-1075-2007	Cideciyan, Artur V/0000-0002-2018-0905; Iannaccone, Alessandro/0000-0001-5737-8424; Jacobson, Samuel/0000-0003-2122-169X; Kohl, Susanne/0000-0002-6438-6331	BCM Families Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY001583] Funding Source: NIH RePORTER	BCM Families Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by BCM Families Foundation (SGJ) and Research to Prevent Blindness (grant to UTHSC Hamilton Eye Institute and Scheie Eye Institute; Physician Scientist Award to AI; Senior Scientific Scholar to AVC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi RV, 2000, INVEST OPHTH VIS SCI, V41, P3805; Aguilar M., 1954, OPT ACTA, V1, DOI [10.1080/713818657, DOI 10.1080/713818657]; Ayyagari R, 1999, MOL VIS, V5; Barthelmes D, 2006, INVEST OPHTH VIS SCI, V47, P1161, DOI 10.1167/iovs.05-0783; BERSON EL, 1983, AM J OPHTHALMOL, V95, P741, DOI 10.1016/0002-9394(83)90058-2; BLACKWELL HR, 1957, J OPT SOC AM, V47, P338; Boye SE, 2013, MOL THER, V21, P509, DOI 10.1038/mt.2012.280; Carroll J, 2012, INVEST OPHTH VIS SCI, V53, P8006, DOI 10.1167/iovs.12-11087; Cideciyan AV, 2015, INVEST OPHTH VIS SCI, V56, P526, DOI 10.1167/iovs.14-15895; Cideciyan AV, 2013, HUM GENE THER, V24, P993, DOI 10.1089/hum.2013.153; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Cideciyan AV, 1997, INVEST OPHTH VIS SCI, V38, P1786; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P328, DOI 10.1073/pnas.95.1.328; Cideciyan AV, 2000, VISUAL NEUROSCI, V17, P667, DOI 10.1017/S0952523800175029; Crognale MA, 2004, VISUAL NEUROSCI, V21, P197, DOI 10.1017/S0952523804213384; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Dalkara D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005708; ELENIUS V, 1985, ARCH OPHTHALMOL-CHIC, V103, P519, DOI 10.1001/archopht.1985.01050040061018; Gardner JC, 2014, HUM MUTAT, V35, P1354, DOI 10.1002/humu.22679; GOTTLOB I, 1994, GRAEF ARCH CLIN EXP, V232, P392, DOI 10.1007/BF00186579; HARWERTH RS, 1993, INVEST OPHTH VIS SCI, V34, P3011; HESS RF, 1989, J PHYSIOL-LONDON, V417, P123, DOI 10.1113/jphysiol.1989.sp017794; Jacobson SG, 2007, P NATL ACAD SCI USA, V104, P15123, DOI 10.1073/pnas.0706367104; Jacobson SG, 2013, HUM MOL GENET, V22, P168, DOI 10.1093/hmg/dds421; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; JACOBSON SG, 1986, OPHTHALMOLOGY, V93, P1604; JACOBSON SG, 1989, EXP EYE RES, V48, P679, DOI 10.1016/0014-4835(89)90009-2; Jacobson SG, 2004, HUM MOL GENET, V13, P1893, DOI 10.1093/hmg/ddh198; JACOBSON SG, 1990, INVEST OPHTH VIS SCI, V31, P827; JACOBSON SG, 1991, AM J OPHTHALMOL, V111, P446, DOI 10.1016/S0002-9394(14)72379-7; KALLONIATIS M, 1990, J OPT SOC AM A, V7, P1912, DOI 10.1364/JOSAA.7.001912; Kay CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062097; Kazmi MA, 1997, INVEST OPHTH VIS SCI, V38, P1074; Kellner U, 2004, GRAEF ARCH CLIN EXP, V242, P729, DOI 10.1007/s00417-004-0921-z; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; MASSOF RW, 1979, INVEST OPHTH VIS SCI, V18, P263; Michaelides M, 2005, EYE, V19, P2, DOI 10.1038/sj.eye.6701391; Mizrahi-Meissonnier L, 2010, INVEST OPHTH VIS SCI, V51, P3884, DOI 10.1167/iovs.09-4592; Moskowitz A, 2009, INVEST OPHTH VIS SCI, V50, P950, DOI 10.1167/iovs.08-2544; NATHANS J, 1993, AM J HUM GENET, V53, P987; NATHANS J, 1989, SCIENCE, V245, P831, DOI 10.1126/science.2788922; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Neitz J, 2011, VISION RES, V51, P633, DOI 10.1016/j.visres.2010.12.002; Roman AJ, 2005, EXP EYE RES, V80, P259, DOI 10.1016/j.exer.2004.09.008; Roman AJ, 2007, PHYSIOL MEAS, V28, pN51, DOI 10.1088/0967-3334/28/8/N02; Roman AJ, 2013, INVEST OPHTH VIS SCI, V54, P1378, DOI 10.1167/iovs.12-11341; ROSS DF, 1984, ARCH OPHTHALMOL-CHIC, V102, P1004; Rotenstreich Y, 2004, OPHTHALMOLOGY, V111, P1222, DOI 10.1016/j.ophtha.2003.10.025; Smithson HE, 2014, VISUAL NEUROSCI, V31, P211, DOI 10.1017/S0952523814000030; STABELL B, 1981, J OPT SOC AM, V71, P836, DOI 10.1364/JOSA.71.000836; Stockman A, 1999, VISION RES, V39, P2901, DOI 10.1016/S0042-6989(98)00225-9; Wiggins D, 2007, INVEST OPHTH VIS SCI, V48, P2089, DOI 10.1167/iovs.06-1108; Wyszecki G, 1982, COLOR SCI CONCEPTS M, P789	54	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125700	10.1371/journal.pone.0125700	http://dx.doi.org/10.1371/journal.pone.0125700			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909963	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000353376800144
J	Teng, CF; Hsieh, WC; Wu, HC; Lin, YJ; Tsai, HW; Huang, WY; Su, IJ				Teng, Chiao-Fang; Hsieh, Wen-Chuan; Wu, Han-Chieh; Lin, Yih-Jyh; Tsai, Hung-Wen; Huang, Wenya; Su, Ih-Jen			Hepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade	PLOS ONE			English	Article							GROUND-GLASS HEPATOCYTES; CANCER-CELL METABOLISM; HEPATOCELLULAR-CARCINOMA; C-MYC; TISSUE METABOLOMICS; TRANSGENIC MICE; X-PROTEIN; S MUTANTS; MTOR; EXPRESSION	Hepatitis B virus (HBV) pre-S2 mutant can induce hepatocellular carcinoma (HCC) via the induction of endoplasmic reticulum stress to activate mammalian target of rapamycin (MTOR) signaling. The association of metabolic syndrome with HBV-related HCC raises the possibility that pre-S2 mutant-induced MTOR activation may drive the development of metabolic disorders to promote tumorigenesis in chronic HBV infection. To address this issue, glucose metabolism and gene expression profiles were analyzed in transgenic mice livers harboring pre-S2 mutant and in an in vitro culture system. The pre-S2 mutant transgenic HCCs showed glycogen depletion. The pre-S2 mutant initiated an MTOR-dependent glycolytic pathway, involving the eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1), Yin Yang 1 (YY1), and myelocytomatosis oncogene (MYC) to activate the solute carrier family 2 (facilitated glucose transporter), member 1 (SLC2A1), contributing to aberrant glucose uptake and lactate production at the advanced stage of pre-S2 mutant transgenic tumorigenesis. Such a glycolysis-associated MTOR signal cascade was validated in human HBV-related HCC tissues and shown to mediate the inhibitory effect of a model of combined resveratrol and silymarin product on tumor growth. Our results provide the mechanism of pre-S2 mutant-induced MTOR activation in the metabolic switch in HBV tumorigenesis. Chemoprevention can be designed along this line to prevent HCC development in high-risk HBV carriers.	[Teng, Chiao-Fang; Hsieh, Wen-Chuan; Wu, Han-Chieh; Su, Ih-Jen] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan; [Lin, Yih-Jyh; Su, Ih-Jen] Natl Cheng Kung Univ Hosp, Dept Surg, Tainan 70428, Taiwan; [Tsai, Hung-Wen; Su, Ih-Jen] Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan 70428, Taiwan; [Huang, Wenya] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan	National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Su, IJ (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan.	suihjen@nhri.org.tw	Huang, Wenya/G-9115-2011; Wu, Han-Chieh/K-6928-2013; Teng, Chiao-Fang/L-6679-2013	Wu, Han-Chieh/0000-0003-2638-7883; Teng, Chiao-Fang/0000-0002-5218-0571	National Health Research Institutes [03A1-IVPP20-014]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	The authors received a grant from National Health Research Institutes (grant number: 03A1-IVPP20-014; http://www.nhri.org.tw/NHRI_WEB/nhriw001Action. do). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2006, ANTICANCER RES, V26, P4457; Amann T, 2009, EXPERT OPIN THER TAR, V13, P1411, DOI 10.1517/14728220903307509; Amann T, 2009, AM J PATHOL, V174, P1544, DOI 10.2353/ajpath.2009.080596; Bannasch P, 2012, WORLD J GASTROENTERO, V18, P6701, DOI 10.3748/wjg.v18.i46.6701; BEASLEY RP, 1981, LANCET, V2, P1129; Beyoglu D, 2013, HEPATOLOGY, V58, P229, DOI 10.1002/hep.26350; Bishayee A, 2010, CANCER TREAT REV, V36, P43, DOI 10.1016/j.ctrv.2009.10.002; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Feher J, 2012, CURR PHARM BIOTECHNO, V13, P210, DOI 10.2174/138920112798868818; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsieh WC, 2013, FUNCT FOODS HEALTH D, V3, P341, DOI 10.31989/ffhd.v3i9.41; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hu HM, 2007, LEUKEMIA, V21, P747, DOI 10.1038/sj.leu.2404583; Huang Q, 2013, CANCER RES, V73, P4992, DOI 10.1158/0008-5472.CAN-13-0308; Jiang Hao, 2009, J Exp Ther Oncol, V8, P25; Joe AK, 2002, CLIN CANCER RES, V8, P893; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977; Pollicino T, 2014, J HEPATOL, V61, P408, DOI 10.1016/j.jhep.2014.04.041; Sankar N, 2008, ONCOGENE, V27, P5717, DOI 10.1038/onc.2008.181; Sitia G, 2012, P NATL ACAD SCI USA, V109, pE2165, DOI 10.1073/pnas.1209182109; Su IJ, 2008, J GASTROEN HEPATOL, V23, P1169, DOI 10.1111/j.1440-1746.2008.05348.x; Su Ih-Jen, 2013, Hepatobiliary Surg Nutr, V2, P37, DOI 10.3978/j.issn.2304-3881.2012.10.08; Teng CF, 2011, HEPATOLOGY, V54, P1199, DOI 10.1002/hep.24529; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; TOSHKOV I, 1994, HEPATOLOGY, V20, P1162, DOI 10.1002/hep.1840200510; Tsai HW, 2011, CANCER-AM CANCER SOC, V117, P2951, DOI 10.1002/cncr.25837; Wang HC, 2005, HEPATOLOGY, V41, P761, DOI 10.1002/hep.20615; Wang HC, 2006, CANCER SCI, V97, P683, DOI 10.1111/j.1349-7006.2006.00235.x; Wu BK, 2006, BIOCHEM BIOPH RES CO, V340, P916, DOI 10.1016/j.bbrc.2005.12.089; Wu HC, 2014, HUM PATHOL, V45, P1294, DOI 10.1016/j.humpath.2013.10.039; Yang JC, 2009, HEPATOLOGY, V49, P1962, DOI 10.1002/hep.22889; Zha XJ, 2011, CELL CYCLE, V10, P1015, DOI 10.4161/cc.10.7.15063; Zhang Qiang, 2011, Critical Reviews in Oncogenesis, V16, P163	37	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122373	10.1371/journal.pone.0122373	http://dx.doi.org/10.1371/journal.pone.0122373			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909713	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800020
J	Welkos, SL; Klimko, CP; Kern, SJ; Bearss, JJ; Bozue, JA; Bernhards, RC; Trevino, SR; Waag, DM; Amemiya, K; Worsham, PL; Cote, CK				Welkos, Susan L.; Klimko, Christopher P.; Kern, Steven J.; Bearss, Jeremy J.; Bozue, Joel A.; Bernhards, Robert C.; Trevino, Sylvia R.; Waag, David M.; Amemiya, Kei; Worsham, Patricia L.; Cote, Christopher K.			Characterization of Burkholderia pseudomallei Strains Using a Murine Intraperitoneal Infection Model and In Vitro Macrophage Assays	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; COLONY MORPHOLOGY; YERSINIA-PESTIS; EXPERIMENTAL MELIOIDOSIS; INTRACELLULAR SURVIVAL; PULMONARY MELIOIDOSIS; VIRULENCE FACTORS; B. THAILANDENSIS; RISK-FACTORS; LIPOPOLYSACCHARIDE	Burkholderia pseudomallei, the etiologic agent of melioidosis, is a gram-negative facultative intracellular bacterium. This bacterium is endemic in Southeast Asia and Northern Australia and can infect humans and animals by several routes. It has also been estimated to present a considerable risk as a potential biothreat agent. There are currently no effective vaccines for B. pseudomallei, and antibiotic treatment can be hampered by nonspecific symptomology, the high incidence of naturally occurring antibiotic resistant strains, and disease chronicity. Accordingly, there is a concerted effort to better characterize B. pseudomallei and its associated disease. Before novel vaccines and therapeutics can be tested in vivo, a well characterized animal model is essential. Previous work has indicated that mice may be a useful animal model. In order to develop standardized animal models of melioidosis, different strains of bacteria must be isolated, propagated, and characterized. Using a murine intraperitoneal (IP) infection model, we tested the virulence of 11 B. pseudomallei strains. The IP route offers a reproducible way to rank virulence that can be readily reproduced by other laboratories. This infection route is also useful in distinguishing significant differences in strain virulence that may be masked by the exquisite susceptibility associated with other routes of infection (e.g., inhalational). Additionally, there were several pathologic lesions observed in mice following IP infection. These included varisized abscesses in the spleen, liver, and haired skin. This model indicated that commonly used laboratory strains of B. pseudomallei (i.e., K96243 and 1026b) were significantly less virulent as compared to more recently acquired clinical isolates. Additionally, we characterized in vitro strain-associated differences in virulence for macrophages and described a potential inverse relationship between virulence in the IP mouse model of some strains and in the macrophage phagocytosis assay. Strains which were more virulent for mice (e.g., HBPU10304a) were often less virulent in the macrophage assays, as determined by several parameters such as intracellular bacterial replication and host cell cytotoxicity.	[Welkos, Susan L.; Klimko, Christopher P.; Bozue, Joel A.; Bernhards, Robert C.; Trevino, Sylvia R.; Waag, David M.; Amemiya, Kei; Worsham, Patricia L.; Cote, Christopher K.] US Army, Med Res Inst Infect Dis, Bacteriol Div, Frederick, MD 21701 USA; [Kern, Steven J.] US Army, Med Res Inst Infect Dis, Div Biostat, Frederick, MD USA; [Bearss, Jeremy J.] US Army, Med Res Inst Infect Dis, Vet Pathol Div, Frederick, MD USA		Cote, CK (corresponding author), US Army, Med Res Inst Infect Dis, Bacteriol Div, Frederick, MD 21701 USA.	christopher.k.cote.civ@mail.mil	Bozue, Joel/AAE-4357-2022; Bozue, Joel/AAE-4363-2022	Bozue, Joel/0000-0001-6959-8176; Bozue, Joel/0000-0001-6959-8176; Bearss, David/0000-0002-4280-5670	Medical Biological Defense Research Program; Defense Threat Reduction Agency (DTRA)	Medical Biological Defense Research Program; Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	This research was funded by the Medical Biological Defense Research Program; Defense Threat Reduction Agency (DTRA). The funders had a role in selecting the bacterial strains which comprised the B. pseudomallei strain panel examined in this work.	Aardema H, 2005, EPIDEMIOL INFECT, V133, P871, DOI 10.1017/S0950268805004103; Allwood EM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00170; Anuntagool N, 2006, AM J TROP MED HYG, V74, P348, DOI 10.4269/ajtmh.2006.74.348; Arjcharoen S, 2007, INFECT IMMUN, V75, P4298, DOI 10.1128/IAI.00285-07; Atkins T, 2002, J MED MICROBIOL, V51, P539, DOI 10.1099/0022-1317-51-7-539; Atkins T, 2002, INFECT IMMUN, V70, P5290, DOI 10.1128/IAI.70.9.5290-5294.2002; Barnes JL, 2005, EMERG INFECT DIS, V11, P638, DOI 10.3201/eid1104.041051; Bozue J, 2011, MICROB PATHOGENESIS, V50, P314, DOI 10.1016/j.micpath.2011.02.005; Breitbach K, 2003, CELL MICROBIOL, V5, P385, DOI 10.1046/j.1462-5822.2003.00277.x; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Burtnick MN, 2010, INFECT IMMUN, V78, P88, DOI 10.1128/IAI.00985-09; Challacombe JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115951; Chantratita N, 2007, J BACTERIOL, V189, P807, DOI 10.1128/JB.01258-06; Chantratita N, 2012, J PROTEOMICS, V75, P1031, DOI 10.1016/j.jprot.2011.10.015; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chieng S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-328; Chin CY, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00085; Chua KL, 2003, INFECT IMMUN, V71, P1622, DOI 10.1128/IAI.71.4.1622-1629.2003; Currie BJ, 2000, T ROY SOC TROP MED H, V94, P301, DOI 10.1016/S0035-9203(00)90333-X; Currie BJ, 2003, EMERG INFECT DIS, V9, P1538, DOI 10.3201/eid0912.020750; Currie BJ, 2003, EUR RESPIR J, V22, P542, DOI 10.1183/09031936.03.00006203; DANCE DAB, 1991, CLIN MICROBIOL REV, V4, P52, DOI 10.1128/CMR.4.1.52-60.1991; Dance DAB, 2000, ACTA TROP, V74, P115, DOI 10.1016/S0001-706X(99)00059-5; Dance D, 2014, INT J ANTIMICROB AG, V43, P310, DOI 10.1016/j.ijantimicag.2014.01.005; DANNENBERG AM, 1958, J EXP MED, V107, P153, DOI 10.1084/jem.107.1.153; Davis KJ, 1997, ARCH PATHOL LAB MED, V121, P865; Doker TJ, 2015, CLIN INFECT DIS, V60, P243, DOI 10.1093/cid/ciu764; Evans E, 1999, J MED MICROBIOL, V48, P825, DOI 10.1099/00222615-48-9-825; Fritz DL, 2000, VET PATHOL, V37, P626, DOI 10.1354/vp.37-6-626; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Gan YH, 2005, J INFECT DIS, V192, P1845, DOI 10.1086/497382; Gee JE, 2014, EMERG INFECT DIS, V20, P682, DOI 10.3201/eid2004.130960; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Hara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006496; Harland DN, 2007, INFECT IMMUN, V75, P4173, DOI 10.1128/IAI.00404-07; Hassan MRA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-302; Haussler S, 2003, INFECT IMMUN, V71, P2970, DOI 10.1128/IAI.71.5.2970-2975.2003; Hoffman M.D., 2011, NO U TURN SAMPLER AD; Hoppe I, 1999, INFECT IMMUN, V67, P2891, DOI 10.1128/IAI.67.6.2891-2900.1999; Jones SM, 2002, J MED MICROBIOL, V51, P1055, DOI 10.1099/0022-1317-51-12-1055; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Kronmann KC, 2009, AM J TROP MED HYG, V80, P182, DOI 10.4269/ajtmh.2009.80.182; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Liu X, 2015, EMERG INFECT DIS, V21, P159, DOI 10.3201/eid2101.140042; Lo TJ, 2009, EMERG INFECT DIS, V15, P1645, DOI 10.3201/eid1510.090246; Manzenyuk I. N., 1999, Antibiotiki i Khimioterapiya, V44, P21; Massey S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04305; Meumann EM, 2012, CLIN INFECT DIS, V54, P362, DOI 10.1093/cid/cir808; Nandi T, 2013, MBIO, V4, DOI 10.1128/mBio.00709-13; Nelson M, 2004, J MED MICROBIOL, V53, P1177, DOI 10.1099/jmm.0.45766-0; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; Nieves W, 2014, CLIN VACCINE IMMUNOL, V21, P747, DOI 10.1128/CVI.00119-14; O'Sullivan BP, 2011, CHEST, V140, P239, DOI 10.1378/chest.10-3336; Parkes JD, 2009, J FELINE MED SURG, V11, P724, DOI 10.1016/j.jfms.2008.09.009; Pegoraro G, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-98; Price EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000725; Pujol C, 2005, P NATL ACAD SCI USA, V102, P12909, DOI 10.1073/pnas.0502849102; Pujol C, 2009, INFECT IMMUN, V77, P2251, DOI 10.1128/IAI.00068-09; Rammaert B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-126; Santanirand P, 1999, INFECT IMMUN, V67, P3593, DOI 10.1128/IAI.67.7.3593-3600.1999; Saonanon P, 2013, OPHTHAL PLAST RECONS, V29, pE81, DOI 10.1097/IOP.0b013e318275b601; Sarkar-Tyson M, 2009, VACCINE, V27, P4447, DOI 10.1016/j.vaccine.2009.05.040; Scott AE, 2014, INFECT IMMUN, V82, P3206, DOI 10.1128/IAI.01847-14; Scott AE, 2013, CLIN VACCINE IMMUNOL, V20, P1041, DOI 10.1128/CVI.00113-13; SHAW D, 1995, FEMS IMMUNOL MED MIC, V11, P99, DOI 10.1016/0928-8244(95)00012-V; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Smith MD, 1997, INFECT IMMUN, V65, P4319, DOI 10.1128/IAI.65.10.4319-4321.1997; Sprague LD, 2004, J VET MED B, V51, P305, DOI 10.1111/j.1439-0450.2004.00797.x; Srilunchang T, 2009, SE ASIAN J TROP MED, V40, P123; Stevens MP, 2003, J BACTERIOL, V185, P4992, DOI 10.1128/JB.185.16.4992-4996.2003; Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x; Suputtamongkol Y, 1999, CLIN INFECT DIS, V29, P408, DOI 10.1086/520223; Tan GYG, 2008, J MED MICROBIOL, V57, P508, DOI 10.1099/jmm.0.47596-0; Tandhavanant S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-303; TARLOW MJ, 1971, P ROY SOC MED, V64, P19, DOI 10.1177/003591577106400111; Team SD, 2013, ATNA C LIB PROBABILI; Team SD, 2014, RSTAN R INTERFACE ST; Titball Richard W, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS111, DOI 10.1016/S0035-9203(08)70026-9; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Tuanyok A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001453; Utaisincharoen P, 2004, CLIN EXP IMMUNOL, V136, P277, DOI 10.1111/j.1365-2249.2004.02445.x; Utaisincharoen P, 2000, CLIN EXP IMMUNOL, V122, P324, DOI 10.1046/j.1365-2249.2000.01386.x; Valade E, 2004, J BACTERIOL, V186, P2288, DOI 10.1128/JB.186.8.2288-2294.2004; Valvano MA, 2005, CURR OPIN MICROBIOL, V8, P99, DOI 10.1016/j.mib.2004.12.002; Van Zandt KE, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00120; Vietri N. J., 2007, MED ASPECTS BIOL WAR, P147; Wand ME, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-11; Warawa JM, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00141; WELKOS SL, 2011, BACILLUS ANTHRACIS A, P179; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wikraiphat C, 2009, FEMS IMMUNOL MED MIC, V56, P253, DOI 10.1111/j.1574-695X.2009.00574.x; WONG KT, 1995, HISTOPATHOLOGY, V26, P51, DOI 10.1111/j.1365-2559.1995.tb00620.x; YABUUCHI E, 1993, MICROBIOL IMMUNOL, V37, P823, DOI 10.1111/j.1348-0421.1993.tb01712.x; Yi EC, 2000, ANALYST, V125, P651, DOI 10.1039/b000368i; Yingst SL, 2014, J MED MICROBIOL, V63, P118, DOI 10.1099/jmm.0.059063-0; Zehnder AM, 2014, EMERG INFECT DIS, V20, P304, DOI 10.3201/eid2002.131314; Zhang BX, 2012, MIL MED, V177, P216, DOI 10.7205/MILMED-D-11-00232	97	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124667	10.1371/journal.pone.0124667	http://dx.doi.org/10.1371/journal.pone.0124667			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909629	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800098
J	Li, X; Peng, MK; Li, Y; Kang, Z; Hao, YH; Sun, H; Gao, LJ; Jiao, ML; Wu, QH; Quan, HD				Li, Xia; Peng, Mingkai; Li, Yuan; Kang, Zheng; Hao, Yanhua; Sun, Hong; Gao, Lijun; Jiao, Mingli; Wu, Qunhong; Quan, Hude			Chinese Herbal Therapy and Western Drug Use, Belief and Adherence for Hypertension Management in the Rural Areas of Heilongjiang Province, China	PLOS ONE			English	Article							ALTERNATIVE MEDICINE USE; RHEUMATIC-DISEASES; BLOOD-PRESSURE; PREVALENCE; KNOWLEDGE; AWARENESS; VALIDITY; EQ-5D	Background Traditional Chinese medicine (TCM) including Chinese herbal therapy has been widely practiced in China. However, little is known about Chinese herbal therapy use for hypertension management, which is one of the most prevalent chronic conditions in China. Thus we described Chinese herbal therapy and western drug users, beliefs, hypertension knowledge, and Chinese herbal and western drug adherence and determinants of Chinese herbal therapy use among patients with hypertension in rural areas of Heilongjiang Province, China. Methodology and Principal Findings This face-to-face cross sectional survey included 665 hypertensive respondents aged 30 years or older in rural areas of Heilongjiang Province, China. Of 665 respondents, 39.7% were male, 27.4% were aged 65 years or older. At the survey, 14.0% reported using Chinese herbal therapy and 71.3% reported using western drug for hypertension management. A majority of patients had low level of treatment adherence (80.6% for the Chinese herbal therapy users and 81.2% for the western drug users). When respondents felt that their blood pressure was under control, 72.0% of the Chinese herbal therapy users and 69.2% of the western drug users sometimes stopped taking their medicine. Hypertensive patients with high education level or better quality of life are more likely use Chinese herbal therapy. Conclusions and Significance Majority of patients diagnosed with hypertension use western drugs to control blood pressure. Chinese herbal therapy use was associated with education level and quality of life.	[Li, Xia; Li, Yuan; Kang, Zheng; Hao, Yanhua; Sun, Hong; Gao, Lijun; Jiao, Mingli; Wu, Qunhong; Quan, Hude] Harbin Med Univ, Sch Publ Hlth, Dept Social Med, Harbin, Peoples R China; [Peng, Mingkai; Quan, Hude] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Li, Xia] Harbin Med Univ, Coll Pharm, Harbin, Peoples R China	Harbin Medical University; University of Calgary; Harbin Medical University	Wu, QH (corresponding author), Harbin Med Univ, Sch Publ Hlth, Dept Social Med, Harbin, Peoples R China.	wuqunhong@163.com	hao, yan/HGB-0465-2022	Quan, Hude/0000-0002-7848-7256	China Medical Board [08-929]; key program National Natural Science Foundation of China [71333003]; Fund of Heilongjiang Province Education Department [12511316]; Heilongjiang Postdoctoral fund [LBH-Z14175]	China Medical Board; key program National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of Heilongjiang Province Education Department; Heilongjiang Postdoctoral fund	This study was funded by China Medical Board grant (Grant No. 08-929), the key program National Natural Science Foundation of China (Grant No. 71333003), Fund of Heilongjiang Province Education Department (Grant No. 12511316) and Heilongjiang Postdoctoral fund (Grant No. LBH-Z14175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, CARDIOVASCULAR DIS R; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Burstein HJ, 1999, NEW ENGL J MED, V340, P1733, DOI 10.1056/NEJM199906033402206; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chou P, 2001, Zhonghua Yi Xue Za Zhi (Taipei), V64, P191; Cunningham CT, 2014, ETHNIC DIS, V24, P276; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Fang YY, 2001, CHINESE J INFORM TRA, V8, P1; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Hilsden RJ, 2011, INFLAMM BOWEL DIS, V17, P655, DOI 10.1002/ibd.21360; Hoeymans N, 2005, QUAL LIFE RES, V14, P655, DOI 10.1007/s11136-004-1214-z; Kim MH, 2005, QUAL LIFE RES, V14, P1401, DOI 10.1007/s11136-004-5681-z; King KM, 2011, J ADV NURS, V67, P2267, DOI 10.1111/j.1365-2648.2011.05679.x; Lam TP, 2001, J EPIDEMIOL COMMUN H, V55, P762, DOI 10.1136/jech.55.10.762; Liao CC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/387164; Luo N, 2003, ANN ACAD MED SINGAP, V32, P685; Ma WJ, 2012, AM J HYPERTENS, V25, P590, DOI 10.1038/ajh.2012.11; Makridakis S, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2014-000048; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Quan H, 2007, CAN J CARDIOL, V23, P635, DOI 10.1016/S0828-282X(07)70225-8; Quan HD, 2008, CAN FAM PHYSICIAN, V54, P1563; Sanne S, 2008, ETHNIC DIS, V18, P42; Shi NN, 2013, J ALTERN COMPLEM MED, V19, P1, DOI 10.1089/acm.2011.0776; Tan Jie, 2008, Zhongguo Zhong Xi Yi Jie He Za Zhi, V28, P897; Verhoef Marja J, 2005, Integr Cancer Ther, V4, P274, DOI 10.1177/1534735405282361; Wang HX, 2008, CHINESE ARCH TRADITI, V26, P338; Wang LD, 2005, COMPREHENSIVE REPORT; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166; Yang TY, 2012, PHYTOTHER RES, V26, P291, DOI 10.1002/ptr.3548; Zhang JJ, 2002, SOC SCI MED, V55, P1795, DOI 10.1016/S0277-9536(01)00311-2; Zhao YK, 2005, CHINESE HLTH SERVICE, P504; Zhong GW, 2011, CHIN J INTEGR MED, V17, P414, DOI 10.1007/s11655-011-0761-6	32	3	5	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123508	10.1371/journal.pone.0123508	http://dx.doi.org/10.1371/journal.pone.0123508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923438	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600050
J	Sahlin, E; Sirotkina, M; Marnerides, A; Iwarsson, E; Papadogiannakis, N				Sahlin, Ellika; Sirotkina, Meeli; Marnerides, Andreas; Iwarsson, Erik; Papadogiannakis, Nikos			Fetal Calcifications Are Associated with Chromosomal Abnormalities	PLOS ONE			English	Article							HEPATIC CALCIFICATIONS; PRENATAL-DIAGNOSIS; LIVER CALCIFICATIONS; HYPERECHOGENICITIES; FOCI	Objective The biological importance of calcifications occasionally noted in fetal tissues (mainly liver) at autopsy or ultrasound is largely unexplored. Previous reports hint at an association to infection, circulatory compromise, malformations or chromosomal abnormalities. To identify factors associated with calcifications, we have performed a case-control study on the largest cohort of fetuses with calcifications described thus far. Methods One-hundred and fifty-one fetuses with calcifications and 302 matched controls were selected from the archives of the Department of Pathology, Karolinska University Hospital. Chromosome analysis by karyotyping or quantitative fluorescence-polymerase chain reaction was performed. Autopsy and placenta reports were scrutinized for presence of malformations and signs of infection. Results Calcifications were mainly located in the liver, but also in heart, bowel, and other tissues. Fetuses with calcifications showed a significantly higher proportion of chromosomal abnormalities than controls; 50% vs. 20%(p<0.001). The most frequent aberrations among cases included trisomy 21 (33%), trisomy 18 (22%), and monosomy X (18%). A similar distribution was seen among controls. When comparing cases and controls with chromosomal abnormalities, the cases had a significantly higher prevalence of malformations (95% vs. 77%, p=0.004). Analyzed the other way around, cases with malformations had a significantly higher proportion of chromosomal abnormalities compared with controls, (66% vs. 31%, p<0.001). Conclusion The presence of fetal calcifications is associated with high risk of chromosomal abnormality in combination with malformations. Identification of a calcification together with a malformation at autopsy more than doubles the probability of detecting a chromosomal abnormality, compared with identification of a malformation only. We propose that identification of a fetal tissue calcification at autopsy, and potentially also at ultrasound examination, should infer special attention towards co-existence of malformations, as this would be a strong indicator for a chromosomal abnormality.	[Sahlin, Ellika; Iwarsson, Erik] Karolinska Univ Hosp, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Sahlin, Ellika; Iwarsson, Erik] Karolinska Univ Hosp, Karolinska Inst, Ctr Mol Med, S-17176 Stockholm, Sweden; [Sirotkina, Meeli; Marnerides, Andreas; Papadogiannakis, Nikos] Karolinska Univ Hosp, Ctr Perinatal Pathol, Huddinge, Sweden; [Sirotkina, Meeli; Marnerides, Andreas; Papadogiannakis, Nikos] Karolinska Univ Hosp, Dept Pathol, Huddinge, Sweden; [Sirotkina, Meeli; Marnerides, Andreas; Papadogiannakis, Nikos] Karolinska Inst, S-14186 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Sahlin, E (corresponding author), Karolinska Univ Hosp, Dept Mol Med & Surg, CMM L8 02, S-17176 Stockholm, Sweden.	ellika.sahlin@ki.se	Iwarsson, Erik/J-4677-2019	Iwarsson, Erik/0000-0002-3827-0263	Department of Pathology, Karolinska University Hospital; Department of Center for Molecular Medicine, Karolinska University Hospital	Department of Pathology, Karolinska University Hospital; Department of Center for Molecular Medicine, Karolinska University Hospital	The authors are grateful for the financial support with grants from the Departments of Pathology and Center for Molecular Medicine, Karolinska University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron R, 1996, ULTRASOUND OBST GYN, V7, P251, DOI 10.1046/j.1469-0705.1996.07040251.x; AVNI EF, 1994, PEDIATR RADIOL, V24, P569, DOI 10.1007/BF02012734; BRONSHTEIN M, 1995, OBSTET GYNECOL, V86, P739, DOI 10.1016/0029-7844(95)00278-Y; Donaghue C, 2003, PRENATAL DIAG, V23, P201, DOI 10.1002/pd.569; HAWASS ND, 1990, PEDIATR RADIOL, V20, P528, DOI 10.1007/BF02011383; Kidron D, 2012, VIRCHOWS ARCH, V460, P399, DOI 10.1007/s00428-012-1214-2; KOGUTT MS, 1991, AM J ROENTGENOL, V156, P634, DOI 10.2214/ajr.156.3.1899768; Koopman E, 1998, PRENATAL DIAG, V18, P339; Kovacs Christopher S, 2011, Curr Osteoporos Rep, V9, P274, DOI 10.1007/s11914-011-0073-0; Mann K, 2004, EUR J HUM GENET, V12, P907, DOI 10.1038/sj.ejhg.5201224; NGUYEN DL, 1986, AM J ROENTGENOL, V147, P596, DOI 10.2214/ajr.147.3.596; Pata O, 2012, J TURK-GER GYNECOL A, V13, P67, DOI 10.5152/jtgga.2011.66; ROBERTS DJ, 1992, HUM PATHOL, V23, P1130, DOI 10.1016/0046-8177(92)90031-W; SATGE D, 1994, PRENATAL DIAG, V14, P303, DOI 10.1002/pd.1970140411; Simchen MJ, 2002, AM J OBSTET GYNECOL, V187, P1617, DOI 10.1067/mob.2002.127899; Slotnick RN, 1996, LANCET, V347, P85, DOI 10.1016/S0140-6736(96)90210-X; STEIN B, 1995, RADIOLOGY, V197, P489, DOI 10.1148/radiology.197.2.7480699; Suzumori N, 2010, CURR MED CHEM, V17, P3431, DOI 10.2174/092986710793176302; Tennstedt C, 2000, PRENATAL DIAG, V20, P287, DOI 10.1002/(SICI)1097-0223(200004)20:4<287::AID-PD802>3.0.CO;2-K; YAMASHITA Y, 1989, ACTA PAEDIATR SCAND, V78, P965, DOI 10.1111/j.1651-2227.1989.tb11187.x	20	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123343	10.1371/journal.pone.0123343	http://dx.doi.org/10.1371/journal.pone.0123343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923652	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600040
J	Thys, A; Vandenberghe, P; Hague, P; Klein, OD; Erneux, C; Vanderwinden, JM				Thys, An; Vandenberghe, Pierre; Hague, Perrine; Klein, Ophir D.; Erneux, Christophe; Vanderwinden, Jean-Marie			Hyperplasia of Interstitial Cells of Cajal in Sprouty Homolog 4 Deficient Mice	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMORS; TYROSINE KINASE KIT; C-KIT; CONSTITUTIVE ACTIVATION; SIGNALING PATHWAYS; GENE-EXPRESSION; SMALL-INTESTINE; ORIGIN; MODEL; MECHANISMS	Gastrointestinal stromal tumors, which are thought to derive from interstitial cells of Cajal or their precursors, often harbor an oncogenic mutation of the KIT receptor tyrosine kinase. Sprouty homolog 4, a known negative regulator of ERK pathway, has been identified in the interstitial cells of Cajal in the Kit(K641E) murine model of gastrointestinal stromal tumors. Sprouty homolog 4 was upregulated both at the mRNA and protein level in these cells, suggesting that Sprouty homolog 4 is downstream of oncogenic KIT activation and potentially engaged in the negative feedback loop of ERK activation in this model. Here, we used Kit(K641E) heterozygous and Sprouty homolog 4 knock out animals to quantify interstitial cells of Cajal in situ, using quantitative immunofluorescence for the receptor tyrosine kinase Kit and for phosphodiesterase 3a (PDE3A). In the antrum of Sprouty homolog 4 knock out mice, hyperplasia of interstitial cells of Cajal was reminiscent of the Kit(K641E) heterozygous mice antrum. Additionally, the density of interstitial cells of Cajal was higher in the colon of adult Sprouty homolog 4 knock out mice than in WT littermates, although hyperplasia seemed more severe in Kit(K641E) heterozygous mice. Functional transit studies also show similarities between Sprouty homolog 4 knock out and Kit(K641E) heterozygous mice, as the total transit time in 9 month old animals was significantly increased in both genotypes compared to WT littermates. We concluded that the lack of Sprouty homolog 4 expression leads to hyperplasia of the interstitial cells of Cajal and is functionally associated with a delayed transit time.	[Thys, An; Vandenberghe, Pierre; Hague, Perrine; Vanderwinden, Jean-Marie] Univ Libre Bruxelles, Fac Med, Neurophysiol Lab, Brussels, Belgium; [Klein, Ophir D.] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Klein, Ophir D.] Univ Calif San Francisco, Program Craniofacial & Mesenchymal Biol, San Francisco, CA 94143 USA; [Klein, Ophir D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Klein, Ophir D.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Erneux, Christophe] Univ Libre Bruxelles, Fac Med, IRIBHM, Brussels, Belgium	Universite Libre de Bruxelles; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universite Libre de Bruxelles	Vanderwinden, JM (corresponding author), Univ Libre Bruxelles, Fac Med, Neurophysiol Lab, Brussels, Belgium.	jmvdwin@ulb.ac.be		Thys, An/0000-0002-6838-312X; Klein, Ophir/0000-0002-6254-7082	Fonds National de la Recherche Scientifique Medicale (Belgium) [7.4552.10, 7.4557.12F]; Fonds National de la Recherche Scientifique Medicale [PDR T.0004.13]; Fondation Rose et Jean Hoguet [2014-20145]	Fonds National de la Recherche Scientifique Medicale (Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds National de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fondation Rose et Jean Hoguet	This work is supported the Fonds National de la Recherche Scientifique Medicale (Belgium) http://www.fnrs.be/, Televie grants no 7.4552.10 and 7.4557.12F to JMV & CE, Fonds National de la Recherche Scientifique Medicale (PDR T.0004.13) to CE and Fondation Rose et Jean Hoguet http://www.fondation-hoguet.be/, fellowship 2014-20145 to AT. The funders had no role in study design, data collection and analys, decision to publish, or preparation of the manuscript.	Ali S, 2007, GENE, V401, P38, DOI 10.1016/j.gene.2007.06.017; Ayada T, 2009, ONCOGENE, V28, P1076, DOI 10.1038/onc.2008.464; Baik SH, 2007, SURG TODAY, V37, P455, DOI 10.1007/s00595-006-3424-1; Bauer S, 2007, ONCOGENE, V26, P7560, DOI 10.1038/sj.onc.1210558; Bellier S, 2005, AM J PHYSIOL-GASTR L, V288, pG151, DOI 10.1152/ajpgi.00048.2004; Beltran Marcelo A, 2007, Int J Surg, V5, P183, DOI 10.1016/j.ijsu.2006.05.006; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Charles C, 2011, DEVELOPMENT, V138, P4063, DOI 10.1242/dev.069195; Chen H, 2007, PHYSIOL GENOMICS, V31, P492, DOI 10.1152/physiolgenomics.00113.2007; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Deneubourg L, 2011, CELL SIGNAL, V23, P1857, DOI 10.1016/j.cellsig.2011.06.023; Druckenbrod NR, 2005, DEV BIOL, V287, P125, DOI 10.1016/j.ydbio.2005.08.040; Frolov A, 2003, MOL CANCER THER, V2, P699; Gromova P, 2009, J CELL MOL MED, V13, P1536, DOI 10.1111/j.1582-4934.2009.00768.x; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hirota S, 2006, PATHOL INT, V56, P1, DOI 10.1111/j.1440-1827.2006.01924.x; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; IEMURA A, 1994, AM J PATHOL, V144, P321; Isozaki K, 2000, AM J PATHOL, V157, P1581, DOI 10.1016/S0002-9440(10)64795-5; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Joensuu H, 2013, LANCET, V382, P973, DOI 10.1016/S0140-6736(13)60106-3; Kitamura Y, 2008, J GASTROENTEROL, V43, P499, DOI 10.1007/s00535-008-2200-y; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Kluppel M, 1998, DEV DYNAM, V211, P60; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Ledda F, 2007, BIOMARK INSIGHTS, V2, P45; Lennartsson J, 2005, STEM CELLS, V23, P16, DOI 10.1634/stemcells.2004-0117; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; Linnekin D, 1999, INT J BIOCHEM CELL B, V31, P1053, DOI 10.1016/S1357-2725(99)00078-3; Lux ML, 2000, AM J PATHOL, V156, P791, DOI 10.1016/S0002-9440(10)64946-2; Manouras A, 2009, ACTA GASTRO-ENT BELG, V72, P257; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; OKA H, 1995, CANCER RES, V55, P4182; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Renouf DJ, 2009, CLIN CANCER RES, V15, P3908, DOI 10.1158/1078-0432.CCR-08-1622; Rios-Moreno MJ, 2011, ANTICANCER RES, V31, P3019; Rubin BP, 2005, CANCER RES, V65, P6631, DOI 10.1158/0008-5472.CAN-05-0891; Rubio MP, 2005, BIOCHEM J, V392, P163, DOI 10.1042/BJ20051103; Rumessen JJ, 2003, INT REV CYTOL, V229, P115, DOI 10.1016/S0074-7696(03)29004-5; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Swaminathan M, 2010, HUM PATHOL, V41, P1097, DOI 10.1016/j.humpath.2009.12.012; Taketomi T, 2005, NAT NEUROSCI, V8, P855, DOI 10.1038/nn1485; Taniguchi K, 2007, BIOCHEM BIOPH RES CO, V352, P896, DOI 10.1016/j.bbrc.2006.11.107; Taniguchi K, 2009, CANCER SCI, V100, P1648, DOI 10.1111/j.1349-7006.2009.01214.x; Thomsen L, 1998, NAT MED, V4, P848, DOI 10.1038/nm0798-848; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Vanderwinden JM, 2000, CELL TISSUE RES, V302, P145, DOI 10.1007/s004410000264; Vanderwinden JM, 2006, CELL SIGNAL, V18, P661, DOI 10.1016/j.cellsig.2005.06.008; Ward SM, 1995, AM J PHYSIOL-CELL PH, V269, pC1577, DOI 10.1152/ajpcell.1995.269.6.C1577; Wu JJ, 2000, J NEUROSCI RES, V59, P384, DOI 10.1002/(SICI)1097-4547(20000201)59:3<384::AID-JNR13>3.0.CO;2-4; Yang J, 2012, INT J CANCER, V130, P959, DOI 10.1002/ijc.26095; Yang Xiaolin, 2013, Evid Based Complement Alternat Med, V2013, P926928, DOI 10.1155/2013/926928; Young HM, 1999, MICROSC RES TECHNIQ, V47, P303, DOI 10.1002/(SICI)1097-0029(19991201)47:5<303::AID-JEMT1>3.0.CO;2-T; Zhang SB, 2001, MECH DEVELOP, V109, P367, DOI 10.1016/S0925-4773(01)00526-3	58	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124861	10.1371/journal.pone.0124861	http://dx.doi.org/10.1371/journal.pone.0124861			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923139	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600107
J	Eiler, JH; Evans, AN; Schreck, CB				Eiler, John H.; Evans, Allison N.; Schreck, Carl B.			Migratory Patterns of Wild Chinook Salmon Oncorhynchus tshawytscha Returning to a Large, Free-Flowing River Basin	PLOS ONE			English	Article							SOCKEYE-SALMON; PACIFIC SALMON; FRASER-RIVER; YUKON RIVER; BEHAVIORAL THERMOREGULATION; BRITISH-COLUMBIA; NERKA SALMON; STEELHEAD; RATES; GORBUSCHA	Upriver movements were determined for Chinook salmon Oncorhynchus tshawytscha returning to the Yukon River, a large, virtually pristine river basin. These returns have declined dramatically since the late 1990s, and information is needed to better manage the run and facilitate conservation efforts. A total of 2,860 fish were radio tagged during 2002-2004. Most (97.5%) of the fish tracked upriver to spawning areas displayed continual upriver movements and strong fidelity to the terminal tributaries entered. Movement rates were substantially slower for fish spawning in lower river tributaries (28-40 km d(-1)) compared to upper basin stocks (52-62 km d(-1)). Three distinct migratory patterns were observed, including a gradual decline, pronounced decline, and substantial increase in movement rate as the fish moved upriver. Stocks destined for the same region exhibited similar migratory patterns. Individual fish within a stock showed substantial variation, but tended to reflect the regional pattern. Differences between consistently faster and slower fish explained 74% of the within-stock variation, whereas relative shifts in sequential movement rates between "hares" (faster fish becoming slower) and "tortoises" (slow but steady fish) explained 22% of the variation. Pulses of fish moving upriver were not cohesive. Fish tagged over a 4-day period took 16 days to pass a site 872 km upriver. Movement rates were substantially faster and the percentage of atypical movements considerably less than reported in more southerly drainages, but may reflect the pristine conditions within the Yukon River, wild origins of the fish, and discrete run timing of the returns. Movement data can provide numerous insights into the status and management of salmon returns, particularly in large river drainages with widely scattered fisheries where management actions in the lower river potentially impact harvests and escapement farther upstream. However, the substantial variation exhibited among individual fish within a stock can complicate these efforts.	[Eiler, John H.] NOAA, Auke Bay Labs, Alaska Fisheries Sci Ctr, Natl Marine Fisheries, Juneau, AK 99801 USA; [Evans, Allison N.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Schreck, Carl B.] Oregon State Univ, US Geol Survey, Oregon Cooperat Fish & Wildlife Res Unit, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University; Oregon State University; United States Department of the Interior; United States Geological Survey	Eiler, JH (corresponding author), NOAA, Auke Bay Labs, Alaska Fisheries Sci Ctr, Natl Marine Fisheries, Juneau, AK 99801 USA.	john.eiler@noaa.gov			National Marine Fisheries Service; Alaska Department of Fish and Game; U.S./Canada Yukon River Treaty Implementation Fund [03NMF4380185]; Alaska Sustainable Salmon Fund Project [45224]	National Marine Fisheries Service; Alaska Department of Fish and Game; U.S./Canada Yukon River Treaty Implementation Fund; Alaska Sustainable Salmon Fund Project	Funding: Funding for this study was provided by the National Marine Fisheries Service and Alaska Department of Fish and Game. Additional support was provided by the U.S./Canada Yukon River Treaty Implementation Fund Grant No. 03NMF4380185, and the Alaska Sustainable Salmon Fund Project No. 45224. Annual study plans were reviewed by the National Marine Fisheries Service (Alaska Fisheries Science Center), Alaska Department of Fish and Game (Division of Commercial Fisheries), and the Joint Technical Committee of the U.S-Canada Yukon River Panel. Editorial review of the paper was provided by the Alaska Fisheries Science Center.	Ahliman DL, 2003, AESOPS FABLES, P113; Aidley DJ, 1981, ANIMAL MIGRATIONS; ARNOLD GP, 1974, BIOL REV, V49, P515, DOI 10.1111/j.1469-185X.1974.tb01173.x; BERMAN CH, 1991, J FISH BIOL, V39, P301, DOI 10.1111/j.1095-8649.1991.tb04364.x; Blem C.R., 1980, P175; Brabets T.P., 2000, USGS WATER RESOURCES; Brett J.R., 1983, P29; Brett J.R., 1995, P3; Bronmark C, 2014, CAN J ZOOL, V92, P467, DOI 10.1139/cjz-2012-0277; BURGER CV, 1985, CAN J FISH AQUAT SCI, V42, P693, DOI 10.1139/f85-089; Connor WP, 2006, T AM FISH SOC, V135, P297, DOI 10.1577/T05-097.1; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; Daum David W., 1998, North American Journal of Fisheries Management, V18, P477, DOI 10.1577/1548-8675(1998)018<0477:UOFLSB>2.0.CO;2; DeCovitch NA, 2011, FISHERY DATA SERIES, V11-65; Dingle H, 1996, MIGRATION BIOL LIFE; Eiler J.H., 1990, American Fisheries Society Symposium, P364; EILER JH, 1995, T AM FISH SOC, V124, P184, DOI 10.1577/1548-8659(1995)124<0184:ARSLTS>2.3.CO;2; EILER JH, 1992, T AM FISH SOC, V121, P701, DOI 10.1577/1548-8659(1992)121<0701:RSBSSI>2.3.CO;2; Eiler JH, 2013, THESIS OREGON STATE; Eiler JH, 2014, T AM FISH SOC, V143, P1476, DOI 10.1080/00028487.2014.959997; Eiler JH, 2012, TELEMETRY TECHNIQUES: A USER GUIDE FOR FISHERIES RESEARCH, P163; Eiler John H., 2000, P138; ENS (Envirnomental News Service), 2010, DIS DECL AL YUK RIV; Farrell AP, 2008, PHYSIOL BIOCHEM ZOOL, V81, P697, DOI 10.1086/592057; Federal Columbia River Power System, 2001, COL RIV SYST INS STO; Flannery BG, 2012, N AM J FISH MANAGE, V32, P720, DOI 10.1080/02755947.2012.686954; Fulton LA, 1968, 571 US FISH WILDL SE, P1; Gilhousen, 1990, INT PAC SALMON FISH, V26, P1; Goniea TM, 2006, T AM FISH SOC, V135, P408, DOI 10.1577/T04-113.1; Hasler A.D., 1971, P429; Healey M.C., 1991, P311; Heard William R., 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P77; Hinch Scott G., 2006, Fish Physiology, V24, P239; Hinch SG, 2002, HYDROBIOLOGIA, V483, P147, DOI 10.1023/A:1021327511881; JTC (Joint Technical Committee of the Yukon River US/Canada Panel), 2012, 3A1201 JTC AL DEP FI; JTC (Joint Technical Committee of the Yukon River US/Canada Panel), 2006, 3A0607 JTC AL DEP FI; JTC (Joint Technical Committee of the Yukon River US/Canada Panel), 2001, 3A0135 JTC AL DEP FI; Karpovich S, 2007, FISHERY DATA SERIES, V07-05; Keefer ML, 2004, T AM FISH SOC, V133, P1413, DOI 10.1577/T03-223.1; Keefer ML, 2004, J FISH BIOL, V65, P1126, DOI 10.1111/j.0022-1112.2004.00522.x; Kocan R, 2006, J FISH DIS, V29, P497, DOI 10.1111/j.1365-2761.2006.00743.x; Kocan R, 2006, J FISH DIS, V29, P521, DOI 10.1111/j.1365-2761.2006.00745.x; Kocan R, 2009, J FISH DIS, V32, P835, DOI 10.1111/j.1365-2761.2009.01059.x; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Leopold L.B., 1992, FLUVIAL PROCESSES GE; Lucas M, 2001, MIGRATION FRESHWATER; Macdonald JS, 2000, 2326 FISH OC CAN; Mather P. M., 1976, COMPUTATIONAL METHOD; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Moritz RE, 2002, SCIENCE, V297, P1497, DOI 10.1126/science.1076522; Myers J, 1998, AM POETRY REV, V27, P27; Northcote T.G., 1978, P326; Peterson EB, 2001, J VEG SCI, V12, P511, DOI 10.2307/3237003; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Quinn TP, 1996, ECOLOGY, V77, P1151, DOI 10.2307/2265584; Quinn TP, 1997, CAN J FISH AQUAT SCI, V54, P1349, DOI 10.1139/f97-038; Rand PS, 1998, CAN J FISH AQUAT SCI, V55, P1832, DOI 10.1139/cjfas-55-8-1832; RAYMOND HL, 1979, T AM FISH SOC, V108, P505, DOI 10.1577/1548-8659(1979)108<505:EODAIO>2.0.CO;2; Reischel TS, 2003, N AM J FISH MANAGE, V23, P1215, DOI 10.1577/M02-113; Schultz KD, 1994, 3A9431 AL DEP FISH G; Spencer TR, 2009, FISHERY DATA SERIES, V09-32; Standen EM, 2002, CAN J FISH AQUAT SCI, V59, P1809, DOI 10.1139/F02-151; Strange JS, 2010, T AM FISH SOC, V139, P1091, DOI 10.1577/T09-171.1; Turchin Peter, 1998; Wedemeyer G.A., 1996, PHYSL FISH INTENSIVE; Westley PAH, 2013, CAN J FISH AQUAT SCI, V70, P735, DOI 10.1139/cjfas-2012-0536; Wydoski R., 1983, P215; Yang DQ, 2009, HYDROL PROCESS, V23, P109, DOI 10.1002/hyp.7216; Yoshiyama Ronald M., 1998, North American Journal of Fisheries Management, V18, P487, DOI 10.1577/1548-8675(1998)018<0487:HAADOC>2.0.CO;2	69	22	22	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123127	10.1371/journal.pone.0123127	http://dx.doi.org/10.1371/journal.pone.0123127			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919286	gold, Green Published			2022-12-27	WOS:000353659400024
J	Jiang, L; Ge, M; Zhao, H; Zhang, TF				Jiang, Lu; Ge, Min; Zhao, Han; Zhang, Tifu			Analysis of Heterosis and Quantitative Trait Loci for Kernel Shape Related Traits Using Triple Testcross Population in Maize	PLOS ONE			English	Article							NITROGEN USE EFFICIENCY; BIOMASS-RELATED TRAITS; GRAIN-YIELD; TEMPERATE MAIZE; GENETIC-BASIS; QTL DETECTION; MAPPING QTLS; MAJOR QTL; COMPONENTS; PHOSPHORUS	Kernel shape related traits (KSRTs) have been shown to have important influences on grain yield. The previous studies that emphasize kernel length (KL) and kernel width (KW) lack a comprehensive evaluation of characters affecting kernel shape. In this study, materials of the basic generations (B73, Mo17, and B73 x Mo17), 82 intermated B73 x Mo17 (IBM) individuals, and the corresponding triple testcross (TTC) populations were used to evaluate heterosis, investigate correlations, and characterize the quantitative trait loci (QTL) for six KSRTs: KL, KW, length to width ratio (LWR), perimeter length (PL), kernel area (KA), and circularity (CS). The results showed that the mid-parent heterosis (MPH) for most of the KSRTs was moderate. The performance of KL, KW, PL, and KA exhibited significant positive correlation with heterozygosity but their Pearson's R values were low. Among KSRTs, the strongest significant correlation was found between PL and KA with R values was up to 0.964. In addition, KW, PL, KA, and CS were shown to be significant positive correlation with 100-kernel weight (HKW). 28 QTLs were detected for KSRTs in which nine were augmented additive, 13 were augmented dominant, and six were dominance x additive epistatic. The contribution of a single QTL to total phenotypic variation ranged from 2.1% to 32.9%. Furthermore, 19 additive x additive digenic epistatic interactions were detected for all KSRTs with the highest total R-2 for KW(78.8%), and nine dominance x dominance digenic epistatic interactions detected for KL, LWR, and CS with the highest total R-2 (55.3%). Among significant digenic interactions, most occurred between genomic regions not mapped with main-effect QTLs. These findings display the complexity of the genetic basis for KSRTs and enhance our understanding on heterosis of KSRTs from the quantitative genetic perspective.	[Jiang, Lu; Ge, Min; Zhao, Han; Zhang, Tifu] Jiangsu Acad Agr Sci, Prov Key Lab Agrobiol, Nanjing, Jiangsu, Peoples R China; [Jiang, Lu] Univ Nottingham, Sch Biosci, Loughborough, Notts, England	Jiangsu Academy of Agricultural Sciences; University of Nottingham	Zhang, TF (corresponding author), Jiangsu Acad Agr Sci, Prov Key Lab Agrobiol, Nanjing, Jiangsu, Peoples R China.	zhangtifu@jaas.ac.cn			NSFC [31301391]; Jiangsu Natural Science Foundation [BK2012375]; Jiangsu Agriculture Science and Technology Innovation Fund [CX(12)5020, CX(14)5055]	NSFC(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Agriculture Science and Technology Innovation Fund	This work was supported by the NSFC (No. 31301391; http://www.nsfc.gov.cn/), Jiangsu Natural Science Foundation (No. BK2012375), and Jiangsu Agriculture Science and Technology Innovation Fund (No. CX(12)5020 and No. CX(14)5055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger DK, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-60; Breseghello F, 2007, FIELD CROP RES, V101, P172, DOI 10.1016/j.fcr.2006.11.008; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; Duvick DN, 1999, CROP SCI, V39, P1622, DOI 10.2135/cropsci1999.3961622x; Duvick DN, 2001, NAT REV GENET, V2, P69, DOI 10.1038/35047587; East EM, 1936, GENETICS, V21, P375; Eghball B, 1999, SOIL SCI SOC AM J, V63, P895, DOI 10.2136/sssaj1999.634895x; Frascaroli E, 2007, GENETICS, V176, P625, DOI 10.1534/genetics.106.064493; GALLAIS A, 1993, AGRONOMIE, V13, P723, DOI 10.1051/agro:19930805; Gassmann AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI 10.1073/pnas.1317179111; Guo TT, 2014, THEOR APPL GENET, V127, P2149, DOI 10.1007/s00122-014-2368-x; Han YP, 2012, THEOR APPL GENET, V125, P671, DOI 10.1007/s00122-012-1859-x; HARBERD NP, 1989, GENETICS, V121, P827; Hirel B, 2001, PLANT PHYSIOL, V125, P1258, DOI 10.1104/pp.125.3.1258; JANSEN RC, 1994, GENETICS, V136, P1447; KEARSEY MJ, 1968, HEREDITY, V23, P403, DOI 10.1038/hdy.1968.52; Kusterer B, 2007, GENETICS, V177, P1839, DOI 10.1534/genetics.107.077628; Kusterer B, 2007, GENETICS, V175, P2009, DOI 10.1534/genetics.106.069005; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Li CH, 2013, EUPHYTICA, V193, P303, DOI 10.1007/s10681-013-0901-7; Li LZ, 2008, GENETICS, V180, P1725, DOI 10.1534/genetics.108.091942; Li LZ, 2013, J GENET, V92, P529, DOI 10.1007/s12041-013-0311-6; Li L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003202; Li M, 2010, PLANT SCI, V178, P454, DOI 10.1016/j.plantsci.2010.02.019; Li YL, 2007, THEOR APPL GENET, V115, P129, DOI 10.1007/s00122-007-0549-6; Li YL, 2009, EUPHYTICA, V169, P273, DOI 10.1007/s10681-009-9966-8; Liu XH, 2010, MAYDICA, V55, P127; Liu Y, 2014, THEOR APPL GENET, V127, P1019, DOI 10.1007/s00122-014-2276-0; Ma XQ, 2007, MOL BREEDING, V20, P41, DOI 10.1007/s11032-006-9071-9; Mansfield BD, 2014, CROP SCI, V54, P157, DOI 10.2135/cropsci2013.04.0252; Melchinger AE, 2007, GENETICS, V177, P1815, DOI 10.1534/genetics.107.077537; Messmer R, 2009, THEOR APPL GENET, V119, P913, DOI 10.1007/s00122-009-1099-x; Peng B, 2013, THEOR APPL GENET, V126, P773, DOI 10.1007/s00122-012-2017-1; Peng B, 2011, THEOR APPL GENET, V122, P1305, DOI 10.1007/s00122-011-1532-9; Qi HH, 2013, THEOR APPL GENET, V126, P369, DOI 10.1007/s00122-012-1985-5; Qiu XJ, 2012, THEOR APPL GENET, V125, P1717, DOI 10.1007/s00122-012-1948-x; Ramya P, 2010, J APPL GENET, V51, P421, DOI 10.1007/BF03208872; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; Revilla P, 1999, CROP SCI, V39, P654, DOI 10.2135/cropsci1999.0011183X003900020007x; Sangoi L., 2001, Ciencia Rural, V31, P159, DOI 10.1590/S0103-84782001000100027; SHULL G.H., 1908, J HERED, V4, P296; Sun XY, 2009, EUPHYTICA, V165, P615, DOI 10.1007/s10681-008-9794-2; Tanabata T, 2012, PLANT PHYSIOL, V160, P1871, DOI 10.1104/pp.112.205120; Tang JH, 2010, THEOR APPL GENET, V120, P333, DOI 10.1007/s00122-009-1213-0; Tao YF, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-162; Tollenaar M, 1999, CROP SCI, V39, P1597, DOI 10.2135/cropsci1999.3961597x; Wan XY, 2008, GENETICS, V179, P2239, DOI 10.1534/genetics.108.089862; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Williams K, 2014, CROP SCI, V54, P98, DOI 10.2135/cropsci2012.10.0609; WINKLER RG, 1994, PLANTA, V193, P341, DOI 10.1007/BF00201811; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Xu Y, 2011, THEOR APPL GENET, V122, P581, DOI 10.1007/s00122-010-1471-x; Yan JB, 2006, EUPHYTICA, V149, P121, DOI 10.1007/s10681-005-9060-9; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang GD, 2013, THEOR APPL GENET, V126, P1545, DOI 10.1007/s00122-013-2072-2; Zhang ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089645	57	22	26	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124779	10.1371/journal.pone.0124779	http://dx.doi.org/10.1371/journal.pone.0124779			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919458	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400061
J	Li, W; Xia, YY; Wang, CZ; Tang, YT; Guo, WY; Li, JL; Zhao, X; Sun, YP; Hu, J; Zhen, HF; Zhang, XD; Chen, C; Shi, YJ; Li, L; Cao, HZ; Du, HL; Li, J				Li, Wei; Xia, Yingying; Wang, Chongzhi; Tang, Y. Tom; Guo, Wenying; Li, Jinliang; Zhao, Xia; Sun, Yepeng; Hu, Juan; Zhen, Hefu; Zhang, Xiandong; Chen, Chao; Shi, Yujian; Li, Lin; Cao, Hongzhi; Du, Hongli; Li, Jian			Identifying Human Genome-Wide CNV, LOH and UPD by Targeted Sequencing of Selected Regions	PLOS ONE			English	Article							COPY-NUMBER VARIATION; STRUCTURAL VARIATION; HETEROZYGOSITY; VARIANTS; MICROARRAY; DISCOVERY; DISEASE; FORMAT; BIAS	Copy-number variations (CNV), loss of heterozygosity (LOH), and uniparental disomy (UPD) are large genomic aberrations leading to many common inherited diseases, cancers, and other complex diseases. An integrated tool to identify these aberrations is essential in understanding diseases and in designing clinical interventions. Previous discovery methods based on whole-genome sequencing (WGS) require very high depth of coverage on the whole genome scale, and are cost-wise inefficient. Another approach, whole exome genome sequencing (WEGS), is limited to discovering variations within exons. Thus, we are lacking efficient methods to detect genomic aberrations on the whole genome scale using next-generation sequencing technology. Here we present a method to identify genome-wide CNV, LOH and UPD for the human genome via selectively sequencing a small portion of genome termed Selected Target Regions (SeTRs). In our experiments, the SeTRs are covered by 99.73%similar to 99.95% with sufficient depth. Our developed bioinformatics pipeline calls genome-wide CNVs with high confidence, revealing 8 credible events of LOH and 3 UPD events larger than 5M from 15 individual samples. We demonstrate that genome-wide CNV, LOH and UPD can be detected using a cost-effective SeTRs sequencing approach, and that LOH and UPD can be identified using just a sample grouping technique, without using a matched sample or familial information.	[Du, Hongli] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510641, Guangdong, Peoples R China; [Li, Wei; Xia, Yingying; Wang, Chongzhi; Tang, Y. Tom; Li, Jinliang; Zhao, Xia; Sun, Yepeng; Hu, Juan; Zhen, Hefu; Zhang, Xiandong; Chen, Chao; Shi, Yujian; Li, Lin; Cao, Hongzhi; Li, Jian] BGI Shenzhen, Shenzhen, Peoples R China; [Guo, Wenying] Weifang Hosp Tradit Chinese Med, Weifang, Shandong, Peoples R China; [Tang, Y. Tom] Complete Genom Inc, Mountain View, CA 94043 USA; [Xia, Yingying] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Cao, Hongzhi; Li, Jian] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	South China University of Technology; Beijing Genomics Institute (BGI); Sun Yat Sen University; University of Copenhagen	Du, HL (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510641, Guangdong, Peoples R China.	hldu@scut.edu.cn; lijian@genomics.cn		Wang, Chongzhi/0000-0003-1494-2552				Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Chen HIH, 2008, BIOINFORMATICS, V24, P1749, DOI 10.1093/bioinformatics/btn321; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Choi CH, 2007, CANCER LETT, V255, P26, DOI 10.1016/j.canlet.2007.03.015; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Coin LJM, 2012, BIOINFORMATICS, V28, pI370, DOI 10.1093/bioinformatics/bts379; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Dalca AV, 2010, BRIEF BIOINFORM, V11, P3, DOI 10.1093/bib/bbp058; Deng FY, 2010, OSTEOPOROSIS INT, V21, P579, DOI 10.1007/s00198-009-0998-7; Fitzgerald TW, 2011, BIOINFORMATICS, V27, P1195, DOI 10.1093/bioinformatics/btr107; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Jankowska AM, 2009, BLOOD, V113, P6403, DOI 10.1182/blood-2009-02-205690; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146; Li XC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085096; Magi A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r120; Marioni JC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r228; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Miller CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016327; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Mount David W, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.top17; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Parla JS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r97; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Rancoita PMV, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-321; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Ruffalo M, 2011, BIOINFORMATICS, V27, P2790, DOI 10.1093/bioinformatics/btr477; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Teo SM, 2012, BIOINFORMATICS, V28, P2711, DOI 10.1093/bioinformatics/bts535; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; van Heesch S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r33; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zhang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054236, DOI 10.1371/J0URNAL.P0NE.0054236]	45	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123081	10.1371/journal.pone.0123081	http://dx.doi.org/10.1371/journal.pone.0123081			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919136	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400023
J	Singhal, N; Srivastava, A; Kumar, M; Virdi, JS				Singhal, Neelja; Srivastava, Abhishikha; Kumar, Manish; Virdi, Jugsharan Singh			Structural Variabilities in beta-Lactamase (blaA) of Different Biovars of Yersinia enterocolitica: Implications for beta-Lactam Antibiotic and beta-Lactamase Inhibitor Susceptibilities	PLOS ONE			English	Article								Yersiniosis caused by Yersinia enterocolitica has been reported from all continents. The bacterial species is divided into more than fifty serovars and six biovars viz. 1A, 1B, 2, 3, 4 and 5 which differ in geographical distribution, ecological niches and pathogenicity. Most Y. enterocolitica strains harbor chromosomal genes for two beta-lactamases, blaA an Ambler class A penicillinase and blaB an Ambler class C inducible cephalosporinase. In the present study, susceptibility to b-lactam antibiotics and beta-lactamase inhibitor was studied for Y. enterocolitica strains of biovars 1A, 1B, 2 and 4. We observed that beta-lactamases were expressed differentially among strains of different biovars. To understand the molecular mechanisms underlying such differential expression, the sequences of genes and promoters of blaA were compared. Also, the variants of blaA present in different biovars were modeled and docked with amoxicillin and clavulanic acid. The mRNA secondary structures of blaA variants were also predicted in-silico. Our findings indicated that neither variations in the promoter regions, nor the secondary structures of mRNA contributed to higher/lower expression of blaA in different biovars. Analysis of H-bonding residues of blaA variants with amoxicillin and clavulanic acid revealed that if amino acid residues of a beta-lactamase interacting with amoxicillin and the clavulanic acid were similar, clavulanic acid was effective in engaging the enzyme, accounting for a significant reduction in MIC of amoxicillin-clavulanate. This finding might aid in designing better beta-lactamase inhibitors with improved efficiencies in future.	[Singhal, Neelja; Virdi, Jugsharan Singh] Univ Delhi, Dept Microbiol, New Delhi, India; [Srivastava, Abhishikha; Kumar, Manish] Univ Delhi, Dept Biophys, New Delhi, India	University of Delhi; University of Delhi	Virdi, JS (corresponding author), Univ Delhi, Dept Microbiol, South Campus,Benito Juarez Rd, New Delhi, India.	virdi_dusc@rediffmail.com	Singhal, Neelja/AAD-2505-2022; Kumar, Manish/AGP-1250-2022; Virdi, Jugsharan Singh/L-8241-2015	Kumar, Manish/0000-0002-7936-9892; Virdi, Jugsharan Singh/0000-0002-6282-0018	UGC; Indian Council of Medical Research [AMR/17/2011-ECD-1]; DU-DST-PURSE grant; UGC-Special Assistance Programme (DRS-I)	UGC(University Grants Commission, India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); DU-DST-PURSE grant; UGC-Special Assistance Programme (DRS-I)	Funding: Neelja Singhal is supported by UGC-Dr. D. S. Kothari Postdoctoral Fellowship. Abhishikha Srivastava was supported by Indian Council of Medical Research grant (Grant no. AMR/17/2011-ECD-1). The project was supported by Indian Council of Medical Research grant (Grant no. AMR/17/2011-ECD-1), DU-DST-PURSE grant and the UGC-Special Assistance Programme (DRS-I) to the Department of Microbiology, University of Delhi South Campus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner A, 2007, INT J FOOD MICROBIOL, V115, P110, DOI 10.1016/j.ijfoodmicro.2006.10.008; Bent ZW, 2010, ANTIMICROB AGENTS CH, V54, P4000, DOI 10.1128/AAC.01754-09; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; Bradford Patricia A., 2001, Curr Infect Dis Rep, V3, P13, DOI 10.1007/s11908-001-0054-z; Clinical and Laboratory Standards Institute, 2010, M100S20 CLINLAB STAN; Dhara L, 2014, INT J ANTIMICROB AG, V43, P518, DOI 10.1016/j.ijantimicag.2014.03.002; Fournier B, 1999, ANTIMICROB AGENTS CH, V43, P850, DOI 10.1128/AAC.43.4.850; Kumar KM, 2014, J BIOMOL STRUCT DYN, V32, P1953, DOI 10.1080/07391102.2013.847804; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lill MA, 2011, J COMPUT AID MOL DES, V25, P13, DOI 10.1007/s10822-010-9395-8; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Neelja Singhal, 2014, Scientific Reports, V4, P05270; PHAM JN, 1991, J ANTIMICROB CHEMOTH, V28, P19, DOI 10.1093/jac/28.1.19; Sarovich Derek S, 2012, Infect Drug Resist, V5, P129, DOI 10.2147/IDR.S35529; Sharma S, 2006, FEMS MICROBIOL LETT, V257, P319, DOI 10.1111/j.1574-6968.2006.00191.x; Yi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037585	16	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123564	10.1371/journal.pone.0123564	http://dx.doi.org/10.1371/journal.pone.0123564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919756	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400030
J	Zou, D; Liu, P; Chen, K; Xie, Q; Liang, XY; Bai, Q; Zhou, QC; Liu, K; Zhang, T; Zhu, JD; Mi, MT				Zou, Dan; Liu, Peng; Chen, Ka; Xie, Qi; Liang, Xinyu; Bai, Qian; Zhou, Qicheng; Liu, Kai; Zhang, Ting; Zhu, Jundong; Mi, Mantian			Protective Effects of Myricetin on Acute Hypoxia-Induced Exercise Intolerance and Mitochondrial Impairments in Rats	PLOS ONE			English	Article							SKELETAL-MUSCLE; ENERGY-METABOLISM; OXIDATIVE STRESS; PGC-1-ALPHA; PERFORMANCE; DYSFUNCTION; BIOGENESIS; SIRT1; COACTIVATORS; EXPRESSION	Purpose Exercise tolerance is impaired in hypoxia. The aim of this study was to evaluate the effects of myricetin, a dietary flavonoid compound widely found in fruits and vegetables, on acute hypoxia-induced exercise intolerance in vivo and in vitro. Methods Male rats were administered myricetin or vehicle for 7 days and subsequently spent 24 hours at a barometric pressure equivalent to 5000 m. Exercise capacity was then assessed through the run-to-fatigue procedure, and mitochondrial morphology in skeletal muscle cells was observed by transmission electron microscopy (TEM). The enzymatic activities of electron transfer complexes were analyzed using an enzyme-linked immuno-sorbent assay (ELISA). mtDNA was quantified by real-time-PCR. Mitochondrial membrane potential was measured by JC-1 staining. Protein expression was detected through western blotting, immunohistochemistry, and immunofluorescence. Results Myricetin supplementation significantly prevented the decline of run-to-fatigue time of rats in hypoxia, and attenuated acute hypoxia-induced mitochondrial impairment in skeletal muscle cells in vivo and in vitro by maintaining mitochondrial structure, mtDNA content, mitochondrial membrane potential, and activities of the respiratory chain complexes. Further studies showed that myricetin maintained mitochondrial biogenesis in skeletal muscle cells under hypoxic conditions by up-regulating the expressions of mitochondrial biogenesis-related regluators, in addition, AMP-activated protein kinase(AMPK) plays a crucial role in this process. Conclusions Myricetin may have important applications for improving physical performance under hypoxic environment, which may be attributed to the protective effect against mitochondrial impairment by maintaining mitochondrial biogenesis.	[Zou, Dan; Liu, Peng; Chen, Ka; Xie, Qi; Liang, Xinyu; Bai, Qian; Zhou, Qicheng; Liu, Kai; Zhang, Ting; Zhu, Jundong; Mi, Mantian] Third Mil Med Univ, Chongqing Med Nutr Res Ctr, Chongqing Key Lab Nutr & Food Safety, Res Ctr Nutr & Food Safety,Inst Mil Prevent Med, Chongqing, Peoples R China	Army Medical University	Zhu, JD (corresponding author), Third Mil Med Univ, Chongqing Med Nutr Res Ctr, Chongqing Key Lab Nutr & Food Safety, Res Ctr Nutr & Food Safety,Inst Mil Prevent Med, Chongqing, Peoples R China.	zjdnfs@126.com; mimantian@sina.cn			key projects of the "Twelfth Five-Year Plan" for Medical Science Development of People's Liberation Army, China [BWS12J034]	key projects of the "Twelfth Five-Year Plan" for Medical Science Development of People's Liberation Army, China	This work was funded by research grants from the key projects of the "Twelfth Five-Year Plan" for Medical Science Development of People's Liberation Army, China (BWS12J034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat R, 2009, J BIOL CHEM, V284, P21872, DOI 10.1074/jbc.M109.022749; Burtscher M, 2006, INT J SPORTS MED, V27, P629, DOI 10.1055/s-2005-872823; Calbet JAL, 2003, AM J PHYSIOL-REG I, V284, pR291, DOI 10.1152/ajpregu.00155.2002; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen K, 2009, BRAIN RES, V1279, P131, DOI 10.1016/j.brainres.2009.04.054; Davis JM, 2009, AM J PHYSIOL-REG I, V296, pR1071, DOI 10.1152/ajpregu.90925.2008; DeLellis SM, 2013, CURR SPORT MED REP, V12, P110, DOI 10.1249/JSR.0b013e3182874d0f; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fulco CS, 1998, AVIAT SPACE ENVIR MD, V69, P793; Garnier A, 2005, FASEB J, V19, P43, DOI 10.1096/fj.04-2173com; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gomes AP, 2012, BBA-MOL BASIS DIS, V1822, P185, DOI 10.1016/j.bbadis.2011.10.008; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hensel M, 1997, INT J MICROCIRC, V17, P67, DOI 10.1159/000179209; Herzig RP, 2000, J BIOL CHEM, V275, P13134, DOI 10.1074/jbc.275.17.13134; Huang JH, 2010, TOXICOL IN VITRO, V24, P21, DOI 10.1016/j.tiv.2009.09.015; Jacobs RA, 2013, J APPL PHYSIOL, V115, P785, DOI 10.1152/japplphysiol.00445.2013; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Li B, 1999, J BIOL CHEM, V274, P17534, DOI 10.1074/jbc.274.25.17534; Lin Tsu-Kung, 2009, Chang Gung Med J, V32, P589; Magalhaes J, 2007, CLIN SCI, V113, P459, DOI 10.1042/CS20070075; Magalhaes J, 2005, J APPL PHYSIOL, V99, P1247, DOI 10.1152/japplphysiol.01324.2004; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nieman DC, 2010, MED SCI SPORT EXER, V42, P338, DOI 10.1249/MSS.0b013e3181b18fa3; Nouette-Gaulain K, 2005, CARDIOVASC RES, V66, P132, DOI 10.1016/j.cardiores.2004.12.023; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pandey KB, 2009, NAT PROD COMMUN, V4, P221; Panickar KS, 2011, NEUROSCIENCE, V183, P1, DOI 10.1016/j.neuroscience.2011.03.064; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rasbach KA, 2008, J PHARMACOL EXP THER, V325, P536, DOI 10.1124/jpet.107.134882; Rasbach KA, 2007, BIOCHEM BIOPH RES CO, V355, P734, DOI 10.1016/j.bbrc.2007.02.023; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; Scicchitano BM, 2005, MOL BIOL CELL, V16, P3632, DOI 10.1091/mbc.E05-01-0055; Shaw JM, 2009, EMBO REP, V10, P1301, DOI 10.1038/embor.2009.247; Wang ZH, 2010, ENVIRON TOXICOL PHAR, V29, P12, DOI 10.1016/j.etap.2009.08.007; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	44	13	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124727	10.1371/journal.pone.0124727	http://dx.doi.org/10.1371/journal.pone.0124727			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919288	Green Published, gold			2022-12-27	WOS:000353659400058
J	Cheng, SJ; Swanson, K; Eliaz, I; McClintick, JN; Sandusky, GE; Sliva, D				Cheng, Shujie; Swanson, Kristen; Eliaz, Isaac; McClintick, Jeanette N.; Sandusky, George E.; Sliva, Daniel			Pachymic Acid Inhibits Growth and Induces Apoptosis of Pancreatic Cancer In Vitro and In Vivo by Targeting ER Stress	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; UNFOLDED PROTEIN RESPONSE; PORIA-COCOS; MEDIATED APOPTOSIS; GENE-EXPRESSION; POLY(ADP-RIBOSE) POLYMERASE; ANTICANCER STRATEGY; PROTEOTOXIC STRESS; PROSTATE-CANCER; CELL-DEATH	Pachymic acid (PA) is a purified triterpene extracted from medicinal fungus Poria cocos. In this paper, we investigated the anticancer effect of PA on human chemotherapy resistant pancreatic cancer. PA triggered apoptosis in gemcitabine-resistant pancreatic cancer cells PANC-1 and MIA PaCa-2. Comparative gene expression array analysis demonstrated that endoplasmic reticulum (ER) stress was induced by PA through activation of heat shock response and unfolded protein response related genes. Induced ER stress was confirmed by increasing expression of XBP-1s, ATF4, Hsp70, CHOP and phospho-eIF2 alpha. Moreover, ER stress inhibitor tauroursodeoxycholic acid (TUDCA) blocked PA induced apoptosis. In addition, 25 mg kg(-1) of PA significantly suppressed MIA PaCa-2 tumor growth in vivo without toxicity, which correlated with induction of apoptosis and expression of ER stress related proteins in tumor tissues. Taken together, growth inhibition and induction of apoptosis by PA in gemcitabine-resistant pancreatic cancer cells were associated with ER stress activation both in vitro and in vivo. PA may be potentially exploited for the use in treatment of chemotherapy resistant pancreatic cancer.	[Cheng, Shujie; Swanson, Kristen; Sliva, Daniel] Indiana Univ Hlth, Methodist Res Inst, Canc Res Lab, Indianapolis, IN 46202 USA; [Eliaz, Isaac] Amitabha Med Clin & Healing Ctr, Santa Rosa, CA USA; [McClintick, Jeanette N.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46204 USA; [Sandusky, George E.] Indiana Univ, Sch Med, Dept Pathol, Indianapolis, IN 46204 USA; [Sliva, Daniel] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46204 USA; [Sliva, Daniel] DSTest Labs, Indianapolis, IN USA	Indiana University System; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Sliva, D (corresponding author), Indiana Univ Hlth, Methodist Res Inst, Canc Res Lab, Indianapolis, IN 46202 USA.	dsliva@dstest-lab.com		Eliaz, Isaac/0000-0002-7935-2038	China Scholarship Council; EcoNugenics, Inc., Santa Rosa, CA, USA; Indiana Genomics Initiative at Indiana University (INGEN); Econugenics, Inc.; Lilly Endowment, Inc.	China Scholarship Council(China Scholarship Council); EcoNugenics, Inc., Santa Rosa, CA, USA; Indiana Genomics Initiative at Indiana University (INGEN); Econugenics, Inc.; Lilly Endowment, Inc.	This study was supported by research grants from China Scholarship Council and EcoNugenics, Inc., Santa Rosa, CA, USA. The Center for Medical Genomics is supported in part by the Indiana Genomics Initiative at Indiana University (INGEN, which is supported in part by the Lilly Endowment, Inc.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder, Econugenics, Inc., provided support in the form of salary for Dr. Isaac Eliaz, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Alosi JA, 2010, J SURG RES, V161, P195, DOI 10.1016/j.jss.2009.07.027; Boelens J, 2007, IN VIVO, V21, P215; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Cheng SJ, 2013, INT J ONCOL, V42, P1869, DOI 10.3892/ijo.2013.1902; Denmeade SR, 2005, CANCER BIOL THER, V4, P14; Gajate C, 2012, ONCOGENE, V31, P2627, DOI 10.1038/onc.2011.446; Gapter L, 2005, BIOCHEM BIOPH RES CO, V332, P1153, DOI 10.1016/j.bbrc.2005.05.044; Gorman AM, 2012, PHARMACOL THERAPEUT, V134, P306, DOI 10.1016/j.pharmthera.2012.02.003; Grant S, 2011, ONCOTARGET, V2, P284; Gungor C, 2014, BRIT J PHARMACOL, V171, P849, DOI 10.1111/bph.12401; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hering J, 2007, ANN SURG ONCOL, V14, P3620, DOI 10.1245/s10434-007-9556-8; Hong R, 2012, ASIAN PAC J CANCER P, V13, P1877, DOI 10.7314/APJCP.2012.13.5.1877; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jiang JH, 2004, NUTR CANCER, V49, P209, DOI 10.1207/s15327914nc4902_13; Kandala PK, 2012, ONCOTARGET, V3, P435; Kim DG, 2002, J BIOL CHEM, V277, P38930, DOI 10.1074/jbc.M205941200; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; KLIMSTRA DS, 1992, AM J SURG PATHOL, V16, P815, DOI 10.1097/00000478-199209000-00001; Lee SM, 2012, J ETHNOPHARMACOL, V141, P368, DOI 10.1016/j.jep.2012.02.048; Lei P, 2008, MOL CANCER THER, V7, P3363, DOI 10.1158/1535-7163.MCT-08-0439; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li JJ, 2012, ONCOL REP, V28, P501, DOI 10.3892/or.2012.1827; Ling H, 2011, BREAST CANCER RES TR, V126, P609, DOI 10.1007/s10549-010-0929-5; Ling H, 2010, MOL CARCINOGEN, V49, P271, DOI 10.1002/mc.20597; Ling Y, 2012, BIOMED CHROMATOGR, V26, P1109, DOI 10.1002/bmc.1756; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logue SE, 2013, APOPTOSIS, V18, P537, DOI 10.1007/s10495-013-0818-6; Lust S, 2009, ANTICANCER RES, V29, P3797; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; Malo A, 2010, AM J PHYSIOL-GASTR L, V299, pG877, DOI 10.1152/ajpgi.00423.2009; Mujumdar N, 2014, AM J PHYSIOL-GASTR L, V306, pG1011, DOI 10.1152/ajpgi.00466.2013; Nawrocki ST, 2005, CANCER RES, V65, P11658, DOI 10.1158/0008-5472.CAN-05-2370; Neznanov N, 2011, ONCOTARGET, V2, P209, DOI 10.18632/oncotarget.246; O'Reilly EM, 2007, SEMIN ONCOL, V34, P347, DOI 10.1053/j.seminoncol.2007.05.009; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Pan X, 2008, CLIN CANCER RES, V14, P8143, DOI 10.1158/1078-0432.CCR-08-1539; Rios JL, 2011, PLANTA MED, V77, P681, DOI 10.1055/s-0030-1270823; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Searle JS, 2010, ONCOTARGET, V1, P228; Sekiya N, 2003, PHYTOTHER RES, V17, P160, DOI 10.1002/ptr.1097; Siegelin MD, 2012, EXPERT OPIN THER TAR, V16, P801, DOI 10.1517/14728222.2012.703655; SKARDA JS, 1994, DIAGN CYTOPATHOL, V10, P20, DOI 10.1002/dc.2840100106; Sood R, 2000, BIOCHEM J, V346, P281, DOI 10.1042/0264-6021:3460281; Suzuki T, 2007, ARCH BIOCHEM BIOPHYS, V468, P1, DOI 10.1016/j.abb.2007.09.004; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Workman P, 2011, ONCOTARGET, V2, P277; Xu LY, 2012, MOL CANCER THER, V11, P2174, DOI 10.1158/1535-7163.MCT-12-0602; Yang Y, 2014, J MOL CELL CARDIOL, V67, P103, DOI 10.1016/j.yjmcc.2013.12.018; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Youns M, 2009, BIOCHEM PHARMACOL, V78, P273, DOI 10.1016/j.bcp.2009.04.014; Zhang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040433; Zhao YY, 2012, J ETHNOPHARMACOL, V144, P775, DOI 10.1016/j.jep.2012.09.033; Zhou L, 2008, CHEM PHARM BULL, V56, P1459, DOI 10.1248/cpb.56.1459; Zhu WB, 2012, PANCREAS, V41, P1029, DOI 10.1097/MPA.0b013e31824abdc0	65	33	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0122270	10.1371/journal.pone.0122270	http://dx.doi.org/10.1371/journal.pone.0122270			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915041	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100007
J	Gale, CR; Eadie, E; Thomas, A; Bastin, ME; Starr, JM; Wardlaw, J; Deary, IJ				Gale, Catharine R.; Eadie, Elizabeth; Thomas, Avril; Bastin, Mark E.; Starr, John M.; Wardlaw, Joanna; Deary, Ian J.			Intelligence in Childhood and Atherosclerosis of the Carotid and Peripheral Arteries in Later Life: The Lothian Birth Cohort 1936	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INTIMA-MEDIA THICKNESS; MIDDLE-AGE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; PREMATURE MORTALITY; VIETNAM EXPERIENCE; ABERDEEN CHILDREN; EARLY ADULTHOOD; MENTAL-ABILITY	Objective There is some evidence that people who score higher on tests of intelligence in childhood have lower carotid intima-media thickness and higher ankle brachial index in middle age. These findings need replicating in other, older populations. We investigated the prospective relationship between intelligence in childhood and atherosclerosis in the carotid and peripheral arteries at age 73 years. Methods Participants were 713 members of the Lothian Birth Cohort 1936 whose intelligence was assessed at age 11 years. At age 73 years, carotid intima-media thickness and degree of stenosis were measured using ultrasound imaging; ankle-brachial index was measured using Doppler ultrasound. Results There were no significant associations between intelligence at age 11 and measures of atherosclerosis at age 73. In age-and sex-adjusted analyses, for a standard deviation higher score in intelligence, intima-media thickness (x 10) was lower by 0.07 (-0.20, 0.06) mm and ankle brachial index (x 10) was lower by 0.09 (-0.24, 0.07); odds ratios for having carotid stenosis >25% or peripheral arterial disease were 0.98 (0.82, 1.16) and 1.05 (0.81, 1.36) respectively. Conclusion In this study of people aged 73 years, higher childhood intelligence was not associated with reduced risk of atherosclerosis in the carotid or peripheral arteries.	[Gale, Catharine R.; Bastin, Mark E.; Starr, John M.; Wardlaw, Joanna; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Gale, Catharine R.] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England; [Eadie, Elizabeth; Thomas, Avril; Bastin, Mark E.; Wardlaw, Joanna] Univ Edinburgh, Western Gen Hosp, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Starr, John M.] Univ Edinburgh, Western Gen Hosp, Geriatr Med Unit, Edinburgh, Midlothian, Scotland; [Eadie, Elizabeth; Thomas, Avril] Western Gen Hosp, Dept Neuroradiol, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Southampton; University of Edinburgh; University of Edinburgh; University of Edinburgh	Gale, CR (corresponding author), Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.	crg@mrc.soton.ac.uk	Hernandez, María/GYU-3543-2022; Wardlaw, Joanna M/Y-3456-2019; Deary, Ian J/C-6297-2009	Wardlaw, Joanna M/0000-0002-9812-6642; Deary, Ian J/0000-0002-1733-263X; Bastin, Mark/0000-0002-0490-0845; Gale, Catharine/0000-0002-3361-8638	Research Into Ageing [251]; Lifelong Health and Wellbeing Initiative [MR/K026992/1]; Scottish Funding Council SINAPSE Collaboration (Scottish Imaging Network, A Platform for Scientific Excellence); MRC [G1001245, G0700704, MC_UU_12011/2, MC_UP_A620_1015, G0701120] Funding Source: UKRI; Medical Research Council [MC_UU_12011/2, G0700704, MC_UP_A620_1015, MR/K026992/1, G1001245, U1475000002, G0701120] Funding Source: researchfish	Research Into Ageing; Lifelong Health and Wellbeing Initiative; Scottish Funding Council SINAPSE Collaboration (Scottish Imaging Network, A Platform for Scientific Excellence); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by the following: Research Into Ageing, grant number 251 (IJD, JMS); Lifelong Health and Wellbeing Initiative, grant number MR/K026992/1 (IJD); and Scottish Funding Council SINAPSE Collaboration (Scottish Imaging Network, A Platform for Scientific Excellence), no grant number (JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov AV, 2005, INTRO VASCULAR SONOG, P107; Ariansen I, 2014, J EPIDEMIOL COMMUNIT; Batty GD, 2008, EUR J CARDIOV PREV R, V15, P359, DOI 10.1097/HJR.0b013e3282f738a6; Batty GD, 2007, J EPIDEMIOL COMMUN H, V61, P997, DOI 10.1136/jech.2006.054494; Batty GD, 2007, J EPIDEMIOL COMMUN H, V61, P241, DOI 10.1136/jech.2006.048215; Batty GD, 2009, EPIDEMIOLOGY, V20, P100, DOI 10.1097/EDE.0b013e31818ba076; Batty GD, 2005, PAEDIATR PERINAT EP, V19, P452, DOI 10.1111/j.1365-3016.2005.00671.x; Calvin CM, 2011, HEALTH PSYCHOL, V30, P710, DOI 10.1037/a0023940; Calvin CM, 2011, INT J EPIDEMIOL, V40, P626, DOI 10.1093/ije/dyq190; Deary I.J., 2009, LIFETIME INTELLIGENC; Deary IJ, 2012, INT J EPIDEMIOL, V41, P1576, DOI 10.1093/ije/dyr197; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Den Ruijter HM, 2012, JAMA-J AM MED ASSOC, V308, P796, DOI 10.1001/jama.2012.9630; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Gale CR, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.109835; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Graner M, 2006, AM J CARDIOL, V97, P624, DOI 10.1016/j.amjcard.2005.09.098; Haller C, 2007, ATHEROSCLEROSIS, V195, pE203, DOI 10.1016/j.atherosclerosis.2007.07.017; Hart CL, 2004, SOC SCI MED, V59, P2131, DOI 10.1016/j.socscimed.2004.03.016; Hemmingsson T, 2007, SOC SCI MED, V65, P1410, DOI 10.1016/j.socscimed.2007.05.006; Kajantie E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046841; Lawlor DA, 2008, EUR J EPIDEMIOL, V23, P695, DOI 10.1007/s10654-008-9281-z; Office of Population Censuses and Surveys, 1980, CLASS OCC 1980; Roberts BA, 2013, ATHEROSCLEROSIS, V231, P234, DOI 10.1016/j.atherosclerosis.2013.09.018; Schmidt M, 2013, EPIDEMIOLOGY, V24, P632, DOI 10.1097/EDE.0b013e31829e0ea2; Silventoinen K, 2007, EUR J CARDIOV PREV R, V14, P555, DOI 10.1097/HJR.0b013e328014672e; SONNEHOLM S, 1989, J EPIDEMIOL COMMUN H, V43, P369, DOI 10.1136/jech.43.4.369; Starr JM, 2004, J HYPERTENS, V22, P893, DOI 10.1097/00004872-200405000-00009; van den Oord SCH, 2013, ATHEROSCLEROSIS, V228, P1, DOI 10.1016/j.atherosclerosis.2013.01.025; Wardlaw JA, 2005, EUR J RADIOL, V56, P205, DOI 10.1016/j.ejrad.2005.04.021; Zuo G, 2014, CELL BIOCH BIOPHYSIC	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125280	10.1371/journal.pone.0125280	http://dx.doi.org/10.1371/journal.pone.0125280			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915652	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100115
J	Hernandez-Medrano, JH; Copping, KJ; Hoare, A; Wapanaar, W; Grivell, R; Kuchel, T; Miguel-Pacheco, G; McMillen, IC; Rodgers, RJ; Perry, VEA				Hernandez-Medrano, Juan H.; Copping, Katrina J.; Hoare, Andrew; Wapanaar, Wendela; Grivell, Rosalie; Kuchel, Tim; Miguel-Pacheco, Giuliana; McMillen, I. Caroline; Rodgers, Raymond J.; Perry, Viv E. A.			Gestational Dietary Protein Is Associated with Sex Specific Decrease in Blood Flow, Fetal Heart Growth and Post-Natal Blood Pressure of Progeny	PLOS ONE			English	Article							TRANSRECTAL DOPPLER SONOGRAPHY; PLACENTAL DEVELOPMENT; NUTRIENT INTAKE; MATERNAL UNDERNUTRITION; VASCULAR DEVELOPMENT; EMBRYO DEVELOPMENT; EARLY-PREGNANCY; HEIFERS; BOVINE; COWS	Study Overview The incidence of adverse pregnancy outcomes is higher in pregnancies where the fetus is male. Sex specific differences in feto-placental perfusion indices identified by Doppler assessment have recently been associated with placental insufficiency and fetal growth restriction. This study aims to investigate sex specific differences in placental perfusion and to correlate these changes with fetal growth. It represents the largest comprehensive study under field conditions of uterine hemodynamics in a monotocous species, with a similar long gestation period to the human. Primiparous 14mo heifers in Australia (n=360) and UK (n=180) were either individually or group fed, respectively, diets with differing protein content (18, 14, 10 or 7% crude protein (CP)) from 60d prior to 98 days post conception (dpc). Fetuses and placentae were excised at 98dpc (n=48). Fetal development an median uterine artery blood flow were assessed monthly from 36dpc until term using B-mode and Doppler ultrasonography. MUA blood flow to the male feto-placental unit increased in early pregnancy associated with increased fetal growth. Protein restriction before and shortly after conception (-60d up to 23dpc) increased MUA diameter and indices of velocity during late pregnancy, reduced fetal heart weight in the female fetus and increased heart rate at birth, but decreased systolic blood pressure at six months of age. Conclusion and Significance Sex specific differences both in feto-placental Doppler perfusion indices and response of these indices to dietary perturbations were observed. Further, maternal diet affected development of fetal cardiovascular system associated with altered fetal haemodynamics in utero, with such effects having a sex bias. The results from this study provide further insight into the gender specific circulatory differences present in the fetal period and developing cardiovascular system.	[Hernandez-Medrano, Juan H.; Wapanaar, Wendela; Miguel-Pacheco, Giuliana; Perry, Viv E. A.] Univ Nottingham, Sch Vet & Med Sci, Loughborough, England; [Copping, Katrina J.; Grivell, Rosalie; Rodgers, Raymond J.] Univ Adelaide, Sch Paediat, Adelaide, SA, Australia; [Copping, Katrina J.; Grivell, Rosalie; Rodgers, Raymond J.] Univ Adelaide, Reprod Hlth Robinson Inst, Adelaide, SA, Australia; [Hoare, Andrew] South East Vets, Mt Gambier, SA, Australia; [McMillen, I. Caroline] Univ Newcastle, The Chancellory, Newcastle, NSW 2300, Australia; [Kuchel, Tim] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Grivell, Rosalie] Womens & Childrens Hosp, Dept Perinatal Med, Adelaide, SA, Australia	University of Nottingham; University of Adelaide; Robinson Research Institute; University of Adelaide; University of Newcastle; South Australian Health & Medical Research Institute (SAHMRI); Womens & Childrens Hospital Australia	Perry, VEA (corresponding author), Univ Nottingham, Sch Vet & Med Sci, Loughborough, England.	viv.perry@nottingham.ac.uk	Hernandez-Medrano, Juan/AAG-2703-2019; perry, viv/AAB-8020-2019; Miguel-Pacheco, Giuliana G/I-1977-2016; Hernandez-Medrano, Juan H/AAI-8027-2020; Hernandez-Medrano, Juan H/A-1818-2012; McMillen, Isabella Caroline/N-5540-2019; Rodgers, Raymond J/C-3476-2009; Hernandez-Medrano, Juan H/HDO-6887-2022; Grivell, Rosalie/N-6852-2015	perry, viv/0000-0003-1330-6204; Miguel-Pacheco, Giuliana G/0000-0003-2765-1324; Hernandez-Medrano, Juan H/0000-0002-2907-2441; Hernandez-Medrano, Juan H/0000-0002-2907-2441; Hernandez-Medrano, Juan H/0000-0002-2907-2441; Grivell, Rosalie/0000-0002-2447-6519	Australian Research Council (ARC) [LP110100649]; EBLEX (English Beef and Lamb Executive) a division of the Agriculture and Horticulture Development Board (AHDB) [RC3815]	Australian Research Council (ARC)(Australian Research Council); EBLEX (English Beef and Lamb Executive) a division of the Agriculture and Horticulture Development Board (AHDB)	This work was supported by the Australian Research Council (ARC) grant number: LP110100649 given to VP, ICM, and RR (www.arc.gov.au); and EBLEX (English Beef and Lamb Executive) a division of the Agriculture and Horticulture Development Board (AHDB) - grant numberRC3815: given to VP (http://www.eblex.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RP, 2007, PEDIATR RES, V62, P385; Ashworth CJ, 2009, PHILOS T R SOC B, V364, P3351, DOI 10.1098/rstb.2009.0184; Bermejo-Alvarez P, 2011, REPRODUCTION, V141, P563, DOI 10.1530/REP-10-0482; Bollwein H, 2002, THERIOGENOLOGY, V57, P2053, DOI 10.1016/S0093-691X(02)00706-9; Borowczyk E, 2006, J ANIM SCI, V84, P1593, DOI 10.2527/2006.8461593x; Bridges GA, 2014, THERIOGENOLOGY, V81, P632, DOI 10.1016/j.theriogenology.2013.11.020; Camacho LE, 2014, J ANIM SCI, V92, P520, DOI 10.2527/jas.2013-7017; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Copping KJ, 2014, ANIM PROD SCI, V54, P1333, DOI 10.1071/AN14278; Dobbs KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066230; FERRELL CL, 1991, J ANIM SCI, V69, P1954, DOI 10.2527/1991.6951954x; Herzog K, 2007, REPROD DOMEST ANIM, V42, P51, DOI 10.1111/j.1439-0531.2007.00903.x; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Long NM, 2009, J ANIM SCI, V87, P1950, DOI 10.2527/jas.2008-1672; MacLaughlin SM, 2007, ENDOCRINOLOGY, V148, P1911, DOI 10.1210/en.2006-0761; Micke G, 2014, THERIOGENOL IN PRESS; Micke GC, 2011, MOL CELL ENDOCRINOL, V332, P234, DOI 10.1016/j.mce.2010.10.018; Micke GC, 2010, ANIM REPROD SCI, V121, P208, DOI 10.1016/j.anireprosci.2010.05.017; Micke GC, 2010, ANIM REPROD SCI, V118, P163, DOI 10.1016/j.anireprosci.2009.08.006; Micke GC, 2010, ANIM REPROD SCI, V117, P1, DOI 10.1016/j.anireprosci.2009.03.010; Micke GC, 2011, REPRODUCTION, V141, P697, DOI 10.1530/REP-10-0332; Mossa F, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107235; O'Connell BA, 2013, PLACENTA, V34, P119, DOI 10.1016/j.placenta.2012.11.009; Panarace M, 2006, THERIOGENOLOGY, V66, P2113, DOI 10.1016/j.theriogenology.2006.03.040; Perry VEA, 1999, ANIM REPROD SCI, V55, P13, DOI 10.1016/S0378-4320(98)00157-2; Prior T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056933; Redmer DA, 2004, DOMEST ANIM ENDOCRIN, V27, P199, DOI 10.1016/j.domaniend.2004.06.006; REYNOLDS LP, 1995, J ANIM SCI, V73, P1839; Stark MJ, 2011, PLACENTA, V32, P865, DOI 10.1016/j.placenta.2011.08.010; Sullivan TM, 2010, ANIM REPROD SCI, V118, P131, DOI 10.1016/j.anireprosci.2009.07.005; Sullivan TM, 2009, THERIOGENOLOGY, V72, P427, DOI 10.1016/j.theriogenology.2009.03.018; Sullivan TM, 2009, REPROD FERT DEVELOP, V21, P773, DOI 10.1071/RD09004; Sullivan TM, 2009, PLACENTA, V30, P348, DOI 10.1016/j.placenta.2009.01.008; Vonnahme KA, 2007, J ANIM SCI, V85, P2464, DOI 10.2527/jas.2006-805; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156	35	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125694	10.1371/journal.pone.0125694	http://dx.doi.org/10.1371/journal.pone.0125694			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915506	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100142
J	Jung, DH; Kim, JH; Chung, HS; Park, JC; Shin, SK; Lee, SK; Lee, YC				Jung, Da Hyun; Kim, Jie-Hyun; Chung, Hyun Soo; Park, Jun Chul; Shin, Sung Kwan; Lee, Sang Kil; Lee, Yong Chan			Helicobacter pylori Eradication on the Prevention of Metachronous Lesions after Endoscopic Resection of Gastric Neoplasm: A Meta-Analysis	PLOS ONE			English	Article							MUCOSAL RESECTION; CANCER; JAPAN; CHINA; AGE	Background There is controversy about the effect of Helicobacter pylori (H. pylori) eradication on the prevention of metachronous gastric cancer after endoscopic resection (ER). Aims The aim of this study was to systematically evaluate the effect of H. pylori eradication on the prevention of metachronous gastric lesions after ER of gastric neoplasms. Methods We performed a systematic search of PubMed, EMBASE, the Cochrane Library, and MEDLINE that encompassed studies through April 2014. Our meta-analysis consisted of 10 studies, which included 5881 patients who underwent ER of gastric neoplasms. Results When we compared the incidence of metachronous lesions between H. pylori-eradicated and non-eradicated groups, H. pylori eradication significantly lowered the risk of metachronous lesions after ER of gastric neoplasms (five studies, OR = 0.392, 95% CI 0.259 - 0.593, P < 0.001). When we compared H. pylori-eradicated and persistent groups, again, H. pylori eradication significantly lowered the incidence of metachronous lesions after ER of gastric neoplasms (six studies, OR = 0.468, 95% CI 0.326 - 0.673, P < 0.001). There was no obvious heterogeneity across the analyzed studies. Conclusions This meta-analysis suggests a preventive role for H. pylori eradication for metachronous gastric lesions after ER of gastric neoplasms. Thus, H. pylori eradication should be considered if H. pylori infection is confirmed during ER.	[Jung, Da Hyun; Chung, Hyun Soo; Park, Jun Chul; Shin, Sung Kwan; Lee, Sang Kil; Lee, Yong Chan] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Jie-Hyun] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, YC (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	leeyc@yuhs.ac	Kim, Jie-Hyun/Q-9061-2019; Park, Jun Chul/H-7218-2019	Kim, Jie-Hyun/0000-0002-9198-3326; Park, Jun Chul/0000-0001-8018-0010; Jung, Da Hyun/0000-0001-6668-3113; Lee, Yong Chan/0000-0001-8800-6906; Chung, Hyunsoo/0000-0001-5159-357X; Lee, Sang Kil/0000-0002-0721-0364; Shin, Sung Kwan/0000-0001-5466-1400				Bae SE, 2014, AM J GASTROENTEROL, V109, P60, DOI 10.1038/ajg.2013.404; Boda T, 2014, HELICOBACTER, V19, P1, DOI 10.1111/hel.12101; Bornschein J, 2013, J CLIN PATHOL, V66, P819, DOI 10.1136/jclinpath-2013-201448; Choi J, 2014, CLIN GASTROENTEROL H, V12, P793, DOI 10.1016/j.cgh.2013.09.057; Choi KS, 2011, GASTROINTEST ENDOSC, V73, P942, DOI 10.1016/j.gie.2010.12.032; Chon Ilyoung, 2013, Korean J Gastroenterol, V61, P307; CORREA P, 1988, CANCER RES, V48, P3554; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Hanaoka N, 2010, J GASTROEN HEPATOL, V25, P1844, DOI 10.1111/j.1440-1746.2010.06442.x; Isomoto H, 2009, GUT, V58, P331, DOI 10.1136/gut.2008.165381; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang KJ, 2010, J KOREAN MED ASSOC, V53, P283, DOI 10.5124/jkma.2010.53.4.283; Kato M, 2007, J GASTROENTEROL, V42, P16, DOI 10.1007/s00535-006-1928-5; Kikuchi S, 2006, HELICOBACTER, V11, P147, DOI 10.1111/j.1523-5378.2006.00392.x; Kim Mi-Young, 2014, Gastrointest Endosc Clin N Am, V24, P283, DOI 10.1016/j.giec.2013.11.001; Kim YI, 2014, HELICOBACTER, V19, P194, DOI 10.1111/hel.12116; Kwon YH, 2014, ALIMENT PHARM THER, V39, P609, DOI 10.1111/apt.12633; Lee SY, 2014, WORLD J GASTROENTERO, V20, P1493, DOI 10.3748/wjg.v20.i6.1493; Maehata Y, 2012, GASTROINTEST ENDOSC, V75, P39, DOI 10.1016/j.gie.2011.08.030; Nakagawa S, 2006, ALIMENT PHARM THER, V24, P214, DOI 10.1111/j.1365-2036.2006.00048.x; Nasu J, 2005, ENDOSCOPY, V37, P990, DOI 10.1055/s-2005-870198; Schistosomes liver flukes and Helicobacter pylori, 1994, IARC MONOGR EVAL CAR, V61, P1; Seo JY, 2013, HEPATO-GASTROENTEROL, V60, P776, DOI 10.5754/hge12929; Seo JH, 2010, DIGESTION, V81, P35, DOI 10.1159/000235921; Shiotani A, 2008, DIGESTION, V78, P113, DOI 10.1159/000173719; Soetikno R, 2005, J CLIN ONCOL, V23, P4490, DOI 10.1200/JCO.2005.19.935; Take S, 2005, AM J GASTROENTEROL, V100, P1037, DOI 10.1111/j.1572-0241.2005.41384.x; Takenaka R, 2007, ALIMENT PHARM THER, V25, P805, DOI 10.1111/j.1365-2036.2007.03268.x; Uemura N, 1997, CANCER EPIDEM BIOMAR, V6, P639; Wang J, 2011, DIGESTION, V83, P253, DOI 10.1159/000280318; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187	31	29	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124725	10.1371/journal.pone.0124725	http://dx.doi.org/10.1371/journal.pone.0124725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915048	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100063
J	Loconte, DC; Grossi, V; Bozzao, C; Forte, G; Bagnulo, R; Stella, A; Lastella, P; Cutrone, M; Benedicenti, F; Susca, FC; Patruno, M; Varvara, D; Germani, A; Chessa, L; Susca, C; Patruno, M; Varvara, D; Germani, A; Chessa, L; Laforgia, N; Tenconi, R; Simone, C; Resta, N				Loconte, Daria C.; Grossi, Valentina; Bozzao, Cristina; Forte, Giovanna; Bagnulo, Rosanna; Stella, Alessandro; Lastella, Patrizia; Cutrone, Mario; Benedicenti, Francesco; Susca, Francesco C.; Patruno, Margherita; Varvara, Dora; Germani, Aldo; Chessa, Luciana; Susca, C.; Patruno, Margherita; Varvara, Dora; Germani, Aldo; Chessa, Luciana; Laforgia, Nicola; Tenconi, Romano; Simone, Cristiano; Resta, Nicoletta			Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors	PLOS ONE			English	Article							ACTIVATING MUTATIONS; PROTEUS-SYNDROME; CANCER	Background PIK3CA-related overgrowth spectrum (PROS) include a group of disorders that affect only the terminal portion of a limb, such as type I macrodactyly, and conditions like fibroadipose overgrowth (FAO), megalencephaly-capillary malformation (MCAP) syndrome, congenital lipomatous asymmetric overgrowth of the trunk, lymphatic, capillary, venous, and combined-type vascular malformations, epidermal nevi, skeletal and spinal anomalies (CLOVES) syndrome and Hemihyperplasia Multiple Lipomatosis (HHML). Heterozygous postzygotic PIK3CA mutations are frequently identified in these syndromes, while timing and tissue specificity of the mutational event are likely responsible for the extreme phenotypic variability observed. Methods We carried out a combination of Sanger sequencing and targeted deep sequencing of genes involved in the PI3K/AKT/mTOR pathway in three patients (1 MCAP and 2 FAO) to identify causative mutations, and performed immunoblot analyses to assay the phosphorylation status of AKT and P70S6K in affected dermal fibroblasts. In addition, we evaluated their ability to grow in the absence of serum and their response to the PI3K inhibitors wortmannin and LY294002 in vitro. Results and Conclusion Our data indicate that patients' cells showed constitutive activation of the PI3K/Akt pathway. Of note, PI3K pharmacological blockade resulted in a significant reduction of the proliferation rate in culture, suggesting that inhibition of PI3K might prove beneficial in future therapies for PROS patients.	[Loconte, Daria C.; Grossi, Valentina; Bagnulo, Rosanna; Stella, Alessandro; Susca, Francesco C.; Patruno, Margherita; Varvara, Dora; Germani, Aldo; Simone, Cristiano; Resta, Nicoletta] Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol DIMO, Div Med Genet, Bari, Italy; [Grossi, Valentina; Simone, Cristiano] IRCCS Oncol Giovanni Paolo II, Natl Canc Inst, Bari, Italy; [Bozzao, Cristina; Chessa, Luciana] Univ Roma La Sapienza, Dept Clin & Mol Med, I-00185 Rome, Italy; [Forte, Giovanna] IRCCS S de Bellis, Canc Genet Lab, Castellana Grotte, Italy; [Lastella, Patrizia] Univ Hosp Bari, Ctr Rare Dis Internal Med C Frugoni, Bari, Italy; [Cutrone, Mario] Osped Angelo Ulss 12 Mestre, US Dermatol Pediatr, Venice, Italy; [Susca, Francesco C.] Reg Hosp Bolzano, Dept Pediat, Genet Counseling Serv, Bolzano, Italy; [Laforgia, Nicola] Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol DIMO, Neonatol & NICU Sect, Bari, Italy; [Tenconi, Romano] Univ Padua, Padua, Italy	Universita degli Studi di Bari Aldo Moro; IRCCS Istituto Tumori Bari Giovanni Paolo II; Sapienza University Rome; IRCCS Saverio de Bellis; Universita degli Studi di Bari Aldo Moro; ULSS 3 Serenissima; Ospedale dell'Angelo Mestre; Krankenhaus Bozen; Universita degli Studi di Bari Aldo Moro; University of Padua	Resta, N (corresponding author), Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol DIMO, Div Med Genet, Bari, Italy.	nicoletta.resta@uniba.it	Forte, Giovanna/AAB-2221-2019; Grossi, Valentina/K-9821-2016; Simone, Cristiano/K-3452-2018; Patruno, Margherita/AAD-9062-2020; Laforgia, Nicola/T-4088-2019; Stella, Alessandro/I-8832-2012; Resta, Nicoletta/I-8424-2018; GROSSI, Valentina/O-6546-2019	Forte, Giovanna/0000-0001-7289-470X; Grossi, Valentina/0000-0003-3843-1618; Simone, Cristiano/0000-0002-2628-7658; Patruno, Margherita/0000-0001-8231-596X; Laforgia, Nicola/0000-0002-4610-1216; Stella, Alessandro/0000-0002-9035-6267; Resta, Nicoletta/0000-0001-8640-5532; GROSSI, Valentina/0000-0003-3843-1618; Germani, Aldo/0000-0001-5108-3924; Benedicenti, Francesco/0000-0002-9458-0688; Susca, Francesco Claudio/0000-0002-9899-8301; VARVARA, DORA/0000-0002-2703-218X	Italian Association for Cancer Research (AIRC) fellowship; FIRB - FUTURO IN RICERCA from the Italian MIUR [RBFR12VP3Q_003]; Fondi d'Ateneo/conto terzi from the University of Bari "Aldo Moro"	Italian Association for Cancer Research (AIRC) fellowship(Fondazione AIRC per la ricerca sul cancro); FIRB - FUTURO IN RICERCA from the Italian MIUR; Fondi d'Ateneo/conto terzi from the University of Bari "Aldo Moro"	V.G. is supported by an Italian Association for Cancer Research (AIRC) fellowship. This study was partially supported by FIRB - FUTURO IN RICERCA RBFR12VP3Q_003 (to C.S.) from the Italian MIUR and by Fondi d'Ateneo/conto terzi (to N.R.) from the University of Bari "Aldo Moro".	Biesecker L, 2006, EUR J HUM GENET, V14, P1151, DOI 10.1038/sj.ejhg.5201638; Biesecker LG, 1998, AM J MED GENET, V79, P311, DOI 10.1002/(SICI)1096-8628(19981002)79:4<311::AID-AJMG14>3.0.CO;2-U; Boscolo E, 2014, ANGIOGENESIS; Chen YW, 2012, J CELL PHYSIOL, V227, P2818, DOI 10.1002/jcp.23038; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Keppler-Noreuil KM, 2015, AM J MED GENET A, V167, P287, DOI 10.1002/ajmg.a.36836; Keppler-Noreuil KM, 2014, AM J MED GENET A, V164, P1713, DOI 10.1002/ajmg.a.36552; Kurek KC, 2012, AM J HUM GENET, V90, P1108, DOI 10.1016/j.ajhg.2012.05.006; Lindhurst MJ, 2012, NAT GENET, V44, P928, DOI 10.1038/ng.2332; Mirzaa GM, 2014, NAT GENET, V46, P510, DOI 10.1038/ng.2948; Moore CA, 1997, AM J MED GENET, V70, P67, DOI 10.1002/(SICI)1096-8628(19970502)70:1<67::AID-AJMG13>3.3.CO;2-4; Osborn AJ, 2015, HUM MOL GENET, V24, P926, DOI 10.1093/hmg/ddu505; Pezze PD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002469; Rios JJ, 2013, HUM MOL GENET, V22, P444, DOI 10.1093/hmg/dds440; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Tosi LL, 2011, J CHILD ORTHOP, V5, P319, DOI 10.1007/s11832-011-0350-6	18	58	61	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123092	10.1371/journal.pone.0123092	http://dx.doi.org/10.1371/journal.pone.0123092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915946	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100013
J	Torres-Costoso, A; Gracia-Marco, L; Sanchez-Lopez, M; Notario-Pacheco, B; Arias-Palencia, N; Martinez-Vizcaino, V				Torres-Costoso, Ana; Gracia-Marco, Luis; Sanchez-Lopez, Mairena; Notario-Pacheco, Blanca; Arias-Palencia, Natalia; Martinez-Vizcaino, Vicente			Physical Activity and Bone Health in Schoolchildren: The Mediating Role of Fitness and Body Fat	PLOS ONE			English	Article							MINERAL DENSITY; LEAN MASS; CHILDREN; ADOLESCENTS; GROWTH; OVERWEIGHT; PREVENTION; ACCRETION; OBESITY; WEIGHT	Background The relationship between physical activity (PA) and bone health is well known, although the role of percent body fat (%BF) and fitness as confounders or mediators in this relationship remains uncertain. Objective To examine whether the association between PA and bone mineral content (BMC) is mediated by %BF and cardiorespiratory fitness (CRF). Methods In this cross sectional study, BMC, total %BF (by DXA), vigorous PA (VPA), CRF, age and height were measured in 132 schoolchildren (62 boys, aged 8-11 years). ANCOVA was used to test differences in BMC by %BF, CRF and VPA, controlling for different sets of confounders. Simple mediation analyses and serial multiple mediation analyses were fitted to examine whether the relationship between PA and BMC is mediated by %BF and fitness. Results Children with high %BF had higher total body BMC than their peers after controlling for all sets of confounders. Children with good CRF or VPA had significantly less total body BMC after controlling for age and sex but in children with good CRF this inverse relation disappeared after adjusting by %BF. %BF and CRF both act as a full mediator in the association between VPA and BMC, after inclusion of the potential confounders in the models. Conclusion Fitness and %BF seem to have a mediator role on the relationship between physical activity and bone mass.	[Torres-Costoso, Ana] Univ Castilla La Mancha, Sch Nursing & Physiotherapy, Toledo, Spain; [Gracia-Marco, Luis] Univ Exeter, CHERC Childrens Hlth & Exercise Res Ctr Sport & H, Exeter, Devon, England; [Gracia-Marco, Luis] Univ Zaragoza, GENUD Growth Exercise Nutr & Dev Res Grp, Zaragoza, Spain; [Sanchez-Lopez, Mairena; Notario-Pacheco, Blanca; Arias-Palencia, Natalia; Martinez-Vizcaino, Vicente] Univ Castilla La Mancha, Social & Hlth Care Res Ctr, Cuenca, Spain; [Sanchez-Lopez, Mairena] Univ Castilla La Mancha, Fac Educ, E-13071 Ciudad Real, Spain; [Martinez-Vizcaino, Vicente] Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile	Universidad de Castilla-La Mancha; University of Exeter; University of Zaragoza; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad Autonoma de Chile	Martinez-Vizcaino, V (corresponding author), Univ Castilla La Mancha, Social & Hlth Care Res Ctr, Cuenca, Spain.	Vicente.Martinez@uclm.es	Torres-Costoso, Ana/R-4847-2019; SANCHEZ-LOPEZ, MAIRENA/J-7933-2016; VIZCAINO, VICENTE MARTINEZ/AAZ-9034-2021; Palencia, Natalia María Arias/Q-5070-2017; Gracia-Marco, Luis/A-8845-2018; Gracia-Marco, Luis/R-4899-2019; VIZCAINO, VICENTE MARTINEZ/R-4336-2017; Notario Pacheco, Blanca/G-2583-2016	VIZCAINO, VICENTE MARTINEZ/0000-0001-6121-7893; Palencia, Natalia María Arias/0000-0001-5004-3197; Gracia-Marco, Luis/0000-0002-4020-0256; Gracia-Marco, Luis/0000-0002-4020-0256; VIZCAINO, VICENTE MARTINEZ/0000-0001-6121-7893; Sanchez Lopez, Mairena/0000-0002-0217-0623; Torres-Costoso, Ana/0000-0001-8961-3169; Notario Pacheco, Blanca/0000-0001-8406-6952	Ministry of Education and Science - Junta de Comunidades de Castilla-La Mancha [PII1I09-0259-9898, POII10-0208-5325]; Ministry of Health (FIS grant) [PI081297]; Research Network on Preventative Activities and Health Promotion [RD06/0018/0038]	Ministry of Education and Science - Junta de Comunidades de Castilla-La Mancha; Ministry of Health (FIS grant); Research Network on Preventative Activities and Health Promotion	This study was funded by grant numbers PII1I09-0259-9898 and POII10-0208-5325 from the Ministry of Education and Science - Junta de Comunidades de Castilla-La Mancha, and Ministry of Health (FIS grant number PI081297). Additional funding was provided by the Research Network on Preventative Activities and Health Promotion (RD06/0018/0038).	Baptista F, 2012, J BONE MINER METAB, V30, P100, DOI 10.1007/s00774-011-0294-4; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Baxter-Jones ADG, 2008, J APPL PHYSIOL, V105, P734, DOI 10.1152/japplphysiol.00869.2007; Cobayashi Fernanda, 2005, J. Pediatr. (Rio J.), V81, P337, DOI [10.2223/JPED.1372, 10.1590/S0021-75572005000500013]; Cole ZA, 2012, BONE, V50, P562, DOI 10.1016/j.bone.2011.05.005; Cole Zoe A, 2008, Curr Rheumatol Rep, V10, P92, DOI 10.1007/s11926-008-0017-6; Diez-Fernandez A, 2014, DIABETES CARE, V37, P855, DOI 10.2337/dc13-0416; El Hage RP, 2009, EUR J APPL PHYSIOL, V105, P759, DOI 10.1007/s00421-008-0959-4; Ellis KJ, 2003, ACTA DIABETOL, V40, pS274, DOI 10.1007/s00592-003-0085-z; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; Gracia-Marco L, 2012, OSTEOPOROSIS INT, V23, P937, DOI 10.1007/s00198-011-1649-3; Gracia-Marco L, 2011, EUR J APPL PHYSIOL, V111, P2671, DOI 10.1007/s00421-011-1897-0; Gracia-Marco L, 2011, AM J PREV MED, V40, P599, DOI 10.1016/j.amepre.2011.03.001; Hrafnkelsson H, 2013, J BONE MINER METAB, V31, P442, DOI 10.1007/s00774-013-0423-3; Ischander M, 2007, MED SCI SPORT EXER, V39, P1131, DOI 10.1249/mss.0b013e318053e7a2; Ivuskans A, 2013, RHEUMATOL INT, V33, P1681, DOI 10.1007/s00296-012-2612-0; Kemper HCG, 2000, BONE, V27, P847, DOI 10.1016/S8756-3282(00)00397-5; Kennedy K, 2013, ARCH DIS CHILD, V98, P204, DOI 10.1136/archdischild-2012-302823; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Leonard MB, 2004, AM J CLIN NUTR, V80, P514, DOI 10.1093/ajcn/80.2.514; MacKelvie KJ, 2003, PEDIATRICS, V112, pE447, DOI 10.1542/peds.112.6.e447; Maggio ABR, 2014, J PEDIATR GASTR NUTR, V58, P723, DOI 10.1097/MPG.0000000000000297; Martinez-Vizcaino V, 2012, REV ESP CARDIOL, V65, P427, DOI [10.1016/j.recesp.2011.12.008, 10.1016/j.rec.2011.12.009]; McVeigh JA, 2007, ACTA PAEDIATR, V96, P874, DOI 10.1111/j.1651-2227.2007.00285.x; Mosca LN, 2013, NUTRIENTS, V5, P2047, DOI 10.3390/nu5062047; Ortega FB, 2008, INT J OBESITY, V32, pS49, DOI 10.1038/ijo.2008.183; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Reid IR, 2004, CALCIFIED TISSUE INT, V74, P313, DOI 10.1007/s00223-002-0015-z; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; Rocher E, 2008, J BONE MINER METAB, V26, P73, DOI 10.1007/s00774-007-0786-4; Rowlands AV, 2007, PEDIATR EXERC SCI, V19, P252, DOI 10.1123/pes.19.3.252; Ruiz JR, 2006, AM J CLIN NUTR, V84, P299; Sardinha LB, 2008, PEDIATRICS, V122, pE728, DOI 10.1542/peds.2007-2573; Sayers A, 2011, J CLIN ENDOCR METAB, V96, pE793, DOI 10.1210/jc.2010-2550; Shaikh MG, 2014, CLIN ENDOCRINOL, V80, P85, DOI 10.1111/cen.12263; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Tobias JH, 2007, J BONE MINER RES, V22, P101, DOI 10.1359/JBMR.060913; Turner RT, 2013, J BONE MINER RES, V28, P22, DOI 10.1002/jbmr.1734; Valtuena J, 2012, OSTEOPOROSIS INT, V23, P2227, DOI 10.1007/s00198-011-1884-7; Vicente-Rodriguez G, 2005, BRIT J SPORT MED, V39, P611, DOI 10.1136/bjsm.2004.014431; Vicente-Rodriguez G, 2004, MED SCI SPORT EXER, V36, P1789, DOI 10.1249/01.MSS.0000142311.75866.D7; Vicente-Rodriguez G, 2008, J BONE MINER METAB, V26, P288, DOI 10.1007/s00774-007-0818-0; Vicente-Rodriguez G, 2006, SPORTS MED, V36, P561, DOI 10.2165/00007256-200636070-00002; Wetzsteon RJ, 2011, BONE, V48, P1103, DOI 10.1016/j.bone.2011.01.005	45	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123797	10.1371/journal.pone.0123797	http://dx.doi.org/10.1371/journal.pone.0123797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915941	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100027
J	Caruso, M; Ferranti, F; Scheri, KC; Dobrowolny, G; Ciccarone, F; Grammatico, P; Catizone, A; Ricci, G				Caruso, Maria; Ferranti, Francesca; Scheri, Katia Corano; Dobrowolny, Gabriella; Ciccarone, Fabio; Grammatico, Paola; Catizone, Angela; Ricci, Giulia			R-Spondin 1/Dickkopf-1/Beta-Catenin Machinery Is Involved in Testicular Embryonic Angiogenesis	PLOS ONE			English	Article							WNT/BETA-CATENIN; BETA-CATENIN; TESTIS DEVELOPMENT; CELL-MIGRATION; WNT4; R-SPONDIN1; EXPRESSION; DIFFERENTIATION; RSPO1; GENE	Testicular vasculogenesis is one of the key processes regulating male gonad morphogenesis. The knowledge of the molecular cues underlining this phenomenon is one of today's most challenging issues and could represent a major contribution toward a better understanding of the onset of testicular morphogenetic disorders. R-spondin 1 has been clearly established as a candidate for mammalian ovary determination. Conversely, very little information is available on the expression and role of R-spondin 1 during testicular morphogenesis. This study aims to clarify the distribution pattern of R-spondin 1 and other partners of its machinery during the entire period of testicular morphogenesis and to indicate the role of this system in testicular development. Our whole mount immunofluorescence results clearly demonstrate that R-spondin 1 is always detectable in the testicular coelomic partition, where testicular vasculature is organized, while Dickkopf-1 is never detectable in this area. Moreover, organ culture experiments of embryonic male UGRs demonstrated that Dickkopf- 1 acted as an inhibitor of testis vasculature formation. Consistent with this observation, real-time PCR analyses demonstrated that DKK1 is able to slightly but significantly decrease the expression level of the endothelial marker Pecam1. The latter experiments allowed us to observe that DKK1 administration also perturbs the expression level of the Pdgf-b chain, which is consistent with some authors' observations relating this factor with prenatal testicular patterning and angiogenesis. Interestingly, the DKK1 induced inhibition of testicular angiogenesis was rescued by the co-administration of R-spondin 1. In addition, R-spondin 1 alone was sufficient to enhance, in culture, testicular angiogenesis.	[Caruso, Maria; Ferranti, Francesca; Scheri, Katia Corano; Dobrowolny, Gabriella; Catizone, Angela] Univ Roma La Sapienza, Sect Histol & Med Embryol, Dept Anat Histol Forens Med & Orthoped, I-00185 Rome, Italy; [Ferranti, Francesca] Italian Space Agcy, Rome, Italy; [Dobrowolny, Gabriella] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [Ciccarone, Fabio] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy; [Grammatico, Paola] Univ Roma La Sapienza, Dept Mol Med, I-00185 Rome, Italy; [Ricci, Giulia] Univ Naples 2, Dept Expt Med, Histol & Embryol Lab, Naples, Italy	Sapienza University Rome; Agenzia Spaziale Italiana (ASI); Istituto Italiano di Tecnologia - IIT; Sapienza University Rome; Sapienza University Rome; Universita della Campania Vanvitelli	Ricci, G (corresponding author), Univ Naples 2, Dept Expt Med, Histol & Embryol Lab, Naples, Italy.	giulia.ricci@unina2.it	Ricci, Giulia/AAO-1856-2020; CICCARONE, FABIO/K-4225-2016; Ciccarone, Fabio/AAR-9128-2021	Ricci, Giulia/0000-0002-2199-170X; Ciccarone, Fabio/0000-0002-2425-2240; Corano Scheri, Katia/0000-0002-2999-6556; Dobrowolny, Gabriella/0000-0001-8693-0724; catizone, angela/0000-0002-7836-9495	Italian Ministero per l'Universita e la Ricerca scientifica e tecnologica (M.U.R.S.T.) Cofin	Italian Ministero per l'Universita e la Ricerca scientifica e tecnologica (M.U.R.S.T.) Cofin(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian Ministero per l'Universita e la Ricerca scientifica e tecnologica (M.U.R.S.T.) Cofin 2008 to Paola Grammatico and Angela Catizone.	Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Biason-Lauber A, 2008, SEX DEV, V2, P210, DOI 10.1159/000152037; Biason-Lauber A, 2004, NEW ENGL J MED, V351, P792, DOI 10.1056/NEJMoa040533; Biason-Lauber A, 2007, HUM REPROD, V22, P224, DOI 10.1093/humrep/del360; Biason-Lauber A, 2010, BEST PRACT RES CL EN, V24, P163, DOI 10.1016/j.beem.2009.12.002; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Boudin E, 2013, SEMIN ARTHRITIS RHEU, V43, P220, DOI 10.1016/j.semarthrit.2013.01.004; Bouma GJ, 2004, GENE EXPR PATTERNS, V5, P141, DOI 10.1016/j.modgep.2004.05.001; Brennan J, 2003, GENE DEV, V17, P800, DOI 10.1101/gad.1052503; Brennan J, 2002, DEV BIOL, V244, P418, DOI 10.1006/dbio.2002.0578; BYSKOV AG, 1986, PHYSIOL REV, V66, P71, DOI 10.1152/physrev.1986.66.1.71; Cederroth CR, 2007, MOL CELL ENDOCRINOL, V265, P3, DOI 10.1016/j.mce.2006.12.029; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Chassot AA, 2012, DEVELOPMENT, V139, P4461, DOI 10.1242/dev.078972; Chassot AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025641; Chen JZ, 2002, MOL BIOL REP, V29, P287, DOI 10.1023/A:1020479301379; Ciccarone F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046927; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Combes AN, 2011, SEX DEV, V5, P124, DOI 10.1159/000327709; Combes AN, 2009, DEV BIOL, V326, P112, DOI 10.1016/j.ydbio.2008.10.040; Cool J, 2011, P NATL ACAD SCI USA, V108, P167, DOI 10.1073/pnas.1010299108; Coveney D, 2008, P NATL ACAD SCI USA, V105, P7212, DOI 10.1073/pnas.0707674105; de Lau WBM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-242; Dor Y, 2003, ANN NY ACAD SCI, V995, P208, DOI 10.1111/j.1749-6632.2003.tb03224.x; ERICKSON RP, 1993, DEV GENET, V14, P274, DOI 10.1002/dvg.1020140405; Fedi P, 1999, J BIOL CHEM, V274, P19465, DOI 10.1074/jbc.274.27.19465; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gore AV, 2011, DEVELOPMENT, V138, P4875, DOI 10.1242/dev.068460; Han XH, 2011, J BIOL CHEM, V286, P10649, DOI 10.1074/jbc.M110.169391; Jameson SA, 2012, DEV BIOL, V370, P24, DOI 10.1016/j.ydbio.2012.06.009; Jeays-Ward K, 2003, DEVELOPMENT, V130, P3663, DOI 10.1242/dev.00591; Jeays-Ward K, 2004, DEV BIOL, V276, P431, DOI 10.1016/j.ydbio.2004.08.049; Kamata T, 2004, BBA-GENE STRUCT EXPR, V1676, P51, DOI 10.1016/j.bbaexp.2003.10.009; Katoh M, 2001, INT J ONCOL, V19, P977; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; Kirikoshi H, 2002, INT J ONCOL, V21, P895; Kuppan P, 2011, BIOMACROMOLECULES, V12, P3156, DOI 10.1021/bm200618w; Liu CF, 2009, HUM MOL GENET, V18, P405, DOI 10.1093/hmg/ddn362; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nagamine CM, 1996, DEVELOPMENT, V122, P3597; Nam JS, 2007, DEV BIOL, V311, P124, DOI 10.1016/j.ydbio.2007.08.023; Nam JS, 2007, GENE EXPR PATTERNS, V7, P306, DOI 10.1016/j.modgep.2006.08.006; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; PESCE M, 1995, DEV BIOL, V170, P722, DOI 10.1006/dbio.1995.1250; Reis M, 2012, J EXP MED, V209, P1611, DOI 10.1084/jem.20111580; Ricci G, 2004, J CELL PHYSIOL, V200, P458, DOI 10.1002/jcp.20035; Tilmann C, 1999, DEVELOPMENT, V126, P2883; Tomaselli S, 2008, HUM MUTAT, V29, P220, DOI 10.1002/humu.20665; Tomaselli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016366; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Yoon JK, 2012, CELL SIGNAL, V24, P369, DOI 10.1016/j.cellsig.2011.09.023	60	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124213	10.1371/journal.pone.0124213	http://dx.doi.org/10.1371/journal.pone.0124213			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910078	gold, Green Submitted, Green Published			2022-12-27	WOS:000353376800067
J	Cho, Y; Ghosh, D				Cho, Youngjoo; Ghosh, Debashis			Weighted Estimation of the Accelerated Failure Time Model in the Presence of Dependent Censoring	PLOS ONE			English	Article							COMPETING RISKS DATA; RANK ESTIMATION; LARGE-SAMPLE; EQUATIONS; INFERENCE; TESTS	Independent censoring is a crucial assumption in survival analysis. However, this is impractical in many medical studies, where the presence of dependent censoring leads to difficulty in analyzing covariate effects on disease outcomes. The semicompeting risks framework offers one approach to handling dependent censoring. There are two representative estimators based on an artificial censoring technique in this data structure. However, neither of these estimators is better than another with respect to efficiency (standard error). In this paper, we propose a new weighted estimator for the accelerated failure time (AFT) model under dependent censoring. One of the advantages in our approach is that these weights are optimal among all the linear combinations of the previously mentioned two estimators. To calculate these weights, a novel resampling-based scheme is employed. Attendant asymptotic statistical results for the estimator are established. In addition, simulation studies, as well as an application to real data, show the gains in efficiency for our estimator.	[Cho, Youngjoo] Penn State Univ, Dept Stat, University Pk, PA 16802 USA; [Ghosh, Debashis] Univ Colorado, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO 80045 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Cho, Y (corresponding author), Penn State Univ, Dept Stat, University Pk, PA 16802 USA.	yvc5154@psu.edu		Ghosh, Debashis/0000-0001-6618-1316	National Institute of Health (NIH) [CA 129102-05]; NATIONAL CANCER INSTITUTE [R01CA129102] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institute of Health (NIH) grant CA 129102-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht MA, 2001, NEW ENGL J MED, V345, P398, DOI 10.1056/NEJM200108093450602; Day R, 1997, BIOMETRIKA, V84, P45, DOI 10.1093/biomet/84.1.45; Ding AA, 2009, SCAND J STAT, V36, P481, DOI 10.1111/j.1467-9469.2008.00635.x; Fine JP, 2001, BIOMETRIKA, V88, P907, DOI 10.1093/biomet/88.4.907; Fleming T, 2005, COUNTING PROCESSES S; Ghosh D, 2003, BIOMETRICS, V59, P877, DOI 10.1111/j.0006-341X.2003.00102.x; Ghosh D, 2010, LIFETIME DATA ANAL, V16, P509, DOI 10.1007/s10985-009-9150-4; HANSEN LP, 1982, ECONOMETRICA, V50, P1029, DOI 10.2307/1912775; HONORE BE, 1994, J ECONOMETRICS, V64, P241, DOI 10.1016/0304-4076(94)90065-5; Hsieh JJ, 2011, BIOMETRICS, V67, P719, DOI 10.1111/j.1541-0420.2010.01497.x; Jin ZZ, 2003, BIOMETRIKA, V90, P341, DOI 10.1093/biomet/90.2.341; La Cruz W, 2006, MATH COMPUT, V75, P1429, DOI 10.1090/S0025-5718-06-01840-0; Lin DY, 1996, BIOMETRIKA, V83, P381, DOI 10.1093/biomet/83.2.381; Lindsay BG, 2011, STAT SINICA, V21, P71; LOUIS TA, 1981, BIOMETRIKA, V68, P381, DOI 10.1093/biomet/68.2.381; PARZEN MI, 1994, BIOMETRIKA, V81, P341, DOI 10.1093/biomet/81.2.341; Peng LM, 2006, J AM STAT ASSOC, V101, P1085, DOI 10.1198/016214506000000131; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; Qu A, 2000, BIOMETRIKA, V87, P823, DOI 10.1093/biomet/87.4.823; TSIATIS AA, 1990, ANN STAT, V18, P354, DOI 10.1214/aos/1176347504; Varadhan R, 2009, J STAT SOFTW, V32, P1; Wang WJ, 2003, J R STAT SOC B, V65, P257, DOI 10.1111/1467-9868.00385; WEI LJ, 1985, BIOMETRIKA, V72, P359; WEI LJ, 1983, J AM STAT ASSOC, V78, P382, DOI 10.2307/2288644; Xue L, 2010, BIOMETRICS, V66, P393, DOI 10.1111/j.1541-0420.2009.01307.x; YING ZL, 1993, ANN STAT, V21, P76, DOI 10.1214/aos/1176349016	26	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124381	10.1371/journal.pone.0124381	http://dx.doi.org/10.1371/journal.pone.0124381			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909753	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800080
J	Dadson, K; Turdi, S; Boo, S; Hinz, B; Sweeney, G				Dadson, Keith; Turdi, Subat; Boo, Stellar; Hinz, Boris; Sweeney, Gary			Temporal and Molecular Analyses of Cardiac Extracellular Matrix Remodeling following Pressure Overload in Adiponectin Deficient Mice	PLOS ONE			English	Article							ALPHA-SKELETAL ACTIN; ANGIOTENSIN-II; TRANSENDOTHELIAL TRANSPORT; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; HEART; ACTIVATION; FIBROSIS; GLUCOSE; HYPERTROPHY	Adiponectin, circulating levels of which are reduced in obesity and diabetes, mediates cardiac extracellular matrix (ECM) remodeling in response to pressure overload (PO). Here, we performed a detailed temporal analysis of progressive cardiac ECM remodelling in adiponectin knockout (AdKO) and wild-type (WT) mice at 3 days and 1, 2, 3 and 4 weeks following the induction of mild PO via minimally invasive transverse aortic banding. We first observed that myocardial adiponectin gene expression was reduced after 4 weeks of PO, whereas increased adiponectin levels were detected in cardiac homogenates at this time despite decreased circulating levels of adiponectin. Scanning electron microscopy and Masson's trichrome staining showed collagen accumulation increased in response to 2 and 4 weeks of PO in WT mice, while fibrosis in AdKO mice was notably absent after 2 weeks but highly apparent after 4 weeks of PO. Time and intensity of fibroblast appearance after PO was not significantly different between AdKO and WT animals. Gene array analysis indicated that MMP2, TIMP2, collagen 1 alpha 1 and collagen 1 alpha 3 were induced after 2 weeks of PO in WT but not AdKO mice. After 4 weeks MMP8 was induced in both genotypes, MMP9 only in WT mice and MMP1 alpha only in AdKO mice. Direct stimulation of primary cardiac fibroblasts with adiponectin induced a transient increase in total collagen detected by picrosirius red staining and collagen III levels synthesis, as well as enhanced MMP2 activity detected via gelatin zymography. Adiponectin also enhanced fibroblast migration and attenuated angiotensin-II induced differentiation to a myofibroblast phenotype. In conclusion, these data indicate that increased myocardial bioavailability of adiponectin mediates ECM remodeling following PO and that adiponectin deficiency delays these effects.	[Dadson, Keith; Turdi, Subat; Sweeney, Gary] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Boo, Stellar; Hinz, Boris] Univ Toronto, Fac Dent, Matrix Dynam Grp, Lab Tissue Repair & Regenerat, Toronto, ON, Canada	York University - Canada; University of Toronto	Sweeney, G (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	gsweeney@yorku.ca		Hinz, Boris/0000-0002-0526-393X	Canadian Diabetes Association; Heart & Stroke Foundation of Canada; Canadian Institutes of Health Research (CIHR) [210820, 286920]	Canadian Diabetes Association; Heart & Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant to GS from the Canadian Diabetes Association. GS also acknowledges support via a Career Investigator Award from Heart & Stroke Foundation of Canada and BH the Canadian Institutes of Health Research (CIHR) grants #210820 and #286920. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Benaitreau D, 2010, J ENDOCRINOL, V207, P45, DOI 10.1677/JOE-10-0170; Berni R, 2009, AM J PHYSIOL-HEART C, V296, pH1625, DOI 10.1152/ajpheart.01057.2008; BLACK FM, 1991, J CLIN INVEST, V88, P1581, DOI 10.1172/JCI115470; Cai XJ, 2010, MOL ENDOCRINOL, V24, P218, DOI 10.1210/me.2009-0128; Clement S, 1999, CIRC RES, V85, pE51; Clement S, 2007, J CELL SCI, V120, P229, DOI 10.1242/jcs.03340; Dadson K, 2014, J CELL BIOCHEM, V115, P785, DOI 10.1002/jcb.24722; Dadson Keith, 2011, Front Endocrinol (Lausanne), V2, P62, DOI 10.3389/fendo.2011.00062; Davis J, 2013, J MOL CELL CARDIOL; Doroudgar S, 2011, TRENDS MOL MED, V17, P207, DOI 10.1016/j.molmed.2010.12.003; Eguchi M, 2012, J CELL MOL MED, V16, P2925, DOI 10.1111/j.1582-4934.2012.01613.x; Eguchi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030450; Essick EE, 2011, AM J PHYSIOL-HEART C, V301, pH984, DOI 10.1152/ajpheart.00428.2011; Fang F, 2013, AM J PHYSIOL-RENAL, V304, pF1366, DOI 10.1152/ajprenal.00137.2012; Fang F, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4070; Fedak PWM, 2005, CARDIOVASC PATHOL, V14, P109, DOI 10.1016/j.carpath.2005.03.004; Fedak PWM, 2005, CARDIOVASC PATHOL, V14, P49, DOI 10.1016/j.carpath.2005.01.005; Fomovsky GM, 2010, J MOL CELL CARDIOL, V48, P490, DOI 10.1016/j.yjmcc.2009.08.003; Fujita K, 2008, ARTERIOSCL THROM VAS, V28, P863, DOI 10.1161/ATVBAHA.107.156687; Guo XH, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.230; Hao G, 2013, ATHEROSCLEROSIS; Hattori Y, 2007, DIABETES, V56, P804, DOI 10.2337/db06-1405; Hecker PA, 2011, HORM METAB RES, V43, P100, DOI 10.1055/s-0030-1269898; Ishikawa Y, 2003, HISTOPATHOLOGY, V42, P43, DOI 10.1046/j.1365-2559.2003.01518.x; Kern S, 2014, FEBS OPEN BIO, V4, P11, DOI 10.1016/j.fob.2013.11.002; Liao YL, 2005, CARDIOVASC RES, V67, P705, DOI 10.1016/j.cardiores.2005.04.018; Liu Y, 2007, J CLIN ENDOCR METAB, V92, P4313, DOI 10.1210/jc.2007-0890; Liu Y, 2013, DIABETES, V62, P743, DOI 10.2337/db12-0687; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; O'Shea KM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-95; O'Shea KM, 2010, AM J PHYSIOL-HEART C, V298, pH1639, DOI 10.1152/ajpheart.00957.2009; Ouchi N, 2006, TRENDS CARDIOVAS MED, V16, P141, DOI 10.1016/j.tcm.2006.03.001; Palanivel R, 2007, CARDIOVASC RES, V75, P148, DOI 10.1016/j.cardiores.2007.04.011; Park M, 2012, HEART FAIL REV; Park M, 2013, HEART FAIL REV, V18, P631, DOI 10.1007/s10741-012-9337-8; Qi GM, 2014, ENDOCRINOLOGY, V155, P2254, DOI 10.1210/en.2013-2011; Rutkowski JM, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-47; Sahebkar A, 2013, METABOLISM, V62, P1876, DOI 10.1016/j.metabol.2013.08.017; Sarrazy V, 2014, CARDIOVASC RES, V102, P407, DOI 10.1093/cvr/cvu053; Schram K, 2008, TRENDS CARDIOVAS MED, V18, P199, DOI 10.1016/j.tcm.2008.10.001; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2007, J MOL CELL CARDIOL, V42, P1065, DOI 10.1016/j.yjmcc.2007.03.808; Shimano M, 2010, J MOL CELL CARDIOL, V49, P210, DOI 10.1016/j.yjmcc.2010.02.021; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Spinale FG, 2013, CIRC RES, V112, P195, DOI 10.1161/CIRCRESAHA.112.266882; Stilli D, 2006, EXP PHYSIOL, V91, P571, DOI 10.1113/expphysiol.2005.032607; Suurmeijer AJH, 2003, J PATHOL, V199, P387, DOI 10.1002/path.1311; Suzuki H, 2006, KIDNEY INT, V70, P1678, DOI 10.1038/sj.ki.5001936; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Turner NA, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-5; van Stijn CMW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086404; Vu V, 2011, INT J OBESITY, V35, P355, DOI 10.1038/ijo.2010.160; Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158; Wu ML, 2009, EUR J PHARMACOL, V616, P155, DOI 10.1016/j.ejphar.2009.05.016; Wu ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078485; Yoon N, 2014, DIABETES METAB J, V38, P92, DOI 10.4093/dmj.2014.38.2.92	58	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0121049	10.1371/journal.pone.0121049	http://dx.doi.org/10.1371/journal.pone.0121049			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910275	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800010
J	Pietersen, E; Peter, J; Streicher, E; Sirgel, F; Rockwood, N; Mastrapa, B; Te Riele, J; Davids, M; van Helden, P; Warren, R; Dheda, K				Pietersen, Elize; Peter, Jonny; Streicher, Elizabeth; Sirgel, Frik; Rockwood, Neesha; Mastrapa, Barbara; Te Riele, Julian; Davids, Malika; van Helden, Paul; Warren, Robin; Dheda, Keertan			High Frequency of Resistance, Lack of Clinical Benefit, and Poor Outcomes in Capreomycin Treated South African Patients with Extensively Drug-Resistant Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MULTIDRUG-RESISTANT; COHORT	Background There are limited data about the epidemiology and treatment-related outcomes associated with capreomycin resistance in patients with XDR-TB. Capreomycin achieves high serum concentrations relative to MIC but whether capreomycin has therapeutic benefit despite microbiological resistance remains unclear. Methods We reviewed the susceptibility profiles and outcomes associated with capreomycin usage in patients diagnosed with XDR-TB between August 2002 and October 2012 in two provinces of South Africa. Patients whose isolates were genotypically tested for capreomycin resistance were included in the analysis. Results Of 178 XDR-TB patients 41% were HIV-infected. 87% (154/178) isolates contained a capreomycin resistance-conferring mutation [80% (143/178) rrs A1401G and 6% (11/178) were heteroresistant (containing both the rrs A1401G mutation and wild-type sequences)]. Previous MDR-TB treatment, prior usage of kanamycin, or strain type was not associated with capreomycin resistance. 92% (163/178) of XDR-TB patients were empirically treated with capreomycin. Capreomycin resistance decreased the odds of sputum culture conversion. In capreomycin sensitive and resistant persons combined weight at diagnosis was the only independent predictor for survival (p=<0.001). By contrast, HIV status and use of co-amoxicillin/clavulanic acid were independent predictors of mortality (p=<0.05). Capreomycin usage was not associated with survival or culture conversion when the analysis was restricted to those whose isolates were resistant to capreomycin. Conclusion In South Africa the frequency of capreomycin conferring mutations was extremely high in XDR-TB isolates. In those with capreomycin resistance there appeared to be no therapeutic benefit of using capreomycin. These data inform susceptibility testing and the design of treatment regimens for XDR-TB in TB endemic settings.	[Pietersen, Elize; Peter, Jonny; Davids, Malika; Dheda, Keertan] Univ Cape Town, Dept Med, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; [Pietersen, Elize; Peter, Jonny; Davids, Malika; Dheda, Keertan] Univ Cape Town, Dept Med, Lung Inst, ZA-7925 Cape Town, South Africa; [Streicher, Elizabeth; Sirgel, Frik; van Helden, Paul; Warren, Robin] Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet,South African MRC,Ctr, Dept Sci & Technol,Natl Res Fdn,Ctr Excellence Bi, ZA-7505 Tygerberg, South Africa; [Mastrapa, Barbara] Gordonia Prov Hosp, Upington, South Africa; [Rockwood, Neesha] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Te Riele, Julian] Brooklyn Chest Hosp, Cape Town, South Africa	University of Cape Town; University of Cape Town; National Research Foundation - South Africa; Stellenbosch University; Imperial College London	Dheda, K (corresponding author), Univ Cape Town, Dept Med, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za	Streicher, Elizabeth M/I-7780-2018; Streicher, Elizabeth/O-9597-2019	Streicher, Elizabeth M/0000-0003-3901-1981; Streicher, Elizabeth/0000-0003-3901-1981; Rockwood, Neesha/0000-0002-7830-1394; Peter, Jonathan/0000-0002-2658-0723; Warren, Robin/0000-0001-5741-7358	South African National Research Foundation; South African Research Chair Initiative (SARChI); Opperheimer Foundation	South African National Research Foundation(National Research Foundation - South Africa); South African Research Chair Initiative (SARChI); Opperheimer Foundation	This study was funded by the South African National Research Foundation, South African Research Chair Initiative (SARChI), and the Opperheimer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, TUBERCULOSIS EDINB, V88, P89, DOI DOI 10.1016/S1472-9792(08)70004-0; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Georghiou SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033275; Jacobson KR, 2011, CLIN INFECT DIS, V53, P369, DOI 10.1093/cid/cir406; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Klopper M, 2013, EMERG INFECT DIS, V19, P449, DOI [10.3201/EID1903.120246, 10.3201//EID1903.120246]; Kvasnovsky CL, 2011, JAIDS-J ACQ IMM DEF, V57, P146, DOI 10.1097/QAI.0b013e31821190a3; Migliori GB, 2008, EUR RESPIR J, V31, P1155, DOI 10.1183/09031936.00028708; Migliori GB, 2013, EUR RESPIR J, V42, P169, DOI 10.1183/09031936.00136312; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; O'Donnell MR, 2009, INT J TUBERC LUNG D, V13, P855; O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008; PELOQUIN CA, 1993, MED CLIN N AM, V77, P1253, DOI 10.1016/S0025-7125(16)30191-2; Pietersen E, 2014, LANCET, V383, P1230, DOI 10.1016/S0140-6736(13)62675-6; Pooran A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054587; Shean K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063057; Sirgel FA, 2012, MICROB DRUG RESIST, V18, P193, DOI 10.1089/mdr.2011.0063; Streicher EM, 2012, ANTIMICROB AGENTS CH, V56, P2420, DOI 10.1128/AAC.05905-11; Streicher EM, 2012, INFECT GENET EVOL, V12, P686, DOI 10.1016/j.meegid.2011.07.019; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; WHO, GLOB TUB REP 2014; World Health organization, 2008, POL GUID DRUG SUSC T	22	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123655	10.1371/journal.pone.0123655	http://dx.doi.org/10.1371/journal.pone.0123655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909847	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800042
J	Gong, P; Lu, ZD; Xing, J; Wang, N; Zhang, Y				Gong, Ping; Lu, Zhidan; Xing, Jing; Wang, Na; Zhang, Yu			Traditional Chinese Medicine Xuebijing Treatment Is Associated with Decreased Mortality Risk of Patients with Moderate Paraquat Poisoning	PLOS ONE			English	Article							NF-KAPPA-B; HERBICIDE PARAQUAT; IN-VIVO; INJECTION; CELLS; MACROPHAGES; EXPRESSION; IDENTIFICATION; INFLAMMATION; ACTIVATION	Paraquat poisoning causes multiple organ injury and high mortality due to severe toxicity and lack of effective treatment. Xuebijing (XBJ) injection, a traditional Chinese medicine preparation of five Chinese herbs (Radix Salviae Miltiorrhiae, Rhizoma Chuanxiong, Flos Carthami, Angelica Sinensis and Radix Paeoniae Rubra), has an anti-inflammatory effect and is widely used in the treatment of sepsis. This retrospective study was designed to evaluate the effects of XBJ combined with conventional therapy on mortality risk of patients with acute paraquat poisoning. Out of 68 patients, 27 were treated with conventional therapy (control group) and 41 were treated with intravenous administration of XBJ (100 ml, twice a day, up to 7 days) plus conventional therapy (XBJ group). Vital organ function, survival time within 28 days and adverse events during the treatment were reviewed. Results indicated that XBJ treatment significantly increased median survival time among patients ingesting 1030 ml of paraquat (P=0.02) compared with the control group. After adjustment for covariates, XBJ treatment was associated significantly with a lower mortality risk (adjusted HR 0.242, 95% CI 0.113 to 0.516, P=0.001) compared with the control group. Additionally, compared with Day 1, on Day 3 the value of PaO2/FiO(2) was significantly decreased, and the values of serum alanine aminotransferase, creatinine and troponin T were significantly increased in the control group (all P<0.05), but these values were significant improved in the XBJ group (all P<0.05). Only one patient had skin rash with itch within 30 minutes after injection and no severe adverse events were found in the XBJ group. In conclusion, XBJ treatment is associated with decreased mortality risk of patients with moderate paraquat poisoning, which may be attributed to improved function of vital organs with no severe adverse events.	[Gong, Ping; Lu, Zhidan; Xing, Jing; Wang, Na; Zhang, Yu] Dalian Med Univ, Affiliated Hosp 1, Emergency Dept, Dalian 116011, Liaoning Provin, Peoples R China	Dalian Medical University	Zhang, Y (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Emergency Dept, Dalian 116011, Liaoning Provin, Peoples R China.	dljizhen@sina.cn	Gong, Ping/AAV-1936-2021	Gong, Ping/0000-0001-9910-7948	Liaoning Province Nature Science Foundation [2013023020]; Training Programs of Talents in Science and Technology [2013D003]	Liaoning Province Nature Science Foundation; Training Programs of Talents in Science and Technology	This study was supported by the Liaoning Province Nature Science Foundation (2013023020) and the Training Programs of Talents in Science and Technology (2013D003). The funders had no role in study design, data collection/analysis, decision to publish, or preparation of the manuscript.	Aires RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073562; Bonneh-Barkay D, 2005, MOL BRAIN RES, V134, P52, DOI 10.1016/j.molbrainres.2004.11.005; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Chao WW, 2010, J ETHNOPHARMACOL, V129, P244, DOI 10.1016/j.jep.2010.03.022; Chen Y, 2013, J TRADIT CHIN MED, V33, P243, DOI 10.1016/S0254-6272(13)60133-8; China's State Food and Drug Administration, 2014, QUAL CONTR STAND DRU; Deng J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010109.pub2; Dinis-Oliveira RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007149; Gawarammana IB, 2011, BRIT J CLIN PHARMACO, V72, P745, DOI 10.1111/j.1365-2125.2011.04026.x; Hsieh YW, 2013, PEDIATR EMERG CARE, V29, P487, DOI 10.1097/PEC.0b013e31828a347e; Hsu CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048397; Hsu HH, 2003, J TOXICOL-CLIN TOXIC, V41, P89, DOI 10.1081/CLT-120018278; Huang H, 2011, PHYTOCHEM ANALYSIS, V22, P330, DOI 10.1002/pca.1284; Jia P, 2013, TALANTA, V107, P103, DOI 10.1016/j.talanta.2012.12.031; Jiang M, 2013, J ETHNOPHARMACOL, V147, P426, DOI 10.1016/j.jep.2013.03.032; Jiang WY, 2013, INT IMMUNOPHARMACOL, V16, P160, DOI 10.1016/j.intimp.2013.03.028; Jones GM, 2000, J TOXICOL-CLIN TOXIC, V38, P123, DOI 10.1081/CLT-100100926; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; [孔飞飞 Kong Feifei], 2012, [中国新药杂志, Chinese Journal New Drugs], V21, P100; Koo JR, 2002, AM J KIDNEY DIS, V39, P55, DOI 10.1053/ajkd.2002.29880; Kratsovnik E, 2005, J MOL NEUROSCI, V26, P27, DOI 10.1385/JMN:26:1:027; Li M, 2012, PHYTOTHER RES, V26, P1195, DOI 10.1002/ptr.3680; Lin NC, 2003, J TOXICOL-CLIN TOXIC, V41, P877, DOI 10.1081/CLT-120025356; Liu L, 2005, PLANTA MED, V71, P808, DOI 10.1055/s-2005-871231; Qi F, 2011, J TRADIT CHIN MED, V31, P46, DOI 10.1016/S0254-6272(11)60011-3; Ran X, 2011, PHARM BIOL, V49, P1180, DOI 10.3109/13880209.2011.576346; Ren ZH, 2010, PHYTOMEDICINE, V17, P212, DOI 10.1016/j.phymed.2009.08.010; Saw CLL, 2013, BIOPHARM DRUG DISPOS, V34, P303, DOI 10.1002/bdd.1846; Schoonbroodt S, 2000, BIOCHEM PHARMACOL, V60, P1075, DOI 10.1016/S0006-2952(00)00371-3; Shi YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040911; Song LJ, 2013, FITOTERAPIA, V84, P107, DOI 10.1016/j.fitote.2012.11.004; Su YW, 2011, INT IMMUNOPHARMACOL, V11, P1166, DOI 10.1016/j.intimp.2011.03.014; Sun JP, 2010, EXP LUNG RES, V36, P211, DOI 10.3109/01902140903312123; Sun ML, 2009, J ALTERN COMPLEM MED, V15, P1375, DOI 10.1089/acm.2009.0049; Tang S, 2011, INFLAMMATION, V34, P111, DOI 10.1007/s10753-010-9214-3; Wang CC, 2011, J SCI FOOD AGR, V91, P218, DOI 10.1002/jsfa.4172; Weng CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051743; Yang W, 2007, J TOXICOL ENV HEAL A, V70, P1849, DOI 10.1080/15287390701459262; Yin X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038381, 10.1371/journal.pone.0051853]; Zheng XB, 2012, J TRADIT CHIN MED, V32, P584, DOI 10.1016/S0254-6272(13)60075-8	40	21	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123504	10.1371/journal.pone.0123504	http://dx.doi.org/10.1371/journal.pone.0123504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923333	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600049
J	London, CA; Gardner, HL; Mathie, T; Stingle, N; Portela, R; Pennell, ML; Clifford, CA; Rosenberg, MP; Vail, DM; Williams, LE; Cronin, KL; Wilson-Robles, H; Borgatti, A; Henry, CJ; Balley, DB; Locke, J; Northrup, NC; Crawford-Jakubiak, M; Gill, VL; Klein, MK; Ruslander, DM; Thamm, DH; Phillips, B; Post, G				London, Cheryl A.; Gardner, Heather L.; Mathie, Tamra; Stingle, Nicole; Portela, Roberta; Pennell, Michael L.; Clifford, Craig A.; Rosenberg, Mona P.; Vail, David M.; Williams, Laurel E.; Cronin, Kim L.; Wilson-Robles, Heather; Borgatti, Antonella; Henry, Carolyn J.; Balley, Dennis B.; Locke, Jennifer; Northrup, Nicole C.; Crawford-Jakubiak, Martin; Gill, Virginia L.; Klein, Mary K.; Ruslander, David M.; Thamm, Doug H.; Phillips, Brenda; Post, Gerald			Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DOXORUBICIN COMBINATION CHEMOTHERAPY; TYROSINE KINASE INHIBITOR; LOW-DOSE CYCLOPHOSPHAMIDE; REGULATORY T-CELLS; METRONOMIC CHEMOTHERAPY; CANINE OSTEOSARCOMA; SOLID TUMORS; ORAL CYCLOPHOSPHAMIDE; ADJUVANT CARBOPLATIN	Background We hypothesized that the addition of toceranib to metronomic cyclophosphamide/piroxicam therapy would significantly improve disease-free interval (DFI) and overall survival (OS) in dogs with appendicular osteosarcoma (OSA) following amputation and carboplatin chemotherapy. Methods and Findings This was a randomized, prospective clinical trial in which dogs with OSA free of gross metastatic disease (n = 126) received carboplatin chemotherapy (4 doses) following amputation. On study entry, dogs were randomized to receive piroxicam/cyclophosphamide with or without toceranib (n = 63 each) after completing chemotherapy. Patient demographics were not significantly different between both groups. During or immediately following carboplatin chemotherapy, 32 dogs (n = 13 toceranib; n = 19 control) developed metastatic disease, and 13 dogs left the study due to other medical conditions or owner preference. Following carboplatin chemotherapy, 81 dogs (n = 46 toceranib; n = 35 control) received the metronomic treatment; 35 dogs (n = 20 toceranib; n = 15 control) developed metastatic disease during the maintenance therapy, and 26 dogs left the study due to other medical conditions or owner preference. Nine toceranib-treated and 11 control dogs completed the study without evidence of metastatic disease 1-year following amputation. Toceranib-treated dogs experienced more episodes of diarrhea, neutropenia and weight loss than control dogs, although these toxicities were low-grade and typically resolved with supportive care. More toceranibtreated dogs (n = 8) were removed from the study for therapy-associated adverse events compared to control dogs (n = 1). The median DFI for control and toceranib treated dogs was 215 and 233 days, respectively (p = 0.274); the median OS for control and toceranib treated dogs was 242 and 318 days, respectively (p = 0.08). The one year survival rate for control dogs was 35% compared to 38% for dogs receiving toceranib. Conclusions The addition of toceranib to metronomic piroxicam/cyclophosphamide therapy following amputation and carboplatin chemotherapy did not improve median DFI, OS or the 1-year survival rate in dogs with OSA.	[London, Cheryl A.; Gardner, Heather L.; Mathie, Tamra; Stingle, Nicole] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA; [London, Cheryl A.; Gardner, Heather L.; Mathie, Tamra; Stingle, Nicole] Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA; [Portela, Roberta] Univ Illinois, Coll Vet Med, Dept Vet Clin Med, Champaign, IL USA; [Pennell, Michael L.] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA; [Clifford, Craig A.] Hope Vet Specialists, Malvern, PA USA; [Rosenberg, Mona P.] Vet Canc Grp, Tustin, CA USA; [Vail, David M.] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA; [Williams, Laurel E.] N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC USA; [Cronin, Kim L.] New England Vet Oncol Grp, Waltham, MA USA; [Wilson-Robles, Heather] Texas A&M Univ, Coll Vet Med, Dept Small Anim Clin Sci, College Stn, TX 77843 USA; [Borgatti, Antonella] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Henry, Carolyn J.] Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA; [Balley, Dennis B.] Oradell Anim Hosp, Paramus, NJ USA; [Locke, Jennifer] Southeast Vet Oncol & Med, Orange, FL USA; [Northrup, Nicole C.] Univ Georgia, Coll Vet Med, Dept Small Anim Med & Surg, Athens, GA USA; [Crawford-Jakubiak, Martin] Sage Ctr Vet Specialty & Emergency Care, Concord, CA USA; [Gill, Virginia L.] VCA Katonah Bedford Vet Ctr, Bedford, NY USA; [Klein, Mary K.] Southwest Vet Oncol, Tucson, AZ USA; [Ruslander, David M.] Vet Specialty Hosp Carolinas, Cary, NC USA; [Thamm, Doug H.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA; [Phillips, Brenda] Vet Specialty Hosp San Diego, San Diego, CA USA; [Post, Gerald] Vet Canc Ctr, Norwalk, CT USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Urbana-Champaign; University System of Ohio; Ohio State University; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; North Carolina State University; Texas A&M University System; Texas A&M University College Station; University of Minnesota System; University of Minnesota Twin Cities; University of Missouri System; University of Missouri Columbia; University System of Georgia; University of Georgia; Colorado State University	London, CA (corresponding author), Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA.	london.20@osu.edu	Post, Gerry/H-4450-2019; Thamm, Douglas H/I-5976-2013; Thamm, Douglas/AAG-3672-2020; Wilson-Robles, Heather/D-4209-2016	Post, Gerry/0000-0002-8309-6209; Thamm, Douglas H/0000-0002-8914-7767; , Carolyn/0000-0002-2761-5203; Clifford, Craig/0000-0002-9896-9906; Wilson-Robles, Heather/0000-0002-6489-8468	National Center for Advancing Translational Sciences [UL1TR001070]; National Cancer Institute [P30CA016058]; Zoetis; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070, UL1TR000090] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Zoetis; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was supported by the following grants: UL1TR001070 from the National Center for Advancing Translational Sciences and P30CA016058 from the National Cancer Institute to The Ohio State University. Funding for this clinical trial and the toceranib for treated dogs was provided by Zoetis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bailey D, 2003, J VET INTERN MED, V17, P199, DOI 10.1892/0891-6640(2003)017&lt;0199:CADCCF&gt;2.3.CO;2; Bergman PJ, 1996, J VET INTERN MED, V10, P76, DOI 10.1111/j.1939-1676.1996.tb02031.x; Bernabe LF, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-190; Bertolini F, 2003, CANCER RES, V63, P4342; Boerman I, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-56; Bracha S, 2014, J SMALL ANIM PRACT, V55, P369, DOI 10.1111/jsap.12228; Browder T, 2000, CANCER RES, V60, P1878; Burton JH, 2011, J VET INTERN MED, V25, P920, DOI 10.1111/j.1939-1676.2011.0753.x; Choisunirachon N, 2013, VET CO IN PRESS 0726; Chun R, 2005, J AM ANIM HOSP ASSOC, V41, P382, DOI 10.5326/0410382; Chun R, 2000, J VET INTERN MED, V14, P495, DOI 10.1892/0891-6640(2000)014&lt;0495:CADCCF&gt;2.3.CO;2; Colleselli D, 2006, EXP CELL RES, V312, P2933, DOI 10.1016/j.yexcr.2006.05.021; Dellapasqua S, 2008, J CLIN ONCOL, V26, P4899, DOI 10.1200/JCO.2008.17.4789; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Elmslie RE, 2008, J VET INTERN MED, V22, P1373, DOI 10.1111/j.1939-1676.2008.0179.x; Fenger JM, 2014, ILAR J, V55, P69, DOI 10.1093/ilar/ilu009; Gaeta R, 2014, VET COMP ONCOL, V12, P277, DOI 10.1111/vco.12009; Garcia-Saenz JA, 2008, J CHEMOTHERAPY, V20, P632, DOI 10.1179/joc.2008.20.5.632; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Jankowski M K, 2003, Vet Comp Oncol, V1, P152, DOI 10.1111/j.1476-5829.2003.00021.x; Kaya M, 2000, CLIN CANCER RES, V6, P572; Kent MS, 2004, J VET INTERN MED, V18, P540, DOI 10.1892/0891-6640(2004)18&lt;540:ACADAA&gt;2.0.CO;2; Klement G, 2000, J CLIN INVEST, V105, pR15, DOI 10.1172/JCI8829; Krzyzanowska MK, 2007, CANCER CHEMOTH PHARM, V60, P135, DOI 10.1007/s00280-006-0347-x; Kuntz CA, 1998, VET SURG, V27, P417, DOI 10.1111/j.1532-950X.1998.tb00150.x; Lana S, 2007, J VET INTERN MED, V21, P764; Leach TN, 2012, VET COMP ONCOL, V10, P102, DOI 10.1111/j.1476-5829.2011.00280.x; London C, 2012, VET COMP ONCOL, V10, P194, DOI 10.1111/j.1476-5829.2011.00275.x; London CA, 2003, CLIN CANCER RES, V9, P2755; London CA, 2009, CLIN CANCER RES, V15, P3856, DOI 10.1158/1078-0432.CCR-08-1860; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Maris JM, 2008, PEDIATR BLOOD CANCER, V50, P581, DOI 10.1002/pbc.21232; McMahon M, 2011, J VET INTERN MED, V25, P511, DOI 10.1111/j.1939-1676.2011.0697.x; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Mitchell L, 2012, J VET INTERN MED, V26, P355, DOI 10.1111/j.1939-1676.2011.00883.x; Moore AS, 2007, J VET INTERN MED, V21, P783, DOI 10.1892/0891-6640(2007)21[783:DABFTT]2.0.CO;2; Ohba T, 2014, MOL CANCER RES, V12, P1100, DOI 10.1158/1541-7786.MCR-14-0037; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Philips B, 2009, J AM ANIM HOSP ASSOC, V45, P33, DOI 10.5326/0450033; Pignochino Y, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-118; Pryer NK, 2003, CLIN CANCER RES, V9, P5729; Saam DE, 2011, JAVMA-J AM VET MED A, V238, P195, DOI 10.2460/javma.238.2.195; Sacornrattana O, 2013, VET COMP ONCOL, V11, P199, DOI 10.1111/j.1476-5829.2011.00312.x; Schmidt AF, 2013, PREV VET MED, V112, P414, DOI 10.1016/j.prevetmed.2013.08.011; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Selmic LE, 2014, J VET INTERN MED, V28, P554, DOI 10.1111/jvim.12313; Singh M, 2012, J PATHOL, V227, P417, DOI 10.1002/path.4053; SPODNICK GJ, 1992, J AM VET MED ASSOC, V200, P995; Stempak D, 2006, J PEDIAT HEMATOL ONC, V28, P720, DOI 10.1097/01.mph.0000243657.64056.c3; Stoelting S, 2008, IN VIVO, V22, P831; Thamm DH, 2008, VET COMP ONCOL, V6, P126, DOI 10.1111/j.1476-5829.2007.00153.x; Vail DM, 2013, WITHROW MACEWENS SMA, V5th, P463; van Cruijsen H, 2010, EUR J CANCER, V46, P901, DOI 10.1016/j.ejca.2009.12.023; Veterinary Co-operative Oncology Group (VCOG), 2004, Vet Comp Oncol, V2, P195, DOI 10.1111/j.1476-5810.2004.0053b.x; Wallace M, 2013, J AM ANIM HOSP ASSOC, V49, P243, DOI 10.5326/JAAHA-MS-5862; Wergin MC, 2004, IN VIVO, V18, P15; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Yang JL, 2011, CANCER-AM CANCER SOC, V117, P4925, DOI 10.1002/cncr.26116	60	38	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124889	10.1371/journal.pone.0124889	http://dx.doi.org/10.1371/journal.pone.0124889			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923466	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600110
J	Mishra, DR; Chaudhary, S; Krishna, BM; Mishra, SK				Mishra, Dipti Ranjan; Chaudhary, Sanjib; Krishna, B. Madhu; Mishra, Sandip K.			Identification of Critical Elements for Regulation of Inorganic Pyrophosphatase (PPA1) in MCF7 Breast Cancer Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SP1; PROTEIN-30 GENE PROMOTER; HUMAN GASTRIC-CANCER; POSTTRANSLATIONAL MODIFICATIONS; CHROMATIN ACCESSIBILITY; INCREASED EXPRESSION; MASS-SPECTROMETRY; BINDING-ACTIVITY; CYCLE ARREST; LIVER	Cytosolic inorganic pyrophosphatase plays an important role in the cellular metabolism by hydrolyzing inorganic pyrophosphate (PPi) formed as a by-product of various metabolic reactions. Inorganic pyrophosphatases are known to be associated with important functions related to the growth and development of various organisms. In humans, the expression of inorganic pyrophosphatase (PPA1) is deregulated in different types of cancer and is involved in the migration and invasion of gastric cancer cells and proliferation of ovarian cancer cells. However, the transcriptional regulation of the gene encoding PPA1 is poorly understood. To gain insights into PPA1 gene regulation, a 1217 bp of its 5'-flanking region was cloned and analyzed. The 5'-deletion analysis of the promoter revealed a 266 bp proximal promoter region exhibit most of the transcriptional activity and upon sequence analysis, three putative Sp1 binding sites were found to be present in this region. Binding of Sp1 to the PPA1 promoter was confirmed by Electrophoretic mobility shift assay (EMSA) and Chromatin immunoprecipitation (ChIP) assay. Importance of these binding sites was verified by site-directed mutagenesis and overexpression of Sp1 transactivates PPA1 promoter activity, upregulates protein expression and increases chromatin accessibility. p300 binds to the PPA1 promoter and stimulates Sp1 induced promoter activity. Trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor induces PPA1 promoter activity and protein expression and HAT activity of p300 was important in regulation of PPA1 expression. These results demonstrated that PPA1 is positively regulated by Sp1 and p300 coactivates Sp1 induced PPA1 promoter activity and histone acetylation/deacetylation may contribute to a local chromatin remodeling across the PPA1 promoter. Further, knockdown of PPA1 decreased colony formation and viability of MCF7 cells.	[Mishra, Dipti Ranjan; Chaudhary, Sanjib; Krishna, B. Madhu; Mishra, Sandip K.] Inst Life Sci, Canc Biol Lab, Gene Funct & Regulat Grp, Bhubaneswar, Odisha, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Mishra, SK (corresponding author), Inst Life Sci, Canc Biol Lab, Gene Funct & Regulat Grp, Bhubaneswar, Odisha, India.	sandipkmishra@hotmail.com		Mishra, Sandip/0000-0002-0776-6581	core grant of Institute of Life Sciences, Department of Biotechnology, Government of India; Indian Council of Medical Research; Department of Biotechnology, India	core grant of Institute of Life Sciences, Department of Biotechnology, Government of India; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by core grant of Institute of Life Sciences, Department of Biotechnology, Government of India. DRM was supported by research fellowship from Indian Council of Medical Research and, SC and BMK were supported by research fellowships from Department of Biotechnology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2002, J BIOL CHEM, V277, P28815, DOI 10.1074/jbc.M203828200; Archer Michael C, 2011, Genes Cancer, V2, P712, DOI 10.1177/1947601911423029; Baykov A A, 1999, Prog Mol Subcell Biol, V23, P127; Billon N, 1999, ONCOGENE, V18, P2872, DOI 10.1038/sj.onc.1202712; Cerella Claudia, 2013, Int J Cell Biol, V2013, P639401, DOI 10.1155/2013/639401; Chahed K, 2005, INT J ONCOL, V27, P1425; Chang WC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-94; Chen GA, 2002, CLIN CANCER RES, V8, P2298; CHEN J, 1990, J BACTERIOL, V172, P5686, DOI 10.1128/jb.172.10.5686-5689.1990; Chiefari E, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-35; Cho KS, 2004, CURR OPIN GENET DEV, V14, P308, DOI 10.1016/j.gde.2004.04.015; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cruickshank M, 2008, BIOCHEM BIOPH RES CO, V367, P349, DOI 10.1016/j.bbrc.2007.12.121; Garnis C, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-9; Giri K, 2014, BIOCONJUGATE CHEM, V25, P1078, DOI 10.1021/bc500084f; Hamler RL, 2004, PROTEOMICS, V4, P562, DOI 10.1002/pmic.200300606; Islam MK, 2005, INFECT IMMUN, V73, P1995, DOI 10.1128/IAI.73.4.1995-2004.2005; Jeong SH, 2012, TUMOR BIOL, V33, P1889, DOI 10.1007/s13277-012-0449-5; Jiang NY, 2008, CANCER EPIDEM BIOMAR, V17, P1648, DOI 10.1158/1055-9965.EPI-07-2791; Kachman MT, 2002, ANAL CHEM, V74, P1779, DOI 10.1021/ac011159c; Kharbhih WJ, 2014, BIOGERONTOLOGY, V15, P81, DOI 10.1007/s10522-013-9481-0; Ko KM, 2007, FEBS LETT, V581, P5445, DOI 10.1016/j.febslet.2007.10.047; LETOVSKY J, 1989, NUCLEIC ACIDS RES, V17, P2639, DOI 10.1093/nar/17.7.2639; Li JJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000910; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Megger DA, 2013, MOL CELL PROTEOMICS, V12, P2006, DOI 10.1074/mcp.M113.028027; Narayan VA, 1997, J BIOL CHEM, V272, P7801, DOI 10.1074/jbc.272.12.7801; Panda H, 2007, BIOGERONTOLOGY, V8, P517, DOI 10.1007/s10522-007-9094-6; Panda H, 2007, GENE EXPRESSION, V14, P13, DOI 10.3727/000000007783991754; Papavassiliou AG, 2001, EMBO REP, V2, P80, DOI 10.1093/embo-reports/kve033; Rath B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-43; Sambrook J., 2001, MOL CLONING LAB MANU; Sar P, 2012, J CANC SCI THER, V4, P227; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Serrano-Bueno G, 2013, J BIOL CHEM, V288, P13082, DOI 10.1074/jbc.M112.439349; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; Solovyev VV, 2003, NUCLEIC ACIDS RES, V31, P3540, DOI 10.1093/nar/gkg525; Sun FY, 2009, NUCLEIC ACIDS RES, V37, P3897, DOI 10.1093/nar/gkp261; Supakar PC, 2000, BIOCHEM BIOPH RES CO, V272, P436, DOI 10.1006/bbrc.2000.2799; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Terzic N, 2003, J GERONTOL A-BIOL, V58, P297; Tezuka Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061649; Tomonaga T, 2004, CLIN CANCER RES, V10, P2007, DOI 10.1158/1078-0432.CCR-03-0321; Vindevoghel L, 1997, J BIOL CHEM, V272, P10196; Wang GG, 2007, TRENDS MOL MED, V13, P373, DOI 10.1016/j.molmed.2007.07.004; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; Wang JY, 2010, BIOCHEM BIOPH RES CO, V393, P291, DOI 10.1016/j.bbrc.2010.01.127; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Wang LW, 2005, CLIN EXP METASTAS, V22, P205, DOI 10.1007/s10585-005-5684-3; Wang X, 2008, ONCOGENE, V27, P1894, DOI 10.1038/sj.onc.1210821; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Xiao HY, 2000, J BIOL CHEM, V275, P1371, DOI 10.1074/jbc.275.2.1371; Zannetti A, 2000, CANCER RES, V60, P1546	53	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124864	10.1371/journal.pone.0124864	http://dx.doi.org/10.1371/journal.pone.0124864			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923237	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600108
J	Wu, KF; Luo, T; Li, L; Zhang, QQ; Zhu, JH; Gao, Q; Chen, M; Zhu, M				Wu, Kefei; Luo, Tao; Li, Li; Zhang, Qiangqiang; Zhu, Junhao; Gao, Qian; Chen, Min; Zhu, Min			Multilocus Sequence Typing of Pathogenic Candida albicans Isolates Collected from a Teaching Hospital in Shanghai, China: A Molecular Epidemiology Study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; BLOOD-STREAM; POPULATION; PHYLOGENETICS	Molecular typing of Candida albicansis important for studying the population structure and epidemiology of this opportunistic yeast, such as population dynamics, nosocomial infections, multiple infections and microevolution. The genetic diversity of C. albicanshas been rarely studied in China. In the present study, multilocus sequence typing (MLST) was used to characterize the genetic diversity and population structure of 62 C. albicansisolates collected from 40 patients from Huashan Hospital in Shanghai, China. A total of 50 diploid sequence types (DSTs) were identified in the 62 C. albicansisolates, with 41 newly identified DSTs. Based on cluster analysis, the 62 isolates were classified into nine existing clades and two new clades (namely clades New 1 and New 2). The majority of the isolates were clustered into three clades, clade 6 (37.5%), clade 1 (15.0%) and clade 17 (15.0%). Isolates of clade New 2 were specifically identified in East Asia. We identified three cases of potential nosocomial transmission based on association analysis between patients' clinical data and the genotypes of corresponding isolates. Finally, by analyzing the genotypes of serial isolates we further demonstrated that the microevolution of C. albicans was due to loss of heterozygosity. Our study represents the first molecular typing of C. albicansin eastern China, and we confirmed that MLST is a useful tool for studying the epidemiology and evolution of C. albicans.	[Wu, Kefei; Li, Li; Zhang, Qiangqiang; Zhu, Junhao; Zhu, Min] Fudan Univ, Huashan Hosp, Dept Dermatol, Ctr Med Mycol, Shanghai 200040, Peoples R China; [Wu, Kefei; Luo, Tao; Gao, Qian] Fudan Univ, Inst Biomed Sci, Key Lab Med Mol Virol, Shanghai 200032, Peoples R China; [Wu, Kefei; Luo, Tao; Gao, Qian] Fudan Univ, Inst Med Microbiol, Shanghai 200032, Peoples R China; [Chen, Min] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Dermatol, Shanghai Key Lab Mol Med Mycol, Shanghai 200003, Peoples R China	Fudan University; Fudan University; Fudan University; Naval Medical University	Zhu, M (corresponding author), Fudan Univ, Huashan Hosp, Dept Dermatol, Ctr Med Mycol, Shanghai 200040, Peoples R China.	zhumin3000@hotmail.com	, 罗涛/AHA-1191-2022					Asticcioli S, 2007, NEW MICROBIOL, V30, P303; Bougnoux ME, 2006, J CLIN MICROBIOL, V44, P1810, DOI 10.1128/JCM.44.5.1810-1820.2006; Bougnoux ME, 2003, J CLIN MICROBIOL, V41, P5265, DOI 10.1128/JCM.41.11.5265-5266.2003; Bougnoux ME, 2002, J CLIN MICROBIOL, V40, P1290, DOI 10.1128/JCM.40.4.1290-1297.2002; Cliff PR, 2008, J HOSP INFECT, V69, P24, DOI 10.1016/j.jhin.2008.02.006; Da Matta DA, 2010, J CLIN MICROBIOL, V48, P3062, DOI 10.1128/JCM.00262-10; Dalle F, 2000, J CLIN MICROBIOL, V38, P4554, DOI 10.1128/JCM.38.12.4554-4559.2000; Dodgson AR, 2004, ANTIMICROB AGENTS CH, V48, P2223, DOI 10.1128/AAC.48.6.2223-2227.2004; Forche A, 2005, EUKARYOT CELL, V4, P156, DOI 10.1128/EC.4.1.156-165.2005; Forche A, 2004, EUKARYOT CELL, V3, P705, DOI 10.1128/EC.3.3.705-714.2004; Ge SH, 2012, FUNGAL GENET BIOL, V49, P86, DOI 10.1016/j.fgb.2011.10.006; Gong YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035311; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Odds FC, 2010, FUTURE MICROBIOL, V5, P67, DOI 10.2217/FMB.09.113; Pittet D, 1997, CLIN INFECT DIS, V24, P1068, DOI 10.1086/513640; Shin JH, 2011, J CLIN MICROBIOL, V49, P2572, DOI 10.1128/JCM.02153-10; Tavanti A, 2005, J CLIN MICROBIOL, V43, P5601, DOI 10.1128/JCM.43.11.5601-5613.2005; Xiao Yu-Ling, 2012, Sichuan Da Xue Xue Bao Yi Xue Ban, V43, P697	19	13	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125245	10.1371/journal.pone.0125245	http://dx.doi.org/10.1371/journal.pone.0125245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919124	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400078
J	Fill, JM; Waldron, JL; Welch, SM; Gibbons, JW; Bennett, SH; Mousseau, TA				Fill, Jennifer M.; Waldron, Jayme L.; Welch, Shane M.; Gibbons, J. Whitfield; Bennett, Stephen H.; Mousseau, Timothy A.			Using Multiscale Spatial Models to Assess Potential Surrogate Habitat for an Imperiled Reptile	PLOS ONE			English	Article							HOME-RANGE SIZE; BANDWIDTH SELECTION; MOVEMENT PATTERNS; FOREST; VULNERABILITY; SPECIFICITY; ATTRIBUTES; ESTIMATORS; HISTORY; REGIME	In evaluating conservation and management options for species, practitioners might consider surrogate habitats at multiple scales when estimating available habitat or modeling species' potential distributions based on suitable habitats, especially when native environments are rare. Species' dependence on surrogates likely increases as optimal habitat is degraded and lost due to anthropogenic landscape change, and thus surrogate habitats may be vital for an imperiled species' survival in highly modified landscapes. We used spatial habitat models to examine a potential surrogate habitat for an imperiled ambush predator (eastern diamondback rattlesnake, Crotalus adamanteus; EDB) at two scales. The EDB is an apex predator indigenous to imperiled longleaf pine ecosystems (Pinus palustris) of the southeastern United States. Loss of native open-canopy pine savannas and woodlands has been suggested as the principal cause of the species' extensive decline. We examined EDB habitat selection in the Coastal Plain tidewater region to evaluate the role of marsh as a potential surrogate habitat and to further quantify the species' habitat requirements at two scales: home range (HR) and within the home range (WHR). We studied EDBs using radiotelemetry and employed an information-theoretic approach and logistic regression to model habitat selection as use vs. availability. We failed to detect a positive association with marsh as a surrogate habitat at the HR scale; rather, EDBs exhibited significantly negative associations with all landscape patches except pine savanna. Within home range selection was characterized by a negative association with forest and a positive association with ground cover, which suggests that EDBs may use surrogate habitats of similar structure, including marsh, within their home ranges. While our HR analysis did not support tidal marsh as a surrogate habitat, marsh may still provide resources for EDBs at smaller scales.	[Fill, Jennifer M.; Mousseau, Timothy A.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Waldron, Jayme L.; Welch, Shane M.] Marshall Univ, Dept Biol Sci, Huntington, WV USA; [Gibbons, J. Whitfield] Savannah River Ecol Lab, Aiken, SC USA; [Bennett, Stephen H.] South Carolina Dept Nat Resources, Columbia, SC USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Marshall University; United States Department of Energy (DOE); Savannah River Ecology Laboratory	Fill, JM (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	jenna999@gmail.com	Mousseau, Timothy A/A-1253-2011	Mousseau, Timothy/0000-0002-2235-4868	South Carolina Department of Natural Resources; National Science Foundation [NSF DGE-0929297]; University of South Carolina (sc.edu); Snake Advisory Group (snaketag.org); Riverbanks Zoo	South Carolina Department of Natural Resources; National Science Foundation(National Science Foundation (NSF)); University of South Carolina (sc.edu); Snake Advisory Group (snaketag.org); Riverbanks Zoo	Funding for this project was provided by the South Carolina Department of Natural Resources (www.dnr.sc.gov) to SHB. The National Science Foundation (www.nsf.gov) awarded NSF DGE-0929297 to JMF, who also received the Presidential Fellowship from the University of South Carolina (sc.edu). The Snake Advisory Group (snaketag.org) awarded the Dana Payne Grant to JMF, and Riverbanks Zoo provided assistance from their Conservation Support Fund to JLW (www.riverbanks.org).	Beckage B, 2009, AM NAT, V174, P805, DOI 10.1086/648458; Berndt LA, 2008, BIODIVERS CONSERV, V17, P1171, DOI 10.1007/s10531-008-9379-3; Bertram N, 2001, IDENTIFICATION CRITI; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Bowne DR, 1999, LANDSCAPE ECOL, V14, P53, DOI 10.1023/A:1008025827895; Boyce MS, 2006, DIVERS DISTRIB, V12, P269, DOI 10.1111/j.1366-9516.2006.00243.x; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Chase J.M., 2009, ECOLOGICAL NICHES LI; Clark RW, 2008, MOL ECOL, V17, P719; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Dillard LO, 2008, BIODIVERS CONSERV, V17, P1475, DOI 10.1007/s10531-008-9356-x; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Ford WM, 2002, FOREST ECOL MANAG, V155, P131, DOI 10.1016/S0378-1127(01)00553-9; FROST CC, 1993, P TALL TIMB FIR EC C, V18, P17; Frost C, 2006, SPRINGER SER ENV MAN, P9; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Gienger CM, 2011, CAN J ZOOL, V89, P1084, DOI 10.1139/Z11-086; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; GLITZENSTEIN JS, 1995, ECOL MONOGR, V65, P441, DOI 10.2307/2963498; Golley F. B., 1965, Journal of Mammalogy, V46, P1, DOI 10.2307/1377811; Hall LS, 1997, WILDLIFE SOC B, V25, P173; Hoss SK, 2010, J HERPETOL, V44, P110, DOI 10.1670/08-277.1; HUEY RB, 1991, AM NAT, V137, pS91, DOI 10.1086/285141; Jenkins CL, 2008, BIOL RATTLESNAKES, P265; Jenness Enterprises, 2013, DEM SURF TOOLS ARCGI; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Jones MC, 1996, J AM STAT ASSOC, V91, P401, DOI 10.2307/2291420; Jose S, 2006, SPRINGER SER ENV MAN, P3; KINCAID WB, 1985, ECOLOGY, V66, P1769, DOI 10.2307/2937373; Kochanny CO, 2009, J WILDLIFE MANAGE, V73, P779, DOI 10.2193/2008-394; Kreye JK, 2013, ECOL APPL, V23, P1976, DOI 10.1890/13-0503.1; Lim K, 2003, PROG PHYS GEOG, V27, P88, DOI 10.1191/0309133303pp360ra; Listopad CMCS, 2011, THESIS U CENTRAL FLO; Manly B.F.J., 2002, RESOURCE SELECTION A; Martin W.H., 2000, HERPETOL NAT HIST, V7, P9; Means DB, 2006, SPRINGER SER ENV MAN, P157; Merola-Zwartjes M, 2005, WILDLIFE SOC B, V33, P435, DOI 10.2193/0091-7648(2005)33[435:ASAONM]2.0.CO;2; MORRIS DW, 1987, ECOLOGY, V68, P362, DOI 10.2307/1939267; Platt William J., 1999, P23; Powell RA, 2012, J MAMMAL, V93, P948, DOI 10.1644/11-MAMM-S-177.1; Pringle RM, 2003, ECOLOGY, V84, P2668, DOI 10.1890/02-0482; Raudenbush SW, 2000, J COMPUT GRAPH STAT, V9, P141, DOI 10.2307/1390617; Row JR, 2006, COPEIA, P797, DOI 10.1643/0045-8511(2006)6[797:KANAEO]2.0.CO;2; Rysava-Novakova M, 2009, FISHERIES MANAG ECOL, V16, P468, DOI 10.1111/j.1365-2400.2009.00698.x; SAS Institute, 2011, SAS V 9 3; Schweiger EW, 2000, ECOL MONOGR, V70, P383, DOI 10.1890/0012-9615(2000)070[0383:TIOHFP]2.0.CO;2; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Sorrie BA, 2006, APPL VEG SCI, V9, P59, DOI 10.1658/1402-2001(2006)9[59:COTEPP]2.0.CO;2; Stohlgren KM, 2013, THESIS U GEORGIA; Swihart Robert K., 1997, Journal of Agricultural Biological and Environmental Statistics, V2, P48, DOI 10.2307/1400640; Timmerman W.W., 2003, 32 SOC STUD AMPH REP; Timmerman Walter W., 1995, Bulletin of the Florida Museum of Natural History, V38, P127; Torre I, 2004, ACTA OECOL, V25, P137, DOI 10.1016/j.actao.2003.10.007; United States Fish and Wildlife Service, 2012, FED REGISTER, V77, P27403; Waldron JL, 2006, ANIM CONSERV, V9, P414, DOI 10.1111/j.1469-1795.2006.00050.x; Waldron JL, 2008, BIOL CONSERV, V141, P2477, DOI 10.1016/j.biocon.2008.07.008; Waldron JL, 2006, HERPETOLOGICA, V62, P389, DOI 10.1655/0018-0831(2006)62[389:UBSTIC]2.0.CO;2; Waldron JL, 2013, BIOL CONSERV, V159, P530, DOI 10.1016/j.biocon.2012.11.021; Waldron Jayme L., 2013, Human Dimensions of Wildlife, V18, P138, DOI 10.1080/10871209.2012.719173; Ware Stewart, 1993, P447; WIENS JA, 1987, OIKOS, V48, P132, DOI 10.2307/3565849; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Zimble DA, 2003, REMOTE SENS ENVIRON, V87, P171, DOI 10.1016/S0034-4257(03)00139-1	65	4	4	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123307	10.1371/journal.pone.0123307	http://dx.doi.org/10.1371/journal.pone.0123307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915926	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100020
J	Pinacho, R; Saia, G; Fuste, M; Melendez-Perez, I; Villalta-Gil, V; Haro, JM; Gill, G; Ramos, B				Pinacho, Raquel; Saia, Gregory; Fuste, Montserrat; Melendez-Perez, Iria; Villalta-Gil, Victoria; Haro, Josep Maria; Gill, Grace; Ramos, Belen			Phosphorylation of Transcription Factor Specificity Protein 4 Is Increased in Peripheral Blood Mononuclear Cells of First-Episode Psychosis	PLOS ONE			English	Article							FACTOR SP4; BIPOLAR DISORDER; REDUCED EXPRESSION; SP-FAMILY; BRAIN; SCHIZOPHRENIA; GENE	Background Altered expression of transcription factor specificity protein 4 (SP4) has been found in the postmortem brain of patients with psychiatric disorders including schizophrenia and bipolar disorder. Reduced levels of SP4 protein have recently been reported in peripheral blood mononuclear cells in first-episode psychosis. Also, SP4 levels are modulated by lithium treatment in cultured neurons. Phosphorylation of SP4 at S770 is increased in the cerebellum of bipolar disorder subjects and upon inhibition of NMDA receptor signaling in cultured neurons. The aim of this study was to investigate whether SP4 S770 phosphorylation is increased in lymphocytes of first-episode psychosis patients and the effect of lithium treatment on this phosphorylation. Methods A cross-sectional study of S770 phosphorylation relative to total SP4 immunoreactivity using specific antibodies in peripheral blood mononuclear cells in first-episode psychosis patients (n = 14, treated with lithium or not) and matched healthy controls (n = 14) by immunoblot was designed. We also determined the effects of the prescribed drugs lithium, olanzapine or valproic acid on SP4 phosphorylation in rat primary cultured cerebellar granule neurons. Results We found that SP4 S770 phosphorylation was significantly increased in lymphocytes in first-episode psychosis compared to controls and decreased in patients treated with lithium compared to patients who did not receive lithium. Moreover, incubation with lithium but not olanzapine or valproic acid reduced SP4 phosphorylation in rat cultured cerebellar granule neurons. Conclusions The findings presented here indicate that SP4 S770 phosphorylation is increased in lymphocytes in first-episode psychosis which may be reduced by lithium treatment in patients. Moreover, our study shows lithium treatment prevents this phosphorylation in vitro in neurons. This pilot study suggests that S770 SP4 phosphorylation could be a peripheral biomarker of psychosis, and may be regulated by lithium treatment in first-episode psychosis.	[Pinacho, Raquel; Fuste, Montserrat; Melendez-Perez, Iria; Villalta-Gil, Victoria; Haro, Josep Maria; Ramos, Belen] Univ Barcelona, Unitat Recerca, Fundacio St Joan de Deu, Ctr Invest Biomed Red Salud Mental,CIBERSAM, Barcelona, Spain; [Saia, Gregory; Gill, Grace] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Saia, Gregory] Tufts Univ, Sch Med, Sackler Sch Biomed Sci, Cell Mol & Dev Biol Program, Boston, MA 02111 USA	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Tufts University; Tufts University	Gill, G (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA.	Grace.Gill@tufts.edu; bramos@fsjd.org	Ramos, Belen/K-8067-2015; Haro, Josep Maria/D-1423-2011	Ramos, Belen/0000-0002-4577-2106; Haro, Josep Maria/0000-0002-3984-277X; Fuste, Montserrat/0000-0002-4508-1022; Pinacho, Raquel/0000-0001-6417-5983	Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria [PI07/0401]; Centro de Investigacion Biomedica en Red de Salud Mental; Ministerio de Ciencia e Innovacion-Spain: Plan Nacional de I+D [BFU2008-01103, T32 NS061764]; National Institutes of Health [RO1 HD043364]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061764] Funding Source: NIH RePORTER	Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Centro de Investigacion Biomedica en Red de Salud Mental; Ministerio de Ciencia e Innovacion-Spain: Plan Nacional de I+D(Ministry of Science and Innovation, Spain (MICINN)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria: Predoctoral fellowship to R.P., Rio Hortega fellowship to M.F., Grant PI07/0401 to J.M.H., the Centro de Investigacion Biomedica en Red de Salud Mental (B. R. and J.M.H.); by the T32 NS061764 training grant to G.S.; and grants from Ministerio de Ciencia e Innovacion-Spain: Plan Nacional de I+D BFU2008-01103 to B. R., and the National Institutes of Health: RO1 HD043364 to G.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bilimoria Parizad M, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5107; Fountoulakis KN, 2008, INT J NEUROPSYCHOPH, V11, P999, DOI 10.1017/S1461145708009231; Fuste M, 2016, BRIT J PSYCHIAT, V208, P591, DOI 10.1192/bjp.bp.114.152140; Fuste M, 2013, J PSYCHIATR RES, V47, P1608, DOI 10.1016/j.jpsychires.2013.07.019; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; Ji BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066327; Kantrowitz JT, 2010, BRAIN RES BULL, V83, P108, DOI 10.1016/j.brainresbull.2010.04.006; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Lenox RH, 2000, J CLIN PSYCHIAT, V61, P5; Mao XR, 2007, J NEUROCHEM, V100, P1300, DOI 10.1111/j.1471-4159.2006.04297.x; Pinacho R, EUR NEUROPSYCHOPHARM; Pinacho R, 2014, J PSYCHIATR RES, V58, P189, DOI 10.1016/j.jpsychires.2014.08.006; Pinacho R, 2013, J PSYCHIATR RES, V47, P926, DOI 10.1016/j.jpsychires.2013.03.004; Pinacho R, 2011, BIPOLAR DISORD, V13, P474, DOI 10.1111/j.1399-5618.2011.00941.x; Ramos B, 2007, P NATL ACAD SCI USA, V104, P9882, DOI 10.1073/pnas.0701946104; Ross SM, 2003, J ENG TECHNOL, V20, P38; Saia G, 2014, J NEUROCHEM, V129, P743, DOI 10.1111/jnc.12657; Shastry BS, 2005, NEUROCHEM INT, V46, P273, DOI 10.1016/j.neuint.2004.10.007; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Sun XX, 2015, DEV NEUROBIOL, V75, P93, DOI 10.1002/dneu.22212; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Tam GWC, 2010, BIOCHEM SOC T, V38, P445, DOI 10.1042/BST0380445; Woods SW, 2003, PSYCHIAT SERV, V54, P177, DOI 10.1176/appi.ps.54.2.177; Zhou X, 2007, GENES BRAIN BEHAV, V6, P269, DOI 10.1111/j.1601-183X.2006.00256.x; Zhou X, 2005, MOL PSYCHIATR, V10, P393, DOI 10.1038/sj.mp.4001621; Zhou XJ, 2010, HUM MOL GENET, V19, P3797, DOI 10.1093/hmg/ddq298; Zhou XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005196	29	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125115	10.1371/journal.pone.0125115	http://dx.doi.org/10.1371/journal.pone.0125115			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915526	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100100
J	Wang, GR; Guo, L; Jiang, B; Huang, M; Zhang, J; Qin, Y				Wang, Guorong; Guo, Ling; Jiang, Bin; Huang, Min; Zhang, Jian; Qin, Ying			Factors Influencing Intracavitary Electrocardiographic P-Wave Changes during Central Venous Catheter Placement	PLOS ONE			English	Article							GUIDANCE	Amplitude changes in the P-wave of intracavitary electrocardiography have been used to assess the tip placement of central venous catheters. The research assessed the sensitivity and specificity of this sign in comparison with standard radiographic techniques for tip location, focusing on factors influencing its clinical utility. Both intracavitary electrocardiography guided tip location and X-ray positioning were used to verify catheter tip locations in patients undergoing central venous catheter insertion. Intracavitary electrocardiograms from 1119 patients (of a total 1160 subjects) showed specific amplitude changes in the P-wave. As the results show, compared with X-ray positioning, the sensitivity of electrocardiography-guided tip location was 97.3%, with false negative rate of 2.7%; the specificity was 1, with false positive rate of zero. Univariate analyses indicated that features including age, gender, height, body weight, and heart rate have no statistically significant influence on P-wave amplitude changes (P>0.05). Multivariate logistic regression revealed that catheter insertion routes (OR = 2.280, P = 0.003) and basal P-wave amplitude (OR = 0.553, P = 0.003) have statistically significant impacts on P-wave amplitude changes. As a reliable indicator of tip location, amplitude change in the P-wave has proved of good sensitivity and excellent specificity, and the minor, zero, false positive rate supports the clinical utility of this technique in early recognition of malpositioned tips. A better sensitivity was achieved in placement of centrally inserted central catheters (CICCs) than that of peripherally inserted central catheters (PICCs). In clinical practice, a combination of intracavitary electrocardiography, ultrasonic inspection and the anthropometric measurement method would further improve the accuracy.	[Wang, Guorong; Huang, Min] Sichuan Canc Hosp, Dept Nursing, Chengdu, Peoples R China; [Guo, Ling] Sichuan Canc Hosp, Chengdu, Peoples R China; [Jiang, Bin] Sichuan Canc Hosp, Dept Thorac Surg, Chengdu, Peoples R China; [Zhang, Jian] Sichuan Canc Hosp, Dept Radiotherapy, Chengdu, Peoples R China; [Qin, Ying] Sichuan Canc Hosp, Dept Med Oncol, Chengdu, Peoples R China		Qin, Y (corresponding author), Sichuan Canc Hosp, Dept Med Oncol, Chengdu, Peoples R China.	wangguorong_000@163.com						Andropoulos DB, 1999, ANESTH ANALG, V89, P65, DOI 10.1097/00000539-199907000-00012; Infusion Nurses Society, 2011, J INFUSION NURSING, V34, pS40; Kremser J, 2011, BRIT J ANAESTH, V107, P567, DOI 10.1093/bja/aer189; Lee JH, 2009, BRIT J ANAESTH, V102, P662, DOI 10.1093/bja/aep046; Moureau NL., 2010, J ASS VASC ACCESS, V15, P8, DOI [10.2309/java.15-1-3, DOI 10.2309/JAVA.15-1-3]; Pittiruti M, 2012, J VASC ACCESS, V13, P357, DOI 10.5301/JVA.2012.9020; Qin Y., 2014, SICHUAN MED J, V35, P709; Wen Q, 2012, CLIN APPL SECURITY M; Zhao R, 2013, CHINESE J EMERGENCY, V22, P428	9	12	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124846	10.1371/journal.pone.0124846	http://dx.doi.org/10.1371/journal.pone.0124846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915758	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100074
J	Wu, AM; Shao, ZX; Wang, JS; Yang, XD; Weng, WQ; Wang, XY; Xu, HZ; Chi, YL; Lin, ZK				Wu, Ai-Min; Shao, Zhen-Xuan; Wang, Jian-Shun; Yang, Xin-Dong; Weng, Wan-Qing; Wang, Xiang-Yang; Xu, Hua-Zi; Chi, Yong-Long; Lin, Zhong-Ke			The Accuracy of a Method for Printing Three-Dimensional Spinal Models	PLOS ONE			English	Article							TRANSLAMINAR SCREW FIXATION; MORPHOMETRIC-ANALYSIS; THORACIC SPINE; CERVICAL-SPINE; PEDICLE; ANATOMY; PLACEMENT; DONATION; SCIENCE; LUMBAR	Background To study the morphology of the human spine and new spinal fixation methods, scientists require cadaveric specimens, which are dependent on donation. However, in most countries, the number of people willing to donate their body is low. A 3D printed model could be an alternative method for morphology research, but the accuracy of the morphology of a 3D printed model has not been determined. Methods Forty-five computed tomography (CT) scans of cervical, thoracic and lumbar spines were obtained, and 44 parameters of the cervical spine, 120 parameters of the thoracic spine, and 50 parameters of the lumbar spine were measured. The CT scan data in DICOM format were imported into Mimics software v10.01 for 3D reconstruction, and the data were saved in .STL format and imported to Cura software. After a 3D digital model was formed, it was saved in Gcode format and exported to a 3D printer for printing. After the 3D printed models were obtained, the above-referenced parameters were measured again. Results Paired t-tests were used to determine the significance, set to P<0.05, of all parameter data from the radiographic images and 3D printed models. Furthermore, 88.6% of all parameters of the cervical spine, 90% of all parameters of the thoracic spine, and 94% of all parameters of the lumbar spine had Intraclass Correlation Coefficient (ICC) values >0.800. The other ICC values were <0.800 and >0.600; none were <0.600. Conclusion In this study, we provide a protocol for printing accurate 3D spinal models for surgeons and researchers. The resulting 3D printed model is inexpensive and easily obtained for spinal fixation research.	[Wu, Ai-Min; Shao, Zhen-Xuan; Wang, Jian-Shun; Weng, Wan-Qing; Wang, Xiang-Yang; Xu, Hua-Zi; Chi, Yong-Long; Lin, Zhong-Ke] Wenzhou Med Univ, Affiliated Hosp 2, Zhejiang Spinal Res Ctr, Dept Orthopaed, Wenzhou, Zhejiang, Peoples R China; [Yang, Xin-Dong] Wenzhou Med Univ, Dept Anat, Higher Educ Zone, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Chi, YL (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Zhejiang Spinal Res Ctr, Dept Orthopaed, 109 Xue Yuan Western Rd, Wenzhou, Zhejiang, Peoples R China.	spinechi@163.com; zhongkelin@163.com			National Natural Science Foundation of China [81372014]; Natural Science Foundation of Zhejiang Province [LY14H060008]; Scientific research project for student of Wenzhou Medical University [WYX201401020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Scientific research project for student of Wenzhou Medical University	This work is supported by National Natural Science Foundation of China (81372014), Natural Science Foundation of Zhejiang Province (LY14H060008), and Scientific research project for student of Wenzhou Medical University (WYX201401020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvin MD, 2012, SPINE, V37, pE745, DOI 10.1097/BRS.0b013e31824c70ef; Asad AL, 2014, SOC SCI MED, V106, P53, DOI 10.1016/j.socscimed.2014.01.041; Boulware LE, 2004, CLIN ANAT, V17, P570, DOI 10.1002/ca.10225; Giordano RA, 1996, J BIOMAT SCI-POLYM E, V8, P63, DOI 10.1163/156856297X00588; Guo SZ, 2014, LANGMUIR, V30, P1142, DOI 10.1021/la4036425; Halou H, 2013, ANAT SCI EDUC, V6, P48, DOI 10.1002/ase.1304; Haverman T M, 2013, Ned Tijdschr Tandheelkd, V120, P136; Horn Timothy J., 2012, Science Progress, V95, P255, DOI 10.3184/003685012X13420984463047; Ji W, 2012, EUR SPINE J, V21, P1483, DOI 10.1007/s00586-012-2151-0; Kabins MB, 1991, IOWA ORTHOPAEDIC J, V11, P127; Kanna PR, 2011, SPINE, V36, P1297, DOI 10.1097/BRS.0b013e3181fb3c17; Lin SL, 2014, SPINE, V39, pE147, DOI 10.1097/BRS.0000000000000105; Puchwein P, 2013, BONE JOINT J, V95B, P536, DOI 10.1302/0301-620X.95B4.30949; Robertson PA, 2000, SPINE, V25, P709, DOI 10.1097/00007632-200003150-00010; Tian NF, 2010, SPINE, V35, P1514, DOI 10.1097/BRS.0b013e3181c6d9ae; VACCARO AR, 1995, J BONE JOINT SURG AM, V77A, P1193, DOI 10.2106/00004623-199508000-00008; Webb PA, 2000, J MED ENG TECHNOL, V24, P149, DOI 10.1080/03091900050163427; Wu AM, 2013, BONE JOINT J, V95B, P977, DOI 10.1302/0301-620X.95B7.31393; Xia DD, 2014, EUR SPINE J, V23, P606, DOI 10.1007/s00586-013-3130-9; YAHIRO MA, 1994, SPINE, V19, pS2274; Zhang LQ, 2008, ANAT SCI EDUC, V1, P56, DOI 10.1002/ase.15	21	62	71	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124291	10.1371/journal.pone.0124291	http://dx.doi.org/10.1371/journal.pone.0124291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915641	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100045
J	Zwart, L; Potgieter, CA; Clift, SJ; van Staden, V				Zwart, Lizahn; Potgieter, Christiaan A.; Clift, Sarah J.; van Staden, Vida			Characterising Non-Structural Protein NS4 of African Horse Sickness Virus	PLOS ONE			English	Article							BLUETONGUE VIRUS; HORSESICKNESS VIRUS; CELLS; VP6; LOCALIZATION; REPLICATION; ORBIVIRUS; CORE; INFECTION; SEQUENCE	African horse sickness is a serious equid disease caused by the orbivirus African horse sickness virus (AHSV). The virus has ten double-stranded RNA genome segments encoding seven structural and three non-structural proteins. Recently, an additional protein was predicted to be encoded by genome segment 9 (Seg-9), which also encodes VP6, of most orbiviruses. This has since been confirmed in bluetongue virus and Great Island virus, and the non-structural protein was named NS4. In this study, in silico analysis of AHSV Seg-9 sequences revealed the existence of two main types of AHSV NS4, designated NS4-I and NS4-II, with different lengths and amino acid sequences. The AHSV NS4 coding sequences were in the +1 reading frame relative to that of VP6. Both types of AHSV NS4 were expressed in cultured mammalian cells, with sizes close to the predicted 17-20 kDa. Fluorescence microscopy of these cells revealed a dual cytoplasmic and nuclear, but not nucleolar, distribution that was very similar for NS4-I and NS4-II. Immunohistochemistry on heart, spleen, and lung tissues from AHSV-infected horses showed that NS4 occurs in microvascular endothelial cells and mononuclear phagocytes in all of these tissues, localising to the both the cytoplasm and the nucleus. Interestingly, NS4 was also detected in stellate-shaped dendritic macrophage-like cells with long cytoplasmic processes in the red pulp of the spleen. Finally, nucleic acid protection assays using bacterially expressed recombinant AHSV NS4 showed that both types of AHSV NS4 bind dsDNA, but not dsRNA. Further studies will be required to determine the exact function of AHSV NS4 during viral replication.	[Zwart, Lizahn; van Staden, Vida] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa; [Potgieter, Christiaan A.] Deltamune Pty Ltd, Lyttelton, Centurion, South Africa; [Potgieter, Christiaan A.] North West Univ, Ctr Human Metabon, Dept Biochem, Potchefstroom, South Africa; [Clift, Sarah J.] Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, ZA-0110 Onderstepoort, South Africa	University of Pretoria; North West University - South Africa; University of Pretoria	van Staden, V (corresponding author), Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa.	vida.vanstaden@up.ac.za	Clift, Sarah J/P-9497-2016	Clift, Sarah J/0000-0003-1368-1215	Deltamune (Pty) Ltd	Deltamune (Pty) Ltd	Deltamune (Pty) Ltd provided support in the form of salaries for authors (CAP), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	Beaton AR, 2002, P NATL ACAD SCI USA, V99, P13154, DOI 10.1073/pnas.192432299; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Belhouchet M, 2010, J GEN VIROL, V91, P2985, DOI 10.1099/vir.0.024760-0; Boyce M, 2004, J VIROL, V78, P3994, DOI 10.1128/JVI.78.8.3994-4002.2004; Boyce M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-178; Clift SJ, 2010, VET PATHOL, V47, P690, DOI 10.1177/0300985810370010; Clift SJ, 2009, J VET DIAGN INVEST, V21, P655, DOI 10.1177/104063870902100510; Coetzer J., 1994, INFECT DIS LIVESTOCK, P601; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; de Waal PJ, 2005, ARCH VIROL, V150, P2037, DOI 10.1007/s00705-005-0547-4; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-48; Forzan M, 2007, J VIROL, V81, P4819, DOI 10.1128/JVI.02284-06; Freitas N, 2009, CURR GENOMICS, V10, P550, DOI 10.2174/138920209789503941; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; HOUSE JA, 1993, VET CLIN N AM-EQUINE, V9, P355, DOI 10.1016/S0749-0739(17)30402-9; HOWELL P. G., 1962, ONDERSTEPOORT JOUR VET RES, V29, P139; HUISMANS H, 1979, VIROLOGY, V92, P397, DOI 10.1016/0042-6822(79)90144-2; HYATT AD, 1991, J GEN VIROL, V72, P2263, DOI 10.1099/0022-1317-72-9-2263; Kar AK, 2003, J VIROL, V77, P11347, DOI 10.1128/JVI.77.21.11347-11356.2003; Kar AK, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-4; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; Manole V, 2012, J VIROL, V86, P7858, DOI 10.1128/JVI.00517-12; Maree FF, 1997, J GEN VIROL, V78, P1077, DOI 10.1099/0022-1317-78-5-1077; Martinez-Costas J, 1998, J MOL BIOL, V280, P859, DOI 10.1006/jmbi.1998.1926; McINTOSH B. M., 1958, ONDERSTEPOORT JOUR VET RES, V27, P465; MELLOR PS, 1995, ANN TROP MED PARASIT, V89, P1; OELLERMA.RA, 1970, ARCH GES VIRUSFORSCH, V29, P163, DOI 10.1007/BF01249302; Owens RJ, 2004, J VIROL, V78, P6649, DOI 10.1128/JVI.78.12.6649-6656.2004; Patel A, 2014, VIRUS RES, V182, P5, DOI 10.1016/j.virusres.2013.12.017; Potgieter AC, 2009, J GEN VIROL, V90, P1423, DOI 10.1099/vir.0.009381-0; Ramos-Vara JA, 2005, VET PATHOL, V42, P405, DOI 10.1354/vp.42-4-405; Ramos-Vara JA, 2008, J VET DIAGN INVEST, V20, P393, DOI 10.1177/104063870802000401; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; ROY P, 1994, COMP IMMUNOL MICROB, V17, P243, DOI 10.1016/0147-9571(94)90046-9; Salvetti A, 2014, BBA-MOL BASIS DIS, V1842, P840, DOI 10.1016/j.bbadis.2013.12.010; SATO M, 1976, VIROLOGY, V69, P691, DOI 10.1016/0042-6822(76)90497-9; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Stassen L, 2011, VIRUS RES; Stoltz MA, 1996, ONDERSTEPOORT J VET, V63, P57; Turnbull PJ, 1996, J GEN VIROL, V77, P1421, DOI 10.1099/0022-1317-77-7-1421; UITENWEERDE JM, 1995, VIROLOGY, V209, P624, DOI 10.1006/viro.1995.1294; van Gennip RGP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085788	43	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124281	10.1371/journal.pone.0124281	http://dx.doi.org/10.1371/journal.pone.0124281			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915516	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100044
J	Chong, YP; Bae, IG; Lee, SR; Chung, JW; Jun, JB; Choo, EJ; Moon, SY; Lee, MS; Jeon, MH; Song, EH; Lee, EJ; Park, SY; Kim, YS				Chong, Yong Pil; Bae, In-Gyu; Lee, Sang-Rok; Chung, Jin-Won; Jun, Jae-Bum; Choo, Eun Ju; Moon, Soo-youn; Lee, Mi Suk; Jeon, Min Hyok; Song, Eun Hee; Lee, Eun Jung; Park, Seong Yeon; Kim, Yang Soo			Clinical and Economic Consequences of Failure of Initial Antibiotic Therapy for Patients with Community-Onset Complicated Intra-Abdominal Infections	PLOS ONE			English	Article							MANAGEMENT; TIGECYCLINE; CHILDREN; CULTURE; SOCIETY; ADULTS	Objectives Complicated intra-abdominal infection (cIAI) is infection that extends beyond the hollow viscus of origin into the peritoneal space, and is associated with either abscess formation or peritonitis. There are few studies that have assessed the actual costs and outcomes associated with failure of initial antibiotic therapy for cIAI. The aims of this study were to evaluate risk factors and impact on costs and outcomes of failure of initial antibiotic therapy for community-onset cIAI. Methods A retrospective study was performed at eleven tertiary-care hospitals. Hospitalized adults with community-onset cIAI who underwent an appropriate source control procedure between August 2008 and September 2011 were included. Failure of initial antibiotic therapy was defined as a change of antibiotics due to a lack of improvement of the clinical symptoms and signs associated with cIAI in the first week. Results A total of 514 patients hospitalized for community-onset cIAI were included in the analysis. The mean age of the patients was 53.3 +/- 17.6 years, 72 patients (14%) had health care-associated infection, and 48 (9%) experienced failure of initial antibiotic therapy. Failure of initial antibiotic therapy was associated with increased costs and morbidity. After adjustment for covariates, patients with unsuccessful initial therapy received an additional 2.9 days of parenteral antibiotic therapy, were hospitalized for an additional 5.3 days, and incurred $3,287 in additional inpatient charges. Independent risk factors for failure of initial antibiotic therapy were health care-associated infection, solid cancer, and APACHE II >= 13. Conclusions To improve outcomes and costs in patients with community-onset cIAI, rapid assessment of health care-associated risk factors and severity of disease, selection of an appropriate antibiotic regimen accordingly, and early infection source control should be performed.	[Chong, Yong Pil; Kim, Yang Soo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea; [Bae, In-Gyu] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Jinju, South Korea; [Lee, Sang-Rok] CheongJu St Marys Hosp, Dept Internal Med, CheongJu, South Korea; [Chung, Jin-Won] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea; [Jun, Jae-Bum] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Internal Med, Seoul, South Korea; [Choo, Eun Ju] Soon Chun Hyang Univ, Bucheon Hosp, Dept Internal Med, Bucheon, South Korea; [Moon, Soo-youn; Lee, Mi Suk] Kyung Hee Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Jeon, Min Hyok] Soon Chun Hyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea; [Song, Eun Hee] Univ Ulsan, GangNeung Asan Hosp, Coll Med, Dept Internal Med, Kangnung, South Korea; [Lee, Eun Jung] Soon Chun Hyang Univ, Seoul Hosp, Dept Internal Med, Seoul, South Korea; [Park, Seong Yeon] Dongguk Univ, Ilsan Hosp, Dept Internal Med, Ilsan, South Korea	University of Ulsan; Asan Medical Center; Gyeongsang National University; Chung Ang University; Chung Ang University Hospital; University of Ulsan; Ulsan University Hospital; Soonchunhyang University; Kyung Hee University; Soonchunhyang University; University of Ulsan; Soonchunhyang University; Dongguk University; NHIS Ilsan Hospital	Kim, YS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea.	yskim@amc.seoul.kr	Chong, Yong Pil/AAB-2623-2021		Pfizer Pharmaceuticals Korea Ltd.	Pfizer Pharmaceuticals Korea Ltd.(Pfizer)	This study was sponsored by Pfizer Pharmaceuticals Korea Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babinchak T, 2005, CLIN INFECT DIS, V41, pS354, DOI 10.1086/431676; Barie Philip S, 2004, Surg Infect (Larchmt), V5, P365, DOI 10.1089/sur.2004.5.365; Blot S, 2005, DRUGS, V65, P1611, DOI 10.2165/00003495-200565120-00002; Blot S, 2012, DRUGS, V72, pE17, DOI 10.2165/11599800-000000000-00000; Cattan P, 2002, EUR J CLIN MICROBIOL, V21, P787, DOI 10.1007/s10096-002-0834-x; Chen YH, 2012, CURR OPIN INFECT DIS, V25, P590, DOI 10.1097/QCO.0b013e32835635cb; CHRISTOU NV, 1993, ARCH SURG-CHICAGO, V128, P193; Dougherty SH, 1997, CLIN INFECT DIS, V25, pS258, DOI 10.1086/516241; Edelsberg J, 2008, SURG INFECT, V9, P335, DOI 10.1089/sur.2006.100; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kokoska ER, 1999, J PEDIATR SURG, V34, P749, DOI 10.1016/S0022-3468(99)90368-8; Krobot K, 2004, EUR J CLIN MICROBIOL, V23, P682, DOI 10.1007/s10096-004-1199-0; Mazuski JE, 2007, EXPERT OPIN PHARMACO, V8, P2933, DOI 10.1517/14656566.8.17.2933; Montravers P, 2004, ANN SURG, V239, P409, DOI 10.1097/01.sla.0000114214.68169.e9; Montravers P, 2009, J ANTIMICROB CHEMOTH, V63, P785, DOI 10.1093/jac/dkp005; MOOREGILLON JC, 1981, BRIT MED J, V283, P819, DOI 10.1136/bmj.283.6295.819; Schein M, 1992, Surg Annu, V24 Pt 1, P47; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; Tellado JM, 2007, SCAND J INFECT DIS, V39, P947, DOI 10.1080/00365540701449377; Towfigh S, 2010, CLIN MICROBIOL INFEC, V16, P1274, DOI 10.1111/j.1469-0691.2010.03122.x	20	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0119956	10.1371/journal.pone.0119956	http://dx.doi.org/10.1371/journal.pone.0119956			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910171	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800007
J	Jiang, XQ; Mei, XD; Feng, D; Wang, XJ				Jiang, Xuqin; Mei, Xiaodong; Feng, Di; Wang, Xiaojing			Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis	PLOS ONE			English	Article							B-CELL LYMPHOMA; CHRONIC LYMPHOCYTIC-LEUKEMIA; NON-HODGKINS-LYMPHOMA; RANDOMIZED CONTROLLED-TRIAL; CHOP-BASED CHEMOTHERAPY; INTERSTITIAL PNEUMONIA; ELDERLY-PATIENTS; PLUS RITUXIMAB; HIGH-RISK; CYCLOPHOSPHAMIDE	Pneumocystis jiroveci pneumonia (PCP) is frequently reported in lymphoma patients treated with rituximab-contained regimens. There is a trend toward a difference in PCP risk between bi- and tri-weekly regimens. The aims of this systemic review and meta-analysis were to estimate the risk for PCP in these patients, compare the impact of different regimens on the risk, and evaluate the efficacy of prophylaxis. The cohort studies with incept up to January 2014 were retrieved from the Cochrane Library, Medline, Embase, and Web of Science databases. Studies that compared the incidence of PCP in patients with and without rituximab treatment were conducted. Studies that reported the results of prophylaxis were concentrated to evaluate the efficacy of prophylaxis. Fixed effect Mantel-Haenszel model was chosen as the main analysis method. Funnel plots were examined to estimate the potential selection bias. Egger's test and Begg's test were used for the determination of possible small study bias. Eleven cohort studies that met the inclusion criteria were finally included. Results indicated that rituximab was associated with a significantly increased risk for PCP (28/942 vs 5/977; risk ratio: 3.65; 95% confidence interval 1.65 to 8.07; P=0.001), and no heterogeneity existed between different studies (I-2=0%). Little significant difference in PCP risk was found between bi-weekly and tri-weekly regimens (risk ratio: 3.11; 95% confidence interval 0.92 to 10.52, P=0.068). PCP risk was inversely associated with prophylaxis in patients treated with rituximab (0/222 vs 26/986; risk ratio: 0.28; 95% confidence interval 0.09 to 0.94; P=0.039). In conclusion, PCP risk was increased significantly in lymphoma patients subjected to rituximab-contained chemotherapies. Difference in PCP risk between biweekly and tri-weekly regimens was not significant. Additionally, prophylaxis was dramatically effective in preventing PCP in rituximab-received lymphoma patients, suggesting that rituximab should be recommended for these patients.	[Jiang, Xuqin; Mei, Xiaodong; Feng, Di; Wang, Xiaojing] Anhui Prov Hosp, Dept Resp Med, Hefei, Peoples R China		Mei, XD (corresponding author), Anhui Prov Hosp, Dept Resp Med, Hefei, Peoples R China.	hfmxd@sina.com						Badoux XC, 2011, BLOOD, V118, P448; Badoux XC, 2011, BLOOD, V118, P2085, DOI 10.1182/blood-2011-03-341032; Beltz K, 2006, KLIN PADIATR, V218, P177, DOI 10.1055/s-2006-933433; Bonilla-Abadia F, 2014, CLIN RHEUMATOL; Boothpur R, 2008, AM J TRANSPLANT, V8, P862, DOI 10.1111/j.1600-6143.2008.02151.x; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Brusamolino E, 2006, HAEMATOLOGICA, V91, P496; Bussone G, 2009, AM J HEMATOL, V84, P153, DOI 10.1002/ajh.21341; Carter SJ, 2011, LEUKEMIA RES, V35, pE223, DOI 10.1016/j.leukres.2011.07.014; Chang H, 2008, J CHIN MED ASSOC, V71, P579, DOI 10.1016/S1726-4901(08)70173-4; Chang H, 2010, ACTA HAEMATOL-BASEL, V123, P30, DOI 10.1159/000261020; Conte GF, 2002, FLUDARABINE THERAPY; Cornely Oliver A, 2004, Wien Med Wochenschr, V154, P209, DOI 10.1007/s10354-004-0067-y; Czarniak P, 2013, PEDIATR NEPHROL, V28, P987, DOI 10.1007/s00467-013-2457-0; DERUNGS A, 2010, SCHWEIZ RUNDSCH MED, V99, P767, DOI DOI 10.1024/1661-8157/a000199; Egle A, 2009, BLOOD, V114, P1341, DOI 10.1182/blood.V114.22.3453.3453; Ennishi D, 2008, INT J HEMATOL, V87, P393, DOI 10.1007/s12185-008-0066-7; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Gea-Banacloche JC, 2010, SEMIN HEMATOL, V47, P187, DOI 10.1053/j.seminhematol.2010.01.002; Green H, 2007, MAYO CLIN PROC, V82, P1052, DOI 10.4065/82.9.1052; Habermann TM, 2006, J CLIN ONCOL, V24, P3121, DOI 10.1200/JCO.2005.05.1003; Haeusler GM, 2013, EUR J HAEMATOL, V91, P157, DOI 10.1111/ejh.12135; Hardak E, 2012, ACTA HAEMATOL-BASEL, V127, P110, DOI 10.1159/000334113; Harigai M, 2012, J RHEUMATOL, V39, P486, DOI 10.3899/jrheum.110994; Hashimoto K, 2010, LEUKEMIA LYMPHOMA, V51, P1816, DOI 10.3109/10428194.2010.506569; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Huang YC, 2011, ANN HEMATOL, V90, P1145, DOI 10.1007/s00277-011-1268-2; Hugle B, 2010, ARTHRIT CARE RES, V62, P1661, DOI 10.1002/acr.20279; Iguchi Toyotaka, 2005, Rinsho Ketsueki, V46, P1049; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Isidori A, 2011, LEUKEMIA LYMPHOMA, V52, P148, DOI 10.3109/10428194.2010.525726; Jiang XQ, 2013, J THORAC DIS, V5, pE162, DOI 10.3978/j.issn.2072-1439.2013.08.35; Kamel S, 2010, LEUKEMIA LYMPHOMA, V51, P797, DOI 10.3109/10428191003699860; Kato H, 2011, CL LYMPH MYELOM LEUK, V11, P483, DOI 10.1016/j.clml.2011.06.011; Kato H, 2009, CLIN LYMPHOMA MYELOM, V9, P443, DOI 10.3816/CLM.2009.n.087; Katsuya H, 2009, LEUKEMIA LYMPHOMA, V50, P1818, DOI 10.3109/10428190903258780; Kavcic M, 2013, J PEDIATR-US, V162, P1252, DOI 10.1016/j.jpeds.2012.11.038; Kelesidis T, 2011, INT J INFECT DIS, V15, pE2, DOI 10.1016/j.ijid.2010.03.025; Kim MG, 2013, NEPHROLOGY CARLTON; Kim T, 2013, ANN HEMATOL, V92, P231, DOI 10.1007/s00277-012-1592-1; Kolstad A, 2007, HAEMATOL-HEMATOL J, V92, P139, DOI 10.3324/haematol.10564; Kumar D, 2009, TRANSPL INFECT DIS, V11, P167, DOI 10.1111/j.1399-3062.2008.00345.x; Kumar N, 2011, J INFECTION, V62, P484, DOI 10.1016/j.jinf.2011.04.008; Kurokawa T, 2011, HEMATOL ONCOL, V29, P5, DOI 10.1002/hon.947; Kurokawa T, 2010, J CLIN EXP HEMATOP, V50, P159, DOI 10.3960/jslrt.50.159; Lamba M, 2002, CARDIOVASC PATHOL, V11, P346, DOI 10.1016/S1054-8807(02)00126-6; Lim Kyu-Hyoung, 2010, Korean Journal of Internal Medicine, V25, P86, DOI 10.3904/kjim.2010.25.1.86; Lin TS, 2007, CONSOLIDATION THER 1, p232A; Lund FE, 2006, J IMMUNOL, V176, P6147, DOI 10.4049/jimmunol.176.10.6147; Martin-Garrido I, 2013, CHEST, V144, P258, DOI 10.1378/chest.12-0477; Morrison VA, 2007, ALEMTUZUMAB INCREA 1, p233A; Morrison VA, 2010, BEST PRACT RES CL HA, V23, P145, DOI 10.1016/j.beha.2009.12.004; Motto DG, 2002, ISRAEL MED ASSOC J, V4, P1006; Nosori A, 2004, HAEMATOLOGICA, V89, P1415; Otremba MD, 2012, AM J OTOLARYNG, V33, P619, DOI 10.1016/j.amjoto.2012.01.006; Owen RG, 2003, ACTIVITY OF ALEMTUZU, p644a; Perez-Ordono L, 2014, TRANSPL INFECT DIS; Pfreundschuh M, 2004, BLOOD, V104, P634, DOI 10.1182/blood-2003-06-2095; Pfreundschuh M, 2008, LANCET ONCOL, V9, P105, DOI 10.1016/S1470-2045(08)70002-0; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Ram R, 2009, LEUKEMIA LYMPHOMA, V50, P1083, DOI 10.1080/10428190902934944; Sato M, 2013, PEDIATR NEPHROL, V28, P145, DOI 10.1007/s00467-012-2286-6; Shelton E, 2009, NEPHROLOGY, V14, P696, DOI 10.1111/j.1440-1797.2009.01168.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Su Gai-xiu, 2012, Zhonghua Er Ke Za Zhi, V50, P697; Tadmor T, 2010, LEUKEMIA LYMPHOMA, V51, P737, DOI 10.3109/10428191003715377; Takeda K, 2009, TRANSPL P, V41, P3941, DOI 10.1016/j.transproceed.2009.02.094; Tam CS, 2005, HAEMATOLOGICA, V90, P700; Taylor SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049991; Teichmann LL, 2008, RHEUMATOLOGY, V47, P1256, DOI 10.1093/rheumatology/ken234; Treon SP, 2009, BLOOD, V113, P3673, DOI 10.1182/blood-2008-09-177329; Tsai MJ, 2012, LUPUS, V21, P914, DOI 10.1177/0961203312436855; Venhuizen AC, 2008, EUR J HAEMATOL, V80, P275, DOI 10.1111/j.1600-0609.2007.00994.x; Wells G.A., NEWCASTLE OTTAWA SCA; White DA, 2004, CLIN CHEST MED, V25, P179, DOI 10.1016/S0272-5231(03)00134-5; Worth LJ, 2005, BRIT J CANCER, V92, P867, DOI 10.1038/sj.bjc.6602412; Yokoyama H, 2008, INT J HEMATOL, V88, P443, DOI 10.1007/s12185-008-0168-2; Zelenetz Andrew D, 2006, J Natl Compr Canc Netw, V4, P258; Zent CS, 2008, CANCER, V113, P2110, DOI 10.1002/cncr.23824	80	36	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122171	10.1371/journal.pone.0122171	http://dx.doi.org/10.1371/journal.pone.0122171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909634	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800018
J	Jin, HX; Go, ML; Yin, P; Qiu, XT; Zhu, P; Yan, XJ				Jin, Hai-Xiao; Go, Mei-Lin; Yin, Peng; Qiu, Xiao-Ting; Zhu, Peng; Yan, Xiao-Jun			Determining the Functions of HIV-1 Tat and a Second Magnesium Ion in the CDK9/Cyclin T1 Complex: A Molecular Dynamics Simulation Study	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; PHOSPHORYL TRANSFER-REACTION; AMBER FORCE-FIELD; P-TEFB; CRYSTAL-STRUCTURE; ACTIVE-SITE; STRUCTURAL-CHARACTERIZATION; CONFORMATIONAL PLASTICITY; CATALYTIC SUBUNIT; ATP HYDROLYSIS	The current paradigm of cyclin-dependent kinase (CDK) regulation based on the well-established CDK2 has been recently expanded. The determination of CDK9 crystal structures suggests the requirement of an additional regulatory protein, such as human immunodeficiency virus type 1 (HIV-1) Tat, to exert its physiological functions. In most kinases, the exact number and roles of the cofactor metal ions remain unappreciated, and the repertoire has thus gained increasing attention recently. Here, molecular dynamics (MD) simulations were implemented on CDK9 to explore the functional roles of HIV-1 Tat and the second Mg2+ ion at site 1 (Mg-1(2+)). The simulations unveiled that binding of HIV-1 Tat to CDK9 not only stabilized hydrogen bonds (H-bonds) between ATP and hinge residues Asp104 and Cys106, as well as between ATP and invariant Lys48, but also facilitated the salt bridge network pertaining to the phosphorylated Thr186 at the activation loop. By contrast, these H-bonds cannot be formed in CDK9 owing to the absence of HIV-1 Tat. MD simulations further revealed that the Mg-1(2+) ion, coupled with the Mg-2(2+) ion, anchored to the triphosphate moiety of ATP in its catalytic competent conformation. This observation indicates the requirement of the Mg-1(2+) ion for CDK9 to realize its function. Overall, the introduction of HIV-1 Tat and Mg-1(2+) ion resulted in the active site architectural characteristics of phosphorylated CDK9. These data highlighted the functional roles of HIV-1 Tat and Mg-1(2+) ion in the regulation of CDK9 activity, which contributes an important complementary understanding of CDK molecular underpinnings.	[Jin, Hai-Xiao; Qiu, Xiao-Ting; Zhu, Peng; Yan, Xiao-Jun] Ningbo Univ, Sch Marine Sci, Key Lab Appl Marine Biotechnol, Minist Educ, Ningbo 315211, Zhejiang, Peoples R China; [Go, Mei-Lin] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore; [Yin, Peng] Hunan Normal Univ, Coll Chem & Chem Engn, Key Lab Chem Biol & Tradit Chinese Med Res, Minist Educ, Changsha, Hunan, Peoples R China	Ningbo University; National University of Singapore; Hunan Normal University	Yan, XJ (corresponding author), Ningbo Univ, Sch Marine Sci, Key Lab Appl Marine Biotechnol, Minist Educ, Ningbo 315211, Zhejiang, Peoples R China.	yanxiaojun@nbu.edu.cn	Mei Lin, Go/C-5500-2014	Jin, Haixiao/0000-0002-0087-4651; Yan, Xiaojun/0000-0003-0257-0157	Natural Science Foundation of Ningbo [2010A610025]; National Science Foundation of China [20903058, 31400683]; Zhejiang Provincial Natural Science Foundation of China [LQ14C050001]; Public Science and Technology Research Funds Projects of Ocean [201305013]; K.C. Wong Magna Fund in Ningbo University	Natural Science Foundation of Ningbo; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Public Science and Technology Research Funds Projects of Ocean; K.C. Wong Magna Fund in Ningbo University	This work was supported by Natural Science Foundation of Ningbo (2010A610025), National Science Foundation of China (20903058, 31400683), Zhejiang Provincial Natural Science Foundation of China (LQ14C050001), Public Science and Technology Research Funds Projects of Ocean (201305013) and K.C. Wong Magna Fund in Ningbo University.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Afanasyeva A, 2014, STRUCTURE, V22, P549, DOI 10.1016/j.str.2014.02.002; [Anonymous], 2012, MOL OP ENV MONTR QUE; Bao ZQ, 2011, STRUCTURE, V19, P675, DOI 10.1016/j.str.2011.02.016; Bartova I, 2005, PROTEIN SCI, V14, P445, DOI 10.1110/ps.04959705; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Baumli S, 2012, STRUCTURE, V20, P1788, DOI 10.1016/j.str.2012.08.011; Baumli S, 2012, ACS CHEM BIOL, V7, P811, DOI 10.1021/cb2004516; Baumli S, 2010, CHEM BIOL, V17, P931, DOI 10.1016/j.chembiol.2010.07.012; Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Bertrand JA, 2003, J MOL BIOL, V333, P393, DOI 10.1016/j.jmb.2003.08.031; Bettayeb Karima, 2010, Genes Cancer, V1, P369, DOI 10.1177/1947601910369817; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Case D.A., 2022, AMBER 2020; Cheng YH, 2005, J AM CHEM SOC, V127, P1553, DOI 10.1021/ja0464084; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Endicott JA, 2013, BIOCHEM SOC T, V41, P1008, DOI 10.1042/BST20130097; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Gerlits O, 2013, BIOCHEMISTRY-US, V52, P3721, DOI 10.1021/bi400066a; Grigorenko BL, 2008, BBA-PROTEINS PROTEOM, V1784, P1908, DOI 10.1016/j.bbapap.2008.08.003; Grigorenko BL, 2007, P NATL ACAD SCI USA, V104, P7057, DOI 10.1073/pnas.0701727104; Grigorenko BL, 2011, J MOL GRAPH MODEL, V31, P1, DOI 10.1016/j.jmgm.2011.07.005; Gu JY, 2014, CELL CYCLE, V13, DOI 10.4161/cc.28756; Hole AJ, 2013, J MED CHEM, V56, P660, DOI 10.1021/jm301495v; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jacobsen DM, 2012, J AM CHEM SOC, V134, P15357, DOI 10.1021/ja304419t; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jin HX, 2007, J MOL STRUC-THEOCHEM, V805, P9, DOI 10.1016/j.theochem.2006.10.020; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Ko TP, 2010, ACTA CRYSTALLOGR D, V66, P145, DOI 10.1107/S0907444909047507; Krystof V, 2010, MED RES REV, V30, P646, DOI 10.1002/med.20172; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Li S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097668; Lu SY, 2013, PROTEINS, V81, P740, DOI 10.1002/prot.24221; Lu SY, 2011, J CHEM INF MODEL, V51, P1025, DOI 10.1021/ci100493j; Lu SY, 2011, PHYS CHEM CHEM PHYS, V13, P7014, DOI 10.1039/c0cp02498h; Lu SY, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003831; Lu SY, 2014, MED RES REV, V34, P1242, DOI 10.1002/med.21317; Lu SY, 2012, J CHEM INF MODEL, V52, P2398, DOI 10.1021/ci300172r; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Montenegro M, 2011, PHYS CHEM CHEM PHYS, V13, P530, DOI 10.1039/c0cp01062f; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Pang YP, 2001, PROTEINS, V45, P183, DOI 10.1002/prot.1138; Perez-Gallegos A, 2014, J COMPUT AID MOL DES, V28, P1077, DOI 10.1007/s10822-014-9786-3; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schulze-Gahmen U, 2014, ELIFE, V3, DOI 10.7554/eLife.02375; Schulze-Gahmen U, 2013, ELIFE, V2, DOI 10.7554/eLife.00327; Shao H, 2013, J MED CHEM, V56, P640, DOI 10.1021/jm301475f; Sun HY, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003729; Szarek P, 2008, J PHYS CHEM B, V112, P11819, DOI 10.1021/jp8040633; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Takaki T, 2009, P NATL ACAD SCI USA, V106, P4171, DOI 10.1073/pnas.0809674106; Tang J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000761; Valiev M, 2003, J AM CHEM SOC, V125, P9926, DOI 10.1021/ja029618u; Wang PF, 2006, BIOCHEMISTRY-US, V45, P11464, DOI 10.1021/bi0607002; Wang S, 2008, TRENDS PHARMACOL SCI, V29, P302, DOI 10.1016/j.tips.2008.03.003; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Zhang B, 2007, BIOCHEMISTRY-US, V46, P10841, DOI 10.1021/bi700890t; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	68	4	4	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124673	10.1371/journal.pone.0124673	http://dx.doi.org/10.1371/journal.pone.0124673			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909811	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800101
J	Singh, DJ				Singh, David Joseph			Multiband Semimetallic Electronic Structure of Superconducting Ta2PdSe5	PLOS ONE			English	Article							UPPER CRITICAL FIELDS; DIRTY; MGB2; TEMPERATURE; STATE	We report the electronic structure and related properties of the superconductor Ta2PdSe5 as determined from density functional calculations. The Fermi surface has two disconnected sheets, both derived from bands of primarily chalcogenide p states. These are a corrugated hole cylinder and a heavier complex shaped electron sheet. The sheets contain 0.048 holes and a compensating number of electrons per formula unit, making the material a semimetallic superconductor. The results support the presence of two band superconductivity, although a discrepancy in the specific heat is noted. This discrepancy is discussed as a possible consequence of Pd deficiency in samples.	Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	Singh, DJ (corresponding author), Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA.	singhdj@ornl.gov			Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division	Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE))	This work was funded by the Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, AUGMENTED PLANE WAVE, P60; Goyal R, 2014, ARXIV14124890; Gurevich A, 2004, SUPERCOND SCI TECH, V17, P278, DOI 10.1088/0953-2048/17/2/008; Gurevich A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.184515; Gurevich A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184504; Hunte F, 2008, NATURE, V453, P903, DOI 10.1038/nature07058; Jha R, 2014, J APPL PHYS, V115, DOI 10.1063/1.4881278; Khim S, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/12/123031; KONDO J, 1963, PROG THEOR PHYS, V29, P1, DOI 10.1143/PTP.29.1; Koshelev AE, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.177002; Kuroki K, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.024501; Kuroki K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.087004; Lu YF, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.023702; Madsen GKH, 2006, COMPUT PHYS COMMUN, V175, P67, DOI 10.1016/j.cpc.2006.03.007; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; Mazin II, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.107002; Niu CQ, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.104507; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Shi H, 2014, ARXIV14125407; SINGH D, 1991, PHYS REV B, V43, P6388, DOI 10.1103/PhysRevB.43.6388; Singh DJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.237003; Singh D. J., 2006, PLANEWAVES PSEUDOPOT, V2nd, DOI DOI 10.1007/978-1-4757-2312-0; Singh DJ, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.144501; Singh DJ, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.174508; Singh DJ, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/12/123003; SQUATTRITO PJ, 1986, J SOLID STATE CHEM, V64, P261, DOI 10.1016/0022-4596(86)90070-8; SUHL H, 1959, PHYS REV LETT, V3, P552, DOI 10.1103/PhysRevLett.3.552; WERTHAME.NR, 1966, PHYS REV, V147, P295, DOI 10.1103/PhysRev.147.295; Yu HY, 2013, J AM CHEM SOC, V135, P12987, DOI 10.1021/ja4062079; Zehetmayer M, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/4/043001; Zhang J, 2014, ARXIV14126983; Zhang Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep01446; Zhang QR, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.024508; Zhou N, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.094520	35	6	6	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123667	10.1371/journal.pone.0123667	http://dx.doi.org/10.1371/journal.pone.0123667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909894	gold, Green Submitted, Green Published			2022-12-27	WOS:000353376800043
J	Arponen, O; Muuronen, A; Taina, M; Sipola, P; Hedman, M; Jakala, P; Vanninen, R; Pulkki, K; Mustonen, P				Arponen, Otso; Muuronen, Antti; Taina, Mikko; Sipola, Petri; Hedman, Marja; Jakala, Pekka; Vanninen, Ritva; Pulkki, Kari; Mustonen, Pirjo			Acute Phase IL-10 Plasma Concentration Associates with the High Risk Sources of Cardiogenic Stroke	PLOS ONE			English	Article							ANTIINFLAMMATORY CYTOKINE INTERLEUKIN-10; ISCHEMIC-STROKE; ECHOCARDIOGRAPHY; INFLAMMATION; ACTIVATION; MECHANISMS; PLATELETS; ELEVATION; CELLS	Background Etiological assessment of stroke is essential for accurate treatment decisions and for secondary prevention of recurrence. There is evidence that interleukin-10 (IL-10) associates with ischemic stroke. The aim of this prospective study was to assess the levels of IL-10 in ischemic stroke with unknown or suspected cardiogenic etiology, and evaluate the correlation between IL-10 plasma concentration and the number of diagnosed high risk sources for cardioembolism. Methods A total of 141 patients (97 males; mean age 61 +/- 11 years) with acute ischemic stroke with unknown etiology or suspected cardiogenic etiology other than known atrial fibrillation (AF) underwent imaging investigations to assess high risk sources for cardioembolic stroke established by the European Association of Echocardiography (EAE). IL-10 was measured on admission to the hospital and on a three month follow-up visit. Results Acute phase IL-10 concentration was higher in patients with EAE high risk sources, and correlated with their number (p<0.01). In patients with no risk sources (n = 104), the mean IL-10 concentration was 2.7 +/- 3.1 ng/L (range 0.3-16.3 ng/L), with one risk source (n = 26) 3.7 +/- 5.5 ng/L (0.3-23.6 ng/L), with two risk sources (n = 10) 7.0 +/- 10.0 ng/L (1.29-34.8 ng/L) and with three risk sources (n = 1) 37.2 ng/L. IL-10 level was not significantly associated with cerebral infarct volume, presence of previous or recent myocardial infarction, carotid/vertebral artery atherosclerosis, paroxysmal AF registered on 24-hour ECG Holter monitoring or given intravenous thrombolytic treatment. Conclusion IL-10 plasma concentration correlates independently with the number of EAE cardioembolic risk sources in patients with acute stroke. IL-10 may have potential to improve differential diagnostics of stroke with unknown etiology.	[Arponen, Otso; Muuronen, Antti; Taina, Mikko; Sipola, Petri; Hedman, Marja; Vanninen, Ritva] Kuopio Univ Hosp, Diagnost Imaging Ctr, Dept Clin Radiol, SF-70210 Kuopio, Finland; [Arponen, Otso; Muuronen, Antti; Sipola, Petri; Vanninen, Ritva] Univ Eastern Finland, Inst Clin Med, Radiol Unit, Kuopio, Finland; [Hedman, Marja] Kuopio Univ Hosp, Ctr Heart, SF-70210 Kuopio, Finland; [Jakala, Pekka] Kuopio Univ Hosp, NeuroCtr, SF-70210 Kuopio, Finland; [Jakala, Pekka] Univ Eastern Finland, Inst Clin Med, Neurol Unit, Kuopio, Finland; [Pulkki, Kari] Univ Eastern Finland, Dept Clin Chem, Kuopio, Finland; [Pulkki, Kari] Eastern Finland Lab Ctr, Kuopio, Finland; [Mustonen, Pirjo] Keski Suomi Cent Hosp, Dept Cardiol, Jyvaskyla, Finland	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Central Finland Central Hospital	Arponen, O (corresponding author), Kuopio Univ Hosp, Diagnost Imaging Ctr, Dept Clin Radiol, SF-70210 Kuopio, Finland.	Otso.Arponen@kuh.fi		Pulkki, Kari/0000-0003-0690-9883	Kuopio University Hospital [5063519]	Kuopio University Hospital	This study is supported by the Kuopio University Hospital (grant number 5063519; www.psshp.fi/web/en/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Anguera I, 2002, AM HEART J, V144, P811, DOI 10.1067/mhj.2002.124831; Aroor AR, 2013, METABOLISM, V62, P1543, DOI 10.1016/j.metabol.2013.07.001; Bang OY, 2003, ANN NEUROL, V54, P227, DOI 10.1002/ana.10644; Caligiuri G, 2003, MOL MED, V9, P10, DOI 10.1007/BF03402102; DOLHABERRIAGUE L, 1989, STROKE, V20, P1648, DOI 10.1161/01.STR.20.12.1648; Downing LJ, 1998, J IMMUNOL, V161, P1471; Emsley HCA, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-5; Ferro JM, 2003, LANCET NEUROL, V2, P177, DOI 10.1016/S1474-4422(03)00324-7; GRAHAM TP, 1973, CIRCULATION, V47, P144, DOI 10.1161/01.CIR.47.1.144; Gudbrandsdottir S, 2013, J IMMUNOL, V191, P4059, DOI 10.4049/jimmunol.1201103; Hagihara M, 2004, J IMMUNOL, V172, P5297, DOI 10.4049/jimmunol.172.9.5297; Heeschen C, 2003, CIRCULATION, V107, P2109, DOI 10.1161/01.CIR.0000065232.57371.25; JUNGI TW, 1994, THROMB RES, V76, P463, DOI 10.1016/0049-3848(95)90178-I; Kilic T, 2006, HEART, V92, P1041, DOI 10.1136/hrt.2005.080382; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Leftheriotis DI, 2009, INT J CARDIOL, V135, P361, DOI 10.1016/j.ijcard.2008.04.012; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Oslund LJP, 1999, ARTERIOSCL THROM VAS, V19, P2847, DOI 10.1161/01.ATV.19.12.2847; Osmancik P, 2012, J THROMB THROMBOLYS, V33, P349, DOI 10.1007/s11239-011-0659-5; Pajkrt D, 1997, BLOOD, V89, P2701, DOI 10.1182/blood.V89.8.2701; Pelidou SH, 1999, EUR J NEUROL, V6, P437, DOI 10.1046/j.1468-1331.1999.640437.x; Pepi M, 2010, EUR J ECHOCARDIOGR, V11, P461, DOI 10.1093/ejechocard/jeq045; Rodriguez-Yanez M, 2011, STROKE, V42, P2813, DOI 10.1161/STROKEAHA.111.614503; Sahlman J, 2010, J SLEEP RES, V19, P341, DOI 10.1111/j.1365-2869.2009.00787.x; Sikka G, 2013, EXP GERONTOL, V48, P128, DOI 10.1016/j.exger.2012.11.001; Sipola P, 2013, CEREBROVASC DIS, V35, P521, DOI 10.1159/000350734; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; Strle K, 2001, CRIT REV IMMUNOL, V21, P427; Taina M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079519; Tarkowski E, 1997, CLIN EXP IMMUNOL, V110, P492, DOI 10.1046/j.1365-2249.1997.4621483.x; Uyemura K, 1996, J CLIN INVEST, V97, P2130, DOI 10.1172/JCI118650; van Exel E, 2002, STROKE, V33, P1135, DOI 10.1161/01.STR.0000014206.05597.9E; Vasse M, 1996, BRIT J HAEMATOL, V93, P955, DOI 10.1046/j.1365-2141.1996.d01-1731.x; Xie GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074126; Yip PK, 1997, STROKE, V28, P2507, DOI 10.1161/01.STR.28.12.2507	39	7	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0120910	10.1371/journal.pone.0120910	http://dx.doi.org/10.1371/journal.pone.0120910			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923658	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600004
J	Bryniarski, K; Ptak, W; Martin, E; Nazimek, K; Szczepanik, M; Sanak, M; Askenase, PW				Bryniarski, Krzysztof; Ptak, Wlodzimierz; Martin, Emilia; Nazimek, Katarzyna; Szczepanik, Marian; Sanak, Marek; Askenase, Philip W.			Free Extracellular miRNA Functionally Targets Cells by Transfecting Exosomes from Their Companion Cells	PLOS ONE			English	Article							T-CELLS; MICRORNAS; VESICLES; MIR-150; MICROVESICLES; RECRUITMENT; BIOMARKERS; INITIATION; DELIVERY; PROTEIN	Lymph node and spleen cells of mice doubly immunized by epicutaneous and intravenous hapten application produce a suppressive component that inhibits the action of the effector T cells that mediate contact sensitivity reactions. We recently re-investigated this phenomenon in an immunological system. CD8+ T lymphocyte-derived exosomes transferred suppressive miR-150 to the effector T cells antigen-specifically due to exosome surface coat of antibody light chains made by B1a lymphocytes. Extracellular RNA (exRNA) is protected from plasma RNases by carriage in exosomes or by chaperones. Exosome transfer of functional RNA to target cells is well described, whereas the mechanism of transfer of exRNA free of exosomes remains unclear. In the current study we describe extracellular miR-150, extracted from exosomes, yet still able to mediate antigen-specific suppression. We have determined that this was due to miR-150 association with antibody-coated exosomes produced by B1a cell companions of the effector T cells, which resulted in antigen-specific suppression of their function. Thus functional cell targeting by free exRNA can proceed by transfecting companion cell exosomes that then transfer RNA cargo to the acceptor cells. This contrasts with the classical view on release of RNA-containing exosomes from the multivesicular bodies for subsequent intercellular targeting. This new alternate pathway for transfer of exRNA between cells has distinct biological and immunological significance, and since most human blood exRNA is not in exosomes may be relevant to evaluation and treatment of diseases.	[Bryniarski, Krzysztof; Askenase, Philip W.] Yale Univ, Sch Med, Dept Internal Med, Sect Allergy & Clin Immunol, New Haven, CT 06510 USA; [Bryniarski, Krzysztof; Ptak, Wlodzimierz; Martin, Emilia; Nazimek, Katarzyna] Jagiellonian Univ, Coll Med, Dept Immunol, Krakow, Poland; [Szczepanik, Marian] Jagiellonian Univ, Coll Med, Dept Med Biol, Krakow, Poland; [Sanak, Marek] Jagiellonian Univ, Coll Med, Dept Internal Med, Krakow, Poland	Yale University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Askenase, PW (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Allergy & Clin Immunol, New Haven, CT 06510 USA.	philip.askenase@yale.edu	Bryniarski, Krzysztof/X-8312-2018; Sanak, Marek/AAV-1628-2021; Szczepanik, Marian/ABA-7001-2021; Nazimek, Katarzyna/X-8292-2018	Bryniarski, Krzysztof/0000-0001-8537-9176; Sanak, Marek/0000-0001-7635-8103; Nazimek, Katarzyna/0000-0003-1302-117X; Martin, Emilia/0000-0001-9847-9811	Polish Ministry of Science and Higher Education [N40109231/2076]; Polish National Scientific Center [2013/11/B/NZ6/02041, 2013/09/N/NZ6/00753]; NIH from NIH / NIDA [AI-05981, AI-076366, AI-07174, U54 DA036134]; KNOW - Leading National Research Centre; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007174, R21AI076366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA036134] Funding Source: NIH RePORTER	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish National Scientific Center; NIH from NIH / NIDA; KNOW - Leading National Research Centre; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	KB was supported by grants from the Polish Ministry of Science and Higher Education: N40109231/2076 and Polish National Scientific Center: 2013/11/B/NZ6/02041; PWA by the NIH: AI-05981, AI-076366, AI-07174, and U54 DA036134 from NIH / NIDA; and KN by Polish National Scientific Center: 2013/09/N/NZ6/00753. The authors would like to express their gratitude to the KNOW - Leading National Research Centre 2012-2017 for the financial support of the process of printing the article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Askenase PW, 2004, TRENDS IMMUNOL, V25, P441, DOI 10.1016/j.it.2004.06.003; Askenase PW, 2000, CURR TOP MICROBIOL, V252, P171; Bezman NA, 2011, J EXP MED, V208, P2717, DOI 10.1084/jem.20111386; Boon RA, 2013, ARTERIOSCL THROM VAS, V33, P186, DOI 10.1161/ATVBAHA.112.300139; Bryniarski K, 2014, CENTR EUR J IMMUN S1, V39, P20; Bryniarski K, 2013, J ALLERGY CLIN IMMUN, V132, P170, DOI 10.1016/j.jaci.2013.04.048; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, PROTEIN CELL, V3, P28, DOI 10.1007/s13238-012-2003-z; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; England T E, 1980, Methods Enzymol, V65, P65; FERRERI NR, 1993, J IMMUNOL, V150, P2102; Ghisi M, 2011, BLOOD, V117, P7053, DOI 10.1182/blood-2010-12-326629; Hussein K, 2010, LEUKEMIA RES, V34, P328, DOI 10.1016/j.leukres.2009.06.014; Hutchinson AT, 2012, IMMUNOL LETT, V142, P75, DOI 10.1016/j.imlet.2011.10.013; Kerfoot SM, 2008, J IMMUNOL, V181, P1717, DOI 10.4049/jimmunol.181.3.1717; Lasser C, 2015, EXPERT OPIN BIOL TH, V15, P103, DOI 10.1517/14712598.2015.977250; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; Liang HW, 2014, WIRES RNA, V5, P285, DOI 10.1002/wrna.1208; Nazimek Katarzyna, 2014, Folia Med Cracov, V54, P37; Ohno S, 2013, ADV DRUG DELIVER REV, V65, P398, DOI 10.1016/j.addr.2012.07.019; Paliwal V, 2002, J IMMUNOL, V169, P4113, DOI 10.4049/jimmunol.169.8.4113; PTAK W, 1980, IMMUNOBIOLOGY, V156, P400, DOI 10.1016/S0171-2985(80)80073-8; Ptak W, 2015, ARCH IMMUNOL THER EX, V63, P345, DOI 10.1007/s00005-015-0331-4; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Redegeld FA, 2002, NAT MED, V8, P694, DOI 10.1038/nm722; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Sheinerman KS, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-304; Szczepanik M, 2003, J IMMUNOL, V171, P6225, DOI 10.4049/jimmunol.171.11.6225; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Turchinovich A., 2013, Frontiers in Genetics, V4, P119, DOI 10.3389/fgene.2013.00119; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Turchinovich A, 2012, RNA BIOL, V9, P1066, DOI 10.4161/rna.21083; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Vickers KC, 2012, CURR OPIN LIPIDOL, V23, P91, DOI 10.1097/MOL.0b013e328350a425; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xu L, 2014, BIO-MED MATER ENG, V24, P3917, DOI 10.3233/BME-141223; Zheng QH, 2012, J IMMUNOL, V188, P2118, DOI 10.4049/jimmunol.1103342; Zhuang XY, 2011, MOL THER, V19, P1769, DOI 10.1038/mt.2011.164	45	54	54	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122991	10.1371/journal.pone.0122991	http://dx.doi.org/10.1371/journal.pone.0122991			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923429	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600026
J	Gonsalves, GS; Kaplan, EH; Paltiel, AD				Gonsalves, Gregg S.; Kaplan, Edward H.; Paltiel, A. David			Reducing Sexual Violence by Increasing the Supply of Toilets in Khayelitsha, South Africa: A Mathematical Model	PLOS ONE			English	Article							EMPIRICAL-FINDINGS; INTERVENTIONS; SANITATION; DIARRHEA; GENDER; CRIME; WOMEN; WATER; COST; RAPE	Background Sexual violence is a major public health issue, affecting 35% of women worldwide. Major risk factors for sexual assault include inadequate indoor sanitation and the need to travel to outdoor toilet facilities. We estimated how increasing the number of toilets in an urban township (Khayelitsha, South Africa) might reduce both economic costs and the incidence and social burden of sexual assault. Methods We developed a mathematical model that links risk of sexual assault to the number of sanitation facilities and the time a woman must spend walking to a toilet. We defined a composite societal cost function, comprising both the burden of sexual assault and the costs of installing and maintaining public chemical toilets. By expressing total social costs as a function of the number of available toilets, we were able to identify an optimal (i.e., cost-minimizing) social investment in toilet facilities. Findings There are currently an estimated 5600 toilets in Khayelitsha. This results in 635 sexual assaults and US$40 million in combined social costs each year. Increasing the number of toilets to 11300 would minimize total costs ($35 million) and reduce sexual assaults to 446. Higher toilet installation and maintenance costs would be more than offset by lower sexual assault costs. Probabilistic sensitivity analysis shows that the optimal number of toilets exceeds the original allocation of toilets in the township in over 80% of the 5000 iterations of the model. Interpretation Improving access to sanitation facilities in urban settlements will simultaneously reduce the incidence of sexual assaults and overall cost to society. Since our analysis ignores the many additional health benefits of improving sanitation in resource-constrained urban areas (e.g., potential reductions in waterborne infectious diseases), the optimal number of toilets identified here should be interpreted as conservative.	[Gonsalves, Gregg S.; Paltiel, A. David] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; [Kaplan, Edward H.] Yale Univ, Sch Management, New Haven, CT 06520 USA	Yale University; Yale University	Gonsalves, GS (corresponding author), Yale Univ, Sch Publ Hlth, POB 208034,60 Coll St, New Haven, CT 06520 USA.	gregg.gonsalves@yale.edu		Paltiel, A. David/0000-0002-4861-3290; Kaplan, Edward/0000-0002-8722-7667; Gonsalves, Gregg/0000-0002-5789-9841	Yale School of Public Health; Yale School of Management; National Institute on Drug Abuse [R01DA015612]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	Yale School of Public Health; Yale School of Management; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	GSG was funded by the Yale School of Public Health. EHK was funded by faculty support from the Yale School of Management. ADP was funded by the National Institute on Drug Abuse (www.drugabuse.gov) via grant R01DA015612. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actionaid, 2013, WOM CIT 2 COMB VIOL; Amnesty International, 2010, RISK RAP TOIL WOM EX; [Anonymous], 2012, WORLD URBANIZATION P; [Anonymous], 2001, MACR HLTH INV HLTH E; Browning RC, 2006, J APPL PHYSIOL, V100, P390, DOI 10.1152/japplphysiol.00767.2005; BURGIO KL, 1991, J UROLOGY, V145, P728, DOI 10.1016/S0022-5347(17)38436-7; City of Cape Town, 2005, POP PROF KHAY SOC IN; Department of Health, 1999, S AFR DEM HLTH SURV; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Felten-Biermann C., 2006, DEVELOPMENT, V49, P82, DOI [https://doi.org/10.1057/palgrave.development.1100276, DOI 10.1057/PALGRAVE.DEVELOPMENT.1100276]; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Granfone M, 2008, ENVISIONING ENDLOVIN; Hutton G, 2007, J WATER HEALTH, V5, P481, DOI 10.2166/wh.2007.009; Institute for Security Studies, 2012, SA CRIM STATS; Jewkes R, 2002, SOC SCI MED, V55, P1231, DOI 10.1016/S0277-9536(01)00242-8; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; McCollister KE, 2010, DRUG ALCOHOL DEPEN, V108, P98, DOI 10.1016/j.drugalcdep.2009.12.002; McIlwaine C, 2013, ENVIRON URBAN, V25, P65, DOI 10.1177/0956247813477359; Pegram GC, 1998, WATER SA, V24, P11; Petchesky RP, 2008, REPROD HEALTH MATTER, V16, P4, DOI 10.1016/S0968-8080(08)31380-9; Phakathi B, 2013, BUSINESS DAY; QSJ Consultants, 2006, SOC PROF URB REN NOD; SHERMAN LW, 1989, CRIMINOLOGY, V27, P27, DOI 10.1111/j.1745-9125.1989.tb00862.x; Social Justice Coalition, 2013, RES KHAYEL MSHENG TO; Swart LA, 2000, S AFR J PSYCHOL, V30, P1; Turok I, 2012, URBANISATION DEV S A; Venis S, 2002, LANCET, V359, P1172, DOI 10.1016/S0140-6736(02)08251-X; Venter C, 2007, TRANSPORT REV, V27, P653, DOI 10.1080/01441640701450627; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; Weisburd D, 2006, CRIMINOLOGY, V44, P549, DOI 10.1111/j.1745-9125.2006.00057.x; WHO; UNICEF, 2012, PROGR DRINK WAT SANT; World Bank, 2014, GNI PPP CURR INT INT; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization, 2021, VIOL WOM PREV EST 20	35	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122244	10.1371/journal.pone.0122244	http://dx.doi.org/10.1371/journal.pone.0122244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923105	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600011
J	Pantaleon, V; Soavelomandroso, AP; Bouttier, S; Briandet, R; Roxas, B; Chu, M; Collignon, A; Janoir, C; Vedantam, G; Candela, T				Pantaleon, Veronique; Soavelomandroso, Anna Philibertine; Bouttier, Sylvie; Briandet, Romain; Roxas, Bryan; Chu, Michele; Collignon, Anne; Janoir, Claire; Vedantam, Gayatri; Candela, Thomas			The Clostridium difficile Protease Cwp84 Modulates both Biofilm Formation and Cell-Surface Properties	PLOS ONE			English	Article							CYSTEINE PROTEASE; PROTEINS; SPORULATION; INFECTION; BACTERIA; INSIGHTS; LAYER; WALL	Clostridium difficile is responsible for 15-20% of antibiotic-associated diarrheas, and nearly all cases of pseudomembranous colitis. Among the cell wall proteins involved in the colonization process, Cwp84 is a protease that cleaves the S-layer protein SlpA into two subunits. A cwp84 mutant was previously shown to be affected for in vitro growth but not in its virulence in a hamster model. In this study, the cwp84 mutant elaborated biofilms with increased biomass compared with the parental strain, allowing the mutant to grow more robustly in the biofilm state. Proteomic analyses of the 630 Delta erm bacteria growing within the biofilm revealed the distribution of abundant proteins either in cell surface, matrix or supernatant fractions. Of note, the toxin TcdA was found in the biofilm matrix. Although the overall proteome differences between the cwp84 mutant and the parental strains were modest, there was still a significant impact on bacterial surface properties such as altered hydrophobicity. In vitro and in vivo competition assays revealed that the mutant was significantly impaired for growth only in the planktonic state, but not in biofilms or in vivo. Taken together, our results suggest that the phenotypes in the cwp84 mutant come from either the accumulation of uncleaved SlpA, or the ability of Cwp84 to cleave as yet undetermined proteins.	[Pantaleon, Veronique; Soavelomandroso, Anna Philibertine; Bouttier, Sylvie; Collignon, Anne; Janoir, Claire; Candela, Thomas] Univ Paris 11, Fac Pharm, EA4043, F-92290 Chatenay Malabry, France; [Briandet, Romain] INRA, UMR1319, Jouy En Josas, France; [Briandet, Romain] AgroParisTech, UMR Micalis, Massy, France; [Roxas, Bryan; Chu, Michele; Vedantam, Gayatri] Univ Arizona, Sch Anim & Comparat Biomed Sci, Dept Immunobiol, Tucson, AZ USA; [Vedantam, Gayatri] Southern Arizona VA Healthcare Syst, Tucson, AZ USA	UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; University of Arizona; US Department of Veterans Affairs; Veterans Health Administration (VHA); Southern Arizona Veterans Affairs Health Care System	Candela, T (corresponding author), Univ Paris 11, Fac Pharm, EA4043, F-92290 Chatenay Malabry, France.	thomas.candela@u-psud.fr	Candela, Thomas/ABA-6367-2021; Briandet, Romain/AAD-2102-2020; Candela, Thomas/AAC-9583-2021	Briandet, Romain/0000-0002-8123-3492; Candela, thomas/0000-0002-4686-2533	French Research Ministry (MNRT); US Dept. of Veterans Affairs; USDA AZRT [570410- A-02-139]	French Research Ministry (MNRT); US Dept. of Veterans Affairs; USDA AZRT	VP and APS were funded by the French Research Ministry (MNRT). Work in the GV laboratory is funded by the US Dept. of Veterans Affairs and experiments for this study were specifically funded by a USDA AZRT 570410- A-02-139 award.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BellonFontaine MN, 1996, COLLOID SURFACE B, V7, P47, DOI 10.1016/0927-7765(96)01272-6; Bouillaut Laurent, 2011, Curr Protoc Microbiol, VChapter 9, DOI 10.1002/9780471729259.mc09a02s20; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Burns DA, 2011, J MICROBIOL METH, V87, P133, DOI 10.1016/j.mimet.2011.07.017; Calabi E, 2001, MOL MICROBIOL, V40, P1187, DOI 10.1046/j.1365-2958.2001.02461.x; ChapetonMontes D, 2011, J BACTERIOL, V193, P5314, DOI 10.1128/JB.00326-11; Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI200320365; Crowther GS, 2014, J ANTIMICROB CHEMOTH, V69, P2137, DOI 10.1093/jac/dku116; Dapa T, 2013, J BACTERIOL, V195, P545, DOI 10.1128/JB.01980-12; Dawson LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050527; de la Riva L, 2011, J BACTERIOL, V193, P3276, DOI 10.1128/JB.00248-11; Donelli G, 2012, FEMS IMMUNOL MED MIC, V65, P318, DOI 10.1111/j.1574-695X.2012.00962.x; Fagan RP, 2011, J MED MICROBIOL, V60, P1225, DOI 10.1099/jmm.0.028472-0; Fagan RP, 2009, MOL MICROBIOL, V71, P1308, DOI 10.1111/j.1365-2958.2009.06603.x; Federle MJ, 2003, J CLIN INVEST, V112, P1291, DOI 10.1172/JCI200320195; Giaouris E, 2009, INT J FOOD MICROBIOL, V131, P2, DOI 10.1016/j.ijfoodmicro.2008.09.006; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Janoir C, 2007, J BACTERIOL, V189, P7174, DOI 10.1128/JB.00578-07; Kirby JM, 2009, J BIOL CHEM, V284, P34666, DOI 10.1074/jbc.M109.051177; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; McQuade R, 2012, ANAEROBE, V18, P614, DOI 10.1016/j.anaerobe.2012.09.004; Mergenhagen KA, 2014, PHARMACOECONOMICS, V32, P639, DOI 10.1007/s40273-014-0161-y; Merrigan MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078404; Miller J.H., 1972, EXPT MOL GENETICS; Ng YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056051; Pantaleon V, 2014, ANAEROBE; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Semenyuk EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087757; Spigaglia P, 2013, J MED MICROBIOL, V62, P1386, DOI 10.1099/jmm.0.056556-0; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; WEXLER H, 1984, REV INFECT DIS, V6, pS229	35	45	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124971	10.1371/journal.pone.0124971	http://dx.doi.org/10.1371/journal.pone.0124971			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922949	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600118
J	Sise, ME; Backman, ES; Wenger, JB; Wood, BR; Sax, PE; Chung, RT; Thadhani, R; Kim, AY				Sise, Meghan E.; Backman, Elke S.; Wenger, Julia B.; Wood, Brian R.; Sax, Paul E.; Chung, Raymond T.; Thadhani, Ravi; Kim, Arthur Y.			Short and Long-Term Effects of Telaprevir on Kidney Function in Patients with Hepatitis C Virus Infection: A Retrospective Cohort Study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CHRONIC HCV INFECTION; GENOTYPE 1; DISEASE; RISK; THERAPY; INJURY; ASSOCIATION; OUTCOMES; PEGINTERFERON	Background Recent reports suggest that telaprevir, a protease inhibitor used to treat hepatitis C infection, is associated with decline in kidney function during therapy, particularly in patients with baseline renal impairment. Methods Patients treated with telaprevir in a single healthcare network were retrospectively reviewed. Kidney function was determined at baseline, during therapy, and twelve weeks and twelve months after telaprevir discontinuation. Significant creatinine rise during therapy was defined as an increase in serum creatinine >= 0.3mg/dL from baseline during treatment with telaprevir. Results Between July 2011 to January 2013, seventy-eight patients began treatment. The majority completed the prescribed twelve weeks of telaprevir therapy; 32% discontinued due to side effects. The average rise in serum creatinine during therapy was 0.22mg/dL (standard deviation 0.22mg/dL). Thirty-one percent experienced a significant creatinine rise during therapy. Decline in estimated glomerular filtration rate (eGFR) was lower in those with baseline eGFR < 90 mL/min/1.73m(2) compared to the group with baseline eGFR >= 90 mL/min/ 1.73m(2) (12 vs. 18 mL/min/1.73m(2), P = 0.047). Serum creatinine fully normalized by twelve weeks after cessation of telaprevir in 83% of patients, however experiencing a significant creatinine rise during telaprevir use was associated with a 6.6mL/min/1.73m(2) decrease in estimated glomerular filtration rate at twelve months in an adjusted model. Conclusions Decline in kidney function during therapy with telaprevir is common and is not associated with baseline eGFR < 90mL/min/1.73m(2) as previously reported.	[Sise, Meghan E.; Wenger, Julia B.; Thadhani, Ravi] Harvard Univ, Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02115 USA; [Backman, Elke S.] Harvard Univ, Massachusetts Gen Hosp, Dept Pharm, Boston, MA 02115 USA; [Wood, Brian R.] Univ Washington, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Sax, Paul E.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Sax, Paul E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chung, Raymond T.] Harvard Univ, Massachusetts Gen Hosp, Dept Med, Gastrointestinal Unit, Boston, MA 02115 USA; [Kim, Arthur Y.] Harvard Univ, Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Sise, ME (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02115 USA.	msise@mgh.harvard.edu			National Institute of Health [K24 DK078772]; American Society of Nephrology Foundation Fellowship Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK094872, K24DK078772] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology Foundation Fellowship Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Institute of Health - K24 DK078772 (RTC); American Society of Nephrology Foundation Fellowship Grant (MES), https://www.asn-online.org/grants/fellowships/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdur RL, 2009, KIDNEY INT, V76, P1089, DOI 10.1038/ki.2009.332; Gervasoni C, 2014, AIDS, V28, P285, DOI 10.1097/QAD.0000000000000088; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Gines P, 2009, NEW ENGL J MED, V361, P1279, DOI 10.1056/NEJMra0809139; Gordon SC, 2014, J HEPATOL; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Hsu YC, 2014, HEPATOLOGY, V59, P1293, DOI 10.1002/hep.26892; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Karino Y, 2014, J VIRAL HEPATITIS, V21, P341, DOI 10.1111/jvh.12162; Kikuchi H, 2014, EUR J GASTROEN HEPAT, V26, P244, DOI 10.1097/MEG.0000000000000005; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Kunze A, 2012, BIOCHEM PHARMACOL, V84, P1096, DOI 10.1016/j.bcp.2012.07.032; Lee JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100790; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lo LJ, 2009, KIDNEY INT, V76, P893, DOI 10.1038/ki.2009.289; Loustaud- Ratti V, 2014, LIVER INT; Mauss S, 2014, HEPATOLOGY, V59, P46, DOI 10.1002/hep.26602; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; Medapalli RK, 2012, JAIDS-J ACQ IMM DEF, V60, P393, DOI 10.1097/QAI.0b013e31825b70d9; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Prowle JR, 2014, CLIN J AM SOC NEPHRO, V9, P1015, DOI 10.2215/CJN.11141113; Roujeau JC, 2013, JAMA DERMATOL, V149, P152, DOI 10.1001/jamadermatol.2013.938; Saadoun D, 2006, ARTHRITIS RHEUM-US, V54, P3696, DOI 10.1002/art.22168; Schwartz EJ, 2005, J AM SOC NEPHROL, V16, P2412, DOI 10.1681/ASN.2005040340; Su FH, 2012, AM J KIDNEY DIS, V60, P553, DOI 10.1053/j.ajkd.2012.04.003; Tsui JI, 2007, ARCH INTERN MED, V167, P1271, DOI 10.1001/archinte.167.12.1271; Van den Eynde E, 2014, AIDS, V28, P1538, DOI 10.1097/QAD.0000000000000265; Veiga Z, 2014, EUR J GASTROEN HEPAT, V26, P687, DOI 10.1097/MEG.0000000000000069; Virlogeux V, 2014, J VIRAL HEPATITIS, V21, pE98, DOI 10.1111/jvh.12237; Yoshida EM, 2015, HEPATOLOGY, V61, P41, DOI 10.1002/hep.27366; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124139	10.1371/journal.pone.0124139	http://dx.doi.org/10.1371/journal.pone.0124139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923243	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600072
J	Volland, S; Esteve-Rudd, J; Hoo, J; Yee, C; Williams, DS				Volland, Stefanie; Esteve-Rudd, Julian; Hoo, Juyea; Yee, Claudine; Williams, David S.			A Comparison of Some Organizational Characteristics of the Mouse Central Retina and the Human Macula	PLOS ONE			English	Article							PIGMENT-EPITHELIUM; LIPOFUSCIN ACCUMULATION; BRUCHS MEMBRANE; OUTER SEGMENTS; BLOOD-FLOW; AGE; PHOTORECEPTOR; DEGENERATION; MICE; DEPOSITS	Mouse models have greatly assisted our understanding of retinal degenerations. However, the mouse retina does not have a macula, leading to the question of whether the mouse is a relevant model for macular degeneration. In the present study, a quantitative comparison between the organization of the central mouse retina and the human macula was made, focusing on some structural characteristics that have been suggested to be important in predisposing the macula to stresses leading to degeneration: photoreceptor density, phagocytic load on the RPE, and the relative thinness of Bruch's membrane. Light and electron microscopy measurements from retinas of two strains of mice, together with published data on human retinas, were used for calculations and subsequent comparisons. As in the human retina, the central region of the mouse retina possesses a higher photoreceptor cell density and a thinner Bruch's membrane than in the periphery; however, the magnitudes of these periphery to center gradients are larger in the human. Of potentially greater relevance is the actual photoreceptor cell density, which is much greater in the mouse central retina than in the human macula, underlying a higher phagocytic load for the mouse RPE. Moreover, at eccentricities that correspond to the peripheral half of the human macula, the rod to cone ratio is similar between mouse and human. Hence, with respect to photoreceptor density and phagocytic load of the RPE, the central mouse retina models at least the more peripheral part of the macula, where macular degeneration is often first evident.	[Williams, David S.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Dept Ophthalmol,Stein Eye Inst,Mol Biol Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Dept Neurobiol,Stein Eye Inst,Mol Biol Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Williams, DS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Dept Ophthalmol,Stein Eye Inst,Mol Biol Inst, Los Angeles, CA 90095 USA.	dswilliams@ucla.edu			National Institutes of Health [R01EY07042, P30EY00331]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY007042, P30EY000331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institutes of Health Grant R01EY07042 (DW) and Core Grant P30EY00331 (Stein Eye research group), and a Research to Prevent Blindness Jules and Doris Stein Professorship (to DW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNELT PK, 1987, J COMP NEUROL, V255, P18, DOI 10.1002/cne.902550103; ALM A, 1973, EXP EYE RES, V15, P15, DOI 10.1016/0014-4835(73)90185-1; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Baehr W, 2009, VISION RES, V49, P2636, DOI 10.1016/j.visres.2009.04.008; Beatty S, 1999, BRIT J OPHTHALMOL, V83, P867, DOI 10.1136/bjo.83.7.867; Beltran WA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090390; BESHARSE JC, 1979, INVEST OPHTH VIS SCI, V18, P1019; Bird AC, 2014, JAMA OPHTHALMOL, V132, P338, DOI 10.1001/jamaophthalmol.2013.5799; BIRNBACH CD, 1994, OPHTHALMOLOGY, V101, P1211; BONE RA, 1993, INVEST OPHTH VIS SCI, V34, P2033; BORWEIN B, 1980, AM J ANAT, V159, P125, DOI 10.1002/aja.1001590202; BRAEKEVELT CR, 1983, ANAT EMBRYOL, V166, P415, DOI 10.1007/BF00305927; BRESSLER NM, 1989, ARCH OPHTHALMOL-CHIC, V107, P847, DOI 10.1001/archopht.1989.01070010869032; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chong NHV, 2005, AM J PATHOL, V166, P241, DOI 10.1016/S0002-9440(10)62248-1; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Curcio C.A., 2013, RETINA-J RET VIT DIS, VVolume 1, P465; Curcio CA, 2005, EXP EYE RES, V80, P761, DOI 10.1016/j.exer.2004.09.017; Curcio CA, 1996, INVEST OPHTH VIS SCI, V37, P1236; Curcio CA, 2001, INVEST OPHTH VIS SCI, V42, P265; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Dalke C, 2005, EXP EYE RES, V81, P503, DOI 10.1016/j.exer.2005.06.004; Delori FC, 2000, INVEST OPHTH VIS SCI, V41, P496; DOBELLE WH, 1969, SCIENCE, V166, P1508, DOI 10.1126/science.166.3912.1508; Espinosa-Heidmann DG, 2006, INVEST OPHTH VIS SCI, V47, P729, DOI 10.1167/iovs.05-0719; Esteve-Rudd J., 2012, INVESTIG OPHTHALMOL, V53, P4756; FARBER DB, 1985, INVEST OPHTH VIS SCI, V26, P1558; FEENEY L, 1973, INVEST OPHTH VISUAL, V12, P635; FEENEYBURNS L, 1983, T OPHTHAL SOC UK, V103, P416; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Geng LJ, 1999, EXP EYE RES, V69, P539, DOI 10.1006/exer.1999.0735; Green W R, 1999, Mol Vis, V5, P27; Hendrickson A, 2005, MACULAR DEGENERATION, P1, DOI 10.1007/3-540-26977-0_1; HENDRICKSON A, 1992, BEHAV BRAIN RES, V49, P21, DOI 10.1016/S0166-4328(05)80191-3; HOGAN M J, 1972, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V76, P64; Jeon CJ, 1998, J NEUROSCI, V18, P8936; JONAS JB, 1992, GRAEF ARCH CLIN EXP, V230, P505, DOI 10.1007/BF00181769; Karan G, 2005, P NATL ACAD SCI USA, V102, P4164, DOI 10.1073/pnas.0407698102; Keeler CE, 1924, P NATL ACAD SCI USA, V10, P329, DOI 10.1073/pnas.10.7.329; Klein R, 2002, OPHTHALMOLOGY, V109, P1767, DOI 10.1016/S0161-6420(02)01146-6; LATIES AM, 1971, INVEST OPHTH VISUAL, V10, P69; Marmorstein LY, 2007, HUM MOL GENET, V16, P2423, DOI 10.1093/hmg/ddm199; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; NEWSOME DA, 1987, CURR EYE RES, V6, P1211, DOI 10.3109/02713688709025231; Nork TM, 2006, ARCH OPHTHALMOL-CHIC, V124, P860, DOI 10.1001/archopht.124.6.860; OBRIEN B, 1951, J OPT SOC AM, V41, P882, DOI 10.1364/JOSA.41.000882; Osterberg G, 1935, Acta Ophthalmol., V13, P11; Pikuleva IA, 2014, PROG RETIN EYE RES, V41, P64, DOI 10.1016/j.preteyeres.2014.03.002; Polyak S., 1957, VERTEBRATE VISUAL SY; Polyak S. L., 1941, RETINA-J RET VIT DIS; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; REMTULLA S, 1985, VISION RES, V25, P21, DOI 10.1016/0042-6989(85)90076-8; Rickman CB, 2013, INVEST OPHTH VIS SCI, V54, pORSF68, DOI 10.1167/iovs.13-12757; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; STEINBERG RH, 1973, J COMP NEUROL, V148, P229, DOI 10.1002/cne.901480209; Sterratt DC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002921; TSO MOM, 1968, ARCH OPHTHALMOL-CHIC, V80, P214, DOI 10.1001/archopht.1968.00980050216012; Wavre-Shapton ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057769; YAMADA E, 1969, ARCH OPHTHALMOL-CHIC, V82, P151; YOUNG RW, 1971, J CELL BIOL, V49, P303, DOI 10.1083/jcb.49.2.303; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; YOUNG RW, 1987, SURV OPHTHALMOL, V31, P291, DOI 10.1145/1165387.275645	64	108	108	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125631	10.1371/journal.pone.0125631	http://dx.doi.org/10.1371/journal.pone.0125631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923208	Green Published, gold			2022-12-27	WOS:000353711600156
J	Gao, X; Su, Y; Chen, YL; Han, MY; Yuan, YY; Xu, JC; Xin, F; Zhang, MG; Huang, SS; Wang, GJ; Kang, DY; Guan, LP; Zhang, JG; Dai, P				Gao, Xue; Su, Yu; Chen, Yu-Lan; Han, Ming-Yu; Yuan, Yong-Yi; Xu, Jin-Cao; Xin, Feng; Zhang, Mei-Guang; Huang, Sha-Sha; Wang, Guo-Jian; Kang, Dong-Yang; Guan, Li-Ping; Zhang, Jian-Guo; Dai, Pu			Identification of Two Novel Compound Heterozygous PTPRQ Mutations Associated with Autosomal Recessive Hearing Loss in a Chinese Family	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; CAUSE OVARIAN DYSGENESIS; PHOSPHATIDYLINOSITOL PHOSPHATASE; PERRAULT SYNDROME; DEAFNESS; ADHESION; DOMAIN	Mutations in PTPRQ are associated with deafness in humans due to defects of stereocilia in hair cells. Using whole exome sequencing, we identified responsible gene of family 1572 with autosomal recessively non-syndromic hearing loss (ARNSHL). We also used DNA from 74 familial patients with ARNSHL and 656 ethnically matched control chromosomes to perform extended variant analysis. We identified two novel compound heterozygous missense mutations, c.3125 A>G p.D1042G (maternal allele) and c.5981 A>G p.E1994G (paternal allele), in the PTPRQ gene, as the cause of recessively inherited sensorineural hearing loss in family 1572. Both variants co-segregated with hearing loss phenotype in family 1572, but were absent in 74 familial patients. Heterozygosity for c.3125 A>G was identified in two samples from unaffected Chinese individuals (656 chromosomes). Therefore, the hearing loss in this family was caused by two novel compound heterozygous mutations in PTPRQ.	[Gao, Xue; Su, Yu; Han, Ming-Yu; Yuan, Yong-Yi; Xin, Feng; Huang, Sha-Sha; Wang, Guo-Jian; Kang, Dong-Yang; Dai, Pu] Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Gao, Xue; Su, Yu; Yuan, Yong-Yi; Dai, Pu] Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Otolaryngol, Sanya, Peoples R China; [Gao, Xue; Xu, Jin-Cao; Zhang, Mei-Guang] Second Artillery Gen Hosp, Dept Otorhinolaryngol, Beijing, Peoples R China; [Chen, Yu-Lan; Guan, Li-Ping; Zhang, Jian-Guo] BGI Shenzhen, Shenzhen 518083, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Beijing Genomics Institute (BGI)	Dai, P (corresponding author), Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	daipu301@vip.sina.com		Yuan, Yongyi/0000-0002-7936-4776	National Natural Science Foundation of China [30801285, 81230020, 81200751, 81371098, 81371096, 81400471, 81371352]; China Postdoctoral Science Foundation [2012M521878, 2013T60947]; Beijing Natural Science Foundation [7132177, 7122172]; Military Twelfth Five-year Project of China [CWS115034]; National Basic Research Program of China (973 Program) [2014CB541706, 2014CB541701];  [2012BAI09B02];  [201202005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Military Twelfth Five-year Project of China; National Basic Research Program of China (973 Program)(National Basic Research Program of China); ; 	This work was supported by grants from the Project of the National Natural Science Foundation of China (30801285, 81230020, 81200751, 81371098, 81371096, 81400471, 81371352), grants from China Postdoctoral Science Foundation (2012M521878, 2013T60947), a grant from the Project of Beijing Natural Science Foundation (7132177, 7122172), a grant from Minister of Science and Technology of China (2012BAI09B02), a grant from Military Twelfth Five-year Project of China (CWS115034), grants from the National Basic Research Program of China (973 Program) (2014CB541706, 2014CB541701) and a grant from Minister of Health of China (201202005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ChiRosso G, 1997, J BIOL CHEM, V272, P31447, DOI 10.1074/jbc.272.50.31447; Delmaghani S, 2012, HUM MOL GENET, V21, P3835, DOI 10.1093/hmg/dds212; Friedman TB, 2003, ANNU REV GENOM HUM G, V4, P341, DOI 10.1146/annurev.genom.4.070802.110347; Gao X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063026; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Imtiaz A, 2014, HUM MUTAT, V35, P618, DOI 10.1002/humu.22545; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Li Y, 2010, AM J HUM GENET, V86, P479, DOI 10.1016/j.ajhg.2010.02.003; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108; Pierce SB, 2010, AM J HUM GENET, V87, P282, DOI 10.1016/j.ajhg.2010.07.007; Richardson GP, 2011, ANNU REV PHYSIOL, V73, P311, DOI 10.1146/annurev-physiol-012110-142228; Schraders M, 2011, AM J HUM GENET, V88, P628, DOI 10.1016/j.ajhg.2011.04.012; Schraders M, 2010, AM J HUM GENET, V86, P604, DOI 10.1016/j.ajhg.2010.02.015; Seifert RA, 2003, EXP CELL RES, V287, P374, DOI 10.1016/S0014-4827(03)00121-6; Shahin H, 2010, J MED GENET, V47, P643, DOI 10.1136/jmg.2009.075697; Sirmaci A, 2010, AM J HUM GENET, V87, P679, DOI 10.1016/j.ajhg.2010.09.018; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; WEBER P, 1995, J BIOL CHEM, V270, P4619, DOI 10.1074/jbc.270.9.4619; Wright MB, 1998, J BIOL CHEM, V273, P23929, DOI 10.1074/jbc.273.37.23929; Yona Simon, 2010, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1415s88; Zheng J, 2011, P NATL ACAD SCI USA, V108, P4218, DOI 10.1073/pnas.1005842108	26	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124757	10.1371/journal.pone.0124757	http://dx.doi.org/10.1371/journal.pone.0124757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919374	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400060
J	Jeng, MJ; Lee, YS; Tsao, PC; Yang, CF; Soong, WJ				Jeng, Mei-Jy; Lee, Yu-Sheng; Tsao, Pei-Chen; Yang, Chia-Feng; Soong, Wen-Jue			A Longitudinal Study on Early Hospitalized Airway Infections and Subsequent Childhood Asthma	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; IMPORTANT RISK-FACTOR; RSV BRONCHIOLITIS; YOUNG-CHILDREN; FOLLOW-UP; AGE 13; INFANCY; ALLERGY; TAIWAN; ASSOCIATION	Background Acute airway infections, including bronchiolitis, are common causes of early childhood hospitalization. The development of later asthma may be related to early airway infections in young children. This study is to investigate the relationship between hospitalized airway infections (HAI) in young children (< 3 years old) and later childhood asthma. Methods Hospitalized children (< 3 years old) with bronchiolitis or other acute airway infections (other HAI group) from 1997-2000 were retrieved from the National Health Insurance Research Database of Taiwan, and compared to age-and gender-matched subjects with regards to asthma until 10 years of age; and potential comorbidities and medical care conditions. Results In total, 3,264 children (1,981 with bronchiolitis; 1,283 with other HAIs) were compared to 18,527 controls. The incidence of childhood asthma was higher in the study (16.2%) than the control (11.7%) group, and most cases were diagnosed between 3-5 years old. The hazard ratios were 1.583 (95% CI: 1.414-1.772) and 1.226 (95% CI: 1.053-1.428) for the bronchiolitis and other HAI subgroups, respectively, compared to the control group, and 1.228 (95% CI: 1.075-1.542) in the bronchiolitis subgroup compared to the other HAIs subgroup. A significantly higher odds ratio (1.973, 95% CI: 1.193-3.263) for the children with congenital heart disease (CHD) in the bronchiolitis subgroup was found at an age of 3-5 years compared to the control group. Conclusions and Clinical Relevance Young children (< 3 years old) hospitalized due to acute HAIs are at a higher risk of developing childhood asthma at age 3 to 10 years. The parents of children with HAIs at age 0 to 2 years should be informed for the higher risk of developing childhood asthma, especially in children with CHD and bronchiolitis.	[Jeng, Mei-Jy] Natl Yang Ming Univ, Sch Med, Inst Emergency & Crit Care Med, Taipei 112, Taiwan; [Jeng, Mei-Jy; Lee, Yu-Sheng; Tsao, Pei-Chen; Yang, Chia-Feng; Soong, Wen-Jue] Natl Yang Ming Univ, Sch Med, Fac Med, Dept Pediat, Taipei 112, Taiwan; [Jeng, Mei-Jy; Lee, Yu-Sheng; Tsao, Pei-Chen; Yang, Chia-Feng; Soong, Wen-Jue] Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Jeng, MJ (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Emergency & Crit Care Med, Taipei 112, Taiwan.	mjjeng@vghtpe.gov.tw			Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C. [V101C-11, V102C-069]	Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.(Taipei Veterans General Hospital)	Funding: This study was supported by the grants from Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C. (research grants V101C-11 and V102C-069). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamko DJ, 2012, J ALLERGY CLIN IMMUN, V130, P101, DOI 10.1016/j.jaci.2012.05.024; [Anonymous], BACKGROUND; [Anonymous], FREE ONL SEARCH 2009; Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P91, DOI 10.1016/j.jaci.2012.02.010; Backman K, 2014, ACTA PAEDIATR, V103, P850, DOI 10.1111/apa.12662; Bode-Thomas F, 2010, CLIN MED INSIGHT-CAS, V3, P5; Bush A, 2007, BMJ-BRIT MED J, V335, P1037, DOI 10.1136/bmj.39374.600081.AD; Carroll KN, 2008, PEDIATRICS, V122, P58, DOI 10.1542/peds.2007-2087; Chang JW, 2015, KIDNEY INT, V87, P632, DOI 10.1038/ki.2014.299; Chen Chun-Jen, 2005, Acta Paediatrica Taiwanica, V46, P72; Chen CY, 2003, PHARMACOEPIDEM DR S, V12, P129, DOI 10.1002/pds.810; Chen TC, 2012, EPILEPSY RES, V102, P188, DOI 10.1016/j.eplepsyres.2012.06.003; Chou YC, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-64; Chuang CM, 2014, PEDIAT NEONATOLOGY; Fjaerli Hans-Olav, 2005, BMC Pediatr, V5, P31, DOI 10.1186/1471-2431-5-31; Garcia CG, 2010, PEDIATRICS, V126, pE1453, DOI 10.1542/peds.2010-0507; Garcia-Garcia ML, 2007, PEDIATR PULM, V42, P458, DOI 10.1002/ppul.20597; Haland G, 2009, PEDIAT ALLERG IMM-UK, V20, P254, DOI 10.1111/j.1399-3038.2008.00781.x; Henderson J, 2005, PEDIAT ALLERG IMM-UK, V16, P386, DOI 10.1111/j.1399-3038.2005.00298.x; Hsu CL, 2015, J MICROBIOL IMMUNOL, V48, P153, DOI 10.1016/j.jmii.2013.07.007; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Jartti T, 2011, PEDIAT ALLERG IMM-UK, V22, P350, DOI 10.1111/j.1399-3038.2011.01170.x; Jeng MJ, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-100; Jung YM, 2014, J MOL STRUCT, V1069, P1, DOI 10.1016/j.molstruc.2014.02.020; Kneyber M, 2000, ACTA PAEDIATR, V89, P654, DOI 10.1080/080352500750043945; Koponen P, 2014, PEDIATR INFECT DIS J, V33, P463, DOI 10.1097/INF.0000000000000253; Koponen P, 2012, PEDIATR INT, V54, P619, DOI 10.1111/j.1442-200X.2012.03651.x; Lauhkonen E, 2015, PEDIATR PULM, V50, P389, DOI 10.1002/ppul.23039; Lee Jian-Te, 2007, Journal of Microbiology Immunology and Infection, V40, P293; Liao JN, 2015, KIDNEY INT, V87, P1209, DOI 10.1038/ki.2014.393; Lin HW, 2012, EUR J PEDIATR, V171, P1645, DOI 10.1007/s00431-012-1788-3; Lin SC, 2015, J ASTHMA, V52, P273, DOI 10.3109/02770903.2014.958854; Lin WS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107694; Mahamid J, 2007, HAREFUAH, V146, P99; Mahamid Jamal, 2007, Harefuah, V146, P480; Montgomery S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004034; Nasreen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089978; National Health Insurance Research Database, DAT SUBS; Pattemore PK, 2013, J PAEDIATR CHILD H, V49, P991, DOI 10.1111/jpc.12395; Ricart S, 2013, PEDIATR PULM, V48, P456, DOI 10.1002/ppul.22633; Schroeckenstein D C, 1988, Semin Respir Infect, V3, P40; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Sigurs N, 2002, RESP RES, V3, DOI 10.1186/rr186; Sigurs N, 2001, AM J RESP CRIT CARE, V163, pS2, DOI 10.1164/ajrccm.163.supplement_1.2011109; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Sigurs N, 2007, ACTA PAEDIATR, V96, P156, DOI 10.1111/j.1651-2227.2007.00105.x; Sigurs Nele, 2002, Paediatr Respir Rev, V3, P177, DOI 10.1016/S1526-0542(02)00191-4; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Stein RT, 2010, THORAX, V65, P1033, DOI 10.1136/thx.2009.133967; Sung CC, 2011, J MICROBIOL IMMUNOL, V44, P184, DOI 10.1016/j.jmii.2011.01.025; Takeyama A, 2014, EUROPEAN J PEDIAT; Teshome G, 2013, PEDIATR CLIN N AM, V60, P1019, DOI 10.1016/j.pcl.2013.06.005; Tormanen S, 2015, PEDIATR PULM, V50, P424, DOI 10.1002/ppul.23053; Valkonen H, 2009, ALLERGY, V64, P1359, DOI 10.1111/j.1398-9995.2009.02022.x; Voort AMMSVD, 2014, J ALLERGY CLIN IMMUN, V133, P1317, DOI 10.1016/j.jaci.2013.12.1082; Wang JY, 2012, ASIA PAC ALLERGY, V2, P167, DOI 10.5415/apallergy.2012.2.3.167; Wennergren G, 2001, EUR RESPIR J, V18, P1044, DOI 10.1183/09031936.01.00254101; Yeh KW, 2008, PEDIAT ALLERG IMM-UK, V19, P13, DOI 10.1111/j.1399-3038.2007.00598.x; Zomer-Kooijker K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087162	60	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0121906	10.1371/journal.pone.0121906	http://dx.doi.org/10.1371/journal.pone.0121906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919024	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400011
J	Li, R; Perneczky, R; Yakushev, I; Forster, S; Kurz, A; Drzezga, A; Kramer, S				Li, Rui; Perneczky, Robert; Yakushev, Igor; Foerster, Stefan; Kurz, Alexander; Drzezga, Alexander; Kramer, Stefan		Alzheimers Dis Neuroimaging Initia	Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer's Disease	PLOS ONE			English	Article							DIAGNOSIS; PET; MILD; PREDICTION	We present a method to discover discriminative brain metabolism patterns in [18F] fluorodeoxyglucose positron emission tomography (PET) scans, facilitating the clinical diagnosis of Alzheimer's disease. In the work, the term "pattern" stands for a certain brain region that characterizes a target group of patients and can be used for a classification as well as interpretation purposes. Thus, it can be understood as a so-called "region of interest (ROI)". In the literature, an ROI is often found by a given brain atlas that defines a number of brain regions, which corresponds to an anatomical approach. The present work introduces a semi-data-driven approach that is based on learning the characteristics of the given data, given some prior anatomical knowledge. A Gaussian Mixture Model (GMM) and model selection are combined to return a clustering of voxels that may serve for the definition of ROIs. Experiments on both an in-house dataset and data of the Alzheimer's Disease Neuroimaging Initiative (ADNI) suggest that the proposed approach arrives at a better diagnosis than a merely anatomical approach or conventional statistical hypothesis testing.	[Li, Rui] Tech Univ Munich, Inst Informat I12, Garching, Germany; [Perneczky, Robert; Kurz, Alexander] Tech Univ Munich, Klin & Poliklin Psychiat & Psychotherapie, D-80290 Munich, Germany; [Yakushev, Igor; Foerster, Stefan] Tech Univ Munich, Nukl Med Klin, D-80290 Munich, Germany; [Drzezga, Alexander] Univ Cologne, Nukl Med Klin & Poliklin, D-50931 Cologne, Germany; [Kramer, Stefan] Johannes Gutenberg Univ Mainz, Inst Informat, D-55122 Mainz, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Cologne; Johannes Gutenberg University of Mainz	Kramer, S (corresponding author), Johannes Gutenberg Univ Mainz, Inst Informat, D-55122 Mainz, Germany.	kramer@informatik.uni-mainz.de	Preda, Adrian/K-8889-2013; Hsiung, Robin/AAT-1661-2021; Perneczky, Robert/AAJ-2550-2020	Preda, Adrian/0000-0003-3373-2438; Hsiung, Robin/0000-0002-8017-0856; Perneczky, Robert/0000-0003-1981-7435; Ponto, Laura/0000-0003-1197-6714; Drzezga, Alexander/0000-0001-6018-716X; Yakushev, Igor/0000-0003-4764-798X	TUM Graduate School of Information Science in Health (GSISH), Technische Universitat Munchen; Johannes Gutenberg-Universitat Mainz; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG024904, P50AG005134] Funding Source: NIH RePORTER	TUM Graduate School of Information Science in Health (GSISH), Technische Universitat Munchen; Johannes Gutenberg-Universitat Mainz; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: RL received PhD scholarship from the TUM Graduate School of Information Science in Health (GSISH), Technische Universitat Munchen. The authors acknowledge the Johannes Gutenberg-Universitat Mainz for publication funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALZ, 2008, ALZH DIS INT; Bishop Christopher M., 2006, PATTERN RECOGNITION; Bouckaert RR, 2004, LECT NOTES ARTIF INT, V3056, P3; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Chu C, 2012, NEUROIMAGE, V60, P59, DOI 10.1016/j.neuroimage.2011.11.066; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; de Leon MJ, 2007, J NEUROL, V254, P1666, DOI 10.1007/s00415-007-0610-z; Degroote P, 2009, ASTRON ASTROPHYS, V506, P111, DOI 10.1051/0004-6361/200911782; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Drzezga A, 2009, BEHAV NEUROL, V21, P101, DOI [10.3233/BEN-2009-0228, 10.1155/2009/276026]; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Echeverria AE, 2013, RADIOTHER ONCOL, V106, P124, DOI 10.1016/j.radonc.2012.09.003; Fjell AM, 2010, J NEUROSCI, V30, P2088, DOI 10.1523/JNEUROSCI.3785-09.2010; Gorriz JM, 2011, APPL SOFT COMPUT, V11, P2313, DOI 10.1016/j.asoc.2010.08.012; Gorriz JM, 2009, NEUROSCI LETT, V460, P108, DOI 10.1016/j.neulet.2009.05.039; Gray KR, 2013, NEUROIMAGE, V65, P167, DOI 10.1016/j.neuroimage.2012.09.065; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Li R, 2010, P 13 C ART INT MED B, P60; Liu MH, 2012, NEUROIMAGE, V60, P1106, DOI 10.1016/j.neuroimage.2012.01.055; Lopez M, 2009, ELECTRON LETT, V45, P389, DOI 10.1049/el.2009.0176; Lu LJ, 2012, PHYS MED BIOL, V57, P5035, DOI 10.1088/0031-9155/57/15/5035; McEvoy LK, 2009, RADIOLOGY, V251, P195, DOI 10.1148/radiol.2511080924; Metz CE, 1999, INT CONGR SER, V1182, P543; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; Naik PA, 2007, J AM STAT ASSOC, V102, P244, DOI 10.1198/016214506000000861; Nobili F, 2008, EUR J NUCL MED MOL I, V35, P2191, DOI 10.1007/s00259-008-0869-z; Preacher KJ, 2013, MULTIVAR BEHAV RES, V48, P28, DOI 10.1080/00273171.2012.710386; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; Salaun PY, 2014, EUR J NUCL MED MOL I, V41, P1501, DOI 10.1007/s00259-014-2772-0; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Segovia F, 2012, NEUROCOMPUTING, V75, P64, DOI 10.1016/j.neucom.2011.03.050; Sharif MS, 2012, ADV FUZZY SYST, V2012, DOI 10.1155/2012/327861; Smialowski P, 2010, BIOINFORMATICS, V26, P440, DOI 10.1093/bioinformatics/btp621; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Witten IH, 2011, MOR KAUF D, P1; Yakushev I, 2008, PSYCHIAT RES-NEUROIM, V164, P143, DOI 10.1016/j.pscychresns.2007.11.004; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008	41	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0122731	10.1371/journal.pone.0122731	http://dx.doi.org/10.1371/journal.pone.0122731			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919662	Green Published, gold			2022-12-27	WOS:000353659400018
J	Sanchez-Juan, P; Bishop, MT; Kovacs, GG; Calero, M; Aulchenko, YS; Ladogana, A; Boyd, A; Lewis, V; Ponto, C; Calero, O; Poleggi, A; Carracedo, A; van der Lee, SJ; Strobel, T; Rivadeneira, F; Hofman, A; Haik, S; Combarros, O; Berciano, J; Uitterlinden, AG; Collins, SJ; Budka, H; Brandel, JP; Laplanche, JL; Pocchiari, M; Zerr, I; Knight, RSG; Will, RG; van Duijn, CM				Sanchez-Juan, Pascual; Bishop, Matthew T.; Kovacs, Gabor G.; Calero, Miguel; Aulchenko, Yurii S.; Ladogana, Anna; Boyd, Alison; Lewis, Victoria; Ponto, Claudia; Calero, Olga; Poleggi, Anna; Carracedo, Angel; van der Lee, Sven J.; Stroebel, Thomas; Rivadeneira, Fernando; Hofman, Albert; Haik, Stephane; Combarros, Onofre; Berciano, Jose; Uitterlinden, Andre G.; Collins, Steven J.; Budka, Herbert; Brandel, Jean-Philippe; Louis Laplanche, Jean; Pocchiari, Maurizio; Zerr, Inga; Knight, Richard S. G.; Will, Robert G.; van Duijn, Cornelia M.			A Genome Wide Association Study Links Glutamate Receptor Pathway to Sporadic Creutzfeldt-Jakob Disease Risk	PLOS ONE			English	Article							PRION PROTEIN; EXPRESSION; GENOTYPE; GENES	We performed a genome-wide association (GWA) study in 434 sporadic Creutzfeldt-Jakob disease (sCJD) patients and 1939 controls from the United Kingdom, Germany and The Netherlands. The findings were replicated in an independent sample of 1109 sCJD and 2264 controls provided by a multinational consortium. From the initial GWA analysis we selected 23 SNPs for further genotyping in 1109 sCJD cases from seven different countries. Five SNPs were significantly associated with sCJD after correction for multiple testing. Subsequently these five SNPs were genotyped in 2264 controls. The pooled analysis, including 1543 sCJD cases and 4203 controls, yielded two genome wide significant results: rs6107516 (p-value=7.62x10(-9)) a variant tagging the prion protein gene (PRNP); and rs6951643 (p-value=1.66x10(-8)) tagging the Glutamate Receptor Metabotropic 8 gene (GRM8). Next we analysed the data stratifying by country of origin combining samples from the pooled analysis with genotypes from the 1000 Genomes Project and imputed genotypes from the Rotterdam Study (Total n=12967). The meta-analysis of the results showed that rs6107516 (p-value=3.00x10(-8)) and rs6951643 (p-value=3.91x10(-5)) remained as the two most significantly associated SNPs. Rs6951643 is located in an intronic region of GRM8, a gene that was additionally tagged by a cluster of 12 SNPs within our top 100 ranked results. GRM8 encodes for mGluR8, a protein which belongs to the metabotropic glutamate receptor family, recently shown to be involved in the transduction of cellular signals triggered by the prion protein. Pathway enrichment analyses performed with both Ingenuity Pathway Analysis and ALIGATOR postulates glutamate receptor signalling as one of the main pathways associated with sCJD. In summary, we have detected GRM8 as a novel, non-PRNP, genome-wide significant marker associated with heightened disease risk, providing additional evidence supporting a role of glutamate receptors in sCJD pathogenesis.	[Sanchez-Juan, Pascual; Combarros, Onofre; Berciano, Jose] Univ Hosp Marques Valdecilla, Dept Neurol, Inst Invest Marques Valdecilla IDIVAL, Santander, Spain; [Sanchez-Juan, Pascual; Combarros, Onofre; Berciano, Jose] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Santander, Spain; [Bishop, Matthew T.; Knight, Richard S. G.; Will, Robert G.] Univ Edinburgh, Natl Creutzfeldt Jakob Dis Res & Surveillance Uni, Edinburgh EH8 9YL, Midlothian, Scotland; [Kovacs, Gabor G.; Stroebel, Thomas; Budka, Herbert] Med Univ Vienna, Inst Neurol, Vienna, Austria; [Calero, Miguel; Calero, Olga] Carlos III Inst Hlth, Chron Dis Programme & CIBERNED, Madrid, Spain; [Calero, Miguel] Carlos III Inst Hlth, Alzheimer Dis Res Unit, CIEN Fdn, Alzheimer Ctr Reina Sofia Fdn, Madrid, Spain; [Aulchenko, Yurii S.; van der Lee, Sven J.; Rivadeneira, Fernando; Hofman, Albert; Uitterlinden, Andre G.; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Aulchenko, Yurii S.] SB RAS, Inst Cytol & Genet, Novosibirsk, Russia; [Aulchenko, Yurii S.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Ladogana, Anna; Poleggi, Anna; Pocchiari, Maurizio] Inst Super Sanita, Dept Cell Biol & Neurosci, Rome, Italy; [Boyd, Alison; Lewis, Victoria; Collins, Steven J.] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; [Ponto, Claudia; Zerr, Inga] Univ Med Ctr, Dept Neurol, Clin Dementia Ctr, Gottingen, Germany; [Ponto, Claudia; Zerr, Inga] German Ctr Neurodegenerat Dis DZNE Site Gottingen, Gottingen, Germany; [Carracedo, Angel] Univ Santiago de Compostela, Grp Med Xenom, Fdn Publ Galega Med Xenom, CIBERER, Santiago De Compostela, Spain; [Carracedo, Angel] King Abdulaziz Univ, CEGMR, Jeddah 21413, Saudi Arabia; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Haik, Stephane; Brandel, Jean-Philippe] Univ Paris 06, Sorbonne Univ, UMR S 1127, F-75013 Paris, France; [Haik, Stephane; Brandel, Jean-Philippe] INSERM, U1127, F-75013 Paris, France; [Haik, Stephane; Brandel, Jean-Philippe] CNRS, UMR 7225, F-75013 Paris, France; [Haik, Stephane; Brandel, Jean-Philippe] ICM, F-75013 Paris, France; [Haik, Stephane; Brandel, Jean-Philippe] Hop La Pitie Salpetriere, AP HP, Cellule Natl Reference Malad Creutzfeldt Jakob, F-75013 Paris, France; [Louis Laplanche, Jean] Hop Lariboisiere, AP HP, Serv Biochim & Biol Mol, Lab Associe CNR ATNC, F-75475 Paris, France	Hospital Universitario Marques de Valdecilla (HUMV); CIBERNED; University of Edinburgh; Medical University of Vienna; CIBERNED; Instituto de Salud Carlos III; Instituto de Salud Carlos III; Erasmus University Rotterdam; Erasmus MC; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University; Istituto Superiore di Sanita (ISS); University of Melbourne; University of Gottingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; King Abdulaziz University; Erasmus University Rotterdam; Erasmus MC; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	van Duijn, CM (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.	c.vanduijn@erasmusmc.nl	Calero, Miguel/H-5691-2015; Aulchenko, Yurii/M-8270-2013; Rivadeneira, Fernando/O-5385-2015; Kovacs, Gabor/A-7468-2013; LAPLANCHE, Jean-Louis/S-8707-2016; Budka, Herbert/I-3486-2019; Haik, Stephane/M-7247-2018; Pocchiari, Maurizio/J-8443-2018; Ladogana, Anna/K-1415-2016; Sanchez-Juan, Pascual/B-9282-2009; Carracedo, Angel/D-4257-2012; Poleggi, Anna/M-7950-2017	Calero, Miguel/0000-0001-5366-3324; Aulchenko, Yurii/0000-0002-7899-1575; Rivadeneira, Fernando/0000-0001-9435-9441; Kovacs, Gabor/0000-0003-3841-5511; Budka, Herbert/0000-0002-1933-1577; Pocchiari, Maurizio/0000-0002-7269-2486; Sanchez-Juan, Pascual/0000-0002-6081-8037; Carracedo, Angel/0000-0003-1085-8986; van der Lee, Sven/0000-0003-1606-8643; Poleggi, Anna/0000-0001-7094-7767; LAPLANCHE, Jean-Louis/0000-0003-2836-2903; ladogana, Anna/0000-0002-7504-6906; Van Duijn, Cornelia/0000-0002-2374-9204	UK: National CJD Research; Department of Health; Scottish Government Health Department; Policy Research Programme in the Department of Health. Germany; European Commission [222887, FP7-KBBE-2007-2A]; EU [01ED1201A]; Robert Koch Institute through Federal Ministry of Health [1369-341]; Ministry of Health, National Centre for Disease Prevention and Control, Central Actions; Netherlands Organization of Scientific Research NWO [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93-015]; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) [050-060-810]; Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission; Municipality of Rotterdam; Russian Science Foundation (RSCF) [14-14-00313]; FIS [PI12/02288]; JPND project DEMTEST [PI11/03028]; Accion Estrategica de Salud del Instituto de Salud Carlos III e INNOPHARMA [PI13/01136]; Commonwealth Department of Health; NHMRC [APP1005816]	UK: National CJD Research; Department of Health; Scottish Government Health Department; Policy Research Programme in the Department of Health. Germany; European Commission(European CommissionEuropean Commission Joint Research Centre); EU(European Commission); Robert Koch Institute through Federal Ministry of Health; Ministry of Health, National Centre for Disease Prevention and Control, Central Actions; Netherlands Organization of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Russian Science Foundation (RSCF)(Russian Science Foundation (RSF)); FIS(Instituto de Salud Carlos III); JPND project DEMTEST; Accion Estrategica de Salud del Instituto de Salud Carlos III e INNOPHARMA; Commonwealth Department of Health; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Funding: This study was supported by: UK: the National CJD Research and Surveillance UK Unit is funded by the Department of Health and the Scottish Government Health Department. The National CJD Research and Surveillance Unit is funded by the Policy Research Programme in the Department of Health. Germany: This work was supported by a grant from the European Commission (Protecting the food chain from prions: shaping European priorities through basic and applied research (PRIORITY, No 222887) Project number: FP7-KBBE-2007-2A). The study was performed within the recently established Clinical Dementia Center at the University Medical Center Gottingen and was partly supported by grants from the EU Joint Programme - Neurodegenerative Disease Research (JPND - DEMTEST "Biomarker based diagnosis of rapid progressive dementias-optimization of diagnostic protocols", 01ED1201A). This study was funded by the Robert Koch Institute through funds from the Federal Ministry of Health (grant no. 1369-341). Italy: The Italian Registry of CJD and related disorders is funded by the Ministry of Health, National Centre for Disease Prevention and Control, Central Actions. This work was partly supported by grant from the EU Joint Programme Neurodegenerative Disease Research (JPND DEMTEST "Biomarker based diagnosis of rapid progressive dementias-optimization of diagnostic protocols", 01ED1201A). The Netherlands: the generation and management of genome-wide association study (GWAS) genotype data for the Rotterdam Study is supported by the Netherlands Organization of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project nr. 050-060-810. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. YSA is supported by Russian Science Foundation (RSCF) grant 14-14-00313. Spain. PSJ was supported by a grant from FIS (PI12/02288) and JPND project DEMTEST (PI11/03028). AC is supported by PI13/01136 Accion Estrategica de Salud del Instituto de Salud Carlos III e INNOPHARMA. Australia: The Australian National Creutzfeldt-Jakob Disease Registry (ANCJDR) is funded by the Commonwealth Department of Health. SJC is supported by a NHMRC Practitioner Fellowship (#APP1005816). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperovitch A, 1999, LANCET, V353, P1673, DOI 10.1016/S0140-6736(99)01342-2; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 1998, Wkly Epidemiol Rec, V73, P361; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beraldo FH, 2011, FASEB J, V25, P265, DOI 10.1096/fj.10-161653; Bishop MT, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-146; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Duan SW, 2009, RNA BIOL, V6, P412, DOI 10.4161/rna.6.4.8830; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Lloyd SE, 2013, CURR OPIN GENET DEV, V23, P345, DOI 10.1016/j.gde.2013.02.012; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mead S, 2012, HUM MOL GENET, V21, P1897, DOI 10.1093/hmg/ddr607; MULLER WEG, 1993, EUR J PHARM-MOLEC PH, V246, P261, DOI 10.1016/0922-4106(93)90040-G; Ostapchenko VG, 2013, J NEUROCHEM, V127, P415, DOI 10.1111/jnc.12296; Sanchez-Juan P, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.011; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Williams RW, 2012, INT REV NEUROBIOL, V104, P135, DOI 10.1016/B978-0-12-398323-7.00006-9; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290	25	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123654	10.1371/journal.pone.0123654	http://dx.doi.org/10.1371/journal.pone.0123654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25918841	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400031
J	Visaya, MV; Sherwell, D; Sartorius, B; Cromieres, F				Visaya, Maria Vivien; Sherwell, David; Sartorius, Benn; Cromieres, Fabien			Analysis of Binary Multivariate Longitudinal Data via 2-Dimensional Orbits: An Application to the Agincourt Health and Socio-Demographic Surveillance System in South Africa	PLOS ONE			English	Article							MODELS; POPULATION; POVERTY; GEE	We analyse demographic longitudinal survey data of South African (SA) and Mozambican (MOZ) rural households from the Agincourt Health and Socio-Demographic Surveillance System in South Africa. In particular, we determine whether absolute poverty status (APS) is associated with selected household variables pertaining to socio-economic determination, namely household head age, household size, cumulative death, adults to minor ratio, and influx. For comparative purposes, households are classified according to household head nationality (SA or MOZ) and APS (rich or poor). The longitudinal data of each of the four subpopulations (SA rich, SA poor, MOZ rich, and MOZ poor) is a five-dimensional space defined by binary variables (questions), subjects, and time. We use the orbit method to represent binary multivariate longitudinal data (BMLD) of each household as a two-dimensional orbit and to visualise dynamics and behaviour of the population. At each time step, a point (x, y) from the orbit of a household corresponds to the observation of the household, where x is a binary sequence of responses and y is an ordering of variables. The ordering of variables is dynamically rearranged such that clusters and holes associated to least and frequently changing variables in the state space respectively, are exposed. Analysis of orbits reveals information of change at both individual-and population-level, change patterns in the data, capacity of states in the state space, and density of state transitions in the orbits. Analysis of household orbits of the four subpopulations show association between (i) households headed by older adults and rich households, (ii) large household size and poor households, and (iii) households with more minors than adults and poor households. Our results are compared to other methods of BMLD analysis.	[Visaya, Maria Vivien] Univ Johannesburg, Dept Pure & Appl Math, Johannesburg, South Africa; [Sherwell, David] Univ Witwatersrand, Sch Computat & Appl Math, Johannesburg, South Africa; [Sartorius, Benn] Univ KwaZulu Natal, Discipline Publ Hlth Med, Sch Nursing & Publ Hlth, Durban, South Africa; [Cromieres, Fabien] Kyoto Univ, Grad Sch Informat, Kyoto, Japan	University of Johannesburg; University of Witwatersrand; University of Kwazulu Natal; Kyoto University	Visaya, MV (corresponding author), Univ Johannesburg, Dept Pure & Appl Math, Johannesburg, South Africa.	mvvisaya@uj.ac.za		, bennsartorius/0000-0001-6761-2325; Visaya, Maria Vivien/0000-0002-4438-8110	Medical Research Council; University of the Witwatersrand, South Africa; Wellcome Trust, UK [058893/Z/99/A, 069683/Z/02/Z, 085477/Z/08/Z]; National Institute on Aging of the NIH [1R24AG032112-01, 5R24AG032112-03]; NATIONAL INSTITUTE ON AGING [R24AG032112] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of the Witwatersrand, South Africa; Wellcome Trust, UK(Wellcome Trust); National Institute on Aging of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to thank the referees for their valuable comments. The data used in this study was supplied by the MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt). The Agincourt HDSS is funded by the Medical Research Council and University of the Witwatersrand, South Africa, Wellcome Trust, UK (grant no. 058893/Z/99/A, 069683/Z/02/Z, 085477/Z/08/Z), and National Institute on Aging of the NIH (grants 1R24AG032112-01 and 5R24AG032112-03).	AI-Aziz J., 2010, JSE P, V18, P1; Bandyopadhyay S, 2011, STAT METHODS MED RES, V20, P299, DOI 10.1177/0962280209340191; Bartholomew DJ, 2008, ANAL MULTIVARIATE SO; Booysen F, 2008, WORLD DEV, V36, P1113, DOI 10.1016/j.worlddev.2007.10.008; Collinson MA, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5080; Cui J, 2007, COMMUN STAT-SIMUL C, V36, P987, DOI 10.1080/03610910701539617; Daw CS, 2003, REV SCI INSTRUM, V74, P915, DOI 10.1063/1.1531823; Dimitrova ES, 2010, J COMPUT BIOL, V17, P853, DOI 10.1089/cmb.2008.0023; Edsall RM, 2003, COMPUT STAT DATA AN, V43, P605, DOI 10.1016/S0167-9473(02)00295-5; GOTTSCHAU A, 1994, SCAND J STAT, V21, P57; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Ilk O., 2004, THESIS IOWA STATE U, DOI [DOI 10.31274/RTD-180813-11012, 10.31274/rtd-180813-11012]; Kahn K, 2007, SCAND J PUBLIC HEALT, V35, P8, DOI 10.1080/14034950701505031; Kirillov A. A., 1962, RUSS MATH SURV+, V17, P53, DOI [10.1070/RM1962v017n04ABEH004118, DOI 10.1070/RM1962V017N04ABEH004118, 10.1070/RM1962v017n0]; Kovalerchuk B, 2010, P SPIE, V7530; Luo S, 2016, STAT METHODS MED RES, V25, P821, DOI 10.1177/0962280212469358; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Rodgers G, 2008, J CONTEMP AFR STUD, V26, P385, DOI 10.1080/02589000802481965; Sartorius B, 2010, GLOBAL HEALTH ACTION, V3, P50, DOI 10.3402/gha.v3i0.5225; Sartorius K, 2013, POPUL SPACE PLACE, V19, P103, DOI 10.1002/psp.697; Tollman SM, 1999, S AFR MED J, V89, P858; Visaya Maria Vivien, 2014, Journal of Nonlinear Dynamics, DOI 10.1155/2014/901838; Wang F, 2014, EUROGRAPHICS 2014; Zeng LL, 2007, J AM STAT ASSOC, V102, P211, DOI 10.1198/016214506000000889	24	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123812	10.1371/journal.pone.0123812	http://dx.doi.org/10.1371/journal.pone.0123812			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919116	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400034
J	Wells, JCK; Stocks, J; Bonner, R; Raywood, E; Legg, S; Lee, S; Treleaven, P; Lum, S				Wells, Jonathan C. K.; Stocks, Janet; Bonner, Rachel; Raywood, Emma; Legg, Sarah; Lee, Simon; Treleaven, Philip; Lum, Sooky			Acceptability, Precision and Accuracy of 3D Photonic Scanning for Measurement of Body Shape in a Multi-Ethnic Sample of Children Aged 5-11 Years: The SLIC Study	PLOS ONE			English	Article							UK CHILDREN; WAIST CIRCUMFERENCE; MASS INDEX; ADIPOSITY; OBESITY; HEALTH; ADOLESCENTS; VARIABILITY; OVERWEIGHT; PHENOTYPES	Background Information on body size and shape is used to interpret many aspects of physiology, including nutritional status, cardio-metabolic risk and lung function. Such data have traditionally been obtained through manual anthropometry, which becomes time-consuming when many measurements are required. 3D photonic scanning (3D-PS) of body surface topography represents an alternative digital technique, previously applied successfully in large studies of adults. The acceptability, precision and accuracy of 3D-PS in young children have not been assessed. Methods We attempted to obtain data on girth, width and depth of the chest and waist, and girth of the knee and calf, manually and by 3D-PS in a multi-ethnic sample of 1484 children aged 5-11 years. The rate of 3D-PS success, and reasons for failure, were documented. Precision and accuracy of 3D-PS were assessed relative to manual measurements using the methods of Bland and Altman. Results Manual measurements were successful in all cases. Although 97.4% of children agreed to undergo 3D-PS, successful scans were only obtained in 70.7% of these. Unsuccessful scans were primarily due to body movement, or inability of the software to extract shape outputs. The odds of scan failure, and the underlying reason, differed by age, size and ethnicity. 3D-PS measurements tended to be greater than those obtained manually (p<0.05), however ranking consistency was high (r(2)>0.90 for most outcomes). Conclusions 3D-PS is acceptable in children aged >= 5 years, though with current hardware/software, and body movement artefacts, approximately one third of scans may be unsuccessful. The technique had poorer technical success than manual measurements, and had poorer precision when the measurements were viable. Compared to manual measurements, 3D-PS showed modest average biases but acceptable limits of agreement for large surveys, and little evidence that bias varied substantially with size. Most of the issues we identified could be addressed through further technological development.	[Wells, Jonathan C. K.] UCL Inst Child Hlth, Childhood Nutr Res Ctr, London, England; [Stocks, Janet; Bonner, Rachel; Raywood, Emma; Legg, Sarah; Lee, Simon; Lum, Sooky] UCL Inst Child Hlth, Resp Crit Care & Anaesthesia Sect, Portex Unit, London, England; [Treleaven, Philip] UCL Dept Comp Sci, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Wells, JCK (corresponding author), UCL Inst Child Hlth, Childhood Nutr Res Ctr, London, England.	jonathan.wells@ucl.ac.uk	Wells, Jonathan/A-4604-2009; Raywood, Emma/AAK-2852-2020	Wells, Jonathan/0000-0003-0411-8025; Raywood, Emma/0000-0002-0993-5115	Wellcome Trust [WT094129MA]; Asthma UK [10/013]; Child Growth Foundation; National Institute for Health Research, through the Comprehensive Clinical Research Network	Wellcome Trust(Wellcome TrustEuropean Commission); Asthma UK; Child Growth Foundation; National Institute for Health Research, through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR))	This work was supported by the Wellcome Trust [WT094129MA], Asthma UK [10/013] and the Child Growth Foundation. The SLIC study team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Douros I, 1999, P SOC PHOTO-OPT INS, V3640, P234, DOI 10.1117/12.341065; Dulloo AG, 2010, INT J OBESITY, V34, pS4, DOI 10.1038/ijo.2010.234; Feng K, 2012, RESPIROLOGY, V17, P1114, DOI 10.1111/j.1440-1843.2012.02219.x; Lum S, 2014, EXPLORING ETHNIC DIF; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; McCarthy HD, 2006, P NUTR SOC, V65, P385, DOI 10.1079/PNS2006514; McKeigue PM, 1996, CIBA F SYMP, V201, P54; Mesa JL, 2006, ANN NUTR METAB, V50, P519, DOI 10.1159/000098144; Nightingale CM, 2013, DIABETES CARE, V36, P1712, DOI 10.2337/dc12-1726; Nightingale CM, 2011, INT J EPIDEMIOL, V40, P33, DOI 10.1093/ije/dyq180; Raju P Sitarama, 2003, Indian Pediatr, V40, P705; Rush EC, 2003, EUR J CLIN NUTR, V57, P1394, DOI 10.1038/sj.ejcn.1601701; Treleaven P, 2004, IEEE SPECTRUM, V41, P29; Treleaven P, 2007, COMPUTER, V40, P28, DOI 10.1109/MC.2007.225; Wang J, 2006, AM J CLIN NUTR, V83, P809; Wells JCK, 2008, INT J OBESITY, V32, P152, DOI 10.1038/sj.ijo.0803685; Wells JCK, 2008, INT J OBESITY, V32, P232, DOI 10.1038/sj.ijo.0803727; Wells JCK, 2006, INT J OBESITY, V30, P1506, DOI 10.1038/sj.ijo.0803402; Wells JCK, 2012, OBES REV, V13, P14, DOI 10.1111/j.1467-789X.2012.01034.x; Wells JCK, 2012, INT J OBESITY, V36, P148, DOI 10.1038/ijo.2011.51; Wells JCK, 2000, INT J OBESITY, V24, P325, DOI 10.1038/sj.ijo.0801132; Wells JCK, 2008, OBESITY, V16, P435, DOI 10.1038/oby.2007.62; Wells JCK, 2007, AM J CLIN NUTR, V85, P419, DOI 10.1093/ajcn/85.2.419; Wells JCK, 2011, AM J HUM BIOL, V23, P291, DOI 10.1002/ajhb.21151; Wells JCK, 2010, AM J HUM BIOL, V22, P456, DOI 10.1002/ajhb.21017	26	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124193	10.1371/journal.pone.0124193	http://dx.doi.org/10.1371/journal.pone.0124193			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919034	gold, Green Submitted, Green Published			2022-12-27	WOS:000353659400044
J	Bergmann, A; Trefz, P; Fischer, S; Klepik, K; Walter, G; Steffens, M; Ziller, M; Schubert, JK; Reinhold, P; Kohler, H; Miekisch, W				Bergmann, Andreas; Trefz, Phillip; Fischer, Sina; Klepik, Klaus; Walter, Gudrun; Steffens, Markus; Ziller, Mario; Schubert, Jochen K.; Reinhold, Petra; Koehler, Heike; Miekisch, Wolfram			In Vivo Volatile Organic Compound Signatures of Mycobacterium avium subsp. paratuberculosis	PLOS ONE			English	Article							JOHNES-DISEASE; CROHNS-DISEASE; METHIONINE; LIPOARABINOMANNAN; METABOLITES; EXTRACTION; PATHWAYS; ORIGIN; THIOLS; GROWTH	Mycobacterium avium ssp. paratuberculosis (MAP) is the causative agent of a chronic enteric disease of ruminants. Available diagnostic tests are complex and slow. In vitro, volatile organic compound (VOC) patterns emitted from MAP cultures mirrored bacterial growth and enabled distinction of different strains. This study was intended to determine VOCs in vivo in the controlled setting of an animal model. VOCs were pre-concentrated from breath and feces of 42 goats (16 controls and 26 MAP-inoculated animals) by means of needle trap microextraction (breath) and solid phase microextraction (feces) and analyzed by gas chromatography/mass spectrometry. Analyses were performed 18, 29, 33, 41 and 48 weeks after inoculation. MAP-specific antibodies and MAP-specific interferon-gamma-response were determined from blood. Identities of all marker-VOCs were confirmed through analysis of pure reference substances. Based on detection limits in the high pptV and linear ranges of two orders of magnitude more than 100 VOCs could be detected in breath and in headspace over feces. Twenty eight substances differed between inoculated and non-inoculated animals. Although patterns of most prominent substances such as furans, oxygenated substances and hydrocarbons changed in the course of infection, differences between inoculated and non-inoculated animals remained detectable at any time for 16 substances in feces and 3 VOCs in breath. Differences of VOC concentrations over feces reflected presence of MAP bacteria. Differences in VOC profiles from breath were linked to the host response in terms of interferon-gamma-response. In a perspective in vivo analysis of VOCs may help to overcome limitations of established tests.	[Bergmann, Andreas; Trefz, Phillip; Klepik, Klaus; Steffens, Markus; Schubert, Jochen K.; Miekisch, Wolfram] Univ Med Rostock, Dept Anaesthesia & Intens Care, Rostock, Germany; [Fischer, Sina; Walter, Gudrun; Reinhold, Petra; Koehler, Heike] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Jena, Germany; [Ziller, Mario] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Greifswald, Germany; [Ziller, Mario] Biomath Working Grp, Insel Riems, Germany	University of Rostock; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; Friedrich Loeffler Institute	Miekisch, W (corresponding author), Univ Med Rostock, Dept Anaesthesia & Intens Care, Rostock, Germany.	wolfram.miekisch@uni-rostock.de	Miekisch, Wolfram/I-1300-2019; Schubert, Jochen/F-4788-2016	Schubert, Jochen/0000-0002-0956-9506; Trefz, Phillip/0000-0001-6138-6515; Miekisch, Wolfram/0000-0003-1619-0315	German Research Foundation (DFG) [RE 1098/4-1, SCHU 1960/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The authors are very grateful to the German Research Foundation (DFG, www.dfg.de, Grant number RE 1098/4-1, SCHU 1960/4-1) for their trust in work of the whole project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058204, 10.1371/journal.pone.0077869]; Appelmelk BJ, 2008, CELL MICROBIOL, V10, P930, DOI 10.1111/j.1462-5822.2007.01097.x; Bonnarme P, 2000, APPL ENVIRON MICROB, V66, P5514, DOI 10.1128/AEM.66.12.5514-5517.2000; BORJESSON T, 1992, APPL ENVIRON MICROB, V58, P2599; Bos LDJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003311; Chhabra A, 2012, P NATL ACAD SCI USA, V109, P5681, DOI 10.1073/pnas.1118680109; Chiodini RJ, 2012, CRIT REV MICROBIOL, V38, P52, DOI 10.3109/1040841X.2011.638273; De Preter V, 2009, J CHROMATOGR A, V1216, P1476, DOI 10.1016/j.chroma.2008.12.095; Dhiman RK, 2011, J BACTERIOL, V193, P5802, DOI 10.1128/JB.05299-11; Dias B, 1998, APPL ENVIRON MICROB, V64, P3320; Dias B, 1998, APPL ENVIRON MICROB, V64, P3327; Dickschat JS, 2004, CHEMBIOCHEM, V5, P778, DOI 10.1002/cbic.200300813; Garner CE, 2009, T ROY SOC TROP MED H, V103, P1171, DOI 10.1016/j.trstmh.2009.02.004; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hanniffy SB, 2009, INT J FOOD MICROBIOL, V135, P223, DOI 10.1016/j.ijfoodmicro.2009.08.009; KIENE RP, 1990, APPL ENVIRON MICROB, V56, P3292, DOI 10.1128/AEM.56.11.3292-3297.1990; KIENE RP, 1990, APPL ENVIRON MICROB, V56, P156, DOI 10.1128/AEM.56.1.156-161.1990; Knobloch H, 2009, AIP CONF PROC, V1137, P195, DOI 10.1063/1.3156505; Kruger C, 2015, VET PATHOL, V52, P276, DOI 10.1177/0300985814533804; Mendoza JL, 2009, WORLD J GASTROENTERO, V15, P417, DOI 10.3748/wjg.15.417; Miekisch W, 2014, BIOANALYSIS, V6, P1275, DOI 10.4155/bio.14.86; Mieth M, 2010, ANAL CHEM, V82, P2541, DOI 10.1021/ac100061k; Mieth M, 2009, ANAL CHEM, V81, P5851, DOI 10.1021/ac9009269; Miller TR, 2003, RES MICROBIOL, V154, P85, DOI 10.1016/S0923-2508(03)00027-5; Ott SL, 1999, PREV VET MED, V40, P179, DOI 10.1016/S0167-5877(99)00037-9; Otte ML, 2004, J EXP BOT, V55, P1919, DOI 10.1093/jxb/erh178; PEREIRA SP, 1992, ANN TROP PAEDIATR, V12, P177, DOI 10.1080/02724936.1992.11747566; Phillips M, 2007, TUBERCULOSIS, V87, P44, DOI 10.1016/j.tube.2006.03.004; Pollak FC, 1996, APPL ENVIRON MICROB, V62, P1295, DOI 10.1128/AEM.62.4.1295-1299.1996; Probert CSJ, 2004, GUT, V53, P58, DOI 10.1136/gut.53.1.58; Proudman CJ, 2014, EQUINE VET J; Purkhart R, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/2/027103; Rafidinarivo E, 2009, J LIPID RES, V50, P477, DOI 10.1194/jlr.M800384-JLR200; Saito Y, 2006, J CHROMATOGR A, V1106, P190, DOI 10.1016/j.chroma.2005.08.048; Scanu AM, 2007, J CLIN MICROBIOL, V45, P3883, DOI 10.1128/JCM.01371-07; Scholler CEG, 2002, J AGR FOOD CHEM, V50, P2615, DOI 10.1021/jf0116754; Schulz S, 2004, TETRAHEDRON, V60, P3863, DOI 10.1016/j.tet.2004.03.005; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Sevilla IA, 2014, APPL ENVIRON MICROB, V80, P3757, DOI 10.1128/AEM.01026-14; Syhre M, 2009, TUBERCULOSIS, V89, P263, DOI 10.1016/j.tube.2009.04.003; Tait E, 2014, J APPL MICROBIOL, V116, P1010, DOI 10.1111/jam.12418; TAYLOR BF, 1991, APPL ENVIRON MICROB, V57, P3581, DOI 10.1128/AEM.57.12.3581-3584.1991; Trefz P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076868; Trefz P, 2013, ANAL BIOANAL CHEM, V405, P3105, DOI 10.1007/s00216-013-6781-9; Walton C, 2013, INFLAMM BOWEL DIS, V19, P2069, DOI 10.1097/MIB.0b013e31829a91f6; Zhu JJ, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/1/016003	47	41	42	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123980	10.1371/journal.pone.0123980	http://dx.doi.org/10.1371/journal.pone.0123980			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915653	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659100031
J	Birtel, J; Walser, JC; Pichon, S; Burgmann, H; Matthews, B				Birtel, Julia; Walser, Jean-Claude; Pichon, Samuel; Buergmann, Helmut; Matthews, Blake			Estimating Bacterial Diversity for Ecological Studies: Methods, Metrics, and Assumptions	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; SPECIES RICHNESS; MICROBIAL BIOGEOGRAPHY; GUT MICROBIOME; COMMUNITY; MICROORGANISMS; PATTERNS; LAKE; BIODIVERSITY; ABUNDANCE	Methods to estimate microbial diversity have developed rapidly in an effort to understand the distribution and diversity of microorganisms in natural environments. For bacterial communities, the 16S rRNA gene is the phylogenetic marker gene of choice, but most studies select only a specific region of the 16S rRNA to estimate bacterial diversity. Whereas biases derived from from DNA extraction, primer choice and PCR amplification are well documented, we here address how the choice of variable region can influence a wide range of standard ecological metrics, such as species richness, phylogenetic diversity, beta-diversity and rank-abundance distributions. We have used Illumina paired-end sequencing to estimate the bacterial diversity of 20 natural lakes across Switzerland derived from three trimmed variable 16S rRNA regions (V3, V4, V5). Species richness, phylogenetic diversity, community composition, beta-diversity, and rank-abundance distributions differed significantly between 16S rRNA regions. Overall, patterns of diversity quantified by the V3 and V5 regions were more similar to one another than those assessed by the V4 region. Similar results were obtained when analyzing the datasets with different sequence similarity thresholds used during sequences clustering and when the same analysis was used on a reference dataset of sequences from the Greengenes database. In addition we also measured species richness from the same lake samples using ARISA Fingerprinting, but did not find a strong relationship between species richness estimated by Illumina and ARISA. We conclude that the selection of 16S rRNA region significantly influences the estimation of bacterial diversity and species distributions and that caution is warranted when comparing data from different variable regions as well as when using different sequencing techniques.	[Birtel, Julia; Matthews, Blake] Eawag, Dept Aquat Ecol, Kastanienbaum, Switzerland; [Birtel, Julia] ETH, Swiss Fed Insitute Technol, Dept Environm Syst Sci D USYS, Zurich, Switzerland; [Walser, Jean-Claude] ETH, GDC, Dept Environm Syst Sci D USYS, Zurich, Switzerland; [Pichon, Samuel] Univ Basel, Dept Environm Sci Zool & Evolut, Basel, Switzerland; [Buergmann, Helmut] Eawag, Dept Surface Waters, Kastanienbaum, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Birtel, J (corresponding author), Eawag, Dept Aquat Ecol, Kastanienbaum, Switzerland.	julia.birtel@eawag.ch	Matthews, Blake/B-5608-2009; PICHON, Samuel/C-4031-2013	Matthews, Blake/0000-0001-9089-704X; PICHON, Samuel/0000-0002-7161-9666; Walser, Jean-Claude/0000-0003-1513-0783; Burgmann, Helmut/0000-0002-5651-5906	SNF [31003A-125006]	SNF	Financial support was provided by the SNF grant 31003A-125006: "Food-web and ecosystem responses to global change". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; [Anonymous], 2009, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0005210; AOKI I, 1995, ECOL MODEL, V82, P21, DOI 10.1016/0304-3800(94)00076-T; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Besemer K, 2012, ISME J, V6, P1459, DOI 10.1038/ismej.2011.205; Burgmann H, 2011, APPL ENVIRON MICROB, V77, P5897, DOI 10.1128/AEM.02986-10; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2010, ECOL LETT, V13, P96, DOI 10.1111/j.1461-0248.2009.01405.x; Cai L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053649; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; Declerck SAJ, 2013, ISME J, V7, P533, DOI 10.1038/ismej.2012.138; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Gobet A, 2013, ENVIRON MICROBIOL; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Guo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076185; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Horner-Devine MC, 2003, ECOL LETT, V6, P613; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Jankowski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086991; Kim M, 2011, J MICROBIOL METH, V84, P81, DOI 10.1016/j.mimet.2010.10.020; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; LECHEVALLIER MW, 1980, APPL ENVIRON MICROB, V40, P922, DOI 10.1128/AEM.40.5.922-930.1980; LEGENDRE P, 2013, MODEL II REGRESSION, P41; Legendre P., 2012, NUMERICAL ECOLOGY; Leibold MA, 2010, ECOL LETT, V13, P1290, DOI 10.1111/j.1461-0248.2010.01523.x; Lliros M, 2008, FEMS MICROBIOL ECOL, V66, P331, DOI 10.1111/j.1574-6941.2008.00583.x; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Morlon H, 2011, ECOL LETT, V14, P141, DOI 10.1111/j.1461-0248.2010.01563.x; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; O'Dwyer JP, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002832; Ofiteru ID, 2010, P NATL ACAD SCI USA, V107, P15345, DOI 10.1073/pnas.1000604107; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; Pace NR, 1985, ADVANCES IN MICROBIA, P1; Pedros-Alio C, 2011, ANNU REV MAR SCI, V4; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Pillar VD, 2010, ECOL LETT, V13, P587, DOI 10.1111/j.1461-0248.2010.01456.x; Pilloni G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040467; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Pinto AJ, 2012, ENVIRON SCI TECHNOL, V46, P8851, DOI 10.1021/es302042t; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; R Core Team, 2013, R A LANGUAGE AND ENV; Rainey F. A., 1994, EXPERIENTIA, V50, P796, DOI DOI 10.1007/BF01956450; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schuster S. C., 2007, NATURE, V200; Shade A, 2013, ISME J, V7, P1493, DOI 10.1038/ismej.2013.54; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vasileiadis S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042671; Venail PA, 2013, ECOLOGY; Vinje Hilde, 2014, Microb Inform Exp, V4, P2, DOI 10.1186/2042-5783-4-2; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063a0; Yannarell AC, 2005, APPL ENVIRON MICROB, V71, P227, DOI 10.1128/AEM.71.1.227-239.2005; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09	77	50	50	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125356	10.1371/journal.pone.0125356	http://dx.doi.org/10.1371/journal.pone.0125356			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915756	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100123
J	Dirk, BS; Jacob, RA; Johnson, AL; Pawlak, EN; Cavanagh, PC; Van Nynatten, L; Haeryfar, SMM; Dikeakos, JD				Dirk, Brennan S.; Jacob, Rajesh Abraham; Johnson, Aaron L.; Pawlak, Emily N.; Cavanagh, P. Craig; Van Nynatten, Logan; Haeryfar, S. M. Mansour; Dikeakos, Jimmy D.			Viral Bimolecular Fluorescence Complementation: A Novel Tool to Study Intracellular Vesicular Trafficking Pathways	PLOS ONE			English	Article							HIV-1 NEF; DOWN-REGULATION; PROTEIN INTERACTIONS; LENTIVIRAL VECTORS; MHC-I; EXPRESSION; CLEAVAGE; CELLS; GENE; SITE	The Human Immunodeficiency Virus type 1 (HIV-1) accessory protein Nef interacts with a multitude of cellular proteins, manipulating the host membrane trafficking machinery to evade immune surveillance. Nef interactions have been analyzed using various in vitro assays, co-immunoprecipitation studies, and more recently mass spectrometry. However, these methods do not evaluate Nef interactions in the context of viral infection nor do they define the sub-cellular location of these interactions. In this report, we describe a novel bimolecular fluorescence complementation (BiFC) lentiviral expression tool, termed viral BiFC, to study Nef interactions with host cellular proteins in the context of viral infection. Using the F2A cleavage site from the foot and mouth disease virus we generated a viral BiFC expression vector capable of concurrent expression of Nef and host cellular proteins; PACS-1, MHC-I and SNX18. Our studies confirmed the interaction between Nef and PACS-1, a host membrane trafficking protein involved in Nef-mediated immune evasion, and demonstrated co-localization of this complex with LAMP-1 positive endolysosomal vesicles. Furthermore, we utilized viral BiFC to localize the Nef/MHC-I interaction to an AP-1 positive endosomal compartment. Finally, viral BiFC was observed between Nef and the membrane trafficking regulator SNX18. This novel demonstration of an association between Nef and SNX18 was localized to AP-1 positive vesicles. In summary, viral BiFC is a unique tool designed to analyze the interaction between Nef and host cellular proteins by mapping the sub-cellular locations of their interactions during viral infection.	[Dirk, Brennan S.; Jacob, Rajesh Abraham; Johnson, Aaron L.; Pawlak, Emily N.; Cavanagh, P. Craig; Van Nynatten, Logan; Haeryfar, S. M. Mansour; Dikeakos, Jimmy D.] Univ Western Ontario, Dept Microbiol & Immunol, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario)	Dikeakos, JD (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, Schulich Sch Med & Dent, London, ON, Canada.	Jimmy.Dikeakos@uwo.ca			Canadian Institutes of Health Research [CIHR-MOP 286719]; Natural Sciences and Engineering Council (NSERC) [435677]; Canadian Foundation for Innovation; CIHR	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by operating grants to JDD from the Canadian Institutes of Health Research (CIHR-MOP 286719), the Natural Sciences and Engineering Council (NSERC Discovery grant 435677) and infrastructure grants to JDD from the Canadian Foundation for Innovation. ENP is supported by a Frederick Banting and Charles Best Canada Graduate Scholarship from the CIHR.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; BENSON RE, 1993, J EXP MED, V177, P1561, DOI 10.1084/jem.177.6.1561; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Borman AM, 1997, NUCLEIC ACIDS RES, V25, P925, DOI 10.1093/nar/25.5.925; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Cai CY, 2011, J IMMUNOL, V186, P5807, DOI 10.4049/jimmunol.1003506; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Chaudhry A, 2009, J IMMUNOL, V183, P2415, DOI 10.4049/jimmunol.0804014; Cockrell AS, 2007, MOL BIOTECHNOL, V36, P184, DOI 10.1007/s12033-007-0010-8; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Cordelieres FP, 2014, METHOD CELL BIOL, V123, P395, DOI [10.1016/B978-0-12.420138-5.00021-S, 10.1016/B978-0-12-420138-5.00021-5]; Dikeakos JD, 2012, MOL BIOL CELL, V23, P2184, DOI 10.1091/mbc.E11-11-0928; Dikeakos JD, 2010, MOL BIOL CELL, V21, P3279, DOI 10.1091/mbc.E10-05-0470; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Emert-Sedlak L, 2009, ACS CHEM BIOL, V4, P939, DOI 10.1021/cb900195c; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Haberg K, 2008, J CELL SCI, V121, P1495, DOI 10.1242/jcs.028530; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Hennecke M, 2001, NUCLEIC ACIDS RES, V29, P3327, DOI 10.1093/nar/29.16.3327; Hung CH, 2007, CELL HOST MICROBE, V1, P121, DOI 10.1016/j.chom.2007.03.004; Husain M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019642.55998.69; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Kafri Tal, 2004, Methods Mol Biol, V246, P367; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Leonard JA, 2011, J VIROL, V85, P6867, DOI 10.1128/JVI.00229-11; Manjunath N, 2009, ADV DRUG DELIVER REV, V61, P732, DOI 10.1016/j.addr.2009.03.004; Martinez-Salas E, 1999, CURR OPIN BIOTECH, V10, P458, DOI 10.1016/S0958-1669(99)00010-5; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Mukerji J, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-33; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Pawlak EN, 2015, BBA-GEN SUBJECTS, V1850, P733, DOI 10.1016/j.bbagen.2015.01.003; Pfeffer SR, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005272; Poe JA, 2014, J BIOMOL SCREEN, V19, P556, DOI 10.1177/1087057113513640; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Renkema GH, 2000, FRONT BIOSCI-LANDMRK, V5, pD268, DOI 10.2741/Renkema; Roberts LO, 1998, RNA, V4, P520, DOI 10.1017/S1355838298971989; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; Singer O, 2008, CURR GENE THER, V8, P483, DOI 10.2174/156652308786848067; Swanson CM, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.005; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; Ye HH, 2004, BIOCHEMISTRY-US, V43, P15775, DOI 10.1021/bi048712f; Youker RT, 2009, BIOCHEM J, V421, P1, DOI 10.1042/BJ20081016	58	13	13	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125619	10.1371/journal.pone.0125619	http://dx.doi.org/10.1371/journal.pone.0125619			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915798	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100137
J	Hao, WM; Fan, LJ; Chen, QQ; Chen, XX; Zhang, SC; Lan, K; Lu, J; Zhang, CY				Hao, Weiming; Fan, Lujuan; Chen, Qianqian; Chen, Xiaoxiang; Zhang, Sichao; Lan, Ke; Lu, Jian; Zhang, Chiyu			Modified Proofreading PCR for Detection of Point Mutations, Insertions and Deletions Using a ddNTP-Blocked Primer	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; ALLELE-SPECIFIC AMPLIFICATION; RESOLUTION MELTING ANALYSIS; ULTRA-RARE MUTATIONS; DNA-SEQUENCES; PYROPHOSPHOROLYSIS; DISCRIMINATION; POLYMERASES; SENSITIVITY; GENE	The development of simple, accurate, rapid and cost-effective technologies for mutation detection is crucial to the early diagnosis and prevention of numerous genetic diseases, pharmacogenetics, and drug resistance. Proofreading PCR (PR-PCR) was developed for mutation detection in 1998 but is rarely applied due to its low efficiency in allele discrimination. Here we developed a modified PR-PCR method using a ddNTP-blocked primer and a mixture of DNA polymerases with and without the 3'-5' proofreading function. The ddNTP-blocked primer exhibited the best blocking efficiency to avoid nonspecific primer extension while the mixture of a tiny amount of high-fidelity DNA polymerase with a routine amount of Taq DNA polymerase provided the best discrimination and amplification effects. The modified PR-PCR method is quite capable of detecting various mutation types, including point mutations and insertions/deletions (indels), and allows discrimination amplification when the mismatch is located within the last eight nucleotides from the 3'-end of the ddNTP-blocked primer. The modified PR-PCR has a sensitivity of 1-5 x 10(2) copies and a selectivity of 5 x 10(-5) mutant among 10(7) copies of wild-type DNA. It showed a 100% accuracy rate in the detection of P72R germ-line mutation in the TP53 gene among 60 clinical blood samples, and a high potential to detect rifampin-resistant mutations at low frequency in Mycobacterium tuberculosis using an adaptor and a fusion-blocked primer. These results suggest that the modified PR-PCR technique is effective in detection of various mutations or polymorphisms as a simple, sensitive and promising approach.	[Hao, Weiming; Fan, Lujuan; Lu, Jian] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Hao, Weiming; Fan, Lujuan; Chen, Qianqian; Zhang, Chiyu] Chinese Acad Sci, Inst Pasteur Shanghai, Pathogen Diagnost Ctr, Shanghai, Peoples R China; [Chen, Xiaoxiang] Nanjing Med Univ, Dept Gynecol Oncol, Jiangsu Canc Hosp, Affiliated Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Zhang, Sichao] Jiangsu Univ, Huzhou Ctr Dis Control & Prevent, Huzhou, Zhejiang, Peoples R China; [Lu, Jian] Jiangsu Univ, Sch Med, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Nanjing Medical University; Jiangsu University; Jiangsu University	Lu, J (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China.	lujian@ujs.edu.cn; zhangcy1999@ips.ac.cn						Bi WL, 1998, NUCLEIC ACIDS RES, V26, P3073, DOI 10.1093/nar/26.12.3073; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Cao WG, 2004, TRENDS BIOTECHNOL, V22, P38, DOI 10.1016/j.tibtech.2003.11.001; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Ihle MA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-13; Kim S, 2007, ANNU REV BIOMED ENG, V9, P289, DOI 10.1146/annurev.bioeng.9.060906.152037; Knoll A, 1996, HUM GENET, V98, P539, DOI 10.1007/s004390050256; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; Lin-Ling C, 2005, J BIOCHEM MOL BIOL, V38, P24; Liu Q, 2004, HUM MUTAT, V23, P426, DOI 10.1002/humu.20036; Liu Q, 2000, BIOTECHNIQUES, V29, P1072, DOI 10.2144/00295rr03; Markoff A, 1997, CLIN CHEM, V43, P30; Milbury CA, 2009, CLIN CHEM, V55, P632, DOI 10.1373/clinchem.2008.113035; MUSSER JM, 1995, CLIN MICROBIOL REV, V8, P496, DOI 10.1128/CMR.8.4.496; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; POURZAND C, 1993, MUTAT RES, V288, P113, DOI 10.1016/0027-5107(93)90213-Y; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Shi JX, 2007, HUM MUTAT, V28, P131, DOI 10.1002/humu.20423; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Wasielewski M, 2006, BREAST CANCER RES TR, V99, P97, DOI 10.1007/s10549-006-9186-z; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; WU DY, 1989, GENOMICS, V4, P560, DOI 10.1016/0888-7543(89)90280-2; WU DY, 1989, P NATL ACAD SCI USA, V86, P2757, DOI 10.1073/pnas.86.8.2757; Zhang J, 2005, TRENDS BIOTECHNOL, V23, P92, DOI 10.1016/j.tibtech.2004.12.009; Zhang J, 2004, J BIOCHEM MOL BIOL, V37, P269; Zhang L, 2004, MOL BIOTECHNOL, V27, P75, DOI 10.1385/MB:27:1:75	30	9	9	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123468	10.1371/journal.pone.0123468	http://dx.doi.org/10.1371/journal.pone.0123468			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915410	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100022
J	Sicuri, E; Fernandes, S; Macete, E; Gonzalez, R; Mombo-Ngoma, G; Massougbodgi, A; Abdulla, S; Kuwawenaruwa, A; Katana, A; Desai, M; Cot, M; Ramharter, M; Kremsner, P; Slustker, L; Aponte, J; Hanson, K; Menendez, C				Sicuri, Elisa; Fernandes, Silke; Macete, Eusebio; Gonzalez, Raquel; Mombo-Ngoma, Ghyslain; Massougbodgi, Achille; Abdulla, Salim; Kuwawenaruwa, August; Katana, Abraham; Desai, Meghna; Cot, Michel; Ramharter, Michael; Kremsner, Peter; Slustker, Laurence; Aponte, John; Hanson, Kara; Menendez, Clara			Economic Evaluation of an Alternative Drug to Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; COST-EFFECTIVENESS; PLASMODIUM-FALCIPARUM; HIV-INFECTION; WEST-AFRICA; IMPACT; MORTALITY; WOMEN; ANTIMALARIAL; EFFICACY	Background Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) is recommended in HIV-negative women to avert malaria, while this relies on cotrimoxazole prophylaxis (CTXp) in HIV-positive women. Alternative antimalarials are required in areas where parasite resistance to antifolate drugs is high. The cost-effectiveness of IPTp with alternative drugs is needed to inform policy. Methods The cost-effectiveness of 2-dose IPTp-mefloquine (MQ) was compared with IPTp-SP in HIV-negative women (Benin, Gabon, Mozambique and Tanzania). In HIV-positive women the cost-effectiveness of 3-dose IPTp-MQ added to CTXp was compared with CTXp alone (Kenya, Mozambique and Tanzania). The outcomes used were maternal clinical malaria, anaemia at delivery and non-obstetric hospital admissions. The poor tolerability to MQ was included as the value of women's loss of working days. Incremental cost-effectiveness ratios (ICERs) were calculated and threshold analysis undertaken. Results For HIV-negative women, the ICER for IPTp-MQ versus IPTp-SP was 136.30 US$ (2012 US$) (95%,CI 131.41; 141.18) per disability-adjusted life-year (DALY) averted, or 237.78 US$ (95%CI 230.99; 244.57), depending on whether estimates from Gabon were included or not. For HIV-positive women, the ICER per DALY averted for IPTp-MQ added to CTXp, versus CTXp alone was 6.96 US$ (95%CI 4.22; 9.70). In HIV-negative women, moderate shifts of variables such as malaria incidence, drug cost, and IPTp efficacy increased the ICERs above the cost-effectiveness threshold. In HIV-positive women the intervention remained cost-effective for a substantial (up to 21 times) increase in cost per tablet. Conclusions Addition of IPTp with an effective antimalarial to CTXp was very cost-effective in HIV-positive women. IPTp with an efficacious antimalarial was more cost-effective than IPTp-SP in HIV-negative women. However, the poor tolerability of MQ does not favour its use as IPTp. Regardless of HIV status, prevention of malaria in pregnancy with a highly efficacious, well tolerated antimalarial would be cost-effective despite its high price.	[Sicuri, Elisa; Gonzalez, Raquel; Aponte, John; Menendez, Clara] Univ Barcelona, Hosp Clin Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Fernandes, Silke; Hanson, Kara] London Sch Hyg & Trop Med, London WC1, England; [Macete, Eusebio; Gonzalez, Raquel; Aponte, John; Menendez, Clara] Manhica Hlth Res Ctr CISM, Manhica, Mozambique; [Mombo-Ngoma, Ghyslain; Ramharter, Michael; Kremsner, Peter] Albert Schweitzer Hosp, Ctr Rech Med Lambarene CERMEL, Lambarene, Gabon; [Mombo-Ngoma, Ghyslain; Ramharter, Michael; Kremsner, Peter] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Massougbodgi, Achille] Univ Abomey Calavi, Fac Sci Sante, Cotonou, Benin; [Abdulla, Salim; Kuwawenaruwa, August] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Katana, Abraham] Kenya Med Res Inst KEMRI, Ctr Global Hlth Res, Kisumu, Kenya; [Desai, Meghna; Slustker, Laurence] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Desai, Meghna; Slustker, Laurence] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Kisumu, Kenya; [Cot, Michel] Inst Rech Dev, Paris, France; [Cot, Michel] Univ Paris 05, Paris, France; [Ramharter, Michael] Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of London; London School of Hygiene & Tropical Medicine; Centro de Investigacao em Saude de Manhica; Eberhard Karls University of Tubingen; University of Abomey Calavi; Ifakara Health Institute; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Medical University of Vienna	Sicuri, E (corresponding author), Univ Barcelona, Hosp Clin Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.	elisa.sicuri@cresib.cat	Cot, Michel/E-7633-2011; Mombo-Ngoma, Ghyslain/I-4305-2019; Sicuri, Elisa/L-8012-2014; Menéndez, Clara/Q-3446-2016; Gonzalez, Raquel/J-3604-2017; Ramharter, Michael/C-5273-2013	Cot, Michel/0000-0003-3014-4294; Mombo-Ngoma, Ghyslain/0000-0003-2658-8706; Sicuri, Elisa/0000-0002-2499-2732; Menéndez, Clara/0000-0002-2641-6907; Gonzalez, Raquel/0000-0001-5487-801X; Fernandes, Silke/0000-0001-7694-4233; Ramharter, Michael/0000-0002-9259-1885	MiP Consortium - Bill AMP; Melinda Gates Foundation	MiP Consortium - Bill AMP; Melinda Gates Foundation	This study was supported by MiP Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine.	Abdulla S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-456; ALONSO PL, 1993, T ROY SOC TROP MED H, V87, P37, DOI 10.1016/0035-9203(93)90174-O; Anglaret X, 2003, AIDS, V17, P575, DOI 10.1097/00002030-200303070-00013; [Anonymous], 1993, Commun Dis Rep CDR Wkly, V3, P137; [Anonymous], 2013, AFR DEV IND 2012 201; [Anonymous], 2013, WHO POL BRIEF IMPL I; Arnesen T, 2004, HEALTH POLICY, V70, P137, DOI 10.1016/j.healthpol.2003.08.004; Bardaji A, 2011, J INFECT DIS, V203, P691, DOI 10.1093/infdis/jiq049; Bardaji A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-27; Barreca AI, 2010, J HUM RESOUR, V45, P865; BLACK WC, 1990, MED DECIS MAKING, V10, P212, DOI 10.1177/0272989X9001000308; Brabin BJ, 2001, J NUTR, V131, p604S, DOI 10.1093/jn/131.2.604S; Briggs AH, 2012, MED DECIS MAKING, V32, P722, DOI 10.1177/0272989X12458348; Burrows JN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-187; Conteh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010313; Croft AM, 2007, J ROY SOC MED, V100, P170, DOI 10.1258/jrsm.100.4.170; Cutler D, 2010, AM ECON J-APPL ECON, V2, P72, DOI 10.1257/app.2.2.72; Danzon P, 2013, HEALTH ECON, DOI [10.1002/hec.3021, DOI 10.1002/HEC.3021PUBMED]; DARAMOLA OO, 1991, T ROY SOC TROP MED H, V85, P345, DOI 10.1016/0035-9203(91)90285-7; Datta SC, 2013, REV DEV ECON, V17, P1, DOI 10.1111/rode.12011; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Drummond M., 2006, METHODS EC EVALUATIO, V3rd ed.; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Fenwick E, 2005, BRIT J PSYCHIAT, V187, P106, DOI 10.1192/bjp.187.2.106; Galloway R, 2002, SOC SCI MED, V55, P529, DOI 10.1016/S0277-9536(01)00185-X; Global Fund, PRIC QUAL REP 2013; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001735; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733; Goodman CA, 2001, AM J TROP MED HYG, V64, P45, DOI 10.4269/ajtmh.2001.64.45; Hendriksen ICE, 2012, CLIN INFECT DIS, V55, P1144, DOI 10.1093/cid/cis590; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Klement E, 2014, CLIN INFECT DIS, V58, P651, DOI 10.1093/cid/cit806; Kuwawenaruwa A, 2013, HOUSEHOLD COST UNPUB; Ladner J, 2003, AIDS, V17, P275, DOI 10.1097/00002030-200301240-00025; Ladner J, 2002, AM J TROP MED HYG, V66, P56, DOI 10.4269/ajtmh.2002.66.56; Lucas AM, 2013, ECON DEV CULT CHANGE, V61, P607, DOI 10.1086/669261; Management Sciences for Health World Health Organization, INT DRUG PRIC IND GU; Mbonye AK, 2008, T ROY SOC TROP MED H, V102, P685, DOI 10.1016/j.trstmh.2008.04.016; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Menendez C, 2008, PLOS MED, V5, P220, DOI 10.1371/journal.pmed.0050044; Mockenhaupt FP, 2008, J INFECT DIS, V198, P1545, DOI 10.1086/592455; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; Prual A, 2000, B WORLD HEALTH ORGAN, V78, P593; Ramsey S, 2005, VALUE HEALTH, V8, P521, DOI 10.1111/j.1524-4733.2005.00045.x; Rocchi Angela, 2013, Cost Eff Resour Alloc, V11, P31, DOI 10.1186/1478-7547-11-31; Rodriguez-Monguio R, 2003, PHARMACOECONOMICS, V21, P623, DOI 10.2165/00019053-200321090-00002; Rollins NC, 2007, JAIDS-J ACQ IMM DEF, V44, P321, DOI 10.1097/QAI.0b013e31802ea4b0; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Sappenfield Elisabeth, 2013, Infect Dis Obstet Gynecol, V2013, P752852, DOI 10.1155/2013/752852; Schultz LJ, 1996, AM J TROP MED HYG, V55, P87, DOI 10.4269/ajtmh.1996.55.87; SCHULTZ LJ, 1995, B WORLD HEALTH ORGAN, V73, P207; Sevene E, 2010, EXPERT OPIN PHARMACO, V11, P1277, DOI 10.1517/14656561003733599; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Sicuri E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-307; Sicuri E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013407; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; Unekel CJ, 2009, T ROY SOC TROP MED H, V103, P761, DOI 10.1016/j.trstmh.2008.06.017; Walter E, 2006, GUIDELINES HLTH EC E; Ward SA, 2007, LANCET INFECT DIS, V7, P136, DOI 10.1016/S1473-3099(07)70025-7; Wolfe EB, 2001, AM J TROP MED HYG, V64, P178, DOI 10.4269/ajtmh.2001.64.178; Woolf SH, 2009, JAMA-J AM MED ASSOC, V301, P536, DOI 10.1001/jama.2009.51; World Health Organization, CHOOSING INT AR COST; Worrall E, 2007, LANCET INFECT DIS, V7, P156, DOI 10.1016/S1473-3099(07)70027-0; Zaba B, 2013, LANCET, V381, P1763, DOI 10.1016/S0140-6736(13)60803-X	69	11	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125072	10.1371/journal.pone.0125072	http://dx.doi.org/10.1371/journal.pone.0125072			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915616	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000353659100094
J	Chen, HW; Liu, GD; Ou, S; Fei, J; Zhao, GS; Wu, LJ; Pan, J				Chen, Hong-wei; Liu, Guo-dong; Ou, Shan; Fei, Jun; Zhao, Gang-sheng; Wu, Li-jun; Pan, Jun			Operative Treatment of Terrible Triad of the Elbow via Posterolateral and Anteromedial Approaches	PLOS ONE			English	Article							MEDIAL COLLATERAL LIGAMENT; CORONOID PROCESS; RADIAL HEAD; FRACTURE-DISLOCATIONS; FIXATION; INJURY; REPAIR; INSTABILITY	The aim of the study was to explore the clinical outcome of posterolateral and anteromedial approaches in treatment of terrible triad of the elbow. The study involved 12 patients with closed terrible triad of the elbow treated by posterolateral and anteromedial approaches between January 2010 and June 2012. The mechanism of injury included fall from height in 9 patients and traffic accident in 3. According to O'Driscoll classification for fractures of the ulnar coronoid, there were 11 patients with type. and 1 with type. fractures. According to Mason classification for fractures of the radial head, there were 3 patients with type., 7 with type. and 2 with type. fractures. All patients were followed up for 12-27 months (average 15.5 months), which showed no pain or severe pain in all patients except for 2 patients with mild pain. At the last follow-up, the mean flexion was for 125 degrees(range, 90 degrees-140 degrees), the mean extension loss for 20 degrees(range, 0 degrees-70 degrees), the mean pronation for 66 degrees(range, 20 degrees-85 degrees) and the mean supination for 60 degrees(range, 30 degrees-85 degrees). The bony union time was 8-14 weeks (average 11 weeks) and the elbows were stable in flexion-extension and varus-valgus in all patients. The elbows maintained a concentric reduction of both the ulnotrochlear and the radiocapitellar articulation. Mild heterotopic ossification of the elbow occurred in 3 patients at 6 months after operation and mild degenerative change in 1 patient at 18 months after operation. The Broberg and Morrey elbow performance score was 82 points (range, 58-98 points). The results were excellent in 6 patients, good in 4, fair in 1 and poor in 1, with excellence rate of 83.3%. The results showed that the combined posterolateral and anteromedial approaches can facilitate the reduction and fixation of terrible triad of the elbow. Repair of radial head, coronoid, medial and lateral collateral ligaments can sufficiently restore the elbow stability, allow early postoperative motion and enhance the functional recovery.	[Chen, Hong-wei; Zhao, Gang-sheng] Cent Hosp Yiwu City, Dept Orthoped, Yiwu 322000, Peoples R China; [Liu, Guo-dong] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept 8, Chongqing 400042, Peoples R China; [Ou, Shan] Chengdu Mil Command, Dept Anesthesiol, Gen Hosp, Chengdu 610083, Peoples R China; [Fei, Jun] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Traumat Ctr, Chongqing 400042, Peoples R China; [Wu, Li-jun] Wenzhou Med Coll, Digital Med Res Inst, Wenzhou 325027, Peoples R China; [Pan, Jun] Wenzhou Med Coll, Affiliated Hosp 2, Dept Orthoped, Wenzhou 325027, Peoples R China	Army Medical University; Army Medical University; Wenzhou Medical University; Wenzhou Medical University	Liu, GD (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept 8, Chongqing 400042, Peoples R China.	frankliugd@163.com						Beingessner DM, 2007, J SHOULDER ELB SURG, V16, P213, DOI 10.1016/j.jse.2006.06.015; BROBERG MA, 1986, J BONE JOINT SURG AM, V68A, P669, DOI 10.2106/00004623-198668050-00005; Doornberg JN, 2007, J SHOULDER ELB SURG, V16, P667, DOI 10.1016/j.jse.2007.03.013; Egol KA, 2007, BULL HOSP JT DIS, V65, P263; Forthman C, 2007, J HAND SURG-AM, V32A, P1200, DOI 10.1016/j.jhsa.2007.06.019; Garrigues GE, 2011, J BONE JOINT SURG AM, V93A, P1873, DOI 10.2106/JBJS.I.01673; Kalicke T, 2007, ARCH ORTHOP TRAUM SU, V127, P925, DOI 10.1007/s00402-007-0424-6; Kraig YB, 2006, J HAND THER, V19, P114; Mathew PK, 2009, J AM ACAD ORTHOP SUR, V17, P137, DOI 10.5435/00124635-200903000-00003; McKee MD, 2003, J SHOULDER ELB SURG, V12, P391, DOI 10.1016/S1058-2746(03)00027-2; McKee MD, 2001, SKELETAL TRAUMA, P1455; O'Driscoll Shawn W, 2003, Instr Course Lect, V52, P113; Pai V, 2009, J Orthop Surg (Hong Kong), V17, P31; Papandrea RF, 2007, J SHOULDER ELB SURG, V16, P68, DOI 10.1016/j.jse.2006.03.011; Reichel Lee M, 2012, Tech Hand Up Extrem Surg, V16, P98, DOI 10.1097/BTH.0b013e31824e6a74; Ring D, 2002, J BONE JOINT SURG AM, V84A, P547, DOI 10.2106/00004623-200204000-00006; Ring D, 2002, J BONE JOINT SURG AM, V84A, P1811, DOI 10.2106/00004623-200210000-00011; Rodriguez-Martin J, 2011, INT ORTHOP, V35, P851, DOI 10.1007/s00264-010-1024-6; Seth D, 2013, ORTHOP CLIN N AM, V44, P47, DOI [10.1016/j.ocl.2012.08.006, DOI 10.1016/J.OCL.2012.08.006]; Steinmann SP, 2008, J AM ACAD ORTHOP SUR, V16, P519; Thomas K, 2007, ARCH ORTHOP TRAUMA S, V127, P925; Toros T, 2012, ACTA ORTHOP TRAUMATO, V46, P96, DOI 10.3944/AOTT.2012.2632; Zeiders GJ, 2008, J BONE JOINT SURG AM, V90A, P75, DOI 10.2106/JBJS.H.00893	23	9	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124821	10.1371/journal.pone.0124821	http://dx.doi.org/10.1371/journal.pone.0124821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910196	Green Submitted, gold, Green Published			2022-12-27	WOS:000353376800108
J	Sanroman-Junquera, M; Mora-Jimenez, I; Almendral, J; Garcia-Alberola, A; Rojo-Alvarez, JL				Sanroman-Junquera, Margarita; Mora-Jimenez, Inmaculada; Almendral, Jesus; Garcia-Alberola, Arcadio; Luis Rojo-Alvarez, Jose			Automatic Supporting System for Regionalization of Ventricular Tachycardia Exit Site in Implantable Defibrillators	PLOS ONE			English	Article							ORIGIN; ELECTROGRAMS; REGRESSION	Electrograms stored in Implantable Cardioverter Defibrillators (ICD-EGM) have been proven to convey useful information for roughly determining the anatomical location of the Left Ventricular Tachycardia exit site (LVTES). Our aim here was to evaluate the possibilities from a machine learning system intended to provide an estimation of the LVTES anatomical region with the use of ICD-EGM in the situation where 12-lead electrocardiogram of ventricular tachycardia are not available. Several machine learning techniques were specifically designed and benchmarked, both from classification (such as Neural Networks (NN), and Support Vector Machines (SVM)) and regression (Kernel Ridge Regression) problem statements. Classifiers were evaluated by using accuracy rates for LVTES identification in a controlled number of anatomical regions, and the regression approach quality was studied in terms of the spatial resolution. We analyzed the ICD-EGM of 23 patients (18 +/- 10 EGM per patient) during left ventricular pacing and simultaneous recording of the spatial coordinates of the pacing electrode with a navigation system. Several feature sets extracted from ICD-EGM (consisting of times and voltages) were shown to convey more discriminative information than the raw waveform. Among classifiers, the SVM performed slightly better than NN. In accordance with previous clinical works, the average spatial resolution for the LVTES was about 3 cm, as in our system, which allows it to support the faster determination of the LVTES in ablation procedures. The proposed approach also provides with a framework suitable for driving the design of improved performance future systems.	[Sanroman-Junquera, Margarita; Mora-Jimenez, Inmaculada; Luis Rojo-Alvarez, Jose] Univ Rey Juan Carlos, Dept Signal Theory & Commun Telemat & Comp, Fuenlabrada 28943, Spain; [Almendral, Jesus] Hosp Madrid Monteprincipe, Arrhythmia Unit, Boadilla Del Monte 28660, Spain; [Garcia-Alberola, Arcadio] Hosp Univ Virgen Arrixaca, Arrhythmia Unit, Murcia 30120, Spain; [Luis Rojo-Alvarez, Jose] Univ Fuerzas Armadas ESPE, Sangolqui, Ecuador	Universidad Rey Juan Carlos; Hospital Clinico Universitario Virgen de la Arrixaca; Escuela Politecnica Superior del Ejercito	Sanroman-Junquera, M (corresponding author), Univ Rey Juan Carlos, Dept Signal Theory & Commun Telemat & Comp, Fuenlabrada 28943, Spain.	margarita.sanroman@urjc.es	Rojo-Álvarez, José-Luis/F-6520-2016; Garcia-Alberola, Arcadi/F-3201-2016; MORA JIMENEZ, INMACULADA/F-9254-2016	Rojo-Álvarez, José-Luis/0000-0003-0426-8912; MORA JIMENEZ, INMACULADA/0000-0003-0735-367X	Spanish Government [TEC2010-19263/TCM, TEC2013-48439-C4-1-R, TSI-020100-2010-0469]; Rey Juan Carlos University [PRIN13\_IYA12]; public Prometeo Project of the Secretariat for Higher Education, Science, Technology and Innovation of the Republic of Ecuador	Spanish Government(Spanish GovernmentEuropean Commission); Rey Juan Carlos University; public Prometeo Project of the Secretariat for Higher Education, Science, Technology and Innovation of the Republic of Ecuador	This work has been partly supported by TEC2010-19263/TCM, TEC2013-48439-C4-1-R, and TSI-020100-2010-0469 public research projects from the Spanish Government; and by PRIN13\_IYA12 project from Rey Juan Carlos University. JLRA has been temporally supported by public Prometeo Project of the Secretariat for Higher Education, Science, Technology and Innovation of the Republic of Ecuador.	Almendral J, 2012, J CARDIOVASC ELECTR, V23, P506, DOI 10.1111/j.1540-8167.2011.02233.x; An S., 2007, P IEEE C COMP VIS PA, V2007, P1, DOI DOI 10.1109/CVPR.2007.383105; BakIr G., 2007, PREDICTING STRUCTURE; Chu C, 2011, NEUROIMAGE, V56, P662, DOI 10.1016/j.neuroimage.2010.03.058; Cristianini N, 2000, INTRO SUPPORT VECTOR; Douak F, 2013, APPL ENERG, V103, P328, DOI 10.1016/j.apenergy.2012.09.055; Duda R.O., 2006, PATTERN CLASSIFICATI; Haykin S., 2009, NEURAL NETWORKS LEAR; Meng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103181; MILLER JM, 1988, CIRCULATION, V77, P759, DOI 10.1161/01.CIR.77.4.759; Sanroman-Junquera M, 2010, COMPUT CARDIOL CONF, V37, P749; Sanroman-Junquera M, 2012, SIGNAL PROCESS, V92, P43, DOI 10.1016/j.sigpro.2011.05.023; Sanroman-Junquera M, 2009, COMPUT CARDIOL, V36, P801; Segal OR, 2007, J CARDIOVASC ELECTR, V18, P161, DOI 10.1111/j.1540-8167.2007.00721.x; Shenasa M., 2012, CARDIAC MAPPING; SPECHT DF, 1990, NEURAL NETWORKS, V3, P109, DOI 10.1016/0893-6080(90)90049-Q; Streitner F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063911; Tschabrunn CM, 2013, J INTERV CARD ELECTR, V36, P243, DOI 10.1007/s10840-012-9731-0; Vapnik V., 2013, NATURE STAT LAERNING; Wilcoxon F, 1964, WILCOXON SIGNED RANK; Yoshida K, 2010, J AM COLL CARDIOL, V56, P969, DOI 10.1016/j.jacc.2010.04.043	21	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124514	10.1371/journal.pone.0124514	http://dx.doi.org/10.1371/journal.pone.0124514			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910170	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800087
J	Ward, LM; Aitchison, RT; Tawse, M; Simmers, AJ; Shahani, U				Ward, Laura McKernan; Aitchison, Ross Thomas; Tawse, Melisa; Simmers, Anita Jane; Shahani, Uma			Reduced Haemodynamic Response in the Ageing Visual Cortex Measured by Absolute fNIRS	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; AGE-RELATED-CHANGES; EVOKED POTENTIALS; BRAIN ACTIVITY; FREQUENCY; STIMULATION; OXYGENATION; HEMOGLOBIN; DEPENDENCY; ACTIVATION	The effect of healthy ageing on visual cortical activation is still to be fully explored. This study aimed to elucidate whether the haemodynamic response (HDR) of the visual cortex altered as a result of ageing. Visually normal (healthy) participants were presented with a simple visual stimulus (reversing checkerboard). Full optometric screening was implemented to identify two age groups: younger adults (n = 12, mean age 21) and older adults (n = 13, mean age 71). Frequency-domain Multi-distance (FD-MD) functional Near-Infrared Spectroscopy (fNIRS) was used to measure absolute changes in oxygenated [HbO] and deoxygenated [HbR] haemoglobin concentrations in the occipital cortices. Utilising a slow event-related design, subjects viewed a full field reversing checkerboard with contrast and check size manipulations (15 and 30 minutes of arc, 50% and 100% contrast). Both groups showed the characteristic response of increased [HbO] and decreased [HbR] during stimulus presentation. However, older adults produced a more varied HDR and often had com parable levels of [HbO] and [HbR] during both stimulus presentation and baseline resting state. Younger adults had significantly greater concentrations of both [HbO] and [HbR] in every investigation regardless of the type of stimulus displayed (p<0.05). The average variance associated with this age-related effect for [HbO] was 88% and [HbR] 91%. Passive viewing of a visual stimulus, without any cognitive input, showed a marked age-related decline in the cortical HDR. Moreover, regardless of stimulus parameters such as check size, the HDR was characterised by age. In concurrence with present neuroimaging literature, we conclude that the visual HDR decreases as healthy ageing proceeds.	[Ward, Laura McKernan; Aitchison, Ross Thomas; Tawse, Melisa; Simmers, Anita Jane; Shahani, Uma] Glasgow Caledonian Univ, Dept Vis Sci, Glasgow G4 0BA, Lanark, Scotland	Glasgow Caledonian University	Ward, LM (corresponding author), Glasgow Caledonian Univ, Dept Vis Sci, Glasgow G4 0BA, Lanark, Scotland.	Laura.McKernanWard@gcu.ac.uk	Shahani, Uma/V-9096-2019	Shahani, Uma/0000-0003-2597-9334; Aitchison, Ross Thomas/0000-0003-0192-9965; Ward, Laura/0000-0003-0880-0662	Glasgow Caledonian University	Glasgow Caledonian University	LMW is funded by a Glasgow Caledonian University studentship for a 3 year PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ances BM, 2009, HUM BRAIN MAPP, V30, P1120, DOI 10.1002/hbm.20574; Bakker SLM, 2004, NEUROEPIDEMIOLOGY, V23, P178, DOI 10.1159/000078503; Bertsch K, 2009, BRAIN RES, V1267, P77, DOI 10.1016/j.brainres.2009.02.053; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brodtmann A, 2003, NEUROIMAGE, V20, P520, DOI 10.1016/S1053-8119(03)00237-4; Buckner RL, 2000, J COGNITIVE NEUROSCI, V12, P24, DOI 10.1162/089892900564046; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Chen XP, 2012, NEUROSCI BULL, V28, P737, DOI 10.1007/s12264-012-1292-9; Cliff M, 2013, CORTEX, V49, P1304, DOI 10.1016/j.cortex.2012.04.003; CRASSINI B, 1988, PERCEPTION, V17, P315, DOI 10.1068/p170315; Fabiani M, 2014, NEUROIMAGE, V85, P592, DOI 10.1016/j.neuroimage.2013.04.113; Gatto R, 2006, J NEUROSCI METH, V157, P274, DOI 10.1016/j.jneumeth.2006.04.013; Gatto R, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804705; Hallacoglu B, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.081406; HOCK C, 1995, J CEREBR BLOOD F MET, V15, P1103, DOI 10.1038/jcbfm.1995.137; Huettel SA, 2001, NEUROIMAGE, V13, P161, DOI 10.1006/nimg.2000.0675; Jasdzewski G, 2003, NEUROIMAGE, V20, P479, DOI 10.1016/S1053-8119(03)00311-2; KATO T, 1993, J CEREBR BLOOD F MET, V13, P516, DOI 10.1038/jcbfm.1993.66; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; McIntosh MA, 2010, INVEST OPHTH VIS SCI, V51, P4856, DOI 10.1167/iovs.09-4940; McKendrick AM, 2013, INVEST OPHTH VIS SCI, V54, P1730, DOI 10.1167/iovs.12-10974; Mehagnoul-Schipper DJ, 2002, HUM BRAIN MAPP, V16, P14, DOI 10.1002/hbm.10026; Mirzajani A, 2007, PHYSIOL MEAS, V28, P547, DOI 10.1088/0967-3334/28/5/008; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Oudegeest-Sander MH, 2014, EXP PHYSIOL, V99, P586, DOI 10.1113/expphysiol.2013.076455; Park DC, 2004, P NATL ACAD SCI USA, V101, P13091, DOI 10.1073/pnas.0405148101; Peca S, 2013, NEUROLOGY, V81, P1659, DOI 10.1212/01.wnl.0000435291.49598.54; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; Rosengarten B, 2003, J NEUROIMAGING, V13, P43, DOI 10.1177/1051228402239716; Ross MH, 1997, NEUROLOGY, V48, P173, DOI 10.1212/WNL.48.1.173; Safonova LP, 2004, ARCH GERONTOL GERIAT, V39, P207, DOI 10.1016/j.archger.2004.03.007; Schroeter ML, 2004, J CEREBR BLOOD F MET, V24, P1183, DOI 10.1097/01.WCB.0000135231.90164.40; Schroeter ML, 2004, NEUROIMAGE, V21, P283, DOI 10.1016/j.neuroimage.2003.09.054; Schroeter ML, 2003, NEUROIMAGE, V19, P555, DOI 10.1016/S1053-8119(03)00155-1; SEKULER R, 1982, AM J OPTOM PHYS OPT, V59, P961; Sergio Fantini, 1995, OPT ENG, V34, P32; Singh KD, 2000, NEUROIMAGE, V12, P550, DOI 10.1006/nimg.2000.0642; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sun BL, 2014, NEUROIMAGE, V87, P190, DOI 10.1016/j.neuroimage.2013.11.003; Tobimatsu S., 1999, OPTOMETRY VISION SCI, V72, P192; Toronov VY, 2007, NEUROIMAGE, V34, P1136, DOI 10.1016/j.neuroimage.2006.08.048; Vermeij A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046210; Wijeakumar S, 2012, INVEST OPHTH VIS SCI, V53, P2266, DOI 10.1167/iovs.11-8680; Wolf M, 2003, PSYCHOPHYSIOLOGY, V40, P521, DOI 10.1111/1469-8986.00054; Wolf M, 2002, NEUROIMAGE, V16, P704, DOI 10.1006/nimg.2002.1128; Yadav NK, 2013, BRAIN INJURY, V27, P1631, DOI 10.3109/02699052.2013.844856; Zaletel M, 2005, FUNCT NEUROL, V20, P115	49	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125012	10.1371/journal.pone.0125012	http://dx.doi.org/10.1371/journal.pone.0125012			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909849	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000353376800122
J	Braun, KVN; Christensen, D; Doernberg, N; Schieve, L; Rice, C; Wiggins, L; Schendel, D; Yeargin-Allsopp, M				Braun, Kim Van Naarden; Christensen, Deborah; Doernberg, Nancy; Schieve, Laura; Rice, Catherine; Wiggins, Lisa; Schendel, Diana; Yeargin-Allsopp, Marshalyn			Trends in the Prevalence of Autism Spectrum Disorder, Cerebral Palsy, Hearing Loss, Intellectual Disability, and Vision Impairment, Metropolitan Atlanta, 1991-2010	PLOS ONE			English	Article							DEVELOPMENTAL-DISABILITIES; CHILDREN	This study examined the prevalence and characteristics of autism spectrum disorder (ASD), cerebral palsy (CP), hearing loss (HL), intellectual disability (ID), and vision impairment (VI) over a 15-20 year time period, with specific focus on concurrent changes in ASD and ID prevalence. We used data from a population-based developmental disabilities surveillance program for 8-year-olds in metropolitan Atlanta. From 1991-2010, prevalence estimates of ID and HL were stable with slight increases in VI prevalence. CP prevalence was constant from 1993-2010. The average annual increase in ASD prevalence was 9.3% per year from 1996-2010, with a 269% increase from 4.2 per 1,000 in 1996 to 15.5 per 1,000 in 2010. From 2000-2010, the prevalence of ID without ASD was stable; during the same time, the prevalence of ASD with and without co-occurring ID increased by an average of 6.6% and 9.6% per year, respectively. ASD prevalence increases were found among both males and females, and among nearly all racial/ethnic subgroups and levels of intellectual ability. Average annual prevalence estimates from 1991-2010 underscore the significant community resources needed to provide early intervention and ongoing supports for children with ID (13.0 per 1,000), CP, (3.5 per 1,000), HL (1.4 per 1,000) and VI (1.3 in 1,000), with a growing urgency for children with ASD.	[Braun, Kim Van Naarden; Christensen, Deborah; Doernberg, Nancy; Schieve, Laura; Rice, Catherine; Wiggins, Lisa; Schendel, Diana; Yeargin-Allsopp, Marshalyn] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Dev Disabil Branch, iPSYCH, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Braun, KVN (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Dev Disabil Branch, iPSYCH, Atlanta, GA 30333 USA.	kbn5@cdc.gov	Rice, Catherine E/D-6305-2016; Romanova, Raisa/O-5724-2018	Schendel, Diana/0000-0002-8588-1227	Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden)		Allen MC, 2008, CURR OPIN NEUROL, V21, P123, DOI 10.1097/WCO.0b013e3282f88bb4; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], SEMINARS PEDIAT INFE; Avchen RN, 2011, J AUTISM DEV DISORD, V41, P227, DOI 10.1007/s10803-010-1050-7; BHASIN TK, 2006, MMWR SURVEILL SUMM, V55, P1; Blumberg Stephen J, 2013, Natl Health Stat Report, P1; Boulet SL, 2009, ARCH PEDIAT ADOL MED, V163, P19, DOI 10.1001/archpediatrics.2008.506; Boyle CA, 2011, PEDIATRICS, V127, P1034, DOI 10.1542/peds.2010-2989; Center for Disease Control and Prevention, 2012, MMWR SURVEILL SUMM, V61, P1; Centers for Disease Control and Prevention, 2011, WORKSH US DAT EV CHA; Centers for Disease Control and Prevention, 2013, WEBINAR         0629; Centers for Disease Control and Prevention, EST JUL 1 2000 JUL 1; Centers for Disease Control and Prevention (CDC), 2010, CDC MORB MORTAL WKLY, V63, P1; Christensen D, 2014, DEV MED CHILD NEUROL, V56, P59, DOI 10.1111/dmcn.12268; Crocker AC, 1989, DEV DISABILITIES DEL; Croen LA, 2002, J AUTISM DEV DISORD, V32, P207, DOI 10.1023/A:1015453830880; Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Hahn Robert, 2007, MMWR Recomm Rep, V56, P1; Jarquin VG, 2011, J DEV BEHAV PEDIATR, V32, P179, DOI 10.1097/DBP.0b013e31820b4260; King M, 2009, INT J EPIDEMIOL, V38, P1224, DOI 10.1093/ije/dyp261; Kirby RS, 2011, RES DEV DISABIL, V32, P462, DOI 10.1016/j.ridd.2010.12.042; Larson SA, 2005, PROBLEMS DEFINING ME, V7; Lazarus C, 2007, AM J MENT RETARD, V112, P462, DOI 10.1352/0895-8017(2007)112[462:IOPVIP]2.0.CO;2; Mendola P, 2002, MENT RETARD DEV D R, V8, P188, DOI 10.1002/mrdd.10033; Meyer Pamela A, 2003, MMWR Surveill Summ, V52, P1; *NAT CTR HLTH STAT, BRIDG RAC INT EST JU; National Center for Health Statistics, BRIDG RAC INT EST RE; National Center for Health Statistics, EST APR 1 2010 RES P; Newschaffer CJ, 2005, PEDIATRICS, V115, pE277, DOI 10.1542/peds.2004-1958; Obi O, 2011, AJIDD-AM J INTELLECT, V116, P360, DOI 10.1352/1944-7558-116.5.360; Oostenbrink R, 2002, SCAND J INFECT DIS, V34, P379, DOI 10.1080/00365540110080179; Ouellette-Kuntz H, 2005, CAN J PUBLIC HEALTH, V96, pS8, DOI 10.1007/BF03403699; Petrini JR, 2009, J PEDIATR-US, V154, P169, DOI 10.1016/j.jpeds.2008.08.020; Rice Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P12; Rice Catherine, 2009, Morbidity and Mortality Weekly Report, V58, P1; Schieve LA, 2011, ANN EPIDEMIOL; Sellier E, 2010, EUR J EPIDEMIOL, V25, P635, DOI 10.1007/s10654-010-9474-0; Shattuck PT, 2006, PEDIATRICS, V117, P1028, DOI 10.1542/peds.2005-1516; Wise MD, 2010, J DEV BEHAV PEDIATR, V31, P469, DOI 10.1097/DBP.0b013e3181e56db2; Yeargin-Allsopp M, 2003, JAMA-J AM MED ASSOC, V289, P49, DOI 10.1001/jama.289.1.49; YEARGINALLSOPP M, 1992, PEDIATRICS, V89, P624; YEARGINALLSOPP M, 1995, AM J PUBLIC HEALTH, V85, P324, DOI 10.2105/AJPH.85.3.324	43	167	168	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124120	10.1371/journal.pone.0124120	http://dx.doi.org/10.1371/journal.pone.0124120			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923140	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600071
J	Duitama, J; Silva, A; Sanabria, Y; Cruz, DF; Quintero, C; Ballen, C; Lorieux, M; Scheffler, B; Farmer, A; Torres, E; Oard, J; Tohme, J				Duitama, Jorge; Silva, Alexander; Sanabria, Yamid; Felipe Cruz, Daniel; Quintero, Constanza; Ballen, Carolina; Lorieux, Mathias; Scheffler, Brian; Farmer, Andrew; Torres, Edgar; Oard, James; Tohme, Joe			Whole Genome Sequencing of Elite Rice Cultivars as a Comprehensive Information Resource for Marker Assisted Selection	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISM; VARIATION REVEALS; WIDE ASSOCIATION; AMYLOSE CONTENT; COPY NUMBER; IDENTIFICATION; RESISTANCE; DISEASE; TRAITS; ORIGIN	Current advances in sequencing technologies and bioinformatics revealed the genomic background of rice, a staple food for the poor people, and provided the basis to develop large genomic variation databases for thousands of cultivars. Proper analysis of this massive resource is expected to give novel insights into the structure, function, and evolution of the rice genome, and to aid the development of rice varieties through marker assisted selection or genomic selection. In this work we present sequencing and bioinformatics analyses of 104 rice varieties belonging to the major subspecies of Oryza sativa. We identified repetitive elements and recurrent copy number variation covering about 200 Mbp of the rice genome. Genotyping of over 18 million polymorphic locations within O. sativa allowed us to reconstruct the individual haplotype patterns shaping the genomic background of elite varieties used by farmers throughout the Americas. Based on a reconstruction of the alleles for the gene GBSSI, we could identify novel genetic markers for selection of varieties with high amylose content. We expect that both the analysis methods and the genomic information described here would be of great use for the rice research community and for other groups carrying on similar sequencing efforts in other crops.	[Duitama, Jorge; Silva, Alexander; Felipe Cruz, Daniel; Quintero, Constanza; Ballen, Carolina; Lorieux, Mathias; Torres, Edgar; Tohme, Joe] Ctr Int Agr Trop, Agrobiodivers Res Area, Cali, Colombia; [Sanabria, Yamid; Oard, James] Louisiana State Univ, Ctr Agr, Rice Res Stn, Rayne, LA USA; [Scheffler, Brian] ARS, Genom & Bioinformat Res Unit, USDA, Jamie Whitten Delta States Res Ctr, Stoneville, MS USA; [Farmer, Andrew] Natl Ctr Genome Resources, Santa Fe, NM USA; [Lorieux, Mathias] Inst Rech Dev, Plant Divers Adaptat & Dev Res Unit, Montpellier, France	Alliance; International Center for Tropical Agriculture - CIAT; Louisiana State University System; Louisiana State University; United States Department of Agriculture (USDA); National Center for Genome Resources (NCGR); Institut de Recherche pour le Developpement (IRD)	Duitama, J (corresponding author), Ctr Int Agr Trop, Agrobiodivers Res Area, Apartado Aereo 6713, Cali, Colombia.	j.duitama@cgiar.org	Castellanos, Jorge Alexander Duitama/I-6484-2019; Ballen-Taborda, Carolina/AAZ-4209-2020	Castellanos, Jorge Alexander Duitama/0000-0002-9105-6266; Sanabria, Yamid/0000-0002-3486-4662; Scheffler, Brian/0000-0003-1968-8952; Ballen Taborda, Carolina/0000-0002-4995-7802	Agricultural Research Service of the United States Department of Agriculture (USDA/ARS); RiceCAP project (USDA/CSREES) [2004-35317-14867]; Mississippi Rice Promotion Board; Rice Foundation; Louisiana Rice Research Board; International Center for Tropical Agriculture; Global Rice Science Partnership (GRiSP) project; National Science Foundation (NSF) [0965420]; ARS [ARS-0425248] Funding Source: Federal RePORTER	Agricultural Research Service of the United States Department of Agriculture (USDA/ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); RiceCAP project (USDA/CSREES); Mississippi Rice Promotion Board; Rice Foundation; Louisiana Rice Research Board; International Center for Tropical Agriculture; Global Rice Science Partnership (GRiSP) project; National Science Foundation (NSF)(National Science Foundation (NSF)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the Agricultural Research Service of the United States Department of Agriculture (USDA/ARS); the RiceCAP project (USDA/CSREES http://www.uark.edu/ua/ricecap/) (2004-35317-14867 to J.O. and B.S.); The Mississippi Rice Promotion Board (http://rice.msstate.edu/members.html); The Rice Foundation (http://www.usarice.com/index.php); the Louisiana Rice Research Board (http://www.lsuagcenter.com/en/crops_livestock/crops/rice/Rice+Research+Board+Reports/From-the-Louisiana-Rice-Research-Board.htm); the International Center for Tropical Agriculture (http://ciat.cgiar.org/); the Global Rice Science Partnership (GRiSP) project (http://www.grisp.net/main/summary); and the National Science Foundation (NSF) (0965420 to J.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Arai-Kichise Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086312; Ayres NM, 1997, THEOR APPL GENET, V94, P773, DOI 10.1007/s001220050477; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Christiaens JF, 2012, EMBO REP, V13, P1145, DOI 10.1038/embor.2012.157; DELWICHE SR, 1995, CEREAL CHEM, V72, P182; Dobo M, 2010, J CEREAL SCI, V52, P450, DOI 10.1016/j.jcs.2010.07.010; Duan JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059128, 10.1371/journal.pone.0062087]; Duitama J, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1381; Falush D, 2003, GENETICS, V164, P1567; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Goff SA, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00034; He ZW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002100; Huang P, 2012, MOL ECOL, V21, P4593, DOI 10.1111/j.1365-294X.2012.05625.x; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jacquemin J, 2011, MOL BIOL EVOL, V28, P3139, DOI 10.1093/molbev/msr144; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lappalainen I, 2013, NUCLEIC ACIDS RES, V41, pD936, DOI 10.1093/nar/gks1213; Larkin PD, 2003, MOL BREEDING, V12, P335, DOI 10.1023/B:MOLB.0000006797.51786.92; Lyu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3138; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Milne I, 2010, BIOINFORMATICS, V26, P3133, DOI 10.1093/bioinformatics/btq580; Molina J, 2011, P NATL ACAD SCI USA, V108, P8351, DOI 10.1073/pnas.1104686108; Monaco MK, 2014, NUCLEIC ACIDS RES, V42, pD1193, DOI 10.1093/nar/gkt1110; Norton GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089685; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Sazuka T, 2009, PLANT J, V60, P227, DOI 10.1111/j.1365-313X.2009.03952.x; SHURE M, 1983, CELL, V35, P225, DOI 10.1016/0092-8674(83)90225-8; Silva J, 2012, THEOR APPL GENET, V124, P63, DOI 10.1007/s00122-011-1687-4; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Xie XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020670; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yamamoto E, 2012, RICE, V5, DOI 10.1186/1939-8433-5-26; Yamamoto E, 2010, MOL GENET GENOMICS, V283, P305, DOI 10.1007/s00438-010-0514-y; Yang CC, 2012, MOL BIOL EVOL, V29, P1471, DOI 10.1093/molbev/msr315; Yu P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-649; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780	47	48	50	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124617	10.1371/journal.pone.0124617	http://dx.doi.org/10.1371/journal.pone.0124617			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923345	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600097
J	Liu, YJ; Lee, YH; Chang, HC; Huang, TY; Chiu, HC; Wang, CW; Chiou, TW; Hsu, K; Juan, CJ; Huang, GS; Hsu, HH				Liu, Yi-Jui; Lee, Yi-Hsiung; Chang, Hing-Chiu; Huang, Teng-Yi; Chiu, Hui-Chu; Wang, Chih-Wei; Chiou, Ta-Wei; Hsu, Kang; Juan, Chun-Jung; Huang, Guo-Shu; Hsu, Hsian-He			A Potential Risk of Overestimating Apparent Diffusion Coefficient in Parotid Glands	PLOS ONE			English	Article							LATE RADIATION-INJURY; SALIVARY-GLANDS; GUSTATORY STIMULATION; ECHO-PLANAR; MRI; MOTION; TUMORS; HEAD; NECK; RADIOTHERAPY	Objectives To investigate transient signal loss on diffusion weighted images (DWI) and overestimation of apparent diffusion coefficient (ADC) in parotid glands using single shot echoplanar DWI (EPDWI). Materials and Methods This study enrolled 6 healthy subjects and 7 patients receiving radiotherapy. All participants received dynamic EPDWI with a total of 8 repetitions. Imaging quality of DWI was evaluated. Probability of severe overestimation of ADC (soADC), defined by an ADC ratio more than 1.2, was calculated. Error on T2WI, DWI, and ADC was computed. Statistical analysis included paired Student t testing and Mann-Whitney U test. A P value less than 0.05 was considered statistically significant. Results Transient signal loss was visually detected on some excitations of DWI but not on T2WI or mean DWI. soADC occurred randomly among 8 excitations and 3 directions of diffusion encoding gradients. Probability of soADC was significantly higher in radiotherapy group (42.86%) than in healthy group (24.39%). The mean error percentage decreased as the number of excitations increased on all images, and, it was smallest on T2WI, followed by DWI and ADC in an increasing order. Conclusions Transient signal loss on DWI was successfully detected by dynamic EPDWI. The signal loss on DWI and overestimation of ADC could be partially remedied by increasing the number of excitations.	[Liu, Yi-Jui] Feng Chia Univ, Dept Automat Control Engn, Taichung 40724, Taiwan; [Lee, Yi-Hsiung] Feng Chia Univ, PhD Program Elect & Commun Engn, Taichung 40724, Taiwan; [Chang, Hing-Chiu] Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC USA; [Chang, Hing-Chiu] GE Healthcare, Appl Sci Lab, Taipei, Taiwan; [Huang, Teng-Yi] Natl Taiwan Univ Sci & Technol, Dept Elect Engn, Taipei, Taiwan; [Chang, Hing-Chiu] Chung Hua Univ, PhD Program Technol Management, Hsinchu, Taiwan; [Wang, Chih-Wei; Juan, Chun-Jung; Huang, Guo-Shu; Hsu, Hsian-He] Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan; [Wang, Chih-Wei; Juan, Chun-Jung; Huang, Guo-Shu; Hsu, Hsian-He] Triserv Gen Hosp, Dept Radiol, Taipei, Taiwan; [Chiou, Ta-Wei] Taipei Med Univ, Dept Med, Taipei, Taiwan; [Hsu, Kang] Natl Def Med Ctr, Dept Dent, Taipei, Taiwan	Feng Chia University; Feng Chia University; Duke University; General Electric; National Taiwan University of Science & Technology; Chung Hua University; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; National Defense Medical Center	Juan, CJ (corresponding author), Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan.	peterjuancj@yahoo.com.tw	Liu, Yi-Jui/AAH-8540-2020; Juan, Chun-Jung/AAE-8438-2020	Liu, Yi-Jui/0000-0001-5865-6836; Chang, Hing-Chiu/0000-0001-8634-328X	National Science Council [NSC100-2314-B-016-009, NSC 101-2314-B-016-031-MY2]; National Defense Medical Center, Taiwan, R.O.C. [NDMC-D101-5-2]	National Science Council(Ministry of Science and Technology, Taiwan); National Defense Medical Center, Taiwan, R.O.C.	CJJ received grant support partly from National Science Council (NSC100-2314-B-016-009 and NSC 101-2314-B-016-031-MY2) and National Defense Medical Center (NDMC-D101-5-2), Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang HC, 2014, EUR RADIOL, V24, P2069, DOI 10.1007/s00330-014-3265-z; Cheng CC, 2013, MAGN RESON IMAGING, V31, P1278, DOI 10.1016/j.mri.2013.03.018; Dirix P, 2008, INT J RADIAT ONCOL, V71, P1365, DOI 10.1016/j.ijrobp.2007.12.011; Eida S, 2007, AM J NEURORADIOL, V28, P116; Habermann CR, 2007, AM J NEURORADIOL, V28, P1547, DOI 10.3174/ajnr.A0587; Ichikawa Y, 2012, AM J NEURORADIOL, V33, P761, DOI 10.3174/ajnr.A2834; Juan CJ, 2009, RADIOLOGY, V253, P144, DOI 10.1148/radiol.2531082228; Juan CJ, 2009, EUR RADIOL, V19, P94, DOI 10.1007/s00330-008-1104-9; Kato H, 2008, AM J NEURORADIOL, V29, P865, DOI 10.3174/ajnr.A0974; Kim S, 2009, CLIN CANCER RES, V15, P986, DOI 10.1158/1078-0432.CCR-08-1287; Konings AWT, 2005, INT J RADIAT ONCOL, V62, P1187, DOI 10.1016/j.ijrobp.2004.12.051; Le Bihan D, 2006, J MAGN RESON IMAGING, V24, P478, DOI 10.1002/jmri.20683; Li J, 2005, INT J RADIAT ONCOL, V62, P1510, DOI 10.1016/j.ijrobp.2005.04.029; Liau J, 2012, J MAGN RESON IMAGING, V35, P318, DOI 10.1002/jmri.22816; Lu YG, 2012, J MAGN RESON IMAGING, V36, P1088, DOI 10.1002/jmri.23770; Matsushima N, 2007, J NEURORADIOLOGY, V34, P183, DOI 10.1016/j.neurad.2007.04.002; Nagler RM, 1998, ARCH ORAL BIOL, V43, P297, DOI 10.1016/S0003-9969(97)00120-9; Norris DG, 2001, J MAGN RESON IMAGING, V13, P486, DOI 10.1002/jmri.1072; Patel RR, 2004, AM J NEURORADIOL, V25, P16; STEPHENS LC, 1986, AM J PATHOL, V124, P469; Sumi M, 2002, AM J ROENTGENOL, V178, P959, DOI 10.2214/ajr.178.4.1780959; Thoeny HC, 2005, RADIOLOGY, V235, P629, DOI 10.1148/radiol.2352040127; Thoeny HC, 2004, J MAGN RESON IMAGING, V20, P786, DOI 10.1002/jmri.20196; Yabuuchi H, 2008, RADIOLOGY, V249, P909, DOI 10.1148/radiol.2493072045; Yoshino N, 2001, RADIOLOGY, V221, P837, DOI 10.1148/radiol.2213010131; Zhang L, 2001, J MAGN RESON IMAGING, V14, P223, DOI 10.1002/jmri.1177	26	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124118	10.1371/journal.pone.0124118	http://dx.doi.org/10.1371/journal.pone.0124118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922948	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600070
J	Paul, CD; Traore, DAK; Olsen, S; Devenish, RJ; Close, DW; Bell, TDM; Bradbury, A; Wilce, MCJ; Prescott, M				Paul, Craig Don; Traore, Daouda A. K.; Olsen, Seth; Devenish, Rodney J.; Close, Devin W.; Bell, Toby D. M.; Bradbury, Andrew; Wilce, Matthew C. J.; Prescott, Mark			X-Ray Crystal Structure and Properties of Phanta, a Weakly Fluorescent Photochromic GFP-Like Protein	PLOS ONE			English	Article							STATE PROTON-TRANSFER; RED FLUORESCENCE; GREEN; DRONPA; CHROMOPHORE; FRET; VARIANTS; DYNAMICS; CHROMOPROTEINS; ISOMERIZATION	Phanta is a reversibly photoswitching chromoprotein (Phi(F), 0.003), useful for pcFRET, that was isolated from a mutagenesis screen of the bright green fluorescent eCGP123 (Phi(F), 0.8). We have investigated the contribution of substitutions at positions His193, Thr69 and Gln62, individually and in combination, to the optical properties of Phanta. Single amino acid substitutions at position 193 resulted in proteins with very low Phi(F), indicating the importance of this position in controlling the fluorescence efficiency of the variant proteins. The substitution Thr69Val in Phanta was important for supressing the formation of a protonated chromophore species observed in some His193 substituted variants, whereas the substitution Gln62Met did not significantly contribute to the useful optical properties of Phanta. X-ray crystal structures for Phanta (2.3 angstrom), eCGP123(T69V) (2.0 angstrom) and eCGP123(H193Q) (2.2 angstrom) in their non-photoswitched state were determined, revealing the presence of a cis-coplanar chromophore. We conclude that changes in the hydrogen-bonding network supporting the cis-chromophore, and its contacts with the surrounding protein matrix, are responsible for the low fluorescence emission of eCGP123 variants containing a His193 substitution.	[Paul, Craig Don] Univ Med, Dept Neuro & Sensory Physiol, D-37073 Gottingen, Germany; [Traore, Daouda A. K.; Devenish, Rodney J.; Wilce, Matthew C. J.; Prescott, Mark] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Bell, Toby D. M.] Monash Univ, Sch Chem, Clayton, Vic 3800, Australia; [Close, Devin W.; Bradbury, Andrew] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Olsen, Seth] Univ Queensland, Sch Math & Phys, Brisbane, Qld 4072, Australia	Monash University; Monash University; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Queensland	Wilce, MCJ (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton Campus, Clayton, Vic 3800, Australia.	Matthew.Wilce@monash.edu; Mark.Prescott@monash.edu	Olsen, Seth/A-6157-2010; Traore, Daouda/B-5242-2013; Bell, Toby/D-5776-2019	Traore, Daouda/0000-0003-1001-4716; Bradbury, Andrew/0000-0002-5567-8172; Bell, Toby/0000-0002-4570-5595	Monash University	Monash University(Monash University)	This work was funded internally by Monash University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam V, 2009, J AM CHEM SOC, V131, P18063, DOI 10.1021/ja907296v; Adam V, 2009, BIOCHEMISTRY-US, V48, P4905, DOI 10.1021/bi900383a; Adam V, 2008, P NATL ACAD SCI USA, V105, P18343, DOI 10.1073/pnas.0805949105; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Andresen M, 2008, NAT BIOTECHNOL, V26, P1035, DOI 10.1038/nbt.1493; Andresen M, 2007, P NATL ACAD SCI USA, V104, P13005, DOI 10.1073/pnas.0700629104; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Battad JM, 2007, J MOL BIOL, V368, P998, DOI 10.1016/j.jmb.2007.02.007; Bizzarri R, 2007, BIOCHEMISTRY-US, V46, P5494, DOI 10.1021/bi602646r; Brakemann T, 2011, NAT BIOTECHNOL, V29, P942, DOI 10.1038/nbt.1952; Bricogne G, 2011, BUSTER 2 10 0 ED; Bulina ME, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-7; Chudakov DM, 2003, NAT BIOTECHNOL, V21, P191, DOI 10.1038/nbt778; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Close DW, 2014, PROTEINS STRUCTURE F; Cox RP, 2012, CHEM PHYS LETT, V521, P59, DOI 10.1016/j.cplett.2011.11.028; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Dai MH, 2007, PROTEIN ENG DES SEL, V20, P69, DOI 10.1093/protein/gzl056; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Drobizhev M, 2012, IEEE PHOTONICS J, V4, P1996, DOI 10.1109/JPHOT.2012.2221124; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fron E, 2007, J AM CHEM SOC, V129, P4870, DOI 10.1021/ja069365v; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Grotjohann T, 2011, NATURE, V478, P204, DOI 10.1038/nature10497; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; Hanson GT, 2002, BIOCHEMISTRY-US, V41, P15477, DOI 10.1021/bi026609p; Henderson JN, 2005, P NATL ACAD SCI USA, V102, P12712, DOI 10.1073/pnas.0502250102; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Kaucikas M, 2015, J PHYS CHEM B, V119, P2350, DOI 10.1021/jp506640q; Khmelinskii A, 2012, NAT BIOTECHNOL, V30, P708, DOI 10.1038/nbt.2281; Kiss C, 2009, PROTEIN ENG DES SEL, V22, P313, DOI 10.1093/protein/gzp006; Lakowicz J. R., 2006, PRINCIPLES OF FLUORE; Lukacs A, 2013, J PHYS CHEM B, V117, P11954, DOI 10.1021/jp406142g; Martynov VI, 2003, J BIOL CHEM, V278, P46288, DOI 10.1074/jbc.M306810200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min W, 2009, NATURE, V461, P1105, DOI 10.1038/nature08438; Mizuno H, 2008, P NATL ACAD SCI USA, V105, P9227, DOI 10.1073/pnas.0709599105; Mizuno H, 2010, J BIOMOL NMR, V48, P237, DOI 10.1007/s10858-010-9453-5; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Nienhaus K, 2008, J AM CHEM SOC, V130, P12578, DOI 10.1021/ja8046443; Olsen S, 2012, THE JOURNAL OF CHEMI, V137; Olsen S, 2010, J AM CHEM SOC, V132, P1192, DOI 10.1021/ja907447k; Oltrogge LM, 2014, BIOCHEMISTRY-US, V53, P5947, DOI 10.1021/bi500147n; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paul CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075835; Paul CD, 2011, ACTA CRYSTALLOGR F, V67, P1266, DOI 10.1107/S1744309111028156; Petersen J, 2003, J BIOL CHEM, V278, P44626, DOI 10.1074/jbc.M307896200; Pettikiriarachchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041028; Piatkevich KD, 2013, PNAS, V107, P5369; Pletnev S, 2012, ACTA CRYSTALLOGR D, V68, P1088, DOI 10.1107/S0907444912020598; Prescott M, 2003, STRUCTURE, V11, P275, DOI 10.1016/S0969-2126(03)00028-5; Rebane A, 2010, J LUMIN, V130, P1619, DOI 10.1016/j.jlumin.2009.12.005; Roy A, 2011, J AM CHEM SOC, V133, P18586, DOI 10.1021/ja2085355; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2008, NATURE; Shcherbakova DM, 2013, NAT METHODS, V10, P751, DOI 10.1038/nmeth.2521; Shcherbakova DM, 2012, J AM CHEM SOC, V134, P7913, DOI 10.1021/ja3018972; Subach FV, 2010, CHEM BIOL, V17, P745, DOI 10.1016/j.chembiol.2010.05.022; Tomosugi W, 2009, NAT METHODS, V6, P351, DOI [10.1038/NMETH.1317, 10.1038/nmeth.1317]; Toniolo A, 2004, FARADAY DISCUSS, V127, P149, DOI 10.1039/b401167h; Tramier M, 2002, BIOPHYS J, V83, P3570, DOI 10.1016/S0006-3495(02)75357-5; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Voityuk AA, 1998, CHEM PHYS, V231, P13, DOI 10.1016/S0301-0104(98)00080-9; Wall MA, 2000, NAT STRUCT BIOL, V7, P1133; Warren MM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2460; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wilmann PG, 2006, J MOL BIOL, V364, P213, DOI 10.1016/j.jmb.2006.08.089; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yadav D, 2015, J PHYS CHEM B, V119, P2404, DOI 10.1021/jp507094f; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5	74	1	1	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123338	10.1371/journal.pone.0123338	http://dx.doi.org/10.1371/journal.pone.0123338			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923520	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000353711600039
J	Francescato, MP; Stel, G; Stenner, E; Geat, M				Francescato, Maria Pia; Stel, Giuliana; Stenner, Elisabetta; Geat, Mario			Prolonged Exercise in Type 1 Diabetes: Performance of a Customizable Algorithm to Estimate the Carbohydrate Supplements to Minimize Glycemic Imbalances	PLOS ONE			English	Article							HIGH-INTENSITY EXERCISE; PHYSICAL-ACTIVITY; SUBSTRATE OXIDATION; MODERATE EXERCISE; AEROBIC EXERCISE; INSULIN ANALOGS; HYPOGLYCEMIA; PREVENTION; MANAGEMENT; GLYCOGEN	Physical activity in patients with type 1 diabetes (T1DM) is hindered because of the high risk of glycemic imbalances. A recently proposed algorithm (named Ecres) estimates well enough the supplemental carbohydrates for exercises lasting one hour, but its performance for prolonged exercise requires validation. Nine T1DM patients (5M/4F; 35-65 years; HbA1c 54 +/- 13 mmol.mol(-1)) performed, under free-life conditions, a 3-h walk at 30% heart rate reserve while insulin concentrations, whole-body carbohydrate oxidation rates (determined by indirect calorimetry) and supplemental carbohydrates (93% sucrose), together with glycemia, were measured every 30 min. Data were subsequently compared with the corresponding values estimated by the algorithm. No significant difference was found between the estimated insulin concentrations and the laboratory-measured values (p = NS). Carbohydrates oxidation rate decreased significantly with time (from 0.84 +/- 0.31 to 0.53 +/- 0.24 g.min(-1), respectively; p<0.001), being estimated well enough by the algorithm (p = NS). Estimated carbohydrates requirements were practically equal to the corresponding measured values (p = NS), the difference between the two quantities amounting to -1.0 +/- 6.1 g, independent of the elapsed exercise time (time effect, p = NS). Results confirm that Ecres provides a satisfactory estimate of the carbohydrates required to avoid glycemic imbalances during moderate intensity aerobic physical activity, opening the prospect of an intriguing method that could liberate patients from the fear of exercise-induced hypoglycemia.	[Francescato, Maria Pia; Stel, Giuliana; Geat, Mario] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy; [Stenner, Elisabetta] Osped Riuniti Trieste, Dept Lab Med, Trieste, Italy	University of Udine; University of Trieste	Francescato, MP (corresponding author), Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy.	maria.francescato@uniud.it	Francescato, Maria Pia/O-7010-2014; Stenner, Elisabetta/AAQ-1595-2021	Francescato, Maria Pia/0000-0002-7892-863X; 	Bayer Italia S.p.A. (Italy); Fondazione Cassa di Risparmio di Gorizia (Italy)	Bayer Italia S.p.A. (Italy); Fondazione Cassa di Risparmio di Gorizia (Italy)	This work was given unconditioned financial support by Bayer Italia S.p.A. (Italy) and by the Fondazione Cassa di Risparmio di Gorizia (Italy). The funders had no role in the study, data collection and analysis, decision to publish, or preparation of the manuscript.	Agin A, 2006, CLIN CHEM LAB MED, V44, P1379, DOI 10.1515/CCLM.2006.257; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Bohannon RW, 2011, PHYSIOTHERAPY, V97, P182, DOI 10.1016/j.physio.2010.12.004; Brazeau AS, 2008, DIABETES CARE, V31, P2108, DOI 10.2337/dc08-0720; Burr JF, 2012, CAN FAM PHYSICIAN, V58, P533; Campbell MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097143; Ceriello A, 2008, NUTR METAB CARDIOVAS, V18, pS17, DOI 10.1016/j.numecd.2008.01.012; Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140; Chimen M, 2012, DIABETOLOGIA, V55, P542, DOI 10.1007/s00125-011-2403-2; Chokkalingam K, 2007, DIABETOLOGIA, V50, P1921, DOI 10.1007/s00125-007-0747-4; Department of Health and Human Services, 2008, PHYSICAL ACTIVITY GU; Dube MC, 2012, MED SCI SPORT EXER, V44, P1427, DOI 10.1249/MSS.0b013e3182500a35; Francescato MP, 2011, CURR DIABETES REV, V7, P253, DOI 10.2174/157339911796397875; Francescato MP, 2011, MED SCI SPORT EXER, V43, P2, DOI 10.1249/MSS.0b013e3181e6d6a1; Francescato MP, 2005, DIABETES CARE, V28, P2028, DOI 10.2337/diacare.28.8.2028; Francescato MP, 2004, METABOLISM, V53, P1126, DOI 10.1016/j.metabol.2004.03.015; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Frier B, 2009, DIABETOLOGIA, V52, P31, DOI 10.1007/s00125-008-1209-3; Gallen I, 2014, DIABETIC HYPOGLYCEMI, V7, P3; Gallen IW, 2011, DIABETES OBES METAB, V13, P130, DOI 10.1111/j.1463-1326.2010.01319.x; Geat M, 2013, METABOLISM, V62, P836, DOI 10.1016/j.metabol.2013.01.004; Grimm JJ, 2004, DIABETES METAB, V30, P465, DOI 10.1016/S1262-3636(07)70144-1; Guelfi KJ, 2005, DIABETES CARE, V28, P416, DOI 10.2337/diacare.28.2.416; Hawley JA, 2004, DIABETES-METAB RES, V20, P383, DOI 10.1002/dmrr.505; Iscoe KE, 2011, DIABETIC MED, V28, P824, DOI 10.1111/j.1464-5491.2011.03274.x; Jenni S, 2008, DIABETOLOGIA, V51, P1457, DOI 10.1007/s00125-008-1045-5; Jeukendrup AE, 2005, INT J SPORTS MED, V26, pS28, DOI 10.1055/s-2004-830512; Kennedy A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058861; Laaksonen DE, 2000, MED SCI SPORT EXER, V32, P1541, DOI 10.1097/00005768-200009000-00003; Lehmann R, 1997, DIABETES CARE, V20, P1603, DOI 10.2337/diacare.20.10.1603; MAEHLUM S, 1977, SCAND J CLIN LAB INV, V37, P309; Maran A, 2010, DIABETES TECHNOL THE, V12, P763, DOI 10.1089/dia.2010.0038; Mauvais-Jarvis F, 2003, DIABETES CARE, V26, P1316, DOI 10.2337/diacare.26.4.1316; MIKINES KJ, 1988, AM J PHYSIOL, V254, pE248, DOI 10.1152/ajpendo.1988.254.3.E248; Owen WE, 2004, CLIN CHEM, V50, P257, DOI 10.1373/clinchem.2003.026625; Perrone C, 2005, DIABETES CARE, V28, P2537, DOI 10.2337/diacare.28.10.2537; Rabasa-Lhoret R, 2001, DIABETES CARE, V24, P625, DOI 10.2337/diacare.24.4.625; Riddell MC, 1999, INT J SPORT NUTR, V9, P24, DOI 10.1123/ijsn.9.1.24; Riddell MC, 2011, DIABETES TECHNOL THE, V13, P819, DOI 10.1089/dia.2011.0052; RUEGEMER JJ, 1990, DIABETES CARE, V13, P104, DOI 10.2337/diacare.13.2.104; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; Soo K, 1996, DIABETES CARE, V19, P575, DOI 10.2337/diacare.19.6.575; Steppel JH, 2003, REV ENDOCR METAB DIS, V4, P355, DOI 10.1023/A:1027302112655; Tsalikian E, 2006, DIABETES CARE, V29, P2200, DOI 10.2337/dc06-0495; Watt MJ, 2002, J PHYSIOL-LONDON, V541, P969, DOI 10.1113/jphysiol.2002.018820; West DJ, 2011, J SPORT SCI, V29, P279, DOI 10.1080/02640414.2010.531753	47	31	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125220	10.1371/journal.pone.0125220	http://dx.doi.org/10.1371/journal.pone.0125220			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25918842	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400075
J	Jarrar, W; Dias, JM; Ericson, J; Arnold, HH; Holz, A				Jarrar, Wassan; Dias, Jose M.; Ericson, Johan; Arnold, Hans-Henning; Holz, Andreas			Nkx2.2 and Nkx2.9 Are the Key Regulators to Determine Cell Fate of Branchial and Visceral Motor Neurons in Caudal Hindbrain	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; AXON GUIDANCE; SPINAL-CORD; IDENTITY; PHOX2B; MOUSE; DIFFERENTIATION; SPECIFICATION; REQUIREMENT; EXPRESSION	Cranial motor nerves in vertebrates are comprised of the three principal subtypes of branchial, visceral, and somatic motor neurons, which develop in typical patterns along the anteroposterior and dorsoventral axes of hindbrain. Here we demonstrate that the formation of branchial and visceral motor neurons critically depends on the transcription factors Nkx2.2 and Nkx2.9, which together determine the cell fate of neuronal progenitor cells. Disruption of both genes in mouse embryos results in complete loss of the vagal and spinal accessory motor nerves, and partial loss of the facial and glossopharyngeal motor nerves, while the purely somatic hypoglossal and abducens motor nerves are not diminished. Cell lineage analysis in a genetically marked mouse line reveals that alterations of cranial nerves in Nkx2.2; Nkx2.9 double-deficient mouse embryos result from changes of cell fate in neuronal progenitor cells. As a consequence progenitors of branchiovisceral motor neurons in the ventral p3 domain of hindbrain are transformed to somatic motor neurons, which use ventral exit points to send axon trajectories to their targets. Cell fate transformation is limited to the caudal hindbrain, as the trigeminal nerve is not affected in double-mutant embryos suggesting that Nkx2.2 and Nkx2.9 proteins play no role in the development of branchiovisceral motor neurons in hindbrain rostral to rhombomere 4.	[Jarrar, Wassan; Arnold, Hans-Henning; Holz, Andreas] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Cell & Mol Biol, Braunschweig, Germany; [Dias, Jose M.; Ericson, Johan] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Braunschweig University of Technology; Karolinska Institutet	Arnold, HH (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Cell & Mol Biol, Braunschweig, Germany.	h.arnold@tu-bs.de; a.holz@tu-bs.de		Dias, Jose/0000-0002-1402-0323; Holz, Andreas/0000-0002-8886-0915; Ericson, Johan/0000-0002-8019-7127; Jarrar, Wassan/0000-0002-2863-9901	Deutsche Forschungsgemeinschaft [AR115/22-1]; Ministry of Science and Culture of Lower Saxony	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Science and Culture of Lower Saxony	This work was supported by AR115/22-1, Deutsche Forschungsgemeinschaft; Ministry of Science and Culture of Lower Saxony. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Cordes SP, 2001, NAT REV NEUROSCI, V2, P611, DOI 10.1038/35090039; Dauger S, 2003, DEVELOPMENT, V130, P6635, DOI 10.1242/dev.00866; Dillon AK, 2005, J NEUROSCI, V25, P10119, DOI 10.1523/JNEUROSCI.3455-05.2005; Dubreuil V, 2000, DEVELOPMENT, V127, P5191; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Glover JC, 2006, J NEUROBIOL, V66, P705, DOI 10.1002/neu.20272; Guthrie S, 2007, NAT REV NEUROSCI, V8, P859, DOI 10.1038/nrn2254; Holz A, 2010, DEVELOPMENT, V137, P4249, DOI 10.1242/dev.053819; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kandel E., 2000, PRINCIPLES NEURAL SC; KEYNES R, 1994, ANNU REV NEUROSCI, V17, P109, DOI 10.1146/annurev.ne.17.030194.000545; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Pabst O, 1998, MECH DEVELOP, V73, P85, DOI 10.1016/S0925-4773(98)00035-5; Pabst O, 2003, DEVELOPMENT, V130, P1193, DOI 10.1242/dev.00346; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 2003, DEVELOPMENT, V130, P4149, DOI 10.1242/dev.00641; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Rhinn M, 2006, CURR OPIN NEUROBIOL, V16, P5, DOI 10.1016/j.conb.2006.01.005; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sussel L, 1998, DEVELOPMENT, V125, P2213; VALARCHE I, 1993, DEVELOPMENT, V119, P881; Ying LT, 2000, DEV DYNAM, V219, P143, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1050>3.3.CO;2-H	30	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124408	10.1371/journal.pone.0124408	http://dx.doi.org/10.1371/journal.pone.0124408			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919494	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659400049
J	Rudisch, A; Dewhurst, MR; Horga, LG; Kramer, N; Harrer, N; Dong, M; van der Kuip, H; Wernitznig, A; Bernthaler, A; Dolznig, H; Sommergruber, W				Rudisch, Albin; Dewhurst, Matthew Richard; Horga, Luminita Gabriela; Kramer, Nina; Harrer, Nathalie; Dong, Meng; van der Kuip, Heiko; Wernitznig, Andreas; Bernthaler, Andreas; Dolznig, Helmut; Sommergruber, Wolfgang			High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NF kappa B Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; TUMOR-CELLS; IN-VITRO; GM-CSF; PREDICTS RESISTANCE; POOR-PROGNOSIS; OVARIAN-CANCER; HUMAN BREAST; EXPRESSION; MACROPHAGE	We established co-cultures of invasive or non-invasive NSCLC cell lines and various types of fibroblasts (FBs) to more precisely characterize the molecular mechanism of tumor-stroma crosstalk in lung cancer. The HGF-MET-ERK1/2-CREB-axis was shown to contribute to the onset of the invasive phenotype of Calu-1 with HGF being secreted by FBs. Differential expression analysis of the respective mono-and co-cultures revealed an upregulation of NF.B-related genes exclusively in co-cultures with Calu-1. Cytokine Array-and ELISA-based characterization of the "cytokine fingerprints" identified CSF2 (GM-CSF), CXCL1, CXCL6, VEGF, IL6, RANTES and IL8 as being specifically upregulated in various co-cultures. Whilst CXCL6 exhibited a strictly FB-type-specific induction profile regardless of the invasiveness of the tumor cell line, CSF2 was only induced in co-cultures of invasive cell lines regardless of the partnered FB type. These cultures revealed a clear link between the induction of CSF2 and the EMT signature of the cancer cell line. The canonical NF kappa B signaling in FBs, but not in tumor cells, was shown to be responsible for the induced and constitutive CSF2 expression. In addition to CSF2, cytokine IL6, IL8 and IL1B, and chemokine CXCL1 and CXCL6 transcripts were also shown to be increased in co-cultured FBs. In contrast, their induction was not strictly dependent on the invasiveness of the co-cultured tumor cell. In a multi-reporter assay, additional signaling pathways (AP-1, HIF1-alpha, KLF4, SP-1 and ELK-1) were found to be induced in FBs co-cultured with Calu-1. Most importantly, no difference was observed in the level of inducibility of these six signaling pathways with regard to the type of FBs used. Finally, upon tumor fibroblast interaction the massive induction of chemokines such as CXCL1 and CXCL6 in FBs might be responsible for increased recruitment of a monocytic cell line (THP-1) in a transwell assay.	[Rudisch, Albin; Dewhurst, Matthew Richard; Horga, Luminita Gabriela; Harrer, Nathalie; Wernitznig, Andreas; Bernthaler, Andreas; Sommergruber, Wolfgang] Boehringer Ingelheim RCV GmbH & Co KG, Dept Lead Discovery, Vienna, Austria; [Rudisch, Albin] Univ Vienna, Dept Microbiol Immunobiol & Genet, Ctr Mol Biol, Max F Perutz Labs, Vienna, Austria; [Kramer, Nina; Dolznig, Helmut] Med Univ Vienna, Inst Med Genet, Vienna, Austria; [Dong, Meng; van der Kuip, Heiko] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Baden Wurttembe, Germany; [Dong, Meng; van der Kuip, Heiko] Univ Tubingen, Stuttgart, Baden Wurttembe, Germany	Boehringer Ingelheim; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Sommergruber, W (corresponding author), Boehringer Ingelheim RCV GmbH & Co KG, Dept Lead Discovery, Vienna, Austria.	wolfgang.sommergruber@boehringer-ingelheim.com	Dolznig, Helmut/L-7005-2015	Dolznig, Helmut/0000-0002-6063-3585; Dewhurst, Matthew/0000-0003-4667-4070	Boehringer Ingelheim RCV GmbH Co KG; European Union [115188]; EFPIA [115188]	Boehringer Ingelheim RCV GmbH Co KG(Boehringer Ingelheim); European Union(European Commission); EFPIA	This work has been supported by the Innovative Medicines Initiative Joint undertaking under grant agreement no 115188, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution. Boehringer Ingelheim RCV GmbH & Co KG provided support in the form of salaries for authors AR, NH, AW, WS, MRD, LGH and AB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Baronzio G, 2003, SEMIN THROMB HEMOST, V29, P489; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beyer C, 2013, BBA-MOL BASIS DIS, V1832, P897, DOI 10.1016/j.bbadis.2012.06.008; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burger JA, 2011, EXPERT REV ANTICANC, V11, P621, DOI [10.1586/era.11.11, 10.1586/ERA.11.11]; Busuttil RA, 2014, CLIN CANCER RES, V20, P2761, DOI 10.1158/1078-0432.CCR-13-3049; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Capparelli C, 2012, CELL CYCLE, V11, P2272, DOI 10.4161/cc.20717; Chandrakesan P, 2010, J BIOL CHEM, V285, P33485, DOI 10.1074/jbc.M110.129353; Chen W-J, 2014, NATURE COMMUNICATION, V5; Chen Z, 1999, CLIN CANCER RES, V5, P1369; Cheng TY, 2014, ANTICANCER RES, V34, P2223; Chiavarina B, 2010, CELL CYCLE, V9, P3534, DOI 10.4161/cc.9.17.12908; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Wever O, 2014, SEMIN CANCER BIOL, V25, P33, DOI 10.1016/j.semcancer.2013.12.009; Dearing KR, 2014, WORLD J CLIN ONCOL, V5, P103, DOI 10.5306/wjco.v5.i2.103; Dolznig H, 2011, AM J PATHOL, V179, P487, DOI 10.1016/j.ajpath.2011.03.015; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Eddy SF, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-3665; El-Nikhely N, 2012, EXPERT OPIN INV DRUG, V21, P1107, DOI 10.1517/13543784.2012.693478; Enzerink A, 2009, MOL IMMUNOL, V46, P1787, DOI 10.1016/j.molimm.2009.01.018; Erez N, 2013, BIOCHEM BIOPH RES CO, V437, P397, DOI 10.1016/j.bbrc.2013.06.089; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Fitzgerald SM, 2003, J INTERF CYTOK RES, V23, P57, DOI 10.1089/107999003321455453; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haubeiss S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-168; Hiscott J, 2003, ANN NY ACAD SCI, V1010, P237, DOI 10.1196/annals.1299.042; Huang JF, 2013, AM J TRANSL RES, V5, P336; Huber Margit A, 2010, Genes Cancer, V1, P101, DOI 10.1177/1947601910361749; Irani S, 2014, CRIT REV ONCOL HEMAT, V89, P314, DOI 10.1016/j.critrevonc.2013.08.011; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Jiang WG, 2003, CLIN CANCER RES, V9, P4274; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Kharaishvili G, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-41; La Monica S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078656; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee MH, 2013, CANCER PREV RES, V6, P455, DOI 10.1158/1940-6207.CAPR-12-0425; Liao ZJ, 2014, INT J ONCOL, V45, P651, DOI 10.3892/ijo.2014.2464; Lin CH, 2013, CELL SIGNAL, V25, P1166, DOI 10.1016/j.cellsig.2013.01.018; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Loessner D, 2014, ADV DRUG DELIVER REV, V79-80, P193, DOI 10.1016/j.addr.2014.06.001; Lou Z, 2005, CANCER RES, V65, P1007; Martinez-Outschoorn UE, 2012, CELL CYCLE, V11, P4152, DOI 10.4161/cc.22226; Mishra P, 2011, J LEUKOCYTE BIOL, V89, P31, DOI 10.1189/jlb.0310182; Nakamura T, 1997, CANCER RES, V57, P3305; Newton R, 2010, BIOCHEM J, V427, P113, DOI 10.1042/BJ20091038; Nonaka M, 1999, INT ARCH ALLERGY IMM, V119, P314, DOI 10.1159/000024209; O'Brien AD, 1998, J LAB CLIN MED, V131, P417, DOI 10.1016/S0022-2143(98)90142-1; O'Mahony D, 2005, J CLIN ONCOL, V23, P9022, DOI 10.1200/JCO.2005.02.3101; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; PROOST P, 1993, J IMMUNOL, V150, P1000; Rho JK, 2014, CANCER RES, V74, P253, DOI 10.1158/0008-5472.CAN-13-1103; RODEMANN HP, 1991, AM J KIDNEY DIS, V17, P684, DOI 10.1016/S0272-6386(12)80352-0; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rupp C., 2014, ONCOGENE; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Santos-Valle P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039097; Saxena R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066246; Schedin P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003228; Shang XZ, 1999, EUR J IMMUNOL, V29, P3571, DOI 10.1002/(SICI)1521-4141(199911)29:11<3571::AID-IMMU3571>3.0.CO;2-V; Sheu BC, 2008, FRONT BIOSCI-LANDMRK, V13, P6255, DOI 10.2741/3152; Siletz A, 2013, CANCER MICROENVIRON, V6, P91, DOI 10.1007/s12307-012-0121-z; Sipos F, 2014, EUR J CANCER PREV, V23, P336, DOI 10.1097/CEJ.0000000000000058; Song J, 2003, INT J MOL MED, V11, P547; Su SC, 2014, CANCER CELL, V25, P605, DOI 10.1016/j.ccr.2014.03.021; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Venepalli NK, 2013, INT J HEPATOL, V2013, DOI 10.1155/2013/341636; Wang R, 2011, LUNG CANCER, V74, P188, DOI 10.1016/j.lungcan.2011.04.009; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Yang CH, 2005, J BIOL CHEM, V280, P31530, DOI 10.1074/jbc.M503120200; Yi S, 1998, BRIT J CANCER, V77, P2162, DOI 10.1038/bjc.1998.361; Yuan A, 2005, FRONT BIOSCI-LANDMRK, V10, P853, DOI 10.2741/1579; Zarkoob H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064169; Zeiser R, 2014, RECENT RESULTS CANC, V201, P241, DOI 10.1007/978-3-642-54490-3_15; Zheng MZ, 2011, J CANCER, V2, P478, DOI 10.7150/jca.2.478; Zhong L, 2008, CANCER RES, V68, P7237, DOI 10.1158/0008-5472.CAN-08-1529; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	92	33	33	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124283	10.1371/journal.pone.0124283	http://dx.doi.org/10.1371/journal.pone.0124283			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919140	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400045
J	Florian, JP; Baisch, FJ; Heer, M; Pawelczyk, JA				Florian, John P.; Baisch, Friedhelm J.; Heer, Martina; Pawelczyk, James A.			Caloric Restriction Decreases Orthostatic Tolerance Independently from 6 degrees Head-Down Bedrest	PLOS ONE			English	Article							SYMPATHETIC NERVOUS-SYSTEM; LEPTIN GENE-EXPRESSION; FREE FATTY-ACIDS; BLOOD-PRESSURE; BED-REST; REFLEX RESPONSES; BODY-FLUID; HUMANS; MUSCLE; SPACEFLIGHT	Astronauts consume fewer calories during spaceflight and return to earth with an increased risk of orthostatic intolerance. Whether a caloric deficiency modifies orthostatic responses is not understood. Thus, we determined the effects of a hypocaloric diet (25% caloric restriction) during 6 degrees head down bedrest (an analog of spaceflight) on autonomic neural control during lower body negative pressure (LBNP). Nine healthy young men completed a randomized crossover bedrest study, consisting of four (2 weeks each) interventions (normocaloric bedrest, normocaloric ambulatory, hypocaloric bedrest, hypocaloric ambulatory), each separated by 5 months. Muscle sympathetic nerve activity (MSNA) was recorded at baseline following normocaloric and hypocaloric interventions. Heart rate (HR) and arterial pressure were recorded before, during, and after 3 consecutive stages (7 min each) of LBNP (-15, -30, -45 mmHg). Caloric and posture effects during LBNP were compared using two-way ANOVA with repeated measures. There was a strong trend toward reduced basal MSNA following caloric restriction alone (normcaloric vs. hypocaloric: 22 +/- 3 vs. 14 +/- 4 burst/min, p = 0.06). Compared to the normocaloric ambulatory, both bedrest and caloric restriction were associated with lower systolic blood pressure during LBNP (p<0.01); however, HR responses were directionally opposite (i.e., increase with bedrest, decrease with caloric restriction). Survival analysis revealed a significant reduction in orthostatic tolerance following caloric restriction (normocaloric finishers: 12/16; hypocaloric finishers: 6/16;chi(2), p = 0.03). Caloric restriction modifies autonomic responses to LBNP, which may decrease orthostatic tolerance after spaceflight.	[Florian, John P.] Navy Expt Div Unit, Panama City, FL 32407 USA; [Pawelczyk, James A.] Penn State Univ, Dept Kinesiol, Noll Lab, University Pk, PA 16802 USA; [Baisch, Friedhelm J.; Heer, Martina] DLR, Inst Aerosp Med, Cologne, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Helmholtz Association; German Aerospace Centre (DLR)	Florian, JP (corresponding author), Navy Expt Div Unit, Panama City, FL 32407 USA.	john.florian@navy.mil	Heer, Martina/Q-4959-2019	Heer, Martina/0000-0001-5534-911X	National Space Biomedical Research Institute [TD00206]	National Space Biomedical Research Institute	This research was supported by National Space Biomedical Research Institute Contract TD00206. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GE, 2005, AM J PHYSIOL-ENDOC M, V289, pE665, DOI 10.1152/ajpendo.00487.2004; Bigard AX, 1998, AVIAT SPACE ENVIR MD, V69, P341; Blomqvist C. G., 1994, J GRAVIT PHYSL, V1, P122; BUCKEY JC, 1992, ACTA PHYSIOL SCAND, V144, P53; Buckey JC, 1996, J APPL PHYSIOL, V81, P7, DOI 10.1152/jappl.1996.81.1.7; Capelli C, 2006, EUR J APPL PHYSIOL, V98, P152, DOI 10.1007/s00421-006-0252-3; Coleman RA, 1999, DIABETOLOGIA, V42, P639, DOI 10.1007/s001250051210; DAVDA RK, 1995, HYPERTENSION, V26, P764, DOI 10.1161/01.HYP.26.5.764; Drummer C, 2000, EUR J CLIN INVEST, V30, P1066, DOI 10.1046/j.1365-2362.2000.00766.x; Fabris R, 2001, DIABETES, V50, P601, DOI 10.2337/diabetes.50.3.601; FISCHER CL, 1967, J AMER MED ASSOC, V200, P579, DOI 10.1001/jama.200.7.579; Florian JP, 2010, EXP PHYSIOL, V95, P486, DOI 10.1113/expphysiol.2009.050997; Florian JP, 2010, CLIN SCI, V118, P61, DOI 10.1042/CS20090063; FRITSCH JM, 1992, J APPL PHYSIOL, V73, P664, DOI 10.1152/jappl.1992.73.2.664; Gerzer R, 2005, CURR PHARM BIOTECHNO, V6, P299, DOI 10.2174/1389201054553662; Gohler L, 2000, PREV MED, V30, P95, DOI 10.1006/pmed.1999.0602; Grassi G, 1998, CIRCULATION, V97, P2037, DOI 10.1161/01.CIR.97.20.2037; Heer M, 2000, AM J PHYSIOL-RENAL, V278, pF585, DOI 10.1152/ajprenal.2000.278.4.F585; Heer M, 2000, PFLUG ARCH EUR J PHY, V441, pR8, DOI 10.1007/s004240000334; Heptulla R, 2001, J CLIN ENDOCR METAB, V86, P90, DOI 10.1210/jc.86.1.90; Hesse C, 2005, J APPL PHYSIOL, V99, P2196, DOI 10.1152/japplphysiol.00888.2005; Hunt LM, 2004, AM J PHYSIOL-HEART C, V287, pH1446, DOI 10.1152/ajpheart.00353.2004; KUSHIRO T, 1991, HYPERTENSION, V17, P965, DOI 10.1161/01.HYP.17.6.965; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Levine BD, 1997, CIRCULATION, V96, P517; Lin PH, 2003, AM J CLIN NUTR, V77, P639, DOI 10.1093/ajcn/77.3.639; Manzella D, 2001, J CLIN ENDOCR METAB, V86, P2769, DOI 10.1210/jc.86.6.2769; Messaoudi L, 1998, METABOLISM, V47, P592, DOI 10.1016/S0026-0495(98)90245-1; Minuz P, 2002, CIRCULATION, V106, P2800, DOI 10.1161/01.CIR.0000039528.49161.E9; Nisoli E, 1999, DIABETOLOGIA, V42, P495; NIXON JV, 1979, J APPL PHYSIOL, V46, P541, DOI 10.1152/jappl.1979.46.3.541; Paolisso G, 2000, AM J CLIN NUTR, V72, P723; Pawelczyk JA, 2001, AM J PHYSIOL-HEART C, V280, pH2230, DOI 10.1152/ajpheart.2001.280.5.H2230; Roberts SB, 2007, J NUTR, V137, P1076, DOI 10.1093/jn/137.4.1076; Robertson D, 1999, AM J MED SCI, V317, P75, DOI 10.1097/00000441-199902000-00001; Shetty PS, 1999, EUR J CLIN NUTR, V53, pS14, DOI 10.1038/sj.ejcn.1600741; Stein TP, 1999, AM J PHYSIOL-REG I, V276, pR1739; Steinberg HO, 1997, J CLIN INVEST, V100, P1230, DOI 10.1172/JCI119636; Stepniakowski KT, 1996, AM J PHYSIOL-REG I, V270, pR1340, DOI 10.1152/ajpregu.1996.270.6.R1340; STRAZNICKY NE, 1993, J HYPERTENS, V11, P427, DOI 10.1097/00004872-199304000-00014; Straznicky NE, 1999, HYPERTENSION, V34, P580, DOI 10.1161/01.HYP.34.4.580; VOLLENWEIDER L, 1995, DIABETES, V44, P641, DOI 10.2337/diabetes.44.6.641; WALLIN BG, 1982, AM J PHYSIOL, V242, pH185, DOI 10.1152/ajpheart.1982.242.2.H185; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; Williams TD, 2002, AM J PHYSIOL-REG I, V282, pR1459, DOI 10.1152/ajpregu.00612.2001; Yates AA, 1998, J AM DIET ASSOC, V98, P699, DOI 10.1016/S0002-8223(98)00160-6; YOUNG JB, 1977, SCIENCE, V196, P1473, DOI 10.1126/science.867049; YOUNG JB, 1982, J CHRON DIS, V35, P879, DOI 10.1016/0021-9681(82)90118-7	48	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0118812	10.1371/journal.pone.0118812	http://dx.doi.org/10.1371/journal.pone.0118812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915488	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659100002
J	Lodder, GMA; Scholte, RHJ; Clemens, IAH; Engels, RCME; Goossens, L; Verhagen, M				Lodder, Gerine M. A.; Scholte, Ron H. J.; Clemens, Ivar A. H.; Engels, Rutger C. M. E.; Goossens, Luc; Verhagen, Maaike			Loneliness and Hypervigilance to Social Cues in Females: An Eye-Tracking Study	PLOS ONE			English	Article							EMOTIONAL INFORMATION; ATTENTIONAL BIAS; THREAT; INDIVIDUALS; ANXIETY; BELONG; MEMORY; GAZE; NEED; SENSITIVITY	The goal of the present study was to examine whether lonely individuals differ from nonlonely individuals in their overt visual attention to social cues. Previous studies showed that loneliness was related to biased post-attentive processing of social cues (e.g., negative interpretation bias), but research on whether lonely and nonlonely individuals also show differences in an earlier information processing stage (gazing behavior) is very limited. A sample of 25 lonely and 25 nonlonely students took part in an eye-tracking study consisting of four tasks. We measured gazing (duration, number of fixations and first fixation) at the eyes, nose and mouth region of faces expressing emotions (Task 1), at emotion quadrants (anger, fear, happiness and neutral expression) (Task 2), at quadrants with positive and negative social and nonsocial images (Task 3), and at the facial area of actors in video clips with positive and negative content (Task 4). In general, participants tended to gaze most often and longest at areas that conveyed most social information, such as the eye region of the face (T1), and social images (T3). Participants gazed most often and longest at happy faces (T2) in still images, and more often and longer at the facial area in negative than in positive video clips (T4). No differences occurred between lonely and nonlonely participants in their gazing times and frequencies, nor at first fixations at social cues in the four different tasks. Based on this study, we found no evidence that overt visual attention to social cues differs between lonely and nonlonely individuals. This implies that biases in social information processing of lonely individuals may be limited to other phases of social information processing. Alternatively, biased overt attention to social cues may only occur under specific conditions, for specific stimuli or for specific lonely individuals.	[Lodder, Gerine M. A.; Scholte, Ron H. J.; Engels, Rutger C. M. E.; Verhagen, Maaike] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [Clemens, Ivar A. H.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Goossens, Luc] Katholieke Univ Leuven, Res Grp Sch Psychol & Child & Adolescent Dev, Leuven, Belgium	Radboud University Nijmegen; Radboud University Nijmegen; KU Leuven	Lodder, GMA (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	g.lodder@pwo.ru.nl	Lodder, Gerine/E-7872-2012	Lodder, Gerine/0000-0002-9253-7504; Clemens, Ivar/0000-0001-6531-0948; Goossens, Luc/0000-0003-3851-0412; Engels, Rutger/0000-0003-1944-9126				Amir N, 2009, J ABNORM PSYCHOL, V118, P28, DOI 10.1037/a0012589; Anderson AK, 2003, J NEUROSCI, V23, P5627; ANDERSON CA, 1988, J SOC CLIN PSYCHOL, V6, P482, DOI 10.1521/jscp.1988.6.3-4.482; Bangee M, 2014, PERS INDIV DIFFER, V63, P16, DOI 10.1016/j.paid.2014.01.039; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Beevers CG, 2011, AM J PSYCHIAT, V168, P735, DOI 10.1176/appi.ajp.2011.10091309; Bodenhausen GV, 2009, FRONT SOC PSYCHOL, P1; Buckner JD, 2010, COGNITIVE THER RES, V34, P449, DOI 10.1007/s10608-009-9254-x; Cacioppo JT, 2006, J RES PERS, V40, P1054, DOI 10.1016/j.jrp.2005.11.007; Cacioppo JT, 2009, TRENDS COGN SCI, V13, P447, DOI 10.1016/j.tics.2009.06.005; Cacioppo JT, 2009, J COGNITIVE NEUROSCI, V21, P83, DOI 10.1162/jocn.2009.21007; Christensen PN, 1998, PERS SOC PSYCHOL B, V24, P322, DOI 10.1177/0146167298243009; Connor KM, 2000, BRIT J PSYCHIAT, V176, P379, DOI 10.1192/bjp.176.4.379; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Dolan RJ, 2003, ANN NY ACAD SCI, V985, P348, DOI 10.1111/j.1749-6632.2003.tb07093.x; Ekman P., 2003, UNMASKING FACE GUIDE; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Gardner WL, 2000, PERS SOC PSYCHOL B, V26, P486, DOI 10.1177/0146167200266007; Gardner WL, 2005, PERS SOC PSYCHOL B, V31, P1549, DOI 10.1177/0146167205277208; Gilmour R., 1991, PERSONAL RELATIONSHI, P31; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P386, DOI 10.1037/0021-843x.113.3.386; Hall JK, 2010, COGNITION EMOTION, V24, P629, DOI 10.1080/02699930902906882; HANLEYDUNN P, 1985, PERS SOC PSYCHOL B, V11, P445, DOI 10.1177/0146167285114010; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Heinrich LA, 2006, CLIN PSYCHOL REV, V26, P695, DOI 10.1016/j.cpr.2006.04.002; Horowitz TS, 2007, PSYCHOL SCI, V18, P356, DOI 10.1111/j.1467-9280.2007.01903.x; Horsley TA, 2010, J ABNORM CHILD PSYCH, V38, P587, DOI 10.1007/s10802-009-9361-x; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; JONES WH, 1983, PERS SOC PSYCHOL B, V9, P437, DOI 10.1177/0146167283093014; Keltner D, 1998, REV GEN PSYCHOL, V2, P320, DOI [10.1037/1089-2680.2.3.320, DOI 10.1037/1089-2680.2.3.320]; Klein JT, 2009, CURR BIOL, V19, pR958, DOI 10.1016/j.cub.2009.08.010; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Lang P.J., 2008, A8 U FLOR; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Machado-de-Sousa JP, 2010, J NEUROSCI METH, V193, P1, DOI 10.1016/j.jneumeth.2010.08.013; Maner JK, 2007, J PERS SOC PSYCHOL, V92, P42, DOI 10.1037/0022-3514.92.1.42; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Murphy NA, 2008, PSYCHOL AGING, V23, P263, DOI 10.1037/0882-7974.23.2.263; Pfeiffer UJ, 2013, NEUROSCI BIOBEHAV R, V37, P2516, DOI 10.1016/j.neubiorev.2013.07.017; Pickett C. L., 2005, SOCIAL OUTCAST OSTRA, P213; Pickett CL, 2004, PERS SOC PSYCHOL B, V30, P1095, DOI 10.1177/0146167203262085; Qualter P, 2013, J ABNORM CHILD PSYCH, V41, P325, DOI 10.1007/s10802-012-9676-x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Smeets JBJ, 2003, J NEUROPHYSIOL, V90, P12, DOI 10.1152/jn.01075.2002; Staugaard SR, 2010, CLIN PSYCHOL REV, V30, P669, DOI 10.1016/j.cpr.2010.05.001; Steinmetz KRM, 2013, MEM COGNITION, V41, P69, DOI 10.3758/s13421-012-0247-8; Theeuwes J, 2002, PERCEPT PSYCHOPHYS, V64, P764, DOI 10.3758/BF03194743; von Ceumern-Lindenstjerna IA, 2010, PSYCHOPATHOLOGY, V43, P25, DOI 10.1159/000255960; WALKERSMITH GJ, 1977, PERCEPTION, V6, P313, DOI 10.1068/p060313; Watson J, 2012, J APPL SOC PSYCHOL, V42, P1984, DOI 10.1111/j.1559-1816.2012.00927.x; Weiss RS, 1979, LONELINESS EXPERIENC; WITTENBERG MT, 1986, PERS SOC PSYCHOL B, V12, P121, DOI 10.1177/0146167286121012	54	5	5	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125141	10.1371/journal.pone.0125141	http://dx.doi.org/10.1371/journal.pone.0125141			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915656	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100101
J	Rizk, MA; El-Sayed, SA; Terkawi, MA; Youssef, MA; El Said, EE; Elsayed, G; El-Khodery, S; El-Ashker, M; Elsify, A; Omar, M; Salama, A; Yokoyama, N; Igarashi, I				Rizk, Mohamed Abdo; El-Sayed, Shimaa Abd El-Salam; Terkawi, Mohamed Alaa; Youssef, Mohamed Ahmed; El Said, El Said El Shirbini; Elsayed, Gehad; El-Khodery, Sabry; El-Ashker, Maged; Elsify, Ahmed; Omar, Mosaab; Salama, Akram; Yokoyama, Naoaki; Igarashi, Ikuo			Optimization of a Fluorescence-Based Assay for Large-Scale Drug Screening against Babesia and Theileria Parasites	PLOS ONE			English	Article							IN-VITRO; GROWTH; INFECTION; VALIDATION; QUERCETIN; DYE	A rapid and accurate assay for evaluating antibabesial drugs on a large scale is required for the discovery of novel chemotherapeutic agents against Babesia parasites. In the current study, we evaluated the usefulness of a fluorescence-based assay for determining the efficacies of antibabesial compounds against bovine and equine hemoparasites in in vitro cultures. Three different hematocrits (HCTs; 2.5%, 5%, and 10%) were used without daily replacement of the medium. The results of a high-throughput screening assay revealed that the best HCT was 2.5% for bovine Babesia parasites and 5% for equine Babesia and Theileria parasites. The IC50 values of diminazene aceturate obtained by fluorescence and microscopy did not differ significantly. Likewise, the IC50 values of luteolin, pyronaridine tetraphosphate, nimbolide, gedunin, and enoxacin did not differ between the two methods. In conclusion, our fluorescence-based assay uses low HCT and does not require daily replacement of culture medium, making it highly suitable for in vitro large-scale drug screening against Babesia and Theileria parasites that infect cattle and horses.	[Rizk, Mohamed Abdo; El-Sayed, Shimaa Abd El-Salam; Terkawi, Mohamed Alaa; Elsify, Ahmed; Yokoyama, Naoaki; Igarashi, Ikuo] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan; [Rizk, Mohamed Abdo; Youssef, Mohamed Ahmed; El-Khodery, Sabry; El-Ashker, Maged] Mansoura Univ, Fac Vet Med, Dept Internal Med & Infect Dis, Mansoura, Egypt; [El-Sayed, Shimaa Abd El-Salam; El Said, El Said El Shirbini; Elsayed, Gehad] Mansoura Univ, Fac Vet Med, Dept Biochem & Chem Nutr, Mansoura, Egypt; [Elsify, Ahmed; Salama, Akram] Minoufiya Univ, Fac Vet Med, Dept Anim Med & Infect Dis, Sadat City, Minoufiya, Egypt; [Omar, Mosaab] South Valley Univ, Fac Vet Med, Dept Parasitol, Qena, Egypt	Obihiro University of Agriculture & Veterinary Medicine; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Menofia University; Egyptian Knowledge Bank (EKB); South Valley University Egypt	Igarashi, I (corresponding author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan.	igarcpmi@obihiro.ac.jp	Omar, Mosaab A./AAF-2216-2019; El-Ashker, Maged/P-5071-2018; Al-Inany, Hesham/AAF-1089-2020; ElSify, Ahmed/ABH-4969-2020; Rizk, Mohamed Abdo/J-7232-2019; Elsify, Ahmed Mahmoud/B-2082-2019; El-khodery, Sabry A/S-8175-2018; Elsayed, Shimaa/P-3399-2018	Omar, Mosaab A./0000-0003-1553-1763; El-Ashker, Maged/0000-0002-3217-9864; ElSify, Ahmed/0000-0003-0660-9071; Rizk, Mohamed Abdo/0000-0002-5250-6172; Elsify, Ahmed Mahmoud/0000-0003-0660-9071; El-khodery, Sabry A/0000-0002-0545-5827; elsayed, gehad/0000-0002-1121-6865; elsherbini, elsaid/0000-0003-2720-8955; Salama, Akram/0000-0002-8047-8965; Elsayed, Shimaa/0000-0001-9224-5731; Terkawi, Alaa/0000-0002-5481-8516	Ministry of Higher Education Egypt; Japanese Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Higher Education Egypt(Ministry of Higher Education & Scientific Research (MHESR)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Ministry of Higher Education Egypt, the Japanese Society for the Promotion of Science, and the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	AbouLaila M, 2012, ANTIMICROB AGENTS CH, V56, P3196, DOI 10.1128/AAC.05488-11; AbouLaila M, 2010, VET PARASITOL, V167, P19, DOI 10.1016/j.vetpar.2009.09.049; Avarzed A, 1997, J VET MED SCI, V59, P479, DOI 10.1292/jvms.59.479; Azirwan G, 2013, J PROTOZOOL RES, V23, P1; Bennett TN, 2004, ANTIMICROB AGENTS CH, V48, P1807, DOI 10.1128/AAC.48.5.1807-1810.2004; Bork S, 2004, ANTIMICROB AGENTS CH, V48, P236, DOI 10.1128/AAC.48.1.236-241.2004; Chavalitshewinkoon-Petmitr Porntip, 2000, Parasitology International, V48, P275, DOI 10.1016/S1383-5769(99)00028-8; DIVO AA, 1988, ANTIMICROB AGENTS CH, V32, P1182, DOI 10.1128/AAC.32.8.1182; FU S, 1986, BRIT J CLIN PHARMACO, V22, P93; Guswanto A, 2014, ANTIMICROB AGENTS CH, V58, P4713, DOI 10.1128/AAC.00022-14; Hasenkamp S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-58; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; HINES SA, 1992, MOL BIOCHEM PARASIT, V55, P85, DOI 10.1016/0166-6851(92)90129-8; Homer MJ, 2000, CLIN MICROBIOL REV, V13, P451, DOI 10.1128/CMR.13.3.451-469.2000; Hotzel I, 1997, MOL BIOCHEM PARASIT, V90, P479, DOI 10.1016/S0166-6851(97)00182-5; Igarashi I, 1998, EXP PARASITOL, V90, P290, DOI 10.1006/expr.1998.4331; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; Kuttler K.L, 1981, BABESIOSIS, P25; Lehane Adele M, 2008, BMC Res Notes, V1, P26, DOI 10.1186/1756-0500-1-26; Mahmoudi N, 2003, ANTIMICROB AGENTS CH, V47, P2636, DOI 10.1128/AAC.47.8.2636-2639.2003; MAKLER MT, 1991, AM J TROP MED HYG, V44, P11, DOI 10.4269/ajtmh.1991.44.11; Mamani-Matsuda M, 2004, ANTIMICROB AGENTS CH, V48, P924, DOI 10.1128/AAC.48.3.924-929.2004; Mayr LM, 2008, J BIOMOL SCREEN, V13, P443, DOI 10.1177/1087057108319644; Mosqueda J, 2012, CURR MED CHEM, V19, P1504, DOI 10.2174/092986712799828355; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; ROCHANAKIJ S, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P66; RUEBUSH TK, 1979, AM J TROP MED HYG, V28, P184, DOI 10.4269/ajtmh.1979.28.184; Salama AA, 2013, VET PARASITOL, V191, P1, DOI 10.1016/j.vetpar.2012.08.022; Schein E., 1988, P197; Sen G, 2005, FREE RADICAL BIO MED, V38, P1257, DOI 10.1016/j.freeradbiomed.2005.01.014; Silva MG, 2013, INT J PARASITOL-DRUG, V3, P59, DOI 10.1016/j.ijpddr.2013.01.003; SKEIDSVOLL J, 1995, ANAL BIOCHEM, V231, P359, DOI 10.1006/abio.1995.9986; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Uilenberg G, 2006, VET PARASITOL, V138, P3, DOI 10.1016/j.vetpar.2006.01.035; Weiss LM, 1998, INFECT IMMUN, V66, P3295, DOI 10.1128/IAI.66.7.3295-3302.1998; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng X.Y., 1982, ACTA PHARMACOL SIN, V17, P118	37	54	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125276	10.1371/journal.pone.0125276	http://dx.doi.org/10.1371/journal.pone.0125276			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915529	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100114
J	Schiessl-Weyer, J; Roa, P; Laccone, F; Kluge, B; Tichy, A; Ribeiro, ED; Prohaska, R; Stoeter, P; Siegl, C; Salzer, U				Schiessl-Weyer, Jasmin; Roa, Pedro; Laccone, Franco; Kluge, Britta; Tichy, Alexander; Ribeiro, Euripedes De Almeida; Prohaska, Rainer; Stoeter, Peter; Siegl, Claudia; Salzer, Ulrich			Acanthocytosis and the c.680 A > G Mutation in the PANK2 Gene: A Study Enrolling a Cohort of PKAN Patients from the Dominican Republic	PLOS ONE			English	Article							KINASE-ASSOCIATED NEURODEGENERATION; BRAIN IRON ACCUMULATION; PANTOTHENATE KINASE-2; ERYTHROCYTES; ACETYLATION; MEMBRANE; PROTEOME; CELLS	Pantothenate Kinase-Associated Neurodegeneration (PKAN) is a form of Neurodegeneration with Brain Iron Accumulation (NBIA) associated with mutations in the pantothenate kinase 2 gene (PANK2). Pantothenate kinases catalyze the rate-limiting step of coenzyme A synthesis and Pank2 is the only pantothenate kinase isoform in humans that is localized to mitochondria. Acanthocytosis, the occurrence of spiculated erythrocytes, is observed in about 10% of the PKAN patients. Therefore PKAN is also classified together with other rare neurodegenerative diseases like Chorea Acanthocytosis (ChAc) and McLeod syndrome (MLS) into the Neuroacanthocytosis (NA) syndromes. It has not been investigated yet whether acanthocytosis in PKAN is associated with a specific subset of Pank2 mutations. In this study, we analyzed acanthocytosis of a cohort of 25 PKAN patients from the Dominican Republic that are homozygous for the c.680 A>G mutation in the PANK2 gene as compared to control donors that are heterozygous or wild-type with respect to this mutation. 3D modeling of this mutation indicated that the replacement of a tyrosine by a cysteine at position 227 in Pank2 disrupts a polar interaction within the A domain of the enzyme. Mean acanthocyte count was elevated in the cohort of patients, however, acanthocytosis varied among the patients with nearly half of them showing high (>20%) or elevated acanthocytosis and the rest showing mild (6-10%) or no (<6%) acanthocytosis. Heterozygous control donors revealed a tendency to mild acanthocytosis. Based on the insight that Pank2 is a normal constituent of red blood cells and de novo biosynthesis of coenzyme A is likely to take place in the erythrocyte cytosol we propose a hypothetical model that accounts for the variability in the occurrence of acanthocytic cells in PKAN.	[Schiessl-Weyer, Jasmin; Prohaska, Rainer; Siegl, Claudia; Salzer, Ulrich] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, Vienna, Austria; [Roa, Pedro; Stoeter, Peter] Ctr Diagnost Med Avanzada Lab & Telemed, Santo Domingo, Dominican Rep; [Laccone, Franco; Kluge, Britta] Med Univ Vienna, Dept Med Genet, Vienna, Austria; [Tichy, Alexander] Univ Vet Med, Platform Bioinformat & Biostat, Vienna, Austria; [Ribeiro, Euripedes De Almeida] Univ Vienna, Dept Struct & Computat Biol, Max F Perutz Labs, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Veterinary Medicine Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Salzer, U (corresponding author), Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, Vienna, Austria.	ulrich.salzer@meduniwien.ac.at	Laccone, Franco A/B-3655-2018	Salzer, Ulrich/0000-0002-3721-7225	NBIA Disorders Association; Herzfelder'sche Familienstiftung; Austrian Science Fund FWF [I 438-B13]; Austrian Science Fund (FWF) [I 438] Funding Source: researchfish	NBIA Disorders Association; Herzfelder'sche Familienstiftung; Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding by the "NBIA Disorders Association (http://www.nbiadisorders.org/) and the "Herzfelder'sche Familienstiftung" to US, and by the Austrian Science Fund FWF (grant I 438-B13)/ERAnet/E-Rare consortium EMINA (European Multidisciplinary Initiative on Neuroacanthocytosis (www.e-rare.eu/financed-projects/emina)) to RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso-Pecchio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049509; An XU, 2008, BRIT J HAEMATOL, V141, P367, DOI 10.1111/j.1365-2141.2008.07091.x; BRECHER G, 1972, BLOOD-J HEMATOL, V40, P333, DOI 10.1182/blood.V40.3.333.333; Daugherty M, 2002, J BIOL CHEM, V277, P21431, DOI 10.1074/jbc.M201708200; Delgado RF, 2012, J MAGN RESON IMAGING, V35, P788, DOI 10.1002/jmri.22884; Dusek P, 2012, CURR OPIN NEUROL, V25, P499, DOI 10.1097/WCO.0b013e3283550cac; Gregory A, 2005, FOLIA NEUROPATHOL, V43, P286, DOI 10.1016/B978-0-444-63233-3.00019-1; Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929; Hayflick SJ, 2003, NEW ENGL J MED, V348, P33, DOI 10.1056/NEJMoa020817; Hong BS, 2007, J BIOL CHEM, V282, P27984, DOI 10.1074/jbc.M701915200; Hortnagel K, 2003, HUM MOL GENET, V12, P321, DOI 10.1093/hmg/ddg026; Jung HH, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-68; Kotzbauer PT, 2005, J NEUROSCI, V25, P689, DOI 10.1523/JNEUROSCI.4265-04.2005; Kuo YM, 2005, HUM MOL GENET, V14, P49, DOI 10.1093/hmg/ddi005; Lach A, 2012, J BIOL CHEM, V287, P18974, DOI 10.1074/jbc.M111.332981; Lange PF, 2014, J PROTEOME RES, V13, P2028, DOI 10.1021/pr401191w; Leonardi R, 2007, FEBS LETT, V581, P4639, DOI 10.1016/j.febslet.2007.08.056; Prohaska R, 2012, NEUROBIOL DIS, V46, P607, DOI 10.1016/j.nbd.2012.03.006; Roux-Dalvai F, 2008, MOL CELL PROTEOMICS, V7, P2254, DOI 10.1074/mcp.M800037-MCP200; Schroeder S, 2014, AUTOPHAGY, V10, P1335, DOI 10.4161/auto.28919; Siegl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076715; Siudeja K, 2011, EMBO MOL MED, V3, P755, DOI 10.1002/emmm.201100180; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Zhang YM, 2006, J BIOL CHEM, V281, P107, DOI 10.1074/jbc.M508825200	24	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125861	10.1371/journal.pone.0125861	http://dx.doi.org/10.1371/journal.pone.0125861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915509	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100149
J	Trajman, A; Durovni, B; Saraceni, V; Menezes, A; Cordeiro-Santos, M; Cobelens, F; Van den Hof, S				Trajman, Anete; Durovni, Betina; Saraceni, Valeria; Menezes, Alexandre; Cordeiro-Santos, Marcelo; Cobelens, Frank; Van den Hof, Susan			Impact on Patients' Treatment Outcomes of XpertMTB/RIF Implementation for the Diagnosis of Tuberculosis: Follow-Up of a Stepped-Wedge Randomized Clinical Trial	PLOS ONE			English	Article							SETTINGS	Introduction The impact on treatment outcomes of XpertMTB/RIF, a molecular-based test that provides rapid diagnosis of tuberculosis (TB) and rifampicin resistance with high accuracy, has not been reported despite its adoption in a few countries. We here report treatment outcomes in a step-wedged cluster randomized trial for patients diagnosed with XpertMTB/RIF compared to patients diagnosed with sputum smear examination in public health facilities in Brazil. Methods Treatment outcome data were added to the trial database of patients diagnosed from 4 February to 4 October 2012, and crosschecked with data from the national mortality and the drug-resistant TB registers. Treatment outcomes in the intervention (n=2232) and baseline (n=1856) arms were compared using a multilevel regression model. Results Unfavourable outcomes were frequent in both arms, mainly due to loss to follow-up (16%). Overall unfavourable outcomes were not reduced in the intervention arm (29.6% versus 31.7%, OR=0.93; 95% CI=0.79-1.08). However, the overall TB-attributed death rate was lower in the intervention arm (2.3% vs. 3.8%). Adjusted for HIV status, age group and city, the intervention resulted in a 35% decrease in TB-attributed deaths (OR=0.65, 95% CI=0.44-0.97). Conclusions The proportion of patients successfully treated did not increase with Xpert MTB/RIF implementation, with high loss to follow-up rates in both arms. We did observe a 35% reduction in TB-related mortality, which we hypothesize may be explained by less advanced disease among the smear-negative patients diagnosed by Xpert. In conclusion, XpertMTB/RIF introduction did not improve TB treatment outcomes in Brazil.	[Trajman, Anete; Durovni, Betina] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Trajman, Anete] McGill Univ, Montreal, PQ, Canada; [Durovni, Betina; Saraceni, Valeria] Rio de Janeiro City Hlth Secretariat, Rio De Janeiro, Brazil; [Saraceni, Valeria; Cordeiro-Santos, Marcelo] Dr Heitor Dourado Vieira Fdn Trop Med, Manaus, Amazonas, Brazil; [Menezes, Alexandre] Global Hlth Strategies, Rio De Janeiro, Brazil; [Cordeiro-Santos, Marcelo] Amazonas State Univ, Manaus, Amazonas, Brazil; [Cobelens, Frank; Van den Hof, Susan] Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Cobelens, Frank; Van den Hof, Susan] KNCV Fdn, The Hague, Netherlands	Universidade Federal do Rio de Janeiro; McGill University; Universidade do Estado do Amazonas; University of Amsterdam; Academic Medical Center Amsterdam; KNCV Tuberculosis Foundation	Trajman, A (corresponding author), Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.	atrajman@gmail.com	Trajman, Anete/C-7679-2016	Trajman, Anete/0000-0002-4000-4984; Cobelens, Frank/0000-0002-4367-1133	InCo-TB project; Fundacao Ataulpho de Paiva Foundation - Bill and Melinda Gates Foundation [OPPGH 5254]; Brazilian National TB Program	InCo-TB project; Fundacao Ataulpho de Paiva Foundation - Bill and Melinda Gates Foundation; Brazilian National TB Program	This work was supported by the InCo-TB project, a partnership of Brazilian National TB Program and the Fundacao Ataulpho de Paiva Foundation, funded by the Bill and Melinda Gates Foundation [Grant number OPPGH 5254]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Camargo K R Jr, 2000, Cad Saude Publica, V16, P439; Churchyard G, 2014, EFFECT XPERT MTB RIF; Durovni B, 2014, PLOS MED IN PRESS; Hayes RJ, 2009, INTERD STAT, P3; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Nakiyingi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074023; Osman M, 2014, J CLIN MICROBIOL, V52, P635, DOI 10.1128/JCM.02517-13; Steingart KR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009593.pub2; Theron G, 2014, LANCET INFECT DIS, V14, P527, DOI 10.1016/S1473-3099(13)70360-8; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2010, ROAD MAP ROLL OUT XP	15	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123252	10.1371/journal.pone.0123252	http://dx.doi.org/10.1371/journal.pone.0123252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915745	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100018
J	Ali, BH; Adham, SA; Al Za'abi, M; Waly, MI; Yasin, J; Nemmar, A; Schupp, N				Ali, Badreldin H.; Adham, Sirin A.; Al Za'abi, Mohammed; Waly, Mostafa I.; Yasin, Javed; Nemmar, Abderrahim; Schupp, Nicole			Ameliorative Effect of Chrysin on Adenine-Induced Chronic Kidney Disease in Rats	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; OXIDATIVE STRESS; INDOXYL SULFATE; WISTAR RATS; UREMIC RATS; KAPPA-B; INFLAMMATION; INJURY; PATHWAY; PLASMA	Chrysin (5, 7-dihydroxyflavone) is a flavonoid with several pharmacological properties that include antioxidant, anti-inflammatory and antiapoptotic activities. in this work, we investigated some effects of three graded oral doses of chrysin (10, 50 and 250 mg/kg) on kidney structure and function in rats with experimental chronic renal disease (CKD) induced by adenine (0.25% w/w in feed for 35 days), which is known to involve inflammation and oxidative stress. Using several indices in plasma, urine and kidney homogenates, adenine was found to impair kidney function as it lowered creatinine clearance and increased plasma concentrations of creatinine, urea, neutrophil gelatinase-associated lipocalin and N-Acetyl-beta-D-glucosaminidase activity. Furthermore, it raised plasma concentrations of the uremic toxin indoxyl sulfate, some inflammatory cytokines and urinary albumin concentration. Renal morphology was severely damaged and histopathological markers of inflammation and fibrosis were especially increased. In renal homogenates, antioxidant indices, including superoxide dismutase and catalase activities, total antioxidant capacity and reduced glutathione were all adversely affected. Most of these adenine - induced actions were moderately and dose - dependently mitigated by chrysin, especially at the highest dose. Chrysin did not cause any overt adverse effect on the treated rats. The results suggest that different doses of chrysin produce variable salutary effects against adenine-induced CKD in rats, and that, pending further pharmacological and toxicological studies, its usability as a possible ameliorative agent in human CKD should be considered.	[Ali, Badreldin H.; Al Za'abi, Mohammed] Sultan Qaboos Univ, Dept Pharmacol, Coll Med & Hlth Sci, Muscat, Oman; [Ali, Badreldin H.; Al Za'abi, Mohammed] Sultan Qaboos Univ, Dept Clin Pharm, Coll Med & Hlth Sci, Muscat, Oman; [Adham, Sirin A.] Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat, Oman; [Waly, Mostafa I.] Sultan Qaboos Univ, Dept Food Sci & Nutr, Coll Agr & Marine Sci, Muscat, Oman; [Yasin, Javed] UAE Univ, Dept Internal Med, Coll Med & Hlth Sci, Al Ain, U Arab Emirates; [Nemmar, Abderrahim] Coll Med & Hlth Sci, Dept Physiol, Al Ain, U Arab Emirates; [Schupp, Nicole] Univ Dusseldorf, Inst Toxicol, Dusseldorf, Germany	Sultan Qaboos University; Sultan Qaboos University; Sultan Qaboos University; Sultan Qaboos University; United Arab Emirates University; Heinrich Heine University Dusseldorf	Ali, BH (corresponding author), Sultan Qaboos Univ, Dept Pharmacol, Coll Med & Hlth Sci, Muscat, Oman.	alibadreldin@hotmail.com	PATHAN, JAVED YASIN/GOE-4396-2022; Adham, Sirin A/ABB-8842-2020; Waly, Mostafa/P-7516-2016; Za'abi, Mohammed Al/C-6591-2013	Adham, Sirin A/0000-0002-8349-6202; Waly, Mostafa/0000-0002-8197-3378; Za'abi, Mohammed Al/0000-0002-2019-1022; PATHAN, JAVED YASIN/0000-0002-5867-2833	Research Council of Oman [RC/MED/PHARM/13/01]	Research Council of Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman)	This study was financially supported by The Research Council of Oman (RC/MED/PHARM/13/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adem S, 2014, J BIOCHEM MOL TOXIC, V28, P510, DOI 10.1002/jbt.21592; Ahad A, 2014, TOXICOL APPL PHARM, V279, P1, DOI 10.1016/j.taap.2014.05.007; Ahmad QZ, 2014, J NEPHROL THER, V4, P170; Al Za'abi M, 2013, J CHROMATOGR SCI, V51, P40, DOI 10.1093/chromsci/bms103; Ali BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102528; Ali BH, 2014, FOOD CHEM TOXICOL, V65, P321, DOI 10.1016/j.fct.2013.12.038; Ali BH, 2013, J PHARMACOL TOX MET, V68, P384, DOI 10.1016/j.vascn.2013.05.001; Ali BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055242; Ali BH, 2010, EXP BIOL MED, V235, P373, DOI 10.1258/ebm.2009.009214; Ali N, 2014, MOL CELL BIOCHEM, V385, P215, DOI 10.1007/s11010-013-1830-4; Almquist T, 2014, EUR J CLIN INVEST, V44, P276, DOI 10.1111/eci.12230; Anand KV, 2012, GERIATR GERONTOL INT, V12, P741, DOI 10.1111/j.1447-0594.2012.00843.x; Anand KV, 2011, TOXICOL IND HEALTH, V27, P923, DOI 10.1177/0748233711399324; Anandhi R, 2014, MOL CELL BIOCHEM, V385, P103, DOI 10.1007/s11010-013-1819-z; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Delanaye P, 2014, NEPHRON CLIN PRACT, V128, P127, DOI 10.1159/000366449; Desjardins L, 2014, NEPHROL THER, V10, P463, DOI 10.1016/j.nephro.2014.04.002; Diwan V, 2014, PHARMACOL RES, V79, P104, DOI 10.1016/j.phrs.2013.11.007; Feng XJ, 2014, BIOCHEM PHARMACOL, V89, P503, DOI 10.1016/j.bcp.2014.03.016; Ferreira JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079721; Garcia-Garcia PM, 2014, WORLD J DIABETES, V5, P431, DOI 10.4239/wjd.v5.i4.431; Hall ME, 2014, INT J NEPHROL RENOV, V7, P75, DOI 10.2147/IJNRD.S39739; Hanson L, 2014, AM J PUBLIC HEALTH, V104, pE9, DOI 10.2105/AJPH.2014.301984; Holmes David, 2014, Nat Rev Endocrinol, V10, P577, DOI 10.1038/nrendo.2014.145; Huang Y, 2013, MOL MED REP, V8, P1831, DOI 10.3892/mmr.2013.1715; Jablonski KL, 2014, JOVE-J VIS EXP, P16; Jiang Y, 2014, INT J MOL SCI, V15, P12270, DOI 10.3390/ijms150712270; Kazancioglu R, 2013, KIDNEY INT SUPPL, V3, P368, DOI 10.1038/kisup.2013.79; Martin-Pardillos A, 2014, TOXICOLOGY, V318, P40, DOI 10.1016/j.tox.2014.01.012; Owada S, 2008, AM J NEPHROL, V28, P446, DOI 10.1159/000112823; Rashid S, 2013, TOXICOL MECH METHOD, V23, P337, DOI 10.3109/15376516.2012.759306; Rehman MU, 2013, TOXICOL LETT, V216, P146, DOI 10.1016/j.toxlet.2012.11.013; Romier B, 2008, BRIT J NUTR, V100, P542, DOI 10.1017/S0007114508966666; Sengul S, 2011, KIDNEY INT S, V3, P308; Seron D, 2012, TRANSPLANT REV-ORLAN, V26, P20, DOI 10.1016/j.trre.2011.07.009; Taki K, 2006, J RENAL NUTR, V16, P199, DOI 10.1053/j.jrn.2006.04.020; Tu Y, 2014, J ETHNOPHARMACOL, V156, P115, DOI 10.1016/j.jep.2014.08.035; Walle T, 2001, BRIT J CLIN PHARMACO, V51, P143, DOI 10.1111/j.1365-2125.2001.01317.x; Yamagata K, 2015, CLIN EXP NEPHROL, V19, P54, DOI 10.1007/s10157-014-0978-x; Yamaguchi S, 2013, EUR J PHARMACOL, V714, P325, DOI 10.1016/j.ejphar.2013.07.032; Yao Y, 2014, INT J MOL SCI, V15, P20913, DOI 10.3390/ijms151120913; Yilmaz MI, 2014, KIDNEY INT, V86, P1213, DOI 10.1038/ki.2014.227	42	36	36	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125285	10.1371/journal.pone.0125285	http://dx.doi.org/10.1371/journal.pone.0125285			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909514	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800136
J	Hoa, NN; Kobayashi, J; Omura, M; Hirakawa, M; Yang, H; Komatsu, K; Paull, TT; Takeda, S; Sasanuma, H				Hoa, Nguyen Ngoc; Kobayashi, Junya; Omura, Masato; Hirakawa, Mayumi; Yang, Soo-Hyun; Komatsu, Kenshi; Paull, Tanya T.; Takeda, Shunichi; Sasanuma, Hiroyuki			BRCA1 and CtIP Are Both Required to Recruit Dna2 at Double-Strand Breaks in Homologous Recombination	PLOS ONE			English	Article							END-RESECTION; REPAIR PATHWAY; MRE11; PROTEIN; MAINTENANCE; COMPLEX; 53BP1; EXO1	Homologous recombination plays a key role in the repair of double-strand breaks (DSBs), and thereby significantly contributes to cellular tolerance to radiotherapy and some chemotherapy. DSB repair by homologous recombination is initiated by 5' to 3' strand resection (DSB resection), with nucleases generating the 3' single-strand DNA (3' ssDNA) at DSB sites. Genetic studies of Saccharomyces cerevisiae demonstrate a two-step DSB resection, wherein CtIP and Mre11 nucleases carry out short-range DSB resection followed by long-range DSB resection done by Dna2 and Exo1 nucleases. Recent studies indicate that CtIP contributes to DSB resection through its non-catalytic role but not as a nuclease. However, it remains elusive how CtIP contributes to DSB resection. To explore the non-catalytic role, we examined the dynamics of Dna2 by developing an immuno-cytochemical method to detect ionizing-radiation (IR)-induced Dna2-subnuclear-focus formation at DSB sites in chicken DT40 and human cell lines. Ionizing-radiation induced Dna2 foci only in wild-type cells, but not in Dna2 depleted cells, with the number of foci reaching its maximum at 30 minutes and being hardly detectable at 120 minutes after IR. Induced foci were detectable in cells in the G2 phase but not in the G1 phase. These observations suggest that Dna2 foci represent the recruitment of Dna2 to DSB sites for DSB resection. Importantly, the depletion of CtIP inhibited the recruitment of Dna2 to DSB sites in both human cells and chicken DT40 cells. Likewise, a defect in breast cancer 1 (BRCA1), which physically interacts with CtIP and contributes to DSB resection, also inhibited the recruitment of Dna2. Moreover, CtIP physically associates with Dna2, and the association is enhanced by IR. We conclude that BRCA1 and CtIP contribute to DSB resection by recruiting Dna2 to damage sites, thus ensuring the robust DSB resection necessary for efficient homologous recombination.	[Hoa, Nguyen Ngoc; Omura, Masato; Hirakawa, Mayumi; Takeda, Shunichi; Sasanuma, Hiroyuki] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto, Japan; [Kobayashi, Junya; Komatsu, Kenshi] Kyoto Univ, Ctr Radiat Biol, Dept Genome Repair Dynam, Sakyo Ku, Kyoto 606, Japan; [Yang, Soo-Hyun; Paull, Tanya T.] Univ Texas Austin, Howard Hughes Med Inst, Dept Mol Biosci, Austin, TX 78712 USA; [Yang, Soo-Hyun; Paull, Tanya T.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	Kyoto University; Kyoto University; Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Takeda, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto, Japan.	stakeda@rg.med.kyoto-u.ac.jp; hiroysasa@rg.med.kyoto-u.ac.jp	Kobayashi, Junjiro/J-8547-2015; Kobayashi, Junya/AAX-6390-2021	Kobayashi, Junya/0000-0003-4645-7500; Paull, Tanya/0000-0002-2991-651X; Takeda, Shunichi/0000-0002-7924-7991	Japanese Ministry of Education, Science, Sport and Culture	Japanese Ministry of Education, Science, Sport and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid from the Japanese Ministry of Education, Science, Sport and Culture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Delia D, 2004, HUM MOL GENET, V13, P2155, DOI 10.1093/hmg/ddh221; Eid W, 2010, EMBO REP, V11, P962, DOI 10.1038/embor.2010.157; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015; Iijima J, 2010, CANCER RES, V70, P8467, DOI 10.1158/0008-5472.CAN-10-0267; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kousholt AN, 2012, J CELL BIOL, V197, P869, DOI 10.1083/jcb.201111065; Makharashvili N, 2014, MOL CELL, V54, P1022, DOI 10.1016/j.molcel.2014.04.011; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Nakamura K, 2010, J SYN ORG CHEM JPN, V68, P1, DOI 10.5059/yukigoseikyokaishi.68.1; Nakamura K, 2006, DNA REPAIR, V5, P741, DOI 10.1016/j.dnarep.2006.03.008; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Peng G, 2012, CANCER RES, V72, P2802, DOI 10.1158/0008-5472.CAN-11-3152; Peterson SE, 2013, MOL CELL, V49, P657, DOI 10.1016/j.molcel.2012.11.020; Qing Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002148; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Sonoda E, 2003, EMBO J, V22, P3188, DOI 10.1093/emboj/cdg308; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang HL, 2014, MOL CELL, V54, P1012, DOI 10.1016/j.molcel.2014.04.012; Wang HJ, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-121; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; Yamaguchi-Iwai Y, 1999, EMBO J, V18, P6619, DOI 10.1093/emboj/18.23.6619; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	38	25	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124495	10.1371/journal.pone.0124495	http://dx.doi.org/10.1371/journal.pone.0124495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909997	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800085
J	Legido-Quigley, H; Lopez, PAC; Balabanova, D; Perel, P; Lopez-Jaramillo, P; Nieuwlaat, R; Schwalm, JD; McCready, T; Yusuf, S; McKee, M				Legido-Quigley, Helena; Camacho Lopez, Paul Anthony; Balabanova, Dina; Perel, Pablo; Lopez-Jaramillo, Patricio; Nieuwlaat, Robby; Schwalm, J-D; McCready, Tara; Yusuf, Salim; McKee, Martin			Patients' Knowledge, Attitudes, Behaviour and Health Care Experiences on the Prevention, Detection, Management and Control of Hypertension in Colombia: A Qualitative Study	PLOS ONE			English	Article							STRATEGIES; TRUST	Hypertension is a leading cause of premature death worldwide and the most important modifiable risk factor for cardiovascular disease. Effective screening programs, communication with patients, regular monitoring, and adherence to treatment are essential to successful management but may be challenging in health systems facing resource constraints. This qualitative study explored patients' knowledge, attitudes, behaviour and health care seeking experiences in relation to detection, treatment and control of hypertension in Colombia. We conducted in-depth interviews and focus group discussions with 26 individuals with hypertension and 4 family members in two regions. Few participants were aware of ways to prevent high blood pressure. Once diagnosed, most reported taking medication but had little information about their condition and had a poor understanding of their treatment regime. The desire for good communication and a trusting relationship with the doctor emerged as key themes in promoting adherence to medication and regular attendance at medical appointments. Barriers to accessing treatment included co-payments for medication; costs of transport to health care facilities; unavailability of drugs; and poor access to specialist care. Some patients overcame these barriers with support from social networks, family members and neighbours. However, those who lacked such support, experienced loneliness and struggled to access health care services. The health insurance scheme was frequently described as administratively confusing and those accessing the state subsidized system believed that the treatment was inferior to that provided under the compulsory contributory system. Measures that should be addressed to improve hypertension management in Colombia include better communication between health care professionals and patients, measures to improve understanding of the importance of adherence to treatment, reduction of co-payments and transport costs, and easier access to care, especially in rural areas.	[Legido-Quigley, Helena; Balabanova, Dina; Perel, Pablo; McKee, Martin] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Camacho Lopez, Paul Anthony; Lopez-Jaramillo, Patricio] Fdn Oftalmol Santander, Bucaramanga, Colombia; [Lopez-Jaramillo, Patricio] Univ Santander, Inst Masira, Sch Med, Bucaramanga, Colombia; [Nieuwlaat, Robby; Schwalm, J-D; McCready, Tara; Yusuf, Salim] Populat Hlth Res Inst, Hamilton, ON, Canada	University of London; London School of Hygiene & Tropical Medicine; Universidad Industrial de Santander; Population Health Research Institute	Legido-Quigley, H (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England.	Helena.legido-quigley@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; /0000-0002-2342-301X; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Camacho, Paul Anthony/0000-0002-6233-9582; Yusuf, Salim/0000-0003-4776-5601	Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institute of Health Research.	Anthony H, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-24; Bernal O, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e802; Borzecki AM, 2005, CURR HYPERTENS REP, V7, P439, DOI 10.1007/s11906-005-0039-7; Calnan M, 2003, SOC SCI MED, V57, P757, DOI 10.1016/S0277-9536(03)00128-X; Charmaz K., 2006, CONSTRUCTING GROUNDE, DOI [10.1093/geront/gns046, DOI 10.1093/GERONT/GNS046]; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; CIES, AS VAM SAL TABL GRAF; Connell P, 2005, BRIT J GEN PRACT, V55, P357; Giedion U, 2009, HEALTH AFFAIR, V28, P853, DOI 10.1377/hlthaff.28.3.853; Khatib R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084238; Lanas F, 2007, CIRCULATION, V115, P1067, DOI 10.1161/CIRCULATIONAHA.106.633552; Legido-Quigley H, 2014, SOCIOL HEALTH ILL, V36, P1243, DOI 10.1111/1467-9566.12163; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lucumi Cuesta D. I., 2014, DISPARITIES HYPERTEN; Maimaris W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001490; Marshall IJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e3953; Mechanic D, 1998, MILBANK Q, V76, P281, DOI 10.1111/1468-0009.00089; Ministerio de Salud, 1999, SER DOC TECN, VIII; Ministry of Social Protection (Colombia), 2008, COL NAT HLTH SURV 20; Oli N, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24023; Strauss AL., 1987, QUALITATIVE ANAL SOC, Vxv, P319; Tlili F, 2014, INT J PUBLIC HLTH; Turnbull F, 2008, EUR HEART J, V29, P2669, DOI 10.1093/eurheartj/ehn427; WHO, 2013, WHODCOWHD20132	24	50	53	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122112	10.1371/journal.pone.0122112	http://dx.doi.org/10.1371/journal.pone.0122112			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG6AH	25909595	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000353376800017
J	Osuna-Mascaro, AJ; Cruz-Bustos, T; Marin, F; Checa, AG				Osuna-Mascaro, Antonio J.; Cruz-Bustos, Teresa; Marin, Frederic; Checa, Antonio G.			Ultrastructure of the Interlamellar Membranes of the Nacre of the Bivalve Pteria hirundo, Determined by Immunolabelling	PLOS ONE			English	Article							MOLLUSK SHELL FORMATION; ORGANIC MATRIX; MACROMOLECULAR STRUCTURE; HALIOTIS-RUFESCENS; CHITIN; COMPONENTS; FRAMEWORK; GROWTH; NUCLEATION; MYTILUS	The current model for the ultrastructure of the interlamellar membranes of molluscan nacre imply that they consist of a core of aligned chitin fibers surrounded on both sides by acidic proteins. This model was based on observations taken on previously demineralized shells, where the original structure had disappeared. Despite other earlier claims, no direct observations exist in which the different components can be unequivocally discriminated. We have applied different labeling protocols on non-demineralized nacreous shells of the bivalve Pteria. With this method, we have revealed the disposition and nature of the different fibers of the interlamellar membranes that can be observed on the surface of the nacreous shell of the bivalve Pteria hirundo by high resolution scanning electron microscopy (SEM). The minor chitin component consists of very thin fibers with a high aspect ratio and which are seemingly disoriented. Each fiber has a protein coat, which probably forms a complex with the chitin. The chitin-protein-complex fibers are embedded in an additional proteinaceous matrix. This is the first time in which the sizes, positions and distribution of the chitin fibers have been observed in situ.	[Osuna-Mascaro, Antonio J.; Checa, Antonio G.] Univ Granada, Dept Estratig & Paleontol, Fac Ciencias, E-18071 Granada, Spain; [Cruz-Bustos, Teresa] Univ Granada, Dept Bioquim & Parasitol Mol, Fac Ciencias, E-18071 Granada, Spain; [Marin, Frederic] Univ Bourgogne, UMR CNRS 6282 Biogeosci, F-21000 Dijon, France	University of Granada; University of Granada; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Osuna-Mascaro, AJ (corresponding author), Univ Granada, Dept Estratig & Paleontol, Fac Ciencias, Av Fuentenueva S-N, E-18071 Granada, Spain.	tay@ugr.es	Checa, Antonio/A-6157-2008	Checa, Antonio/0000-0001-7873-7545; Cruz Bustos, Teresa/0000-0002-6976-4354; Osuna Mascaro, Antonio Jose/0000-0002-6954-6453; Marin, Francisco/0000-0001-7246-7708	FPI program from the Spanish Ministerio de Ciencia e Innovacion; Projects of mentioned Ministry [CGL2010-20748-C02-01, CGL2013-48247-P]; Consejeria de Economia, Innovacion y Ciencia of the Junta de Andalucia [RNM6433]	FPI program from the Spanish Ministerio de Ciencia e Innovacion; Projects of mentioned Ministry; Consejeria de Economia, Innovacion y Ciencia of the Junta de Andalucia	AJOM was financed by a PhD Grant of the FPI program from the Spanish Ministerio de Ciencia e Innovacion; TCB's PhD Grant belonged to the FPU Program of the same Ministry. AJOM and AGC were supported by Projects CGL2010-20748-C02-01 and CGL2013-48247-P of the mentioned Ministry, and RNM6433 of the Consejeria de Economia, Innovacion y Ciencia of the Junta de Andalucia. The European COST Action TD0903 contributed via two Short Term Scientific Missions to AJOM in FM's lab in Dijon.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Bezares J, 2008, J STRUCT BIOL, V163, P61, DOI 10.1016/j.jsb.2008.04.009; Bezares J, 2012, THEOR APPL MECH, V39, P343, DOI 10.2298/TAM1204343B; Bezares J, 2011, THEOR APPL MECH, V38, P75, DOI 10.2298/TAM1102075B; Bezares J, 2010, J STRUCT BIOL, V170, P484, DOI 10.1016/j.jsb.2010.01.006; BIRCHALL JD, 1983, J MATER SCI, V18, P2081, DOI 10.1007/BF00555001; BLACKWELL J, 1980, J MOL BIOL, V137, P49, DOI 10.1016/0022-2836(80)90156-4; Box GE.P., 1986, EMPIRICAL MODEL BUIL; Cartwright JHE, 2007, J R SOC INTERFACE, V4, P491, DOI 10.1098/rsif.2006.0188; Checa AG, 2005, BIOMATERIALS, V26, P6404, DOI 10.1016/j.biomaterials.2005.04.016; Checa AG, 2008, MATER RES SOC S P, V1094, DOI [10.1557/PROC-1094-DD01-02, DOI 10.1557/PROC-1094-DD01-02]; Checa AG, 2013, J STRUCT BIOL, V183, P368, DOI 10.1016/j.jsb.2013.07.014; Checa AG, 2011, J STRUCT BIOL, V176, P330, DOI 10.1016/j.jsb.2011.09.011; Farre B, 2009, COMP BIOCHEM PHYS B, V152, P103, DOI 10.1016/j.cbpb.2008.10.003; GOFFINET G, 1969, COMP BIOCHEM PHYSIOL, V29, P835, DOI 10.1016/0010-406X(69)91635-1; GOFFINET G, 1979, CAH BIOL MAR, V20, P341; GREGOIRE C, 1957, J BIOPHYS BIOCHEM CY, V3, P797, DOI 10.1083/jcb.3.5.797; Gregoire C., 1972, P45; Hackman R. H., 1960, AUST J BIOL SCI, V13, P568, DOI DOI 10.1071/B19600568; HACKMAN RH, 1965, AUST J BIOL SCI, V18, P935, DOI 10.1071/BI9650935; Hare PE, 1964, REP DIR GEOPHYS LAB, V63, P267; Harper EM, 2009, ACTA ZOOL-STOCKHOLM, V90, P132, DOI 10.1111/j.1463-6395.2008.00338.x; Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372; Meyer W.T., 1913, TINTENFISCHE BESONDE; MUTVEI H, 1977, CALC TISS RES, V24, P11, DOI 10.1007/BF02223291; Nudelman F, 2006, J STRUCT BIOL, V153, P176, DOI 10.1016/j.jsb.2005.09.009; Nudelman F, 2008, J STRUCT BIOL, V162, P290, DOI 10.1016/j.jsb.2008.01.008; OKAFOR N, 1965, BIOCHIM BIOPHYS ACTA, V101, P193, DOI 10.1016/0926-6534(65)90050-3; PETERS W, 1972, COMP BIOCHEM PHYSIOL, V41, P541, DOI 10.1016/0305-0491(72)90117-4; Schaffer TE, 1997, CHEM MATER, V9, P1731, DOI 10.1021/cm960429i; TAYLOR J D, 1972, Palaeontology (Oxford), V15, P73; WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036; WEINER S, 1980, FEBS LETT, V111, P311, DOI 10.1016/0014-5793(80)80817-9; WEINER S, 1983, BIOCHEMISTRY-US, V22, P4139, DOI 10.1021/bi00286a023; Zentz F, 2001, MAR BIOTECHNOL, V3, P36, DOI 10.1007/s101260000042	35	15	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122934	10.1371/journal.pone.0122934	http://dx.doi.org/10.1371/journal.pone.0122934			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909912	gold, Green Submitted, Green Published			2022-12-27	WOS:000353376800023
J	Southwell, C; Emmerson, L; Newbery, K; McKinlay, J; Kerry, K; Woehler, E; Ensor, P				Southwell, Colin; Emmerson, Louise; Newbery, Kym; McKinlay, John; Kerry, Knowles; Woehler, Eric; Ensor, Paul			Re-Constructing Historical Adelie Penguin Abundance Estimates by Retrospectively Accounting for Detection Bias	PLOS ONE			English	Article							CLIMATE-CHANGE; ANTARCTIC PENINSULA; POPULATION-SIZE; PACIFIC SECTOR; AERIAL SURVEYS; SEA-ICE; AVAILABILITY; ENVIRONMENTS; SEABIRDS; BEHAVIOR	Seabirds and other land-breeding marine predators are considered to be useful and practical indicators of the state of marine ecosystems because of their dependence on marine prey and the accessibility of their populations at breeding colonies. Historical counts of breeding populations of these higher-order marine predators are one of few data sources available for inferring past change in marine ecosystems. However, historical abundance estimates derived from these population counts may be subject to unrecognised bias and uncertainty because of variable attendance of birds at breeding colonies and variable timing of past population surveys. We retrospectively accounted for detection bias in historical abundance estimates of the colonial, land-breeding Adelie penguin through an analysis of 222 historical abundance estimates from 81 breeding sites in east Antarctica. The published abundance estimates were de-constructed to retrieve the raw count data and then re-constructed by applying contemporary adjustment factors obtained from remotely operating time-lapse cameras. The re-construction process incorporated spatial and temporal variation in phenology and attendance by using data from cameras deployed at multiple sites over multiple years and propagating this uncertainty through to the final revised abundance estimates. Our re-constructed abundance estimates were consistently higher and more uncertain than published estimates. The re-constructed estimates alter the conclusions reached for some sites in east Antarctica in recent assessments of long-term Adelie penguin population change. Our approach is applicable to abundance data for a wide range of colonial, land-breeding marine species including other penguin species, flying seabirds and marine mammals.	[Southwell, Colin; Emmerson, Louise; Newbery, Kym; McKinlay, John; Kerry, Knowles; Woehler, Eric; Ensor, Paul] Australian Antarctic Div, Dept Environm, Kingston, Tas 7050, Australia	Australian Antarctic Division	Southwell, C (corresponding author), Australian Antarctic Div, Dept Environm, 203 Channel Highway, Kingston, Tas 7050, Australia.	colin.southwell@aad.gov.au		McKinlay, John/0000-0003-4858-2604; Chiaradia, Andre/0000-0002-6178-4211; Woehler, Eric/0000-0002-1125-0748	Australian Antarctic Division [4088]	Australian Antarctic Division	The work was funded by the Australian Antarctic Division (www.aad.gov.au) for approved AAS project 4088.	Ainley D.G., 2002, ADELIE PENGUIN BELLW, DOI DOI 10.7312/AINL12306; Ainley DG, 2005, ANTARCT SCI, V17, P171, DOI 10.1017/S0954102005002567; Barbraud C, 2006, P NATL ACAD SCI USA, V103, P6248, DOI 10.1073/pnas.0510397103; Barbraud C, 2001, NATURE, V411, P183, DOI 10.1038/35075554; Barbraud C, 2011, ANTARCT SCI, V23, P461, DOI 10.1017/S0954102011000356; BASSETT JA, 1990, EMU, V90, P58, DOI 10.1071/MU9900058; Borchers D.L., 2002, ESTIMATING ANIMAL AB; CCAMLR, 2004, CCAMLR EC MON PROGR; Croxall JP, 1979, DISTRIBUTION PENGUES; Emmerson L, 2011, MAR ECOL PROG SER, V440, P203, DOI 10.3354/meps09265; Ensor PH, 1987, BREEDING STATUS ADEL; Falla RA, 1937, BANZARE REPORT; Francis Robert C., 1994, Fisheries Oceanography, V3, P279, DOI 10.1111/j.1365-2419.1994.tb00105.x; FRASER WR, 1992, POLAR BIOL, V11, P525; Furness RW, 1997, ICES J MAR SCI, V54, P726, DOI 10.1006/jmsc.1997.0243; Horne, 1983, DISTRIBUTION PENGUIN; Kerry Knowles, 1993, Proceedings of the NIPR Symposium on Polar Biology, V6, P62; KERRY KR, 1993, WILDLIFE RES, V20, P725, DOI 10.1071/WR9930725; Kucera TE, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P9, DOI 10.1007/978-4-431-99495-4_2; LaRue MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060568; LINK WA, 1994, OIKOS, V69, P539, DOI 10.2307/3545869; Lynch HJ, 2014, AUK, V131, P457, DOI 10.1642/AUK-14-31.1; Lynch HJ, 2009, CCAMLR SCI, V16, P149; Lynch HJ, 2012, ECOLOGY, V93, P1367; Lyver PO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091188; MARSH H, 1989, J WILDLIFE MANAGE, V53, P1017, DOI 10.2307/3809604; McKinlay J, 2010, CCAMLR SCI, V17, P213; Montevecchi W.A., 1993, P217; Naveen R, 2012, POLAR BIOL, V35, P1879, DOI 10.1007/s00300-012-1230-3; Newbery KB, 2009, COLD REG SCI TECHNOL, V55, P47, DOI 10.1016/j.coldregions.2008.06.001; OConnell AF, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P1, DOI 10.1007/978-4-431-99495-4; ORTON M. N., 1963, EMU, V63, P15; Piatt JF, 2007, MAR ECOL PROG SER, V352, P199, DOI 10.3354/meps07070; Pollock Kenneth H., 2004, P43; Pollock KH, 2006, J WILDLIFE MANAGE, V70, P255, DOI 10.2193/0022-541X(2006)70[255:EAAIHE]2.0.CO;2; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Southwell C, 2010, CCAMLR SCI, V17, P229; Southwell C, 2014, HIST ADELIE PENGUIN; Southwell C, 2015, J NAT CONSERV, V23, P1, DOI 10.1016/j.jnc.2014.11.002; Southwell C, 2013, POLAR BIOL, V36, P843, DOI 10.1007/s00300-013-1310-z; Takahashi A, 2008, POLAR BIOL, V31, P1291, DOI 10.1007/s00300-008-0502-4; Thompson WL, 2002, AUK, V119, P18, DOI 10.1642/0004-8038(2002)119[0018:TRBSAF]2.0.CO;2; Thomson JA, 2012, METHODS ECOL EVOL, V3, P378, DOI 10.1111/j.2041-210X.2011.00163.x; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WHITEHEAD MD, 1990, P NIPR S POLAR BIOL, V0003; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wilson PR, 2001, MAR ECOL PROG SER, V213, P301, DOI 10.3354/meps213301; Woehler E.J., 1991, Marine Ornithology, V19, P1; Woehler EJ, 2001, STAT ASSESSMEN STATU; Woehler EJ, 1989, DISTRIBUTION ABUNDAN, V2, P71; Woehler EJ, 1993, DISTRIBUTION ABUNDAN	53	5	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123540	10.1371/journal.pone.0123540	http://dx.doi.org/10.1371/journal.pone.0123540			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909636	Green Published, gold			2022-12-27	WOS:000353376800038
J	Teng, SS; Yi, CQ; Krettek, C; Jagodzinski, M				Teng, Songsong; Yi, Chengqing; Krettek, Christian; Jagodzinski, Michael			Smoking and Risk of Prosthesis-Related Complications after Total Hip Arthroplasty: A Meta-Analysis of Cohort Studies	PLOS ONE			English	Article							TOTAL KNEE ARTHROPLASTY; INCREASED REVISION; BLOOD-FLOW; REPLACEMENT; INFECTION; FAILURE; SURGERY; QUALITY; IMPACT; RATES	Objective Increasing evidence suggests that smoking may increase the incidence of prosthesis-related complications after total hip arthroplasty (THA). We performed a meta-analysis of cohort studies to quantitatively evaluate the association between smoking and the risk of prosthesis-related complications after THA. Methods Relevant articles published before August 15, 2014, were identified by searching the PubMed, EMBASE and Cochrane library databases. Pooled risk ratios (RRs) or weighted mean differences (WMDs) with 95% confidence intervals (CIs) were calculated with either a fixed- or random-effects model. Results Six cohort studies, involving a total of 8181 participants, were included in the meta-analysis. Compared with the patients who never smoked, smokers had a significantly increased risk of aseptic loosening of prosthesis (summary RR=3.05, 95% CI: 1.42-6.58), deep infection (summary RR=3.71, 95% CI: 1.86-7.41) and all-cause revisions (summary RR=2.58, 95% CI: 1.27-5.22). However, no significant difference in the risk of implant dislocation (summary RR=1.27, 95% CI: 0.77-2.10) or length of hospital stay (WMD=0.03, 95% CI: -0.65-0.72) was found between smokers and nonsmokers. Conclusions Smoking is associated with a significantly increased risk of aseptic loosening of prosthesis, deep infection and all-cause revisions after THA, but smoking is not correlated with a risk of implant dislocation or the length of hospital stay after surgery.	[Teng, Songsong; Krettek, Christian; Jagodzinski, Michael] Hannover Med Sch, Dept Orthoped Trauma, Hannover, Germany; [Teng, Songsong; Yi, Chengqing] Shanghai Jiao Tong Univ, Dept Orthoped, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China; [Jagodzinski, Michael] Agaplesion Ev Hosp Bethel, Dept Orthoped Trauma, Buckeburg, Germany	Hannover Medical School; Shanghai Jiao Tong University	Yi, CQ (corresponding author), Shanghai Jiao Tong Univ, Dept Orthoped, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China.	ycq3000@126.com		Krettek, Christian/0000-0001-9807-0020	National Natural Science Foundation of China [30700853, 81371979]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (30700853, 81371979) to CY http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saffar N, 1999, J LONG-TERM EFF MED, V9, P23; Azodi OS, 2006, J BONE JOINT SURG BR, V88B, P1316, DOI 10.1302/0301-620X.88B10.17957; Azodi OS, 2008, ACTA ORTHOP, V79, P141, DOI 10.1080/17453670710014897; Blom AW, 2003, J BONE JOINT SURG BR, V85B, P956, DOI 10.1302/0301-620X.85B7.14095; Chen YH, 2011, INT ORTHOP, V35, P1267, DOI 10.1007/s00264-011-1243-5; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; Fender D, 1999, J BONE JOINT SURG BR, V81B, P577, DOI 10.1302/0301-620X.81B4.9859; Fini M, 2011, J BONE MINER METAB, V29, P633, DOI 10.1007/s00774-011-0309-1; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Ibrahim MS, 2013, BONE JOINT J, V95B, P1587, DOI 10.1302/0301-620X.95B12.31303; Inoue K, 1999, INT ORTHOP, V23, P330, DOI 10.1007/s002640050384; JENSEN JA, 1991, ARCH SURG-CHICAGO, V126, P1131; Kapadia BH, 2014, J ARTHROPLASTY, V29, P777, DOI 10.1016/j.arth.2013.08.023; Kapadia BH, 2012, J ARTHROPLASTY, V27, P1690, DOI 10.1016/j.arth.2012.03.057; Khan LAK, 2009, HIP INT, V19, P47, DOI 10.1177/112070000901900109; Lavernia CJ, 1999, CLIN ORTHOP RELAT R, P172; Lombardi AV, 2013, CLIN ORTHOP RELAT R, V471, P486, DOI 10.1007/s11999-012-2748-y; Lubbeke A, 2014, J ORTHOP RES, V32, P762, DOI 10.1002/jor.22603; Meldrum Russell D, 2005, Iowa Orthop J, V25, P17; Moller AM, 2003, J BONE JOINT SURG BR, V85B, P178, DOI 10.1302/0301-620X.85B2.13717; Moller AM, 2002, LANCET, V359, P114, DOI 10.1016/S0140-6736(02)07369-5; MORECRAFT R, 1994, J HAND SURG-AM, V19A, P1, DOI 10.1016/0363-5023(94)90216-X; Scharfenberger A, 2007, CAN J SURG, V50, P24; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Sorensen LT, 2012, ARCH SURG-CHICAGO, V147, P373, DOI 10.1001/archsurg.2012.5; Sorensen LT, 2009, J SURG RES, V152, P224, DOI 10.1016/j.jss.2008.02.066; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Thomsen T, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002294.pub4; Whitlock RP, 2008, EUR HEART J, V29, P2592, DOI 10.1093/eurheartj/ehn333; Woolson ST, 1999, J ARTHROPLASTY, V14, P662, DOI 10.1016/S0883-5403(99)90219-X; Wu CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085562	33	45	48	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125294	10.1371/journal.pone.0125294	http://dx.doi.org/10.1371/journal.pone.0125294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909602	gold, Green Submitted, Green Published			2022-12-27	WOS:000353376800137
J	Yamasawa, W; Tasaka, S; Betsuyaku, T; Yamaguchi, K				Yamasawa, Wakako; Tasaka, Sadatomo; Betsuyaku, Tomoko; Yamaguchi, Kazuhiro			Correlation of a Decline in Aerobic Capacity with Development of Emphysema in Patients with Chronic Obstructive Pulmonary Disease: A Prospective Observational Study	PLOS ONE			English	Article							AIR-FLOW LIMITATION; CLINICAL-FEATURES; EXERCISE CAPACITY; FOLLOW-UP; DIMENSIONS; DENSITY; EXACERBATION; PERFORMANCE; VENTILATION; SEVERITY	In patients with COPD, CT assessment of emphysema and airway disease is known to be associated with lung function and 6-minute walk distance. However, it remains to be determined whether low attenuation area (LAA) on CT is associated with aerobic capacity assessed using cardiopulmonary exercise testing (CPET). In this prospective observational study, we repeatedly conducted high-resolution CT and CPET using a treadmill in 81 COPD patients over a median interval of 3.5 years. Two investigators independently scored LAA on images obtained at the aortic arch level, tracheal bifurcation level, and supradiaphragmatic level. Grades for the images of each lung were added to yield the total LAA score. Total LAA score was negatively correlated with peak aerobic capacity (VO2) (p<0.001, r = -0.485). LAA scores of the upper (aortic arch level) and the lower (supradiaphragmatic level) lungs were both significantly associated with peak VO2. There was a significant correlation between total LAA score and peak CO2 output (VCO2) (p<0.001, r = -0.433). Total LAA score was correlated with oxygen saturation at peak exercise (p<0.001, r = -0.634) and the estimated dead space fraction (p<0.001, r = 0.416). The mean annual change in total LAA score was significantly correlated with those in peak VO2 (p<0.001, r = -0.546) and peak VCO2 (p<0.001, r = -0.488). The extent of emphysema measured by CT was associated with the results of CPET. The time-dependent changes in CPET data were also correlated with that in total LAA score. CT assessment could be a non-invasive tool to predict aerobic capacity in patients with COPD.	[Yamasawa, Wakako; Tasaka, Sadatomo; Betsuyaku, Tomoko] Keio Univ, Sch Med, Div Pulm Med, Tokyo, Japan; [Yamasawa, Wakako] Keio Univ, Sch Med, Dept Lab Med, Tokyo, Japan; [Yamaguchi, Kazuhiro] Tokyo Womens Med Univ, Med Ctr East, Comprehens & Internal Med, Tokyo, Japan	Keio University; Keio University; Tokyo Women's Medical University	Tasaka, S (corresponding author), Keio Univ, Sch Med, Div Pulm Med, Tokyo, Japan.	tasaka@cpnet.med.keio.ac.jp			Ministry of Health, Labour and Welfare, Japan	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a grant to the Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; BRUCE RA, 1973, AM HEART J, V85, P546, DOI 10.1016/0002-8703(73)90502-4; Casanova C, 2007, EUR RESPIR J, V29, P535, DOI 10.1183/09031936.00071506; Diaz AA, 2010, RESP MED, V104, P1145, DOI 10.1016/j.rmed.2010.02.023; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Fukuchi Y, 2004, RESPIROLOGY, V9, P458, DOI 10.1111/j.1440-1843.2004.00637.x; GEVENOIS PA, 1995, AM J RESP CRIT CARE, V152, P653, DOI 10.1164/ajrccm.152.2.7633722; Gietema HA, 2011, ACAD RADIOL, V18, P661, DOI 10.1016/j.acra.2011.01.011; GODDARD PR, 1982, CLIN RADIOL, V33, P379, DOI 10.1016/S0009-9260(82)80301-2; GOULD GA, 1991, EUR RESPIR J, V4, P141; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; Kanner RE, 2001, AM J RESP CRIT CARE, V164, P358, DOI 10.1164/ajrccm.164.3.2010017; Lee YK, 2008, LUNG, V186, P157, DOI 10.1007/s00408-008-9071-0; Lowery EM, 2013, CLIN INTERV AGING, V8, P1489, DOI 10.2147/CIA.S51152; Mair G, 2009, EUR RESPIR J, V33, P536, DOI 10.1183/09031936.00111808; Marin JM, 2001, AM J RESP CRIT CARE, V163, P1395, DOI 10.1164/ajrccm.163.6.2003172; Martinez CH, 2012, THORAX, V67, P399, DOI 10.1136/thoraxjnl-2011-201185; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Nakano Y, 2005, AM J RESP CRIT CARE, V171, P142, DOI 10.1164/rccm.200407-874OC; Orlandi I, 2005, RADIOLOGY, V234, P604, DOI 10.1148/radiol.2342040013; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; Rennard S, 2002, EUR RESPIR J, V20, P799, DOI 10.1183/09031936.02.03242002; Reybrouck T, 2003, CHEST, V123, P325, DOI 10.1378/chest.123.2.325; ROBERTS A, 1977, CHEST, V72, P489, DOI 10.1378/chest.72.4.489; Schroeder JD, 2013, AM J ROENTGENOL, V201, pW460, DOI 10.2214/AJR.12.10102; Schutz Y, 2002, INT J OBESITY, V26, P953, DOI 10.1038/sj.ijo.0802037; Singer J, 2011, J CARDIOPULM REHABIL, V31, P111, DOI 10.1097/HCR.0b013e3182033663; Soejima K, 2000, AM J RESP CRIT CARE, V161, P1264, DOI 10.1164/ajrccm.161.4.9905040; Suzuki M, 2014, EUR RESPIR J, V43, P1289, DOI 10.1183/09031936.00110213; SWINBURN CR, 1985, THORAX, V40, P581, DOI 10.1136/thx.40.8.581; Tanabe N, 2011, AM J RESP CRIT CARE, V183, P1653, DOI 10.1164/rccm.201009-1535OC; TARKOFF MP, 1968, AM J MED, V45, P220, DOI 10.1016/0002-9343(68)90040-5; WAGNER PD, 1977, J CLIN INVEST, V59, P203, DOI 10.1172/JCI108630; WAKAYAMA K, 1993, EUR RESPIR J, V6, P1362; WIJKSTRA PJ, 1994, THORAX, V49, P468, DOI 10.1136/thx.49.5.468	38	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125053	10.1371/journal.pone.0125053	http://dx.doi.org/10.1371/journal.pone.0125053			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909949	Green Submitted, gold, Green Published			2022-12-27	WOS:000353376800124
J	Alderliesten, T; de Vries, LS; Khalil, Y; van Haastert, IC; Benders, MJNL; Koopman-Esseboom, C; Groenendaal, F				Alderliesten, Thomas; de Vries, Linda S.; Khalil, Yara; van Haastert, Ingrid C.; Benders, Manon J. N. L.; Koopman-Esseboom, Corine; Groenendaal, Floris			Therapeutic Hypothermia Modifies Perinatal Asphyxia-Induced Changes of the Corpus Callosum and Outcome in Neonates	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; TERM INFANTS; WALLERIAN DEGENERATION; DIFFUSION; BRAIN; CHILDREN; PATTERN; MRI; LESIONS; INJURY	What Is Known about this Subject? Diffusion-weighted MRI has demonstrated changes in the corpus callosum of term neonates with perinatal asphyxia. The severity of cerebral changes demonstrated using diffusion-weighted MRI is difficult to assess without measuring values of the Apparent Diffusion Coefficient (ADC). What Is New? ADC values of the anterior part of the corpus callosum are slightly higher than of the posterior part in full term infants with perinatal asphyxia. Low ADC values of the corpus callosum were associated with an adverse outcome in infants with perinatal asphyxia. In infants treated with hypothermia lower ADC values than with normothermia were associated with a poor outcome, supporting neuroprotective effects of hypothermia Background Using MRI, changes can be detected in the corpus callosum (CC) following perinatal asphyxia which are associated with later neurodevelopmental outcome. Aim To study the association between the apparent diffusion coefficient of water (ADC) in the CC on MRI in neonates with perinatal asphyxia and neurodevelopmental outcome at 18 months of age. Subjects, Methods Of 121 infants 32 (26%) died and 13 (11%) survived with an adverse neurological outcome. Sixty-five (54%) received therapeutic hypothermia. MRI was performed within 7 days after birth using a 1.5 T or 3.0 T system, and ADC values were measured in the anterior and posterior CC. The association between ADC and composite outcome (death or abnormal neurodevelopment) was analyzed for both normothermia and hypothermia cases using receiver operating characteristics. Results ADC values of the posterior CC were lower than of the anterior part (mean difference 0.050 x 10(-3) mm(2)/s, p<0.001). Field strength did not affect ADC values. ADC values of the posterior part of the CC were significantly lower in infants with basal ganglia/thalamus or near total brain injury (p<0.001). Lower ADC values were associated with an adverse outcome, but cut-off levels were lower after hypothermia (1.024 x 10(-3) mm(2)/s vs 0.969 x 10(-3) mm(2)/s) Conclusion Low ADC values of the posterior part of the corpus callosum are associated with an adverse outcome in term or near term neonates with perinatal asphyxia. Therapeutic hypothermia slightly modifies this association, showing that lower values were needed for an adverse outcome.	[Alderliesten, Thomas; de Vries, Linda S.; Khalil, Yara; van Haastert, Ingrid C.; Benders, Manon J. N. L.; Koopman-Esseboom, Corine; Groenendaal, Floris] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Groenendaal, F (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands.	F.groenendaal@umcutrecht.nl	de Vries, Linda S/AAB-6454-2021; Groenendaal, Floris/P-6872-2019	Groenendaal, Floris/0000-0002-9284-1637				Alderliesten T, 2011, RADIOLOGY, V261, P235, DOI 10.1148/radiol.11110213; Ancora G, 2013, NEURORADIOLOGY, V55, P1017, DOI 10.1007/s00234-013-1202-5; Bednarek N, 2012, NEUROLOGY, V78, P1420, DOI 10.1212/WNL.0b013e318253d589; Cowan F, 2003, LANCET, V361, P736, DOI 10.1016/S0140-6736(03)12658-X; de Vries LS, 2010, NEURORADIOLOGY, V52, P555, DOI 10.1007/s00234-010-0674-9; Dudink J, 2008, AM J NEURORADIOL, V29, P1966, DOI 10.3174/ajnr.A1241; EKEN P, 1994, NEUROPEDIATRICS, V25, P301, DOI 10.1055/s-2008-1073044; Epelman M, 2012, PEDIATR RADIOL, V42, P321, DOI 10.1007/s00247-011-2238-5; Griffiths R, 1984, ABILITIES YOUNG CHIL; Groenendaal F, 2006, SEMIN PERINATOL, V30, P146, DOI 10.1053/j.semperi.2006.04.005; Groenendaal F, 2013, NEONATOLOGY, V104, P15, DOI 10.1159/000348823; Harteman JC, 2013, J PEDIATR-US, V163, P968, DOI 10.1016/j.jpeds.2013.06.010; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Kohlhauser C, 2000, LIFE SCI, V67, P2355, DOI 10.1016/S0024-3205(00)00816-X; Maneru C, 2003, BRAIN INJURY, V17, P1003, DOI 10.1080/0269905031000110454; Mazumdar A, 2003, AM J NEURORADIOL, V24, P1057; Nagy Z, 2005, PEDIATR RES, V58, P936, DOI 10.1203/01.pdr.0000186516.85702.61; NJIOKIKTJIEN C, 1994, BEHAV BRAIN RES, V64, P213, DOI 10.1016/0166-4328(94)90133-3; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Porter EJ, 2010, PEDIATR RES, V68, P205, DOI 10.1203/00006450-201011001-00399; RADEMAKERS RP, 1995, J COMPUT ASSIST TOMO, V19, P256, DOI 10.1097/00004728-199503000-00017; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V109, P8, DOI DOI 10.1111/J.1469-8749.2007.TB12610.X; Rutherford M, 2004, PEDIATRICS, V114, P1004, DOI 10.1542/peds.2004-0222; Rutherford M, 2010, LANCET NEUROL, V9, P39, DOI 10.1016/S1474-4422(09)70295-9; Sakai K, 2012, IEEE ENG MED BIO, P2291, DOI 10.1109/EMBC.2012.6346420; Shankaran S, 2012, ARCH DIS CHILD-FETAL, V97, pF398, DOI 10.1136/archdischild-2011-301524; Takenouchi T, 2010, PEDIATR NEUROL, V43, P190, DOI 10.1016/j.pediatrneurol.2010.04.014; Tekgul H, 2004, PEDIATR NEUROL, V31, P35, DOI 10.1016/j.pediatrneurol.2003.11.012; Twomey E, 2010, PEDIATR RADIOL, V40, P1526, DOI 10.1007/s00247-010-1692-9; van der Aa NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056784; Van Kooij BJM, 2008, PEDIATR RES, V63, P103, DOI 10.1203/PDR.0b013e31815b4435; van Rooij LGM, 2010, PEDIATRICS, V125, pE358, DOI 10.1542/peds.2009-0136; Vermeulen RJ, 2003, NEUROPEDIATRICS, V34, P72	33	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123230	10.1371/journal.pone.0123230	http://dx.doi.org/10.1371/journal.pone.0123230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923113	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600035
J	Dong, N; Xu, B; Chu, LQ; Tang, X				Dong, Ning; Xu, Bing; Chu, Liqun; Tang, Xin			Study of 27 Aqueous Humor Cytokines in Type 2 Diabetic Patients with or without Macular Edema	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VISUAL IMPAIRMENT; RISK-FACTORS; RETINOPATHY; INTERLEUKIN-6; ANGIOGENESIS; INHIBITION; EXPRESSION; FLUID; EYES	The aim of the present study was to compare the changes in the levels of 27 aqueous humor cytokines between diabetic patients with macular edema (ME) and diabetic patients without ME. Undiluted aqueous humor samples were obtained from 68 consecutive type 2 diabetic patients without ME and 56 consecutive type 2 diabetic patients with ME. The concentrations of 27 cytokines in the aqueous humor samples were measured using a multiplex bead immunoassay. Compared with diabetic patients without ME, diabetic patients with ME had significantly higher concentrations of IL-1 beta, IL-6, IL-8, IP-10, MCP-1, and VEGF in the aqueous humor. However, the concentrations of IL-10 and IL-12 were significantly lower in the diabetic patients with ME. The aqueous humor levels of IL-1 beta, IL-6, IL-8, MCP-1, IP-10, and VEGF were closely correlated with retinal macular thickness, retinal macular volume and the severity of ME. In addition, the aqueous humor levels of IL-10 and IL-12 decreased with increasing the severity of ME. A variety of cytokines associated with inflammation and angiogenesis may contribute to the pathogenesis of diabetic macular edema, and both anti-inflammatory and antiangiogenic agents should be included in the treatment of ME simultaneously.	[Dong, Ning; Xu, Bing; Chu, Liqun] Capital Med Univ, Beijing Shijitan Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Tang, Xin] Tianjin Med Univ, Tianjin Eye Hosp, Clin Coll Ophthalmol, Tianjin, Peoples R China	Capital Medical University; Tianjin Medical University	Tang, X (corresponding author), Tianjin Med Univ, Tianjin Eye Hosp, Clin Coll Ophthalmol, Tianjin, Peoples R China.	eye_tangxin@163.com						Aiello LP, 1998, DIABETES CARE, V21, P143, DOI 10.2337/diacare.21.1.143; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; [Anonymous], 1991, OPHTHALMOLOGY, V98, P823; BRESNICK GH, 1986, OPHTHALMOLOGY, V93, P989; Chernykh VV, 2015, INDIAN J OPHTHALMOL, V63, P33, DOI 10.4103/0301-4738.151464; Chou TH, 2009, EYE, V23, P1360, DOI 10.1038/eye.2008.279; Chu LQ, 2013, MOL VIS, V19, P2418; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; de Faria JML, 1999, ACTA OPHTHALMOL SCAN, V77, P170; Dieleman M, 2011, J CATARACT REFR SURG, V37, P1589, DOI 10.1016/j.jcrs.2011.03.049; Dong N, 2013, MOL VIS, V19, P1734; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fong DS, 2003, DIABETES CARE, V26, P226, DOI 10.2337/diacare.26.1.226; Funatsu H, 2002, AM J OPHTHALMOL, V133, P70, DOI 10.1016/S0002-9394(01)01269-7; Funk M, 2010, RETINA-J RET VIT DIS, V30, P1412, DOI 10.1097/IAE.0b013e3181e095c0; Graves DT, 2008, FRONT BIOSCI-LANDMRK, V13, P1227, DOI 10.2741/2757; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Jonas JB, 2012, RETINA-J RET VIT DIS, V32, P2150, DOI 10.1097/IAE.0b013e3182576d07; Kim SJ, 2007, OPHTHALMOLOGY, V114, P881, DOI 10.1016/j.ophtha.2006.08.053; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1; KLEIN R, 1995, OPHTHALMOLOGY, V102, P7; Ko F, 2012, JAMA-J AM MED ASSOC, V308, P2361, DOI 10.1001/jama.2012.85685; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Quan DN, 2010, OPHTHALMOLOGY, V117, P2146, DOI 10.1016/j.ophtha.2010.08.016; Ribeiro FP, 2003, MEDIAT INFLAMM, V12, P173, DOI 10.1080/0962935031000134897; Silvestre JS, 2000, CIRC RES, V87, P448; Sohn HJ, 2011, AM J OPHTHALMOL, V152, P686, DOI 10.1016/j.ajo.2011.03.033; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; Wu L, 2013, WORLD J DIABETES, V4, P290, DOI 10.4239/wjd.v4.i6.290; Xu AJ, 2010, MOL CELL BIOCHEM, V344, P163, DOI 10.1007/s11010-010-0539-x; Yao L, 1999, BLOOD, V93, P1612, DOI 10.1182/blood.V93.5.1612.405a13_1612_1621; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Zhou JZ, 2012, CURR EYE RES, V37, P416, DOI 10.3109/02713683.2012.661114	36	73	76	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125329	10.1371/journal.pone.0125329	http://dx.doi.org/10.1371/journal.pone.0125329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923230	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600144
J	Gwiazdowski, RA; Foottit, RG; Maw, HEL; Hebert, PDN				Gwiazdowski, Rodger A.; Foottit, Robert G.; Maw, H. Eric L.; Hebert, Paul D. N.			The Hemiptera (Insecta) of Canada: Constructing a Reference Library of DNA Barcodes	PLOS ONE			English	Article							IDENTIFICATION	DNA barcode reference libraries linked to voucher specimens create new opportunities for high-throughput identification and taxonomic re-evaluations. This study provides a DNA barcode library for about 45% of the recognized species of Canadian Hemiptera, and the publically available R workflow used for its generation. The current library is based on the analysis of 20,851 specimens including 1849 species belonging to 628 genera and 64 families. These individuals were assigned to 1867 Barcode Index Numbers (BINs), sequence clusters that often coincide with species recognized through prior taxonomy. Museum collections were a key source for identified specimens, but we also employed high-throughput collection methods that generated large numbers of unidentified specimens. Many of these specimens represented novel BINs that were subsequently identified by taxonomists, adding barcode coverage for additional species. Our analyses based on both approaches includes 94 species not listed in the most recent Canadian checklist, representing a potential 3% increase in the fauna. We discuss the development of our workflow in the context of prior DNA barcode library construction projects, emphasizing the importance of delineating a set of reference specimens to aid investigations in cases of nomenclatural and DNA barcode discordance. The identification for each specimen in the reference set can be annotated on the Barcode of Life Data System (BOLD), allowing experts to highlight questionable identifications; annotations can be added by any registered user of BOLD, and instructions for this are provided.	[Gwiazdowski, Rodger A.; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Foottit, Robert G.; Maw, H. Eric L.] Agr & Agri Food Canada, Invertebrate Biodivers Natl Environm Hlth Program, Ottawa, ON K1A 0C6, Canada; [Foottit, Robert G.; Maw, H. Eric L.] Canadian Natl Collect Insects Arachnids & Nematod, Ottawa, ON K1A 0C6, Canada	University of Guelph; Agriculture & Agri Food Canada	Gwiazdowski, RA (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	rodger.gwiazdowski@gmail.com	Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700	NSERC; Genome Canada through the Ontario Genomics Institute; Agriculture and Agri-Food Canada	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada through the Ontario Genomics Institute(Genome Canada); Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	This research was enabled by funding from NSERC, Genome Canada through the Ontario Genomics Institute, and by Agriculture and Agri-Food Canada. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich JM, 1919, ANN REPORT SMITH SON, P367; [Anonymous], 2014, GERMAN BARCODE LIFE, V5, P14; [Anonymous], 2014, QUARANTINE BARCODE L, V5, P14; Aylagas E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090529; Bartlett CR, 2002, ENTOMOL NEWS, V113, P97; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Burge S, 2012, DATABASE, V2012, P1; Chamberlain Scott A, 2013, F1000Res, V2, P191, DOI 10.12688/f1000research.2-191.v1; de Vere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037945; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; DeWaard Jeremy R., 2008, V410, P275; Dietrich CH, 2006, B ILLINOIS NATURAL H, V37, P119, DOI DOI 10.1653/0015-4040(2005)88[; Foottit RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101385; Forbes S. A., 1885, ILLINOIS DEP AGR T, V22, P1; Gibson CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037528; Gleason J, 2012, BARCODE B NEWSLETTER, V2012, P8; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Grebennikov VV, 2014, ARTHROPOD SYST PHYLO, V72, P213; Hahn CW, 1833, ZEHSCHEN BUCHHANDLUN, P147; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Heraty M.J., 2012, CLADISTICS, P1; Howe D, 2008, NATURE, V455, P47, DOI 10.1038/455047a; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jung S, 2011, MOL ECOL RESOUR, V11, P266, DOI 10.1111/j.1755-0998.2010.02945.x; Kvist S, 2013, MOL PHYLOGENET EVOL, V69, P39, DOI 10.1016/j.ympev.2013.05.012; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Maddison DR, 2012, TRENDS ECOL EVOL, V27, P72, DOI 10.1016/j.tree.2011.10.010; Maw HEL, 2000, CHECKLIST HEMIPTERA; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller JA, 2013, ZOOKEYS, P245, DOI 10.3897/zookeys.365.5787; Palisot de Beauvois A.-M.-F.-J., 1818, INSECTES RECUEILLIS, P173; Park DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018749; Pigg S, 2013, STAR; Ratnasingham S, 2011, MOL ECOL RESOUR, V11, P941, DOI 10.1111/j.1755-0998.2011.03067.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Raupach MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106940; RDC Team R, 2013, R LANG ENV STAT COMP; Rebijith KB, 2012, ENVIRON ENTOMOL, V41, P1239, DOI 10.1603/EN12096; Roskov Y, 2000, SPECIES 2000 ITIS CA; Ruedas LA, 2000, MOL PHYLOGENET EVOL, V17, P129, DOI 10.1006/mpev.2000.0737; Santschi L, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001471; Smith CR, 1926, T KANSAS ACAD SCI, V31, P77; Steinke D., 2013, BARCODE B NEWSLETTER, P8; Suter W.R., 1974, Entomological News, V85, P298; Tembe S, 2014, META GENE, V2, P737, DOI 10.1016/j.mgene.2014.09.006; Uhler P.R., 1878, P BOSTON SOC NATURAL, V19, P365; Vasilevsky NA, 2013, PEERJ, V1, DOI 10.7717/peerj.148; Virgilio M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031581; Wei LL, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.80; Wheeler QD, 2010, NATURE ED KNOWLEDGE, V3, P6; Zahniser JN, 2013, EUR J TAXON, V45, P1, DOI 10.5852/ejt.2013.45; Zhou CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034528	54	54	56	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125635	10.1371/journal.pone.0125635	http://dx.doi.org/10.1371/journal.pone.0125635			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923328	Green Published, gold			2022-12-27	WOS:000353711600157
J	Knabel, MK; Ramachandran, K; Karhadkar, S; Hwang, HW; Creamer, TJ; Chivukula, RR; Sheikh, F; Clark, KR; Torbenson, M; Montgomery, RA; Cameron, AM; Mendell, JT; Warren, DS				Knabel, Matthew K.; Ramachandran, Kalyani; Karhadkar, Sunil; Hwang, Hun-Way; Creamer, Tyler J.; Chivukula, Raghu R.; Sheikh, Farooq; Clark, K. Reed; Torbenson, Michael; Montgomery, Robert A.; Cameron, Andrew M.; Mendell, Joshua T.; Warren, Daniel S.			Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS; COLLAGEN EXPRESSION; PULMONARY-FIBROSIS; RENAL FIBROSIS; HUMAN-DISEASE; MICRORNAS; CELLS; CANCER; TRANSDUCTION; REGULATOR	Fibrosis refers to the accumulation of excess extracellular matrix (ECM) components and represents a key feature of many chronic inflammatory diseases. Unfortunately, no currently available treatments specifically target this important pathogenic mechanism. MicroRNAs (miRNAs) are short, non-coding RNAs that post-transcriptionally repress target gene expression and the development of miRNA-based therapeutics is being actively pursued for a diverse array of diseases. Because a single miRNA can target multiple genes, often within the same pathway, variations in the level of individual miRNAs can potently influence disease phenotypes. Members of the miR-29 family, which include miR-29a, miR-29b and miR-29c, are strong inhibitors of ECM synthesis and fibrosis-associated decreases in miR-29 have been reported in multiple organs. We observed downregulation of miR-29a/b/c in fibrotic livers of carbon tetrachloride (CCl4) treated mice as well as in isolated human hepatocytes exposed to the pro-fibrotic cytokine TGF-beta. Importantly, we demonstrate that a single systemic injection of a miR-29a expressing adeno-associated virus (AAV) can prevent and even reverse histologic and biochemical evidence of fibrosis despite continued exposure to CCl4. The observed therapeutic benefits were associated with AAV transduction of hepatocytes but not hepatic stellate cells, which are the main ECM producing cells in fibroproliferative liver diseases. Our data therefore demonstrate that delivery of miR-29 to the hepatic parenchyma using a clinically relevant gene delivery platform protects injured livers against fibrosis and, given the consistent fibrosis-associated downregulation of miR-29, suggests AAV-miR-29 based therapies may be effective in treating a variety of fibroproliferative disorders.	[Knabel, Matthew K.; Ramachandran, Kalyani; Creamer, Tyler J.; Montgomery, Robert A.; Cameron, Andrew M.; Warren, Daniel S.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Knabel, Matthew K.; Ramachandran, Kalyani; Creamer, Tyler J.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Karhadkar, Sunil] Temple Univ, Sch Med, Dept Surg, Philadelphia, PA 19122 USA; [Hwang, Hun-Way] Rockefeller Univ, Lab Mol Neurooncol, New York, NY 10021 USA; [Chivukula, Raghu R.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Sheikh, Farooq] Washington Hosp Ctr, Dept Cardiol, Washington, DC 20010 USA; [Clark, K. Reed] Nationwide Childrens Hosp, Ctr Gene Therapy, Res Inst, Columbus, OH USA; [Torbenson, Michael] Mayo Clin, Dept Pathol, Rochester, MN USA; [Mendell, Joshua T.] UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX USA; [Mendell, Joshua T.] UT Southwestern Med Ctr, Ctr Regenerat Sci & Med, Dallas, TX USA; [Mendell, Joshua T.] UT Southwestern Med Ctr, Simmons Canc Ctr, Dallas, TX USA	Johns Hopkins University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Rockefeller University; Harvard University; Massachusetts General Hospital; MedStar Washington Hospital Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Mayo Clinic; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Warren, DS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA.	warren@jhmi.edu	Karhadkar, Sunil/Y-9235-2019	Karhadkar, Sunil/0000-0001-7943-0203; Hwang, Hun-Way/0000-0003-0522-1577; Creamer, Tyler/0000-0003-1872-5248	NIH [R01CA120185, P01CA134292]; Cancer Prevention and Research Institute of Texas; Charles T. Bauer Foundation; NATIONAL CANCER INSTITUTE [P01CA134292, R01CA120185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Charles T. Bauer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01CA120185 and P01CA134292 (J. Mendell), the Cancer Prevention and Research Institute of Texas (J. Mendell) and by a grant from the Charles T. Bauer Foundation (D. Warren). K. Reed Clark's participation occurred during his prior affiliation with the Center for Gene Therapy at The Research Institute at Nationwide Children's Hospital in Columbus, Ohio. Therefore, Dimension Therapeutics did not provide any financial support in the form of authors' salaries and/or research materials and played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonnenc M, 2013, CIRC RES, V113, P1138, DOI 10.1161/CIRCRESAHA.113.302400; Bader AG, 2011, GENE THER, V18, P1121, DOI 10.1038/gt.2011.79; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bowen T, 2013, J PATHOL, V229, P274, DOI 10.1002/path.4119; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Grimm D, 2006, J VIROL, V80, P426, DOI 10.1128/JVI.80.1.426-439.2006; Hu G, 2012, CELL DEATH DIS, V3, P381, DOI DOI 10.1038/CDDIS.2012.114; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; Kogure T, 2012, J CELL MOL MED, V16, P2647, DOI 10.1111/j.1582-4934.2012.01578.x; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kriegel AJ, MIR 29 FAMILY GENOMI; Kwiecinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024568; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372; Luna C, 2011, INVEST OPHTH VIS SCI, V52, P3567, DOI 10.1167/iovs.10-6448; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Nakai H, 2005, J VIROL, V79, P214, DOI 10.1128/JVI.79.1.214-224.2005; Ott CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016250; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Roderburg C, 2010, HEPATOLOGY, V53, P209; Rutnam ZJ, 2013, MATRIX BIOL, V32, P74, DOI 10.1016/j.matbio.2012.11.003; Song SH, 2004, P NATL ACAD SCI USA, V101, P2112, DOI 10.1073/pnas.0307833100; Thorsen SB, 2012, CANCER J, V18, P275, DOI 10.1097/PPO.0b013e318258b5d6; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Vettori Serena, 2012, Open Rheumatol J, V6, P130, DOI 10.2174/1874312901206010130; Villarreal G, 2011, INVEST OPHTH VIS SCI, V52, P3391, DOI 10.1167/iovs.10-6165; WAKABAYASHIITO N, 1994, J BIOL CHEM, V269, P29831; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wang LJ, 2012, MOL THER, V20, P1222, DOI 10.1038/mt.2012.35; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xiao J, 2012, MOL THER, V20, P1251, DOI 10.1038/mt.2012.36; Zhang YQ, 2012, J BIOL CHEM, V287, P14851, DOI 10.1074/jbc.M111.314922	38	34	37	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124411	10.1371/journal.pone.0124411	http://dx.doi.org/10.1371/journal.pone.0124411			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923107	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600083
J	Stepanek, J; Kopecky, V; Turpin, PY; Li, ZL; Alpert, B; Zentz, C				Stepanek, Josef; Kopecky, Vladimir, Jr.; Turpin, Pierre-Yves; Li, Zhenlin; Alpert, Bernard; Zentz, Christian			DNA Electric Charge Oscillations Govern Protein-DNA Recognition	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; HUMAN C-FOS; TRANSCRIPTION FACTOR; RAMAN-SPECTROSCOPY; TEMPERATURE-DEPENDENCE; MELTING TRANSITIONS; BINDING; ELEMENT; IDENTIFICATION; SPECIFICITY	The transcriptional activity of the serum response factor (SRF) protein is triggered by its binding to a 10-base-pair DNA consensus sequence designated the CArG box, which is the core sequence of the serum response element (SRE). Sequence-specific recognition of the CArG box by a core domain of 100 amino acid residues of SRF (core-SRF) was asserted to depend almost exclusively on the intrinsic SRE conformation and on the degree of protein-induced SRE bending. Nevertheless, this paradigm was invalidated by a temperature-dependent Raman spectroscopy study of 20-mer oligonucleotides involved in bonding interactions with core-SRF that reproduced both wild type and mutated c-fos SREs. Indeed, the SRE moieties that are complexed with core-SRF exhibit permanent interconversion dynamics between bent and linear conformers. Thus, sequence-specific recognition of the CArG box by core-SRF cannot be explained only in terms of the three-dimensional structure of the SRE. A particular dynamic pairing process discriminates between the wild type and mutated complexes. Specific oscillations of the phosphate charge network of the SRE govern the recognition between both partners rather than an intrinsic set of conformations of the SRE.	[Stepanek, Josef; Turpin, Pierre-Yves] Univ Paris 06, CNRS, Lab Jean Perrin, FRE 3231, Paris, France; [Stepanek, Josef; Alpert, Bernard; Zentz, Christian] Univ Paris 06, ER12, Paris, France; [Stepanek, Josef; Kopecky, Vladimir, Jr.] Charles Univ Prague, Fac Math & Phys, Inst Phys, Prague, Czech Republic; [Li, Zhenlin] Univ Paris 06, UR4, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Charles University Prague; UDICE-French Research Universities; Sorbonne Universite	Kopecky, V (corresponding author), Charles Univ Prague, Fac Math & Phys, Inst Phys, Prague, Czech Republic.	kopecky@karlov.mff.cuni.cz	Kopecký, Vladimír/A-6965-2008; Stepanek, Josef/B-2309-2009; Li, Zhenlin/E-3937-2016	Kopecký, Vladimír/0000-0002-7331-9018; Stepanek, Josef/0000-0001-7307-2257; LI, Zhenlin/0000-0002-3706-4505	Czech Science Foundation [15-06785S]	Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by the Czech Science Foundation (http://www.gacr.cz/; No. 15-06785S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benevides JM, 2005, J RAMAN SPECTROSC, V36, P279, DOI 10.1002/jrs.1324; Chen CY, 1997, MOL ENDOCRINOL, V11, P812, DOI 10.1210/me.11.6.812; Deng H, 2000, NUCLEIC ACIDS RES, V28, P3379, DOI 10.1093/nar/28.17.3379; GREENBERG ME, 1987, MOL CELL BIOL, V7, P1217, DOI 10.1128/MCB.7.3.1217; GUSTAFSON TA, 1989, P NATL ACAD SCI USA, V86, P2162, DOI 10.1073/pnas.86.7.2162; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; Huet A, 2005, FEBS J, V272, P3105, DOI 10.1111/j.1742-4658.2005.04724.x; LEUNG S, 1989, NUCLEIC ACIDS RES, V17, P1177, DOI 10.1093/nar/17.3.1177; Lickwar CR, 2012, NATURE, V484, P251, DOI 10.1038/nature10985; Mericskay M, 2000, DEV BIOL, V226, P192, DOI 10.1006/dbio.2000.9865; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Mo Y, 2001, J MOL BIOL, V314, P495, DOI 10.1006/jmbi.2001.5138; Movileanu L, 2002, BIOPOLYMERS, V63, P181, DOI 10.1002/bip.10022; Movileanu L, 1999, J RAMAN SPECTROSC, V30, P637, DOI 10.1002/(SICI)1097-4555(199908)30:8<637::AID-JRS431>3.0.CO;2-B; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; NURRISH SJ, 1995, MOL CELL BIOL, V15, P4076; Overman SA, 1999, BIOCHEMISTRY-US, V38, P4018, DOI 10.1021/bi982901e; OVERMAN SA, 1995, BIOCHEMISTRY-US, V34, P5440, DOI 10.1021/bi00016a015; PELLEGRINI L, 1995, NATURE, V376, P490, DOI 10.1038/376490a0; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; SCHWARZSOMMER Z, 1990, SCIENCE, V250, P931, DOI 10.1126/science.250.4983.931; SHARROCKS AD, 1993, NUCLEIC ACIDS RES, V21, P215, DOI 10.1093/nar/21.2.215; Shepard W, 2011, FEBS J, V278, P2689, DOI 10.1111/j.1742-4658.2011.08195.x; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; Stepanek J, 2007, FEBS J, V274, P2333, DOI 10.1111/j.1742-4658.2007.05768.x; Stepanek J, 2010, BIOCHEM BIOPH RES CO, V391, P203, DOI 10.1016/j.bbrc.2009.11.032; TREISMAN R, 1992, EMBO J, V11, P4631, DOI 10.1002/j.1460-2075.1992.tb05565.x; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; Tuma R, 2005, J RAMAN SPECTROSC, V36, P307, DOI 10.1002/jrs.1323; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; West AG, 1997, MOL CELL BIOL, V17, P2876, DOI 10.1128/MCB.17.5.2876; Yu LP, 1996, BIOCHEMISTRY-US, V35, P9661, DOI 10.1021/bi960507f	34	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124444	10.1371/journal.pone.0124444	http://dx.doi.org/10.1371/journal.pone.0124444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923532	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600087
J	Lohbeck, M; Lebrija-Trejos, E; Martinez-Ramos, M; Meave, JA; Poorter, L; Bongers, F				Lohbeck, Madelon; Lebrija-Trejos, Edwin; Martinez-Ramos, Miguel; Meave, Jorge A.; Poorter, Lourens; Bongers, Frans			Functional Trait Strategies of Trees in Dry and Wet Tropical Forests Are Similar but Differ in Their Consequences for Succession	PLOS ONE			English	Article							PLANT ECONOMICS SPECTRUM; LEAF LIFE-SPANS; SEED SIZE; SECONDARY SUCCESSION; TRADE-OFF; DROUGHT; SHADE; TOLERANCE; RESPONSES; SEEDLINGS	Global plant trait studies have revealed fundamental trade-offs in plant resource economics. We evaluated such trait trade-offs during secondary succession in two species-rich tropical ecosystems that contrast in precipitation: dry deciduous and wet evergreen forests of Mexico. Species turnover with succession in dry forest largely relates to increasing water availability and in wet forest to decreasing light availability. We hypothesized that while functional trait trade-offs are similar in the two forest systems, the successful plant strategies in these communities will be different, as contrasting filters affect species turnover. Research was carried out in 15 dry secondary forest sites (5-63 years after abandonment) and in 17 wet secondary forest sites (<1-25 years after abandonment). We used 11 functional traits measured on 132 species to make species-trait PCA biplots for dry and wet forest and compare trait trade-offs. We evaluated whether multivariate plant strategies changed during succession, by calculating a 'Community-Weighted Mean' plant strategy, based on species scores on the first two PCA-axes. Trait spectra reflected two main trade-off axes that were similar for dry and wet forest species: acquisitive versus conservative species, and drought avoiding species versus evergreen species with large animal-dispersed seeds. These trait associations were consistent when accounting for evolutionary history. Successional changes in the most successful plant strategies reflected different functional trait spectra depending on the forest type. In dry forest the community changed from having drought avoiding strategies early in succession to increased abundance of evergreen strategies with larger seeds late in succession. In wet forest the community changed from species having mainly acquisitive strategies to those with more conservative strategies during succession. These strategy changes were explained by increasing water availability during dry forest succession and increasing light scarcity during wet forest succession. Although similar trait spectra were observed among dry and wet secondary forest species, the consequences for succession were different resulting from contrasting environmental filters.	[Lohbeck, Madelon; Lebrija-Trejos, Edwin; Poorter, Lourens; Bongers, Frans] Wageningen Univ, Forest Ecol & Forest Management Grp, NL-6700 AA Wageningen, Netherlands; [Lebrija-Trejos, Edwin] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Lohbeck, Madelon; Martinez-Ramos, Miguel] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia 58190, Michoacan, Mexico; [Lebrija-Trejos, Edwin; Meave, Jorge A.] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Mexico City 04510, DF, Mexico	Wageningen University & Research; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Lohbeck, M (corresponding author), Wageningen Univ, Forest Ecol & Forest Management Grp, POB 47, NL-6700 AA Wageningen, Netherlands.	madelon.lohbeck@wur.nl	Poorter, Lourens/AAL-1709-2021; Martínez-Ramos, Miguel/G-8451-2019; Meave, Jorge/B-3673-2008; Lohbeck, Madelon/M-6390-2014	Martínez-Ramos, Miguel/0000-0002-7785-1917; Meave, Jorge/0000-0002-6241-8803; Lohbeck, Madelon/0000-0002-3959-1800; Lebrija-Trejos, Edwin/0000-0003-1511-1718; Poorter, Lourens/0000-0003-1391-4875	Wageningen University; Wageningen Research Center; NSF-LTREB [DEB-0639393, DEB 1147429]; SEMARNAT-CONACYT [2002-C01-0597]; SEP-CONACYT [CB-2005-01-51043, 2009-129740]; CONACYT; CONACYT-SEMARNAT [2002-C01-0267]; PAPIIT [IN216007]; SNI, Panama; SENACYT, Panama; Nucleo DiverSus project by Inter-American Institute for Global Change Research (IAI)CRN; SGP-CRA (National Science Foundation) [GEO-0452325, GEO-1138881];  [SEP CONACYT-2009-01-128136]; Directorate For Geosciences [1138881] Funding Source: National Science Foundation; Division Of Environmental Biology [1147429] Funding Source: National Science Foundation	Wageningen University(European Commission); Wageningen Research Center; NSF-LTREB(National Science Foundation (NSF)); SEMARNAT-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); SEP-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT-SEMARNAT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); SNI, Panama; SENACYT, Panama; Nucleo DiverSus project by Inter-American Institute for Global Change Research (IAI)CRN; SGP-CRA (National Science Foundation); ; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding: ML and FB were supported by a research grant from Wageningen University and Research Center. FB and MMR were supported by NSF-LTREB DEB-0639393 and #DEB 1147429. MMR was supported by grants SEMARNAT-CONACYT 2002-C01-0597, SEP-CONACYT CB-2005-01-51043, SEP-CONACYT 2009-129740. ELT acknowledges support by CONACYT (personal scholarship), CONACYT-SEMARNAT (grant 2002-C01-0267), PAPIIT (grant IN216007) and SNI, SENACYT, Panama. JAM was supported by SEP CONACYT-2009-01-128136. LP was partly supported by the Nucleo DiverSus project, which was supported by the Inter-American Institute for Global Change Research (IAI)CRN 2015 and SGP-CRA2015 (through National Science Foundation grants GEO-0452325 and GEO-1138881). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 1999, AM J BOT, V86, P1272, DOI 10.2307/2656775; AUGSPURGER CK, 1984, OECOLOGIA, V61, P211, DOI 10.1007/BF00396763; Baltzer JL, 2008, FUNCT ECOL, V22, P221, DOI 10.1111/j.1365-2435.2007.01374.x; Baraloto C, 2010, ECOL LETT, V13, P1338, DOI 10.1111/j.1461-0248.2010.01517.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bullock Stephen H., 1995, P277, DOI 10.1017/CBO9780511753398.011; Cavender-Bares J, 2004, ECOL MONOGR, V74, P635, DOI 10.1890/03-4007; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Dahlgren JP, 2006, J VEG SCI, V17, P577, DOI 10.1111/j.1654-1103.2006.tb02481.x; Dalling JW, 2002, J ECOL, V90, P557, DOI 10.1046/j.1365-2745.2002.00695.x; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; FAO, 2020, GLOBAL FOREST RESOUR; Fortunel C, 2012, FUNCT ECOL, V26, P1153, DOI 10.1111/j.1365-2435.2012.02020.x; FOSTER SA, 1985, ECOLOGY, V66, P773, DOI 10.2307/1940538; Freschet GT, 2010, J ECOL, V98, P362, DOI 10.1111/j.1365-2745.2009.01615.x; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Givnish TJ, 2002, SILVA FENN, V36, P703, DOI 10.14214/sf.535; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; HAMMOND DS, 1995, ECOLOGY, V76, P2544, DOI 10.2307/2265827; Holmgren M, 2000, OIKOS, V90, P67, DOI 10.1034/j.1600-0706.2000.900107.x; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Ishida A, 2008, OECOLOGIA, V156, P193, DOI 10.1007/s00442-008-0965-6; Jager MM, 2015, J ECOL, V103, P374, DOI 10.1111/1365-2745.12366; Jansen PA, 2008, ECOGRAPHY, V31, P43, DOI 10.1111/j.2007.0906-7590.05156.x; Kahmen S, 2004, J VEG SCI, V15, P21, DOI 10.1111/j.1654-1103.2004.tb02233.x; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kitajima K, 2012, NEW PHYTOL, V195, P640, DOI 10.1111/j.1469-8137.2012.04203.x; Kitajima K, 2010, NEW PHYTOL, V186, P708, DOI 10.1111/j.1469-8137.2010.03212.x; Kursar TA, 2009, FUNCT ECOL, V23, P93, DOI 10.1111/j.1365-2435.2008.01483.x; Lavorel S, 2008, FUNCT ECOL, V22, P134, DOI 10.1111/j.1365-2435.2007.01339.x; Lebrija-Trejos E, 2008, BIOTROPICA, V40, P422, DOI 10.1111/j.1744-7429.2008.00398.x; Lebrija-Trejos E, 2011, J TROP ECOL, V27, P477, DOI 10.1017/S0266467411000253; Leishman M. R., 2000, Seeds: the ecology of regeneration in plant communities, P31, DOI 10.1079/9780851994321.0031; Lohbeck M, 2013, ECOLOGY, V94, P1211, DOI 10.1890/12-1850.1; MA, 2005, MILL EC ASS; Markesteijn L, 2009, J ECOL, V97, P311, DOI 10.1111/j.1365-2745.2008.01466.x; Martinez-Garza C, 2013, FOREST ECOL MANAG, V303, P35, DOI 10.1016/j.foreco.2013.03.046; Mendez-Alonzo R, 2013, TREES-STRUCT FUNCT, V27, P745, DOI 10.1007/s00468-012-0829-x; Mendez-Alonzo R, 2012, ECOLOGY, V93, P2397, DOI 10.1890/11-1213.1; Moles AT, 2005, P NATL ACAD SCI USA, V102, P10540, DOI 10.1073/pnas.0501473102; Nicotra AB, 1999, ECOLOGY, V80, P1908, DOI 10.1890/0012-9658(1999)080[1908:SHOLAW]2.0.CO;2; Niinemets U, 1998, PLANT ECOL, V134, P1, DOI 10.1023/A:1009773704558; Oksanen J, 2011, R PACKAGE VEGAN COMM; Pakeman RJ, 2007, APPL VEG SCI, V10, P91, DOI 10.1111/j.1654-109X.2007.tb00507.x; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perez-Garcia E. A., 2001, Acta Botanica Mexicana, P19; Perez-Garcia EA, 2010, FOLIA GEOBOT, V45, P143, DOI 10.1007/s12224-010-9064-7; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pineda-Garcia F, 2013, PLANT CELL ENVIRON, V36, P405, DOI 10.1111/j.1365-3040.2012.02582.x; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Poorter L, ECOLOGY IN PRESS; Poorter L, 2008, BIOTROPICA, V40, P321, DOI 10.1111/j.1744-7429.2007.00380.x; R Development Core Team, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUR0IMAGE.2011.01.013]; REICH PB, 1991, OECOLOGIA, V86, P16, DOI 10.1007/BF00317383; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Romero C, 2008, CAN J FOREST RES, V38, P611, DOI 10.1139/X07-205; Ross MS, 2001, BIOTROPICA, V33, P23, DOI 10.1111/j.1744-7429.2001.tb00154.x; Sack L, 2004, OIKOS, V107, P110, DOI 10.1111/j.0030-1299.2004.13184.x; Sterck FJ, 2006, AM NAT, V167, P758, DOI 10.1086/503056; van Breugel M, 2006, J TROP ECOL, V22, P663, DOI 10.1017/S0266467406003452; Villar R, 2001, NEW PHYTOL, V151, P213, DOI 10.1046/j.1469-8137.2001.00147.x; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114; Wright IJ, 2007, ANN BOT-LONDON, V99, P1003, DOI 10.1093/aob/mcl066; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yates MJ, 2010, FUNCT ECOL, V24, P485, DOI 10.1111/j.1365-2435.2009.01678.x; YOUNG KR, 1987, VEGETATIO, V71, P157; Zieminska K, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt046	72	82	90	5	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123741	10.1371/journal.pone.0123741	http://dx.doi.org/10.1371/journal.pone.0123741			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919023	gold, Green Submitted, Green Published			2022-12-27	WOS:000353659400033
J	Lopez, DS; Wang, R; Tsilidis, KK; Zhu, HR; Daniel, CR; Sinha, A; Canfield, S				Lopez, David S.; Wang, Run; Tsilidis, Konstantinos K.; Zhu, Huirong; Daniel, Carrie R.; Sinha, Arup; Canfield, Steven			Role of Caffeine Intake on Erectile Dysfunction in US Men: Results from NHANES 2001-2004	PLOS ONE			English	Article							SEXUAL DYSFUNCTION; RISK-FACTORS; PREVALENCE; OBESITY; ADULTS	Objectives Caffeine is consumed by more than 85% of adults and little is known about its role on erectile dysfunction (ED) in population-based studies. We investigated the association of caffeine intake and caffeinated beverages with ED, and whether these associations vary among comorbidities for ED. Material and Method Data were analyzed for 3724 men (>= 20 years old) who participated in the National Health and Nutrition Examination Survey (NHANES). ED was assessed by a single question during a self-paced, computer-assisted self-interview. We analyzed 24-h dietary recall data to estimate caffeine intake (mg/day). Multivariable logistic regression analyses using appropriate sampling weights were conducted. Results We found that men in the 3rd (85-170 mg/day) and 4th (171-303 mg/day) quintiles of caffeine intake were less likely to report ED compared to men in the lowest 1st quintile (0-7 mg/day) [OR: 0.58; 95% CI, 0.37-0.89; and OR: 0.61; 95% CI, 0.38-0.97, respectively], but no evidence for a trend. Similarly, among overweight/obese and hypertensive men, there was an inverse association between higher quintiles of caffeine intake and ED compared to men in the lowest 1st quintile, P <= 0.05 for each quintile. However, only among men without diabetes we found a similar inverse association (P-trend = 0.01). Conclusion Caffeine intake reduced the odds of prevalent ED, especially an intake equivalent to approximately 2-3 daily cups of coffee (170-375 mg/day). This reduction was also observed among overweight/obese and hypertensive, but not among diabetic men. Yet, these associations are warranted to be investigated in prospective studies.	[Lopez, David S.; Zhu, Huirong] Univ Texas Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77004 USA; [Lopez, David S.; Wang, Run; Canfield, Steven] Univ Texas Houston, Sch Med, Div Urol, Houston, TX USA; [Tsilidis, Konstantinos K.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Daniel, Carrie R.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Sinha, Arup] Univ Texas Houston, Sch Publ Hlth, Div Biostat, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Ioannina; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Lopez, DS (corresponding author), Univ Texas Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77004 USA.	David.S.Lopez@uth.tmc.edu		Lopez, David S./0000-0002-2321-0372; Tsilidis, Konstantinos/0000-0002-8452-8472	Division of Urology - The University of Texas- Medical School at Houston	Division of Urology - The University of Texas- Medical School at Houston	Funding: Dr. David S. Lopez was supported by the Division of Urology - The University of Texas- Medical School at Houston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebiyi A, 2004, CLIN EXP PHARMACOL P, V31, P82, DOI 10.1111/j.1440-1681.2004.03955.x; Ahuja JKA, 2012, USDA FOOD NUTR DATAB; Akkus E, 2002, EUR UROL, V41, P298, DOI 10.1016/S0302-2838(02)00027-1; [Anonymous], 1994, Vital Health Stat 1, P1; Bernert JT, 1997, CLIN CHEM, V43, P2281; Berrada S, 2003, INT J IMPOT RES, V15, pS3, DOI 10.1038/sj.ijir.3900968; Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883; DIOKNO AC, 1990, ARCH INTERN MED, V150, P197, DOI 10.1001/archinte.150.1.197; Ford ES, 2003, DIABETES CARE, V26, P575, DOI 10.2337/diacare.26.3.575; Francis ME, 2007, J UROLOGY, V178, P591, DOI 10.1016/j.juro.2007.03.127; Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027; Guay Andre T, 2003, Endocr Pract, V9, P77; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Janiszewski PM, 2009, J SEX MED, V6, P1990, DOI 10.1111/j.1743-6109.2009.01302.x; Laumann EO, 2008, J SEX MED, V5, P2300, DOI 10.1111/j.1743-6109.2008.00974.x; Lue TF, 2000, NEW ENGL J MED, V342, P1802, DOI 10.1056/NEJM200006153422407; Martin SA, 2014, J SEX MED, V11, P1136, DOI 10.1111/jsm.12483; Moore CR, 2006, ASIAN J ANDROL, V8, P675, DOI 10.1111/j.1745-7262.2006.00223.x; National Center for Health Statistics. National Health and Nutrition Examination Survey, 2001 2004 DAT DOC CO; O'Donnell AB, 2005, J GEN INTERN MED, V20, P515, DOI 10.1111/j.1525-1497.2005.0076.x; O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035; Leon-Carmona JR, 2011, J PHYS CHEM B, V115, P4538, DOI 10.1021/jp201383y; Selvin E, 2007, AM J MED, V120, P151, DOI 10.1016/j.amjmed.2006.06.010; Shamloul R, 2013, LANCET, V381, P153, DOI 10.1016/S0140-6736(12)60520-0; Shiri R, 2004, INT J IMPOT RES, V16, P389, DOI 10.1038/sj.ijir.3901196; Walsh TJ, 2014, INT J IMPOT RES, V26, P112, DOI 10.1038/ijir.2013.46; Wessells H, 2007, J UROLOGY, V177, P1675, DOI 10.1016/j.juro.2007.01.057; Yang R, 2008, J ANDROL, V29, P586, DOI 10.2164/jandrol.107.004721; Zhang Q, 2009, ETHNIC HEALTH, V14, P439, DOI 10.1080/13557850802699155	29	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123547	10.1371/journal.pone.0123547	http://dx.doi.org/10.1371/journal.pone.0123547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919661	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400029
J	Battaggia, A; Donzelli, A; Font, M; Molteni, D; Galvano, A				Battaggia, Alessandro; Donzelli, Alberto; Font, Maria; Molteni, Davide; Galvano, Antonio			Clinical Efficacy and Safety of Ezetimibe on Major Cardiovascular Endpoints: Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							EXTENDED-RELEASE NIACIN; SIMVASTATIN; THERAPY; ATHEROSCLEROSIS; DISEASE; BIAS; INTERVENTION; CHOLESTEROL; PROTECTION; OUTCOMES	Background Randomized clinical trials (RCTs) about Ezetimibe's efficacy on patient-oriented outcomes have given discordant results. The aim of this study was to determine the net effect of Ezetimibe and of the widely marketed combination, Ezetimibe+simvastatin, on mortality and morbidity outcomes. Methods and Findings We searched for RCT on Ezetimibe using MEDLINE, CCTR, EMBASE, ClinicalTrials.gov databases up to December 2013, Merck and Novartis online registers, and personal communications. Two authors independently selected trials fulfilling these criteria: RCTs comparing Ezetimibe +/- statin or another lipid-lowering drug against placebo, or against the same lipid-lowering drug at the same dosage, with a follow-up at least 24 weeks and one or more of these outcomes: all-cause mortality, cardiovascular (CV) mortality, stroke, myocardial infarction (MI), cancer, serious adverse events (SAEs); we assessed the risk of bias using the Cochrane checklist. We extracted the data for major clinical events as a dichotomous measure, with the patient the unit of analysis. Pooled analysis was done with random and fixed effect based models. Trials comparing Ezetimibe plus a lipid-lowering drug against the same lipidlowering drug representing the net effect of Ezetimibe, showed a nonsignificant tendency toward damage for cancer, MI, stroke and SAEs. Ezetimibe+simvastatin vs. simvastatin alone showed a stronger tendency towards a higher risk for all-cause death (2.52; 0.65-9.74), CV death (3.04; 0.48-19.21), non-CV death (3.03; 0.12-73.50), MI (1.91; 0.428.70), stroke (2.38; 0.46-12.35), cancer (RR 11.11; 0.62-198.29), and SAEs (1.45; 0.952.23). Limitations include small numbers of events and inadequate power of the pooling. Trials comparing Ezetimibe+simvastatin vs placebo showed non-significant effects: MI (0.81; 0.66-1.00 p = 0.051), all-cause death (1.02; 0.95-1.09), CV death (0.91; 0.80-1.04), non-CV death (108; 0.99-1.18), stroke (0.86; 0.72-1.04), cancer (1.18; 0.80-1.74), SAEs (1.01; 0.961.06). Conclusions Ezetimibe +/- simvastatin had inconsistent effects on important outcomes. No firm conclusions are possible, but findings indicative of damage suggest much more selective use of Ezetimibe +/- simvastatin.	[Battaggia, Alessandro; Font, Maria] Infofarma Unita Locale Socio Sanitaria 20, Verona, Italy; [Donzelli, Alberto] Azienda Sanitaria Locale Milano, Milan, Italy; [Molteni, Davide] Univ Milan, Milan, Italy; [Galvano, Antonio] Univ Palermo, Palermo, Italy	University of Milan; University of Palermo	Battaggia, A (corresponding author), Infofarma Unita Locale Socio Sanitaria 20, Verona, Italy.	a.battaggia@libero.it	Battaggia, Alessandro/A-9581-2019	Battaggia, Alessandro/0000-0003-2067-6422; Donzelli, Alberto/0000-0002-4365-6814; Galvano, Antonio/0000-0003-4365-5683				Arimura T, 2012, J CARDIOL, V60, P111, DOI 10.1016/j.jjcc.2012.03.002; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Ballantyne CM, 2004, INT J CLIN PRACT, V58, P653, DOI 10.1111/j.1368-5031.2004.00278.x; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Borenstein M, 2008, INTRO METAANALYSIS; Collins R, 2003, LANCET, V361, P2005; Crowther MJ, 2013, STATA J, V13, P451, DOI 10.1177/1536867X1301300302; Doggrell SA, 2012, EXPERT OPIN PHARMACO, V13, P1469, DOI 10.1517/14656566.2012.696098; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fleg JL, 2008, J AM COLL CARDIOL, V52, P2198, DOI 10.1016/j.jacc.2008.10.031; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Higgins JPT, 2008, CLIN TRIALS, V5, P225, DOI 10.1177/1740774508091600; Howard BV, 2008, JAMA-J AM MED ASSOC, V299, P1678, DOI 10.1001/jama.299.14.1678; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Kouvelos GN, 2013, J CARDIOVASC PHARM T, V18, P5, DOI 10.1177/1074248412445506; Landray M, 2006, AM J KIDNEY DIS, V47, P385, DOI 10.1053/j.ajkd.2005.11.018; Mascitelli L, 2010, ARCH MED RES, V41, P649, DOI 10.1016/j.arcmed.2010.10.008; McKenney JM, 2006, J AM COLL CARDIOL, V47, P1584, DOI 10.1016/j.jacc.2005.11.072; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Peto R, 2008, NEW ENGL J MED, V359, P1357, DOI 10.1056/NEJMsa0806603; Rayner BL, 1996, CLIN NEPHROL, V46, P219; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Strippoli GFM, 2008, BMJ-BRIT MED J, V336, P645, DOI 10.1136/bmj.39472.580984.AE; Taylor AJ, 2009, NEW ENGL J MED, V361, P2113, DOI 10.1056/NEJMoa0907569; Teo KK, 2013, STROKE, V44, P2688, DOI 10.1161/STROKEAHA.113.001529; Therapeutics Initiative, 2010, THERAPEUTICS LETT, V77, P1; Villines TC, 2010, J AM COLL CARDIOL, V55, P2721, DOI 10.1016/j.jacc.2010.03.017; Walker RJ, 1997, NEPHROL DIAL TRANSPL, V12, P87, DOI 10.1093/ndt/12.1.87; West AM, 2011, ATHEROSCLEROSIS, V218, P156, DOI 10.1016/j.atherosclerosis.2011.04.005; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	32	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124587	10.1371/journal.pone.0124587	http://dx.doi.org/10.1371/journal.pone.0124587			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915909	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100054
J	Fischer, R; Ensslin, A; Rutten, G; Fischer, M; Costa, DS; Kleyer, M; Hemp, A; Paulick, S; Huth, A				Fischer, Rico; Ensslin, Andreas; Rutten, Gemma; Fischer, Markus; Costa, David Schellenberger; Kleyer, Michael; Hemp, Andreas; Paulick, Sebastian; Huth, Andreas			Simulating Carbon Stocks and Fluxes of an African Tropical Montane Forest with an Individual-Based Forest Model	PLOS ONE			English	Article							NET ECOSYSTEM EXCHANGE; LONG-TERM IMPACTS; CLIMATE-CHANGE; RAIN-FOREST; MT. KILIMANJARO; BIOMASS; TEMPERATE; DYNAMICS; GROWTH; PRODUCTIVITY	Tropical forests are carbon-dense and highly productive ecosystems. Consequently, they play an important role in the global carbon cycle. In the present study we used an individual-based forest model (FORMIND) to analyze the carbon balances of a tropical forest. The main processes of this model are tree growth, mortality, regeneration, and competition. Model parameters were calibrated using forest inventory data from a tropical forest at Mt. Kilimanjaro. The simulation results showed that the model successfully reproduces important characteristics of tropical forests (aboveground biomass, stem size distribution and leaf area index). The estimated aboveground biomass (385 t/ha) is comparable to biomass values in the Amazon and other tropical forests in Africa. The simulated forest reveals a gross primary production of 24 t(c)ha(-1)yr(-1). Modeling above-and belowground carbon stocks, we analyzed the carbon balance of the investigated tropical forest. The simulated carbon balance of this old-growth forest is zero on average. This study provides an example of how forest models can be used in combination with forest inventory data to investigate forest structure and local carbon balances.	[Fischer, Rico; Paulick, Sebastian; Huth, Andreas] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, D-04318 Leipzig, Germany; [Ensslin, Andreas; Rutten, Gemma; Fischer, Markus] Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland; [Costa, David Schellenberger; Kleyer, Michael] Carl von Ossietzky Univ Oldenburg, Dept Biol & Environm Sci, D-26111 Oldenburg, Germany; [Hemp, Andreas] Univ Bayreuth, Dept Plant Systemat, D-95440 Bayreuth, Germany; [Huth, Andreas] Univ Osnabruck, Inst Environm Syst Res, D-49076 Osnabruck, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Bern; Carl von Ossietzky Universitat Oldenburg; University of Bayreuth; University Osnabruck	Fischer, R (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Permoserstr 15, D-04318 Leipzig, Germany.	rico.fischer@ufz.de	Fischer, Rico/AAI-4543-2021; Fischer, Markus/C-6411-2008; Schellenberger Costa, David/AAT-5413-2020	Fischer, Rico/0000-0002-0482-0095; Fischer, Markus/0000-0002-5589-5900; Schellenberger Costa, David/0000-0003-1747-1506; Rutten, Gemma/0000-0001-9552-4605	German Research Foundation (DFG) within the Research Unit FOR1246	German Research Foundation (DFG) within the Research Unit FOR1246	This study was financially supported by the German Research Foundation (DFG) within the Research Unit FOR1246 (Kilimanjaro ecosystems under global changes: linking biodiversity, biotic interactions and biogeochemical ecosystem processes; www.kilimanjaro.biozentrum.uni-wuerzburg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch JK, 2014, NATURE, V506, P41, DOI 10.1038/506041a; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Bennett ND, 2013, ENVIRON MODELL SOFTW, V40, P1, DOI 10.1016/j.envsoft.2012.09.011; Bohn FJ, 2014, ECOL MODEL, V278, P9, DOI 10.1016/j.ecolmodel.2014.01.021; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Botkin D. B., 1993, FOREST DYNAMICS; Brown S, 2002, ENVIRON POLLUT, V116, P363, DOI 10.1016/S0269-7491(01)00212-3; Bugmann H, 2001, CLIMATIC CHANGE, V51, P259, DOI 10.1023/A:1012525626267; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Clark DB, 2012, J VEG SCI, V23, P1191, DOI 10.1111/j.1654-1103.2012.01471.x; Clark DB, 2000, FOREST ECOL MANAG, V137, P185, DOI 10.1016/S0378-1127(99)00327-8; Cox PM, 2004, THEOR APPL CLIMATOL, V78, P137, DOI 10.1007/s00704-004-0049-4; Dislich C, 2009, ERDKUNDE, V63, P347, DOI 10.3112/erdkunde.2009.04.05; FAO, 2011, STAT WORLDS FOR, P179; Fischer R, 2014, ENVIRON MODELL SOFTW, V52, P200, DOI 10.1016/j.envsoft.2013.10.026; Granier A, 1999, ECOL MODEL, V116, P269, DOI 10.1016/S0304-3800(98)00205-1; Grant RF, 2009, ECOL MONOGR, V79, P445, DOI 10.1890/08-0074.1; Gutierrez AG, 2012, PERSPECT PLANT ECOL, V14, P243, DOI 10.1016/j.ppees.2012.01.004; Hartig F, 2014, BIOGEOSCIENCES, V11, P1261, DOI 10.5194/bg-11-1261-2014; Hemp A, 2006, LAND USE CHANGE AND MOUNTAIN BIODIVERSITY, P51, DOI 10.1201/9781420002874.ch4; Hemp A, 2005, GLOBAL CHANGE BIOL, V11, P1013, DOI 10.1111/j.1365-2486.2005.00968.x; Hemp A, 2002, PLANT ECOL, V159, P211, DOI 10.1023/A:1015569125417; Hemp A, 2009, AFR J ECOL, V47, P3, DOI 10.1111/j.1365-2028.2008.01043.x; Hemp A, 2006, PLANT ECOL, V184, P27, DOI 10.1007/s11258-005-9049-4; Hemp A, 2006, BIODIVERS CONSERV, V15, P1193, DOI 10.1007/s10531-004-8230-8; Houghton R.A., 2009, J GEOPHYS RES-BIOGEO, V114; Houghton RA, 2001, GLOBAL CHANGE BIOL, V7, P731, DOI 10.1046/j.1365-2486.2001.00426.x; Huth A, 2000, ECOL MODEL, V134, P1, DOI 10.1016/S0304-3800(00)00328-8; Huth A, 2001, FOREST ECOL MANAG, V142, P33, DOI 10.1016/S0378-1127(00)00338-8; Kammesheidt L, 2001, J APPL ECOL, V38, P756, DOI 10.1046/j.1365-2664.2001.00629.x; Kazmierczak M, 2014, ECOL MODEL, V288, P94, DOI 10.1016/j.ecolmodel.2014.05.002; Kohler P, 2010, BIOGEOSCIENCES, V7, P2531, DOI 10.5194/bg-7-2531-2010; Kohler P, 2007, ECOL MODEL, V203, P511, DOI 10.1016/j.ecolmodel.2006.11.023; Kohler P, 2004, CLIMATIC CHANGE, V67, P95, DOI 10.1007/s10584-004-0713-9; Kohler P, 2003, ECOSYSTEMS, V6, P114, DOI 10.1007/s10021-002-0121-9; Kohler P, 2000, J TROP ECOL, V16, P591, DOI 10.1017/S0266467400001590; Lasslop G, 2010, GLOBAL CHANGE BIOL, V16, P187, DOI 10.1111/j.1365-2486.2009.02041.x; Lehmann S, 2015, ECOL MODEL, V301, P98, DOI 10.1016/j.ecolmodel.2015.01.013; Lewis SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0295; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Malhi Y, 2012, J ECOL, V100, P65, DOI 10.1111/j.1365-2745.2011.01916.x; MARTINEZRAMOS M, 1989, ECOLOGY, V70, P555, DOI 10.2307/1940203; Pabst H, 2013, APPL SOIL ECOL, V67, P10, DOI 10.1016/j.apsoil.2013.02.006; Pacala S, 2002, MG POP BIOL, V33, P169; Pachauri R.K., 2008, CLIMATE CHANGE 2007, P104; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; PHILLIPS OL, 1994, P NATL ACAD SCI USA, V91, P2805, DOI 10.1073/pnas.91.7.2805; PHILLIPS OL, 1994, SCIENCE, V263, P954, DOI 10.1126/science.263.5149.954; PRENTICE IC, 1993, ECOL MODEL, V65, P51, DOI 10.1016/0304-3800(93)90126-D; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Ruger N, 2008, ECOSYSTEMS, V11, P868, DOI 10.1007/s10021-008-9166-8; Ruger N, 2007, FOREST ECOL MANAG, V252, P52, DOI 10.1016/j.foreco.2007.06.020; Rutten G, 2015, FOREST ECOL MANAG, V337, P61, DOI 10.1016/j.foreco.2014.10.036; Shugart H. H., 2003, THEORY FOREST DYNAMI; Shugart H.H., 1984, THEORY FOREST DYNAMI; Smith T. M, 1997, PLANT FUNCTIONAL TYP; Taubert F, 2012, ECOL MODEL, V245, P84, DOI 10.1016/j.ecolmodel.2012.04.007; Verbeeck H, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001544; WHITMORE TC, 1998, INTRO TROPICAL RAIN; Wright SJ, 2013, GLOBAL CHANGE BIOL, V19, P337, DOI 10.1111/gcb.12052	65	15	15	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123300	10.1371/journal.pone.0123300	http://dx.doi.org/10.1371/journal.pone.0123300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915854	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659100019
J	Fomda, BA; Khan, A; Thokar, MA; Malik, AA; Fazili, A; Dar, RA; Sharma, M; Malla, N				Fomda, Bashir Ahmad; Khan, Asiya; Thokar, Manzoor Ahmad; Malik, Ajaz Ahmad; Fazili, Anjum; Dar, Rayees Ahmad; Sharma, Monika; Malla, Nancy			Sero-Epidemiological Survey of Human Cystic Echinococcosis in Kashmir, North India	PLOS ONE			English	Article							HUMAN HYDATIDOSIS; PERCUTANEOUS DRAINAGE; GRANULOSUS CYSTS; SEROPREVALENCE; POPULATION; MANAGEMENT; INFECTION; DIAGNOSIS; BULGARIA; ALVEOLAR	Background Echinococcosis is a human and animal health problem in many endemic areas worldwide. There are numerous reports and hospital-based studies from Kashmir, North India, yet there has been no epidemiological study conducted in Kashmir, the apparently endemic area for human hydatidosis. This study was designed to determine the seroprevalence of hydatid infection in Kashmir Valley and to find out association of risk factors for acquisition of this infection. Methodology Fourteen hundred and twenty-nine samples were collected from different districts in the Kashmir region (North India) using systematic random sampling. The 130 control samples included were from apparently healthy blood donors (100), patients with other parasitic infections (20), surgically confirmed hydatidosis patients (5), and apparently healthy subjects excluded for hydatidosis and intestinal parasitic infections (5). Hydatid-specific IgG antibody was detected by enzyme-linked immunosorbent assay, and seropositive samples were analysed further by Western blotting. Results Out of 1,429 samples, 72 (5.03%) were IgG positive by ELISA. The percentage occurrence of the highly immunoreactive antigenic fractions in IgG ELISA positive samples was 57 kDa (72.2%) followed by 70 kDa (66.7%) and 39kDa (58.3%) by immunoblotting. Samples with other parasitic infections were reactive with the cluster of 54-59 kDa antigenic fractions. Age <15 years, male gender, contact with dog, and rural residence were the most significant factors associated with the seropositivity. Conclusion The study revealed that 72 (5.03%) out of 1,429 subjects asymptomatic for hydatidosis were seropositve to E. granulosus antigen by ELISA. Western blot analysis of 72 ELISA seropositive samples showed that 66.7% and 58.3% of samples were immunoreactive with 70 and 39kDa specific antigenic fractions, respectively. The seropositivity was significantly higher (5.79%) in the younger age group (<15 years) as compared to the 16-55 years (4.07%) and >55 years (3.05%) age groups, suggesting ongoing transmission of this infection in the younger age group. The number of seropositive males was significantly higher as compared to females. The risk factors identified were rural residence and contact with dogs. The study suggests the presence of asymptomatic infection in subjects in Kashmir, North India, and efforts need to be made for implementation of effective prevention measures to reduce the infection burden, which may otherwise lead to symptomatology and complications in the infected subjects.	[Fomda, Bashir Ahmad; Khan, Asiya; Thokar, Manzoor Ahmad] Sherikashmir Inst Med Sci, Dept Microbiol, Srinagar, Jammu & Kashmir, India; [Malik, Ajaz Ahmad] Sherikashmir Inst Med Sci, Dept Gen Surg, Srinagar, Jammu & Kashmir, India; [Fazili, Anjum] Sherikashmir Inst Med Sci, Dept Community Med, Srinagar, Jammu & Kashmir, India; [Dar, Rayees Ahmad] Sherikashmir Inst Med Sci, Dept Biostat, Srinagar, Jammu & Kashmir, India; [Sharma, Monika; Malla, Nancy] Post Grad Inst Med Educ & Res, Dept Med Parasitol, Chandigarh, India	Sher-i-Kashmir Institute of Medical Sciences; Sher-i-Kashmir Institute of Medical Sciences; Sher-i-Kashmir Institute of Medical Sciences; Sher-i-Kashmir Institute of Medical Sciences; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Fomda, BA (corresponding author), Sherikashmir Inst Med Sci, Dept Microbiol, Srinagar, Jammu & Kashmir, India.	bashirfomda@gmail.com			Indian Council of Medical Research, New Delhi, India [5/3/3/5/2006-ECD 1]	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	This work was supported by a grant from the Indian Council of Medical Research, New Delhi, India (grant no 5/3/3/5/2006-ECD 1), sanctioned to BAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arambulo P, 1997, ACTA TROP, V67, P113, DOI 10.1016/S0001-706X(97)00049-1; Arif Sajad Hussain, 2008, Int J Surg, V6, P448, DOI 10.1016/j.ijsu.2008.08.003; Asghari M, 2013, IRAN J PUBLIC HEALTH, V42, P391; Chiraga S., 2014, J HELMINTHOL, P1; Craig P. S., 2007, Tropical Medicine and Health, V35, P283, DOI 10.2149/tmh.35.283; Dhar SN, 1988, RESP MED, V9, P409; Doiz O, 2001, DIAGN MICR INFEC DIS, V41, P139, DOI 10.1016/S0732-8893(01)00293-0; Eckert J, 2004, CLIN MICROBIOL REV, V17, P107, DOI 10.1128/CMR.17.1.107-135.2004; Eckert J, 2000, INT J PARASITOL, V30, P1283, DOI 10.1016/S0020-7519(00)00130-2; Fomda B. A., 2002, Journal of Parasitic Diseases, V26, P34; Fotiou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037112; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Grosso G, 2012, WORLD J GASTROENTERO, V18, P1425, DOI 10.3748/wjg.v18.i13.1425; Gutierrez MP, 2003, ENFERM INFEC MICR CL, V21, P563, DOI 10.1157/13054549; Hanillo A, 2004, J ZANJAN U MED SCI H, V12, P41; Heidari Z, 2011, IRAN J PARASITOL, V6, P19; KANWAR JR, 1992, J MED MICROBIOL, V36, P46, DOI 10.1099/00222615-36-1-46; Kaur M, 1999, INDIAN J MED RES, V110, P18; Kaur Manjit, 1995, Immunology and Infectious Diseases (Oxford), V5, P67; Kayal Ankit, 2014, ISRN Gastroenterol, V2014, P514757, DOI 10.1155/2014/514757; Khurana S, 2007, TROP DOCT, V37, P100, DOI 10.1258/004947507780609149; Khuroo MS, 1997, NEW ENGL J MED, V337, P881, DOI 10.1056/NEJM199709253371303; KHUROO MS, 1993, GASTROENTEROLOGY, V104, P1452, DOI 10.1016/0016-5085(93)90355-G; KHUROO MS, 1991, RADIOLOGY, V180, P141, DOI 10.1148/radiology.180.1.2052682; Kouser Sideeq, 2014, National Journal of Community Medicine, V5, P66; Logar J, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-63; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malik AA, 2010, WORLD J GASTRO SURG, V2, P78, DOI 10.4240/wjgs.v2.i3.78; Moro P, 2009, INT J INFECT DIS, V13, P125, DOI 10.1016/j.ijid.2008.03.037; Parikh Falguni, 2012, J Assoc Physicians India, V60, P9; Shams-Ul-Bari, 2011, SAUDI J GASTROENTERO, V17, P343, DOI 10.4103/1319-3767.84493; Sharma M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082904; Sharma M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002262; Siddharth SR, 2012, ANN TROP MED PUBLIC, V5, P225; Sudarshan M K, 2006, J Commun Dis, V38, P32; Todorov T, 1999, B WORLD HEALTH ORGAN, V77, P110; Todorov T, 2000, ANN TROP MED PARASIT, V94, P135, DOI 10.1080/00034980057473; Torgerson PR, 2003, RES VET SCI, V74, P191, DOI 10.1016/S0034-5288(03)00006-7; WATTAL C, 1986, J CLIN MICROBIOL, V24, P41, DOI 10.1128/JCM.24.1.41-46.1986; Yang YR, 2008, TROP MED INT HEALTH, V13, P1086, DOI 10.1111/j.1365-3156.2008.02101.x; Yang YR, 2006, B WORLD HEALTH ORGAN, V84, P714, DOI 10.2471/BLT.05.025718; Yu SH, 2008, JPN J INFECT DIS, V61, P242; ZARGAR SA, 1992, GASTROINTEST RADIOL, V17, P41, DOI 10.1007/BF01888506	43	16	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124813	10.1371/journal.pone.0124813	http://dx.doi.org/10.1371/journal.pone.0124813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915867	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659100068
J	Amin, ARMR; Haque, A; Rahman, MA; Chen, ZG; Khuri, FR; Shin, DM				Amin, A. R. M. Ruhul; Haque, Abedul; Rahman, Mohammad Aminur; Chen, Zhuo Georgia; Khuri, Fadlo Raja; Shin, Dong Moon			Curcumin Induces Apoptosis of Upper Aerodigestive Tract Cancer Cells by Targeting Multiple Pathways	PLOS ONE			English	Article							BCL-2; INHIBITION; P53; PERSPECTIVES; INDUCTION; GROWTH; ASSAY	Curcumin, a natural compound isolated from the Indian spice "Haldi" or "curry powder", has been used for centuries as a traditional remedy for many ailments. Recently, the potential use of curcumin in cancer prevention and therapy urges studies to uncover the molecular mechanisms associated with its anti-tumor effects. In the current manuscript, we investigated the mechanism of curcumin-induced apoptosis in upper aerodigestive tract cancer cell lines and showed that curcumin-induced apoptosis is mediated by the modulation of multiple pathways such as induction of p73, and inhibition of p-AKT and Bcl-2. Treatment of cells with curcumin induced both p53 and the related protein p73 in head and neck and lung cancer cell lines. Inactivation of p73 by dominant negative p73 significantly protected cells from curcumin-induced apoptosis, whereas ablation of p53 by shRNA had no effect. Curcumin treatment also strongly inhibited p-AKT and Bcl-2 and overexpression of constitutively active AKT or Bcl-2 significantly inhibited curcumin-induced apoptosis. Taken together, our findings suggest that curcumin-induced apoptosis is mediated via activating tumor suppressor p73 and inhibiting p-AKT and Bcl-2.	[Amin, A. R. M. Ruhul; Haque, Abedul; Rahman, Mohammad Aminur; Chen, Zhuo Georgia; Khuri, Fadlo Raja; Shin, Dong Moon] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Emory University	Amin, ARMR (corresponding author), Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.	aamin9@emory.edu	Khuri, Fadlo R./AAU-4942-2020; Shin, Dong Moon/G-9649-2013	Khuri, Fadlo R./0000-0002-8638-7618; Shin, Dong Moon/0000-0002-8245-4174; AMIN, ARM/0000-0001-9144-2960	Robbins Scholar Award of the Emory Winship Cancer Institute;  [NCI R03CA159369];  [NCI R03CA171663];  [NCI P50 CA128613]; NATIONAL CANCER INSTITUTE [R03CA159369, P50CA128613, R03CA171663] Funding Source: NIH RePORTER	Robbins Scholar Award of the Emory Winship Cancer Institute; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NCI R03CA159369, NCI R03CA171663, NCI P50 CA128613 and a Robbins Scholar Award of the Emory Winship Cancer Institute.	Amin ARMR, 2007, CANCER RES, V67, P5617, DOI 10.1158/0008-5472.CAN-07-0655; Amin ARMR, 2007, P NATL ACAD SCI USA, V104, P5419, DOI 10.1073/pnas.0700642104; Amin ARMR, 2013, ONCOGENE, V32, P920, DOI 10.1038/onc.2012.96; Amin ARMR, 2010, J BIOL CHEM, V285, P34557, DOI 10.1074/jbc.M110.141135; Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; Botchkarev VA, 2014, COLD SPRING HARB PER, V4, DOI [10.1101/cshperspect.a019802, DOI 10.1101/CSHPERSPECT.A019802]; Collett NP, 2010, SEMIN ONCOL, V37, P258, DOI 10.1053/j.seminoncol.2010.06.014; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Houghton P, 2007, METHODS, V42, P377, DOI 10.1016/j.ymeth.2007.01.003; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Loriot Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.365; Moldoveanu T, 2014, TRENDS BIOCHEM SCI, V39, P101, DOI 10.1016/j.tibs.2013.12.006; Newton AC, 2014, ANNU REV PHARMACOL, V54, P537, DOI 10.1146/annurev-pharmtox-011112-140338; Park W, 2013, CANCER PREV RES, V6, P387, DOI 10.1158/1940-6207.CAPR-12-0410; Perkins S, 2002, CANCER EPIDEM BIOMAR, V11, P535; Pillai GR, 2004, CANCER LETT, V208, P163, DOI 10.1016/j.canlet.2004.01.008; Qu MH, 2014, INT J PHARMACEUT, V474, P112, DOI 10.1016/j.ijpharm.2014.08.019; Rahman MA, 2013, CLIN CANCER RES, V19, P3416, DOI 10.1158/1078-0432.CCR-13-0073; Saha A, 2010, CANCER PREV RES, V3, P953, DOI 10.1158/1940-6207.CAPR-09-0247; Seo BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095588; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singletary K, 1996, CANCER LETT, V103, P137, DOI 10.1016/0304-3835(96)04224-3; Slade N, 2011, CURR PHARM DESIGN, V17, P591, DOI 10.2174/138161211795222621; Sreepriya M, 2006, MOL CELL BIOCHEM, V284, P49, DOI 10.1007/s11010-005-9012-7; Tekedereli I, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.45; Ushida J, 2000, JPN J CANCER RES, V91, P893, DOI 10.1111/j.1349-7006.2000.tb01031.x; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wu JJ, 2014, INT J ONCOL, V45, P95, DOI 10.3892/ijo.2014.2420	30	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124218	10.1371/journal.pone.0124218	http://dx.doi.org/10.1371/journal.pone.0124218			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910231	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800069
J	Crespo, A; Pedraz, L; Torrents, E				Crespo, Anna; Pedraz, Lucas; Torrents, Eduard			Function of the Pseudomonas aeruginosa NrdR Transcription Factor: Global Transcriptomic Analysis and Its Role on Ribonucleotide Reductase Gene Expression	PLOS ONE			English	Article							BIOFILM FORMATION; ESCHERICHIA-COLI; STREPTOMYCES; INFECTION; SEQUENCE; ENZYMES	Ribonucleotide reductases (RNRs) are a family of sophisticated enzymes responsible for the synthesis of the deoxyribonucleotides (dNTPs), the building blocks for DNA synthesis and repair. Although any living cell must contain one RNR activity to continue living, bacteria have the capacity to encode different RNR classes in the same genome, allowing them to adapt to different environments and growing conditions. Pseudomonas aeruginosa is well known for its adaptability and surprisingly encodes all three known RNR classes (Ia, II and III). There must be a complex transcriptional regulation network behind this RNR activity, dictating which RNR class will be expressed according to specific growing conditions. In this work, we aim to uncover the role of the transcriptional regulator NrdR in P. aeruginosa. We demonstrate that NrdR regulates all three RNR classes, being involved in differential control depending on whether the growth conditions are aerobic or anaerobic. Moreover, we also identify for the first time that NrdR is not only involved in controlling RNR expression but also regulates topoisomerase I (topA) transcription. Finally, to obtain the entire picture of NrdR regulon, we performed a global transcriptomic analysis comparing the transcription profile of wild-type and nrdR mutant strains. The results provide many new data about the regulatory network that controls P. aeruginosa RNR transcription, bringing us a step closer to the understanding of this complex system.	[Crespo, Anna; Pedraz, Lucas; Torrents, Eduard] Inst Bioengn Catalonia IBEC, Bacterial Infect & Antimicrobial Therapies Grp, Barcelona 08028, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona	Torrents, E (corresponding author), Inst Bioengn Catalonia IBEC, Bacterial Infect & Antimicrobial Therapies Grp, Baldiri Reixac 15-21, Barcelona 08028, Spain.	etorrents@ibecbarcelona.eu	Torrents, Eduard/C-7184-2008; Pedraz, Lucas/T-1731-2019	Torrents, Eduard/0000-0002-3010-1609; Pedraz, Lucas/0000-0003-3666-3343	Ministerio de Economia y Competitividad [BFU2011-24066]; Generalitat de Catalunya [2014-SGR01260]; Ministerio de Ciencia e Innovacion	Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported in part through Project: BFU2011-24066. Ministerio de Economia y Competitividad. Principal Investigator: Eduard Torrents; Project: 2014-SGR01260. Generalitat de Catalunya. Principal Investigator: Eduard Torrents; Project: Ramon y Cajal program + I3. Ministerio de Ciencia e Innovacion. Principal Investigator: Eduard Torrents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKLEY RL, 1966, J BIOL CHEM, V241, P176; Borovok I, 2004, MOL MICROBIOL, V54, P1022, DOI 10.1111/j.1365-2958.2004.04325.x; Case ED, 2011, J BACTERIOL, V193, P4396, DOI 10.1128/JB.00294-11; Chuanchuen R, 2002, BIOTECHNIQUES, V33, P760, DOI 10.2144/02334bm08; Cirz RT, 2006, J BACTERIOL, V188, P7101, DOI 10.1128/JB.00807-06; Davies JC, 2007, BMJ-BRIT MED J, V335, P1255, DOI 10.1136/bmj.39391.713229.AD; Grinberg I, 2006, J BACTERIOL, V188, P7635, DOI 10.1128/JB.00903-06; Grinberg I, 2009, J BACTERIOL, V191, P1169, DOI 10.1128/JB.01145-08; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jordan A, 1999, J BACTERIOL, V181, P3974, DOI 10.1128/JB.181.13.3974-3980.1999; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lee KM, 2012, INFECT IMMUN, V80, P1639, DOI 10.1128/IAI.06161-11; Lundin D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-383; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; McKethan BL, 2013, MOL MICROBIOL, V90, P278, DOI 10.1111/mmi.12364; Mowa MB, 2009, J BACTERIOL, V191, P985, DOI 10.1128/JB.01409-08; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Panosa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011328; Rodionov DA, 2005, TRENDS GENET, V21, P385, DOI 10.1016/j.tig.2005.05.011; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schobert M, 2010, FUTURE MICROBIOL, V5, P603, DOI 10.2217/FMB.10.16; Sjoberg BM, 2011, INFECT IMMUN, V79, P2663, DOI 10.1128/IAI.01212-10; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Torrents E, 2005, J BIOL CHEM, V280, P16571, DOI 10.1074/jbc.M501322200; Torrents E, 2008, RIBONUCLEOTIDE REDUC, P17; Torrents E, 2007, J BACTERIOL, V189, P5012, DOI 10.1128/JB.00440-07; Torrents E, 2006, J BIOL CHEM, V281, P25287, DOI 10.1074/jbc.M601794200; Torrents E, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00052; Van Alst NE, 2007, INFECT IMMUN, V75, P3780, DOI 10.1128/IAI.00201-07; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Zechiedrich EL, 2000, J BIOL CHEM, V275, P8103, DOI 10.1074/jbc.275.11.8103	33	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123571	10.1371/journal.pone.0123571	http://dx.doi.org/10.1371/journal.pone.0123571			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909779	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800041
J	Heeren, A; Baeken, C; Vanderhasselt, MA; Philippot, P; de Raedt, R				Heeren, Alexandre; Baeken, Chris; Vanderhasselt, Marie-Anne; Philippot, Pierre; de Raedt, Rudi			Impact of Anodal and Cathodal Transcranial Direct Current Stimulation over the Left Dorsolateral Prefrontal Cortex during Attention Bias Modification: An Eye-Tracking Study	PLOS ONE			English	Article							SOCIAL ANXIETY; SELECTIVE ATTENTION; FACIAL EXPRESSIONS; CAUSAL ROLE; TIME-COURSE; THREAT; INDIVIDUALS; VALIDATION; GAZE; DISENGAGEMENT	People with anxiety disorders show an attentional bias for threat (AB), and Attention Bias Modification (ABM) procedures have been found to reduce this bias. However, the underlying processes accounting for this effect remain poorly understood. One explanation suggests that ABM requires the modification of attention control, driven by the recruitment of the dorsolateral prefrontal cortex (DLPFC). In the present double-blind study, we examined whether modifying left DLPFC activation influences the effect of ABM on AB. We used transcranial direct current stimulation (tDCS) to directly modulate cortical excitability of the left DLPFC during an ABM procedure designed to reduce AB to threat. Anodal tDCS increases excitability, whereas cathodal tDCS decreases it. We randomly assigned highly trait-anxious individuals to one of three conditions: 1) ABM combined with cathodal tDCS, 2) ABM combined with anodal tDCS, or 3) ABM combined with sham tDCS. We assessed the effects of these manipulations on both reaction times and eye-movements on a task indexing AB. Results indicate that combining ABM and anodal tDCS over the left DLPFC reduces the total duration that participants' gaze remains fixated on threat, as assessed using eye-tracking measurement. However, in contrast to previous studies, there were no changes in AB from baseline to post-training for participants that received ABM without tDCS. As the tendency to maintain attention to threat is known to play an important role in the maintenance of anxiety, the present findings suggest that anodal tDCS over the left DLPFC may be considered as a promising tool to reduce the maintenance of gaze to threat. Implications for future translational research combining ABM and tDCS are discussed.	[Heeren, Alexandre; Philippot, Pierre] Catholic Univ Louvain, Psychol Sci Res Inst, Lab Expt Psychopathol, Louvain La Neuve, Belgium; [Baeken, Chris] Univ Ghent, Dept Psychiat & Med Psychol, B-9000 Ghent, Belgium; [Vanderhasselt, Marie-Anne; de Raedt, Rudi] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	Universite Catholique Louvain; Ghent University; Ghent University	Heeren, A (corresponding author), Catholic Univ Louvain, Psychol Sci Res Inst, Lab Expt Psychopathol, Louvain La Neuve, Belgium.	Alexandre.Heeren@uclouvain.be	De Raedt, Rudi/AAL-4093-2021; Heeren, Alexandre/U-9748-2019; De Raedt, Rudi/A-3269-2012; Baeken, Chris/D-6790-2013	De Raedt, Rudi/0000-0001-6781-4808; Heeren, Alexandre/0000-0003-0553-6149; De Raedt, Rudi/0000-0001-6781-4808; Vanderhasselt, Marie-Anne/0000-0002-4045-1055	Belgian National Fund for Scientific Research [FC 78142]; Research Foundation Flanders [FWO08/PDO/168]; Concerted Research Action of Ghent University [BOF10/GOA/014]; Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control"; Belgian University Foundation [IS179]	Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Research Foundation Flanders(FWO); Concerted Research Action of Ghent University; Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control"; Belgian University Foundation	This research was supported by a Grant (FC 78142) from the Belgian National Fund for Scientific Research (awarded to Dr. Alexandre Heeren), a Grant (FWO08/PDO/168) from the Research Foundation Flanders (awarded to Dr. Marie- Anne Vanderhasselt), a Grant (BOF10/GOA/014) for a Concerted Research Action of Ghent University (awarded to Prof. Rudi De Raedt). This research was also supported by the Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control". The open-access publication of this paper also received the support (IS179) from the Belgian University Foundation (awarded to Dr. Alexandre Heeren). These funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accornero N, 2007, EXP BRAIN RES, V178, P261, DOI 10.1007/s00221-006-0733-y; Amir N, 2009, J CONSULT CLIN PSYCH, V77, P961, DOI 10.1037/a0016685; [Anonymous], 1980, HANDLEIDING BIJ ZELF; Armstrong T, 2012, CLIN PSYCHOL REV, V32, P704, DOI 10.1016/j.cpr.2012.09.004; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bikson M, 2010, CLIN NEUROPHYSIOL, V121, P1976, DOI 10.1016/j.clinph.2010.05.020; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Bishop SJ, 2009, NAT NEUROSCI, V12, P92, DOI 10.1038/nn.2242; Browning M, 2010, BIOL PSYCHIAT, V67, P919, DOI 10.1016/j.biopsych.2009.10.031; Brunoni AR, 2014, BRAIN COGNITION, V86, P1, DOI 10.1016/j.bandc.2014.01.008; Calvo MG, 2005, COGNITION EMOTION, V19, P433, DOI 10.1080/02699930441000157; Chen Nigel T. M., 2012, Cognitive Behaviour Therapy, V41, P96, DOI 10.1080/16506073.2012.666562; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Clarke PJF, 2014, BIOL PSYCHIAT, V76, P946, DOI 10.1016/j.biopsych.2014.03.003; Clarke PJF, 2013, ANXIETY STRESS COPIN, V26, P1, DOI 10.1080/10615806.2011.638054; Cohen J.E., 1988, STAT POWER ANAL BEHA; DaSilva AF, 2011, JOVE-J VIS EXP, DOI 10.3791/2744; Dear BF, 2011, J PAIN, V12, P1247, DOI 10.1016/j.jpain.2011.07.003; Derryberry D, 2002, J ABNORM PSYCHOL, V111, P225, DOI 10.1037//0021-843X.111.2.225; Eldar S, 2010, PSYCHOL MED, V40, P667, DOI 10.1017/S0033291709990766; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Garner M, 2006, J ABNORM PSYCHOL, V115, P760, DOI 10.1037/0021-843X.115.4.760; Goeleven E, 2008, COGNITION EMOTION, V22, P1094, DOI 10.1080/02699930701626582; Hakamata Y, 2010, BIOL PSYCHIAT, V68, P982, DOI 10.1016/j.biopsych.2010.07.021; Heeren A, J BEHAV THE IN PRESS; Heeren A, 2012, BEHAV RES THER, V50, P30, DOI 10.1016/j.brat.2011.10.005; Heeren A, 2015, J ANXIETY DISORD, V29, P35, DOI 10.1016/j.janxdis.2014.10.007; Heeren A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00119; Heeren A, 2012, COGNITIVE THER RES, V36, P512, DOI 10.1007/s10608-011-9394-7; Heeren A, 2011, J ANXIETY DISORD, V25, P1108, DOI 10.1016/j.janxdis.2011.08.001; Kuckertz JM, 2014, BEHAV RES THER, V53, P30, DOI 10.1016/j.brat.2013.12.003; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Lundqvist D., 1998, KAROLINSKA DIRECTED, DOI 10.1037/t27732-000; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; MacLeod C, 2015, CLIN PSYCHOL SCI, V3, P58, DOI 10.1177/2167702614560749; Maoz K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00389; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mogg K, 2003, ADDICTION, V98, P825, DOI 10.1046/j.1360-0443.2003.00392.x; Mogg K, 2000, J ABNORM PSYCHOL, V109, P695, DOI 10.1037/0021-843X.109.4.695; Mogoase C, 2014, J CLIN PSYCHOL, V70, P1133, DOI 10.1002/jclp.22081; Moliadze V, 2010, CLIN NEUROPHYSIOL, V121, P2165, DOI 10.1016/j.clinph.2010.04.033; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; Nummenmaa L, 2006, EMOTION, V6, P257, DOI 10.1037/1528-3542.6.2.257; Raes F, 2007, REVISED VERSION DUTC; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Reese HE, 2010, J ANXIETY DISORD, V24, P657, DOI 10.1016/j.janxdis.2010.04.006; Rohner JC, 2002, COGNITION EMOTION, V16, P837, DOI 10.1080/02699930143000572; Roy AK, 2008, J AM ACAD CHILD PSY, V47, P1189, DOI 10.1097/CHI.0b013e3181825ace; Salemink E, 2007, BEHAV RES THER, V45, P607, DOI 10.1016/j.brat.2006.04.004; Schmukle SC, 2005, EUR J PERSONALITY, V19, P595, DOI 10.1002/per.554; Schofield CA, 2012, COGNITION EMOTION, V26, P300, DOI 10.1080/02699931.2011.602050; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Spielberger DC, 1983, MANUAL FOR THE STATE; Staugaard SR., 2009, PSYCHOL SCI Q, V51, P339, DOI [DOI 10.1080/02699930903205698, 10.4081/mi.2011.e5, DOI 10.4081/MI.2011.E5]; Van Bockstaele B, 2014, PSYCHOL BULL, V140, P682, DOI 10.1037/a0034834; Van Bockstaele B, 2011, J BEHAV THER EXP PSY, V42, P211, DOI 10.1016/j.jbtep.2010.12.004; Van der Does A. J. W., 2002, HANDLEIDING NEDERLAN; Vervoort T, 2013, PAIN, V154, P836, DOI 10.1016/j.pain.2013.02.017	63	56	57	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124182	10.1371/journal.pone.0124182	http://dx.doi.org/10.1371/journal.pone.0124182			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909846	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800062
J	Toosizadeh, N; Mohler, J; Lei, H; Parvaneh, S; Sherman, S; Najafi, B				Toosizadeh, Nima; Mohler, Jane; Lei, Hong; Parvaneh, Saman; Sherman, Scott; Najafi, Bijan			Motor Performance Assessment in Parkinson's Disease: Association between Objective In-Clinic, Objective In-Home, and Subjective/Semi-Objective Measures	PLOS ONE			English	Article							POSTURAL CONTROL; OPEN-LOOP; AMBULATORY SYSTEM; SCALE; GAIT; EFFICACY; BALANCE; WALKING; FALLS; FEAR	Advances in wearable technology allow for the objective assessment of motor performance in both in-home and in-clinic environments and were used to explore motor impairments in Parkinson's disease (PD). The aims of this study were to: 1) assess differences between in-clinic and in-home gait speed, and sit-to-stand and stand-to-sit duration in PD patients (in comparison with healthy controls); and 2) determine the objective physical activity measures, including gait, postural balance, instrumented Timed-up-and-go (iTUG), and in-home spontaneous physical activity (SPA), with the highest correlation with subjective/semi-objective measures, including health survey, fall history (fallers vs. non-fallers), fear of falling, pain, Unified Parkinson's Disease Rating Scale, and PD stage (Hoehn and Yahr). Objective assessments of motor performance were made by measuring physical activities in the same sample of PD patients (n = 15, Age: 71.2 +/- 6.3 years) and age-matched healthy controls (n = 35, Age: 71.9 +/- 3.8 years). The association between in-clinic and in-home parameters, and between objective parameters and subjective/semi-objective evaluations in the PD group was assessed using linear regression-analysis of variance models and reported as Pearson correlations (R). Both in-home SPA and in-clinic assessments demonstrated strong discriminatory power in detecting impaired motor function in PD. However, mean effect size (0.94 +/- 0.37) for in-home measures was smaller compared to in-clinic assessments (1.30 +/- 0.34) for parameters that were significantly different between PD and healthy groups. No significant correlation was observed between identical in-clinic and in-home parameters in the PD group (R = 0.10-0.25; p> 0.40), while the healthy showed stronger correlation in gait speed, sit-to-stand duration, and stand-to-sit duration (R = 0.36-0.56; p< 0.03). This suggests a better correlation between supervised and unsupervised motor function assessments in healthy controls compared to PD group. In the PD group, parameters related to velocity and range-of-motion of lower extremity within gait assessment (R = 0.58-0.84), and	[Toosizadeh, Nima; Mohler, Jane; Parvaneh, Saman; Najafi, Bijan] Univ Arizona, Coll Med, Interdisciplinary Consortium Adv Motion Performan, Tucson, AZ 85721 USA; [Toosizadeh, Nima; Mohler, Jane; Parvaneh, Saman; Najafi, Bijan] Univ Arizona, Coll Med, SALSA, Dept Surg, Tucson, AZ USA; [Mohler, Jane; Parvaneh, Saman; Najafi, Bijan] Univ Arizona, Arizona Ctr Aging, Tucson, AZ USA; [Lei, Hong; Sherman, Scott] Univ Arizona, Coll Med, Dept Neurol, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona	Najafi, B (corresponding author), Univ Arizona, Coll Med, Interdisciplinary Consortium Adv Motion Performan, Tucson, AZ 85721 USA.	bnajafi@surgery.arizona.edu	Parvaneh, Saman/F-1326-2010; Najafi, Bijan/AAK-5650-2020	Parvaneh, Saman/0000-0002-3618-0125; Najafi, Bijan/0000-0002-0320-8101	National Institute on Aging [2R42AG032748]; University of Arizona including Consortium on Advanced Motion Performance (iCAMP), Department of Surgery; Arizona Center on Aging, Department of Medicine; Department of Neurology; NATIONAL INSTITUTE ON AGING [R42AG032748] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Arizona including Consortium on Advanced Motion Performance (iCAMP), Department of Surgery; Arizona Center on Aging, Department of Medicine; Department of Neurology; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was partially supported by an STTR-Phase II Grant (Award Number 2R42AG032748) from the National Institute on Aging. The rest of the support came from different departments at the University of Arizona including Consortium on Advanced Motion Performance (iCAMP), Department of Surgery; the Arizona Center on Aging, Department of Medicine; and Department of Neurology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkin AL, 2003, MOVEMENT DISORD, V18, P496, DOI 10.1002/mds.10396; Aminian K, 2002, J BIOMECH, V35, P689, DOI 10.1016/S0021-9290(02)00008-8; Aminian K, 2004, COMPUT ANIMAT VIRT W, V15, P79, DOI 10.1002/cav.2; Beauchet O, 2003, J AM GERIATR SOC, V51, P1187, DOI 10.1046/j.1532-5415.2003.51385.x; BLOEM BR, 1992, CLIN NEUROL NEUROSUR, V94, pS41; BRACHA HS, 1987, LIFE SCI, V40, P1127, DOI 10.1016/0024-3205(87)90576-5; COLLINS JJ, 1995, EXP BRAIN RES, V104, P480, DOI 10.1007/BF00231982; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; Crenna P, 2007, GAIT POSTURE, V26, P172, DOI 10.1016/j.gaitpost.2007.04.010; Dibble LE, 2008, PHYS THER, V88, P323, DOI 10.2522/ptj.20070082; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ford B., 1997, CLIN NEUROS NEW YORK, V5, P63; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Goetz C G, 1986, Mov Disord, V1, P45, DOI 10.1002/mds.870010106; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Grewal G, 2012, J DIABETES SCI TECHN, V7, P1138; Horak FB, 2013, MOVEMENT DISORD, V28, P1544, DOI 10.1002/mds.25684; Kempen GIJM, 2008, AGE AGEING, V37, P45, DOI 10.1093/ageing/afm157; Kerr GK, 2010, NEUROLOGY, V75, P116, DOI 10.1212/WNL.0b013e3181e7b688; LANGLEY GB, 1985, RHEUMATOL INT, V5, P145, DOI 10.1007/BF00541514; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lowry KA, 2009, MOVEMENT DISORD, V24, P261, DOI 10.1002/mds.22352; Maetzler W, 2009, LANCET NEUROL, V8, P1158, DOI 10.1016/S1474-4422(09)70291-1; Mak MKY, 2009, J NEUROL, V256, P1689, DOI 10.1007/s00415-009-5184-5; MITCHELL S, 1995, NEUROSCI LETT, V197, P133, DOI 10.1016/0304-3940(95)11924-L; Najafi B, 2003, IEEE T BIO-MED ENG, V50, P711, DOI 10.1109/TBME.2003.812189; Najafi Bijan, 2013, J Diabetes Sci Technol, V7, P1147; Najafi Bijan, 2010, J Diabetes Sci Technol, V4, P780; O'Shea S, 2002, PHYS THER, V82, P888, DOI 10.1093/ptj/82.9.888; Palhagen S, 2006, NEUROLOGY, V66, P1200, DOI 10.1212/01.wnl.0000204007.46190.54; Paquet JM, 2003, REV NEUROL-FRANCE, V159, P786; Pluck GC, 2002, J NEUROL NEUROSUR PS, V73, P636, DOI 10.1136/jnnp.73.6.636; Salarian A, 2007, IEEE T BIO-MED ENG, V54, P2296, DOI 10.1109/TBME.2007.896591; SCHWAB RS, 1965, PSYCHIAT NEUROL, V150, P345; TINETTI ME, 1994, J GERONTOL, V49, pM140, DOI 10.1093/geronj/49.3.M140; Toosizadeh N, 2015, GERONTOLOGY, V61, P3, DOI 10.1159/000363442; Toosizadeh N, 2015, GERONTOLOGY, V61, P51, DOI 10.1159/000362549; Visser JE, 2007, CLIN NEUROPHYSIOL, V118, P1602, DOI 10.1016/j.clinph.2007.03.010; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; YACK HJ, 1993, J GERONTOL, V48, pM225, DOI 10.1093/geronj/48.5.M225; Yardley L, 2005, AGE AGEING, V34, P614, DOI 10.1093/ageing/afi196; Zampieri C, 2010, J NEUROL NEUROSUR PS, V81, P171, DOI 10.1136/jnnp.2009.173740	45	56	57	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124763	10.1371/journal.pone.0124763	http://dx.doi.org/10.1371/journal.pone.0124763			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909898	gold, Green Submitted, Green Published			2022-12-27	WOS:000353376800103
J	Xiao, SJ; Han, ZF; Wang, PP; Han, F; Liu, Y; Li, JT; Wang, Y				Xiao, Shijun; Han, Zhaofang; Wang, Panpan; Han, Fang; Liu, Yang; Li, Jiongtang; Wang, Yong			Functional Marker Detection and Analysis on a Comprehensive Transcriptome of Large Yellow Croaker by Next Generation Sequencing	PLOS ONE			English	Article							GENE-ASSOCIATED MARKERS; PROTEIN-CODING REGIONS; RNA-SEQ DATA; PSEUDOSCIAENA-CROCEA; CRASSOSTREA-VIRGINICA; LARIMICHTHYS-CROCEA; REFERENCE GENOME; EASTERN OYSTER; IN-SILICO; IDENTIFICATION	Large yellow croaker (Larimichthys crocea) is an important economic fish in China and Eastern Asia. Because of the exhaustive fishing and overdense aquaculture, the wild population and the mariculture of the species are facing serious challenges on germplasm degeneration and susceptibility to infectious disease agents. However, a comprehensive transcriptome from multi-tissues of the species has not been reported and functional molecular markers have not yet been detected and analyzed. In this work, we applied RNA-seq with the Illumina Hiseq2000 platform for a multi-tissue sample of large yellow croaker and assembled the transcriptome into 88,103 transcripts. Of them, 52,782 transcripts have been successfully annotated by nt/nr, InterPro, GO and KEGG database. Comparing with public fish proteins, we have found that 34,576 protein coding transcripts are shared in large yellow croaker with zebrafish, medaka, pufferfish, and stickleback. For functional markers, we have discovered 1,276 polymorphic SSRs and 261, 000 SNPs. The functional impact analysis of SNPs showed that the majority (similar to 75%) of small variants cause synonymous mutations in proteins, followed by variations in 3' UTR region. The functional enrichment analysis illuminated that transcripts involved in DNA bindings, enzyme activities, and signal pathways prominently exhibit less single-nucleotide variants but genes for the constituent of the muscular tissue, the cytoskeleton, and the immunity system contain more frequent SNP mutations, which may reflect the structural and functional selections of the translated proteins. This is the first work for the high-throughput detection and analysis of functional polymorphic SSR and SNP markers in a comprehensive transcriptome of large yellow croaker. Our study provides valuable transcript sequence and functional marker resources for the quantitative trait locus (QTL) identification and molecular selection of the species in the research community.	[Xiao, Shijun; Han, Zhaofang; Wang, Panpan; Han, Fang; Liu, Yang; Wang, Yong] Jimei Univ, Key Lab Hlth Mariculture East China Sea, Minist Agr, Coll Fisheries, Xiamen, Fujian, Peoples R China; [Li, Jiongtang] Chinese Acad Fishery Sci, Beijing, Peoples R China	Jimei University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences	Wang, Y (corresponding author), Jimei Univ, Key Lab Hlth Mariculture East China Sea, Minist Agr, Coll Fisheries, Xiamen, Fujian, Peoples R China.	zywang@jmu.edu.cn			National "863" Project of China [2012AA10A403]; National Natural Science Foundation of China [U1205122]; Natural Science Foundation of Fujian Province [2014J05040]; Foundation for Innovation Research Team of Jimer University [2010A02]	National "863" Project of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Foundation for Innovation Research Team of Jimer University	This work was supported by grants from National "863" Project of China (2012AA10A403), National Natural Science Foundation of China (U1205122), Natural Science Foundation of Fujian Province (2014J05040), and the Foundation for Innovation Research Team of Jimer University (2010A02).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bioinformatics B., 2012, FASTQC QUAL CONTR TO; Cao M, 2014, BRIEF BIOINFORM; Chen YL, 2014, NUCLEIC ACIDS RES, V42, P7330, DOI 10.1093/nar/gku357; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092502; Duran C, 2013, MOL ECOL RESOUR, V13, P538, DOI 10.1111/1755-0998.12078; FISHER RA, 1949, HEREDITY, V3, P229, DOI 10.1038/hdy.1949.16; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gymrek M, 2012, GENOME RES, V22, P1154, DOI 10.1101/gr.135780.111; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Houston RD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-90; Kucuktas H, 2009, GENETICS, V181, P1649, DOI 10.1534/genetics.108.098855; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Linke WA, 2002, J STRUCT BIOL, V137, P194, DOI 10.1006/jsbi.2002.4468; Liu F, 2014, SCI REP-UK, V4, DOI 10.1038/srep07256; Liu J, 2004, MAR SCI, V2, P001; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Liu XD, 2013, J FISH BIOL, V82, P34, DOI 10.1111/j.1095-8649.2012.03472.x; Lu ZM, 2013, BIOCHEM SYST ECOL, V51, P314, DOI 10.1016/j.bse.2013.09.019; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mu YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097471; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; O'Dushlaine CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r69; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Quilang J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-157; Reumers J, 2005, NUCLEIC ACIDS RES, V33, pD527; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Serapion J, 2004, MAR BIOTECHNOL, V6, P364, DOI 10.1007/s10126-003-0039-z; Song WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052097; Sun LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109666; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Wang J, 2014, AQUACULTURE, V432, P321, DOI 10.1016/j.aquaculture.2014.05.027; Wang SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-450; Wang W, 2014, MAR BIOTECHNOL, V16, P547, DOI 10.1007/s10126-014-9573-0; Wang XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066522; Wang XX, 2015, AQUAC RES, V46, P272, DOI 10.1111/are.12176; Wondji CS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-5; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Xia JH, 2014, AQUACULTURE, V432, P67, DOI 10.1016/j.aquaculture.2014.04.028; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Ye H, 2010, ACTA OCEANOL SIN, V29, P83, DOI 10.1007/s13131-010-0079-y; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087218; Zeng K, 2010, J MOL EVOL, V70, P116, DOI 10.1007/s00239-009-9314-6; Zhang LL, 2014, MAR BIOTECHNOL, V16, P17, DOI 10.1007/s10126-013-9526-z; Zhou P, 2010, COMP BIOCHEM PHYS D, V5, P89, DOI 10.1016/j.cbd.2010.01.002; Zhou ZC, 2014, MOL ECOL RESOUR, V14, P127, DOI 10.1111/1755-0998.12147	58	32	37	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124432	10.1371/journal.pone.0124432	http://dx.doi.org/10.1371/journal.pone.0124432			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909910	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800083
J	Yoo, K; Chung, SJ; Kim, HS; Choung, OH; Lee, YB; Kim, MJ; You, S; Jeong, Y				Yoo, Kwangsun; Chung, Sun Ju; Kim, Ho Sung; Choung, Oh-Hyeon; Lee, Young-Beom; Kim, Mi-Jung; You, Sooyeoun; Jeong, Yong			Neural Substrates of Motor and Non-Motor Symptoms in Parkinson's Disease: A Resting fMRI Study	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; ANTERIOR CINGULATE; FUNCTIONAL CONNECTIVITY; DEPRESSED-PATIENTS; CEREBRAL ATROPHY; FRONTAL-LOBE; LEWY BODY; BRAIN; ASYMMETRY; CORTEX	Background Recently, non-motor symptoms of Parkinson's disease (PD) have been considered crucial factors in determining a patient's quality of life and have been proposed as the predominant features of the premotor phase. Researchers have investigated the relationship between non-motor symptoms and the motor laterality; however, this relationship remains disputed. This study investigated the neural connectivity correlates of non-motor and motor symptoms of PD with respect to motor laterality. Methods Eight-seven patients with PD were recruited and classified into left-more-affected PD (n = 44) and right-more affected PD (n = 37) based on their MDS-UPDRS (Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale) motor examination scores. The patients underwent MRI scanning, which included resting fMRI. Brain regions were labeled as ipsilateral and contralateral to the more-affected body side. Correlation analysis between the functional connectivity across brain regions and the scores of various symptoms was performed to identify the neural connectivity correlates of each symptom. Results The resting functional connectivity centered on the ipsilateral inferior orbito-frontal area was negatively correlated with the severity of non-motor symptoms, and the connectivity of the contralateral inferior parietal area was positively correlated with the severity of motor symptoms (p < 0.001, vertical bar r vertical bar > 0.3). Conclusions These results suggest that the inferior orbito-frontal area may play a crucial role in non-motor dysfunctions, and that the connectivity information may be utilized as a neuroimaging biomarker for the early diagnosis of PD.	[Yoo, Kwangsun; Choung, Oh-Hyeon; Lee, Young-Beom; Jeong, Yong] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Lab Cognit Neurosci & NeuroImaging, Taejon 305701, South Korea; [Chung, Sun Ju; Kim, Mi-Jung; You, Sooyeoun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea; [Kim, Ho Sung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Jeong, Y (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Lab Cognit Neurosci & NeuroImaging, Taejon 305701, South Korea.	yong@kaist.ac.kr	Yoo, Kwangsun/F-1408-2014; Jeong, Yong/C-1677-2011	Yoo, Kwangsun/0000-0002-5213-4575; Jeong, Yong/0000-0002-5907-3787	World Class University program [R32-2008-000-10218-0]; Brain Research Program [NRF-2010-0018843]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning [NRF-2012R1A1A2044776]; Asan Institute for Life Sciences, Seoul, South Korea [2012-0416]	World Class University program; Brain Research Program; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning; Asan Institute for Life Sciences, Seoul, South Korea	This research was supported by World Class University program (R32-2008-000-10218-0), the Brain Research Program (NRF-2010-0018843), Basic Science Research Program (NRF-2012R1A1A2044776) through the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning, and a grant (2012-0416) from the Asan Institute for Life Sciences, Seoul, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballmaier M, 2004, AM J PSYCHIAT, V161, P99, DOI 10.1176/appi.ajp.161.1.99; Bezzola L, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00067; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brown RG, 1996, EUR NEUROL, V36, P24, DOI 10.1159/000118880; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Critchley HD, 2001, BRAIN, V124, P1003, DOI 10.1093/brain/124.5.1003; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Cubo E, 2010, MOVEMENT DISORD, V25, P70, DOI 10.1002/mds.22896; Djaldetti R, 2006, LANCET NEUROL, V5, P796, DOI 10.1016/S1474-4422(06)70549-X; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; FLEMINGER S, 1991, PSYCHOL MED, V21, P629, DOI 10.1017/S0033291700022261; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; GROSSMAN M, 1991, NEUROLOGY, V41, P1620; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; Hoehn MM, 1998, NEUROLOGY, V50, P318, DOI 10.1212/WNL.50.2.318; Hubbard PS, 2007, J ANAT, V211, P117, DOI 10.1111/j.1469-7580.2007.00748.x; HUBER SJ, 1989, CORTEX, V25, P461, DOI 10.1016/S0010-9452(89)80059-0; Kalbe E, 2009, NEUROLOGY, V72, P42, DOI 10.1212/01.wnl.0000338536.31388.f0; Kendi ATK, 2008, AM J NEURORADIOL, V29, P501, DOI 10.3174/ajnr.A0850; Kovari E, 2003, ACTA NEUROPATHOL, V106, P83, DOI 10.1007/s00401-003-0705-2; MAYBERG HS, 1990, ANN NEUROL, V28, P57, DOI 10.1002/ana.410280111; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; PLAYFORD ED, 1992, ANN NEUROL, V32, P151, DOI 10.1002/ana.410320206; Prakash BD, 2012, PARKINSONISM RELAT D, V18, P1029, DOI 10.1016/j.parkreldis.2012.05.021; Ramirez-Ruiz B, 2008, MOVEMENT DISORD, V23, P2335, DOI 10.1002/mds.22258; Reijnders JSAM, 2010, MOVEMENT DISORD, V25, P2318, DOI 10.1002/mds.23268; Rinne JO, 1993, MOVEMENT DISORD, V8, P34; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Sohn WS, 2014, ALZ DIS ASSOC DIS, V28, P239, DOI 10.1097/WAD.0000000000000027; Tessitore A, 2012, NEUROLOGY, V79, P2226, DOI 10.1212/WNL.0b013e31827689d6; Tolosa E, 2009, NEUROLOGY, V72, pS12, DOI 10.1212/WNL.0b013e318198db11; TOMER R, 1993, ANN NEUROL, V34, P579, DOI 10.1002/ana.410340412; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uitti RJ, 2005, NEUROLOGY, V64, P1925, DOI 10.1212/01.WNL.0000163993.82388.C8; van Eimeren T, 2010, NEUROLOGY, V75, P1711, DOI 10.1212/WNL.0b013e3181fc27fa; Williams LN, 2007, MOVEMENT DISORD, V22, P141, DOI 10.1002/mds.21220; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Yoo K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00049; Zhang KY, 2011, EUR J RADIOL, V77, P269, DOI 10.1016/j.ejrad.2009.07.032	44	16	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125455	10.1371/journal.pone.0125455	http://dx.doi.org/10.1371/journal.pone.0125455			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909812	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800141
J	Grimaldi, D; Ginsberg, PS; Thayer, L; McEvey, S; Hauser, M; Turelli, M; Brown, B				Grimaldi, David; Ginsberg, Paul S.; Thayer, Lesley; McEvey, Shane; Hauser, Martin; Turelli, Michael; Brown, Brian			Strange Little Flies in the Big City: Exotic Flower-Breeding Drosophilidae (Diptera) in Urban Los Angeles	PLOS ONE			English	Article							CHROMOSOMAL-POLYMORPHISM; MOLECULAR PHYLOGENY; UNITED-STATES; 1ST RECORDS; FLAVOPILOSA; SUZUKII; EUCALYPTUS; GLYCOSIDES; INVASION; FRUITS	Urban landscapes are commonly considered too mundane and corrupted to be biotically interesting. Recent insect surveys employing 29 Malaise traps throughout Los Angeles, California, however, have uncovered breeding populations of two unexpected species of one of the most studied and familiar groups of organisms, Drosophila "fruit" flies. Unlike most introduced species of drosophilids, which breed in fresh or decaying fruits, these are specialized flower-breeders. A common species in the survey was Drosophila (Drosophila) gentica Wheeler and Takada, previously collected only once, in El Salvador. It belongs to the flavopilosa species group, all species of which have been known until now from central Chile, Argentina and Uruguay, to Veracruz, Mexico and the Caribbean, breeding in flowers of Cestrum ("jessamine") and Sessea (Solanaceae). The Los Angeles populations are probably breeding in a native and/or introduced Cestrum; in addition, populations in San Luis Obispo County were visiting ornamental Cestrum. Drosophila gentica occurs as far north as San Francisco, where it was found breeding in Cestrum aurantiacum. D. gentica is redescribed and figured in detail for diagnostic and identification purposes. Specimens from Jamaica previously identified as D. gentica are a distinct species but are not formally described in lieu of complete male specimens. Rare in the Malaise traps was Drosophila (Sophophora) flavohirta Malloch, a common species in Australia on the blossoms of native Myrtaceae, found on introduced Eucalyptus in South Africa and both Eucalyptus and Syzygium in Madagascar; adults feed on myrtaceous pollen and nectar, larvae breed in the flowers. It is also redescribed in detail, including its unusual egg. This is the first New World report of this species; DNA sequences confirm it is a morphologically highly aberrant member of the D. melanogaster species group. This study reveals how intensive field sampling can uncover remarkable biodiversity in even the most urbanized areas.	[Grimaldi, David; Thayer, Lesley] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Ginsberg, Paul S.; Turelli, Michael] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [McEvey, Shane] Australian Museum, Dept Entomol, Sydney, NSW 2000, Australia; [Hauser, Martin] Calif Dept Food & Agr, Sacramento, CA 95814 USA; [Brown, Brian] Nat Hist Museum Los Angeles Cty, Entomol Sect, Los Angeles, CA USA	American Museum of Natural History (AMNH); University of California System; University of California Davis; Australian Museum; California Department of Food & Agriculture	Grimaldi, D (corresponding author), Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA.	grimaldi@amnh.org	Brown, Brian/K-6558-2019; McEvey, Shane F/E-7084-2010	McEvey, Shane F/0000-0002-7747-789X	Seaver Foundation; Natural History Museum of Los Angeles County; National Institutes of Health [R01GM104325]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104325] Funding Source: NIH RePORTER	Seaver Foundation; Natural History Museum of Los Angeles County; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	BioSCAN project by BB was funded by the Seaver Foundation (website: none) and the Natural History Museum of Los Angeles County (website: www.nhm.org) Research by MT was supported in part by National Institutes of Health grant R01GM104325 (website: www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams L., 1917, FLORA ANGELES VICINI, V3, DOI [10.5962/bhl.title.7705, DOI 10.5962/BHL.TITLE.7705]; Ashburner M, 1981, GENET BIOL DROSOPHIL, V3a, P375; Ashburner M., 2004, DROSOPHILA LAB HDB; Bachli G., 2004, FAUNA ENTOMOL SCAD, V39; Baldwin B.G., 2012, JEPSON MANUAL VASCUL, V2nd ed.; Bannina O, 2007, DEV BIOL, V311, P277, DOI 10.1016/j.ydbio.2007.07.030; Blaustein R, 2013, BIOSCIENCE, V63, P72, DOI 10.1525/bio.2013.63.2.3; Bock I, 1976, AUST J ZOOL        S, V24, P1, DOI DOI 10.1071/AJZS040; BRNCIC D, 1978, Revista Brasileira de Biologia, V38, P647; BRNCIC D, 1966, EVOLUTION, V20, P16, DOI 10.1111/j.1558-5646.1966.tb03340.x; BRNCIC D, 1962, CHROMOSOMA, V13, P183, DOI 10.1007/BF00326570; Brncic D., 1983, Genetics and Biology of Drosophila, V3d, P333; BRNCIC D, 1976, CAN J GENET CYTOL, V18, P111, DOI 10.1139/g76-016; BRNCIC D, 1968, GENETICS, V59, P427; BRNCIC D, 1972, U TEXAS PUBL, V7213, P103; Brown GK, 2001, AUST SYST BOT, V14, P565, DOI 10.1071/SB00029; Buys B., 1983, South African Bee Journal, V55, P129; Castrezana S., 2010, Drosophila Information Service, V93, P93; Castrezana S, 2012, DROSOPHILA INFO SERV, V93, P91; Castro Flabeano L., 2001, Drosophila Information Service, V84, P15; Cini A, 2012, B INSECTOL, V65, P149; Da Lage JL, 2007, J ZOOL SYST EVOL RES, V45, P47, DOI 10.1111/j.1439-0469.2006.00389.x; DARCY WG, 1976, SOLANACEAE, V3, P75; Davis AJ, 1996, AFR ENTOMOL, V4, P277; Depra M, 2014, J PEST SCI, V87, P379, DOI 10.1007/s10340-014-0591-5; dos Santos RDO, 2005, REV BRAS ENTOMOL, V49, P544, DOI 10.1590/S0085-56262005000400015; Doughty RW, 2000, EUCALYPTUS NATURAL C; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feinberg JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108213; Ferreira LB, 2005, BIODIVERS CONSERV, V14, P1809, DOI 10.1007/s10531-004-0701-4; Fourie A, 2011, AFR ENTOMOL, V19, P278, DOI 10.4001/003.019.0204; Gibson JF, 2011, ANN ENTOMOL SOC AM, V104, P976, DOI 10.1603/AN10153; HARLIM AF, 1971, PLANTA MED, V20, P44, DOI 10.1055/s-0028-1099663; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; HUGHES MR, 1977, NATURE, V268, P347, DOI 10.1038/268347a0; Kanzawa T, 1939, REV APPL ENTOMOLOGY, V29, p[49, 622]; Kingsbury JM, 1964, POISONOUS PLANTS US; Kohler R.E., 1994, LORDS FLY DROSOPHILA; KROOK L, 1975, CORNELL VET, V65, P557; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; Matteson KC, 2008, ANN ENTOMOL SOC AM, V101, P140, DOI 10.1603/0013-8746(2008)101[140:BRAAIN]2.0.CO;2; MCEVEY SF, 1989, J AUST ENTOMOL SOC, V28, P53; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; MCLENNAN MW, 1984, AUST VET J, V61, P289, DOI 10.1111/j.1751-0813.1984.tb06013.x; Mimaki Y, 2001, J NAT PROD, V64, P17, DOI 10.1021/np0003701; Munz PA, 1959, COLLABORATION DD KE; Newman CE, 2012, MOL PHYLOGENET EVOL, V63, P445, DOI 10.1016/j.ympev.2012.01.021; NICOLSON SW, 1994, PHYSIOL ENTOMOL, V19, P58, DOI 10.1111/j.1365-3032.1994.tb01074.x; PEARCE CM, 1992, J CHEM SOC PERK T 1, P593, DOI 10.1039/p19920000593; PIPKIN SB, 1966, AM NAT, V100, P135, DOI 10.1086/282407; Robe LJ, 2013, FLY, V7, P59, DOI 10.4161/fly.23923; Robe LJ, 2010, J ZOOL SYST EVOL RES, V48, P310, DOI 10.1111/j.1439-0469.2009.00563.x; Robe LJ, 2005, MOL PHYLOGENET EVOL, V36, P623, DOI 10.1016/j.ympev.2005.05.005; Russo CAM, 2013, ZOOL J LINN SOC-LOND, V169, P765, DOI [10.1111/zoj12062, 10.1111/zoj.12062]; Schmitz HJ, 2010, THESIS U FEDERAL RI; Stewart B, 2002, NY TIMES; Sturtevant AH., 1921, CARNEGIE I WASH YR B, V301, P1; Sultana Farhat, 1999, Entomological Science, V2, P121; Toit A. P. du, 1987, South African Forestry Journal, P53; TSACAS L, 1988, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V142, P143; van der Linde K, 2006, FLA ENTOMOL, V89, P402, DOI 10.1653/0015-4040(2006)89[402:FROZID]2.0.CO;2; VELA D, 2004, REV ECUATORIANA MED, V26, P14; VELA D, 2005, REV ECUATORIANA MED, V27, P27; VILELA C R, 1992, Revista Brasileira de Entomologia, V36, P475; Vilela C.R., 1999, Drosophila Information Service, V82, P37; Vilela CR, 1984, REV BRAS ZOOL, V2, P63, DOI DOI 10.1590/S0101-81751983000200004; Wheeler M. R., 1962, P395	68	8	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122575	10.1371/journal.pone.0122575	http://dx.doi.org/10.1371/journal.pone.0122575			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923661	Green Published, gold			2022-12-27	WOS:000353711600016
J	Pastorino, B; Baronti, C; Gould, EA; Charrel, RN; de Lamballerie, X				Pastorino, Boris; Baronti, Cecile; Gould, Ernest A.; Charrel, Remi N.; de Lamballerie, Xavier			Effect of Chemical Stabilizers on the Thermostability and Infectivity of a Representative Panel of Freeze Dried Viruses	PLOS ONE			English	Article							PETITS RUMINANTS VACCINE; LYOPHILIZATION; MICROORGANISMS; EFFICACY; STORAGE	As a partner of the European Virus Archive (EVA) FP7 project, our laboratory maintains a large collection of freeze-dried viruses. The distribution of these viruses to academic researchers, public health organizations and industry is one major aim of the EVA consortium. It is known that lyophilization requires appropriate stabilizers to prevent inactivation of the virus. However, few studies have investigated the influence of different stabilizers and lyophilization protocols on the thermostability of different viruses. In order to identify optimal lyophilization conditions that will deliver maximum retention of viral infectivity titre, different stabilizer formulations containing trehalose, sorbitol, sucrose or foetal bovine serum were evaluated for their efficacy in stabilizing a representative panel of freeze dried viruses at different storage temperatures (-20 degrees C, +4 degrees C and +20 degrees C) for one week, the two latter mimicking suboptimal shipping conditions. The Tissue Culture Infectious Dose 50% (TCID50) assay was used to compare the titres of infectious virus. The results obtained using four relevant and model viruses (enveloped/non enveloped RNA/DNA viruses) still serve to improve the freeze drying conditions needed for the development and the distribution of a large virus collection.	[Baronti, Cecile] Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, EPV UMR 190 Emergence Pathol Virales, F-13385 Marseille, France; Aix Marseille Univ, IHU Inst Hosp Univ Mediterranee Infect, APHM Publ Hosp Marseille, F-13385 Marseille, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Baronti, C (corresponding author), Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, EPV UMR 190 Emergence Pathol Virales, F-13385 Marseille, France.	cecile.baronti@univ-amu.fr		baronti, cecile/0000-0002-2319-9484; Charrel, Remi/0000-0002-7675-8251; pastorino, boris/0000-0001-5233-5193	European Virus Archive (European Union 7th Framework Programme) [228292]; EDENext FP7 [261504 EU]; European Network for Diagnostics of "Imported" Viral Diseases (ENIVD) from the European Centre for Disease Prevention and Control	European Virus Archive (European Union 7th Framework Programme); EDENext FP7; European Network for Diagnostics of "Imported" Viral Diseases (ENIVD) from the European Centre for Disease Prevention and Control	This work was supported in part by (i) the European Virus Archive (European Union 7th Framework Programme under grant agreement no. 228292)(http://www.european-virus-archive.com/), (ii) the EDENext FP7-no261504 EU project and this paper is catalogued by the EDENext Steering Committee (http://www.edenext.eu), (iii) European Network for Diagnostics of "Imported" Viral Diseases (ENIVD) funded from the European Centre for Disease Prevention and Control (http://www.enivd.de/index.htm). The work of RNC was done under the frame of EurNegVec COST Action TD1303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams G D, 1996, Methods Mol Med, V4, P167, DOI 10.1385/0-89603-334-1:167; Adams Gerald, 2007, Methods Mol Biol, V368, P15; Adebayo AA, 1998, BIOLOGICALS, V26, P309, DOI 10.1006/biol.1998.0157; Bedu-Addo FK, 2004, PHARM RES-DORDR, V21, P1353, DOI 10.1023/B:PHAM.0000036908.70139.f1; BOVARNICK MR, 1950, J BACTERIOL, V59, P509, DOI 10.1128/JB.59.4.509-522.1950; Day John G., 2007, METHOD MOL BIOL, P368; de Rizzo E, 1989, Bull Pan Am Health Organ, V23, P299; Gould EA, 2012, ANTIVIR RES, V95, P167, DOI 10.1016/j.antiviral.2012.05.005; HOWELL CL, 1983, J CLIN MICROBIOL, V18, P658, DOI 10.1128/JCM.18.3.658-662.1983; Hubalek Z, 2003, CRYOBIOLOGY, V46, P205, DOI 10.1016/s0011-2240(03)00046-4; Jamil RK, 2014, J VIROL METHODS, V199, P35, DOI 10.1016/j.jviromet.2013.12.020; Kang MS, 2010, POULTRY SCI, V89, P1167, DOI 10.3382/ps.2009-00620; MARINER JC, 1990, VET MICROBIOL, V21, P195, DOI 10.1016/0378-1135(90)90032-Q; Monath TP, 1996, DEV BIOL STAND, V87, P219; Morgan CA, 2006, J MICROBIOL METH, V66, P183, DOI 10.1016/j.mimet.2006.02.017; Prabhu M, 2014, BIOLOGICALS, V42, P169, DOI 10.1016/j.biologicals.2014.02.001; Riyesh Thachamvally, 2011, Virologica Sinica, V26, P324, DOI 10.1007/s12250-011-3205-x; Sarkar J, 2003, VACCINE, V21, P4728, DOI 10.1016/S0264-410X(03)00512-7; Silva AC, 2014, VACCINE, V32, P2878, DOI 10.1016/j.vaccine.2014.02.039; Silva AC, 2011, VACCINE, V29, P4983, DOI 10.1016/j.vaccine.2011.04.102; TANNOCK GA, 1987, J CLIN MICROBIOL, V25, P1769, DOI 10.1128/JCM.25.9.1769-1771.1987; Terada S., 2013, BMC P S6, V7, pP104; Zhai SL, 2004, BIOTECHNOL PROGR, V20, P1113, DOI 10.1021/bp034362x	23	19	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0118963	10.1371/journal.pone.0118963	http://dx.doi.org/10.1371/journal.pone.0118963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923434	Green Published, gold			2022-12-27	WOS:000353711600002
J	Barnhoorn, KJ; Staal, JB; van Dongen, RTM; Frolke, JPM; Klomp, FP; van de Meent, H; Samwel, H; Nijhuis-van der Sanden, MWG				Barnhoorn, Karlijn J.; Staal, J. Bart; van Dongen, Robert T. M.; Frolke, Jan Paul M.; Klomp, Frank P.; van de Meent, Henk; Samwel, Han; Nijhuis-van der Sanden, Maria W. G.			Are Pain-Related Fears Mediators for Reducing Disability and Pain in Patients with Complex Regional Pain Syndrome Type 1? An Explorative Analysis on Pain Exposure Physical Therapy	PLOS ONE			English	Article							TAMPA SCALE; CORTICAL REORGANIZATION; PSYCHOMETRIC PROPERTIES; CATASTROPHIZING SCALE; DIAGNOSTIC-CRITERIA; KINESIOPHOBIA; AVOIDANCE; REDUCTION	Objective To investigate whether pain-related fears are mediators for reducing disability and pain in patients with Complex Regional Pain Syndrome type 1 when treating with Pain Exposure Physical Therapy. Design An explorative secondary analysis of a randomised controlled trial. Participants Fifty-six patients with Complex Regional Pain Syndrome type 1. Interventions The experimental group received Pain Exposure Physical Therapy in a maximum of five treatment sessions; the control group received conventional treatment following the Dutch multidisciplinary guideline. Outcome measures Levels of disability, pain, and pain-related fears (fear-avoidance beliefs, pain catastrophizing, and kinesiophobia) were measured at baseline and after 3, 6, and 9 months follow-up. Results The experimental group had a significantly larger decrease in disability of 7.77 points (95% CI 1.09 to 14.45) and in pain of 1.83 points (95% CI 0.44 to 3.23) over nine months than the control group. The potential mediators pain-related fears decreased significantly in both groups, but there were no significant differences between groups, which indicated that there was no mediation. Conclusion The reduction of pain-related fears was comparable in both groups. We found no indication that pain-related fears mediate the larger reduction of disability and pain in patients with Complex Regional Pain Syndrome type 1 treated with Pain Exposure Physical Therapy compared to conventional treatment.	[Barnhoorn, Karlijn J.; Staal, J. Bart; Nijhuis-van der Sanden, Maria W. G.] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, NL-6525 ED Nijmegen, Netherlands; [van Dongen, Robert T. M.] Radboud Univ Nijmegen, Med Ctr, Dept Anaesthesiol Pain & Palliat Care, NL-6525 ED Nijmegen, Netherlands; [Frolke, Jan Paul M.] Radboud Univ Nijmegen, Med Ctr, Dept Surg, NL-6525 ED Nijmegen, Netherlands; [Klomp, Frank P.] Radboud Univ Nijmegen, Med Ctr, Sect Phys Therapy, Dept Orthopaed, NL-6525 ED Nijmegen, Netherlands; [van de Meent, Henk; Nijhuis-van der Sanden, Maria W. G.] Radboud Univ Nijmegen, Med Ctr, Dept Rehabil, NL-6525 ED Nijmegen, Netherlands; [Samwel, Han] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Barnhoorn, KJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, NL-6525 ED Nijmegen, Netherlands.	karlijn.barnhoorn@radboudumc.nl	Klomp, Frank/GOV-6720-2022; Meent, H./L-4509-2015; der Sanden, Maria WG Nijhuis-van/B-3463-2012; Frolke, J.P.M./L-4312-2015; van Dongen, Robert/L-4279-2015; Staal, Bart/ABA-4313-2020; Staal, J. Bart/A-9632-2014; van den Brule-Barnhoorn, Karlijn/AAE-7892-2021	der Sanden, Maria WG Nijhuis-van/0000-0003-2637-6877; Staal, Bart/0000-0002-0083-6380; Staal, J. Bart/0000-0002-0083-6380; 	Netherlands Organization for Health Research and Development (ZonMw) [170991004]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	Funding: This study was financially supported by The Netherlands Organization for Health Research and Development (ZonMw), project number 170991004, www.zonmw.nl/en/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhoorn KJ, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-58; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bean DJ, 2014, J PAIN, V15, P677, DOI 10.1016/j.jpain.2014.01.500; Bean DJ, 2014, CLIN J PAIN, V30, P647, DOI 10.1097/AJP.0000000000000007; Bruehl S, 1999, PAIN, V81, P147, DOI 10.1016/S0304-3959(99)00011-1; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Castien R, 2013, J ORTHOP SPORT PHYS, V43, P693, DOI 10.2519/jospt.2013.4868; Crossley KM, 2004, ARCH PHYS MED REHAB, V85, P815, DOI 10.1016/S0003-9993(03)00613-0; de Jong JR, 2012, PAIN, V153, P2109, DOI 10.1016/j.pain.2012.07.001; de Jong JR, 2011, J PAIN, V12, P1209, DOI 10.1016/j.jpain.2011.06.010; de Jong JR, 2005, PAIN, V116, P264, DOI 10.1016/j.pain.2005.04.019; Ek JW, 2009, CLIN REHABIL, V23, P1059, DOI 10.1177/0269215509339875; Flor H, 2003, J REHABIL MED, V35, P66, DOI 10.1080/16501960310010179; Fritz JM, 2002, PHYS THER, V82, P973, DOI 10.1093/ptj/82.10.973; Harden RN, 2007, PAIN MED, V8, P326, DOI 10.1111/j.1526-4637.2006.00169.x; Inrig T, 2012, J OCCUP REHABIL, V22, P59, DOI 10.1007/s10926-011-9323-3; Juottonen K, 2002, PAIN, V98, P315, DOI 10.1016/S0304-3959(02)00119-7; Lohnberg JA, 2013, J CLIN PSYCHOL MED S, V20, P247, DOI 10.1007/s10880-012-9322-3; Maihofner C, 2004, NEUROLOGY, V63, P693, DOI 10.1212/01.WNL.0000134661.46658.B0; Marinus J, 2013, CLIN J PAIN, V29, P563, DOI 10.1097/AJP.0b013e31826f9a8a; Marinus J, 2011, LANCET NEUROL, V10, P637, DOI 10.1016/S1474-4422(11)70106-5; Osman A, 2000, J BEHAV MED, V23, P351, DOI 10.1023/A:1005548801037; Perez RS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-20; Pleger B, 2005, ANN NEUROL, V57, P425, DOI 10.1002/ana.20394; Roelofs J, 2011, PAIN, V152, P1090, DOI 10.1016/j.pain.2011.01.028; Severeijns R, 2002, PAIN, V99, P367, DOI 10.1016/S0304-3959(02)00219-1; Sloot S, 2011, MEDISCH CONTACT, P42; Soer R, 2013, SPINE, V38, pE562, DOI 10.1097/BRS.0b013e31828af21f; Sullivan MJL, 1998, PAIN, V77, P253, DOI 10.1016/S0304-3959(98)00097-9; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tkachuk GA, 2012, J PAIN, V13, P970, DOI 10.1016/j.jpain.2012.07.001; Twisk JWR, 2010, INLEIDING TOEGEPASTE, V2nd; van de Meent H, 2011, PAIN, V152, P1431, DOI 10.1016/j.pain.2011.02.032; van Velzen GAJ, 2014, PAIN, V155, P629, DOI 10.1016/j.pain.2013.12.017; Vendrig A, 1998, NEDERLANDS TIJDSCHRI, V18, P11; Vlaeyen JWS, 2005, CLIN J PAIN, V21, P1, DOI 10.1097/00002508-200501000-00001; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Woby SR, 2005, PAIN, V117, P137, DOI 10.1016/j.pain.2005.05.029; Zale EL, 2013, J PAIN, V14, P1019, DOI 10.1016/j.jpain.2013.05.005	40	7	7	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123008	10.1371/journal.pone.0123008	http://dx.doi.org/10.1371/journal.pone.0123008			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SE	25919011	gold, Green Submitted, Green Published			2022-12-27	WOS:000353659400021
J	Sasaki, S; Kobayashi, M; Futagi, Y; Ogura, J; Yamaguchi, H; Iseki, K				Sasaki, Shotaro; Kobayashi, Masaki; Futagi, Yuya; Ogura, Jiro; Yamaguchi, Hiroaki; Iseki, Ken			Involvement of Histidine Residue His382 in pH Regulation of MCT4 Activity	PLOS ONE			English	Article							BLOOD-RETINAL BARRIER; MONOCARBOXYLATE TRANSPORTER; FOLATE TRANSPORTER; ACID; IDENTIFICATION; EXPRESSION; NICOTINATE; PROTEIN; CLONING; CELLS	Monocarboxylate transporter 4 (MCT4) is a pH-dependent bi-directional lactate transporter. Transport of lactate via MCT4 is increased by extracellular acidification. We investigated the critical histidine residue involved in pH regulation of MCT4 function. Transport of lactate via MCT4 was measured by using a Xenopus laevis oocyte expression system. MCT4-mediated lactate transport was inhibited by Zn2+ in a pH physiological condition but not in an acidic condition. The histidine modifier DEPC (diethyl pyrocarbonate) reduced MCT4 activity but did not completely inactivate MCT4. After treatment with DEPC, pH regulation of MCT4 function was completely knocked out. Inhibitory effects of DEPC were reversed by hydroxylamine and suppressed in the presence of excess lactate and Zn2+. Therefore, we performed an experiment in which the extracellular histidine residue was replaced with alanine. Consequently, the pH regulation of MCT4-H382A function was also knocked out. Our findings demonstrate that the histidine residue His382 in the extracellular loop of the transporter is essential for pH regulation of MCT4-mediated substrate transport activity.	[Sasaki, Shotaro; Kobayashi, Masaki; Futagi, Yuya; Ogura, Jiro; Yamaguchi, Hiroaki; Iseki, Ken] Hokkaido Univ, Fac Pharmaceut Sci, Div Pharmasci,Lab Clin Pharmaceut & Therapeut, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Iseki, Ken] Hokkaido Univ Hosp, Dept Pharm, Sapporo, Hokkaido 0608648, Japan	Hokkaido University; Hokkaido University	Iseki, K (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Div Pharmasci,Lab Clin Pharmaceut & Therapeut, Kita Ku, Kita 12 Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	ken-i@pharm.hokudai.ac.jp	kobayashi, masaki/B-1638-2015; Yamaguchi, Hiroaki/G-9969-2012; Ogura, Jiro/F-7260-2012	Yamaguchi, Hiroaki/0000-0003-3021-6120; Ogura, Jiro/0000-0001-5139-137X; Futagi, Yuya/0000-0003-2829-2845	Northern Advancement Center for Science and Technology	Northern Advancement Center for Science and Technology	Funding: This work was funded in part by a grant from the Northern Advancement Center for Science and Technology and from the Grant-in-Aid for Young Scientists (B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird FE, 2006, BIOCHEM J, V397, P369, DOI 10.1042/BJ20060026; Boll M, 2003, GENOMICS, V82, P47, DOI 10.1016/S0888-7543(03)00099-5; Clemmitt RH, 2000, BIOTECHNOL BIOENG, V67, P206, DOI 10.1002/(SICI)1097-0290(20000120)67:2<206::AID-BIT10>3.0.CO;2-X; Emoto A, 2002, AM J PHYSIOL-CELL PH, V282, pC1064, DOI 10.1152/ajpcell.00179.2001; Fei YJ, 1997, BIOCHEMISTRY-US, V36, P452, DOI 10.1021/bi962058p; FEI YJ, 1994, NATURE, V368, P563, DOI 10.1038/368563a0; Fujisawa Y, 2006, BIOL PHARM BULL, V29, P997, DOI 10.1248/bpb.29.997; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; HEMDAN ES, 1989, P NATL ACAD SCI USA, V86, P1811, DOI 10.1073/pnas.86.6.1811; Hosoya K, 2001, PHARM RES-DORDR, V18, P1669, DOI 10.1023/A:1013310210710; Ju PC, 2004, J BIOL CHEM, V279, P22983, DOI 10.1074/jbc.M312484200; Lam-Yuk-Tseung S, 2003, BLOOD, V101, P3699, DOI 10.1182/blood-2002-07-2108; Lin RY, 1998, J BIOL CHEM, V273, P28959, DOI 10.1074/jbc.273.44.28959; Metzner L, 2008, BBA-BIOMEMBRANES, V1778, P1042, DOI 10.1016/j.bbamem.2007.12.026; Metzner L, 2006, EUR J PHARM BIOPHARM, V63, P360, DOI 10.1016/j.ejpb.2006.01.009; Miles E W, 1977, Methods Enzymol, V47, P431; Miyauchi S, 2004, J BIOL CHEM, V279, P13293, DOI 10.1074/jbc.C400059200; Plata C, 2007, J BIOL CHEM, V282, P11996, DOI 10.1074/jbc.M609313200; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Sasaki S, 2015, J BIOL CHEM, V290, P2303, DOI 10.1074/jbc.M114.581892; Sasaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067690; Shimada A, 2006, NEUROSCI LETT, V392, P207, DOI 10.1016/j.neulet.2005.09.030; Sloane RP, 1996, J BIOTECHNOL, V49, P231, DOI 10.1016/0168-1656(96)01538-6; Tachikawa M, 2011, MICROVASC RES, V82, P385, DOI 10.1016/j.mvr.2011.06.009; Thwaites DT, 2007, EXP PHYSIOL, V92, P603, DOI 10.1113/expphysiol.2005.029959; Unal ES, 2009, J BIOL CHEM, V284, P17846, DOI 10.1074/jbc.M109.008060; Zong XG, 2001, J BIOL CHEM, V276, P6313, DOI 10.1074/jbc.M010326200	27	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0122738	10.1371/journal.pone.0122738	http://dx.doi.org/10.1371/journal.pone.0122738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919709	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400019
J	Helbig, C; Bilke, L; Bauer, HS; Bottinger, M; Kolditz, O				Helbig, Carolin; Bilke, Lars; Bauer, Hans-Stefan; Boettinger, Michael; Kolditz, Olaf			MEVA - An Interactive Visualization Application for Validation of Multifaceted Meteorological Data with Multiple 3D Devices	PLOS ONE			English	Article							COMPUTER GAMES; TOOL; SIMULATIONS; ENGINES; MODELS	To achieve more realistic simulations, meteorologists develop and use models with increasing spatial and temporal resolution. The analyzing, comparing, and visualizing of resulting simulations becomes more and more challenging due to the growing amounts and multifaceted character of the data. Various data sources, numerous variables and multiple simulations lead to a complex database. Although a variety of software exists suited for the visualization of meteorological data, none of them fulfills all of the typical domain-specific requirements: support for quasi-standard data formats and different grid types, standard visualization techniques for scalar and vector data, visualization of the context (e.g., topography) and other static data, support for multiple presentation devices used in modern sciences (e.g., virtual reality), a user-friendly interface, and suitability for cooperative work.	[Helbig, Carolin; Bilke, Lars; Kolditz, Olaf] UFZ Helmholtz Ctr Environm Res, Dept Environm Informat, Leipzig, Germany; [Helbig, Carolin; Kolditz, Olaf] Tech Univ Dresden, Fac Environm Sci, D-01062 Dresden, Germany; [Bauer, Hans-Stefan] Univ Hohenheim, Inst Phys & Meteorol, Stuttgart, Germany; [Boettinger, Michael] German Climate Comp Ctr DKRZ, Hamburg, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technische Universitat Dresden; University Hohenheim	Helbig, C (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Environm Informat, Leipzig, Germany.	carolin.helbig@ufz.de	Bilke, Lars/K-7350-2015	Bilke, Lars/0000-0001-8986-2413; Kolditz, Olaf/0000-0002-8098-4905; Helbig, Carolin/0000-0001-8508-2751; Bottinger, Michael/0000-0001-9704-8235	European Social Fund (ESF) as part of the program "Europa fordert Sachsen"	European Social Fund (ESF) as part of the program "Europa fordert Sachsen"(European Social Fund (ESF))	CH: Scholarship by the European Social Fund (ESF) as part of the program "Europa fordert Sachsen" (www.esf.de).	Ahrens J., 2005, VISUALIZATION HDB, P717, DOI [10.1016/B978-012387582-2/50038-1, DOI 10.1016/B978-012387582-2/50038-1]; Aigner W, 2007, COMPUT GRAPH-UK, V31, P401, DOI 10.1016/j.cag.2007.01.030; [Anonymous], VTKFBXCONVERTER; Bilke L, 2014, ENVIRON EARTH SCI, V72, P3881, DOI 10.1007/s12665-014-3785-5; Bohrer G, 2008, LECT NOTES COMPUT SC, V5358, P856, DOI 10.1007/978-3-540-89639-5_82; Braun J, 2001, OPEN DX PATHS VISUAL, P1; Cain AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046401; Castrillon M, 2011, COMPUT GEOSCI-UK, V37, P390, DOI 10.1016/j.cageo.2010.04.011; Clyne J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/8/301; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Doswell C.A., 1993, GEOPHYS MONOGR SER, V79, P161, DOI DOI 10.1029/GM079P0161; Friese KI, 2008, INT FED INFO PROC, V279, P11; Fuchs R, 2009, COMPUT GRAPH FORUM, V28, P1670, DOI 10.1111/j.1467-8659.2009.01429.x; Gerasch A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087397; Goldstone W, 2011, UNITY 3 X GAME DEV E, P1; Grundy E, 2009, COMPUT GRAPH FORUM, V28, P815, DOI 10.1111/j.1467-8659.2009.01469.x; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Helbig C, 2014, MEVA MULTIFACETED EN; Helbig C, 2014, ENVIRON EARTH SCI, V72, P3767, DOI 10.1007/s12665-014-3136-6; Hibbard WL, 1996, INT J SUPERCOMPUT AP, V10, P211, DOI 10.1177/109434209601000208; Kehrer J, 2013, IEEE T VIS COMPUT GR, V19, P495, DOI 10.1109/TVCG.2012.110; Lawrence Livermore National Laboratory, 2014, VIS INT PAR VIS GRAP; Lewis M, 2002, COMMUN ACM, V45, P27; Lidal E, 2013, WORKSH VIS ENV SCI, P1; Lv ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057990; Lynch P., 2006, EMERGENCE NUMERICAL, P1; Lynch P, 2008, J COMPUT PHYS, V227, P3431, DOI 10.1016/j.jcp.2007.02.034; Mayo MJ, 2009, SCIENCE, V323, P79, DOI 10.1126/science.1166900; Meyer M, 2010, COMPUT GRAPH FORUM, V29, P1043, DOI 10.1111/j.1467-8659.2009.01710.x; MOLLER AR, 1994, WEATHER FORECAST, V9, P327, DOI 10.1175/1520-0434(1994)009<0327:TOROST>2.0.CO;2; Nocke T, 2008, DIGITAL EARTH SUMMIT, P226; Nocke T, 2007, PROCEEDINGS OF THE 2007 WINTER SIMULATION CONFERENCE, VOLS 1-5, P682; Olbrich S, 2000, THESIS; Phadke MN, 2012, P SPIE; Rhyne TM, 2000, COMPUTER, V33, P154, DOI 10.1109/2.889099; Rhyne TM, 2002, COMMUN ACM, V45, P40, DOI 10.1145/514236.514261; Rink K, 2014, ENVIRON EARTH SCI, V72, P3857, DOI 10.1007/s12665-013-2970-2; Rink K, 2013, ENVIRON EARTH SCI, V69, P469, DOI 10.1007/s12665-012-2030-3; Sanyal J, 2010, IEEE T VIS COMPUT GR, V16, P1421, DOI 10.1109/TVCG.2010.181; Sedlmair M, 2012, IEEE T VIS COMPUT GR, V18, P2431, DOI 10.1109/TVCG.2012.213; Shamoun-Baranes J, 2012, BIOL LETTERS, V8, P6, DOI 10.1098/rsbl.2011.0764; Skamarock W.C., 2008, DESCRIPTION ADV RES; Sun XJ, 2012, COMPUT GEOSCI-UK, V47, P160, DOI 10.1016/j.cageo.2011.09.010; Thomas JJ, 2006, IEEE COMPUT GRAPH, V26, P10, DOI 10.1109/MCG.2006.5; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; van Dam A, 2002, COMPUT GRAPH-UK, V26, P535, DOI 10.1016/S0097-8493(02)00113-9; van Dam A, 2000, IEEE COMPUT GRAPH, V20, P26, DOI 10.1109/38.888006; Visualization Sciences Group, 2014, AVIZ 3D AN SOFTW SCI; Wang YS, 2013, COMPUT GEOSCI-UK, V61, P23, DOI 10.1016/j.cageo.2013.07.016	50	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123811	10.1371/journal.pone.0123811	http://dx.doi.org/10.1371/journal.pone.0123811			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915061	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100028
J	Moilanen, AM; Rysa, J; Kaikkonen, L; Karvonen, T; Mustonen, E; Serpi, R; Szabo, Z; Tenhunen, O; Bagyura, Z; Napankangas, J; Ohukainen, P; Tavi, P; Kerkela, R; Leosdottir, M; Wahlstrand, B; Hedner, T; Melander, O; Ruskoaho, H				Moilanen, Anne-Mari; Rysa, Jaana; Kaikkonen, Leena; Karvonen, Teemu; Mustonen, Erja; Serpi, Raisa; Szabo, Zoltan; Tenhunen, Olli; Bagyura, Zsolt; Napankangas, Juha; Ohukainen, Pauli; Tavi, Pasi; Kerkela, Risto; Leosdottir, Margret; Wahlstrand, Bjorn; Hedner, Thomas; Melander, Olle; Ruskoaho, Heikki			WDR12, a Member of Nucleolar PeBoW-Complex, Is Up-Regulated in Failing Hearts and Causes Deterioration of Cardiac Function	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NATRIURETIC-PEPTIDE; IMMUNE-RESPONSES; GENE-EXPRESSION; WD-REPEAT; IN-VIVO; AFRICAN ANCESTRY; BLOOD-PRESSURE; AGING RESEARCH; FAILURE	Aims In a recent genome-wide association study, WD-repeat domain 12 (WDR12) was associated with early-onset myocardial infarction (MI). However, the function of WDR12 in the heart is unknown. Methods and Results We characterized cardiac expression of WDR12, used adenovirus-mediated WDR12 gene delivery to examine effects of WDR12 on left ventricular (LV) remodeling, and analyzed relationship between MI associated WDR12 allele and cardiac function in human subjects. LV WDR12 protein levels were increased in patients with dilated cardiomyopathy and rats post-infarction. In normal adult rat hearts, WDR12 gene delivery into the anterior wall of the LV decreased interventricular septum diastolic and systolic thickness and increased the diastolic and systolic diameters of the LV. Moreover, LV ejection fraction (9.1%, P<0.05) and fractional shortening (12.2%, P<0.05) were declined. The adverse effects of WDR12 gene delivery on cardiac function were associated with decreased cellular proliferation, activation of p38 mitogen-activated protein kinase (MAPK)/heat shock protein (HSP) 27 pathway, and increased protein levels of Block of proliferation 1 (BOP1), essential for ribosome biogenesis. Post-infarction WDR12 gene delivery decreased E/A ratio (32%, P<0.05) suggesting worsening of diastolic function. In human subjects, MI associated WDR12 allele was associated significantly with diastolic dysfunction and left atrial size. Conclusions WDR12 triggers distinct deterioration of cardiac function in adult rat heart and the MI associated WDR12 variant is associated with diastolic dysfunction in human subjects.	[Moilanen, Anne-Mari; Rysa, Jaana; Kaikkonen, Leena; Karvonen, Teemu; Mustonen, Erja; Serpi, Raisa; Szabo, Zoltan; Tenhunen, Olli; Ohukainen, Pauli; Kerkela, Risto; Ruskoaho, Heikki] Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, Oulu, Finland; [Moilanen, Anne-Mari; Napankangas, Juha] Univ Oulu, Dept Pathol, Inst Diagnost, Oulu, Finland; [Serpi, Raisa] Univ Oulu, Fac Biochem & Mol Med, Bioctr Oulu, Oulu, Finland; [Bagyura, Zsolt] Semmelweis Univ, Ctr Heart, H-1085 Budapest, Hungary; [Tavi, Pasi] Univ Eastern Finland, Dept Biotechnol & Mol Med, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Moilanen, Anne-Mari; Kerkela, Risto] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Moilanen, Anne-Mari; Kerkela, Risto] Univ Oulu, Oulu, Finland; [Wahlstrand, Bjorn; Hedner, Thomas] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden; [Leosdottir, Margret; Melander, Olle] Lund Univ, Dept Clin Sci, Lund, Sweden; [Melander, Olle] Skane Univ Hosp, Dept Internal Med, Malmo, Sweden; [Leosdottir, Margret] Skane Univ Hosp, Dept Cardiol, Malmo, Sweden; [Ruskoaho, Heikki] Univ Helsinki, Div Pharmacol & Pharmacotherapy, Helsinki, Finland	University of Oulu; University of Oulu; University of Oulu; Semmelweis University; University of Eastern Finland; University of Oulu; University of Oulu; University of Gothenburg; Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; University of Helsinki	Ruskoaho, H (corresponding author), Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, Oulu, Finland.	heikki.ruskoaho@helsinki.fi	Ohukainen, Pauli/P-7811-2019	Ohukainen, Pauli/0000-0002-0919-7204; Rysa, Jaana/0000-0003-2205-6323; Melander, Olle/0000-0002-2581-484X; Serpi, Raisa/0000-0002-8207-4673; Szabo, Zoltan/0000-0003-0778-1113; Napankangas, Juha/0000-0003-3088-5180; Leosdottir, Margret/0000-0003-1677-1566	Academy of Finland (Center of Excellence); Academy of Finland; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; National Technology Foundation TEKES; Biocenter Finland; European Research Council [StG-282255]; Swedish Medical Research Council; Swedish Heart and Lung Foundation; Novo Nordisk Foundation; LUA/ALF [ALFGBG151121]; Novo Nordisk Fonden [NNF14OC0009819, NNF13OC0005339] Funding Source: researchfish	Academy of Finland (Center of Excellence)(Academy of Finland); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; National Technology Foundation TEKES(Finnish Funding Agency for Technology & Innovation (TEKES)); Biocenter Finland; European Research Council(European Research Council (ERC)European Commission); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); LUA/ALF; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Academy of Finland (Center of Excellence) (HR), Academy of Finland (JR), Sigrid Juselius Foundation (HR), Finnish Foundation for Cardiovascular Research (HR, JR and RS), the National Technology Foundation TEKES (HR), Biocenter Finland (HR and RS) and European Research Council StG-282255 (OM), the Swedish Medical Research Council (OM), the Swedish Heart and Lung Foundation (OM), the Novo Nordisk Foundation (OM) and LUA/ALF - ALFGBG151121 (TH and BW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berglund G, 2000, J INTERN MED, V247, P19, DOI 10.1046/j.1365-2796.2000.00568.x; Blattmann P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003338; Cataliotti A, 2008, CIRCULATION, V118, P1729, DOI 10.1161/CIRCULATIONAHA.107.759241; Cohn JN, 1997, CIRCULATION, V95, P766; Connelly S, 1996, BLOOD, V88, P3846, DOI 10.1182/blood.V88.10.3846.bloodjournal88103846; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; dUscio LV, 1997, HYPERTENSION, V29, P435, DOI 10.1161/01.HYP.29.1.435; Fava C, 2013, HYPERTENSION, V61, P319, DOI 10.1161/HYPERTENSIONAHA.112.202655; Fields PA, 2000, MOL THER, V1, P225, DOI 10.1006/mthe.2000.0032; Fischer M, 2003, EUR HEART J, V24, P320, DOI 10.1016/S0195-668X(02)00428-1; Hautala N, 2001, CIRCULATION, V103, P730; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; HUELSEMANN JL, 1985, HYPERTENSION, V7, P374, DOI 10.1161/01.HYP.7.3_Pt_1.374; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Koivisto E, 2011, CAN J PHYSIOL PHARM, V89, P539, DOI [10.1139/Y11-049, 10.1139/y11-049]; Koivisto E, 2011, MOL CELL ENDOCRINOL, V338, P18, DOI 10.1016/j.mce.2011.02.015; Lako-Futo Z, 2003, CIRCULATION, V108, P2414, DOI 10.1161/01.CIR.0000093193.63314.D9; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lapik YR, 2004, MOL CELL, V15, P17, DOI 10.1016/j.molcel.2004.05.020; Leosdottir M, 2010, AM HEART J, V159, P414, DOI 10.1016/j.ahj.2009.12.028; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Magga J, 1997, CIRC RES, V81, P694; McGuigan FEA, 2002, PSYCHIATR GENET, V12, P133, DOI 10.1097/00041444-200209000-00003; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Moilanen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041404; Moilanen AM, 2011, CIRC-HEART FAIL, V4, P483, DOI 10.1161/CIRCHEARTFAILURE.110.958033; Morrison AC, 2010, CIRC-CARDIOVASC GENE, V3, P248, DOI 10.1161/CIRCGENETICS.109.895995; Nal B, 2002, GENOMICS, V79, P77, DOI 10.1006/geno.2001.6682; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Pfeffer MA, 1979, CIRC RES, V13, P293; Pikkarainen S, 2003, J BIOL CHEM, V278, P23807, DOI 10.1074/jbc.M302719200; Rohrmoser M, 2007, MOL CELL BIOL, V27, P3682, DOI 10.1128/MCB.00172-07; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Rysa J, 2005, HYPERTENSION, V45, P927, DOI 10.1161/01.HYP.0000161873.27088.4c; Rysa J, 2010, CIRC-HEART FAIL, V3, P440, DOI 10.1161/CIRCHEARTFAILURE.109.889642; Schagen FHE, 2004, CRIT REV ONCOL HEMAT, V50, P51, DOI 10.1016/S1040-8428(03)00172-0; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Smith NL, 2010, CIRC-CARDIOVASC GENE, V3, P256, DOI 10.1161/CIRCGENETICS.109.895763; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; SMITS GJ, 1991, HYPERTENSION, V18, P17, DOI 10.1161/01.HYP.18.1.17; Strezoska Z, 2002, J BIOL CHEM, V277, P29617, DOI 10.1074/jbc.M204381200; Suo M, 2002, HYPERTENSION, V39, P803, DOI 10.1161/hy0302.105214; Szatkowski ML, 2001, J CLIN INVEST, V107, P191, DOI 10.1172/JCI9862; Tenhunen O, 2004, J BIOL CHEM, V279, P24852, DOI 10.1074/jbc.M314317200; Tenhunen O, 2006, FASEB J, V20, P1907, DOI 10.1096/fj.05-5618fje; Tenhunen O, 2006, CIRC RES, V99, P485, DOI 10.1161/01.RES.0000238387.85144.92; TOKOLA H, 1994, EUR J PHARM-MOLEC PH, V267, P195, DOI 10.1016/0922-4106(94)90171-6; Tripathy SK, 1996, NAT MED, V2, P545, DOI 10.1038/nm0596-545; Wang JW, 2009, CIRCULATION, V119, P1146, DOI 10.1161/CIRCULATIONAHA.108.822676; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Willis MS, 2010, CIRCULATION, V122, P1740, DOI 10.1161/CIRCULATIONAHA.110.942250	55	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124907	10.1371/journal.pone.0124907	http://dx.doi.org/10.1371/journal.pone.0124907			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915632	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100080
J	Trussoni, CE; Tabibian, JH; Splinter, PL; O'Hara, SP				Trussoni, Christy E.; Tabibian, James H.; Splinter, Patrick L.; O'Hara, Steven P.			Lipopolysaccharide (LPS)-Induced Biliary Epithelial Cell NRas Activation Requires Epidermal Growth Factor Receptor (EGFR)	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; INCREASED INTESTINAL PERMEABILITY; PRIMARY SCLEROSING CHOLANGITIS; PROTEIN-COUPLED RECEPTORS; TOLL-LIKE RECEPTOR; CRYPTOSPORIDIUM-PARVUM; MULTIPLE TLRS; BILE-DUCT; CONTRIBUTES; PATHOGENESIS	Cholangiocytes (biliary epithelial cells) actively participate in microbe-induced proinflammatory responses in the liver and contribute to inflammatory and infectious cholangiopathies. We previously demonstrated that cholangiocyte TLR-dependent NRas activation contributes to proinflammatory/proliferative responses. We test the hypothesis that LPS-induced activation of NRas requires the EGFR. SV40-transformed human cholangiocytes (H69 cells), or low passage normal human cholangiocytes (NHC), were treated with LPS in the presence or absence of EGFR or ADAM metallopeptidase domain 17 (TACE) inhibitors. Ras activation assays, quantitative RT-PCR, and proliferation assays were performed in cells cultured with or without inhibitors or an siRNA to Grb2. Immunofluorescence for phospho-EGFR was performed on LPS-treated mouse samples and specimens from patients with primary sclerosing cholangitis, primary biliary cirrhosis, hepatitis C, and normal livers. LPS-treatment induced an association between the TLR/MyD88 and EGFR/Grb2 signaling apparatus, NRas activation, and EGFR phosphorylation. NRas activation was sensitive to EGFR and TACE inhibitors and correlated with EGFR phosphorylation. The TACE inhibitor and Grb2 depletion prevented LPS-induced IL6 expression (p<0.05) and proliferation (p<0.01). Additionally, cholangiocytes from LPS-treated mouse livers and human primary sclerosing cholangitis (PSC) livers exhibited increased phospho-EGFR (p<0.01). Moreover, LPS-induced mouse cholangiocyte proliferation was inhibited by concurrent treatment with the EGFR inhibitor, Erlotinib. Our results suggest that EGFR is essential for LPS-induced, TLR4/MyD88-mediated NRas activation and induction of a robust proinflammatory cholangiocyte response. These findings have implications not only for revealing the signaling potential of TLRs, but also implicate EGFR as an integral component of cholangiocyte TLR-induced proinflammatory processes.	[O'Hara, Steven P.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; Mayo Clin, Ctr Cell Signaling Gastroenterol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	O'Hara, SP (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.	ohara.steven@mayo.edu		Trussoni, Christy/0000-0002-4247-076X	NIH [R01 AI089713]; Mayo Foundation; Clinical and Optical Microscopy Cores of the Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; Clinical and Optical Microscopy Cores of the Mayo Clinic Center for Cell Signaling in Gastroenterology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH Grants R01 AI089713 to S.P.O., the Mayo Foundation, and the Clinical and Optical Microscopy Cores of the Mayo Clinic Center for Cell Signaling in Gastroenterology (P30DK084567). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agley CC, 2012, J HISTOCHEM CYTOCHEM, V60, P428, DOI 10.1369/0022155412442897; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alpini G, 1997, AM J PHYSIOL-GASTR L, V273, pG518, DOI 10.1152/ajpgi.1997.273.2.G518; Alpini G, 1999, GASTROENTEROLOGY, V116, P179, DOI 10.1016/S0016-5085(99)70242-8; Amiri H, 2003, CELL CALCIUM, V33, P463, DOI 10.1016/S0143-4160(03)00061-7; Bhola NE, 2008, FRONT BIOSCI-LANDMRK, V13, P1857, DOI 10.2741/2805; Buhner S, 2006, GUT, V55, P342, DOI 10.1136/gut.2005.065557; Burgel PR, 2008, EUR RESPIR J, V32, P1068, DOI 10.1183/09031936.00172007; Chen WNU, 2004, J BIOL CHEM, V279, P18488, DOI 10.1074/jbc.M310874200; Chen XM, 2008, IMMUNOL CELL BIOL, V86, P497, DOI 10.1038/icb.2008.37; Chen XM, 2005, J IMMUNOL, V175, P7447, DOI 10.4049/jimmunol.175.11.7447; Finzi L, 2009, J IMMUNOL, V182, P2269, DOI 10.4049/jimmunol.0801768; GRUBMAN SA, 1994, AM J PHYSIOL, V266, pG1060, DOI 10.1152/ajpgi.1994.266.6.G1060; Gwak GY, 2005, J CANCER RES CLIN, V131, P649, DOI 10.1007/s00432-005-0016-1; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Harada K, 2006, J CLIN PATHOL, V59, P184, DOI 10.1136/jcp.2004.023507; Harada K, 2004, HEPATOLOGY, V40, P925, DOI 10.1002/hep.20379; Harada K, 2009, CLIN EXP IMMUNOL, V157, P261, DOI 10.1111/j.1365-2249.2009.03947.x; Hiramatsu K, 2000, J HEPATOL, V33, P9, DOI 10.1016/S0168-8278(00)80153-1; JOPLIN R, 1989, IN VITRO CELL DEV B, V25, P1189; Karrar A, 2007, GASTROENTEROLOGY, V132, P1504, DOI 10.1053/j.gastro.2007.01.039; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Lazaridis KN, 2004, GASTROENTEROLOGY, V127, P1565, DOI 10.1053/j.gastro.2004.08.006; Leone F, 2006, CLIN CANCER RES, V12, P1680, DOI 10.1158/1078-0432.CCR-05-1692; MIMURA Y, 1995, GASTROENTEROLOGY, V109, P1969, DOI 10.1016/0016-5085(95)90765-3; Modlin RL, 2004, NAT MED, V10, P1173, DOI 10.1038/nm1104-1173; Mueller T, 2011, LIVER INT, V31, P1574, DOI 10.1111/j.1478-3231.2011.02635.x; Ngu JH, 2011, CLIN GASTROENTEROL H, V9, P1092, DOI 10.1016/j.cgh.2011.08.027; O'Hara SP, 2011, J PARASITOL, V97, P813, DOI 10.1645/GE-2703.1; O'Hara SP, 2011, J BIOL CHEM, V286, P30352, DOI 10.1074/jbc.M111.269464; Olsson R, 1998, J HEPATOL, V28, P426, DOI 10.1016/S0168-8278(98)80316-4; Pohl J, 2006, EUR J GASTROEN HEPAT, V18, P69, DOI 10.1097/00042737-200601000-00012; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sasatomi K, 1998, J HEPATOL, V29, P409, DOI 10.1016/S0168-8278(98)80058-5; Seo DW, 2004, AM J PHYSIOL-GASTR L, V287, pG1247, DOI 10.1152/ajpgi.00013.2004; Sia D, 2013, ONCOGENE, V32, P4861, DOI 10.1038/onc.2012.617; Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993; Tabibian JH, 2013, LAB INVEST, V93, P733, DOI 10.1038/labinvest.2013.52; Tabibian JH, 2013, COMPR PHYSIOL, V3, P541, DOI 10.1002/cphy.c120019; Tabibian JH, 2013, EXPERT REV GASTROENT, V7, P103, DOI [10.1586/egh.12.80, 10.1586/EGH.12.80]; Tarnawski AS, 2005, DIGEST DIS SCI, V50, pS24, DOI 10.1007/s10620-005-2803-6; Welcker K, 2004, EUR J MED RES, V9, P456; Werneburg NW, 2003, AM J PHYSIOL-GASTR L, V285, pG31, DOI 10.1152/ajpgi.00536.2002; WIESNER RH, 1980, GASTROENTEROLOGY, V79, P200; Yokoyama T, 2006, LIVER INT, V26, P467, DOI 10.1111/j.1478-3231.2006.01254.x; Yoon JH, 2004, J HEPATOL, V41, P808, DOI 10.1016/j.jhep.2004.07.016	47	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125793	10.1371/journal.pone.0125793	http://dx.doi.org/10.1371/journal.pone.0125793			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915403	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100148
J	Wu, SM; Lei, YL; Li, L				Wu, Sanmang; Lei, Yalin; Li, Li			Evaluation of the Contributions of Four Components of Gross Domestic Product in Various Regions in China	PLOS ONE			English	Article								Four major components influence the growth of the gross domestic product in Chinese provinces: consumption, investment, transnational exports, and inter-provincial exports. By splitting a competitive input-output table into a non-competitive input-output table, this study used an input-output model to measure the contributions of the four components of gross domestic product in various regions in China. We found that international exports drove the growth of the gross domestic product more strongly in the eastern region than in other regions. Investment and inter-provincial exports were the major impetus for gross domestic product growth in the central and western regions. We also found that consumption played a minimal role in driving the growth of the gross domestic product in all regions in China. According to these findings, although various regions can share much in terms of policies to transform the impetus for economic growth, there should be different foci for different regions. Their shared policy is to increase the role of final consumption in stimulating economic growth. Region-specific policies mandate that the eastern region should strengthen the driving force provided by international exports and that the central and western regions should strengthen indigenous growth capabilities by improving scientific innovation, industrial support, and institutional innovation.	[Wu, Sanmang; Lei, Yalin] China Univ Geosci, Sch Humannities & Econ Management, Beijing 100083, Peoples R China; [Wu, Sanmang; Lei, Yalin; Li, Li] Minist Land & Resource, Key Lab Carrying Capac Assessment Resource & Envi, Beijing 100083, Peoples R China; [Li, Li] Tsinghua Univ, Sch Publ Policy & Management, Beijing 100084, Peoples R China	China University of Geosciences; Tsinghua University	Wu, SM (corresponding author), China Univ Geosci, Sch Humannities & Econ Management, Beijing 100083, Peoples R China.	1614483397@qq.com	wu, sanmang/AAE-4087-2020	wu, sanmang/0000-0002-0375-1761	National Natural Science Foundation of China [71003066, 71133003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are grateful for financial support from the National Natural Science Foundation of China under grant nos. 71003066 and 71133003. The financial support from the National Natural Science Foundation of China under grant nos. 71003066 and 71133003 supported the data collection of the manuscript.	Chenery H., 1960, AM ECON REV, V1, P624; Chenery H, 1962, ECONOMETRICA, V21, P98; Chenery H.B., 1953, STRUCTURE GROWTH ITA, P97; Gao WG, 2009, EC RES GUIDE, V3, P34; General Administration of Customs of the P.R.C, 2008, CUST STAT YB CHIN; General Administration of Customs of the P.R.C, 1998, CUST STAT YB CHIN; General Administration of Customs of the P.R.C, 2003, CUST STAT YB CHIN; Ghirmay T, 2001, APPL ECON, V6, P88; Islam N, 1998, APPL ECON, V3, P124; Lawrence J, 2007, SOCIAL SCI CHINA, V5, P45; Li ST, 2010, REV EC RES, V29, P158; Li ST, 2010, EC RES, V29, P45; Lin YF, 2003, INT TRADE ISSUES, V5, P87; Liu ZB, 2008, ACAD MONTHLY, V65, P78; Moses I., 1995, AM ECON REV, V45, P803; National Bureau of Statistics of the P.R.C, 2006, REG INP OUTP TABL CH; National Bureau of Statistics of the P.R.C, 2001, REG INP OUTP TABL CH; Peng FW, 1998, INT TRADE ISSUES, V1, P15; Shan J, 2001, APPL ECON LETT, V4, P66; SHEN Li-sheng, 2009, J QUANTITATIVE TECHN, V4, P139; Shen LS, 2003, EC RES, V9, P102; Takahiro A., 1991, ASIAN ECON J, V2, P139; Tregenna F, 1970, CAMBRIDGE WORKING PA; Tregenna F., 200898 UNUWIDER; Wang ZX, 1998, INT TRADE, V10, P32; Yao Y., 2009, J CHONGQIN TECHNOLOG, V23, P18; Zakaria A, 1999, DEV ECON, V2, P162; Zhang XJ, 1998, INT TRADE ISSUES, V4, P57	28	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0121594	10.1371/journal.pone.0121594	http://dx.doi.org/10.1371/journal.pone.0121594			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915927	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659100006
J	Freitas, EO; Nico, D; Guan, R; Meyer-Fernandes, JR; Clinch, K; Evans, GB; Tyler, PC; Schramm, VL; Palatnik-de-Sousa, CB				Freitas, Elisangela Oliveira; Nico, Dirlei; Guan, Rong; Meyer-Fernandes, Jose Roberto; Clinch, Keith; Evans, Gary B.; Tyler, Peter C.; Schramm, Vern L.; Palatnik-de-Sousa, Clarisa B.			Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro	PLOS ONE			English	Article							NUCLEOSIDE HYDROLASE; VISCERAL LEISHMANIASIS; PYRIMIDINE METABOLISM; CRYSTAL-STRUCTURES; PURINE METABOLISM; VIVO ACTIVITY; DONOVANI; INHIBITORS; COMPLEX; ENZYMES	Chemotherapy against visceral leishmaniasis is associated with high toxicity and drug resistance. Leishmania parasites are purine auxotrophs that obtain their purines from exogenous sources. Nucleoside hydrolases release purines from nucleosides and are drug targets for anti-leishmanial drugs, absent in mammal cells. We investigated the substrate specificity of the Leishmania (L.) donovani recombinant nucleoside hydrolase NH36 and the inhibitory effect of the immucillins IA (ImmA), DIA (DADMe-ImmA), DIH (DADMe-ImmH), SMIH (SerMe-ImmH), IH (ImmH), DIG (DADMe-ImmG), SMIG (SerMe-ImmG) and SMIA (SerMEImmA) on its enzymatic activity. The inhibitory effects of immucillins on the in vitro multiplication of L. (L.) infantum chagasi and L. (L.) amazonensis promastigotes were determined using 0.05-500 mu M and, when needed, 0.01-50 nM of each drug. The inhibition on multiplication of L. (L.) infantum chagasi intracellular amastigotes in vitro was assayed using 0.5, 1, 5 and 10 mu M of IA, IH and SMIH. The NH36 shows specificity for inosine, guanosine, adenosine, uridine and cytidine with preference for adenosine and inosine. IA, IH, DIH, DIG, SMIH and SMIG immucillins inhibited L. (L.) infantum chagasi and L. (L.) amazonensis promastigote growth in vitro at nanomolar to micromolar concentrations. Promastigote replication was also inhibited in a chemically defined medium without a nucleoside source. Addition of adenosine decreases the immucillin toxicity. IA and IH inhibited the NH36 enzymatic activity (Ki = 0.080 mu M for IA and 0.019 mu M for IH). IA, IH and SMIH at 10 mu M concentration, reduced the in vitro amastigote replication inside mice macrophages by 95% with no apparent effect on macrophage viability. Transmission electron microscopy revealed global alterations and swelling of L. (L.) infantum chagasi promastigotes after treatment with IA and IH while SMIH treatment determined intense cytoplasm vacuolization, enlarged vesicles and altered kinetoplasts. Our results suggest that IA, IH and SMIH may provide new chemotherapy agents for leishmaniasis.	[Freitas, Elisangela Oliveira; Nico, Dirlei; Palatnik-de-Sousa, Clarisa B.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Dept Microbiol Geral, Rio De Janeiro, Brazil; [Freitas, Elisangela Oliveira; Guan, Rong; Schramm, Vern L.] Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, New York, NY 10033 USA; [Meyer-Fernandes, Jose Roberto] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Clinch, Keith; Evans, Gary B.; Tyler, Peter C.] Victoria Univ Wellington, Ferrier Res Inst, Wellington, New Zealand	Universidade Federal do Rio de Janeiro; Yeshiva University; Universidade Federal do Rio de Janeiro; Victoria University Wellington	Palatnik-de-Sousa, CB (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Dept Microbiol Geral, Rio De Janeiro, Brazil.	immgcpa@micro.ufrj.br	Evans, Gary/I-4123-2019; Nico, Dirlei/GZA-3726-2022; Freitas, Elisangela/I-7384-2017; Evans, Gary/B-8343-2011	Evans, Gary/0000-0002-6973-2002; Evans, Gary/0000-0002-6973-2002; Clinch, Keith/0000-0002-3300-4396; Palatnik-de-Sousa, Clarisa B./0000-0002-6231-0608	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [301215-2007-3, 302039/2010-4, 559756/2010-0, 404400/2012-4]; Fundacao de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ) [E-26/102733/2008, E-26/102957/2011, E-26/102415/2010, E-26/110535/2010]; PROLAB Award PABMB/ASBMB PROLAB (Promoting Research Opportunities For Latin American Biochemists (PROLAB) of the American Society for Biochemistry and Molecular Biology)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); PROLAB Award PABMB/ASBMB PROLAB (Promoting Research Opportunities For Latin American Biochemists (PROLAB) of the American Society for Biochemistry and Molecular Biology)	This work has been supported by: EOF, DN, JRMF, CPS: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ, Fellowships 301215-2007-3, 302039/2010-4, 559756/2010-0 and grant 404400/2012-4), by Fundacao de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ, grants E-26/102733/2008 and E-26/102957/2011 and Fellowships E-26/102415/2010 and E-26/110535/2010). EOF, VLS, RG, CPS: PROLAB Award PABMB/ASBMB PROLAB (Promoting Research Opportunities For Latin American Biochemists (PROLAB) of the American Society for Biochemistry and Molecular Biology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Barrett MP, 2012, BRIT MED BULL, V104, P175, DOI 10.1093/bmb/lds031; Carter NS, 2008, ADV EXP MED BIOL, V625, P141, DOI 10.1007/978-0-387-77570-8_12; Carvalho AK, 2012, PARASITE IMMUNOL, V34, P395, DOI 10.1111/j.1365-3024.2012.01370.x; Cassera MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026916; Clinch K, 2009, J MED CHEM, V52, P1126, DOI 10.1021/jm801421q; Soares DC, 2007, PARASITOL INT, V56, P135, DOI 10.1016/j.parint.2007.01.004; Cui LW, 2001, GENE, V280, P153, DOI 10.1016/S0378-1119(01)00768-5; de Morais-Teixeira E, 2008, MEM I OSWALDO CRUZ, V103, P358, DOI 10.1590/S0074-02762008000400008; de Morais-Teixeira E, 2014, J ANTIMICROB CHEMOTH, V69, P150, DOI 10.1093/jac/dkt318; Donaldson TM, 2014, EUKARYOT CELL, V13, P572, DOI 10.1128/EC.00308-13; Dye C, 1996, AM J TROP MED HYG, V55, P125, DOI 10.4269/ajtmh.1996.55.125; Giannese F, 2013, ACTA CRYSTALLOGR D, V69, P1553, DOI 10.1107/S0907444913010792; HASSAN HF, 1986, MOL BIOCHEM PARASIT, V19, P19, DOI 10.1016/0166-6851(86)90061-7; Kiffer-Moreira T, 2010, FEMS YEAST RES, V10, P735, DOI 10.1111/j.1567-1364.2010.00641.x; KRUG EC, 1989, J BIOL CHEM, V264, P10601; LO HS, 1985, J PARASITOL, V71, P662, DOI 10.2307/3281440; Lovane E, 2008, BIOCHEMISTRY-US, V47, P4418, DOI 10.1021/bi702448s; Maia C, 2013, EXP PARASITOL, V135, P36, DOI 10.1016/j.exppara.2013.05.015; Maltezou HC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/617521; MARR JJ, 1978, BIOCHIM BIOPHYS ACTA, V544, P360, DOI 10.1016/0304-4165(78)90104-6; Martin JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003938; Mauricio IL, 2006, INT J PARASITOL, V36, P757, DOI 10.1016/j.ijpara.2006.03.006; Mlika RB, 2012, DERMATOL THER, V25, P615, DOI 10.1111/j.1529-8019.2012.01522.x; Nico D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00189; Nico D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000866; Nogueira RC, 2013, ENVIRON TOXICOL PHAR, V36, P1304, DOI 10.1016/j.etap.2013.10.013; Paladi CD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001626; Palatnik-de-Sousa CB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-197; PARKIN DW, 1991, J BIOL CHEM, V266, P20658; Parkin DW, 1996, J BIOL CHEM, V271, P21713, DOI 10.1074/jbc.271.36.21713; Ramirez-Macias I, 2012, MEM I OSWALDO CRUZ, V107, P370, DOI 10.1590/S0074-02762012000300012; Real F, 2013, DNA RES, V20, P567, DOI 10.1093/dnares/dst031; REYES P, 1982, MOL BIOCHEM PARASIT, V5, P275, DOI 10.1016/0166-6851(82)90035-4; Rodrigues RF, 2012, J ANTIMICROB CHEMOTH, V67, P182, DOI 10.1093/jac/dkr409; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Santana DM, 2002, MOL BIOCHEM PARASIT, V120, P315, DOI 10.1016/S0166-6851(02)00010-5; Santos LO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004918; Sarver AE, 2002, J BIOL CHEM, V277, P39973, DOI 10.1074/jbc.M205595200; Shi WX, 2004, J BIOL CHEM, V279, P18103, DOI 10.1074/jbc.C400068200; Shi WX, 1999, J BIOL CHEM, V274, P21114, DOI 10.1074/jbc.274.30.21114; Shokri A, 2012, PARASITOL RES, V110, P1113, DOI 10.1007/s00436-011-2599-6; Solano-Gallego L, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-86; Stauch Anette, 2012, PLoS Negl Trop Dis, V6, pe1973, DOI 10.1371/journal.pntd.0001973; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; Sundar S, 2013, EXPERT OPIN PHARMACO, V14, P53, DOI 10.1517/14656566.2013.755515; Todd SJ, 2003, J BACTERIOL, V185, P3373, DOI 10.1128/JB.185.11.3373-3378.2003; Versees W, 2009, BBA-PROTEINS PROTEOM, V1794, P953, DOI 10.1016/j.bbapap.2009.02.011; Wright PK, 2010, FRONT ANTI-CANC DRUG, V1, P758, DOI 10.2174/978160805161811001010758	49	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124183	10.1371/journal.pone.0124183	http://dx.doi.org/10.1371/journal.pone.0124183			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909893	Green Submitted, gold, Green Published			2022-12-27	WOS:000353376800063
J	Hayslip, J; Dressler, EV; Weiss, H; Taylor, TJ; Chambers, M; Noel, T; Miriyala, S; Keeney, JTR; Ren, XJ; Sultana, R; Vore, M; Butterfield, DA; St Clair, D; Moscow, JA				Hayslip, John; Dressler, Emily V.; Weiss, Heidi; Taylor, Tammy J.; Chambers, Mara; Noel, Teresa; Miriyala, Sumitra; Keeney, Jeriel T. R.; Ren, Xiaojia; Sultana, Rukhsana; Vore, Mary; Butterfield, D. Allan; St Clair, Daret; Moscow, Jeffrey A.			Plasma TNF-alpha and Soluble TNF Receptor Levels after Doxorubicin with or without Co-Administration of Mesna-A Randomized, Cross-Over Clinical Study	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; 2-MERCAPTOETHANE SULFONATE MESNA; MANGANESE SUPEROXIDE-DISMUTASE; CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; ADRIAMYCIN; PHARMACOKINETICS; CHEMOBRAIN; INSIGHT; DYSFUNCTION	Purpose Chemotherapy-induced cognitive impairment (CICI) is a common sequelae of cancer therapy. Recent preclinical observations have suggested that CICI can be mediated by chemotherapy-induced plasma protein oxidation, which triggers TNF-alpha mediated CNS damage. This study evaluated sodium-2-mercaptoethane sulfonate (Mesna) co-administration with doxorubicin to reduce doxorubicin-induced plasma protein oxidation and resultant cascade of TNF-alpha, soluble TNF receptor levels and related cytokines. Methods Thirty-two evaluable patients were randomized using a crossover design to receive mesna or saline in either the first or second cycle of doxorubicin in the context of a standard chemotherapy regimen for either non-Hodgkin lymphoma or breast cancer. Mesna (360 mg/m(2)) or saline administration occurred 15 minutes prior and three hours post doxorubicin. Pre-treatment and post-treatment measurements of oxidative stress, TNF-alpha and related cytokines were evaluated during the two experimental cycles of chemotherapy. Results Co-administration of mesna with chemotherapy reduced post-treatment levels of TNF-related cytokines and TNF-receptor 1 (TNFR1) and TNF-receptor 2 (TNFR2) (p = 0.05 and p = 0.002, respectively). Patients with the highest pre-treatment levels of each cytokine and its receptors were the most likely to benefit from mesna co-administration. Conclusions The extracellular anti-oxidant mesna, when co-administered during a single cycle of doxorubicin, reduced levels of TNF-alpha and its receptors after that cycle of therapy, demonstrating for the first time a clinical interaction between mesna and doxorubicin, drugs often coincidentally co-administered in multi-agent regimens. These findings support further investigation to determine whether rationally-timed mesna co-administration with redox active chemotherapy may prevent or reduce the cascade of events that lead to CICI.	[Hayslip, John; Dressler, Emily V.; Weiss, Heidi; Chambers, Mara; Vore, Mary; Butterfield, D. Allan; St Clair, Daret; Moscow, Jeffrey A.] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40506 USA; [Hayslip, John] Univ Kentucky, Div Hematol & Blood & Marrow Transplantat, Lexington, KY USA; [Taylor, Tammy J.; Moscow, Jeffrey A.] Univ Kentucky, Dept Pediat, Lexington, KY USA; [Chambers, Mara] Univ Kentucky, Div Med Oncol, Lexington, KY USA; [Noel, Teresa; Miriyala, Sumitra; Vore, Mary; St Clair, Daret] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Keeney, Jeriel T. R.; Ren, Xiaojia; Sultana, Rukhsana; Butterfield, D. Allan] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Moscow, JA (corresponding author), Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40506 USA.	jmoscow@uky.edu	Ren, Xiaojia/HII-8545-2022	Dressler, Emily/0000-0002-6054-7839; Miriyala, Sumitra/0000-0001-7158-9295	National Cancer Institute [CA153227, CA 139843]; Markey Cancer Foundation; University of Kentucky; NATIONAL CANCER INSTITUTE [P30CA177558, R01CA153227, R01CA139843] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Markey Cancer Foundation; University of Kentucky; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grant CA153227 and CA 139843 from the National Cancer Institute and by additional funding from the Markey Cancer Foundation (http://www.markeycancerfoundation.org) and from DanceBlue, a student-run effort to support pediatric oncology research at the University of Kentucky (http://danceblue.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluise CD, 2011, FREE RADICAL BIO MED, V50, P1630, DOI 10.1016/j.freeradbiomed.2011.03.009; Aluise CD, 2009, CANCER LETT, V282, P25, DOI 10.1016/j.canlet.2009.02.047; BENJAMIN RS, 1977, CANCER RES, V37, P1416; Bower JE, 2008, J CLIN ONCOL, V26, P768, DOI 10.1200/JCO.2007.14.3248; BROCK N, 1982, EUR J CANCER CLIN ON, V18, P1377, DOI 10.1016/0277-5379(82)90143-2; BROCK N, 1984, J CANCER RES CLIN, V108, P87, DOI 10.1007/BF00390979; ElYazigi A, 1997, J CLIN PHARMACOL, V37, P618, DOI 10.1002/j.1552-4604.1997.tb04344.x; Ganz PA, 2013, BRAIN BEHAV IMMUN, V30, pS99, DOI 10.1016/j.bbi.2012.07.015; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; JAMES CA, 1987, BRIT J CLIN PHARMACO, V23, P561, DOI 10.1111/j.1365-2125.1987.tb03092.x; Joshi G, 2005, FREE RADICAL RES, V39, P1147, DOI 10.1080/10715760500143478; Kannarkat G, 2007, CURR OPIN NEUROL, V20, P719; Olivier J, 2008, ANN ALLERG ASTHMA IM, V100, P333, DOI 10.1016/S1081-1206(10)60595-9; Piaggio Gilda, 2003, BMC Med Res Methodol, V3, P19, DOI 10.1186/1471-2288-3-19; RICHARDSON RP, 1989, ANN SURG, V210, P239, DOI 10.1097/00000658-198908000-00018; Senn S, 2002, CROSS OVER TRIALS CL; Tangpong J, 2008, NEUROSCIENCE, V151, P622, DOI 10.1016/j.neuroscience.2007.10.046; Tangpong J, 2006, NEUROBIOL DIS, V23, P127, DOI 10.1016/j.nbd.2006.02.013; Tangpong J, 2007, J NEUROCHEM, V100, P191, DOI 10.1111/j.1471-4159.2006.04179.x	19	31	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124988	10.1371/journal.pone.0124988	http://dx.doi.org/10.1371/journal.pone.0124988			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909710	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800120
J	Kalies, S; Antonopoulos, GC; Rakoski, MS; Heinemann, D; Schomaker, M; Ripken, T; Meyer, H				Kalies, Stefan; Antonopoulos, Georgios C.; Rakoski, Mirko S.; Heinemann, Dag; Schomaker, Markus; Ripken, Tammo; Meyer, Heiko			Investigation of Biophysical Mechanisms in Gold Nanoparticle Mediated Laser Manipulation of Cells Using a Multimodal Holographic and Fluorescence Imaging Setup	PLOS ONE			English	Article							PHOTOTHERMAL THERAPY; CALCIUM WAVES; LIVING CELLS; GENERATION; RESPONSES	Laser based cell manipulation has proven to be a versatile tool in biomedical applications. In this context, combining weakly focused laser pulses and nanostructures, e.g. gold nanoparticles, promises to be useful for high throughput cell manipulation, such as transfection and photothermal therapy. Interactions between laser pulses and gold nanoparticles are well understood. However, it is still necessary to study cell behavior in gold nanoparticle mediated laser manipulation. While parameters like cell viability or perforation efficiency are commonly addressed, the influence of the manipulation process on other essential cell parameters is not sufficiently investigated yet. Thus, we set out to study four relevant cell properties: cell volume and area, ion exchange and cytoskeleton structure after gold nanoparticle based laser manipulation. For this, we designed a multimodal imaging and manipulation setup. 200 nm gold nanoparticles were attached unspecifically to canine cells and irradiated by weakly focused 850 ps laser pulses. Volume and area change in the first minute post laser manipulation was monitored using digital holography. Calcium imaging and cells expressing a marker for filamentous actin (F-actin) served to analyze the ion exchange and the cytoskeleton, respectively. High radiant exposures led to cells exhibiting a tendency to shrink in volume and area, possibly due to outflow of cytoplasm. An intracellular raise in calcium was observed and accompanied by an intercellular calcium wave. This multimodal approach enabled for the first time a comprehensive analysis of the cell behavior in gold nanoparticle mediated cell manipulation. Additionally, this work can pave the way for a better understanding and the evaluation of new applications in the context of cell transfection or photothermal therapy.	[Kalies, Stefan; Antonopoulos, Georgios C.; Rakoski, Mirko S.; Heinemann, Dag; Schomaker, Markus; Ripken, Tammo; Meyer, Heiko] Laser Zentrum Hannover eV, Biomed Opt Dept, Hannover, Germany; [Meyer, Heiko] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany	Hannover Medical School	Kalies, S (corresponding author), Laser Zentrum Hannover eV, Biomed Opt Dept, Hannover, Germany.	s.kalies@lzh.de	Heinemann, Dag/A-2861-2019; Heinemann, Dag/AAZ-9970-2021	Heinemann, Dag/0000-0003-3506-1762; Kalies, Stefan/0000-0003-3025-264X	German Research Foundation (DFG); REBIRTH Cluster of Excellence; "Industrielle Gemeinschaftsforschung" (IGF) of the German Federal Ministry for Economic Affairs and Energy (BMWi) [18129N]; Hannover Biomedical Research School (HBRS)	German Research Foundation (DFG)(German Research Foundation (DFG)); REBIRTH Cluster of Excellence; "Industrielle Gemeinschaftsforschung" (IGF) of the German Federal Ministry for Economic Affairs and Energy (BMWi); Hannover Biomedical Research School (HBRS)	The authors gratefully acknowledge the German Research Foundation (DFG) and the REBIRTH Cluster of Excellence for funding. Further funding was provided by the "Industrielle Gemeinschaftsforschung" (IGF, grant number 18129N) of the German Federal Ministry for Economic Affairs and Energy (BMWi). SK receives a stipend by the Hannover Biomedical Research School (HBRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antkowiak M, 2010, J BIOPHOTONICS, V3, P696, DOI 10.1002/jbio.201000052; Bisker G, 2012, J OPT SOC AM B, V29, P1383, DOI 10.1364/JOSAB.29.001383; BOITANO S, 1992, SCIENCE, V258, P292, DOI 10.1126/science.1411526; Boulais E, 2012, NANO LETT, V12, P4763, DOI 10.1021/nl302200w; Cacace VI, 2014, CELL PHYSIOL BIOCHEM, V33, P1745, DOI 10.1159/000362955; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chen X, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0071; Cuche E, 1996, P SOC PHOTO-OPT INS, V2927, P61, DOI 10.1117/12.260653; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Ding HF, 2011, SPRINGER SER SURF SC, V46, P229, DOI 10.1007/978-3-642-15813-1_9; Escobar HM, 2003, CYTOGENET GENOME RES, V101, P33, DOI 10.1159/000073415; Fonck E, 2009, STROKE, V40, P2552, DOI 10.1161/STROKEAHA.108.528091; Freitas RA, 2005, NANOMED-NANOTECHNOL, V1, P2, DOI 10.1016/j.nano.2004.11.003; Gnaiger E, 2000, Transpl Int, V13 Suppl 1, pS555, DOI 10.1111/j.1432-2277.2000.tb02103.x; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Hashimoto S, 2012, J PHOTOCH PHOTOBIO C, V13, P28, DOI 10.1016/j.jphotochemrev.2012.01.001; Heinemann D, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/24/245101; Heinemann D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058604; Herraez MA, 2002, APPL OPTICS, V41, P7437, DOI 10.1364/AO.41.007437; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Huang XH, 2008, LASER MED SCI, V23, P217, DOI 10.1007/s10103-007-0470-x; Iserovich P, 1998, ADV EXP MED BIOL, V438, P687; Kalies S, 2013, J BIOPHOTONICS; Kalies S, 2014, BIOMED OPT EXPRESS, V5, P2686, DOI 10.1364/BOE.5.002686; Kemper B, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3540674; Kim MK, 2011, SPRINGER SER OPT SCI, V162, P1, DOI 10.1007/978-1-4419-7793-9; Lapotko D, 2009, INT J HEAT MASS TRAN, V52, P1540, DOI 10.1016/j.ijheatmasstransfer.2008.08.010; Leybaert L, 2012, PHYSIOL REV, V92, P1359, DOI 10.1152/physrev.00029.2011; Lukianova-Hleb EY, 2011, J SURG RES, V166, pE3, DOI 10.1016/j.jss.2010.10.039; Minai L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02146; Mitchell CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079235; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; Pavillon N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030912; Rappaz B, 2005, OPT EXPRESS, V13, P9361, DOI 10.1364/OPEX.13.009361; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Roderick HL, 2003, CURR BIOL, V13, pR425, DOI 10.1016/S0960-9822(03)00358-0; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaked NT, 2011, QUANTITATIVE ANAL BI; Smith NI, 2001, APPL PHYS LETT, V79, P1208, DOI 10.1063/1.1397255; Sperling RA, 2008, CHEM SOC REV, V37, P1896, DOI 10.1039/b712170a; Tseeb V, 2009, HFSP J, V3, P117, DOI 10.2976/1.3073779; Weichsel J, 2010, CYTOM PART A, V77A, P52, DOI 10.1002/cyto.a.20818; Xiong RH, 2014, ACS NANO, V8, P6288, DOI 10.1021/nn5017742	47	18	18	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124052	10.1371/journal.pone.0124052	http://dx.doi.org/10.1371/journal.pone.0124052			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909631	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800058
J	Lefebvre, B; Levesque, S; Bourgault, AM; Mulvey, MR; Mataseje, L; Boyd, D; Doualla-Bell, F; Tremblay, C				Lefebvre, Brigitte; Levesque, Simon; Bourgault, Anne-Marie; Mulvey, Michael R.; Mataseje, Laura; Boyd, David; Doualla-Bell, Florence; Tremblay, Cecile			Carbapenem Non-Susceptible Enterobacteriaceae in Quebec, Canada: Results of a Laboratory Surveillance Program (2010-2012)	PLOS ONE			English	Article							OXA-48-PRODUCING KLEBSIELLA-PNEUMONIAE; METALLO-BETA-LACTAMASE; ESCHERICHIA-COLI; EMERGENCE; OUTBREAK; DISSEMINATION; RESISTANCE; ONTARIO	The emergence and spread of carbapenemase-producing Enterobacteriaceae (CPE) represent a major public health concern because these bacteria are usually extensively resistant to most antibiotics. In order to evaluate their dissemination in Quebec, a surveillance program was introduced in 2010. We report the molecular and epidemiological profiles of CPE isolates collected. Between August 2010 and December 2012, a total of 742 non-duplicate isolates non-susceptible to carbapenems were analysed. AmpC beta-lactamase and metallo-beta-lactamase production were detected by Etest and carbapenemase production by the modified Hodge test (MHT). Antibiotic susceptibility profiles were determined using broth microdilution or Etest. Clonality of Klebsiella pneumoniae carbapenemase (KPC) strains was analyzed by pulsed-field gel electrophoresis (PFGE). The presence of genes encoding carbapenemases as well as other beta-lactamases was detected using PCR. Of the 742 isolates tested, 169 (22.8%) were CPE. Of these 169 isolates, 151 (89.3%) harboured a bla(KPC) gene while the remaining isolates carried bla(SME) (n = 9), bla(OXA-48) (n = 5), bla(NDM) (n = 3), and bla(NMC) (n = 1) genes. Among the 93 KPC strains presenting with a unique pattern (unique PFGE pattern and/or unique antibiotics susceptibility profile), 99% were resistant to ertapenem, 95% to imipenem, 87% to meropenem, 97% to aztreonam, 31% to colistin and 2% to tigecycline. In 19 patients, 2 to 5 KPC strains from different species or with a different PFGE pattern were isolated. CPE strains were present in the province of Quebec with the majority of strains harbouring KPC. Alternately, SME, OXA-48 and NMC containing strains were rarely found.	[Lefebvre, Brigitte; Levesque, Simon; Doualla-Bell, Florence; Tremblay, Cecile] Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada; [Bourgault, Anne-Marie] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Bourgault, Anne-Marie] McGill Univ, Dept Med, Montreal, PQ, Canada; [Mulvey, Michael R.; Mataseje, Laura; Boyd, David] Publ Hlth Agcy Canada, Bacteriol & Enter Dis Program, Natl Microbiol Lab, Winnipeg, MB, Canada; [Tremblay, Cecile] Univ Montreal, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada	Institut national de sante publique du Quebec (INSPQ); McGill University; McGill University; Public Health Agency of Canada; Universite de Montreal	Lefebvre, B (corresponding author), Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada.	brigitte.lefebvre@inspq.qc.ca		Levesque, Simon/0000-0002-4356-9702; Boyd, David/0000-0001-8618-4848	LSPQ; NML internal	LSPQ; NML internal	This work was supported by LSPQ and NML internal funding and was done as a part of the routine work.	Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P750; Barlow M, 2002, ANTIMICROB AGENTS CH, V46, P1190, DOI 10.1128/AAC.46.5.1190-1198.2002; Borgia S, 2012, CLIN INFECT DIS, V55, pE109, DOI 10.1093/cid/cis737; CLSI, 2012, M100S22 CLSI; CLSI, 2011, PERFORMANCE STANDARD; Cuzon G, 2011, ANTIMICROB AGENTS CH, V55, P2420, DOI 10.1128/AAC.01452-10; Cuzon G, 2010, EMERG INFECT DIS, V16, P1349, DOI 10.3201/eid1609.091389; Perez JAE, 2013, ANTIMICROB AGENTS CH, V57, P1957, DOI 10.1128/AAC.01447-12; Haraoui LP, 2013, J CLIN MICROBIOL, V51, P2406, DOI 10.1128/JCM.02480-12; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Leung V, 2012, CAN J INFECT DIS MED, V23, P117, DOI 10.1155/2012/725151; Lowe CF, 2013, INFECT CONT HOSP EP, V34, P49, DOI 10.1086/668778; Mataseje LF, 2012, J ANTIMICROB CHEMOTH, V67, P1359, DOI 10.1093/jac/dks046; Mataseje LF, 2013, EMERG INFECT DIS, V19, P157, DOI 10.3201/eid1901.120706; Mnif B, 2013, J ANTIMICROB CHEMOTH, V68, P329, DOI 10.1093/jac/dks386; Mulvey MR, 2011, EMERG INFECT DIS, V17, P103, DOI 10.3201/eid1701.101358; Mushtaq S, 2011, J ANTIMICROB CHEMOTH, V66, P2002, DOI 10.1093/jac/dkr226; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Oteo J, 2013, J ANTIMICROB CHEMOTH, V68, P317, DOI 10.1093/jac/dks383; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Peirano G, 2011, DIAGN MICR INFEC DIS, V71, P106, DOI 10.1016/j.diagmicrobio.2011.06.013; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pisney L, 2013, MMWR-MORBID MORTAL W, V62, P108; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Potron A, 2011, CLIN MICROBIOL INFEC, V17, pE24, DOI 10.1111/j.1469-0691.2011.03669.x; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Pano-Pardo JR, 2013, J ANTIMICROB CHEMOTH, V68, P89, DOI 10.1093/jac/dks364; Samuelsen O, 2009, J ANTIMICROB CHEMOTH, V63, P654, DOI 10.1093/jac/dkp018; Tijet N, 2011, EMERG INFECT DIS, V17, P306, DOI 10.3201/eid1702.101561; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Voulgari E, 2013, J ANTIMICROB CHEMOTH, V68, P84, DOI 10.1093/jac/dks356; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09	36	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125076	10.1371/journal.pone.0125076	http://dx.doi.org/10.1371/journal.pone.0125076			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910041	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800126
J	Rossi, O; Khan, MT; Schwarzer, M; Hudcovic, T; Srutkova, D; Duncan, SH; Stolte, EH; Kozakova, H; Flint, HJ; Samsom, JN; Harmsen, HJM; Wells, JM				Rossi, Oriana; Khan, M. Tanweer; Schwarzer, Martin; Hudcovic, Tomas; Srutkova, Dagmar; Duncan, Sylvia H.; Stolte, Ellen H.; Kozakova, Hana; Flint, Harry J.; Samsom, Janneke N.; Harmsen, Hermie J. M.; Wells, Jerry M.			Faecalibacterium prausnitzii Strain HTF-F and Its Extracellular Polymeric Matrix Attenuate Clinical Parameters in DSS-Induced Colitis	PLOS ONE			English	Article							COMMENSAL BACTERIUM; DENDRITIC CELLS; MICROBIOTA; DISEASE; BUTYRATE; GROWTH	A decrease in the abundance and biodiversity of intestinal bacteria within the Firmicutes phylum has been associated with inflammatory bowel disease (IBD). In particular, the anti-inflammatory bacterium Faecalibacterium prausnitzii, member of the Firmicutes phylum and one of the most abundant species in healthy human colon, is underrepresented in the microbiota of IBD patients. The aim of this study was to investigate the immunomodulatory properties of F. prausnitzii strain A2-165, the biofilm forming strain HTF-F and the extracellular polymeric matrix (EPM) isolated from strain HTF-F. For this purpose, the immunomodulatory properties of the F. prausnitzii strains and the EPM were studied in vitro using human monocyte-derived dendritic cells. Then, the capacity of the F. prausnitzii strains and the EPM of HTF-F to suppress inflammation was assessed in vivo in the mouse dextran sodium sulphate (DSS) colitis model. The F. prausnitzii strains and the EPM had anti-inflammatory effects on the clinical parameters measured in the DSS model but with different efficacy. The immunomodulatory effects of the EPM were mediated through the TLR2-dependent modulation of IL-12 and IL-10 cytokine production in antigen presenting cells, suggesting that it contributes to the anti-inflammatory potency of F. prausnitzii HTF-F. The results show that F. prausnitzii HTF-F and its EPM may have a therapeutic use in IBD.	[Rossi, Oriana; Stolte, Ellen H.; Wells, Jerry M.] Wageningen Univ, Host Microbe Interact Grp, Dept Anim Sci, NL-6700 AP Wageningen, Netherlands; [Khan, M. Tanweer; Harmsen, Hermie J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Sect Membrane Cell Biol, NL-9713 AV Groningen, Netherlands; [Schwarzer, Martin; Hudcovic, Tomas; Srutkova, Dagmar; Kozakova, Hana] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic; [Duncan, Sylvia H.; Flint, Harry J.] Univ Aberdeen, Microbial Ecol Grp, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Samsom, Janneke N.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat, Div Gastroenterol & Nutr, Rotterdam, Netherlands	Wageningen University & Research; University of Groningen; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Aberdeen; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Wells, JM (corresponding author), Wageningen Univ, Host Microbe Interact Grp, Dept Anim Sci, NL-6700 AP Wageningen, Netherlands.	jerry.wells@wur.nl	Srutkova, Dagmar/H-8511-2014; Schwarzer, Martin/P-9871-2017	Srutkova, Dagmar/0000-0003-0054-5396; Duncan, Sylvia/0000-0002-4903-0978; Schwarzer, Martin/0000-0002-1401-6578				Barcenilla A, 2000, APPL ENV MICROBIOLOG; COOPER HS, 1993, LAB INVEST, V69, P238; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hamer HM, 2010, CLIN NUTR, V29, P738, DOI 10.1016/j.clnu.2010.04.002; Lopez-Siles M, 2012, APPL ENVIRON MICROB, V78, P420, DOI 10.1128/AEM.06858-11; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Macfarlane GT, 2009, CURR PHARM DESIGN, V15, P1528, DOI 10.2174/138161209788168146; Manuzak J, 2012, CLIN VACCINE IMMUNOL, V19, P1207, DOI 10.1128/CVI.00282-12; Martin R, 2014, INFLAMM BOWEL DIS, V20, P417, DOI 10.1097/01.MIB.0000440815.76627.64; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Meijerink M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035849; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ricciardi A, 1998, BIOTECHNOL TECH, V12, P649, DOI 10.1023/A:1008896400383; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Rozen S, 2000, Methods Mol Biol, V132, P365; Schabussova I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040271; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Veenbergen S, 2012, CURR OPIN IMMUNOL, V24, P269, DOI 10.1016/j.coi.2012.03.004; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118	27	70	71	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123013	10.1371/journal.pone.0123013	http://dx.doi.org/10.1371/journal.pone.0123013			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910186	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800027
J	Tripathi, S; Wang, GS; White, M; Qi, L; Taubenberger, J; Hartshorn, KL				Tripathi, Shweta; Wang, Guangshun; White, Mitchell; Qi, Li; Taubenberger, Jeffery; Hartshorn, Kevan L.			Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses	PLOS ONE			English	Article							SURFACTANT PROTEIN-D; ANTIMICROBIAL PEPTIDES; HOST-DEFENSE; HEMAGGLUTININ; MECHANISM; INFECTION; COLLECTIN; BINDING	Human LL-37, a cationic antimicrobial peptide, was recently shown to have antiviral activity against influenza A virus (IAV) strains in vitro and in vivo. In this study we compared the anti-influenza activity of LL-37 with that of several fragments derived from LL-37. We first tested the peptides against a seasonal H3N2 strain and the mouse adapted H1N1 strain, PR-8. The N-terminal fragment, LL-23, had slight neutralizing activity against these strains. In LL-23V9 serine 9 is substituted by valine creating a continuous hydrophobic surface. LL-23V9 has been shown to have increased anti-bacterial activity compared to LL-23 and we now show slightly increased antiviral activity compared to LL-23 as well. The short central fragments, FK-13 and KR-12, which have anti-bacterial activity did not inhibit IAV. In contrast, a longer 20 amino acid central fragment of LL-37 (GI-20) had neutralizing activity similar to LL-37. None of the peptides inhibited viral hemagglutination or neuraminidase activity. We next tested activity of the peptides against a strain of pandemic H1N1 of 2009 (A/California/04/09/H1N1 or "Cal09"). Unexpectedly, LL-37 had markedly reduced activity against Cal09 using several cell types and assays of antiviral activity. A mutant viral strain containing just the hemagglutinin (HA) of 2009 pandemic H1N1 was inhibited by LL-37, suggested that genes other than the HA are involved in the resistance of pH1N1. In contrast, GI-20 did inhibit Cal09. In conclusion, the central helix of LL-37 incorporated in GI-20 appears to be required for optimal antiviral activity. The finding that GI-20 inhibits Cal09 suggests that it may be possible to engineer derivatives of LL-37 with improved antiviral properties.	[Tripathi, Shweta; White, Mitchell; Hartshorn, Kevan L.] Boston Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Wang, Guangshun] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Qi, Li; Taubenberger, Jeffery] NIAID, Bethesda, MD 20892 USA	Boston University; University of Nebraska System; University of Nebraska Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hartshorn, KL (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02215 USA.	khartsho@bu.edu	Taubenberger, Jeffery/AAQ-1407-2021		NIH [AI-83222, HL069031]; NIH intramural funds (JKT); Nebraska Research Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000986, P01AI083222, R56AI105147, R01AI105147] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH intramural funds (JKT)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Research Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH Grant AI-83222 (KLH) and Grant HL069031 (KLH), NIH intramural funds (JKT) and the Nebraska Research Initiative (GW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25; Barlow PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025333; Currie SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073659; Doss M, 2010, J LEUKOCYTE BIOL, V87, P79, DOI 10.1189/jlb.0609382; Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049; Gaudreault E, 2008, J IMMUNOL, V180, P6211, DOI 10.4049/jimmunol.180.9.6211; Hartshorn KL, 2006, J IMMUNOL, V176, P6962, DOI 10.4049/jimmunol.176.11.6962; Hartshorn KL, 2000, BIOCHEM J, V351, P449, DOI 10.1042/0264-6021:3510449; HARTSHORN KL, 1988, J IMMUNOL, V141, P1295; HARTSHORN KL, 1994, J CLIN INVEST, V94, P311, DOI 10.1172/JCI117323; Hou M, 2013, CELL PHYSIOL BIOCHEM, V32, P614, DOI 10.1159/000354465; Iwaarden J., 1993, AM REV RESPIR DIS, V148, pA146; Job ER, 2013, J IMMUNOL, V190, P2169, DOI 10.4049/jimmunol.1202433; Job ER, 2010, J IMMUNOL, V185, P4284, DOI 10.4049/jimmunol.1001613; Li X, 2006, J AM CHEM SOC, V128, P5776, DOI 10.1021/ja0584875; Lysenko ES, 2000, INFECT IMMUN, V68, P1664, DOI 10.1128/IAI.68.3.1664-1671.2000; Qi L, 2011, VIROLOGY, V412, P426, DOI 10.1016/j.virol.2011.01.029; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; Reading PC, 1997, J VIROL, V71, P8204, DOI 10.1128/JVI.71.11.8204-8212.1997; Schaller-Bals S, 2002, AM J RESP CRIT CARE, V165, P992, DOI 10.1164/ajrccm.165.7.200110-020; SMITH H, 1988, REV INFECT DIS, V10, P56; Tate MD, 2011, J IMMUNOL, V187, P1884, DOI 10.4049/jimmunol.1100295; Tate MD, 2010, J VIROL, V84, P7569, DOI 10.1128/JVI.00291-10; Tecle T, 2007, ARCH VIROL, V152, P1731, DOI 10.1007/s00705-007-0983-4; Tripathi S, 2013, J GEN VIROL, V94, P40, DOI 10.1099/vir.0.045013-0; Verma A, 2012, J IMMUNOL, V189, P2478, DOI 10.4049/jimmunol.1103786; Wang G., 2008, OPEN MAGN RESON J, V1, P9; Wang GS, 2008, J BIOL CHEM, V283, P32637, DOI 10.1074/jbc.M805533200; Wang GS, 2008, ANTIMICROB AGENTS CH, V52, P3438, DOI 10.1128/AAC.00452-08; Wang GS, 2012, BIOCHEMISTRY-US, V51, P653, DOI 10.1021/bi2016266; Wang GS, 2012, ANTIMICROB AGENTS CH, V56, P845, DOI 10.1128/AAC.05637-11; Wang GS, 2010, BBA-BIOMEMBRANES, V1798, P114, DOI 10.1016/j.bbamem.2009.07.028; White MR, 2000, J IMMUNOL, V165, P2108, DOI 10.4049/jimmunol.165.4.2108; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com	34	51	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124706	10.1371/journal.pone.0124706	http://dx.doi.org/10.1371/journal.pone.0124706			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909853	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800102
J	Vermeer-de Bondt, PE; Schoffelen, T; Vanrolleghem, AM; Isken, LD; van Deuren, M; Sturkenboom, MCJM; Timen, A				Vermeer-de Bondt, Patricia E.; Schoffelen, Teske; Vanrolleghem, Ann M.; Isken, Leslie D.; van Deuren, Marcel; Sturkenboom, Miriam C. J. M.; Timen, Aura			Coverage of the 2011 Q Fever Vaccination Campaign in the Netherlands, Using Retrospective Population-Based Prevalence Estimation of Cardiovascular Risk-Conditions for Chronic Q Fever	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; ABDOMINAL AORTIC-ANEURYSM; INFECTIVE ENDOCARDITIS; PATIENT RECORDS; DETERMINANTS; IMMUNIZATION; PROGRAM	Background In 2011, a unique Q fever vaccination campaign targeted people at risk for chronic Q fever in the southeast of the Netherlands. General practitioners referred patients with defined cardiovascular risk-conditions (age >15 years). Prevalence rates of those risk-conditions were lacking, standing in the way of adequate planning and coverage estimation. We aimed to obtain prevalence rates retrospectively in order to estimate coverage of the Q fever vaccination campaign. Methods With broad search terms for these predefined risk-conditions, we extracted patient-records from a large longitudinal general-practice research-database in the Netherlands (IPCI-database). After validation of these records, obtained prevalence rates (stratified for age and sex) extrapolated to the Q fever high-incidence area population, gave an approximation of the size of the targeted patient-group. Coverage calculation addressed people actually screened by a pre-vaccination Q fever skin test and serology (coverage) and patients referred by their general practitioners (adjusted-coverage) in the 2011 campaign. Results Our prevalence estimate of any risk-condition was 3.1% (lower-upper limits 2.9-3.3%). For heart valve defects, aorta aneurysm/prosthesis, congenital anomalies and endocarditis, prevalence was 2.4%, 0.6%, 0.4% and 0.1%, respectively. Estimated number of eligible people in the Q fever high-incidence area was 11,724 (10,965-12,532). With 1330 people screened for vaccination, coverage of the vaccination campaign was 11%. For referred people, the adjusted coverage was 18%. Coverage was lowest among the very-old and highest for people aged 50-70 years. Conclusion The estimated coverage of the vaccination campaign was limited. This should be interpreted in the light of the complexity of this target-group with much co-morbidity, and of the vaccine that required invasive pre-vaccination screening. Calculation of prevalence rates of risk-conditions based on the IPCI-database was feasible. This procedure proved an efficient tool for future use, when prevalence estimates for policy, implementation or surveillance of subgroup-vaccination or other health-care interventions are needed.	[Vermeer-de Bondt, Patricia E.; Isken, Leslie D.; Timen, Aura] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Schoffelen, Teske; van Deuren, Marcel] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Vanrolleghem, Ann M.; Sturkenboom, Miriam C. J. M.] Erasmus Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC	Vermeer-de Bondt, PE (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	patricia.vermeer@rivm.nl	Timen, Aura/GLV-4130-2022	Sturkenboom, Miriam/0000-0003-1360-2388	Netherlands Organisation for Health Research and Development [205520002]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	The Netherlands Organisation for Health Research and Development (http://www.zonmw.nl/en/), grant number 205520002: TS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other authors received any funding for this work.	[Anonymous], 2010, PUBL HLTH COUNC NETH; [Anonymous], 2013, PUBL HLTH COUNC NETH; [Anonymous], 2010, PUBL HLTH COUNC NETH; Boudoulas Harisios, 2003, Expert Rev Cardiovasc Ther, V1, P523; Brearley S, 2008, BMJ-BRIT MED J, V336, P862, DOI 10.1136/bmj.39517.443796.AD; Bults M, 2012, VACCINE, V30, P3369, DOI 10.1016/j.vaccine.2012.03.056; Byrd KK, 2012, VACCINE, V30, P3376, DOI 10.1016/j.vaccine.2012.03.055; COLLIN J, 1988, LANCET, V2, P613; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; Dolk H, 2011, CIRCULATION, V123, P841, DOI 10.1161/CIRCULATIONAHA.110.958405; Fedeli U, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-48; Fernandez-Hidalgo N, 2013, REV ESP CARDIOL, V66, P728, DOI [10.1016/j.rec.2013.05.002, 10.1016/j.recesp.2013.05.003]; Gidding HF, 2009, VACCINE, V27, P2037, DOI 10.1016/j.vaccine.2009.02.007; Hahne S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067866; Hawker J I, 1998, Commun Dis Public Health, V1, P180; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; Isken LD, 2013, VACCINE, V31, P2617, DOI 10.1016/j.vaccine.2013.03.062; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Kampschreur LM, 2013, EPIDEMIOL INFECT, V141, P847, DOI 10.1017/S0950268812001203; Kampschreur LM, 2012, EMERG INFECT DIS, V18, P563, DOI 10.3201/eid1804.111478; Karagiannis I, 2009, EPIDEMIOL INFECT, V137, P1283, DOI 10.1017/S0950268808001908; LAMBERTS H, 1992, FAM PRACT, V9, P330, DOI 10.1093/fampra/9.3.330; LINDROOS M, 1993, J AM COLL CARDIOL, V21, P1220, DOI 10.1016/0735-1097(93)90249-Z; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; Marmion, 2009, GUIDE Q FEVER Q FEVE; MARMION BP, 1990, EPIDEMIOL INFECT, V104, P275, DOI 10.1017/S0950268800059458; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; MITCHELL SC, 1971, CIRCULATION, V43, P323, DOI 10.1161/01.CIR.43.3.323; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; Patel DK, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000879; Q-VAX Q fever vaccine and Q-VAX skin test, 2008, PROD INF TGA APPR; Rasmussen TA, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5823; Reiter PL, 2011, SEX TRANSM DIS, V38, P235, DOI 10.1097/OLQ.0b013e3181f422bb; Schoffelen T, 2014, VACCINE, V32, P6622, DOI 10.1016/j.vaccine.2014.09.061; Schoffelen T, 2013, J INFECTION, V67, P565, DOI 10.1016/j.jinf.2013.08.008; SCOTT RAP, 1991, BRIT J SURG, V78, P1122, DOI 10.1002/bjs.1800780929; Shen AK, 2013, VACCINE, V31, P279, DOI 10.1016/j.vaccine.2012.11.033; Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9; Singh K, 2001, AM J EPIDEMIOL, V154, P236, DOI 10.1093/aje/154.3.236; Tissot-Dupont H, 2004, EMERG INFECT DIS, V10, P1264, DOI 10.3201/eid1007.030724; Vahanian A, 2011, INT J CARDIOVAS IMAG, V27, P1115, DOI 10.1007/s10554-011-9804-7; van der Bom T, 2012, AM HEART J, V164, P568, DOI 10.1016/j.ahj.2012.07.023; Van der Graaf Y, 1998, BRIT J SURG, V85, P778; van der Hoek W, 2012, EUROSURVEILLANCE, V17, P20059; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; van Lier A, 2014, EUR J PUBLIC HEALTH, V24, P304, DOI 10.1093/eurpub/ckt042; VANDERLEI J, 1993, ANN INTERN MED, V119, P1036, DOI 10.7326/0003-4819-119-10-199311150-00011; Verweij MF, 2014, VACCINE, V32, P7163, DOI 10.1016/j.vaccine.2014.10.008; Vlug AE, 1999, METHOD INFORM MED, V38, P339; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Williams WW, 2012, MMWR-MORBID MORTAL W, V2014, P95; Wolfe RM, 2012, J AM BOARD FAM MED, V25, P496, DOI 10.3122/jabfm.2012.04.100274; Yuen CYS, 2014, VACCINE, V32, P4602, DOI 10.1016/j.vaccine.2014.06.067	54	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123570	10.1371/journal.pone.0123570	http://dx.doi.org/10.1371/journal.pone.0123570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909712	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800040
J	Wang, JQ; Qi, RR; Zhou, W; Tang, YF; Pan, LL; Cai, YL				Wang, Jun-Qin; Qi, Rui-Rui; Zhou, Wei; Tang, Yi-Fan; Pan, Lei-Lei; Cai, Yi-Ling			Differential Gene Expression Profile in the Rat Caudal Vestibular Nucleus is Associated with Individual Differences in Motion Sickness Susceptibility	PLOS ONE			English	Article							OTOLITH-RELATED NEURONS; MULTIMODAL INTEGRATION; DELIVERY SYSTEMS; BRAIN-STEM; RESPONSES; STIMULATION; PROJECTIONS; ANTAGONIST; RECEPTORS; ROTATION	Objective To identify differentially expressed genes associated with motion sickness (MS) susceptibility in the rat caudal vestibular nucleus. Methods We identified MS susceptible (MSS) and insusceptible (inMSS) rats by quantifying rotation-induced MS symptoms: defecation and spontaneous locomotion activity. Microarray analysis was used to screen differentially expressed genes in the caudal vestibular nucleus (CVN) after rotation. Plasma stress hormones were identified by radioimmunoassay. Candidate genes were selected by bioinformatics analysis and the microarray results were verified by real-time quantitative-PCR (RT-qPCR) methods. By using Elvax implantation, receptor antagonists or recombinant adenovirus targeting the candidate genes were applied to the CVN to evaluate their contribution to MS susceptibility variability. Validity of gene expression manipulation was verified by RT-qPCR and western blot analysis. Results A total of 304 transcripts were differentially expressed in the MSS group compared with the inMSS group. RT-qPCR analysis verified the expression pattern of candidate genes, including nicotinic cholinergic receptor (nAchR) alpha 3 subunit, 5-hydroxytryptamine receptor 4 (5-HT4R), tachykinin neurokinin-1 (NK1R),gamma-aminobutyric acid A receptor (GABA(A)R) alpha 6 subunit, olfactory receptor 81 (Olr81) and homology 2 domain-containing transforming protein 1 (Shc1). In MSS animals, the nAchR antagonist mecamylamine significantly alleviated rotation- induced MS symptoms and the plasma beta-endorphin response. The NK1R antagonist CP99994 and Olr81 knock-down were effective for the defecation response, while the 5-HT4R antagonist RS39604 and Shc1 over-expression showed no therapeutic effect. In inMSS animals, rotation-induced changes in spontaneous locomotion activity and the plasma beta-endorphin level occurred in the presence of the GABA(A)R antagonist gabazine. Conclusion Our findings suggested that the variability of the CVN gene expression profile aftermotion stimulation might be a putative molecular basis for individual differences in MS susceptibility and provide information for the development of new therapeutic strategies for MSS individuals.	[Wang, Jun-Qin; Qi, Rui-Rui; Zhou, Wei; Tang, Yi-Fan; Pan, Lei-Lei; Cai, Yi-Ling] Second Mil Med Univ, Fac Navy Med, Dept Naut Injury Prevent, Shanghai, Peoples R China	Naval Medical University	Cai, YL (corresponding author), Second Mil Med Univ, Fac Navy Med, Dept Naut Injury Prevent, Shanghai, Peoples R China.	yilingcai1@sohu.com			National Natural Science Foundation of China [81272178]; Natural Science Foundation of Shanghai [12ZR1437300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This study is supported by grants from the National Natural Science Foundation of China (81272178) and the Natural Science Foundation of Shanghai (12ZR1437300).	Aleksandrov VG, 1998, NEUROSCI LETT, V250, P66, DOI 10.1016/S0304-3940(98)00408-X; Anomal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064208; Arshian MS, 2013, EXP BRAIN RES, V228, P353, DOI 10.1007/s00221-013-3568-3; Balaban CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086730; Balaban CD, 1996, EXP BRAIN RES, V108, P367; BALABAN CD, 1994, EXP BRAIN RES, V98, P200; Balaban CD, 1999, CURR OPIN NEUROL, V12, P29, DOI 10.1097/00019052-199902000-00005; Beraneck M, 2007, J NEUROPHYSIOL, V98, P1549, DOI 10.1152/jn.00590.2007; Berry A, 2013, NEUROSCI BIOBEHAV R, V37, P790, DOI 10.1016/j.neubiorev.2013.03.005; Cai YL, 2007, NEUROSCI LETT, V417, P132, DOI 10.1016/j.neulet.2007.01.079; Cai YL, 2010, NEUROSCI LETT, V480, P87, DOI 10.1016/j.neulet.2010.06.011; CHAN YS, 1992, ANN NY ACAD SCI, V656, P755, DOI 10.1111/j.1749-6632.1992.tb25254.x; Chouker A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010752; Coelho CM, 2015, NEUROSCI BIOBEHAV R, V48, P148, DOI 10.1016/j.neubiorev.2014.10.023; Conder GA, 2008, J VET PHARMACOL THER, V31, P528, DOI 10.1111/j.1365-2885.2008.00990.x; CONTRUCCI RB, 1985, ANN OTO RHINOL LARYN, V94, P322; Cordick N, 1999, NEUROREPORT, V10, P1557, DOI 10.1097/00001756-199905140-00030; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Dornhoffer J, 2004, OTOL NEUROTOL, V25, P740, DOI 10.1097/00129492-200409000-00016; Glick SD, 2008, EUR J PHARMACOL, V599, P91, DOI 10.1016/j.ejphar.2008.09.038; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Goddard M, 2008, BEHAV NEUROSCI, V122, P448, DOI 10.1037/0735-7044.122.2.448; Golding JF, 1998, BRAIN RES BULL, V47, P507, DOI 10.1016/S0361-9230(98)00091-4; Golding JF, 2005, AVIAT SPACE ENVIR MD, V76, P970; Golding JF, 2006, AUTON NEUROSCI-BASIC, V129, P67, DOI 10.1016/j.autneu.2006.07.019; Golding JF, 2011, AUTON NEUROSCI-BASIC, V160, P53, DOI 10.1016/j.autneu.2010.09.009; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Horii A, 2004, J NEUROCHEM, V91, P975, DOI 10.1111/j.1471-4159.2004.02781.x; Horn CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060537; Improgo MRD, 2010, PROG NEUROBIOL, V92, P212, DOI 10.1016/j.pneurobio.2010.05.003; Javid FA, 2001, PHARMACOL BIOCHEM BE, V68, P761, DOI 10.1016/S0091-3057(01)00470-1; Javid FA, 2002, PHARMACOL BIOCHEM BE, V73, P979, DOI 10.1016/S0091-3057(02)00955-3; Johnson WH, 1999, J VESTIBUL RES-EQUIL, V9, P83; Kato A, 2009, CELL MOL LIFE SCI, V66, P3743, DOI 10.1007/s00018-009-0111-6; Keshavarz B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101016; Kilkenny C, 2012, VET CLIN PATH, V41, P27, DOI 10.1111/j.1939-165X.2012.00418.x; KOHL RL, 1992, AVIAT SPACE ENVIR MD, V63, P986; Kraemer S, 2004, PHYSIOL BEHAV, V81, P435, DOI 10.1016/j.physbeh.2004.01.012; Lai CH, 2004, J COMP NEUROL, V470, P282, DOI 10.1002/cne.11048; LANGER R, 1981, J BIOMED MATER RES, V15, P267, DOI 10.1002/jbm.820150212; Limebeer CL, 2008, BEHAV BRAIN RES, V187, P33, DOI 10.1016/j.bbr.2007.08.024; LUCOT JB, 1989, LIFE SCI, V44, P1239, DOI 10.1016/0024-3205(89)90359-7; Lucot JB, 1997, BRIT J PHARMACOL, V120, P116, DOI 10.1038/sj.bjp.0700888; Markia B, 2008, BRAIN STRUCT FUNCT, V213, P239, DOI 10.1007/s00429-008-0172-6; MCCAFFREY RJ, 1985, PHYSIOL BEHAV, V35, P151, DOI 10.1016/0031-9384(85)90329-4; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Miller DM, 2008, EXP BRAIN RES, V188, P175, DOI 10.1007/s00221-008-1359-z; Mo FF, 2012, PHYSIOL BEHAV, V105, P394, DOI 10.1016/j.physbeh.2011.08.024; Mori RL, 2005, J APPL PHYSIOL, V98, P526, DOI 10.1152/japplphysiol.00970.2004; Morley BJ, 1997, MOL BRAIN RES, V48, P407, DOI 10.1016/S0169-328X(97)00159-9; Nakayama H, 2005, J PHARMACOL SCI, V98, P396, DOI 10.1254/jphs.FPJ05001X; Nickell JR, 2013, PHARMACOL BIOCHEM BE, V108, P28, DOI 10.1016/j.pbb.2013.04.005; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Nodal FR, 2012, J PHYSIOL-LONDON, V590, P3965, DOI 10.1113/jphysiol.2011.222828; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; OSSENKOPP KP, 1982, PHYSIOL PSYCHOL, V10, P355, DOI 10.3758/BF03332964; Ossenkopp KP, 2003, BEHAV NEUROSCI, V117, P105, DOI 10.1037/0735-7044.117.1.105; OSSENKOPP KP, 1994, PHYSIOL BEHAV, V56, P319, DOI 10.1016/0031-9384(94)90201-1; Paillard AC, 2013, J VESTIBUL RES-EQUIL, V23, P203, DOI 10.3233/VES-130501; Park MK, 2012, ANN OTO RHINOL LARYN, V121, P761, DOI 10.1177/000348941212101110; Persico AM, 1997, J NEUROSCI METH, V76, P105, DOI 10.1016/S0165-0270(97)00087-3; PHELAN KD, 1992, SYNAPSE, V10, P349, DOI 10.1002/syn.890100410; Pompeiano O, 2004, NEUROSCIENCE, V124, P53, DOI 10.1016/j.neuroscience.2003.09.027; Rahn EJ, 2013, NEUROBIOL LEARN MEM, V105, P133, DOI 10.1016/j.nlm.2013.06.008; REASON JT, 1978, J ROY SOC MED, V71, P819, DOI 10.1177/014107687807101109; Sadeghi SG, 2009, EXP BRAIN RES, V195, P45, DOI 10.1007/s00221-009-1751-3; Schmal F, 2013, PHARMACOLOGY, V91, P229, DOI 10.1159/000350185; SEFTON MV, 1984, J PHARM SCI-US, V73, P1859, DOI 10.1002/jps.2600731258; Shupak A, 2006, AVIAT SPACE ENVIR MD, V77, P1213; Shytle RD, 2002, J HUM HYPERTENS, V16, P453, DOI 10.1038/sj.jhh.1001416; SILBERSTEIN GB, 1982, DEV BIOL, V93, P272, DOI 10.1016/0012-1606(82)90259-7; Smart LJ, 1998, BRAIN RES BULL, V47, P449, DOI 10.1016/S0361-9230(98)00103-8; Stiles L, 2014, BRAIN RES; Stoffregen TA, 2014, EXP BRAIN RES, V232, P1389, DOI 10.1007/s00221-014-3859-3; Stoffregen TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066949; TAKEDA N, 1990, AVIAT SPACE ENVIR MD, V61, P1018; Talsma H, 1997, INT J PHARMACEUT, V157, P233, DOI 10.1016/S0378-5173(97)00244-5; Tu SC, 2000, J NEUROSCI, V20, P5346, DOI 10.1523/JNEUROSCI.20-14-05346.2000; Wang JQ, 2012, BRAIN RES, V1461, P30, DOI 10.1016/j.brainres.2012.04.041; Wang XC, 2013, J MOL NEUROSCI, V51, P514, DOI 10.1007/s12031-013-0087-4; Wang XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047308; Wei X, 2011, CNS NEUROSCI THER, V17, P790, DOI 10.1111/j.1755-5949.2011.00272.x; Yu XH, 2007, PHYSIOL BEHAV, V92, P702, DOI 10.1016/j.physbeh.2007.05.067; Zhang FX, 2005, BRAIN RES, V1062, P92, DOI 10.1016/j.brainres.2005.09.025; Zhang Lei, 2014, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V30, P279; Zingler VC, 2007, J NEUROL, V254, P1689, DOI 10.1007/s00415-007-0621-9	86	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124203	10.1371/journal.pone.0124203	http://dx.doi.org/10.1371/journal.pone.0124203			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910039	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800066
J	Aerts, J; Metz, JR; Ampe, B; Decostere, A; Flik, G; De Saeger, S				Aerts, Johan; Metz, Juriaan Rogier; Ampe, Bart; Decostere, Annemie; Flik, Gert; De Saeger, Sarah			Scales Tell a Story on the Stress History of Fish	PLOS ONE			English	Article							PLASMA-CORTISOL; TRICAINE METHANESULFONATE; ANESTHETIC EFFICACY; RESPONSES; GROWTH; TROUT; WATER; METOMIDATE; ALLOSTASIS; PHYSIOLOGY	Fish faced with stressful stimuli launch an endocrine stress response through activation of the hypothalamic-pituitary-interrenal (HPI-) axis to release cortisol into the blood. Scientifically validated biomarkers to capture systemic cortisol exposure over longer periods of time are of utmost importance to assess chronic stress in governmental, wildlife, aquaculture and scientific settings. Here we demonstrate that cortisol in scales of common carp (Cyprinus carpio L.) is the long-sought biomarker for chronic stress. Undisturbed (CTR) and daily stressed (STRESS) carp were compared. Dexamethasone (DEX) or cortisol (CORT) fed fish served as negative and positive controls, respectively. Scale cortisol was quantified with a validated ultra-performance liquid chromatography tandem mass spectrometry method. An increase in scale cortisol content was found in STRESS and CORT but not in CTR and DEX fish. Scale cortisol content reflects its accumulation in a stressor and time dependent manner and validates the scale cortisol content as biomarker for chronic stress. Plasma analyses confirmed that (i) CTR, DEX and CORT treatments were effective, (ii) plasma cortisol of STRESS fish showed no signs of chronic HPI-axis activation, and (iii) plasma cortisol is a poor predictor for chronic stress. The expression of HPI key genes crf, pomc, and star were up-regulated in STRESS fish in the absence of a plasma cortisol response, as was the target gene of cortisol encoding subunit alpha 1 of the Na+/K+-ATPase in gills. When lost, scales of fish regenerate fast. Regenerated scales corroborate our findings, offering (i) unsurpassed time resolution for cortisol incorporation and as such for stressful events, and (ii) the possibility to investigate stress in a well defined and controlled environment and time frame creating novel opportunities for bone physiological research. We conclude that the cortisol content in ontogenetic and regenerated scales is an innovative biomarker for chronic stress offering ample applications in science and industry.	[Aerts, Johan] Inst Agr & Fisheries Res, Anim Sci Unit, Bioanal Res Grp, Melle, Belgium; [Aerts, Johan; De Saeger, Sarah] Univ Ghent, Fac Pharmaceut Sci, Dept Bioanal, Lab Food Anal, B-9000 Ghent, Belgium; [Metz, Juriaan Rogier; Flik, Gert] Radboud Univ Nijmegen, Fac Sci, Inst Water & Wetland Res, Dept Anim Physiol, NL-6525 ED Nijmegen, Netherlands; [Ampe, Bart] Inst Agr & Fisheries Res, Anim Sci Unit, Biostat & Data Modeling, Melle, Belgium; [Decostere, Annemie] Univ Ghent, Fac Vet Med, Dept Morphol, B-9000 Ghent, Belgium	Institute For Agricultural & Fisheries Research; Ghent University; Radboud University Nijmegen; Institute For Agricultural & Fisheries Research; Ghent University	Aerts, J (corresponding author), Inst Agr & Fisheries Res, Anim Sci Unit, Bioanal Res Grp, Melle, Belgium.	Johan.aerts@ilvo.vlaanderen.be	Flik, Gert/C-8229-2011; Metz, Juriaan R./A-3290-2012	Flik, Gert/0000-0001-9285-7957; Metz, Juriaan R./0000-0002-1515-1958	Institute for Agricultural and Fisheries Research; Laboratory of Food Analysis of the Faculty of Pharmaceutical Sciences of Ghent University; Department of Morphology of the Faculty of Veterinary Medicine of Ghent University; Department of Animal Physiology of Radboud University Nijmegen	Institute for Agricultural and Fisheries Research; Laboratory of Food Analysis of the Faculty of Pharmaceutical Sciences of Ghent University; Department of Morphology of the Faculty of Veterinary Medicine of Ghent University; Department of Animal Physiology of Radboud University Nijmegen	This research was financially supported by the Institute for Agricultural and Fisheries Research, the Laboratory of Food Analysis of the Faculty of Pharmaceutical Sciences of Ghent University, the Department of Morphology of the Faculty of Veterinary Medicine of Ghent University, and the Department of Animal Physiology of Radboud University Nijmegen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PA, 2013, AQUACULT ENG, V54, P72, DOI 10.1016/j.aquaeng.2012.11.004; Anderson PA, 2011, AQUACULTURE, V311, P129, DOI 10.1016/j.aquaculture.2010.11.013; [Anonymous], 2004, 21748 ISOTS; [Anonymous], 2013, SUST AQ EUR; [Anonymous], Patent application, Patent No. [EP1319845, 1319845]; [Anonymous], 2007, 12007 EUR; Baker MR, 2013, J NAT CONSERV, V21, P309, DOI 10.1016/j.jnc.2013.03.003; Barnett V., 1994, OUTLIERS STAT DATA; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; BARTON BA, 1987, DIS AQUAT ORGAN, V2, P173; Bergqvist J, 2013, J AGR ENVIRON ETHIC, V26, P75, DOI 10.1007/s10806-011-9346-y; Bertotto D, 2010, AQUAC RES, V41, P1261, DOI 10.1111/j.1365-2109.2009.02417.x; Blas J, 2007, P NATL ACAD SCI USA, V104, P8880, DOI 10.1073/pnas.0700232104; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Boonstra R, 2013, FUNCT ECOL, V27, P7, DOI 10.1111/1365-2435.12048; Bortolotti GR, 2009, J EXP BIOL, V212, P1477, DOI 10.1242/jeb.022152; Bush SR, 2013, SCIENCE, V341, P1067, DOI 10.1126/science.1237314; Cadrin SX, 2013, STOCK IDENTIFICATION; Canalis E, 2002, ANN NY ACAD SCI, V966, P73, DOI 10.1111/j.1749-6632.2002.tb04204.x; Close DA, 2010, P NATL ACAD SCI USA, V107, P13942, DOI 10.1073/pnas.0914026107; Cockrem JF, 2013, GEN COMP ENDOCR, V181, P45, DOI 10.1016/j.ygcen.2012.11.025; COHEN SA, 1979, CLIN CHEM, V25, P1519; Cook NJ, 2012, CAN J ANIM SCI, V92, P227, DOI 10.4141/CJAS2012-045; Dang ZC, 2000, J EXP BIOL, V203, P2349; de Vrieze E, 2014, OSTEOPOROSIS INT, V25, P567, DOI 10.1007/s00198-013-2441-3; Diggles BK, 2011, REV FISH BIOL FISHER, V21, P739, DOI 10.1007/s11160-011-9206-x; EFSA, 2008, ANNEX 1 EFSA J, V843, P1; Ellis T, 2004, J FISH BIOL, V65, P1233, DOI 10.1111/j.0022-1112.2004.00499.x; *EN, 2005, 17025 EN ISOIEC; Eurachem, 2000, EUR CITAC GUID; Gorissen M, 2012, GEN COMP ENDOCR, V178, P75, DOI 10.1016/j.ygcen.2012.04.004; International Organization for Standardization Accuracy (Trueness and Precision) of Measurement Methods and Results, 1994, 5725 ISODIS; ISO GUM, 1995, NBN1040001 ISO GUM; Kawajiri M, 2011, ENVIRON BIOL FISH, V92, P285, DOI 10.1007/s10641-011-9839-6; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Lupica SJ, 2009, AQUAC RES, V40, P437, DOI 10.1111/j.1365-2109.2008.02112.x; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Metz JR, 2012, J APPL ICHTHYOL, V28, P382, DOI 10.1111/j.1439-0426.2012.01990.x; Nash RDM, 2006, FISHERIES, V31, P236; O'Connor CM, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00388.1; Oliveira CCV, 2013, FISH PHYSIOL BIOCHEM, V39, P479, DOI 10.1007/s10695-012-9713-2; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Palic D, 2006, AQUACULTURE, V254, P675, DOI 10.1016/j.aquaculture.2005.11.004; Payan P, 2004, CAN J FISH AQUAT SCI, V61, P1247, DOI 10.1139/F04-059; Persson P, 2000, GEN COMP ENDOCR, V120, P35, DOI 10.1006/gcen.2000.7536; Pinto PIS, 2009, GEN COMP ENDOCR, V160, P19, DOI 10.1016/j.ygcen.2008.10.011; Richardson K, 2013, ANTHROPOGENICALLY IN; Romano MC, 2010, NEUROIMMUNOMODULAT, V17, P209, DOI 10.1159/000258726; Russell E, 2012, PSYCHONEUROENDOCRINO, V37, P589, DOI 10.1016/j.psyneuen.2011.09.009; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SCHONBORNER AA, 1979, CELL TISSUE RES, V202, P203; Schram E, 2010, AQUACULTURE, V306, P108, DOI 10.1016/j.aquaculture.2010.06.005; Simontacchi C, 2008, J FISH BIOL, V72, P747, DOI 10.1111/j.1095-8649.2007.01717.x; Small BC, 2003, AQUACULTURE, V218, P177, DOI 10.1016/S0044-8486(02)00302-2; Takahara T, 2011, HYDROBIOLOGIA, V675, P65, DOI 10.1007/s10750-011-0796-z; Tellis MS, 2012, COMP BIOCHEM PHYS C, V155, P281, DOI 10.1016/j.cbpc.2011.09.008; The Research Council of Norway, 2009, FISH RES ENV REQ WEL; Toorchi M, 2012, J APPL ICHTHYOL, V28, P130, DOI 10.1111/j.1439-0426.2011.01818.x; TSERPES G, 1995, FISH B-NOAA, V93, P594; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; [No title captured]	61	69	69	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123411	10.1371/journal.pone.0123411	http://dx.doi.org/10.1371/journal.pone.0123411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922947	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600046
J	Allan, TW; Francis, ST; Caballero-Gaudes, C; Morris, PG; Liddle, EB; Liddle, PF; Brookes, MJ; Gowland, PA				Allan, Thomas W.; Francis, Susan T.; Caballero-Gaudes, Cesar; Morris, Peter G.; Liddle, Elizabeth B.; Liddle, Peter F.; Brookes, Matthew J.; Gowland, Penny A.			Functional Connectivity in MRI Is Driven by Spontaneous BOLD Events	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; SPONTANEOUS BRAIN ACTIVITY; RESTING-STATE NETWORKS; DEFAULT-MODE; SOMATOSENSORY CORTEX; MOTOR CORTEX; TASK; FMRI; DYNAMICS; MAGNETOENCEPHALOGRAPHY	Functional brain signals are frequently decomposed into a relatively small set of large scale, distributed cortical networks that are associated with different cognitive functions. It is generally assumed that the connectivity of these networks is static in time and constant over the whole network, although there is increasing evidence that this view is too simplistic. This work proposes novel techniques to investigate the contribution of spontaneous BOLD events to the temporal dynamics of functional connectivity as assessed by ultra-high field functional magnetic resonance imaging (fMRI). The results show that: 1) spontaneous events in recognised brain networks contribute significantly to network connectivity estimates; 2) these spontaneous events do not necessarily involve whole networks or nodes, but clusters of voxels which act in concert, forming transiently synchronising sub-networks and 3) a task can significantly alter the number of localised spontaneous events that are detected within a single network. These findings support the notion that spontaneous events are the main driver of the large scale networks that are commonly detected by seed-based correlation and ICA. Furthermore, we found that large scale networks are manifestations of smaller, transiently synchronising sub-networks acting dynamically in concert, corresponding to spontaneous events, and which do not necessarily involve all voxels within the network nodes oscillating in unison.	[Allan, Thomas W.; Francis, Susan T.; Morris, Peter G.; Brookes, Matthew J.; Gowland, Penny A.] Univ Nottingham, Sch Phys & Astron, Sir Peter Mansfield Imagaing Ctr, Nottingham NG7 2RD, England; [Liddle, Elizabeth B.; Liddle, Peter F.] Univ Nottingham, Inst Mental Hlth, Nottingham NG7 2RD, England; [Caballero-Gaudes, Cesar] Basque Ctr Cognit Brain & Language, Donostia San Sebastian, Spain	University of Nottingham; University of Nottingham	Gowland, PA (corresponding author), Univ Nottingham, Sch Phys & Astron, Sir Peter Mansfield Imagaing Ctr, Univ Pk, Nottingham NG7 2RD, England.	penny.gowland@nottingham.ac.uk	Gowland, Penny A./I-9016-2012; Caballero-Gaudes, Cesar/H-6369-2015; Liddle, Peter/AAU-7939-2020; Liddle, Elizabeth/A-2034-2015	Gowland, Penny A./0000-0002-4900-4817; Caballero-Gaudes, Cesar/0000-0002-9068-5810; Liddle, Elizabeth/0000-0002-9299-094X; Brookes, Matthew/0000-0002-8687-8185; francis, sue/0000-0003-0903-7507; Basque Center on Cognition, Brain and Language, BCBL./0000-0002-8345-6892	'Realising the benefits of structural and functional MRI at ultra-high-field' - Medical Research Council Programme Grant [G0901321]; MRC [G0901321] Funding Source: UKRI; Medical Research Council [G0901321] Funding Source: researchfish	'Realising the benefits of structural and functional MRI at ultra-high-field' - Medical Research Council Programme Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Support was provided by 'Realising the benefits of structural and functional MRI at ultra-high-field' - Medical Research Council Programme Grant, (G0901321). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Barnes A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006626; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, CEREB CORTEX, V20, P2188, DOI 10.1093/cercor/bhp284; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Chang C, 2010, FILM COMMENT, V46, P81; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Pasquale F, 2012, NEURON, V74, P753, DOI 10.1016/j.neuron.2012.03.031; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; Di X, 2015, BRAIN STRUCT FUNCT, V220, P37, DOI 10.1007/s00429-013-0634-3; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Gaudes CC, 2013, HUM BRAIN MAPP, V34, P501, DOI 10.1002/hbm.21452; Gaudes CC, 2011, HUM BRAIN MAPP, V32, P1400, DOI 10.1002/hbm.21116; Gembris D, 2000, MAGN RESON MED, V43, P259, DOI 10.1002/(SICI)1522-2594(200002)43:2<259::AID-MRM13>3.0.CO;2-P; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gordon EM, 2014, HUM BRAIN MAPP, V35, P1004, DOI 10.1002/hbm.22230; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hampson M, 2010, MAGN RESON IMAGING, V28, P1051, DOI 10.1016/j.mri.2010.03.021; HUTCHISON RM, 2012, HUM BRAIN MAPP, V34, P2154, DOI DOI 10.1002/HBM.22058; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Karahanoglu FI, 2013, NEUROIMAGE, V73, P121, DOI 10.1016/j.neuroimage.2013.01.067; Liu X, 2013, P NATL ACAD SCI USA, V110, P4392, DOI 10.1073/pnas.1216856110; Luckhoo H, 2012, NEUROIMAGE, V62, P530, DOI 10.1016/j.neuroimage.2012.04.046; Munchau A, 2002, J NEUROSCI, V22, P554, DOI 10.1523/JNEUROSCI.22-02-00554.2002; Nakai T, 2006, J NEUROSCI METH, V157, P158, DOI 10.1016/j.jneumeth.2006.04.017; Newton AT, 2011, HUM BRAIN MAPP, V32, P1649, DOI 10.1002/hbm.21138; Petridou N, 2013, HUM BRAIN MAPP, V34, P1319, DOI 10.1002/hbm.21513; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Saenz M, 2014, HEARING RES, V307, P42, DOI 10.1016/j.heares.2013.07.016; Sanchez-Panchuelo RM, 2010, J NEUROPHYSIOL, V103, P2544, DOI 10.1152/jn.01017.2009; Sanchez-Panchuelo RM, 2012, J NEUROSCI, V32, P15815, DOI 10.1523/JNEUROSCI.2501-12.2012; Sestieri C, 2011, J NEUROSCI, V31, P4407, DOI 10.1523/JNEUROSCI.3335-10.2011; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Tagliazucchi E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00015; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531	44	29	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124577	10.1371/journal.pone.0124577	http://dx.doi.org/10.1371/journal.pone.0124577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922945	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600094
J	Altner, M; Reichenbacher, B				Altner, Melanie; Reichenbacher, Bettina			dagger Kenyaichthyidae fam. nov and dagger Kenyaichthys gen. nov - First Record of a Fossil Aplocheiloid Killifish (Teleostei, Cyprinodontiformes)	PLOS ONE			English	Article							VERTEBRAL COLUMN; LAGUNA-CHICHANCANAB; NATURAL-POPULATIONS; TAXONOMIC REVISION; SPINAL DEFORMITIES; CAUDAL SKELETON; SPECIES FLOCK; BARINGO BASIN; UPPER MIOCENE; FISHES	The extant Cyprinodontiformes (killifishes) with their two suborders Cyprinodontoidei and Aplocheiloidei represent a diverse and well-studied group of fishes. However, their fossil record is comparatively sparse and has so far yielded members of the Cyprinodontoidei only. Here we report on cyprinodontiform fossils from the upper Miocene Lukeino Formation in the Tugen Hills of the Central Rift Valley of Kenya, which represent the first fossil record of an aplocheiloid killifish. A total of 169 specimens - mostly extraordinarily well preserved and a sample of ten extant cyprinodontiform species were studied on the basis of morphometrics, meristics and osteology. A phylogenetic analysis using PAUP was also conducted for the fossils. Both the osteological data and the phylogenetic analysis provide strong evidence for the assignment of the fossils to the Aplocheiloidei, and justify the definition of the new family dagger Kenyaichthyidae, the new genus dagger Kenyaichthys and the new species dagger K. kipkechi sp. nov. The phylogenetic analysis unexpectedly places dagger Kenyaichthys gen. nov. in a sister relationship to the Rivulidae (a purely Neotropical group), a probable explanation might be lack of available synapomorphies for the Rivulidae, Nothobranchiidae and Aplocheilidae. The specimens of dagger K. kipkechi sp. nov. show several polymorphic characters and large overlap in meristic traits, which justifies their interpretation as a species flock in statu nascendi. Patterns of variation in neural and haemal spine dimensions in the caudal vertebrae of dagger Kenyaichthys gen. nov. and the extant species studied indicate that some previously suggested synapomorphies of the Cyprinodontoidei and Aplocheiloidei need to be revised.	[Altner, Melanie; Reichenbacher, Bettina] Univ Munich, Dept Earth & Environm Sci Palaeontol & Geobiol, Munich, Germany	University of Munich	Altner, M (corresponding author), Univ Munich, Dept Earth & Environm Sci Palaeontol & Geobiol, Munich, Germany.	m.altner@lrz.uni-muenchen.de	Reichenbacher, Bettina/AAM-9684-2020	Reichenbacher, Bettina/0000-0001-6678-5080	Deutsche Forschungsgemeinschaft (DFG) [RE 113/18-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was supported by the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de/); grant number is RE 113/18-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHL ERNST, 1934, ZOOL ANZ, V108, P304; Allen G.R., 1980, Records of the Western Australian Museum, V8, P449; [Anonymous], 1989, HEAVY METAL TOLERANC; [Anonymous], 2000, WORLD NUTR SIT NUTR, P136; Arratia Gloria, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P9; Bamford MK, 2013, GEOBIOS-LYON, V46, P253, DOI 10.1016/j.geobios.2013.02.001; BARLOW GEORGE W., 1961, AMER MIDLAND NAT, V65, P339, DOI 10.2307/2422959; BENGTSSON A, 1988, J FISH BIOL, V33, P517, DOI 10.1111/j.1095-8649.1988.tb05496.x; BENGTSSON B E, 1975, Ambio, V4, P166; Bensimon-Brito A, 2012, EVOL DEV, V14, P116, DOI 10.1111/j.1525-142X.2011.00526.x; Betancur-R R, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; Bobe R, 2006, J ARID ENVIRON, V66, P564, DOI 10.1016/j.jaridenv.2006.01.010; Bogan Sergio, 2009, Pap. Avulsos Zool. (São Paulo), V49, P81, DOI 10.1590/S0031-10492009000500001; Bogutskaya NG, 2011, J FISH BIOL, V79, P991, DOI 10.1111/j.1095-8649.2011.03078.x; Briggs JC, 2003, SYST BIOL, V52, P548, DOI 10.1080/10635150390218385; Carnevale G, 2006, J GEOL SOC LONDON, V163, P75, DOI 10.1144/0016-764904-158; Cione Alberto L., 2007, Asociacion Paleontologica Argentina Publicacion Especial, V11, P195; Cione Alberto Luis, 1986, P101; COCKERELL T. D. A., 1936, AMER MUS NOVITATES, V886, P1; COLLETTE BRUCE B., 1966, AMER MUS NOVI TATES, V2274, P1; Collier GE, 2009, MOL PHYLOGENET EVOL, V50, P190, DOI 10.1016/j.ympev.2008.10.006; COSTA W J E M, 1990, Revista Brasileira de Biologia, V50, P65; Costa Wilson J.E.M., 2004, Ichthyological Exploration of Freshwaters, V15, P105; Costa WJEM, 2013, VERTEBR ZOOL, V63, P139; Costa WJEM, 2012, VERTEBR ZOOL, V62, P161; Costa WJEM, 2011, CYBIUM, V35, P181; Costa Wilson J. E. M., 2009, Vertebrate Zoology, V59, P31; Costa Wilson J.E.M., 1998, Journal of Comparative Biology, V3, P33; Costa Wilson J.E.M., 1998, P537; Costa Wilson J. E. M., 2007, Vertebrate Zoology, V57, P57; Costa WJEM, 2005, ZOOTAXA, P41; Cubells JF, 1994, GEOLOGIE MEDITERRANE, V21, P19; Dasilao JC, 1997, ICHTHYOL RES, V44, P101, DOI 10.1007/BF02678688; Dasilao JC, 1998, ICHTHYOL RES, V45, P303, DOI 10.1007/BF02673928; Dasilao Juanito C. Jr., 1998, Bulletin of Marine Sciences and Fisheries Kochi University, V0, P13; DEDI J, 1995, AQUACULTURE, V133, P135, DOI 10.1016/0044-8486(95)00015-T; Edenbrow M, 2012, J FISH BIOL, V80, P503, DOI 10.1111/j.1095-8649.2011.03181.x; Esmaeili HR, 2014, ZOOTAXA, V3786, P246, DOI 10.11646/zootaxa.3786.3.2; Ferrer J, 2008, NEOTROP ICHTHYOL, V6, P175, DOI 10.1590/S1679-62252008000200004; Froese R., 2011, FISHBASE WORLD WIDE; Fujita K., 1990, CAUDAL SKELETON TELE; Fuller RC, 2001, COPEIA, P823; Garcia G, 2012, J BIOGEOGR, V39, P1707, DOI 10.1111/j.1365-2699.2012.02722.x; GAUDANT J, 1993, GEOBIOS-LYON, V26, P449, DOI 10.1016/S0016-6995(06)80229-9; Gaudant Jean, 2002, Geodiversitas, V24, P691; Gaudant J, 2012, GEODIVERSITAS, V34, P409, DOI 10.5252/g2012n2a9; Gaudant J, 2011, GEODIVERSITAS, V33, P347, DOI 10.5252/g2011n2a9; Gavaia PJ, 2002, AQUACULTURE, V211, P305, DOI 10.1016/S0044-8486(02)00167-9; Gayet M., 1998, PHYLOGENY CLASSIFICA, P85; Gayet Mireille, 1991, Revista Tecnica de Yacimientos Petroliferos Fiscales Bolivianos, V12, P393; Gayet Mireille, 1991, Revista Tecnica de Yacimientos Petroliferos Fiscales Bolivianos, V12, P453; Geiger MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074901; Gholami Z, 2013, ZOOTAXA, V3619, P467, DOI 10.11646/zootaxa.3619.4.5; Gorman KF, 2007, COMP BIOCHEM PHYS C, V145, P28, DOI 10.1016/j.cbpc.2006.10.004; Greenwood P.H., 1984, P13; Guzman A. F., 2009, SETENTA CINCO ANOS E, P313; HAAS R, 1976, EVOLUTION, V30, P614, DOI 10.1111/j.1558-5646.1976.tb00938.x; Hertwig ST, 2008, ZOOL SCR, V37, P141, DOI 10.1111/j.1463-6409.2007.00314.x; HILL A, 1985, J HUM EVOL, V14, P759, DOI 10.1016/S0047-2484(85)80058-0; Hill A., 1986, Geological Society Special Publication, P285; Holcik J., 1989, FRESHWATER FISHES 2, V1; Horstkotte J, 2005, BIOL J LINN SOC, V85, P125, DOI 10.1111/j.1095-8312.2005.00476.x; Hosoya Kazumi, 1998, Bulletin of the National Research Institute of Fisheries Science, V0, P97; IBM Corp, 2012, IBM SPSS STAT MAC VE; Jacobs Bonnie F., 2010, P57; Karino K, 2006, ZOOL SCI, V23, P255, DOI 10.2108/zsj.23.255; Kessabi K, 2009, BIOL TRACE ELEM RES, V128, P72, DOI 10.1007/s12011-008-8255-z; Kingston JD, 2002, J HUM EVOL, V42, P95, DOI 10.1006/jhev.2001.0503; KODRICBROWN A, 1992, ENVIRON BIOL FISH, V35, P169, DOI 10.1007/BF00002191; Kumar P., 2010, GERF B BIOSCI, V1, P41, DOI DOI 10.1016/J.AQUAT0X.2003.11.010; Kvellestad A, 2000, DIS AQUAT ORGAN, V39, P97, DOI 10.3354/dao039097; Livingston TD, 2004, GEOLOGICAL SOC AM AB, V36, P286; LUNDBERG JG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P156; Madsen L, 1999, AQUACULTURE, V171, P41, DOI 10.1016/S0044-8486(98)00427-X; Marchio EA, 2013, BIOL J LINN SOC, V109, P848, DOI 10.1111/bij.12076; Mayr E, 1984, EVOLUTION FISH SPECI, P3; Meisner AD, 2001, ZOOL J LINN SOC-LOND, V133, P199, DOI 10.1111/j.1096-3642.2001.tb00690.x; Messaoudi I, 2009, AFR J ECOL, V47, P360, DOI 10.1111/j.1365-2028.2008.00972.x; Messaoudi I, 2009, ENVIRON MONIT ASSESS, V156, P551, DOI 10.1007/s10661-008-0504-2; Miller R.R., 1986, P487; Murphy WJ, 1997, MOL BIOL EVOL, V14, P790, DOI 10.1093/oxfordjournals.molbev.a025819; Murphy WJ, 1999, MOL PHYLOGENET EVOL, V11, P351, DOI 10.1006/mpev.1998.0566; Murray AM, 2000, J VERTEBR PALEONTOL, V20, P651, DOI 10.1671/0272-4634(2000)020[0651:ECFFTE]2.0.CO;2; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Northcote TG, 2000, ADV ECOL RES, V31, P399, DOI 10.1016/S0065-2504(00)31021-2; PARENTI LR, 1984, B AM MUS NAT HIST, V178, P110; PARENTI LR, 1993, B MAR SCI, V52, P170; Parenti LR, 1981, B AM MUS NAT HIST, V168, P335, DOI DOI 10.1080/00222930210135631; Parenti LR, 2008, ZOOL J LINN SOC-LOND, V154, P494, DOI 10.1111/j.1096-3642.2008.00417.x; Parenti LR, 2014, RAFFLES B ZOOL, V62, P175; PARKER A, 1995, COPEIA, P8; PICKFORD M, 1975, NATURE, V256, P279, DOI 10.1038/256279a0; Pickford M, 2009, GEO PAL KENYA, V1, P72; Pickford MHL, 1978, GEOL SOC LOND SPEC P, V6, P263, DOI DOI 10.1144/GSL.SP.1978.006.01.19; Porto JC., 1982, 5 C LAT ARG ACT, VIV, P253; Rasband W., 2006, IMAGEJ; Reichenbacher B, 2009, PALAEOGEOGR PALAEOCL, V281, P43, DOI 10.1016/j.palaeo.2009.07.008; Rosen D. E., 1964, Bulletin of the American Museum of Natural History, V127, P217; Rosen D. E., 1981, AM MUS NOVIT, V2719, P1; Ruckert-Ulkumen N, 2002, MITTEILUNGEN BAYERIS, V42, P51; SAEED B, 1989, AUST J MAR FRESH RES, V40, P719; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; SHUTE PW, 1983, ENVIRON BIOL FISH, V8, P293, DOI 10.1007/BF00001095; SMITH GR, 1981, ANNU REV ECOL SYST, V12, P163, DOI 10.1146/annurev.es.12.110181.001115; Sparks JS, 2004, MOL PHYLOGENET EVOL, V33, P719, DOI 10.1016/j.ympev.2004.07.002; STIASSNY MLJ, 1990, AM MUS NOVIT, P1; Strecker U, 2002, CYBIUM, V26, P301; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TAYLOR W R, 1985, Cybium, V9, P107; Uyeno T., 1962, Copeia, V1962, P520, DOI 10.2307/1441173; Vasilyan D, 2009, PALAEONTOL Z, V83, P511, DOI 10.1007/s12542-009-0034-4; Villwock W., 1994, Ecological Studies, V106, P51; VILLWOCK W, 1982, Z ZOOL SYST EVOL, V20, P187; WEITZMAN SH, 1967, COPEIA, P89; Wiley E.O., 2010, P123	115	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123056	10.1371/journal.pone.0123056	http://dx.doi.org/10.1371/journal.pone.0123056			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923654	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600028
J	Fanti, F; Cau, A; Cantelli, L; Hassine, M; Auditore, M				Fanti, Federico; Cau, Andrea; Cantelli, Luigi; Hassine, Mohsen; Auditore, Marco			New Information on Tataouinea hannibalis from the Early Cretaceous of Tunisia and Implications for the Tempo and Mode of Rebbachisaurid Sauropod Evolution	PLOS ONE			English	Article							SOUTHERNMOST SOUTH-AMERICA; PHYLOGENETIC ANALYSIS; TECTONIC EVOLUTION; DINOSAUR BONE; DIPLODOCOIDEA; DEPOSITS; PALEOSOLS; BASIN; VERTEBRATES; DIVERSITY	The rebbachisaurid sauropod Tataouinea hannibalis represents the first articulated dinosaur skeleton from Tunisia and one of the best preserved in northern Africa. The type specimen was collected from the lower Albian, fluvio-estuarine deposits of the Ain el Guettar Formation (southern Tunisia). We present detailed analyses on the sedimentology and facies distribution at the main quarry and a revision of the vertebrate fauna associated with the skeleton. Data provide information on a complex ecosystem dominated by crocodilian and other brackish water taxa. Taphonomic interpretations indicate a multi-event, pre-burial history with a combination of rapid segregation in high sediment supply conditions and partial subaerial exposure of the carcass. After the collection in 2011 of the articulated sacrum and proximalmost caudal vertebrae, all showing a complex pattern of pneumatization, newly discovered material of the type specimen allows a detailed osteological description of Tataouinea. The sacrum, the complete and articulated caudal vertebrae 1-17, both ilia and ischia display asymmetrical pneumatization, with the left side of vertebrae and the left ischium showing a more extensive invasion by pneumatic features than their right counterparts. A pneumatic hiatus is present in caudal centra 7 to 13, whereas caudal centra 14-16 are pneumatised by shallow fossae. Bayesian inference analyses integrating morphological, stratigraphic and paleogeographic data support a flagellicaudatan-rebbachisaurid divergence at about 163 Ma and a South American ancestral range for rebbachisaurids. Results presented here suggest an exclusively South American Limaysaurinae and a more widely distributed Rebbachisaurinae lineage, the latter including the South American taxon Katepensaurus and a clade including African and European taxa, with Tataouinea as sister taxon of Rebbachisaurus. This scenario would indicate that South America was not affected by the end-Jurassic extinction of diplodocoids, and was most likely the centre of the rapid radiation of rebbachisaurids to Africa and Europe between 135 and 130 Ma.	[Fanti, Federico; Cau, Andrea; Cantelli, Luigi] Univ Bologna, Alma Mater Studiorum, Dipartimento Sci Biol Geol & Ambientali, Bologna, Italy; [Fanti, Federico; Cau, Andrea] Univ Bologna, Alma Mater Studiorum, Museo Geol Giovanni Capellini, Bologna, Italy; [Hassine, Mohsen] Off Natl Mines, Serv Patrimoine Geol, Tunis, Tunisia; [Auditore, Marco] Museo Paleontol Cittadino, Gorizia, Italy	University of Bologna; University of Bologna; Office National des Mines	Fanti, F (corresponding author), Univ Bologna, Alma Mater Studiorum, Dipartimento Sci Biol Geol & Ambientali, Bologna, Italy.	federico.fanti@unibo.it	Cau, Andrea/ABB-7972-2021; Cantelli, Luigi/A-5346-2016; Cau, Andrea/S-8546-2016; Fanti, Federico/K-6624-2015	Cau, Andrea/0000-0001-8761-3720; Cantelli, Luigi/0000-0001-6153-5170; Fanti, Federico/0000-0002-2961-8301	Fondazione Alma Mater; Integrated Geoscience Research Group (Department of Earth and Geo-Environmental Sciences, University of Bologna, Italy); TITAN Project; Museo Geologico Giovanni Capellini (Bologna, Italy)	Fondazione Alma Mater; Integrated Geoscience Research Group (Department of Earth and Geo-Environmental Sciences, University of Bologna, Italy); TITAN Project; Museo Geologico Giovanni Capellini (Bologna, Italy)	This research was conducted in collaboration with the Office National Des Mines, Tunis, and was financially supported by Fondazione Alma Mater (Professor G. Gabbianelli), the Integrated Geoscience Research Group (Department of Earth and Geo-Environmental Sciences, University of Bologna, Italy), the TITAN Project (Professor L. Cantelli) and the Museo Geologico Giovanni Capellini (Bologna, Italy) who supported field and laboratory activities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PE, 2007, PALAEOGEOGR PALAEOCL, V243, P118, DOI 10.1016/j.palaeo.2006.07.015; Apesteguia S, 2007, GONDWANA RES, V12, P533, DOI 10.1016/j.gr.2007.04.007; Barale G, 2002, CRETACEOUS RES, V23, P707, DOI 10.1006/cres.2002.1025; Benson RBJ, 2012, BIOL REV, V87, P168, DOI 10.1111/j.1469-185X.2011.00190.x; Benton MJ, 2000, PALAEOGEOGR PALAEOCL, V157, P227, DOI 10.1016/S0031-0182(99)00167-4; Bonaparte JF., 1997, AMEGHINIANA, V34, P116; Bouaziz S, 2002, TECTONOPHYSICS, V357, P227, DOI 10.1016/S0040-1951(02)00370-0; BOUAZIZ S, 1989, GEOLOGIE MEDITERRANE, V0015, P00067, DOI DOI 10.3406/geolm.1989.1415; Britt BB, 2008, ICHNOS, V15, P59, DOI 10.1080/10420940701193284; Campobasso CP, 2001, FORENSIC SCI INT, V120, P18, DOI 10.1016/S0379-0738(01)00411-X; Carvalho ID, 2003, CRETACEOUS RES, V24, P697, DOI 10.1016/j.cretres.2003.07.005; Cohen KM, 2013, EPISODES, V36, P199, DOI 10.18814/epiiugs/2013/v36i3/002; Courel L, 2003, PALAEOGEOGR PALAEOCL, V196, P157, DOI 10.1016/S0031-0182(03)00317-1; Crame JA, 1999, SCI MAR, V63, P1; CUNNINGHAM WD, 1995, J GEOPHYS RES-SOL EA, V100, P8257, DOI 10.1029/95JB00033; Cuny Gilles, 2004, Revue de Paleobiologie Volume Special, V9, P127; Cuny G, 2010, GEOBIOS-LYON, V43, P615, DOI 10.1016/j.geobios.2010.07.001; DELAPPARENT AF, 1951, CR HEBD ACAD SCI, V232, P1430; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Fanti F., 2012, EARTH LIFE GLOBAL BI, P883; Fanti F, 2013, NATURE COMMUNICATION, V4, P2028, DOI [10.1038/ncomms3028, DOI 10.1038/NC0MMS3028]; Fanti F, 2014, PALAEOGEOGR PALAEOCL, V410, P39, DOI 10.1016/j.palaeo.2014.05.033; Fanti F, 2014, J AFR EARTH SCI, V90, P1, DOI 10.1016/j.jafrearsci.2013.10.010; Fanti F, 2012, J AFR EARTH SCI, V73-74, P1, DOI 10.1016/j.jafrearsci.2012.07.006; Fanti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031330; Gallina PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097128; Gheerbrant E, 2006, PALAEOGEOGR PALAEOCL, V241, P224, DOI 10.1016/j.palaeo.2006.03.016; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goloboff PA, 2008, CLADISTICS, V24, P758, DOI 10.1111/j.1096-0031.2008.00209.x; Guedes E, 2005, J S AM EARTH SCI, V18, P371, DOI 10.1016/j.jsames.2004.11.008; Harrison EP, 1973, THESIS TEXAS TU; Hasiotis ST, 1997, COMB ROCK MOUNT SOUT, V29, p13A; Ibiricu LM, 2013, J VERTEBR PALEONTOL, V33, P1351, DOI 10.1080/02724634.2013.776562; Ibiricu LM, 2012, CRETACEOUS RES, V34, P220, DOI 10.1016/j.cretres.2011.11.003; Canale JI, 2015, HIST BIOL, V27, P1, DOI 10.1080/08912963.2013.861830; Jokat W, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001802; Kilian C., 1931, COMPTES RENDUS SOMMA, V9, P109; Kilian C., 1937, CHRONIQUE MINES COLO, V58, P21; Kraus MJ, 2006, J SEDIMENT RES, V76, P633, DOI 10.2110/jsr.2006.052; Lapparent A. F. de, 1960, Memoires de la Societe Geologique de France Paleontologie, V88A, P1; Le Loeuff J, 2010, GEOL MAG, V147, P750, DOI 10.1017/S0016756810000178; Lee MSY, 2014, SCIENCE, V345, P562, DOI 10.1126/science.1252243; Lee MSY, 2014, SYST BIOL, V63, P442, DOI 10.1093/sysbio/syt110; LEFRANC JP, 1990, J AFR EARTH SCI, V10, P27, DOI 10.1016/0899-5362(90)90047-I; LEHMAN TM, 1989, GEOL SOC AM BULL, V101, P188, DOI 10.1130/0016-7606(1989)101<0188:UCMPIT>2.3.CO;2; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Carballido JL, 2012, HIST BIOL, V24, P631, DOI 10.1080/08912963.2012.672416; Macdonald D, 2003, MAR PETROL GEOL, V20, P287, DOI 10.1016/S0264-8172(03)00045-X; Mannion PD, 2013, CRETACEOUS RES, V45, P49, DOI 10.1016/j.cretres.2013.07.007; Mannion PD, 2011, CRETACEOUS RES, V32, P774, DOI 10.1016/j.cretres.2011.05.005; Mateus O, 2014, J VERTEBR PALEONTOL, V34, P618, DOI 10.1080/02724634.2013.822875; Ouaja M, 2004, GEOBIOS-LYON, V37, P89, DOI 10.1016/j.geobios.2002.12.002; Paik IS, 2000, PALAEOGEOGR PALAEOCL, V157, P213, DOI 10.1016/S0031-0182(99)00166-2; Pervinquiere L., 1912, B SOC GEOL FR, V4, P160; Philip J., 2000, ATLAS PERI TETHYS PA, P137; RAMBAUT A, TRACER MCMC TRACE AN; Remes K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006924; Roberts E, 2003, J VERTEBR PALEONTOL, V23, p89A; Royo-Torres R, 2006, SCIENCE, V314, P1925, DOI 10.1126/science.1132885; SALGADO L, 1991, Ameghiniana, V28, P333; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Saneyoshi M, 2011, PALAEOGEOGR PALAEOCL, V311, P38, DOI 10.1016/j.palaeo.2011.07.024; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; Torcida Fernandez-Baldor F, 2012, THESIS U ZARAGOZA; Fernandez-Baldor FT, 2011, ACTA PALAEONTOL POL, V56, P535, DOI 10.4202/app.2010.0003; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wedel MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078213; Wedel MJ, 2009, J EXP ZOOL PART A, V311A, P611, DOI 10.1002/jez.513; Whitlock JA, 2011, ZOOL J LINN SOC-LOND, V161, P872, DOI 10.1111/j.1096-3642.2010.00665.x; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, J VERTEBRAT IN PRESS; Wilson J, 2011, TLS-TIMES LIT SUPPL, P6; Wilson Jeffrey A., 2011, Contributions from the Museum of Paleontology University of Michigan, V32, P59; Yates AM, 2012, ACTA PALAEONTOL POL, V57, P85, DOI 10.4202/app.2010.0075; Yu Y., 2011, RASP RECONSTRUCT ANC; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zarbout M, 1994, STRATA, V6, P141	79	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123475	10.1371/journal.pone.0123475	http://dx.doi.org/10.1371/journal.pone.0123475			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923211	Green Submitted, gold, Green Published			2022-12-27	WOS:000353711600048
J	Lin, TH; Yu, HY; Chen, CF; Chou, LS				Lin, Tzu-Hao; Yu, Hsin-Yi; Chen, Chi-Fang; Chou, Lien-Siang			Passive Acoustic Monitoring of the Temporal Variability of Odontocete Tonal Sounds from a Long-Term Marine Observatory	PLOS ONE			English	Article							AUTOMATIC DETECTION; TURSIOPS-TRUNCATUS; SIGNATURE WHISTLES; INFORMATION-THEORY; DOLPHIN WHISTLES; BEHAVIOR; FREQUENCY; WHALES; CLASSIFICATION; OCEAN	The developments of marine observatories and automatic sound detection algorithms have facilitated the long-term monitoring of multiple species of odontocetes. Although classification remains difficult, information on tonal sound in odontocetes (i.e., toothed whales, including dolphins and porpoises) can provide insights into the species composition and group behavior of these species. However, the approach to measure whistle contour parameters for detecting the variability of odontocete vocal behavior may be biased when the signal-to-noise ratio is low. Thus, methods for analyzing the whistle usage of an entire group are necessary. In this study, a local-max detector was used to detect burst pulses and representative frequencies of whistles within 4.5-48 kHz. Whistle contours were extracted and classified using an unsupervised method. Whistle characteristics and usage pattern were quantified based on the distribution of representative frequencies and the composition of whistle repertoires. Based on the one year recordings collected from the Marine Cable Hosted Observatory off northeastern Taiwan, odontocete burst pulses and whistles were primarily detected during the nighttime, especially after sunset. Whistle usage during the nighttime was more complex, and whistles with higher frequency were mainly detected during summer and fall. According to the multivariate analysis, the diurnal variation of whistle usage was primarily related to the change of mode frequency, diversity of representative frequency, and sequence complexity. The seasonal variation of whistle usage involved the previous three parameters, in addition to the diversity of whistle clusters. Our results indicated that the species and behavioral composition of the local odontocete community may vary among seasonal and diurnal cycles. The current monitoring platform facilitates the evaluation of whistle usage based on group behavior and provides feature vectors for species and behavioral classification in future studies.	[Lin, Tzu-Hao; Yu, Hsin-Yi; Chou, Lien-Siang] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10617, Taiwan; [Chen, Chi-Fang] Natl Taiwan Univ, Dept Engn Sci & Ocean Engn, Taipei 10617, Taiwan	National Taiwan University; National Taiwan University	Chou, LS (corresponding author), Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.	chouls@ntu.edu.tw	Lin, Tzu-Hao/GLT-9168-2022; Lin, Tzu-Hao/T-3229-2019	Lin, Tzu-Hao/0000-0002-6973-3953; Lin, Tzu-Hao/0000-0002-6973-3953; Chou, Lien-Siang/0000-0003-4610-5257	Ministry of Science and Technology of Taiwan (R.O.C.) [NSC 101-2221-E-002-028-MY2, NSC 102-3113-P-002-032]	Ministry of Science and Technology of Taiwan (R.O.C.)	This study was supported by the Ministry of Science and Technology of Taiwan (R.O.C.) under the project of NSC 101-2221-E-002-028-MY2 and NSC 102-3113-P-002-032. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2005, P ROY SOC B-BIOL SCI, V272, P797, DOI 10.1098/rspb.2004.3024; Akamatsu T, 2010, MAR BIOL, V157, P1879, DOI 10.1007/s00227-010-1459-8; Andre M, 2011, MAR POLLUT BULL, V63, P18, DOI 10.1016/j.marpolbul.2011.04.038; Baumgartner MF, 2011, J ACOUST SOC AM, V129, P2889, DOI 10.1121/1.3562166; Chang Y-L, 2009, J GEOPHYS RES, V114; Chen Y, 2001, THESIS U CHARLESTON; Chuang W.S., 1994, J OCEANOGR, V50, P531, DOI [10.1007/BF02235422, DOI 10.1007/BF02235422]; Doyle LR, 2008, ENTROPY, V10, P33, DOI 10.3390/entropy-e10020033; Erbe C, 2008, J ACOUST SOC AM, V124, P2833, DOI 10.1121/1.2982368; Fernandez R, 2013, CONT SHELF RES, V64, P88, DOI 10.1016/j.csr.2013.05.008; Frankel AS, 2010, J ACOUST SOC AM, V127, P3248, DOI 10.1121/1.3365259; Gannier A, 2010, APPL ACOUST, V71, P1063, DOI 10.1016/j.apacoust.2010.05.019; Gillespie D, 2013, J ACOUST SOC AM, V134, P2427, DOI 10.1121/1.4816555; Hernandez EN, 2010, J ACOUST SOC AM, V127, P3232, DOI 10.1121/1.3365254; Hsin YC, 2013, J GEOPHYS RES-OCEANS, V118, P4305, DOI 10.1002/jgrc.20323; Janik VM, 1999, ANIM BEHAV, V57, P133, DOI 10.1006/anbe.1998.0923; Janik VM, 1998, ANIM BEHAV, V56, P829, DOI 10.1006/anbe.1998.0881; Kimura S, 2012, MAR MAMMAL SCI, V28, P308, DOI 10.1111/j.1748-7692.2011.00490.x; Lee MA, 2011, J MAR SCI TECH-TAIW, V19, P253; Lin T.-H., 2013, UND TECHN S UT 2013, P1; Lin TH, 2015, ESTUAR COAST, V38, P1376, DOI 10.1007/s12237-014-9886-2; Lin TH, 2013, J ACOUST SOC AM, V134, P2477, DOI 10.1121/1.4816572; Lin TH, 2013, MAR BIOL, V160, P1353, DOI 10.1007/s00227-013-2187-7; Lopez BD, 2011, MAMM BIOL, V76, P180, DOI 10.1016/j.mambio.2010.06.006; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Mallawaarachchi A, 2008, J ACOUST SOC AM, V124, P1159, DOI 10.1121/1.2945711; McCowan B, 1999, ANIM BEHAV, V57, P409, DOI 10.1006/anbe.1998.1000; MCCOWAN B, 1995, ETHOLOGY, V100, P177; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Mellinger DK, 2011, J ACOUST SOC AM, V129, P4055, DOI 10.1121/1.3531926; Moore SE, 2006, BIOSCIENCE, V56, P49, DOI 10.1641/0006-3568(2006)056[0049:LFLWIT]2.0.CO;2; Oswald JN, 2003, MAR MAMMAL SCI, V19, P20, DOI 10.1111/j.1748-7692.2003.tb01090.x; Overstrom N.A., 1983, Zoo Biology, V2, P93, DOI 10.1002/zoo.1430020203; Roch MA, 2011, J ACOUST SOC AM, V130, P2212, DOI 10.1121/1.3624821; Seekings PJ, 2010, OC 10 IEEE SYDN NSW, P1, DOI DOI 10.1109/OCEANSSYD.2010.5603596; SMOLKER RA, 1993, BEHAV ECOL SOCIOBIOL, V33, P393; Soldevilla MS, 2011, MAR ECOL PROG SER, V423, P247, DOI 10.3354/meps08927; Soldevilla MS, 2010, J ACOUST SOC AM, V127, P124, DOI 10.1121/1.3257586; Stanistreet JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061263; Sveegaard S, 2012, MAR ECOL PROG SER, V468, P245, DOI 10.3354/meps09959; Van Parijs SM, 2001, ETHOLOGY, V107, P701, DOI 10.1046/j.1439-0310.2001.00714.x; Wang D., 1995, SENSORY SYSTEMS AQUA, P299; Zaugg S, 2012, APPL ACOUST, V73, P281, DOI 10.1016/j.apacoust.2011.09.009	43	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123943	10.1371/journal.pone.0123943	http://dx.doi.org/10.1371/journal.pone.0123943			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923338	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600061
J	Emiola, A; George, J; Andrews, SS				Emiola, Akintunde; George, John; Andrews, Steven S.			A Complete Pathway Model for Lipid A Biosynthesis in Escherichia coli	PLOS ONE			English	Article							UDP-N-ACETYLGLUCOSAMINE; ZINC-DEPENDENT DEACETYLASE; LIPOPOLYSACCHARIDE BIOSYNTHESIS; ANTIBACTERIAL AGENTS; 3-DEOXY-D-MANNO-OCTULOSONIC ACID; STOCHASTIC SIMULATION; CHEMICAL-MODIFICATION; MULTICOPY SUPPRESSOR; ANTIBIOTIC-ACTIVITY; METABOLIC-CONTROL	Lipid A is a highly conserved component of lipopolysaccharide (LPS), itself a major component of the outer membrane of Gram-negative bacteria. Lipid A is essential to cells and elicits a strong immune response from humans and other animals. We developed a quantitative model of the nine enzyme-catalyzed steps of Escherichia coli lipid A biosynthesis, drawing parameters from the experimental literature. This model accounts for biosynthesis regulation, which occurs through regulated degradation of the LpxC and WaaA (also called KdtA) enzymes. The LpxC degradation signal appears to arise from the lipid A disaccharide concentration, which we deduced from prior results, model results, and new LpxK overexpression results. The model agrees reasonably well with many experimental findings, including the lipid A production rate, the behaviors of mutants with defective LpxA enzymes, correlations between LpxC half-lives and cell generation times, and the effects of LpxK overexpression on LpxC concentrations. Its predictions also differ from some experimental results, which suggest modifications to the current understanding of the lipid A pathway, such as the possibility that LpxD can replace LpxA and that there may be metabolic channeling between LpxH and LpxB. The model shows that WaaA regulation may serve to regulate the lipid A production rate when the 3-deoxy-D-manno-oct-2-ulosonic acid (KDO) concentration is low and/or to control the number of KDO residues that get attached to lipid A. Computation of flux control coefficients showed that LpxC is the rate-limiting enzyme if pathway regulation is ignored, but that LpxK is the rate-limiting enzyme if pathway regulation is present, as it is in real cells. Control also shifts to other enzymes if the pathway substrate concentrations are not in excess. Based on these results, we suggest that LpxK may be a much better drug target than LpxC, which has been pursued most often.	[Emiola, Akintunde; George, John] Univ E London, Sch Hlth Sports & Biosci, London E15 4LZ, England; [Andrews, Steven S.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of East London; Fred Hutchinson Cancer Center	Emiola, A (corresponding author), Univ E London, Sch Hlth Sports & Biosci, London E15 4LZ, England.	a.emiola@uel.ac.uk			National Institute of General Medical Science [R01 GM08666615]	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: SSA was funded in part by National Institute of General Medical Science grant R01 GM08666615, awarded to Roger Brent and Richard Yu. There were no addition internal/external funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; ANDERSON MS, 1988, BIOCHEMISTRY-US, V27, P1908, DOI 10.1021/bi00406a017; ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; ANDERSON MS, 1987, J BIOL CHEM, V262, P5159; Andrews S. S., 2009, ENCY COMPLEXITY SYST, V9, P8730, DOI DOI 10.1007/978-0-387-30440-3_524; Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; Andrews SS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000705; Babinski KJ, 2002, J BIOL CHEM, V277, P25937, DOI 10.1074/jbc.M204067200; Barb AW, 2008, CURR PHARM BIOTECHNO, V9, P9; Barb AW, 2007, BIOCHEMISTRY-US, V46, P3793, DOI 10.1021/bi6025165; Bartling CM, 2008, BIOCHEMISTRY-US, V47, P5290, DOI 10.1021/bi800240r; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; BROZEK KA, 1989, J BIOL CHEM, V264, P6956; BROZEK KA, 1990, J BIOL CHEM, V265, P15410; Bruce A., 2002, MOL BIOL CELL, V4th ed.; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; CLEMENTZ T, 1991, J BIOL CHEM, V266, P9687; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Clementz T, 1997, J BIOL CHEM, V272, P10353; Cornish-Bowden A, 2001, EUR J BIOCHEM, V268, P6616, DOI 10.1046/j.0014-2956.2001.02616.x; DEMENDOZA D, 1983, J BIOL CHEM, V258, P2098; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Emiola A, 2013, COMPUT BIOL CHEM, V47, P1, DOI 10.1016/j.compbiolchem.2013.06.001; Emptage RP, 2012, P NATL ACAD SCI USA, V109, P12956, DOI 10.1073/pnas.1206072109; Fell D, 1971, UNDERSTANDING CONTRO; FELL DA, 1985, EUR J BIOCHEM, V148, P555, DOI 10.1111/j.1432-1033.1985.tb08876.x; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Fuhrer F, 2007, J MOL BIOL, V372, P485, DOI 10.1016/j.jmb.2007.06.083; Fuhrer F, 2006, MOL MICROBIOL, V59, P1025, DOI 10.1111/j.1365-2958.2005.04994.x; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; Garrett TA, 1997, J BIOL CHEM, V272, P21855, DOI 10.1074/jbc.272.35.21855; Garrett TA, 1998, J BIOL CHEM, V273, P12457, DOI 10.1074/jbc.273.20.12457; GHALAMBOR MA, 1966, J BIOL CHEM, V241, P3222; GOLDMAN R, 1987, NATURE, V329, P162, DOI 10.1038/329162a0; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Gronow S, 2001, J ENDOTOXIN RES, V7, P3, DOI 10.1179/096805101101532468; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heath RJ, 1996, J BIOL CHEM, V271, P27795, DOI 10.1074/jbc.271.44.27795; Hernick M, 2005, J BIOL CHEM, V280, P16969, DOI 10.1074/jbc.M413560200; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Jackman JE, 1999, BIOCHEMISTRY-US, V38, P1902, DOI 10.1021/bi982339s; Jackman JE, 2000, J BIOL CHEM, V275, P11002, DOI 10.1074/jbc.275.15.11002; Jayasekera MMK, 2000, ARCH BIOCHEM BIOPHYS, V380, P103, DOI 10.1006/abbi.2000.1903; KAROW M, 1993, MOL MICROBIOL, V7, P69, DOI 10.1111/j.1365-2958.1993.tb01098.x; Katz C, 2008, J BACTERIOL, V190, P7117, DOI 10.1128/JB.00871-08; KELLY TM, 1993, J BIOL CHEM, V268, P19866; Kenanov D, 2010, FEBS J, V277, P1023, DOI 10.1111/j.1742-4658.2009.07546.x; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Langklotz S, 2012, BBA-MOL CELL RES, V1823, P40, DOI 10.1016/j.bbamcr.2011.08.015; Mackie GA, 2013, NAT REV MICROBIOL, V11, P45, DOI 10.1038/nrmicro2930; Mahalakshmi S, 2014, MOL MICROBIOL, V91, P145, DOI 10.1111/mmi.12452; Mansilla MC, 2004, J BACTERIOL, V186, P6681, DOI 10.1128/JB.186.20.6681-6688.2004; Marangoni AG, 2003, ENZYME KINETICS MODE, DOI [10.1002/0471267295.ch7, DOI 10.1002/0471267295.CH7]; MATTSBYBALTZER I, 1991, INFECT IMMUN, V59, P689, DOI 10.1128/IAI.59.2.689-695.1991; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P16574, DOI 10.1021/bi0518186; Mendes Pedro, 2009, V500, P17, DOI 10.1007/978-1-59745-525-1_2; MENGINLECREULX D, 1983, J BACTERIOL, V154, P1284, DOI 10.1128/JB.154.3.1284-1290.1983; Metzger LE, 2009, BIOCHEMISTRY-US, V48, P11559, DOI 10.1021/bi901750f; MOHAN S, 1994, J BIOL CHEM, V269, P32896; Narberhaus F, 2009, RES MICROBIOL, V160, P652, DOI 10.1016/j.resmic.2009.08.011; Nikaido H., 1996, ESCHERICHIA COLI SAL, P29; NISHIJIMA M, 1979, J BIOL CHEM, V254, P7837; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; PLANK LD, 1979, J GEN MICROBIOL, V115, P69, DOI 10.1099/00221287-115-1-69; RADIKA K, 1988, J BIOL CHEM, V263, P14859; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAY BL, 1987, J BIOL CHEM, V262, P1122; RAY PH, 1981, J BACTERIOL, V145, P1273, DOI 10.1128/JB.145.3.1273-1280.1981; Ridgway D, 2006, CURR OPIN BIOTECH, V17, P493, DOI 10.1016/j.copbio.2006.08.004; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Roberts E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002010; Sanft KR, 2011, BIOINFORMATICS, V27, P2457, DOI 10.1093/bioinformatics/btr401; Schakermann M, 2013, J BACTERIOL, V195, P1912, DOI 10.1128/JB.02134-12; Six DA, 2008, BIOCHEMISTRY-US, V47, P8623, DOI 10.1021/bi800873n; Slominska M, 1999, VIROLOGY, V262, P431, DOI 10.1006/viro.1999.9907; Sorensen PG, 1996, J BIOL CHEM, V271, P25898, DOI 10.1074/jbc.271.42.25898; Sundararaj S, 2004, NUCLEIC ACIDS RES, V32, pD293, DOI 10.1093/nar/gkh108; TAKAYAMA K, 1983, J BIOL CHEM, V258, P4245; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Vigh L, 1998, TRENDS BIOCHEM SCI, V23, P369, DOI 10.1016/S0968-0004(98)01279-1; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14194, DOI 10.1074/jbc.M200409200; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14186, DOI 10.1074/jbc.M200408200; Walker SL, 2004, LANGMUIR, V20, P7736, DOI 10.1021/la049511f; Walsh CT, 2014, J ANTIBIOT, V67, P7, DOI 10.1038/ja.2013.49; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Wyckoff TJO, 1999, J BIOL CHEM, V274, P27047, DOI 10.1074/jbc.274.38.27047; Yokoyama K, 2008, CHEMBIOCHEM, V9, P865, DOI 10.1002/cbic.200700717; Young K, 1995, J BIOL CHEM, V270, P30384, DOI 10.1074/jbc.270.51.30384; Zeng DN, 2013, J BIOL CHEM, V288, P5475, DOI 10.1074/jbc.M112.447607; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	96	42	44	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0121216	10.1371/journal.pone.0121216	http://dx.doi.org/10.1371/journal.pone.0121216			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919634	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000353659400006
J	Quinteiro, J; Manent, P; Perez-Dieguez, L; Gonzalez, JA; Almeida, C; Lopes, E; Araujo, R; Carreira, GP; Rey-Mendez, M; Gonzalez-Henriquez, N				Quinteiro, Javier; Manent, Pablo; Perez-Dieguez, Lois; Gonzalez, Jose A.; Almeida, Corrine; Lopes, Evandro; Araujo, Ricardo; Carreira, Gilberto P.; Rey-Mendez, Manuel; Gonzalez-Henriquez, Nieves			Phylogeography of a Marine Insular Endemic in the Atlantic Macaronesia: The Azorean Barnacle, Megabalanus azoricus (Pilsbry, 1916)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-GROWTH; GENETIC-STRUCTURE; CIRRIPEDIA BALANOMORPHA; CRUSTACEA; OCEAN; DIVERGENCE; SOFTWARE; DIFFERENTIATION; SUBSTITUTIONS	The Azorean barnacle, Megabalanus azoricus (Pilsbry, 1916), is a Macaronesian endemic whose obscure taxonomy and the unknown relationships among forms inhabiting isolated Northern Atlantic oceanic islands is investigated by means of molecular analysis herein. Mitochondrial data from the 16S rRNA and COX1 genes support its current species status, tropical ancestry, and the taxonomic homogeneity throughout its distribution range. In contrast, at the intraspecific level and based on control region sequences, we detected an overall low level of genetic diversity and three divergent lineages. The haplogroups a and. were sampled in the Azores, Madeira, Canary, and Cabo Verde archipelagos; whereas haplogroup beta was absent from Cabo Verde. Consequently, population analysis suggested a differentiation of the Cabo Verde population with respect to the genetically homogenous northern archipelagos generated by current oceanographic barriers. Furthermore, haplogroup a, beta, and. demographic expansions occurred during the interglacial periods MIS5 (130 Kya - thousands years ago -), MIS3 (60 Kya), and MIS7 (240 Kya), respectively. The evolutionary origin of these lineages is related to its survival in the stable southern refugia and its demographic expansion dynamics are associated with the glacial-interglacial cycles. This phylogeographic pattern suggests the occurrence of genetic discontinuity informative to the delimitation of an informally defined biogeographic entity, Macaronesia, and its generation by processes that delineate genetic diversity of marine taxa in this area.	[Quinteiro, Javier; Perez-Dieguez, Lois; Rey-Mendez, Manuel] Univ Santiago de Compostela, Dept Biochem & Mol Biol, Mol Systemat Lab, La Coruna, Galicia, Spain; [Manent, Pablo; Gonzalez, Jose A.; Gonzalez-Henriquez, Nieves] Univ Las Palmas Gran Canaria, Dept Biol, Las Palmas Gran Canaria, Spain; [Almeida, Corrine; Lopes, Evandro] Univ Cabo Verde, Dept Enginery & Sea Sci, Mindelo, Sao Vicente, Cape Verde; [Araujo, Ricardo] Nat Hist Museum Funchal, Funchal, Madeira, Portugal; [Carreira, Gilberto P.] Reg Secretary Nat Resources, Reg Directorate Sea Affaires, Horta, Acores, Portugal	Universidade de Santiago de Compostela; Universidad de Las Palmas de Gran Canaria	Quinteiro, J (corresponding author), Univ Santiago de Compostela, Dept Biochem & Mol Biol, Mol Systemat Lab, La Coruna, Galicia, Spain.	javier.quinteiro@gmail.com	GONZÁLEZ-HENRÍQUEZ, NIEVES/AAA-4911-2019; Quinteiro, Javier/C-4410-2011; GONZÁLEZ, JOSE/H-2187-2015	GONZÁLEZ-HENRÍQUEZ, NIEVES/0000-0003-1110-0448; Quinteiro, Javier/0000-0002-8683-9522; GONZÁLEZ, JOSE/0000-0001-8584-6731; Lopes, Evandro/0000-0003-3938-1560	EU project BANGEN BANGEMAC Network: Genetic Bank for Macaronesia Transnational Cooperation 702 Program Azores-Madeira-Canaries (PCT-MAC) [(MAC/1/C070) 701]	EU project BANGEN BANGEMAC Network: Genetic Bank for Macaronesia Transnational Cooperation 702 Program Azores-Madeira-Canaries (PCT-MAC)	This work was supported by the EU project BANGEN (MAC/1/C070) 701 BANGEMAC Network: Genetic Bank for Macaronesia Transnational Cooperation 702 Program Azores-Madeira-Canaries (PCT-MAC 2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; Briggs JC, 1995, GLOBAL BIOGEOGRAPHY, pxvii; BRIGGS JOHN C., 1966, SYST ZOOL, V15, P153, DOI 10.2307/2411634; Buckeridge J. S., 1983, NZ GEOLOGICAL SURVEY, V50, P1; Caldeira RMA, 2002, REMOTE SENS ENVIRON, V80, P336, DOI 10.1016/S0034-4257(01)00316-9; Campo D, 2010, MAR BIOL, V157, P147, DOI 10.1007/s00227-009-1305-z; Carlton JT, 2011, INVAD NAT SPRING SER, V6, P159, DOI 10.1007/978-94-007-0591-3_5; Chan BKK, 2007, ZOOL SCR, V36, P79, DOI 10.1111/j.1463-6409.2007.00260.x; Chan BKK, 2009, RAFFLES B ZOOL, P83; Chan BKK, 2007, ZOOL STUD, V46, P46; DANSEREAU PIERRE, 1961, AGRON LUSITANA, V23, P151; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DARWIN C, 1854, BALANIDAE SESSILE CI, P1; Dawson MN, 2010, MOL ECOL, V19, P1585, DOI 10.1111/j.1365-294X.2010.04588.x; De Wolf H, 2000, J EXP MAR BIOL ECOL, V246, P69, DOI 10.1016/S0022-0981(99)00177-X; Dionisio M., 2012, Marine Biodiversity Records, V5, pe110, DOI 10.1017/S1755267212000590; Dionisio M, 2007, INVERTEBR REPROD DEV, V50, P155, DOI 10.1080/07924259.2007.9652240; Dowle EJ, 2013, HEREDITY, V110, P501, DOI 10.1038/hdy.2013.4; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; ENGLER A, 1879, VERSUCH EINER ENTWIC; Ewers C, 2012, INTEGR COMP BIOL, V52, P410, DOI 10.1093/icb/ics047; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flight PA, 2012, J HERED, V103, P153, DOI 10.1093/jhered/esr083; Flores JA, 2000, PALAEOGEOGR PALAEOCL, V161, P459, DOI 10.1016/S0031-0182(00)00099-7; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foltz DW, 2003, J MOL EVOL, V57, P607, DOI 10.1007/s00239-003-2495-5; Fu YX, 1997, GENETICS, V147, P915; Gonzalez JA, 2012, J MAR BIOL ASSOC UK, V92, P129, DOI 10.1017/S002531541100066X; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARPENDING HC, 1994, HUM BIOL, V66, P591; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hawkins SJ, 2000, HYDROBIOLOGIA, V440, P3, DOI 10.1023/A:1004118220083; Hayashi R, 2013, MOL PHYLOGENET EVOL, V67, P9, DOI 10.1016/j.ympev.2012.12.018; Henry DP, 1986, ZOOLOGISCHE VERHANDE, V235, P3; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hoek PPC, 1913, SIBOGA EXPED, V31b, P129, DOI DOI 10.5962/BHL.TI-TLE.12959; Huber C, 2006, EARTH PLANET SC LETT, V243, P504, DOI 10.1016/j.epsl.2006.01.002; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Leung PTY, 2011, J MAR BIOL ASSOC UK, V91, P173, DOI 10.1017/S0025315410000937; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lloris D., 1991, Boletim do Museu Municipal do Funchal, V43, P191; Lopez DA, 2010, AQUAC RES, V41, pe367, DOI 10.1111/j.1365-2109.2010.02508.x; Fernandez-Palacios JM, 2011, J BIOGEOGR, V38, P226, DOI 10.1111/j.1365-2699.2010.02427.x; Martin PR, 2004, EVOLUTION, V58, P938; Meckler AN, 2013, NATURE, V495, P495, DOI 10.1038/nature12006; Meunier T, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC007905; MITTELSTAEDT E, 1991, PROG OCEANOGR, V26, P307, DOI 10.1016/0079-6611(91)90011-A; Morri C, 2000, ARQUIPELAGO-LIFE AND MARINE SCIENCES, SUPPLEMENT 2, PART A, 2000, PROCEEDINGS, P157; Morton B, 2000, ARQUIPEL LIFE MAR S, V2, P22; Muss A, 2001, EVOLUTION, V55, P561, DOI 10.1554/0014-3820(2001)055[0561:POOTRO]2.0.CO;2; Newman WA, 1976, SAN DIEGO SOC NAT HI, P108; O'Riordan RM, 2004, J EXP MAR BIOL ECOL, V304, P243, DOI 10.1016/j.jembe.2003.12.005; OSPAR, 2010, QUAL STAT REP 2010; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Palumbi SR, 1996, J EXP MAR BIOL ECOL, V203, P75, DOI 10.1016/0022-0981(96)02571-3; Pastor MV, 2012, CIENC MAR, V38, P223, DOI 10.7773/cm.v38i1B.1831; Pena-Izquierdo J, 2012, SCI MAR, V76, P65, DOI 10.3989/scimar.03607.18C; Perez-Losada M, 2004, SYST BIOL, V53, P244, DOI 10.1080/10635150490423458; Perez-Losada M, 2008, MOL PHYLOGENET EVOL, V46, P328, DOI 10.1016/j.ympev.2007.10.004; Pham Christopher K., 2011, Arquipelago-Life and Marine Sciences, P47; Pilsbry HA., 1916, B US NATN MUS, V93, P1, DOI DOI 10.5479/SI.03629236.93.1; Quinteiro J, 2007, MAR BIOL, V153, P47, DOI 10.1007/s00227-007-0783-0; Quinteiro J, 2011, J MAR BIOL ASSOC UK, V91, P1537, DOI 10.1017/S0025315411000166; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rogerson M, 2004, EARTH PLANET SC LETT, V222, P779, DOI 10.1016/j.epsl.2004.03.039; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruddiman W., 1976, MEM GEOL SOC AM, V145, P111, DOI [DOI 10.1130/MEM145-P111, 10.1130/MEM145-p111]; Ruiz S, 2014, J GEOPHYS RES-OCEANS, V119, P1257, DOI 10.1002/2013JC009169; Santos RS, 1995, AQUAT CONSERV, V5, P311, DOI 10.1002/aqc.3270050406; Schneider S, 1999, GENETICS, V152, P1079; Simon-Blecher N, 2007, MOL PHYLOGENET EVOL, V44, P1333, DOI 10.1016/j.ympev.2007.03.026; SLATKIN M, 1991, GENETICS, V129, P555; Sotka EE, 2004, MOL ECOL, V13, P2143, DOI 10.1111/j.1365-294X.2004.02225.x; Southward Alan J., 1998, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V16A, P11; Stearn W. T., 1973, MONOGRAPHIAE BIOL CA, V4, P15; Sunding P., 1979, PLANTS ISLANDS, P13; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torres P, 2012, HELGOLAND MAR RES, V66, P513, DOI 10.1007/s10152-011-0287-7; Tsang LM, 2012, INTEGR COMP BIOL, V52, P388, DOI 10.1093/icb/ics044; Van den Broeck H, 2008, MAR BIOL, V153, P421, DOI 10.1007/s00227-007-0820-z; Vanderpoorten A, 2007, AM J BOT, V94, P625, DOI 10.3732/ajb.94.4.625; Wares JP, 2011, J CRUSTACEAN BIOL, V31, P339, DOI 10.1651/10-3407.1; Wares JP, 2001, MOL PHYLOGENET EVOL, V18, P104, DOI 10.1006/mpev.2000.0857; Whittaker RJ, 2007, ISLAND BIOGEOGRAPHY, pxii; Wirtz P, 2006, HELGOLAND MAR RES, V60, P207, DOI 10.1007/s10152-006-0036-5; Xavier RJ, 2010, CONTRIB ZOOL, V79, P10; Yamaguchi T, 2009, BIOFOULING, V25, P325, DOI 10.1080/08927010902738048	96	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124707	10.1371/journal.pone.0124707	http://dx.doi.org/10.1371/journal.pone.0124707			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919141	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400057
J	Saito, S; Saito, W; Saito, M; Hashimoto, Y; Mori, S; Noda, K; Namba, K; Ishida, S				Saito, Saho; Saito, Wataru; Saito, Michiyuki; Hashimoto, Yuki; Mori, Shohei; Noda, Kousuke; Namba, Kenichi; Ishida, Susumu			Acute Zonal Occult Outer Retinopathy in Japanese Patients: Clinical Features, Visual Function, and Factors Affecting Visual Function	PLOS ONE			English	Article							BLOOD-FLOW-VELOCITY; SEGMENT; THERAPY; AZOOR	Purpose To evaluate the clinical features and investigate their relationship with visual function in Japanese patients with acute zonal occult outer retinopathy (AZOOR). Methods Fifty-two eyes of 38 Japanese AZOOR patients (31 female and 7 male patients; mean age at first visit, 35.0 years; median follow-up duration, 31 months) were retrospectively collected: 31 untreated eyes with good visual acuity and 21 systemic corticosteroid-treated eyes with progressive visual acuity loss. Variables affecting the logMAR values of best-corrected visual acuity (BCVA) and the mean deviation (MD) on Humphrey perimetry at initial and final visits were examined using multiple stepwise linear regression analysis. Results In untreated eyes, the mean MD at the final visit was significantly higher than that at the initial visit (P = 0.00002). In corticosteroid-treated eyes, the logMAR BCVA and MD at the final visit were significantly better than the initial values (P = 0.007 and P = 0.02, respectively). The final logMAR BCVA was 0.0 or less in 85% of patients. Variables affecting initial visual function were moderate anterior vitreous cells, myopia severity, and a-wave amplitudes on electroretinography; factors affecting final visual function were the initial MD values, female sex, moderate anterior vitreous cells, and retinal atrophy. Conclusions Our data indicated that visual functions in enrolled patients significantly improved spontaneously or after systemic corticosteroids therapy, suggesting that Japanese patients with AZOOR have good visual outcomes during the follow-up period of this study. Furthermore, initial visual field defects, gender, anterior vitreous cells, and retinal atrophy affected final visual functions in these patients.	[Saito, Saho; Saito, Wataru; Saito, Michiyuki; Hashimoto, Yuki; Mori, Shohei; Noda, Kousuke; Namba, Kenichi; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan; [Saito, Wataru; Noda, Kousuke; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ocular Circulat & Metab, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Saito, W (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan.	wsaito@med.hokudai.ac.jp		Saito, Wataru/0000-0001-8181-6252				Arai M, 1998, AM J OPHTHALMOL, V126, P466, DOI 10.1016/S0002-9394(98)00117-2; Chai Y, 2011, CLIN OPHTHALMOL, V5, P1235, DOI 10.2147/OPTH.S23194; Fagan XJ, 2014, CLIN EXP OPHTHALMOL, V42, P103, DOI 10.1111/ceo.12295; Fujiwara T, 2010, RETINA-J RET VIT DIS, V30, P1206, DOI 10.1097/IAE.0b013e3181e097f0; Gass JD, 2002, AM J OPHTHALMOL, V134, P329, DOI 10.1016/S0002-9394(02)01640-9; GASS JDM, 1993, J CLIN NEURO-OPHTHAL, V13, P79; Hirose S, 2008, ACTA OPHTHALMOL, V86, P902, DOI 10.1111/j.1755-3768.2008.01384.x; HOGAN MJ, 1959, AM J OPHTHALMOL, V47, P155, DOI 10.1016/S0002-9394(14)78239-X; Kitakawa T, 2012, DOC OPHTHALMOL, V124, P249, DOI 10.1007/s10633-012-9318-1; Li D, 2007, ARCH OPHTHALMOL-CHIC, V125, P1194, DOI 10.1001/archopht.125.9.1194; Monson DM, 2011, SURV OPHTHALMOL, V56, P23, DOI 10.1016/j.survophthal.2010.07.004; Mrejen S, 2014, JAMA OPHTHALMOL, V132, P1089, DOI 10.1001/jamaophthalmol.2014.1683; Neri P, 2014, INT OPHTHALMOL, V34, P359, DOI 10.1007/s10792-013-9801-z; Saito A, 2007, JPN J OPHTHALMOL, V51, P295, DOI 10.1007/s10384-007-0451-4; Saito M, 2014, CLIN EXP OPHTHALMOL, V42, P139, DOI 10.1111/ceo.12143; So K, 2011, CASE REP OPHTHALM, V2, P307, DOI 10.1159/000332734; Song ZM, 2008, OPHTHALMOLOGICA, V222, P149, DOI 10.1159/000126076; Spaide RF, 2008, AM J OPHTHALMOL, V146, P111, DOI 10.1016/j.ajo.2008.02.027; Takahashi A, 2014, OCUL IMMUNOL INFLAMM, V22, P409, DOI 10.3109/09273948.2014.902075; Takai Y, 2009, ACTA OPHTHALMOL, V87, P408, DOI 10.1111/j.1755-3768.2008.01269.x; Tsunoda K, 2011, ARCH OPHTHALMOL-CHIC, V129, P1099, DOI 10.1001/archophthalmol.2011.217	21	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125133	10.1371/journal.pone.0125133	http://dx.doi.org/10.1371/journal.pone.0125133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919689	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400073
J	Shen, GT; Hu, XY; Guan, GP; Wang, L				Shen, Gaotian; Hu, Xingyou; Guan, Guoping; Wang, Lu			Surface Modification and Characterisation of Silk Fibroin Fabric Produced by the Layer-by-Layer Self-Assembly of Multilayer Alginate/Regenerated Silk Fibroin	PLOS ONE			English	Article							BOMBYX-MORI SILK; PLATELET-ADHESION; ALGINATE; SCAFFOLDS; FILMS; DEPOSITION; CELLS	Silk-based medical products have a long history of use as a material for surgical sutures because of their desirable mechanical properties. However, silk fibroin fabric has been reported to be haemolytic when in direct contact with blood. The layer-by-layer self-assembly technique provides a method for surface modification to improve the biocompatibility of silk fibroin fabrics. Regenerated silk fibroin and alginate, which have excellent biocompatibility and low immunogenicity, are outstanding candidates for polyelectrolyte deposition. In this study, silk fabric was degummed and positively charged to create a silk fibroin fabric that could undergo self-assembly. The multilayer self-assembly of the silk fibroin fabric was achieved by alternating the polyelectrolyte deposition of a negatively charged alginate solution (pH = 8) and a positively charged regenerated silk fibroin solution (pH = 2). Finally, the negatively charged regenerated silk fibroin solution (pH = 8) was used to assemble the outermost layer of the fabric so that the surface would be negatively charged. A stable structural transition was induced using 75% ethanol. The thickness and morphology were characterised using atomic force microscopy. The properties of the self-assembled silk fibroin fabric, such as the bursting strength, thermal stability and flushing stability, indicated that the fabric was stable. In addition, the cytocompatibility and haemocompatibility of the self-assembled silk fibroin fabrics were evaluated. The results indicated that the biocompatibility of the self-assembled multilayers was acceptable and that it improved markedly. In particular, after the self-assembly, the fabric was able to prevent platelet adhesion. Furthermore, other non-haemolytic biomaterials can be created through self-assembly of more than 1.5 bilayers, and we propose that self-assembled silk fibroin fabric may be an attractive candidate for anticoagulation applications and for promoting endothelial cell adhesion for vascular prostheses.	[Shen, Gaotian; Hu, Xingyou; Guan, Guoping; Wang, Lu] Donghua Univ, Coll Text, Key Lab Text Sci & Technol, Minist Educ, Shanghai 201620, Peoples R China; [Guan, Guoping] Minist Educ, Engn Res Ctr Tech Text, Shanghai 201620, Peoples R China	Donghua University	Wang, L (corresponding author), Donghua Univ, Coll Text, Key Lab Text Sci & Technol, Minist Educ, Shanghai 201620, Peoples R China.	wanglu@dhu.edu.cn	Wang, Fujun/Y-2957-2019		National Natural Science Foundation of China [51003014, 31100682, 81371648]; Fundamental Research Funds for the Central Universities [2232015A3-02]; 111 Project "Biomedical Textile Materials Science and Technology" [B07024]; Chinese Universities Scientific Fund [CUSF-DH-D-2013031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 111 Project "Biomedical Textile Materials Science and Technology"; Chinese Universities Scientific Fund	This work was supported by the National Natural Science Foundation of China (Grant NO. 51003014, 31100682 and 81371648 to Lu Wang); the Fundamental Research Funds for the Central Universities (Grant NO. 2232015A3-02); the 111 Project "Biomedical Textile Materials Science and Technology" (Grant NO. B07024 to Lu Wang); and the Chinese Universities Scientific Fund (Grant NO. CUSF-DH-D-2013031 to Gaotian Shen).	Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393; Ariga K, 2011, ADV DRUG DELIVER REV, V63, P762, DOI 10.1016/j.addr.2011.03.016; Cao TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065654; Chue WL, 2004, J VASC SURG, V39, P859, DOI 10.1016/j.jvs.2003.03.003; Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036; de Moraes MA, 2015, BIOMACROMOLECULES, V16, P97, DOI 10.1021/bm5012135; Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5; Dinis TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109770; Elahi MF, 2014, J APPL POLYM SCI, V131, DOI [10.1002/app.40772, 10.1002/APP.40772]; Enomoto S, 2010, J VASC SURG, V51, P155, DOI 10.1016/j.jvs.2009.09.005; Giesa T, 2011, NANO LETT, V11, P5038, DOI 10.1021/nl203108t; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5; Gouveia, 2010, MICROSCOPY SCI TECHN, P286; Jaganathan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091986; Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405; Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u; Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013; Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044; Konnova SA, 2013, CHEM COMMUN, V49, P4208, DOI 10.1039/c2cc38254g; Kotov NA, 1999, NANOSTRUCT MATER, V12, P789, DOI 10.1016/S0965-9773(99)00237-8; Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024; Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172; Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f; Lawrence BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050190; Lee JH, 2002, J BIOMED MATER RES, V60, P44, DOI 10.1002/jbm.10013; Lee JH, 1998, J BIOMED MATER RES, V40, P180, DOI 10.1002/(SICI)1097-4636(199805)40:2<180::AID-JBM2>3.0.CO;2-H; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Lin X, 2015, J NANOSCI NANOTECHNO, V15, P3893, DOI 10.1166/jnn.2015.9275; Liu XX, 2003, POLYMER, V44, P407, DOI 10.1016/S0032-3861(02)00771-1; Lojou T, 2004, LANGMUIR, V20, P748, DOI 10.1021/la030286w; LUPU C, 1988, ATHEROSCLEROSIS, V72, P77, DOI 10.1016/0021-9150(88)90065-2; LVOV Y, 1993, LANGMUIR, V9, P481, DOI 10.1021/la00026a020; LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026; Nuyttens BP, 2011, THROMB RES, V127, pS26, DOI 10.1016/S0049-3848(10)70151-1; Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207; Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936; Qi YX, 2011, P NATL ACAD SCI USA, V108, P1908, DOI 10.1073/pnas.1019219108; Qiu Y, 2014, THE FASEB JOURNAL SU, V28, P544; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Sarker B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107952; Sato M, 2010, MATER LETT, V64, P1786, DOI 10.1016/j.matlet.2010.05.024; Serizawa T, 2002, BIOMACROMOLECULES, V3, P724, DOI 10.1021/bm0200027; Shchepelina O, 2011, ADV MATER, V23, P4655, DOI 10.1002/adma.201102234; Sutherland TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016489; Tamada Y, 2003, J APPL POLYM SCI, V87, P2377, DOI 10.1002/app.12022; van Gils JM, 2009, J LEUKOCYTE BIOL, V85, P195, DOI 10.1189/jlb.0708400; Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m; Whited BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061275; Woloszyk A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111010; Wu WL, 2014, SYNTHETIC MET, V193, P48, DOI 10.1016/j.synthmet.2014.03.029; Yagi T, 2011, J ARTIF ORGANS, V14, P89, DOI 10.1007/s10047-011-0554-z; Ye SQ, 2005, J BIOMAT SCI-POLYM E, V16, P909, DOI 10.1163/1568562054255691; You JO, 2001, J MICROENCAPSUL, V18, P521; Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022	55	28	29	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124811	10.1371/journal.pone.0124811	http://dx.doi.org/10.1371/journal.pone.0124811			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919690	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659400063
J	Banach, M; Prudhomme, N; Carpentier, M; Duprat, E; Papandreou, N; Kalinowska, B; Chomilier, J; Roterman, I				Banach, Mateusz; Prudhomme, Nicolas; Carpentier, Mathilde; Duprat, Elodie; Papandreou, Nikolaos; Kalinowska, Barbara; Chomilier, Jacques; Roterman, Irena			Contribution to the Prediction of the Fold Code: Application to Immunoglobulin and Flavodoxin Cases	PLOS ONE			English	Article							NUCLEATION-CONDENSATION MECHANISM; PHI-VALUE ANALYSIS; TRANSITION-STATE; GLOBULAR-PROTEINS; CONTACT PREDICTION; CORE; NUCLEUS; RESIDUES; POSITIONS; BINDING	Background Folding nucleus of globular proteins formation starts by the mutual interaction of a group of hydrophobic amino acids whose close contacts allow subsequent formation and stability of the 3D structure. These early steps can be predicted by simulation of the folding process through a Monte Carlo (MC) coarse grain model in a discrete space. We previously defined MIRs (Most Interacting Residues), as the set of residues presenting a large number of noncovalent neighbour interactions during such simulation. MIRs are good candidates to define the minimal number of residues giving rise to a given fold instead of another one, although their proportion is rather high, typically [15-20]% of the sequences. Having in mind experiments with two sequences of very high levels of sequence identity (up to 90%) but different folds, we combined the MIR method, which takes sequence as single input, with the "fuzzy oil drop" (FOD) model that requires a 3D structure, in order to estimate the residues coding for the fold. FOD assumes that a globular protein follows an idealised 3D Gaussian distribution of hydrophobicity density, with the maximum in the centre and minima at the surface of the "drop". If the actual local density of hydrophobicity around a given amino acid is as high as the ideal one, then this amino acid is assigned to the core of the globular protein, and it is assumed to follow the FOD model. Therefore one obtains a distribution of the amino acids of a protein according to their agreement or rejection with the FOD model. Results We compared and combined MIR and FOD methods to define the minimal nucleus, or keystone, of two populated folds: immunoglobulin-like (Ig) and flavodoxins (Flav). The combination of these two approaches defines some positions both predicted as a MIR and assigned as accordant with the FOD model. It is shown here that for these two folds, the intersection of the predicted sets of residues significantly differs from random selection. It reduces the number of selected residues by each individual method and allows a reasonable agreement with experimentally determined key residues coding for the particular fold. In addition, the intersection of the two methods significantly increases the specificity of the prediction, providing a robust set of residues that constitute the folding nucleus.	[Banach, Mateusz; Kalinowska, Barbara; Roterman, Irena] Jagiellonian Univ, Coll Med, Dept Bioinformat & Telemed, Krakow, Poland; [Prudhomme, Nicolas; Carpentier, Mathilde; Duprat, Elodie; Chomilier, Jacques] UPMC, IMPMC, Prot Struct Predict Grp, Paris, France; [Prudhomme, Nicolas; Carpentier, Mathilde; Duprat, Elodie; Chomilier, Jacques] CNRS, Paris, France; [Carpentier, Mathilde; Duprat, Elodie; Chomilier, Jacques] RPBS, F-75013 Paris, France; [Papandreou, Nikolaos] Agr Univ Athens, Dept Genet, GR-11855 Athens, Greece	Jagiellonian University; Collegium Medicum Jagiellonian University; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Agricultural University of Athens	Chomilier, J (corresponding author), UPMC, IMPMC, Prot Struct Predict Grp, Paris, France.	chomilier@impmc.jussieu.fr; myroterm@cyf-kr.edu.pl		Banach, Mateusz/0000-0003-1806-9877; CHOMILIER, Jacques/0000-0002-4250-0762; Duprat, Elodie/0000-0003-4150-6967	French Polish bilateral collaborative grant [27748NE]	French Polish bilateral collaborative grant	Funding came from the French Polish bilateral collaborative grant under number 27748NE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AL, 2009, J MOL BIOL, V394, P522, DOI 10.1016/j.jmb.2009.09.031; Acuna R, 2014, SMIR METHOD PREDICT, P223; Acuna R, 2014, BIO-ALGORITHMS MED-S, V10, P227, DOI 10.1515/bams-2014-0015; Alejster P, 2013, IDENTIFICATION LIGAN, P55; Alexander PA, 2009, P NATL ACAD SCI USA, V106, P21149, DOI 10.1073/pnas.0906408106; Allison JR, 2011, BIOCHEMISTRY-US, V50, P10965, DOI 10.1021/bi2015663; Banach M, 2012, WOODH PUB SER BIOMED, P79; Banach M, 2013, J BIOMOL STRUCT DYN, DOI [10.1080/07391102.07392013.07829756, DOI 10.1080/07391102.07392013.07829756]; Best R, 1997, P NATL ACAD SCI USA, V110, P17874; Billings KS, 2008, J MOL BIOL, V375, P560, DOI 10.1016/j.jmb.2007.10.056; Bollen YJM, 2005, BIOPHYS CHEM, V114, P181, DOI 10.1016/j.bpc.2004.12.005; Bottini S, 2013, COMPUT BIOL CHEM, V43, P29, DOI 10.1016/j.compbiolchem.2012.12.007; Bresler SE, 1944, CR ACAD SCI URSS, V43, P310; Bryan PN, 2010, CURR OPIN STRUC BIOL, V20, P482, DOI 10.1016/j.sbi.2010.06.002; Brylinski Michal, 2007, Int J Bioinform Res Appl, V3, P234, DOI 10.1504/IJBRA.2007.013605; Bueno M, 2006, J MOL BIOL, V359, P813, DOI 10.1016/j.jmb.2006.03.067; Chen J, 2008, J PHYS CHEM B, V112, P16115, DOI 10.1021/jp806161k; Chomilier J, 2004, CR BIOL, V327, P431, DOI 10.1016/j.crvi.2004.02.002; Clarke J, 1999, STRUCT FOLD DES, V7, P1145, DOI 10.1016/S0969-2126(99)80181-6; Cota E, 2001, J MOL BIOL, V305, P1185, DOI 10.1006/jmbi.2000.4378; Cuff A, 2009, NUCLEIC ACIDS RES, V37, pD301; Deane CM, 2001, BIOINFORMATICS, V17, P541, DOI 10.1093/bioinformatics/17.6.541; Feng HQ, 2003, BIOCHEMISTRY-US, V42, P12461, DOI 10.1021/bi035561s; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; FERSHT AR, 1995, P NATL ACAD SCI USA, V92, P10869, DOI 10.1073/pnas.92.24.10869; Fersht AR, 1997, CURR OPIN STRUC BIOL, V7, P3, DOI 10.1016/S0959-440X(97)80002-4; Fowler SB, 2001, STRUCTURE, V9, P355, DOI 10.1016/S0969-2126(01)00596-2; Galzitskaya OV, 1999, P NATL ACAD SCI USA, V96, P11299, DOI 10.1073/pnas.96.20.11299; Galzitskaya OV, 2012, PROTEINS, V80, P2711, DOI 10.1002/prot.24156; Garbuzynskiy SO, 2008, FEBS LETT, V582, P768, DOI 10.1016/j.febslet.2008.01.049; GERSTEIN M, 1995, J MOL BIOL, V251, P161, DOI 10.1006/jmbi.1995.0423; Gianni S, 2007, P NATL ACAD SCI USA, V104, P128, DOI 10.1073/pnas.0602770104; Grana O, 2005, PROTEINS, V61, P214, DOI 10.1002/prot.20739; Guo ZY, 1997, FOLD DES, V2, P377, DOI 10.1016/S1359-0278(97)00052-7; Haglund E, 2008, J BIOL CHEM, V283, P27904, DOI 10.1074/jbc.M801776200; Hamill SJ, 2000, J MOL BIOL, V297, P165, DOI 10.1006/jmbi.2000.3517; He YA, 2012, STRUCTURE, V20, P283, DOI 10.1016/j.str.2011.11.018; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Illingworth CJR, 2010, J COMPUT CHEM, V31, P2677, DOI 10.1002/jcc.21561; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; Jain RK, 2004, P NATL ACAD SCI USA, V101, P111, DOI 10.1073/pnas.2534352100; Johnson NL, 2005, WILEY SER PROBAB ST, P1, DOI 10.1002/0471715816; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kister AE, 2009, P NATL ACAD SCI USA, V106, P18996, DOI 10.1073/pnas.0909714106; KOLINSKI A, 1991, J CHEM PHYS, V94, P3978, DOI 10.1063/1.460675; Konagurthu AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010048; Konieczny Leszek, 2006, In Silico Biology, V6, P15; Lappalainen I, 2008, J MOL BIOL, V375, P547, DOI 10.1016/j.jmb.2007.09.088; Larson SM, 2002, J MOL BIOL, V316, P225, DOI 10.1006/jmbi.2001.5344; LEVITT M, 1976, J MOL BIOL, V104, P59, DOI 10.1016/0022-2836(76)90004-8; Lindberg M, 2002, NAT STRUCT BIOL, V9, P818, DOI 10.1038/nsb847; Lindberg MO, 2001, J MOL BIOL, V314, P891, DOI 10.1006/jmbi.2001.5186; Longo L, 2013, STRUCTURE, V21, P1, DOI [10.1016/j.str.2012.12.004, DOI 10.1016/J.STR.2012.12.004]; Lonquety M, 2009, NUCLEIC ACIDS RES, V37, pD374, DOI 10.1093/nar/gkn704; LopezHernandez E, 1996, FOLD DES, V1, P43, DOI 10.1016/S1359-0278(96)00011-9; Melo F, 1997, J MOL BIOL, V267, P207, DOI 10.1006/jmbi.1996.0868; Michel M, 2014, BIOINFORMATICS, V30, pI482, DOI 10.1093/bioinformatics/btu458; Mirny LA, 1996, FOLD DES, V1, P103, DOI 10.1016/S1359-0278(96)00019-3; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; Munoz V, 1999, P NATL ACAD SCI USA, V96, P11311, DOI 10.1073/pnas.96.20.11311; Nelson ED, 2006, J MOL BIOL, V358, P646, DOI 10.1016/j.jmb.2006.02.026; Nickson AA, 2010, METHODS, V52, P38, DOI 10.1016/j.ymeth.2010.06.003; Noel J, 2010, J PHYS CHEM B, V116, P8692; Ohman A, 2010, PROTEIN SCI, V19, P183, DOI 10.1002/pro.298; Onofrio A, 2014, PHYS CHEM CHEM PHYS, V16, P18907, DOI 10.1039/c4cp01131g; Papandreou N, 2004, EUR J BIOCHEM, V271, P4762, DOI 10.1111/j.1432-1033.2004.04440.x; Papandreou N, 1998, CR ACAD SCI III-VIE, V321, P835, DOI 10.1016/S0764-4469(99)80023-7; Poupon A, 1999, FEBS LETT, V452, P283, DOI 10.1016/S0014-5793(99)00622-5; Poupon A, 1998, PROTEINS, V33, P329, DOI 10.1002/(SICI)1097-0134(19981115)33:3<329::AID-PROT3>3.0.CO;2-E; Poupon A, 1999, THEOR CHEM ACC, V101, P2, DOI 10.1007/s002140050397; Prudhomme N, 2009, BIOCHIMIE, V91, P1465, DOI 10.1016/j.biochi.2009.07.016; PTITSYN OB, 1991, FEBS LETT, V285, P176, DOI 10.1016/0014-5793(91)80799-9; Rajgaria R, 2009, PROTEINS, V74, P929, DOI 10.1002/prot.22202; Rizzuti B, 2009, PROTEINS, V74, P961, DOI 10.1002/prot.22204; ROSE GD, 1994, PROTEINS, V19, P1, DOI 10.1002/prot.340190102; Sanchez IE, 2003, J MOL BIOL, V334, P1077, DOI 10.1016/j.jmb.2003.10.016; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; SKOLNICK J, 1991, J MOL BIOL, V221, P499, DOI 10.1016/0022-2836(91)80070-B; Skolnick J, 1997, J MOL BIOL, V265, P217, DOI 10.1006/jmbi.1996.0720; Soundararajan V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009391; Treptow WL, 2002, PROTEINS, V49, P167, DOI 10.1002/prot.10166; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; Znamenskiy D, 2003, PROTEIN ENG, V16, P925, DOI 10.1093/protein/gzg140	84	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125098	10.1371/journal.pone.0125098	http://dx.doi.org/10.1371/journal.pone.0125098			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915049	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100098
J	Chawla, A; Stobdan, T; Srivastava, RB; Jaiswal, V; Chauhan, RS; Kant, A				Chawla, Aseem; Stobdan, Tsering; Srivastava, Ravi B.; Jaiswal, Varun; Chauhan, Rajinder S.; Kant, Anil			Sex-Biased Temporal Gene Expression in Male and Female Floral Buds of Seabuckthorn (Hippophae rhamnoides)	PLOS ONE			English	Article							CONTROL CARPEL DEVELOPMENT; ZINC-FINGER PROTEIN; FLOWER DEVELOPMENT; HOMEOTIC GENE; PHYTOCHROME-B; MOLECULAR-MECHANISMS; ARABIDOPSIS-THALIANA; LINKED MARKERS; RABBIT-EARS; MERISTEM	Seabuckthorn is an economically important dioecious plant in which mechanism of sex determination is unknown. The study was conducted to identify seabuckthorn homologous genes involved in floral development which may have role in sex determination. Forty four putative Genes involved in sex determination (GISD) reported in model plants were short-listed from literature survey, and twenty nine seabuckthorn homologous sequences were identified from available seabuckthorn genomic resources. Of these, 21 genes were found to differentially express in either male or female flower bud stages. HrCRY2 was significantly expressed in female flower buds only while HrCO had significant expression in male flowers only. Among the three male and female floral development stages (FDS), male stage II had significant expression of most of the GISD. Information on these sex-specific expressed genes will help in elucidating sex determination mechanism in seabuckthorn.	[Chawla, Aseem; Jaiswal, Varun; Chauhan, Rajinder S.; Kant, Anil] Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Waknaghat, Solan, India; [Stobdan, Tsering; Srivastava, Ravi B.] Def R&D Org, Def Inst High Altitude Res, Leh, Jammu & Kashmir, India	Jaypee University of Information Technology; Defence Research & Development Organisation (DRDO); Defence Institute of High Altitude Research (DIHAR)	Kant, A (corresponding author), Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Waknaghat, Solan, India.	anil_kantv@yahoo.com	Jaiswal, Varun/AAE-4853-2019; Chauhan, Rajinder Singh/HGB-5642-2022	Jaiswal, Varun/0000-0001-8068-0672; Stobdan, Tsering/0000-0002-7859-3868	Defence Institute of High Altitude Research, DRDO, Leh, Jammu and Kashmir, India [118/JUIT-4/DIHAR]	Defence Institute of High Altitude Research, DRDO, Leh, Jammu and Kashmir, India	The current study was funded by Defence Institute of High Altitude Research, DRDO, Leh, Jammu and Kashmir, India and the funding was received by AK under the Sanction No: 118/JUIT-4/DIHAR. URL of agency - http://drdo.gov.in/drdo/labs/DIHAR/English/index.jsp?pg = homebody.	Adhikari S, 2012, NUCLEUS CALCUTTA, V55, P115, DOI 10.1007/s13237-012-0061-5; AINSWORTH C, 1995, PLANT CELL, V7, P1583, DOI 10.1105/tpc.7.10.1583; Alvarez J, 1999, DEVELOPMENT, V126, P2377; ALVAREZ J, 1992, PLANT J, V2, P103, DOI 10.1111/j.1365-313X.1992.00103.x; Amit Sharma, 2010, Forestry Studies in China, V12, P62, DOI 10.1007/s11632-010-0012-7; Ariizumi T, 2004, PLANT J, V39, P170, DOI 10.1111/j.1365-313X.2004.02118.x; BOWMAN JL, 1992, DEVELOPMENT, V114, P599; BOWMAN JL, 1993, DEVELOPMENT, V119, P721; BRADLEY D, 1993, CELL, V72, P85, DOI 10.1016/0092-8674(93)90052-R; Caporali E, 2000, SEX PLANT REPROD, V13, P151, DOI 10.1007/s004970000049; Charlesworth D, 2002, HEREDITY, V88, P94, DOI 10.1038/sj.hdy.6800016; Chawla A, 2014, SCI HORTIC-AMSTERDAM, V170, P281, DOI 10.1016/j.scienta.2014.03.013; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Chuck G, 2010, ADV BOT RES, V54, P53, DOI 10.1016/S0065-2296(10)54002-3; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; COEN ES, 1990, CELL, V63, P1311, DOI 10.1016/0092-8674(90)90426-F; Delph LF, 2010, EVOLUTION, V64, P2873, DOI 10.1111/j.1558-5646.2010.01048.x; Di Stilio VS, 2005, PLANT J, V41, P755, DOI 10.1111/j.1365-313X.2005.02336.x; Dinneny JR, 2006, DEVELOPMENT, V133, P1645, DOI 10.1242/dev.02335; Dinneny JR, 2004, DEVELOPMENT, V131, P1101, DOI 10.1242/dev.00949; Esumi T, 2005, SEX PLANT REPROD, V17, P277, DOI 10.1007/s00497-004-0239-3; Fan JL, 2007, FOOD CHEM, V102, P168, DOI 10.1016/j.foodchem.2006.05.049; Fatima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034099; Foucart Camille, 2012, Biologie Aujourd hui, V206, P57, DOI 10.1051/jbio/2012005; Fraser LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-102; GAISER JC, 1995, PLANT CELL, V7, P333, DOI 10.1105/tpc.7.3.333; Ghangal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072516; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Gupta Sanjay Mohan, 2012, Physiology and Molecular Biology of Plants, V18, P377, DOI 10.1007/s12298-012-0133-7; HALLIDAY KJ, 1994, PLANT PHYSIOL, V104, P1311, DOI 10.1104/pp.104.4.1311; HARDENACK S, 1994, PLANT CELL, V6, P1775, DOI 10.1105/tpc.6.12.1775; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; HUIJSER P, 1992, EMBO J, V11, P1239, DOI 10.1002/j.1460-2075.1992.tb05168.x; INGRAM GC, 1995, PLANT CELL, V7, P1501, DOI 10.1105/tpc.7.9.1501; Iovene M, 2014, GENETICS; IRISH VF, 1990, PLANT CELL, V2, P741, DOI 10.1105/tpc.2.8.741; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Jain Ankit, 2010, Physiology and Molecular Biology of Plants, V16, P375, DOI 10.1007/s12298-010-0037-3; JOHNSON E, 1994, PLANT PHYSIOL, V105, P141, DOI 10.1104/pp.105.1.141; Kalia RK, 2011, TREES-STRUCT FUNCT, V25, P559, DOI 10.1007/s00468-011-0543-0; Kania T, 1997, PLANT CELL, V9, P1327, DOI 10.1105/tpc.9.8.1327; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kim HB, 2010, AFR J BIOTECHNOL, V9, P6684; Koizumi A, 2010, PLANT CELL PHYSIOL, V51, P282, DOI 10.1093/pcp/pcp187; Korekar G, 2012, BIOTECHNOL LETT, V34, P973, DOI 10.1007/s10529-012-0852-4; Krizek BA, 2006, PLANT J, V45, P369, DOI 10.1111/j.1365-313X.2005.02633.x; Krizek BA, 2005, NAT REV GENET, V6, P688, DOI 10.1038/nrg1675; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laux T, 1996, DEVELOPMENT, V122, P87; Lebel-Hardenack S, 2002, GENETICS, V160, P717; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Li CY, 2007, TREE PHYSIOL, V27, P399, DOI 10.1093/treephys/27.3.399; Liu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060181; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandel MA, 1992, MOL CHARACTERIZATION; Matsunaga S, 1996, PLANT J, V10, P679, DOI 10.1046/j.1365-313X.1996.10040679.x; Matsunaga S, 2006, GENES GENET SYST, V81, P219, DOI 10.1266/ggs.81.219; Miko I, 2008, NATURE ED, V1, P108; Moon J, 2003, PLANT J, V35, P613, DOI 10.1046/j.1365-313X.2003.01833.x; Neff MM, 1998, PLANT PHYSIOL, V118, P27, DOI 10.1104/pp.118.1.27; Nole-Wilson S, 2006, PLANT PHYSIOL, V141, P977, DOI 10.1104/pp.106.076604; Payne T, 2004, DEVELOPMENT, V131, P3737, DOI 10.1242/dev.01216; Perl-Treves R., 1999, MALE FEMALE CONVERSI; Persson HA, 1998, HEREDITAS, V129, P45, DOI 10.1111/j.1601-5223.1998.00045.x; Ray A, 1996, DEVELOPMENT, V122, P2631; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Reeves PH, 2000, CURR OPIN PLANT BIOL, V3, P37, DOI 10.1016/S1369-5266(99)00041-2; Sakai H, 2000, PLANT CELL, V12, P1607, DOI 10.1105/tpc.12.9.1607; Sakai H, 1995, ROLE SUPERMAN MAINTA; Salanoubat M, 2000, NATURE, V408, P820, DOI 10.1038/35048706; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sandhu KS, 2012, G3-GENES GENOM GENET, V2, P1585, DOI 10.1534/g3.112.004580; Schiefthaler U, 1999, P NATL ACAD SCI USA, V96, P11664, DOI 10.1073/pnas.96.20.11664; SCHULTZ EA, 1991, PLANT CELL, V3, P1221, DOI 10.1105/tpc.3.11.1221; Semerikov V, 2003, HEREDITY, V91, P293, DOI 10.1038/sj.hdy.6800327; Shepard H., 1999, SEX DETERMINATION PL, V8, P139; Shephard HL, 1998, MADS BOX EXPRESSION, P70; SIMON R, 1994, CELL, V78, P99, DOI 10.1016/0092-8674(94)90576-2; Song YP, 2013, PLANT MOL BIOL, V83, P559, DOI 10.1007/s11103-013-0108-2; Souza CD, 2009, PLANT CELL, V21, P507, DOI 10.1105/tpc.108.062513; Stobdan T, 2008, SEABUCKTHOM EMERGING; Takeda S, 2004, DEVELOPMENT, V131, P425, DOI 10.1242/dev.00938; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; TROBNER W, 1992, EMBO J, V11, P4693, DOI 10.1002/j.1460-2075.1992.tb05574.x; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wu T, 2010, J PLANT PHYSIOL, V167, P905, DOI 10.1016/j.jplph.2010.02.004; Yamasaki S, 2000, PLANT CELL PHYSIOL, V41, P608, DOI 10.1093/pcp/41.5.608; Yang WC, 1999, GENE DEV, V13, P2108, DOI 10.1101/gad.13.16.2108; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; YANOFSKY MF, 1995, ANNU REV PLANT PHYS, V46, P167, DOI 10.1146/annurev.pp.46.060195.001123; Zhao HX, 2009, PLANT CELL ENVIRON, V32, P1401, DOI 10.1111/j.1365-3040.2009.02007.x; Zubarev YA, 2008, SEABUCKTHORN HIPPOPH, V3, P49	93	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124890	10.1371/journal.pone.0124890	http://dx.doi.org/10.1371/journal.pone.0124890			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915052	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659100077
J	Klumpers, DD; Smit, TH; Mooney, DJ				Klumpers, Darinka D.; Smit, Theo H.; Mooney, David J.			The Effect of Growth-Mimicking Continuous Strain on the Early Stages of Skeletal Development in Micromass Culture	PLOS ONE			English	Article							LIMB CHONDROGENESIS; CARTILAGE FORMATION; CELLS; DIFFERENTIATION; CONDENSATIONS; MORPHOGENESIS; MESENCHYME; PATHWAYS; MOUSE; BUDS	Embryonic skeletogenesis involves proliferation, condensation and subsequent chondrogenic differentiation of mesenchymal precursor cells, and the strains and stresses inherent to these processes have been hypothesized to influence skeletal development. The aim of this study was to determine the effect of growth-mimicking strain on the process of early skeletal development in vitro. To this end, we applied continuous uniaxial strain to embryonic skeletal precursor cells in micromass culture. Strain was applied at different times of culture to specifically address the effect of mechanical loading on the sequential stages of cellular proliferation, condensation and differentiation. We found that growth-mimicking strain at all three times did not affect proliferation or chondrogenic differentiation under the tested conditions. However, the timing of the applied strain did play a role in the density of mesenchymal condensations. This finding suggests that a mechanically dynamic environment, and specifically strain, can influence skeletal patterning. The growth-mimicking micromass model presented here may be a useful tool for further studies into the role of mechanical loading in early skeletal development.	[Klumpers, Darinka D.; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Klumpers, Darinka D.; Mooney, David J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Klumpers, Darinka D.; Smit, Theo H.] Vrije Univ Amsterdam, Med Ctr, Res Inst MOVE, Dept Orthoped Surg, NL-1081 HV Amsterdam, Netherlands	Harvard University; Harvard University; Vrije Universiteit Amsterdam	Mooney, DJ (corresponding author), Harvard Univ, Sch Engn & Appl Sci, 29 Oxford St, Cambridge, MA 02138 USA.	mooneyd@seas.harvard.edu	Smit, Theo/N-7534-2019; Smit, Theodoor/AAX-6657-2020	Smit, Theo/0000-0002-8906-7433; Mooney, David/0000-0001-6299-1194	National Institutes of Health [R37 DE013033]; ZonMW-VICI grant (The Netherlands) [918.11.635]; Research Institute MOVE at the VU University, Amsterdam; Wyss Institute at Harvard University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE013033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ZonMW-VICI grant (The Netherlands); Research Institute MOVE at the VU University, Amsterdam; Wyss Institute at Harvard University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by National Institutes of Health (R37 DE013033), ZonMW-VICI grant 918.11.635 (The Netherlands), and Research Institute MOVE at the VU University, Amsterdam. T.H.S. was supported by a visiting scholarship from the Wyss Institute at Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; Bacabac RG, 2004, BIOCHEM BIOPH RES CO, V315, P823, DOI 10.1016/j.bbrc.2004.01.138; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Centola M, 2013, STEM CELLS DEV, V22, P2849, DOI 10.1089/scd.2013.0216; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; DeLise AM, 2000, METH MOL B, V137, P359; EdwallArvidsson C, 1996, ANAT EMBRYOL, V193, P453; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Henderson JH, 2002, BONE, V31, P645, DOI 10.1016/S8756-3282(02)00911-0; Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di; JANNERS MY, 1970, DEV BIOL, V23, P136, DOI 10.1016/S0012-1606(70)80011-2; Juhasz T, 2014, CELL SIGNAL, V26, P468, DOI 10.1016/j.cellsig.2013.12.001; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173; Klumpers DD, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0215; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; NEWMAN SA, 1985, SCIENCE, V228, P885, DOI 10.1126/science.4001925; OBERLENDER SA, 1994, DEVELOPMENT, V120, P177; Onodera K, 2005, EUR J CELL BIOL, V84, P45, DOI 10.1016/j.ejcb.2004.09.004; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; RODRIGUEZ JI, 1988, J BONE JOINT SURG AM, V70A, P1052, DOI 10.2106/00004623-198870070-00014; Sart S, 2013, TISSUE ENG B; WIDELITZ RB, 1993, J CELL PHYSIOL, V156, P399, DOI 10.1002/jcp.1041560224; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Yung YC, 2009, J BIOMECH, V42, P178, DOI 10.1016/j.jbiomech.2008.10.038; ZIMMERMANN B, 1984, HISTOCHEMISTRY, V81, P353, DOI 10.1007/BF00514329	28	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124948	10.1371/journal.pone.0124948	http://dx.doi.org/10.1371/journal.pone.0124948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915898	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100082
J	Peng, HS; Ma, JJ; Bai, Y; Lu, JW; Yu, TW				Peng, Hesen; Ma, Junjie; Bai, Yun; Lu, Jianwei; Yu, Tianwei			MeDiA: Mean Distance Association and Its Applications in Nonlinear Gene Set Analysis	PLOS ONE			English	Article							CELIAC-DISEASE; LUNG-CANCER; RHEUMATOID-ARTHRITIS; ALVEOLAR MACROPHAGE; GROWTH-FACTOR; EXPRESSION; METHOTREXATE; METABOLISM; CELLS; COEXPRESSION	Probabilistic association discovery aims at identifying the association between random vectors, regardless of number of variables involved or linear/nonlinear functional forms. Recently, applications in high-dimensional data have generated rising interest in probabilistic association discovery. We developed a framework based on functions on the observation graph, named MeDiA (Mean Distance Association). We generalize its property to a group of functions on the observation graph. The group of functions encapsulates major existing methods in association discovery, e.g. mutual information and Brownian Covariance, and can be expanded to more complicated forms. We conducted numerical comparison of the statistical power of related methods under multiple scenarios. We further demonstrated the application of MeDiA as a method of gene set analysis that captures a broader range of responses than traditional gene set analysis methods.	[Peng, Hesen; Yu, Tianwei] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Ma, Junjie] Yantai Yuhuangding Hosp, Dept Hematol, Yantai, Shandong, Peoples R China; [Bai, Yun] Philadelphia Coll Osteopath Med, Sch Pharm, Dept Pharmaceut Sci, Suwanee, GA USA; [Lu, Jianwei] Tongji Univ, Sch Software Engn, Shanghai 200092, Peoples R China; [Lu, Jianwei] Tongji Univ, Adv Inst Translat Med, Shanghai 200092, Peoples R China	Emory University; Tongji University; Tongji University	Lu, JW (corresponding author), Tongji Univ, Sch Software Engn, Shanghai 200092, Peoples R China.	jwlu33@gmail.com; tianwei.yu@emory.edu		Yu, Tianwei/0000-0003-2502-1628	National Institutes of Health [P20HL113451, U19AI090023]; China Ministry of Science and Technology 973 Program [2013CB967101]; Shanghai Science Committee Foundation [13PJ1433200]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL113451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Ministry of Science and Technology 973 Program(Ministry of Science and Technology, ChinaNational Basic Research Program of China); Shanghai Science Committee Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Tianwei Yu was supported by National Institutes of Health grants P20HL113451 and U19AI090023. Jianwei Lu was supported by China Ministry of Science and Technology 973 Program (No. 2013CB967101), and Shanghai Science Committee Foundation (13PJ1433200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Wadei HAN, 2006, ONCOL REP, V15, P431; Alaedini A, 2005, ANN INTERN MED, V142, P289, DOI 10.7326/0003-4819-142-4-200502150-00011; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aviezer D, 2000, CANCER RES, V60, P2973; Baker JA, 2005, NUTR CANCER, V52, P15, DOI 10.1207/s15327914nc5201_2; Banerjee DK, 2007, CELL MOL BIOL, V53, P55, DOI 10.1170/T797; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Benjamini Y, 2001, ANN STAT, V29, P1165; Bianchi ML, 2010, ARCH BIOCHEM BIOPHYS, V503, P54, DOI 10.1016/j.abb.2010.06.026; BICKEL PJ, 1983, ANN PROBAB, V11, P185, DOI 10.1214/aop/1176993668; Carrillo JA, 1996, BRIT J CLIN PHARMACO, V41, P605, DOI 10.1046/j.1365-2125.1996.35418.x; CAUGHEY RH, 1955, PEDIATRICS, V16, P174; Chen WW, 2011, P NATL ACAD SCI USA, V108, P9589, DOI 10.1073/pnas.1017945108; Cho SB, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-109; Choi Y, 2009, BIOINFORMATICS, V25, P2780, DOI 10.1093/bioinformatics/btp502; Chong PSY, 2014, CANCER RES, V74, P3043, DOI 10.1158/0008-5472.CAN-13-2321; De Carolis S, 2004, LUPUS, V13, P653, DOI 10.1191/0961203304lu1096oa; de Leon J, 2003, PROG NEURO-PSYCHOPH, V27, P165, DOI 10.1016/S0278-5846(02)00348-2; Derby KS, 2008, CANCER EPIDEM BIOMAR, V17, P3526, DOI 10.1158/1055-9965.EPI-08-0424; DESSI S, 1992, ONCOLOGY, V49, P436; Dubielecka PM, 2005, BIOCHEM PHARMACOL, V69, P73, DOI 10.1016/j.bcp.2004.08.031; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Elliot KJ, 2004, RHEUMATOLOGY, V43, P1226, DOI 10.1093/rheumatology/keh296; Francesconi M, 2014, NATURE, V505, P208, DOI 10.1038/nature12772; GABAZZA EC, 1995, CLIN CHIM ACTA, V236, P101, DOI 10.1016/0009-8981(95)06043-8; Georgiou KR, 2012, INT J EXP PATHOL, V93, P104, DOI 10.1111/j.1365-2613.2011.00800.x; Giovacchini G, 2009, TUMORI J, V95, P177; Giovannini C, 2000, TOXICOLOGY, V145, P63, DOI 10.1016/S0300-483X(99)00223-1; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Goria MN, 2005, J NONPARAMETR STAT, V17, P277, DOI 10.1080/104852504200026815; Heap GA, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-1; HEBER D, 1982, CANCER RES, V42, P4815; HOSKER HSR, 1991, CANCER DETECT PREV, V15, P103; Jaskiewicz K, 1996, J TOXICOL-CLIN TOXIC, V34, P301, DOI 10.3109/15563659609013794; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kiyohara Chikako, 2002, Environ Health Prev Med, V7, P47, DOI 10.1007/BF02897330; KLUCINSKI W, 1988, J VET MED A, V35, P632; Korthuis PM, 2014, LEUKEMIA; Koukourakis MI, 2007, CANCER BIOL THER, V6, P1476, DOI 10.4161/cbt.6.9.4635; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Kraskov A, 2004, PHYS REV E, V69; Kurgan J, 1969, Gruzlica, V37, P297; KURGAN J, 1970, Zeitschrift fuer Erkrankungen der Atmungsorgane, V132, P181; Lee JM, 2011, INT J CANC; Leonenko N, 2008, ANN STAT, V36, P2153, DOI 10.1214/07-AOS539; Li KC, 2002, P NATL ACAD SCI USA, V99, P16875, DOI 10.1073/pnas.252466999; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Maeda S, 2009, J BACTERIOL, V191, P3265, DOI 10.1128/JB.00013-09; Majumdar S, 2001, J IMMUNOL, V167, P2911, DOI 10.4049/jimmunol.167.5.2911; Malandrino N, 2008, DIGEST DIS, V26, P128, DOI 10.1159/000116770; MARTINET Y, 1992, REV MAL RESPIR, V9, P587; Meresse B, 2009, MUCOSAL IMMUNOL, V2, P8, DOI 10.1038/mi.2008.75; Moss SF, 1996, GUT, V39, P811, DOI 10.1136/gut.39.6.811; Murray RP, 2009, NICOTINE TOB RES, V11, P1076, DOI 10.1093/ntr/ntp104; Myrsky E, 2009, SCAND J GASTROENTERO, V44, P162, DOI 10.1080/00365520802400875; Pirkmajer S, 2014, DIABETES; Pouniotis DS, 2006, CLIN EXP IMMUNOL, V143, P363, DOI 10.1111/j.1365-2249.2006.02998.x; Puliyappadamba VT, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-220; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Oliveira RDR, 2012, J RHEUMATOL, V39, P1524, DOI 10.3899/jrheum.120092; Rubio-Tapia A, 2010, CURR OPIN GASTROEN, V26, P116, DOI 10.1097/MOG.0b013e3283365263; Senthilnathan P, 2006, LIFE SCI, V78, P1010, DOI 10.1016/j.lfs.2005.06.005; Shemon AN, 2007, IMMUNOL CELL BIOL, V85, P68, DOI 10.1038/sj.icb.7100005; Shibuya M, 2001, CELL STRUCT FUNCT, V26, P25, DOI 10.1247/csf.26.25; Sison EAR, 2014, ONCOTARGET, V5, P8947, DOI 10.18632/oncotarget.2407; Soma T, 2006, INT J CANCER, V119, P771, DOI 10.1002/ijc.21917; Sorich MJ, 2008, PLOS MED, V5, P646, DOI 10.1371/journal.pmed.0050083; Spira A, 2007, NAT MED, V13, P361, DOI 10.1038/nm1556; Stirewalt DL, 2008, GENE CHROMOSOME CANC, V47, P8, DOI 10.1002/gcc.20500; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SULOWICZ W, 1983, Folia Haematologica (Leipzig), V110, P48; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Szekely GJ, 2009, ANN APPL STAT, V3, P1236, DOI 10.1214/09-AOAS312; Teodori E, 2006, CURR DRUG TARGETS, V7, P893, DOI 10.2174/138945006777709520; TIGHE MR, 1994, HUM IMMUNOL, V39, P9; TOKOVOI V. A., 1967, VOP ONKOL, V13, P74; Toms TE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2765; Tostevin F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.218101; Tsuji Y, 2006, INT J MOL MED, V18, P489; Wessels JAM, 2008, RHEUMATOLOGY, V47, P249, DOI 10.1093/rheumatology/kem279; Yu TW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-563; Yu TW, 2011, GENOMICS, V98, P469, DOI 10.1016/j.ygeno.2011.09.001; Yu TW, 2005, BIOINFORMATICS, V21, P3651, DOI 10.1093/bioinformatics/bti599; Zevin S, 1999, CLIN PHARMACOKINET, V36, P425, DOI 10.2165/00003088-199936060-00004	84	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124620	10.1371/journal.pone.0124620	http://dx.doi.org/10.1371/journal.pone.0124620			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915206	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100057
J	Stansell, E; Panico, M; Canis, K; Pang, PC; Bouche, L; Binet, D; O'Connor, MJ; Chertova, E; Bess, J; Lifson, JD; Haslam, SM; Morris, HR; Desrosiers, RC; Dell, A				Stansell, Elizabeth; Panico, Maria; Canis, Kevin; Pang, Poh-Choo; Bouche, Laura; Binet, Daniel; O'Connor, Michael-John; Chertova, Elena; Bess, Julian; Lifson, Jeffrey D.; Haslam, Stuart M.; Morris, Howard R.; Desrosiers, Ronald C.; Dell, Anne			Gp120 on HIV-1 Virions Lacks O-Linked Carbohydrate	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 ENVELOPE GLYCOPROTEIN; STRUCTURAL-CHARACTERIZATION; ENDOPROTEOLYTIC CLEAVAGE; PROTEOLYTIC CLEAVAGE; GLYCOSYLATION SITES; PROTEINS; INFECTIVITY; RECOMBINANT; ACTIVATION	As HIV-1-encoded envelope protein traverses the secretory pathway, it may be modified with N- and O-linked carbohydrate. When the gp120s of HIV-1 NL4-3, HIV-1 YU2, HIV-1 Bal, HIV-1 JRFL, and HIV-1 JRCSF were expressed as secreted proteins, the threonine at consensus position 499 was found to be O-glycosylated. For SIVmac239, the corresponding threonine was also glycosylated when gp120 was recombinantly expressed. Similarlypositioned, highly-conserved threonines in the influenza A virus H1N1 HA1 and H5N1 HA1 envelope proteins were also found to carry O-glycans when expressed as secreted proteins. In all cases, the threonines were modified predominantly with disialylated core 1 glycans, together with related core 1 and core 2 structures. Secreted HIV-1 gp140 was modified to a lesser extent with mainly monosialylated core 1 O-glycans, suggesting that the ectodomain of the gp41 transmembrane component may limit the accessibility of Thr499 to glycosyltransferases. In striking contrast to these findings, gp120 on purified virions of HIV-1 Bal and SIV CP-MAC lacked any detectable O-glycosylation of the C-terminal threonine. Our results indicate the absence of O-linked carbohydrates on Thr499 as it exists on the surface of virions and suggest caution in the interpretation of analyses of post-translational modifications that utilize recombinant forms of envelope protein.	[Stansell, Elizabeth; Desrosiers, Ronald C.] Harvard Univ, Sch Med, New England Primate Res Ctr, Southborough, MA 01772 USA; [Panico, Maria; Canis, Kevin; Pang, Poh-Choo; Bouche, Laura; Haslam, Stuart M.; Morris, Howard R.; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Chertova, Elena; Bess, Julian; Lifson, Jeffrey D.] Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick Natl Lab, Frederick, MD 21702 USA	Harvard University; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Desrosiers, RC (corresponding author), Harvard Univ, Sch Med, New England Primate Res Ctr, Southborough, MA 01772 USA.	r.desrosiers@med.miami.edu; a.dell@imperial.ac.uk		Dell, Anne/0000-0003-1380-2347	National Institutes of Health (NIH) [R01-AI025328, R01-AI104523, P30-AI060354, P51-RR000168]; National Cancer Institute, NIH [HHSN261200800001E]; Biotechnology and Biological Sciences Research Council [BBF0083091, BBK016164/1, BB/K015164/1]; Wellcome Trust [082098]; Leidos Biomedical Research Inc.; BBSRC [BB/F008309/1, BB/K016164/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K016164/1, BB/F008309/1] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104523, P30AI060354, R01AI025328] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Leidos Biomedical Research Inc.; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The National Institutes of Health (NIH) R01-AI025328 (ES and RCD), R01-AI104523 (ES and RCD), P30-AI060354 (ES), and P51-RR000168 (ES and RCD), federal funds from the National Cancer Institute, NIH, under contract HHSN261200800001E (EC and JDL), the Biotechnology and Biological Sciences Research Council, grants BBF0083091, BBK016164/1 and BB/K015164/1 (to AD, SMH and HRM) and the Wellcome Trust (grant 082098 to SMH and AD) supported this work. Leidos Biomedical Research Inc., provided support in the form of salaries for authors EC, JB and JDL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Ahmed AA, 2014, J MOL BIOL, V426, P3166, DOI 10.1016/j.jmb.2014.07.006; Arthur LO, 1998, AIDS RES HUM RETROV, V14, pS311; BERNSTEIN HB, 1994, J VIROL, V68, P463, DOI 10.1128/JVI.68.1.463-468.1994; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Chackerian B, 1997, J VIROL, V71, P7719, DOI 10.1128/JVI.71.10.7719-7727.1997; DAMONTE EB, 1994, VIRUS RES, V34, P317, DOI 10.1016/0168-1702(94)90131-7; Dell A, 2001, SCIENCE, V291, P2351, DOI 10.1126/science.1058890; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; FENOUILLET E, 1992, VIROLOGY, V187, P825, DOI 10.1016/0042-6822(92)90487-A; Go EP, 2014, J PROTEOME RES, V13, P4012, DOI 10.1021/pr5003643; Go EP, 2013, J PROTEOME RES, V12, P1223, DOI 10.1021/pr300870t; Guttman M, 2012, J VIROL, V86, P8750, DOI 10.1128/JVI.07224-11; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; HANSEN JES, 1992, ARCH VIROL, V126, P11, DOI 10.1007/BF01309680; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; KIELY ML, 1976, J BIOL CHEM, V251, P5490; Kuiken C, 2010, HIV SEQUENCE COMPEND; LAZAROWI.SG, 1973, VIROLOGY, V52, P199, DOI 10.1016/0042-6822(73)90409-1; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; Moody AM, 2003, J BIOL CHEM, V278, P7240, DOI 10.1074/jbc.M210468200; Naim HY, 1999, J BIOL CHEM, V274, P17961, DOI 10.1074/jbc.274.25.17961; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; SASTRY MVK, 1986, J BIOL CHEM, V261, P1726; ShakinEshleman SH, 1996, J BIOL CHEM, V271, P6363, DOI 10.1074/jbc.271.11.6363; Stansell E, 2011, GLYCOBIOLOGY, V21, P1454; Stansell E, 2011, J VIROL, V85, P582, DOI 10.1128/JVI.01871-10; STEIN BS, 1990, J BIOL CHEM, V265, P2640; STROUS GJAM, 1979, P NATL ACAD SCI USA, V76, P2694, DOI 10.1073/pnas.76.6.2694; Tachibana K, 2006, GLYCOBIOLOGY, V16, P46, DOI 10.1093/glycob/cwj038; Teng-umnuay P, 1998, J BIOL CHEM, V273, P18242, DOI 10.1074/jbc.273.29.18242; Tissot B, 2009, FEBS LETT, V583, P1728, DOI 10.1016/j.febslet.2009.03.049; Yang WM, 2014, ANAL CHEM, V86, P6959, DOI 10.1021/ac500876p; Yuste E, 2006, J VIROL, V80, P3030, DOI 10.1128/JVI.80.6.3030-3041.2006	34	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124784	10.1371/journal.pone.0124784	http://dx.doi.org/10.1371/journal.pone.0124784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915761	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659100067
J	Yang, FC; Kuang, WD; Li, C; Sun, WW; Qu, D; Wang, JH				Yang, Fu-Chun; Kuang, Wen-Dong; Li, Chuan; Sun, Wei-Wei; Qu, Di; Wang, Jian-Hua			Toll-Interacting Protein Suppresses HIV-1 Long-Terminal-Repeat-Driven Gene Expression and Silences the Post-Integrational Transcription of Viral Proviral DNA	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; T-CELLS; DENDRITIC CELLS; INNATE IMMUNITY; IL-1 RECEPTOR; INFECTION; ACTIVATION; MACROPHAGES; UBIQUITIN	Toll-interacting protein (Tollip) is a host adaptor protein for negatively regulating Toll-like receptor 2-, 4-, and IL-1R (interleukin-1 receptor)-mediated signaling. We found that Tollip expression could be induced in MDDCs (monocyte-derived dendritic cells) by HIV-1 particles and recombinant gp120 glycoprotein. Hence, we investigated the role of Tollip in modulating HIV-1 infection. We found that Tollip expression suppressed NF-kappa B-dependent HIV-1 long terminal repeat (LTR)-driven transcription and thus inhibited HIV-1 infection. Our protein truncation experiments proved that the intact C-terminus of Tollip was required for inhibition of both NF-kappa B activity and HIV-1 LTR-driven gene expression. Intriguingly, Tollip silenced the post-integrational transcription of HIV-1 proviral DNA, indicating the potential role of Tollip in maintaining viral persistence. Our results reveal the novel role of host factor Tollip in modulating HIV-1 infection, and may suggest the hijacking of Tollip as the negative regulator of the TLR pathway and even the downstream signaling, by HIV-1 for maintaining persistent infection. Further elucidation of the mechanisms by which HIV-1 induces Tollip expression and identification of the role of Tollip in modulating HIV-1 latency will facilitate the understanding of host regulation in viral replication and benefit the exploration of novel strategies for combating HIV-1 infection.	[Yang, Fu-Chun; Kuang, Wen-Dong; Li, Chuan; Sun, Wei-Wei; Qu, Di; Wang, Jian-Hua] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Wang, JH (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.	Jh_wang@sibs.ac.cn						Ahmed N, 2010, J GEN VIROL, V91, P2804, DOI 10.1099/vir.0.022442-0; Beima-Sofie KM, 2013, AIDS, V27, P2431, DOI 10.1097/QAD.0b013e3283629117; Berg RS, 2009, APMIS, V117, P124, DOI 10.1111/j.1600-0463.2008.00024.x; Bochud PY, 2007, AIDS, V21, P441, DOI 10.1097/QAD.0b013e328012b8ac; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Capelluto DGS, 2012, MICROBES INFECT, V14, P140, DOI 10.1016/j.micinf.2011.08.018; Carrithers MD, 2014, HAND CLINIC, V123, P215, DOI 10.1016/B978-0-444-53488-0.00009-2; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Diao LR, 2005, CELL SIGNAL, V17, P217, DOI 10.1016/j.cellsig.2004.07.003; Dong CS, 2009, J VIROL, V83, P3518, DOI 10.1128/JVI.02665-08; Ellegard R, 2011, CURR OPIN HIV AIDS, V6, P435, DOI 10.1097/COH.0b013e32834970d8; Huik K, 2013, INFECT GENET EVOL, V20, P78, DOI 10.1016/j.meegid.2013.08.008; Katoh Y, 2006, BIOCHEM BIOPH RES CO, V341, P143, DOI 10.1016/j.bbrc.2005.12.156; Katoh Y, 2004, J BIOL CHEM, V279, P24435, DOI 10.1074/jbc.M400059200; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Kumar A, 2014, VIRUSES-BASEL, V6, P1837, DOI 10.3390/v6041837; Lehner T, 2008, VACCINE, V26, P2997, DOI 10.1016/j.vaccine.2007.11.060; Lehner T, 2011, Adv Dent Res, V23, P19, DOI 10.1177/0022034511399081; Liu LH, 2011, J VIROL, V85, P8467, DOI 10.1128/JVI.00520-11; Lu KF, 2014, AUTOPHAGY, V10, P2381, DOI 10.4161/15548627.2014.981919; Mackelprang RD, 2014, J INFECT DIS, V209, P1623, DOI 10.1093/infdis/jit807; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Margolis David M, 2010, Curr HIV/AIDS Rep, V7, P37, DOI 10.1007/s11904-009-0033-9; MCILROY D, 1995, J VIROL, V69, P4737, DOI 10.1128/JVI.69.8.4737-4745.1995; Mitra S, 2013, J BIOL CHEM, V288, P25780, DOI 10.1074/jbc.M113.484170; Mosoian A, 2010, P NATL ACAD SCI USA, V107, P10178, DOI 10.1073/pnas.0914870107; Mukherjee S, 2014, CELL SIGNAL, V26, P2674, DOI 10.1016/j.cellsig.2014.08.009; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Oguro A, 2011, NEUROSCI LETT, V503, P234, DOI 10.1016/j.neulet.2011.08.043; Pace MJ, 2011, VIROLOGY, V411, P344, DOI 10.1016/j.virol.2010.12.041; PATTERSON S, 1987, J GEN VIROL, V68, P1177, DOI 10.1099/0022-1317-68-4-1177; Pine SO, 2009, AIDS, V23, P2387, DOI 10.1097/QAD.0b013e328330b489; Qin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027609; Qu XY, 2013, NUCLEIC ACIDS RES, V41, P7771, DOI 10.1093/nar/gkt571; Reuven EM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004248; Rustagi A, 2014, J MOL BIOL, V426, P1161, DOI 10.1016/j.jmb.2013.12.003; Sang M, 2014, ANTIVIR RES, V112, P103, DOI 10.1016/j.antiviral.2014.10.008; Schlaepfer E, 2014, J VIROL, V88, P9769, DOI 10.1128/JVI.01053-14; Shen CJ, 2012, FASEB J, V26, P4755, DOI 10.1096/fj.12-209023; Thibault S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-42; Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67; Victoria S, 2013, IMMUNOBIOLOGY, V218, P1529, DOI 10.1016/j.imbio.2013.06.006; Wang JH, 2007, J VIROL, V81, P8933, DOI 10.1128/JVI.00878-07; West MJ, 2001, J VIROL, V75, P8524, DOI 10.1128/JVI.75.18.8524-8537.2001; Willie B, 2014, GENES IMMUN, V15, P569, DOI 10.1038/gene.2014.54; Yamakami M, 2003, J BIOL CHEM, V278, P52865, DOI 10.1074/jbc.M306740200; ZEICHNER SL, 1991, J VIROL, V65, P2436, DOI 10.1128/JVI.65.5.2436-2444.1991; Zhai RR, 2013, VIROLOGY, V442, P163, DOI 10.1016/j.virol.2013.04.009; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	51	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125563	10.1371/journal.pone.0125563	http://dx.doi.org/10.1371/journal.pone.0125563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915421	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100134
J	Binh, CTT; Peterson, CG; Tong, TZ; Gray, KA; Gaillard, JF; Kelly, JJ				Chu Thi Thanh Binh; Peterson, Christopher G.; Tong, Tiezheng; Gray, Kimberly A.; Gaillard, Jean-Francois; Kelly, John J.			Comparing Acute Effects of a Nano-TiO2 Pigment on Cosmopolitan Freshwater Phototrophic Microbes Using High-Throughput Screening	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; PHYTOPLANKTON COMMUNITY STRUCTURE; OXIDATIVE DNA-DAMAGE; TIO2 NANOPARTICLES; METABOLIC-ACTIVITY; ALGAL GROWTH; TOXICITY; PHOTOSYNTHESIS; NANOMATERIALS; MARINE	Production of titanium-dioxide nanomaterials (nano-TiO2) is increasing, leading to potential risks associated with unintended release of these materials into aquatic ecosystems. We investigated the acute effects of nano-TiO2 on metabolic activity and viability of algae and cyanobacteria using high-throughput screening. The responses of three diatoms (Surirella angusta, Cocconeis placentula, Achnanthidium lanceolatum), one green alga (Scenedesmus quadricauda), and three cyanobacteria (Microcystis aeruginosa, Gloeocapsasp., Synechococcus cedrorum) to short-term exposure (15 to 60 min) to a common nano-TiO2 pigment (PW6; average crystallite size 81.5 nm) with simulated solar illumination were assessed. Five concentrations of nano-TiO2 (0.5, 2.5, 5, 10, and 25 mg L-1) were tested and a fluorescent reporter (fluorescein diacetate) was used to assess metabolic activity. Algae were sensitive to nano-TiO2, with all showing decreased metabolic activity after 30-min exposure to the lowest tested concentration. Microscopic observation of algae revealed increased abundance of dead cells with nano-TiO2 exposure. Cyanobacteria were less sensitive to nano-TiO2 than algae, with Gloeocapsashowing no significant decrease in activity with nano-TiO2 exposure and Synechococcusshowing an increase in activity. These results suggest that nanomaterial contamination has the potential to alter the distribution of phototrophic microbial taxa within freshwater ecosystems. The higher resistance of cyanobacteria could have significant implications as cyanobacteria represent a less nutritious food source for higher trophic levels and some cyanobacteria can produce toxins and contribute to harmful algal blooms.	[Chu Thi Thanh Binh; Kelly, John J.] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Peterson, Christopher G.] Loyola Univ, Inst Environm Sustainabil, Chicago, IL 60626 USA; [Tong, Tiezheng; Gray, Kimberly A.; Gaillard, Jean-Francois] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL USA	Loyola University Chicago; Loyola University Chicago; Northwestern University	Kelly, JJ (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.	jkelly7@luc.edu	Gaillard, Jean-Francois/B-6981-2009; Gray, Kimberly A/B-6989-2009; Gaillard, Jean-Francois JF/E-9445-2013	Gaillard, Jean-Francois JF/0000-0002-8276-6418; Kelly, John/0000-0002-0894-137X; Tong, Tiezheng/0000-0002-9289-3330	National Science Foundation [CBET-1067439, CBET-1067751]	National Science Foundation(National Science Foundation (NSF))	The work described in this study was performed with support from the National Science Foundation (Grant No. CBET-1067439 to JK and CP and Grant No. CBET-1067751 to KG and J-FG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MS, 2004, ENVIRON TOXICOL CHEM, V23, P1957, DOI 10.1897/03-232; AGUSTI S, 1990, LIMNOL OCEANOGR, V35, P181, DOI 10.4319/lo.1990.35.1.0181; Munoz-Martin MA, 2014, SCI TOTAL ENVIRON, V475, P169, DOI 10.1016/j.scitotenv.2013.07.015; [Anonymous], [No title captured], DOI DOI 10.1007/978-94-007-3855-3; Aruoja V, 2009, SCI TOTAL ENVIRON, V407, P1461, DOI 10.1016/j.scitotenv.2008.10.053; Blaise C, 2008, ENVIRON TOXICOL, V23, P591, DOI 10.1002/tox.20402; Carmichael WW, 2006, SALINE SYSTEMS, V2, P1746; Chen JS, 2003, WATER RES, V37, P3815, DOI 10.1016/S0043-1354(03)00332-4; Chen LZ, 2012, ECOTOX ENVIRON SAFE, V84, P155, DOI 10.1016/j.ecoenv.2012.07.019; Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535; Cherchi C, 2010, ENVIRON SCI TECHNOL, V44, P8302, DOI 10.1021/es101658p; Christoffersen Kirsten, 1996, Phycologia, V35, P42, DOI 10.2216/i0031-8884-35-6S-42.1; Binh CTT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106280; Binh CTT, 2014, ENVIRON TOXICOL CHEM, V33, P317, DOI 10.1002/etc.2442; COHEN RRH, 1984, LIMNOL OCEANOGR, V29, P170, DOI 10.4319/lo.1984.29.1.0170; COOPER WJ, 1983, SCIENCE, V220, P711, DOI 10.1126/science.220.4598.711; Cronin MTD, 2004, CHEM RES TOXICOL, V17, P545, DOI 10.1021/tx0342518; Dalai S, 2013, AQUAT TOXICOL, V138, P1, DOI 10.1016/j.aquatox.2013.04.005; Domingos RF, 2009, ENVIRON SCI TECHNOL, V43, P1282, DOI 10.1021/es8023594; DORSEY J, 1989, CYTOMETRY, V10, P622, DOI 10.1002/cyto.990100518; Drury B, 2013, ENVIRON SCI TECHNOL, V47, P8923, DOI 10.1021/es401919k; Federici G, 2007, AQUAT TOXICOL, V84, P415, DOI 10.1016/j.aquatox.2007.07.009; Feng Y, 2013, ECOL ENG, V53, P306, DOI 10.1016/j.ecoleng.2012.12.066; Franklin NM, 2001, ARCH ENVIRON CON TOX, V40, P469; GARCIAPICHEL F, 1993, APPL ENVIRON MICROB, V59, P170, DOI 10.1128/AEM.59.1.170-176.1993; GILBERT F, 1992, MAR BIOL, V112, P199, DOI 10.1007/BF00702462; GRATZEL CK, 1990, J MOL CATAL, V60, P375, DOI 10.1016/0304-5102(90)85260-O; Griffitt RJ, 2008, ENVIRON TOXICOL CHEM, V27, P1972, DOI 10.1897/08-002.1; Hader DP, 2002, PHOTOCH PHOTOBIO SCI, V1, P809, DOI 10.1039/b206152j; Hader DP, 2001, J PHOTOCH PHOTOBIO B, V62, P43, DOI 10.1016/S1011-1344(01)00162-2; HANELT D, 1992, BOT ACTA, V105, P278, DOI 10.1111/j.1438-8677.1992.tb00299.x; Hartmann NB, 2010, TOXICOLOGY, V269, P190, DOI 10.1016/j.tox.2009.08.008; Hund-Rinke K, 2006, ENVIRON SCI POLLUT R, V13, P225, DOI 10.1065/espr2006.06.311; Hund-Rinke Kerstin, 2010, Umweltwissenschaften und Schadstoff-Forschung, V22, P517, DOI 10.1007/s12302-010-0147-0; Ji J, 2011, CHEM ENG J, V170, P525, DOI 10.1016/j.cej.2010.11.026; Jin X, 2010, ENVIRON SCI TECHNOL, V44, P7321, DOI 10.1021/es100854g; Kaegi R, 2008, ENVIRON POLLUT, V156, P233, DOI 10.1016/j.envpol.2008.08.004; KANEY AR, 1973, ARCH MIKROBIOL, V92, P139, DOI 10.1007/BF00425011; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Kim SC, 2005, MICROCHEM J, V80, P227, DOI 10.1016/j.microc.2004.07.008; Kiser MA, 2009, ENVIRON SCI TECHNOL, V43, P6757, DOI 10.1021/es901102n; Kulacki KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047130; LAMPERT W, 1987, NEW ZEAL J MAR FRESH, V21, P483, DOI 10.1080/00288330.1987.9516244; Li MH, 2011, ENVIRON SCI TECHNOL, V45, P8989, DOI 10.1021/es201675m; Li MH, 2011, ENVIRON SCI TECHNOL, V45, P755, DOI 10.1021/es102266g; LIDHOLM J, 1987, PLANT CELL PHYSIOL, V28, P1133; Lovern SB, 2006, ENVIRON TOXICOL CHEM, V25, P1132, DOI 10.1897/05-278R.1; Loza V, 2014, WATER RES, V48, P622, DOI 10.1016/j.watres.2013.10.014; Machado MD, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-012-1358-3; MARTIN TC, 1974, J PHYCOL, V10, P204; Martirosyan A, 2014, INT J ENV RES PUB HE, V11, P5720, DOI 10.3390/ijerph110605720; Oh HM, 2000, APPL ENVIRON MICROB, V66, P176, DOI 10.1128/AEM.66.1.176-179.2000; Orvos DR, 2002, ENVIRON TOXICOL CHEM, V21, P1338, DOI 10.1897/1551-5028(2002)021<1338:ATOT>2.0.CO;2; Paerl HW, 2011, SCI TOTAL ENVIRON, V409, P1739, DOI 10.1016/j.scitotenv.2011.02.001; PENALOZA R, 1990, FRESHWATER BIOL, V24, P233, DOI 10.1111/j.1365-2427.1990.tb00705.x; PETERSON CG, 1993, J PHYCOL, V29, P442, DOI 10.1111/j.1529-8817.1993.tb00145.x; Peterson CG, 1998, FRESHWATER BIOL, V40, P607, DOI 10.1046/j.1365-2427.1998.00358.x; Reeves JF, 2008, MUTAT RES-FUND MOL M, V640, P113, DOI 10.1016/j.mrfmmm.2007.12.010; Robichaud CO, 2009, ENVIRON SCI TECHNOL, V43, P4227, DOI 10.1021/es8032549; Romero OC, 2011, ENVIRON SCI TECHNOL, V45, P10385, DOI 10.1021/es202067f; Sadiq IM, 2011, ECOTOX ENVIRON SAFE, V74, P1180, DOI 10.1016/j.ecoenv.2011.03.006; SAMUELSSON G, 1985, PLANT PHYSIOL, V79, P992, DOI 10.1104/pp.79.4.992; Shih YH, 2012, ENVIRON TOXICOL CHEM, V31, P1693, DOI 10.1002/etc.1898; Smith TE, 1998, J PLANKTON RES, V20, P1567, DOI 10.1093/plankt/20.8.1567; Sun TY, 2014, ENVIRON POLLUT, V185, P69, DOI 10.1016/j.envpol.2013.10.004; Szelag-Wasielewska E, 2003, HYDROBIOLOGIA, V506, P229, DOI 10.1023/B:HYDR.0000008587.33966.78; Boncagni NT, 2009, ENVIRON SCI TECHNOL, V43, P7699, DOI 10.1021/es900424n; Tong TZ, 2013, ENVIRON SCI TECHNOL, V47, P12486, DOI 10.1021/es403079h; Tong TZ, 2013, WATER RES, V47, P2352, DOI 10.1016/j.watres.2013.02.008; United States Geological Survey, 2008, MINERAL COMMODITY SU, P178; USEPA, 2002, SHORT TERM METHODS F; Velzeboer I, 2008, ENVIRON TOXICOL CHEM, V27, P1942, DOI 10.1897/07-509.1; WAKI K, 1995, J MOL CATAL A-CHEM, V95, P53, DOI 10.1016/1381-1169(94)00135-9; Wang JX, 2008, CHEMOSPHERE, V73, P1121, DOI 10.1016/j.chemosphere.2008.07.040; Warheit DB, 2007, TOXICOL LETT, V171, P99, DOI 10.1016/j.toxlet.2007.04.008; Weir A, 2012, ENVIRON SCI TECHNOL, V46, P2242, DOI 10.1021/es204168d; Westerhoff P, 2011, J ENVIRON MONITOR, V13, P1195, DOI 10.1039/c1em10017c; WHITELAM GC, 1983, PLANTA, V157, P561, DOI 10.1007/BF00396889; World Meteorological Organization (WMO), 2008, GUIDE TO METEOROLOGI; Zegura B, 2003, TOXICON, V41, P41, DOI 10.1016/S0041-0101(02)00207-6; Zilliges Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017615	81	6	7	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125613	10.1371/journal.pone.0125613	http://dx.doi.org/10.1371/journal.pone.0125613			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923116	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600155
J	Gregory, SJ; Anderson, CWN; Camps-Arbestain, M; Biggs, PJ; Ganley, ARD; O'Sullivan, JM; McManus, MT				Gregory, Samuel J.; Anderson, Christopher W. N.; Camps-Arbestain, Marta; Biggs, Patrick J.; Ganley, Austen R. D.; O'Sullivan, Justin M.; McManus, Michael T.			Biochar in Co-Contaminated Soil Manipulates Arsenic Solubility and Microbiological Community Structure, and Promotes Organochlorine Degradation	PLOS ONE			English	Article							MICROBIAL BIOMASS; DDT; IMPACT; CARBON; BIOAVAILABILITY; MICROORGANISMS; INSECTICIDES; METABOLISM; PESTICIDES; AMENDMENTS	We examined the effect of biochar on the water-soluble arsenic (As) concentration and the extent of organochlorine degradation in a co-contaminated historic sheep-dip soil during a 180-d glasshouse incubation experiment. Soil microbial activity, bacterial community and structure diversity were also investigated. Biochar made from willow feedstock (Salix sp) was pyrolysed at 350 or 550 degrees C and added to soil at rates of 10 g kg(-1) and 20 g kg(-1) (representing 30 t ha(-1) and 60 t ha(-1)). The isomers of hexachlorocyclohexane (HCH) alpha-HCH and gamma-HCH (lindane), underwent 10-fold and 4-fold reductions in concentration as a function of biochar treatment. Biochar also resulted in a significant reduction in soil DDT levels (P < 0.01), and increased the DDE: DDT ratio. Soil microbial activity was significantly increased (P < 0.01) under all biochar treatments after 60 days of treatment compared to the control. 16S amplicon sequencing revealed that biochar-amended soil contained more members of the Chryseobacterium, Flavobacterium, Dyadobacter and Pseudomonadaceae which are known bioremediators of hydrocarbons. We hypothesise that a recorded short-term reduction in the soluble As concentration due to biochar amendment allowed native soil microbial communities to overcome As-related stress. We propose that increased microbiological activity (dehydrogenase activity) due to biochar amendment was responsible for enhanced degradation of organochlorines in the soil. Biochar therefore partially overcame the co-contaminant effect of As, allowing for enhanced natural attenuation of organochlorines in soil.	[Gregory, Samuel J.; Camps-Arbestain, Marta] Massey Univ, New Zealand Biochar Res Ctr, Palmerston North, New Zealand; [Anderson, Christopher W. N.] Massey Univ, Soil & Earth Sci, Inst Agr & Environm, Palmerston North, New Zealand; [Biggs, Patrick J.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Ganley, Austen R. D.] Massey Univ, Inst Nat & Math Sci, Auckland, New Zealand; [O'Sullivan, Justin M.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [McManus, Michael T.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand	Massey University; Massey University; Massey University; Massey University; University of Auckland; Massey University	Anderson, CWN (corresponding author), Massey Univ, Soil & Earth Sci, Inst Agr & Environm, Palmerston North, New Zealand.	C.W.N.Anderson@massey.ac.nz	O'Sullivan, Justin/HDO-1639-2022; Biggs, Patrick Jon/H-3355-2014; Ganley, Austen/L-8120-2013	O'Sullivan, Justin/0000-0003-2927-450X; Biggs, Patrick Jon/0000-0002-0285-4101; Ganley, Austen/0000-0002-1917-7522; Camps Arbestain, Marta/0000-0002-5354-2087	Massey University Strategic Innovation Fund (SIF); New Zealand Microbiology Society; Maurice Wilkins Centre; Ministry of Science and Innovation (New Zealand)	Massey University Strategic Innovation Fund (SIF); New Zealand Microbiology Society; Maurice Wilkins Centre; Ministry of Science and Innovation (New Zealand)	Metagenomics work was funded by Massey University Strategic Innovation Fund (SIF) grant (to JMO), with support from the New Zealand Microbiology Society and the Maurice Wilkins Centre, and from commercial sources: Custom Science, Roche, New Zealand Genomics Limited and KapaBiosystems. The first author gratefully acknowledges the Ministry of Science and Innovation (New Zealand) for the award of a Ti Tipu Putaiao Fellowshop (PhD scholarship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Acceptance of funding from the named sources does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Ahmedna M, 1997, J SCI FOOD AGR, V75, P117, DOI [10.1002/(SICI)1097-0010(199709)75:1<117::AID-JSFA850>3.3.CO;2-D, 10.1002/(SICI)1097-0010(199709)75:1&lt;117::AID-JSFA850&gt;3.0.CO;2-M]; Aislabie JM, 1997, NEW ZEAL J AGR RES, V40, P269, DOI 10.1080/00288233.1997.9513247; Anderson CR, 2011, PEDOBIOLOGIA, V54, P309, DOI 10.1016/j.pedobi.2011.07.005; [Anonymous], 2006, ID INV MAN RISKS ASS; Antonious GF, 2003, J ENVIRON SCI HEAL B, V38, P479, DOI 10.1081/PFC-120021667; Beesley L, 2011, ENVIRON POLLUT, V159, P3269, DOI 10.1016/j.envpol.2011.07.023; Beesley L, 2011, ENVIRON POLLUT, V159, P474, DOI 10.1016/j.envpol.2010.10.016; Beesley L, 2010, ENVIRON POLLUT, V158, P2282, DOI 10.1016/j.envpol.2010.02.003; Blakemore L.C., 1987, NZ SOIL BUR SCI REP; Bruun S, 2008, ORG GEOCHEM, V39, P839, DOI 10.1016/j.orggeochem.2008.04.020; Camina F, 1998, SOIL BIOL BIOCHEM, V30, P1005, DOI 10.1016/S0038-0717(98)00010-8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CHANDER K, 1991, SOIL BIOL BIOCHEM, V23, P909, DOI 10.1016/0038-0717(91)90170-O; Chaudhry Q, 2005, ENVIRON SCI POLLUT R, V12, P34, DOI 10.1065/espr2004.08.213; Chopra BK, 2007, SCI TOTAL ENVIRON, V378, P331, DOI 10.1016/j.scitotenv.2007.02.036; CORNFORTH I, 1998, PRACTICAL SOIL MANAG; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edvantoro BB, 2003, ECOTOX ENVIRON SAFE, V55, P344, DOI 10.1016/S0147-6513(02)00092-1; Elliott JE, 1994, ARCH ENV CONTAMINATI, V26, P35; Gaw SK, 2006, SCI TOTAL ENVIRON, V355, P31, DOI 10.1016/j.scitotenv.2005.02.020; Gomez JD, 2014, EUR J SOIL SCI, V65, P28, DOI 10.1111/ejss.12097; Graber ER, 2012, PLANT SOIL, V353, P95, DOI 10.1007/s11104-011-1012-7; Gregory S., 2013, THESIS MASSEY U NZ; Gregory SJ, 2014, AGR ECOSYST ENVIRON, V191, P133, DOI 10.1016/j.agee.2014.03.035; Hesse P. R., 1971, TXB SOIL CHEM ANAL; Hills Laboratories, 2014, SOIL TESTS INT; Jones DL, 2011, SOIL BIOL BIOCHEM, V43, P804, DOI 10.1016/j.soilbio.2010.12.015; Joseph SD, 2010, AUST J SOIL RES, V48, P501, DOI 10.1071/SR10009; Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419; Klose S, 2004, SOIL BIOL BIOCHEM, V36, P1625, DOI 10.1016/j.soilbio.2004.07.009; Ko BG, 2008, AUST J SOIL RES, V46, P493, DOI 10.1071/SR07200; Kolb SE, 2009, SOIL SCI SOC AM J, V73, P1173, DOI 10.2136/sssaj2008.0232; Kookana RS, 2011, ADV AGRON, V112, P103, DOI 10.1016/B978-0-12-385538-1.00003-2; Kookana RS, 2010, AUST J SOIL RES, V48, P627, DOI 10.1071/SR10007; Kuzyakov Y, 2009, SOIL BIOL BIOCHEM, V41, P210, DOI 10.1016/j.soilbio.2008.10.016; LAL R, 1982, MICROBIOL REV, V46, P95, DOI 10.1128/MMBR.46.1.95-127.1982; Lee DH, 1996, APPL ENVIRON MICROB, V62, P3112, DOI 10.1128/AEM.62.9.3112-3120.1996; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Lo KV, 1998, ENVIRON TECHNOL, V19, P91, DOI 10.1080/09593331908616659; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lu GN, 2010, J HAZARD MATER, V177, P1145, DOI 10.1016/j.jhazmat.2009.12.051; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Margesin R, 2000, CHEMOSPHERE, V40, P339, DOI 10.1016/S0045-6535(99)00218-0; McBride GL., 1998, P WASTE MANAGEMENT I, P129; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Ministry of Agriculture and Fisheries, 1976, REP COMM INQ DIPP SH; National Rivers Authority, 1994, DISP SHEEP DIP WAST; Pampulha ME, 2006, CURR MICROBIOL, V53, P238, DOI 10.1007/s00284-006-0116-4; Pereira RC, 2011, ORG GEOCHEM, V42, P1331, DOI 10.1016/j.orggeochem.2011.09.002; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quilty JR, 2011, SOIL RES, V49, P1, DOI 10.1071/SR10059; RICE CP, 1973, B ENVIRON CONTAM TOX, V9, P116, DOI 10.1007/BF01684766; RICE CP, 1973, J AGR FOOD CHEM, V21, P148, DOI 10.1021/jf60186a012; Saimmai A, 2012, ANN MICROBIOL, V62, P1757, DOI 10.1007/s13213-012-0434-7; Singh BP, 2014, SCI REP-UK, V4, DOI 10.1038/srep03687; Sohi SP, 2010, ADV AGRON, V105, P47, DOI 10.1016/S0065-2113(10)05002-9; Steinbeiss S, 2009, SOIL BIOL BIOCHEM, V41, P1301, DOI 10.1016/j.soilbio.2009.03.016; Sutton NB, 2013, APPL ENVIRON MICROB, V79, P619, DOI 10.1128/AEM.02747-12; Teixido M, 2013, ENVIRON SCI TECHNOL, V47, P6197, DOI 10.1021/es400911c; Tyagi M, 2011, BIODEGRADATION, V22, P231, DOI 10.1007/s10532-010-9394-4; Van Zwieten L, 2003, ENVIRON POLLUT, V124, P331, DOI 10.1016/S0269-7491(02)00463-3; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang T, 2012, PLANT SOIL, V357, P173, DOI 10.1007/s11104-012-1131-9; Warnock DD, 2007, PLANT SOIL, V300, P9, DOI 10.1007/s11104-007-9391-5; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Whitman W.B., 2010, BERGEYS MANUAL SYSTE, DOI [10.1007/978-0-387-68572-4, DOI 10.1007/978-0-387-68572-4]; Yang YN, 2003, ENVIRON SCI TECHNOL, V37, P3635, DOI 10.1021/es034006a; Yu XY, 2009, CHEMOSPHERE, V76, P665, DOI 10.1016/j.chemosphere.2009.04.001; Zhou Ying, 2006, Yingyong Shengtai Xuebao, V17, P1305	73	33	35	2	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125393	10.1371/journal.pone.0125393	http://dx.doi.org/10.1371/journal.pone.0125393			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923541	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600147
J	Nansen, C; Ribeiro, LP; Dadour, I; Roberts, JD				Nansen, Christian; Ribeiro, Leandro Prado; Dadour, Ian; Roberts, John Dale			Detection of Temporal Changes in Insect Body Reflectance in Response to Killing Agents	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; CUTICULAR HYDROCARBONS; OPTICAL-PROPERTIES; COLEOPTERA; HYMENOPTERA; LARVAE; HOST	Computer vision and reflectance-based analyses are becoming increasingly important methods to quantify and characterize phenotypic responses by whole organisms to environmental factors. Here, we present the first study of how a non-destructive and completely non-invasive method, body reflectance profiling, can be used to detect and time stress responses in adult beetles. Based on high-resolution hyperspectral imaging, we acquired time series of average reflectance profiles (70 spectral bands from 434-876 nm) from adults in two beetle species, maize weevils (Sitophilus zeamais) and larger black flour beetles (Cynaus angustus). For each species, we acquired reflectance data from untreated controls and from individuals exposed continuously to killing agents (an insecticidal plant extract applied to maize kernels or entomopathogenic nematodes applied to soil applied at levels leading to approximate to 100% mortality). In maize weevils (exposed to hexanic plant extract), there was no significant effect of the on reflectance profiles acquired from adult beetles after 0 and 12 hours of exposure, but a significant treatment response in spectral bands from 434 to 550 nm was detected after 36 to 144 hours of exposure. In larger black flour beetles, there was no significant effect of exposure to entomopathogenic nematodes after 0 to 26 hours of exposure, but a significant response in spectral bands from 434-480 nm was detected after 45 and 69 hours of exposure. Spectral bands were used to develop reflectance-based classification models for each species, and independent validation of classification algorithms showed sensitivity (ability to positively detect terminal stress in beetles) and specificity (ability to positively detect healthy beetles) of about 90%. Significant changes in body reflectance occurred at exposure times, which coincided with published exposure times and known physiological responses to each killing agent. The results from this study underscore the potential of hyperspectral imaging as an approach to non-destructively and non-invasively quantify stress detection in insects and other animals.	[Nansen, Christian] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Ribeiro, Leandro Prado] Univ Sao Paulo, Dept Entomol & Acarol, Piracicaba, SP, Brazil; [Dadour, Ian] Univ Western Australia, Ctr Forens Sci, Perth, WA 6009, Australia; [Roberts, John Dale] Univ Western Australia, Sch Anim Biol, Albany, WA, Australia; [Roberts, John Dale] Univ Western Australia, Ctr Evolutionary Biol, Albany, WA, Australia; [Roberts, John Dale] Univ Western Australia, Ctr Excellence Nat Resource Management, Albany, WA, Australia	University of California System; University of California Davis; Universidade de Sao Paulo; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Nansen, C (corresponding author), Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.	christian.nansen@uwa.edu.au		Dadour, Ian Robert/0000-0001-7527-4936				Aw WC, 2012, G3-GENES GENOM GENET, V2, P1057, DOI 10.1534/g3.112.003103; Berggren A, 2010, INSECT SCI, V17, P400, DOI 10.1111/j.1744-7917.2010.01319.x; Bluhm BA, 2001, MAR BIOL, V138, P247, DOI 10.1007/s002270000458; Burleigh JG, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.085c713acafc8711b2ff7010a4b03733; Butler SM, 2009, MED VET ENTOMOL, V23, P426, DOI 10.1111/j.1365-2915.2009.00831.x; Carter GA, 2001, AM J BOT, V88, P677, DOI 10.2307/2657068; Chapman RF., 2012, INSECTS STRUCTURE FU; Colom OA, 2008, J PEST SCI, V81, P85, DOI 10.1007/s10340-007-0189-2; Cotter SC, 2008, J EVOLUTION BIOL, V21, P1744, DOI 10.1111/j.1420-9101.2008.01587.x; De Loof A, 2010, J INSECT PHYSIOL, V56, P919, DOI 10.1016/j.jinsphys.2010.02.021; Faber NM, 2007, ANAL CHIM ACTA, V595, P98, DOI 10.1016/j.aca.2007.05.030; Ferreira-Caliman MJ, 2010, J INSECT PHYSIOL, V56, P800, DOI 10.1016/j.jinsphys.2010.02.004; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Freitak D, 2005, ENTOMOL EXP APPL, V116, P237, DOI 10.1111/j.1570-7458.2005.00330.x; FUZEAUBR.S, 1972, ANNU REV ENTOMOL, V17, P403, DOI 10.1146/annurev.en.17.010172.002155; GOODWIN TW, 1951, BIOCHEM J, V48, P199, DOI 10.1042/bj0480199; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Howard RW, 2003, ARCH INSECT BIOCHEM, V53, P1, DOI 10.1002/arch.10078; Howard RW, 2002, ARCH INSECT BIOCHEM, V50, P75, DOI 10.1002/arch.10034; Kastenbaum R, 1989, DEFINITIONS OF DEATH; Koc H, 2008, J CEREAL SCI, V48, P394, DOI 10.1016/j.jcs.2007.09.015; Lacoste C, ENV ENTOMOLOGY; Lammertyn J, 2000, POSTHARVEST BIOL TEC, V18, P121, DOI 10.1016/S0925-5214(99)00071-X; Lapointe SL, 2004, AGR FOREST ENTOMOL, V6, P251, DOI 10.1111/j.1461-9555.2004.00230.x; Mietchen D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003826; Nansen C, 2013, COMPUT ELECTRON AGR, V97, P21, DOI 10.1016/j.compag.2013.06.007; Nansen C, 2015, J PHOTOCHEMISTRY P B; Nansen C, 2008, J AGR FOOD CHEM, V56, P2933, DOI 10.1021/jf073237o; Nansen C, 2014, J EXP BIOL, V217, P1187, DOI 10.1242/jeb.095661; Nansen C, 2014, J FOOD ENG, V123, P17, DOI 10.1016/j.jfoodeng.2013.09.001; Nansen C, 2013, APPL SPECTROSC, V67, P1332, DOI 10.1366/12-06933; Nansen C, 2013, J ECON ENTOMOL, V106, P648, DOI 10.1603/EC12380; Nunes TM, 2009, GENET MOL RES, V8, P589, DOI 10.4238/vol8-2kerr012; Prabhakar M, 2012, CROP STRESS AND ITS MANAGEMENT: PERSPECTIVES AND STRATEGIES, P517, DOI 10.1007/978-94-007-2220-0_16; Qin JW, 2008, POSTHARVEST BIOL TEC, V49, P355, DOI 10.1016/j.postharvbio.2008.03.010; Ribeiro LD, 2013, J STORED PROD RES, V55, P6, DOI 10.1016/j.jspr.2013.06.001; Ribeiro LP, 2010, BIOPROSPECCAO EXTRAT; Robson SKA, 2009, AUST J ENTOMOL, V48, P102, DOI 10.1111/j.1440-6055.2009.00692.x; Rosa JS, 2002, J INVERTEBR PATHOL, V80, P46, DOI 10.1016/S0022-2011(02)00038-1; Roux O, 2008, MED VET ENTOMOL, V22, P309, DOI 10.1111/j.1365-2915.2008.00752.x; Singh CB, 2009, J STORED PROD RES, V45, P151, DOI 10.1016/j.jspr.2008.12.002; Singh CB, 2010, COMPUT ELECTRON AGR, V73, P118, DOI 10.1016/j.compag.2010.06.001; Wang J, 2011, POSTHARVEST BIOL TEC, V59, P272, DOI 10.1016/j.postharvbio.2010.09.017; Wang J, 2010, J FOOD ENG, V101, P78, DOI 10.1016/j.jfoodeng.2010.06.011; Webster TC, 2009, APIDOLOGIE, V40, P565, DOI 10.1051/apido/2009038; WILSON BC, 1990, IEEE J QUANTUM ELECT, V26, P2186, DOI 10.1109/3.64355; Zhang X, APPL SPECTROSCOPY; Zhu GH, 2006, MED VET ENTOMOL, V20, P438, DOI 10.1111/j.1365-2915.2006.00651.x	49	15	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124866	10.1371/journal.pone.0124866	http://dx.doi.org/10.1371/journal.pone.0124866			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923362	Green Published, gold			2022-12-27	WOS:000353711600109
J	Chen, C; Song, YF; Zhuang, K; Li, L; Xia, Y; Shen, ZG				Chen, Chen; Song, Yufeng; Zhuang, Kai; Li, Lu; Xia, Yan; Shen, Zhenguo			Proteomic Analysis of Copper-Binding Proteins in Excess Copper-Stressed Roots of Two Rice (Oryza sativa L.) Varieties with Different Cu Tolerances	PLOS ONE			English	Article							METAL AFFINITY-CHROMATOGRAPHY; METHIONINE SULFOXIDE REDUCTASE; TRANSLATION INITIATION-FACTOR; MASS-SPECTROMETRY; DISULFIDE-ISOMERASE; OXIDATIVE STRESS; GENE-EXPRESSION; 2-DIMENSIONAL ELECTROPHORESIS; COMPREHENSIVE ANALYSIS; ARABIDOPSIS-THALIANA	To better understand the mechanisms involved in the heavy metal stress response and tolerance in plants, a proteomic approach was used to investigate the differences in Cu-binding protein expression in Cu-tolerant and Cu-sensitive rice varieties. Cu-binding proteins from Cu-treated rice roots were separated using a new IMAC method in which an IDA-sepharose column was applied prior to the Cu-IMAC column to remove metal ions from protein samples. More than 300 protein spots were reproducibly detected in the 2D gel. Thirty-five protein spots exhibited changes greater than 1.5-fold in intensity compared to the control. Twenty-four proteins contained one or more of nine putative metal-binding motifs reported by Smith et al., and 19 proteins (spots) contained one to three of the top six motifs reported by Kung et al. The intensities of seven protein spots were increased in the Cu-tolerant variety B1139 compared to the Cu-sensitive variety B1195 (p<0.05) and six protein spots were markedly up-regulated in B1139, but not detectable in B1195. Four protein spots were significantly up-regulated in B1139, but unchanged in B1195 under Cu stress. In contrast, two protein spots were significantly down-regulated in B1195, but unchanged in B1139. These Cu-responsive proteins included those involved in antioxidant defense and detoxification (spots 5, 16, 21, 22, 28, 29 and 33), pathogenesis (spots 5, 16, 21, 22, 28, 29 and 33), regulation of gene transcription (spots 8 and 34), amino acid synthesis (spots 8 and 34), protein synthesis, modification, transport and degradation (spots 1, 2, 4, 10, 15, 19, 30, 31, 32 and 35), cell wall synthesis (spot 14), molecular signaling (spot 3), and salt stress (spots 7, 9 and 27); together with other proteins, such as a putative glyoxylate induced protein, proteins containing dimeric alpha-beta barrel domains, and adenosine kinase-like proteins. Our results suggest that these proteins, together with related physiological processes, play an important role in the detoxification of excess Cu and in maintaining cellular homeostasis.	[Chen, Chen; Song, Yufeng; Zhuang, Kai; Li, Lu; Xia, Yan; Shen, Zhenguo] Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Shen, ZG (corresponding author), Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	zgshen@njau.edu.cn			Specialized Research Fund for the Doctoral Program of Higher Education [20120097130004]; National Natural Science Foundation of China [31172021, 31471938]; Innovative Research Team Development Plan of the Ministry of Education of China [IRT1256]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Team Development Plan of the Ministry of Education of China	This work was financially supported by Specialized Research Fund for the Doctoral Program of Higher Education (20120097130004), the National Natural Science Foundation of China (31172021 and 31471938), and the Innovative Research Team Development Plan of the Ministry of Education of China (IRT1256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2007, PLANT PHYSIOL, V143, P263, DOI 10.1104/pp.106.088609; Alvarez S, 2009, PROTEOMICS, V9, P3220, DOI [10.1002/pmic.200800478, 10.1002/pmic.200990042]; Bae MS, 2003, PLANT J, V36, P652, DOI 10.1046/j.1365-313X.2003.01907.x; Balestrasse KB, 2006, PLANT SOIL, V284, P187, DOI 10.1007/s11104-006-0050-z; Banerjee J, 2010, BIOCHEM BIOPH RES CO, V402, P637, DOI 10.1016/j.bbrc.2010.10.073; Barnett JP, 2012, ANAL BIOANAL CHEM, V402, P3311, DOI 10.1007/s00216-012-5743-y; Barrett A.J., 1986, PLANT PROTEOLYTIC EN, p1 ~16; Bechtold U, 2004, PLANT CELL, V16, P908, DOI 10.1105/tpc.015818; Bouchenak F, 2012, J PLANT PHYSIOL, V169, P1445, DOI 10.1016/j.jplph.2012.06.009; Breen J, 2010, FUNCT INTEGR GENOMIC, V10, P463, DOI 10.1007/s10142-010-0184-1; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chang HL, 2014, PHYSIOL PLANTARUM, V150, P550, DOI 10.1111/ppl.12102; Chen LM, 2012, J PLANT GENETIC RESO, V13, P858; Chen Z, 2012, PLANT SCI, V197, P10, DOI 10.1016/j.plantsci.2012.08.005; Chou WC, 2004, PHYSIOL PLANTARUM, V121, P50, DOI 10.1111/j.0031-9317.2004.00292.x; Christensen AB, 2004, MOL PLANT MICROBE IN, V17, P109, DOI 10.1094/MPMI.2004.17.1.109; Eisenberg D, 2000, BBA-PROTEIN STRUCT M, V1477, P122, DOI 10.1016/S0167-4838(99)00270-8; El-Banna A, 2010, J BIOTECHNOL, V150, P277, DOI 10.1016/j.jbiotec.2010.09.934; Fu YP, 2007, J PLANT RES, V120, P465, DOI 10.1007/s10265-007-0080-5; Gajewska E, 2009, J PLANT PHYSIOL, V166, P1034, DOI 10.1016/j.jplph.2008.12.004; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Gill T, 2012, J PLANT RES, V125, P165, DOI 10.1007/s10265-011-0421-2; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Guo Y, 2002, P NATL ACAD SCI USA, V99, P7786, DOI 10.1073/pnas.112040099; Hansch R, 2009, CURR OPIN PLANT BIOL, V12, P259, DOI 10.1016/j.pbi.2009.05.006; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Jwa NS, 2006, PLANT PHYSIOL BIOCH, V44, P261, DOI 10.1016/j.plaphy.2006.06.010; Kieffer P, 2008, PROTEOMICS, V8, P2514, DOI 10.1002/pmic.200701110; Kung CCS, 2006, PROTEOMICS, V6, P2746, DOI 10.1002/pmic.200500108; LEBECHE D, 1994, BIOCHEM BIOPH RES CO, V202, P556, DOI 10.1006/bbrc.1994.1964; Lee HJ, 2013, PLANT CELL REP, V32, P1521, DOI 10.1007/s00299-013-1464-8; Li CL, 2010, PLANT PHYSIOL, V154, P211, DOI 10.1104/pp.110.161182; Li F, 2009, PLANT MOL BIOL, V71, P251, DOI 10.1007/s11103-009-9521-y; Li LC, 2013, J PHYCOL, V49, P1181, DOI 10.1111/jpy.12129; Liu Z, 2008, J EXP BOT, V59, P939, DOI 10.1093/jxb/ern017; Llorens N, 2000, PLANT SCI, V160, P159, DOI 10.1016/S0168-9452(00)00379-4; Llorente A, 2003, J BIOL CHEM, V278, P35850, DOI 10.1074/jbc.M303425200; Mahajan NS, 2014, PLANT PHYSIOL BIOCH, V74, P212, DOI 10.1016/j.plaphy.2013.11.017; Martinez M, 2012, PHYSIOL PLANTARUM, V145, P85, DOI 10.1111/j.1399-3054.2012.01569.x; Murad AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098463; MURPHY A, 1995, PLANT PHYSIOL, V109, P945, DOI 10.1104/pp.109.3.945; Opella SJ, 2002, CURR OPIN CHEM BIOL, V6, P217, DOI 10.1016/S1367-5931(02)00314-9; Parkash J, 2014, GENE, V542, P1, DOI 10.1016/j.gene.2014.03.032; Parker R, 2006, J EXP BOT, V57, P1109, DOI 10.1093/jxb/erj134; Pechan T, 1999, PLANT MOL BIOL, V40, P111, DOI 10.1023/A:1026494813936; Rajalingam D, 2005, BIOCHEMISTRY-US, V44, P14431, DOI 10.1021/bi051387r; Rana NK, 2008, BIOL PLANTARUM, V52, P361, DOI 10.1007/s10535-008-0075-7; Romero HM, 2004, PLANT PHYSIOL, V136, P3784, DOI 10.1104/pp.104.046656; Roth U, 2006, J EXP BOT, V57, P4003, DOI 10.1093/jxb/erl170; Rouhier N, 2006, PHOTOSYNTH RES, V89, P247, DOI 10.1007/s11120-006-9097-1; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Sarowar S, 2005, PLANT CELL REP, V24, P216, DOI 10.1007/s00299-005-0928-x; Sharmin SA, 2012, PLANT SCI, V187, P113, DOI 10.1016/j.plantsci.2012.02.002; She YM, 2003, MOL CELL PROTEOMICS, V2, P1306, DOI 10.1074/mcp.M300080-MCP200; Shinya T, 2007, PLANT CELL PHYSIOL, V48, P1404, DOI 10.1093/pcp/pcm115; Smith AP, 2004, J BIOL CHEM, V279, P26098, DOI 10.1074/jbc.M402807200; Smith SD, 2004, J PROTEOME RES, V3, P834, DOI 10.1021/pr049941r; Song YF, 2014, BIOMETALS, V27, P265, DOI 10.1007/s10534-014-9707-x; Song YF, 2013, PLANT SOIL, V366, P647, DOI 10.1007/s11104-012-1458-2; Sun XS, 2011, PROTEOMICS, V11, P3288, DOI 10.1002/pmic.201000396; Tan YF, 2010, PLANT PHYSIOL, V152, P747, DOI 10.1104/pp.109.147942; Tang SS, 1996, FREE RADICAL BIO MED, V21, P955, DOI 10.1016/S0891-5849(96)00230-4; Utriainen M, 1998, PLANT CELL ENVIRON, V21, P821, DOI 10.1046/j.1365-3040.1998.00326.x; Vaas LAI, 2012, PLANT CELL REP, V31, P1061, DOI 10.1007/s00299-011-1225-5; Wang YQ, 2005, MOL PLANT MICROBE IN, V18, P385, DOI 10.1094/MPMI-18-0385; Wang Y, 2014, PLANT BIOSYST, V148, P88, DOI 10.1080/11263504.2013.770807; Wen R, 2008, PLANT CELL, V20, P213, DOI 10.1105/tpc.107.051862; Xia Y, 2012, J HAZARD MATER, V233, P65, DOI 10.1016/j.jhazmat.2012.06.047; Xu JY, 2011, PLANT MOL BIOL, V75, P167, DOI 10.1007/s11103-010-9716-2; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Yanez M, 2012, ADV EXP MED BIOL, V740, P461, DOI 10.1007/978-94-007-2888-2_19; Yang GX, 2005, J PROTEOME RES, V4, P456, DOI 10.1021/pr049801h; Yang QS, 2007, PROTEOMICS, V7, P737, DOI 10.1002/pmic.200600703; Yruela I, 2009, FUNCT PLANT BIOL, V36, P409, DOI 10.1071/FP08288; Yu CL, 2008, PHYTOCHEMISTRY, V69, P1989, DOI 10.1016/j.phytochem.2008.04.006; Zang X, 2007, PHYTOCHEMISTRY, V68, P426, DOI 10.1016/j.phytochem.2006.11.005; Zhang HX, 2009, ANN BOT-LONDON, V103, P923, DOI 10.1093/aob/mcp012; Zhao L, 2011, CHEMOSPHERE, V85, P56, DOI 10.1016/j.chemosphere.2011.06.029; Zhou SP, 2009, J EXP BOT, V60, P1849, DOI 10.1093/jxb/erp065	81	33	34	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125367	10.1371/journal.pone.0125367	http://dx.doi.org/10.1371/journal.pone.0125367			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919452	gold, Green Submitted, Green Published			2022-12-27	WOS:000353659400082
J	Guo, J; Shi, X; Yang, WL; Gong, SG; Zhao, QH; Wang, L; He, J; Shi, XF; Sun, XG; Liu, JM				Guo, Jian; Shi, Xue; Yang, Wenlan; Gong, Sugang; Zhao, Qinhua; Wang, Lan; He, Jing; Shi, Xiaofang; Sun, Xingguo; Liu, Jinming			Exercise Physiology and Pulmonary Hemodynamic Abnormality in PH Patients with Exercise Induced Venous-To-Systemic Shunt	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; PATENT FORAMEN OVALE; UPTAKE EFFICIENCY PLATEAU; VENTILATORY EFFICIENCY; OXYGEN-UPTAKE; ATRIAL SEPTOSTOMY; GAS-EXCHANGE; CAPACITY; SURVIVAL; PREVALENCE	Objectives To identify the pulmonary hypertension (PH) patients who develop an exercise induced venous-to-systemic shunt (EIS) by performing the cardiopulmonary exercise test (CPET), analyse the changes of CPET measurements during exercise and compare the exercise physiology and resting pulmonary hemodynamics between shunt-PH and no-shunt-PH patients. Methods Retrospectively, resting pulmonary function test (PFT), right heart catheterization (RHC), and CPET for clinical evaluation of 104 PH patients were studied. Results Considering all 104 PH patients by three investigators, 37 were early EIS+, 61 were EIS-, 3 were late EIS+, and 3 others were placed in the discordant group. PeakVO(2), AT and OUES were all reduced in the shunt-PH patients compared with the no-shunt-PH subjects, whereas VE/VCO2 slope and the lowest VE/VCO2 increased. Besides, the changes and the response characteristics of the key CPET parameters at the beginning of exercise in the shunt group were notably different from those of the no shunt one. At cardiac catheterization, the shunt patients had significantly increased mean pulmonary artery pressure (mPAP), mean right atrial pressure (mRAP) and pulmonary vascular resistance (PVR), reduced cardiac output (CO) and cardiac index (CI) compared with the no shunt ones (P<0.05). Resting CO was significantly correlated with exercise parameters of AT (r = 0.527, P<0.001), OUES (r = 0.410, P<0.001) and Peak VO2 (r = 0.405, P<0.001). PVR was significantly, but weakly, correlated with the above mentioned CPET parameters. In Conclusions CPET may allow a non-invasive method for detecting an EIS and assessing the severity of the disease in PH patients.	[Guo, Jian; Shi, Xue; Yang, Wenlan; Shi, Xiaofang; Liu, Jinming] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Pulm Funct Test, Shanghai 200433, Peoples R China; [Gong, Sugang; Zhao, Qinhua; Wang, Lan; He, Jing; Liu, Jinming] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Pulm Circulat, Shanghai 200433, Peoples R China; [Sun, Xingguo] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Heart Lung Funct Testing Ctr, State Key Lab Cardiovasc Dis,Fuwai Hosp, Beijing 100037, Peoples R China; [Sun, Xingguo] Peking Union Med Coll, Beijing 100037, Peoples R China	Tongji University; Tongji University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Sun, XG (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Heart Lung Funct Testing Ctr, State Key Lab Cardiovasc Dis,Fuwai Hosp, Beijing 100037, Peoples R China.	xgsun@labiomed.org; jinmingliu2013@126.com						American Thoracic Society, 2002, AM J RESP CRIT CARE, V166; Arena R, 2008, HEART FAIL REV, V13, P245, DOI 10.1007/s10741-007-9067-5; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Baba R, 1996, J AM COLL CARDIOL, V28, P1567, DOI 10.1016/S0735-1097(96)00412-3; Barst RJ, 2000, THORAX, V55, P95, DOI 10.1136/thorax.55.2.95; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Davies LC, 2006, EUR HEART J, V27, P684, DOI 10.1093/eurheartj/ehi672; DEBELDER MA, 1992, AM J CARDIOL, V69, P1316, DOI 10.1016/0002-9149(92)91228-V; Fleg JL, 2000, CIRCULATION, V102, P1591, DOI 10.1161/01.CIR.102.13.1591; Groepenhoff H, 2008, MED SCI SPORT EXER, V40, P1725, DOI 10.1249/MSS.0b013e31817c92c0; Guazzi M, 2005, J AM COLL CARDIOL, V46, P1883, DOI 10.1016/j.jacc.2005.07.051; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802; LYNCH JJ, 1984, AM J CARDIOL, V53, P1478, DOI 10.1016/S0002-9149(84)91617-5; MOORTHY SS, 1974, ANESTHESIOLOGY, V41, P405, DOI 10.1097/00000542-197410000-00022; Mortara A, 1997, CIRCULATION, V96, P3450; Opitz CF, 2005, EUR HEART J, V26, P1895, DOI 10.1093/eurheartj/ehi283; Oudiz RJ, 2007, EUR J HEART FAIL, V9, P917, DOI 10.1016/j.ejheart.2007.06.013; Oudiz RJ, 2010, AM J CARDIOL, V105, P1186, DOI 10.1016/j.amjcard.2009.12.024; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Ponikowski P, 1997, AM J CARDIOL, V79, P1645, DOI 10.1016/S0002-9149(97)00215-4; Reindl I, 1998, AM HEART J, V136, P778, DOI 10.1016/S0002-8703(98)70121-8; RHODES J, 1991, J AM COLL CARDIOL, V18, P1738, DOI 10.1016/0735-1097(91)90513-9; RICH S, 1983, AM J CARDIOL, V51, P1560, DOI 10.1016/0002-9149(83)90678-1; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; SIETSEMA KE, 1988, J APPL PHYSIOL, V64, P234, DOI 10.1152/jappl.1988.64.1.234; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; SUE DY, 1991, CHEST, V99, P981, DOI 10.1378/chest.99.4.981; Sun XG, 2001, CIRCULATION, V104, P429, DOI 10.1161/hc2901.093198; Sun XG, 2002, AM J RESP CRIT CARE, V166, P1443, DOI 10.1164/rccm.2202033; Sun XG, 2002, CIRCULATION, V105, P54, DOI 10.1161/hc0102.101509; Sun XG, 2012, CHEST, V141, P1284, DOI 10.1378/chest.11-1270; Sun XG, 2012, EUR J APPL PHYSIOL, V112, P919, DOI 10.1007/s00421-011-2030-0; Ting H, 2001, CHEST, V119, P824, DOI 10.1378/chest.119.3.824; Wensel R, 2000, CIRCULATION, V101, P2388, DOI 10.1161/01.CIR.101.20.2388; Yasunobu Y, 2005, CHEST, V127, P1637, DOI 10.1378/chest.127.5.1637; Zheng JP, 2002, CHINESE MED J-PEKING, V115, P50	38	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0121690	10.1371/journal.pone.0121690	http://dx.doi.org/10.1371/journal.pone.0121690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25918847	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659400009
J	Nakashima, R; Shioiri, S				Nakashima, Ryoichi; Shioiri, Satoshi			Facilitation of Visual Perception in Head Direction: Visual Attention Modulation Based on Head Direction	PLOS ONE			English	Article							EYE-MOVEMENTS; SET-SIZE; SEARCH; PSYCHOPHYSICS; RESOLUTION; GAZE; AMPLITUDE; SELECTION; ACCURACY; DURATION	People usually see things using frontal viewing, and avoid lateral viewing ( or eccentric gaze) where the directions of the head and eyes are largely different. Lateral viewing interferes with attentive visual search performance, probably because the head is directed away from the target and/or because the head and eyes are misaligned. In this study, we examined which of these factors is the primary one for interference by conducting a visual identification experiment where a target was presented in the peripheral visual field. The critical manipulation was the participants' head direction and fixation position: the head was directed to the fixation location, the target position, or the opposite side of the fixation. The performance was highest when the head was directed to the target position even when there was misalignment of the head and eye, suggesting that visual perception can be influenced by both head direction and fixation position.	[Nakashima, Ryoichi] Tohoku Univ, Sendai, Miyagi 980, Japan; Japan Sci & Technol Agcy, Sendai, Miyagi, Japan	Tohoku University; Japan Science & Technology Agency (JST)	Nakashima, R (corresponding author), Tohoku Univ, Sendai, Miyagi 980, Japan.	one.island.one@gmail.com	Shioiri, Satoshi/B-9625-2008	Shioiri, Satoshi/0000-0003-2149-6132	Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST); JSPS KAKENHI [25780441]; Cooperative Research Project of the Research Institute of Electrical Communication (RIEC) at Tohoku University; Grants-in-Aid for Scientific Research [25780441] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cooperative Research Project of the Research Institute of Electrical Communication (RIEC) at Tohoku University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding from The Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST) (http://www.jst.go.jp/kisoken/crest/research_area/ongoing/bunyah21-1.html) to RN and SS; JSPS KAKENHI (http://www.jsps.go.jp/english/e-grants/) Grant Number 25780441 to RN; and The Cooperative Research Project of the Research Institute of Electrical Communication (RIEC) at Tohoku University (http://www.riec.tohoku.ac.jp/nation-wide/index-j.shtml) to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHILL AT, 1975, INVEST OPHTH VISUAL, V14, P468; BERGEN JR, 1983, NATURE, V303, P696, DOI 10.1038/303696a0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carrasco M, 1997, VISION RES, V37, P63, DOI 10.1016/S0042-6989(96)00102-2; Chelazzi L, 1995, BEHAV BRAIN RES, V71, P81, DOI 10.1016/0166-4328(95)00134-4; Cohen J.E., 1988, STAT POWER ANAL BEHA; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Doshi A, 2012, J VISION, V12, DOI [10.1167/12.6.9, 10.1167/12.2.9]; Dunham DN, 1997, INT J PSYCHOPHYSIOL, V27, P171, DOI 10.1016/S0167-8760(97)00054-8; Eckstein MP, 2000, PERCEPT PSYCHOPHYS, V62, P425, DOI 10.3758/BF03212096; Einhauser W, 2009, ANN NY ACAD SCI, V1164, P188, DOI 10.1111/j.1749-6632.2008.03714.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FULLER JH, 1992, EXP BRAIN RES, V92, P152; Fuller JH, 1996, EXP BRAIN RES, V109, P457; HENDERSON JM, 1989, PERCEPT PSYCHOPHYS, V45, P196, DOI 10.3758/BF03210697; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Irwin DE, 2011, ATTEN PERCEPT PSYCHO, V73, P1374, DOI 10.3758/s13414-011-0111-0; KERR JL, 1971, PERCEPT PSYCHOPHYS, V9, P375, DOI 10.3758/BF03212671; Khan AZ, 2009, J NEUROPHYSIOL, V101, P198, DOI 10.1152/jn.90815.2008; KITTERLE FL, 1986, BRAIN COGNITION, V5, P131, DOI 10.1016/0278-2626(86)90052-7; KLEIN R, 1989, PERCEPT PSYCHOPHYS, V46, P476, DOI 10.3758/BF03210863; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Krebs RM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00193; Kunar MA, 2007, J EXP PSYCHOL HUMAN, V33, P816, DOI 10.1037/0096-1523.33.4.816; Loschky LC, 2005, VIS COGN, V12, P1057, DOI 10.1080/13506280444000652; Mannan SK, 1997, SPATIAL VISION, V11, P157, DOI 10.1163/156856897X00177; Nakashima R, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092284, DOI 10.1371/J0URNAL.P0NE.0092284]; Nakashima R, 2013, ATTEN PERCEPT PSYCHO, V75, P299, DOI 10.3758/s13414-012-0402-0; Oommen BS, 2005, BRAIN RES, V1065, P68, DOI 10.1016/j.brainres.2005.10.029; Oommen BS, 2004, EXP BRAIN RES, V155, P9, DOI 10.1007/s00221-003-1694-z; OSAKA N, 1992, J OPT SOC AM A, V9, P5, DOI 10.1364/JOSAA.9.000005; Parkhurst DJ, 2003, SPATIAL VISION, V16, P125, DOI 10.1163/15685680360511645; Pavlovskaya M, 2001, SPATIAL VISION, V14, P151, DOI 10.1163/156856801300202913; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; ROVAMO J, 1982, INVEST OPHTH VIS SCI, V23, P666; SAGI D, 1985, Spatial Vision, V1, P141, DOI 10.1163/156856885X00152; Stahl JS, 2001, EXP BRAIN RES, V136, P200, DOI 10.1007/s002210000593; Stahl JS, 1999, EXP BRAIN RES, V126, P41, DOI 10.1007/s002210050715; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; Tatler BW, 2005, VISION RES, V45, P643, DOI 10.1016/j.visres.2004.09.017; Thumser ZC, 2009, EXP BRAIN RES, V195, P393, DOI 10.1007/s00221-009-1803-8; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; WHITE CT, 1962, J OPT SOC AM, V52, P210, DOI 10.1364/JOSA.52.000210; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016; Wright R.D, 2008, ORIENTING ATTENTION; Xu YD, 2010, J VISION, V10, DOI 10.1167/10.14.24; Zelinsky GJ, 1997, J EXP PSYCHOL HUMAN, V23, P244, DOI 10.1037/0096-1523.23.1.244; Zhao G, 2012, J VISION, V12, DOI 10.1167/12.6.11	50	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124367	10.1371/journal.pone.0124367	http://dx.doi.org/10.1371/journal.pone.0124367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919316	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659400047
J	Singh, SK; Mishra, S; Aspi, J; Kvist, L; Nigam, P; Pandey, P; Sharma, R; Goyal, SP				Singh, Sujeet Kumar; Mishra, Sudhanshu; Aspi, Jouni; Kvist, Laura; Nigam, Parag; Pandey, Puneet; Sharma, Reeta; Goyal, Surendra Prakash			Tigers of Sundarbans in India: Is the Population a Separate Conservation Unit?	PLOS ONE			English	Article							MICROSATELLITE LOCI; COMPUTER-PROGRAM; GENE FLOW; SIZE; INFERENCE; SOFTWARE; RATES; EVOLUTION; SELECTION; SAMPLES	The Sundarbans tiger inhabits a unique mangrove habitat and are morphologically distinct from the recognized tiger subspecies in terms of skull morphometrics and body size. Thus, there is an urgent need to assess their ecological and genetic distinctiveness and determine if Sundarbans tigers should be defined and managed as separate conservation unit. We utilized nine microsatellites and 3 kb from four mitochondrial DNA (mtDNA) genes to estimate genetic variability, population structure, demographic parameters and visualize historic and contemporary connectivity among tiger populations from Sundarbans and mainland India. We also evaluated the traits that determine exchangeability or adaptive differences among tiger populations. Data from both markers suggest that Sundarbans tiger is not a separate tiger subspecies and should be regarded as Bengal tiger (P. t. tigris) subspecies. Maximum likelihood phylogenetic analyses of the mtDNA data revealed reciprocal monophyly. Genetic differentiation was found stronger for mtDNA than nuclear DNA. Microsatellite markers indicated low genetic variation in Sundarbans tigers (He=0.58) as compared to other mainland populations, such as northern and Peninsular (Hebetween 0.67-0.70). Molecular data supports migration between mainland and Sundarbans populations until very recent times. We attribute this reduction in gene flow to accelerated fragmentation and habitat alteration in the landscape over the past few centuries. Demographic analyses suggest that Sundarbans tigers have diverged recently from peninsular tiger population within last 2000 years. Sundarbans tigers are the most divergent group of Bengal tigers, and ecologically non-exchangeable with other tiger populations, and thus should be managed as a separate "evolutionarily significant unit" (ESU) following the adaptive evolutionary conservation (AEC) concept.	[Singh, Sujeet Kumar; Aspi, Jouni; Kvist, Laura] Univ Oulu, Dept Biol, Oulu, Finland; [Singh, Sujeet Kumar; Mishra, Sudhanshu; Nigam, Parag; Pandey, Puneet; Goyal, Surendra Prakash] Wildlife Inst India, Dept Anim Ecol & Conservat Biol, Dehra Dun, India; [Sharma, Reeta] Inst Gulbenkian Ciencias, Populat & Conservat Genet, P-2780156 Oeiras, Portugal	University of Oulu; Wildlife Institute of India; Instituto Gulbenkian de Ciencia	Goyal, SP (corresponding author), Wildlife Inst India, Dept Anim Ecol & Conservat Biol, Dehra Dun, India.	goyalsp@wii.gov.in	Singh, Sujeet Kumar/ABC-2594-2020; Aspi, Jouni O/B-3087-2012; MISHRA, SUDHANSHU/E-6732-2011	Singh, Sujeet Kumar/0000-0002-3671-1328; PANDEY, PUNEET/0000-0001-5891-3927; Sharma, Reeta/0000-0001-9862-9218; Aspi, Jouni/0000-0002-2451-3201	Wildlife Institute of India, Dehra Dun, India	Wildlife Institute of India, Dehra Dun, India	Funding: This work was supported by the Wildlife Institute of India, Dehra Dun, India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F., 2007, CONSERVATION GENETIC; Allendorf F, 2013, CONSERV GENET, V2nd; Balloux F, 2000, ACTA THERIOL, V45, P93, DOI 10.4098/AT.arch.00-65; Balow DCA, 2009, THESIS U MINNESOTA, P29; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barlow ACD, 2010, MAMMALIA, V74, P329, DOI 10.1515/MAMM.2010.040; Bera G. K., 2010, LAGOONS GANGETIC DEL; Borthakur U, 2010, NONINVASIVE GENETIC, DOI [10.1007/s10344-010-0471-0, DOI 10.1007/S10344-010-0471-0]; Chakrabarti K., 1992, MAN EATING TIGERS; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Coyne J.A., 2004, SPECIATION; CRANDALL KA, 1993, GENETICS, V134, P959; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Dinerstein E, 2007, BIOSCIENCE, V57, P508, DOI 10.1641/B570608; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eaton R.M., 1990, AGR HUM VALUES, V7, P6, DOI [10.1007/BF01530432, DOI 10.1007/BF01530432]; England PR, 2010, CONSERV GENET, V11, P2425, DOI 10.1007/s10592-010-0112-x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faubet P, 2007, MOL ECOL, V16, P1149, DOI 10.1111/j.1365-294X.2007.03218.x; Fernando P, 2003, PLOS ONE, V3, P382; Fitzpatrick BM, 2004, EVOLUTION, V58, P1865; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hedrick PW, 2013, J HERED, V104, P713, DOI 10.1093/jhered/est047; Hemmer H, 2004, NEUES JB GEOLOGIE PA, V233, P97; Holycross AT, 2007, BIOL CONSERV, V134, P142, DOI 10.1016/j.biocon.2006.07.020; Hoogesteijn Rafael, 1996, Bulletin of the Florida Museum of Natural History, V39, P195; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; IRIARTE JA, 1990, OECOLOGIA, V85, P185, DOI 10.1007/BF00319400; Jackson P., 1996, BIOL CONSERVATION; Janecka JE, 2008, ANIM CONSERV, V11, P401, DOI 10.1111/j.1469-1795.2008.00195.x; Jhala Y, 2008, STATUS TIGERS COPRED; Jhala Y. V., 2011, STATUS TIGERS COPRED; Johnsingh A., 2004, RR04001 WILDL I IND; Johnson PCD, 2007, GENETICS, V175, P827, DOI 10.1534/genetics.106.064618; Joshi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077980; Karanth K. Ullas, 2003, Journal of the Bombay Natural History Society, V100, P169; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kershaw F, 2013, J HERED, V104, P755, DOI 10.1093/jhered/est057; Khan H, 2008, J BOMBAY NAT HIST SO, V105; Khan M.M.H., 2004, THESIS U CAMBRIDGE THESIS U CAMBRIDGE; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Loucks C, 2010, CLIMATIC CHANGE, V98, P291, DOI 10.1007/s10584-009-9761-5; Luo SJ, 2004, PLOS BIOL, V2, P2275, DOI 10.1371/journal.pbio.0020442; Mayr E, 1942, SYSTEMATICS ORIGIN S; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Mishra S, 2014, AFRI J BIOT, DOI [10.5897/AJB12.2977, DOI 10.5897/AJB12.2977]; Mishra S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-4; Mondol S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0496; Mondol S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000585; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Najman Y, 2008, EARTH PLANET SC LETT, V273, P1, DOI 10.1016/j.epsl.2008.04.028; Nunn PD, 2006, COAST SYST CONT MARG, V10, P93; Owen-Smith N, 2008, J ANIM ECOL, V77, P173, DOI 10.1111/j.1365-2656.2007.01314.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; PRAGER EM, 1975, P NATL ACAD SCI USA, V72, P200, DOI 10.1073/pnas.72.1.200; Pritchard JK, 2000, GENETICS, V155, P945; Qureshi Q, 2006, EVALUATING TIGER HAB; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reddy PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029827; Reza A, 2001, J ZOOL, V29, P173; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Sanderson E., 2006, SETTING PRIORITIES C; Sharma R, 2008, MOL ECOL RESOUR, V8, P1480, DOI 10.1111/j.1755-0998.2008.02292.x; Sharma R, 2011, MAMM BIOL, V76, P484, DOI 10.1016/j.mambio.2010.10.005; Sharma R, 2009, CONSERV GENET, V10, P909, DOI 10.1007/s10592-008-9568-3; Sharma S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1506; SLATKIN M, 1995, GENETICS, V139, P457; SMITH JLD, 1991, CONSERV BIOL, V5, P484, DOI 10.1111/j.1523-1739.1991.tb00355.x; Smith L. M., 2004, BMC Ecology, V4, P4, DOI 10.1186/1472-6785-4-4; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waples R.S., 1991, MAR FISH REV, V53, P11; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GA, 2003, GENETICS, V163, P1177; Wright S, 1931, GENETICS, V16, P0097; Zhu Y, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-227	93	27	28	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0118846	10.1371/journal.pone.0118846	http://dx.doi.org/10.1371/journal.pone.0118846			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919139	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400001
J	Soleyman-Jahi, S; Nedjat, S; Abdirad, A; Hoorshad, N; Heidari, R; Zendehdel, K				Soleyman-Jahi, Saeed; Nedjat, Saharnaz; Abdirad, Afshin; Hoorshad, Niloofar; Heidari, Reza; Zendehdel, Kazem			Prognostic Significance of Matrix Metalloproteinase-7 in Gastric Cancer Survival: A Meta-Analysis	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE-9 EXPRESSION; MATRILYSIN EXPRESSION; POOR-PROGNOSIS; INVASIVE FRONT; MESSENGER-RNA; E-CADHERIN; TUMORS; MMP-7; RECURRENCE; INHIBITOR	The prognostic role of matrix metalloproteinase-7 in gastric cancer survival has been widely evaluated. However, the results are controversial. We aimed to set up a meta-analysis to reach a conclusion on the prognostic significance of metalloproteinase-7 in gastric cancer survival as well as its association with clinicopathological parameters. We searched popular databases from 1988 until October 2014 to gather eligible peer-reviewed papers addressing the prognostic effect of matrix metalloproteinase-7 in gastric cancer patients' survival. The CASP check list was used for quality appraisal. Pooled hazard ratio (HR) for survival and odds ratio (OR) for association with their 95% confidence interval (CI) were considered as summary measurements. Finally, 1208 gastric cancer patients from nine studies were included in the meta-analysis. Pooled HR estimate for survival was 2.01 (95% CI = 1.62 - 2.50, P < 0.001), which indicated a significant poor prognostic effect for matrix metalloproteinase-7. Sensitivity analysis detected no dominancy for any study. No publication bias was detected according to Egger's and Begg's tests. Clinicopathological assessment revealed that higher matrix metalloproteinase-7 expression is associated with deeper invasion (pooled OR = 3.20; 95% CI = 1.14 - 8.96; P = 0.026), higher TNM stage (pooled OR = 3.67; 95% CI = 2.281-5.99; P<0.001), lymph node metastasis (pooled OR = 2.84; 95% CI = 1.89 -4.25; P<0.001), and distant metastasis (pooled OR = 3.68; 95% CI = 1.85 - 7.29; P<0.001), but not with histological grade. This meta-analysis indicated a significant poor prognostic effect of matrix metalloproteinase-7 in gastric cancer survival. Additionally it was associated with aggressive tumor phenotype.	[Soleyman-Jahi, Saeed; Abdirad, Afshin; Hoorshad, Niloofar; Zendehdel, Kazem] Univ Tehran Med Sci, Canc Inst Iran, Canc Res Ctr, Tehran, Iran; [Nedjat, Saharnaz] Univ Tehran Med Sci, KURC, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Heidari, Reza] Univ Tehran Med Sci, Sch Med, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Zendehdel, K (corresponding author), Univ Tehran Med Sci, Canc Inst Iran, Canc Res Ctr, Tehran, Iran.	kzendeh@tums.ac.ir		Soleymanjahi, Saeed/0000-0002-9281-3476; Zendehdel, Kazem/0000-0002-0269-4945	Tehran University of Medical Sciences [93-01-51-25150]	Tehran University of Medical Sciences(Tehran University of Medical Sciences)	Funding: This project is supported by grant number 93-01-51-25150 from Tehran University of Medical Sciences (http://research.tums.ac.ir) to KZ and SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2001, INT J CANCER, V95, P290, DOI 10.1002/1097-0215(20010920)95:5<290::AID-IJC1050>3.0.CO;2-I; Ajisaka H, 2004, HEPATO-GASTROENTEROL, V51, P900; Beeghly-Fadiel A, 2009, INT J CANCER, V124, P208, DOI 10.1002/ijc.23859; Blanco-Calvo M, 2014, FUTURE ONCOL, V10, P1187, DOI 10.2217/fon.13.263; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Chaudhary AK, 2013, MUTAT RES-REV MUTAT, V753, P7, DOI 10.1016/j.mrrev.2013.01.002; DAVIES B, 1993, CANCER RES, V53, P2087; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fanelli MF, 2012, HISTOPATHOLOGY, V61, P153, DOI 10.1111/j.1365-2559.2011.04139.x; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gadducci A, 2009, CRIT REV ONCOL HEMAT, V69, P12, DOI 10.1016/j.critrevonc.2008.05.001; Gershtein ES, 2007, B EXP BIOL MED+, V143, P459, DOI 10.1007/s10517-007-0156-1; Gershtein ES, 2010, B EXP BIOL MED+, V149, P628, DOI 10.1007/s10517-010-1010-4; Gerstein ES, 2009, B EXP BIOL MED+, V148, P899, DOI 10.1007/s10517-010-0847-x; Hadler-Olsen E, 2013, TUMOR BIOL, V34, P2041, DOI 10.1007/s13277-013-0842-8; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ii M, 2006, EXP BIOL MED, V231, P20; IMAI K, 1995, J BIOL CHEM, V270, P6691, DOI 10.1074/jbc.270.12.6691; Jezierska A, 2009, MED SCI MONITOR, V15, pRA32; Katunina AI, 2011, B EXP BIOL MED+, V151, P359, DOI 10.1007/s10517-011-1330-z; Kim BS, 2011, HEPATO-GASTROENTEROL, V58, P1032; Kim JH, 2011, J KOREAN SURG SOC, V80, P29, DOI 10.4174/jkss.2011.80.1.29; Koskensalo S, 2011, TUMOR BIOL, V32, P259, DOI 10.1007/s13277-010-0080-2; Koskensalo S, 2010, TUMOR BIOL, V31, P149, DOI 10.1007/s13277-010-0020-1; Kubben FJGM, 2006, BRIT J CANCER, V94, P1035, DOI 10.1038/sj.bjc.6603041; Lee KH, 2006, ONCOL REP, V16, P823; Li CY, 2013, TUMOR BIOL, V34, P735, DOI 10.1007/s13277-012-0601-2; Li Z, 2014, TUMOR BIOL, V35, P3463, DOI 10.1007/s13277-013-1458-8; Liu D, 2007, LUNG CANCER, V58, P384, DOI 10.1016/j.lungcan.2007.07.005; Liu XP, 2002, JPN J CANCER RES, V93, P291, DOI 10.1111/j.1349-7006.2002.tb02171.x; Long ZW, 2014, TUMOR BIOL, V35, P11415, DOI 10.1007/s13277-014-2441-8; MATRISIAN LM, 1992, BIOESSAYS, V14, P455, DOI 10.1002/bies.950140705; MIYAZAKI K, 1990, CANCER RES, V50, P7758; North H, 2000, Int J Surg Investig, V2, P213; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; PAJOUH MS, 1991, J CANCER RES CLIN, V117, P144, DOI 10.1007/BF01613138; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Parsons SL, 1997, BRIT J SURG, V84, P160, DOI 10.1002/bjs.1800840206; Peng WJ, 2012, CLIN CHIM ACTA, V413, P1121, DOI 10.1016/j.cca.2012.03.012; Qian QA, 2010, CANCER INVEST, V28, P661, DOI 10.3109/07357901003735634; Sawada T, 2015, GASTRIC CANCER, V18, P119, DOI 10.1007/s10120-014-0338-2; Shen WS, 2014, J CANCER RES CLIN, V140, P1003, DOI 10.1007/s00432-014-1630-6; Song J, 2013, ASIAN PAC J CANCER P, V14, P1615, DOI 10.7314/APJCP.2013.14.3.1615; Szarvas T, 2011, NAT REV UROL, V8, P241, DOI 10.1038/nrurol.2011.44; Szarvas T, 2011, PATHOL ONCOL RES, V17, P325, DOI 10.1007/s12253-010-9320-4; Szarvas T, 2011, INT J CANCER, V128, P1486, DOI 10.1002/ijc.25454; Tierney GM, 1999, EUR J CANCER, V35, P563, DOI 10.1016/S0959-8049(99)00007-6; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Van Der Jagt MFP, 2010, J SURG ONCOL, V101, P259, DOI 10.1002/jso.21462; Vihinen P, 2002, INT J CANCER, V99, P157, DOI 10.1002/ijc.10329; vonBredow DC, 1997, EXP CELL RES, V236, P341, DOI 10.1006/excr.1997.3711; Wang WS, 2006, CARCINOGENESIS, V27, P1113, DOI 10.1093/carcin/bgi351; Wen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059154; Wielockx B, 2004, CYTOKINE GROWTH F R, V15, P111, DOI 10.1016/j.cytogfr.2003.12.001; Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303; WOESSNER JF, 1988, J BIOL CHEM, V263, P16918; Yamamoto H, 1999, CANCER RES, V59, P3313; Yeh YC, 2010, DIGEST DIS SCI, V55, P1649, DOI 10.1007/s10620-009-0926-x; Yonemura Y, 2001, J EXP CLIN CANC RES, V20, P205; Yonemura Yutaka, 2000, Gastric Cancer, V3, P63, DOI 10.1007/PL00011698; Zhang QW, 2012, ASIAN PAC J CANCER P, V13, P2903, DOI 10.7314/APJCP.2012.13.6.2903	64	24	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0122316	10.1371/journal.pone.0122316	http://dx.doi.org/10.1371/journal.pone.0122316			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919283	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659400013
J	Zhu, W; Wu, Y; Xu, M; Wang, JY; Meng, YF; Gu, Z; Lu, J				Zhu, Wei; Wu, Yan; Xu, Ming; Wang, Jin-Yu; Meng, Yi-Fang; Gu, Zheng; Lu, Jiong			Antiphospholipid Antibody and Risk of Retinal Vein Occlusion: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							HYPERCOAGULABLE STATES; THROMBOPHILIA; HOMOCYSTEINE; THROMBOSIS	Background Retinal vein occlusion (RVO) is a common retinal vascular disease and it is one of the most frequently reported causes of visual damage and blindness in the elderly. The current study investigated the potential association between antiphospholipid antibodies (APLA) and RVO risk by conducting a meta-analysis of case-control studies. Methods A systematic literature search of Pubmed and Embase databases was conducted in August 1st, 2014. Odds ratios (ORs) were used to evaluate the associations between APLA and the incidence of RVO. A random-effects model was obtained for the quantitative synthesis. Results A total of 11 studies were included in this meta-analysis. A meta-analysis of all studies assessing the risk of RVO revealed that APLA was associated with a statistically increased risk of RVO incidence (OR = 5.18, 95% CI = [3.37, 7.95]). The association between anticardiolipin antibodies (ACA) and the risk of RVO was significant (n = 8, OR = 4.59, 95% CI = [ 2.75, 7.66]). However, the association between lupus anticoagulants (LA) and risk of RVO was non-significant (n = 5, OR = 3.90, 95% CI = [0.99, 15.37]). No significant publication bias was found in the 11 selected studies. Conclusion APLA was significantly associated with the risk of RVO. Advanced analyses showed that ACA rather than LA affected the risk of RVO. Additional well-designed and well-conducted epidemiological studies are required to further our understanding of the relationship between APLA and RVO risk.	[Zhu, Wei; Xu, Ming; Wang, Jin-Yu; Meng, Yi-Fang; Gu, Zheng; Lu, Jiong] Changshu 2 Peoples Hosp, Dept Ophthalmol, Changsha, Hunan, Peoples R China; [Wu, Yan] Jiangsu Univ, Peoples Hosp Kunshan 1, Dept Ophthalmol, Suzhou, Peoples R China	Jiangsu University	Lu, J (corresponding author), Changshu 2 Peoples Hosp, Dept Ophthalmol, Changsha, Hunan, Peoples R China.	cslujiong@163.com						Abayi DAM, 2012, J FR OPHTALMOL, V35, P426, DOI 10.1016/j.jfo.2011.11.008; Abu El-Asrar AM, 1998, DOC OPHTHALMOL, V95, P133, DOI 10.1023/A:1001795918894; AbuElAsrar AM, 1997, INT OPHTHALMOL, V20, P197; Adamczuk YP, 2002, BLOOD COAGUL FIBRIN, V13, P623, DOI 10.1097/00001721-200210000-00007; Aggarwal Rohina S, 2013, J Hum Reprod Sci, V6, P79, DOI 10.4103/0974-1208.112389; Ali O, 2011, OPTOMETRY, V82, P428, DOI 10.1016/j.optm.2010.07.032; Atchaneeyasakul LO, 2005, JPN J OPHTHALMOL, V49, P211, DOI 10.1007/s10384-005-0190-3; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Braithwaite T, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007325.pub3; Cernak M, 2012, BRATISL MED J, V113, P228, DOI 10.4149/BLL_2012_052; Cobo-Soriano R, 1999, AM J OPHTHALMOL, V128, P725, DOI 10.1016/S0002-9394(99)00311-6; de Medeiros DM, 2014, LUPUS; Dong N, 2013, CURR EYE RES, V38, P1153, DOI 10.3109/02713683.2013.809124; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fiebai B, 2014, NIGER J CLIN PRACT, V17, P462, DOI 10.4103/1119-3077.134040; GLACETBERNARD A, 1994, ARCH OPHTHALMOL-CHIC, V112, P790, DOI 10.1001/archopht.1994.01090180088041; Glueck CJ, 2012, CLIN OPHTHALMOL, V6, P1377, DOI 10.2147/OPTH.S34627; Kamei M, 2014, JAMA OPHTHALMOL, V132, P361, DOI 10.1001/jamaophthalmol.2013.6334; Kolar P, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/724780; Maaroufi R M, 2004, East Mediterr Health J, V10, P627; Marcucci R, 2001, THROMB HAEMOSTASIS, V86, P772; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mrad M, 2014, J STROKE CEREBROVASC, V23, P1592, DOI 10.1016/j.jstrokecerebrovasdis.2013.12.048; Pasoto SG, 2012, CLIN RHEUMATOL, V31, P1331, DOI 10.1007/s10067-012-2019-z; Plunkett O, 2014, BRIT J OPHTHALMOL, V98, P1141, DOI 10.1136/bjophthalmol-2013-304646; Risse F, 2014, OPHTHALMOLOGICA, V232, P46, DOI 10.1159/000360013; Ruffatti A, 2014, THROMB HAEMOST, V112; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Van Cott EM, 2004, BLOOD COAGUL FIBRIN, V15, P393, DOI 10.1097/01.mbc.0000114442.59147.8d	29	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0122814	10.1371/journal.pone.0122814	http://dx.doi.org/10.1371/journal.pone.0122814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25918850	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400020
J	Agaisse, H; Derre, I				Agaisse, Herve; Derre, Isabelle			STIM1 Is a Novel Component of ER-Chlamydia trachomatis Inclusion Membrane Contact Sites	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; WADDLIA-CHONDROPHILA; GOLGI-APPARATUS; PLASMA-MEMBRANE; CELLS; TRAFFICKING; SPHINGOLIPIDS; COMPLEX; ENTRY; ORGANIZATION	Productive developmental cycle of the obligate intracellular bacterial pathogen Chlamydia trachomatis depends on the interaction of the replicative vacuole, named the inclusion, with cellular organelles. We have recently reported the formation of ER-Inclusion membrane contact sites (MCSs), where the endoplasmic reticulum (ER) is in apposition to the inclusion membrane. These platforms contain the C. trachomatis inclusion membrane protein IncD, the mammalian ceramide transfer protein CERT and the ER resident proteins VAPA/B and were proposed to play a role in the non-vesicular trafficking of lipids to the inclusion. Here, we identify STIM1 as a novel component of ER-Inclusion MCSs. STIM1, an ER calcium (Ca2+) sensor that relocate to ER-Plasma Membrane (PM) MCSs upon Ca2+ store depletion, associated with C. trachomatis inclusion. STIM1, but not the general ER markers Rtn3C and Sec61 beta, was enriched at the inclusion membrane. Ultra-structural studies demonstrated that STIM1 localized to ER-Inclusion MCSs. Time-course experiments showed that STIM1, CERT and VAPB co-localized throughout the developmental cycle. By contrast, Orai1, the PM Ca2+ channel that interacts with STIM1 at ER-PM MCSs, did not associate with C. trachomatis inclusion. Upon ER Ca2+ store depletion, a pool of STIM1 relocated to ER-PM MCSs, while the existing ER-Inclusion MCSs remained enriched in STIM1. Finally, we have identified the CAD domain, which mediates STIM1-Orai1 interaction, as the minimal domain required for STIM1 enrichment at ER-Inclusion MCSs. Altogether this study identifies STIM1 as a novel component of ER-C. trachomatis inclusion MCSs. We discuss the potential role(s) of STIM1 during the infection process.	[Agaisse, Herve; Derre, Isabelle] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA	Yale University	Derre, I (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA.	isabelle.derre@yale.edu			National Institute of Allergy and Infectious Diseases (NIAID) [AI101441]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101441] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases (NIAID) grant AI101441 to ID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2014, INFECT IMMUN, V82, P2037, DOI 10.1128/IAI.01530-14; Agaisse H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057090; Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; Bastidas RJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010256; CONNOLLY CN, 1994, J CELL BIOL, V127, P641, DOI 10.1083/jcb.127.3.641; Croxatto A, 2010, MICROBIOL-SGM, V156, P340, DOI 10.1099/mic.0.034546-0; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; de Barsy M, 2013, MICROBES INFECT, V15, P1033, DOI 10.1016/j.micinf.2013.09.010; Derre I, 2007, PLOS PATHOG, V3, P1446, DOI 10.1371/journal.ppat.0030155; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Dumoux M, 2012, TRAFFIC, V13, P1612, DOI 10.1111/tra.12002; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; FRIIS RR, 1972, J BACTERIOL, V110, P706, DOI 10.1128/JB.110.2.706-721.1972; Giles DK, 2008, MICROBES INFECT, V10, P1494, DOI 10.1016/j.micinf.2008.09.001; Grieshaber SS, 2003, J CELL SCI, V116, P3793, DOI 10.1242/jcs.00695; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Hyser JM, 2013, J VIROL, V87, P13579, DOI 10.1128/JVI.02629-13; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Lewis RS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003970; Majeed M, 1999, J CELL SCI, V112, P35; Mehlitz A, 2014, CELL MICROBIOL, V16, P1224, DOI 10.1111/cmi.12278; Mogelsvang S, 2004, TRAFFIC, V5, P338, DOI 10.1111/j.1398-9219.2004.00186.x; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Pilhofer M, 2014, ENVIRON MICROBIOL, V16, P417, DOI 10.1111/1462-2920.12299; Prakriya M, 2013, CURR TOP MEMBR, V71, P1, DOI 10.1016/B978-0-12-407870-3.00001-9; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Schwan C, 2014, P NATL ACAD SCI USA, V111, P2313, DOI 10.1073/pnas.1311589111; Scidmore MA, 1996, J CELL BIOL, V134, P363, DOI 10.1083/jcb.134.2.363; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Srikanth S, 2012, J PHYSIOL-LONDON, V590, P4169, DOI 10.1113/jphysiol.2012.231522; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; van Ooij C, 2000, CELL MICROBIOL, V2, P627, DOI 10.1046/j.1462-5822.2000.00077.x; Vignola MJ, 2010, J BIOL CHEM, V285, P21625, DOI 10.1074/jbc.M110.103010; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014	41	16	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125671	10.1371/journal.pone.0125671	http://dx.doi.org/10.1371/journal.pone.0125671			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915399	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100141
J	Ni, GZ; Qin, JM; Li, HL; Chen, ZY; Zhou, YF; Fang, ZY; Chen, YS; Zhou, JQ; Huang, M; Zhou, LM				Ni, Guanzhong; Qin, Jiaming; Li, Hongliang; Chen, Ziyi; Zhou, Yafang; Fang, Ziyan; Chen, Yishu; Zhou, Jueqian; Huang, Min; Zhou, Liemin			Effects of Antiepileptic Drug Monotherapy on One-Carbon Metabolism and DNA Methylation in Patients with Epilepsy	PLOS ONE			English	Article							PLASMA HOMOCYSTEINE; VASCULAR-DISEASE; SODIUM VALPROATE; RISK-FACTORS; SERUM-LEVELS; FOLATE; HYPERHOMOCYSTEINEMIA; VITAMIN-B12; EXPOSURE; CHILDREN	Purpose The aim of this study was to compare the serum levels of one-carbon metabolism (OCM) nutrients (e.g., folate, homocysteine and vitamin B12) and peripheral blood DNA methylation in epileptic patients under treatment with antiepileptic drugs (AEDs) and in healthy controls. Methods In this cross-sectional study, 60 patients with epilepsy who were receiving valproate (VPA) (n = 30) or lamotrigine (LTG) (n = 30) monotherapy were enrolled. Thirty age and sex matched healthy subjects served as the controls. Serum concentrations of OCM nutrients and peripheral blood DNA methylation status were measured. Results Compared to the control group, the VPA group had higher serum levels of homocysteine (p<0.05). No difference in homocysteine concentration was observed in the LTG group. Patients receiving VPA or LTG had significantly lower serum folate levels in comparison with controls (p<0.001). The level of methylation of long interspersed nucleotide element-1 (LINE-1) in peripheral blood was not significantly different between the AED monotherapy group and healthy controls. A difference in the methylation levels of methylenetetrahydrofolate reductase (MTHFR) amplicon was observed between AED-treated patients with epilepsy and controls (p<0.01). A positive correlation between serum folate levels and peripheral blood MTHFR amplicon methylation status was also observed (r = 0.25, p = 0.023). Conclusion Our findings suggest that the effects of AED monotherapy on OCM may induce specific regions of DNA hypomethylation.	[Ni, Guanzhong; Qin, Jiaming; Chen, Ziyi; Fang, Ziyan; Chen, Yishu; Zhou, Jueqian; Zhou, Liemin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Hongliang; Zhou, Yafang; Huang, Min] Sun Yat Sen Univ, Sch Pharmaceut Sci, Inst Clin Pharmacol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhou, LM (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	lmzhou56@163.com		Ni, Guanzhong/0000-0002-2334-3423	National Natural Science Foundation of China [81071050]; Natural Science Foundation of Guangdong Province [S2011020005483]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was funded by grants from the National Natural Science Foundation of China (81071050, http://isisn.nsfc.gov.cn) and the Natural Science Foundation of Guangdong Province (S2011020005483, http://gdsf.gdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apeland T, 2001, EPILEPSY RES, V47, P27, DOI 10.1016/S0920-1211(01)00288-1; Belcastro V, 2010, EPILEPSIA, V51, P274, DOI 10.1111/j.1528-1167.2009.02303.x; Campbell E, 2014, J NEUROL NEUROSUR PS, V85, P1029, DOI 10.1136/jnnp-2013-306318; Chang SY, 2013, J CELL BIOCHEM, V114, P1549, DOI 10.1002/jcb.24496; Chuang YC, 2012, EPILEPSIA, V53, P120, DOI 10.1111/j.1528-1167.2011.03316.x; Crider KS, 2012, ADV NUTR, V3, P21, DOI 10.3945/an.111.000992; Emes RD, 2013, EPILEPSIA, V54, pe16, DOI 10.1111/j.1528-1167.2012.03673.x; Felkner M, 2009, BIRTH DEFECTS RES A, V85, P574, DOI 10.1002/bdra.20545; Gidal BE, 2005, EPILEPSY RES, V64, P161, DOI 10.1016/j.eplepsyres.2005.03.005; Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001/jama.277.22.1775; Hernandez-Diaz S, 2012, NEUROLOGY, V78, P1692, DOI 10.1212/WNL.0b013e3182574f39; Iqbal MM, 2001, SOUTH MED J, V94, P304; Karabiber H, 2003, BRAIN DEV-JPN, V25, P113, DOI 10.1016/S0387-7604(02)00163-8; Kim YI, 2004, ENVIRON MOL MUTAGEN, V44, P10, DOI 10.1002/em.20025; Meador KJ, 2013, LANCET NEUROL, V12, P244, DOI 10.1016/S1474-4422(12)70323-X; Mintzer S, 2010, CURR OPIN NEUROL, V23, P164, DOI 10.1097/WCO.0b013e32833735e7; Ni G, 2014, BMJ OPEN, V4, DOI [10.1136/bmjopen-2014-004936, DOI 10.1136/BMJ0PEN-2014-004936]; Ornoy A, 2009, REPROD TOXICOL, V28, P1, DOI 10.1016/j.reprotox.2009.02.014; Perng W, 2014, NUTR METAB CARDIOVAS, V24, P614, DOI 10.1016/j.numecd.2013.11.011; Roy M, 2008, J CELL BIOCHEM, V105, P467, DOI 10.1002/jcb.21847; Semmler A, 2013, CLIN CHEM LAB MED, V51, P665, DOI 10.1515/cclm-2012-0580; Shah S, 2014, GENOME RES, V24, P1725, DOI 10.1101/gr.176933.114; Sheng W, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-20; Smith AK, 2012, EPIGENETICS-US, V7, P458, DOI 10.4161/epi.19617; Stolk L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078462; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tremolizzo L, 2012, PROG NEURO-PSYCHOPH, V39, P47, DOI 10.1016/j.pnpbp.2012.04.016; Tumer L, 2002, ACTA PAEDIATR, V91, P923, DOI 10.1080/080352502760272597; Verrotti A, 2000, EPILEPSY RES, V41, P253, DOI 10.1016/S0920-1211(00)00150-9; Verrotti A, 2011, EPILEPSIA, V52, P199, DOI 10.1111/j.1528-1167.2010.02897.x; Yoo JH, 1999, METABOLISM, V48, P1047, DOI 10.1016/S0026-0495(99)90204-4	31	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125656	10.1371/journal.pone.0125656	http://dx.doi.org/10.1371/journal.pone.0125656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915064	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659100140
J	Ogihara, MH; Hikiba, J; Suzuki, Y; Taylor, D; Kataoka, H				Ogihara, Mari Horigane; Hikiba, Juri; Suzuki, Yutaka; Taylor, Demar; Kataoka, Hiroshi			Ovarian Ecdysteroidogenesis in Both Immature and Mature Stages of an Acari, Ornithodoros moubata	PLOS ONE			English	Article							SOFT TICK; MOLTING HORMONE; BOMBYX-MORI; PROTHORACIC GLANDS; ECDYSONE; EXPRESSION; ARGASIDAE; BIOSYNTHESIS; DROSOPHILA; SILKWORM	Ecdysteroidogenesis is essential for arthropod development and reproduction. Although the importance of ecdysteroids has been demonstrated, there is little information on the sites and enzymes for synthesis of ecdysteroids from Chelicerates. Ecdysteroid functions have been well studied in the soft tick Ornithodoros moubata, making this species an excellent candidate for elucidating ecdysteroidogenesis in Chelicerates. Results showed that O. moubata has at least two ecdysteroidogenic enzymes, Spook (OmSpo) and Shade (OmShd). RNAi showed both enzymes were required for ecdysteroidogenesis. Enzymatic assays demonstrated OmShd has the conserved functions of ecdysone 20-hydroxylase. OmSpo showed specific expression in the ovaries of final nymphal and adult stages, indicating O. moubata utilizes the ovary as an ecdysteroidogenic tissue instead of specific tissues as seen in other arthropods. On the other hand, OmShd expression was observed in various tissues including the midgut, indicating functional ecdysteroids can be produced in these tissues. In nymphal stages, expression of both OmSpo and OmShd peaked before molting corresponding with high ecdysteroid titers in the hemolymph. In fed adult females, OmSpo expression peaked at 8-10 days after engorgement, while OmShd expression peaked immediately after engorgement. Mated females showed more frequent surges of OmShd than virgin females. These results indicate that the regulation of synthesis of ecdysteroids differs in nymphs and adult females, and mating modifies adult female ecdysteroidogenesis. This is the first report to focus on synthesis of ecdysteroids in ticks and provides essential knowledge for understanding the evolution of ecdysteroidogenesis in arthropods.	[Ogihara, Mari Horigane; Hikiba, Juri; Suzuki, Yutaka; Kataoka, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Taylor, Demar] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Tokyo; University of Tsukuba	Ogihara, MH (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan.	m-h-ogihara@ib.k.u-tokyo.ac.jp; taylor.de.mar.ge@u.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23-5268]; Promotion of Basic Research Activities for Innovation Biosciences; Suntory Foundation for Life Sciences	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promotion of Basic Research Activities for Innovation Biosciences; Suntory Foundation for Life Sciences	A Grants-in-Aid (23-5268) for Japan Society for the Promotion of Science (JSPS) Fellows from The Ministry of Education, Culture, Sports, Science and Technology, Japan (to MHO) had main role for the study design, data collection and analysis and preparation of the manuscript. This study was also supported in part for the study design and preparation of the manuscript by Promotion of Basic Research Activities for Innovation Biosciences (to HK). A SUNBOR GRANT from the Suntory Foundation for Life Sciences (to MHO) supported for the manuscript preparation.	Ali MS, 2013, GENE, V512, P337, DOI 10.1016/j.gene.2012.09.126; Belles X, 2015, BBA-GENE REGUL MECH, V1849, P181, DOI 10.1016/j.bbagrm.2014.05.025; Cabrera AR, 2015, INSECT MOL BIOL, V24, P277, DOI 10.1111/imb.12155; CHINZEI Y, 1983, J COMP PHYSIOL, V152, P13, DOI 10.1007/BF00689722; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Gu SH, 2012, INSECT BIOCHEM MOLEC, V42, P296, DOI 10.1016/j.ibmb.2011.12.010; Harshman LG, 1999, J INSECT PHYSIOL, V45, P571, DOI 10.1016/S0022-1910(99)00038-4; Hikiba J, 2013, J CHROMATOGR B, V915, P52, DOI 10.1016/j.jchromb.2012.12.014; Horigane M, 2007, INSECT MOL BIOL, V16, P601, DOI 10.1111/j.1365-2583.2007.00754.x; Horigane M, 2010, INSECT MOL BIOL, V19, P501, DOI 10.1111/j.1365-2583.2010.01007.x; Horigane M, 2008, GEN COMP ENDOCR, V156, P298, DOI 10.1016/j.ygcen.2008.01.021; Horigane M, 2007, ARCH INSECT BIOCHEM, V64, P186, DOI 10.1002/arch.20170; Iga M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103239; Iga M, 2012, BIOL PHARM BULL, V35, P838, DOI 10.1248/bpb.35.838; Iga M, 2010, PEPTIDES, V31, P456, DOI 10.1016/j.peptides.2009.08.002; Kanematsu S, 2014, GENE, V533, P520, DOI 10.1016/j.gene.2013.08.005; Lafont R., 2005, COMPREHENSIVE MOL IN, V3, P125, DOI DOI 10.1016/B0-44-451924-6/00035-1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lomas LO, 1997, P ROY SOC B-BIOL SCI, V264, P589, DOI 10.1098/rspb.1997.0084; Marchal E, 2012, J INSECT PHYSIOL, V58, P890, DOI 10.1016/j.jinsphys.2012.03.013; Mykles DL, 2011, J STEROID BIOCHEM, V127, P196, DOI 10.1016/j.jsbmb.2010.09.001; Nakagawa Y, 2009, FEBS J, V276, P6128, DOI 10.1111/j.1742-4658.2009.07347.x; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Ogihara K, 2007, GEN COMP ENDOCR, V150, P371, DOI 10.1016/j.ygcen.2006.09.007; Ogihara MH, 2014, TICK BIOL, V1, P416; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Rewitz KF, 2006, MOL CELL ENDOCRINOL, V247, P166, DOI 10.1016/j.mce.2005.12.053; Rewitz KF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-60; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sonobe H, 2004, ZOOL SCI, V21, P503, DOI 10.2108/zsj.21.503; Swevers L, 2003, INSECT BIOCHEM MOLEC, V33, P1285, DOI 10.1016/j.ibmb.2003.06.012; ZHU XX, 1991, P NATL ACAD SCI USA, V88, P3744, DOI 10.1073/pnas.88.9.3744	35	17	18	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124953	10.1371/journal.pone.0124953	http://dx.doi.org/10.1371/journal.pone.0124953			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915939	gold, Green Submitted, Green Published			2022-12-27	WOS:000353659100083
J	Zhang, W; Zhu, YH; Yang, JC; Yang, GY; Zhou, D; Wang, JF				Zhang, Wei; Zhu, Yao-Hong; Yang, Jin-Cai; Yang, Gui-Yan; Zhou, Dong; Wang, Jiu-Feng			A Selected Lactobacillus rhamnosus Strain Promotes EGFR-Independent Akt Activation in an Enterotoxigenic Escherichia coli K88-Infected IPEC-J2 Cell Model	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; TIGHT JUNCTION PROTEINS; BARRIER FUNCTION; SOLUBLE-PROTEIN; NISSLE 1917; INFLAMMATION; RECOGNITION; EXPRESSION; CONTRIBUTES; DISRUPTION	Enterotoxigenic Escherichia coli (ETEC) are important intestinal pathogens that cause diarrhea in humans and animals. Although probiotic bacteria may protect against ETEC-induced enteric infections, the underlying mechanisms are unknown. In this study, porcine intestinal epithelial J2 cells (IPEC-J2) were pre-incubated with and without Lactobacillus rhamnosus ATCC 7469 and then exposed to F4(+) ETEC. Increases in TLR4 and NOD2 mRNA expression were observed at 3 h after F4(+) ETEC challenge, but these increases were attenuated by L. rhamnosus treatment. Expression of TLR2 and NOD1 mRNA was upregulated in cells pre-treated with L. rhamnosus. Pre-treatment with L. rhamnosus counteracted F4(+) ETEC-induced increases in TNF-alpha concentration. Increased PGE2. concentrations were observed in cells infected with F4(+) ETEC and in cells treated with L. rhamnosus only. A decrease in phosphorylated epidermal growth factor receptor (EGFR) was observed at 3 h after F4(+) ETEC challenge in cells treated with L. rhamnosus. Pre-treatment with L. rhamnosus enhanced Akt phosphorylation and increased ZO-1 and occludin protein expression. Our findings suggest that L. rhamnosus protects intestinal epithelial cells from F4(+) ETEC-induced damage, partly through the anti-inflammatory response involving synergism between TLR2 and NOD1. In addition, L. rhamnosus promotes EGFR-independent Akt activation, which may activate intestinal epithelial cells in response to bacterial infection, in turn increasing tight junction integrity and thus enhancing the barrier function and restricting pathogen invasion. Pre-incubation with L. rhamnosus was superior to co-incubation in reducing the adhesion of F4(+) ETEC to IPEC-J2 cells and subsequently attenuating F4(+) ETEC-induced mucin layer destruction and suppressing apoptosis. Our data indicate that a selected L. rhamnosus strain interacts with porcine intestinal epithelial cells to maintain the epithelial barrier and promote intestinal epithelial cell activation in response to bacterial infection, thus protecting cells from the deleterious effects of F4(+) ETEC.	[Zhang, Wei; Zhu, Yao-Hong; Yang, Jin-Cai; Yang, Gui-Yan; Zhou, Dong; Wang, Jiu-Feng] China Agr Univ, Coll Vet Med, Dept Vet Clin Sci, Beijing 100094, Peoples R China	China Agricultural University	Wang, JF (corresponding author), China Agr Univ, Coll Vet Med, Dept Vet Clin Sci, Beijing 100094, Peoples R China.	jiufeng_wang@hotmail.com			National Natural Science Foundation of China [31372493, 31472242]; Special Fund for Agro-Scientific Research in the Public Interest (China) [201003060-07, 201403054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research in the Public Interest (China)	This work was supported by grants from the National Natural Science Foundation of China (Project Nos. 31372493 and 31472242), and the Special Fund for Agro-Scientific Research in the Public Interest (China; Project Nos. 201003060-07 and 201403054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Banck MS, 2013, J CLIN INVEST, V123, P2502, DOI 10.1172/JCI67963; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Chen XY, 2014, APPL ENVIRON MICROB, V80, P5752, DOI 10.1128/AEM.01782-14; Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635; Clarke TB, 2011, CELL HOST MICROBE, V9, P404, DOI 10.1016/j.chom.2011.04.012; Corr SC, 2014, MUCOSAL IMMUNOL, V7, P57, DOI 10.1038/mi.2013.24; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Dey I, 2006, BRIT J PHARMACOL, V149, P611, DOI 10.1038/sj.bjp.0706923; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Ey B, 2013, J IMMUNOL, V190, P5676, DOI 10.4049/jimmunol.1201592; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Finamore A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094891; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Gibson DL, 2008, CELL MICROBIOL, V10, P388, DOI 10.1111/j.1462-5822.2007.01052.x; Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Jensen H, 2014, MICROBIOL-SGM, V160, P671, DOI 10.1099/mic.0.073551-0; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Karczewski J, 2010, AM J PHYSIOL-GASTR L, V298, pG851, DOI 10.1152/ajpgi.00327.2009; Kim JG, 2004, INFECT IMMUN, V72, P1487, DOI 10.1128/IAI.72.3.1487-1495.2004; Kleta S, 2014, INFECT IMMUN, V82, P1801, DOI 10.1128/IAI.01431-13; Kumar P, 2014, INFECT IMMUN, V82, P500, DOI 10.1128/IAI.01078-13; Kuo IH, 2013, J INVEST DERMATOL, V133, P988, DOI 10.1038/jid.2012.437; Lebeer S, 2007, APPL ENVIRON MICROB, V73, P6768, DOI 10.1128/AEM.01393-07; Li XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040666; Mack DR, 2003, GUT, V52, P827, DOI 10.1136/gut.52.6.827; Maisonneuve C, 2014, P NATL ACAD SCI USA, V111, P12294, DOI 10.1073/pnas.1400478111; Mathias A, 2010, J BIOL CHEM, V285, P33906, DOI 10.1074/jbc.M110.135111; McLamb BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059838; Mukiza CN, 2013, INFECT IMMUN, V81, P2819, DOI 10.1128/IAI.00455-13; Oppong GO, 2013, INFECT IMMUN, V81, P478, DOI 10.1128/IAI.00453-12; Orlando A, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-19; Otte JM, 2009, NUTR CANCER, V61, P103, DOI 10.1080/01635580802372625; Pan Q, 2013, J BIOL CHEM, V288, P5407, DOI 10.1074/jbc.M112.408245; Prince T, 2012, APPL ENVIRON MICROB, V78, P5119, DOI 10.1128/AEM.00595-12; Resta-Lenert S, 2003, GUT, V52, P988, DOI 10.1136/gut.52.7.988; Rieu A, 2014, CELL MICROBIOL, V16, P1836, DOI 10.1111/cmi.12331; Roxas JL, 2007, INFECT IMMUN, V75, P2316, DOI 10.1128/IAI.01690-06; Rubino SJ, 2012, CURR OPIN IMMUNOL, V24, P398, DOI 10.1016/j.coi.2012.04.010; Seo GS, 2014, BIOCHEM PHARMACOL, V90, P115, DOI 10.1016/j.bcp.2014.05.006; Seth A, 2008, AM J PHYSIOL-GASTR L, V294, pG1060, DOI 10.1152/ajpgi.00202.2007; Shimazu T, 2012, INFECT IMMUN, V80, P276, DOI 10.1128/IAI.05729-11; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wang LH, 2014, J BIOL CHEM, V289, P20234, DOI 10.1074/jbc.M114.553800; Yan F, 2013, J BIOL CHEM, V288, P30742, DOI 10.1074/jbc.M113.492397; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031; Yan F, 2009, GASTROENTEROLOGY, V136, P1297, DOI 10.1053/j.gastro.2008.12.059; Yang KM, 2014, J ANIM SCI, V92, P1496, DOI 10.2527/jas.2013-6619; Zhang L, 2010, VET MICROBIOL, V141, P142, DOI 10.1016/j.vetmic.2009.09.003; Zhu YH, 2014, APPL ENVIRON MICROB, V80, P1787, DOI 10.1128/AEM.03668-13; Zyrek AA, 2007, CELL MICROBIOL, V9, P804, DOI 10.1111/j.1462-5822.2006.00836.x	56	44	49	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125717	10.1371/journal.pone.0125717	http://dx.doi.org/10.1371/journal.pone.0125717			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915861	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100145
J	Hattori, M; Komatsu, S; Noda, H; Matsumoto, Y				Hattori, Makoto; Komatsu, Setsuko; Noda, Hiroaki; Matsumoto, Yukiko			Proteome Analysis of Watery Saliva Secreted by Green Rice Leafhopper, Nephotettix cincticeps	PLOS ONE			English	Article							MOLECULAR-CLONING; BROWN PLANTHOPPER; LONGICORN BEETLE; RUSSIAN WHEAT; PROTEINS; GLANDS; TRANSFERRIN; APHIDS; IDENTIFICATION; PURIFICATION	The green rice leafhopper, Nephotettix cincticeps, is a vascular bundle feeder that discharges watery and gelling saliva during the feeding process. To understand the potential functions of saliva for successful and safe feeding on host plants, we analyzed the complexity of proteinaceous components in the watery saliva of N. cincticeps. Salivary proteins were collected from a sucrose diet that adult leafhoppers had fed on through a membrane of stretched parafilm. Protein concentrates were separated using SDS-PAGE under reducing and non-reducing conditions. Six proteins were identified by a gas-phase protein sequencer and two proteins were identified using LC-MS/MS analysis with reference to expressed sequence tag (EST) databases of this species. Full -length cDNAs encoding these major proteins were obtained by rapid amplification of cDNA ends-PCR (RACE-PCR) and degenerate PCR. Furthermore, gel-free proteome analysis that was performed to cover the broad range of salivary proteins with reference to the latest RNA-sequencing data from the salivary gland of N. cincticeps, yielded 63 additional protein species. Out of 71 novel proteins identified from the watery saliva, about 60% of those were enzymes or other functional proteins, including GH5 cellulase, transferrin, carbonic anhydrases, aminopeptidase, regucalcin, and apolipoprotein. The remaining proteins appeared to be unique and species-specific. This is the first study to identify and characterize the proteins in watery saliva of Auchenorrhyncha species, especially sheath-producing, vascular bundle-feeders.	[Hattori, Makoto; Noda, Hiroaki; Matsumoto, Yukiko] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; [Komatsu, Setsuko] Natl Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan	National Institute of Agrobiological Sciences - Japan; National Agriculture & Food Research Organization - Japan	Hattori, M (corresponding author), Natl Inst Agrobiol Sci, 1-2 Ohwashi, Tsukuba, Ibaraki 3058634, Japan.	hatto@affrc.go.jp			Kakenhi fund of Japan [25450075]	Kakenhi fund of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Kakenhi fund of Japan (No. 25450075) to MH and YM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna R, 2012, P NATL ACAD SCI USA, V109, P4197, DOI 10.1073/pnas.1121190109; ANDERSEN PC, 1989, ENTOMOL EXP APPL, V50, P149, DOI 10.1007/BF00365399; Backus EA, 2012, J INSECT PHYSIOL, V58, P949, DOI 10.1016/j.jinsphys.2012.04.011; BAUMANN L, 1995, ENTOMOL EXP APPL, V77, P57, DOI 10.1007/BF02383018; Brennan M, 2011, MOL PLANT, V4, P144, DOI 10.1093/mp/ssq067; Calderon-Cortes N, 2012, ANNU REV ECOL EVOL S, V43, P45, DOI 10.1146/annurev-ecolsys-110411-160312; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Cherqui A, 2000, J INSECT PHYSIOL, V46, P1177, DOI 10.1016/S0022-1910(00)00037-8; Chino M, 1986, PHLOEM TRANSPORT, P463; Cooper WR, 2011, ENVIRON ENTOMOL, V40, P151, DOI 10.1603/EN10153; Cooper WR, 2010, ENVIRON ENTOMOL, V39, P223, DOI 10.1603/EN09079; De Vos M, 2009, PLANT CELL ENVIRON, V32, P1548, DOI 10.1111/j.1365-3040.2009.02019.x; DeLay B, 2012, J INSECT PHYSIOL, V58, P1626, DOI 10.1016/j.jinsphys.2012.10.002; Eyun SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094052; Habibi J, 2001, ENTOMOL EXP APPL, V98, P369, DOI 10.1023/A:1018971827110; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Hattori M, 2005, J INSECT PHYSIOL, V51, P1359, DOI 10.1016/j.jinsphys.2005.08.010; Hattori M, 2012, INSECT BIOCHEM MOLEC, V42, P1, DOI 10.1016/j.ibmb.2011.10.001; Hattori M, 2010, INSECT BIOCHEM MOLEC, V40, P331, DOI 10.1016/j.ibmb.2010.02.009; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Hirai M, 2000, ARCH INSECT BIOCHEM, V44, P17, DOI 10.1002/(SICI)1520-6327(200005)44:1&lt;17::AID-ARCH3&gt;3.0.CO;2-O; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; JAMROZ RC, 1993, P NATL ACAD SCI USA, V90, P1320, DOI 10.1073/pnas.90.4.1320; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kalume DE, 2005, PROTEOMICS, V5, P3765, DOI 10.1002/pmic.200401210; KAWABE S, 1985, JARQ-JPN AGR RES Q, V19, P115; Kawabe S., 1994, KENKYU SEIKA, V295, P52; Kim BY, 2008, COMP BIOCHEM PHYS B, V150, P161, DOI 10.1016/j.cbpb.2008.02.009; Konishi H, 2009, APPL ENTOMOL ZOOL, V44, P525, DOI 10.1303/aez.2009.525; Leopold RA, 2003, ARTHROPOD STRUCT DEV, V32, P189, DOI 10.1016/S1467-8039(03)00047-1; MA R, 1990, J INSECT PHYSIOL, V36, P507, DOI 10.1016/0022-1910(90)90102-L; Matsumoto Y, 2014, J INSECT PHYSIOL, V71, P170, DOI 10.1016/j.jinsphys.2014.10.010; Miles P.W., 1972, Advances Insect Physiol, V9, P183, DOI 10.1016/S0065-2806(08)60277-5; MILES P. W., 1965, J INSECT PHYSIOL, V11, P1261, DOI 10.1016/0022-1910(65)90119-8; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; MILES PW, 1989, J INSECT PHYSIOL, V35, P865, DOI 10.1016/0022-1910(89)90102-9; MILES PW, 1959, NATURE, V183, P756, DOI 10.1038/183756b0; MILES PW, 1991, ENTOMOL EXP APPL, V59, P123, DOI 10.1007/BF00351957; Moreno A, 2011, ENTOMOL EXP APPL, V139, P145, DOI 10.1111/j.1570-7458.2011.01117.x; NABA K, 1988, JPN J APPL ENTOMOL Z, V32, P31, DOI 10.1303/jjaez.32.31; Naito A, 1964, SHOKUBUTSU BOEKI, V18, P482; Nakamura M, 2013, APPL ENTOMOL ZOOL, V48, P489, DOI 10.1007/s13355-013-0210-6; Nanjo Y, 2013, J PROTEOME RES, V12, P4785, DOI 10.1021/pr4002349; Nicholson SJ, 2014, J PROTEOMICS, V105, P186, DOI 10.1016/j.jprot.2013.12.005; Nicholson SJ, 2012, J PROTEOMICS, V75, P2252, DOI 10.1016/j.jprot.2012.01.031; Noda H, 2012, APPL ENTOMOL ZOOL, V47, P217, DOI 10.1007/s13355-012-0110-1; Ong SE, 2001, BIOMOL ENG, V18, P195, DOI 10.1016/S1389-0344(01)00095-8; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Rao SAK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057413; Shi F, 2008, PHYTOCHEMISTRY, V69, P1295, DOI 10.1016/j.phytochem.2008.01.007; SOGAWA K, 1968, Applied Entomology and Zoology, V3, P13; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; SOGAWA K, 1967, Applied Entomology and Zoology, V2, P13; Sugimura M, 2003, EUR J BIOCHEM, V270, P3455, DOI 10.1046/j.1432-1033.2003.03735.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; Urbanska A, 1998, ENTOMOL EXP APPL, V86, P197, DOI 10.1023/A:1003119900578; Vandermoten S, 2014, INSECT MOL BIOL, V23, P67, DOI 10.1111/imb.12061; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Wei YD, 2006, COMP BIOCHEM PHYS B, V145, P220, DOI 10.1016/j.cbpb.2006.07.007; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Yamaguchi M, 2005, INT J MOL MED, V15, P371; Yokoyama R., 2014, BSJ REV, V5, P45; Yoshiga T, 1997, P NATL ACAD SCI USA, V94, P12337, DOI 10.1073/pnas.94.23.12337; Yun EY, 1999, BIOL CHEM, V380, P1455, DOI 10.1515/BC.1999.188	67	40	41	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123671	10.1371/journal.pone.0123671	http://dx.doi.org/10.1371/journal.pone.0123671			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909947	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800044
J	Hofer, FXE; Habermeyer, E; Mokros, A; Lau, S; Gairing, SK				Hoefer, Friederike X. E.; Habermeyer, Elmar; Mokros, Andreas; Lau, Steffen; Gairing, Stefanie K.			The Impact of Legal Coercion on the Therapeutic Relationship in Adult Schizophrenia Patients	PLOS ONE			English	Article							MENTAL-HEALTH-CARE; GERMAN VERSION; HOSPITAL ADMISSION; PERCEIVED COERCION; ALLIANCE; SCALE; PSYCHIATRY; PSYCHOSIS; VARIABLES; PREDICT	The quality of the therapeutic relationship between psychiatric patients and their attending physicians plays a key role in treatment success. We hypothesize that mandatory treatment is negatively associated with the quality of the therapeutic relationship. In a cross-sectional study design, data on psychopathological symptom load (as captured with the Brief Psychiatric Rating Scale) and on the quality of the therapeutic relationship (as measured with the Scale to Assess the Therapeutic Relationship) were collected from 113 adult male psychiatric patients and 35 attending physicians. Patients belonged to one of three groups: self-referred or involuntarily admitted patients from general psychiatry wards or patients from medium secure forensic psychiatric units. On average, self-referred patients rated the quality of the therapeutic relationship significantly more positive than did involuntarily admitted patients in general psychiatry wards. Forensic psychiatric patients, on average, gave an intermediate rating of the quality of the therapeutic relationship. There was no association between patients' ratings and physicians' ratings of the quality of the therapeutic relationship. Patients' ratings of the quality of the therapeutic relationship were inversely related to symptom severity in general and hostility in particular. Ratings of the quality of the therapeutic relationship are not associated with patients' legal status but rather with patients' symptoms of hostility.	[Hoefer, Friederike X. E.; Habermeyer, Elmar; Mokros, Andreas; Lau, Steffen] Univ Zurich, Univ Hosp Psychiat, Dept Forens Psychiat, Rheinau, Switzerland; [Gairing, Stefanie K.] Univ Basel, Univ Hosp Psychiat, Dept Gen Psychiat, Basel, Switzerland	University of Basel	Hofer, FXE (corresponding author), Univ Zurich, Univ Hosp Psychiat, Dept Forens Psychiat, Rheinau, Switzerland.	friederike.hoefer@puk.zh.ch	Habermeyer, Elmar/GLT-1137-2022; Mokros, Andreas/AFR-1424-2022	Mokros, Andreas/0000-0002-9706-0928				Barrowclough C, 2010, J NERV MENT DIS, V198, P373, DOI 10.1097/NMD.0b013e3181da4d4e; Beauford JE, 1997, AM J PSYCHIAT, V154, P1272; BENNETT NS, 1993, BEHAV SCI LAW, V11, P295, DOI 10.1002/bsl.2370110307; Catty J, 2011, PSYCHIAT RES, V187, P68, DOI 10.1016/j.psychres.2010.10.018; Chue Pierre, 2006, J Psychopharmacol, V20, P38, DOI 10.1177/1359786806071246; Couture SM, 2006, J NERV MENT DIS, V194, P10, DOI 10.1097/01.nmd.0000195315.39196.52; Davis LW, 2004, J NERV MENT DIS, V192, P508, DOI 10.1097/01.nmd.0000131919.60151.a7; Day JC, 2005, ARCH GEN PSYCHIAT, V62, P717, DOI 10.1001/archpsyc.62.7.717; Deahl M, 1997, BRIT J PSYCHIAT, V171, P6, DOI 10.1192/bjp.171.1.6; Gairing SK, 2011, PSYCHIAT PRAX, V38, P178, DOI 10.1055/s-0030-1265979; Gilburt H, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-92; Horvath AO, 2011, PSYCHOTHERAPY, V48, P9, DOI 10.1037/a0022186; HORVATH AO, 1991, J COUNS PSYCHOL, V38, P139, DOI 10.1037/0022-0167.38.2.139; Huddy V, 2012, J NERV MENT DIS, V200, P614, DOI 10.1097/NMD.0b013e31825bfc31; Kim KH, 2005, STRUCT EQU MODELING, V12, P368, DOI 10.1207/s15328007sem1203_2; LIDZ CW, 1995, ARCH GEN PSYCHIAT, V52, P1034; Loos S, 2012, EUR J PSYCHOL ASSESS, V28, P255, DOI 10.1027/1015-5759/a000105; Lysaker PH, 2011, J NERV MENT DIS, V199, P191, DOI 10.1097/NMD.0b013e31820c73eb; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; Mass R, 1997, NERVENARZT, V68, P239, DOI 10.1007/s001150050119; McCabe R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036080; McGuire-Snieckus R, 2007, PSYCHOL MED, V37, P85, DOI 10.1017/S0033291706009299; Minamisawa A, 2011, EUR ARCH PSY CLIN N, V261, P603, DOI 10.1007/s00406-011-0199-1; OVERALL JE, 1962, PSYCHOL REP, V10, P799; OVERALL JE, 1974, COMPR PSYCHIAT, V15, P103, DOI 10.1016/0010-440X(74)90026-1; Priebe S, 2011, PSYCHOTHER PSYCHOSOM, V80, P70, DOI 10.1159/000320976; Priebe S, 2008, INT REV PSYCHIATR, V20, P521, DOI 10.1080/09540260802565257; Safran JD, 2011, PSYCHOTHERAPY, V48, P80, DOI 10.1037/a0022140; Skeem JL, 2007, PSYCHOL ASSESSMENT, V19, P397, DOI 10.1037/1040-3590.19.4.397; Svensson B, 1999, ACTA PSYCHIAT SCAND, V99, P281, DOI 10.1111/j.1600-0447.1999.tb07226.x; Theodoridou A, 2012, PSYCHIAT RES, V200, P939, DOI 10.1016/j.psychres.2012.04.012; Wittorf A, 2009, EUR PSYCHIAT, V24, P259, DOI 10.1016/j.eurpsy.2008.12.015; World Health Organization: Internationale Klassifikation psychischer Storungen, 2004, ICD10 DIAGN KRIT FOR	33	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124043	10.1371/journal.pone.0124043	http://dx.doi.org/10.1371/journal.pone.0124043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG6AH	25909589	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800057
J	Teixeira, AL; Dias, F; Ferreira, M; Gomes, M; Santos, JI; Lobo, F; Mauricio, J; Machado, JC; Medeiros, R				Teixeira, Ana L.; Dias, Francisca; Ferreira, Marta; Gomes, Monica; Santos, Juliana I.; Lobo, Francisco; Mauricio, Joaquina; Machado, Jose Carlos; Medeiros, Rui			Combined Influence of EGF+61G > A and TGFB+869T > C Functional Polymorphisms in Renal Cell Carcinoma Progression and Overall Survival: The Link to Plasma Circulating MiR-7 and MiR-221/222 Expression	PLOS ONE			English	Article							FACTOR EGF POLYMORPHISM; GROWTH-FACTOR-BETA; GENE-EXPRESSION; POOR-PROGNOSIS; SERUM-LEVELS; PROTEIN; CANCER; ASSOCIATION; RESISTANCE; PROMOTES	The epidermal growth factor (EGF) is responsible for the activation of intracellular signal transducers that act on cell-cycle progression, cell motility, angiogenesis and inhibition of apoptosis. However, cells can block these effects activating opposite signaling pathways, such as the transforming growth factor beta 1 (TGF beta 1) pathway. Thus changes in expression levels of EGF and TGFB1 in renal cells might modulate the renal cell carcinoma (RCC) development, in consequence of changes in regulatory elements of signaling networks such as the microRNAs (miRNAs). Our purpose was to investigate the synergic role of EGF+61G>A and TGFB1+869T>C polymorphisms in RCC development. Genetic polymorphisms were studied by allelic discrimination using real-time PCR in 133 RCC patients vs. 443 healthy individuals. The circulating EGF/EGFR-MAPK-related miR-7, miR-221 and miR-222 expression was analyzed by a quantitative real-time PCR in plasma from 22 RCC patients vs. 27 healthy individuals. The intermediate/high genetic proliferation profile patients carriers present a significantly reduced time-to-progression and a higher risk of an early relapse compared with the low genetic proliferation profile carriers (HR = 8.8, P = 0.038) with impact in a lower overall survival (Log rank test, P = 0.047). The RCC patients presented higher circulating expression levels of miR-7 than healthy individuals (6.1-fold increase, P<0.001). Moreover, the intermediate/high genetic proliferation profile carriers present an increase in expression levels of miR-7, miR-221 and miR-222 during the RCC development and this increase is not observed in low genetic proliferation profile (P<0.001, P = 0.004, P<0.001, respectively). The stimulus to angiogenesis, cell-cycle progression and tumoral cells invasion, through activation of EGFR/MAPK signaling pathway in intermediate/high proliferation profile carriers is associated with an early disease progression, resulting in a poor overall survival. We also demonstrated that the intermediate/high proliferation profile is an unfavorable prognostic factor of RCC and miR-7, miR-221 and miR-222 expressions may be useful phenotype biomarkers of EGFR/MAPK activation.	[Teixeira, Ana L.; Dias, Francisca; Gomes, Monica; Santos, Juliana I.; Medeiros, Rui] Portuguese Inst Oncol Porto, Mol Oncol Grp & Virol Pathol, Porto, Portugal; [Teixeira, Ana L.; Dias, Francisca; Gomes, Monica; Santos, Juliana I.; Medeiros, Rui] Univ Porto, Abel Salazar Inst Biomed Sci ICBAS, P-4100 Porto, Portugal; [Teixeira, Ana L.; Dias, Francisca; Gomes, Monica; Medeiros, Rui] Portuguese League Canc NRNorte, Res Dept, Porto, Portugal; [Ferreira, Marta; Mauricio, Joaquina] Portuguese Inst Oncol Porto, Dept Oncol, Porto, Portugal; [Lobo, Francisco] Portuguese Inst Oncol Porto, Dept Urol, Porto, Portugal; [Machado, Jose Carlos] Univ Porto, Inst Mol Pathol & Immunol IPATIMUP, P-4100 Porto, Portugal; [Machado, Jose Carlos] Univ Porto, Fac Med, P-4100 Porto, Portugal; [Medeiros, Rui] Fernando Pessoa Univ, Fac Hlth Sci, Porto, Portugal	Universidade de Coimbra; Universidade do Porto; Universidade de Coimbra; Universidade de Coimbra; Universidade do Porto; Universidade do Porto; Universidade Fernando Pessoa	Medeiros, R (corresponding author), Portuguese Inst Oncol Porto, Mol Oncol Grp & Virol Pathol, Porto, Portugal.	ruimedei@ipoporto.min-saude.pt	Teixeira, Ana Luísa/ABB-3437-2020; Dias, Francisca/AAH-4148-2021; Dias, Francisca/P-1272-2018; Medeiros, Rui/C-7938-2009; Machado, Jose Carlos/C-5907-2009	Dias, Francisca/0000-0002-4993-4467; Dias, Francisca/0000-0002-4993-4467; Medeiros, Rui/0000-0003-3010-8373; Machado, Jose Carlos/0000-0003-4741-8415; Gomes, Monica/0000-0001-9947-5775; Teixeira, Ana L/0000-0002-7489-2211; Santos, Juliana Ines/0000-0001-8613-6942	Liga Portuguesa Contra o Cancro-Centro Regional do Norte (Portuguese League Against Cancer); FCT -Fundacao para a Ciencia e Tecnologia; FCT [SFRH/BD/47381/2008]; AstraZeneca Foundation	Liga Portuguesa Contra o Cancro-Centro Regional do Norte (Portuguese League Against Cancer); FCT -Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); AstraZeneca Foundation(AstraZeneca)	The authors would like to thank the Liga Portuguesa Contra o Cancro-Centro Regional do Norte (Portuguese League Against Cancer) and FCT -Fundacao para a Ciencia e Tecnologia. ALT is a Doctoral degree grant holder from FCT (SFRH/BD/47381/2008). This project was partially sponsored by an unrestricted educational grant for basic research in Molecular Oncology from AstraZeneca Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gallego GA, 2012, INT J MOL SCI, V13, P12710, DOI 10.3390/ijms131012710; Avraham R, 2012, BIOCHEM SOC T, V40, P26, DOI 10.1042/BST20110623; Avraham R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000876; Bex A, 2010, EUR UROL, V58, P819, DOI 10.1016/j.eururo.2010.08.029; Brannon AR, 2012, EUR UROL, V61, P258, DOI 10.1016/j.eururo.2011.10.007; Brannon A Rose, 2010, Genes Cancer, V1, P152; Brooks SA, 2014, EUR UROL, V25; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dias F, 2013, PHARMACOGENOMICS, V14, P1793, DOI 10.2217/pgs.13.184; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fukasawa H, 2010, INT J CANCER, V127, P1517, DOI 10.1002/ijc.25164; Hegele A, 2002, UROL RES, V30, P126, DOI 10.1007/s00240-002-0245-6; Ikeda Y, 2012, MOL CANCER RES, V10, P259, DOI 10.1158/1541-7786.MCR-11-0035; Jung HM, 2012, J BIOL CHEM, V287, P29261, DOI 10.1074/jbc.M112.366518; Kataoka H, 2009, J DERMATOL SCI, V56, P148, DOI 10.1016/j.jdermsci.2009.10.002; Kominsky SL, 2007, J BONE MINER RES, V22, P37, DOI 10.1359/JBMR.061005; Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183; Lanuti M, 2008, CLIN CANCER RES, V14, P3216, DOI 10.1158/1078-0432.CCR-07-4932; Liang L, 2012, ONCOL REP, V28, P999, DOI 10.3892/or.2012.1874; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Lu X, 2010, BRIT J CANCER, V102, P457, DOI 10.1038/sj.bjc.6605490; Melenhorst WBWH, 2008, HYPERTENSION, V52, P987, DOI 10.1161/HYPERTENSIONAHA.108.113860; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Mitropoulos D, 2004, UROL RES, V32, P317, DOI 10.1007/s00240-003-0360-z; Niu X, 2012, ONCOGENE, V31, P776, DOI 10.1038/onc.2011.266; O-charoenrat P, 2000, CANCER RES, V60, P1121; Ravaud A, 2008, EUR UROL, V54, P315, DOI 10.1016/j.eururo.2008.04.056; Ravaud A, 2012, CANCER TREAT REV, V38, P996, DOI 10.1016/j.ctrv.2012.01.003; Reis ST, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-18; Rydzanicz M, 2013, CANCER LETT, V341, P111, DOI 10.1016/j.canlet.2013.08.006; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shah MY, 2011, GENOME MED, V3, DOI 10.1186/gm272; Shahbazi M, 2002, LANCET, V359, P397, DOI 10.1016/S0140-6736(02)07600-6; Smaldone MC, 2009, UROL ONCOL-SEMIN ORI, V27, P238, DOI 10.1016/j.urolonc.2007.12.001; Teixeira AL, 2013, TUMOR BIOL, V31, P31; Teixeira AL, 2008, CLIN CANCER RES, V14, P3367, DOI 10.1158/1078-0432.CCR-07-5119; Teixeira AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072419; Teixeira Ana L., 2012, Frontiers in Genetics, V3, P286, DOI 10.3389/fgene.2012.00286; Villaamil VM, 2012, J MOL SIGNAL, V7, P1750; Xiao LJ, 2012, INT J ONCOL, V40, P1714, DOI 10.3892/ijo.2011.1320; Yokota M, 2000, CIRCULATION, V101, P2783, DOI 10.1161/01.CIR.101.24.2783; Yu Z, 2013, J MOL HISTOL, V21, P21; Zhang CZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-229; Zhang CZ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-119; Zhang Y, 2012, CANCER SCI, V103, P1084, DOI 10.1111/j.1349-7006.2012.02265.x; Zhou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023936; Zhu J, 2010, J HUM GENET, V55, P236, DOI 10.1038/jhg.2010.12	48	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0103258	10.1371/journal.pone.0103258	http://dx.doi.org/10.1371/journal.pone.0103258			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909813	Green Submitted, gold, Green Published			2022-12-27	WOS:000353376800001
J	Li, MC; Shi, J; Guo, J; Cao, JF; Niu, JD; Xiong, MM				Li, Mingcai; Shi, Jun; Guo, Jun; Cao, Jingfu; Niu, Jide; Xiong, Mingming			Climate Impacts on Extreme Energy Consumption of Different Types of Buildings	PLOS ONE			English	Article							CHINA; DEMAND	Exploring changes of building energy consumption and its relationships with climate can provide basis for energy-saving and carbon emission reduction. Heating and cooling energy consumption of different types of buildings during 1981-2010 in Tianjin city, was simulated by using TRNSYS software. Daily or hourly extreme energy consumption was determined by percentile methods, and the climate impact on extreme energy consumption was analyzed. The results showed that days of extreme heating consumption showed apparent decrease during the recent 30 years for residential and large venue buildings, whereas days of extreme cooling consumption increased in large venue building. No significant variations were found for the days of extreme energy consumption for commercial building, although a decreasing trend in extreme heating energy consumption. Daily extreme energy consumption for large venue building had no relationship with climate parameters, whereas extreme energy consumption for commercial and residential buildings was related to various climate parameters. Further multiple regression analysis suggested heating energy consumption for commercial building was affected by maximum temperature, dry bulb temperature, solar radiation and minimum temperature, which together can explain 71.5 % of the variation of the daily extreme heating energy consumption. The daily extreme cooling energy consumption for commercial building was only related to the wet bulb temperature (R-2= 0.382). The daily extreme heating energy consumption for residential building was affected by 4 climate parameters, but the dry bulb temperature had the main impact. The impacts of climate on hourly extreme heating energy consumption has a 1-3 hour delay in all three types of buildings, but no delay was found in the impacts of climate on hourly extreme cooling energy consumption for the selected buildings.	[Li, Mingcai; Shi, Jun; Guo, Jun; Cao, Jingfu; Xiong, Mingming] Tianjin Climate Ctr, Tianjin 300074, Peoples R China; [Niu, Jide] Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China	Tianjin University	Li, MC (corresponding author), Tianjin Climate Ctr, 100 Qixiangtai Rd, Tianjin 300074, Peoples R China.	mingcaili3394@163.com	Guo, Jun/L-4876-2016		Climate Change Special Funding of China Meteorological Bureau [CCSF201332, CCSF201423]	Climate Change Special Funding of China Meteorological Bureau	This study was supported by Climate Change Special Funding (CCSF201332, CCSF201423) of China Meteorological Bureau (http://www.cma.gov.cn/) to LMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argueso D, 2014, CLIM DYNAM, V42, P2183, DOI 10.1007/s00382-013-1789-6; Cai WG, 2009, ENERG POLICY, V37, P2054, DOI 10.1016/j.enpol.2008.11.037; Chen L, 2007, CHINESE SCI BULL, V52, P2854, DOI 10.1007/s11434-007-0386-7; Ding YH, 2007, ADV ATMOS SCI, V24, P954, DOI 10.1007/s00376-007-0954-4; Fan Li-Jun, 2007, Chinese Journal of Atmospheric Sciences, V31, P887; Grawley DB, 2005, P 9 IBPSA C, V43, P231; [郭军 Guo Jun], 2009, [生态环境学报, Ecology and Environmental Sciences], V18, P29; Jiang FQ, 2009, THEOR APPL CLIMATOL, V97, P349, DOI 10.1007/s00704-008-0078-5; Kalvelage K, 2014, ENERG BUILDINGS, V76, P373, DOI 10.1016/j.enbuild.2014.03.009; Li DHW, 2013, ENERGY, V54, P1, DOI 10.1016/j.energy.2013.01.070; Li MC, 2014, BUILD SERV ENG RES T, V35, P362, DOI 10.1177/0143624413498245; McGilligan C, 2011, ENERG BUILDINGS, V43, P2767, DOI 10.1016/j.enbuild.2011.06.037; Papakostas K, 2010, RENEW ENERG, V35, P1376, DOI 10.1016/j.renene.2009.11.012; Ren GY, 2008, J CLIMATE, V21, P1333, DOI 10.1175/2007JCLI1348.1; Sadineni SB, 2012, ENERGY, V37, P689, DOI 10.1016/j.energy.2011.10.026; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Wan KKW, 2011, ENERGY, V36, P1404, DOI 10.1016/j.energy.2011.01.033; Wan KKW, 2011, BUILD ENVIRON, V46, P223, DOI 10.1016/j.buildenv.2010.07.016; Wang XM, 2010, BUILD ENVIRON, V45, P1663, DOI 10.1016/j.buildenv.2010.01.022; Yang XC, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015452; Yao RM, 2005, RENEW ENERG, V30, P1973, DOI 10.1016/j.renene.2005.01.013; Yau YH, 2013, RENEW SUST ENERG REV, V18, P430, DOI 10.1016/j.rser.2012.10.035; Zhang QY, 2004, ENERG BUILDINGS, V36, P1217, DOI 10.1016/j.enbuild.2003.08.002	23	14	14	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124413	10.1371/journal.pone.0124413	http://dx.doi.org/10.1371/journal.pone.0124413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923205	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600084
J	Lindsay, S; Hartman, LR; Reed, N; Gan, C; Thomson, N; Solomon, B				Lindsay, Sally; Hartman, Laura R.; Reed, Nick; Gan, Caron; Thomson, Nicole; Solomon, Beverely			A Systematic Review of Hospital-to-School Reintegration Interventions for Children and Youth with Acquired Brain Injury	PLOS ONE			English	Review							CHRONIC ILLNESS; SKILLS; PROGRAM; REHABILITATION; TRANSITION; STRATEGIES; EFFICACY; DEFICITS; PARTICIPATION; ADOLESCENTS	Objectives We reviewed the literature on interventions that aimed to improve hospital-to-school reintegration for children and youth with acquired brain injury (ABI). ABI is the leading cause of disability among children and youth. A successful hospital-to-school reintegration process is essential to the rehabilitative process. However, little is known about the effective components of of such interventions. Methods and findings Our research team conducted a systematic review, completing comprehensive searches of seven databases and selected reference lists for relevant articles published in a peer-reviewed journal between 1989 and June 2014. We selected articles for inclusion that report on studies involving: a clinical population with ABI; sample had an average age of 20 years or younger; an intentional structured intervention affecting hospital-to-school transitions or related components; an experimental design; and a statistically evaluated health outcome. Two independent reviewers applied our inclusion criteria, extracted data, and rated study quality. A meta-analysis was not feasible due to the heterogeneity of the studies reported. Of the 6933 articles identified in our initial search, 17 articles (reporting on 350 preadoles-cents and adolescents, aged 4-19, (average age 11.5 years, SD: 2.21) met our inclusion criteria. They reported on interventions varying in number of sessions (one to 119) and session length (20 minutes to 4 hours). The majority of interventions involved multiple one-to-one sessions conducted by a trained clinician or educator, homework activities, and parental involvement. The interventions were delivered through different settings and media, including hospitals, schools, and online. Although outcomes varied (with effect sizes ranging from small to large), 14 of the articles reported at least one significant improvement in cognitive, social, psychological, or behavioral functioning or knowledge of ABI. Conclusions Cognitive, behavioral, and problem-solving interventions have the potential to improve school reintegration for youth with ABI. However, more comprehensive interventions are needed to help link rehabilitation clinicians, educators, adolescents, and families.	[Lindsay, Sally; Hartman, Laura R.; Reed, Nick; Gan, Caron] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Lindsay, Sally; Reed, Nick] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Thomson, Nicole] Bridgepoint Act Healthcare, Toronto, ON, Canada; [Solomon, Beverely] Holland Bloorview Kids Rehabil Hosp, Brain Injury Rehabil Outpatient Team, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital	Lindsay, S (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada.	slindsay@hollandbloorview.ca		Bowman, Laura/0000-0001-7246-7863; Thomson, Nicole/0000-0001-9335-5959	Canadian Institutes of Health Research [315247]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding for this study was provided by the Canadian Institutes of Health Research, grant 315247. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agnihotri S, 2014, DEV NEUROREHABIL, V17, P44, DOI 10.3109/17518423.2013.844739; Agnihotri S, 2010, DEV NEUROREHABIL, V13, P369, DOI 10.3109/17518423.2010.499409; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Arroyos-Jurado E, 2008, INTERV SCH CLIN, V43, P252, DOI 10.1177/1053451208314907; Badger K, 2008, SCH SOC WORK J, V32, P87; Beardmore S, 1999, NEUROPSYCHOL REHABIL, V9, P45, DOI 10.1080/713755588; Bedell GM, 2005, AM J OCCUP THER, V59, P273, DOI 10.5014/ajot.59.3.273; Blobaum P, 2006, J MED LIBR ASSOC, V94, P477; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Brain Injury Society of Toronto, 2013, BRAIN INJURY FACTS A; Centres for Disease Control and Prevention, 2013, HOW MANY PEOPLE HAVE; Chan DYK, 2011, DISABIL REHABIL, V33, P2023, DOI 10.3109/09638288.2011.556207; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Deidrick KKM, 2005, PREV SCH FAIL, V49, P23, DOI 10.3200/PSFL.49.4.23-33; Denslow P, 2012, PERSPECT NEUROPHYSIO, V22, P106; DePompei R, 2003, CHILD DEV DISABILITI, V29, P73; Dykeman B, 2009, EDUCATION, V130, P295; Dykeman B, 2003, J INSTRUCTIONAL PSYC, P225; Edlund W, 2004, CLINICAL PRACTICE GU; Ennis SK, 2013, BRAIN INJURY, V27, P179, DOI 10.3109/02699052.2012.729291; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Finkelstein E, 2006, THE INCIDENCE AND EC; Getchius TSD, 2010, NEUROLOGY, V75, P1126, DOI 10.1212/WNL.0b013e3181f4d883; Glang A, 1997, J HEAD TRAUMA REHAB, V12, P32, DOI 10.1097/00001199-199704000-00005; Glang A, 2007, J HEAD TRAUMA REHAB, V22, P198, DOI 10.1097/01.HTR.0000271121.42523.3a; Glang A, 2010, J HEAD TRAUMA REHAB, V25, P403; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Ilie G, 2014, JAMA-J AM MED ASSOC, V309, P2550; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Johnson AR, 2009, DEV DISABIL RES REV, V15, P124, DOI 10.1002/ddrr.63; Kesler SR, 2011, BRAIN INJURY, V25, P101, DOI 10.3109/02699052.2010.536194; King GA, 2006, CHILD HEALTH CARE, V35, P155, DOI 10.1207/s15326888chc3502_4; Knafl K. A., 2002, PEDIAT NURSING, V28, P49; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lindsay S, 2014, DISABIL REHABIL, V36, P276, DOI 10.3109/09638288.2013.785605; Lindsay S, 2013, DISABIL REHABIL, V35, P623, DOI 10.3109/09638288.2012.702850; McDougall J, 2006, BRAIN INJURY, V20, P1189, DOI 10.1080/02699050600975541; Mealings M, 2010, BRAIN IMPAIR, V11, P1, DOI 10.1375/brim.11.1.1; Missiuna C, 2010, PHYS OCCUP THER PEDI, V30, P205, DOI 10.3109/01942631003761554; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mottram Lisa, 2004, Pediatr Rehabil, V7, P133, DOI 10.1080/1363849042000202286; Ontario Brain Injury Association (OBIA), 2009, WHAT IS BRAIN INJURY; Petticrew M, 2006, SYSTEMATIC REVIEWS IN THE SOCIAL SCIENCES: A PRACTICAL GUIDE, P1, DOI 10.1002/9780470754887; Prevatt FF, 2000, J SCHOOL PSYCHOL, V38, P447, DOI 10.1016/S0022-4405(00)00046-7; Reistetter T, 2006, OCCUPATIONAL THERAPY, V12, P196; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shaw SR, 2008, PSYCHOL SCHOOLS, V45, P74, DOI 10.1002/pits.20280; Suzman KB, 1997, J BEHAV THER EXP PSY, V28, P203, DOI 10.1016/S0005-7916(97)00023-2; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; van 't Hooft I, 2007, NEUROREHABILITATION, V22, P109; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; Vollmer D G, 1991, Neurosurg Clin N Am, V2, P437; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Whittemore R, 2005, J ADV NURS, V52, P546, DOI 10.1111/j.1365-2648.2005.03621.x; Yeo M, 2005, BRIT MED J, V330, P721, DOI 10.1136/bmj.330.7493.721	63	30	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124679	10.1371/journal.pone.0124679	http://dx.doi.org/10.1371/journal.pone.0124679			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923534	Green Published, gold			2022-12-27	WOS:000353711600099
J	Kim, T				Kim, Thomas			The Predecessors of Bitcoin and Their Implications for the Prospect of Virtual Currencies	PLOS ONE			English	Article							TRANSACTION COSTS	To examine whether the recent price patterns and transaction costs of Bitcoin represent a general characteristic of decentralized virtual currencies, we analyze virtual currencies in online games that have been voluntarily managed by individuals since 1990s. We find that matured game currencies have price stability similar to that of small size equities or gold, and their transaction costs are sometimes lower than real currencies. Assuming that virtual currencies with a longer history can provide an estimate for Bitcoin's prospects, we project that Bitcoin will be less influenced by speculative trades and become a low cost alternative to real currencies.	Univ Calif Riverside, Sch Business Adm, Riverside, CA 92521 USA	University of California System; University of California Riverside	Kim, T (corresponding author), Univ Calif Riverside, Sch Business Adm, Riverside, CA 92521 USA.	suk-won.kim@ucr.edu						[Anonymous], 2012, 2012 BITC VIRT CURR; [Anonymous], 2013, WORKING PAPER; Castronova E, 2008, WORKING PAPER; Dibbell Julian., 2007, NY TIMES; Elliott J, 2013, NY TIMES; Goyenko RY, 2009, J FINANC ECON, V92, P153, DOI 10.1016/j.jfineco.2008.06.002; Heeks R, 2008, WORKING PAPER; Krugman P., 2013, NY TIMES; Lesmond DA, 1999, REV FINANC STUD, V12, P1113, DOI 10.1093/rfs/12.5.1113; Marshall BR, 2012, REV FINANC STUD, V25, P599, DOI 10.1093/rfs/hhr075; ROLL R, 1984, J FINANC, V39, P1127, DOI 10.2307/2327617; Stoll HR, 2000, J FINANC, V55, P1479, DOI 10.1111/0022-1082.00259; Surowiecki J., 2011, CRYPTOCURRENCY	13	7	7	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123071	10.1371/journal.pone.0123071	http://dx.doi.org/10.1371/journal.pone.0123071			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SE	25919027	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400022
J	Little, KM; Pal, M; Dowdy, DW				Little, Kristen M.; Pal, Madhukar; Dowdy, David W.			Costs and Consequences of Using Interferon-gamma Release Assays for the Diagnosis of Active Tuberculosis in India	PLOS ONE			English	Article							POSITIVE PULMONARY TUBERCULOSIS; HEALTH-CARE WORKERS; MYCOBACTERIUM-TUBERCULOSIS; SMEAR MICROSCOPY; PREDICTIVE-VALUE; INFECTION; LATENT; ANTIGENS; TESTS	Background There is growing concern that interferon-gamma release assays (IGRAs) are being used off-label for the diagnosis of active tuberculosis (TB) disease in many high-burden settings, including India, where the background prevalence of latent TB infection is high. We analyzed the costs and consequences of using IGRAs for the diagnosis of active TB in India from the perspective of the Indian TB control sector. Methods and Findings We constructed a decision analytic model to estimate the incremental cost and effectiveness of IGRAs for the diagnosis of active TB in India. We compared a reference scenario of clinical examination and non-microbiological tests against scenarios in which clinical diagnosis was augmented by the addition of either sputum smear microscopy, IGRA, or Xpert MTB/RIF. We examined costs (in 2013 US dollars) and consequences from the perspective of the Indian healthcare sector. Relative to sputum smear microscopy, use of IGRA for active TB resulted in 23,700 (95% uncertainty range, UR: 3,800 - 38,300) additional truepositive diagnoses, but at the expense of 315,700 (95% UR: 118,300 - 388,400) additional false-positive diagnoses and an incremental cost of US$49.3 million (95% UR: $34.9 - $58.0 million) (2.9 billion Indian Rupees). Relative to Xpert MTB/RIF (including the cost of treatment for drug resistant TB), use of IGRA led to 400 additional TB cases treated (95% UR: [-8,000] - 16,200), 370,600 (95% UR: 252,200 - 441,700) more false-positive diagnoses, 70,400 (95% UR: [-7,900] - 247,200) fewer disability-adjusted life years averted, and US$14.6 million (95% UR: [-$7.2] - $28.7 million) (854 million Indian Rupees) in additional costs. Conclusion Using IGRAs for diagnosis of active TB in a setting like India results in tremendous over-treatment of people without TB, and substantial incremental cost with little gain in health. These results support the policies by WHO and Standards for TB Care in India, which discourage the use of IGRAs for the diagnosis of active TB in India and similar settings.	[Little, Kristen M.; Dowdy, David W.] Johns Hopkins Bloomberg, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Pal, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Pal, Madhukar] McGill Int TB Ctr, Montreal, PQ, Canada	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; McGill University	Little, KM (corresponding author), Johns Hopkins Bloomberg, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	klittl11@jhu.edu	Pai, Madhukar/AAX-9901-2021	Pai, Madhukar/0000-0003-3667-4536	Canadian Institutes of Health Research [MOP 123291, MOP-130330]; Fonds de recherche du Quebec - Sante (FRQS)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec)	MP is funded by Canadian Institutes of Health Research (MOP 123291 and MOP-130330). MP is also supported by the Fonds de recherche du Quebec - Sante (FRQS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.	[Anonymous], HIST EXCH RAT; Babu K, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-9; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P1072; Clinton Health Access Initiative Social and Rural Research Institute IMRB International, 2014, TB DIAGN IND PRIV SE, P1; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Creek TL, 2000, INT J TUBERC LUNG D, V4, P956; Dowdy DW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001074; Foundation for Innovative New Diagnostics. Special Programme for Research and Training in Tropical DiseasesWorld Health Organization, 2006, DIAGN TUB GLOB DEM M; Institute of Actuaries of India, 2010, PUBL MORT TABL; Jaroslawski S, 2012, J EPIDEMIOL GLOB HEA, V2, P39, DOI 10.1016/j.jegh.2011.12.001; Joint United Nations Programme on HIV/AIDS, 2010, UNAIDS REP GLOB EP 2; Joshi R, 2011, EUR RESPIR J, V38, P1475, DOI 10.1183/09031936.00014611; Kay M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2161; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Kik SV, 2014, EUR RESPIR J, V43, P1793, DOI 10.1183/09031936.00217313; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lu CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056074; MacPherson P, 2014, B WORLD HEALTH ORGAN, V92, P126, DOI 10.2471/BLT.13.124800; Menon S, 2012, 2012 JUL 16 MONTR CA; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Ministry of Health and Family Welfare, 2010, RNTCP STAT REP; Murray CJL, 1996, GLOBAL BURDEN DIS CO; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Prasad R., 2013, HINDU; Pronyk PM, 2001, INT J TUBERC LUNG D, V5, P619; Qian FC, 2013, INDIAN J PATHOL MICR, V56, P125, DOI 10.4103/0377-4929.118694; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Rabita A, SCI SPEAKS; Raizada N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089301; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Revised National Tuberculosis Control Programme, 2010, DOTS PLUS GUID, P1; Salaniponi FML, 2000, INT J TUBERC LUNG D, V4, P327; Salje H, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001674; Squire SB, 2005, INT J TUBERC LUNG D, V9, P25; Stall N, 2011, INT J TUBERC LUNG D, V15, P641, DOI 10.5588/ijtld.10.0195; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Styblo K, 1991, EPIDEMIOLOGY TUBERCU; Treatment Action Group and Global TB Community Advisory Board, 2013, COMMUNICATION; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Wells WA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018964; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Bank, 2013, INFL GDP DEFL ANN; World Health Organization, 2014, STAND TB CAR IND; World Health Organization, WHO GLOB TUB CONTR E; World Health Organization, 2012, COUNTR TB REP IND; Zhang S, 2010, CLIN VACCINE IMMUNOL, V17, P1985, DOI 10.1128/CVI.00294-10	51	10	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124525	10.1371/journal.pone.0124525	http://dx.doi.org/10.1371/journal.pone.0124525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25918999	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400054
J	Masek, M; Palata, V; Bray, TC; Bocak, L				Masek, Michal; Palata, Vaclav; Bray, Timothy C.; Bocak, Ladislav			Molecular Phylogeny Reveals High Diversity, Geographic Structure and Limited Ranges in Neotenic Net-Winged Beetles Platerodrilus (Coleoptera: Lycidae)	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SEA-LEVEL; ASIA; CLASSIFICATION; EVOLUTION; INFERENCE; PROGRAM; LARVAE; MODEL	The neotenic Platerodrilus net-winged beetles have strongly modified development where females do not pupate and retain larval morphology when sexually mature. As a result, dispersal propensity of females is extremely low and the lineage can be used for reconstruction of ancient dispersal and vicariance patterns and identification of centres of diversity. We identified three deep lineages in Platerodrilus occurring predominantly in (1) Borneo and the Philippines, (2) continental Asia, and (3) Sumatra, the Malay Peninsula and Java. We document limited ranges of all species of Platerodrilus and complete species level turnover between the Sunda Islands and even between individual mountain regions in Sumatra. Few dispersal events were recovered among the major geographical regions despite long evolutionary history of occurrence; all of them were dated at the early phase of Platerodrilus diversification up to the end of Miocene and no exchange of island faunas was identified during the Pliocene and Pleistocene despite the frequently exposed Sunda Shelf as sea levels fluctuated with each glacial cycle. We observed high diversity in the regions with persisting humid tropical forests during cool periods. The origins of multiple species were inferred in Sumatra soon after the island emerged and the mountain range uplifted 15 million years ago with the speciation rate lower since then. We suppose that the extremely low dispersal propensity makes Platerodrilus a valuable indicator of uninterrupted persistence of rainforests over a long time span. Additionally, if the diversity of these neotenic lineages is to be protected, a high dense system of protected areas would be necessary.	[Masek, Michal; Palata, Vaclav; Bray, Timothy C.; Bocak, Ladislav] Palacky Univ, Fac Sci, Dept Zool, Olomouc 77146, Czech Republic	Palacky University Olomouc	Bocak, L (corresponding author), Palacky Univ, Fac Sci, Dept Zool, 17 Listopadu 50, Olomouc 77146, Czech Republic.	ladislav.bocak@upol.cz	Bocak, Ladislav/J-5989-2019		Grant Agency of the Czech Republic [P506/11/1757]; Palacky University [IGA_PrF_2014013]; grant POST-UP - European Science Foundation; Ministry of Education of the Czech Republic [CZ.1.07/2.3.00/30.0004]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Palacky University; grant POST-UP - European Science Foundation; Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	Funding: The study was funded by the Grant Agency of the Czech Republic (P506/11/1757). MM and VP were additionally supported by the Internal Grant of the Palacky University (IGA_PrF_2014013) and TB was supported by the grant POST-UP funded by the European Science Foundation and the Ministry of Education of the Czech Republic (CZ.1.07/2.3.00/30.0004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belshaw R, 2005, BIOINFORMATICS, V21, P122, DOI 10.1093/bioinformatics/bth459; Bocak L, 2008, P ROY SOC B-BIOL SCI, V275, P2015, DOI 10.1098/rspb.2008.0476; Bocak L, 2008, ANN ZOOL, V58, P695, DOI 10.3161/000345408X396639; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dwyer GS, 2009, PHILOS T R SOC A, V367, P157, DOI 10.1098/rsta.2008.0222; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gathorne-Hardy FJ, 2002, BIOL J LINN SOC, V75, P453, DOI 10.1046/j.1095-8312.2002.00031.x; Gould S. J., 1977, ONTOGENY PHYLOGENY; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Hanebuth T, 2000, SCIENCE, V288, P1033, DOI 10.1126/science.288.5468.1033; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kazantsev Sergey V., 2009, Russian Entomological Journal, V18, P55; Levkanicova Z, 2009, SYST ENTOMOL, V34, P210, DOI 10.1111/j.1365-3113.2008.00457.x; Malohlava V, 2010, MOL ECOL, V19, P4800, DOI 10.1111/j.1365-294X.2010.04850.x; Masek M, 2014, RAFFLES B ZOOL, V62, P136; Masek M, 2014, ZOOKEYS, P29, DOI 10.3897/zookeys.426.7398; Mjoberg E., 1925, Psyche Boston, V32, P119, DOI 10.1155/1925/19784; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2014, TRACER V1 6; Ray N., 2001, INTERNET ARCHAEOLOGY, V11, P1, DOI [DOI 10.11141/IA.11.2, 10.11141/ia.11.2]; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sklenarova K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067957; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wong ATC, 1996, RAFFLES B ZOOL, V44, P173; Woodruff DS, 2010, BIODIVERS CONSERV, V19, P919, DOI 10.1007/s10531-010-9783-3; Yu Y., 2012, RASP RECONSTRUCT ANC; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	31	28	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123855	10.1371/journal.pone.0123855	http://dx.doi.org/10.1371/journal.pone.0123855			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919357	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400037
J	Mearns, ES; Sobieraj, DM; White, CM; Saulsberry, WJ; Kohn, CG; Doleh, Y; Zaccaro, E; Coleman, CI				Mearns, Elizabeth S.; Sobieraj, Diana M.; White, C. Michael; Saulsberry, Whitney J.; Kohn, Christine G.; Doleh, Yunes; Zaccaro, Eric; Coleman, Craig I.			Comparative Efficacy and Safety of Antidiabetic Drug Regimens Added to Metformin Monotherapy in Patients with Type 2 Diabetes: A Network Meta-Analysis	PLOS ONE			English	Article							ADD-ON THERAPY; INADEQUATE GLYCEMIC CONTROL; DIPEPTIDYL PEPTIDASE-4 INHIBITOR; RANDOMIZED CONTROLLED-TRIAL; BETA-CELL FUNCTION; DOUBLE-BLIND; PLUS METFORMIN; OPEN-LABEL; TREATED PATIENTS; COMBINATION THERAPY	Introduction When first line therapy with metformin is insufficient for patients with type 2 diabetes (T2D), the optimal adjunctive therapy is unclear. We assessed the efficacy and safety of adjunctive antidiabetic agents in patients with inadequately controlled T2D on metformin alone. Materials and Methods A search of MEDLINE and CENTRAL, clinicaltrials.gov, regulatory websites was performed. We included randomized controlled trials of 3-12 months duration, evaluating Food and Drug Administration or European Union approved agents (noninsulin and long acting, once daily basal insulins) in patients experiencing inadequate glycemic control with metformin monotherapy (>= 1500 mg daily or maximally tolerated dose for >= 4 weeks). Random-effects network meta-analyses were used to compare the weighted mean difference for changes from baseline in HbA1c, body weight (BW) and systolic blood pressure (SBP), and the risk of developing hypoglycemia, urinary (UTI) and genital tract infection (GTI). Results Sixty-two trials evaluating 25 agents were included. All agents significantly reduced HbA1c vs. placebo; albeit not to the same extent (range, 0.43% for miglitol to 1.29% for glibenclamide). Glargine, sulfonylureas (SUs) and nateglinide were associated with increased hypoglycemia risk vs. placebo (range, 4.00-11.67). Sodium glucose cotransporter-2 (SGLT2) inhibitors, glucagon-like peptide-1 analogs, miglitol and empagliflozin/linagliptin significantly reduced BW(range, 1.15-2.26kg) whereas SUs, thiazolindinediones, glargine and alogliptin/pioglitazone caused weight gain (range, 1.19-2.44kg). SGLT2 inhibitors, empagliflozin/linagliptin, liraglutide and sitagliptin decreased SBP (range, 1.88-5.43mmHg). No therapy increased UTI risk vs. placebo; however, SGLT2 inhibitors were associated with an increased risk of GTI (range, 2.16-8.03). Conclusions Adding different AHAs to metformin was associated with varying effects on HbA1c, BW, SBP, hypoglycemia, UTI and GTI which should impact clinician choice when selecting adjunctive therapy.	[Mearns, Elizabeth S.; Sobieraj, Diana M.; White, C. Michael; Saulsberry, Whitney J.; Doleh, Yunes; Zaccaro, Eric; Coleman, Craig I.] Univ Connecticut, Sch Pharm, Dept Pharm Practice, Storrs, CT 06269 USA; [Mearns, Elizabeth S.; Sobieraj, Diana M.; White, C. Michael; Saulsberry, Whitney J.; Coleman, Craig I.] Hartford Hosp, Evidence Based Practice Ctr, Hartford, CT 06115 USA; [Kohn, Christine G.] Univ St Joseph, Sch Pharm, Dept Pharm Practice, Hartford, CT USA	University of Connecticut; Hartford Hospital	Coleman, CI (corresponding author), Univ Connecticut, Sch Pharm, Dept Pharm Practice, Storrs, CT 06269 USA.	craig.coleman@hhchealth.org		Sobieraj, Diana/0000-0002-5227-0681; Coleman, Craig/0000-0003-4868-7158	Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI)	Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI)(Boehringer Ingelheim)	This work was supported by Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI). The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICJME) and were fully responsible for all content and editorial decisions, and were involved in all stages of manuscript development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2004, DIABETES CARE, V27, P2874, DOI 10.2337/diacare.27.12.2874; [Anonymous], 2014, PACKAGE NETMETA; Arechavaleta R, 2011, DIABETES OBES METAB, V13, P160, DOI 10.1111/j.1463-1326.2010.01334.x; Aschner P, 2012, LANCET, V379, P2262, DOI 10.1016/S0140-6736(12)60439-5; Bailey CJ, 2010, LANCET, V375, P2223, DOI 10.1016/S0140-6736(10)60407-2; Baker WL, 2014, J AM SOC HYPERTENS, V8, P262, DOI 10.1016/j.jash.2014.01.007; Bergenstal Richard M, 2012, Diabetes Ther, V3, P13, DOI 10.1007/s13300-012-0013-8; Bolen S., 2007, COMP EFFECTIVENESS S; Bolli GB, 2014, DIABETIC MED, V31, P176, DOI 10.1111/dme.12328; Bosi E, 2007, DIABETES CARE, V30, P890, DOI 10.2337/dc06-1732; Cefalu WT, 2013, LANCET, V382, P941, DOI 10.1016/S0140-6736(13)60683-2; Charbonnel B, 2013, DIABETOLOGIA, V56, P1503, DOI 10.1007/s00125-013-2905-1; Charpentier G, 2001, DIABETIC MED, V18, P828, DOI 10.1046/j.1464-5491.2001.00582.x; Chawla S, 2013, J PHARMACOL PHARMACO, V4, P27, DOI 10.4103/0976-500X.107656; DeFronzo RA, 2012, J CLIN ENDOCR METAB, V97, P1615, DOI 10.1210/jc.2011-2243; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Defronzo RA, 2000, AM DIAB ASS ADA 74 S; DeFronzo RA, 2009, DIABETES CARE, V32, P1649, DOI 10.2337/dc08-1984; Derosa G, 2012, DIABETIC MED, V29, P1515, DOI 10.1111/j.1464-5491.2012.03699.x; Derosa G, 2014, METABOLISM, V63, P957, DOI 10.1016/j.metabol.2014.04.008; Derosa G, 2013, PHARMACOL RES, V73, P20, DOI 10.1016/j.phrs.2013.04.005; Derosa G, 2012, DIABETES RES CLIN PR, V98, P51, DOI 10.1016/j.diabres.2012.05.022; Feinglos M, 2005, DIABETES RES CLIN PR, V68, P167, DOI 10.1016/j.diabres.2004.09.002; Ferrannini E, 2009, DIABETES OBES METAB, V11, P157, DOI 10.1111/j.1463-1326.2008.00994.x; Filozof C, 2010, DIABETIC MED, V27, P318, DOI 10.1111/j.1464-5491.2010.02938.x; Fonseca V, 2000, JAMA-J AM MED ASSOC, V283, P1695, DOI 10.1001/jama.283.13.1695; Gallwitz B, 2012, LANCET, V380, P475, DOI 10.1016/S0140-6736(12)60691-6; Gallwitz B, 2012, LANCET, V379, P2270, DOI 10.1016/S0140-6736(12)60479-6; Goke B, 2010, INT J CLIN PRACT, V64, P1619, DOI 10.1111/j.1742-1241.2010.02510.x; Gomez-Perez FJ, 2002, DIABETES-METAB RES, V18, P127, DOI 10.1002/dmrr.264; Goodman M, 2009, HORM METAB RES, V41, P368, DOI 10.1055/s-0028-1104604; Haring HU, 2014, DIABETES CARE, V37, P1650, DOI 10.2337/dc13-2105; Halimi S, 2000, DIABETES RES CLIN PR, V50, P49, DOI 10.1016/S0168-8227(00)00163-7; Hamann A, 2008, EXP CLIN ENDOCR DIAB, V116, P6, DOI 10.1055/s-2007-984441; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Khanolkar MP, 2008, ATHEROSCLEROSIS, V197, P718, DOI 10.1016/j.atherosclerosis.2007.07.020; Lavalle-Gonzalez FJ, 2013, DIABETOLOGIA, V56, P2582, DOI 10.1007/s00125-013-3039-1; Ljunggren O, 2012, DIABETES OBES METAB, V14, P990, DOI 10.1111/j.1463-1326.2012.01630.x; Marre A, 2002, DIABETES OBES METAB, V4, P177, DOI 10.1046/j.1463-1326.2002.00196.x; Matthews DR, 2005, DIABETES-METAB RES, V21, P167, DOI 10.1002/dmrr.478; McIntosh Brendan, 2011, Open Med, V5, pe35; Mills EJ, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5195; Monami M, 2008, DIABETES RES CLIN PR, V79, P196, DOI 10.1016/j.diabres.2007.08.024; Moses R, 1999, DIABETES CARE, V22, P119, DOI 10.2337/diacare.22.1.119; Nauck MA, 2007, DIABETES OBES METAB, V9, P194, DOI 10.1111/j.1463-1326.2006.00704.x; Nauck MA, 2009, INT J CLIN PRACT, V63, P46, DOI 10.1111/j.1742-1241.2008.01933.x; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; Nauck M, 2014, DIABETES CARE, V37, P2149, DOI 10.2337/dc13-2761; Nauck MA, 2011, DIABETES CARE, V34, P2015, DOI 10.2337/dc11-0606; Pan C, 2012, DIABETES OBES METAB, V14, P737, DOI 10.1111/j.1463-1326.2012.01593.x; Pfutzner A, 2011, DIABETES TECHNOL THE, V13, P637, DOI 10.1089/dia.2010.0233; Phung OJ, 2010, JAMA-J AM MED ASSOC, V303, P1410, DOI 10.1001/jama.2010.405; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Raz I, 2008, CURR MED RES OPIN, V24, P537, DOI [10.1185/030079908X260925, 10.1185/030079908X260925 ]; Reboldi G, 2011, J HYPERTENS, V29, P1253, DOI 10.1097/HJH.0b013e3283469976; Ridderstrale M, 2014, LANCET DIABETES ENDO, V2, P691, DOI 10.1016/S2213-8587(14)70120-2; Rigby SP, 2010, ENDOCR PRACT, V16, P53, DOI 10.4158/EP09146.OR; Ristic S, 2006, DIABETIC MED, V23, P757, DOI 10.1111/j.1464-5491.2006.01914.x; Rizzo MR, 2012, DIABETES CARE, V35, P2076, DOI 10.2337/dc12-0199; Rosenstock J, 1998, DIABETES CARE, V21, P2050, DOI 10.2337/diacare.21.12.2050; Rosenstock J, 2013, DIABETES OBES METAB, V15, P1154, DOI 10.1111/dom.12185; Rosenstock J, 2013, DIABETES CARE, V36, P2945, DOI 10.2337/dc12-2709; Rosenstock J, 2012, DIABETES CARE, V35, P1232, DOI 10.2337/dc11-1926; Ross SA, 2012, CURR MED RES OPIN, V28, P1465, DOI 10.1185/03007995.2012.714360; Scheen AJ, 2010, DIABETES-METAB RES, V26, P540, DOI 10.1002/dmrr.1114; Scott R, 2008, DIABETES OBES METAB, V10, P959, DOI 10.1111/j.1463-1326.2007.00839.x; Sherwood NE, 2000, INT J OBESITY, V24, P395, DOI 10.1038/sj.ijo.0801169; StJeor ST, 1997, J AM DIET ASSOC, V97, P481, DOI 10.1016/S0002-8223(97)00126-0; Taskinen MR, 2011, DIABETES OBES METAB, V13, P65, DOI 10.1111/j.1463-1326.2010.01326.x; Unick JL, 2011, DIABETES CARE, V34, P2152, DOI 10.2337/dc11-0874; US Food and Drug Administration, GUID IND DIAB MELL D; Van Gaal L, 2001, DIABETES OBES METAB, V3, P326, DOI 10.1046/j.1463-1326.2001.00141.x; Wang JS, 2011, CLIN THER, V33, P1932, DOI 10.1016/j.clinthera.2011.10.014; White JL, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-17; Yang WY, 2011, DIABETES RES CLIN PR, V94, P217, DOI 10.1016/j.diabres.2011.07.035	78	106	109	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125879	10.1371/journal.pone.0125879	http://dx.doi.org/10.1371/journal.pone.0125879			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919293	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659400090
J	Richards, P; Pellegrina, H; VanWey, L; Spera, S				Richards, Peter; Pellegrina, Heitor; VanWey, Leah; Spera, Stephanie			Soybean Development: The Impact of a Decade of Agricultural Change on Urban and Economic Growth in Mato Grosso, Brazil	PLOS ONE			English	Article							DEFORESTATION; EXPANSION	In this research we consider the impact of export-driven, soybean agriculture in Mato Grosso on regional economic growth. Here we argue that the soybean sector has served as a motor to the state's economy by increasing the demand for services, housing, and goods, and by providing a source of investment capital to the non-agricultural sector. Specifically, we show that each square kilometer of soybean production supports 2.5 formal sector jobs outside of agriculture, and the equivalent of approximately 150,000US in annual, non-agricultural GDP. We also show that annual gains in non-agricultural employment and GDP are closely tied to soybean profitability, and thus vary from year to year. However, while this article highlights the potential of the agricultural sector as a driver of regional economic growth, it also acknowledges that this growth has been sustained by profits determined by externally set prices and the rate of exchange, and that future growth trajectories will be susceptible to potential currency of market shocks. We also show that while Mato Grosso's economic growth has come at a significant cost to the environment, value added by the agriculture sector, directly and indirectly, has surpassed the value of the CO2-e emitted through land clearings.	[Richards, Peter] Brown Univ, Inst Study Environm & Soc, Populat Studies & Training Ctr, Providence, RI 02912 USA; [Pellegrina, Heitor] Brown Univ, Inst Study Environm & Soc, Dept Econ, Providence, RI 02912 USA; [VanWey, Leah] Brown Univ, Inst Study Environm & Soc, Populat Studies & Training Ctr, Dept Sociol, Providence, RI 02912 USA; [Spera, Stephanie] Brown Univ, Inst Study Environm & Soc, Dept Geol Sci, Providence, RI 02912 USA	Brown University; Brown University; Brown University; Brown University	Richards, P (corresponding author), Brown Univ, Inst Study Environm & Soc, Populat Studies & Training Ctr, Providence, RI 02912 USA.	peter_richards@brown.edu	VanWey, Leah/A-2908-2013	Spera, Stephanie/0000-0002-8681-7315	National Science Foundation [SMA-1305489]; National Aeronautics and Space Administration [NNX11AH91G]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007338] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding: National Science Foundation Grant #SMA-1305489 financed the salary of the lead author. National Aeronautics and Space Administration Grant # NNX11AH91G contributed to the land use classifications, and financed a portion of the second and fourth authors' salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral S, 2006, INT J REMOTE SENS, V27, P855, DOI 10.1080/01431160500181861; Arima EY, 2014, LAND USE POLICY, V41, P465, DOI 10.1016/j.landusepol.2014.06.026; Arima EY, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024010; Assuncao J.A., 2012, CLIMATE POLICY INITI, V01, P03, DOI DOI 10.1017/S1355770X15000078; Awokuse TO, 2014, CANADIAN J AGR EC; Brannstrom C, 2012, LAND USE POLICY, V29, P357, DOI 10.1016/j.landusepol.2011.07.006; Brazilian Institute of Geography and Statistics (IBGE), 2010, RES POP SEX HOUS SIT; Christiaensen L, 2011, J DEV ECON, V96, P239, DOI 10.1016/j.jdeveco.2010.10.006; Cohn AS, 2014, P NATL ACAD SCI USA, V07, P163; CONAB Companhia Nacional de Abastecimento, 2014, CONAB HIST TIM SER; Dercon S, 2014, ANNU REV RESOUR ECON, V6, P471, DOI 10.1146/annurev-resource-100913-012706; Foster AD, 2004, ECON DEV CULT CHANGE, V52, P509, DOI 10.1086/420968; Galford GL, 2011, ECOL APPL, V21, P750, DOI 10.1890/09-1957.1; Gardner BL, 2000, AM J AGR ECON, V82, P1059, DOI 10.1111/0002-9092.00104; Garrett RD, 2013, LAND USE POLICY, V31, P385, DOI 10.1016/j.landusepol.2012.08.002; Gemmell N, 2000, J AGR ECON, V51, P353, DOI 10.1111/j.1477-9552.2000.tb01236.x; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Henderson JV, 2012, AM ECON REV, V102, P994, DOI 10.1257/aer.102.2.994; IBGE, 2000, RES POP SEX HOUS SIT; IBGE, 2014, PROD AG MUN 1990 201, DOI [10.1016/S0176-1617(85)80065-1, DOI 10.1016/S0176-1617(85)80065-1]; IBGE Instituto Brasileiro de Geografia e Estatistica, 2014, TAB 21 PROD INT BRUT; IMEA Instituto Mato-grossense de Economia Agropecuaria, 2012, SOYB PRIC; JOHNSTON BF, 1961, AM ECON REV, V51, P566; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Lewis, 1954, MANCHESTER SCH EC SO, V22, P139, DOI [DOI 10.1111/J.1467-9957.1954.TB00021.X, 10.1111/j.1467-9957.1954.tb00021.x]; Macedo M, 2012, P NATL ACAD SCI US; May P.H., 2013, MUCH IS AMAZON WORTH; McDonald RI, 2011, P NATL ACAD SCI USA, V108, P6312, DOI 10.1073/pnas.1011615108; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; NOAA, 2013, VERS 4 DMSP OLS NIGH; PNUD, 2013, RANK IDH MUN BRAS 20; RAIS, 2014, REL AN INF SOC RAIS; Richards P, ANN ASS AM IN PRESS; Richards PD, 2014, GLOBAL ENVIRON CHANG, V29, P1, DOI 10.1016/j.gloenvcha.2014.06.011; Richards PD, 2012, GLOBAL ENVIRON CHANG, V22, P454, DOI 10.1016/j.gloenvcha.2012.01.004; Rudel TK, 2009, P NATL ACAD SCI USA, V106, P20675, DOI 10.1073/pnas.0812540106; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Spera SA, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/6/064010; Tiffen M, 2003, WORLD DEV, V31, P1343, DOI 10.1016/S0305-750X(03)00088-3; Tiffin R, 2006, AGR ECON-BLACKWELL, V35, P79, DOI 10.1111/j.1574-0862.2006.00141.x; VanWey LK, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0168; Weinhold D, 2013, WORLD DEV, V52, P132, DOI 10.1016/j.worlddev.2012.11.016	43	46	46	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0122510	10.1371/journal.pone.0122510	http://dx.doi.org/10.1371/journal.pone.0122510			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SE	25919305	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400014
J	Camacho-Ortiz, A; Lopez-Barrera, D; Hernandez-Garcia, R; Galvan-De los Santos, AM; Flores-Trevino, SM; Llaca-Diaz, JM; Maldonado Garza, HJ; Bosques-Padilla, FJ; Garza-Gonzalez, E				Camacho-Ortiz, Adrian; Lopez-Barrera, Daniel; Hernandez-Garcia, Raul; Galvan-De los Santos, Alejandra M.; Flores-Trevino, Samantha M.; Llaca-Diaz, Jorge M.; Maldonado Garza, Hector J.; Bosques-Padilla, Francisco J.; Garza-Gonzalez, Elvira			First Report of Clostridium difficile NAP1/027 in a Mexican Hospital	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; TOXIN PRODUCTION; NORTH-AMERICA; INFECTION; GENE; EPIDEMIC; DIARRHEA; POLYMORPHISM; STRAINS; DISEASE	Background and Objective Clostridium difficile NAP1/ribotype 027 is associated with severe disease and high mortality rates. Our aim was to determine the prevalence of NAP1/ribotype 027 among C. difficile isolates in a tertiary care hospital, and review the main clinical data. Methods We included 106 stool samples from 106 patients. Samples were tested for A&B toxins and were cultured on CCFA agar. The genes tcdA, tcdB, tcdC, cdtA, and cdtB were amplified using PCR in clinical isolates. The tcdA 3 '-end deletion analysis, PCR-ribotyping, and pulsed-field gel electrophoresis (PFGE) were also performed. Stool samples that were positive for culture were tested by the GeneXpert C. difficile assay. Clinical data were collected. Results Thirty-six patients tested positive for A&B toxins; and 22 patients had positive culture for C. difficile, 14 of which tested positive for the A&B toxins and all 22 patients tested positive by the GeneXpert C. difficile assay. Risk factors included an average hospital stay of 16.1 days prior to toxin detection, average antibiotic use for 16.2 days, and a median of 3 antibiotics used. The 30-day crude mortality rate was 8.4%. Six of the 22 patients died, and 3 of those deaths were directly attributed to C. difficile infection. The majority of isolates, 90.9% (20/22), carried genes tcdB, tcdA, cdtA, and cdtB; and these strains carried the corresponding downregulator gene tcdC, with an 18-bp deletion. PFGE was performed on 17 isolates, and one main pattern was observed. Analysis of the ribotyping data showed similar results. Conclusion The above findings represent the clonal spread of C. difficile in our institution, which mainly includes the NAP1/027 strain. This is the first report of C. difficile ribotype NAP1/027 in Mexico.	[Camacho-Ortiz, Adrian; Hernandez-Garcia, Raul; Galvan-De los Santos, Alejandra M.] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Infectol, Monterrey, Nuevo Leon, Mexico; [Lopez-Barrera, Daniel; Flores-Trevino, Samantha M.; Maldonado Garza, Hector J.; Bosques-Padilla, Francisco J.; Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico; [Llaca-Diaz, Jorge M.; Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Dept Clin Pathol, Monterrey, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon	Garza-Gonzalez, E (corresponding author), Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico.	elvira_garza_gzz@yahoo.com	Flores-Treviño, Samantha M/E-8601-2019; Flores-Treviño, Samantha/AAB-4537-2020	Flores-Treviño, Samantha M/0000-0003-1259-7425; Flores-Treviño, Samantha/0000-0003-1259-7425; Maldonado-Garza, Hector Jesus/0000-0001-9217-7169; Bosques, Francisco/0000-0002-9795-7209; Llaca Diaz, Jorge Martin/0000-0001-6875-2530				Alonso R, 2005, J MED MICROBIOL, V54, P155, DOI 10.1099/jmm.0.45808-0; Bidet P, 1999, FEMS MICROBIOL LETT, V175, P261, DOI 10.1016/S0378-1097(99)00204-9; Elliott B, 2007, INTERN MED J, V37, P561, DOI 10.1111/j.1445-5994.2007.01403.x; Forster AJ, 2012, CAN MED ASSOC J, V184, P37, DOI 10.1503/cmaj.110543; Ghantoji SS, 2010, J HOSP INFECT, V74, P309, DOI 10.1016/j.jhin.2009.10.016; Heinlen L, 2010, AM J MED SCI, V340, P247, DOI 10.1097/MAJ.0b013e3181e939d8; Hernandez-Rocha C, 2012, EMERG INFECT DIS, V18, P1370, DOI 10.3201/eid1808.120211; Kato H, 1999, FEMS MICROBIOL LETT, V175, P197, DOI [10.1016/S0378-1097(99)00196-2, 10.1111/j.1574-6968.1999.tb13620.x]; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Mylonakis E, 2001, ARCH INTERN MED, V161, P525, DOI 10.1001/archinte.161.4.525; O'Horo JC, 2012, MAYO CLIN PROC, V87, P643, DOI 10.1016/j.mayocp.2012.02.024; Oake N, 2010, ARCH INTERN MED, V170, P1804, DOI 10.1001/archinternmed.2010.405; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Persson S, 2011, J CLIN MICROBIOL, V49, P4299, DOI 10.1128/JCM.05161-11; Poutanen SM, 2004, CAN MED ASSOC J, V171, P51, DOI 10.1503/cmaj.1031189; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X	19	29	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0122627	10.1371/journal.pone.0122627	http://dx.doi.org/10.1371/journal.pone.0122627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915544	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000353659100009
J	Donadio, G; Sarcinelli, C; Pizzo, E; Notomista, E; Pezzella, A; Di Cristo, C; De Lise, F; Di Donato, A; Izzo, V				Donadio, Giuliana; Sarcinelli, Carmen; Pizzo, Elio; Notomista, Eugenio; Pezzella, Alessandro; Di Cristo, Carlo; De Lise, Federica; Di Donato, Alberto; Izzo, Viviana			The Toluene o-Xylene Monooxygenase Enzymatic Activity for the Biosynthesis of Aromatic Antioxidants	PLOS ONE			English	Article							PSEUDOMONAS-STUTZERI OX1; H9C2 CELL-LINE; OXIDATIVE STRESS; HYDROXYTYROSOL; GRANULES; HYDROXYLASE; SPECIFICITY; POLYPHENOLS; BACTERIAL	Monocyclic phenols and catechols are important antioxidant compounds for the food and pharmaceutic industries; their production through biotransformation of low-added value starting compounds is of major biotechnological interest. The toluene o-xylene monooxygenase (ToMO) from Pseudomonas sp. OX1 is a bacterial multicomponent monooxygenase (BMM) that is able to hydroxylate a wide array of aromatic compounds and has already proven to be a versatile biochemical tool to produce mono-and dihydroxylated derivatives of aromatic compounds. The molecular determinants of its regioselectivity and substrate specificity have been thoroughly investigated, and a computational strategy has been developed which allows designing mutants able to hydroxylate non-natural substrates of this enzyme to obtain high-added value compounds of commercial interest. In this work, we have investigated the use of recombinant ToMO, expressed in cells of Escherichia coli strain JM109, for the biotransformation of non-natural substrates of this enzyme such as 2-phenoxyethanol, phthalan and 2-indanol to produce six hydroxylated derivatives. The hydroxylated products obtained were identified, isolated and their antioxidant potential was assessed both in vitro, using the DPPH assay, and on the rat cardiomyoblast cell line H9c2. Incubation of H9c2 cells with the hydroxylated compounds obtained from ToMO-catalyzed biotransformation induced a differential protective effect towards a mild oxidative stress induced by the presence of sodium arsenite. The results obtained confirm once again the versatility of the ToMO system for oxyfunctionalization reactions of biotechnological importance. Moreover, the hydroxylated derivatives obtained possess an interesting antioxidant potential that encourages the use of the enzyme for further functionalization reactions and their possible use as scaffolds to design novel bioactive molecules.	[Donadio, Giuliana; Sarcinelli, Carmen; Pizzo, Elio; Notomista, Eugenio; De Lise, Federica; Di Donato, Alberto; Izzo, Viviana] Univ Naples Federico II, Dept Biol, I-80126 Naples, Italy; [Pezzella, Alessandro] Univ Naples Federico II, Dept Chem Sci, I-80126 Naples, Italy; [Di Cristo, Carlo] Univ Sannio, Dept Sci & Technol, Benevento, Italy; [Izzo, Viviana] Univ Salerno, Dept Med & Surg, I-84081 Baronissi, SA, Italy	University of Naples Federico II; University of Naples Federico II; University of Sannio; University of Salerno	Izzo, V (corresponding author), Univ Naples Federico II, Dept Biol, Via Cinthia I, I-80126 Naples, Italy.	vizzo@unisa.it	De Lise, Federica/L-6904-2019; Izzo, Viviana/Q-2076-2015; Pizzo, Elio/Q-4722-2017; Pezzella, Alessandro/E-1440-2011; De Lise, Federica/AAN-6065-2021	Izzo, Viviana/0000-0001-6066-7569; Pizzo, Elio/0000-0002-3652-8865; Pezzella, Alessandro/0000-0001-6925-922X; De Lise, Federica/0000-0002-9614-9226; DI DONATO, Alberto/0000-0001-9129-9850; NOTOMISTA, Eugenio/0000-0003-0097-6487	FARB ORSA [132082]; POR CAMPANIA FSE, Progetto CARINA CUP [B25B0900080007]	FARB ORSA; POR CAMPANIA FSE, Progetto CARINA CUP	This research was supported by FARB 2013 ORSA 132082. Dr. C. Sarcinelli was supported by grant POR CAMPANIA FSE 2007/2013, Progetto CARINA CUP B25B0900080007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bernini R, 2013, CURR MED CHEM, V20, P655, DOI 10.2174/092986713804999367; Brouk M, 2009, FOOD CHEM, V116, P114, DOI 10.1016/j.foodchem.2009.02.020; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cafaro V, 2002, EUR J BIOCHEM, V269, P5689, DOI 10.1046/j.1432-1033.2002.03281.x; Cafaro V, 2004, APPL ENVIRON MICROB, V70, P2211, DOI 10.1128/AEM.70.4.2211-2219.2004; Cafaro V, 2005, APPL ENVIRON MICROB, V71, P4744, DOI 10.1128/AEM.71.8.4744-4750.2005; Conti V, 2012, MED SCI SPORT EXER, V44, P39, DOI 10.1249/MSS.0b013e318227f69c; Dror A, 2012, COMPUT STRUCT BIOTEC, V2, DOI 10.5936/csbj.201209011; Feingersch R, 2008, APPL ENVIRON MICROB, V74, P1555, DOI 10.1128/AEM.01849-07; Foti MC, 2007, J PHARM PHARMACOL, V59, P1673, DOI 10.1211/jpp.59.12.0010; Granados-Principal S, 2010, NUTR REV, V68, P191, DOI 10.1111/j.1753-4887.2010.00278.x; Gulcin I, 2012, ARCH TOXICOL, V86, P345, DOI 10.1007/s00204-011-0774-2; Huang CH, 2011, J AM CHEM SOC, V133, P17630, DOI 10.1021/ja208572v; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; INGOLD KU, 1961, CHEM REV, V61, P563, DOI 10.1021/cr60214a002; Jimenez-Escrig A, 2000, J SCI FOOD AGR, V80, P1686, DOI 10.1002/1097-0010(20000901)80:11<1686::AID-JSFA694>3.0.CO;2-Y; Kedare SB, 2011, J FOOD SCI TECH MYS, V48, P412, DOI 10.1007/s13197-011-0251-1; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kelsey NA, 2010, MOLECULES, V15, P7792, DOI 10.3390/molecules15117792; Liu RH, 2013, ADV NUTR, V4, p384S, DOI 10.3945/an.112.003517; Manna C, 2005, J AGR FOOD CHEM, V53, P9602, DOI 10.1021/jf058110i; Marco S, 2013, BIOCHIMIE, V95, P2145, DOI 10.1016/j.biochi.2013.08.008; Mohajeri A, 2009, J MOL STRUCT, V930, P15, DOI 10.1016/j.molstruc.2009.04.031; Murray LJ, 2007, ACCOUNTS CHEM RES, V40, P466, DOI 10.1021/ar600040e; Notomista E, 2003, J MOL EVOL, V56, P435, DOI 10.1007/s00239-002-2414-1; Notomista E, 2011, APPL ENVIRON MICROB, V77, P5428, DOI 10.1128/AEM.00461-11; Notomista E, 2009, APPL ENVIRON MICROB, V75, P823, DOI 10.1128/AEM.01951-08; Owen R W, 2000, Lancet Oncol, V1, P107, DOI 10.1016/S1470-2045(00)00015-2; Pazmino DET, 2010, J BIOTECHNOL, V146, P9, DOI 10.1016/j.jbiotec.2010.01.021; Raederstorff D, 2009, INT J VITAM NUTR RES, V79, P152, DOI 10.1024/0300-9831.79.3.152; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Rietjens SJ, 2007, J AGR FOOD CHEM, V55, P7609, DOI 10.1021/jf0706934; Sambrook J., 1989, MOLECULAR CLONING A; Sazinsky MH, 2004, J BIOL CHEM, V279, P30600, DOI 10.1074/jbc.M400710200; Schweigert N, 2001, ENVIRON MICROBIOL, V3, P81, DOI 10.1046/j.1462-2920.2001.00176.x; Vardar G, 2004, APPL ENVIRON MICROB, V70, P3253, DOI 10.1128/AEM.70.6.3253-3262.2004; Vardar G, 2005, J BIOTECHNOL, V115, P145, DOI 10.1016/j.jbiotec.2004.08.008; Visioli F, 2011, CURR PHARM DESIGN, V17, P786, DOI 10.2174/138161211795428885; Waterman E, 2007, ALTERN MED REV, V12, P331; Watkins SJ, 2011, IN VITRO CELL DEV-AN, V47, P125, DOI 10.1007/s11626-010-9368-1; Yang DP, 2007, MOLECULES, V12, P878, DOI 10.3390/12040878; Zhang HY, 2005, CURR COMPUT-AID DRUG, V1, P257, DOI 10.2174/1573409054367691; Zhang HY, 2000, QUANT STRUCT-ACT REL, V19, P50, DOI 10.1002/(SICI)1521-3838(200002)19:1<50::AID-QSAR50>3.0.CO;2-#; Zordoky Beshay N. M., 2007, Journal of Pharmacological and Toxicological Methods, V56, P317, DOI 10.1016/j.vascn.2007.06.001	48	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124427	10.1371/journal.pone.0124427	http://dx.doi.org/10.1371/journal.pone.0124427			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915063	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100049
J	Falcini, F; Palatella, L; Cuttitta, A; Nardelli, BB; Lacorata, G; Lanotte, AS; Patti, B; Santoleri, R				Falcini, Federico; Palatella, Luigi; Cuttitta, Angela; Nardelli, Bruno Buongiorno; Lacorata, Guglielmo; Lanotte, Alessandra S.; Patti, Bernardino; Santoleri, Rosalia			The Role of Hydrodynamic Processes on Anchovy Eggs and Larvae Distribution in the Sicily Channel (Mediterranean Sea): A Case Study for the 2004 Data Set	PLOS ONE			English	Article							SMALL PELAGIC FISH; ENGRAULIS-ENCRASICOLUS; OCEANOGRAPHIC CONDITIONS; MESOSCALE VARIABILITY; LIFE-HISTORY; STRAIT; CIRCULATION; MIGRATION; TRANSPORT; PATTERNS	Knowledge of the link between ocean hydrodynamics and distribution of small pelagic fish species is fundamental for the sustainable management of fishery resources. Both commercial and scientific communities are indeed seeking to provide services that could "connect the dots" among in situ and remote observations, numerical ocean modelling, and fisheries. In the Mediterranean Sea and, in particular, in the Sicily Channel the reproductive strategy of the European Anchovy (Engraulis encrasicolus) is strongly influenced by the oceanographic patterns, which are often visible in sea surface temperature satellite data. Based on these experimental evidences, we propose here a more general approach where the role of ocean currents, wind effects, and mesoscale activity are tied together. To investigate how these features affect anchovy larvae distribution, we pair ichthyoplankton observations to a wide remote sensing data set, and to Lagrangian numerical simulations for larval transport. Our analysis shows that while the wind-induced coastal current is able to transport anchovy larvae from spawning areas to the recruiting area off the Sicilian south-eastern tip, significant cross-shore transport due to the combination of strong northwesterly mistral winds and topographic effects delivers larvae away from the coastal conveyor belt. We then use a potential vorticity approach to describe the occurrence of larvae cross-shore transport. We conclude that monitoring and quantifying the upwelling on the southern Sicilian coast during the spawning season allows to estimate the cross-shore transport of larvae and the consequent decrease of individuals within the recruiting area.	[Falcini, Federico; Nardelli, Bruno Buongiorno; Santoleri, Rosalia] CNR, Ist Sci Atmosfera & Clima, Rome, Italy; [Palatella, Luigi; Lacorata, Guglielmo; Lanotte, Alessandra S.] CNR, Ist Sci Atmosfera & Clima, Lecce, Italy; [Cuttitta, Angela; Patti, Bernardino] CNR, Ist Ambiente Marino Costiero, Capo Granitola, TP, Italy; [Nardelli, Bruno Buongiorno] CNR, Ist Ambiente Marino Costiero, I-80125 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell'Atmosfera e del Clima (ISAC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell'Atmosfera e del Clima (ISAC-CNR); Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Falcini, F (corresponding author), CNR, Ist Sci Atmosfera & Clima, Rome, Italy.	f.falcini@isac.cnr.it	Palatella, Luigi Nicola Antonio/ABE-3647-2020; Nardelli, Bruno Buongiorno/AAY-4289-2020; Nardelli, Bruno Buongiorno/I-4810-2012; Lacorata, Guglielmo/AAW-9410-2020; Lacorata, Guglielmo/B-7202-2009; Cuttitta, Angela/AAK-2097-2020; Patti, Bernardo/ABG-7214-2020; SANTOLERI, ROSALIA/B-8711-2015; Lanotte, Alessandra S./C-5238-2009	Nardelli, Bruno Buongiorno/0000-0002-3416-7189; Lacorata, Guglielmo/0000-0002-8594-3934; Lacorata, Guglielmo/0000-0002-8594-3934; Cuttitta, Angela/0000-0002-4896-5114; SANTOLERI, ROSALIA/0000-0002-2900-5054; Falcini, Federico/0000-0001-8105-2491; Patti, Bernardo/0000-0003-0193-5628; Palatella, Luigi Nicola/0000-0003-0075-8287; Lanotte, Alessandra S./0000-0001-7201-2965	SSD PESCA; RITMARE Italian Research Ministry (MIUR) Projects	SSD PESCA; RITMARE Italian Research Ministry (MIUR) Projects	This work has been funded supported by the SSD PESCA and the RITMARE Italian Research Ministry (MIUR) Projects.	Allain G, 2001, FISH OCEANOGR, V10, P151, DOI 10.1046/j.1365-2419.2001.00164.x; Basilone G, 2013, FISH OCEANOGR, V22, P309, DOI 10.1111/fog.12024; Buongiorno Nardelli B, 2001, J PHYS OCEANOGR, V31, P2227, DOI 10.1175/1520-0485(2001)031<2227:SMFAAM>2.0.CO;2; Buongiorno Nardelli B, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003191; Buongiorno Nardelli B, 1999, J GEOPHYS RES-OCEANS, V104, P20585, DOI 10.1029/1999JC900103; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Coombs SH, 2003, MAR ECOL PROG SER, V248, P221, DOI 10.3354/meps248221; CRISANTI A, 1991, RIV NUOVO CIMENTO, V14, P1, DOI 10.1007/BF02811193; CSANADY GT, 1982, J PHYS OCEANOGR, V12, P84, DOI 10.1175/1520-0485(1982)012<0084:OTSOTU>2.0.CO;2; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Cuttitta A, 2003, HYDROBIOLOGIA, V503, P117, DOI 10.1023/B:HYDR.0000008473.96144.d3; Garcia A, 1996, SCI MAR, V60, P155; Garcia A., 1994, NW MEDITERRANEAN ANC; Hays GC, 2014, ECOL LETT, V17, P137, DOI 10.1111/ele.12219; Hays GC, 2010, J R SOC INTERFACE, V7, P1319, DOI 10.1098/rsif.2010.0009; Iudicone D, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001647; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Lacorata G, 2008, J ATMOS SCI, V65, P2389, DOI 10.1175/2007JAS2410.1; Lacorata G, 2014, J GEOPHYS RES-OCEANS, V119, P8029, DOI 10.1002/2014JC010313; Lafuente JG, 2005, FISH OCEANOGR, V14, P32, DOI 10.1111/j.1365-2419.2004.00304.x; Lafuente JG, 2002, FISH OCEANOGR, V11, P31, DOI 10.1046/j.1365-2419.2002.00186.x; LARGE WG, 1981, J PHYS OCEANOGR, V11, P324, DOI 10.1175/1520-0485(1981)011<0324:OOMFMI>2.0.CO;2; Lee ZP, 2002, APPL OPTICS, V41, P5755, DOI 10.1364/AO.41.005755; Lermusiaux PFJ, 1999, DYNAM ATMOS OCEANS, V29, P255, DOI 10.1016/S0377-0265(99)00008-1; Lermusiaux PFJ, 2001, DEEP-SEA RES PT I, V48, P1953, DOI 10.1016/S0967-0637(00)00114-X; Lett C, 2007, J MARINE SYST, V64, P189, DOI 10.1016/j.jmarsys.2006.03.012; Lloret J, 2000, ICES J MAR SCI, V57, P171, DOI 10.1006/jmsc.2000.0570; Marullo S, 2007, OCEAN SCI, V3, P299, DOI 10.5194/os-3-299-2007; Mazzola S, 2000, DISTRIBUTION BIOL BI; MAZZOLA S, 2002, SICILIAN CHANNEL ANC; MCCLAIN CR, 1993, J GEOPHYS RES-OCEANS, V98, P12327, DOI 10.1029/93JC00868; MCNAMARA JM, 1987, ECOLOGY, V68, P1515, DOI 10.2307/1939235; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; OLIVAR M-P, 1991, Scientia Marina, V55, P1; OLIVAR MP, 1993, B MAR SCI, V53, P450; Onken R, 1998, J GEOPHYS RES-OCEANS, V103, P24799, DOI 10.1029/98JC00891; Orensanz J. M. Lobo, 1998, Canadian Special Publication of Fisheries and Aquatic Sciences, V125, P143; Palatella L, 2014, J GEOPHYS RES-OCEANS, V119, P1306, DOI 10.1002/2013JC009384; Palomera I, 2007, PROG OCEANOGR, V74, P377, DOI 10.1016/j.pocean.2007.04.012; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pedlosky J., 1982, GEOPHYS FLUID DYNAMI; Pickett MH, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001902; Pierini S, 1996, J GEOPHYS RES-OCEANS, V101, P6429, DOI 10.1029/95JC03138; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Poulain PM, 2007, CONT SHELF RES, V27, P981, DOI 10.1016/j.csr.2007.01.005; Pratt L. J., 2007, ROTATING HYDRAULICS, V36; RE P, 1986, Ciencia Biologica Ecology and Systematics, V6, P9; Re P, 1987, PUBLICACION TECNICA, V12, P257; Re P, 1990, 1 C TEJ, V2, P231; Rinaldi E, 2014, CONT SHELF RES, V77, P61, DOI 10.1016/j.csr.2014.01.010; Robinson AR, 1999, J MARINE SYST, V20, P129, DOI 10.1016/S0924-7963(98)00079-7; Rykaczewski RR, 2008, P NATL ACAD SCI USA, V105, P1965, DOI 10.1073/pnas.0711777105; Sabates A, 2007, PROG OCEANOGR, V74, P355, DOI 10.1016/j.pocean.2007.04.017; Santos AMP, 2007, PROG OCEANOGR, V74, P192, DOI 10.1016/j.pocean.2007.04.008; Serra IA, 2010, MOL ECOL, V19, P557, DOI 10.1111/j.1365-294X.2009.04462.x; Smith P. E., 1977, STANDARD TECHNIQUES; SOLOMON TH, 1988, PHYS REV A, V38, P6280, DOI 10.1103/PhysRevA.38.6280; Somarakis S, 2002, J PLANKTON RES, V24, P339, DOI 10.1093/plankt/24.4.339; Tonani M, 2008, OCEAN SCI, V4, P1, DOI 10.5194/os-4-1-2008; Zainuddin M, 2008, FISH OCEANOGR, V17, P61, DOI 10.1111/j.1365-2419.2008.00461.x	60	29	29	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123213	10.1371/journal.pone.0123213	http://dx.doi.org/10.1371/journal.pone.0123213			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915489	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659100016
J	Li, LY; Yang, WM; Chen, HZ; Wu, YH; Fang, X; Zhang, J; Wang, Z; Han, YS; Wang, Y				Li, Liang-Yong; Yang, Wen-Ming; Chen, Huai-Zhen; Wu, Yun-Hu; Fang, Xiang; Zhang, Jing; Wang, Zhen; Han, Yong-Sheng; Wang, Yu			Successful Splenectomy for Hypersplenism in Wilson's Disease: A Single Center Experience from China	PLOS ONE			English	Article							BLEEDING ESOPHAGEAL-VARICES; BLOOD-BRAIN-BARRIER; LIVER-TRANSPLANTATION; HEPATITIS-C; NEUROLOGICAL DETERIORATION; INTERFERON THERAPY; COPPER; CIRRHOSIS; PENICILLAMINE; DIAGNOSIS	Splenomegaly and pancytopenia are common in Wilson's disease (WD) and splenectomy is one of the conventional treatments for splenomegaly and the associated pancytopenia. However, splenectomy remained controversial for hypersplenism in WD as it was reported that splenectomy leaded to serious emotional and neurological deterioration in WD patients with hypersplenism. In the current study, we present our experiences in 70 WD patients with hypersplenism who had undergone splenectomy, outlining the safety and efficacy of splenectomy in WD. The clinical database of 70 WD patients with hypersplenism who had undergone splenectomy in our hospital between 2009 and 2013 were reviewed and followed-up regularly. Before splenectomy, all the patients accepted a short period of anti-copper treatment with intravenous sodium 2, 3-dimercapto-1-propane sulfonate (DMPS). All the patients demonstrated a marked improvement in platelet and leucocyte counts after splenectomy. No severe postoperative complication was observed. In particular, none of the 37 patients with mixed neurologic and hepatic presentations experienced neurological deterioration after splenectomy, and none of the patients with only hepatic presentations newly developed neurological symptoms. During the one year follow-up period, no patient presented hepatic failure or hepatic encephalopathy, no hepatic patient newly developed neurological presentations, and only 3 patients with mixed neurologic and hepatic presentations suffered neurological deterioration and these 3 patients had poor compliance of anti-copper treatment. Quantative analysis of the neurological symptoms in the 37 patients using the Unified Wilson's Disease Rating Scale (UWDRS) showed that the neurological symptoms were not changed in a short-term of one week after splenectomy but significantly improved in a long-term of one year after splenectomy. Additionally, compared to that before splenectomy, the esophageal gastric varices in most patients significantly improved one year after splenectomy. Thus, we may conclude that splenectomy is a safe and effective therapeutic measure for hypersplenism in WD patients who had been preoperatively treated with DMPS for powerful anti-copper therapy.	[Li, Liang-Yong; Yang, Wen-Ming; Chen, Huai-Zhen; Wu, Yun-Hu; Fang, Xiang; Zhang, Jing] Anhui Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Neurol, Hefei 230031, Peoples R China; [Wang, Zhen] Anhui Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Gen Surg, Hefei 230031, Peoples R China; [Han, Yong-Sheng] Anhui Univ Tradit Chinese Med, Inst Neurol, Hefei 230061, Peoples R China; [Wang, Yu] Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei 230022, Peoples R China	Anhui University of Chinese Medicine; Anhui University of Chinese Medicine; Anhui University of Chinese Medicine; Anhui Medical University	Wang, Y (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei 230022, Peoples R China.	yw4d@hotmail.com						Akahoshi T, 2012, J GASTROEN HEPATOL, V27, P286, DOI 10.1111/j.1440-1746.2011.06870.x; Aposhian HV, 1998, ENVIRON HEALTH PERSP, V106, P1017, DOI 10.2307/3434146; Baykal Mehmet, 2010, J Clin Med Res, V2, P99, DOI 10.4021/jocmr2010.04.292w; Brauer DL, 2014, BONE MARROW TRANSPL, V49, P717, DOI 10.1038/bmt.2013.238; Brewer GJ, 2006, ARCH NEUROL-CHICAGO, V63, P521, DOI 10.1001/archneur.63.4.521; Brewer GJ, 2006, EXPERT OPIN PHARMACO, V7, P317, DOI 10.1517/14656566.7.3.317; Casale M, 2013, EUR J HAEMATOL, V91, P69, DOI 10.1111/ejh.12121; Choi BS, 2009, BRAIN RES, V1248, P14, DOI 10.1016/j.brainres.2008.10.056; Cztonkowska A, 2007, NEUROL NEUROCHIR POL, V41, P1; Deng XG, 2012, PEDIATR SURG INT, V28, P1201, DOI 10.1007/s00383-012-3215-2; Digestive Endoscopy Branch of the Chinese Medical Association, 2000, CHIN J DIG ENDOSC, V17, P198; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; Ferenci P, 2004, ALIMENT PHARM THER, V19, P157, DOI 10.1046/j.1365-2036.2003.01813.x; Guillaud O, 2014, J HEPATOL, V60, P579, DOI 10.1016/j.jhep.2013.10.025; Harada M, 2014, HEPATOL RES; Hirooka M, 2008, HEPATOL RES, V38, P1172, DOI 10.1111/j.1872-034X.2008.00389.x; Hu J, 2001, J RADIOIMMUNOLOGY, V14, P1; Inagaki Y, 2014, MOL MED REP, V9, P487, DOI 10.3892/mmr.2013.1856; Iwamoto T, 2012, J GASTROENTEROL, V47, P300, DOI 10.1007/s00535-011-0486-7; Iwanski S, 2014, NEUROPSYCHOLOGY; Jiang XZ, 2009, WORLD J GASTROENTERO, V15, P3421, DOI 10.3748/wjg.15.3421; Kaetz H W, 1966, Conn Med, V30, P338; Kalita J, 2014, EUR NEUROL, V71, P126, DOI 10.1159/000355276; Kedia S, 2012, ANN HEPATOL, V11, P921, DOI 10.1016/S1665-2681(19)31419-X; Kim B, 2013, J CLIN NEUROSCI, V20, P606, DOI 10.1016/j.jocn.2012.02.041; Kim YE, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-127; Kleinig TJ, 2008, J CLIN NEUROSCI, V15, P575, DOI 10.1016/j.jocn.2007.03.001; Kuriyama N, 2012, LIVER TRANSPLANT, V18, P1361, DOI 10.1002/lt.23519; LANG CJG, 1993, ARCH NEUROL-CHICAGO, V50, P1008; Leinweber B, 2008, MOVEMENT DISORD, V23, P54, DOI 10.1002/mds.21761; Limenta LMG, 2011, CLIN PHARMACOKINET, V50, P41, DOI 10.2165/11536630-000000000-00000; Loudianos Georgios, 2014, Pril (Makedon Akad Nauk Umet Odd Med Nauki), V35, P93; Masuya M, 2014, HEPATOL RES, V44, pE376, DOI 10.1111/hepr.12319; Monnot AD, 2011, TOXICOL APPL PHARM, V256, P249, DOI 10.1016/j.taap.2011.02.003; Nomura Y, 2014, HEPATOL RES, V44, pE100, DOI 10.1111/hepr.12234; Peedikayil MC, 2013, WORLD J HEPATOL, V5, P127, DOI 10.4254/wjh.v5.i3.127; Pfeiffer RF, 2007, SEMIN NEUROL, V27, P123, DOI 10.1055/s-2007-971173; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Rosencrantz R, 2011, SEMIN LIVER DIS, V31, P245, DOI 10.1055/s-0031-1286056; Sandberg M, 1934, J EXP MED, V60, P395, DOI 10.1084/jem.60.3.395; Schilsky ML, 2014, ANN NY ACAD SCI, V1315, P45, DOI 10.1111/nyas.12454; STEINER P, 1975, SCHWEIZ MED WSCHR, V105, P872; STERNLIEB I, 1970, LANCET, V1, P638; STRICKLAND GT, 1972, GUT, V13, P220, DOI 10.1136/gut.13.3.220; Stuerenburg HJ, 2000, J NEURAL TRANSM, V107, P321, DOI 10.1007/s007020050026; Tokgoz Orhan, 2013, Middle East Journal of Anesthesiology, V22, P103; UMEKI S, 1985, ARCH INTERN MED, V145, P2271, DOI 10.1001/archinte.1985.00360120143044; Weiss KH, 2013, CLIN TRANSPLANT, V27, P914, DOI 10.1111/ctr.12259; Wenisch E, 2013, REV NEUROL-FRANCE, V169, P944, DOI 10.1016/j.neurol.2013.06.002; Xu SQ, 2013, J HUAZHONG U SCI-MED, V33, P743, DOI 10.1007/s11596-013-1190-z; Yalaz M, 2003, Minerva Pediatr, V55, P625	51	8	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124569	10.1371/journal.pone.0124569	http://dx.doi.org/10.1371/journal.pone.0124569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910248	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800089
J	Momose, H; Mizukami, T; Kuramitsu, M; Takizawa, K; Masumi, A; Araki, K; Furuhata, K; Yamaguchi, K; Hamaguchi, I				Momose, Haruka; Mizukami, Takuo; Kuramitsu, Madoka; Takizawa, Kazuya; Masumi, Atsuko; Araki, Kumiko; Furuhata, Keiko; Yamaguchi, Kazunari; Hamaguchi, Isao			Establishment of a New Quality Control and Vaccine Safety Test for Influenza Vaccines and Adjuvants Using Gene Expression Profiling	PLOS ONE			English	Article							CELL-LINE; CULTURE; SYSTEM; RATS	We have previously identified 17 biomarker genes which were upregulated by whole virion influenza vaccines, and reported that gene expression profiles of these biomarker genes had a good correlation with conventional animal safety tests checking body weight and leukocyte counts. In this study, we have shown that conventional animal tests showed varied and no dose-dependent results in serially diluted bulk materials of influenza HA vaccines. In contrast, dose dependency was clearly shown in the expression profiles of biomarker genes, demonstrating higher sensitivity of gene expression analysis than the current animal safety tests of influenza vaccines. The introduction of branched DNA based-concurrent expression analysis could simplify the complexity of multiple gene expression approach, and could shorten the test period from 7 days to 3 days. Furthermore, upregulation of 10 genes, Zbp1, Mx2, Irf7, Lgals9, Ifi47, Tapbp, Timp1, Trafd1, Psmb9, and Tap2, was seen upon virosomal-adjuvanted vaccine treatment, indicating that these biomarkers could be useful for the safety control of virosomal-adjuvanted vaccines. In summary, profiling biomarker gene expression could be a useful, rapid, and highly sensitive method of animal safety testing compared with conventional methods, and could be used to evaluate the safety of various types of influenza vaccines, including adjuvanted vaccine.	[Momose, Haruka; Mizukami, Takuo; Kuramitsu, Madoka; Takizawa, Kazuya; Masumi, Atsuko; Araki, Kumiko; Furuhata, Keiko; Yamaguchi, Kazunari; Hamaguchi, Isao] Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo, Japan	National Institute of Infectious Diseases (NIID)	Hamaguchi, I (corresponding author), Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo, Japan.	130hama@niid.go.jp	Mizukami, Takuo/F-9248-2016	Mizukami, Takuo/0000-0001-6105-6049	Ministry of Health, Labor, and Welfare of Japan [09000019, 10650301]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	HM and IH received the Grants-in-Aid from Ministry of Health, Labor, and Welfare of Japan (09000019 and 10650301, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett PN, 2011, LANCET, V377, P751, DOI 10.1016/S0140-6736(10)62228-3; Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI 10.1586/ERV.09.19; Calabro S, 2013, VACCINE, V31, P3363, DOI 10.1016/j.vaccine.2013.05.007; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Chan CYY, 2012, EXPERT REV VACCINES, V11, P759, DOI [10.1586/erv.12.55, 10.1586/ERV.12.55]; Ching LK, 2011, J IMMUNOL METHODS, V373, P54, DOI 10.1016/j.jim.2011.07.021; Chu C, 2009, P NATL ACAD SCI USA, V106, P14802, DOI 10.1073/pnas.0905912106; Couch Robert B., 1997, Journal of Infectious Diseases, V176, pS38, DOI 10.1086/514173; Doroshenko A, 2009, EXPERT REV VACCINES, V8, P679, DOI 10.1586/ERV.09.31; Fiore AE, 2013, VACCINES, P257; Genzel Y, 2009, EXPERT REV VACCINES, V8, P1681, DOI [10.1586/erv.09.128, 10.1586/ERV.09.128]; Hamaguchi I, 2008, VACCINE, V26, P4686, DOI 10.1016/j.vaccine.2008.06.086; Hamaguchi I, 2007, VACCINE, V25, P3355, DOI 10.1016/j.vaccine.2006.12.059; Hamamoto I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059892; Hicks SD, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-128; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Kang SM, 2009, VIRUS RES, V143, P140, DOI 10.1016/j.virusres.2009.04.005; Leroux-Roels I, 2010, VACCINE, V28, P849, DOI 10.1016/j.vaccine.2009.10.017; Magnusson SE, 2013, VACCINE, V31, P1725, DOI 10.1016/j.vaccine.2013.01.039; Mizukami T, 2008, VACCINE, V26, P2270, DOI 10.1016/j.vaccine.2008.02.031; Mizukami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101835; Mizukami T, 2009, BIOLOGICALS, V37, P8, DOI 10.1016/j.biologicals.2008.07.007; Momose H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/361841; Momose H, 2010, JPN J INFECT DIS, V63, P25; Moser C, 2013, EXPERT REV VACCINES, V12, P779, DOI 10.1586/14760584.2013.811195; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; National Institute of Infectious Diseases J, 2006, MIN REQ BIOL PROD; Nichols JE, 2009, VACCINES FOR BIODEFENSE AND EMERGING AND NEGLECTED DISEASES, P497, DOI 10.1016/B978-0-12-369408-9.00027-5; Pau MG, 2001, VACCINE, V19, P2716, DOI 10.1016/S0264-410X(00)00508-9; Pletneva LM, 2006, J INTERF CYTOK RES, V26, P914, DOI 10.1089/jir.2006.26.914; Raymond F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-125; REIMER C. B., 1967, J VIROL, V1, P1207; REIMER CB, 1966, SCIENCE, V152, P1379, DOI 10.1126/science.152.3727.1379; Tsai TF, 2011, YAKUGAKU ZASSHI, V131, P1733, DOI 10.1248/yakushi.131.1733; Verhelst J, 2013, MICROBIOL MOL BIOL R, V77, P551, DOI 10.1128/MMBR.00024-13; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691; Zeiger RS, 2002, J ALLERGY CLIN IMMUN, V110, P834, DOI 10.1067/mai.2002.129372	37	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124392	10.1371/journal.pone.0124392	http://dx.doi.org/10.1371/journal.pone.0124392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909814	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800081
J	Qi, HY; Liu, MD; Emery, DW; Stamatoyannopoulos, G				Qi, Heyuan; Liu, Mingdong; Emery, David W.; Stamatoyannopoulos, George			Functional Validation of a Constitutive Autonomous Silencer Element	PLOS ONE			English	Article							REGULATORY ELEMENTS; CHAIN GENE; EXPRESSION; SEQUENCE; TRANSCRIPTION; REPRESSION; INSULATOR	Sequences of the genome that are capable of silencing gene expression are thought to play a key role in gene regulation. However, very few silencer elements capable of functioning in mammalian cells have been described, and only a fraction of these have been tested for the ability to function in an autonomous fashion. We report here the characterization and functional validation of a constitutive autonomous silencer element from the human genome called T39, and the comparison of T39 to three other putative silencer elements previously described by others. Functional analysis included one assay for enhancer-blocking insulator activity and two independent assays for silencer activity, all based on stable transfection and comparison to a neutral spacer control. In erythroid K562 cells, T39 exhibited potent silencer activity, the previously described element PRE2-S5 exhibited modest silencer activity, and the two other previously described elements exhibited no silencer activity. T39 was further found to be capable of silencing three disparate promoters, of silencing gene expression in three disparate cell lines, and of functioning as a single copy in a topology-independent manner. Of the four elements analyzed, only T39 exhibits a constitutive pattern of DNase hypersensitivity and binding by CTCF. In its native location the T39 element also exhibits a unique interaction profile with a subset of distal putative regulatory elements. Taken together, these studies validate T39 as a constitutive autonomous silencer, identify T39 as a defined control for future studies of other regulatory elements such as insulators, and provide a basic chromatin profile for one highly potent silencer element.	[Qi, Heyuan] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Qi, Heyuan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Qi, Heyuan; Liu, Mingdong; Emery, David W.; Stamatoyannopoulos, George] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Emery, David W.] WIRB Copernicus Grp, Inst Biosafety Comm Serv, Puyallup, WA USA	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Washington; University of Washington Seattle	Stamatoyannopoulos, G (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	gstam@uw.edu			National Institutes of Health [PO1 HL53750]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant PO1 HL53750. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aker M, 2007, HUM GENE THER, V18, P333, DOI 10.1089/hum.2007.021; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Dean A, 2011, BRIEF FUNCT GENOMICS, V10, P3, DOI 10.1093/bfgp/elq033; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; Groth AC, 2007, PLOS ONE; Gupta M, 1998, MOL CELL BIOL, V18, P7243, DOI 10.1128/MCB.18.12.7243; HAECKER SAE, 1995, MOL ENDOCRINOL, V9, P1113, DOI 10.1210/me.9.9.1113; Kadlec J, 2011, NAT STRUCT MOL BIOL, V18, P142, DOI 10.1038/nsmb.1960; Kim MK, 1996, MOL CELL BIOL, V16, P4366; Klochkov D, 2006, MOL CELL BIOL, V26, P1589, DOI 10.1128/MCB.26.5.1589-1597.2006; Liu B, 1996, J BIOL CHEM, V271, P26281, DOI 10.1074/jbc.271.42.26281; Liu J, 2006, HUM MOL GENET, V15, P1769, DOI 10.1093/hmg/ddl099; Liu MD, 2015, NAT BIOTECHNOL, V33, P198, DOI 10.1038/nbt.3062; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Ogbourne S, 1998, BIOCHEM J, V331, P1; Raab JR, 2012, EMBO J, V31, P330, DOI 10.1038/emboj.2011.406; Tubb J, 2005, BIOTECHNIQUES, V39, P553, DOI 10.2144/000112030; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136	20	7	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124588	10.1371/journal.pone.0124588	http://dx.doi.org/10.1371/journal.pone.0124588			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910277	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800090
J	Chen, YY; Xu, GB; Yang, F				Chen, YangYang; Xu, GuoBin; Yang, Feng			Effect of Neoadjuvant Chemotherapy on the Serum Levels of Bone Turnover Markers in Women with Early-Stage Breast Cancer	PLOS ONE			English	Article							VITAMIN-D; ADJUVANT CHEMOTHERAPY; POSTMENOPAUSAL WOMEN; MINERAL DENSITY; OSTEOPOROSIS; METASTASIS; MECHANISMS	Background To evaluate effects of neoadjuvant chemotherapy on the bone turnover markers of preoperational breast cancer patients. Methods Forty-one breast cancer patients (29 premenopausal and 12 postmenopausal) and 60 healthy women (30 premenopausal and 30 postmenopausal) aged 30-64 years, were evaluated for their bone status. Serum levels of the bone formation markers PINP and BAP, as well as the resorption markers ICTP and beta-Crosslaps in addition to E2, FSH, 25(OH)D and PTH were measured at the initial diagnosis and at 24 hours after each four chemotherapy cycles. BMD T-scores were determined in 12 patients 6 months after the neoadjuvant chemotherapies. Results The baseline levels of both bone formation and resorption markers in premenopausal patients were higher than in premenopausal healthy women (p<0.05), while no statistic difference was observed between postmenopausal patients and postmenopausal healthy women. Regardless of the menopausal status, chemotherapy increased the ICTP and beta-Crosslaps levels (p<0.05), but decreased the BAP and PINP levels (p<0.05), the later one significantly more with Taxane medication (p<0.01, p<0.05). Chemotherapy caused significant decreases of 25(OH) D levels in premenopausal (p<0.01) and postmenopausal (p<0.05) patients, however, did not affect the PTH concentrations. In premenopausal patients the E2 level decreased, while the FSH level increased after chemotherapy (p<0.05). Patients with pronounced ICTP and beta-Crosslaps combined with reduced BAP and PINP serum concentrations after neoadjuvant chemotherapies were prone to develop osteoporosis 6 month later. Conclusions Neoadjuvant chemotherapy appeared to promote bone resorption and inhibit bone formation in both postmenopausal and premenopausal early-stage breast patients.	[Chen, YangYang; Xu, GuoBin] Peking Univ, Canc Hosp & Inst, Dept Clin Lab, Beijing 100871, Peoples R China; [Yang, Feng] Peking Univ, Canc Hosp & Inst, Dept Breast Surg, Beijing 100871, Peoples R China	Peking University; Peking University	Xu, GB (corresponding author), Peking Univ, Canc Hosp & Inst, Dept Clin Lab, Beijing 100871, Peoples R China.	cyyjyk02@163.com						Bendre M, 2003, CLIN ORTHOP RELAT R, pS39, DOI 10.1097/01.blo.0000093844.72468.f4; Bines J, 1996, J CLIN ONCOL, V14, P1718, DOI 10.1200/JCO.1996.14.5.1718; Bischoff-Ferrari HA, 2004, AM J MED, V116, P634, DOI 10.1016/j.amjmed.2003.12.029; Cauley JA, 2010, J BONE MINER RES, V25, P545, DOI 10.1359/jbmr.090826; Coleman RE, 2013, NAT REV RHEUMATOL, V9, P365, DOI 10.1038/nrrheum.2013.36; Delmas PD, 1998, EUR J CANCER, V34, P260, DOI 10.1016/S0959-8049(97)10135-6; Demers Laurence M., 2000, Cancer, V88, P2919, DOI 10.1002/1097-0142(20000615)88:12+<2919::AID-CNCR7>3.0.CO;2-Z; Fohr B, 2003, J CLIN ENDOCR METAB, V88, P5059, DOI 10.1210/jc.2003-030910; Hadji P, 2009, EUR J CANCER, V45, P3205, DOI 10.1016/j.ejca.2009.09.026; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Kennel KA, 2013, CURR OPIN SUPPORT PA, V7, P272, DOI 10.1097/SPC.0b013e3283640f74; Kleerekoper M, 2005, INT J FERTIL WOMEN M, V50, P61; Marcus R, 1999, J BONE MINER RES, V14, P1583, DOI 10.1359/jbmr.1999.14.9.1583; Miller PD, 1999, J CLIN ENDOCR METAB, V84, P1867, DOI 10.1210/jc.84.6.1867; Pederson L, 1999, CANCER RES, V59, P5849; Pfeilschifter J, 2000, J CLIN ONCOL, V18, P1570, DOI 10.1200/JCO.2000.18.7.1570; Ramaswamy B, 2003, SEMIN ONCOL, V30, P763, DOI 10.1053/j.seminoncol.2003.08.028; Ricos C, 1999, SCAND J CLIN LAB INV, V59, P491; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Saarto T, 1997, J CLIN ONCOL, V15, P1341, DOI 10.1200/JCO.1997.15.4.1341; Seibel Markus J, 2005, Clin Biochem Rev, V26, P97; Seibel MJ, 2005, NAT CLIN PRACT ONCOL, V2, P504, DOI 10.1038/ncponc0320; Shapiro CL, 2001, J CLIN ONCOL, V19, P3306, DOI 10.1200/JCO.2001.19.14.3306; Tan KML, 2013, J CLIN LAB ANAL, V27, P301, DOI 10.1002/jcla.21602; Tang CH, 2013, CLIN CHIM ACTA, V426, P102, DOI 10.1016/j.cca.2013.09.011; Twiss J J, 2001, J Am Acad Nurse Pract, V13, P276; Waltman NL, 2008, CANCER NURS, V31, P182, DOI 10.1097/01.NCC.0000305722.75647.26; Yin JJ, 2005, CELL RES, V15, P57, DOI 10.1038/sj.cr.7290266; Yu B, 2010, CANCER-AM CANCER SOC, V116, P2099, DOI 10.1002/cncr.25037	30	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0126053	10.1371/journal.pone.0126053	http://dx.doi.org/10.1371/journal.pone.0126053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923354	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600169
J	Serrano-Fochs, S; De Esteban-Trivigno, S; Marce-Nogue, J; Fortuny, J; Farina, RA				Serrano-Fochs, Slvia; De Esteban-Trivigno, Soledad; Marce-Nogue, Jordi; Fortuny, Josep; Farina, Richard A.			Finite Element Analysis of the Cingulata Jaw: An Ecomorphological Approach to Armadillo's Diets	PLOS ONE			English	Article							CHAETOPHRACTUS-VELLEROSUS MAMMALIA; DENTAL MICROWEAR; HAIRY ARMADILLO; ALLIED GENERA; FOOD-HABITS; XENARTHRA; DASYPODIDAE; PATTERNS; ORTHODENTINE; BIOMECHANICS	Finite element analyses (FEA) were applied to assess the lower jaw biomechanics of cingulate xenarthrans: 14 species of armadillos as well as one Pleistocene pampathere (11 extant taxa and the extinct forms Vassallia, Eutatus and Macroeuphractus). The principal goal of this work is to comparatively assess the biomechanical capabilities of the mandible based on FEA and to relate the obtained stress patterns with diet preferences and variability, in extant and extinct species through an ecomorphology approach. The results of FEA showed that omnivorous species have stronger mandibles than insectivorous species. Moreover, this latter group of species showed high variability, including some similar biomechanical features of the insectivorous Tolypeutes matacus and Chlamyphorus truncatus to those of omnivorous species, in agreement with reported diets that include items other than insects. It remains unclear the reasons behind the stronger than expected lower jaw of Dasypus kappleri. On the other hand, the very strong mandible of the fossil taxon Vassallia maxima agrees well with the proposed herbivorous diet. Moreover, Eutatus seguini yielded a stress pattern similar to Vassalia in the posterior part of the lower jaw, but resembling that of the stoutly built Macroeuphractus outesi in the anterior part. The results highlight the need for more detailed studies on the natural history of extant armadillos. FEA proved a powerful tool for biomechanical studies in a comparative framework.	[Serrano-Fochs, Slvia; De Esteban-Trivigno, Soledad; Marce-Nogue, Jordi; Fortuny, Josep] Inst Catala Paleontol M Crusafont, Catalonia, Spain; [Marce-Nogue, Jordi; Fortuny, Josep] Univ Politecn Cataluna, Terrassa, Catalonia, Spain; [Farina, Richard A.] Univ Republica, Fac Ciencias, Paleontol, Montevideo, Uruguay; [De Esteban-Trivigno, Soledad] Transmitting Sci, Piera, Spain	Institut Catala de Paleontologia Miquel Crusafont (ICP); Universitat Politecnica de Catalunya; Universidad de la Republica, Uruguay	De Esteban-Trivigno, S (corresponding author), Inst Catala Paleontol M Crusafont, Catalonia, Spain.	soledad.esteban@icp.cat	Marcé-Nogué, Jordi/B-3933-2012; Fortuny, Josep/L-2523-2014; Fariña, Richard/GRF-6009-2022; De Esteban-Trivigno, Soledad/K-8081-2017	Marcé-Nogué, Jordi/0000-0001-9852-7027; Fortuny, Josep/0000-0003-4282-1619; De Esteban-Trivigno, Soledad/0000-0002-2049-0890	 [DE-TAF-2273];  [FR-TAF-2323]	; 	Funding: The collection of part of the pictures was supported by two Synthesys Projects, DE-TAF-2273 and FR-TAF-2323 (Synthesys website: http://www.synthesys.info/). For the rest of the research, the author(s) received no specific funding for this work.	Abba AM, 2011, REV CHIL HIST NAT, V84, P51, DOI 10.4067/S0716-078X2011000100004; Aguiar John M., 2008, P215; Alexander RM, 1992, ANIMALS MOTION, P247; [Anonymous], 1971, FINITE ELEMENT METHO; BARRETO M, 1985, J MAMMAL, V66, P188, DOI 10.2307/1380985; BOLKOVIC ML, 1995, J MAMMAL, V76, P1199, DOI 10.2307/1382612; Borghi Carlos E., 2011, Edentata, V12, P14; Bright JA, 2011, ANAT REC, V294, P610, DOI 10.1002/ar.21358; CROMPTON A W, 1969, Discovery (New Haven), V5, P23; Anacleto TCDS, 2007, ZOOL STUD, V46, P529; De Esteban-Trivigno S, 2008, THESIS U VALENCIA BU; De Esteban-Trivigno S, 2005, MISCELANEA PALEONTOL, P241; De Esteban-Trivigno S, 2011, AMEGHINIANA, V48, P381; De Iuliis G, 2000, J VERTEBR PALEONTOL, V20, P743; Dechow PC, 2000, AM J PHYS ANTHROPOL, V112, P553, DOI 10.1002/1096-8644(200008)112:4<553::AID-AJPA9>3.0.CO;2-R; Delsuc F, 2012, MOL PHYLOGENET EVOL, V62, P673, DOI 10.1016/j.ympev.2011.11.008; Delsuc Frederic, 2009, P475; Doblare M, 2004, ENG FRACT MECH, V71, P1809, DOI 10.1016/j.engfracmech.2003.08.003; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Farina R.A., 1988, Boletin de la Sociedad Zoologica del Uruguay Segunda Epoca, V4, P5; FARINA RA, 1985, FORTS ZOOL, V30, P277; Farina RA, 2001, ACTA PALAEONTOL POL, V46, P219; Farina RA., 2013, MEGAFAUNA GIANT BEAS; Fletcher TM, 2010, PALAEONTOL ELECTRON, V13, P15; Fortuny J, 2011, J EVOLUTION BIOL, V24, P2040, DOI 10.1111/j.1420-9101.2011.02338.x; Fortuny J, 2012, ANAT REC, V295, P1134, DOI 10.1002/ar.22486; Gaudin Timothy J., 2006, P153; Green JL, 2009, J MAMMAL, V90, P768, DOI 10.1644/08-MAMM-A-257R1.1; Green JL, 2009, ZOOL J LINN SOC-LOND, V156, P201, DOI 10.1111/j.1096-3642.2008.00486.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Haupt RJ, 2013, J MAMMAL, V94, P856, DOI 10.1644/12-MAMM-A-204.1; Kupczik K, 2008, J ANTHROPOL SCI, V86, P193; Lessa EP, 1996, PALAEONTOLOGY, V39, P651; Loughry WJ, 2013, 9 BANDED ARMA DILLO, P323; Lydekker R., 1894, ANALES MUSEO LA PLAT, V3, P1; Marce-Nogue J, 2013, PALAEONTOL ELECTRON, V16; Mase GE, 1999, CONTINUUM MECH ENG, P400; Morris AJ., 2008, PRACTICAL GUIDE RELI; Neenan JM, 2014, P ROY SOC LOND B BIO, V281; Piras P, 2013, SYST BIOL, V62, P878, DOI 10.1093/sysbio/syt053; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; REDFORD K H, 1985, Mammalian Species, P1, DOI 10.2307/3503786; Redford K.H., 1985, P429; RICHARD AF, 1989, INT J PRIMATOL, V10, P569, DOI 10.1007/BF02739365; SIKES RS, 1990, AM MIDL NAT, V123, P383, DOI 10.2307/2426566; Smith J. M., 1959, School Science Review, V40, P289; SMITH KK, 1990, J ZOOL, V222, P27, DOI 10.1111/j.1469-7998.1990.tb04027.x; Smith PM, 2008, MAMMALS PARAGUAY, V12, P1; Soibelzon E, 2007, J MAMMAL, V88, P1319, DOI 10.1644/06-MAMM-A-335R.1; Superina M, 2009, J ARID ENVIRON, V73, P683, DOI 10.1016/j.jaridenv.2009.01.011; Superina M, 2010, MAMMAL REV, V4, P69; Vizcaino Sergio F., 1998, Journal of Mammalian Evolution, V5, P291, DOI 10.1023/A:1020500127041; Vizcaino SF, 2009, PALEOBIOLOGY, V35, P343, DOI 10.1666/0094-8373-35.3.343; Vizcaino Sergio F., 2008, P86; Vizcaino SF, 1998, PALEOBIOLOGY, V24, P371; Vizcaino SF, 2004, AMEGHINIANA, V41, P651; Vizcaino SF, 2003, PALEOBIOLOGY, V29, P123, DOI 10.1666/0094-8373(2003)029<0123:EFACIF>2.0.CO;2; Vizcaino SF, 1997, LETHAIA, V30, P79	58	23	25	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0120653	10.1371/journal.pone.0120653	http://dx.doi.org/10.1371/journal.pone.0120653			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919313	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659400003
J	von Bargen, K; Gagnaire, A; Arce-Gorvel, V; de Bovis, B; Baudimont, F; Chasson, L; Bosilkovski, M; Papadopoulos, A; Martirosyan, A; Henri, S; Mege, JL; Malissen, B; Gorvel, JP				von Bargen, Kristine; Gagnaire, Aurelie; Arce-Gorvel, Vilma; de Bovis, Beatrice; Baudimont, Fannie; Chasson, Lionel; Bosilkovski, Mile; Papadopoulos, Alexia; Martirosyan, Anna; Henri, Sandrine; Mege, Jean-Louis; Malissen, Bernard; Gorvel, Jean-Pierre			Cervical Lymph Nodes as a Selective Niche for Brucella during Oral Infections	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; PERITONEAL-MACROPHAGES; ABORTUS INFECTION; GAMMA-INTERFERON; IMMUNE-RESPONSE; DENDRITIC CELLS; T-CELLS; IN-VIVO; TOLERANCE; SALMONELLA	Cervical lymph nodes (CLN) are the first lymph nodes encountered by material taking the oral route. To study their role in orally acquired infections, we analyzed 307 patients of up to 14 years treated in the university clinic of Skopje, Macedonia, for brucellosis, a zoonotic bacterial disease frequently acquired by ingestion of contaminated dairy products. From these children, 36% had lymphadenopathy. Among orally infected children, lymphadenopathy with CLN being the only lymph nodes affected was significantly more frequent as compared to those infected by contact with animals (83% vs. 63%), suggesting a possible involvement of CLN during orally acquired human brucellosis. Using a murine model where bacteria are delivered into the oral cavity, we show that Brucella quickly and selectively colonize the CLN where they proliferate and persist over long periods of time for up to 50 days post-infection. A similar efficient though less specific drainage to CLN was found for Brucella, Salmonella typhimurium and fluorescent microspheres delivered by gavage, a pathway likely representing a mixed infection mode of intragastric and oral infection, suggesting a central pathway of drained material. Microspheres as well as bacteria drained to CLN predominately reside in cells expressing CD68 and no or low levels of CD11c. Even though no systemic response could be detected, Brucella induced a locally restricted inflammatory reaction with increased expression levels of interferon., interleukin (IL)-6, IL-12, granzyme B and a delayed induction of Nos2. Inflammation led to pronounced lymphadenopathy, infiltration of macrophages/monocytes expressing high levels of major histocompatibility complex II and to formation of epitheloid granulomas. Together, these results highlight the role of CLN in oral infections as both, an initial and efficient trap for bacterial invaders and as possible reservoir for chronic pathogens. They likewise cast a new light on the significance of oral routes for means of vaccination.	[von Bargen, Kristine; Gagnaire, Aurelie; Arce-Gorvel, Vilma; de Bovis, Beatrice; Baudimont, Fannie; Chasson, Lionel; Papadopoulos, Alexia; Martirosyan, Anna; Henri, Sandrine; Malissen, Bernard; Gorvel, Jean-Pierre] Aix Marseille Univ, CIML, UM2, Marseille, France; [von Bargen, Kristine; Gagnaire, Aurelie; Arce-Gorvel, Vilma; de Bovis, Beatrice; Baudimont, Fannie; Chasson, Lionel; Papadopoulos, Alexia; Martirosyan, Anna; Henri, Sandrine; Malissen, Bernard; Gorvel, Jean-Pierre] INSERM, U1104, F-13258 Marseille, France; [von Bargen, Kristine; Gagnaire, Aurelie; Arce-Gorvel, Vilma; de Bovis, Beatrice; Baudimont, Fannie; Chasson, Lionel; Papadopoulos, Alexia; Martirosyan, Anna; Henri, Sandrine; Malissen, Bernard; Gorvel, Jean-Pierre] CNRS, UMR7280, Marseille, France; [Bosilkovski, Mile] Univ Clin Infect Dis & Febrile Condit, Skopje, North Macedonia; [Mege, Jean-Louis] Aix Marseille Univ, CNRS, Fac Med, Unite Rickettsies,UMR6020, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Gorvel, JP (corresponding author), Aix Marseille Univ, CIML, UM2, Marseille, France.	gorvel@ciml.univ-mrs.fr	Gorvel, Jean-Pierre/O-1332-2018; Henri, Sandrine/O-3045-2016; MEGE, JEAN-LOUIS/O-6063-2016; Malissen, Bernard/AAK-4659-2020	Gorvel, Jean-Pierre/0000-0002-2829-9804; Arce-Gorvel, Vilma/0000-0003-0090-837X; HENRI, Sandrine/0000-0002-8980-9193; Malissen, Bernard/0000-0003-1340-9342; Gagnaire, Aurelie/0000-0001-9536-8438	Fondation pour la recherche Medicale; Institut National Pour la sante et la Recherche Medicale; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche	Fondation pour la recherche Medicale(Fondation pour la Recherche Medicale); Institut National Pour la sante et la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	Funding: Funding was provided by Fondation pour la recherche Medicale to AM; Institut National Pour la sante et la Recherche Medicale to JPG BM JLM; Centre National de la Recherche Scientifique to JPG BM JLM; Agence Nationale de la Recherche to JPG KvB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariza J, 2007, PLOS MED, V4, P1872, DOI 10.1371/journal.pmed.0040317; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Bonneau M, 2006, J LEUKOCYTE BIOL, V79, P268, DOI 10.1189/jlb.0605288; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; CARON E, 1994, INFECT IMMUN, V62, P5267, DOI 10.1128/IAI.62.12.5267-5274.1994; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Colmenero JD, 1996, MEDICINE, V75, P195, DOI 10.1097/00005792-199607000-00003; Copin R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002575; Corbel M.J, 2006, BRUC HUM AN; Corthesy-Theulaz IE, 1998, INFECT IMMUN, V66, P581; Dasaraju PV, 1996, MED MICROBIOLOGY; Dokuzoguz B, 2005, J INFECTION, V50, P41, DOI 10.1016/j.jinf.2004.02.005; Eskra L, 2003, INFECT IMMUN, V71, P1125, DOI 10.1128/IAI.71.3.1125-1133.2003; Eze MO, 2000, INFECT IMMUN, V68, P257, DOI 10.1128/IAI.68.1.257-263.2000; Fernandez-Lago L, 2005, J MED MICROBIOL, V54, P527, DOI 10.1099/jmm.0.45936-0; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fugier E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000487; Golden MP, 2005, AM FAM PHYSICIAN, V72, P1761; Gorvel JP, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2012-c1; Gosche John R, 2006, Semin Pediatr Surg, V15, P99, DOI 10.1053/j.sempedsurg.2006.02.007; Grillo MJ, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-29; Gross A, 1998, INFECT IMMUN, V66, P1309, DOI 10.1128/IAI.66.4.1309-1316.1998; Gur A, 2003, YONSEI MED J, V44, P33, DOI 10.3349/ymj.2003.44.1.33; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Hamrah Pedram, 2007, Chem Immunol Allergy, V92, P58, DOI 10.1159/000099254; Hume DA, 2011, J LEUKOCYTE BIOL, V89, P525, DOI 10.1189/jlb.0810472; JIANG XS, 1993, CELL IMMUNOL, V151, P309, DOI 10.1006/cimm.1993.1241; JONES SM, 1992, INFECT IMMUN, V60, P3011, DOI 10.1128/IAI.60.7.3011-3014.1992; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; KIDA S, 1993, NEUROPATH APPL NEURO, V19, P480, DOI 10.1111/j.1365-2990.1993.tb00476.x; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Lee JJ, 2012, COMP IMMUNOLOGY MICR; LULU AR, 1988, Q J MED, V66, P39; MCCABE RE, 1987, REV INFECT DIS, V9, P754; MCCULLOUGH N B, 1970, P324; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; MOUSA ARM, 1988, REV INFECT DIS, V10, P211; Murphy EA, 2001, IMMUNOLOGY, V103, P511, DOI 10.1046/j.1365-2567.2001.01258.x; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Neelakantan S, 2013, BMJ CASE REP, V2013; Netea MG, 2000, EUR J IMMUNOL, V30, P3057, DOI 10.1002/1521-4141(200010)30:10<3057::AID-IMMU3057>3.0.CO;2-P; Nobrega C, 2007, MICROBES INFECT, V9, P1521, DOI 10.1016/j.micinf.2007.08.006; Nobrega C, 2010, J IMMUNOL, V184, P351, DOI 10.4049/jimmunol.0902152; Nunes-Alves C, 2013, TRENDS IMMUNOL, V34, P502, DOI 10.1016/j.it.2013.06.004; Paixao TA, 2009, INFECT IMMUN, V77, P4197, DOI 10.1128/IAI.00417-09; Plommet M, 1976, Ann Rech Vet, V7, P1; Plommet M., 1977, STUDIES EXPT BRUCELL; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Spahn TW, 2002, EUR J IMMUNOL, V32, P1109, DOI 10.1002/1521-4141(200204)32:4<1109::AID-IMMU1109>3.3.CO;2-B; Spink WW, 1956, NATURE BRUCELLOSIS; Tessaro SV, 2004, J WILDLIFE DIS, V40, P60, DOI 10.7589/0090-3558-40.1.60; Troy SB, 2005, MEDICINE, V84, P174, DOI 10.1097/01.md.0000165659.20988.25; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; van Helvoort JMLM, 2004, ALLERGY, V59, P1211, DOI 10.1111/j.1398-9995.2004.00510.x; Wolvers DAW, 1999, J IMMUNOL, V162, P1994; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Yamazaki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051665; YINNON AM, 1993, ISRAEL J MED SCI, V29, P11; Zhan YF, 1996, INFECT IMMUN, V64, P2782, DOI 10.1128/IAI.64.7.2782-2786.1996; Zumla A, 1996, CLIN INFECT DIS, V23, P146, DOI 10.1093/clinids/23.1.146	66	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0121790	10.1371/journal.pone.0121790	http://dx.doi.org/10.1371/journal.pone.0121790			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919005	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400010
J	Dai, YC; Zhang, XF; Xia, M; Tan, M; Quigley, C; Lei, W; Fang, H; Zhong, WM; Lee, B; Pang, XL; Nie, J; Jiang, X				Dai, Ying-Chun; Zhang, Xu-Fu; Xia, Ming; Tan, Ming; Quigley, Christina; Lei, Wen; Fang, Hao; Zhong, Weiming; Lee, Bonita; Pang, Xiaoli; Nie, Jun; Jiang, Xi			Antigenic Relatedness of Norovirus GII.4 Variants Determined by Human Challenge Sera	PLOS ONE			English	Article							BLOOD GROUP ANTIGENS; CAPSID PROTEIN FORMS; UNITED-STATES; STRUCTURAL BASIS; ACUTE GASTROENTERITIS; BINDING SPECIFICITY; P-DOMAIN; OUTBREAKS; STRAIN; RECOGNITION	The GII.4 noroviruses (NoVs) are a single genotype that is responsible for over 50% of NoV gastroenteritis epidemics worldwide. However, GII.4 NoVs have been found to undergo antigenic drifts, likely selected by host herd immunity, which raises an issue for vaccine strategies against NoVs. We previously characterized GII.4 NoV antigenic variations and found significant levels of antigenic relatedness among different GII.4 variants. Further characterization of the genetic and antigenic relatedness of recent GII.4 variants (2008b and 2010 cluster) was performed in this study. The amino acid sequences of the receptor binding interfaces were highly conserved among all GII.4 variants from the past two decades. Using serum samples from patients enrolled in a GII.4 virus challenge study, significant cross-reactivity between major GII.4 variants from 1998 to 2012 was observed using enzyme-linked immunosorbent assays and HBGA receptor blocking assays. The overall abilities of GII.4 NoVs to bind to the A/B/H HBGAs were maintained while their binding affinities to individual ABH antigens varied. These results highlight the importance of human HBGAs in NoV evolution and how conserved antigenic types impact vaccine development against GII.4 variants.	[Dai, Ying-Chun; Nie, Jun] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China; [Zhang, Xu-Fu] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China; [Dai, Ying-Chun; Zhang, Xu-Fu; Xia, Ming; Tan, Ming; Quigley, Christina; Lei, Wen; Fang, Hao; Zhong, Weiming; Jiang, Xi] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Tan, Ming; Jiang, Xi] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Lee, Bonita; Pang, Xiaoli] Prov Lab Publ Hlth ProvLab, Edmonton, AB, Canada; [Lee, Bonita; Pang, Xiaoli] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada	Southern Medical University - China; Southern Medical University - China; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Alberta	Nie, J (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China.	niejun@fimmu.com; jason.jiang@cchmc.org	Xia, Ming/AAY-7154-2021	Zhang, Xufu/0000-0002-7178-2412	National Institutes of Health of the United States [R01 AI 055649, R01 AI 37093, R01 AI 089634, P01 HD 13021]; Agriculture and Food Research Initiative Competitive Grants Program of the USDA National Institute of Food and Agriculture, NIFA [2011-68003-30005]; National Natural Science Foundation of China [81473402]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD013021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055649, R01AI089634, R01AI037093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	National Institutes of Health of the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agriculture and Food Research Initiative Competitive Grants Program of the USDA National Institute of Food and Agriculture, NIFA; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the following: the National Institutes of Health of the United States (R01 AI 055649, R01 AI 37093, R01 AI 089634 and P01 HD 13021); the Agriculture and Food Research Initiative Competitive Grants Program of the USDA National Institute of Food and Agriculture, NIFA Award No.: 2011-68003-30005; and the National Natural Science Foundation of China (81473402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmar RL, 2014, J INFECT DIS, V209, P1016, DOI 10.1093/infdis/jit620; Bok K, 2012, NEW ENGL J MED, V367, P2126, DOI 10.1056/NEJMra1207742; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; Bu WM, 2008, J VIROL, V82, P5340, DOI 10.1128/JVI.00135-08; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Chen YT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002152; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Choi JM, 2008, P NATL ACAD SCI USA, V105, P9175, DOI 10.1073/pnas.0803275105; Dai YC, 2012, J VIROL METHODS, V186, P126, DOI 10.1016/j.jviromet.2012.07.002; Dai YC, 2011, ARCH VIROL, V156, P1641, DOI 10.1007/s00705-011-1010-3; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; Fang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063269; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fonager J, 2013, EURO SURVEILL, V18; Frenck R, 2012, J INFECT DIS, V206, P1386, DOI 10.1093/infdis/jis514; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hall AJ, 2012, EMERG INFECT DIS, V18, P1566, DOI 10.3201/eid1810.120833; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hansman GS, 2011, J VIROL, V85, P6687, DOI 10.1128/JVI.00246-11; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Kitamoto N, 2002, J CLIN MICROBIOL, V40, P2459, DOI 10.1128/JCM.40.7.2459-2465.2002; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Kubota T, 2012, J VIROL, V86, P11138, DOI 10.1128/JVI.00278-12; Le VP, 2010, J MED VIROL, V82, P1065, DOI 10.1002/jmv.21761; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; Lindesmith LC, 2011, J VIROL, V85, P231, DOI 10.1128/JVI.01364-10; Martella V, 2008, EMERG INFECT DIS, V14, P1306, DOI 10.3201/eid1408.080062; Pang XLL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011599; Parra GI, 2012, J VIROL, V86, P7414, DOI 10.1128/JVI.06729-11; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Reeck A, 2010, J INFECT DIS, V202, P1212, DOI 10.1086/656364; Schwartz S, 2011, BLOOD, V117, P5850, DOI 10.1182/blood-2010-12-325886; Shanker S, 2011, J VIROL, V85, P8635, DOI 10.1128/JVI.00848-11; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Tan M, 2005, J VIROL, V79, P14017, DOI 10.1128/JVI.79.22.14017-14030.2005; Tan M, 2004, J VIROL, V78, P6233, DOI 10.1128/JVI.78.12.6233-6242.2004; Tan M, 2008, VIROLOGY, V382, P115, DOI 10.1016/j.virol.2008.08.047; Tan M, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.2; Tan M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000983; Tan M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005058; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Tu ETV, 2008, CLIN INFECT DIS, V46, P413, DOI 10.1086/525259; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Widdowson MA, 2004, J INFECT DIS, V190, P27, DOI 10.1086/420888; Wikswo Mary E., 2012, Morbidity and Mortality Weekly Report, V61, P1; Yang Y, 2010, J VIROL, V84, P9595, DOI 10.1128/JVI.02614-09; Zhang XF, 2012, BIOORGAN MED CHEM, V20, P1616, DOI 10.1016/j.bmc.2011.11.040; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015; Zheng DP, 2010, J CLIN MICROBIOL, V48, P168, DOI 10.1128/JCM.01622-09	50	10	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124945	10.1371/journal.pone.0124945	http://dx.doi.org/10.1371/journal.pone.0124945			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915764	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100081
J	Gleason, RL; Caulk, AW; Seifu, D; Parker, I; Vidakovic, B; Getenet, H; Assefa, G; Amogne, W				Gleason, Rudolph L., Jr.; Caulk, Alexander W.; Seifu, Daniel; Parker, Ivana; Vidakovic, Brani; Getenet, Helena; Assefa, Getachew; Amogne, Wondwossen			Current Efavirenz (EFV) or Ritonavir-Boosted Lopinavir (LPV/r) Use Correlates with Elevate Markers of Atherosclerosis in HIV-Infected Subjects in Addis Ababa, Ethiopia	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; C-REACTIVE PROTEIN; ACTIVE ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE INHIBITORS; ENDOTHELIAL FUNCTION; MYOCARDIAL-INFARCTION; ARTERIAL STIFFNESS; RISK-FACTORS; ADHESION MOLECULES; ISCHEMIC-STROKE	Background HIV patients on antiretroviral therapy have shown elevated incidence of dyslipidemia, lipodystrophy, and cardiovascular disease (CVD). Most studies, however, focus on cohorts from developed countries, with less data available for these co-morbidities in Ethiopia and sub-Saharan Africa. Methods Adult HIV-negative (n = 36), treatment naive (n = 51), efavirenz (EFV)-treated (n = 91), nevi-rapine (NVP)-treated (n = 95), or ritonavir-boosted lopinavir (LPV/r)-treated (n= 44) subjects were recruited from Black Lion Hospital in Addis Ababa, Ethiopia. Aortic pressure, augmentation pressure, and pulse wave velocity (PWV) were measured via applanation tonometry and carotid intima-media thickness (cIMT) and carotid arterial stiffness, and brachial artery flow-mediated dilation (FMD) were measured via non-invasive ultrasound. Body mass index, waist-to-hip circumference ratio (WHR), skinfold thickness, and self-reported fat redistribution were used to quantify lipodystrophy. CD4+ cell count, plasma HIV RNA levels, fasting glucose, total-, HDL-, and LDL-cholesterol, triglycerides, hsCRP, sVCAM-1, sICAM-1, leptin and complete blood count were measured. Results PWV and normalized cIMT were elevate and FMD impaired in EFV- and LPV/r-treated subjects compared to NVP-treated subjects; normalized cIMT was also elevated and FMD impaired in the EFV- and LPV/r-treated subjects compared to treatment-naive subjects. cIMT was not statistically different across groups. Treated subjects exhibited elevated markers of dyslipidemia, inflammation, and lipodystrophy. PWV was associated with age, current EFV and LPV/r used, heart rate, blood pressure, triglycerides, LDL, and hsCRP, FMD with age, HIV duration, WHR, and glucose, and cIMT with age, current EFV use, skin-fold thickness, and blood pressure. Conclusions Current EFV- or LPV/r-treatment, but not NVP-treatment, correlated with elevated markers of atherosclerosis, which may involve mechanisms distinct from traditional risk factors.	[Gleason, Rudolph L., Jr.; Caulk, Alexander W.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Gleason, Rudolph L., Jr.; Parker, Ivana; Vidakovic, Brani] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Gleason, Rudolph L., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Seifu, Daniel] Univ Addis Ababa, Fac Med, Dept Biochem, Addis Ababa, Ethiopia; [Getenet, Helena; Amogne, Wondwossen] Univ Addis Ababa, Fac Med, Dept Internal Med, Addis Ababa, Ethiopia; [Assefa, Getachew] Univ Addis Ababa, Fac Med, Dept Radiol, Addis Ababa, Ethiopia	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Addis Ababa University; Addis Ababa University; Addis Ababa University	Gleason, RL (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.	rudy.gleason@me.gatech.edu	Amogne, Wondwossen/AGM-9855-2022; Degu, Wondwossen Amogne/GON-3590-2022		Fulbright Scholars Program [11-21255]; American Heart Association [11GRNT7990055]	Fulbright Scholars Program; American Heart Association(American Heart Association)	Funding from Fulbright Scholars Program (11-21255, RLG) and American Heart Association (11GRNT7990055, RLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT DK, 1994, AM J EPIDEMIOL, V140, P669, DOI 10.1093/oxfordjournals.aje.a117315; Baker J, 2010, J INFECT DIS, V201, P285, DOI 10.1086/649560; Ballantyne CM, 2005, ARCH INTERN MED, V165, P2479, DOI 10.1001/archinte.165.21.2479; Blum A, 2005, CLIN CARDIOL, V28, P149, DOI 10.1002/clc.4960280311; Bonnet D, 2004, AIDS, V18, P1037, DOI 10.1097/00002030-200404300-00012; Buchacz K, 2008, JAIDS-J ACQ IMM DEF, V47, P304, DOI 10.1097/QAI.0b013e31815e7453; Calmy A, 2009, AIDS, V23, P929, DOI 10.1097/QAD.0b013e32832995fa; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Charakida M, 2005, CIRCULATION; Chironi G, 2003, JAIDS-J ACQ IMM DEF, V32, P490, DOI 10.1097/00126334-200304150-00004; Choi AI, 2011, AIDS, V25, P1289, DOI 10.1097/QAD.0b013e328347fa16; Currier JS, 2005, AIDS, V19, P927, DOI 10.1097/01.aids.0000171406.53737.f9; Currier JS, 2007, AIDS, V21, P1137, DOI 10.1097/QAD.0b013e32811ebf79; Dolan SE, 2005, JAIDS-J ACQ IMM DEF, V39, P44, DOI 10.1097/01.qai.0000159323.59250.83; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Estrada V, 2011, AIDS REV, V13, P49; Falcone EL, 2011, ANTIVIR THER, V16, P1, DOI 10.3851/IMP1682; Fisher SD, 2006, ATHEROSCLEROSIS, V185, P1, DOI 10.1016/j.atherosclerosis.2005.09.025; Fontas E, 2004, J INFECT DIS, V189, P1056, DOI 10.1086/381783; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; GATTEGNO L, 1995, CELL ADHES COMMUN, V3, P179, DOI 10.3109/15419069509081285; Gougeon ML, 2004, ANTIVIR THER, V9, P161; Grubb JR, 2006, J INFECT DIS, V193, P1516, DOI 10.1086/503807; Gupta SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045716; Hansen L, AZT INDUCES INTIMA M; Hansen L, 2013, J BIOMECHAN IN PRESS; Hansen L, 2013, J BIOMECH, V46, P1540, DOI 10.1016/j.jbiomech.2013.03.021; Hsue PY, 2009, AIDS, V23, P2021, DOI 10.1097/QAD.0b013e32832e7140; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Johnsen S, 2006, J CLIN ENDOCR METAB, V91, P4916, DOI 10.1210/jc.2006-1140; JOSHI V V, 1987, Pediatric Pathology, V7, P261; Kaplan RC, 2011, T CELL ACTIVATION PR; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Kline ER, 2008, J INVEST MED, V56, P752, DOI 10.1097/JIM.0b013e3181788d15; Kowalska JD, 2010, HIV MED, V11, P200, DOI 10.1111/j.1468-1293.2009.00763.x; Kristoffersen US, 2009, HIV MED, V10, P79, DOI 10.1111/j.1468-1293.2008.00661.x; Lichtner Miriam, 2009, Atherosclerosis, V204, pe1, DOI 10.1016/j.atherosclerosis.2008.12.025; Longenecker C, 2013, HIV MED; Loonam CR, 2012, NUTR RES REV, V25, P267, DOI 10.1017/S0954422411000138; Lorenz MW, 2008, ATHEROSCLEROSIS, V196, P720, DOI 10.1016/j.atherosclerosis.2006.12.022; Lorenz MW, 2007, ATHEROSCLEROSIS; Lundgren JD, 2008, AIDS, V22, pF17, DOI 10.1097/QAD.0b013e32830fe35e; Maggi P, 2004, AIDS, V18, P1023, DOI 10.1097/00002030-200404300-00010; Mangili A, 2011, ATHEROSCLEROSIS, V214, P468, DOI 10.1016/j.atherosclerosis.2010.11.013; Maniker AH, 1996, SURG NEUROL, V46, P49, DOI 10.1016/0090-3019(96)00030-4; Mary-Krause M, 2003, AIDS, V17, P2479, DOI 10.1097/00002030-200311210-00010; Masia M, 2007, ATHEROSCLEROSIS, V195, P167, DOI 10.1016/j.atherosclerosis.2006.09.013; Masia M, 2010, ANTIVIR THER, V15, P101, DOI 10.3851/IMP1491; Mastroianni CM, 2000, CLIN IMMUNOL, V95, P212, DOI 10.1006/clim.2000.4865; Matarese G, 2007, CURR PHARM DESIGN, V13, P3676, DOI 10.2174/138161207783018635; Mercie P, 2005, HIV MED, V6, P380, DOI 10.1111/j.1468-1293.2005.00324.x; Miller TL, 2010, JAIDS-J ACQ IMM DEF, V55, P182, DOI 10.1097/QAI.0b013e3181e222c9; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Nolan D, 2003, QJM-INT J MED, V96, P825, DOI 10.1093/qjmed/hcg145; Oliviero U, 2009, ATHEROSCLEROSIS, V204, P586, DOI 10.1016/j.atherosclerosis.2008.10.012; PATON P, 1993, RES VIROLOGY, V144, P225, DOI 10.1016/S0923-2516(06)80033-6; Perez-Atayde AR, 2004, PEDIATR DEVEL PATHOL, V7, P61, DOI 10.1007/s10024-003-1001-9; Ribaudo HJ, 2011, CLIN INFECT DIS, V52, P929, DOI 10.1093/cid/ciq244; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Rios Blanco JJ, 2006, J ANTIMICROB CHEMOTH, V58, P133, DOI 10.1093/jac/dkl190; Ross AC, 2010, ATHEROSCLEROSIS, V211, P492, DOI 10.1016/j.atherosclerosis.2010.04.008; Ross AC, 2008, JAIDS-J ACQ IMM DEF, V49, P499, DOI 10.1097/QAI.0b013e318189a794; Rost NS, 2001, STROKE, V32, P2575, DOI 10.1161/hs1101.098151; Seaberg EC, 2010, STROKE, V41, P2163, DOI 10.1161/STROKEAHA.110.583856; Sevastianova K, 2005, ANTIVIR THER, V10, P925; Shankar SS, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.2005.06.005; Solages A, 2006, CLIN INFECT DIS, V42, P1325, DOI 10.1086/503261; Stein JH, 2001, CIRCULATION, V104, P257, DOI 10.1161/01.CIR.104.3.257; Sutliff RL, 2002, AM J PHYSIOL-HEART C, V283, pH2363, DOI 10.1152/ajpheart.00151.2002; Takemura Yukihiro, 2007, Curr Atheroscler Rep, V9, P238, DOI 10.1007/s11883-007-0025-4; Torriani FJ, 2008, J AM COLL CARDIOL, V52, P569, DOI 10.1016/j.jacc.2008.04.049; UNAIDS, 2012, REP GLOB AIDS EP; van Vonderen MGA, 2009, J INFECT DIS, V199, P1186, DOI 10.1086/597475; van Vonderen MGA, 2009, JAIDS-J ACQ IMM DEF, V50, P153, DOI 10.1097/QAI.0b013e31819367cd; van Wijk JPH, 2006, J AM COLL CARDIOL, V47, P1117, DOI 10.1016/j.jacc.2005.09.073; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Yeboah J, 2009, CIRCULATION, V120, P502, DOI 10.1161/CIRCULATIONAHA.109.864801	80	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0117125	10.1371/journal.pone.0117125	http://dx.doi.org/10.1371/journal.pone.0117125			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915208	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659100001
J	Kee, MF; Myers, DR; Sakurai, Y; Lam, WA; Qiu, YZ				Kee, Matthew F.; Myers, David R.; Sakurai, Yumiko; Lam, Wilbur A.; Qiu, Yongzhi			Platelet Mechanosensing of Collagen Matrices	PLOS ONE			English	Article							ALPHA(2)BETA(1) INTEGRIN; ARTERIAL STIFFNESS; GLYCOPROTEIN-VI; ACTIVATION; GPVI; ADHESION; KINASE; PHOSPHATIDYLSERINE; ATHEROSCLEROSIS; ALPHA-2-BETA-1	During vascular injury, platelets adhere to exposed subendothelial proteins, such as collagen, on the blood vessel walls to trigger clot formation. Although the biochemical signalings of platelet-collagen interactions have been well characterized, little is known about the role microenvironmental biomechanical properties, such as vascular wall stiffness, may have on clot formation. To that end, we investigated how substrates of varying stiffness conjugated with the same concentration of Type I collagen affect platelet adhesion, spreading, and activation. Using collagen-conjugated polyacrylamide (PA) gels of different stiffnesses, we observed that platelets do in fact mechanotransduce the stiffness cues of collagen substrates, manifesting in increased platelet spreading on stiffer substrates. In addition, increasing substrate stiffness also increases phosphatidylserine exposure, a key aspect of platelet activation that initiates coagulation on the platelet surface. Mechanistically, these collagen substrate stiffness effects are mediated by extracellular calcium levels and actomyosin pathways driven by myosin light chain kinase but not Rho-associated protein kinase. Overall, our results improve our understanding of how the mechanics of different tissues and stroma affect clot formation, what role the increased vessel wall stiffness in atherosclerosis may directly have on thrombosis leading to heart attacks and strokes, and how age-related increased vessel wall stiffness affects hemostasis and thrombosis.	[Kee, Matthew F.; Myers, David R.; Sakurai, Yumiko; Lam, Wilbur A.; Qiu, Yongzhi] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Kee, Matthew F.; Myers, David R.; Sakurai, Yumiko; Lam, Wilbur A.; Qiu, Yongzhi] Emory Univ, Atlanta, GA 30322 USA; [Myers, David R.; Sakurai, Yumiko; Lam, Wilbur A.; Qiu, Yongzhi] Emory Univ, Aflac Canc Ctr, Div Pediat Hematol Oncol, Dept Pediat,Sch Med, Atlanta, GA 30322 USA; [Myers, David R.; Sakurai, Yumiko; Lam, Wilbur A.; Qiu, Yongzhi] Emory Univ, Blood Disorders Serv Childrens Healthcare Atlanta, Sch Med, Atlanta, GA 30322 USA; [Myers, David R.; Sakurai, Yumiko; Lam, Wilbur A.; Qiu, Yongzhi] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Lam, Wilbur A.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Emory University; Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; Emory University; University System of Georgia; Georgia Institute of Technology	Qiu, YZ (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	yongzhi.qiu@emory.edu	Myers, David Richard/G-7542-2017	Myers, David Richard/0000-0001-9659-3274	National Science Foundation CAREER Award [1150235]; American Heart Association Innovative Research Grant; National Institutes of Health [U54HL112309, R01HL121264]; American Heart Association Postdoctoral Fellowships; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL112309, R01HL121264] Funding Source: NIH RePORTER	National Science Foundation CAREER Award(National Science Foundation (NSF)); American Heart Association Innovative Research Grant(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowships(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Financial support for this work was provided by National Science Foundation CAREER Award 1150235 (to W.A.L.); an American Heart Association Innovative Research Grant (to W.A.L.); National Institutes of Health grants U54HL112309 (to W.A.L.) and R01HL121264 (to W.A.L.); and an American Heart Association Postdoctoral Fellowships (to D.R.M.). The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; BRACE LD, 1985, AM J PHYSIOL, V249, pH1, DOI 10.1152/ajpheart.1985.249.1.H1; Cecelja M, 2012, JRSM CARDIOVASC DIS, V1, DOI 10.1258/cvd.2012.012016; Chen H, 2003, MOL CELL BIOL, V23, P4764, DOI 10.1128/MCB.23.14.4764-4777.2003; Chen H, 2002, J BIOL CHEM, V277, P3011, DOI 10.1074/jbc.M109714200; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Claridge MW, 2009, ATHEROSCLEROSIS, V205, P477, DOI 10.1016/j.atherosclerosis.2008.12.030; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; FOX JEB, 1991, J BIOL CHEM, V266, P13289; HATHAWAY DR, 1979, P NATL ACAD SCI USA, V76, P1653, DOI 10.1073/pnas.76.4.1653; He L, 2003, BLOOD, V102, P3652, DOI 10.1182/blood-2003-04-1323; Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186; Heemskerk JWM, 1997, BLOOD, V90, P2615, DOI 10.1182/blood.V90.7.2615.2615_2615_2625; Inoue O, 2003, J CELL BIOL, V160, P769, DOI 10.1083/jcb.200208043; Jung SM, 2000, TRENDS CARDIOVAS MED, V10, P285, DOI 10.1016/S1050-1738(01)00064-0; Kuchay SM, 2012, J THROMB HAEMOST, V10, P1120, DOI 10.1111/j.1538-7836.2012.04715.x; Kuchay SM, 2007, CURR OPIN HEMATOL, V14, P249, DOI 10.1097/MOH.0b013e3280ef68f8; Lam WA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-35; Lecut C, 2004, ARTERIOSCL THROM VAS, V24, P1727, DOI 10.1161/01.ATV.0000137974.85068.93; Lentz BR, 2003, PROG LIPID RES, V42, P423, DOI 10.1016/S0163-7827(03)00025-0; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Mangin P, 2003, FEBS LETT, V542, P53, DOI 10.1016/S0014-5793(03)00337-5; Monroe D, 2002, ARTERIOSCL THROM VAS, V22, P1381, DOI 10.1161/01.ATV.0000031340.68494.34; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Ohayon J, 2011, AM J PHYSIOL-HEART C, V301, pH1097, DOI 10.1152/ajpheart.01120.2010; Ohlmann P, 2000, BLOOD, V96, P2134, DOI 10.1182/blood.V96.6.2134.h8002134_2134_2139; Pathak A, 2012, P NATL ACAD SCI USA, V109, P10334, DOI 10.1073/pnas.1118073109; Pleines I, 2012, BLOOD, V119, P1054, DOI 10.1182/blood-2011-08-372193; Polanowska-Grabowska R, 2003, ARTERIOSCL THROM VAS, V23, P1934, DOI 10.1161/01.ATV.0000086937.46974.70; Qiu YZ, 2014, P NATL ACAD SCI USA, V111, P14430, DOI 10.1073/pnas.1322917111; Reed GL, 2000, BLOOD, V96, P3334; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; Safar ME, 2000, STROKE, V31, P782, DOI 10.1161/01.STR.31.3.782; Sarratt KL, 2005, BLOOD, V106, P1268, DOI 10.1182/blood-2004-11-4434; Siljander P, 2001, ARTERIOSCL THROM VAS, V21, P618, DOI 10.1161/01.ATV.21.4.618; Stroka KM, 2011, BLOOD, V118, P1632, DOI 10.1182/blood-2010-11-321125; Tse J.R., 2010, CURR PROTOC CELL BIO, V10, pUnit, DOI [DOI 10.1002/0471143030.CB1016S47, 10.1002/0471143030.cb1016s47]; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; van Popele NM, 2001, STROKE, V32, P454, DOI 10.1161/01.STR.32.2.454; Woulfe D, 2001, J CLIN INVEST, V107, P1503, DOI 10.1172/JCI13361	40	25	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0126624	10.1371/journal.pone.0126624	http://dx.doi.org/10.1371/journal.pone.0126624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915413	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100155
J	Pinhassi, RI; Kallmann, D; Soper, G; Larom, S; Linkov, A; Boulouis, A; Schottler, MA; Bock, R; Rothschild, A; Adir, N; Schuster, G				Pinhassi, Roy I.; Kallmann, Dan; Soper, Gadiel; Larom, Shirley; Linkov, Artyom; Boulouis, Alix; Schoettler, Mark-Aurel; Bock, Ralph; Rothschild, Avner; Adir, Noam; Schuster, Gadi			Photosynthetic Membranes of Synechocystis or Plants Convert Sunlight to Photocurrent through Different Pathways due to Different Architectures	PLOS ONE			English	Article							PHOTOSYSTEM-II; THYLAKOID MEMBRANES; TOBACCO; PROTEINS; CRYSTALLIZATION; EVOLUTION	Thylakoid membranes contain the redox active complexes catalyzing the light-dependent reactions of photosynthesis in cyanobacteria, algae and plants. Crude thylakoid membranes or purified photosystems from different organisms have previously been utilized for generation of electrical power and/or fuels. Here we investigate the electron transferability from thylakoid preparations from plants or the cyanobacterium Synechocystis. We show that upon illumination, crude Synechocystis thylakoids can reduce cytochrome c. In addition, this crude preparation can transfer electrons to a graphite electrode, producing an un-mediated photocurrent of 15 mu A/cm(2). Photocurrent could be obtained in the presence of the PSII inhibitor DCMU, indicating that the source of electrons is Q(A), the primary Photosystem II acceptor. In contrast, thylakoids purified from plants could not reduce cyt c, nor produced a photocurrent in the photocell in the presence of DCMU. The production of significant photocurrent (100 mu A/cm(2)) from plant thylakoids required the addition of the soluble electron mediator DCBQ. Furthermore, we demonstrate that use of crude thylakoids from the D1-K238E mutant in Synechocystis resulted in improved electron transferability, increasing the direct photocurrent to 35 mu A/cm(2). Applying the analogous mutation to tobacco plants did not achieve an equivalent effect. While electron abstraction from crude thylakoids of cyanobacteria or plants is feasible, we conclude that the site of the abstraction of the electrons from the thylakoids, the architecture of the thylakoid preparations influence the site of the electron abstraction, as well as the transfer pathway to the electrode. This dictates the use of different strategies for production of sustainable electrical current from photosynthetic thylakoid membranes of cyanobacteria or higher plants.	[Pinhassi, Roy I.; Kallmann, Dan; Soper, Gadiel; Rothschild, Avner; Adir, Noam; Schuster, Gadi] Technion Israel Inst Technol, Grand Tech Energy Program, IL-32000 Haifa, Israel; [Pinhassi, Roy I.; Kallmann, Dan; Soper, Gadiel; Larom, Shirley; Schuster, Gadi] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel; [Pinhassi, Roy I.; Kallmann, Dan; Soper, Gadiel; Linkov, Artyom; Adir, Noam] Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Haifa, Israel; [Pinhassi, Roy I.; Kallmann, Dan; Soper, Gadiel; Rothschild, Avner] Technion Israel Inst Technol, Dept Sci & Mat Engn, IL-32000 Haifa, Israel; [Boulouis, Alix; Schoettler, Mark-Aurel; Bock, Ralph] Max Planck Inst Mol Pflanzenphysiol, D-14476 Golm, Germany	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Max Planck Society	Adir, N (corresponding author), Technion Israel Inst Technol, Grand Tech Energy Program, IL-32000 Haifa, Israel.	noam@cc.technion.ac.il; gadis@cc.technion.ac.il	Bock, Ralph/B-4352-2009; Rothschild, Avner/F-6476-2011; Adir, Noam/ABE-6990-2020; Schuster, Gadi/AAE-2010-2019; Rothschild, Avner/B-7896-2009	Bock, Ralph/0000-0001-7502-6940; Rothschild, Avner/0000-0002-2512-0370; Rothschild, Avner/0000-0002-2512-0370; Boulouis, Alix/0000-0002-2552-3938; Schottler, Mark Aurel/0000-0003-3210-0260	Nancy & Stephen Grand Technion Energy Program (GTEP); Adelis Foundation; Israeli Ministry of Science, Technology and Space; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [152/11]; US-Israel Binational Science Foundation [2011556]; DIP grant from the Deutsche Forschungsgemeinschaft [LU315/17-1]	Nancy & Stephen Grand Technion Energy Program (GTEP); Adelis Foundation; Israeli Ministry of Science, Technology and Space; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); DIP grant from the Deutsche Forschungsgemeinschaft	RP, DK and G. Saper are supported by fellowships of The Nancy & Stephen Grand Technion Energy Program (GTEP). The authors thank the Adelis Foundation for their support. RIP fellowship is supported in addition by The Israeli Ministry of Science, Technology and Space. This work was funded by The I-CORE Program of the Planning and Budgeting Committee, The Israel Science Foundation (Grant No. 152/11), a grant from the transformative program of US-Israel Binational Science Foundation (2011556), and a DIP grant (LU315/17-1) from the Deutsche Forschungsgemeinschaft.	Adir N, 1999, ACTA CRYSTALLOGR D, V55, P891, DOI 10.1107/S0907444998016497; ANDREASSON E, 1988, BIOCHIM BIOPHYS ACTA, V936, P339, DOI 10.1016/0005-2728(88)90010-2; [Anonymous], 2015, PHOTOSYNTH RES; [Anonymous], 1991, MOL TECHNIQUES TAXON; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Blankenship R. E., 2014, MOL MECH PHOTOSYNTHE; BOCK R, 1994, EMBO J, V13, P4623, DOI 10.1002/j.1460-2075.1994.tb06784.x; Calkins JO, 2013, ENERG ENVIRON SCI, V6, P1891, DOI 10.1039/c3ee40634b; Croce R, 2012, ADV PHOTOSYNTH RESP, V34, P127, DOI 10.1007/978-94-007-1579-0_6; Dekker JP, 2002, PHOTOSYNTH RES, V72, P203, DOI 10.1023/A:1016188818591; Elghabi Z, 2011, PLANT BIOTECHNOL J, V9, P599, DOI 10.1111/j.1467-7652.2011.00598.x; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Hasan K, 2014, CHEMELECTROCHEM, V1, P131, DOI 10.1002/celc.201300148; Higuchi R, 1990, PCR PROTOCOLS GUIDE, V177; HOGANSON CW, 1988, BIOCHEMISTRY-US, V27, P5848, DOI 10.1021/bi00416a005; Kato M, 2012, J AM CHEM SOC, V134, P8332, DOI 10.1021/ja301488d; Kirchhoff H, 2002, BIOCHEMISTRY-US, V41, P4872, DOI 10.1021/bi011650y; Kirchhoff H, 2004, BBA-BIOENERGETICS, V1659, P63, DOI 10.1016/j.bbabio.2004.08.004; Komenda J, 2000, PLANT MOL BIOL, V42, P635, DOI 10.1023/A:1006305308196; LaRoche J, 1996, P NATL ACAD SCI USA, V93, P15244; Larom S, 2010, P NATL ACAD SCI USA, V107, P9650, DOI 10.1073/pnas.1000187107; Lebedev N, 2006, J AM CHEM SOC, V128, P12044, DOI 10.1021/ja063367y; McKone JR, 2014, CHEM MATER, V26, P407, DOI 10.1021/cm4021518; Mulo P, 1997, PLANT MOL BIOL, V33, P1059, DOI 10.1023/A:1005765305956; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nelson N, 2005, BIOESSAYS, V27, P914, DOI 10.1002/bies.20278; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Pagliano C, 2013, PHOTOSYNTH RES, V116, P167, DOI 10.1007/s11120-013-9803-8; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Rukhman V, 2000, PHOTOSYNTH RES, V65, P249, DOI 10.1023/A:1010618527974; Sakurai I, 2006, J BIOCHEM, V140, P201, DOI 10.1093/jb/mvj141; STRALEY SC, 1973, BIOCHIM BIOPHYS ACTA, V305, P597, DOI 10.1016/0005-2728(73)90079-0; SVAB Z, 1993, P NATL ACAD SCI USA, V90, P913, DOI 10.1073/pnas.90.3.913; Terasaki N, 2008, THIN SOLID FILMS, V516, P2553, DOI 10.1016/j.tsf.2007.04.127; Terazono Y, 2009, J PHYS CHEM B, V113, P7147, DOI 10.1021/jp900835s	38	19	19	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0122616	10.1371/journal.pone.0122616	http://dx.doi.org/10.1371/journal.pone.0122616			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915422	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100008
J	Rochat, T; Delumeau, O; Figueroa-Bossi, N; Noirot, P; Bossi, L; Dervyn, E; Bouloc, P				Rochat, Tatiana; Delumeau, Olivier; Figueroa-Bossi, Nara; Noirot, Philippe; Bossi, Lionello; Dervyn, Etienne; Bouloc, Philippe			Tracking the Elusive Function of Bacillus subtilis Hfq	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS REVEALS; ENVELOPE STRESS-RESPONSE; BINDING PROTEIN HFQ; SMALL RNA; LISTERIA-MONOCYTOGENES; NONCODING RNAS; GENES; IDENTIFICATION; GENOME; REPLICATION	RNA-binding protein Hfq is a key component of the adaptive responses of many proteobacterial species including Escherichia coli, Salmonella enterica and Vibrio cholera. In these organisms, the importance of Hfq largely stems from its participation to regulatory mechanisms involving small non-coding RNAs. In contrast, the function of Hfq in Gram-positive bacteria has remained elusive and somewhat controversial. In the present study, we have further addressed this point by comparing growth phenotypes and transcription profiles between wild-type and an hfq deletion mutant of the model Gram-positive bacterium, Bacillus subtilis. The absence of Hfq had no significant consequences on growth rates under nearly two thousand metabolic conditions and chemical treatments. The only phenotypic difference was a survival defect of B. subtilis hfq mutant in rich medium in stationary phase. Transcriptomic analysis correlated this phenotype with a change in the levels of nearly one hundred transcripts. Albeit a significant fraction of these RNAs (36%) encoded sporulation-related functions, analyses in a strain unable to sporulate ruled out sporulation per se as the basis of the hfq mutant's stationary phase fitness defect. When expressed in Salmonella, B. subtilis hfq complemented the sharp loss of viability of a degP hfq double mutant, attenuating the chronic sigma(E)-activated phenotype of this strain. However, B. subtilis hfq did not complement other regulatory deficiencies resulting from loss of Hfq-dependent small RNA activity in Salmonella indicating a limited functional overlap between Salmonella and B. subtilis Hfqs. Overall, this study confirmed that, despite structural similarities with other Hfq proteins, B. subtilis Hfq does not play a central role in post-transcriptional regulation but might have a more specialized function connected with stationary phase physiology. This would account for the high degree of conservation of Hfq proteins in all 17 B. subtilis strains whose genomes have been sequenced.	[Rochat, Tatiana; Bouloc, Philippe] Univ Paris 11, CNRS, CEA, Inst Integrat Biol Cell I2BC, F-91405 Orsay, France; [Rochat, Tatiana] INRA, UR892, Virol & Immunol Mol, F-78352 Jouy En Josas, France; [Delumeau, Olivier; Noirot, Philippe; Dervyn, Etienne] INRA, Micalis UMR1319, F-78350 Jouy En Josas, France; [Delumeau, Olivier; Noirot, Philippe; Dervyn, Etienne] AgroParisTech, UMR Micalis, F-78350 Jouy En Josas, France; [Figueroa-Bossi, Nara; Bossi, Lionello] Univ Paris 11, CNRS, CEA, Inst Integrat Biol Cell I2BC, F-91190 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Bouloc, P (corresponding author), Univ Paris 11, CNRS, CEA, Inst Integrat Biol Cell I2BC, F-91405 Orsay, France.	philippe.bouloc@u-psud.fr	Bouloc, Philippe/ABA-5732-2021	Bouloc, Philippe/0000-0003-4601-3387; Rochat, Tatiana/0000-0002-4533-1220	Agence Nationale pour la Recherche [ANR-2010-BLAN-1602-01, ANR-12-BSV6-0008]; European Commission [LSHG-CT-2006-037469]	Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Agence Nationale pour la Recherche (http://www.agence-nationale-recherche.fr/) (ANR-2010-BLAN-1602-01 'Duplex-Omics' and ANR-12-BSV6-0008 'ReadRNA') to PB and by the European Commission funded BaSysBio project (http://ec.europa.eu/research/fp6/index_en.cfm) (LSHG-CT-2006-037469) to PN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bohn C, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-10; Bohn C, 2010, NUCLEIC ACIDS RES, V38, P6620, DOI 10.1093/nar/gkq462; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Bossi L, 2008, BIOCHIMIE, V90, P1539, DOI 10.1016/j.biochi.2008.06.001; Bossi L, 2007, MOL MICROBIOL, V65, P799, DOI 10.1111/j.1365-2958.2007.05829.x; Boudry P, 2014, J BACTERIOL, V196, P3234, DOI 10.1128/JB.01923-14; Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Caillet J, 2014, RNA, V20, P1567, DOI 10.1261/rna.043372.113; Chabelskaya S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000927; CHEDIN F, 1994, MOL MICROBIOL, V12, P561, DOI 10.1111/j.1365-2958.1994.tb01042.x; Christiansen JK, 2006, RNA, V12, P1383, DOI 10.1261/rna.49706; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Dambach M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055156; Douchin V, 2006, J BIOL CHEM, V281, P12253, DOI 10.1074/jbc.M600819200; Durand S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004957; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gonzalez-Pastor JE, 2011, FEMS MICROBIOL REV, V35, P415, DOI 10.1111/j.1574-6976.2010.00253.x; FERNANDEZ MT, 1972, J BIOL CHEM, V247, P824; Figueroa-Bossi N, 2006, MOL MICROBIOL, V62, P838, DOI 10.1111/j.1365-2958.2006.05413.x; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; FigueroaBossi N, 1997, MOL MICROBIOL, V25, P161, DOI 10.1046/j.1365-2958.1997.4451807.x; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Geisinger E, 2006, MOL MICROBIOL, V61, P1038, DOI 10.1111/j.1365-2958.2006.05292.x; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; Guisbert E, 2007, J BACTERIOL, V189, P1963, DOI 10.1128/JB.01243-06; Hammerle H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098661; Heidrich N, 2007, NUCLEIC ACIDS RES, V35, P4331, DOI 10.1093/nar/gkm439; Heidrich N, 2006, MOL MICROBIOL, V62, P520, DOI 10.1111/j.1365-2958.2006.05384.x; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Karlinsey JE, 2007, METHOD ENZYMOL, V421, P199, DOI 10.1016/S0076-6879(06)21016-4; Kovach AR, 2014, RNA, V20, P1548, DOI 10.1261/rna.044032.113; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lecointe F, 2007, EMBO J, V26, P4239, DOI 10.1038/sj.emboj.7601848; Liu YX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010020; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; Marincola G, 2012, MOL MICROBIOL, V85, P817, DOI 10.1111/j.1365-2958.2012.08144.x; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Nielsen JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019019; Nielsen JS, 2010, NUCLEIC ACIDS RES, V38, P907, DOI 10.1093/nar/gkp1081; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Phillips ZEV, 2002, CELL MOL LIFE SCI, V59, P392, DOI 10.1007/s00018-002-8431-9; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Robinson KE, 2014, NUCLEIC ACIDS RES, V42, P2736, DOI 10.1093/nar/gkt1171; Rochat T, 2012, NUCL ACIDS RES; Rochat T, 2012, BIOCHIMIE, V94, P1554, DOI 10.1016/j.biochi.2012.01.016; Schmalisch M, 2010, J BACTERIOL, V192, P5402, DOI 10.1128/JB.00534-10; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Sharma CM, 2011, MOL MICROBIOL, V81, P1144, DOI 10.1111/j.1365-2958.2011.07751.x; Silvaggi JM, 2005, J BACTERIOL, V187, P6641, DOI 10.1128/JB.187.19.6641-6650.2005; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; STEINMETZ M, 1994, GENE, V142, P79, DOI 10.1016/0378-1119(94)90358-1; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Sun XG, 2002, NUCLEIC ACIDS RES, V30, P3662, DOI 10.1093/nar/gkf508; Tanaka K, 2013, NUCLEIC ACIDS RES, V41, P687, DOI 10.1093/nar/gks963; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Westers H, 2003, MOL BIOL EVOL, V20, P2076, DOI 10.1093/molbev/msg219; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x	68	35	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124977	10.1371/journal.pone.0124977	http://dx.doi.org/10.1371/journal.pone.0124977			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915524	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100086
J	Tan, YQ; Wang, YX; Li, L; Xia, JY; Peng, SG; He, YL				Tan, Yaqi; Wang, Yixuan; Li, Li; Xia, Jinyu; Peng, Shiguang; He, Yanling			Chemokine-Like Factor 1-Derived C-Terminal Peptides Induce the Proliferation of Dermal Microvascular Endothelial Cells in Psoriasis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FOCAL CEREBRAL-ISCHEMIA; ATOPIC-DERMATITIS; MESANGIAL CELLS; MUSCLE-CELLS; MIGRATION; CYTOKINE; INFLAMMATION; ANGIOGENESIS; CONTRIBUTES	Psoriasis is an inflammatory disease characterized by the abnormal proliferation of skin cells, including dermal microvascular endothelial cells. Recently, chemokine-like factor 1 (CKLF1) was found to participate in the local inflammation and cell proliferation. To explore its role in the pathogenesis of psoriasis, the expression of both CKLF1 and its receptor (CCR4) was determined in the psoriatic lesions. Also, the effect of the C-terminal peptides (C19 and C27) of CKLF1 on the proliferation of human umbilical vein endothelial cells was studied in vitro. By immunohistochemistry and immunofluorescence, the expression of both CKLF1 and CCR4 was determined in the psoriatic lesions. The effect of C-terminal peptides on human umbilical vein endothelial cells (HUVECs) was studied in vitro by the evaluation of cell proliferation and apoptosis. The in vivo assessment was performed accordingly through the subcutaneous injection peptides on BALB/c mice. The results showed that, by immunohistochemistry, both CKLF1 and CCR4 were increasingly expressed in psoriatic lesions as compared to normal skins. Moreover, the primary umbilical vein endothelial cells exhibited higher proliferation ratio under the C19 or C27 stimulation, which was even enhanced by the addition of psoriatic sera or TNF-alpha. Furthermore, the enhancement of peptide simulation was accompanied with the activation of ERK1/2-MAPKs pathway. In addition, such effect of C19 and C27 was mirrored by the hyperproliferation of cutaneous microvessels in BALB/c mice that were subcutaneously injected with the two peptides. Therefore, we concluded that CKLF1 plays a role in the pathogenesis of psoriasis by promoting the proliferation of microvascular endothelial cells that possibly correlates with ERK1/2-MAPKs activation.	[Tan, Yaqi; Wang, Yixuan; Li, Li; Xia, Jinyu; Peng, Shiguang; He, Yanling] Capital Med Univ, Beijing Chao Yang Hosp, Dept Dermatol, Beijing, Peoples R China	Capital Medical University	He, YL (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Dermatol, Beijing, Peoples R China.	heyldoc@163.com	Wang, Yijun/GXW-1763-2022; Wang, Yixuan/GZK-6559-2022; wang, yi/GVT-8516-2022; wang, yixuan/GXW-2866-2022		 [30972653];  [81371733]	; 	This study was supported by grant numbers: 30972653 and 81371733 (URLs. http://www.nsfc.gov.cn) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salahi OSA, 2013, MICROVASC RES, V90, P30, DOI 10.1016/j.mvr.2013.07.007; Bhushan M, 1999, BRIT J DERMATOL, V141, P1054, DOI 10.1046/j.1365-2133.1999.03205.x; Brotas AM, 2012, AN BRAS DERMATOL, V87, P673, DOI 10.1590/S0365-05962012000500001; ETTEHADI P, 1994, CLIN EXP IMMUNOL, V96, P146, DOI 10.1111/j.1365-2249.1994.tb06244.x; Han WL, 2001, BIOCHEM J, V357, P127, DOI 10.1042/0264-6021:3570127; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kakinuma T, 2003, J ALLERGY CLIN IMMUN, V111, P592, DOI 10.1067/mai.2003.114; Kong LL, 2014, NEUROCHEM INT, V76, P91, DOI 10.1016/j.neuint.2014.07.004; Kong LL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-112; Kong LL, 2012, NEUROSCI LETT, V508, P13, DOI 10.1016/j.neulet.2011.11.048; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Li T, 2006, LIFE SCI, V79, P519, DOI 10.1016/j.lfs.2006.01.042; Lo IC, 2005, J BIOMED SCI, V12, P377, DOI 10.1007/s11373-005-1703-2; Loai Yasir, 2012, Int J Mol Imaging, V2012, P230942, DOI 10.1155/2012/230942; MacDonald A, 2007, POSTGRAD MED J, V83, P690, DOI 10.1136/pgmj.2007.061473; Miyake M, 2013, LAB INVEST, V93, P768, DOI 10.1038/labinvest.2013.71; Peplow PV, 2013, CYTOKINE, V62, P1, DOI 10.1016/j.cyto.2013.02.015; Petch D, 2012, BIOORGAN MED CHEM, V20, P5901, DOI 10.1016/j.bmc.2012.07.048; Rottman JB, 2001, LAB INVEST, V81, P335, DOI 10.1038/labinvest.3780242; Shao LN, 2010, CELL IMMUNOL, V263, P188, DOI 10.1016/j.cellimm.2010.03.015; Singh M, 2010, ASIAN PAC J CANCER P, V11, P257; Tan YX, 2004, CHINESE MED J-PEKING, V117, P1123; Tian L, 2011, ALLERGY, V66, P287, DOI 10.1111/j.1398-9995.2010.02478.x; Wang KP, 2013, ANN RHEUM DIS, V72, P100, DOI 10.1136/annrheumdis-2012-202201; Wang Y, 2006, LIFE SCI, V78, P614, DOI 10.1016/j.lfs.2005.05.070; Wang Y, 2008, INT J BIOCHEM CELL B, V40, P909, DOI 10.1016/j.biocel.2007.10.028; Wang ZZ, 2012, NEUROSCI LETT, V519, P51, DOI 10.1016/j.neulet.2012.05.019; Wang ZZ, 2010, BRAIN RES, V1308, P24, DOI 10.1016/j.brainres.2009.10.047; Wolfram JA, 2009, AM J PATHOL, V174, P1443, DOI 10.2353/ajpath.2009.080858; Xia DL, 2002, BBA-MOL CELL RES, V1591, P163, DOI 10.1016/S0167-4889(02)00270-7; Yang GY, 2013, INT J BIOL SCI, V9, P759, DOI 10.7150/ijbs.6291; Yasuda K, 2014, EXP DERMATOL, V23, P119, DOI 10.1111/exd.12324; Young CN, 2008, J INVEST DERMATOL, V128, P2606, DOI 10.1038/jid.2008.122; Zhang T, 2013, MOL BIOL REP, V40, P2939, DOI 10.1007/s11033-012-2309-1; Zhang T, 2013, ATHEROSCLEROSIS, V226, P49, DOI 10.1016/j.atherosclerosis.2012.09.023; Zhang Y, 2008, GROWTH FACTORS, V26, P125, DOI 10.1080/08977190802105909; Zhang Y, 2011, BIOCHEM BIOPH RES CO, V409, P356, DOI 10.1016/j.bbrc.2011.05.047; Zhang Y, 2012, J CLIN IMMUNOL, V32, P1270, DOI 10.1007/s10875-012-9724-x; Zheng Y, 2011, INT IMMUNOPHARMACOL, V11, P2188, DOI 10.1016/j.intimp.2011.09.017; Zou XY, 2015, J INVEST DERMATOL, V135, P589, DOI 10.1038/jid.2014.377; Zou XY, 2012, EXP BIOL MED, V237, P1023, DOI 10.1258/ebm.2012.012033	43	13	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125073	10.1371/journal.pone.0125073	http://dx.doi.org/10.1371/journal.pone.0125073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915746	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100095
J	Wang, H; Luo, X; Meng, SQ; Bei, YJ; Song, T; Meng, T; Li, GF; Zhang, BW				Wang, Hui; Luo, Xia; Meng, Shaoquan; Bei, Yongjian; Song, Tao; Meng, Tao; Li, Guifen; Zhang, Baowei			The Phylogeography and Population Demography of the Yunnan Caecilian (Ichthyophis bannanicus): Massive Rivers as Barriers to Gene Flow	PLOS ONE			English	Article							GEGENEOPHIS-RAMASWAMII AMPHIBIA; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENY; SPECIES GROUP; GYMNOPHIONA; FROG; SOFTWARE; BIOGEOGRAPHY; HYPOTHESES; DIVERSITY	Ichthyophis bannanicus is the only caecilian species in China. In this study, the phylogeography and population demography of I. bannanicus were explored, based on the mitochondrial DNA genes (cyt b and ND2) and 15 polymorphic microsatellite loci. Altogether 158 individuals were collected from five populations in Yunnan province, Guangxi province, Guangdong province, and Northern Vietnam. Phylogeographical and population structure analysis identified either two groups (Xishuangbanna, Northern Vietnam-Yulin-Yangchun-Deqing) or three groups (Xishuangbanna, Northern Vietnam-Yulin-Yangchun, and Deqing), indicating that the Red River and Pearl River systems may have acted as gene-flow barriers for I. bannanicus. Historical population expansion that happened 15-17 Ka ago was detected for mtDNA data and was possibly triggered by warmer weather after the Last Glacial Maximum. However, the Bayesian simulations of population history based on microsatellite data pinpointed population decline in all populations since 19,123 to 1,029 years ago, demonstrating a significant influence of anthropogenic habitat alteration on I. bannanicus.	[Wang, Hui; Luo, Xia; Song, Tao; Zhang, Baowei] Anhui Univ, Sch Life Sci, Anhui Key Lab Ecoengn & Biotech, Hefei 230601, Anhui, Peoples R China; [Meng, Shaoquan; Bei, Yongjian; Li, Guifen] Yulin Normal Univ, Coll Life Sci & Technol, Yulin 537000, Guangxi, Peoples R China; [Meng, Tao] Guangxi Forestry Inventory & Planning Inst, Nanning 530011, Guangxi, Peoples R China	Anhui University; Yulin Normal University	Li, GF (corresponding author), Yulin Normal Univ, Coll Life Sci & Technol, Yulin 537000, Guangxi, Peoples R China.	ylsylgf@163.com; zhangbw@ahu.edu.cn			National Natural Science Foundation of China [31260509]; Natural Science Foundation of Guangxi Province [GXNSFSA018107]; Outstanding Young Talents in Colleges and Universities Support Plan, Anhui Province; Foundation for Young and Key Teachers Project of Anhui University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi Province(National Natural Science Foundation of Guangxi Province); Outstanding Young Talents in Colleges and Universities Support Plan, Anhui Province; Foundation for Young and Key Teachers Project of Anhui University	The research was supported by the National Natural Science Foundation of China (No. 31260509) and the Natural Science Foundation of Guangxi Province (No. GXNSFSA018107), Outstanding Young Talents in Colleges and Universities Support Plan, Anhui Province (2014), the Foundation for Young and Key Teachers Project of Anhui University (2011-2014).	Agudo R, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-384; AmphibiaWeb, 2014, INF AMPH BIOL CONS; [Anonymous], 1996, 5000 CNRS UMR; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Burland T G, 2000, Methods Mol Biol, V132, P71; Burney DA, 2005, TRENDS ECOL EVOL, V20, P395, DOI 10.1016/j.tree.2005.04.022; Carmichael LE, 2001, MOL ECOL, V10, P2787, DOI 10.1046/j.1365-294X.2001.t01-1-01408.x; Chen SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033378; Cornell JD, 2011, SLASH AND BURN; Cornuet JM, 1996, GENETICS, V144, P2001; Daniels RJR, 2002, SOME ASPECTS THREATE; Deng Xiao-Bao, 2003, Acta Ecologica Sinica, V23, P130; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Emel SL, 2012, CONSERV GENET, V13, P1685, DOI 10.1007/s10592-012-0407-1; Eriksson J, 2004, MOL ECOL, V13, P3425, DOI 10.1111/j.1365-294X.2004.02332.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fu YX, 1997, GENETICS, V147, P915; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Gower DJ, 2002, P ROY SOC B-BIOL SCI, V269, P1563, DOI 10.1098/rspb.2002.2050; Gower DJ, 2005, CONSERV BIOL, V19, P45, DOI 10.1111/j.1523-1739.2005.00589.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hofer D., 2000, FROGLOG, P1; Kettle AJ, 2008, QUATERNARY SCI REV, V27, P1309, DOI 10.1016/j.quascirev.2008.03.005; Kupfer A, 2004, BIOL J LINN SOC, V83, P207, DOI 10.1111/j.1095-8312.2004.00382.x; Kupfer A, 2004, AMPHIBIA-REPTILIA, V25, P87, DOI 10.1163/156853804322992869; Lampert KP, 2003, MOL ECOL, V12, P3325, DOI 10.1046/j.1365-294X.2003.02016.x; Leache AD, 2002, SYST BIOL, V51, P44, DOI 10.1080/106351502753475871; Li Gui-Fen, 2010, Acta Zootaxonomica Sinica, V35, P494; Li Gui-fen, 2010, Sichuan Journal of Zoology, V29, P81; Li GF, 2010, CONSERV GENET RESOUR, V2, P129, DOI 10.1007/s12686-010-9246-x; [李吉均 Li Jijun], 2004, [冰川冻土, Journal of Glaciology and Geocryology], V26, P235; Li R, 2009, J ZOOL, V277, P309, DOI 10.1111/j.1469-7998.2008.00543.x; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034013; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036334; Loader C., 2007, LOCFIT LOCAL REGRESS; Lougheed SC, 1999, P ROY SOC B-BIOL SCI, V266, P1829, DOI 10.1098/rspb.1999.0853; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Macey JR, 1998, MOL PHYLOGENET EVOL, V9, P80, DOI 10.1006/mpev.1997.0440; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Measey G. John, 2004, Journal of East African Natural History, V93, P1, DOI 10.2982/0012-8317(2004)93[1:ACRAEA]2.0.CO;2; Measey GJ, 2003, APPL SOIL ECOL, V23, P43, DOI 10.1016/S0929-1393(02)00175-0; Meng S, 2006, J YULIN TEACHERS COL, V127, P114; Meng Shao-quan, 2006, Sichuan Journal of Zoology, V25, P423; Nguyen V. S., 2009, HERPETOFAUNA VIETNAM; Nishikawa K, 2012, MOL PHYLOGENET EVOL, V63, P714, DOI 10.1016/j.ympev.2012.02.017; Nussbaum RA, 1989, HERPETOL MONOGR, V3, P1, DOI [10.2307/1466984, DOI 10.2307/1466984]; Nylander JAA., 2004, BIOINFORMATICS; Oommen OV, 2000, CURR SCI INDIA, V79, P1386; Pan J, 1985, J S CHINA NORMAL U N, V1, P111; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Qu Y, 2010, MOL ECOL, V19, P338, DOI 10.1111/j.1365-294X.2009.04445.x; Rambaut A., 2007, TRACER PROGRAM ANAL; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shi Wenbo, 2010, Acta Theriologica Sinica, V30, P390; Shi Y.F., 2011, NEW UNDERSTANDING QU; Song G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-143; Storz JF, 2002, EVOLUTION, V56, P154; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan AM, 1995, MOL PHYLOGENET EVOL, V4, P383, DOI 10.1006/mpev.1995.1036; Taylor E.H., 1968, CAECILIANS WORLD TAX; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041579; Wang S, 2006, CHINA SPECIES RED LI, V1; Weisrock DW, 2001, MOL PHYLOGENET EVOL, V18, P434, DOI 10.1006/mpev.2000.0905; Wen Yetang, 1985, Acta Herpetologica Sinica, V4, P147; Xiang A, 2005, AGR ARCHAEOLOGY CHIN, V1, P149; Yan F, 2013, MOL ECOL, V22, P1120, DOI 10.1111/mec.12153; Yang D, 1986, ACTA GEOGRAPHICA SIN, V41, P302, DOI DOI 10.11821/XB198604002); Yang D, 1976, ACTA ZOOL SINICA, V22, P175; Yang D, 1984, J HERPETOLOGICA CHIN, V3, P73; Yang Yu-Hui, 2004, Acta Zoologica Sinica, V50, P193; Yu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056066; Zhang BW, 2007, MOL BIOL EVOL, V24, P1801, DOI 10.1093/molbev/msm099; Zhang DR, 2010, MOL ECOL, V19, P3406, DOI 10.1111/j.1365-294X.2010.04747.x; Zhang WenXu, 1998, Acta Agronomica Sinica, V24, P416; Zhao E., 1998, CHINA RED DATA BOOK; Zhao S, 2009, J ZOOL, V279, P270, DOI 10.1111/j.1469-7998.2009.00615.x; [郑卓 Zheng Zhuo], 2004, [第四纪研究, Quaternary Sciences], V24, P387	89	8	9	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125770	10.1371/journal.pone.0125770	http://dx.doi.org/10.1371/journal.pone.0125770			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915933	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659100146
J	Zhu, CY; Yang, HL; Geng, QS; Ma, QL; Long, Y; Zhou, C; Chen, M				Zhu, Chunyan; Yang, Hongling; Geng, Qingshan; Ma, Qingling; Long, Yan; Zhou, Cheng; Chen, Ming			Association of Oxidative Stress Biomarkers with Gestational Diabetes Mellitus in Pregnant Women: A Case-Control Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INSULIN-RESISTANCE; CERULOPLASMIN; INFLAMMATION; ACTIVATION; RELEASE	Objective The relationship between gestational diabetes mellitus (GDM) and oxidative stress has not been fully elucidated. This study examined the association between biomarkers of oxidative stress and GDM. Methods We conducted a case-control study which included 36 women presenting with GDM and 36 asymptomatic matched control subjects who visited Guangzhou Women and Children's Medical Centre, China, from June 2012 to December 2012. Pregnant women were prospectively recruited to the study, and blood samples were collected at the time of a routine oral glucose tolerance test. These samples were then analyzed for levels of endocrine and surrogate markers of oxidative stress. Results Compared to control subjects, women with GDM exhibited elevated values for plasma glucose, insulin, and insulin resistance (IR), and showed reduced HOMA pancreatic beta-cell function (HOMA-B), insulin sensitivity index (ISI), insulinogenic index, and corrected insulin response at 24-28 weeks gestation. A bivariate logistic regression analysis showed that levels of high-sensitivity C reactive protein (hs-CRP) and high fluorescence reticulocytes at fasting, and hs-CRP in a 1-h OGTT, were significantly associated with GDM. A linear regression analysis showed that levels of hs-CRP (P = 0.003) and reticulocytes (P = 0.029) at fasting were associated with IR, and levels of hs-CRP (P = 0.002) and monocytes (P = 0.006) in a 1-h OGTT were associated with ISI. Conclusions Pregnant women with GDM developed a pathological IR and exhibited beta-cell dysfunction. Their decreased ability to compensate for oxidative stress was associated with increased IR and a reduced ISI, which might be important factors in GDM.	[Zhu, Chunyan; Zhou, Cheng; Chen, Ming] Guangzhou Med Univ, Sch Publ Hlth, Dept Prevent Med, Guangzhou 510182, Guangdong, Peoples R China; [Yang, Hongling; Ma, Qingling; Long, Yan] Guangzhou Med Univ, Dept Lab, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China; [Geng, Qingshan] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangzhou 510080, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Yang, HL (corresponding author), Guangzhou Med Univ, Dept Lab, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China.	hlyang62@163.com		Yang, Hongling/0000-0001-6303-4193	National Natural Science Fund of China [81102197]; Science and Technology Fund of Guangzhou [2012J4100015]; college scientific research project of Guangzhou [1201410026]; Science and Technology Fund of Guangdong Province [20120318067]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Science and Technology Fund of Guangzhou; college scientific research project of Guangzhou; Science and Technology Fund of Guangdong Province	This study was supported by the National Natural Science Fund of China (81102197; CYZ; http://www.nsfc.gov.cn/), the Science and Technology Fund of Guangzhou (2012J4100015; CYZ; http://apply.gzkj.gov.cn/), the college scientific research project of Guangzhou (1201410026; CYZ; http://gxky.gzsjks.com/), and the Science and Technology Fund of Guangdong Province (20120318067; HLY; http://www.gdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; [Anonymous], 2008, ACTA DIABETOL, DOI DOI 10.1007/400592.0087; Atalay Mustafa, 2002, J Sports Sci Med, V1, P1; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Bo S, 2005, J ENDOCRINOL INVEST, V28, P779, DOI 10.1007/BF03347566; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Catalano PM, 2012, DIABETES CARE, V35, P780, DOI 10.2337/dc11-1790; CATALANO PM, 1991, AM J OBSTET GYNECOL, V165, P1667, DOI 10.1016/0002-9378(91)90012-G; Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; Coughlan MT, 2004, PLACENTA, V25, P78, DOI 10.1016/S0143-4004(03)00183-8; CUNNINGHAM J, 1995, METABOLISM, V44, P996, DOI 10.1016/0026-0495(95)90095-0; Daci A, 2003, MED ARH, p[67, 88]; Hu FB, 2003, ARTERIOSCL THROM VAS, V23, P1715, DOI 10.1161/01.ATV.0000094360.38911.71; Kabiri N., 2012, Journal of Medicinal Plants Research, V6, P2540; Kelstrup L, 2013, J CLIN ENDOCR METAB, V98, P3793, DOI 10.1210/jc.2013-1536; Lopez-Tinoco C, 2013, ACTA DIABETOL, V50, P201, DOI 10.1007/s00592-011-0264-2; Memisogullari R, 2004, J DIABETES COMPLICAT, V18, P193, DOI 10.1016/S1056-8727(03)00032-1; Pattanathaiyanon P, 2014, J OBSTET GYNAECOL RE, V40, P976, DOI 10.1111/jog.12306; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Radaelli T, 2003, DIABETES, V52, P2951, DOI 10.2337/diabetes.52.12.2951; Rasanen JP, 2013, OBSTET GYNECOL, V122, P586, DOI 10.1097/AOG.0b013e3182a0c88b; Roebuck KA, 1999, INT J MOL MED, V4, P223; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Vrachnis N, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/549748; Wang J, 2012, CHINESE J PERINATAL, V15, P705; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Zhang Z, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00433	28	59	60	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0126490	10.1371/journal.pone.0126490	http://dx.doi.org/10.1371/journal.pone.0126490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915047	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100154
J	Pruller, S; Fromke, C; Kaspar, H; Klein, G; Kreienbrock, L; Kehrenberg, C				Prueller, Sandra; Froemke, Cornelia; Kaspar, Heike; Klein, Guenter; Kreienbrock, Lothar; Kehrenberg, Corinna			Recommendation for a Standardised Method of Broth Microdilution Susceptibility Testing for Porcine Bordetella bronchiseptica	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ANTIMICROBIAL SUSCEPTIBILITY; LISTERIA-MONOCYTOGENES; RESISTANCE; CRITERIA	The objective was to establish and standardise a broth microdilution susceptibility testing method for porcine Bordetella(B.) bronchiseptica. B. bronchiseptica isolates from different geographical regions and farms were genotyped by macrorestriction analysis and subsequent pulsed-field gel electrophoresis. One reference and one type strain plus two field isolates of B. bronchiseptica were chosen to analyse growth curves in four different media: cation-adjusted Mueller-Hinton broth (CAMHB) with and without 2% lysed horse blood, Brain-Heart-Infusion (BHI), and Caso broth. The growth rate of each test strain in each medium was determined by culture enumeration and the suitability of CAMHB was confirmed by comparative statistical analysis. Thereafter, reference and type strain and eight epidemiologically unrelated field isolates of B. bronchiseptica were used to test the suitability of a broth microdilution susceptibility testing method following CLSI-approved performance standards given in document VET01-A4. Susceptibility tests, using 20 antimicrobial agents, were performed in five replicates, and data were collected after 20 and 24 hours incubation and statistically analysed. Due to the low growth rate of B. bronchiseptica, an incubation time of 24 hours resulted in significantly more homogeneous minimum inhibitory concentrations after five replications compared to a 20-hour incubation. An interlaboratory comparison trial including susceptibility testing of 24 antimicrobial agents revealed a high mean level of reproducibility (97.9%) of the modified method. Hence, in a harmonization for broth microdilution susceptibility testing of B. bronchiseptica, an incubation time of 24 hours in CAMHB medium with an incubation temperature of 35 degrees C and an inoculum concentration of approximately 5 x 10(5)cfu/ml was proposed.	[Prueller, Sandra; Klein, Guenter; Kehrenberg, Corinna] Univ Vet Med Hannover, Inst Food Qual & Food Safety, D-30173 Hannover, Germany; [Froemke, Cornelia] Univ Vet Med Hannover, WHO Collaborating Ctr Res & Training Vet Publ Hlt, Dept Biometry Epidemiol & Informat Proc, D-30173 Hannover, Germany; [Kaspar, Heike; Kreienbrock, Lothar] Fed Off Consumer Protect & Food Safety, Berlin, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Kehrenberg, C (corresponding author), Univ Vet Med Hannover, Inst Food Qual & Food Safety, Bischofsholer Damm 15, D-30173 Hannover, Germany.	corinna.kehrenberg@tiho-hannover.de	Klein, Günter/G-5321-2013; Kehrenberg, Corinna/GSI-9835-2022	Klein, Günter/0000-0003-1931-2701; 	Federal Ministry of Food and Agriculture (BMEL) through the DART project [FKZ 2811HS020]	Federal Ministry of Food and Agriculture (BMEL) through the DART project	This study was financially supported by the Federal Ministry of Food and Agriculture (BMEL) through the DART project (grant number FKZ 2811HS020). The funders had no role in study design, data colection and analysis, decision to publish, or preparation of the manuscript.	Brockmeier S.L., 2012, DIS SWINE, P670; Brown, 2006, APPL MIXED MODELS ME; Burton PJ, 1996, J VET DIAGN INVEST, V8, P464, DOI 10.1177/104063879600800411; Clinical and Laboratory Standards Institute, 2013, VET01A4 CLIN LAB STA; Coutinho TA, 2009, BRAZ J MICROBIOL, V40, P470, DOI 10.1590/S1517-83822009000300009; DEEB BJ, 1990, J CLIN MICROBIOL, V28, P70, DOI 10.1128/JCM.28.1.70-75.1990; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Fenwick BW, 2013, VET MICROBIOL, P120; Francois K, 2005, J APPL MICROBIOL, V99, P1503, DOI 10.1111/j.1365-2672.2005.02727.x; Friedman LE, 2001, LETT APPL MICROBIOL, V33, P285, DOI 10.1046/j.1472-765X.2001.00997.x; GILES CJ, 1980, VET REC, V106, P25, DOI 10.1136/vr.106.2.25; Harvill ET, 2000, INFECT IMMUN, V68, P6720, DOI 10.1128/IAI.68.12.6720-6728.2000; He Q, 2006, PRINCIPLES PRACTICE, P253; Hozbor D, 1999, RES MICROBIOL, V150, P333, DOI 10.1016/S0923-2508(99)80059-X; Kadlec K, 2005, J ANTIMICROB CHEMOTH, V56, P485, DOI 10.1093/jac/dki262; Kadlec K, 2007, J ANTIMICROB CHEMOTH, V59, P396, DOI 10.1093/jac/dkl515; Koidl C, 2007, J CLIN MICROBIOL, V45, P347, DOI 10.1128/JCM.01303-06; MCCANDLISH IAP, 1978, VET REC, V102, P298, DOI 10.1136/vr.102.14.293; Rajeev S, 2002, THESIS U TENNESSEE; Rensch U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078310; Roorda Lieuwe, 2011, BMC Res Notes, V4, P11, DOI 10.1186/1756-0500-4-11; SAS Institute Inc, 2011, SAS STAT 9 3 USERS G; Shin EK, 2007, J VET SCI, V8, P65, DOI 10.4142/jvs.2007.8.1.65; Speakman AJ, 1997, VET MICROBIOL, V54, P63, DOI 10.1016/S0378-1135(96)01256-4; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tyrovouzis NA, 2014, INT J FOOD MICROBIOL, V186, P110, DOI 10.1016/j.ijfoodmicro.2014.06.021	26	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123883	10.1371/journal.pone.0123883	http://dx.doi.org/10.1371/journal.pone.0123883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910232	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800049
J	Yin, ST; Jiang, HY; Chen, DR; Murchie, AIH				Yin, Sitao; Jiang, Hengyi; Chen, Dongrong; Murchie, Alastair I. H.			Substrate Recognition and Modification by the Nosiheptide Resistance Methyltransferase	PLOS ONE			English	Article							TRANSFER-RNA RECOGNITION; ELONGATION-FACTOR-G; 23S RIBOSOMAL-RNA; ACID-SEQUENCE MOTIFS; HIV-1 TAR RNA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; GM18 METHYLTRANSFERASE; BACTERIAL RIBOSOME; AQUIFEX-AEOLICUS	Background The proliferation of antibiotic resistant pathogens is an increasing threat to the general public. Resistance may be conferred by a number of mechanisms including covalent or mutational modification of the antibiotic binding site, covalent modification of the drug, or the over-expression of efflux pumps. The nosiheptide resistance methyltransferase (NHR) confers resistance to the thiazole antibiotic nosiheptide in the nosiheptide producer organism Streptomyces actuosus through 2'O-methylation of 23S rRNA at the nucleotide A1067. Although the crystal structures of NHR and the closely related thiostrepton-resistance methyltransferase (TSR) in complex with the cofactor S-Adenosyl-L-methionine (SAM) are available, the principles behind NHR substrate recognition and catalysis remain unclear. Methodology/Principal Findings We have analyzed the binding interactions between NHR and model 58 and 29 nucleotide substrate RNAs by gel electrophoresis mobility shift assays (EMSA) and fluorescence anisotropy. We show that the enzyme binds to RNA as a dimer. By constructing a heterodimer complex composed of one wild-type subunit and one inactive mutant NHR-R135A subunit, we show that only one functional subunit of the NHR homodimer is required for its enzymatic activity. Mutational analysis suggests that the interactions between neighbouring bases (G1068 and U1066) and A1067 have an important role in methyltransfer activity, such that the substitution of a deoxy sugar spacer (5') to the target nucleotide achieved near wild-type levels of methylation. A series of atomic substitutions at specific positions on the substrate adenine show that local base-base interactions between neighbouring bases are important for methylation. Conclusion/Significance Taken together these data suggest that local base-base interactions play an important role in aligning the substrate 2' hydroxyl group of A1067 for methyl group transfer. Methylation of nucleic acids is playing an increasingly important role in fundamental biological processes and we anticipate that the approach outlined in this manuscript may be useful for investigating other classes of nucleic acid methyltransferases.	[Yin, Sitao; Jiang, Hengyi; Chen, Dongrong; Murchie, Alastair I. H.] Fudan Univ, Dept Biochem & Mol Biol, Key Lab Mol Med, Minist Educ,Shanghai Med Coll, Shanghai 200032, Peoples R China; [Yin, Sitao; Jiang, Hengyi; Chen, Dongrong; Murchie, Alastair I. H.] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Chen, DR (corresponding author), Fudan Univ, Dept Biochem & Mol Biol, Key Lab Mol Med, Minist Educ,Shanghai Med Coll, Shanghai 200032, Peoples R China.	drchen@fudan.edu.cn; aihm@fudan.edu.cn			National Key 973 grant [2010CB912602]; Natural Science Foundation [31170749, 31100543]	National Key 973 grant(National Basic Research Program of China); Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Key 973 grant (2010CB912602) and Natural Science Foundation grants 31170749 and 31100543.	Ahn HJ, 2003, EMBO J, V22, P2593, DOI 10.1093/emboj/cdg269; Anantharaman V, 2002, J MOL MICROB BIOTECH, V4, P71; BECHTHOLD A, 1994, EUR J BIOCHEM, V224, P431, DOI 10.1111/j.1432-1033.1994.00431.x; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; BJORK GR, 1989, SCIENCE, V244, P986, DOI 10.1126/science.2471265; Bjork GR, 2001, EMBO J, V20, P231, DOI 10.1093/emboj/20.1.231; Bower J, 2003, BIOORG MED CHEM LETT, V13, P2455, DOI 10.1016/S0960-894X(03)00495-5; Cameron DM, 2002, J MOL BIOL, V319, P27, DOI 10.1016/S0022-2836(02)00235-8; Cavaille J, 1999, RNA, V5, P66, DOI 10.1017/S1355838299981475; Christian T, 2007, J MOL BIOL, V373, P623, DOI 10.1016/j.jmb.2007.08.010; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; Coward J, 1977, CHEMICAL MECHANISMS; Davis B, 2004, J MOL BIOL, V336, P343, DOI 10.1016/j.jmb.2003.12.046; Dunstan MS, 2009, J BIOL CHEM, V284, P17013, DOI 10.1074/jbc.M901618200; EGEBJERG J, 1990, J MOL BIOL, V213, P275, DOI 10.1016/S0022-2836(05)80190-1; Elkins PA, 2003, J MOL BIOL, V333, P931, DOI 10.1016/j.jmb.2003.09.011; Fu Y, 2012, CURR OPIN CHEM BIOL, V16, P516, DOI 10.1016/j.cbpa.2012.10.002; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Goto-Ito S, 2009, NAT STRUCT MOL BIOL, V16, P1109, DOI 10.1038/nsmb.1653; Green R, 1996, RNA, V2, P1011; Gustafsson C, 1996, NUCLEIC ACIDS RES, V24, P3756, DOI 10.1093/nar/24.19.3756; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; Hori H, 2003, J BIOL CHEM, V278, P25081, DOI 10.1074/jbc.M212577200; Hori H, 2002, GENES CELLS, V7, P259, DOI 10.1046/j.1365-2443.2002.00520.x; HOUNTONDJI C, 1979, EUR J BIOCHEM, V102, P247, DOI 10.1111/j.1432-1033.1979.tb06286.x; Jia GF, 2013, TRENDS GENET, V29, P108, DOI 10.1016/j.tig.2012.11.003; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jia X, 2013, CELL, V152, P68, DOI 10.1016/j.cell.2012.12.019; Jonker HRA, 2007, NUCLEIC ACIDS RES, V35, P441, DOI 10.1093/nar/gkl1066; Knowles DJC, 2002, CURR OPIN PHARMACOL, V2, P501, DOI 10.1016/S1471-4892(02)00205-9; Kuiper EG, 2014, J BIOL CHEM, V289, P26189, DOI 10.1074/jbc.M114.574780; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; Lentzen G, 2003, CHEM BIOL, V10, P769, DOI 10.1016/S1074-5521(03)00173-X; LIMBACH PA, 1994, NUCLEIC ACIDS RES, V22, P2183, DOI 10.1093/nar/22.12.2183; Liu MF, 2000, MOL MICROBIOL, V37, P811, DOI 10.1046/j.1365-2958.2000.02046.x; Mikhailov SN, 2002, NUCLEIC ACIDS RES, V30, P1124, DOI 10.1093/nar/30.5.1124; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; Murchie AIH, 2004, J MOL BIOL, V336, P625, DOI 10.1016/j.jmb.2003.12.028; MURCHIE AIH, 1987, NUCLEIC ACIDS RES, V15, P9641, DOI 10.1093/nar/15.23.9641; MURCHIE AIH, 1989, J MOL BIOL, V205, P593, DOI 10.1016/0022-2836(89)90228-3; Nureki O, 2004, STRUCTURE, V12, P593, DOI 10.1016/j.str.2004.03.003; Ochi A, 2010, J BIOL CHEM, V285, P9018, DOI 10.1074/jbc.M109.065698; Pan T, 2013, TRENDS BIOCHEM SCI, V38, P204, DOI 10.1016/j.tibs.2012.12.006; Persson BC, 1997, NUCLEIC ACIDS RES, V25, P4093, DOI 10.1093/nar/25.20.4093; Ragsdale SW, 2008, VITAM HORM, V79, P293, DOI 10.1016/S0083-6729(08)00410-X; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rodnina MV, 1999, P NATL ACAD SCI USA, V96, P9586, DOI 10.1073/pnas.96.17.9586; Sakaguchi R, 2012, RNA, V18, P1687, DOI 10.1261/rna.032029.111; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; SCHMIDT FJ, 1981, J BIOL CHEM, V256, P2301; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; SKOLD SE, 1983, NUCLEIC ACIDS RES, V11, P4923, DOI 10.1093/nar/11.14.4923; Takeda H, 2006, GENES CELLS, V11, P1353, DOI 10.1111/j.1365-2443.2006.01022.x; Thomas SR, 2011, NUCLEIC ACIDS RES, V39, P2445, DOI 10.1093/nar/gkq1131; THOMPSON J, 1982, J BIOL CHEM, V257, P7915; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; Watanabe K, 2006, J BIOL CHEM, V281, P34630, DOI 10.1074/jbc.M606141200; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Wu TP, 1996, NUCLEIC ACIDS RES, V24, P3472, DOI 10.1093/nar/24.17.3472; Yang HR, 2010, BIOCHEMISTRY-US, V49, P6440, DOI 10.1021/bi1005915; Zhang Q, 2012, ACCOUNTS CHEM RES, V45, P555, DOI 10.1021/ar200202c	65	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122972	10.1371/journal.pone.0122972	http://dx.doi.org/10.1371/journal.pone.0122972			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910005	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800025
J	Goodlin, GT; Roos, AK; Roos, TR; Hawkins, C; Beache, S; Baur, S; Kim, SK				Goodlin, Gabrielle T.; Roos, Andrew K.; Roos, Thomas R.; Hawkins, Claire; Beache, Sydney; Baur, Stephen; Kim, Stuart K.			Applying Personal Genetic Data to Injury Risk Assessment in Athletes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CRUCIATE LIGAMENT RUPTURES; PROFESSIONAL SOCCER PLAYERS; ELITE SPORTING PERFORMANCE; SOFT-TISSUE INJURIES; ACHILLES TENDINOPATHY; COL5A1 GENE; RUNNING INJURIES; COMMON VARIANTS; POLYMORPHISM	Recent studies have identified genetic markers associated with risk for certain sports-related injuries and performance-related conditions, with the hope that these markers could be used by individual athletes to personalize their training and diet regimens. We found that we could greatly expand the knowledge base of sports genetic information by using published data originally found in health and disease studies. For example, the results from large genome-wide association studies for low bone mineral density in elderly women can be re-purposed for low bone mineral density in young endurance athletes. In total, we found 124 single-nucleotide polymorphisms associated with: anterior cruciate ligament tear, Achilles tendon injury, low bone mineral density and stress fracture, osteoarthritis, vitamin/mineral deficiencies, and sickle cell trait. Of these single nucleotide polymorphisms, 91% have not previously been used in sports genetics. We conducted a pilot program on fourteen triathletes using this expanded knowledge base of genetic variants associated with sports injury. These athletes were genotyped and educated about how their individual genetic make-up affected their personal risk profile during an hour-long personal consultation. Overall, participants were favorable of the program, found it informative, and most acted upon their genetic results. This pilot program shows that recent genetic research provides valuable information to help reduce sports injuries and to optimize nutrition. There are many genetic studies for health and disease that can be mined to provide useful information to athletes about their individual risk for relevant injuries.	[Goodlin, Gabrielle T.; Baur, Stephen; Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; [Goodlin, Gabrielle T.; Baur, Stephen; Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; [Roos, Andrew K.; Roos, Thomas R.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Div Epidemiol, Stanford, CA 94305 USA; [Hawkins, Claire; Beache, Sydney] Stanford Univ, Dept Human Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Kim, SK (corresponding author), Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA.	stuartkm@stanford.edu		Roos, Thomas/0000-0003-3677-3219	NIH/Stanford University [S13-064]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025941] Funding Source: NIH RePORTER	NIH/Stanford University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: This work was supported by a Spectrum grant from NIH/Stanford University (#S13-064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Alfredson H, 1998, AM J SPORT MED, V26, P360, DOI 10.1177/03635465980260030301; [Anonymous], 2013, WORLD TRIATHL SER RE; Ashley-Koch A, 2000, AM J EPIDEMIOL, V151, P839; Bennell K, 1999, SPORTS MED, V28, P91, DOI 10.2165/00007256-199928020-00004; Bennell K, 2012, NAT REV RHEUMATOL, V8, P747, DOI 10.1038/nrrheum.2012.119; Bohl CH, 2002, CRIT REV FOOD SCI, V42, P533, DOI 10.1080/20024091054247; Caine DJ, 2011, BRIT J SPORT MED, V45, P298, DOI 10.1136/bjsm.2010.081984; Collins M, 2010, BRIT J SPORT MED, V44, P915, DOI 10.1136/bjsm.2009.058040; Collins M, 2010, BRIT J SPORT MED, V44, P1063, DOI 10.1136/bjsm.2008.056184; Cupeiro R, 2010, J SCI MED SPORT, V13, P526, DOI 10.1016/j.jsams.2009.07.004; Daneshjoo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050979; Egermann M, 2003, INT J SPORTS MED, V24, P271, DOI 10.1055/s-2003-39498; Eichner E Randy, 2007, Curr Sports Med Rep, V6, P134, DOI 10.1007/s11932-007-0016-9; Eirale C, 2013, BRIT J SPORT MED, V47, P807, DOI 10.1136/bjsports-2012-091040; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Evangelou E, 2011, ANN RHEUM DIS, V70, P349, DOI 10.1136/ard.2010.132787; Field AE, 2011, ARCH PEDIAT ADOL MED, V165, P723, DOI 10.1001/archpediatrics.2011.34; Fujii K., 1994, SPORTS TRAUMATOL ART, V2, P229, DOI DOI 10.1007/BF01845593; Ghansah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034565; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hootman JM, 2007, J ATHL TRAINING, V42, P311; INGRAM VM, 1959, BIOCHIM BIOPHYS ACTA, V36, P402, DOI 10.1016/0006-3002(59)90183-0; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Jin H, 2011, OSTEOPOROSIS INT, V22, P911, DOI 10.1007/s00198-010-1364-5; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Kader D, 2002, BRIT J SPORT MED, V36, P239, DOI 10.1136/bjsm.36.4.239; Kambouris M, 2014, TRANSL MED UNISA, V9, P18; Kambouris Marios, 2012, Recent Pat DNA Gene Seq, V6, P229; Kapur K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001035; Khoschnau S, 2008, AM J SPORT MED, V36, P2432, DOI 10.1177/0363546508320805; Klossner D, 2012, 2012 2013 NCAA SPORT; Kullo IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013011; Lange LA, 2010, HUM MOL GENET, V19, P2050, DOI 10.1093/hmg/ddq062; Lewiecki EM, 2009, J CLIN DENSITOM, V12, P135, DOI 10.1016/j.jocd.2009.02.002; Lin XL, 2012, HUM MOL GENET, V21, P2610, DOI 10.1093/hmg/dds062; Lopes AD, 2012, SPORTS MED, V42, P891, DOI [10.2165/11631170-000000000-00000, 10.1007/BF03262301]; Maffulli N, 2004, J ROY SOC MED, V97, P472, DOI 10.1258/jrsm.97.10.472; Maffulli Nicola, 2013, Muscles Ligaments Tendons J, V3, P173; Mafi N, 2001, KNEE SURG SPORT TR A, V9, P42, DOI 10.1007/s001670000148; Major JM, 2011, HUM MOL GENET, V20, P3876, DOI 10.1093/hmg/ddr296; Meyer TE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001045; Mokone GG, 2006, SCAND J MED SCI SPOR, V16, P19, DOI 10.1111/j.1600-0838.2005.00439.x; Mokone GG, 2005, AM J SPORT MED, V33, P1016, DOI 10.1177/0363546504271986; Nell EM, 2012, J ORTHOP RES, V30, P1719, DOI 10.1002/jor.22144; O'Seaghdha CM, 2010, HUM MOL GENET, V19, P4296, DOI 10.1093/hmg/ddq342; OBrien M, 1997, SCAND J MED SCI SPOR, V7, P55; Oexle K, 2011, HUM MOL GENET, V20, P1042, DOI 10.1093/hmg/ddq538; OTOOLE ML, 1989, AM J SPORT MED, V17, P514, DOI 10.1177/036354658901700411; Pare G, 2009, CIRC-CARDIOVASC GENE, V2, P142, DOI 10.1161/CIRCGENETICS.108.829804; Paternoster L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001217; Pitsiladis Y, 2013, BRIT J SPORT MED, V47, P550, DOI 10.1136/bjsports-2013-092400; Posthumus M, 2012, SCAND J MED SCI SPOR, V22, P523, DOI 10.1111/j.1600-0838.2010.01270.x; Posthumus M, 2009, BRIT J SPORT MED, V43, P352, DOI 10.1136/bjsm.2008.056150; Posthumus M, 2010, RHEUMATOLOGY, V49, P2090, DOI 10.1093/rheumatology/keq072; Posthumus M, 2010, BRIT J SPORT MED, V44, P1160, DOI 10.1136/bjsm.2009.060756; Posthumus M, 2009, AM J SPORT MED, V37, P2234, DOI 10.1177/0363546509338266; Pruna R, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-221; Puddu G, 1976, Am J Sports Med, V4, P145, DOI 10.1177/036354657600400404; Raleigh SM, 2009, BRIT J SPORT MED, V43, P514, DOI 10.1136/bjsm.2008.053892; Ralston SH, 2010, ENDOCR REV, V31, P629, DOI 10.1210/er.2009-0044; Rodriguez NR, 2009, MED SCI SPORT EXER, V41, P709, DOI 10.1249/MSS.0b013e31890eb86; Ryan K, 2010, BRIT J HAEMATOL, V149, P35, DOI 10.1111/j.1365-2141.2009.08054.x; Schneider KI, 2014, J COMMUN GENET, V5, P31, DOI 10.1007/s12687-013-0160-2; Schwellnus MP, 2013, BRIT J SPORT MED, V47, P530, DOI 10.1136/bjsports-2013-092515; September AV, 2009, BRIT J SPORT MED, V43, P357, DOI 10.1136/bjsm.2008.048793; Tanaka T, 2009, AM J HUM GENET, V84, P477, DOI 10.1016/j.ajhg.2009.02.011; Teupser D, 2010, CIRC-CARDIOVASC GENE, V3, P331, DOI 10.1161/CIRCGENETICS.109.907873; Valdes AM, 2011, ANN RHEUM DIS, V70, P873, DOI 10.1136/ard.2010.134155; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Wagner JK, 2012, J PERS MED, V2, P119, DOI 10.3390/jpm2030119; Wagner JK, 2013, VA SPORTS ENTERTAINM, V12, P1; Wang G, 2013, ADV GENET, V84, P123, DOI 10.1016/B978-0-12-407703-4.00004-9; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Zeggini E, 2012, LANCET, V380, P815, DOI 10.1016/S0140-6736(12)60681-3; Zhang LS, 2012, OSTEOPOROSIS INT, V23, P1867, DOI 10.1007/s00198-011-1863-z	77	13	13	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0122676	10.1371/journal.pone.0122676	http://dx.doi.org/10.1371/journal.pone.0122676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919592	Green Published, gold			2022-12-27	WOS:000353659400017
J	Jay, L; Bourget, JM; Goyer, B; Singh, K; Brunette, I; Ozaki, T; Proulx, S				Jay, Louis; Bourget, Jean-Michel; Goyer, Benjamin; Singh, Kanwarpal; Brunette, Isabelle; Ozaki, Tsuneyuki; Proulx, Stephanie			Characterization of Tissue-Engineered Posterior Corneas Using Second- and Third-Harmonic Generation Microscopy	PLOS ONE			English	Article							SELF-ASSEMBLY APPROACH; 2ND-HARMONIC GENERATION; HARMONIC-GENERATION; IMAGING MICROSCOPY; COLLAGEN; CELLS; REGENERATION; ORIENTATION; EQUIVALENT; RESOLUTION	Three-dimensional tissues, such as the cornea, are now being engineered as substitutes for the rehabilitation of vision in patients with blinding corneal diseases. Engineering of tissues for translational purposes requires a non-invasive monitoring to control the quality of the resulting biomaterial. Unfortunately, most current methods still imply invasive steps, such as fixation and staining, to clearly observe the tissue-engineered cornea, a transparent tissue with weak natural contrast. Second-and third-harmonic generation imaging are well known to provide high-contrast, high spatial resolution images of such tissues, by taking advantage of the endogenous contrast agents of the tissue itself. In this article, we imaged tissue-engineered corneal substitutes using both harmonic microscopy and classic histopathology techniques. We demonstrate that second-and third-harmonic imaging can non-invasively provide important information regarding the quality and the integrity of these partial-thickness posterior corneal substitutes (observation of collagen network, fibroblasts and endothelial cells). These two nonlinear imaging modalities offer the new opportunity of monitoring the engineered corneas during the entire process of production.	[Jay, Louis; Singh, Kanwarpal; Ozaki, Tsuneyuki] Inst Natl Rech Sci, Ctr Energie Mat Telecommun, Varennes, PQ, Canada; [Jay, Louis; Bourget, Jean-Michel; Singh, Kanwarpal; Brunette, Isabelle] Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ, Canada; [Jay, Louis; Bourget, Jean-Michel; Singh, Kanwarpal; Brunette, Isabelle] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada; [Goyer, Benjamin; Proulx, Stephanie] CHU Quebec, Hop St Sacrement, Ctr Rech, Axe Med Regeneratrice, Quebec City, PQ, Canada; [Goyer, Benjamin; Proulx, Stephanie] Univ Laval, LOEX, Ctr Rech Organogenese Exprt, Quebec City, PQ, Canada; [Proulx, Stephanie] Univ Laval, Fac Med, Dept Ophtalmol & Otorhinolaryngol, Quebec City, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); Universite de Montreal; Universite de Montreal; Laval University; Laval University; Laval University	Proulx, S (corresponding author), CHU Quebec, Hop St Sacrement, Ctr Rech, Axe Med Regeneratrice, Quebec City, PQ, Canada.	stephanie.proulx@fmed.ulaval.ca	Singh, Kanwarpal/P-3789-2019	Ozaki, Tsuneyuki/0000-0001-8857-3900; Proulx, Stephanie/0000-0002-1227-4039; Singh, Kanwarpal/0000-0002-6884-8089	Canadian Institutes for Health Research (CIHR) [CPG121034]; Natural Sciences and Engineering Research Council of Canada (NSERC) [414484-2012]; FRQS Vision Health Research Network;  [CHRPJ 313019-05]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); FRQS Vision Health Research Network; 	This work was supported by the Canadian Institutes for Health Research (CIHR grant #CPG121034) in partnership with the Natural Sciences and Engineering Research Council of Canada (NSERC grant #414484-2012) (SP, IB) and grant #CHRPJ 313019-05 (TO). The Eye Bank Banque d'yeux du Centre Universitaire d'Ophtalmologie" is partly supported by the FRQS Vision Health Research Network (SP, IB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aptel F, 2010, INVEST OPHTH VIS SCI, V51, P2459, DOI 10.1167/iovs.09-4586; Auxenfans C, 2009, EUR J DERMATOL, V19, P107, DOI 10.1684/ejd.2008.0573; Barad Y, 1997, APPL PHYS LETT, V70, P922, DOI 10.1063/1.118442; Barzda V, 2005, OPT EXPRESS, V13, P8263, DOI 10.1364/OPEX.13.008263; Buhrmann R., 2007, FDN CANADIAN HLTH ST; Campagnola P, 2011, ANAL CHEM, V83, P3224, DOI 10.1021/ac1032325; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Carrier P, 2008, INVEST OPHTH VIS SCI, V49, P1376, DOI 10.1167/iovs.07-0904; Carrier P, 2009, INVEST OPHTH VIS SCI, V50, P2645, DOI 10.1167/iovs.08-2001; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Debarre D, 2006, NAT METHODS, V3, P47, DOI 10.1038/NMETH813; EBAA, 2013, 2013 EYE BANK STAT R, P1; Gauvin R, 2010, TISSUE ENG PT A, V16, P1737, DOI [10.1089/ten.tea.2009.0313, 10.1089/ten.TEA.2009.0313]; Germain L, 2000, PROG RETIN EYE RES, V19, P497, DOI 10.1016/S1350-9462(00)00005-7; Germain L, 2004, TISSUE ENG CORNEA EN, P1533; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Guillemette MD, 2009, INTEGR BIOL, V1, P196, DOI 10.1039/b820208g; Howat WJ, 2014, METHODS, V70, P12, DOI 10.1016/j.ymeth.2014.01.022; Hsueh CM, 2009, BIOPHYS J, V97, P1198, DOI 10.1016/j.bpj.2009.05.040; Jay L, 2008, OPT EXPRESS, V16, P16284, DOI 10.1364/OE.16.016284; L'Heureux N, 1998, FASEB J, V12, P47, DOI 10.1096/fasebj.12.1.47; Larouche Danielle, 2009, V482, P233, DOI 10.1007/978-1-59745-060-7_15; Lee GG, 2013, IEEE T BIOMED CIRC S, V7, P158, DOI 10.1109/TBCAS.2013.2253463; McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8; Mega Y, 2012, OPT LETT, V37, P3312, DOI 10.1364/OL.37.003312; Mimura T, 2013, PROG RETIN EYE RES, V35, P1, DOI 10.1016/j.preteyeres.2013.01.003; Morishige N, 2011, INVEST OPHTH VIS SCI, V52, P911, DOI 10.1167/iovs.10-5657; Morishige N, 2009, CORNEA, V28, pS46, DOI 10.1097/ICO.0b013e3181ae9f37; Muller M, 1998, J MICROSC-OXFORD, V191, P266, DOI 10.1046/j.1365-2818.1998.00399.x; Pankert MB, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14720; PIHLAJANIEMI T, 1991, J HEPATOL, V13, pS2, DOI 10.1016/0168-8278(91)90002-S; Proulx S, 2012, EXP EYE RES, V95, P68, DOI 10.1016/j.exer.2011.06.013; Proulx S, 2010, MOL VIS, V16, P2192; Su PJ, 2010, BIOMATERIALS, V31, P9415, DOI 10.1016/j.biomaterials.2010.08.055; TAYLOR MJ, 1981, BRIT J OPHTHALMOL, V65, P815, DOI 10.1136/bjo.65.12.815; Teng SW, 2006, INVEST OPHTH VIS SCI, V47, P1216, DOI 10.1167/iovs.04-1520; Tserevelakis GJ, 2010, MICRON, V41, P444, DOI 10.1016/j.micron.2010.02.006; Vielreicher M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0263; Yelin D, 1999, OPT EXPRESS, V5, P169, DOI 10.1364/OE.5.000169; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	41	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125564	10.1371/journal.pone.0125564	http://dx.doi.org/10.1371/journal.pone.0125564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25918849	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400086
J	Monen, J; Hattersley, N; Muroyama, A; Stevens, D; Oegema, K; Desai, A				Monen, Joost; Hattersley, Neil; Muroyama, Andrew; Stevens, Deanna; Oegema, Karen; Desai, Arshad			Separase Cleaves the N-Tail of the CENP-A Related Protein CPAR-1 at the Meiosis I Metaphase-Anaphase Transition in C-elegans	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CHROMOSOME SEGREGATION; GENOME DUPLICATION; CELL-DIVISION; AUTO-CLEAVAGE; KINETOCHORE; CHROMATIN; EMBRYO; MEI-1/KATANIN; SUBSTRATE	Centromeres are defined epigenetically in the majority of eukaryotes by the presence of chromatin containing the centromeric histone H3 variant CENP-A. Most species have a single gene encoding a centromeric histone variant whereas C. elegans has two: HCP-3 (also known as CeCENP-A) and CPAR-1. Prior RNAi replacement experiments showed that HCP-3 is the functionally dominant isoform, consistent with CPAR-1 not being detectable in embryos. GFP::CPAR-1 is loaded onto meiotic chromosomes in diakinesis and is enriched on bivalents until meiosis I. Here we show that GFP:: CPAR-1 signal loss from chromosomes precisely coincides with homolog segregation during anaphase I. This loss of GFP:: CPAR-1 signal reflects proteolytic cleavage between GFP and the histone fold of CPAR-1, as CPAR-1:: GFP, in which GFP is fused to the C-terminus of CPAR-1, does not exhibit any loss of GFP signal. A focused candidate screen implicated separase, the protease that initiates anaphase by cleaving the kleisin subunit of cohesin, in this cleavage reaction. Examination of the N-terminal tail sequence of CPAR-1 revealed a putative separase cleavage site and mutation of the signature residues in this site eliminated the cleavage reaction, as visualized by retention of GFP::CPAR-1 signal on separating homologous chromosomes at the metaphase-anaphase transition of meiosis I. Neither cleaved nor uncleavable CPAR-1 were centromere-localized in mitosis and instead localized throughout chromatin, indicating that centromere activity has not been retained in CPAR-1. Although the functions of CPAR-1 and of its separase-dependent cleavage remain to be elucidated, this effort reveals a new substrate of separase and provides an in vivo biosensor to monitor separase activity at the onset of meiosis I anaphase.	[Desai, Arshad] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Desai, A (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	abdesai@ucsd.edu		Muroyama, Andrew/0000-0003-0701-212X	NIH [GM074215]; Institutional Ruth L. Kirschstein National Research Service Award from the National Institute for General Medical Sciences [T32 GM008666]; Ramapo College Foundation and Faculty Development Fund; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215, T32GM007184, T32GM008666] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Ruth L. Kirschstein National Research Service Award from the National Institute for General Medical Sciences; Ramapo College Foundation and Faculty Development Fund; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH grant (GM074215) to AD. JM was supported by an Institutional Ruth L. Kirschstein National Research Service Award from the National Institute for General Medical Sciences to the UCSD Genetics Training Program (T32 GM008666) and by a grant from the Ramapo College Foundation and Faculty Development Fund. AD and KO received salary and other support from the Ludwig Institute for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bembenek JN, 2007, DEVELOPMENT, V134, P3837, DOI 10.1242/dev.011361; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Drinnenberg IA, 2014, ELIFE, V3, DOI 10.7554/eLife.03676; Dumont J, 2010, NAT CELL BIOL, V12, P894, DOI 10.1038/ncb2093; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Fukagawa T, 2014, DEV CELL, V30, P497, DOI 10.1016/j.devcel.2014.08.016; Gassmann R, 2012, NATURE, V484, P534, DOI 10.1038/nature10973; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Heckmann S, 2013, PLANT CENTROMERE BIOLOGY, P83; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maddox PS, 2012, CURR OPIN GENET DEV, V22, P139, DOI 10.1016/j.gde.2011.11.005; Maddox PS, 2004, CHROMOSOME RES, V12, P641, DOI 10.1023/B:CHRO.0000036588.42225.2f; Matsuo K, 2012, CURR BIOL, V22, P915, DOI 10.1016/j.cub.2012.03.048; Melters DP, 2012, CHROMOSOME RES, V20, P579, DOI 10.1007/s10577-012-9292-1; Monen J, 2005, NAT CELL BIOL, V7, P1248, DOI 10.1038/ncb1331; Nagaki K, 2005, PLANT CELL, V17, P1886, DOI 10.1105/tpc.105.032961; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Papi M, 2005, NAT CELL BIOL, V7, P1029, DOI 10.1038/ncb1303; Pellettieri J, 2014, CELL, V5, P451, DOI [10.1016/S1534-5807(03)00231-4, DOI 10.1016/S1534-5807(03)00231-4]; PIMPINELLI S, 1989, TRENDS GENET, V5, P310, DOI 10.1016/0168-9525(89)90114-5; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Pintard L, 2003, CURR BIOL, V13, P911, DOI 10.1016/S0960-9822(03)00336-1; Praitis V, 2001, GENETICS, V157, P1217; Quintin S, 2003, EMBO REP, V4, P1175, DOI 10.1038/sj.embor.7400029; Robertson S, 2013, ADV EXP MED BIOL, V757, P351, DOI 10.1007/978-1-4614-4015-4_12; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sekulic N, 2012, TRENDS BIOCHEM SCI, V37, P220, DOI 10.1016/j.tibs.2012.01.003; Severson AF, 2014, ELIFE, V3, DOI 10.7554/eLife.03467; Siomos MF, 2001, CURR BIOL, V11, P1825, DOI 10.1016/S0960-9822(01)00588-7; Srayko M, 2000, GENE DEV, V14, P1072; Sullivan M, 2004, J BIOL CHEM, V279, P1191, DOI 10.1074/jbc.M309761200; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; Sun YX, 2009, CELL, V137, P123, DOI 10.1016/j.cell.2009.01.040; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Verlhac MH, 2010, CURR OPIN CELL BIOL, V22, P758, DOI 10.1016/j.ceb.2010.09.003; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Westhorpe FG, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015818; Zou H, 2002, FEBS LETT, V528, P246, DOI 10.1016/S0014-5793(02)03238-6	47	17	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125382	10.1371/journal.pone.0125382	http://dx.doi.org/10.1371/journal.pone.0125382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919583	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400083
J	Yamanaka, K; Houben, P; Bruns, H; Schultze, D; Hatano, E; Schemmer, P				Yamanaka, Kenya; Houben, Philipp; Bruns, Helge; Schultze, Daniel; Hatano, Etsuro; Schemmer, Peter			A Systematic Review of Pharmacological Treatment Options Used to Reduce Ischemia Reperfusion Injury in Rat Liver Transplantation	PLOS ONE			English	Article							COLD ISCHEMIA/REPERFUSION INJURY; SINUSOIDAL ENDOTHELIAL-CELLS; RECEPTOR ANTAGONIST TAK-044; PLATELET-ACTIVATING-FACTOR; IMPROVES GRAFT-SURVIVAL; N-ACETYLCYSTEINE; PRESERVATION INJURY; PROTECTIVE ROLE; BIOLOGICAL MODULATION; PRIMARY NONFUNCTION	Background Although animal studies models are frequently used for the purpose of attenuating ischemia reperfusion injury (IRI) in liver transplantation (LT), many of pharmacological agents have not become part of clinical routine. Methods A search was performed using the PubMed database to identify agents, from which 58 articles containing 2700 rat LT procedures were selected. The identified pharmacological agents were categorized as follows: I - adenosine agonists, nitric oxide agonists, endothelin antagonists, and prostaglandins, II - Kupffer cell inactivator, III - complement inhibiter, IV - antioxidant, V - neutrophil inactivator, VI - anti-apoptosis agent, VII - heat shock protein and nuclear factor kappa B inducer, VIII - metabolic agent, IX - traditional Chinese medicine, and X others. Meta-analysis using 7-day-survival rate was also performed with Mantel-Haenszel's Random effects model. Results The categorization revealed that the rate of donor-treated experiments in each group was highest for agents from Group II (70%) and VII (71%), whereas it was higher for agents from Group V (83%) in the recipient-treated experiments. Furthermore, 90% of the experiments with agents in Group II provided 7-day-survival benefits. The Risk Ratio (RR) of the meta-analysis was 2.43 [95% CI: 1.88-3.14] with moderate heterogeneity. However, the RR of each of the studies was too model-dependent to be used in the search for the most promising pharmacological agent. Conclusion With regard to hepatic IRI pathology, the categorization of agents of interest would be a first step in designing suitable multifactorial and pleiotropic approaches to develop pharmacological strategies.	[Yamanaka, Kenya; Houben, Philipp; Bruns, Helge; Schultze, Daniel; Schemmer, Peter] Univ Heidelberg Hosp, Dept Gen & Transplant Surg, Heidelberg, Germany; [Yamanaka, Kenya; Hatano, Etsuro] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan	Ruprecht Karls University Heidelberg; Kyoto University	Schemmer, P (corresponding author), Univ Heidelberg Hosp, Dept Gen & Transplant Surg, Heidelberg, Germany.	Peter.Schemmer@med.uni-heidelberg.de	Hatano, Etsuro/AAX-2407-2020	Hatano, Etsuro/0000-0003-3407-1918				Abu-Amara M, 2010, LIVER TRANSPLANT, V16, P1016, DOI 10.1002/lt.22117; Aguilar-Melero P, 2013, J SURG RES, V181, pE83, DOI 10.1016/j.jss.2012.07.046; Amatschek S, 2012, J HEPATOL, V56, P1305, DOI 10.1016/j.jhep.2012.01.020; Amersi F, 2003, AM J PATHOL, V162, P1229, DOI 10.1016/S0002-9440(10)63919-3; Anthuber M, 1997, HEPATOLOGY, V25, P648, DOI 10.1002/hep.510250326; Baskin-Bey ES, 2007, AM J TRANSPLANT, V7, P218, DOI 10.1111/j.1600-6143.2006.01595.x; Busuttil RW, 2011, AM J TRANSPLANT, V11, P786, DOI 10.1111/j.1600-6143.2011.03441.x; Busuttil RW, 2003, LIVER TRANSPLANT, V9, P651, DOI 10.1053/jlts.2003.50105; Carithers RL, 2000, LIVER TRANSPLANT, V6, P122; Chen LP, 2010, LIVER TRANSPLANT, V16, P204, DOI 10.1002/lt.21985; Chen T, 2012, TRANSPL P, V44, P978, DOI 10.1016/j.transproceed.2012.03.052; Cheng MX, 2012, J SURG RES, V176, P666, DOI 10.1016/j.jss.2011.12.005; Chimalakonda AP, 2007, PHARM RES, V24, P2231, DOI 10.1007/s11095-007-9414-1; Clavien PA, 2012, LANCET ONCOL, V13, pE11, DOI 10.1016/S1470-2045(11)70175-9; COSENZA CA, 1994, HEPATOLOGY, V19, P418; de Rougemont O, 2010, CURR OPIN ORGAN TRAN, V15, P183, DOI 10.1097/MOT.0b013e3283373ced; Dulkanchainun TS, 1998, ANN SURG, V227, P832, DOI 10.1097/00000658-199806000-00006; Fondevila C, 2004, HEPATOLOGY, V40, P1333, DOI 10.1002/hep.20480; Fondevila C, 2009, AM J TRANSPLANT, V9, P2240, DOI 10.1111/j.1600-6143.2009.02759.x; Former DG, 2008, LIVER TRANSPLANT, V14, P1737, DOI 10.1002/lt.21621; Fudaba Y, 2001, TRANSPLANTATION, V72, P184, DOI 10.1097/00007890-200107270-00003; Fudaba Y, 2000, Transpl Int, V13 Suppl 1, pS278, DOI 10.1007/s001470050341; Gao WS, 1997, GASTROENTEROLOGY, V113, P1692, DOI 10.1053/gast.1997.v113.pm9352874; Geller DA, 2001, JPEN-PARENTER ENTER, V25, P142, DOI 10.1177/0148607101025003142; Ghonem N, 2011, AM J TRANSPLANT, V11, P2508, DOI 10.1111/j.1600-6143.2011.03568.x; Grutzner U, 2006, WORLD J GASTROENTERO, V12, P1049, DOI 10.3748/wjg.v12.i7.1049; Hashimoto K, 2000, TRANSPLANTATION, V70, P1318, DOI 10.1097/00007890-200011150-00009; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hilmi IA, 2010, NEPHROL DIAL TRANSPL, V25, P2328, DOI 10.1093/ndt/gfq077; Huser N, 2009, ARCH PHARM RES, V32, P215, DOI 10.1007/s12272-009-1138-9; Johnson SR, 2007, AM J TRANSPLANT, V7, P1003, DOI 10.1111/j.1600-6143.2006.01702.x; Kaizu T, 2008, AM J PHYSIOL-GASTR L, V294, pG236, DOI 10.1152/ajpgi.00144.2007; Kamo N, 2011, AM J TRANSPLANT, V11, P2499, DOI 10.1111/j.1600-6143.2011.03700.x; Koeppel TA, 1996, TRANSPLANTATION, V61, P1397, DOI 10.1097/00007890-199605150-00020; Kotsch K, 2008, ANN SURG, V248, P1042, DOI 10.1097/SLA.0b013e318190e70c; Lehmann TG, 1998, TRANSPLANTATION, V66, P717, DOI 10.1097/00007890-199809270-00005; Liang R, 2009, TRANSPL INT, V22, P1100, DOI 10.1111/j.1432-2277.2009.00925.x; Liu H, 1998, CHINESE MED J-PEKING, V111, P1079; Liu ZJ, 2006, ACTA PHARMACOL SIN, V27, P1479, DOI 10.1111/j.1745-7254.2006.00413.x; Ma ZW, 2007, COLLOID SURFACE B, V54, P25, DOI 10.1016/j.colsurfb.2006.05.017; Maeda T, 1998, TRANSPLANTATION, V66, P844, DOI 10.1097/00007890-199810150-00006; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Manika A, 1999, TRANSPLANTATION, V68, P327, DOI 10.1097/00007890-199908150-00002; McCormack L, 2011, J HEPATOL, V54, P1055, DOI 10.1016/j.jhep.2010.11.004; Mendes-Braz M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/298657; Menger MD, 2007, TRANSPL P, V39, P485, DOI 10.1016/j.transproceed.2007.01.022; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Monbaliu D, 2009, ANN SURG, V250, P808, DOI 10.1097/SLA.0b013e3181bdd787; Moore C, 2005, TRANSPL P, V37, P432, DOI 10.1016/j.transproceed.2004.12.206; Morimoto Y, 1996, GASTROENTEROLOGY, V111, P1071, DOI 10.1016/S0016-5085(96)70076-8; Mueller THJ, 2004, TRANSPLANTATION, V78, P1267, DOI 10.1097/01.TP.0000141095.06273.10; Natori S, 1999, TRANSPLANTATION, V68, P89, DOI 10.1097/00007890-199907150-00018; Nishizawa H, 1997, J SURG RES, V72, P170, DOI 10.1006/jsre.1997.5169; Nowak G, 2004, TRANSPL INT, V17, P804, DOI 10.1111/j.1432-2277.2004.tb00514.x; Oshima K, 2009, J INVEST SURG, V22, P239, DOI 10.1080/08941930903040080; Reid KM, 2007, AM J PHYSIOL-GASTR L, V292, pG512, DOI 10.1152/ajpgi.00227.2006; Rentsch M, 2005, TRANSPLANT INT, V18, P1079, DOI 10.1111/j.1432-2277.2005.00185.x; Schauer RJ, 2004, WORLD J GASTROENTERO, V10, P864; Schemmer P, 1999, AM J PHYSIOL-GASTR L, V276, pG924, DOI 10.1152/ajpgi.1999.276.4.G924; Schemmer P, 2005, LIVER TRANSPLANT, V11, P950, DOI 10.1002/lt.20501; Schemmer P, 1998, TRANSPLANTATION, V65, P1015, DOI 10.1097/00007890-199804270-00001; Schmeding M, 2010, TRANSPLANTATION, V89, P161, DOI 10.1097/TP.0b013e3181c425fd; Selzner N, 2003, GASTROENTEROLOGY, V125, P917, DOI 10.1016/S0016-5085(03)01048-5; Shen XD, 2007, AM J TRANSPLANT, V7, P2463, DOI 10.1111/j.1600-6143.2007.01967.x; Soejima Y, 1999, J SURG RES, V86, P150, DOI 10.1006/jsre.1999.5661; Song SH, 2010, INT IMMUNOPHARMACOL, V10, P679, DOI 10.1016/j.intimp.2010.03.011; Sun K, 2012, AM J SURG, V204, P389, DOI 10.1016/j.amjsurg.2011.10.020; TAKADA Y, 1995, TRANSPLANTATION, V59, P10, DOI 10.1097/00007890-199501150-00003; Tanaka W, 2000, J GASTROENTEROL, V35, P120, DOI 10.1007/s005350050024; Tarrab E, 2012, J SURG RES, V175, P333, DOI 10.1016/j.jss.2011.04.018; TERAKURA M, 1995, BBA-GEN SUBJECTS, V1245, P207, DOI 10.1016/0304-4165(95)00100-P; Tian YH, 2000, TRANSPLANTATION, V69, P2277, DOI 10.1097/00007890-200006150-00010; Tsuchihashi S, 2006, AM J TRANSPLANT, V6, P2013, DOI 10.1111/j.1600-6143.2006.01435.x; Tsuchihashi S, 2006, J IMMUNOL, V176, P616, DOI 10.4049/jimmunol.176.1.616; Tsuchihashi S, 2003, SURGERY, V133, P556, DOI 10.1067/msy.2003.124; Uhlmann D, 2006, SURGERY, V139, P61, DOI 10.1016/j.surg.2005.07.006; Urata K, 2000, TRANSPL INT, V13, P420; Valero R, 2000, TRANSPLANTATION, V70, P730, DOI 10.1097/00007890-200009150-00004; Walcher F, 1996, J SURG RES, V61, P244, DOI 10.1006/jsre.1996.0111; WALCHER F, 1995, TRANSPLANT INT, V8, P317, DOI 10.1111/j.1432-2277.1995.tb01528.x; Weigand Kilian, 2012, HPB Surg, V2012, P176723, DOI 10.1155/2012/176723; Weigand MA, 2001, TRANSPLANTATION, V72, P694, DOI 10.1097/00007890-200108270-00023; XU HS, 1994, ANN SURG, V220, P53, DOI 10.1097/00000658-199407000-00009; Yagnik GP, 2002, HEPATOLOGY, V36, P573, DOI 10.1053/jhep.2002.35058; Yamanaka N, 1997, J SURG RES, V70, P156, DOI 10.1006/jsre.1997.5116; Yokoyama I, 1996, J SURG RES, V60, P232, DOI 10.1006/jsre.1996.0036; Zeng Z, 2012, WORLD J GASTROENTERO, V18, P1765, DOI 10.3748/wjg.v18.i15.1765; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x; Zhang JY, 2011, AM J PATHOL, V179, P2876, DOI 10.1016/j.ajpath.2011.08.040; Zhu Wei-Hua, 2006, Hepatobiliary Pancreat Dis Int, V5, P205; Zhu XH, 2003, ANN CLIN LAB SCI, V33, P216; Zhu XH, 2003, ACTA PHARMACOL SIN, V24, P169	92	24	25	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0122214	10.1371/journal.pone.0122214	http://dx.doi.org/10.1371/journal.pone.0122214			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919110	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659400012
J	Mecenero, S; Altwegg, R; Colville, JF; Beale, CM				Mecenero, Silvia; Altwegg, Res; Colville, Jonathan F.; Beale, Colin M.			Roles of Spatial Scale and Rarity on the Relationship between Butterfly Species Richness and Human Density in South Africa	PLOS ONE			English	Article							HUMAN-POPULATION DENSITY; CONSERVATION CONFLICTS; HABITAT HETEROGENEITY; PRIMARY PRODUCTIVITY; EUROPEAN COUNTRIES; NATIONAL SCALE; BIODIVERSITY; PATTERNS; PEOPLE; DIVERSITY	Wildlife and humans tend to prefer the same productive environments, yet high human densities often lead to reduced biodiversity. Species richness is often positively correlated with human population density at broad scales, but this correlation could also be caused by unequal sampling effort leading to higher species tallies in areas of dense human activity. We examined the relationships between butterfly species richness and human population density at five spatial resolutions ranging from 2' to 60' across South Africa. We used atlas-type data and spatial interpolation techniques aimed at reducing the effect of unequal spatial sampling. Our results confirm the general positive correlation between total species richness and human population density. Contrary to our expectations, the strength of this positive correlation did not weaken at finer spatial resolutions. The patterns observed using total species richness were driven mostly by common species. The richness of threatened and restricted range species was not correlated to human population density. None of the correlations we examined were particularly strong, with much unexplained variance remaining, suggesting that the overlap between butterflies and humans is not strong compared to other factors not accounted for in our analyses. Special consideration needs to be made regarding conservation goals and variables used when investigating the overlap between species and humans for biodiversity conservation.	[Mecenero, Silvia] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Mecenero, Silvia; Altwegg, Res; Colville, Jonathan F.] South African Natl Biodivers Inst, Kirstenbosch Res Ctr, Claremont, South Africa; [Mecenero, Silvia] Univ Western Cape, Dept Biodivers & Conservat Biol, ZA-7535 Bellville, South Africa; [Altwegg, Res; Colville, Jonathan F.] Univ Cape Town, Dept Stat Sci, Stat Ecol Environm & Conservat, ZA-7700 Rondebosch, South Africa; [Beale, Colin M.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of Pretoria; South African National Biodiversity Institute; University of the Western Cape; University of Cape Town; University of York - UK	Altwegg, R (corresponding author), South African Natl Biodivers Inst, Kirstenbosch Res Ctr, Claremont, South Africa.	res.altwegg@gmail.com		Beale, Colin Michael/0000-0002-2960-5666	University of Pretoria; South African National Biodiversity Institute; National Research Foundation of South Africa [85802]; National Research Foundation of South Africa's Research Career Award Fellowship	University of Pretoria; South African National Biodiversity Institute; National Research Foundation of South Africa(National Research Foundation - South Africa); National Research Foundation of South Africa's Research Career Award Fellowship	SM was supported by a postdoctoral fellowship from the University of Pretoria (www.up.ac.za), followed by one from the South African National Biodiversity Institute (www.sanbi.org.za). RA was supported by the National Research Foundation of South Africa (Grant 85802; www.nrf.ac.za). JFC was supported by a National Research Foundation of South Africa's Research Career Award Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The National Research Foundation accepts no liability for opinions, findings and conclusions or recommendations expressed in this publication.	ACKERY PR, 1995, CARCASSONS AFRICAN B; [Anonymous], 1997, VEGETATION SO AFRICA; Araujo MB, 2003, GLOBAL ECOL BIOGEOGR, V12, P5, DOI 10.1046/j.1466-822X.2003.00314.x; Bailey LL, 2014, METHODS ECOL EVOL, V5, P1269, DOI 10.1111/2041-210X.12100; Baldock KCR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2849; Balmford A, 2001, SCIENCE, V291, P2616, DOI 10.1126/science.291.5513.2616; Balmford A, 2001, SCIENCE, V293, P1591; Barbosa AM, 2010, ANIM CONSERV, V13, P432, DOI 10.1111/j.1469-1795.2010.00363.x; Bates MF, 2014, ATLAS RED LIST REPTI, V1; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Calabrese JM, 2014, GLOBAL ECOL BIOGEOGR, V23, P99, DOI 10.1111/geb.12102; Cantarello E, 2010, NATURWISSENSCHAFTEN, V97, P265, DOI 10.1007/s00114-009-0636-4; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chown SL, 2003, ECOL APPL, V13, P1233, DOI 10.1890/02-5105; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Colville JF, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P73; COWLING RM, 1989, BIOTIC DIVERSITY SO; Crainiceanu C. M., 2005, J STAT SOFTW, V14, P1, DOI DOI 10.18637/JSS.V014.I14; Cressie N., 2011, STAT SPATIO TEMPORAL; Dennis R. L., 1993, BUTTERFLIES CLIMATE; Duelli P, 2003, AGR ECOSYST ENVIRON, V98, P87, DOI 10.1016/S0167-8809(03)00072-0; Edge DA, 2015, J INSECT CONSERV, V19, P325, DOI 10.1007/s10841-015-9758-5; Evans KL, 2006, GLOBAL ECOL BIOGEOGR, V15, P625, DOI 10.1111/j.1466-8238.2006.00253.x; Evans KL, 2011, GLOBAL CHANGE BIOL, V17, P32, DOI 10.1111/j.1365-2486.2010.02247.x; Evans KL, 2005, GLOBAL ECOL BIOGEOGR, V14, P187, DOI 10.1111/j.1466-822X.2004.00139.x; Fairbanks DHK, 2004, AGR ECOSYST ENVIRON, V101, P269, DOI 10.1016/j.agee.2003.09.009; Fjeldsa J, 2008, AFR J ECOL, V46, P33, DOI 10.1111/j.1365-2028.2008.00927.x; Forister ML, 2010, P NATL ACAD SCI USA, V107, P2088, DOI 10.1073/pnas.0909686107; Gaston K.J., 1994, RARITY, P1; Gaston KJ, 2005, PROG PHYS GEOG, V29, P239, DOI 10.1191/0309133305pp445pr; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Hardy PB, 1999, BIODIVERS CONSERV, V8, P1261, DOI 10.1023/A:1008984905413; Hengl T, 2009, ECOL MODEL, V220, P3499, DOI 10.1016/j.ecolmodel.2009.06.038; Henning G. A., 2009, SANBI BIODIVERSITY S, V13; Hugo S, 2008, GLOBAL ECOL BIOGEOGR, V17, P611, DOI 10.1111/j.1466-8238.2008.00391.x; IUCN Standards and Petitions Subcommittee, 2017, GUID US IUCN RED LIS; Koh CN, 2006, DIVERS DISTRIB, V12, P546, DOI 10.1111/j.1366-9516.2006.00238.x; Lennon JJ, 2011, ECOGRAPHY, V34, P529, DOI 10.1111/j.1600-0587.2010.06669.x; Lennon JJ, 2004, ECOL LETT, V7, P81, DOI 10.1046/j.1461-0248.2004.00548.x; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; Luck GW, 2007, J BIOGEOGR, V34, P201, DOI 10.1111/j.1365-2699.2006.01575.x; Luck GW, 2004, P NATL ACAD SCI USA, V101, P182, DOI 10.1073/pnas.2237148100; Barbosa AM, 2013, DIVERS DISTRIB, V19, P1188, DOI 10.1111/ddi.12106; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Mecenero S., 2013, CONSERVATION ASSESSM; Minter L.R., 2004, ATLAS RED DATA BOOK, V9; Moreno-Rueda G, 2009, ECOL RES, V24, P335, DOI 10.1007/s11284-008-0509-x; NEW TR, 1995, ANNU REV ENTOMOL, V40, P57, DOI 10.1146/annurev.en.40.010195.000421; Pautasso M, 2009, BIODIVERS CONSERV, V18, P473, DOI 10.1007/s10531-008-9511-4; Pautasso M, 2007, ECOL LETT, V10, P16, DOI 10.1111/j.1461-0248.2006.00993.x; Pautasso M, 2009, OECOLOGIA, V160, P839, DOI 10.1007/s00442-009-1329-6; Pearman PB, 2007, BIOL CONSERV, V138, P109, DOI 10.1016/j.biocon.2007.04.005; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; R-project, R LANG ENV STAT COMP; Samways M.J., 2005, INSECT DIVERSITY CON; Samways MJ., 2010, TECHNIQUES ECOLOGY C; Schlick-Steiner BC, 2008, J BIOGEOGR, V35, P2195, DOI 10.1111/j.1365-2699.2008.01968.x; Schulze R. E, 2001, S AFRICAN ATLAS AGRO; Slotow R, 2000, S AFR J SCI, V96, P222; Steck CE, 2008, ACTA OECOL, V34, P303, DOI 10.1016/j.actao.2008.06.003; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Turner WR, 2004, BIOSCIENCE, V54, P585, DOI 10.1641/0006-3568(2004)054[0585:GUATSO]2.0.CO;2; Van Dyck H, 2009, CONSERV BIOL, V23, P957, DOI 10.1111/j.1523-1739.2009.01175.x; van Rensburg BJ, 2002, AM NAT, V159, P566, DOI 10.1086/339464; Vazquez LB, 2004, GLOBAL ECOL BIOGEOGR, V13, P535, DOI 10.1111/j.1466-822X.2004.00126.x; Vazquez LB, 2006, BIODIVERS CONSERV, V15, P2397, DOI 10.1007/s10531-004-3954-z; Vernon CJ, 1999, KAROO ECOLOGICAL PAT; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; White PJT, 2007, GLOBAL ECOL BIOGEOGR, V16, P290, DOI 10.1111/j.1466-8238.2007.00298.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	73	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124327	10.1371/journal.pone.0124327	http://dx.doi.org/10.1371/journal.pone.0124327			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915899	Green Published, gold, Green Accepted			2022-12-27	WOS:000353659100047
J	Piao, J; Lee, JY; Weon, JB; Ma, CJ; Ko, HJ; Kim, DD; Kang, WS; Cho, HJ				Piao, Jingpei; Lee, Jae-Young; Weon, Jin Bae; Ma, Choong Je; Ko, Hyun-Jeong; Kim, Dae-Duk; Kang, Wie-Soo; Cho, Hyun-Jong			Angelica gigas Nakai and Soluplus-Based Solid Formulations Prepared by Hot-Melting Extrusion: Oral Absorption Enhancing and Memory Ameliorating Effects	PLOS ONE			English	Article							DISSOLUTION; DECURSINOL; DISPERSIONS; SCOPOLAMINE; EXTRACT	Oral solid formulations based on Angelica gigas Nakai (AGN) and Soluplus were prepared by the hot-melting extrusion (HME) method. AGN was pulverized into coarse and ultrafine particles, and their particle size and morphology were investigated. Ultrafine AGN particles were used in the HME process with high shear to produce AGN-based formulations. In simulated gastrointestinal fluids (pH 1.2 and pH 6.8) and water, significantly higher amounts of the major active components of AGN, decursin (D) and decursinol angelate (DA), were extracted from the HME-processed AGN/Soluplus (F8) group than the AGN EtOH extract (ext) group (p < 0.05). Based on an in vivo pharmacokinetic study in rats, the relative oral bioavailability of decursinol (DOH), a hepatic metabolite of D and DA, in F8-administered mice was 8.75-fold higher than in AGN EtOH ext-treated group. In scopolamine-induced memory- impaired mice, F8 exhibited a more potent cognitive enhancing effect than AGN EtOH ext in both a Morris water maze test and a passive avoidance test. These findings suggest that HME-processed AGN/Soluplus formulation (F8) could be a promising therapeutic candidate for memory impairment.	[Piao, Jingpei; Kang, Wie-Soo] Kangwon Natl Univ, Sch Biosci & Biotechnol, Chunchon 200701, South Korea; [Lee, Jae-Young; Kang, Wie-Soo] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea; [Lee, Jae-Young; Kim, Dae-Duk] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul 151742, South Korea; [Weon, Jin Bae; Ma, Choong Je] Kangwon Natl Univ, Coll Biomed Sci, Dept Med Biomat Engn, Chunchon 200701, South Korea; [Ma, Choong Je] Kangwon Natl Univ, Biotechnol Res Inst, Chunchon 200701, South Korea; [Ko, Hyun-Jeong; Cho, Hyun-Jong] Kangwon Natl Univ, Coll Pharm, Chunchon 200701, South Korea	Kangwon National University; Seoul National University (SNU); Seoul National University (SNU); Kangwon National University; Kangwon National University; Kangwon National University	Kang, WS (corresponding author), Kangwon Natl Univ, Sch Biosci & Biotechnol, Chunchon 200701, South Korea.	kangwiso@kangwon.ac.kr; hjcho@kangwon.ac.kr	Kim, Dae Duk/D-8864-2013	Ko, Hyun-Jeong/0000-0002-3844-928X; Lee, Jae-Young/0000-0002-8093-043X; Cho, Hyun-Jong/0000-0002-5070-9371	Kangwon National University; National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2012R1A1A1038944]	Kangwon National University; National Research Foundation of Korea (NRF) - Korean government (MSIP)	This study is supported by Kangwon National University (http://www.kangwon.ac.kr) and the National Research Foundation of Korea (NRF), funded by the Korean government (MSIP) (No. NRF-2012R1A1A1038944, URL http://www.nrf.re.kr/nrf tot cms/index.jsp?pmi-sso-return2=none&pmi-sso-return2=none).	Bae IY, 2011, FOOD SCI BIOTECHNOL, V20, P1113, DOI 10.1007/s10068-011-0151-1; Cho HJ, 2014, INT J NANOMED, V9, P495, DOI 10.2147/IJN.S56648; Choi KO, 2012, J MED FOOD, V15, P863, DOI 10.1089/jmf.2011.2047; Crowley MM, 2007, DRUG DEV IND PHARM, V33, P909, DOI 10.1080/03639040701498759; Djuris J, 2013, EUR J PHARM BIOPHARM, V84, P228, DOI 10.1016/j.ejpb.2012.12.018; Doh HJ, 2013, COLLOID SURFACE B, V101, P475, DOI 10.1016/j.colsurfb.2012.07.019; Godavarti S, 1997, J AGR ENG RES, V67, P277, DOI 10.1006/jaer.1997.0172; Hughey JR, 2013, EUR J PHARM SCI, V48, P758, DOI 10.1016/j.ejps.2013.01.004; Joo SS, 2010, ENVIRON TOXICOL PHAR, V30, P127, DOI 10.1016/j.etap.2010.04.007; Kang SY, 2007, J PHARM PHARMACOL, V59, P863, DOI 10.1211/jpp.59.6.0013; Kang SY, 2003, NEUROBIOL LEARN MEM, V79, P11, DOI 10.1016/S1074-7427(02)00007-2; KITE FRANCIS E., 1957, BAKER S DIGEST, V31, P42; Li L, 2013, PLANTA MED, V79, P275, DOI 10.1055/s-0032-1328202; Linn M, 2012, EUR J PHARM SCI, V45, P336, DOI 10.1016/j.ejps.2011.11.025; Liu X, 2012, PHARM RES-DORDR, V29, P806, DOI 10.1007/s11095-011-0605-4; Mu HL, 2013, INT J PHARMACEUT, V453, P215, DOI 10.1016/j.ijpharm.2013.03.054; Park HS, 2012, PLANTA MED, V78, P909, DOI 10.1055/s-0031-1298517; Park SJ, 2012, J ETHNOPHARMACOL, V143, P611, DOI 10.1016/j.jep.2012.07.019; Pina MF, 2014, J PHARM SCI-US, V103, P1214, DOI 10.1002/jps.23894; Repka MA, 2007, DRUG DEV IND PHARM, V33, P1043, DOI 10.1080/03639040701525627; Repka MA, 2008, EXPERT OPIN DRUG DEL, V5, P1357, DOI [10.1517/17425240802583421, 10.1517/17425240802583421 ]; Sarker SD, 2004, CURR MED CHEM, V11, P1479, DOI 10.2174/0929867043365189; Seo YJ, 2009, ARCH PHARM RES, V32, P937, DOI 10.1007/s12272-009-1617-z; Song JS, 2011, XENOBIOTICA, V41, P895, DOI 10.3109/00498254.2011.587551; Weon JB, 2014, PHARMACOGN MAG, V10, P249, DOI 10.4103/0973-1296.133266; Weon JB, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/464576; Wilson M, 2012, THER DELIV, V3, P787, DOI 10.4155/TDE.12.26; Yan JJ, 2004, PROG NEURO-PSYCHOPH, V28, P25, DOI 10.1016/S0278-5846(03)00168-4; Yun F, 2014, INT J PHARMACEUT, V465, P436, DOI 10.1016/j.ijpharm.2014.02.040; Zhang JH, 2012, ANTI-CANCER AGENT ME, V12, P1239, DOI 10.2174/187152012803833071; Zhang KR, 2013, EUR J PHARM BIOPHARM, V85, P1285, DOI 10.1016/j.ejpb.2013.03.002	31	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124447	10.1371/journal.pone.0124447	http://dx.doi.org/10.1371/journal.pone.0124447			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915423	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100050
J	Zhu, K; Yang, SN; Ma, FF; Gu, XF; Zhu, YC; Zhu, YZ				Zhu, Kai; Yang, Su-Na; Ma, Fen-Fen; Gu, Xian-Feng; Zhu, Yi-Chun; Zhu, Yi-Zhun			The Novel Analogue of Hirsutine as an Anti-Hypertension and Vasodilatary Agent Both In Vitro and In Vivo	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; MESENTERIC-ARTERY; ENDOTHELIUM; RELAXATION; NIFEDIPINE; CHANNELS	In this paper, an analogue of hirsutine (compound 1) has been synthesized and evaluated as an anti-hypertension agent, which exhibits extraordinary effects on the contractile response of thoracic aorta rings from male SD rats in vitro (IC50 = 1.129x10(-9)+/- 0.5025) and the abilities of reducing the systolic blood pressure (SBP) and heart rate (HR) of SHR in vivo. The mechanism investigation reveals that the vasodilatation induced by compound 1 is mediated by both endothelium-dependent and -independent manners. The relaxation in endothelium-intact aortic rings induced by compound 1 can be inhibited by L-NAME (1x10(-6) mol.L-1) and ODQ (1x10(-6) mol.L-1). Moreover, compound 1 can also block Ca2+ influx through L-type Ca2+ channels and inhibit intracellular Ca2+ release while no effect on K+ channel has been observed. All these data demonstrated that the NO/cyclic GMP pathway can be involved in endothelium-dependent manner induced by compound 1. Meanwhile the mechanism on the vasodilatation of compound 1 probably also related to blockade of Ca2+ influx through L-type Ca2+ channels and inhibition of intracellular Ca2+ release may have no relationship with K+ channels.	[Zhu, Kai; Yang, Su-Na; Ma, Fen-Fen; Zhu, Yi-Zhun] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 201203, Peoples R China; [Gu, Xian-Feng] Fudan Univ, Sch Pharm, Dept Med Chem, Shanghai 201203, Peoples R China; [Zhu, Kai; Yang, Su-Na; Ma, Fen-Fen; Gu, Xian-Feng; Zhu, Yi-Zhun] Fudan Univ, Inst Biomed Sci, Shanghai 201203, Peoples R China; [Zhu, Yi-Chun] Fudan Univ, Shanghai Coll Med, Dept Physiol, Shanghai 201203, Peoples R China; [Zhu, Yi-Chun] Fudan Univ, Shanghai Coll Med, Dept Pathophysiol, Shanghai 201203, Peoples R China; [Zhu, Yi-Zhun] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; National University of Singapore	Gu, XF (corresponding author), Fudan Univ, Sch Pharm, Dept Med Chem, Shanghai 201203, Peoples R China.	xfgu@fudan.edu.cn; zhuyz@fudan.edu.cn	Zhu, Yi Zhun/ABG-8449-2021	Zhu, Yi Zhun/0000-0001-7700-8041	National Nature Science Foundation of China [21002013]; National Basic Research Program of China (973 Program) [2010CB912600]; Science and Technology Commission of Shanghai Municipality [10431903200, 12431900201]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	ZYZ received the funding from National Nature Science Foundation of China (No. 21002013), National Basic Research Program of China (973 Program) (No. 2010CB912600), The Science and Technology Commission of Shanghai Municipality (No. 10431903200), The Science and Technology Commission of Shanghai Municipality (No. 12431900201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cacanyiova S, 2013, J PHYSIOL PHARMACOL, V64, P241; Magalhaes PJ, 2008, FUND CLIN PHARMACOL, V22, P169, DOI 10.1111/j.1472-8206.2008.00571.x; Egan BM, 2013, J HYPERTENS, V31, P2123, DOI 10.1097/HJH.0b013e328365b932; Kaimoto T, 2010, HYPERTENSION, V56, P247, DOI 10.1161/HYPERTENSIONAHA.110.149781; Karaki H, 1997, PHARMACOL REV, V49, P157; Li PY, 2013, N-S ARCH PHARMACOL, V386, P973, DOI 10.1007/s00210-013-0888-6; Lu Y, 2002, LIFE SCI, V71, P1465, DOI 10.1016/S0024-3205(02)01922-7; Ndagijimana A, 2013, FITOTERAPIA, V86, P35, DOI 10.1016/j.fitote.2013.01.018; Pereira SL, 2014, FUND CLIN PHARMACOL, V28, P29, DOI 10.1111/j.1472-8206.2012.01076.x; Pinto NV, 2009, PHYTOMEDICINE, V16, P1151, DOI 10.1016/j.phymed.2009.04.007; Tietze LF, 1999, ANGEW CHEM INT EDIT, V38, P2045, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<2045::AID-ANIE2045>3.0.CO;2-U; Venturi E, 2013, PFLUG ARCH EUR J PHY, V465, P187, DOI 10.1007/s00424-012-1197-5; Vergara-Galicia J, 2008, VASC PHARMACOL, V49, P26, DOI 10.1016/j.vph.2008.04.002; Wu LX, 2011, EUR J PHARMACOL, V650, P290, DOI 10.1016/j.ejphar.2010.09.057; Xin H, 2009, EUR J PHARMACOL, V612, P75, DOI 10.1016/j.ejphar.2009.03.067; Yang GD, 2010, CARDIOVASC RES, V86, P487, DOI 10.1093/cvr/cvp420; Yeh JL, 2005, J CARDIOVASC PHARM, V46, P130, DOI 10.1097/01.fjc.0000167016.61845.c8; Zhu XM, 2007, VASC PHARMACOL, V46, P160, DOI 10.1016/j.vph.2006.09.003; Ziegelhoffer A, 2012, CAN J PHYSIOL PHARM, V90, P1311, DOI [10.1139/Y2012-107, 10.1139/y2012-107]	19	14	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0119477	10.1371/journal.pone.0119477	http://dx.doi.org/10.1371/journal.pone.0119477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909998	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800005
J	Abril-Gil, M; Garcia-Just, A; Perez-Cano, FJ; Franch, A; Castell, M				Abril-Gil, Mar; Garcia-Just, Alba; Perez-Cano, Francisco J.; Franch, Angels; Castell, Margarida			Development and Characterization of an Effective Food Allergy Model in Brown Norway Rats	PLOS ONE			English	Article							HOUSE-DUST MITE; ORAL-EXPOSURE; MAST-CELLS; BETA-LACTOGLOBULIN; IGE SYNTHESIS; COWS MILK; OVALBUMIN; ALLERGENICITY; SENSITIZATION; EXPRESSION	Background Food allergy (FA) is an adverse health effect produced by the exposure to a given food. Currently, there is no optimal animal model of FA for the screening of immunotherapies or for testing the allergenicity of new foods. Objective The aim of the present study was to develop an effective and rapid model of FA in Brown Norway rats. In order to establish biomarkers of FA in rat, we compared the immune response and the anaphylactic shock obtained in this model with those achieved with only intraperitoneal immunization. Methods Rats received an intraperitoneal injection of ovalbumin (OVA) with alum and toxin from Bordetella pertussis, and 14 days later, OVA by oral route daily for three weeks (FA group). A group of rats receiving only the i.p. injection (IP group) were also tested. Serum anti-OVA IgE, IgG1, IgG2a, IgG2b and IgA antibodies were quantified throughout the study. After an oral challenge, body temperature, intestinal permeability, motor activity, and mast cell protease II (RMCP-II) levels were determined. At the end of the study, anti-OVA intestinal IgA, spleen cytokine production, lymphocyte composition of Peyer's patches and mesenteric lymph nodes, and gene expression in the small intestine were quantified. Results Serum OVA-specific IgG1, IgG2a and IgG2b concentrations rose with the i.p. immunization but were highly augmented after the oral OVA administration. Anti-OVA IgE increased twofold during the first week of oral OVA gavage. The anaphylaxis in both IP and FA groups decreased body temperature and motor activity, whereas intestinal permeability increased. Interestingly, the FA group showed a much higher RMCP II serum protein and intestinal mRNA expression. Conclusions These results show both an effective and relatively rapid model of FA assessed by means of specific antibody titres and the high production of RMCP-II and its intestinal gene expression.	[Abril-Gil, Mar; Garcia-Just, Alba; Perez-Cano, Francisco J.; Franch, Angels; Castell, Margarida] Univ Barcelona, Fac Farm, Dept Fisiol, E-08028 Barcelona, Spain; [Abril-Gil, Mar; Garcia-Just, Alba; Perez-Cano, Francisco J.; Franch, Angels; Castell, Margarida] Univ Barcelona INSA UB, Inst Recerca Nutr & Seguretat Alimentaria, Barcelona, Spain	University of Barcelona; University of Barcelona	Castell, M (corresponding author), Univ Barcelona, Fac Farm, Dept Fisiol, E-08028 Barcelona, Spain.	margaridacastell@ub.edu	Abril-Gil, Mar/AAO-4061-2021; Castell, Margarida/G-9078-2015; Franch, Àngels/G-5669-2019; Perez-Cano, Francisco J/G-6516-2019	Abril-Gil, Mar/0000-0003-0318-6755; Castell, Margarida/0000-0001-5408-0593; Franch, Àngels/0000-0002-2362-1374; Perez-Cano, Francisco J/0000-0001-6243-9164	Spanish Ministry of Science and Innovation [AGL2008-02790]; Spanish Ministry of Economy and Competitivity [AGL2011-24279]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitivity(Spanish Government)	This study was supported by grants from the Spanish Ministries of Science and Innovation (AGL2008-02790) and Economy and Competitivity (AGL2011-24279). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril-Gil M, 2015, EXP BIOL MED MAYWOOD; Abril-Gil M, 2012, PHARMACOL RES, V65, P603, DOI 10.1016/j.phrs.2012.02.001; Ahrens B, 2014, INT ARCH ALLERGY IMM, V164, P89, DOI 10.1159/000363109; Ahuja V, 2010, ARCH TOXICOL, V84, P909, DOI 10.1007/s00204-010-0582-0; Albert N, 2013, BEHAV BRAIN RES, V252, P347, DOI 10.1016/j.bbr.2013.06.025; Aldemir H, 2009, REGUL TOXICOL PHARM, V54, pS52, DOI 10.1016/j.yrtph.2008.11.004; Ando T, 2013, J INVEST DERMATOL, V133, P2695, DOI 10.1038/jid.2013.250; Bailon E, 2012, J IMMUNOL METHODS, V381, P41, DOI 10.1016/j.jim.2012.04.007; Bellou A, 2003, SCAND J IMMUNOL, V57, P271, DOI 10.1046/j.1365-3083.2003.01233.x; Berin MC, 2009, MUCOSAL IMMUNOL, V2, P24, DOI 10.1038/mi.2008.72; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Bogh KL, 2009, CLIN EXP ALLERGY, V39, P1611, DOI 10.1111/j.1365-2222.2009.03333.x; Bogh KL, 2013, INT ARCH ALLERGY IMM, V161, P21, DOI 10.1159/000343042; Boyce JA, 2011, J AM ACAD DERMATOL, V64, P175, DOI [10.1016/j.jaad.2010.11.020, 10.1016/j.nutres.2011.01.001]; Buchanan BB, 2002, ANN NY ACAD SCI, V964, P173; Burks AW, 2012, J ALLERGY CLIN IMMUN, V129, P906, DOI 10.1016/j.jaci.2012.02.001; Camps-Bossacoma M, 2015, CLIN IMMUNO IN PRESS; Cao SS, 2012, REGUL TOXICOL PHARM, V63, P181, DOI 10.1016/j.yrtph.2012.03.017; de Jonge JD, 2008, J IMMUNOTOXICOL, V5, P385, DOI 10.1080/15476910802586126; Dearman RJ, 2001, TOXICOLOGY, V167, P217, DOI 10.1016/S0300-483X(01)00462-0; Dong W, 2003, TOXICOL SCI, V72, P113, DOI 10.1093/toxsci/kfg015; Duncker Swantje C, 2012, PLoS One, V7, pe39841, DOI 10.1371/journal.pone.0039841; Fattouh R, 2005, AM J RESP CRIT CARE, V172, P314, DOI 10.1164/rccm.200502-198OC; Fox M, 2013, EUR J PUBLIC HEALTH, V23, P757, DOI 10.1093/eurpub/ckt010; Fritsche R, 2003, TOXICOL LETT, V140, P303, DOI 10.1016/S0378-4274(03)00026-2; Ganeshan K, 2009, J ALLERGY CLIN IMMUN, V123, P231, DOI 10.1016/j.jaci.2008.10.011; GIBSON S, 1987, IMMUNOLOGY, V62, P621; Golias J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037156; Gracie JA, 1996, EUR J IMMUNOL, V26, P1217, DOI 10.1002/eji.1830260605; Helm RM, 2002, J ALLERGY CLIN IMMUN, V109, P136, DOI 10.1067/mai.2002.120551; Huang JA, 2010, FEMS IMMUNOL MED MIC, V60, P132, DOI 10.1111/j.1574-695X.2010.00727.x; Jardi F, 2012, NEUROGASTROENT MOTIL, V24, pe580, DOI 10.1111/nmo.12027; Chiesa JJ, 2010, J BIOL RHYTHM, V25, P37, DOI 10.1177/0748730409352843; Khodoun M, 2009, J ALLERGY CLIN IMMUN, V123, P342, DOI 10.1016/j.jaci.2008.11.004; Kimber I, 2002, ENV HLTH PERSPECT, V111, P1125; KITAGAWA S, 1995, AM J MED SCI, V310, P183, DOI 10.1097/00000441-199511000-00002; Knippels LMJ, 1999, TOXICOL APPL PHARM, V156, P161, DOI 10.1006/taap.1999.8641; Knippels LMJ, 1999, FOOD CHEM TOXICOL, V37, P881, DOI 10.1016/S0278-6915(99)00064-2; Knippels LMJ, 1998, J ALLERGY CLIN IMMUN, V101, P815, DOI 10.1016/S0091-6749(98)70309-4; Konstantinou GN, 2014, PEDIAT ALLERG IMM-UK, V25, P64, DOI 10.1111/pai.12143; Kroghsbo S, 2011, INT ARCH ALLERGY IMM, V155, P212, DOI 10.1159/000321200; Leonard SA, 2012, J ALLERGY CLIN IMMUN, V129, P1579, DOI 10.1016/j.jaci.2012.04.009; Li XM, 1999, J ALLERGY CLIN IMMUN, V103, P206, DOI 10.1016/S0091-6749(99)70492-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makabe-Kobayashi Y, 2002, J ALLERGY CLIN IMMUN, V110, P298, DOI 10.1067/mai.2002.125977; Massot-Cladera M, 2012, ARCH BIOCHEM BIOPHYS, V527, P105, DOI 10.1016/j.abb.2012.05.015; Nwaru BI, 2014, ALLERGY, V69, P992, DOI 10.1111/all.12423; Ogawa T, 2004, AM J PHYSIOL-GASTR L, V286, pG702, DOI 10.1152/ajpgi.00183.2003; Oka T, 2013, J ALLERGY CLIN IMMUN, V132, P922, DOI 10.1016/j.jaci.2013.05.004; Okada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044338; Orivuori L, 2014, PEDIAT ALLERG IMM-UK, V25, P329, DOI 10.1111/pai.12246; Oyoshi MK, 2014, J ALLERGY CLIN IMMUN, V133, P309, DOI 10.1016/j.jaci.2013.12.1045; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Patel DA, 2011, J ALLERGY CLIN IMMUN, V128, P110, DOI 10.1016/j.jaci.2011.03.013; Penninks AH, 2001, TOXICOL LETT, V120, P171, DOI 10.1016/S0378-4274(01)00275-2; Perez-Berezo T, 2012, EXP BIOL MED, V237, P1181, DOI [10.1258/ebm.2012.012083, 10.1258/]; Perez-Berezo T, 2011, MOL NUTR FOOD RES, V55, pS56, DOI 10.1002/mnfr.201000588; Piacentini GL, 2003, ANN ALLERG ASTHMA IM, V91, P61, DOI 10.1016/S1081-1206(10)62060-1; Pilegaard K, 2004, TOXICOLOGY, V196, P247, DOI 10.1016/j.tox.2003.11.010; Ramiro-Puig E, 2008, J NUTR BIOCHEM, V19, P555, DOI 10.1016/j.jnutbio.2007.07.002; Ruiter B, 2012, J ALLERGY CLIN IMMUN, V129, P921, DOI 10.1016/j.jaci.2012.01.080; Saavedra Y, 2005, NEUROGASTROENT MOTIL, V17, P112, DOI 10.1111/j.1365-2982.2004.00597.x; Sakamoto Y, 1998, PEDIATR ALLERGY IMMU, V9, P20, DOI 10.1111/j.1399-3038.1998.tb00295.x; Shindo T, 2012, J TOXICOL SCI, V37, P307, DOI 10.2131/jts.37.307; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Sicherer SH, 2006, J ALLERGY CLIN IMMUN, V117, pS470, DOI 10.1016/j.jaci.2005.05.048; Sun JF, 2007, J IMMUNOL, V179, P6696, DOI 10.4049/jimmunol.179.10.6696; Sun N, 2013, J IMMUNOTOXICOL, V10, P67, DOI 10.3109/1547691X.2012.693546; Terhune TD, 2013, J IMMUNOTOXICOL, V10, P210, DOI 10.3109/1547691X.2012.708366; Teuber SS, 2002, J ALLERGY CLIN IMMUN, V110, P921, DOI 10.1067/mai.2002.130056; Traver E, 2010, NEUROGASTROENT MOTIL, V22, pE34, DOI 10.1111/j.1365-2982.2009.01377.x; Vazquez-Ortiz M, 2013, ALLERGY, V68, P1327, DOI 10.1111/all.12217; Vinje NE, 2009, CLIN EXP ALLERGY, V39, P1255, DOI 10.1111/j.1365-2222.2009.03269.x; Zanardo V, 2007, PEDIATR RES, V62, P191, DOI 10.1203/PDR.0b013e31809871c9; Zhong Y, 2012, FEMS IMMUNOL MED MIC, V66, P71, DOI 10.1111/j.1574-695X.2012.00991.x	75	16	17	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125314	10.1371/journal.pone.0125314	http://dx.doi.org/10.1371/journal.pone.0125314			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923134	gold, Green Published			2022-12-27	WOS:000353711600143
J	Tay, AK; Rees, S; Chen, J; Kareth, M; Lahe, S; Kitau, R; David, K; Sonoling, J; Silove, D				Tay, Alvin Kuowei; Rees, Susan; Chen, Jack; Kareth, Moses; Lahe, Sylvester; Kitau, Russell; David, Kura; Sonoling, Joyce; Silove, Derrick			Associations of Conflict-Related Trauma and Ongoing Stressors with the Mental Health and Functioning of West Papuan Refugees in Port Moresby, Papua New Guinea (PNG)	PLOS ONE			English	Article							BOSNIAN REFUGEES; HUMAN-RIGHTS; COMORBIDITY; DISORDER; PTSD; PREVALENCE; DISABILITY; COUNTRIES; SYMPTOMS; ANXIETY	Documentation is limited in relation to the mental health of the people of West Papua, a territory that has been exposed to decades-long political persecution. We examined associations of traumatic events (TEs) and current stressors with mental disorder and functioning, amongst 230 West Papuan refugees residing in six settlements in Port Morseby, Papua New Guinea (PNG). We used culturally adapted modules to assess exposure to TEs and mental disorders. Current stressors and functioning were assessed using modifications of measures developed by the World Health Organization (WHO). 129 of 230 respondents (56%) reported exposure to at least one traumatic event (TE), including: political upheaval (36.5%), witnessing or hearing about family members tortured and murdered (33.9%), and not being able to access medical care for family members (33%). One fifth of respondents (47, 20.4%) experienced exposure to high levels of TEs (16 to 23). 211 (91.7%) endorsed at least one or more ongoing stressors, including: exposure to illicit substance use in the community (91.7%), problems with safety and the protection of women (89.6%), no access to legal rights and citizenship (88.3%), and lack of adequate shelter and facilities (85.2%). A quarter (26.9%) met criteria for one or more current mental disorder, and 69.1% reported functional impairment ranging from mild to extreme. Mental disorder was associated with being male (adjusted odds ratio=2.00; 95% CI=1.01-3.97), and exposure to the highest category of ongoing stressors (AOR=2.89; 95% CI=1.08-7.72). The TE count showed a dose-response pattern in its relationship with functional impairment, the greatest risk (AOR=11.47; 95% CI=2.11-62.37) being for those experiencing the highest level of TE exposure (16-23 events). West Papuans living in settlements in Port Moresby reported a range of TEs, ongoing stressors and associated mental disorders characteristic of populations exposed to mass conflict and persecution, prolonged displacement, and ongoing conditions of extreme hardship.	[Tay, Alvin Kuowei; Rees, Susan; Kareth, Moses; Silove, Derrick] Univ New S Wales, Sch Psychiat, Psychiat Res & Teaching Unit, Liverpool Hosp, Sydney, NSW, Australia; [Tay, Alvin Kuowei; Chen, Jack] Univ New S Wales, South Western Sydney Clin Sch, Liverpool Hosp, Fac Med, Sydney, NSW, Australia; [Chen, Jack] Univ New S Wales, Simpson Ctr Hlth Serv Res, Fac Med, Sydney, NSW, Australia; [Lahe, Sylvester; Kitau, Russell] Univ Papua New Guinea, Sch Med & Hlth Sci, Div Publ Hlth, Port Moresby, Papua N Guinea; [David, Kura; Sonoling, Joyce] Univ Papua New Guinea, Port Moresby Gen Hosp, Port Moresby, Papua N Guinea; [David, Kura; Sonoling, Joyce] Univ Papua New Guinea, Sch Med & Hlth Sci, Port Moresby, Papua N Guinea	Liverpool Hospital; University of New South Wales Sydney; Liverpool Hospital; University of New South Wales Sydney; University of New South Wales Sydney; University of Papua New Guinea; University of Papua New Guinea; University of Papua New Guinea	Tay, AK (corresponding author), Univ New S Wales, Sch Psychiat, Psychiat Res & Teaching Unit, Liverpool Hosp, Sydney, NSW, Australia.	alvin.tay@unsw.edu.au	Chen, Jack/AAR-7346-2020; Tay, Alvin Kuowei/AAW-3508-2021	Tay, Alvin Kuowei/0000-0002-9330-3929; Chen, Jack/0000-0003-4693-5234				American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Andrews G, 2001, BRIT J PSYCHIAT, V178, P145, DOI 10.1192/bjp.178.2.145; Brundige E, 2004, INDONESIAN HUMAN RIG; Cordell M, 2013, W PAPUANS TORTURED K; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Fazel M, 2005, LANCET, V365, P1309, DOI 10.1016/S0140-6736(05)61027-6; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Glazebrook, 2001, DWELLING EXILE PERCE; Griva M, 2013, BORDER REFUGEES PNG2; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; International A, 2013, PNG VIOL DEATH STILL; IRIN, 2012, PAP NEW GUIN W PAP R; Jones L, 2009, LANCET, V374, P654, DOI 10.1016/S0140-6736(09)61253-8; Jurists ICo, 2003, SEEK REF STAT W PAP; Miller KE, 2006, AM J ORTHOPSYCHIAT, V76, P409, DOI 10.1037/0002-9432.76.4.409; Miller KE, 2010, SOC SCI MED, V70, P7, DOI 10.1016/j.socscimed.2009.09.029; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Momartin S, 2004, COMPR PSYCHIAT, V45, P475, DOI 10.1016/j.comppsych.2004.07.013; OHCHR, 2012, UN PER REV 2 CYCL IN; Pemberton A, 2011, PAPUA NEW GUINEA W P; Rasmussen A, 2010, AM J ORTHOPSYCHIAT, V80, P227, DOI 10.1111/j.1939-0025.2010.01026.x; Rayfield A, 2011, W PAPUA MEDIA ALERTS; Rees, 2013, MED J AUST, V199; Rees S, 2007, LANCET, V370, P637, DOI 10.1016/S0140-6736(07)61318-X; Rees S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069207; Rees S, 2013, MED J AUSTRALIA, V199, P280, DOI 10.5694/mja12.11651; Rees SJ, 2008, MED J AUSTRALIA, V189, P641, DOI 10.5694/j.1326-5377.2008.tb02226.x; Robinson J, 2013, HIST FLAG RAISING EV; Scott Kate M, 2013, PLoS One, V8, pe80573, DOI 10.1371/journal.pone.0080573; Semrau M, 2012, AM J PUBLIC HEALTH, V102, pE55, DOI 10.2105/AJPH.2012.300720; Silove D, 2008, ARCH GEN PSYCHIAT, V65, P1205, DOI 10.1001/archpsyc.65.10.1205; Silove D, 2010, J TRAUMA STRESS, V23, P169, DOI 10.1002/jts.20490; Soosay I, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-229; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Stein DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010574; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; UNHCR, 2014, 2014 UNHCR REG OP PR; Van Ommeren M, 2002, J TRAUMA STRESS, V15, P415, DOI 10.1023/A:1020141510005; van Ommeren M., 1999, TRANSCULT PSYCHIATRY, V36, P285, DOI [10.1177/136346159903600304, DOI 10.1177/136346159903600304]; Zocca F, 1995, CATALYST, V25, P60	40	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125178	10.1371/journal.pone.0125178	http://dx.doi.org/10.1371/journal.pone.0125178			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923209	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600132
J	Svoboda, T				Svoboda, Tomislav			Difficult Behaviors in the Emergency Department: A Cohort Study of Housed, Homeless and Alcohol Dependent Individuals	PLOS ONE			English	Article							HEALTH-CARE UTILIZATION; INFORMED-CONSENT; SERVICE USE; VIOLENCE; COMPREHENSION; AGGRESSION; ABUSE	Background This study contrasted annual rates of difficult behaviours in emergency departments among cohorts of individuals who were homeless and low-income housed and examined predictors of these events. Methods Interviews in 1999 with men who were chronically homeless with drinking problems (CHDP) (n = 50), men from the general homeless population (GH) (n = 61), and men residing in low-income housing (LIH) (n = 58) were linked to catchment area emergency department records (n = 2817) from 1994 to 1999. Interview and hospital data were linked to measures of difficult behaviours. Results Among the CHDP group, annual rates of visits with difficult behaviours were 5.46; this was 13.4 (95% CI 10.3-16.5) and 14.3 (95% CI 11.2-17.3) times higher than the GH and LIH groups. Difficult behaviour incidents included physical violence, verbal abuse, uncooperativeness, drug seeking, difficult histories and security involvement. Difficult behaviours made up 57.54% (95% CI 55.43-59.65%), 24% (95% CI 19-29%), and 20% (95% CI 16-24%) of CHDP, GH and LIH visits. Among GH and LIH groups, 87% to 95% were never involved in verbal abuse or violence. Intoxication increased all difficult behaviours while decreasing drug seeking and leaving without being seen. Verbal abuse and violence were less likely among those housed, with odds ratios of 0.24 (0.08, 0.72) and 0.32 (0.15, 0.69), respectively. Conclusions Violence and difficult behaviours are much higher among chronically homeless men with drinking problems than general homeless and low-income housed populations. They are concentrated among subgroups of individuals. Intoxication is the strongest predictor of difficult behaviour incidents.	Univ Toronto, Dept Family & Community Med, Ctr Res Inner City Hlth, Li Ka Shing Knowledge Inst,St Michaels Hosp, Toronto, ON M5S 1A1, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Svoboda, T (corresponding author), Univ Toronto, Dept Family & Community Med, Ctr Res Inner City Hlth, Li Ka Shing Knowledge Inst,St Michaels Hosp, Toronto, ON M5S 1A1, Canada.	tomislav.svoboda@utoronto.ca			Central East Health Information Partnership; City of Toronto Shelter, Housing and Support Division, Physician Services Incorporated; St. Michael's Hospital Research Department; Canadian Institutes for Health Research	Central East Health Information Partnership; City of Toronto Shelter, Housing and Support Division, Physician Services Incorporated; St. Michael's Hospital Research Department; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Central East Health Information Partnership, the former City of Toronto Shelter, Housing and Support Division, Physician Services Incorporated, and St. Michael's Hospital Research Department as well as a post-doctoral fellowship from the Canadian Institutes for Health Research to Tomislav Svoboda.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Ambrosio E, 1992, STREET HLTH REPORT; CLEGG and ASSOCIATES, 1993, REC ARR SERV CHRON P; Cox GB, 1998, J STUD ALCOHOL, V59, P523, DOI 10.15288/jsa.1998.59.523; Crilly Julia, 2004, Accid Emerg Nurs, V12, P67, DOI 10.1016/j.aaen.2003.11.003; Fernandes CMB, 1999, CAN MED ASSOC J, V161, P1245; Fulde GWO, 2003, MED J AUSTRALIA, V179, P651, DOI 10.5694/j.1326-5377.2003.tb05735.x; GIESBRECHT NA, 1981, CAN J PUBLIC HEALTH, V72, P101; Goodacre S, 2005, EMERG MED J, V22, P93, DOI 10.1136/emj.2003.007690; Greene J, 2007, ANN EMERG MED, V49, P791, DOI 10.1016/j.annemergmed.2007.04.011; Henson VL, 2005, EMERG MED J, V22, P499, DOI 10.1136/emj.2003.005447; Hwang SW, 2001, CAN MED ASSOC J, V164, P229; James A, 2006, EMERG MED J, V23, P431, DOI 10.1136/emj.2005.028621; Kushel MB, 2001, JAMA-J AM MED ASSOC, V285, P200, DOI 10.1001/jama.285.2.200; Larimer ME, 2009, JAMA-J AM MED ASSOC, V301, P1349, DOI 10.1001/jama.2009.414; Leonard EC, 1997, AM J ADDICTION, V6, P1; LISSAUER T, 1993, ARCH DIS CHILD, V69, P423, DOI 10.1136/adc.69.4.423; Mahoney B S, 1991, J Emerg Nurs, V17, P282; Mandelberg JH, 2000, ACAD EMERG MED, V7, P637, DOI 10.1111/j.1553-2712.2000.tb02037.x; Mason K, 2007, STREET HLTH REPORT 2; MAYER D, 1990, ANN EMERG MED, V19, P1436, DOI 10.1016/S0196-0644(05)82617-4; McNiel DE, 2005, PSYCHIAT SERV, V56, P699, DOI 10.1176/appi.ps.56.6.699; Mohsin M, 2007, EMERG MED J, V24, P175, DOI 10.1136/emj.2006.038679; Morrison LJ, 1999, CAN MED ASSOC J, V161, P1262; PADGETT DK, 1995, SOC SCI MED, V41, P547, DOI 10.1016/0277-9536(94)00364-Y; PANE GA, 1991, ANN EMERG MED, V20, P283, DOI 10.1016/S0196-0644(05)80941-2; Parker D, 2010, J URBAN HEALTH, V87, P912, DOI 10.1007/s11524-010-9504-y; PilossophGelb S, 1997, ACAD EMERG MED, V4, P589, DOI 10.1111/j.1553-2712.1997.tb03583.x; Podymow T, 2006, CAN MED ASSOC J, V174, P45, DOI 10.1503/cmaj.1041350; REDELMEIER DA, 1995, LANCET, V345, P1131, DOI 10.1016/S0140-6736(95)90975-3; Svoboda TJ, 2005, MEASURING REDUCTION; TANKANOW RM, 1992, AM J HOSP PHARM, V49, P633, DOI 10.1093/ajhp/49.3.633; TAUB HA, 1983, EXP AGING RES, V9, P135, DOI 10.1080/03610738308258441; TAUB HA, 1987, EXP AGING RES, V13, P173; Thornquist L, 2002, ACAD EMERG MED, V9, P300, DOI 10.1111/j.1553-2712.2002.tb01323.x; Vardy J, 2009, EMERG MED J, V26, P164, DOI 10.1136/emj.2007.056259; Young Daniel R, 1990, IRB, V12, P1, DOI 10.2307/3564107	37	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124528	10.1371/journal.pone.0124528	http://dx.doi.org/10.1371/journal.pone.0124528			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SE	25919015	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400055
J	Hola, M; Jezek, M; Kusta, T; Kosatova, M				Hola, Michaela; Jezek, Milos; Kusta, Tomas; Kosatova, Michaela			Trophic Discrimination Factors of Stable Carbon and Nitrogen Isotopes in Hair of Corn Fed Wild Boar	PLOS ONE			English	Article							SUS-SCROFA L.; FACTORS DELTA-C-13; DIET CHANGES; CROP DAMAGE; DELTA-N-15; FRACTIONATION; DIGESTIBILITY; MIGRATION; TURNOVER; PATTERNS	Stable isotope measurements are increasingly being used to gain insights into the nutritional ecology of many wildlife species and their role in ecosystem structure and function. Such studies require estimations of trophic discrimination factors (i.e. differences in the isotopic ratio between the consumer and its diet). Although trophic discrimination factors are tissue-and species- specific, researchers often rely on generalized, and fixed trophic discrimination factors that have not been experimentally derived. In this experimental study, captive wild boar (Sus scrofa) were fed a controlled diet of corn (Zea mays), a popular and increasingly dominant food source for wild boar in the Czech Republic and elsewhere in Europe, and trophic discrimination factors for stable carbon (Delta C-13) and nitrogen (Delta N-15) isotopes were determined from hair samples. The mean Delta C-13 and Delta N-15 in wild boar hair were -2.3 parts per thousand and +3.5 parts per thousand, respectively. Also, in order to facilitate future derivations of isotopic measurements along wild boar hair, we calculated the average hair growth rate to be 1.1 mm d(-1). Our results serve as a baseline for interpreting isotopic patterns of free-ranging wild boar in current European agricultural landscapes. However, future research is needed in order to provide a broader understanding of the processes underlying the variation in trophic discrimination factors of carbon and nitrogen across of variety of diet types.	[Hola, Michaela; Jezek, Milos; Kusta, Tomas] Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Dept Game Management & Wildlife Biol, Prague, Czech Republic; [Kosatova, Michaela] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech University of Life Sciences Prague	Hola, M (corresponding author), Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Dept Game Management & Wildlife Biol, Prague, Czech Republic.	mhola@fld.czu.cz	Ježek, Miloš/AAB-8880-2021	Ježek, Miloš/0000-0002-4127-9947	Grant Agency of the Czech University of Life Sciences Prague, CIGA [20134314]; Ministry of Agriculture of the Czech Republic [QJ1220314]	Grant Agency of the Czech University of Life Sciences Prague, CIGA(Grant Agency of the Czech Republic); Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This study was supported by the Grant Agency of the Czech University of Life Sciences Prague, CIGA (Project No. 20134314) and by the Ministry of Agriculture of the Czech Republic, Grant No. QJ1220314. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LG, 2010, ECOL APPL, V20, P251, DOI 10.1890/08-1437.1; AMBROSE SH, 1991, J ARCHAEOL SCI, V18, P293, DOI 10.1016/0305-4403(91)90067-Y; Amici A, 2012, AGRON SUSTAIN DEV, V32, P683, DOI 10.1007/s13593-011-0057-6; ARENTSON RA, 1995, J ANIM SCI, V73, P1077; Ballari SA, 2014, MAMMAL REV, V44, P124, DOI 10.1111/mam.12015; BASSHAM JA, 1954, J AM CHEM SOC, V76, P1760, DOI 10.1021/ja01636a012; Ben-David M, 2001, OECOLOGIA, V127, P180, DOI 10.1007/s004420000570; Ben-David M, 2012, J MAMMAL, V93, P312, DOI 10.1644/11-MAMM-S-166.1; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Bradfield RB, 1981, HAIR RES STATUS FUTU, P251; Caut S, 2008, CAN J ZOOL, V86, P438, DOI 10.1139/Z08-012; Caut S, 2008, FUNCT ECOL, V22, P255, DOI 10.1111/j.1365-2435.2007.01360.x; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cerling TE, 2006, P NATL ACAD SCI USA, V103, P371, DOI 10.1073/pnas.0509606102; Cerling TE, 2004, AFR J ECOL, V42, P88, DOI 10.1111/j.1365-2028.2004.00500.x; Codron D, 2007, EUR J WILDLIFE RES, V53, P161, DOI 10.1007/s10344-006-0075-x; Codron D, 2011, CAN J ZOOL, V89, P453, DOI [10.1139/Z11-010, 10.1139/z11-010]; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Darr RL, 2008, J WILDLIFE MANAGE, V72, P1525, DOI 10.2193/2006-293; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Felicetti LA, 2003, CAN J ZOOL, V81, P763, DOI [10.1139/z03-054, 10.1139/Z03-054]; Fry B., 2006, STABLE ISOTOPE ECOLO; Giuffra E, 2000, GENETICS, V154, P1785; HATCH MD, 1967, BIOCHEM J, V102, P417, DOI 10.1042/bj1020417; Hemmer H., 1990, DOMESTICATION DECLIN; Herrero J, 2006, EUR J WILDLIFE RES, V52, P245, DOI 10.1007/s10344-006-0045-3; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hobson KA, 2014, ISOT ENVIRON HEALT S, V50, P300, DOI 10.1080/10256016.2014.867852; Iacumin P, 2005, PALAEOGEOGR PALAEOCL, V218, P317, DOI 10.1016/j.palaeo.2004.12.021; Johnson E, 1977, PHYSL PATHOPHYSIOLOG, P1237; Jones GF, 1998, GENETICS OF THE PIG, P17; JONES RJ, 1981, SEARCH, V12, P85; Kelly DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053071; Keuling O, 2010, 8 S WILD BOAR OTH SU; Kurle CM, 2014, ISOT ENVIRON HEALT S, V50, P307, DOI 10.1080/10256016.2014.908872; Lecomte N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021357; LYNFIELD YL, 1970, J INVEST DERMATOL, V55, P170, DOI 10.1111/1523-1747.ep12280667; Marques TS, 2014, J HERPETOL, V48, P332, DOI 10.1670/12-274; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; MOHN MP, 1958, BIOLOGY HAIR GROWTH, P336; Murray PJ, 1997, RECENT ADV ANIMAL NU, V14, P253; Nardoto GB, 2006, SCI AGR, V63, P579, DOI 10.1590/S0103-90162006000600012; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Parng E, 2014, J MAMMAL, V95, P151, DOI 10.1644/13-MAMM-A-014.1; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2012, J MAMMAL, V93, P342, DOI 10.1644/11-MAMM-S-158.1; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; R Core Team, 2014, LANG ENV STAT COMP V; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; Schley L, 2003, MAMMAL REV, V33, P43, DOI 10.1046/j.1365-2907.2003.00010.x; Schwertl M, 2003, RAPID COMMUN MASS SP, V17, P1312, DOI 10.1002/rcm.1042; Sponheimer M, 2003, CAN J ZOOL, V81, P871, DOI 10.1139/Z03-066; Therrien JF, 2011, CAN J ZOOL, V89, P343, DOI 10.1139/Z11-008; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; VANSCOTT EJ, 1957, J INVEST DERMATOL, V29, P197, DOI 10.1038/jid.1957.87; Venables WN., 2002, MODERN APPL STAT S 4; Warinner C, 2009, J ARCHAEOL SCI, V36, P1690, DOI 10.1016/j.jas.2009.03.034; WEILER U, 1995, ANAT HISTOL EMBRYOL, V24, P77, DOI 10.1111/j.1439-0264.1995.tb00013.x; West AG, 2004, FUNCT ECOL, V18, P616, DOI 10.1111/j.0269-8463.2004.00862.x; Wildauer L, 2007, 28 INT UN GAM BIOL C; Wurster CM, 2012, PLOS ONE, V7, DOI [10.1371/joumal.pone.0043538, DOI 10.1371/JOUMAL.PONE.0043538]; Zazzo A, 2007, CAN J ZOOL, V85, P1239, DOI 10.1139/Z07-110	67	11	11	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125042	10.1371/journal.pone.0125042	http://dx.doi.org/10.1371/journal.pone.0125042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915400	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100092
J	Li, B; Wang, L; Lu, MS; Mo, XF; Lin, FY; Ho, SC; Zhang, CX				Li, Bin; Wang, Lian; Lu, Min-Shan; Mo, Xiong-Fei; Lin, Fang-Yu; Ho, Suzanne C.; Zhang, Cai-Xia			Passive Smoking and Breast Cancer Risk among Non-Smoking Women: A Case-Control Study in China	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; CIGARETTE-SMOKING; ACTIVE SMOKING; EXPOSURE; ESTROGEN; ALCOHOL; ADDUCTS; CANADA	Background The role of passive smoking on breast cancer risk was unclear. This study aimed to evaluate the association between passive smoking and breast cancer risk among Chinese women. Methods/Principal Findings A hospital-based case-control study, including 877 breast cancer cases and 890 controls, frequency-matched by age and residence, was conducted. A structured questionnaire was used to collect information on passive smoking history through face-to-face interview by trained interviewers. Unconditional logistic regression models were used to estimate the association between passive smoking and breast cancer risk. A positive association between any passive smoking exposure and breast cancer risk was observed. Compared with women who were never exposed to passive smoking, women who were ever exposed had a higher breast cancer risk, with the adjusted odds ratio (OR) and 95% confidence interval (CI) of 1.35 (1.11-1.65). Similar result was found on home passive smoking exposure and breast cancer risk, but not on workplace passive smoking exposure. Women who were ever exposed to tobacco smoke at home had a higher risk of breast cancer compared with never exposed women, with the adjusted OR (95% CI) of 1.30 (1.05-1.61). Home passive smoking exposure showed significant dose-response relationships with breast cancer risk in smoker-years, cigarettes/day and total pack-years (P-trend=0.003, 0.006 and 0.009, respectively). An increased total smoker-years of any passive exposure significantly elevated the risk of breast cancer (P-trend<0.001). Positive associations and dose-response relationships were found among postmenopausal women and all subtypes of estrogen receptor (ER) and progesterone receptor (PR) status of breast cancer. Conclusions Passive smoking was associated with an increased risk of breast cancer among non-smoking Chinese women. A stronger positive association with breast cancer risk was seen mainly among postmenopausal women.	[Li, Bin; Wang, Lian; Lu, Min-Shan; Zhang, Cai-Xia] Sun Yat Sen Univ, Dept Med Stat & Epidemiol, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Li, Bin] Sun Yat Sen Univ, Affiliated Hosp 1, Epidemiol Res Unit, Guangzhou 510275, Guangdong, Peoples R China; [Mo, Xiong-Fei] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc Surg, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Fang-Yu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nursing, Guangzhou 510275, Guangdong, Peoples R China; [Ho, Suzanne C.] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Chinese University of Hong Kong	Ho, SC (corresponding author), Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China.	suzanneho@cuhk.edu.hk; zhangcx3@mail.sysu.edu.cn			National Natural Science Foundation of China [81102188]; New Teachers' Fund for Doctor Stations, Ministry of Education of China [20100171120057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Teachers' Fund for Doctor Stations, Ministry of Education of China	This study was supported by the National Natural Science Foundation of China (no. 81102188), the New Teachers' Fund for Doctor Stations, Ministry of Education of China (no. 20100171120057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosone CB, 2008, CANCER EPIDEM BIOMAR, V17, P15, DOI 10.1158/1055-9965.EPI-07-0598; *CA ENV PROT AG, 2005, PROP ID ENV TOB SMOK; Chen CZ, 2005, ENVIRON HEALTH PERSP, V113, P412, DOI 10.1289/ehp.7436; Chen Z, 2013, ASIA PAC J IN PRESS; Collishaw NE, 2009, CANADIAN EXPERT PANE; Conway K, 2002, CANCER RES, V62, P1987; Cui Y, 2006, BREAST CANCER RES TR, V100, P293, DOI 10.1007/s10549-006-9255-3; Delfino RJ, 2000, PHARMACOGENETICS, V10, P461, DOI 10.1097/00008571-200007000-00009; Egan KM, 2002, EPIDEMIOLOGY, V13, P138, DOI 10.1097/00001648-200203000-00007; Faraglia B, 2003, CARCINOGENESIS, V24, P719, DOI 10.1093/carcin/bgg013; Firozi PF, 2002, CARCINOGENESIS, V23, P301, DOI 10.1093/carcin/23.2.301; Gammon MD, 2004, ENVIRON RES, V96, P176, DOI 10.1016/j.envres.2003.08.009; Gao CM, 2013, ASIAN PAC J CANCER P, V14, P993, DOI 10.7314/APJCP.2013.14.2.993; He Qian, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P159; Hu MB, 2013, CANCER CAUSE CONTROL, V24, P629, DOI 10.1007/s10552-012-0137-1; IARC (International Agency for Research on Cancer), 1986, IARC MON EV CARC RIS, P127; Jee SH, 1999, INT J EPIDEMIOL, V28, P824, DOI 10.1093/ije/28.5.824; Johnson KC, 1999, EPIDEMIOLOGY, V10, pS61; Johnson KC, 2005, INT J CANCER, V117, P619, DOI 10.1002/ijc.21150; Johnson KC, 2000, CANCER CAUSE CONTROL, V11, P211, DOI 10.1023/A:1008906105790; Kropp S, 2002, AM J EPIDEMIOL, V156, P616, DOI 10.1093/aje/kwf093; Lash TL, 1999, AM J EPIDEMIOL, V149, P5; Lin Y, 2008, J EPIDEMIOL, V18, P77, DOI 10.2188/jea.18.77; Luo JH, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1016; Ma JM, 2005, CHIN J EPIDEMIOL, V26, P77; MACMAHON B, 1982, NEW ENGL J MED, V307, P1062, DOI 10.1056/NEJM198210213071707; McKenzie F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063132; MICHNOVICZ JJ, 1986, NEW ENGL J MED, V315, P1305, DOI 10.1056/NEJM198611203152101; Morabia A, 1996, AM J EPIDEMIOL, V143, P918, DOI 10.1093/oxfordjournals.aje.a008835; Morabia A, 1998, INT J CANCER, V75, P339, DOI 10.1002/(SICI)1097-0215(19980130)75:3<339::AID-IJC2>3.0.CO;2-3; Nishino Y, 2001, CANCER CAUSE CONTROL, V12, P797, DOI 10.1023/A:1012273806199; Nishino Y, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-65; PERERA FP, 1995, CANCER EPIDEM BIOMAR, V4, P233; Pirie K, 2008, INT J EPIDEMIOL, V37, P1069, DOI 10.1093/ije/dyn110; Prescott J, 2007, CANCER EPIDEM BIOMAR, V16, P620, DOI 10.1158/1055-9965.EPI-06-0873; Reynolds P, 2004, JNCI-J NATL CANCER I, V96, P29, DOI 10.1093/jnci/djh002; Reynolds P, 2013, J MAMMARY GLAND BIOL, V18, P15, DOI 10.1007/s10911-012-9269-x; Reynolds P, 2009, CANCER EPIDEM BIOMAR, V18, P3389, DOI 10.1158/1055-9965.EPI-09-0936; Roddam AW, 2007, BRIT J CANCER, V97, P434, DOI 10.1038/sj.bjc.6603859; Rollison DE, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-157; SANDLER DP, 1985, AM J EPIDEMIOL, V121, P37, DOI 10.1093/oxfordjournals.aje.a113980; Shrubsole MJ, 2004, INT J CANCER, V110, P605, DOI 10.1002/ijc.20168; SMITH SJ, 1994, BRIT J CANCER, V70, P112, DOI 10.1038/bjc.1994.258; Tang LY, 2013, GENE, V524, P84, DOI 10.1016/j.gene.2013.04.064; Terry PD, 2002, CANCER EPIDEM BIOMAR, V11, P953; Tong JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097498; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; [王萍玉 Wang Pingyu], 2011, [中国现代医学杂志, China Journal of Modern Medicine], V21, P3271; Xu Tao, 2010, Chinese Journal of Prevention and Control of Chronic Diseases, V18, P229; Zhang CX, 2009, INT J CANCER, V125, P181, DOI 10.1002/ijc.24358; [No title captured]	51	12	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125894	10.1371/journal.pone.0125894	http://dx.doi.org/10.1371/journal.pone.0125894			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915759	gold, Green Submitted, Green Published			2022-12-27	WOS:000353659100151
J	Sazanavets, I; Warwicker, J				Sazanavets, Ivan; Warwicker, Jim			Computational Tools for Interpreting Ion Channel pH-Dependence	PLOS ONE			English	Article							POTASSIUM CHANNELS; PROTON SENSITIVITY; BINDING-SITES; OPEN STATE; ACID; PROTEIN; RESIDUES; ROMK; IDENTIFICATION; ACTIVATION	Activity in many biological systems is mediated by pH, involving proton titratable groups with pKas in the relevant pH range. Experimental analysis of pH-dependence in proteins focusses on particular sidechains, often with mutagenesis of histidine, due to its pKa near to neutral pH. The key question for algorithms that predict pKas is whether they are sufficiently accurate to effectively narrow the search for molecular determinants of pH-dependence. Through analysis of inwardly rectifying potassium (Kir) channels and acid-sensing ion channels (ASICs), mutational effects on pH-dependence are probed, distinguishing between groups described as pH-coupled or pH-sensor. Whereas mutation can lead to a shift in transition pH between open and closed forms for either type of group, only for pH-sensor groups does mutation modulate the amplitude of the transition. It is shown that a hybrid Finite Difference Poisson-Boltzmann (FDPB) - Debye-Hckel continuum electrostatic model can filter mutation candidates, providing enrichment for key pH-coupled and pH-sensor residues in both ASICs and Kir channels, in comparison with application of FDPB alone.	[Sazanavets, Ivan; Warwicker, Jim] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England	University of Manchester	Warwicker, J (corresponding author), Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England.	jim.warwicker@manchester.ac.uk		Warwicker, Jim/0000-0002-1302-0815	UK BBSRC; Astra Zeneca	UK BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Astra Zeneca(AstraZeneca)	The authors thank the UK BBSRC and Astra Zeneca for the award of a CASE studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexov E, 2011, PROTEINS, V79, P3260, DOI 10.1002/prot.23189; ANTOSIEWICZ J, 1994, J MOL BIOL, V238, P415, DOI 10.1006/jmbi.1994.1301; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BEROZA P, 1991, P NATL ACAD SCI USA, V88, P5804, DOI 10.1073/pnas.88.13.5804; Bollepalli MK, 2014, STRUCTURE, V22, P1037, DOI 10.1016/j.str.2014.04.018; Chanchevalap S, 2000, J BIOL CHEM, V275, P7811, DOI 10.1074/jbc.275.11.7811; Chen XM, 2007, J BIOL CHEM, V282, P30406, DOI 10.1074/jbc.M702229200; Choe H, 1997, AM J PHYSIOL-RENAL, V273, pF516, DOI 10.1152/ajprenal.1997.273.4.F516; Cole C, 2002, PROTEIN SCI, V11, P2860, DOI 10.1110/ps.0222702; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Fakler B, 1996, EMBO J, V15, P4093, DOI 10.1002/j.1460-2075.1996.tb00784.x; Garcia-Moreno Bertrand, 2009, Journal of Biology (London), V8, P98, DOI 10.1186/jbiol199; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Gonzalez W, 2012, BIOCHEM J, V442, P57, DOI 10.1042/BJ20111498; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Ishikita H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016920; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kemp LR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0323; KOEHL P, 1994, J MOL BIOL, V239, P249, DOI 10.1006/jmbi.1994.1366; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leng Q, 2006, P NATL ACAD SCI USA, V103, P1982, DOI 10.1073/pnas.0510610103; Li TB, 2011, J GEN PHYSIOL, V137, P289, DOI 10.1085/jgp.201010576; Li TB, 2010, AM J PHYSIOL-CELL PH, V299, pC66, DOI 10.1152/ajpcell.00100.2010; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Liu BB, 2007, J MOL BIOL, V368, P328, DOI 10.1016/j.jmb.2007.02.041; Ojemalm K, 2013, J CELL SCI, V126, P464, DOI 10.1242/jcs.111773; Onufriev AV, 2013, Q REV BIOPHYS, V46, P181, DOI 10.1017/S0033583513000024; Passero CJ, 2009, J BIOL CHEM, V284, P36473, DOI 10.1074/jbc.M109.055418; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Paynter JJ, 2010, CHANNELS, V4, P390, DOI 10.4161/chan.4.5.13006; Petukh M, 2013, CURR PHARM DESIGN, V19, P4182, DOI 10.2174/1381612811319230004; Rapedius M, 2006, EMBO REP, V7, P611, DOI 10.1038/sj.embor.7400678; Sackin H, 2006, BIOPHYS J, V90, P3582, DOI 10.1529/biophysj.105.076653; Schulte U, 2000, EUR J BIOCHEM, V267, P5837, DOI 10.1046/j.1432-1327.2000.01671.x; Shaikh SA, 2008, BIOPHYS J, V95, P5153, DOI 10.1529/biophysj.108.141606; Sherwood T, 2009, J BIOL CHEM, V284, P27899, DOI 10.1074/jbc.M109.029009; Sherwood TW, 2012, AM J PHYSIOL-CELL PH, V303, pC699, DOI 10.1152/ajpcell.00188.2012; Smith ESJ, 2007, NEUROSCI LETT, V426, P12, DOI 10.1016/j.neulet.2007.07.047; Spassov VZ, 2013, PROTEINS, V81, P704, DOI 10.1002/prot.24230; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Starkus JG, 2003, PFLUG ARCH EUR J PHY, V447, P44, DOI 10.1007/s00424-003-1121-0; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Talley K, 2010, PROTEINS, V78, P2699, DOI 10.1002/prot.22786; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang L, 2013, COMMUN COMPUT PHYS, V13, P13, DOI 10.4208/cicp.300611.120911s; Warwicker J, 1999, PROTEIN SCI, V8, P418; WARWICKER J, 1982, J MOL BIOL, V157, P671, DOI 10.1016/0022-2836(82)90505-8; Warwicker J, 2004, PROTEIN SCI, V13, P2793, DOI 10.1110/ps.04785604; WARWICKER J, 1986, J THEOR BIOL, V121, P199, DOI 10.1016/S0022-5193(86)80093-5; Warwicker J, 2011, PROTEINS, V79, P3374, DOI 10.1002/prot.23078; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]	65	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125293	10.1371/journal.pone.0125293	http://dx.doi.org/10.1371/journal.pone.0125293			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915903	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100117
J	Simhadri, VR; Dimitrova, M; Mariano, JL; Zenarruzabeitia, O; Zhong, WM; Ozawa, T; Muraguchi, A; Kishi, H; Eichelberger, MC; Borrego, F				Simhadri, Venkateswara R.; Dimitrova, Milena; Mariano, John L.; Zenarruzabeitia, Olatz; Zhong, Weimin; Ozawa, Tatsuhiko; Muraguchi, Atsushi; Kishi, Hiroyuki; Eichelberger, Maryna C.; Borrego, Francisco			A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) Cells	PLOS ONE			English	Article							INFLUENZA-A VIRUS; HUMAN MONOCLONAL-ANTIBODY; MATRIX PROTEIN-2; M2 PROTEIN; EXTRACELLULAR DOMAIN; SEASONAL INFLUENZA; ADAPTIVE IMMUNITY; UNIVERSAL VACCINE; INFECTION; PROTECTION	The highly conserved matrix protein 2 (M2) is a good candidate for the development of a broadly protective influenza vaccine that induces long-lasting immunity. In animal models, natural killer (NK) cells have been proposed to play an important role in the protection provided by M2-based vaccines through a mechanism of antibody-dependent cell-mediated cytotoxicity (ADCC). We investigated the ability of the human anti-M2 Ab1-10 monoclonal antibody (mAb) to activate human NK cells. They mediated ADCC against M2-expressing cells in the presence of Ab1-10 mAb. Furthermore, NK cell pro-inflammatory cytokine and chemokine secretion is also enhanced when Ab1-10 mAb is present. We also generated cytokine-preactivated NK cells and showed that they still displayed increased effector functions in the presence of Ab1-10 mAb. Thus, our study has demonstrated that human resting and cytokine-preactivated NK cells may have a very important role in the protection provided by anti-M2 Abs.	[Simhadri, Venkateswara R.; Dimitrova, Milena; Mariano, John L.; Borrego, Francisco] US FDA, Div Biotechnol Review & Res 1, Off Biotechnol Prod Review & Res, Ctr Drug Evaluat & Res, Silver Spring, MD 20903 USA; [Zenarruzabeitia, Olatz] BioCruces Hlth Res Inst, Immunopathol Grp, Baracaldo, Basque Country, Spain; [Zenarruzabeitia, Olatz] Basque Ctr Transfus & Human Tissues, Cell Therapy & Stem Cell Grp, Galdakao, Basque Country, Spain; [Zhong, Weimin] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Ozawa, Tatsuhiko; Muraguchi, Atsushi; Kishi, Hiroyuki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Immunol, Toyama, Japan; [Eichelberger, Maryna C.] Food & Drug Adm, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Borrego, Francisco] Basque Fdn Sci, Ikerbasque, Bilbao, Basque Country, Spain	US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA; University of Toyama; US Food & Drug Administration (FDA); Basque Foundation for Science	Simhadri, VR (corresponding author), US FDA, Div Biotechnol Review & Res 1, Off Biotechnol Prod Review & Res, Ctr Drug Evaluat & Res, Silver Spring, MD 20903 USA.	venkateswara.simhadri@fda.hhs.gov; francisco.borregorabasco@osakidetza.net	Zenarruzabeitia, Olatz/AAD-6772-2019; Borrego, Francisco/ABI-1391-2020	Zenarruzabeitia, Olatz/0000-0002-0869-9034; Borrego, Francisco/0000-0002-3105-981X; Ozawa, Tatsuhiko/0000-0002-3112-452X	Medical Counter Measure Initiatives (MCMi), U.S. Food and Drug Administration (FDA)	Medical Counter Measure Initiatives (MCMi), U.S. Food and Drug Administration (FDA)	This work was funded by the Medical Counter Measure Initiatives (MCMi), U.S. Food and Drug Administration (FDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson KL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/379123; Arnon TI, 2006, SEMIN CANCER BIOL, V16, P348, DOI 10.1016/j.semcancer.2006.07.005; Beerli RR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-224; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200; De Filette M, 2006, VACCINE, V24, P6597, DOI 10.1016/j.vaccine.2006.05.082; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Fiore AE, 2009, CURR TOP MICROBIOL, V333, P43, DOI 10.1007/978-3-540-92165-3_3; Frace AM, 1999, VACCINE, V17, P2237, DOI 10.1016/S0264-410X(99)00005-5; Ge MQ, 2012, J IMMUNOL, V189, P2099, DOI 10.4049/jimmunol.1103474; Jegaskanda S, 2014, J IMMUNOL, V193, P469, DOI 10.4049/jimmunol.1400432; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Jiang XR, 2011, NAT REV DRUG DISCOV, V10, P101, DOI 10.1038/nrd3365; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; Kaufmann A, 2001, IMMUNOBIOLOGY, V204, P603, DOI 10.1078/0171-2985-00099; Kim MC, 2013, ANTIVIR RES, V99, P328, DOI 10.1016/j.antiviral.2013.06.010; Kohlmeier JE, 2008, IMMUNITY, V29, P101, DOI 10.1016/j.immuni.2008.05.011; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; Li CKF, 2013, CURR OPIN IMMUNOL, V25, P470, DOI 10.1016/j.coi.2013.07.005; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Matikainen S, 2006, J VIROL, V80, P3515, DOI 10.1128/JVI.80.7.3515-3522.2006; Min-Oo G, 2013, TRENDS IMMUNOL, V34, P251, DOI 10.1016/j.it.2013.02.005; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Nieto M, 1998, J IMMUNOL, V161, P3330; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Ozawa T, 2011, ANTIVIR RES, V91, P283, DOI 10.1016/j.antiviral.2011.06.012; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Robertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Schultz-Cherry S, 2015, CURR TOP MICROBIOL, V386, P109, DOI 10.1007/82_2014_403; Simhadri VR, 2014, J ALLERGY CLIN IMMUN, V134, P1190, DOI 10.1016/j.jaci.2014.06.006; Srivastava V, 2013, J VIROL, V87, P5831, DOI 10.1128/JVI.00273-13; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; van Helden MJG, 2012, J IMMUNOL, V189, P2333, DOI 10.4049/jimmunol.1200008; VERHOEYEN M, 1980, NATURE, V286, P771, DOI 10.1038/286771a0; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wang RF, 2008, ANTIVIR RES, V80, P168, DOI 10.1016/j.antiviral.2008.06.002; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yewdell JW, 2013, CURR OPIN VIROL, V3, P316, DOI 10.1016/j.coviro.2013.05.008; Zhong WM, 2011, J IMMUNOL METHODS, V369, P115, DOI 10.1016/j.jim.2011.04.010; Zhou Q, 2013, CLIN EXP IMMUNOL, V173, P131, DOI 10.1111/cei.12095	49	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124677	10.1371/journal.pone.0124677	http://dx.doi.org/10.1371/journal.pone.0124677			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915748	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100060
J	Vezzulli, L; Stauder, M; Grande, C; Pezzati, E; Verheye, HM; Owens, NJP; Pruzzo, C				Vezzulli, Luigi; Stauder, Monica; Grande, Chiara; Pezzati, Elisabetta; Verheye, Hans M.; Owens, Nicholas J. P.; Pruzzo, Carla			gbpA as a Novel qPCR Target for the Species-Specific Detection of Vibrio cholerae O1, O139, Non-O1/Non-O139 in Environmental, Stool, and Historical Continuous Plankton Recorder Samples	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; COLONIZATION FACTOR; REACTION ASSAY; WATER SAMPLES; PARAHAEMOLYTICUS; DIVERSITY; SURVIVAL; CELLS; COLI	The Vibrio cholerae N-acetyl glucosamine-binding protein A (GbpA) is a chitin-binding protein involved in V. cholerae attachment to environmental chitin surfaces and human intestinal cells. We previously investigated the distribution and genetic variations of gbpA in a large collection of V. cholerae strains and found that the gene is consistently present and highly conserved in this species. Primers and probe were designed from the gbpA sequence of V. cholerae and a new Taq-based qPCR protocol was developed for diagnostic detection and quantification of the bacterium in environmental and stool samples. In addition, the positions of primers targeting the gbpA gene region were selected to obtain a short amplified fragment of 206 bp and the protocol was optimized for the analysis of formalin-fixed samples, such as historical Continuous Plankton Recorder (CPR) samples. Overall, the method is sensitive (50 gene copies), highly specific for V. cholerae and failed to amplify strains of the closely-related species Vibrio mimicus. The sensitivity of the assay applied to environmental and stool samples spiked with V. cholerae ATCC 39315 was comparable to that of pure cultures and was of 10(2) genomic units/l for drinking and seawater samples, 10(1) genomic units/g for sediment and 10(2) genomic units/g for bivalve and stool samples. The method also performs well when tested on artificially formalin-fixed and degraded genomic samples and was able to amplify V. cholerae DNA in historical CPR samples, the earliest of which date back to August 1966. The detection of V. cholerae in CPR samples collected in cholera endemic areas such as the Benguela Current Large Marine Ecosystem (BCLME) is of particular significance and represents a proof of concept for the possible use of the CPR technology and the developed qPCR assay in cholera studies.	[Vezzulli, Luigi; Stauder, Monica; Grande, Chiara; Pezzati, Elisabetta; Pruzzo, Carla] Univ Genoa, Dept Earth Environm & Life Sci DISTAV, Genoa, Italy; [Verheye, Hans M.] Univ Cape Town, Dept Environm Affairs, Oceans & Coastal Res, ZA-7925 Cape Town, South Africa; [Verheye, Hans M.] Univ Cape Town, Marine Res Inst, ZA-7925 Cape Town, South Africa; [Owens, Nicholas J. P.] Sir Alister Hardy Fdn Ocean Sci, Plymouth, Devon, England	University of Genoa; Department of Environment, Forestry & Fisheries; University of Cape Town; University of Cape Town	Vezzulli, L (corresponding author), Univ Genoa, Dept Earth Environm & Life Sci DISTAV, Genoa, Italy.	luigi.vezzulli@unige.it	Vezzulli, Luigi/J-2312-2015; Owens, Nicholas John Paul/GRX-5013-2022	Vezzulli, Luigi/0000-0002-4368-1454; Owens, Nicholas John Paul/0000-0001-7972-7285	FP7-AQUAVALENS project [311846]; Royal Society "International Exchanges R2 (inc CNRS)" [IE130623]; UK Natural Environment Research Council; UK Department for Environment, Food and Rural Affairs	FP7-AQUAVALENS project; Royal Society "International Exchanges R2 (inc CNRS)"; UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	This work was supported by the FP7-AQUAVALENS project (grant number 311846) and the Royal Society "International Exchanges 2013/R2 (inc CNRS)" (grant number IE130623). The Continuous Plankton Recorder Survey is supported by the UK Natural Environment Research Council and the UK Department for Environment, Food and Rural Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AZURIN JC, 1967, B WORLD HEALTH ORGAN, V37, P745; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bopp CA, 1999, LAB METHODS DIAGNOSI; Choopun N, 2002, APPL ENVIRON MICROB, V68, P995, DOI 10.1128/AEM.68.2.995-998.2002; Chun J, 1999, APPL ENVIRON MICROB, V65, P2202; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Colwell RR, 2006, OCEANS AND HEALTH: PATHOGENS IN THE MARINE ENVIRONMENT, P297; Coombs N J, 1999, Nucleic Acids Res, V27, pe12, DOI 10.1093/nar/27.16.e12; DAVIS BR, 1981, J CLIN MICROBIOL, V14, P631, DOI 10.1128/JCM.14.6.631-639.1981; DEGIORGI C, 1994, MOL CELL PROBE, V8, P459, DOI 10.1006/mcpr.1994.1065; Devault AM, 2014, NEW ENGL J MED, V370, P334, DOI 10.1056/NEJMoa1308663; Dietrich D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077771; Fakruddin M D, 2013, Pak J Biol Sci, V16, P267, DOI 10.3923/pjbs.2013.267.274; Fykse EM, 2012, MAR POLLUT BULL, V64, P200, DOI 10.1016/j.marpolbul.2011.12.007; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hossain MT, 2013, J APPL MICROBIOL, V114, P448, DOI 10.1111/jam.12056; Huq A, 2000, NONCULTURABLE MICROORGANISMS IN THE ENVIRONMENT, P301; Kirk JL, 2004, J MICROBIOL METH, V58, P169, DOI 10.1016/j.mimet.2004.04.006; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kurakawa T, 2012, MICROBIOL IMMUNOL, V56, P10, DOI 10.1111/j.1348-0421.2011.00405.x; Lam JT, 2014, J WATER HEALTH, V12, P51, DOI 10.2166/wh.2013.038; Lister AM, 2011, TRENDS ECOL EVOL, V26, P153, DOI 10.1016/j.tree.2010.12.009; Low KF, 2013, BIOSENS BIOELECTRON, V47, P38, DOI 10.1016/j.bios.2013.03.004; Lyon WJ, 2001, APPL ENVIRON MICROB, V67, P4685, DOI 10.1128/AEM.67.10.4685-4693.2001; Malayil L, 2011, J APPL MICROBIOL, V110, P1470, DOI 10.1111/j.1365-2672.2011.04996.x; Neogi SB, 2010, LETT APPL MICROBIOL, V51, P293, DOI 10.1111/j.1472-765X.2010.02895.x; Oliver JD, 2005, J MICROBIOL, V43, P93; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Reid PC, 2003, PROG OCEANOGR, V58, P117, DOI 10.1016/j.pocean.2003.08.002; Ripley SJ, 2008, J MICROBIOL METH, V73, P118, DOI 10.1016/j.mimet.2008.02.001; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Schauer S, 2012, APPL ENVIRON MICROB, V78, P7369, DOI 10.1128/AEM.02190-12; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stauder M, 2012, ENV MICROBIOL REP, V4, P439, DOI 10.1111/j.1758-2229.2012.00356.x; Tamrakar AK, 2006, INT J ENVIRON HEAL R, V16, P305, DOI 10.1080/09603120600734303; Thompson JR, 2004, APPL ENVIRON MICROB, V70, P4103, DOI 10.1128/AEM.70.7.4103-4110.2004; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Utsalo SJ, 1999, EUR J EPIDEMIOL, V15, P379, DOI 10.1023/A:1007541317104; Vezzulli L, 2013, MICROB ECOL, V65, P817, DOI 10.1007/s00248-012-0163-2; Vezzulli L, 2012, ISME J, V6, P21, DOI 10.1038/ismej.2011.89; Vezzulli L, 2010, ENV MICROBIOL REP, V2, P27, DOI 10.1111/j.1758-2229.2009.00128.x; Vezzulli L, 2009, CHEM ECOL, V25, P285, DOI 10.1080/02757540903062509; Vezzulli L, 2009, MICROB ECOL, V58, P808, DOI 10.1007/s00248-009-9542-8; Wang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021299; Wang DC, 2010, APPL ENVIRON MICROB, V76, P5520, DOI 10.1128/AEM.02559-09; World Health Organization, 2014, Weekly Epidemiological Record, V89, P345; Zampini M, 2005, FEMS MICROBIOL LETT, V244, P267, DOI 10.1016/j.femsle.2005.01.052	49	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123983	10.1371/journal.pone.0123983	http://dx.doi.org/10.1371/journal.pone.0123983			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915771	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100032
J	Zhou, T; Chen, XF; Li, ZZ; Li, LZ				Zhou, Tao; Chen, Xiaofang; Li, Zhanzhan; Li, Lezhi			Relationship between Serum Bilirubin and Left Ventricular Hypertrophy in Patients with Essential Hypertension	PLOS ONE			English	Article							BLOOD-PRESSURE; AMERICAN SOCIETY; HEART-DISEASE; RISK; ECHOCARDIOGRAPHY; ASSOCIATION; ANTIOXIDANT; UPDATE; STROKE; LEVEL	Background Prospective studies have found low bilirubin levels were an important predictive factor of cardiovascular events. However, few have yet investigated possible association between serum bilirubin level and LVH in essential hypertension. The aim of the present study was to evaluate the relationship between serum bilirubin levels with LVH in newly diagnosed hypertension patients. Methods The present study evaluated the relationship between serum total bilirubin level and left ventricle hypertrophy (LVH) in newly diagnosed hypertensive patients with a sample size of 344. We divided subjects into LVH group (n=138) and non-LVH group (n=206). Physical examination, laboratory tests and echocardiography were conducted. The multivariate logistic regression model was used to verify the independent association between RDW and LVH. Results Our results found that patients with LVH had lower bilirubin levels than non-LVH ones. Step-wise multiple linear regression analysis showed total bilirubin level (B=-0.017, P=0.008) was negatively associated with left ventricle mass index (LVMI) even adjusting for some confounders. The multiples logistic regression found total bilirubin level was independently related with of LVH, as a protective factors (OR=0.91, P=0.010). Conclusion As a routine and quick laboratory examination index, serum bilirubin may be treated as novel marker for evaluating LVH risk in hypertensive patients. Cohort study with larger sample size are needed.	[Zhou, Tao] Southern Med Univ, Affiliated Hosp 3, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Chen, Xiaofang] Cent South Univ, Xiangya Nursing Sch, Changsha, Hunan, Peoples R China; [Chen, Xiaofang] Southern Med Univ, Affiliated Hosp 3, Dept Nursing, Guangzhou, Guangdong, Peoples R China; [Li, Zhanzhan] Cent South Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Li, Lezhi] Cent South Univ, Xiangya Med Sch, Affiliated Hosp 2, Dept Nursing, Changsha, Hunan, Peoples R China	Southern Medical University - China; Central South University; Southern Medical University - China; Central South University; Central South University	Zhou, T (corresponding author), Southern Med Univ, Affiliated Hosp 3, Dept Cardiol, Guangzhou, Guangdong, Peoples R China.	taozhou1965@126.com						Abbasi A, 2015, DIABETES, V64, P1459, DOI 10.2337/db14-0228; [Anonymous], 2001, Am J Kidney Dis, V37, pS182; [Anonymous], 2001, REGRESSION MODELING; Ayaz T, 2014, KOREAN CIRC J, V44, P336, DOI 10.4070/kcj.2014.44.5.336; Faraco G, 2013, HYPERTENSION, V62, P810, DOI 10.1161/HYPERTENSIONAHA.113.01063; Hopkins PN, 1996, ARTERIOSCL THROM VAS, V16, P250, DOI 10.1161/01.ATV.16.2.250; Horsfall LJ, 2012, CIRCULATION, V126, P2556, DOI 10.1161/CIRCULATIONAHA.112.114066; Kawamoto R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114281; Kawamura K, 2005, ARTERIOSCL THROM VAS, V25, P155, DOI 10.1161/01.ATV.0000148405.18071.6a; Kimm H, 2009, STROKE, V40, P3422, DOI 10.1161/STROKEAHA.109.560649; Kotani K, 2014, ANN ACAD MED SINGAP, V43, P216; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Leoncini G, 2004, J HUM HYPERTENS, V18, P511, DOI 10.1038/sj.jhh.1001689; LEVY D, 1992, CLIN EXP HYPERTENS A, V14, P85, DOI 10.3109/10641969209036173; Lippi G, 2012, CLIN CHEM LAB MED, V50, P2229, DOI 10.1515/cclm-2012-0343; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Mayer M, 2000, CLIN CHEM, V46, P1723; Muntner P, 2009, HYPERTENSION, V53, P617, DOI 10.1161/HYPERTENSIONAHA.108.120154; Ndisang JF, 2009, J CARD FAIL, V15, P616, DOI 10.1016/j.cardfail.2009.02.003; Parfenova H, 2012, J CEREBR BLOOD F MET, V32, P1024, DOI 10.1038/jcbfm.2012.13; Perlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262; Porter TR, 2014, J AM SOC ECHOCARDIOG, V27, P797, DOI 10.1016/j.echo.2014.05.011; Sahin DY, 2013, BLOOD PRESSURE, V22, P329, DOI 10.3109/08037051.2013.778006; Song YS, 2014, AM J CARDIOL, V114, P1695, DOI 10.1016/j.amjcard.2014.08.043; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Subramaniam A, 2013, BBA-REV CANCER, V1835, P46, DOI 10.1016/j.bbcan.2012.10.002; Tiribelli C, 2005, J HEPATOL, V42, P170, DOI 10.1016/j.jhep.2004.12.002; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; Varis JP, 2014, BLOOD PRESSURE, V23, P39, DOI 10.3109/08037051.2013.803313; Verdecchia P, 2015, HYPERTENSION, V65, P108, DOI 10.1161/HYPERTENSIONAHA.114.04310; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Vitek L, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00055	32	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125275	10.1371/journal.pone.0125275	http://dx.doi.org/10.1371/journal.pone.0125275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915415	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100113
J	Sladitschek, HL; Neveu, PA				Sladitschek, Hanna L.; Neveu, Pierre A.			MXS-Chaining: A Highly Efficient Cloning Platform for Imaging and Flow Cytometry Approaches in Mammalian Systems	PLOS ONE			English	Article							REGULATED GENE-EXPRESSION; NEIGHBOR BASE SEQUENCES; EMBRYONIC STEM-CELLS; MOUSE PGK-1 GENE; FLUORESCENT PROTEIN; DEOXYRIBONUCLEIC-ACID; ENZYMATIC-SYNTHESIS; MONOMERIC RED; TETRACYCLINE; PROMOTER	The continuous improvement of imaging technologies has driven the development of sophisticated reporters to monitor biological processes. Such constructs should ideally be assembled in a flexible enough way to allow for their optimization. Here we describe a highly reliable cloning method to efficiently assemble constructs for imaging or flow cytometry applications in mammalian cell culture systems. We bioinformatically identified a list of restriction enzymes whose sites are rarely found in human and mouse cDNA libraries. From the best candidates, we chose an enzyme combination (MluI, XhoI and SalI: MXS) that enables iterative chaining of individual building blocks. The ligation scar resulting from the compatible XhoI-and SalI-sticky ends can be translated and hence enables easy in-frame cloning of coding sequences. The robustness of the MXS-chaining approach was validated by assembling constructs up to 20 kb long and comprising up to 34 individual building blocks. By assessing the success rate of 400 ligation reactions, we determined cloning efficiency to be 90% on average. Large polycistronic constructs for single-cell imaging or flow cytometry applications were generated to demonstrate the versatility of the MXS-chaining approach. We devised several constructs that fluorescently label subcellular structures, an adapted version of FUCCI (fluorescent, ubiquitination-based cell cycle indicator) optimized to visualize cell cycle progression in mouse embryonic stem cells and an array of artificial promoters enabling dosage of doxycyline-inducible transgene expression. We made publicly available through the Addgene repository a comprehensive set of MXS-building blocks comprising custom vectors, a set of fluorescent proteins, constitutive promoters, polyadenylation signals, selection cassettes and tools for inducible gene expression. Finally, detailed guidelines describe how to chain together prebuilt MXS-building blocks and how to generate new customized MXS-building blocks.	[Sladitschek, Hanna L.; Neveu, Pierre A.] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Baden Wurttembe, Germany	European Molecular Biology Laboratory (EMBL)	Neveu, PA (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Baden Wurttembe, Germany.	neveu@embl.de		Sladitschek-Martens, Hanna Lucie/0000-0001-8910-1999; Neveu, Pierre/0000-0003-4939-3418	European Molecular Biology Laboratory	European Molecular Biology Laboratory	The study was funded by the European Molecular Biology Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Ballabeni A, 2011, P NATL ACAD SCI USA, V108, P19252, DOI 10.1073/pnas.1116794108; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Das AT, 2004, J BIOL CHEM, V279, P18776, DOI 10.1074/jbc.M313895200; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; FALCKPEDERSEN E, 1985, CELL, V40, P897, DOI 10.1016/0092-8674(85)90349-6; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; FITZGERALD M, 1981, CELL, V24, P251, DOI 10.1016/0092-8674(81)90521-3; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GOLDFARB DS, 1986, NATURE, V322, P641, DOI 10.1038/322641a0; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Jabbari K, 2004, GENE, V333, P143, DOI 10.1016/j.gene.2004.02.043; JOSSE J, 1961, J BIOL CHEM, V236, P864; KAPLAN JM, 1988, MOL CELL BIOL, V8, P2435, DOI 10.1128/MCB.8.6.2435; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KENDALL JM, 1992, BIOCHEM BIOPH RES CO, V189, P1008, DOI 10.1016/0006-291X(92)92304-G; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; KOEGL M, 1994, BIOCHEM J, V303, P749, DOI 10.1042/bj3030749; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; MCBURNEY MW, 1991, NUCLEIC ACIDS RES, V19, P5755, DOI 10.1093/nar/19.20.5755; Mizuno H, 2003, MOL CELL, V12, P1051, DOI 10.1016/S1097-2765(03)00393-9; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nagy A., 2003, MANIPULATING MOUSE E; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Piatkevich KD, 2010, P NATL ACAD SCI USA, V107, P5369, DOI 10.1073/pnas.0914365107; POWER SD, 1984, J BIOL CHEM, V259, P6575; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shcherbakova DM, 2013, NAT METHODS, V10, P751, DOI 10.1038/nmeth.2521; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Strack RL, 2009, BIOCHEMISTRY-US, V48, P8279, DOI 10.1021/bi900870u; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; SWARTZ MN, 1962, J BIOL CHEM, V237, P1961; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; WOYCHIK RP, 1984, P NATL ACAD SCI-BIOL, V81, P3944, DOI 10.1073/pnas.81.13.3944; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	64	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124958	10.1371/journal.pone.0124958	http://dx.doi.org/10.1371/journal.pone.0124958			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909630	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800118
J	Szczepaniak, P; Zabczyk, M; Undas, A				Szczepaniak, Piotr; Zabczyk, Michal; Undas, Anetta			Increased Plasma Clot Permeability and Susceptibility to Lysis Are Associated with Heavy Menstrual Bleeding of Unknown Cause: A Case-Control Study	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; VENOUS THROMBOSIS; BLOOD-LOSS; FIBRIN; MENORRHAGIA; WOMEN; HYPOFIBRINOLYSIS; ARCHITECTURE; PLASMINOGEN; DEFICIENCY	Background Formation of compact and poorly lysable clots has been reported in thromboembolic disorders. Little is known about clot properties in bleeding disorders. Objectives We hypothesized that more permeable and lysis-sensitive fibrin clots can be detected in women with heavy menstrual bleeding (HMB). Methods We studied 52 women with HMB of unknown cause and 52 age-matched control women. Plasma clot permeability (K-s), turbidity and efficiency of fibrinolysis, together with coagulation factors, fibrinolysis proteins, and platelet aggregation were measured. Results Women with HMB formed looser plasma fibrin clots (+16%[95% CI 7-18%] Ks) that displayed lower maximum absorbancy (-7% [95% CI -9- -1%]Delta Abs(max)), and shorter clot lysis time (-17% [95% CI -23 - -11%] CLT). The HMB patients and controls did not differ with regard to coagulation factors, fibrinogen, von Willebrand antigen, thrombin generation markers and the proportion of subjects with defective platelet aggregation. The patients had lower platelet count (-12% [95% CI -19 - -2%]), tissue plasminogen activator antigen (-39% [95% CI -41 - -29%] tPA: Ag), and plasminogen activator inhibitor-1 antigen (-28% [95% CI -38 - -18%] PAI-1:Ag) compared with the controls. Multiple regression analysis upon adjustment for age, body mass index, glucose, and fibrinogen showed that decreased tPA: Ag and shortened CLT were the independent predictors of HMB. Conclusions Increased clot permeability and susceptibility to fibrinolysis are associated with HMB, suggesting that altered plasma fibrin clot properties might contribute to bleeding disorders of unknown origin.	[Szczepaniak, Piotr; Zabczyk, Michal; Undas, Anetta] John Paul 2 Hosp, Krakow, Poland; [Zabczyk, Michal; Undas, Anetta] Jagiellonian Univ, Inst Cardiol, Coll Med, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University	Undas, A (corresponding author), John Paul 2 Hosp, Krakow, Poland.	mmundas@cyf-kr.edu.pl	Ząbczyk, Michał/AHA-6044-2022; Szczepaniak, Piotr/GYD-8024-2022	Ząbczyk, Michał/0000-0003-1762-308X; Szczepaniak, Piotr/0000-0003-2622-7337	 [K/ZDS/002936]		The university (grant no. K/ZDS/002936) supported the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Collet JP, 2006, ARTERIOSCL THROM VAS, V26, P2567, DOI 10.1161/01.ATV.0000241589.52950.4c; Collet JP, 1999, THROMB HAEMOSTASIS, V82, P1482; Comerota AJ, 1997, ANN SURG, V226, P306, DOI 10.1097/00000658-199709000-00010; Cote I, 2002, OBSTET GYNECOL, V100, P683, DOI 10.1016/S0029-7844(02)02094-X; Gajos G, 2010, J AM COLL CARDIOL, V55, P1671, DOI 10.1016/j.jacc.2009.11.080; HIGHAM JM, 1990, BRIT J OBSTET GYNAEC, V97, P734, DOI 10.1111/j.1471-0528.1990.tb16249.x; James AH, 2010, HAEMOPHILIA, V16, P160, DOI 10.1111/j.1365-2516.2010.02315.x; Jayo A, 2009, THROMB HAEMOSTASIS, V101, P770, DOI 10.1160/TH08-11-0777; Knol HM, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.059; Kujovich JL, 2005, AM J HEMATOL, V79, P220, DOI 10.1002/ajh.20372; Kyrle PA, 2014, POL ARCH MED WEWN, V124, P65; Lisman T, 2001, GASTROENTEROLOGY, V121, P131, DOI 10.1053/gast.2001.25481; Lord ST, 2011, ARTERIOSCL THROM VAS, V31, P494, DOI 10.1161/ATVBAHA.110.213389; Marret H, 2010, EUR J OBSTET GYN R B, V152, P133, DOI 10.1016/j.ejogrb.2010.07.016; Meltzer ME, 2010, BLOOD, V116, P113, DOI 10.1182/blood-2010-02-267740; Mutch NJ, 2010, BLOOD, V115, P3980, DOI 10.1182/blood-2009-11-254029; O'Flynn N, 2000, SOC SCI MED, V50, P651, DOI 10.1016/S0277-9536(99)00318-4; Okraska-Bylica A, 2012, POL ARCH MED WEWN, V122, P608, DOI 10.20452/pamw.1535; Oriel KA, 1999, AM FAM PHYSICIAN, V60, P1371; Pankiw-Bembenek O, 2012, THROMB HAEMOSTASIS, V107, P513, DOI 10.1160/TH11-09-0662; Peyvandi F, 2011, J THROMB HAEMOST, V9, P236, DOI 10.1111/j.1538-7836.2011.04372.x; Philipp CS, 2003, J THROMB HAEMOST, V1, P477, DOI 10.1046/j.1538-7836.2003.00061.x; Repine T, 2004, CLIN APPL THROMB-HEM, V10, P293, DOI 10.1177/107602960401000316; Undas A, 2006, J THROMB HAEMOST, V4, P1029, DOI 10.1111/j.1538-7836.2006.01882.x; Undas A, 2008, ATHEROSCLEROSIS, V196, P551, DOI 10.1016/j.atherosclerosis.2007.05.028; Undas A, 2014, THROMB HAEMOSTASIS, V112, P32, DOI 10.1160/TH14-01-0032; Undas A, 2009, STROKE, V40, P1499, DOI 10.1161/STROKEAHA.108.532812; VANEIJKEREN MA, 1991, LAB INVEST, V64, P284; VESSEY MP, 1992, BRIT J OBSTET GYNAEC, V99, P402, DOI 10.1111/j.1471-0528.1992.tb13758.x; Warner PE, 2004, AM J OBSTET GYNECOL, V190, P1216, DOI 10.1016/j.ajog.2003.11.015; Wiewel-Verschueren S, 2014, J THROMB HAEMOST, V12, P1488, DOI 10.1111/jth.12645; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001	33	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125069	10.1371/journal.pone.0125069	http://dx.doi.org/10.1371/journal.pone.0125069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909989	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800125
J	Ewan, VC; Sails, AD; Walls, AWG; Rushton, S; Newton, JL				Ewan, Victoria C.; Sails, Andrew D.; Walls, Angus W. G.; Rushton, Steven; Newton, Julia L.			Dental and Microbiological Risk Factors for Hospital-Acquired Pneumonia in Non-Ventilated Older Patients	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE-UNIT; PLAQUE ANTISEPTIC DECONTAMINATION; POTENTIAL RESPIRATORY PATHOGENS; NOSOCOMIAL INFECTIONS; BACTERIAL-COLONIZATION; ELDERLY-PEOPLE; HIP FRACTURE; IMPACT; MORTALITY	Hospital acquired pneumonia (HAP) is often fatal in older patients. The mouth is the main reservoir of infection and studies have suggested that oral hygiene interventions may prevent HAP. The aim of this study was to investigate associations between HAP and preceding a) heavy dental plaque and b) oral carriage of potential respiratory pathogens in older patients with lower limb fracture to determine the target for intervention studies. Methods We obtained a time series of tongue/throat swabs from 90 patients with lower limb fracture, aged 65-101 in a general hospital in the North East of England between April 2009-July 2010. We used novel real-time multiplex PCR assays to detect S. aureus, MRSA, E. coli, P. aeruginosa, S. pneumoniae, H. influenza and Acinetobacter spp. We collected data on dental/denture plaque (modified Quigley-Hein index) and outcomes of clinician-diagnosed HAP. Results The crude incidence of HAP was 10% (n = 90), with mortality of 80% at 90 days post discharge. 50% of cases occurred within the first 25 days. HAP was not associated with being dentate, tooth number, or heavy dental/denture plaque. HAP was associated with prior oral carriage with E. coli/S. aureus/P. aeruginosa/MRSA (p = 0.002, OR 9.48 95% CI 2.28-38.78). The incidence of HAP in those with carriage was 35% (4% without), with relative risk 6.44 (95% CI 2.04-20.34, p = 0.002). HAP was associated with increased length of stay (Fishers exact test, p=0.01), with mean 30 excess days (range -11.5-115). Target organisms were first detected within 72 hours of admission in 90% participants, but HAP was significantly associated with S. aureus/MRSA/P. aeruginosa/E. coli being detected at days 5 (OR 4.39, 95% CI1.73-11.16) or 14 (OR 6.69, 95% CI 2.40-18.60). Conclusions Patients with lower limb fracture who were colonised orally with E. coli/S. aureus/MRSA/P. aeruginosa after 5 days in hospital were at significantly greater risk of HAP (p = 0.002).	[Ewan, Victoria C.; Newton, Julia L.] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Sails, Andrew D.] Publ Hlth England, Microbiol Serv, Newcastle Lab, Newcastle Upon Tyne, Tyne & Wear, England; [Walls, Angus W. G.] Univ Edinburgh, Edinburgh Dent Inst, Edinburg, TX USA; [Rushton, Steven] Newcastle Univ, Biol Modelling, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Public Health England; Newcastle University - UK	Ewan, VC (corresponding author), Newcastle Univ, Inst Ageing, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Victoria.ewan@ncl.ac.uk		Newton, Julia/0000-0002-1249-5253	Medical Research Counciil UK [G0800440]; MRC [G0800440] Funding Source: UKRI; Medical Research Council [G0800440] Funding Source: researchfish; National Institute for Health Research [CL-2012-01-004, 2311] Funding Source: researchfish	Medical Research Counciil UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	VE received a Clinical research training fellowship from the Medical Research Counciil UK, grant number G0800440. www.mrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bassim CW, 2008, J AM GERIATR SOC, V56, P1601, DOI 10.1111/j.1532-5415.2008.01825.x; Belda J, 2005, CHEST, V128, P1571, DOI 10.1378/chest.128.3.1571; Berdal JE, 2007, CLIN MICROBIOL INFEC, V13, P476, DOI 10.1111/j.1469-0691.2006.01678.x; Binkley CJ, 2009, ORAL SURG ORAL MED O, V108, P722, DOI 10.1016/j.tripleo.2009.06.027; Brook I, 2011, J DENT RES, V90, P704, DOI 10.1177/0022034510391794; CELIS R, 1988, CHEST, V93, P318, DOI 10.1378/chest.93.2.318; Chan EY, 2007, BMJ-BRIT MED J, V334, P889, DOI 10.1136/bmj.39136.528160.BE; Chlebicki MN, 2007, CRIT CARE MED, V35, P595, DOI 10.1097/01.CCM.0000253395.70708.AC; Demidenko E., STAT MED, V26, P3385; Dickson RP, 2014, LANCET RESP MED, V2, P238, DOI 10.1016/S2213-2600(14)70028-1; DILWORTH JP, 1991, THORAX, V46, P165, DOI 10.1136/thx.46.3.165; El-Solh AA, 2004, CHEST, V126, P1575, DOI 10.1378/chest.126.5.1575; Ewan V, 2010, AGE AGEING, V39, P122, DOI 10.1093/ageing/afp166; Ewig S, 1999, AM J RESP CRIT CARE, V159, P188, DOI 10.1164/ajrccm.159.1.9803097; Fourrier F, 2000, INTENS CARE MED, V26, P1239, DOI 10.1007/s001340000585; Fourrier F, 2005, CRIT CARE MED, V33, P1728, DOI 10.1097/01.CCM.0000171537.03493.B0; Fourrier F, 1998, CRIT CARE MED, V26, P301, DOI 10.1097/00003246-199802000-00032; Freemantle N, 2012, J ROY SOC MED, V105, P74, DOI 10.1258/jrsm.2012.120009; Garcia-Alvarez F, 2010, ARCH GERONTOL GERIAT, V50, P51, DOI 10.1016/j.archger.2009.01.009; Griscelli F, 2001, J CLIN MICROBIOL, V39, P4362, DOI 10.1128/JCM.39.12.4362-4369.2001; HANSON LC, 1992, AM J MED, V92, P161, DOI 10.1016/0002-9343(92)90107-M; Health Protection Agency, 2012, ENGL NAT POINT PREV; Heo SM, 2008, CLIN INFECT DIS, V47, P1562, DOI 10.1086/593193; Khasraghi FA, 2003, ORTHOPEDICS, V26, P49; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; LEU HS, 1989, AM J EPIDEMIOL, V129, P1258, DOI 10.1093/oxfordjournals.aje.a115245; Lieberman D, 2006, J CLIN MICROBIOL, V44, P525, DOI 10.1128/JCM.44.2.525-528.2006; MAHONEY F I, 1965, Md State Med J, V14, P61; Masterton RG, 2008, J ANTIMICROB CHEMOTH, V62, P5, DOI 10.1093/jac/dkn162; Mobbs KJ, 1999, RESP MED, V93, P540, DOI 10.1016/S0954-6111(99)90152-X; Mojon P, 1997, Gerodontology, V14, P9, DOI 10.1111/j.1741-2358.1997.00009.x; Morris AC, 2009, THORAX, V64, P516, DOI 10.1136/thx.2008.110239; Morris AC, 2011, CRIT CARE MED, V39, P2218, DOI 10.1097/CCM.0b013e3182227d52; Mylotte JM, 2001, INFECT CONT HOSP EP, V22, P83, DOI 10.1086/501868; NICOLLE LE, 1986, AGE AGEING, V15, P47, DOI 10.1093/ageing/15.1.47; Niederman M S, 1990, Semin Respir Infect, V5, P173; Palmer LB, 2001, AM J RESP CRIT CARE, V164, P464, DOI 10.1164/ajrccm.164.3.2008149; Preston AJ, 1999, GERONTOLOGY, V45, P49, DOI 10.1159/000022055; QUIGLEY GA, 1962, J AM DENT ASSOC, V65, P26, DOI 10.14219/jada.archive.1962.0184; Quinn B, 2014, J NURS SCHOLARSHIP, V46, P11, DOI 10.1111/jnu.12050; Roche JJW, 2005, BMJ-BRIT MED J, V331, P1374, DOI 10.1136/bmj.38643.663843.55; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rockwood K, 2008, J AM GERIATR SOC, V56, P1213, DOI 10.1111/j.1532-5415.2008.01773.x; Rothan-Tondeur M, 2003, J AM GERIATR SOC, V51, P997, DOI 10.1046/j.1365-2389.2003.51314.x; Russell S L, 1999, Spec Care Dentist, V19, P128, DOI 10.1111/j.1754-4505.1999.tb01413.x; Saeed K, 2010, CURR ORTHOP PRACT, V21, P628, DOI 10.1097/BCO.0b013e3181f20439; SCANNAPIECO FA, 1992, CRIT CARE MED, V20, P740, DOI 10.1097/00003246-199206000-00007; Scannapieco FA, 2009, CRIT CARE, V13, DOI 10.1186/cc7967; Sumi Yasunori, 2003, Gerodontology, V20, P84, DOI 10.1111/j.1741-2358.2003.00084.x; Terpenning MS, 2001, J AM GERIATR SOC, V49, P557, DOI 10.1046/j.1532-5415.2001.49113.x; Thompson DA, 2006, ANN SURG, V243, P547, DOI 10.1097/01.sla.0000207097.38963.3b; TURESKY S, 1970, J PERIODONTOL, V41, P41, DOI 10.1902/jop.1970.41.1.41; Vergis EN, 2001, ARCH INTERN MED, V161, P2378, DOI 10.1001/archinte.161.19.2378; Yoneyama T, 2002, J AM GERIATR SOC, V50, P430, DOI 10.1046/j.1532-5415.2002.50106.x	55	27	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123622	10.1371/journal.pone.0123622	http://dx.doi.org/10.1371/journal.pone.0123622			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923662	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600052
J	Sinn, DH; Cho, JY; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Yoo, BC				Sinn, Dong Hyun; Cho, Ju-Yeon; Gwak, Geum-Youn; Paik, Yong-Han; Choi, Moon Seok; Lee, Joon Hyeok; Koh, Kwang Cheol; Paik, Seung Woon; Yoo, Byung Chul			Different Survival of Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma Patients by the Extent of Portal Vein Invasion and the Type of Extrahepatic Spread	PLOS ONE			English	Article							SURGICAL RESECTION; SORAFENIB; CHEMOEMBOLIZATION; INTERMEDIATE; CHEMOTHERAPY; RADIOTHERAPY; FEASIBILITY; IMPACT	Portal vein invasion (PVI) and extrahepatic spread (ES) are two tumor-related factors that define advanced stage in the Barcelona Clinic Liver Cancer (BCLC) staging system (BCLC stage C), and the recommended first line therapy in this stage is sorafenib. However, the extent of PVI and the type of ES may affect patient prognosis as well as treatment outcome. This study analyzed survival of BCLC stage C HCC patients in order to see whether subclassification of BCLC stage C is necessary. A total of 582 treatment naive, BCLC stage C HCC patients [age: 54.3 +/- 10.8 years, males = 494 (84.9%), hepatitis B virus (458, 78.7%)], defined by PVI and/or ES, were analyzed. Extent of PVI was divided into none, type I-segmental/ sectoral branches, type II-left and/or right portal vein, and type III-main portal vein trunk. Type of ES was divided into nodal and distant metastasis. The extent of PVI and type of ES were independent factors for survival. When patients were sub-classified according to the extent of PVI and type of ES, the median survival was significantly different [11.7 months, 5.7 months, 4.9 months and 2.3 months for C1 (PVI-O/I without distant ES), C2 (PVI-II/III without distant ES), C3 (PVI-0/I with distant ES), and C4 (PVI-II/III with distant ES), respectively, P = 0.01]. Patients' survival was different according to the treatment modality in each sub-stage. Sub-classification of BCLC stage C according to the extent of PVI and type of ES resulted in a better prediction of survival. Also, different outcome was observed by treatment modalities in each sub-stage. Sub-classification of BCLC stage C is required to minimize heterogeneity within the same tumor stage, that will help better predict survival and to select optimal treatment strategies.	[Sinn, Dong Hyun; Cho, Ju-Yeon; Gwak, Geum-Youn; Paik, Yong-Han; Choi, Moon Seok; Lee, Joon Hyeok; Koh, Kwang Cheol; Paik, Seung Woon; Yoo, Byung Chul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Gwak, GY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.	gy.gwak@samsung.com	Gwak, Geum Youn/F-4605-2014; Sinn, Dong Hyun/O-5941-2014; Sinn, Dong Hyun/L-3701-2019	Sinn, Dong Hyun/0000-0002-7126-5554; 				Bolondi L, 2012, SEMIN LIVER DIS, V32, P348, DOI 10.1055/s-0032-1329906; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cha J, 2013, YONSEI MED J, V54, P1178, DOI 10.3349/ymj.2013.54.5.1178; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Cho JY, 2014, LIVER INT, V34, P795, DOI 10.1111/liv.12445; Choi GH, 2013, RADIOLOGY, V269, P602, DOI 10.1148/radiol.13130150; Cillo U, 2013, DIGEST LIVER DIS, V45, P460, DOI 10.1016/j.dld.2013.03.010; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Hasegawa K, 2014, ANN SURG, V259, P166, DOI 10.1097/SLA.0b013e31828d4960; Kee KM, 2013, DIGEST DIS SCI, V58, P2721, DOI 10.1007/s10620-013-2716-8; Kim DY, 2012, DIGEST DIS, V30, P598, DOI 10.1159/000343088; Korean Liver Cancer Study Group and National Cancer Center Korea, 2009, Korean J Hepatol, V15, P391, DOI 10.3350/kjhep.2009.15.3.391; Lee HS, 2011, DIGEST DIS, V29, P333, DOI 10.1159/000327572; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077240; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Livraghi T, 2010, J SURG ONCOL, V102, P868, DOI 10.1002/jso.21733; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mazzaferro V, 2013, HEPATOLOGY, V57, P1826, DOI 10.1002/hep.26014; Memon K, 2013, J HEPATOL, V58, P73, DOI 10.1016/j.jhep.2012.09.003; Osaki Y, 2015, HEPATOL RES, V45, P59, DOI 10.1111/hepr.12378; Park JY, 2007, CANCER-AM CANCER SOC, V110, P129, DOI 10.1002/cncr.22759; Park KW, 2008, J GASTROEN HEPATOL, V23, P467, DOI 10.1111/j.1440-1746.2007.05112.x; Prajapati HJ, 2013, J VASC INTERV RADIOL, V24, P307, DOI 10.1016/j.jvir.2012.11.026; Shi J, 2010, ANN SURG ONCOL, V17, P2073, DOI 10.1245/s10434-010-0940-4; Yang T, 2012, J CANCER RES CLIN, V138, P1121, DOI 10.1007/s00432-012-1188-0; Yoo EJ, 2013, ONCOTARGETS THER, V6, DOI 10.2147/OTT.S45602; Yoon EL, 2014, J CLIN GASTROENTEROL, V48, pE22, DOI 10.1097/MCG.0b013e3182a54ec8	27	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124434	10.1371/journal.pone.0124434	http://dx.doi.org/10.1371/journal.pone.0124434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923439	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600086
J	Andreeva, ER; Andrianova, IV; Sotnezova, EV; Buravkov, SV; Bobyleva, PI; Romanov, YA; Buravkova, LB				Andreeva, Elena R.; Andrianova, Irina V.; Sotnezova, Elena V.; Buravkov, Sergey V.; Bobyleva, Polina I.; Romanov, Yury A.; Buravkova, Ludmila B.			Human Adipose-Tissue Derived Stromal Cells in Combination with Hypoxia Effectively Support Ex Vivo Expansion of Cord Blood Haematopoietic Progenitors	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IN-VITRO; MONONUCLEAR-CELLS; OXYGEN; MICROENVIRONMENT; PROLIFERATION; EXPRESSION; COCULTURE; MAINTAIN; CULTURE	The optimisation of haematopoietic stem and progenitor cell expansion is on demand in modern cell therapy. In this work, haematopoietic stem/progenitor cells (HSPCs) have been selected from unmanipulated cord blood mononuclear cells (cbMNCs) due to adhesion to human adipose-tissue derived stromal cells (ASCs) under standard (20%) and tissue-related (5%) oxygen. ASCs efficiently maintained viability and supported further HSPC expansion at 20% and 5% O-2. During co-culture with ASCs, a new floating population of differently committed HSPCs (HSPCs-1) grew. This suspension was enriched with CD34(+) cells up to 6 (20% O-2) and 8 (5% O-2) times. Functional analysis of HSPCs-1 revealed cobble-stone area forming cells (CAFCs) and lineage-restricted colony-forming cells (CFCs). The number of CFCs was 1.6 times higher at tissue-related O-2, than in standard cultivation (20% O-2). This increase was related to a rise in the number of multipotent precursors -BFU-E, CFU-GEMM and CFU-GM. These changes were at least partly ensured by the increased concentration of MCP-1 and IL-8 at 5% O-2. In summary, our data demonstrated that human ASCs enables the selection of functionally active HSPCs from unfractionated cbMNCs, the further expansion of which without exogenous cytokines provides enrichment with CD34+ cells. ASCs efficiently support the viability and proliferation of cord blood haematopoietic progenitors of different commitment at standard and tissue-related O-2 levels at the expense of direct and paracrine cell-to-cell interactions.	[Andreeva, Elena R.; Andrianova, Irina V.; Sotnezova, Elena V.; Bobyleva, Polina I.; Buravkova, Ludmila B.] Russian Acad Sci, Inst Biomed Problems, Moscow, Russia; [Andrianova, Irina V.; Romanov, Yury A.] Cardiol Res Ctr, Inst Expt Cardiol, Moscow 121552, Russia; [Buravkov, Sergey V.] Moscow MV Lomonosov State Univ, Fac Basic Med, Moscow, Russia	Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; National Medical Research Center of Cardiology; Lomonosov Moscow State University	Andreeva, ER (corresponding author), Russian Acad Sci, Inst Biomed Problems, Moscow, Russia.	andreeva_er@mail.ru	Sotnezova, Elena/GOP-0041-2022; Buravkova, Ludmila/B-2211-2017; Romanov, Yuri/AAB-2828-2020; Buravkov, Sergey V/K-3083-2013; Bobyleva, Polina/F-4053-2017; Andreeva, Elena/H-2512-2011	Buravkov, Sergey V/0000-0002-1461-464X; Buravkova, Ludmila/0000-0001-6994-557X; Andreeva, Elena/0000-0002-1000-5804; Romanov, Yuri/0000-0003-3748-6860; Sotnezova, Elena/0000-0002-2091-0218	Presidium of Russian Academy of Sciences; Russian Basic Research Foundation [13-04-00791]	Presidium of Russian Academy of Sciences(Russian Academy of Sciences); Russian Basic Research Foundation(Russian Foundation for Basic Research (RFBR))	This work was supported by Grant "BRMT" from Presidium of Russian Academy of Sciences (https://www.ras.ru/presidium.aspx) and Grant #13-04-00791 from Russian Basic Research Foundation (http://www.rfbr.ru/rffi/ru/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade PZ, 2015, J TISSUE ENG REGEN M, V9, P988, DOI 10.1002/term.1741; Andreeva ER, 2013, AM J BIOMEDICAL RES, V1, P7; Basciano L, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-12; BROXMEYER HE, 1990, BLOOD, V76, P1110; Buravkova LB, 2014, MITOCHONDRION, V19, P105, DOI 10.1016/j.mito.2014.07.005; Buravkova LB, 2013, BBA-GEN SUBJECTS, V1830, P4418, DOI 10.1016/j.bbagen.2013.05.029; [Буравкова Л.Б. Buravkova L.B.], 2009, [Цитология, Cell and Tissue Biology, Tsitologiya], V51, P5; Cashman JD, 1998, BLOOD, V92, P2338, DOI 10.1182/blood.V92.7.2338.2338_2338_2344; Corre J, 2006, J CELL PHYSIOL, V208, P282, DOI 10.1002/jcp.20655; Dexter T M, 1984, Prog Clin Biol Res, V148, P13; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; FAHEY TJ, 1992, J IMMUNOL, V148, P2764; Freund D, 2006, STEM CELLS DEV, V15, P815, DOI 10.1089/scd.2006.15.815; Guitart AV, 2010, EXP HEMATOL, V38, P847, DOI 10.1016/j.exphem.2010.06.002; Hammoud M, 2012, J CELL PHYSIOL, V227, P2750, DOI 10.1002/jcp.23019; Han ZC, 1997, BLOOD, V89, P2328, DOI 10.1182/blood.V89.7.2328; Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Jing DH, 2012, HAEMATOL-HEMATOL J, V97, P331, DOI 10.3324/haematol.2011.050815; Jing DH, 2010, HAEMATOL-HEMATOL J, V95, P542, DOI 10.3324/haematol.2009.010736; Kanai M, 2000, BONE MARROW TRANSPL, V26, P837, DOI 10.1038/sj.bmt.1702634; Koller M R, 1995, J Hematother, V4, P159, DOI 10.1089/scd.1.1995.4.159; KOLLER MR, 1992, BLOOD, V80, P403; KOLLER MR, 1993, BLOOD, V82, P378; Li T, 2011, BONE MARROW RES, DOI 10.1155/2011/353878; Magin AS, 2009, STEM CELLS DEV, V18, P173, DOI 10.1089/scd.2007.0273; Maslova EV, 2014, B EXP BIOL MED+, V156, P584, DOI 10.1007/s10517-014-2400-9; McNiece I, 2004, CYTOTHERAPY, V6, P311, DOI 10.1080/14653240410004871; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Nakao N, 2010, AM J PATHOL, V177, P547, DOI 10.2353/ajpath.2010.091042; Nishiwaki S, 2012, INT J HEMATOL, V96, P295, DOI 10.1007/s12185-012-1140-8; Punzel M, 2003, EXP HEMATOL, V31, P339, DOI 10.1016/S0301-472X(03)00024-9; Robinson S, 2005, CYTOTHERAPY, V7, P243, DOI 10.1080/14653240510027172; Singh RP, 2012, HIGH ALT MED BIOL, V13, P162, DOI 10.1089/ham.2012.1043; Song KD, 2009, BIOTECHNOL LETT, V31, P923, DOI 10.1007/s10529-009-9961-0; Steiner D, 2009, STEM CELLS, V27, P1932, DOI 10.1002/stem.111; Valtieri M, 2008, J CELL PHYSIOL, V217, P296, DOI 10.1002/jcp.21521; van Os Ronald P., 2008, V430, P143, DOI 10.1007/978-1-59745-182-6_10; Wagner W, 2005, STEM CELLS, V23, P1180, DOI 10.1634/stemcells.2004-0361; Wagner WG, 2007, STEM CELLS, V25, P2638, DOI 10.1634/stemcells.2007-0280; Zanjani ED, 2003, EXP HEMATOL, V31, P406, DOI 10.1016/S0301-472X(03)00051-1; Zanjani ED, 1998, EXP HEMATOL, V26, P353; Zhambalova AP, 2009, B EXP BIOL MED+, V147, P525, DOI 10.1007/s10517-009-0542-y; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	44	13	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124939	10.1371/journal.pone.0124939	http://dx.doi.org/10.1371/journal.pone.0124939			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919031	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400066
J	Daya, M; van der Merwe, L; van Helden, PD; Moller, M; Hoal, EG				Daya, Michelle; van der Merwe, Lize; van Helden, Paul D.; Moeller, Marlo; Hoal, Eileen G.			Investigating the Role of Gene-Gene Interactions in TB Susceptibility	PLOS ONE			English	Article							MISSING HERITABILITY; BENEFICIAL MUTATIONS; ASSOCIATION; EPISTASIS; TUBERCULOSIS; POLYMORPHISMS; POPULATION; STRATEGIES; VARIANTS; LOCI	Tuberculosis (TB) is the second leading cause of mortality from infectious disease worldwide. One of the factors involved in developing disease is the genetics of the host, yet the field of TB susceptibility genetics has not yielded the answers that were expected. A commonly posited explanation for the missing heritability of complex disease is gene-gene interactions, also referred to as epistasis. In this study we investigate the role of gene-gene interactions in genetic susceptibility to TB using a cohort recruited from a high TB incidence community from Cape Town, South Africa. Our discovery data set incorporates genotypes from a large a number of candidate gene studies as well as genome-wide data. After limiting our search space to pairs of putative TB susceptibility genes, as well as pairs of genes that have been curated in online databases as potential interactors, we use statistical modelling to identify pairs of interacting SNPs. We attempt to validate the top models identified in our discovery data set using an independent genome-wide TB case-control data set from The Gambia. A number of models were successfully validated, indicating that interplay between the NRG1-NRG3, GRIK1-GRIK3 and IL23R-ATG4C gene pairs may modify susceptibility to TB. Gene pairs involved in the NF-kappa B pathway were also identified in the discovery data set (SFTPD-NOD2, ISG15-TLR8 and NLRC5-IL12RB1), but could not be tested in the Gambian study group due to lack of overlapping data.	[Daya, Michelle; van der Merwe, Lize; van Helden, Paul D.; Moeller, Marlo; Hoal, Eileen G.] Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, Fac Med & Hlth Sci, Div Mol Biol & Human Genet,SA MRC Ctr TB Res, Cape Town, South Africa	National Research Foundation - South Africa; Stellenbosch University	Hoal, EG (corresponding author), Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, Fac Med & Hlth Sci, Div Mol Biol & Human Genet,SA MRC Ctr TB Res, Cape Town, South Africa.	egvh@sun.ac.za	Moller, Marlo/AAC-6973-2020; van der Merwe, Lize/C-9445-2013	Moller, Marlo/0000-0002-0805-6741; van der Merwe, Lize/0000-0001-9705-8126	South African National Research Foundation	South African National Research Foundation(National Research Foundation - South Africa)	Funding: South African National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel L, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0428; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Beltrao P, 2010, CELL, V141, P739, DOI 10.1016/j.cell.2010.05.019; Benzel I, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-31; Bhangale TR, 2008, NAT GENET, V40, P841, DOI 10.1038/ng.180; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Brinza D, 2010, BIOINFORMATICS, V26, P2856, DOI 10.1093/bioinformatics/btq529; Bush WS, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P368; Buzkova P, 2011, ANN HUM GENET, V75, P36, DOI 10.1111/j.1469-1809.2010.00572.x; Chen GJ, 2012, BIOINFORM BIOL INSIG, V6, P169, DOI 10.4137/BBI.S9867; Chimusa ER, 2014, HUM MOL GENET, V23, P796, DOI 10.1093/hmg/ddt462; Chimusa ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073971; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Collins RL, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-4; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Daya M, 2014, TUBERCULOSIS, V94, P413, DOI 10.1016/j.tube.2014.03.012; Daya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082224; DCunha J, 1996, P NATL ACAD SCI USA, V93, P211, DOI 10.1073/pnas.93.1.211; de Wit E, 2010, MAMM GENOME, P1; de Wit E, 2010, HUM GENET, V128, P145, DOI 10.1007/s00439-010-0836-1; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Edwards DRV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032275; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Emily M, 2009, EUR J HUM GENET, V17, P1231, DOI 10.1038/ejhg.2009.15; Fallahi-Sichani M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00170; FERGUSON EL, 1989, GENETICS, V123, P109; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Franke A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000691; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Fukami T, 2003, GENE, V323, P11, DOI 10.1016/j.gene.2003.09.018; Fukuhara H, 2001, ONCOGENE, V20, P5401, DOI 10.1038/sj.onc.1204696; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Gallant CJ, 2010, INT J TUBERC LUNG D, V14, P952; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Greene CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005639; Hayes MG, 2007, DIABETES, V56, P3033, DOI 10.2337/db07-0482; Hoal EG, 2004, INT J TUBERC LUNG D, V8, P1464; Hu T, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-364; Huang W, 2012, P NATL ACAD SCI USA, V109, P15553, DOI 10.1073/pnas.1213423109; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kam-Thong Tony, 2011, Eur J Hum Genet, V19, P465, DOI 10.1038/ejhg.2010.196; Kanakry CG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001369; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kerr KF, 2009, BIOINFORMATICS, V25, P2035, DOI 10.1093/bioinformatics/btp363; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kingma PS, 2006, J BIOL CHEM, V281, P24496, DOI 10.1074/jbc.M600651200; Kuenzel S, 2010, J IMMUNOL, V184, P1990, DOI 10.4049/jimmunol.0900557; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lin YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036408; Linden RO, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-45; Liu Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001338; Luce MJ, 1999, GENE, V231, P121, DOI 10.1016/S0378-1119(99)00093-1; Ma L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002714; Marballi K, 2010, J MOL MED, V88, P1133, DOI 10.1007/s00109-010-0653-y; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; McKinney BA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000432; McLeod IX, 2012, J LEUKOCYTE BIOL, V92, P409, DOI 10.1189/jlb.0612269; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Moore JH, 2007, LECT NOTES COMPUT SC, V4447, P166; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Motsinger-Reif AA, 2008, GENET EPIDEMIOL, V32, P325, DOI 10.1002/gepi.20307; Motsinger-Reif AA, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-37; MRC, 2006, REV BURD DIS EST COM; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Okser S, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-5; Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410; Patterson N, 2010, HUM MOL GENET, V19, P411, DOI 10.1093/hmg/ddp505; Pattin KA, 2008, HUM GENET, V124, P19, DOI 10.1007/s00439-008-0522-8; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quintana-Murci L, 2010, AM J HUM GENET, V86, P611, DOI 10.1016/j.ajhg.2010.02.014; R Core Team, 2021, R LANGUAGE ENV STAT; Ramos E, 2011, DIABETOLOGIA, V54, P783, DOI 10.1007/s00125-010-2002-7; Ravikumar M., 1999, Tubercle and Lung Disease, V79, P309, DOI 10.1054/tuld.1999.0213; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Rosenzweig SD, 2005, IMMUNOL REV, V203, P38, DOI 10.1111/j.0105-2896.2005.00227.x; Rothman KJ, 2014, J GEN INTERN MED, P1; Seldin MF, 2011, NAT REV GENET, V12, P523, DOI 10.1038/nrg3002; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Shriner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008398; Sinnwell JP, 2013, HAPLO STATS STAT ANA; Songane M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041618; Stein CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001189; Thye T, 2012, NAT GENET, V44, P257, DOI 10.1038/ng.1080; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Turner SD, 2010, BIODATA MIN, V3, DOI 10.1186/1756-0381-3-5; Ueki M, 2012, PLOS GENET, V8, P141, DOI 10.1371/journal.pgen.1002625; UHLINHANSEN L, 1989, J BIOL CHEM, V264, P14916; Velez DR, 2009, INT J TUBERC LUNG D, V13, P1068; Warnes G, 2012, GENETICS POPULATION; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Wellek S, 2009, HUM HERED, V67, P128, DOI 10.1159/000179560; Wenning AS, 2011, BBA-MOL CELL RES, V1813, P412, DOI 10.1016/j.bbamcr.2010.12.022; White MJ, 2014, GENES IMMUN, V15, P370, DOI 10.1038/gene.2014.28; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; World Health Organization, 2021, 10 THREATS GLOB HLTH; Wu XS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001131; Zhang X, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-1; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	110	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123970	10.1371/journal.pone.0123970	http://dx.doi.org/10.1371/journal.pone.0123970			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919455	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400038
J	Li, N; An, LL; Hang, HY				Li, Nan; An, Lili; Hang, Haiying			Increased Sensitivity of DNA Damage Response-Deficient Cells to Stimulated Microgravity-Induced DNA Lesions	PLOS ONE			English	Article							SENSOR RAD9-RAD1-HUS1 INTERACTS; RAD9 PLAYS; CHECKPOINT CLAMP; LIGASE-I; REPAIR; STABILITY; MDC1; PROLIFERATION; DELETION; PROTEIN	Microgravity is a major stress factor that astronauts have to face in space. In the past, the effects of microgravity on genomic DNA damage were studied, and it seems that the effect on genomic DNA depends on cell types and the length of exposure time to microgravity or simulated microgravity (SMG). In this study we used mouse embryonic stem (MES) and mouse embryonic fibroblast (MEF) cells to assess the effects of SMG on DNA lesions. To acquire the insight into potential mechanisms by which cells resist and/or adapt to SMG, we also included Rad9-deleted MES and Mdc1-deleted MEF cells in addition to wild type cells in this study. We observed significant SMG-induced DNA double strand breaks (DSBs) in Rad9(-/-) MES and Mdc1(-/-) MEF cells but not in their corresponding wild type cells. A similar pattern of DNA single strand break or modifications was also observed in Rad9(-/-) MES. As the exposure to SMG was prolonged, Rad9(-/-) MES cells adapted to the SMG disturbance by reducing the induced DNA lesions. The induced DNA lesions in Rad9(-/-) MES were due to SMG-induced reactive oxygen species (ROS). Interestingly, Mdc1(-/-) MEF cells were only partially adapted to the SMG disturbance. That is, the induced DNA lesions were reduced over time, but did not return to the control level while ROS returned to a control level. In addition, ROS was only partially responsible for the induced DNA lesions in Mdc1(-/-) MEF cells. Taken together, these data suggest that SMG is a weak genomic DNA stress and can aggravate genomic instability in cells with DNA damage response (DDR) defects.	[Li, Nan; An, Lili; Hang, Haiying] Chinese Acad Sci, Inst Biophys, Key Lab Prot & Peptide Pharmaceut, Beijing 100080, Peoples R China; [Li, Nan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	An, LL (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Prot & Peptide Pharmaceut, Beijing 100080, Peoples R China.	afxdxz@163.com; hh91@sun5.ibp.ac.cn			Chinese Academy of Sciences [XDA04020202-13, XDA04020413]; National Natural Science Foundation of China [111790400, 31370792]; Ministry of Science and Technology of People's Republic of China [2011YQ03013404]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of People's Republic of China(Ministry of Science and Technology, China)	This work was supported by the Strategic Priority Research Program on Space Science, the Chinese Academy of Sciences (XDA04020202-13 and XDA04020413, HYH); the National Natural Science Foundation of China (No. 111790400, LLA); the National Natural Science Foundation of China (No. 31370792, HYH); and the Ministry of Science and Technology of People's Republic of China (No. 2011YQ03013404, HYH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An LL, 2010, J BIOL CHEM, V285, P35267, DOI 10.1074/jbc.M110.161208; Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Bai HB, 2010, DNA REPAIR, V9, P478, DOI 10.1016/j.dnarep.2010.01.011; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Buggisch M, 2007, J CELL SCI, V120, P885, DOI 10.1242/jcs.03386; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Coster G, 2010, NUCLEUS-PHILA, V1, P166, DOI 10.4161/nucl.1.2.11176; Degan P, 2005, J CELL BIOCHEM, V94, P460, DOI 10.1002/jcb.20302; Durante M, 2003, CYTOGENET GENOME RES, V103, P40, DOI 10.1159/000076288; Friedrich-Heineken F, 2005, J MOL BIOL, V353, P980, DOI 10.1016/j.jmb.2005.09.018; Gembka A, 2007, NUCLEIC ACIDS RES, V35, P2596, DOI 10.1093/nar/gkl1139; Guan X, 2007, NUCLEIC ACIDS RES, V35, P6207, DOI 10.1093/nar/gkm678; Guan X, 2007, NUCLEIC ACIDS RES, V35, P2463, DOI 10.1093/nar/gkm075; He W, 2008, NUCLEIC ACIDS RES, V36, P6406, DOI 10.1093/nar/gkn686; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hopkins KM, 2004, MOL CELL BIOL, V24, P7235, DOI 10.1128/MCB.24.16.7235-7248.2004; Hu Z, 2008, CANCER RES, V68, P5552, DOI 10.1158/0008-5472.CAN-07-5670; Huang Xuan, 2006, Methods Mol Biol, V314, P73; [蒋远大 JIANG Yuanda], 2008, [航天医学与医学工程, Space Medicine & Medical Engineering], V21, P368; Jungmichel S, 2010, CHROMOSOMA, V119, P337, DOI 10.1007/s00412-010-0266-9; Kumari R, 2009, J CELL BIOCHEM, V107, P723, DOI 10.1002/jcb.22171; Li TP, 2013, DNA REPAIR, V12, P284, DOI 10.1016/j.dnarep.2013.01.006; Lieberman HB, 2006, J CELL BIOCHEM, V97, P690, DOI 10.1002/jcb.20759; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Marechal A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012716; Matise M, 2000, APPROACH GTAP, P111; Minter-Dykhouse K, 2008, J CELL BIOL, V181, P727, DOI 10.1083/jcb.200801083; Ohnishi T, 1999, Biol Sci Space, V13, P82; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Roberts JE, 2006, MOL VIS, V12, P633; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Shen YC, 2001, MOL PHARMACOL, V60, P1083, DOI 10.1124/mol.60.5.1083; Shi GL, 2006, BIOCHEM J, V400, P53, DOI 10.1042/BJ20060774; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Song W, 2007, J BIOL CHEM, V282, P22721, DOI 10.1074/jbc.M703774200; Wang JH, 2009, NEUROCHEM INT, V55, P710, DOI 10.1016/j.neuint.2009.07.002; Wang WS, 2006, J BIOL CHEM, V281, P20865, DOI 10.1074/jbc.M602289200; Wang YXJ, 2011, QUANT IMAGING MED SU, V1, P1, DOI 10.3978/j.issn.2223-4292.2011.09.01; Yildiz L, 2002, CLIN CHEM LAB MED, V40, P612, DOI 10.1515/CCLM.2002.106; Yin YX, 2004, P NATL ACAD SCI USA, V101, P8864, DOI 10.1073/pnas.0403130101; Zhang CB, 2008, CELL PHYSIOL BIOCHEM, V22, P295, DOI 10.1159/000149808	44	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125236	10.1371/journal.pone.0125236	http://dx.doi.org/10.1371/journal.pone.0125236			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915950	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100111
J	Park, JS; Halegoua, S; Kishida, S; Neiman, AM				Park, Jae-Sook; Halegoua, Simon; Kishida, Shosei; Neiman, Aaron M.			A Conserved Function in Phosphatidylinositol Metabolism for Mammalian Vps13 Family Proteins	PLOS ONE			English	Article							PHEOCHROMOCYTOMA CELLS; CHOREA-ACANTHOCYTOSIS; PLASMA-MEMBRANE; ACTIN; POLYMERIZATION; LOCALIZATION; SPORULATION; SENSITIVITY; DOMAINS; SYSTEM	The Vps13 protein family is highly conserved in eukaryotic cells. In humans, mutations in the gene encoding the family member VPS13A lead to the neurodegenerative disorder chorea-acanthocytosis. In the yeast Saccharomyces cerevisiae, there is just a single version of VPS13, thereby simplifying the task of unraveling its molecular function(s). While VPS13 was originally identified in yeast by its role in vacuolar sorting, recent studies have revealed a completely different function for VPS13 in sporulation, where VPS13 regulates phosphatidylinositol-4-phosphate (PtdIns(4) P) levels in the prospore membrane. This discovery raises the possibility that the disease phenotype associated with vps13A mutants in humans is due to misregulation of PtdIns(4) P in membranes. To determine whether VPS13A affects PtdIns(4) P in membranes from mammalian neuronal cells, phosphatidylinositol phosphate pools were compared in PC12 tissue culture cells in the absence or presence of VPS13A. Consistent with the yeast results, the localization of PtdIns(4) P is specifically altered in VPS13A knockdown cells while other phosphatidylinositol phosphates appear unaffected. In addition, VPS13A is necessary to prevent the premature degeneration of neurites that develop in response to Nerve Growth Factor. The regulation of PtdIns(4) P is therefore a conserved function of the Vps13 family and may play a role in the maintenance of neuronal processes in mammals.	[Park, Jae-Sook; Neiman, Aaron M.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Halegoua, Simon] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Kishida, Shosei] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Kagoshima University	Neiman, AM (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	aaron.neiman@stonybrook.edu		kishida, shosei/0000-0003-0405-851X; Neiman, Aaron/0000-0002-6600-6996	NIH [R01 GM072540]; Hartman Center for Parkinson's Research at SBU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072540] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartman Center for Parkinson's Research at SBU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH grant R01 GM072540 to and a research grant from the Advocacy for Neuroacanthocytosis Patients www.naadvocacy.org to AMN and the Hartman Center for Parkinson's Research at SBU to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alesutan I, 2013, CELL PHYSIOL BIOCHEM, V32, P728, DOI 10.1159/000354475; An XL, 2006, BIOCHEMISTRY-US, V45, P5725, DOI 10.1021/bi060015v; An XL, 2005, BIOCHEMISTRY-US, V44, P10681, DOI 10.1021/bi047331z; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; BANKAITIS VA, 1986, P NATL ACAD SCI USA, V83, P9075, DOI 10.1073/pnas.83.23.9075; Brickner JH, 1997, J CELL BIOL, V139, P23, DOI 10.1083/jcb.139.1.23; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; DECKWERTH TL, 1994, DEV BIOL, V165, P63, DOI 10.1006/dbio.1994.1234; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Foller M, 2012, FASEB J, V26, P1526, DOI 10.1096/fj.11-198317; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HARDIE RJ, 1991, BRAIN, V114, P13; Hayashi T, 2012, BIOCHEM BIOPH RES CO, V419, P511, DOI 10.1016/j.bbrc.2012.02.047; Henkel K, 2006, MOVEMENT DISORD, V21, P1728, DOI 10.1002/mds.21046; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Nakanishi H, 2007, J CELL SCI, V120, P908, DOI 10.1242/jcs.03405; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Neiman AM, 2011, GENETICS, V189, P737, DOI 10.1534/genetics.111.127126; Park JS, 2012, J CELL SCI; Park JS, 2013, EUKARYOT CELL; PITTMAN RN, 1993, J NEUROSCI, V13, P3669; Rampoldi L, 2001, NAT GENET, V28, P119, DOI 10.1038/88821; Schmidt EM, 2013, FASEB J, V27, P2799, DOI 10.1096/fj.13-229286; Shiokawa N, 2013, BIOCHEM BIOPH RES CO, V441, P96, DOI 10.1016/j.bbrc.2013.10.011; Sinnamon JR, 2012, RNA, V18, P704, DOI 10.1261/rna.030742.111; Tomemori Y, 2005, J NEUROCHEM, V92, P759, DOI 10.1111/j.1471-4159.2004.02924.x; Ueno S, 2001, NAT GENET, V28, P121, DOI 10.1038/88825; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012; Walker RH, 2008, NEUROACANTHOCYTOSIS SYNDROMES II, P3, DOI 10.1007/978-3-540-71693-8_1; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X	36	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124836	10.1371/journal.pone.0124836	http://dx.doi.org/10.1371/journal.pone.0124836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915401	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659100071
J	Wu, CH; Li, KJ; Yu, CL; Tsai, CY; Hsieh, SC				Wu, Cheng-Han; Li, Ko-Jen; Yu, Chia-Li; Tsai, Chang-Youh; Hsieh, Song-Chou			Sjogren's Syndrome Antigen B Acts as an Endogenous Danger Molecule to Induce Interleukin-8 Gene Expression in Polymorphonuclear Neutrophils	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; DENDRITIC CELLS; CYTOKINES; AUTOANTIGENS; ACTIVATION; DISEASE; LUPUS; DIFFERENTIATION; AUTOANTIBODIES; INFLAMMATION	Background Sjogren's syndrome antigen B is expressed in the nucleus and surface membrane of human polymorphonuclear neutrophils and is released after cell death. However, its biological role is not clear. This study is aimed to investigate the effect of Sjogren's syndrome antigen B on human polymorphonuclear neutrophils. Methods Human recombinant Sjogren's syndrome antigen B (rSSB) purified from E. coli was incubated with human polymorphonuclear neutrophils as well as retinoid acid-induced granulocytic differentiated HL-60 cells, HL-60 (RA). Interleukin (IL)-8 protein production and mRNA expressions were measured by enzyme-linked immunosorbent assay and quantitative-polymerase chain reaction, respectively. Uptake of fluorescein isothiocyanate (FITC)-rSSB was assessed by flow cytometry and fluorescence microscopy. Moreover, mitogen-activated protein kinase (MAPK) pathways and nuclear factor-kappaB activation were investigated. Results Human rSSB stimulated IL-8 production from normal human neutrophils and HL-60 (RA) cells in a time-and dose-dependent manner. This IL-8-stimulated activity was blocked by chloroquine and NH4Cl, indicating that endosomal acidification is important for this effect. We found rSSB activated both MAPK pathway and nuclear factor-kappaB signaling to transcribe the IL-8 gene expression of cells. Furthermore, tumor necrosis factor-a exerted an additive effect and rSSB-anti-SSB immune complex exhibited a synergistic effect on rSSB-induced IL-8 production. Conclusions Sjogren's syndrome antigen B might act as an endogenous danger molecule to enhance IL-8 gene expression in human polymorphonuclear neutrophils.	[Wu, Cheng-Han] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Li, Ko-Jen] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Wu, Cheng-Han; Li, Ko-Jen; Yu, Chia-Li; Hsieh, Song-Chou] Natl Taiwan Univ Hosp, Dept Internal Med, Div Immunol Rheumatol & Allergy, Taipei 100, Taiwan; [Wu, Cheng-Han; Li, Ko-Jen; Yu, Chia-Li; Hsieh, Song-Chou] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Yu, Chia-Li] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10764, Taiwan; [Tsai, Chang-Youh] Taipei Vet Gen Hosp, Sect Allergy Immunol & Rheumatol, Taipei, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Taipei Veterans General Hospital	Hsieh, SC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Immunol Rheumatol & Allergy, Taipei 100, Taiwan.	hsiehsc@ntu.edu.tw	Tsai, Chang-Youh/G-1747-2013	Tsai, Chang-Youh/0000-0002-4154-4018; LI, KO-JEN/0000-0002-4544-4620	Ministry of Science and Technology, Taiwan [MOST 99-2314-B-002-079-MY2, MOST 101-2314-B-002-159-]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Ministry of Science and Technology, Taiwan (http://www.most.gov.tw), Grant number: MOST 99-2314-B-002-079-MY2, MOST 101-2314-B-002-159- to CHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Bethke K, 2002, J IMMUNOL, V169, P6141, DOI 10.4049/jimmunol.169.11.6141; Betteridge ZE, 2009, CURR OPIN RHEUMATOL, V21, P604, DOI 10.1097/BOR.0b013e328331638a; Bondanza A, 2004, ARTHRITIS RHEUM-US, V50, P1549, DOI 10.1002/art.20187; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Brito-Zeron P, 2009, SEMIN ARTHRITIS RHEU, V38, P389, DOI 10.1016/j.semarthrit.2008.01.014; Bruce A., 2002, MOL BIOL CELL, V4th ed.; CASSATELLA MA, 1993, J EXP MED, V178, P2207, DOI 10.1084/jem.178.6.2207; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; Cassatella MA, 1999, ADV IMMUNOL, V73, P369, DOI 10.1016/S0065-2776(08)60791-9; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Deshmukh US, 2008, ARTHRITIS RHEUM-US, V58, P1318, DOI 10.1002/art.23368; Elst EF, 2008, ARTHRITIS RHEUM-US, V58, P547, DOI 10.1002/art.23202; Ford LP, 2001, RNA, V7, P1068, DOI 10.1017/S1355838201010159; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; GOTTLIEB E, 1989, EMBO J, V8, P851, DOI 10.1002/j.1460-2075.1989.tb03446.x; Hedegaard CJ, 2008, IMMUNOLOGY, V125, P161, DOI 10.1111/j.1365-2567.2008.02837.x; Henson PM, 2005, NAT IMMUNOL, V6, P1179, DOI 10.1038/ni1205-1179; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Howard OMZ, 2006, CURR OPIN RHEUMATOL, V18, P642, DOI 10.1097/01.bor.0000245728.40630.27; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Hsieh SC, 2003, CLIN EXP IMMUNOL, V131, P506, DOI 10.1046/j.1365-2249.2003.02084.x; Kaplan MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4325; Lazarowski ER, 1997, J BIOL CHEM, V272, P24348, DOI 10.1074/jbc.272.39.24348; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Oppenheim JJ, 2005, J LEUKOCYTE BIOL, V77, P854, DOI 10.1189/jlb.1004623; Pittoni Valerio, 2002, Autoimmunity Reviews, V1, P154, DOI 10.1016/S1568-9972(02)00032-0; Plotz PH, 2003, NAT REV IMMUNOL, V3, P73, DOI 10.1038/nri976; Rock KL, 2005, SPRINGER SEMIN IMMUN, V26, P231, DOI 10.1007/s00281-004-0173-3; Schnurr M, 2000, J IMMUNOL, V165, P4704, DOI 10.4049/jimmunol.165.8.4704; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Streicher KL, 2007, MOL CANCER RES, V5, P847, DOI 10.1158/1541-7786.MCR-06-0427; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Sutterwala FS, 2007, J LEUKOCYTE BIOL, V82, P259, DOI 10.1189/jlb.1206755; Torsteinsdottir I, 1998, CLIN EXP RHEUMATOL, V16, P255; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; van Woerkom JM, 2004, CLIN EXP RHEUMATOL, V22, P285; VANVENROOIJ WJ, 1991, J IMMUNOL METHODS, V140, P181, DOI 10.1016/0022-1759(91)90369-Q; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Yoshida H, 2002, ARTHRITIS RHEUM, V46, P2235, DOI 10.1002/art.10441	46	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125501	10.1371/journal.pone.0125501	http://dx.doi.org/10.1371/journal.pone.0125501			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915936	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100132
J	Adams, AM; Nababan, HY; Hanifi, SMMA				Adams, Alayne M.; Nababan, Herfina Y.; Hanifi, S. M. Manzoor Ahmed			Building Social Networks for Maternal and Newborn Health in Poor Urban Settlements: A Cross-Sectional Study in Bangladesh	PLOS ONE			English	Article							DELIVERY; BEHAVIOR; IMPACT	Background The beneficial influence of social networks on health and wellbeing is well-established. In poor urban settlements in Bangladesh, BRAC's Manoshi programme trains community health workers (CHWs) to support women through pregnancy, delivery and postpartum periods. This paper test the hypothesis that the introduction of CHWs as weak ties into the social networks of Manoshi members mediates improvements in maternal and neonatal health (MNH) best practices by providing support, facilitating ideational change, connecting mother to resources, and strengthening or countering the influence of strong ties. Methods 1000 women who had given birth in the last three months were identified and interviewed as part of ongoing monitoring of 5 poor urban settlements in Dhaka, Bangladesh. A social networks questionnaire was administered which elicited women's perceived networks around pregnancy, delivery and post-partum periods. Mediation analysis was performed to test the hypothesis that penetration of Manoshi CHWs into women's perceived networks has a beneficial effect on MNH best practises. Results The presence and influence of Manoshi CHWs in women's networks significantly mediated the effect of Manoshi membership on MNH best practices. Respondents who were Manoshi members and who listed Manoshi CHWs as part of their support networks were significantly more likely to deliver with a trained birth attendant (OR 3.61; 95% CI 2.36-5.51), to use postnatal care (OR 3.09; 95% CI 1.83-5.22), and to give colostrum to their newborn (OR 7.51; 95% CI 3.51-16.05). Conclusion Manoshi has succeeded in penetrating the perceived pregnancy, delivery and post-partum networks of poor urban women through the introduction of trained CHWs. Study findings demonstrate the benefits of moving beyond urban health care delivery models that concentrate on the provision of clinical services by medical providers, to an approach that nurtures the power of social networks as a means to support the poorest and most marginalized in changing behaviour and effectively accessing appropriate maternal services.	[Adams, Alayne M.; Nababan, Herfina Y.; Hanifi, S. M. Manzoor Ahmed] Int Ctr Diarrhoeal Dis Res, Ctr Equ & Hlth Syst, Dhaka 1000, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR)	Adams, AM (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Equ & Hlth Syst, GPO Box 128, Dhaka 1000, Bangladesh.	aadams@icddrb.org		Hanifi, Manzoor A./0000-0002-1483-5557; Nababan, Herfina/0000-0002-7818-4132; Adams, Alayne/0000-0002-0961-9825	Bill and Melinda Gates Foundation [GR-00535]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research activity was part of the study titled "Community-based Maternal, Newborn, and Child Health Program (Manoshi) for Urban Bangladesh" funded by Bill and Melinda Gates Foundation (Grant number GR-00535). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The activities of Bill and Melinda Gates Foundation can be found in http://www.gatesfoundation.org/	Adams AM, 2002, SOC SCI MED, V54, P165, DOI 10.1016/S0277-9536(01)00017-X; Afsana K, 2009, MANOSHI PROGRAM IMPR; Ahmed SM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-663; Alam N, 2011, MANOSHI COMMUNITY HL; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Due P, 1999, SOC SCI MED, V48, P661, DOI 10.1016/S0277-9536(98)00381-5; Eng PM, 2002, AM J EPIDEMIOL, V155, P700, DOI 10.1093/aje/155.8.700; Feeney BC, 2003, PERS SOC PSYCHOL B, V29, P950, DOI 10.1177/0146167203252807; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fortuny G, 2011, URBAN PARTNERSHIPS P; Friedman AR, 2006, HEALTH PROMOT PRACT, V7, pS96, DOI 10.1177/1524839906287065; Gayen K, 2007, SOC SCI MED, V65, P900, DOI 10.1016/j.socscimed.2007.03.037; Gayen K, 2010, SOC SCI MED, V71, P1584, DOI 10.1016/j.socscimed.2010.08.002; Granovetter M., 1983, SOCIOLOGICAL THEORY, V1, P201, DOI [10.2307/202051, DOI 10.2307/202051]; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Haider Rukhsana, 2002, J Hum Lact, V18, P7, DOI 10.1177/089033440201800102; Heaney C.A., 2008, HLTH BEHAV HLTH ED T, V4, P189, DOI DOI 10.1177/109019818501200106; Kincaid DL, 2000, SOC SCI MED, V50, P215, DOI 10.1016/S0277-9536(99)00276-2; Marsden PV, 2002, SOC NETWORKS, V24, P407, DOI 10.1016/S0378-8733(02)00016-3; Nahar S, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-11; NIPORT MEASURE UNC and ICDDRb, 2014, BANGL URB HLTH SURV; Phillips JF, 2003, INT FAM PLAN PERSPEC, V29, P138, DOI 10.2307/3181080; Poortinga W, 2012, HEALTH PLACE, V18, P286, DOI 10.1016/j.healthplace.2011.09.017; ROOK KS, 1984, J PERS SOC PSYCHOL, V46, P1097, DOI 10.1037/0022-3514.46.5.1097; Rosenquist JN, 2011, CURR OPIN PSYCHIATR, V24, P139, DOI 10.1097/YCO.0b013e3283438061; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; The Commission on Paternal Involvement in Pregnancy Outcomes, 2010, COMM OUTL BEST PROM; United Nations, 2012, WORLD URB PROSP 2011; United Nations, 2014, WORLD URB PROSP 2014, DOI [10.1007/978-1-4614-8887-3_1, DOI 10.1007/978-1-4614-8887-3_1]; Walsham M, 2011, C SOC PROT DHAK BANG; World Health Organization, 1998, BAS NEWB RES PRACT G; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R	34	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123817	10.1371/journal.pone.0123817	http://dx.doi.org/10.1371/journal.pone.0123817			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG6AH	25910191	Green Submitted, gold, Green Published			2022-12-27	WOS:000353376800048
J	Anzalone, A; Gabriel, M; Estrada, LC; Gratton, E				Anzalone, Andrea; Gabriel, Manuela; Estrada, Laura C.; Gratton, Enrico			Spectral Properties of Single Gold Nanoparticles in Close Proximity to Biological Fluorophores Excited by 2-Photon Excitation	PLOS ONE			English	Article							DYNAMICS; ENHANCEMENT	Metallic nanoparticles (NPs) are able to modify the excitation and emission rates (plasmonic enhancement) of fluorescent molecules in their close proximity. In this work, we measured the emission spectra of 20 nm Gold Nanoparticles (AuNPs) fixed on a glass surface submerged in a solution of different fluorophores using a spectral camera and 2-photon excitation. While on the glass surface, we observed the presence in the emission at least 3 components: i) second harmonic signal (SHG), ii) a broad emission from AuNPS and iii) fluorescence arising from fluorophores nearby. When on the glass surface, we found that the 3 spectral components have different relative intensities when the incident direction of linear polarization was changed indicating different physical origins for these components. Then we measured by fluctuation correlation spectroscopy (FCS) the scattering and fluorescence signal of the particles alone and in a solution of 100 nM EGFP using the spectral camera or measuring the scattering and fluorescence from the particles. We observed occasional fluorescence bursts when in the suspension we added fluorescent proteins. The spectrum of these burst was devoid of the SHG and of the broad emission in contrast to the signal collected from the gold nanoparticles on the glass surface. Instead we found that the spectrum during the burst corresponded closely to the spectrum of the fluorescent protein. An additional control was obtained by measuring the cross-correlation between the reflection from the particles and the fluorescence arising from EGFP both excited at 488 nm. We found a very weak cross-correlation between the AuNPs and the fluorescence confirming that the burst originate from a few particles with a fluorescence signal.	[Anzalone, Andrea; Gabriel, Manuela; Estrada, Laura C.; Gratton, Enrico] Univ Calif Irvine, Fluorescence Dynam Lab, Dept Biomed Engn, Irvine, CA 92697 USA; [Gratton, Enrico] Univ New England, Ctr Bioact Discovery Hlth & Ageing, Sch Sci & Technol, Armidale, NSW, Australia	University of California System; University of California Irvine; University of New England	Gratton, E (corresponding author), Univ Calif Irvine, Fluorescence Dynam Lab, Dept Biomed Engn, Irvine, CA 92697 USA.	egratton@uci.edu			National Institutes of Health NIH [P41 GM103540, P50-GM076516]; Universidad de Buenos Aires [20020130300045BA]; ANPCyT [PICT 2013-2340]; Laboratory for Fluorescence Dynamics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103540, P50GM076516] Funding Source: NIH RePORTER	National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Universidad de Buenos Aires(University of Buenos Aires); ANPCyT(ANPCyT); Laboratory for Fluorescence Dynamics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health NIH (P41 GM103540 and P50-GM076516 to EG, RD, LCE. MG was supported by grants from Universidad de Buenos Aires (20020130300045BA) and from ANPCyT (Prestamo BID PICT 2013-2340) and funds from the Laboratory for Fluorescence Dynamics. LCE is member of CONICET and MG a fellow from CIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzalone A, 2014, JOVE-J VIS EXP, DOI 10.3791/51794; Aslan K, 2005, CURR OPIN CHEM BIOL, V9, P538, DOI 10.1016/j.cbpa.2005.08.021; Biswas A, 2010, NANOSCALE, V2, P1560, DOI 10.1039/c0nr00133c; Estrada LC, 2012, CHEMPHYSCHEM, V13, P1087, DOI 10.1002/cphc.201100771; Estrada LC, 2012, J PHYS CHEM B, V116, P2306, DOI 10.1021/jp209467t; Estrada LC, 2011, NANO LETT, V11, P4656, DOI 10.1021/nl2022042; Estrada LC, 2008, OPT EXPRESS, V16, P20597, DOI 10.1364/OE.16.020597; Eustis S, 2006, CHEM SOC REV, V35, P209, DOI 10.1039/b514191e; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Kis-Petikova K, 2004, MICROSC RES TECHNIQ, V63, P34, DOI 10.1002/jemt.10417; Levi V, 2008, CHROMOSOME RES, V16, P439, DOI 10.1007/s10577-008-1240-8; Levi V, 2007, CELL BIOCHEM BIOPHYS, V48, P1, DOI 10.1007/s12013-007-0010-0; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Tam F, 2007, NANO LETT, V7, P496, DOI 10.1021/nl062901x; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518	16	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124975	10.1371/journal.pone.0124975	http://dx.doi.org/10.1371/journal.pone.0124975			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909648	Green Published, gold			2022-12-27	WOS:000353376800119
J	Fan, FX; Du, PC; Kan, B; Yan, MY				Fan, Fenxia; Du, Pengcheng; Kan, Biao; Yan, Meiying			The Development and Evaluation of a Loop-Mediated Isothermal Amplification Method for the Rapid Detection of Salmonella enterica serovar Typhi	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; DIAGNOSTIC-TESTS; FEVER; BLOOD; PCR; POPULATION; PAKISTAN; INDIA	Typhoid fever remains a public health threat in many countries. A positive result in traditional culture is a gold-standard for typhoid diagnosis, but this method is time consuming and not sensitive enough for detection of samples containing a low copy number of the target organism. The availability of the loop-mediated isothermal amplification (LAMP) assay, which offers high speed and simplicity in detection of specific targets, has vastly improved the diagnosis of numerous infectious diseases. However, little research efforts have been made on utilizing this approach for diagnosis of Salmonella enterica serovar Typhi by targeting a single and specific gene. In this study, a LAMP assay for rapid detection of S. Typhi based on a novel marker gene, termed STY2879-LAMP, was established and evaluated with realtime PCR (RT-PCR). The specificity tests showed that STY2879 could be amplified in all S. Typhi strains isolated in different years and regions in China, whereas no amplification was observable in non-typhoidal strains covering 34 Salmonella serotypes and other pathogens causing febrile illness. The detection limit of STY2879-LAMP for S. Typhi was 15 copies/reaction in reference plasmids, 200 CFU/g with simple heat-treatment of DNA extracted from simulated stool samples and 20 CFU/ml with DNA extracted from simulated blood samples, which was 10 fold more sensitive than the parallel RT-PCR control experiment. Furthermore, the sensitivity of STY2879-LAMP and RT-PCR combining the traditional culture enrichment method for simulated stool and blood spiked with lower S. Typhi count during the 10 h enrichment time was also determined. In comparison with LAMP, the positive reaction time for RT-PCR required additional 2-3 h enrichment time for either simulated stool or blood specimens. Therefore, STY2879-LAMP is of practical value in the clinical settings and has a good potential for application in developing regions due to its easy-to-use protocol.	[Fan, Fenxia; Du, Pengcheng; Kan, Biao; Yan, Meiying] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Fan, Fenxia; Du, Pengcheng; Kan, Biao; Yan, Meiying] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Kan, B (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	kanbiao@icdc.cn; yanmeiying@icdc.cn			Ministry of Health, China [2012ZX10004215, 2008ZX10004-008]	Ministry of Health, China	This work was supported by the Priority Project on Infectious Disease Control and Prevention (2012ZX10004215 and 2008ZX10004-008) from the Ministry of Health, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2009, EPIDEMIOL INFECT, V137, P102, DOI 10.1017/S0950268808000654; Ali K, 2006, SAUDI MED J, V27, P1134; Ambati SR, 2007, INDIAN J PEDIATR, V74, P909, DOI 10.1007/s12098-007-0167-y; Baker S, 2005, J CLIN MICROBIOL, V43, P4418, DOI 10.1128/JCM.43.9.4418-4425.2005; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P78, DOI 10.1136/bmj.333.7558.78; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Dong B, 2007, EPIDEMIOL INFECT, V135, P1014, DOI 10.1017/S0950268806007801; Fan FenXia, 2012, Disease Surveillance, V27, P325; Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x; He PY, 2012, THESIS SUZHOU U; Jaffery G, 2004, ANN PATH C 2003 PAK; Kawano RL, 2007, J CLIN MICROBIOL, V45, P246, DOI 10.1128/JCM.01403-06; Kumar A, 2010, BIOTECHNOL LETT, V32, P707, DOI 10.1007/s10529-010-0211-2; Kumar R, 2006, TROP MED INT HEALTH, V11, P41, DOI 10.1111/j.1365-3156.2005.01538.x; Levy H, 2008, J CLIN MICROBIOL, V46, P1861, DOI 10.1128/JCM.00109-08; Mahbubur Rahman P-LL, 2005, 6 INT C TYPH FEV SAL; Malorny B, 2004, APPL ENVIRON MICROB, V70, P7046, DOI 10.1128/AEM.70.12.7046-7052.2004; Massi Muhammad Nasrum, 2003, Journal of Infection and Chemotherapy, V9, P233, DOI 10.1007/s10156-003-0256-4; Maurya P, 2010, SE ASIAN J TROP MED, V41, P913; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Murdoch DR, 2004, AM J TROP MED HYG, V70, P670, DOI 10.4269/ajtmh.2004.70.670; Naheed A, 2008, DIAGN MICR INFEC DIS, V61, P381, DOI 10.1016/j.diagmicrobio.2008.03.018; Nakhla I, 2011, DIAGN MICR INFEC DIS, V70, P435, DOI 10.1016/j.diagmicrobio.2011.03.020; Nie K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052486; Nizami SQ, 2006, SCAND J CLIN LAB INV, V66, P429, DOI 10.1080/00365510600791724; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Olsen SJ, 2004, J CLIN MICROBIOL, V42, P1885, DOI 10.1128/JCM.42.5.1885-1889.2004; Parry CM, 2011, EXPERT REV ANTI-INFE, V9, P711, DOI [10.1586/eri.11.47, 10.1586/ERI.11.47]; PETIT PLC, 1994, E AFR MED J, V71, P183; Sharma V, 1995, Indian J Med Sci, V49, P157; Singh A, 2014, APPL BIOCH BIOTECHNO; Wain J, 1998, J CLIN MICROBIOL, V36, P1683, DOI 10.1128/JCM.36.6.1683-1687.1998; World Health Organization, 2003, COMM DIS SURV RESP V	33	26	31	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124507	10.1371/journal.pone.0124507	http://dx.doi.org/10.1371/journal.pone.0124507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910059	gold, Green Submitted, Green Published			2022-12-27	WOS:000353376800086
J	Wu, SQ; Xu, R; Wan, Q; Zhu, X; Zhang, L; Jiang, HY; Zhao, XK				Wu, Shuiqing; Xu, Ran; Wan, Qi; Zhu, Xuan; Zhang, Lei; Jiang, Hongyi; Zhao, Xiaokun			Assessment of the Potential Diagnostic Role of Anaplastic Lymphoma Kinase for Inflammatory Myofibroblastic Tumours: A Meta-Analysis	PLOS ONE			English	Article							ALK-1 PROTEIN EXPRESSION; URINARY-BLADDER; PROLIFERATIONS; REARRANGEMENTS; FEATURES; TESTS	Objective To assess the value of anaplastic lymphoma kinase for the diagnosis of inflammatory myofibroblastic tumours using a comprehensive meta-analysis. Methods We searched the related literature using electronic databases and manual searches. Approximately 454 cases from several countries were included in this analysis. The quality of studies included was assessed by QUADAS (quality assessment of studies of diagnostic accuracy). The diagnostic odds ratio (DOR), positive likelihood ratio (PLR), negative likelihood ratio (NLR), sensitivity and specificity were calculated to assess the role of anaplastic lymphoma kinase in the diagnosis of inflammatory myofibroblastic tumours. The overall test performance was summarised by an SROC (summary receiver operating characteristic curve). The heterogeneity and publication bias were analysed using Meta-regression and Deeks' test. All data were analysed by Stata 12.0 software. Results Eight studies were included according to our inclusion criteria. The overall results for the specificity, sensitivity, PLR, NLR, DOR and area under the curve (AUC) were 0.99 (95% CI 0.82-1.00), 0.67 (95% CI 0.46-0.83), 0.67 (95% CI 0.46-0.83), 60.6 (95% CI 3.3-1112.4), 0.33 (95% CI 0.19-0.60), 181 (95% CI 9-3684) and 0.95 (95% CI 0.93-0.97), respectively, while the specificity, sensitivity, PLR, NLR, DOR and AUC for bladder IMTs were 0.99 (95% CI 0.67-1.00), 0.86 (95% CI 0.58-0.96), 95.6 (95% CI 2.0-4616.2), 0.14 (95% CI 0.04-0.50), 671 (95% CI 16-28913) and 0.99 (95% CI 0.97-0.99), respectively. Conclusion The present meta-analysis indicated that anaplastic lymphoma kinase plays a significant role in the differential diagnosis of inflammatory myofibroblastic tumours, particularly for inflammatory myofibroblastic tumours of the urinary bladder.	[Wu, Shuiqing; Xu, Ran; Zhu, Xuan; Zhang, Lei; Jiang, Hongyi; Zhao, Xiaokun] Cent South Univ, Dept Urol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Wan, Qi] Hosp Changsha City 1, Neural Med Ctr, Changsha, Hunan, Peoples R China	Central South University	Zhao, XK (corresponding author), Cent South Univ, Dept Urol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.	yuqing591@126.com						Alderman M, 2014, ARCH PATHOL LAB MED, V138, P1272, DOI 10.5858/arpa.2014-0274-CC; Alquati S, 2013, ARCH PATHOL LAB MED, V137, P1117, DOI 10.5858/arpa.2012-0326-RA; BAHADORI M, 1973, CANCER, V31, P191, DOI 10.1002/1097-0142(197301)31:1<191::AID-CNCR2820310127>3.0.CO;2-D; Cessna MH, 2002, MODERN PATHOL, V15, P931, DOI 10.1097/01.MP.0000026615.04130.1F; Coffin CM, 2007, AM J SURG PATHOL, V31, P509, DOI 10.1097/01.pas.0000213393.57322.c7; Cook JR, 2001, AM J SURG PATHOL, V25, P1364, DOI 10.1097/00000478-200111000-00003; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Freeman A, 2004, MODERN PATHOL, V17, P765, DOI 10.1038/modpathol.3800078; Fuehrer NE, 2012, ARCH PATHOL LAB MED, V136, P623, DOI 10.5858/arpa.2011-0341-OA; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Griffin CA, 1999, CANCER RES, V59, P2776; Gurzu S, 2013, J CLIN ONCOL, V31, pE155, DOI 10.1200/JCO.2012.42.8961; Hamza TH, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-73; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirsch MS, 2006, HISTOPATHOLOGY, V48, P569, DOI 10.1111/j.1365-2559.2006.02376.x; Jin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050812; Mao R, 2008, PRACT J CANC, V23, P233; Medeiros LJ, 2007, AM J CLIN PATHOL, V127, P707, DOI 10.1309/R2Q9CCUVTLRYCF3H; Montgomery EA, 2006, AM J SURG PATHOL, V30, P1502, DOI 10.1097/01.pas.0000213280.35413.1b; Qiu XF, 2008, HUM PATHOL, V39, P846, DOI 10.1016/j.humpath.2007.10.010; Rao RN, 2012, UROL ANNALS, V4, P115, DOI 10.4103/0974-7796.95567; ROTH JA, 1980, UROLOGY, V16, P635, DOI 10.1016/0090-4295(80)90578-6; Sukov WR, 2007, MODERN PATHOL, V20, P592, DOI 10.1038/modpathol.3800776; Takeshita Hideki, 2006, Hinyokika Kiyo, V52, P375; Teoh JYC, 2014, UROLOGY, V84, P503, DOI 10.1016/j.urology.2014.05.039; Tsuzuki T, 2004, AM J SURG PATHOL, V28, P1609, DOI 10.1097/00000478-200412000-00009; Whiting P, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8250; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wu SQ, 2014, EXP THER MED, V7, P1010, DOI 10.3892/etm.2014.1525; Zhao HD, 2013, ONCOL LETT, V5, P97, DOI 10.3892/ol.2012.948	31	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125087	10.1371/journal.pone.0125087	http://dx.doi.org/10.1371/journal.pone.0125087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910080	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800127
J	Yang, MK; Wee, WR; Kwon, JW; Han, YK				Yang, Min Kyu; Wee, Won Ryang; Kwon, Ji-Won; Han, Young Keun			Anterior Chamber Depth and Refractive Change in Late Postoperative Capsular Bag Distension Syndrome: A Retrospective Analysis	PLOS ONE			English	Article							BLOCK SYNDROME; APRACLONIDINE; BRIMONIDINE	Purpose To assess the characteristic findings and effects of laser capsulotomy in patients with late postoperative capsular bag distension syndrome (CBDS). Methods Twenty patients diagnosed with late postoperative CBDS between July 2010 and August 2013 were retrospectively reviewed. Before and 1 week after capsulotomy, changes in the anterior chamber depth (ACD) were assessed using ultrasound biomicroscopy. Changes in the refractive status and uncorrected visual acuity (UCVA) were also measured 1 week and 1 month after capsulotomy. For patients who received bilateral cataract surgery, preoperative ACD and axial length measured by IOLMaster were compared between the two eyes. Results Twenty-two eyes from 20 patients who had undergone laser capsulotomy showed a mean UCVA improvement of 0.27 +/- 0.24 logMAR (range, 0.00-0.90). ACD was increased by an average of +0.04 mm (95% confidence interval, +0.01 to +0.06 mm, p = 0.034), equivalent to predicted refractive change of +0.10 D. The discrepancy between actual (+1.33 D) and predicted refractive change after capsulotomy suggests that refractive change may not be generated from IOL displacement in late postoperative CBDS. Preoperative ACD was deeper in the eye with late postoperative CBDS in all bilaterally pseudophakic patients (mean, 3.68 mm vs. 3.44 mm in the fellow eye, p = 0.068). Conclusions Late postoperative CBDS showed refractive changes that were resolved successfully after laser capsulotomy. The convex lens effects of opalescent material in the distended capsular bag may play a major role in myopic shift. A larger preoperative ACD is possibly associated with the development of late postoperative CBDS.	[Yang, Min Kyu; Han, Young Keun] Seoul Natl Univ, Seoul Metropolitan Government, Boramae Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Yang, Min Kyu; Wee, Won Ryang] Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul 110744, South Korea; [Kwon, Ji-Won] Kwandong Univ, Myongji Hosp, Coll Med, Dept Ophthalmol, Goyang Si, Gyeonggi, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Catholic Kwandong University; Myongji Hospital	Han, YK (corresponding author), Seoul Natl Univ, Seoul Metropolitan Government, Boramae Med Ctr, Dept Ophthalmol, Seoul, South Korea.	eye129@paran.com						Bao YZ, 2008, J CATARACT REFR SURG, V34, P1799, DOI 10.1016/j.jcrs.2008.04.057; Colakoglu A, 2007, J CATARACT REFR SURG, V33, P1344, DOI 10.1016/j.jcrs.2007.02.041; DAVISON JA, 1990, J CATARACT REFR SURG, V16, P99, DOI 10.1016/S0886-3350(13)80883-8; Durak I, 2001, J CATARACT REFR SURG, V27, P555, DOI 10.1016/S0886-3350(00)00689-1; Durig J, 1999, EUR J OPHTHALMOL, V9, P66, DOI 10.1177/112067219900900111; Eifrig DE, 1997, J CATARACT REFR SURG, V23, P450, DOI 10.1016/S0886-3350(97)80193-9; GABELT BT, 1994, EXP EYE RES, V59, P633, DOI 10.1006/exer.1994.1149; HOLTZ SJ, 1992, J CATARACT REFR SURG, V18, P310, DOI 10.1016/S0886-3350(13)80910-8; Kim HK, 2008, J CATARACT REFR SURG, V34, P357, DOI 10.1016/j.jcrs.2007.11.026; Landa G, 2006, CLIN EXP OPHTHALMOL, V34, P866, DOI 10.1111/j.1442-9071.2006.01338.x; Lo Presti L, 1998, ACTA OPHTHALMOL SCAN, V76, P32; Miyake K, 1998, J CATARACT REFR SURG, V24, P1230, DOI 10.1016/S0886-3350(98)80017-5; Omar O, 1996, J CATARACT REFR SURG, V22, P1365, DOI 10.1016/S0886-3350(96)80099-X; Patil S, 2007, EYE, V21, P113, DOI 10.1038/sj.eye.6702419; Pinarci EY, 2012, J CATARACT REFR SURG, V38, P672, DOI 10.1016/j.jcrs.2011.11.024; Qu JF, 2010, J CATARACT REFR SURG, V36, P1687, DOI 10.1016/j.jcrs.2010.02.026; Rozema JJ, 2014, AM J OPHTHALMOL, V158, P1111, DOI 10.1016/j.ajo.2014.08.014; Shah NA, 2006, J CATARACT REFR SURG, V32, P1974, DOI 10.1016/j.jcrs.2006.06.026; Sorenson AL, 2000, OPHTHALMOLOGY, V107, P902, DOI 10.1016/S0161-6420(00)00020-8	19	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125895	10.1371/journal.pone.0125895	http://dx.doi.org/10.1371/journal.pone.0125895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910003	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800145
J	Hojgard, S; Aspevall, O; Bengtsson, B; Haeggman, S; Lindberg, M; Mieziewska, K; Nilsson, S; Unnerstad, HE; Viske, D; Wahlstrom, H				Hojgard, Soren; Aspevall, Olov; Bengtsson, Bjorn; Haeggman, Sara; Lindberg, Maria; Mieziewska, Kristina; Nilsson, Svante; Unnerstad, Helle Ericsson; Viske, Diana; Wahlstrom, Helene			Preventing Introduction of Livestock Associated MRSA in a Pig Population - Benefits, Costs, and Knowledge Gaps from the Swedish Perspective	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SLAUGHTERHOUSE WORKERS; ST398; PREVALENCE; CARRIAGE; TRANSMISSION; FARMERS; HUMANS	Antibiotic resistance is a growing concern in human, as well as in veterinary medicine. Part of the problem concerns how to respond to the risk presented by animal reservoirs of resistant bacteria with the potential of spreading to humans. One example is livestock associated methicillin-resistant Staphylococcus aureus (LA-MRSA). In countries where LA-MRSA is endemic in the pig population, people in contact with pigs have a higher risk of being colonised with LA-MRSA, and persons from this group are subjected to precautionary measures when visiting health care facilities. In the present study, it is assumed that, if LA-MRSA was introduced to the Swedish pig population, the prevalence in the risk groups would be the same as in Denmark or the Netherlands (two countries with low human prevalence that have implemented measures to detect, trace and isolate human LA-MRSA cases and, therefore, have comprehensive data with good coverage regarding prevalence of LA-MRSA), and that similar interventions would be taken in Swedish health care facilities. It is also assumed that the Swedish pig population is free of MRSA or that the prevalence is very low. We analyse if it would be efficient for Sweden to prevent its introduction by testing imported live breeding pigs. Given that quarantining and testing at import will prevent introduction to the pig population, the study shows that the preventive measures may indeed generate a societal net benefit. Benefits are estimated to be between (sic) 870 720 and (sic) 1 233 511, and costs to (sic) 211 129. Still, due to gaps in knowledge, the results should be confirmed when more information become available.	[Hojgard, Soren] Swedish Univ Agr Sci, Uppsala, Sweden; [Hojgard, Soren] AgriFood Econ Ctr, Uppsala, Sweden; [Aspevall, Olov; Haeggman, Sara] Publ Hlth Agcy Sweden, Solna, Sweden; [Bengtsson, Bjorn; Unnerstad, Helle Ericsson; Wahlstrom, Helene] Natl Vet Inst, S-75007 Uppsala, Sweden; [Lindberg, Maria] Federat Swedish Farmers, Stockholm, Sweden; [Lindberg, Maria] Swedish Anim Hlth Serv, Uppsala, Sweden; [Mieziewska, Kristina; Nilsson, Svante; Viske, Diana] Swedish Board Agr, Jonkoping, Sweden	Swedish University of Agricultural Sciences; Public Health Agency of Sweden; National Veterinary Institute SVA	Hojgard, S (corresponding author), Swedish Univ Agr Sci, Uppsala, Sweden.	soren.hojgard@slu.se						Andre M, 2008, SCAND J INFECT DIS, V40, P648, DOI 10.1080/00365540801932439; [Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; [Anonymous], 2013, US ANT AG OCC ANT RE; [Anonymous], NOT FOLK VURD RIS KO; [Anonymous], 201323 SJVFS; [Anonymous], 200940 SJVFS; Aspiroz C, 2010, EMERG INFECT DIS, V16, P157, DOI 10.3201/eid1601.090694; Bisdorff B, 2012, EPIDEMIOL INFECT, V140, P1800, DOI 10.1017/S0950268811002378; Boardman AE, 2011, J BENEFIT-COST ANAL, V2, DOI 10.2202/2152-2812.1050; Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; Broens EM, 2011, PREV VET MED, V98, P182, DOI 10.1016/j.prevetmed.2010.10.010; County Council of Vastra Gotaland, 2008, HALS OCH SJUKV KOSTN; Cuny C, 2013, INT J MED MICROBIOL, V303, P331, DOI 10.1016/j.ijmm.2013.02.010; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; DANMAP, 2012, US ANT AG OCC ANT RE; DANMAP, 2013, US ANT AG OCC ANT RE; Department of Communicable Diseases Control and Prevention Stockholm County Council, 2011, HANDL VID AVSKR CONT; Drummond MF., 2005, METHODS EC EVALUATIO, P55; EFSA (European Food Safety Authority), 2009, EFSAQ200900612; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Finnish Food Authority Finnish Medicines Agency Fimea University of Helsinki FINRES-Vet 2020, 2021, FINN VET ANT RES MON; Frank Robert H., 2010, MICROECONOMICS BEHAV; Garcia-Graells C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065512; Gilbert MJ, 2012, OCCUP ENVIRON MED, V69, P472, DOI 10.1136/oemed-2011-100069; Groves MD, 2014, J ANTIMICROB CHEMOTH, V69, P1428, DOI [10.1093/jac/dkt499, DOI 10.1093/JAC/DKT499]; Hanberger H, 2011, ANTIBIOTIKA VUXNA PA; Kock R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055040; Kock R, 2011, DTSCH ARZTEBL INT, V108, P761, DOI 10.3238/arztebl.2011.0761; Mas-Colell A., 1995, MICROECONOMIC THEORY; NethMap, 2014, CONS ANT AG ANT RES; NETHMAP and MARAN, 2013, CONS ANT AG ANT RES; Pan A, 2009, EMERG INFECT DIS, V15, P845, DOI 10.3201/eid1505.081417; Porphyre T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047504; Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12; SJV, 2009, 20098 SJV SWED BOARD; Statens Seruminstitut, 2014, EPI NYT 24A 2014; Sundhedsstyrelsen, 2012, VEJL FOR SPREAD MRSA; Swedish Board of Health and Welfare, 2013, DIAGN SLUT VARD; Swedish Medical Products Agency, 2009, FARM BEH BAKT HUD OC; Swedish Pharmacies, 2014, FASS; SWEDRES SVARM, 2013, US ANT OCC ANT RES S; SWEDRES-SVARM, 2010, US ANT OCC ANT RES S; SWEDRES-SVARM, 2011, US ANT OCC ANT RES S; Vading M, 2013, ANTIBIOTIKA OPPEN OC; van Cleef BAGL, 2014, CLIN MICROBIOL INFEC, V20, pO764, DOI 10.1111/1469-0691.12582; van Cleef BAGL, 2010, EPIDEMIOL INFECT, V138, P756, DOI 10.1017/S0950268810000245; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; van Cleef BAGL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073096; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021; van Rijen MML, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-3; Verkade E, 2013, INFECT GENET EVOL; Verkade E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100823; Vose D., 2000, RISK ANAL QUANTITATI; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Werner G, 2012, VET MICROBIOL, V160, P162, DOI [10.1016/j.vetmic.2012.05.019, 10.1016/j.vetmic.2012.05.005]; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x	58	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122875	10.1371/journal.pone.0122875	http://dx.doi.org/10.1371/journal.pone.0122875			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923329	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600025
J	Sahlmann, C; Gu, J; Kortner, TM; Lein, I; Krogdahl, A; Bakke, AM				Sahlmann, Christian; Gu, Jinni; Kortner, Trond M.; Lein, Ingrid; Krogdahl, Ashild; Bakke, Anne Marie			Ontogeny of the Digestive System of Atlantic Salmon (Salmo salar L.) and Effects of Soybean Meal from Start-Feeding	PLOS ONE			English	Article							DISTAL INTESTINE; GASTROINTESTINAL-TRACT; ENZYME-ACTIVITIES; INDUCED ENTERITIS; GENE-EXPRESSION; ABSORPTION; SUPPLEMENTATION; ENTEROPATHY; TRYPSIN; STOMACH	Despite a long history of rearing Atlantic salmon in hatcheries in Norway, knowledge of molecular and physiological aspects of juvenile development is still limited. To facilitate introduction of alternative feed ingredients and feed additives during early phases, increased knowledge regarding the ontogeny of the digestive apparatus in salmon is needed. In this study, we characterized the development of the gastrointestinal tract and accessory digestive organs for five months following hatch by using histological, biochemical and molecular methods. Furthermore, the effects of a diet containing 16.7% soybean meal (SBM) introduced at start-feeding were investigated, as compared to a fishmeal based control diet. Salmon yolk sac alevins and fry were sampled at 18 time points from hatch until 144 days post hatch (dph). Histomorphological development was investigated at 7, 27, 46, 54 and 144 dph. Ontogenetic expression patterns of genes encoding key digestive enzymes, nutrient transporters, gastrointestinal peptide hormones and T-cell markers were analyzed from 13 time points by qPCR. At 7 dph, the digestive system of Atlantic salmon alevins was morphologically distinct with an early stomach, liver, pancreas, anterior and posterior intestine. About one week before the yolk sac was internalized and exogenous feeding was started, gastric glands and developing pyloric caeca were observed, which coincided with an increase in gene expression of gastric and pancreatic enzymes and nutrient transporters. Thus, the observed organs seemed ready to digest external feed well before the yolk sac was absorbed into the abdominal cavity. In contrast to post-smolt Atlantic salmon, inclusion of SBM did not induce intestinal inflammation in the juveniles. This indicates that SBM can be used in compound feeds for salmon fry from start-feeding to at least 144 dph and/or 4-5 g body weight.	[Sahlmann, Christian; Gu, Jinni; Kortner, Trond M.; Krogdahl, Ashild; Bakke, Anne Marie] Norwegian Univ Life Sci, Fac Vet Med & Biosci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Lein, Ingrid] Nofima AS, Sunndalsora, Norway	Norwegian University of Life Sciences; Nofima	Bakke, AM (corresponding author), Norwegian Univ Life Sci, Fac Vet Med & Biosci, Dept Basic Sci & Aquat Med, Oslo, Norway.	annemarie.bakke@nmbu.no			Research Council of Norway's Centre of Excellence (CoE) "Aquaculture Protein Centre" (APC) [145949/120]; European Union [211820]	Research Council of Norway's Centre of Excellence (CoE) "Aquaculture Protein Centre" (APC); European Union(European Commission)	The study was financed by the Research Council of Norway's Centre of Excellence (CoE) "Aquaculture Protein Centre" (APC, grant no. 145949/120) and a European Union Seventh Framework Programme grant "Biomarkers for post market monitoring of short and long-term effects of genetically modified organisms on animal and human health" (GMSAFOOD, grant no. 211820). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeverfjord G, 1996, J FISH DIS, V19, P375, DOI 10.1111/j.1365-2761.1996.tb00376.x; Bakke-McKellep AM, 2007, J FISH DIS, V30, P13, DOI 10.1111/j.1365-2761.2007.00769.x; BISBAL GA, 1995, J FISH BIOL, V47, P277, DOI 10.1006/jfbi.1995.0133; BOULHIC M, 1992, AQUACULTURE, V102, P373, DOI 10.1016/0044-8486(92)90190-V; Buddington RK, 2004, COMP BIOCHEM PHYS A, V139, P261, DOI 10.1016/j.cbpb.2004.09.007; Chikwati EM, 2013, AQUACULTURE, V402, P28, DOI 10.1016/j.aquaculture.2013.03.023; DAHLQVIST A, 1970, ENZYMOL BIOL CLIN, V11, P52, DOI 10.1159/000458348; Darias MJ, 2007, AQUACULTURE, V270, P369, DOI 10.1016/j.aquaculture.2007.04.045; Darias MJ, 2005, AQUACULTURE, V248, P245, DOI 10.1016/j.aquaculture.2005.04.044; Deng XY, 2001, AM J PHYSIOL-REG I, V281, pR645, DOI 10.1152/ajpregu.2001.281.2.R645; Douglas SE, 2000, AQUACULTURE, V190, P247, DOI 10.1016/S0044-8486(00)00398-7; Einarsdottir IE, 2011, CELL TISSUE RES, V344, P481, DOI 10.1007/s00441-011-1158-x; Einarsson S, 1997, COMP BIOCHEM PHYS C, V117, P63, DOI 10.1016/S0742-8413(96)00226-5; Faulk CK, 2007, J FISH BIOL, V70, P567, DOI 10.1111/j.1095-8649.2007.01330.x; Froystad MK, 2006, COMP BIOCHEM PHYS A, V145, P479, DOI 10.1016/j.cbpa.2006.08.003; Gargiulo AM, 1998, ANAT HISTOL EMBRYOL, V27, P89, DOI 10.1111/j.1439-0264.1998.tb00162.x; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; GAWLICKA A, 1995, FISH PHYSIOL BIOCHEM, V14, P357, DOI 10.1007/BF00003374; Gorodilov YN, 1996, ENVIRON BIOL FISH, V47, P109, DOI 10.1007/BF00005034; GOVONI JJ, 1986, ENVIRON BIOL FISH, V16, P59, DOI 10.1007/BF00005160; Gu JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099932; Gu JN, 2013, BRIT J NUTR, V109, P1408, DOI 10.1017/S000711451200325X; Gu M, 2014, BRIT J NUTR, V111, P432, DOI 10.1017/S0007114513002717; GUNNES K, 1979, AQUACULTURE, V16, P211, DOI 10.1016/0044-8486(79)90109-1; GUYOT E, 1995, J FISH BIOL, V47, P427, DOI 10.1111/j.1095-8649.1995.tb01912.x; He T, 2012, FISH PHYSIOL BIOCHEM, V38, P297, DOI 10.1007/s10695-011-9507-y; Heming T.A., 1988, P407; HEMING TA, 1982, CAN J FISH AQUAT SCI, V39, P184, DOI 10.1139/f82-021; Hernandez MPG, 2001, ANAT EMBRYOL, V204, P39, DOI 10.1007/s004290100173; Infante JLZ, 2001, COMP BIOCHEM PHYS C, V130, P477, DOI 10.1016/S1532-0456(01)00274-5; Jantzen Stuart G, 2011, BMC Res Notes, V4, P88, DOI 10.1186/1756-0500-4-88; KAKADE ML, 1973, J NUTR, V103, P1772, DOI 10.1093/jn/103.12.1772; Killeen J, 1999, J FISH BIOL, V55, P382, DOI 10.1111/j.1095-8649.1999.tb00686.x; KNOPH MB, 1992, COMP BIOCHEM PHYS C, V101, P275, DOI 10.1016/0742-8413(92)90273-A; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Kortner TM, 2014, BRIT J NUTR, V111, P2089, DOI 10.1017/S0007114514000373; Kortner TM, 2013, BRIT J NUTR, V109, P593, DOI 10.1017/S0007114512002024; Kortner TM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-101; Kortner TM, 2011, AQUACULTURE, V318, P355, DOI 10.1016/j.aquaculture.2011.05.038; Krogdahl A, 2000, AQUACULT NUTR, V6, P77; Krogdahl A, 1999, AQUACULT NUTR, V5, P121; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; Krogdahl A, 2010, AQUAC RES, V41, P333, DOI 10.1111/j.1365-2109.2009.02426.x; KUROKAWA T, 1995, CAN J FISH AQUAT SCI, V52, P1030, DOI 10.1139/f95-101; Lazo J.P., 2011, LARVAL FISH NUTR, P5, DOI DOI 10.1002/dvdy.22113; Lilleeng E, 2007, COMP BIOCHEM PHYS A, V147, P25, DOI 10.1016/j.cbpa.2006.10.043; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macqueen DJ, 2008, BIOL LETTERS, V4, P294, DOI 10.1098/rsbl.2007.0620; Marjara IS, 2012, CYTOKINE, V60, P186, DOI 10.1016/j.cyto.2012.05.027; Moen AGG, 2010, DEV NEUROBIOL, V70, P649, DOI 10.1002/dneu.20803; Murashita K, 2006, GEN COMP ENDOCR, V145, P287, DOI 10.1016/j.ygcen.2005.09.008; Murashita K, 2009, GEN COMP ENDOCR, V160, P223, DOI 10.1016/j.ygcen.2008.11.024; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Niot I, 2009, PROG LIPID RES, V48, P101, DOI 10.1016/j.plipres.2009.01.001; NOAILLACDEPEYRE J, 1973, Z ZELLFORSCH MIK ANA, V146, P525, DOI 10.1007/BF02347181; NRC, 1993, NUTR REQ FISH, DOI [10.17226/2115, DOI 10.17226/2115]; PEDERSEN T, 1992, J FISH BIOL, V41, P449, DOI 10.1111/j.1095-8649.1992.tb02673.x; Pena R, 2003, AQUACULTURE, V219, P633, DOI 10.1016/S0044-8486(02)00352-6; Pradhan PK, 2012, FISH PHYSIOL BIOCHEM, V38, P1601, DOI 10.1007/s10695-012-9655-8; ROMBOUGH PJ, 1982, CAN J ZOOL, V60, P2006, DOI 10.1139/z82-258; Ronnestad I, 2007, AQUACULTURE, V268, P82, DOI 10.1016/j.aquaculture.2007.04.031; Sahlmann C, 2013, FISH SHELLFISH IMMUN, V34, P599, DOI 10.1016/j.fsi.2012.11.031; Sanden M, 2005, J FISH DIS, V28, P317, DOI 10.1111/j.1365-2761.2005.00618.x; SARASQUETE MC, 1995, AQUACULTURE, V130, P79, DOI 10.1016/0044-8486(94)00175-N; SEGNER H, 1994, MAR BIOL, V119, P471, DOI 10.1007/BF00347544; Segner Helmut, 1993, Journal of the World Aquaculture Society, V24, P121, DOI 10.1111/j.1749-7345.1993.tb00001.x; Skugor S, 2011, AQUACULT NUTR, V17, P505, DOI 10.1111/j.1365-2095.2010.00832.x; STROBAND HWJ, 1981, CELL TISSUE RES, V215, P397; Tacon AG, 2011, 56487 FAO, P56487; TAKAHASHI K, 1978, Tohoku Journal of Agricultural Research, V29, P98; Tipsmark CK, 2010, J EXP BIOL, V213, P368, DOI 10.1242/jeb.034785; Uran PA, 2008, J FISH BIOL, V73, P2571, DOI 10.1111/j.1095-8649.2008.02091.x; VANDENINGH TSGAM, 1991, AQUACULTURE, V94, P297, DOI 10.1016/0044-8486(91)90174-6; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Zhou J, 2010, LIPIDS, V45, P301, DOI 10.1007/s11745-010-3396-1	75	40	40	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124179	10.1371/journal.pone.0124179	http://dx.doi.org/10.1371/journal.pone.0124179			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923375	Green Published, Green Accepted, gold			2022-12-27	WOS:000353711600073
J	Pu, SH; Nakagome, K; Yamada, T; Matsumura, H; Yokoyama, K; Kaneko, K; Kurosawa, Y				Pu, Shenghong; Nakagome, Kazuyuki; Yamada, Takeshi; Matsumura, Hiroshi; Yokoyama, Katsutoshi; Kaneko, Koichi; Kurosawa, Yoichi			Association between Fish Consumption and Prefrontal Function during a Cognitive Task in Male Japanese Workers: A Multi-Channel Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; WORKING-MEMORY TASK; VERBAL FLUENCY TASK; DOCOSAHEXAENOIC ACID; OMEGA-3-FATTY-ACID LEVELS; SEAFOOD CONSUMPTION; ECOLOGICAL ANALYSIS; CORTEX ACTIVATION; MAJOR DEPRESSION; DOUBLE-BLIND	The purpose of this study was to examine the relationship between fish consumption and prefrontal function during a cognitive task in male Japanese workers. The study included 208 male workers who underwent medical health examinations 3 months after a change in their work assignment. We measured the hemoglobin concentration changes in the prefrontal region during working memory tasks using 52-channel near-infrared spectroscopy. The frequency of fish consumption was calculated on the basis of the subjects' self-reported customary intake frequency over the previous 3 months. A significant positive relationship was observed between fish consumption and left dorsolateral prefrontal function during a working memory task. To our knowledge, this is the first study to report an association between fish consumption and functional cortical activity with an ample sample size, suggesting that fish consumption modulates functional activity in the left dorsolateral prefrontal cortex.	[Pu, Shenghong; Yamada, Takeshi; Matsumura, Hiroshi; Yokoyama, Katsutoshi; Kaneko, Koichi] Tottori Univ, Fac Med, Div Neuropsychiat, Dept Brain & Neurosci, Yonago, Tottori 683, Japan; [Nakagome, Kazuyuki] Natl Ctr Neurol & Psychiat Hosp, Dept Psychiat, Tokyo, Japan; [Kurosawa, Yoichi] Tottori Univ, Fac Med, Div Hlth Adm & Promot, Dept Social Med, Yonago, Tottori 683, Japan	Tottori University; Tottori University	Pu, SH (corresponding author), Tottori Univ, Fac Med, Div Neuropsychiat, Dept Brain & Neurosci, Yonago, Tottori 683, Japan.	pshh0517@yahoo.co.jp		Nakagome, Kazuyuki/0000-0003-2919-8180	National Center of Neurology and Psychiatry (NCNP) [23-10, 26-3]	National Center of Neurology and Psychiatry (NCNP)	Funding: This study was supported by the Intramural Research Grant (23-10 and 26-3) for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry (NCNP). Funders of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PB, 1996, LIPIDS, V31, pS157, DOI 10.1007/BF02637069; Aihara H, 2003, J EPIDEMIOL, V13, P56, DOI 10.2188/jea.13.56; Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; Barberger-Gateau P, 2005, EUR J CLIN NUTR, V59, P817, DOI 10.1038/sj.ejcn.1602145; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Borsonelo EC, 2008, PROSTAG LEUKOTR ESS, V78, P237, DOI 10.1016/j.plefa.2008.03.005; Bosc M, 1997, EUR NEUROPSYCHOPHARM, V7, pS57, DOI 10.1016/S0924-977X(97)00420-3; Bourre JM, 2007, BIOMED PHARMACOTHER, V61, P105, DOI 10.1016/j.biopha.2006.09.015; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; Colangelo LA, 2009, NUTRITION, V25, P1011, DOI 10.1016/j.nut.2008.12.008; Condray R, 2008, SCHIZOPHR RES, V106, P13, DOI 10.1016/j.schres.2008.03.009; da Silva TM, 2008, J AFFECT DISORDERS, V111, P351, DOI 10.1016/j.jad.2008.03.008; Daniels JL, 2004, EPIDEMIOLOGY, V15, P394, DOI 10.1097/01.ede.0000129514.46451.ce; Das UN, 2000, PROSTAG LEUKOTR ESS, V63, P351, DOI 10.1054/plef.2000.0226; Frasure-Smith N, 2004, BIOL PSYCHIAT, V55, P891, DOI 10.1016/j.biopsych.2004.01.021; Gale CR, 2008, J CHILD PSYCHOL PSYC, V49, P1061, DOI 10.1111/j.1469-7610.2008.01908.x; Galobardes B, 2001, INT J EPIDEMIOL, V30, P334, DOI 10.1093/ije/30.2.334; Goto M, 2005, CLIN PSYCHIATR, V47, P483, DOI DOI 10.11477/mf.1405100063; GRIER JB, 1971, PSYCHOL BULL, V75, P424, DOI 10.1037/h0031246; Hibbeln JR, 1998, LANCET, V351, P1213, DOI 10.1016/S0140-6736(05)79168-6; Hibbeln JR, 2002, J AFFECT DISORDERS, V69, P15, DOI 10.1016/S0165-0327(01)00374-3; Jackson PA, 2012, BIOL PSYCHOL, V89, P183, DOI 10.1016/j.biopsycho.2011.10.006; Kawakami Norito, 2007, Nihon Rinsho, V65, P1578; Kimura T, 2001, Nihon Rinsho, V59, P1444; Lin PY, 2010, BIOL PSYCHIAT, V68, P140, DOI 10.1016/j.biopsych.2010.03.018; Maes M, 1999, PSYCHIAT RES, V85, P275, DOI 10.1016/S0165-1781(99)00014-1; Mamalakis G, 2002, PROSTAG LEUKOTR ESS, V67, P311, DOI 10.1054/plef.2002.0435; McNamara RK, 2006, PROSTAG LEUKOTR ESS, V75, P329, DOI 10.1016/j.plefa.2006.07.010; McNamara RK, 2010, AM J CLIN NUTR, V91, P1060, DOI 10.3945/ajcn.2009.28549; Mickleborough TD, 2006, CHEST, V129, P39, DOI 10.1378/chest.129.1.39; Ministry of Health Labour and Welfare of Japan, 2001, PAT SURV 1999, VI; Ministry of Health Labour and Welfare of Japan, 2004, PAT SURV 2002, VI; Ministry of Health Labour and Welfare of Japan, 2007, PAT SURV 2005, VI; Noaghiul S, 2003, AM J PSYCHIAT, V160, P2222, DOI 10.1176/appi.ajp.160.12.2222; Okada E, 2003, APPL OPTICS, V42, P2915, DOI 10.1364/AO.42.002915; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pawlosky RJ, 2001, J LIPID RES, V42, P1257; Peet M, 2004, BRIT J PSYCHIAT, V184, P404, DOI 10.1192/bjp.184.5.404; Peet M, 1998, BIOL PSYCHIAT, V43, P315, DOI 10.1016/S0006-3223(97)00206-0; Pu S, 2013, PSYCHIAT RES-NEUROIM, V214, P73, DOI 10.1016/j.pscychresns.2013.05.011; Pu SH, 2012, PSYCHIAT RES-NEUROIM, V203, P222, DOI 10.1016/j.pscychresns.2012.01.007; Pu S, 2011, NEUROSCI RES, V70, P91, DOI 10.1016/j.neures.2011.01.001; Raji CA, 2014, AM J PREV MED, V47, P444, DOI 10.1016/j.amepre.2014.05.037; Richardson AJ, 2002, PROG NEURO-PSYCHOPH, V26, P233, DOI 10.1016/S0278-5846(01)00254-8; Riemer S, 2010, J AFFECT DISORDERS, V123, P173, DOI 10.1016/j.jad.2009.08.004; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Sato H, 2013, NEUROIMAGE, V83, P158, DOI 10.1016/j.neuroimage.2013.06.043; Singh AK, 2006, NEUROIMAGE, V33, P542, DOI 10.1016/j.neuroimage.2006.06.047; Skosnik PD, 2003, PROSTAG LEUKOTR ESS, V69, P367, DOI 10.1016/j.plefa.2003.08.008; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Sugano M, 2000, AM J CLIN NUTR, V71, p189S, DOI 10.1093/ajcn/71.1.189S; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Takizawa R, 2008, SCHIZOPHR RES, V99, P250, DOI 10.1016/j.schres.2007.10.025; Tanskanen A, 2001, PSYCHIATR SERV, V52, P529, DOI 10.1176/appi.ps.52.4.529; Timonen M, 2004, J AFFECT DISORDERS, V82, P447, DOI 10.1016/j.jad.2004.02.002; Toronov V, 2001, MED PHYS, V28, P521, DOI 10.1118/1.1354627; Trivedi MH, 2014, J AFFECT DISORDERS, V152, P19, DOI 10.1016/j.jad.2013.09.012; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Virtanen JK, 2008, NEUROLOGY, V71, P439, DOI 10.1212/01.wnl.0000324414.12665.b0; Wakai K, 2005, J EPIDEMIOL, V15, P211, DOI 10.2188/jea.15.211; Yamashita Y, 1996, OPT ENG, V35, P1046, DOI 10.1117/1.600721; Yatoh S, 2010, MED TECHNOLOGY, V38, P1347; Zhao HJ, 2002, PHYS MED BIOL, V47, P2075, DOI 10.1088/0031-9155/47/12/306; Zimmer L, 2002, AM J CLIN NUTR, V75, P662, DOI 10.1093/ajcn/75.4.662	66	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123972	10.1371/journal.pone.0123972	http://dx.doi.org/10.1371/journal.pone.0123972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919586	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400039
J	Bilotas, MA; Olivares, CN; Ricci, AG; Baston, JI; Bengochea, TS; Meresman, GF; Baranao, RI				Andrea Bilotas, Mariela; Noemi Olivares, Carla; Gabriela Ricci, Analia; Ignacio Baston, Juan; Soledad Bengochea, Tatiana; Fabiana Meresman, Gabriela; Ines Baranao, Rosa			Interplay between Endometriosis and Pregnancy in a Mouse Model	PLOS ONE			English	Article							SURGICALLY INDUCED ENDOMETRIOSIS; INFERTILE WOMEN; PERITONEAL ENDOMETRIOSIS; PERFORATION; FERTILITY; THERAPIES; DIENOGEST; TISSUE; CELLS; LACTATION	Objectives To evaluate the effect of endometriosis on fertility and the levels of the IL-2 and IFN-gamma in the peritoneal fluid in a mouse model; to evaluate the effect of pregnancy on endometriotic lesion growth, apoptosis and cell proliferation. Study Design Two month old C57BL/6 female mice underwent either a surgical procedure to induce endometriosis or a sham surgery. Four weeks after surgery mice were mated and sacrificed at day 18 of pregnancy. Number of implantation sites, fetuses and fetal weight were recorded. Endometriotic lesions were counted, measured, excised and fixed. Apoptosis and cell proliferation were evaluated in lesions by TUNEL and immunohistochemistry for PCNA respectively. Levels of IL-2 and IFN-gamma were assessed by ELISA in the peritoneal fluid. Results Pregnancy rate (i.e. pregnant mice/N) decreased in mice with endometriosis. However there were no significant differences in resorption rate, litter size and pup weight between groups. IFN-gamma augmented in endometriosis mice independently of pregnancy outcome. Additionally IFN-gamma increased in pregnant endometriosis mice compared to pregnant sham animals. While IFN-gamma increased in non pregnant versus pregnant mice in the sham group, IL-2 was increased in non pregnant mice in the endometriosis group. The size of endometriotic lesions increased in pregnant mice while apoptosis increased in the stroma and cell proliferation decreased in the epithelium of these lesions. Additionally, leukocyte infiltration, necrosis and decidualization were increased in the same lesions. Conclusions Pregnancy rate is reduced in this mouse model of endometriosis. Levels of IL-2 are increased in the peritoneal fluid of mice with endometriosis suggesting a role of this cytokine in infertility related to this disease. The size of endometriotic lesions is increased in pregnant mice; however pregnancy has a beneficial effect on lesions by decreasing cell proliferation and by increasing apoptosis, decidualization and necrosis.	[Andrea Bilotas, Mariela; Noemi Olivares, Carla; Gabriela Ricci, Analia; Ignacio Baston, Juan; Soledad Bengochea, Tatiana; Fabiana Meresman, Gabriela; Ines Baranao, Rosa] Consejo Nacl Invest Cient & Tecn, IBYME, RA-1033 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Bilotas, MA (corresponding author), Consejo Nacl Invest Cient & Tecn, IBYME, RA-1033 Buenos Aires, DF, Argentina.	mabilotas@dna.uba.ar		Meresman, Gabriela Fabiana/0000-0002-5058-8450	Agencia Nacional de Promocion Cientifica y Tecnologica de Argentina (PRESTAMO BID PICT) [01632]; Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina [PIP 1223]	Agencia Nacional de Promocion Cientifica y Tecnologica de Argentina (PRESTAMO BID PICT); Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was supported by Agencia Nacional de Promocion Cientifica y Tecnologica de Argentina (PRESTAMO BID PICT No 01632) http://www.agencia.mincyt.gob.ar/ - RIB GFM Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (PIP 1223) http://www.conicet.gob.ar/ - RIB GFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akande VA, 2004, HUM REPROD, V19, P96, DOI 10.1093/humrep/deh045; Balasch J, 1996, HUM REPROD, V11, P387, DOI 10.1093/HUMREP/11.2.387; Barbieri M, 2009, HUM REPROD, V24, P1818, DOI 10.1093/humrep/dep089; BARRAGAN JC, 1992, FERTIL STERIL, V58, P1215; Bilotas M, 2010, FERTIL STERIL, V93, P2513, DOI 10.1016/j.fertnstert.2009.08.058; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; CHAOUAT G, 1990, J REPROD FERTIL, V89, P447; CHAOUAT G, 1995, J IMMUNOL, V154, P4261; Coccia ME, 2012, EUR J OBSTET GYN R B, V160, P35, DOI 10.1016/j.ejogrb.2011.10.004; Cummings AM, 1996, P SOC EXP BIOL MED, V212, P332; D'Hooghe TM, 1997, ARCH GYNECOL OBSTET, V261, P15, DOI 10.1007/s004040050191; de Ziegler D, 2010, LANCET, V376, P730, DOI 10.1016/S0140-6736(10)60490-4; DONNA A, 1967, Cancro, V20, P400; DUNSELMAN GAJ, 1991, FERTIL STERIL, V56, P340; Fu L, 2008, FERTIL STERIL, V89, P1344, DOI 10.1016/j.fertnstert.2007.03.042; Garrido N, 2000, HUM REPROD UPDATE, V6, P67, DOI 10.1093/humupd/6.1.67; GINI PC, 1981, BRIT J OBSTET GYNAEC, V88, P456, DOI 10.1111/j.1471-0528.1981.tb01014.x; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Ho HN, 1997, HUM REPROD, V12, P2528, DOI 10.1093/humrep/12.11.2528; Katorza E, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.030; Katsuki Y, 1998, EUR J ENDOCRINOL, V138, P216, DOI 10.1530/eje.0.1380216; KISTNER RW, 1958, AM J OBSTET GYNECOL, V75, P264, DOI 10.1016/0002-9378(58)90384-3; Kwak-Kim JYH, 2003, HUM REPROD, V18, P767, DOI 10.1093/humrep/deg156; Macer ML, 2012, OBSTET GYN CLIN N AM, V39, P535, DOI 10.1016/j.ogc.2012.10.002; MAHMOOD TA, 1991, HUM REPROD, V6, P544, DOI 10.1093/oxfordjournals.humrep.a137377; McArthur J W, 1965, Obstet Gynecol Surv, V20, P709, DOI 10.1097/00006254-196510000-00001; Minami T, 2013, EUR J OBSTET GYN R B, V166, P76, DOI 10.1016/j.ejogrb.2012.08.023; Nishikawa A, 2013, EUR J OBSTET GYN R B, V170, P20, DOI 10.1016/j.ejogrb.2013.04.018; Okada H, 2001, MOL HUM REPROD, V7, P341, DOI 10.1093/molehr/7.4.341; Olivares CN, 2013, REPRODUCTION, V145, P119, DOI 10.1530/REP-12-0386; Oral E, 1996, FERTIL STERIL, V66, P787, DOI 10.1016/S0015-0282(16)58637-3; Pisanu A, 2010, WORLD J GASTROENTERO, V16, P648, DOI 10.3748/wjg.v16.i5.648; Podgaec S, 2007, HUM REPROD, V22, P1373, DOI 10.1093/humrep/del516; Podgaec S, 2010, REV ASSOC MED BRAS, V56, P92, DOI 10.1590/S0104-42302010000100022; Porpora MG, 2010, FERTIL STERIL, V93, P716, DOI 10.1016/j.fertnstert.2008.10.018; Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P591, DOI 10.1016/j.fertnstert.2012.05.031; Preciado Ruiz Raymundo, 2005, Ginecol Obstet Mex, V73, P471; Raghupathy R, 1999, CELL IMMUNOL, V196, P122, DOI 10.1006/cimm.1999.1532; RAJKUMAR K, 1990, FERTIL STERIL, V53, P921; Ricci AG, 2013, HUM REPROD, V28, P178, DOI 10.1093/humrep/des369; Rozen P, 2003, ENDOSCOPY, V35, P975; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422, DOI 10.1016/S0002-9378(15)30003-X; SCHENKEN RS, 1980, FERTIL STERIL, V34, P581; SCHENKEN RS, 1987, AM J OBSTET GYNECOL, V157, P1392, DOI 10.1016/S0002-9378(87)80230-2; Schweitzer KJ, 2006, INT J GYNECOL OBSTET, V93, P152, DOI 10.1016/j.ijgo.2006.01.022; Soares SR, 2012, FERTIL STERIL, V98, P529, DOI 10.1016/j.fertnstert.2012.07.1120; Stilley JAW, 2012, CELL TISSUE RES, V349, P849, DOI 10.1007/s00441-011-1309-0; Stilley JAW, 2009, BIOL REPROD, V80, P649, DOI 10.1095/biolreprod.108.073411; SURREY ES, 1992, FERTIL STERIL, V58, P273; Ueda Y, 2010, FERTIL STERIL, V94, P78, DOI 10.1016/j.fertnstert.2009.02.092; Vercellini P, 2009, DRUGS, V69, P649, DOI 10.2165/00003495-200969060-00002; VERNON MW, 1985, FERTIL STERIL, V44, P684; Yuan P, 2012, HUM REPROD, V27, P2089, DOI 10.1093/humrep/des142	54	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124900	10.1371/journal.pone.0124900	http://dx.doi.org/10.1371/journal.pone.0124900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915402	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100078
J	Saenz-de-Juano, MD; Vicente, JS; Hollung, K; Marco-Jimenez, F				Desemparats Saenz-de-Juano, Maria; Salvador Vicente, Jose; Hollung, Kristin; Marco-Jimenez, Francisco			Effect of Embryo Vitrification on Rabbit Foetal Placenta Proteome during Pregnancy	PLOS ONE			English	Article							GEL-ELECTROPHORESIS; NEONATAL OUTCOMES; MOUSE EMBRYOS; LONG-TERM; CRYOPRESERVATION; EXPRESSION; GROWTH; CANCER; MICE	Very limited information on the post-implantatory effects of vitrification has been published till now. We observed in a previous study that the vitrification procedure for the cryopreservation of embryos introduced transcriptomic and proteomic modifications in the rabbit foetal placenta at the middle of gestation. Now, we have conducted a proteomic study to determine whether protein alterations in the foetal placenta induced by the vitrification procedure remain during pregnancy. In this study, we used 2D-DIGE and mass spectrometry (MALDI-TOF-TOF and LC-MS/MS analysis) to identify the protein changes during middle and late stages of gestation (Day 14 and Day 24, respectively) in rabbit foetal placenta. We identified 11 differentially expressed proteins at Day 14 and 13 proteins at Day 24. Data are available via ProteomeXchange with identifiers PXD001840 and PXD001836. In addition, we demonstrate the presence of three proteins, serum albumin, isocitrate dehydrogenase 1 [ NADP+], and phosphoglycerate mutase 1, which were altered during pregnancy. We demonstrate the existence of changes in foetal placental protein during pregnancy induced by the vitrification procedure, which brings into question whether vitrification effects observed during foetal development could lead to physiological and metabolic disorders in adulthood. This effect, taken together with other effects reported in the literature, suggests that embryo cryopreservation is not neutral.	[Desemparats Saenz-de-Juano, Maria; Salvador Vicente, Jose; Marco-Jimenez, Francisco] Univ Politecn Valencia, Inst Ciencia & Tecnol Anim, E-46022 Valencia, Spain; [Hollung, Kristin] Nofima AS, As, Norway	Universitat Politecnica de Valencia; Nofima	Marco-Jimenez, F (corresponding author), Univ Politecn Valencia, Inst Ciencia & Tecnol Anim, E-46022 Valencia, Spain.	fmarco@dca.upv.es	Jiménez, Francisco Marco/I-7126-2012; Vicente, Jose/F-7738-2017	Jiménez, Francisco Marco/0000-0002-5226-4118; Vicente, Jose/0000-0003-0481-3802; Saenz-de-Juano, Mara D./0000-0002-2860-2252	Generalitat Valenciana research program [Prometeo 2014/036]; Spanish Research Projects [CICYT AGL2011-29831-C03-01]; Generalitat Valenciana (Programa VALI+d) [ACIF/2011/254]; Nofima AS	Generalitat Valenciana research program; Spanish Research Projects(Spanish Government); Generalitat Valenciana (Programa VALI+d)(Center for Forestry Research & Experimentation (CIEF)); Nofima AS(Nofima)	This work was supported by the Generalitat Valenciana research program (Prometeo 2014/036) and the Spanish Research Projects (CICYT AGL2011-29831-C03-01). M. D. Saenz-de-Juano was supported by a research grant from Generalitat Valenciana (Programa VALI+d, ACIF/2011/254). Nofima AS provided support in the form of salaries for author KH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	Auroux M, 2004, REPROD TOXICOL, V18, P813, DOI 10.1016/j.reprotox.2004.04.010; BESENFELDER U, 1993, J REPROD FERTIL, V99, P53, DOI 10.1530/jrf.0.0990053; Boison D, 2013, PHARMACOL REV, V65, P906, DOI 10.1124/pr.112.006361; Bruchova H, 2010, PLACENTA, V31, P186, DOI 10.1016/j.placenta.2009.12.016; Calle A, 2012, THERIOGENOLOGY, V77, P785, DOI 10.1016/j.theriogenology.2011.07.016; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Desai NN, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-41; Gharesi-Fard B, 2010, PLACENTA, V31, P121, DOI 10.1016/j.placenta.2009.11.004; Hitosugi T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2759; Jensen ON, 1998, PROTEINS, P74; Jia X, 2009, J ANIM SCI, V87, P2391, DOI 10.2527/jas.2009-1792; Landers KA, 2013, PLACENTA, V34, P513, DOI 10.1016/j.placenta.2013.04.013; Lau Christopher, 2004, Birth Defects Res C Embryo Today, V72, P300, DOI 10.1002/bdrc.20029; Lavara R, 2014, THERIOGENOLOGY, V81, P988, DOI 10.1016/j.theriogenology.2014.01.030; Leonardi R, 2012, J BIOL CHEM, V287, P14615, DOI 10.1074/jbc.C112.353946; Liu SY, 2013, HUM REPROD, V28, P2093, DOI 10.1093/humrep/det104; Marco-Jimenez F, 2013, THERIOGENOLOGY, V79, P1124, DOI 10.1016/j.theriogenology.2013.02.008; McMillen IC, 2004, P NUTR SOC, V63, P405, DOI 10.1079/PNS2004370; Moce ML, 2010, THERIOGENOLOGY, V73, P704, DOI 10.1016/j.theriogenology.2009.11.010; Mushahary D, 2013, PLACENTA, V34, P193, DOI 10.1016/j.placenta.2012.11.015; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Saenz-de-Juano MD, 2014, REPRODUCTION, V147, P789, DOI 10.1530/REP-14-0019; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shi WH, 2012, FERTIL STERIL, V97, P1338, DOI 10.1016/j.fertnstert.2012.02.051; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Vicente JS, 2013, CRYOBIOLOGY, V67, P321, DOI 10.1016/j.cryobiol.2013.09.165; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang ZY, 2010, FERTIL STERIL, V93, P2729, DOI 10.1016/j.fertnstert.2010.03.025; Wikland M, 2010, HUM REPROD, V25, P1699, DOI 10.1093/humrep/deq117; Zhang YX, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-69; Zhao XM, 2012, MOL REPROD DEV, V79, P445, DOI 10.1002/mrd.22052	32	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125157	10.1371/journal.pone.0125157	http://dx.doi.org/10.1371/journal.pone.0125157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915775	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000353659100102
J	Fauchier, L; Greenlaw, N; Ferrari, R; Ford, I; Fox, KM; Tardif, JC; Tendera, M; Steg, PG				Fauchier, Laurent; Greenlaw, Nicola; Ferrari, Roberto; Ford, Ian; Fox, Kim M.; Tardif, Jean-Claude; Tendera, Michal; Steg, Ph. Gabriel		CLARIFY Investigators	Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry	PLOS ONE			English	Article							ADHERENT ANTITHROMBOTIC TREATMENT; EURO HEART SURVEY; STENT IMPLANTATION; ORAL ANTICOAGULATION; CONSENSUS DOCUMENT; WORKING GROUP; TASK-FORCE; HIGH-RISK; THERAPY; CLOPIDOGREL	Background Few data are available regarding the use of antithrombotic strategies in coronary artery disease patients with atrial fibrillation (AF) in everyday practice. We sought to describe the prevalence of AF and its antithrombotic management in a contemporary population of patients with stable coronary artery disease. Methods and Findings CLARIFY is an international, prospective, longitudinal registry of outpatients with stable coronary artery disease, defined as prior (>= 12 months) myocardial infarction, revascularization procedure, coronary stenosis >50%, or chest pain associated with evidence of myocardial ischemia. Overall, 33,428 patients were screened, of whom 32,954 had data available for analysis at baseline; of these 2,229 (6.7%) had a history of AF. Median (interquartile range) CHA2DS2-VASc score was 4 (3, 5). Oral anticoagulation alone was used in 25.7%, antiplatelet therapy alone in 52.8% (single 41.8%, dual 11.0%), and both in 21.5%. OAC use was independently associated with permanent AF (p<0.001), CHA2DS2-VASc score (p=0.006), pacemaker (p<0.001), stroke (p=0.04), absence of angina (p=0.004), decreased left ventricular ejection fraction (p<0.001), increased waist circumference (p=0.005), and longer history of coronary artery disease (p=0.008). History of percutaneous coronary intervention (p=0.004) and no/partial reimbursement for cardiovascular medication (p=0.01, p<0.001, respectively) were associated with reduced oral anticoagulant use. Conclusions In this contemporary cohort of patients with stable coronary artery disease and AF, most of whom are theoretical candidates for anticoagulation, oral anticoagulants were used in only 47.2%. Half of the patients received antiplatelet therapy alone and one-fifth received both antiplatelets and oral anticoagulants. Efforts are needed to improve adherence to guidelines in these patients.	[Fauchier, Laurent] CHU Trousseau, Serv Cardiol, Tours, France; [Fauchier, Laurent] Univ Tours, Tours, France; [Greenlaw, Nicola; Ford, Ian] Univ Glasgow, Robertson Ctr, Glasgow, Lanark, Scotland; [Ferrari, Roberto] Univ Hosp Ferrara, Dept Cardiol, Cotignola, Italy; [Ferrari, Roberto] ES Hlth Sci Fdn, Maria Cecilia Hosp, GVM Care&Res, Cotignola, Italy; [Fox, Kim M.; Steg, Ph. Gabriel] Royal Brompton Hosp, NHLI Imperial Coll, ICMS, London SW3 6LY, England; [Tardif, Jean-Claude] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Tendera, Michal] Med Univ Silesia, Katowice, Poland; [Steg, Ph. Gabriel] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Steg, Ph. Gabriel] INSERM U1148, Paris, France; [Steg, Ph. Gabriel] Dept Hosp Univ FIRE, Hop Bichat, AP HP, F-75877 Paris, France	CHU Tours; Universite de Tours; University of Glasgow; University of Ferrara; Arcispedale Sant'Anna; Maria Cecilia Hospital; Imperial College London; Royal Brompton Hospital; Universite de Montreal; Medical University Silesia; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP	Fauchier, L (corresponding author), CHU Trousseau, Serv Cardiol, Tours, France.	lfau@med.univ-tours.fr	Hairullina, Adelya/AAF-6013-2019; Díaz, José Luis JLDD Díaz/Q-2523-2015; fauchier, laurent/HDN-2353-2022; Lago, Noelia Faginas/E-8015-2011; Nkombua, Lushiku/N-7043-2019; Marchionni, Niccolò/ABE-3977-2020; Nguyen, Thach N./N-1711-2019; Dženkevičiūtė, Vilma/AAB-6975-2021; Nastari, Luciano/C-8528-2012; Chioncel, Ovidiu/R-7556-2017; Ford, Ian/ABE-6145-2020; Idoate, Miguel-Ángel/D-8502-2019; Ushakov, Alexei V/P-4465-2015; Bogdański, Paweł/ABB-2938-2020; Sosner, Philippe/I-6119-2019; Pes, Giovanni Mario/AAH-3340-2019; CESAR, LUIZ ANTONIO MACHADO/N-7296-2014; Christodorescu, Ruxandra Maria/AAB-4653-2021; Tendera, Michal/AAA-1875-2022; Fauchier, Laurent/AAE-6366-2021; Georgescu, Catalina Arsenescu/R-5709-2017; Climent, Vicente/D-6129-2019; Gowdak, Luis Henrique Wolff/C-4844-2012; Prunier, Fabrice/A-5210-2011; BUAKHAMSRI, ADISAI/ABD-3971-2020; Бородина, Наталья/ABC-9347-2021; Popova, Ludmila viktorovna/ABC-5841-2021; Makarenkova, Kseniia/AAB-5482-2019; STEG, Philippe Gabriel/Z-1567-2019; Lukina, Yulia/J-9925-2017; Gowdak, Luis Henrique Wolff/M-7153-2017; FERRARI, ROBERTO/ABD-5169-2020; chioncel, ovidiu/K-8425-2019; Colquhoun, David M/F-9078-2013; Gruchala, Marcin/S-8407-2018; Smith, Albert Vernon/K-5150-2015; Ferrieres, Jean/S-7993-2016; MORENO-ARRIBAS, JOSE/G-4047-2011; Serazhim, Anna/G-6857-2016; Hernandez Afonso, Julio/I-2223-2017	Hairullina, Adelya/0000-0002-7832-2267; Lago, Noelia Faginas/0000-0002-4056-3364; Nkombua, Lushiku/0000-0002-8992-0465; Marchionni, Niccolò/0000-0002-8101-4695; Nguyen, Thach N./0000-0002-1252-8174; Dženkevičiūtė, Vilma/0000-0003-1471-9131; Nastari, Luciano/0000-0002-7959-3827; Chioncel, Ovidiu/0000-0002-3197-3628; Idoate, Miguel-Ángel/0000-0002-1596-1192; Ushakov, Alexei V/0000-0002-7020-4442; Bogdański, Paweł/0000-0002-0563-1624; Sosner, Philippe/0000-0002-5771-8174; Pes, Giovanni Mario/0000-0003-3265-2823; CESAR, LUIZ ANTONIO MACHADO/0000-0003-4436-1791; Christodorescu, Ruxandra Maria/0000-0001-8267-5404; Fauchier, Laurent/0000-0002-9267-1658; Georgescu, Catalina Arsenescu/0000-0001-5142-7598; Climent, Vicente/0000-0001-7362-1922; Gowdak, Luis Henrique Wolff/0000-0002-6785-7506; BUAKHAMSRI, ADISAI/0000-0002-1026-1349; Бородина, Наталья/0000-0003-3265-006X; Popova, Ludmila viktorovna/0000-0002-3496-6466; Lukina, Yulia/0000-0001-8252-3099; Gowdak, Luis Henrique Wolff/0000-0002-6785-7506; Baleeva, Larisa/0000-0002-7974-5894; Gruchala, Marcin/0000-0003-4901-2291; Aylward, Philip/0000-0002-5358-8552; Ferrari, Roberto/0000-0003-2046-9175; Pedretti, Roberto/0000-0003-1789-8657; STEG, Philippe Gabriel/0000-0001-6896-2941; GALINIER, Michel/0000-0003-1735-3390; LOPEZ-CABANILLAS, NESTOR HUGO/0000-0001-5653-1255; Aksutina, Natal'a/0000-0002-4856-2729; Gomez Doblas, Juan Jose/0000-0002-9020-639X; Boonyapisit, Warangkna/0000-0002-5278-0091; Alexanderson-Rosas, Erick/0000-0002-2408-8727; TAVAZZI, LUIGI/0000-0003-4448-5209; Bravo Baptista, Sergio/0000-0002-4546-5261; Walker, David/0000-0002-3541-8955; jourdain, patrick/0000-0002-5202-6902; Facila, Lorenzo/0000-0003-1402-4364; Playford, David/0000-0003-4492-1103; Jerjes - Sanchez, Carlos/0000-0003-3222-7405; Steeds, Richard/0000-0001-5687-2535; Pella, Daniel/0000-0001-9999-6271; Phrommintikul, Arintaya/0000-0003-3986-1951; Gomez-Barrado, Jose Javier/0000-0002-4623-9952; Smith, Albert Vernon/0000-0003-1942-5845; Florescu, Cristina/0000-0001-8597-3407; Ferrieres, Jean/0000-0001-6144-1297; Lang, Irene/0000-0003-0485-2692; Reid, Christopher/0000-0001-9173-3944; Morais, Joao/0000-0003-3406-2878; Bryl, Wieslaw/0000-0003-0135-409X; Oganov, Rafael/0000-0003-0875-0773; Monteiro, Pedro/0000-0002-6631-207X; MORENO-ARRIBAS, JOSE/0000-0002-4070-6476; Wongcharoen, Wanwarang/0000-0002-2418-329X; HEDDLE, WILLIAM/0000-0001-8167-2826; Aboyans, Victor/0000-0002-0322-9818; Serazhim, Anna/0000-0002-0090-4785; Escobedo, Jorge/0000-0003-1942-7402; Yusufali, Afzalhussein/0000-0003-3378-2646; Hernandez Afonso, Julio/0000-0002-0982-1759; Streb, Witold/0000-0003-4856-8511; Shin, Jinho/0000-0001-6706-6504; Oganov, Rafael G./0000-0001-8087-4231; Antonicelli, Roberto/0000-0002-5921-1828; Khripun, Alexey/0000-0001-6765-2837; Tendera, Michal/0000-0002-0812-6113; Erglis, Andrejs/0000-0002-3999-0182; Arias-Mendoza, Alexandra/0000-0002-5942-4102	Servier, France; National Institute for Health Research [NF-SI-0611-10149] Funding Source: researchfish	Servier, France(Servier); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was designed and conducted by the investigators and funded via research grants from Servier, France, including a grant to the academic statistical centre. The sponsor provided assistance for study set-up and management in each country, and funded editorial assistance in the preparation of the manuscript, tables, and figures. The sponsor was sent the manuscript before submission. Data collection was performed via an electronic case record form; all data analysis was conducted by an independent academic data statistics center. The funder did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript.	Aguilar E, 2012, THROMB RES, V130, P390, DOI 10.1016/j.thromres.2012.05.016; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; De Caterina R, 2012, J AM COLL CARDIOL, V59, P1413, DOI 10.1016/j.jacc.2012.02.008; De Caterina R, 2010, EUR HEART J, V31, P2133, DOI 10.1093/eurheartj/ehq250; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Faxon DP, 2011, THROMB HAEMOSTASIS, V106, P572, DOI 10.1160/TH11-04-0262; Gao F, 2010, CIRC J, V74, P701, DOI 10.1253/circj.CJ-09-0880; Gorin L, 2011, CHEST, V140, P911, DOI 10.1378/chest.10-2436; Goto S, 2008, AM HEART J, V156, P855, DOI 10.1016/j.ahj.2008.06.029; Hohnloser SH, 2012, CIRCULATION, V125, P669, DOI 10.1161/CIRCULATIONAHA.111.055970; Huber K, 2011, THROMB HAEMOSTASIS, V106, P569, DOI 10.1160/TH11-08-0602; January CT, 2014, J AM COLL CARDIOL; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lip GYH, 2010, THROMB HAEMOSTASIS, V103, P13, DOI 10.1160/TH09-08-0580; Lip GYH, 1996, HEART, V75, P200, DOI 10.1136/hrt.75.2.200; Man-Son-Hing M, 2003, ARCH INTERN MED, V163, P1580, DOI 10.1001/archinte.163.13.1580; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Nieuwlaat R, 2007, AM HEART J, V153, P1006, DOI 10.1016/j.ahj.2007.03.008; Patrono C, 2013, CIRCULATION, V128, P684, DOI 10.1161/CIRCULATIONAHA.113.004564; Peterson GM, 2002, INTERN MED J, V32, P15, DOI 10.1046/j.1445-5994.2002.00156.x; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Rubboli A, 2011, CHEST, V139, P981, DOI 10.1378/chest.10-2719; Ruiz-Nodar JM, 2008, J AM COLL CARDIOL, V51, P818, DOI 10.1016/j.jacc.2007.11.035; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; Steg PG, 2012, EUR HEART J, V33, P2831, DOI 10.1093/eurheartj/ehs289; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Waldo AL, 2005, J AM COLL CARDIOL, V46, P1729, DOI 10.1016/j.jacc.2005.06.077; Zhao HJ, 2011, CHEST, V139, P260, DOI 10.1378/chest.09-3083	29	16	16	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125164	10.1371/journal.pone.0125164	http://dx.doi.org/10.1371/journal.pone.0125164			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915904	Green Published, Green Accepted, gold			2022-12-27	WOS:000353659100103
J	Lee, D; Hahn, KS; Yook, SH; Park, J				Lee, Deokjae; Hahn, Kyu S.; Yook, Soon-Hyung; Park, Juyong			Quantifying Discrepancies in Opinion Spectra from Online and Offline Networks	PLOS ONE			English	Article								Online social media such as Twitter are widely used for mining public opinions and sentiments on various issues and topics. The sheer volume of the data generated and the eager adoption by the online-savvy public are helping to raise the profile of online media as a convenient source of news and public opinions on social and political issues as well. Due to the uncontrollable biases in the population who heavily use the media, however, it is often difficult to measure how accurately the online sphere reflects the offline world at large, undermining the usefulness of online media. One way of identifying and overcoming the online-offline discrepancies is to apply a common analytical and modeling framework to comparable data sets from online and offline sources and cross-analyzing the patterns found therein. In this paper we study the political spectra constructed from Twitter and from legislators' voting records as an example to demonstrate the potential limits of online media as the source for accurate public opinion mining, and how to overcome the limits by using offline data simultaneously.	[Lee, Deokjae] Seoul Natl Univ, Ctr Complex Syst Studies, Seoul, South Korea; [Lee, Deokjae] Seoul Natl Univ, CTP, Dept Phys & Astron, Seoul, South Korea; [Hahn, Kyu S.] Seoul Natl Univ, Dept Commun, Seoul, South Korea; [Yook, Soon-Hyung; Park, Juyong] Kyung Hee Univ, Dept Phys, Seoul, South Korea; [Park, Juyong] Korea Adv Inst Sci & Technol, Grad Sch Culture Technol, Taejon 305701, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University; Korea Advanced Institute of Science & Technology (KAIST)	Park, J (corresponding author), Kyung Hee Univ, Dept Phys, Seoul, South Korea.	juyongp@kaist.ac.kr	Park, Juyong/I-2290-2012; Yook, Soon-Hyung/AAH-9157-2020		National Research Foundation of Korea [20100004910, 2013S1A3A2055285, 2011-0016450]; Kyung Hee University [20110088]; Ministry of Science, ICT and Future Planning of Korea [10045459]	National Research Foundation of Korea(National Research Foundation of Korea); Kyung Hee University; Ministry of Science, ICT and Future Planning of Korea	This work was supported by National Research Foundation of Korea 20100004910, 2013S1A3A2055285, and 2011-0016450 (http://www.nrf.re.kr); Kyung Hee University 20110088 (http://www.khu.ac.kr); and Ministry of Science, ICT and Future Planning of Korea 10045459 (http://www.msip.go.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Brazill TJ, 2002, SOC NETWORKS, V24, P201, DOI 10.1016/S0378-8733(02)00004-7; Burdein I, 2006, POLIT PSYCHOL, V27, P359, DOI 10.1111/j.1467-9221.2006.00504.x; Cha Meeyoung, 2010, AAAI C WEBL SOC MED, P14; Chang Dukjin, 2011, [Journal of Communication Research, 언론정보연구], V48, P80; Conover M. D., 2011, 5 INT AAAI C WEBL SO, DOI DOI 10.1021/JA202932E; COX TF, 2001, MONOGRAPHS STAT APPL, V88; Duggan M, 2014, SOCIAL MEDIA UPDATE; Giles J, 2012, NATURE, V488, P448, DOI 10.1038/488448a; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Hargittai E, 2007, J COMPUT-MEDIAT COMM, V13, P276, DOI 10.1111/j.1083-6101.2007.00396.x; Hausdorf B, 2003, SYST BIOL, V52, P717, DOI 10.1080/10635150390235584; HUBALEK Z, 1982, BIOL REV, V57, P669, DOI 10.1111/j.1469-185X.1982.tb00376.x; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Newman M., 1999, MONTE CARLO METHODS; Nosek B. A., 2010, HDB IMPLICIT SOCIAL, P548; Parmelee J.H., 2012, POLITICS TWITTER REV; POOLE KT, 1984, J POLIT, V46, P1061, DOI 10.2307/2131242; Porter MA, 2005, P NATL ACAD SCI USA, V102, P7057, DOI 10.1073/pnas.0500191102	21	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124722	10.1371/journal.pone.0124722	http://dx.doi.org/10.1371/journal.pone.0124722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915931	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659100062
J	Lu, NN; Jin, J; Wang, SL; Wang, WH; Song, YW; Liu, YP; Ren, H; Fang, H; Liu, XF; Yu, ZH; Li, YX				Lu, Ning-Ning; Jin, Jing; Wang, Shu-Lian; Wang, Wei-Hu; Song, Yong-Wen; Liu, Yue-Ping; Ren, Hua; Fang, Hui; Liu, Xin-Fan; Yu, Zi-Hao; Li, Ye-Xiong			Postoperative Capecitabine with Concurrent Intensity-Modulated Radiotherapy or Three-Dimensional Conformal Radiotherapy for Patients with Stage II and III Rectal Cancer	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; TOTAL MESORECTAL EXCISION; FLUOROURACIL PLUS LEUCOVORIN; SURGICAL ADJUVANT BREAST; PREOPERATIVE RADIOTHERAPY; PHASE-III; INTRAVENOUS FLUOROURACIL; RADIATION-THERAPY; ORAL CAPECITABINE; FINAL REPORT	Background The aim of this study was to evaluate the survival outcomes and toxicity of postoperative chemoradiotherapy with capecitabine and concurrent intensity-modulated radiotherapy (IMRT) or three-dimensional conformal radiotherapy (3D-CRT) in patients with stage II and III rectal cancer. Patients We recruited 184 patients with pathologically proven, stage II or III rectal cancer. Following total mesorectal excision (TME), the patients were treated with capecitabine and concurrent IMRT/3D-CRT. The treatment regimen consisted of two cycles of oral capecitabine (1600 mg/m(2)/day), administered twice daily from day 1-14 of radiotherapy, followed by a 7-day rest. The median pelvic dose was 50 Gy in 25 fractions. Oxaliplatin-based adjuvant chemotherapy was administered after the chemoradiotherapy. Results The 5-year overall survival, disease-free survival and locoregional control (LRC) rates were 85.1%, 80% and 95.4%, respectively. Grade 3 and 4 toxicities were observed in 28.3% of patients during treatment. Grade 3 or 4 late toxicity, including neurotoxicity or gastrointestinal toxicity, was only observed in nine patients (4.9%). Conclusions This study demonstrated that capecitabine chemotherapy with concurrent IMRT/3D-CRT following TME is safe, is well tolerated and achieves superior LRC and favorable survival rates, with acceptable toxicity.	[Jin, Jing] CAMS, Canc Hosp, Natl Canc Ctr, Dept Radiat Oncol, Beijing 100021, Peoples R China; PUMC, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Jin, J (corresponding author), CAMS, Canc Hosp, Natl Canc Ctr, Dept Radiat Oncol, Beijing 100021, Peoples R China.	jingjin1025@163.com; yexiong12@163.com	li, ye/GWN-2672-2022		Ministry of Health of the People's Republic of China [07090010, WKJ2005-3-006(21)]; National Natural Science Foundation of China [81402524]; Beijing Hope Run Special Fund [LC2007A17]	Ministry of Health of the People's Republic of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Hope Run Special Fund	This study was funded from the Ministry of Health of the People's Republic of China Grant [07090010, WKJ2005-3-006(21)], and Dr. YXL received the funding; National Natural Science Foundation of China [81402524] which was received by Dr. NNL; and Beijing Hope Run Special Fund [LC2007A17] which was received by Dr. JJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, NEW ENGL J MED, V312, P1465; Arbea L, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-17; Cassidy J, 2002, ANN ONCOL, V13, P566, DOI 10.1093/annonc/mdf089; Cheng L, 2011, AM J CLIN ONCOL-CANC, V34, P573, DOI DOI 10.1097/C0C.0B013E3181FE41ED; Das P, 2006, INT J RADIAT ONCOL, V66, P1378, DOI 10.1016/j.ijrobp.2006.07.1374; [邓垒 DENG Lei], 2008, [中华放射肿瘤学杂志, Chinese Journal of Radiation Oncology], V17, P450; Diaz-Rubio E, 2007, J CLIN ONCOL, V25, P4224, DOI 10.1200/JCO.2006.09.8467; Dunst J, 2002, J CLIN ONCOL, V20, P3983, DOI 10.1200/JCO.2002.02.049; Duthoy W, 2004, INT J RADIAT ONCOL, V60, P794, DOI 10.1016/j.ijrobp.2004.04.016; FISHER B, 1988, JNCI-J NATL CANCER I, V80, P21, DOI 10.1093/jnci/80.1.21; Havenga K, 1999, EUR J SURG ONCOL, V25, P368, DOI 10.1053/ejso.1999.0659; Hoff PM, 2001, J CLIN ONCOL, V19, P2282, DOI 10.1200/JCO.2001.19.8.2282; Hofheinz RD, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70116-X; Jin J, 2006, INT J RADIAT ONCOL, V64, P725, DOI 10.1016/j.ijrobp.2005.08.017; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Kim DY, 2007, INT J RADIAT ONCOL, V67, P378, DOI 10.1016/j.ijrobp.2006.08.063; KROOK JE, 1991, NEW ENGL J MED, V324, P709, DOI 10.1056/NEJM199103143241101; Lembersky BC, 2006, J CLIN ONCOL, V24, P2059, DOI 10.1200/JCO.2005.04.7498; OCONNELL M, 1994, NEW ENGL J MED, V331, P502, DOI 10.1056/NEJM199408253310803; Pacelli F, 2004, DIS COLON RECTUM, V47, P170, DOI 10.1007/s10350-003-0028-3; Parekh Arti, 2013, Gastrointest Cancer Res, V6, P137; Park JH, 2011, CANCER-AM CANCER SOC, V117, P3703, DOI 10.1002/cncr.25943; Porschen R, 2007, J CLIN ONCOL, V25, P4217, DOI 10.1200/JCO.2006.09.2684; Qian LT, 2003, CHIN J RAD ONCOL, V11, P101; Ridgway Paul F, 2003, Cancer Control, V10, P205; Roels S, 2006, INT J RADIAT ONCOL, V65, P1129, DOI 10.1016/j.ijrobp.2006.02.050; Roh MS, 2009, J CLIN ONCOL, V27, P5124, DOI 10.1200/JCO.2009.22.0467; Samuelian JM, 2012, INT J RADIAT ONCOL, V82, P1981, DOI 10.1016/j.ijrobp.2011.01.051; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sebag-Montefiore D, 2009, LANCET, V373, P811, DOI 10.1016/S0140-6736(09)60484-0; Souglakos J, 2003, INT J RADIAT ONCOL, V56, P1284, DOI 10.1016/S0360-3016(03)00275-X; Tepper JE, 2002, J CLIN ONCOL, V20, P1744, DOI 10.1200/JCO.2002.07.132; Twelves C, 2005, NEW ENGL J MED, V352, P2696, DOI 10.1056/NEJMoa043116; Urbano MTG, 2006, INT J RADIAT ONCOL, V65, P907, DOI 10.1016/j.ijrobp.2005.12.056; Van Cutsem E, 2001, J CLIN ONCOL, V19, P4097, DOI 10.1200/JCO.2001.19.21.4097; van Gijn W, 2011, LANCET ONCOL, V12, P575, DOI 10.1016/S1470-2045(11)70097-3; Wolmark N, 2000, JNCI-J NATL CANCER I, V92, P388, DOI 10.1093/jnci/92.5.388	37	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124601	10.1371/journal.pone.0124601	http://dx.doi.org/10.1371/journal.pone.0124601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915948	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659100055
J	Roy, C				Roy, Christian			Quantifying Geographic Variation in the Climatic Drivers of Midcontinent Wetlands with a Spatially Varying Coefficient Model	PLOS ONE			English	Article							PRAIRIE POTHOLE REGION; NORTH-DAKOTA; GREAT-PLAINS; WATER; AREA; AUTOCORRELATION; DISTRIBUTIONS; CONVERSION	The wetlands in the Prairie Pothole Region and in the Great Plains are notorious for their sensitivity to weather variability. These wetlands have been the focus of considerable attention because of their ecological importance and because of the expected impact of climate change. Few models in the literature, however, take into account spatial variation in the importance of wetland drivers. This is surprising given the importance spatial heterogeneity in geomorphology and climatic conditions have in the region. In this paper, I use spatially-varying coefficients to assess the variation in ecological drivers in a number of ponds observed over a 50-year period (1961-2012). I included the number of ponds observed the year before on a log scale, the log of total precipitation, and mean maximum temperature during the four previous seasons as explanatory variables. I also included a temporal component to capture change in the number of ponds due to anthropogenic disturbance. Overall, fall and spring precipitation were most important in pond abundance in the west, whereas winter and summer precipitation were the most important drivers in the east. The ponds in the east of the survey area were also more dependent on pond abundance during the previous year than those in the west. Spring temperature during the previous season influenced pond abundance; while the temperature during the other seasons had a limited effect. The ponds in the southwestern part of the survey area have been increasing independently of climatic conditions, whereas the ponds in the northeast have been steadily declining. My results underline the importance of accounting the spatial heterogeneity in environmental drivers, when working at large spatial scales. In light of my results, I also argue that assessing the impacts of climate change on wetland abundance in the spring, without more accurate climatic forecasting, will be difficult.	[Roy, Christian] Univ Laval, Fac Foresterie Geog & Geomat, Quebec City, PQ, Canada; [Roy, Christian] Univ Laval, Ctr Etud Foret, Quebec City, PQ, Canada	Laval University; Laval University	Roy, C (corresponding author), Univ Laval, Fac Foresterie Geog & Geomat, Pavillon Abitibi Price, Quebec City, PQ, Canada.	christian.roy.79@gmail.com	Roy, Christian/AAB-4016-2019	Roy, Christian/0000-0002-5599-6234	BMP-Innovation Scholarship - Ducks Unlimited Canada; Natural Sciences and Engineering Research Council of Canada; Le Fonds quebecois de la recherche sur la nature et les technologies	BMP-Innovation Scholarship - Ducks Unlimited Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Le Fonds quebecois de la recherche sur la nature et les technologies(FQRNT)	This work was supported by a BMP-Innovation Scholarship funded by by Ducks Unlimited Canada, the Natural Sciences and Engineering Research Council of Canada, Le Fonds quebecois de la recherche sur la nature et les technologies during this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Adams, 1988, ECOLOGICAL LAND CLAS, V24, P155; Assuncao RM, 2003, ENVIRONMETRICS, V14, P453, DOI 10.1002/env.599; Banerjee S., 2004, HIERARCHICAL MODELIN; Batt B.D.J., 1989, P204; BETHKE RW, 1995, ECOL APPL, V5, P588, DOI 10.2307/1941969; BETHKE RW, 1993, OECOLOGIA, V93, P242, DOI 10.1007/BF00317677; Congdon P, 2006, COMPUT STAT DATA AN, V50, P422, DOI 10.1016/j.csda.2004.08.008; Congdon P., 2003, J GEOGRAPHICAL SYSTE, V5, P161, DOI DOI 10.1007/S10109-003-0099-7.AC-CESSED; Covich AP, 1997, HYDROL PROCESS, V11, P993; Dahl T.E., 2006, STATUS TRENDS WETLAN; Dahl TE, 2011, STATUS TRENDS WETLAN; Euliss NH, 2004, WETLANDS, V24, P448, DOI 10.1672/0277-5212(2004)024[0448:TWCACF]2.0.CO;2; Fang X, 2008, HYDROL PROCESS, V22, P2858, DOI 10.1002/hyp.7074; Finley AO, 2011, METHODS ECOL EVOL, V2, P143, DOI 10.1111/j.2041-210X.2010.00060.x; Foody GM, 2003, REMOTE SENS ENVIRON, V88, P283, DOI 10.1016/j.rse.2003.08.004; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Garbrecht JD, 2002, J HYDROL ENG, V7, P64, DOI 10.1061/(ASCE)1084-0699(2002)7:1(64); Gelfand AE, 2003, J AM STAT ASSOC, V98, P387, DOI 10.1198/016214503000170; Gleason RA, 2011, ECOL APPL, V21, pS65, DOI 10.1890/09-0216.1; Herfindal I, 2012, LANDSCAPE ECOL, V27, P1435, DOI 10.1007/s10980-012-9798-0; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; HOWERTER DW, 2014, WILDLIFE MONOGR JUL, P1, DOI DOI 10.1002/WM0N.1012.ACCESSED; JOHNSON DH, 1988, WILDLIFE MONOGR, P1; Johnson WC, 2010, BIOSCIENCE, V60, P128, DOI 10.1525/bio.2010.60.2.7; Johnson WC, 2005, BIOSCIENCE, V55, P863, DOI 10.1641/0006-3568(2005)055[0863:VONPWT]2.0.CO;2; Johnson WC, 2004, WETLANDS, V24, P385, DOI 10.1672/0277-5212(2004)024[0385:IOWEOT]2.0.CO;2; Johnston CA, 2013, WETLANDS, V33, P175, DOI 10.1007/s13157-012-0365-x; Kery M., 2010, INTRO WINBUGS ECOLOG; LARSON DL, 1995, CLIMATIC CHANGE, V30, P169, DOI 10.1007/BF01091840; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lewandowski D, 2009, J MULTIVARIATE ANAL, V100, P1989, DOI 10.1016/j.jmva.2009.04.008; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; McKenney DW, 2011, B AM METEOROL SOC, V92, P1611, DOI 10.1175/2011BAMS3132.1; Miller JA, 2012, PROG PHYS GEOG, V36, P681, DOI 10.1177/0309133312442522; Millett B, 2009, CLIMATIC CHANGE, V93, P243, DOI 10.1007/s10584-008-9543-5; Murkin HR, 1997, ECOL APPL, V7, P1144; Niemuth ND, 2003, WATERBIRDS, V26, P233, DOI 10.1675/1524-4695(2003)026[0233:ROWTNO]2.0.CO;2; Niemuth ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100034; Niemuth ND, 2010, WETLANDS, V30, P1053, DOI 10.1007/s13157-010-0111-1; O'Sullivan D, 2003, GEOGR ANAL, V35, P272, DOI 10.1353/geo.2003.0008; Obe R., 2011, POSTGIS IN ACTION; PICKETT STA, 1995, SCIENCE, V269, P331, DOI 10.1126/science.269.5222.331; Prairie Habitat Joint Venture, 2008, PRAIR HAB JOINT VENT; R Core Team, 2021, R LANGUAGE ENV STAT; Rashford BS, 2011, CONSERV BIOL, V25, P276, DOI 10.1111/j.1523-1739.2010.01618.x; Schindler DW, 2006, P NATL ACAD SCI USA, V103, P7210, DOI 10.1073/pnas.0601568103; Smith G. W., 1995, CRITICAL REV AERIAL; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sorenson LG, 1998, CLIMATIC CHANGE, V40, P343, DOI 10.1023/A:1005441608819; Stan Development Team, 2013, STAN A C LIB PROB SA; Steen V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096747; Stephens SE, 2008, CONSERV BIOL, V22, P1320, DOI 10.1111/j.1523-1739.2008.01022.x; Unwin A, 1998, J ROY STAT SOC D-STA, V47, P415, DOI 10.1111/1467-9884.00143; Watmough M., 2007, ENV CANADAS PRAIRIE; Wheeler DC, 2007, J GEOGR SYST, V9, P145, DOI 10.1007/s10109-006-0040-y; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winiarski KJ, 2013, MAR ECOL PROG SER, V492, P273, DOI 10.3354/meps10492; WINTER TC, 1995, WETLANDS, V15, P193, DOI 10.1007/BF03160700; Withey P, 2011, ECOL ECON, V70, P798, DOI 10.1016/j.ecolecon.2010.11.019	62	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0126961	10.1371/journal.pone.0126961	http://dx.doi.org/10.1371/journal.pone.0126961			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915770	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100158
J	Shi, HB; Guo, XY; Zhang, Q; Wu, HM; Du, HM; Liu, L; Wang, CJ; Xia, Y; Liu, X; Li, CL; Sun, SM; Wang, X; Zhou, M; Jia, QY; Zhao, HL; Song, K; Wei, DJ; Niu, KJ				Shi, Hongbin; Guo, Xiaoyan; Zhang, Qing; Wu, Hongmei; Du, Huanmin; Liu, Li; Wang, Chongjin; Xia, Yang; Liu, Xing; Li, Chunlei; Sun, Shaomei; Wang, Xing; Zhou, Ming; Jia, Qiyu; Zhao, Honglin; Song, Kun; Wei, Dianjun; Niu, Kaijun			Serum Immunoglobulin M Concentration Varies with Triglyceride Levels in an Adult Population: Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) Cohort Study	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; METABOLIC SYNDROME; IGM ANTIBODIES; RISK-FACTORS; FATTY-ACIDS; OBESITY; PREVALENCE; CHILDREN; IMPACT; LINKS	Persistent low-grade inflammation is thought to underlie the pathogenesis of many chronic diseases, such as cardiovascular diseases and metabolic syndrome. Autoimmunity is correlated with increased levels of chronic low-grade inflammation, and immunoglobulin M (IgM) is reactive to autoantigens and believed to be important for autoimmunity. Triglyceride (TG) is fatty acid carrier and initiator of oxidative stress, and it has been hypothesized that TG stimulates B cells to secrete IgM. However, few studies have investigated the relationship between TG and IgM in human populations. We designed a cross-sectional and prospective cohort study to evaluate how serum TG levels are related to IgM concentration. Participants were recruited from Tianjin Medical University General Hospital-Health Management Centre. Both a baseline cross-sectional (n = 10,808) and a prospective assessment (n = 2,615) were performed. Analysis of covariance was used in the cross-sectional analysis. After multiple adjustments for confounding factors, serum IgM level in the highest quartile of TG in males was significantly higher than levels in lower quartiles (P < 0.05). There was no significant difference between the four quartiles in females (P = 0.91). In follow-up analysis, a multiple linear regression model showed a significant and positive correlation between changes in IgM levels and changes of TG concentration in males (P = 0.04, standard beta coefficient = 0.882). This cross-sectional and cohort study is the first to show that serum concentration of IgM varies with TG levels in adult male populations. Further research is needed to explore the mechanism by which TG leads to increased IgM concentration.	[Shi, Hongbin; Wei, Dianjun] Tianjin Med Univ, Hosp 2, Tianjin, Peoples R China; [Shi, Hongbin; Zhang, Qing; Liu, Li; Wang, Chongjin; Sun, Shaomei; Wang, Xing; Zhou, Ming; Jia, Qiyu; Zhao, Honglin; Song, Kun; Niu, Kaijun] Tianjin Med Univ, Gen Hosp, Hlth Management Ctr, Tianjin, Peoples R China; [Guo, Xiaoyan; Wu, Hongmei; Du, Huanmin; Xia, Yang; Liu, Xing; Li, Chunlei; Niu, Kaijun] Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China; [Guo, Xiaoyan; Wu, Hongmei; Du, Huanmin; Xia, Yang; Liu, Xing; Li, Chunlei; Niu, Kaijun] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Wei, DJ (corresponding author), Tianjin Med Univ, Hosp 2, Tianjin, Peoples R China.	nkj0809@gmail.com; nkj0809@163.com	Xia, Yang/AAW-9116-2021	Xia, Yang/0000-0001-8783-1592; Niu, Kaijun/0000-0002-8772-2481	key technologies R&D program of Tianjin [11ZCGYSY05700, 12ZCZDSY20400, 13ZCZDSY20200]; Technologies development program of Beichen District of Tianjin [bcws2013-21, bc2014-05]; technologies project of Tianjin Binhai New Area [2013-02-04, 2013-02-06]; Science Foundation of Tianjin Medical University [2010KY28]; technology fund of Tianjin Health Bureau, China [2013KZ099]	key technologies R&D program of Tianjin; Technologies development program of Beichen District of Tianjin; technologies project of Tianjin Binhai New Area; Science Foundation of Tianjin Medical University; technology fund of Tianjin Health Bureau, China	This study was supported by grants from the key technologies R&D program of Tianjin (Key Project: No. 11ZCGYSY05700, 12ZCZDSY20400, and 13ZCZDSY20200), the Technologies development program of Beichen District of Tianjin (No. bcws2013-21 and bc2014-05), the technologies project of Tianjin Binhai New Area (No. 2013-02-04 and 2013-02-06), the Science Foundation of Tianjin Medical University (No. 2010KY28) and the technology fund of Tianjin Health Bureau (No. 2013KZ099), China.	Agarwal C, 2013, INT J PEDIAT ENDOCRI, V2013, P18, DOI [10.1186/1687-9856-2013-18, DOI 10.1186/1687-9856-2013-18]; Arai S, 2013, CELL REP, V3, P1187, DOI 10.1016/j.celrep.2013.03.006; Binder CJ, 2010, J CLIN IMMUNOL, V30, pS56, DOI 10.1007/s10875-010-9396-3; Boes M, 2000, MOL IMMUNOL, V37, P1141, DOI 10.1016/S0161-5890(01)00025-6; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Brogan K, 2014, CHILD OBES, V10, P207, DOI 10.1089/chi.2013.0146; Alves MIB, 2010, J PHYSIOL BIOCHEM, V66, P221, DOI 10.1007/s13105-010-0028-4; Buscemi S, 2014, EAT WEIGHT DISORD-ST, V19, P225, DOI 10.1007/s40519-014-0117-4; Ciccone MM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-22; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Doria A, 2005, RHEUM DIS CLIN N AM, V31, P355, DOI 10.1016/j.rdc.2005.01.006; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Feng RN, 2014, WORLD J GASTROENTERO, V20, P17932, DOI 10.3748/wjg.v20.i47.17932; Fernandez-Nebro A, 2014, LUPUS; Galle J, 2006, ATHEROSCLEROSIS, V185, P219, DOI 10.1016/j.atherosclerosis.2005.10.005; Gonzalez-Quintela A, 2008, CLIN EXP IMMUNOL, V151, P42, DOI 10.1111/j.1365-2249.2007.03545.x; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Marzullo P, 2014, ENDOCRINE, V45, P392, DOI 10.1007/s12020-013-0006-z; Montgomery IA, 2010, DIABETES OBES METAB, V12, P744, DOI 10.1111/j.1463-1326.2010.01228.x; MORROW JD, 1994, J BIOL CHEM, V269, P4317; dos Santos FDM, 2013, RHEUMATOL INT, V33, P681, DOI 10.1007/s00296-012-2402-8; Nikolopoulou A, 2012, EXPERT REV CARDIOVAS, V10, P933, DOI [10.1586/erc.12.74, 10.1586/ERC.12.74]; Odaka Y, 2010, OBESITY, V18, P1688, DOI 10.1038/oby.2009.513; Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853; Quan W, 2013, DIABETES OBES METAB, V15, P141, DOI 10.1111/dom.12153; Rashidi H, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-53; Rosenbloom AL, 2003, DIABETES CARE, V26, P2954, DOI 10.2337/diacare.26.10.2954; Sakcak I, 2010, OBES SURG, V20, P610, DOI 10.1007/s11695-009-0061-y; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Song K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088701; Sun J, 2014, INT J ENV RES PUB HE, V11, P3956, DOI 10.3390/ijerph110403956; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Vollmers HP, 2006, ADV DRUG DELIVER REV, V58, P755, DOI 10.1016/j.addr.2005.08.007; Winer DA, 2013, CELL MOL LIFE SCI; Yang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047990; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097865	38	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124255	10.1371/journal.pone.0124255	http://dx.doi.org/10.1371/journal.pone.0124255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915947	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659100041
J	Staege, MS				Staege, Martin S.			A Multi-Component Model of Hodgkin's Lymphoma	PLOS ONE			English	Article							REGULATORY T-CELLS; EPSTEIN-BARR-VIRUS; REED-STERNBERG CELLS; DISEASE; ENHANCEMENT; EXPRESSION; THERAPY; IMPACT; LINES	Hodgkin's lymphoma is an example for a tumor with an extremely tight interaction of tumor cells with cells from the tumor micro-environment. These so-called bystander cells are not inert but interact actively with the tumor cells. Some of these cells support tumor growth by delivery of co-stimulating and anti-apoptotic signals ("helper cells"). Other cells ("killer cells") are involved in the anti-tumor immune response which is obviously not efficient enough for tumor elimination. The activity of both helper cells and killer cells is regulated by additional cells in the stroma ("regulatory cells"). The dynamic behavior of such multicomponent systems is difficult to predict. In the present paper we propose a model that can be used for simulation of essential features of this system. In this model, tumor growth depends on (i) presence of few cancer stem cells, (ii) co-stimulation of cancer cells by the tumor stroma, (iii) activity of regulatory cells that suppress killer cells without suppression of helper cells. The success of cytotoxic/cytostatic therapy in this model varies depending on the therapy-related toxicity for each of the cell populations. The model also allows the analysis of immunotherapeutic interventions. Under certain conditions, paradox enhancement of tumor growth can occur after therapeutic intervention. The model might be useful for the design of new treatment strategies for Hodgkin's lymphoma and other tumors with prominent tumor-stroma interaction.	Univ Halle Wittenberg, Dept Pediat, Halle, S, Germany	Martin Luther University Halle Wittenberg	Staege, MS (corresponding author), Univ Halle Wittenberg, Dept Pediat, Halle, S, Germany.	martin.staege@medizin.uni-halle.de	Staege, Martin/AAX-8994-2021	Staege, Martin/0000-0003-3765-7068				Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Asano N, 2006, J CLIN ONCOL, V24, P4626, DOI 10.1200/JCO.2006.06.5342; Assis MCG, 2012, MED ONCOL, V29, P3614, DOI 10.1007/s12032-012-0299-4; Bhatia S, 2003, J CLIN ONCOL, V21, P4386, DOI 10.1200/JCO.2003.11.059; Bollard CM, J EXP MED, V204, P1623; Chiarella P, 2008, CLIN MED INSIGHTS-ON, V2, P237; Cruse JM, 2002, EXP MOL PATHOL, V73, P112, DOI 10.1006/exmp.2002.2458; DREXLER HG, 1993, LEUKEMIA LYMPHOMA, V9, P1, DOI 10.3109/10428199309148499; Ikeda JI, 2010, AM J PATHOL, V177, P3081, DOI 10.2353/ajpath.2010.100089; Jones RJ, 2009, BLOOD, V113, P5920, DOI 10.1182/blood-2008-11-189688; Karan D, 2007, INT J CANCER, V121, P1520, DOI 10.1002/ijc.22873; Kelley TW, 2007, AM J CLIN PATHOL, V128, P958, DOI 10.1309/NB3947K383DJ0LQ2; Koreishi AF, 2010, APPL IMMUNOHISTO M M, V18, P206, DOI 10.1097/PAI.0b013e3181c7138b; Lucas KG, 2004, CANCER, V100, P1892, DOI 10.1002/cncr.20188; Moreno-Ramirez D, 2014, CANCER IMMUNOL IMMUN, V63, P1229, DOI 10.1007/s00262-014-1583-2; Nakashima M, 2010, CANCER SCI, V101, P2490, DOI 10.1111/j.1349-7006.2010.01693.x; PREHN RT, 1994, CANCER RES, V54, P908; Schellong G, 2004, KLIN PADIATR, V216, P364, DOI 10.1055/s-2004-832340; Schreck S, 2009, HEMATOL ONCOL, V27, P31, DOI 10.1002/hon.878; Smolewski P, 2000, INT J ONCOL, V17, P603; Steidl C, 2011, J CLIN ONCOL, V29, P1812, DOI 10.1200/JCO.2010.32.8401	21	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124614	10.1371/journal.pone.0124614	http://dx.doi.org/10.1371/journal.pone.0124614			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915037	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100056
J	Zhang, HJ; Kawase-Koga, Y; Sun, T				Zhang, Haijun; Kawase-Koga, Yoko; Sun, Tao			Protein Expression Profiles Characterize Distinct Features of Mouse Cerebral Cortices at Different Developmental Stages	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; PROGENITOR CELLS; BRAIN; NEURONS; MUTATIONS; GENES; KINASE; PHOSPHORYLATION; PROLIFERATION; BEHAVIOR	The proper development of the mammalian cerebral cortex requires precise protein synthesis and accurate regulation of protein expression levels. To reveal signatures of protein expression in developing mouse cortices, we here generate proteomic profiles of cortices at embryonic and postnatal stages using tandem mass spectrometry (MS/MS). We found that protein expression profiles are mostly consistent with biological features of the developing cortex. Gene Ontology (GO) and KEGG pathway analyses demonstrate conserved molecules that maintain cortical development such as proteins involved in metabolism. GO and KEGG pathway analyses further identify differentially expressed proteins that function at specific stages, for example proteins regulating the cell cycle in the embryonic cortex, and proteins controlling axon guidance in the postnatal cortex, suggesting that distinct protein expression profiles determine biological events in the developing cortex. Furthermore, the STRING network analysis has revealed that many proteins control a single biological event, such as the cell cycle regulation, through cohesive interactions, indicating a complex network regulation in the cortex. Our study has identified protein networks that control the cortical development and has provided a protein reference for further investigation of protein interactions in the cortex.	[Zhang, Haijun; Kawase-Koga, Yoko; Sun, Tao] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA; [Zhang, Haijun] Cornell Univ, Weill Med Coll, Dept Med Genet, New York, NY 10021 USA; [Kawase-Koga, Yoko] Tokyo Univ Hosp, Dept Oral & Maxillofacial Surg, Tokyo 113, Japan	Cornell University; Cornell University; University of Tokyo	Sun, T (corresponding author), Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA.	haz2004@med.cornell.edu; tas2009@med.cornell.edu			Hirschl/Weill-Caulier Trust; NIH/NIMH [2R01MH083680-06]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083680] Funding Source: NIH RePORTER	Hirschl/Weill-Caulier Trust; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by an award from the Hirschl/Weill-Caulier Trust (TS) and a 2R01MH083680-06 grant from the NIH/NIMH (TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi MR, 2009, AM J HUM GENET, V85, P737, DOI 10.1016/j.ajhg.2009.10.007; Breuss M, 2012, CELL REP, V2, P1554, DOI 10.1016/j.celrep.2012.11.017; Burger C, 2008, NEUROBIOL LEARN MEM, V89, P379, DOI 10.1016/j.nlm.2007.11.006; Carrette O, 2006, PROTEOMICS, V6, P4940, DOI 10.1002/pmic.200600084; Cheah PS, 2012, MOL PSYCHIATR, V17, P451, DOI 10.1038/mp.2011.158; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Cushion TD, 2014, AM J HUM GENET, V94, P634, DOI 10.1016/j.ajhg.2014.03.009; Dai XQ, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-107; Drinjakovic J, 2010, NEURON, V65, P341, DOI 10.1016/j.neuron.2010.01.017; Dubravka D, 2000, CELL RES, V10, P1, DOI 10.1038/sj.cr.7290031; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ishihara K, 2014, NEUROSCIENCE, V281, P1, DOI 10.1016/j.neuroscience.2014.09.039; Jablonska B, 2007, J CELL BIOL, V179, P1231, DOI 10.1083/jcb.200702031; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; KUBBEN FJGM, 1994, GUT, V35, P530, DOI 10.1136/gut.35.4.530; Lee AS, 2012, MOL PSYCHIATR, V17, P1054, DOI [10.1038/mp.2012.149, 10.1038/mp.2012.71]; Lian GW, 2012, J NEUROSCI, V32, P7672, DOI 10.1523/JNEUROSCI.0894-12.2012; Liu C, 2011, PLACENTA, V32, P168, DOI 10.1016/j.placenta.2010.11.007; Lonic A, 2008, MOL CELL BIOL, V28, P3372, DOI 10.1128/MCB.01837-07; Manavalan A, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.76; Middleton FA, 2005, NEUROPSYCHOPHARMACOL, V30, P974, DOI 10.1038/sj.npp.1300674; Mignon-Ravix C, 2010, J MED GENET, V47, P132, DOI 10.1136/jmg.2009.069112; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; MORIMURA R, 2013, J PEDIATR ONCOL NURS, V30, P911, DOI DOI 10.1002/DNEU.22117; Nakajima J, 2014, CLIN GENET; Ngo L, 2014, HUM MOL GENET, V23, P5147, DOI 10.1093/hmg/ddu238; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Ozeki Y, 2011, NEUROSCI RES, V69, P154, DOI 10.1016/j.neures.2010.10.003; PAGANO M, 1993, J CELL BIOL, V121, P101, DOI 10.1083/jcb.121.1.101; Radhakrishnan VM, 2012, J BIOL CHEM, V287, P43300, DOI 10.1074/jbc.M112.397877; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; Ramachandran R, 2010, J COMP NEUROL, V518, P4196, DOI 10.1002/cne.22448; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Romaniello R, 2012, DEV MED CHILD NEUROL, V54, P765, DOI 10.1111/j.1469-8749.2012.04316.x; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Tanaka H, 2012, DEV BIOL, V370, P223, DOI 10.1016/j.ydbio.2012.07.032; Taraslia VK, 2013, CANCER GENOM PROTEOM, V10, P125; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; von Holst A, 2007, J BIOL CHEM, V282, P9172, DOI 10.1074/jbc.M608067200; Wang HX, 2006, J PROTEOME RES, V5, P361, DOI 10.1021/pr0503681; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wong AHC, 2003, MOL PSYCHIATR, V8, P156, DOI 10.1038/sj.mp.4001237; Wu XW, 2010, CANCER RES, V70, P2718, DOI 10.1158/0008-5472.CAN-09-3631; Yamashita N, 2006, J NEUROSCI, V26, P13357, DOI 10.1523/JNEUROSCI.4276-06.2006; Yang YT, 2012, NAT NEUROSCI	54	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125608	10.1371/journal.pone.0125608	http://dx.doi.org/10.1371/journal.pone.0125608			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915664	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100136
J	Zhou, M; Tan, SK; Zhang, L				Zhou, Min; Tan, Shukui; Zhang, Lu			Influences of Different Land Use Spatial Control Schemes on Farmland Conversion and Urban Development	PLOS ONE			English	Article							LANDSCAPE PATTERN CHANGES; CHINA; SPRAWL; FRAGMENTATION; REGION; POLICY; SUSTAINABILITY; URBANIZATION; CHALLENGE	Land use planning is always officially implemented as an effective tool to control urban development and protect farmland. However, its impact on land use change remains untested in China. Using a case study of Hang-Jia-Hu region, the main objective of this paper was to investigate the influence of different land use spatial control schemes on farmland conversion and urban development. Comparisons of farmland conversion and urban development patterns between the urban planning area and the non-urban planning area were characterized by using remote sensing, geographical information systems, and landscape metrics. Results indicated that farmland conversion in the non-urban planning area was more intensive than that in the urban planning area, and that farmland patterns was more fragmented in the non-urban planning area. Built-up land patterns in the non-urban planning area showed a trend of aggregation, while those in the urban planning area had a dual trend of fragmentation and aggregation. Existing built-up areas had less influence on built-up land sprawl in the non-urban planning area than that in the urban planning area. Built-up land sprawl in the form of continuous development in the urban planning area led to farmland conversion; and in the non-urban planning area, built-up land sprawl in the form of leapfrogging development resulted in farmland areal declines and fragmentation. We argued that it is a basic requirement to integrate land use plans in urban and non-urban planning areas for land use planning and management.	[Zhou, Min; Tan, Shukui; Zhang, Lu] Huazhong Univ Sci & Technol, Nontradit Secur Ctr, Wuhan 430074, Peoples R China; [Zhou, Min; Tan, Shukui; Zhang, Lu] Huazhong Univ Sci & Technol, Coll Publ Adm, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Tan, SK (corresponding author), Huazhong Univ Sci & Technol, Nontradit Secur Ctr, Wuhan 430074, Peoples R China.	tansk@126.com			National 985 Project of Non-traditional Security at Huazhong University of Science and Technology; National Natural Science Foundation of China [41401631, 41401192]	National 985 Project of Non-traditional Security at Huazhong University of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National 985 Project of Non-traditional Security at Huazhong University of Science and Technology and National Natural Science Foundation of China (No. 41401631 and No. 41401192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri L, 2014, ECOL INDIC, V36, P315, DOI 10.1016/j.ecolind.2013.07.011; Basu P, 2008, SOUTHEAST GEOGR, V48, P219, DOI 10.1353/sgo.0.0015; Carsjens GJ, 2002, LANDSCAPE URBAN PLAN, V58, P79, DOI 10.1016/S0169-2046(01)00210-9; Chen CH, 2005, SCI TOTAL ENVIRON, V346, P17, DOI 10.1016/j.scitotenv.2004.12.057; Flannery W, 2015, LAND USE POLICY, V43, P161, DOI 10.1016/j.landusepol.2014.11.001; Haase D, 2007, LANDSCAPE URBAN PLAN, V80, P1, DOI 10.1016/j.landurbplan.2006.03.011; Haase D, 2012, ENVIRON MODELL SOFTW, V35, P92, DOI 10.1016/j.envsoft.2012.02.012; Huang SL, 2009, LANDSCAPE URBAN PLAN, V90, P20, DOI 10.1016/j.landurbplan.2008.10.010; Inostroza L, 2013, J ENVIRON MANAGE, V115, P87, DOI 10.1016/j.jenvman.2012.11.007; Jaeger JAG, 2014, ECOL INDIC, V38, P294, DOI 10.1016/j.ecolind.2013.11.022; Li HB, 2004, LANDSCAPE ECOL, V19, P389, DOI 10.1023/B:LAND.0000030441.15628.d6; Lin CS, 2005, LAND USE POLICY, V20, P87; Long HL, 2009, LAND USE POLICY, V26, P322, DOI 10.1016/j.landusepol.2008.04.001; Lu PW, 2013, CITIES, V35, P200, DOI 10.1016/j.cities.2013.06.001; Marshall T, 2014, PROG PLANN, V89, P1, DOI 10.1016/j.progress.2013.03.003; Mazzocchi C, 2013, LAND USE POLICY, V35, P155, DOI 10.1016/j.landusepol.2013.05.019; McGarigal K., 2002, FRAGSTATS SPATIAL PA; Meng Y, 2008, LANDSCAPE URBAN PLAN, V85, P40, DOI 10.1016/j.landurbplan.2007.09.004; Nesheim I, 2014, LAND USE POLICY, V37, P60, DOI 10.1016/j.landusepol.2012.04.024; Paul V, 2013, LAND USE POLICY, V30, P94, DOI 10.1016/j.landusepol.2012.02.009; Peng H, 2007, J ENVIRON MANAGE, V85, P774, DOI 10.1016/j.jenvman.2006.09.015; Powell RL, 2007, REMOTE SENS ENVIRON, V106, P253, DOI 10.1016/j.rse.2006.09.005; Qureshi S, 2014, ECOL INDIC, V42, P1, DOI 10.1016/j.ecolind.2014.04.017; Sayer J, 2013, P NATL ACAD SCI USA, V110, P8345, DOI 10.1073/pnas.1208054110; Schetke S, 2012, ENVIRON IMPACT ASSES, V32, P195, DOI 10.1016/j.eiar.2011.08.008; Skinner MW, 2001, LAND USE POLICY, V18, P329, DOI 10.1016/S0264-8377(01)00026-6; Su SL, 2014, ECOL INDIC, V46, P477, DOI 10.1016/j.ecolind.2014.06.044; Su SL, 2014, APPL GEOGR, V53, P20, DOI 10.1016/j.apgeog.2014.06.002; Su SL, 2014, AGR SYST, V131, P87, DOI 10.1016/j.agsy.2014.08.005; Su SL, 2014, ECOL INDIC, V40, P10, DOI 10.1016/j.ecolind.2013.12.013; Su SL, 2013, ENVIRON MANAGE, V52, P907, DOI 10.1007/s00267-013-0141-6; Su SL, 2011, APPL GEOGR, V31, P439, DOI 10.1016/j.apgeog.2010.10.008; Tan MH, 2005, LAND USE POLICY, V22, P187, DOI 10.1016/j.landusepol.2004.03.003; Thompson AW, 2009, LAND USE POLICY, V26, P194, DOI 10.1016/j.landusepol.2008.02.005; UNFPA, 2007, STAT WORLD POP 2007; Verburg PH, 2009, J ENVIRON MANAGE, V90, P1327, DOI 10.1016/j.jenvman.2008.08.005; World Bank, 2005, DYNAMICS GLOBAL URBA, P200; Wu JX, 2009, AGR ECOSYST ENVIRON, V129, P523, DOI 10.1016/j.agee.2008.11.008; Xie YC, 2005, GLOBAL ENVIRON CHANG, V15, P238, DOI 10.1016/j.gloenvcha.2005.03.002	39	8	10	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125008	10.1371/journal.pone.0125008	http://dx.doi.org/10.1371/journal.pone.0125008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915897	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100089
J	Li, XM; Li, J; Wu, YK				Li, Xinmiao; Li, Jing; Wu, Yukeng			A Global Optimization Approach to Multi-Polarity Sentiment Analysis	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; FEATURE-SELECTION; CLASSIFICATION; REDUCTION	Following the rapid development of social media, sentiment analysis has become an important social media mining technique. The performance of automatic sentiment analysis primarily depends on feature selection and sentiment classification. While information gain (IG) and support vector machines (SVM) are two important techniques, few studies have optimized both approaches in sentiment analysis. The effectiveness of applying a global optimization approach to sentiment analysis remains unclear. We propose a global optimization-based sentiment analysis (PSOGO-Senti) approach to improve sentiment analysis with IG for feature selection and SVM as the learning engine. The PSOGO-Senti approach utilizes a particle swarm optimization algorithm to obtain a global optimal combination of feature dimensions and parameters in the SVM. We evaluate the PSOGO-Senti model on two datasets from different fields. The experimental results showed that the PSOGO-Senti model can improve binary and multi-polarity Chinese sentiment analysis. We compared the optimal feature subset selected by PSOGO-Senti with the features in the sentiment dictionary. The results of this comparison indicated that PSOGO-Senti can effectively remove redundant and noisy features and can select a domain-specific feature subset with a higherexplanatory power for a particular sentiment analysis task. The experimental results showed that the PSOGO-Senti approach is effective and robust for sentiment analysis tasks in different domains. By comparing the improvements of two-polarity, three-polarity and five-polarity sentiment analysis results, we found that the five-polarity sentiment analysis delivered the largest improvement. The improvement of the two-polarity sentiment analysis was the smallest. We conclude that the PSOGO-Senti achieves higher improvement for a more complicated sentiment analysis task. We also compared the results of PSOGO-Senti with those of the genetic algorithm (GA) and grid search method. From the results of this comparison, we found that PSOGO-Senti is more suitable for improving a difficult multipolarity sentiment analysis problem.	[Li, Xinmiao; Li, Jing; Wu, Yukeng] Shanghai Univ Finance & Econ, Sch Informat Management & Engn, Shanghai, Peoples R China	Shanghai University of Finance & Economics	Li, XM (corresponding author), Shanghai Univ Finance & Econ, Sch Informat Management & Engn, Shanghai, Peoples R China.	xinmiaoli@shufe.edu.cn			National Natural Science Foundation of China [71001059]; Shanghai Municipal Natural Science Foundation of China [14ZR1413400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation of China	This work was supported by the National Natural Science Foundation of China (NO. 71001059). The URL is http://www.nsfc.gov.cn/. It was also supported by the Shanghai Municipal Natural Science Foundation of China (NO. 14ZR1413400). The URL is http://www.stcsm.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2010, MIS QUART, V34, P435; Abbasi A, 2008, ACM T INFORM SYST, V26, DOI [10.1145/1344411.1344413, 10.1145/1361684.1361685]; Agarwal Basant, 2013, Computational Linguistics and Intelligent Text Processing. 14th International Conference, CICLing 2013. Proceedings, P13, DOI 10.1007/978-3-642-37256-8_2; Akay MF, 2009, EXPERT SYST APPL, V36, P3240, DOI 10.1016/j.eswa.2008.01.009; Basari AH, 2013, PROCEDIA ENGINEER, V53, P453, DOI 10.1016/j.proeng.2013.02.059; Chen CC, 2011, DECIS SUPPORT SYST, V50, P755, DOI 10.1016/j.dss.2010.08.023; Chuang LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037018; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Coussement K, 2008, EXPERT SYST APPL, V34, P313, DOI 10.1016/j.eswa.2006.09.038; Desmet B, 2013, EXPERT SYST APPL, V40, P6351, DOI 10.1016/j.eswa.2013.05.050; Dyrba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064925; Frohlich H, 2003, PROC INT C TOOLS ART, P142, DOI 10.1109/TAI.2003.1250182; Gamon M., 2004, P 20 INT C COMP LING, P841, DOI [10.3115/1220355.1220476, DOI 10.3115/1220355.1220476]; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; He Y, 2010, INFORM PROCESSING MA, V47, P606; Heisele B, 2003, PATTERN RECOGN, V36, P2007, DOI 10.1016/S0031-3203(03)00062-1; Huang CL, 2007, EXPERT SYST APPL, V33, P847, DOI 10.1016/j.eswa.2006.07.007; Huang CF, 2012, APPL SOFT COMPUT, V12, P807, DOI 10.1016/j.asoc.2011.10.009; Kim H, 2005, J MACH LEARN RES, V6, P37; Lane PCR, 2012, DECIS SUPPORT SYST, V53, P712, DOI 10.1016/j.dss.2012.05.028; Li JX, 2006, COMMUN ACM, V49, P76, DOI 10.1145/1121949.1121951; Li N, 2010, DECIS SUPPORT SYST, V48, P354, DOI 10.1016/j.dss.2009.09.003; Lin SW, 2009, EXPERT SYST APPL, V36, P11543, DOI 10.1016/j.eswa.2009.03.029; Liu B, 2010, IEEE INTELL SYST, V25, P76; Lu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056221; Manevitz LM, 2002, J MACH LEARN RES, V2, P139, DOI 10.1162/15324430260185574; Manimala K, 2011, APPL SOFT COMPUT, V11, P5485, DOI 10.1016/j.asoc.2011.05.010; Moraes R, 2013, EXPERT SYST APPL, V40, P621, DOI 10.1016/j.eswa.2012.07.059; O'Leary DE, 2011, DECIS SUPPORT SYST, V51, P821, DOI 10.1016/j.dss.2011.01.016; Pang B, 2002, PROCEEDINGS OF THE 2002 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING, P79, DOI 10.3115/1118693.1118704; Park Y, 2011, EXPERT SYST APPL, V38, P10638, DOI 10.1016/j.eswa.2011.02.125; Tan SB, 2011, EXPERT SYST APPL, V38, P12094, DOI 10.1016/j.eswa.2011.02.105; Uguz H, 2011, KNOWL-BASED SYST, V24, P1024, DOI 10.1016/j.knosys.2011.04.014; Waila P, 2012, IEEE INT C COMP INT; Wiebe J, 2004, COMPUT LINGUIST, V30, P277, DOI 10.1162/0891201041850885; Xia YQ, 2008, INT J COMPUTER PROCE, V21, P309; Yi J., 2003, P 2 INT C KNOWL CAPT, P70, DOI DOI 10.1145/945645.945658	37	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124672	10.1371/journal.pone.0124672	http://dx.doi.org/10.1371/journal.pone.0124672			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909740	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800100
J	Karlsson, LC; Soveri, A; Rasanen, P; Karna, A; Delatte, S; Lagerstrom, E; Mard, L; Steffansson, M; Lehtonen, M; Laine, M				Karlsson, Linda C.; Soveri, Anna; Rasanen, Pekka; Karna, Antti; Delatte, Sonia; Lagerstrom, Emma; Mard, Lena; Steffansson, Mikaela; Lehtonen, Minna; Laine, Matti			Bilingualism and Performance on Two Widely Used Developmental Neuropsychological Test Batteries	PLOS ONE			English	Article							WORKING-MEMORY; ADVANTAGE; EXPERIENCE; LANGUAGE; CHILDREN; TASKS	The present study investigated the effect of bilingualism on the two widely used developmental neuropsychological test batteries Wechsler Intelligence Scale for Children - Fourth Edition (WISC-IV) and A Developmental Neuropsychological Assessment, Second Edition (NEPSY-II) in children. The sample consisted of 100 Finland-Swedish children in two age groups. About half (n = 52) of the participants were early simultaneous bilinguals, and the other half (n = 48) were monolinguals. As no Finland-Swedish versions of the tests are available at the moment, both tests were translated and adapted to suit this population. The results revealed no difference in the performance between bilingual and monolingual children. This speaks against a cognitive advantage in bilingual children and indicates that development of separate norms for monolingual and bilingual children is not needed for clinical use.	[Karlsson, Linda C.; Soveri, Anna; Delatte, Sonia; Lagerstrom, Emma; Mard, Lena; Steffansson, Mikaela; Lehtonen, Minna; Laine, Matti] Abo Akad Univ, Dept Psychol, Turku, Finland; [Rasanen, Pekka] Niilo Maki Inst, Jyvaskyla, Finland; [Karna, Antti] Univ Turku, Dept Psychol, Turku, Finland; [Lehtonen, Minna] Univ Helsinki, Cognit Brain Res Unit, Cognit Sci, Helsinki, Finland	Abo Akademi University; University of Turku; University of Helsinki	Karlsson, LC (corresponding author), Abo Akad Univ, Dept Psychol, Turku, Finland.	linda.karlsson@abo.fi	Lehtonen, Minna/AAN-8202-2020; Lehtonen, Minna/K-3672-2012; Räsänen, Pekka/AAR-3456-2020; Räsänen, Pekka J/GLV-1902-2022	Lehtonen, Minna/0000-0002-6137-8854; Lehtonen, Minna/0000-0002-6137-8854; Räsänen, Pekka/0000-0002-6290-3649; Karlsson, Linda/0000-0002-2883-9153; Soveri, Anna/0000-0002-1443-6097	Swedish Cultural Foundation in Finland; Stiftelsen Brita Maria Renlunds minne; Suomen Akatemia [135688]; BrainTrain Research Centre of Excellence	Swedish Cultural Foundation in Finland; Stiftelsen Brita Maria Renlunds minne; Suomen Akatemia(Academy of Finland); BrainTrain Research Centre of Excellence	This study was supported by the Swedish Cultural Foundation in Finland (http://www.kulturfonden.fi/en/); Stiftelsen Brita Maria Renlunds minne (http://www.britamariarenlundsminne.fi/start/); Suomen Akatemia, grant number 135688, (ML2), (http://www.aka.fi/en-GB/A/); and BrainTrain Research Centre of Excellence (http://www.braintrain.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesope OO, 2010, REV EDUC RES, V80, P207, DOI 10.3102/0034654310368803; Dunabeitia JA, 2014, EXP PSYCHOL, V61, P234, DOI 10.1027/1618-3169/a000243; Anton Eneko, 2014, Front Psychol, V5, P398, DOI 10.3389/fpsyg.2014.00398; Barac R, 2014, EARLY CHILD RES Q, V29, P699, DOI 10.1016/j.ecresq.2014.02.003; Bialystok E, 1998, APPL PSYCHOLINGUIST, V19, P69, DOI 10.1017/S0142716400010584; Bialystok Ellen, 2009, Psychol Sci Public Interest, V10, P89, DOI 10.1177/1529100610387084; Bialystok E, 2008, J NEUROLINGUIST, V21, P522, DOI 10.1016/j.jneuroling.2007.07.001; Carlson SM, 2008, DEVELOPMENTAL SCI, V11, P282, DOI 10.1111/j.1467-7687.2008.00675.x; de Abreu PMJE, 2011, MEMORY, V19, P529, DOI 10.1080/09658211.2011.590504; de Bruin A, 2015, PSYCHOL SCI, V26, P99, DOI 10.1177/0956797614557866; Garratt LC, 2008, CHILD NEUROPSYCHOL, V14, P71, DOI 10.1080/09297040701218405; Gathercole VCM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00011; Gollan TH, 2007, J INT NEUROPSYCH SOC, V13, P197, DOI 10.1017/S1355617707070038; Hilchey MD, 2011, PSYCHON B REV, V18, P625, DOI 10.3758/s13423-011-0116-7; Kharkhurin AV, 2010, INT J BILINGUAL, V14, P211, DOI 10.1177/1367006910363060; Korkman M., 2000, NEPSY NEUROPSYKOLOGI; Korkman M., 2008, NEPSY 2 LASTEN NEURO; Korkman M., 2007, NEPSY 2 DEVELOPMENTA; Korkman M., 2007, NEPSY 2, V2nd; Korkman M, 2012, ACTA PAEDIATR, V101, P946, DOI 10.1111/j.1651-2227.2012.02733.x; Lauchlan F, 2013, INT J BILINGUAL, V17, P43, DOI 10.1177/1367006911429622; Macnamara BN, 2014, PSYCHON B REV, V21, P520, DOI 10.3758/s13423-013-0524-y; Morales J, 2013, J EXP CHILD PSYCHOL, V114, P187, DOI 10.1016/j.jecp.2012.09.002; Morton JB, 2007, DEVELOPMENTAL SCI, V10, P719, DOI 10.1111/j.1467-7687.2007.00623.x; Morton JB, 2010, PSYCHOL REP, V107, P888, DOI 10.2466/04.11.28.PR0.107.6.888-890; Paap KR, 2014, J COGN PSYCHOL, V26, P242, DOI 10.1080/20445911.2014.891597; Paap KR, 2013, COGNITIVE PSYCHOL, V66, P232, DOI 10.1016/j.cogpsych.2012.12.002; RICCIARDELLI LA, 1992, J PSYCHOLINGUIST RES, V21, P301, DOI 10.1007/BF01067515; Rubin DB, 1987, MULTIPLE IMPUTATION, DOI [10.1002/sim.6008, DOI 10.1002/SIM.6008]; Vipunen, 2013, ESI PER SEK LIS OPP; Wechsler D., 2007, WECHSLER INTELLIGENC; Wechsler D, 2010, WISC 4 WECHSLER INTE; Wechsler D., 2006, WECHSLER INTELLIGENC; Wechsler DW., 1999, INTELLIGENCE SCALE C; Ye Z, 2009, NEUROSCI BIOBEHAV R, V33, P1168, DOI 10.1016/j.neubiorev.2009.03.003	35	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125867	10.1371/journal.pone.0125867	http://dx.doi.org/10.1371/journal.pone.0125867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25922937	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600166
J	Marzola, E; Desedime, N; Giovannone, C; Amianto, F; Fassino, S; Abbate-Daga, G				Marzola, Enrica; Desedime, Nadia; Giovannone, Cristina; Amianto, Federico; Fassino, Secondo; Abbate-Daga, Giovanni			Atypical Antipsychotics as Augmentation Therapy in Anorexia Nervosa	PLOS ONE			English	Article							COMPULSIVE PERSONALITY-TRAITS; PSYCHIATRY WFSBP GUIDELINES; EATING-DISORDERS; DOUBLE-BLIND; OPEN-LABEL; WORLD FEDERATION; ANXIETY; INDIVIDUALS; FLUOXETINE; OLANZAPINE	Anorexia nervosa (AN) is a life-threatening and difficult to treat mental illness with the highest mortality rates of any psychiatric disorder. We aimed to garner preliminary data on the real-world use of olanzapine and aripiprazole as augmentation agents of Selective Serotonin Reuptake Inhibitors (SSRIs) in adult inpatients affected by AN. We retrospectively evaluated the clinical charts of patients who were hospitalized between 2012 and 2014. Patients were evaluated upon admission and discharge. We investigated eating symptomatology, and both general and eating psychopathology using: Hamilton Rating Scale for Anxiety, Hamilton Rating Scale for Depression, and Yale-Brown-Cornell Eating Disorders Scale. The charts of 75 patients were included in this study. The sample resulted equally distributed among those receiving SSRIs and either aripiprazole or olanzapine in addition to SSRIs. Notwithstanding a few baseline clinical differences, upon discharge all groups were significantly improved on all measures. Interestingly, aripiprazole showed the greatest effectiveness in reducing eating-related preoccupations and rituals with a large effect size. The body of evidence on medication management in AN is in dismal condition. Augmentation therapy is a well-established approach to a variety of mental disorders and it is often used in every-day clinical practice with patients affected by AN as well. Nevertheless, to date very little data is available on this topic. Results from our sample yielded promising results on the effectiveness of aripiprazole augmentation in reducing eating-related obsessions and compulsions. Randomized controlled trials are warranted to confirm these encouraging findings.	[Marzola, Enrica; Desedime, Nadia; Giovannone, Cristina; Amianto, Federico; Fassino, Secondo; Abbate-Daga, Giovanni] Univ Turin, Dept Neurosci, Eating Disorders Ctr Treatment & Res, Turin, Italy	University of Turin	Abbate-Daga, G (corresponding author), Univ Turin, Dept Neurosci, Eating Disorders Ctr Treatment & Res, Turin, Italy.	giovanni.abbatedaga@unito.it	Abbate Daga, Giovanni/AAE-3155-2022; Marzola, Enrica/I-5984-2012	Marzola, Enrica/0000-0003-1328-9678; Abbate-Daga, Giovanni/0000-0002-5826-5664				Abbate-Daga G, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-294; Abdel-Ahad P, 2013, CURR CLIN PHARMACOL; Aigner M, 2011, WORLD J BIOL PSYCHIA, V12, P400, DOI 10.3109/15622975.2011.602720; American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; Anderluh MB, 2003, AM J PSYCHIAT, V160, P242, DOI 10.1176/appi.ajp.160.2.242; Bailer UF, 2007, BIOL PSYCHIAT, V61, P1090, DOI 10.1016/j.biopsych.2006.07.018; Bailer UF, 2012, INT J EAT DISORDER, V45, P263, DOI 10.1002/eat.20937; Barbarich NC, 2004, J CLIN PSYCHIAT, V65, P1480, DOI 10.4088/JCP.v65n1106; Bauer M, 2013, WORLD J BIOL PSYCHIA, V14, P334, DOI 10.3109/15622975.2013.804195; Bissada H, 2008, AM J PSYCHIAT, V165, P1281, DOI 10.1176/appi.ajp.2008.07121900; Blinder BJ, 2006, PSYCHOSOM MED, V68, P454, DOI 10.1097/01.psy.0000221254.77675.f5; Bosanac P, 2007, HUM PSYCHOPHARM CLIN, V22, P223, DOI 10.1002/hup.845; Brambilla F, 2007, INT CLIN PSYCHOPHARM, V22, P197, DOI 10.1097/YIC.0b013e328080ca31; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; Court A, 2010, J PSYCHIATR RES, V44, P1027, DOI 10.1016/j.jpsychires.2010.03.011; Crane AM, 2007, INT J EAT DISORDER, V40, P581, DOI 10.1002/eat.20419; Daga GA, 2011, PSYCHOTHER PSYCHOSOM, V80, P319, DOI 10.1159/000324761; Dold M, 2015, PSYCHOTHER PSYCHOSOM, V84, P110, DOI 10.1159/000369978; Fairburn C. G., 2008, COGNITIVE BEHAVIOR T; Fassino S, 2002, EUR NEUROPSYCHOPHARM, V12, P453, DOI 10.1016/S0924-977X(02)00058-5; First M., 1997, STRUCTURED CLIN INTE; Flament MF, 2012, INT J NEUROPSYCHOPH, V15, P189, DOI 10.1017/S1461145711000381; Gable KN, 2005, CURR THER RES CLIN E, V66, P572, DOI 10.1016/j.curtheres.2005.12.011; Halmi KA, 2008, AM J PSYCHIAT, V165, P1227, DOI 10.1176/appi.ajp.2008.08060957; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hoffman ER, 2012, EUR EAT DISORD REV, V20, pe129, DOI 10.1002/erv.2161; Jon DI, 2013, CLIN NEUROPHARMACOL, V36, P157, DOI 10.1097/WNF.0b013e3182a31f3d; Kaye WH, 2013, TRENDS NEUROSCI, V36, P110, DOI 10.1016/j.tins.2013.01.003; Kaye WH, 2001, BIOL PSYCHIAT, V49, P644, DOI 10.1016/S0006-3223(00)01013-1; Kishi Taro, 2012, J Clin Psychiatry, V73, pe757, DOI 10.4088/JCP.12r07691; Klump KL, 2009, INT J EAT DISORDER, V42, P97, DOI 10.1002/eat.20589; Lebow J, 2013, INT J EAT DISORDER, V46, P332, DOI 10.1002/eat.22059; Leucht S, 2014, SCHIZOPHRENIA BULL, V40, P314, DOI 10.1093/schbul/sbu001; MAIER W, 1988, J AFFECT DISORDERS, V14, P61, DOI 10.1016/0165-0327(88)90072-9; MAZURE CM, 1994, J PSYCHIATR RES, V28, P425, DOI 10.1016/0022-3956(94)90002-7; McKnight RF, 2010, EUR EAT DISORD REV, V18, P10, DOI 10.1002/erv.988; Miotto P, 2010, PSYCHIAT RES, V175, P237, DOI 10.1016/j.psychres.2009.03.011; Mischoulon D, 2011, J AFFECT DISORDERS, V130, P470, DOI 10.1016/j.jad.2010.10.043; Mondraty Naresh, 2005, Australas Psychiatry, V13, P72, DOI 10.1111/j.1440-1665.2004.02154.x; National Institute for Clinical Excellence (NICE), 2004, CORE INTERVENTIONS I; Powers PS, 2007, INT J EAT DISORDER, V40, P21, DOI 10.1002/eat.20325; Ruggiero GM, 2001, PROG NEURO-PSYCHOPH, V25, P1049, DOI 10.1016/S0278-5846(01)00174-9; Steinglass Joanna E, 2007, J Psychiatr Pract, V13, P65, DOI 10.1097/01.pra.0000265762.79753.88; Swinbourne J, 2012, AUST NZ J PSYCHIAT, V46, P118, DOI 10.1177/0004867411432071; Trajkovic G, 2011, PSYCHIAT RES, V189, P1, DOI 10.1016/j.psychres.2010.12.007; Trunko ME, 2011, INT J EAT DISORDER, V44, P269, DOI 10.1002/eat.20807; Walsh BT, 2006, JAMA-J AM MED ASSOC, V295, P2605, DOI 10.1001/jama.295.22.2605; Wright BM, 2013, PHARMACOTHERAPY, V33, P344, DOI 10.1002/phar.1204	49	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125569	10.1371/journal.pone.0125569	http://dx.doi.org/10.1371/journal.pone.0125569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922939	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600154
J	Miller, LMS; Cassady, DL; Beckett, LA; Applegate, EA; Wilson, MD; Gibson, TN; Ellwood, K				Miller, Lisa M. Soederberg; Cassady, Diana L.; Beckett, Laurel A.; Applegate, Elizabeth A.; Wilson, Machelle D.; Gibson, Tanja N.; Ellwood, Kathleen			Misunderstanding of Front-Of-Package Nutrition Information on US Food Products	PLOS ONE			English	Article							ATTENTION; LABEL; MOTIVATION; PERCEPTION; KNOWLEDGE; CONSUMERS	Front-of-package nutrition symbols (FOPs) are presumably readily noticeable and require minimal prior nutrition knowledge to use. Although there is evidence to support this notion, few studies have focused on Facts Up Front type symbols which are used in the US. Participants with varying levels of prior knowledge were asked to view two products and decide which was more healthful. FOPs on packages were manipulated so that one product was more healthful, allowing us to assess accuracy. Attention to nutrition information was assessed via eye tracking to determine what if any FOP information was used to make their decisions. Results showed that accuracy was below chance on half of the comparisons despite consulting FOPs. Negative correlations between attention to calories, fat, and sodium and accuracy indicated that consumers over-relied on these nutrients. Although relatively little attention was allocated to fiber and sugar, associations between attention and accuracy were positive. Attention to vitamin D showed no association to accuracy, indicating confusion surrounding what constitutes a meaningful change across products. Greater nutrition knowledge was associated with greater accuracy, even when less attention was paid. Individuals, particularly those with less knowledge, are misled by calorie, sodium, and fat information on FOPs.	[Miller, Lisa M. Soederberg; Gibson, Tanja N.] Univ Calif Davis, Dept Human Ecol, Davis, CA 95616 USA; [Cassady, Diana L.; Beckett, Laurel A.; Wilson, Machelle D.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Applegate, Elizabeth A.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Ellwood, Kathleen] Coll Southern Maryland, La Plata, MD 20646 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Miller, LMS (corresponding author), Univ Calif Davis, Dept Human Ecol, One Shields Ave, Davis, CA 95616 USA.	lmsmiller@ucdavis.edu	Miller, Lisa M.S./L-4027-2016	Miller, Lisa M.S./0000-0001-8261-1814; Wilson, Machelle/0000-0003-1734-2755	National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) [UL1 TR000002, R01CA159447]; NATIONAL CANCER INSTITUTE [R01CA159447] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000002] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The project described was supported in part by the National Center for Advancing Translational Sciences (NCATS), and the National Institutes of Health (NIH), through grant #UL1 TR000002 (LB, MW) and R01CA159447 (LM, DC, EA, LB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bialkova S, 2014, APPETITE, V76, P66, DOI 10.1016/j.appet.2013.11.021; Bialkova S, 2010, FOOD QUAL PREFER, V21, P1042, DOI 10.1016/j.foodqual.2010.07.001; Edge MS, 2014, J ACAD NUTR DIET, V114, P843, DOI 10.1016/j.jand.2014.01.018; Feunekes GI, 2008, APPETITE, V50, P57, DOI 10.1016/j.appet.2007.05.009; Graham DJ, 2014, HEALTH PSYCHOL; Grunert KG, 2007, J PUBLIC HEALTH-HEID, V15, P385, DOI 10.1007/s10389-007-0101-9; Grunert KG, 2010, APPETITE, V55, P177, DOI 10.1016/j.appet.2010.05.045; Hawley KL, 2013, PUBLIC HEALTH NUTR, V16, P430, DOI 10.1017/S1368980012000754; Hersey JC, 2013, NUTR REV, V71, P1, DOI 10.1111/nure.12000; Institute of Medicine, 2011, FRONT OF PACK NUTR R, DOI [10.3945/an.112.001933, DOI 10.3945/AN.112.001933]; International Food Information Council, CONS ATT FOOD SAF NU; International Food Information Council, PULS AM DIET BEL BEH; Jones G, 2007, PUBLIC HEALTH NUTR, V10, P238, DOI 10.1017/S1368980007258513; Mejean C, 2013, J HUM NUTR DIET, V26, P494, DOI 10.1111/jhn.12039; Mejean C, 2013, PUBLIC HEALTH NUTR, V16, P392, DOI 10.1017/S1368980012003515; Miller LMS, 2015, NUTRIENTS, V7, P1068, DOI 10.3390/nu7021068; Miller LMS, 2011, J HEALTH PSYCHOL, V16, P794, DOI 10.1177/1359105310392090; Pomeranz JL, 2011, AM J PREV MED, V40, P382, DOI 10.1016/j.amepre.2010.11.009; Roberto CA, 2012, AM J PREV MED, V43, P134, DOI 10.1016/j.amepre.2012.04.022; Siegrist M, 2015, FOOD QUAL PREFER, V39, P183, DOI 10.1016/j.foodqual.2014.07.010; Streppel MT, 2014, EUR J CLIN NUTR, V68, P741, DOI 10.1038/ejcn.2014.35; Turner MM, 2014, J HEALTH COMMUN, V19, P1017, DOI 10.1080/10810730.2013.864726; United States Department of Agriculture (USDA), DIET GUID AM; van Herpen E, 2011, APPETITE, V57, P148, DOI 10.1016/j.appet.2011.04.011	24	21	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125306	10.1371/journal.pone.0125306	http://dx.doi.org/10.1371/journal.pone.0125306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922942	gold, Green Submitted, Green Published			2022-12-27	WOS:000353711600142
J	Ma, WJ; Ma, HQ; Mosher, DF				Ma, Wenjiang; Ma, Hanqing; Mosher, Deane F.			On-Off Kinetics of Engagement of FNI Modules of Soluble Fibronectin by beta-Strand Addition	PLOS ONE			English	Article							GELATIN-BINDING DOMAIN; BORRELIA-BURGDORFERI; STREPTOCOCCUS-PYOGENES; PROTEIN BBK32; COOPERATIVE BINDING; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURES; COLLAGEN-BINDING; EPITHELIAL-CELLS; LIGAND-BINDING	Intrinsically disordered sequences within bacterial adhesins bind to E-strands in the beta-sheets of multiple FNI modules of fibronectin (FN) by anti-parallel beta-strand addition, also called tandem beta-zipper formation. The FUD segment of SfbI of Streptococcus pyogenes and Bbk32 segment of BBK32 of Borrelia burgdorferi, despite being imbedded in different adhesins from different bacteria, target the same FNI modules, 2-5,8-9FNI, in the N-terminal 70-kDa region (FN70K) of FN. To facilitate further comparisons, FUD, Bbk32, two other polypeptides based on SfbI that target 1-5FNI (HADD) and 2-5FNI (FRD), and mutant Bbk32 (Delta Bbk32) were produced with fluorochromes placed just outside of the binding sequences. Unlabeled FUD competed similar to 1000-fold better for binding of labeled Bbk32 to FN than unlabeled Bbk32 competed for binding of labeled FUD to FN. Binding kinetics were determined by fluorescence polarization in a stopped-flow apparatus. On-rates for FUD, Bbk32, HADD, and FRD were similar, and all bound more rapidly to FN70K fragment than to full length FN. In stopped-flow displacement and size exclusion chromatographic assays, however, k(off) for FUD or HADD to FN70K or FN was considerably lower compared to k(off) of FRD or Bbk32. FUD and Bbk32 differ in the spacing between sequences that interact with (FNI)-F-3 and (FNI)-F-4 or with (FNI)-F-5 and (FNI)-F-8. Delta Bbk32, in which 2 residues were removed from Bbk32 to make the spacing more like FUD, had a k(off) intermediate between that of Bbk32 and FUD. These results indicate a "folding-after-binding" process after initial association of certain polypeptide sequences to FN that results in formation of a stable complex and is a function of number of FNI modules engaged by the polypeptide, spacing of engagement sites, and perhaps flexibility within the polypeptide-FN complex. We suggest that contributions of SfbI and BBK32 adhesins to bacterial pathogenicity may be determined in part by stability of adhesin-FN complexes.	[Ma, Wenjiang; Ma, Hanqing; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53718 USA	University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), Univ Wisconsin, Dept Biomol Chem, Madison, WI 53718 USA.	dfmosher@wisc.edu			National Institute of Health [P01 HL088594]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021644, P01HL088594] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health P01 HL088594 to NJ, P.I. Reagents and ideas for these studies also were developed with National Institute of Health RO1 HL021644 to DFM, P.I.	Atkin KE, 2010, J BIOL CHEM, V285, P36977, DOI 10.1074/jbc.M110.156935; BARON M, 1990, NATURE, V345, P642, DOI 10.1038/345642a0; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Brissette CA, 2009, INFECT IMMUN, V77, P2802, DOI 10.1128/IAI.00227-09; Chabria M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1135; Erat MC, 2013, J BIOL CHEM, V288, P17441, DOI 10.1074/jbc.M113.469841; Erat MC, 2010, J BIOL CHEM, V285, P33764, DOI 10.1074/jbc.M110.139394; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; Harris G, 2014, J BIOL CHEM, V289, P22490, DOI 10.1074/jbc.M114.578419; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; Hyde JA, 2011, MOL MICROBIOL, V82, P99, DOI 10.1111/j.1365-2958.2011.07801.x; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Kiefhaber T, 2012, CURR OPIN STRUC BIOL, V22, P21, DOI 10.1016/j.sbi.2011.09.010; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Ma WJ, 2015, J BIOL CHEM, V290, P4866, DOI 10.1074/jbc.M114.612259; Marjenberg ZR, 2011, J BIOL CHEM, V286, P1884, DOI 10.1074/jbc.M110.183053; Matthews JM, 2013, FEBS LETT, V587, P1164, DOI 10.1016/j.febslet.2013.01.002; Maurer LM, 2012, J BIOL CHEM, V287, P13303, DOI 10.1074/jbc.M111.294041; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; Moschioni M, 2010, MICROB BIOTECHNOL, V3, P370, DOI 10.1111/j.1751-7915.2009.00138.x; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; Neeman R, 1998, LANCET, V352, P1974, DOI 10.1016/S0140-6736(97)12452-7; Norman MU, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000169; Norris NC, 2011, J BIOL CHEM, V286, P38311, DOI 10.1074/jbc.M111.276592; Nyberg P, 2004, EMBO J, V23, P2166, DOI 10.1038/sj.emboj.7600214; Ozeri V, 2001, MOL MICROBIOL, V41, P561, DOI 10.1046/j.1365-2958.2001.02535.x; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Probert WS, 2001, INFECT IMMUN, V69, P4129, DOI 10.1128/IAI.69.6.4129-4133.2001; ROCCO M, 1987, EMBO J, V6, P2343, DOI 10.1002/j.1460-2075.1987.tb02510.x; Rudino-Pinera E, 2007, J MOL BIOL, V368, P833, DOI 10.1016/j.jmb.2007.02.061; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; Uversky VN, 2011, CHEM SOC REV, V40, P1623, DOI 10.1039/c0cs00057d; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673	42	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124941	10.1371/journal.pone.0124941	http://dx.doi.org/10.1371/journal.pone.0124941			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919138	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659400067
J	Mendonsa, AM; Chalfant, MC; Gorden, LD; VanSaun, MN				Mendonsa, Alisha M.; Chalfant, Madeleine C.; Gorden, Lee D.; VanSaun, Michael N.			Modulation of the Leptin Receptor Mediates Tumor Growth and Migration of Pancreatic Cancer Cells	PLOS ONE			English	Article							HIGH-FAT; ACTIVATION; OBESITY; INVASION; PROMOTE; PROLIFERATION; DISSEMINATION; INFLAMMATION; ADIPONECTIN; CARCINOMA	Obesity has been implicated as a significant risk factor for development of pancreatic cancer. In the setting of obesity, a systemic chronic inflammatory response is characterized by alterations in the production and secretion of a wide variety of growth factors. Leptin is a hormone whose level increases drastically in the serum of obese patients. High fat diet induced obesity in mice leads to an overall increased body weight, pancreatic weight, serum leptin, and pancreatic tissue leptin levels. Here we report the contribution of obesity and leptin to pancreatic cancer growth utilizing an in vivo orthotopic murine pancreatic cancer model, which resulted in increased tumor proliferation with concomitant increased tumor burden in the diet induced obese mice compared to lean mice. Human and murine pancreatic cancer cell lines were found to express the short as well as the long form of the leptin receptor and functionally responded to leptin induced activation through an increased phosphorylation of AKT473. In vitro, leptin stimulation increased cellular migration which was blocked by addition of a PI3K inhibitor. In vivo, depletion of the leptin receptor through shRNA knockdown partially abrogated increased orthotopic tumor growth in obese mice. These findings suggest that leptin contributes to pancreatic tumor growth through activation of the PI3K/AKT pathway, which promotes pancreatic tumor cell migration.	[Mendonsa, Alisha M.; Chalfant, Madeleine C.; Gorden, Lee D.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Gorden, Lee D.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN USA; [VanSaun, Michael N.] Univ Miami, Sylvester Canc Ctr, Dept Surg, Div Surg Oncol, Miami, FL 33177 USA	Vanderbilt University; Vanderbilt University; University of Miami	VanSaun, MN (corresponding author), Univ Miami, Sylvester Canc Ctr, Dept Surg, Div Surg Oncol, Miami, FL 33177 USA.	mvansaun@med.miami.edu		VanSaun, Michael/0000-0002-2538-8107	Pancreatic Cancer Action Network-AACR Career Development Award [10-20-25-VANS]; NIH [5U01CA143072]; NATIONAL CANCER INSTITUTE [U01CA143072] Funding Source: NIH RePORTER	Pancreatic Cancer Action Network-AACR Career Development Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research was supported by the 2010 Pancreatic Cancer Action Network-AACR Career Development Award, Grant Number 10-20-25-VANS and NIH #5U01CA143072 provided salary support for AMM, MCC, MNV, and LG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer S, 2008, CANC FACTS FIG 2008, P6979; Aune D, 2012, ANN ONCOL, V23, P843, DOI 10.1093/annonc/mdr398; Balistreri CR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/802078; Barone I, 2012, CANCER RES, V72, P1416, DOI 10.1158/0008-5472.CAN-11-2558; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Bullen JW, 2007, AM J PHYSIOL-ENDOC M, V292, pE1079, DOI 10.1152/ajpendo.00245.2006; Ceddia RB, 2005, INT J OBESITY, V29, P1175, DOI 10.1038/sj.ijo.0803025; Chen CC, 2013, INT J ONCOL, V42, P1113, DOI 10.3892/ijo.2013.1789; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cheon EC, 2011, INT J CANCER, V128, P2783, DOI 10.1002/ijc.25622; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; CORBETT TH, 1984, CANCER RES, V44, P717; Cottrell Elizabeth C, 2012, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-24716-3_1; Couturier C, 2003, J BIOL CHEM, V278, P26604, DOI 10.1074/jbc.M302002200; Dawson DW, 2013, CANCER PREV RES, V6, P1064, DOI 10.1158/1940-6207.CAPR-13-0065; De Luis DA, 2011, NUTR HOSP, V26, P91, DOI 10.3305/nh.2011.26.1.4685; Ebert T, 2014, HORM METAB RES, V46, P41, DOI 10.1055/s-0033-1353198; Endo H, 2011, GUT, V60, P1363, DOI 10.1136/gut.2010.235754; Exley MA, 2014, J ENDOCRINOL, V223, pR41, DOI 10.1530/JOE-13-0516; Fantuzzi G, 2005, CLIN EXP IMMUNOL, V142, P31, DOI 10.1111/j.1365-2249.2005.02898.X; Fava G, 2008, CANCER RES, V68, P6752, DOI 10.1158/0008-5472.CAN-07-6682; Ghilardi N, 1997, MOL ENDOCRINOL, V11, P393, DOI 10.1210/me.11.4.393; Giordano C, 2013, MOL ONCOL, V7, P379, DOI 10.1016/j.molonc.2012.11.002; Han GS, 2012, BRAIN RES BULL, V87, P274, DOI 10.1016/j.brainresbull.2011.11.007; Hardwick JCH, 2001, GASTROENTEROLOGY, V121, P79, DOI 10.1053/gast.2001.25490; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Inadera Hidekuni, 2008, Int J Med Sci, V5, P248; Islam MS, 1997, BIOCHEM BIOPH RES CO, V238, P851, DOI 10.1006/bbrc.1997.7399; Jaffe T, 2008, INT J CANCER, V123, P2543, DOI 10.1002/ijc.23821; Khan M, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/328592; Khasawneh J, 2009, P NATL ACAD SCI USA, V106, P3354, DOI 10.1073/pnas.0802864106; Lanza-Jacoby S, 2013, EXP BIOL MED, V238, P787, DOI 10.1177/1535370213493727; Li C, 1999, P NATL ACAD SCI USA, V96, P9677, DOI 10.1073/pnas.96.17.9677; Liu Y, 2011, J HUAZHONG U SCI-MED, V31, P365, DOI 10.1007/s11596-011-0382-7; Lopez R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079708; Mathur A, 2009, J AM COLL SURGEONS, V208, P989, DOI 10.1016/j.jamcollsurg.2008.12.026; Murakami T, 1997, BIOCHEM BIOPH RES CO, V231, P26, DOI 10.1006/bbrc.1996.6030; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Pitt Henry A, 2007, HPB (Oxford), V9, P92, DOI 10.1080/13651820701286177; Saxena NK, 2007, J BIOL CHEM, V282, P13316, DOI 10.1074/jbc.M609798200; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Saxena NK, 2008, CANCER RES, V68, P9712, DOI 10.1158/0008-5472.CAN-08-1952; Shen XM, 2009, J GASTROINTEST SURG, V13, P1955, DOI 10.1007/s11605-009-1002-8; Somasundar P, 2003, J SURG RES, V113, P50, DOI 10.1016/S0022-4804(03)00166-5; VanSaun MN, 2013, CLIN CANCER RES, V19, P1926, DOI 10.1158/1078-0432.CCR-12-0930; VanSaun MN, 2009, AM J PATHOL, V175, P355, DOI 10.2353/ajpath.2009.080703; Wang D, 2012, J BIOSCIENCES, V37, P91, DOI 10.1007/s12038-011-9172-4; Wang Feng, 2003, Mol Cancer, V2, P4, DOI 10.1186/1476-4598-2-4; Wannamethee SG, 1999, DIABETES CARE, V22, P1266, DOI 10.2337/diacare.22.8.1266; White PB, 2010, J GASTROINTEST SURG, V14, P1888, DOI 10.1007/s11605-010-1349-x; Yeh WL, 2009, GLIA, V57, P454, DOI 10.1002/glia.20773; Zyromski NJ, 2009, SURGERY, V146, P258, DOI 10.1016/j.surg.2009.02.024	53	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0126686	10.1371/journal.pone.0126686	http://dx.doi.org/10.1371/journal.pone.0126686			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919692	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400095
J	Aleman, MM; Holle, LA; Stember, KG; Devette, CI; Monroe, DM; Wolberg, AS				Aleman, Maria M.; Holle, Lori A.; Stember, Katherine G.; Devette, Christa I.; Monroe, Dougald M.; Wolberg, Alisa S.			Cystamine Preparations Exhibit Anticoagulant Activity	PLOS ONE			English	Article							FACTOR-XIII; TISSUE TRANSGLUTAMINASE; THROMBIN GENERATION; HUNTINGTON-DISEASE; MODEL; INFLAMMATION; CONTRIBUTES; INHIBITION; MECHANISMS; STABILITY	Transglutaminases are a superfamily of isoenzymes found in cells and plasma. These enzymes catalyze the formation of epsilon-N-(gamma-glutamyl)-lysyl crosslinks between proteins. Cystamine blocks transglutaminase activity and is used in vitro in human samples and in vivo in mice and rats in studies of coagulation, immune dysfunction, and inflammatory disease. These studies have suggested cystamine blocks fibrin crosslinking and has antiinflammatory effects, implicating transglutaminase activity in the pathogenesis of several diseases. We measured the effects of cystamine on fibrin crosslinking, tissue factortriggered plasma clot formation and thrombin generation, and coagulation factor enzymatic activity. At concentrations that blocked fibrin crosslinking, cystamine also inhibited plasma clot formation and reduced thrombin generation. Cystamine inhibited the amidolytic activity of coagulation factor XI and thrombin towards chromogenic substrates. These findings demonstrate that cystamine exhibits anticoagulant activity during coagulation. Given the close relationship between coagulation and inflammation, these findings suggest prior studies that used cystamine to implicate transglutaminase activity in disease pathogenesis warrant re-examination.	[Aleman, Maria M.; Holle, Lori A.; Stember, Katherine G.; Devette, Christa I.; Wolberg, Alisa S.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Aleman, Maria M.; Monroe, Dougald M.; Wolberg, Alisa S.] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA; [Monroe, Dougald M.] Univ N Carolina, Dept Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wolberg, AS (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.	alisa_wolberg@med.unc.edu		Monroe, Dougald/0000-0002-0493-2943; Aleman, Maria M./0000-0002-1714-0363; DeVette, Christa/0000-0001-9972-0646	National Institutes of Health [R01HL094740, R56HL094740]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health [1UL1TR001111]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001111] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL094740, R01HL094740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences (NCATS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by funding from the National Institutes of Health (R01HL094740 and R56HL094740 to ASW) and by the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through Grant Award Number 1UL1TR001111. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman MM, 2014, J CLIN INVEST, V124, P3590, DOI 10.1172/JCI75386; Bailey CDC, 2006, NEUROBIOL AGING, V27, P871, DOI 10.1016/j.neurobiolaging.2005.04.001; Bakker ENTP, 2005, CIRC RES, V96, P119, DOI 10.1161/01.RES.0000151333.56089.66; Bakker ENTP, 2006, CIRC RES, V99, P86, DOI 10.1161/01.RES.0000229657.83816.a7; Borrell-Pages M, 2006, J CLIN INVEST, V116, P1410, DOI 10.1172/JCI27607; Bortvedt SF, 2010, NEUROBIOL DIS, V40, P130, DOI 10.1016/j.nbd.2010.04.007; Dardik R, 2006, J THROMB HAEMOST, V4, P19, DOI 10.1111/j.1538-7836.2005.01473.x; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Elli L, 2011, LAB INVEST, V91, P452, DOI 10.1038/labinvest.2010.186; Hsu TC, 2008, EUR J PHARMACOL, V591, P307, DOI 10.1016/j.ejphar.2008.06.078; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Kasahara K, 2010, BLOOD, V115, P1277, DOI 10.1182/blood-2009-06-227645; KORSGREN C, 1990, P NATL ACAD SCI USA, V87, P613, DOI 10.1073/pnas.87.2.613; Lerner A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-89; Levy JH, 2013, TRANSFUSION, V53, P1120, DOI 10.1111/j.1537-2995.2012.03865.x; Liu C, 2014, HYPERTENSION, V63, P353, DOI 10.1161/HYPERTENSIONAHA.113.02361; Machlus KR, 2009, THROMB HAEMOSTASIS, V102, P936, DOI 10.1160/TH09-03-0180; Marty I, 2001, J CLIN INVEST, V107, P631, DOI 10.1172/JCI11064; Pawlinski R, 2007, CIRCULATION, V116, P2298, DOI 10.1161/CIRCULATIONAHA.107.692764; Raghu H, 2015, BLOOD, V125, P427, DOI 10.1182/blood-2014-08-594754; Ribeiro M, 2013, TOXICOL SCI, V136, P487, DOI 10.1093/toxsci/kft199; Tang JJ, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/753483; Tzang BS, 2013, LIFE SCI, V92, P719, DOI 10.1016/j.lfs.2013.01.027; Van Raamsdonk JM, 2005, J NEUROCHEM, V95, P210, DOI 10.1111/j.1471-4159.2005.03357.x; Varisco PA, 2000, ANN RHEUM DIS, V59, P781, DOI 10.1136/ard.59.10.781; Villella VR, 2013, AUTOPHAGY, V9, P1431, DOI 10.4161/auto.25517; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Zucker M, 2014, J THROMB HAEMOST, V12, P1121, DOI 10.1111/jth.12600	28	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124448	10.1371/journal.pone.0124448	http://dx.doi.org/10.1371/journal.pone.0124448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915545	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100051
J	Hastings, KG; Jose, PO; Kapphahn, KI; Frank, ATH; Goldstein, BA; Thompson, CA; Eggleston, K; Cullen, MR; Palaniappan, LP				Hastings, Katherine G.; Jose, Powell O.; Kapphahn, Kristopher I.; Frank, Ariel T. H.; Goldstein, Benjamin A.; Thompson, Caroline A.; Eggleston, Karen; Cullen, Mark R.; Palaniappan, Latha P.			Leading Causes of Death among Asian American Subgroups (2003-2011)	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK-FACTORS; CAUSE-SPECIFIC MORTALITY; CANCER INCIDENCE; SOCIOECONOMIC-STATUS; SOUTH-KOREA; HEALTH-CARE; ACCULTURATION; POPULATIONS; IMMIGRANTS	Background Our current understanding of Asian American mortality patterns has been distorted by the historical aggregation of diverse Asian subgroups on death certificates, masking important differences in the leading causes of death across subgroups. In this analysis, we aim to fill an important knowledge gap in Asian American health by reporting leading causes of mortality by disaggregated Asian American subgroups. Methods and Findings We examined national mortality records for the six largest Asian subgroups (Asian Indian, Chinese, Filipino, Japanese, Korean, Vietnamese) and non-Hispanic Whites (NHWs) from 2003-2011, and ranked the leading causes of death. We calculated all-cause and cause-specific age-adjusted rates, temporal trends with annual percent changes, and rate ratios by race/ethnicity and sex. Rankings revealed that as an aggregated group, cancer was the leading cause of death for Asian Americans. When disaggregated, there was notable heterogeneity. Among women, cancer was the leading cause of death for every group except Asian Indians. In men, cancer was the leading cause of death among Chinese, Korean, and Vietnamese men, while heart disease was the leading cause of death among Asian Indians, Filipino and Japanese men. The proportion of death due to heart disease for Asian Indian males was nearly double that of cancer (31% vs. 18%). Temporal trends showed increased mortality of cancer and diabetes in Asian Indians and Vietnamese; increased stroke mortality in Asian Indians; increased suicide mortality in Koreans; and increased mortality from Alzheimer's disease for all racial/ethnic groups from 2003-2011. All-cause rate ratios revealed that overall mortality is lower in Asian Americans compared to NHWs. Conclusions Our findings show heterogeneity in the leading causes of death among Asian American subgroups. Additional research should focus on culturally competent and cost-effective approaches to prevent and treat specific diseases among these growing diverse populations.	[Hastings, Katherine G.; Kapphahn, Kristopher I.; Goldstein, Benjamin A.; Cullen, Mark R.; Palaniappan, Latha P.] Stanford Univ, Sch Med, Div Gen Med Disciplines, Stanford, CA 94305 USA; [Jose, Powell O.] Sutter Hlth Med Fdn, Dept Cardiol, Davis, CA USA; [Frank, Ariel T. H.] Columbia Univ, Sch Nursing, New York, NY USA; [Thompson, Caroline A.] Palo Alto Med Fdn, Res Inst, Palo Alto, CA 94301 USA; [Eggleston, Karen] Stanford Univ, Shorenstein Asia Pacific Res Ctr, Stanford, CA 94305 USA	Stanford University; Columbia University; Palo Alto Medical Foundation Research Institute; Stanford University	Palaniappan, LP (corresponding author), Stanford Univ, Sch Med, Div Gen Med Disciplines, Stanford, CA 94305 USA.	lathap@stanford.edu		cullen, mark/0000-0001-7996-1864; Thompson, Caroline/0000-0001-9990-9756; Palaniappan, Latha/0000-0002-1245-665X	National Institute on Minority Health and Health Disparities (CAUSES: Causes of Asian American mortality Understood by Socio-Economic Status) [1 R01 MD 007012-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K25DK097279] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007012] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities (CAUSES: Causes of Asian American mortality Understood by Socio-Economic Status); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by a grant from the National Institute on Minority Health and Health Disparities (1 R01 MD 007012-01 CAUSES: Causes of Asian American mortality Understood by Socio-Economic Status). No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2008, DISP HLTH CAR QUAL R; Arias E, 2010, AM J PUBLIC HEALTH, V100, pS171, DOI 10.2105/AJPH.2008.135863; Arias Elizabeth, 2008, Vital Health Stat 2, P1; BALARAJAN R, 1991, BMJ-BRIT MED J, V302, P560, DOI 10.1136/bmj.302.6776.560; BENFANTE R, 1992, HUM BIOL, V64, P791; Bulatao RA, 2004, UNDERSTANDING RACIAL; Chae DH, 2006, PUBLIC HEALTH REP, V121, P755, DOI 10.1177/003335490612100616; Chang ET, 2010, CANCER EPIDEM BIOMAR, V19, P3106, DOI 10.1158/1055-9965.EPI-10-0863; CHOI BCK, 1993, AM J EPIDEMIOL, V138, P723, DOI 10.1093/oxfordjournals.aje.a116910; Cullen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032930; Derose KP, 2007, HEALTH AFFAIR, V26, P1258, DOI 10.1377/hlthaff.26.5.1258; Gomez SL, 2013, JNCI-J NATL CANCER I, V105, P1096, DOI 10.1093/jnci/djt157; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; Heron Melonie, 2013, Natl Vital Stat Rep, V62, P1; Holland AT, 2012, ANN EPIDEMIOL, V22, P397, DOI 10.1016/j.annepidem.2012.04.001; Hoyert D L, 1997, Mon Vital Stat Rep, V46, P1; Hoyert DL, 2011, NATL VITAL STAT REP, V61, P1; Jose PO, 2014, J AM COLL CARDIOL, V64, P2486, DOI 10.1016/j.jacc.2014.08.048; Keppel KG, 2010, PUBLIC HEALTH REP, V125, P689, DOI 10.1177/003335491012500511; Khang YH, 2005, INT J EPIDEMIOL, V34, P1291, DOI 10.1093/ije/dyi224; Kim G, 2010, J AM GERIATR SOC, V58, P2003, DOI 10.1111/j.1532-5415.2010.03034.x; Kim SY, 2011, CRISIS, V32, P5, DOI 10.1027/0227-5910/a000046; KLATSKY AL, 1991, AM J PUBLIC HEALTH, V81, P1423, DOI 10.2105/AJPH.81.11.1423; KLATSKY AL, 1994, AM J PUBLIC HEALTH, V84, P1672, DOI 10.2105/AJPH.84.10.1672; Klatsky AL, 1996, PUBLIC HEALTH REP, V111, P62; Ku L, 2001, HEALTH AFFAIR, V20, P247, DOI 10.1377/hlthaff.20.1.247; Lauderdale DS, 2000, POPUL RES POLICY REV, V19, P283, DOI 10.1023/A:1026582308352; Lee HY, 2010, J WOMENS HEALTH, V19, P1877, DOI 10.1089/jwh.2009.1783; Lee SM, 2014, J COMMUN HEALTH, V39, P201, DOI 10.1007/s10900-013-9763-0; MARMOT MG, 1976, AM J EPIDEMIOL, V104, P225, DOI 10.1093/oxfordjournals.aje.a112296; McCracken M, 2007, CA-CANCER J CLIN, V57, P190, DOI 10.3322/canjclin.57.4.190; MCKEIGUE PM, 1989, J CLIN EPIDEMIOL, V42, P597, DOI 10.1016/0895-4356(89)90002-4; Miller BA, 2008, CANCER CAUSE CONTROL, V19, P227, DOI 10.1007/s10552-007-9088-3; Moran A, 2007, AM J HYPERTENS, V20, P354, DOI 10.1016/j.amjhyper.2006.09.025; MUIR CS, 1960, BRIT HEART J, V22, P45; Murphy SL, 2013, NATL VITAL STAT REPO, P61; Narayan KMV, 2010, J AM COLL CARDIOL, V55, P966, DOI 10.1016/j.jacc.2009.07.075; National Center for Health Statistics CfDCaP, REP EV US STAND CERT; Palaniappan L, 2004, ANN EPIDEMIOL, V14, P499, DOI 10.1016/j.annepidem.2003.12.001; Palaniappan L, 2010, ETHNIC DIS, V20, P53; Palaniappan LP, 2010, CIRCULATION, V122, P1242, DOI 10.1161/CIR.0b013e3181f22af4; Qureshi Adnan I, 2014, J Vasc Interv Neurol, V7, P1; Rosenberg H M, 1999, Vital Health Stat 2, P1; Shahidi NC, 2013, AM J CLIN ONCOL-CANC, V36, P381, DOI 10.1097/COC.0b013e318248da66; Sohn Linda, 2004, J Cross Cult Gerontol, V19, P203, DOI 10.1023/B:JCCG.0000034219.97686.69; SORLIE PD, 1992, EPIDEMIOLOGY, V3, P181, DOI 10.1097/00001648-199203000-00018; Taylor VM, 2007, J COMMUN HEALTH, V32, P299, DOI 10.1007/s10900-007-9057-5; Thompson CA, 2014, CANCER EPIDEM BIOMAR, V23, P2208, DOI 10.1158/1055-9965.EPI-14-0487; U. S. Census Bureau, 2012, TABL 4 PROJ POP SEX; Ursua RA, 2013, J COMMUN HEALTH, V38, P847, DOI 10.1007/s10900-013-9689-6; US Census bureau, 2015, DET LANG SPOK HOM AD; *US WHIT HOUS OFF, 2009, EX ORD INCR PART AS; Us White House Office of the Press Secretary, 2009, EX ORD INCR PART AS; Wang EJ, 2011, DIABETES RES CLIN PR, V93, P248, DOI 10.1016/j.diabres.2011.05.025; Watts J, 1998, LANCET, V352, P1365, DOI 10.1016/S0140-6736(05)60762-3; Weintraub WS, 2011, CIRCULATION, V124, P967, DOI 10.1161/CIR.0b013e3182285a81; Wild Sarah H., 1995, Annals of Epidemiology, V5, P432, DOI 10.1016/1047-2797(95)00058-5; Winkleby MA, 2003, J EPIDEMIOL COMMUN H, V57, P444, DOI 10.1136/jech.57.6.444; Wong JS, 1999, KIDNEY INT, V55, P2515, DOI 10.1046/j.1523-1755.1999.00464.x; Ye JL, 2009, ANN EPIDEMIOL, V19, P718, DOI 10.1016/j.annepidem.2009.03.022	60	99	99	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124341	10.1371/journal.pone.0124341	http://dx.doi.org/10.1371/journal.pone.0124341			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915940	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100048
J	Staudigl, C; Concin, N; Grimm, C; Pfeiler, G; Nehoda, R; Singer, CF; Polterauer, S				Staudigl, Christine; Concin, Nicole; Grimm, Christoph; Pfeiler, Georg; Nehoda, Regina; Singer, Christian F.; Polterauer, Stephan			Prognostic Relevance of Pretherapeutic Gamma-Glutamyltransferase in Patients with Primary Metastatic Breast Cancer	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; UNITED-STATES; RISK; TRANSPEPTIDASE; ASSOCIATION; RESISTANCE; DIAGNOSIS; MORTALITY; SURVIVAL; DISEASE	Background Gamma-glutamyltransferase (GGT) is a known marker for apoptotic balance and cell detoxification. Recently, an association of baseline GGT levels and breast cancer incidence, tumor progression and chemotherapy resistance was shown. The purpose of this study was to evaluate the association of pre-therapeutic GGT levels, clinical-pathological parameters and survival in patients with primary metastatic breast cancer (PMBC). Methods In this multicenter analysis, pre-therapeutic GGT levels and clinical-pathological parameters of 114 patients diagnosed with PMBC between 1996 and 2012 were evaluated. The association between GGT levels and clinical-pathological parameters were analysed. Patients were stratified into four GGT risk-groups (GGT < 18.00 U/L: normal low, 18.00 to 35.99 U/L: normal high, 36.00 to 71.99 U/L: elevated and >= 72.00 U/L: highly elevated) and survival analyses were performed. Findings Patients in the high risk GGT group had a poorer overall survival, when compared to the low risk group with five-year overall survival rates of 39.5% and 53.7% (p = 0.04), respectively. Patients with larger breast tumors had a trend towards higher GGT levels (p = 0.053). Pre-therapeutic GGT levels were not associated with indicators of aggressive tumor biology such as HER2-status, triple negative histology, or poorly differentiated cancers. Conclusion Pre-therapeutic GGT serum level might serve as a novel prognostic factor for overall-survival in patients with PMBC.	[Staudigl, Christine; Grimm, Christoph; Pfeiler, Georg; Singer, Christian F.; Polterauer, Stephan] Med Univ Vienna, Ctr Comprehens Canc, Dept Gen Gynecol & Gynecol Oncol, Vienna, Austria; [Concin, Nicole; Nehoda, Regina] Med Univ Innsbruck, Dept Obstet & Gynecol, A-6020 Innsbruck, Austria	Medical University of Vienna; Medical University of Innsbruck	Polterauer, S (corresponding author), Med Univ Vienna, Ctr Comprehens Canc, Dept Gen Gynecol & Gynecol Oncol, Vienna, Austria.	stephan.polterauer@meduniwien.ac.at	Grimm, Christoph/GSJ-3020-2022; Polterauer, Stephan/AAG-1331-2021	Grimm, Christoph/0000-0003-2948-8129; Polterauer, Stephan/0000-0002-9649-4505; Concin, Nicole/0000-0002-9795-2643				Cardoso F, 2012, ANN ONCOL, V23, P11, DOI 10.1093/annonc/mds232; Corti A, 2010, ANTICANCER RES, V30, P1169; Fentiman IS, 2012, BRIT J CANCER, V106, P1467, DOI 10.1038/bjc.2012.128; Fentiman IS, 2010, BRIT J CANCER, V103, P90, DOI 10.1038/sj.bjc.6605719; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Franzini M, 2006, EUR J CANCER, V42, P2623, DOI 10.1016/j.ejca.2006.04.016; Gradishar WJ, 2014, J NATL COMPR CANC NE, V12, P542, DOI 10.6004/jnccn.2014.0058; Grimm C, 2013, BRIT J CANCER, V109, P610, DOI 10.1038/bjc.2013.323; Hanigan MH, 1999, CARCINOGENESIS, V20, P553, DOI 10.1093/carcin/20.4.553; He WZ, 2013, COLORECTAL DIS, V15, pe443, DOI 10.1111/codi.12258; Kazemi-Shirazi L, 2007, CLIN CHEM, V53, P940, DOI 10.1373/clinchem.2006.081620; Kim DJ, 2005, DIABETIC MED, V22, P1134, DOI 10.1111/j.1464-5491.2005.01581.x; Kunutsor SK, 2015, INT J CANCER, V136, P1162, DOI 10.1002/ijc.29084; Lee DS, 2007, ARTERIOSCL THROM VAS, V27, P127, DOI 10.1161/01.ATV.0000251993.20372.40; Polterauer S, 2011, GYNECOL ONCOL, V122, P590, DOI 10.1016/j.ygyno.2011.05.027; Ruhl CE, 2009, GASTROENTEROLOGY, V136, P477, DOI 10.1053/j.gastro.2008.10.052; Ruiterkamp J, 2010, BREAST CANCER RES TR, V120, P9, DOI 10.1007/s10549-009-0670-0; Sandock DS, 1997, J UROLOGY, V157, P798, DOI 10.1016/S0022-5347(01)65043-2; Sant M, 2004, CANCER-AM CANCER SOC, V100, P715, DOI 10.1002/cncr.20038; Seebacher V, 2012, BRIT J CANCER, V106, P1551, DOI 10.1038/bjc.2012.16; Simic T, 2007, INT J UROL, V14, P289, DOI 10.1111/j.1442-2042.2006.01719.x; Strasak AM, 2008, INT J CANCER, V123, P1902, DOI 10.1002/ijc.23714; Strasak AM, 2008, CANCER RES, V68, P3970, DOI 10.1158/0008-5472.CAN-07-6686; Van Hemelrijck M, 2011, EUR J CANCER, V47, P2033, DOI 10.1016/j.ejca.2011.03.010; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227	25	35	38	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125317	10.1371/journal.pone.0125317	http://dx.doi.org/10.1371/journal.pone.0125317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915044	gold, Green Submitted, Green Published			2022-12-27	WOS:000353659100119
J	Biswas, S; Vadrevu, KP; Lwin, ZM; Lasko, K; Justice, CO				Biswas, Sumalika; Vadrevu, Krishna Prasad; Lwin, Zin Mar; Lasko, Kristofer; Justice, Christopher O.			Factors Controlling Vegetation Fires in Protected and Non-Protected Areas of Myanmar	PLOS ONE			English	Article							MAINLAND SOUTHEAST-ASIA; LAND-COVER CHANGE; PROPENSITY SCORE; MATCHING METHODS; FOREST; DEFORESTATION; CONSERVATION; BIODIVERSITY; FEEDBACKS; CLIMATE	Fire is an important disturbance agent in Myanmar impacting several ecosystems. In this study, we quantify the factors impacting vegetation fires in protected and non-protected areas of Myanmar. Satellite datasets in conjunction with biophysical and anthropogenic factors were used in a spatial framework to map the causative factors of fires. Specifically, we used the frequency ratio method to assess the contribution of each causative factor to overall fire susceptibility at a 1km scale. Results suggested the mean fire density in non-protected areas was two times higher than the protected areas. Fire-land cover partition analysis suggested dominant fire occurrences in the savannas (protected areas) and woody savannas (non-protected areas). The five major fire causative factors in protected areas in descending order include population density, land cover, tree cover percent, travel time from nearest city and temperature. In contrast, the causative factors in non-protected areas were population density, tree cover percent, travel time from nearest city, temperature and elevation. The fire susceptibility analysis showed distinct spatial patterns with central Myanmar as a hot spot of vegetation fires. Results from propensity score matching suggested that forests within protected areas have 11% less fires than non-protected areas. Overall, our results identify important causative factors of fire useful to address broad scale fire risk concerns at a landscape scale in Myanmar.	[Biswas, Sumalika; Vadrevu, Krishna Prasad; Lasko, Kristofer; Justice, Christopher O.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Lwin, Zin Mar] Mandalay Technol Univ, Patheingyi, Mandalay, Myanmar	University System of Maryland; University of Maryland College Park	Biswas, S (corresponding author), Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA.	sbiswas2@umd.edu	lasko, kristofer/I-1705-2019; Vadrevu, Krishna Prasad/B-5919-2012; Vadrevu, Krishna/AAE-9552-2019	lasko, kristofer/0000-0001-8980-8943; Vadrevu, Krishna/0000-0003-4407-5605	NASA [NNX10AU77G]	NASA(National Aeronautics & Space Administration (NASA))	NASA grant NNX10AU77G "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Abd Manap M, 2014, ARAB J GEOSCI, V7, P711, DOI 10.1007/s12517-012-0795-z; Akther MS, 2011, IEEE J-STARS, V4, P992, DOI 10.1109/JSTARS.2011.2165940; Aldersley A, 2011, SCI TOTAL ENVIRON, V409, P3472, DOI 10.1016/j.scitotenv.2011.05.032; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Andam KS, 2010, P NATL ACAD SCI USA, V107, P9996, DOI 10.1073/pnas.0914177107; Anderson H.E., 1982, GEN TECHNICAL REPORT; Andrew N., 2008, ESTIMATED TRAVEL TIM; [Anonymous], 2010, GLOBAL FOREST RESOUR; Arima EY, 2005, ANN ASSOC AM GEOGR, V95, P525, DOI 10.1111/j.1467-8306.2005.00473.x; Armsworth PR, 2006, P NATL ACAD SCI USA, V103, P5403, DOI 10.1073/pnas.0505278103; Baker Patrick J., 2009, P311, DOI 10.1007/978-3-540-77381-8_11; Bennett M., 2010, REDUCING FIRE RISK Y; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Chowdhury EH, 2015, ISPRS J PHOTOGRAMM, V104, P224, DOI 10.1016/j.isprsjprs.2014.03.011; Chuvieco E, 2004, REMOTE SENS ENVIRON, V92, P322, DOI 10.1016/j.rse.2004.01.019; CIESIN of Columbia University Food and Agriculture Organization of United Nations International Center for Tropical Agriculture, 2005, GRIDD POP WORLD VERS; Cochrane MA, 2002, J TROP ECOL, V18, P311, DOI 10.1017/S0266467402002237; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Cochrane MA, 2001, CONSERV BIOL, V15, P1515, DOI 10.1046/j.1523-1739.2001.01091.x; Cochrane Mark., 2010, TROPICAL FIRE ECOLOG; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Dong JW, 2012, REMOTE SENS ENVIRON, V127, P60, DOI 10.1016/j.rse.2012.08.022; Dudley N., 2008, GUIDELINES APPL PROT, DOI [10.2305/IUCN.CH.2008.PAPS.2.en, DOI 10.2305/IUCN.CH.2008.PAPS.2.EN]; Ferraro PJ, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/025011; FIRMS, 2011, MODIS HOTSP ACT FIR; Fox J, 2013, J PEASANT STUD, V40, P155, DOI 10.1080/03066150.2012.750605; Fox J, 2009, HUM ECOL, V37, P305, DOI 10.1007/s10745-009-9240-7; Giglio L, 2020, COLLECTION 6 MODIS B; Giri C, 2003, INT J REMOTE SENS, V24, P4181, DOI 10.1080/0143116031000139827; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; HARMON M, 1982, B TORREY BOT CLUB, V109, P74, DOI 10.2307/2484470; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Istituto Oikos & BANCA., 2011, MYANM PROT AR CONT C; IUCN and UNEP-WCMC, 2010, WORLD DAT PROT AR WD; Justice CO, 2002, REMOTE SENS ENVIRON, V83, P3, DOI 10.1016/S0034-4257(02)00084-6; Kellman M, 1998, J APPL ECOL, V35, P195, DOI 10.1046/j.1365-2664.1998.00300.x; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Langner A, 2007, GLOBAL CHANGE BIOL, V13, P2329, DOI 10.1111/j.1365-2486.2007.01442.x; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Lee S, 2006, ENVIRON GEOL, V50, P847, DOI 10.1007/s00254-006-0256-7; McKenzie D, 2004, CONSERV BIOL, V18, P890, DOI 10.1111/j.1523-1739.2004.00492.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagendra H, 2008, AMBIO, V37, P330, DOI 10.1579/06-R-184.1; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad D, 2001, FOREST ECOL MANAG, V154, P395, DOI 10.1016/S0378-1127(01)00511-4; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Nolte C, 2013, P NATL ACAD SCI USA, V110, P4956, DOI 10.1073/pnas.1214786110; Nolte C, 2013, CONSERV BIOL, V27, P155, DOI 10.1111/j.1523-1739.2012.01930.x; Nunes MCS, 2005, LANDSCAPE ECOL, V20, P661, DOI 10.1007/s10980-005-0070-8; Prasad VK, 2008, J ENVIRON MANAGE, V86, P1, DOI 10.1016/j.jenvman.2006.11.017; Pyne Stephen J., 1998, P64; Rao M, 2002, CONSERV BIOL, V16, P360, DOI 10.1046/j.1523-1739.2002.00219.x; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rothermel R. C., 1972, USDA Forests Service Research Paper, Intermountain Forest and Range Experiment Station; Rothermel R.C., 1991, INT438 USDA FOR SERV; Saha S, 2002, CURR SCI INDIA, V82, P1144; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Sodhi NS, 2010, BIODIVERS CONSERV, V19, P317, DOI 10.1007/s10531-009-9607-5; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Soutullo A, 2010, CONSERV BIOL, V24, P362, DOI 10.1111/j.1523-1739.2010.01465.x; Stolle F, 2003, FOREST ECOL MANAG, V179, P277, DOI 10.1016/S0378-1127(02)00547-9; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Trejo I, 2000, BIOL CONSERV, V94, P133, DOI 10.1016/S0006-3207(99)00188-3; Union of Myanmar. Ministry of Forestry, 2005, NAT ACT PROGR MYANM; Vadrevu K.P., 2011, GLOBAL ENV RES, V15, P65; van der Werf GR, 2008, P NATL ACAD SCI USA, V105, P20350, DOI 10.1073/pnas.0803375105; Veblen TT, 2000, ECOL APPL, V10, P1178, DOI 10.1890/1051-0761(2000)010[1178:CAHIOF]2.0.CO;2; Woods K, 2011, RUBBER PLANTING MILI; Woods K, 2011, J PEASANT STUD, V38, P747, DOI 10.1080/03066150.2011.607699; Wyman MS, 2010, APPL GEOGR, V30, P329, DOI 10.1016/j.apgeog.2009.10.001; [No title captured]	74	27	27	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124346	10.1371/journal.pone.0124346	http://dx.doi.org/10.1371/journal.pone.0124346			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909632	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800078
J	Jarvi, SI; Pitt, WC; Farias, ME; Shiels, L; Severino, MG; Howe, KM; Jacquier, SH; Shiels, AB; Amano, KK; Luiz, BC; Maher, DE; Allison, ML; Holtquist, ZC; Scheibelhut, NT				Jarvi, Susan I.; Pitt, William C.; Farias, Margaret E.; Shiels, Laura; Severino, Michael G.; Howe, Kathleen M.; Jacquier, Steven H.; Shiels, Aaron B.; Amano, Karis K.; Luiz, Blaine C.; Maher, Daisy E.; Allison, Maureen L.; Holtquist, Zachariah C.; Scheibelhut, Neil T.			Detection of Angiostrongylus cantonensis in the Blood and Peripheral Tissues of Wild Hawaiian Rats (Rattus rattus) by a Quantitative PCR (qPCR) Assay	PLOS ONE			English	Article							EOSINOPHILIC MENINGITIS; INFECTION; DIAGNOSIS; LUNGWORM	The nematode Angiostrongylus cantonensis is a rat lungworm, a zoonotic pathogen that causes human eosinophilic meningitis and ocular angiostrongyliasis characteristic of rat lungworm (RLW) disease. Definitive diagnosis is made by finding and identifying A. cantonensis larvae in the cerebral spinal fluid or by using a custom immunological or molecular test. This study was conducted to determine if genomic DNA from A. cantonensis is detectable by qPCR in the blood or tissues of experimentally infected rats. F1 offspring from wild rats were subjected to experimental infection with RLW larvae isolated from slugs, then blood or tissue samples were collected over multiple time points. Blood samples were collected from 21 rats throughout the course of two trials (15 rats in Trial I, and 6 rats in Trial II). In addition to a control group, each trial had two treatment groups: the rats in the low dose (LD) group were infected by approximately 10 larvae and the rats in the high dose (HD) group were infected with approximately 50 larvae. In Trial I, parasite DNA was detected in cardiac bleed samples from five of five LD rats and five of five HD rats at six weeks post-infection (PI), and three of five LD rats and five of five HD rats from tail tissue. In Trial II, parasite DNA was detected in peripheral blood samples from one of two HD rats at 53 minutes PI, one of two LD rats at 1.5 hours PI, one of two HD rats at 18 hours PI, one of two LD rats at five weeks PI and two of two at six weeks PI, and two of two HD rats at weeks five and six PI. These data demonstrate that parasite DNA can be detected in peripheral blood at various time points throughout RLW infection in rats.	[Jarvi, Susan I.; Farias, Margaret E.; Shiels, Laura; Severino, Michael G.; Howe, Kathleen M.; Jacquier, Steven H.; Amano, Karis K.; Luiz, Blaine C.; Maher, Daisy E.; Allison, Maureen L.; Holtquist, Zachariah C.; Scheibelhut, Neil T.] Univ Hawaii, Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA; [Pitt, William C.; Shiels, Laura; Shiels, Aaron B.] Natl Wildlife Res Ctr, Hawaii Field Stn, USDA APHIS Wildlife Serv, Hilo, HI 96720 USA; [Pitt, William C.] Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA	University of Hawaii System; University Hawaii Hilo; United States Department of Agriculture (USDA); Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Jarvi, SI (corresponding author), Univ Hawaii, Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA.	jarvi@hawaii.edu			UHH Daniel K. Inouye College of Pharmacy; University of Hawaii at Hilo; United States Department of Agriculture-APHIS National Wildlife Research Center's National Wildlife Disease Program; University of Hawaii at Hilo Research Council; National Institute of General Medical Sciences, National Institutes of Health [P20GM 103466]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103466] Funding Source: NIH RePORTER	UHH Daniel K. Inouye College of Pharmacy; University of Hawaii at Hilo; United States Department of Agriculture-APHIS National Wildlife Research Center's National Wildlife Disease Program; University of Hawaii at Hilo Research Council; National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the UHH Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo, United States Department of Agriculture-APHIS National Wildlife Research Center's National Wildlife Disease Program, University of Hawaii at Hilo Research Council, and a grant from the National Institute of General Medical Sciences, National Institutes of Health, award number: P20GM 103466. The content is solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALICATA JE, 1991, PARASITOL TODAY, V7, P151, DOI 10.1016/0169-4758(91)90285-V; Baermann G., 1917, Geneeskundig Tijdschrift voor Nederlandsch-Indie Batavia, V57; Chen H. T., 1935, Annales de Parasitologie Paris, V13, P312; Chye SM, 2004, CLIN CHEM, V50, P51, DOI 10.1373/clinchem.2003.020867; CROSS JH, 1987, PARASITOL TODAY, V3, P367, DOI 10.1016/0169-4758(87)90242-0; Silva Ana Cristina Arámburu da, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P295, DOI 10.1590/S0036-46652003000500011; Eamsobhana P, 2013, MEM I OSWALDO CRUZ, V108, P116, DOI 10.1590/S0074-02762013000100020; Er-Hu J, 2008, CHINESE MED J-PEKING, V121, P67, DOI 10.1097/00029330-200801010-00013; Graeff-Teixeira C, 2009, CLIN MICROBIOL REV, V22, P322, DOI 10.1128/CMR.00044-08; Hollingsworth Robert G., 2006, P121; Hollingsworth Robert G, 2013, Hawaii J Med Public Health, V72, P75; JAROONVESAMA N, 1988, PARASITOL TODAY, V4, P262, DOI 10.1016/0169-4758(88)90146-9; JARRETT EEE, 1983, IMMUNOLOGY, V48, P49; Jarvi SI, 2012, MOL BIOCHEM PARASIT, V185, P174, DOI 10.1016/j.molbiopara.2012.08.002; Jeffries R, 2011, PARASITOL RES; Jin E, 2005, CLIN RADIOL, V60, P242, DOI 10.1016/j.crad.2004.05.012; Kanpittaya J, AJNR AM J NEURORADIO, P1090; KLIKS MM, 1992, SOC SCI MED, V34, P199, DOI 10.1016/0277-9536(92)90097-A; Lindo JF, 2004, AM J TROP MED HYG, V70, P425, DOI 10.4269/ajtmh.2004.70.425; MACKERRAS M. JOSEPHINE, 1955, AUSTRALIAN JOUR ZOOL, V3, P1, DOI 10.1071/ZO9550001; Martin-Alonso A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027747; Prociv P, 2000, INT J PARASITOL, V30, P1295, DOI 10.1016/S0020-7519(00)00133-8; Punyagupta S., 1979, Studies on angiostrongyliasis in Eastern Asia and Australia., P138; Qvarnstrom Y, 2010, APPL ENVIRON MICROB, V76, P5287, DOI 10.1128/AEM.00546-10; SHIH SL, 1992, PEDIATR INFECT DIS J, V11, P1064, DOI 10.1097/00006454-199211120-00018; Simoes RO, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-100; Tsai HC, 2003, AM J TROP MED HYG, V68, P281, DOI 10.4269/ajtmh.2003.68.281; Wang QP, 2008, LANCET INFECT DIS, V8, P621, DOI 10.1016/S1473-3099(08)70229-9; Wang QP, 2011, EUR J CLIN MICROBIOL, DOI [10.1007/s10096-0111328-5, DOI 10.1007/S10096-0111328-5]; Wu G.H., 2006, NATURE BORNE DIS, P1182	30	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123064	10.1371/journal.pone.0123064	http://dx.doi.org/10.1371/journal.pone.0123064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910229	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800028
J	Jiang, S; Tang, G; Liu, K				Jiang, Sheng; Tang, Guoan; Liu, Kai			A New Extraction Method of Loess Shoulder-Line Based on Marr-Hildreth Operator and Terrain Mask	PLOS ONE			English	Article							PLATEAU; EROSION	Loess shoulder-lines are significant structural lines which divide the complicated loess land-form into loess interfluves and gully-slope lands. Existing extraction algorithms for shoulder-lines mainly are based on local maximum of terrain features. These algorithms are sensitive to noise for complicated loess surface and the extraction parameters are difficult to be determined, making the extraction results usually inaccurate. This paper presents a new extraction approach for loess shoulder-lines, in which Marr-Hildreth edge operator is employed to construct initial shoulder-lines. Then the terrain mask for confining the boundary of shoulder-lines is proposed based on slope degree classification and morphology methods, avoiding interference from non-valley area and modify the initial loess shoulder-lines. A case study is conducted in Yijun located in the northern Shanxi Loess Plateau of China. The Digital Elevation Models with a grid size of 5 m is applied as original data. To obtain optimal scale parameters, the Euclidean Distance Offset Percentages between shoulder-lines is calculated by the Marr-Hildreth operator and the manual delineations. The experimental results show that the new method could achieve the highest extraction accuracy when sigma = 5 in Gaussian smoothing. According to the accuracy assessment, the average extraction accuracy is about 88.5%, which indicates that the proposed method is applicable for the extraction of loess shoulder-lines in the loess hilly and gully areas.	[Jiang, Sheng; Tang, Guoan; Liu, Kai] Nanjing Normal Univ, Minist Educ, Key Lab Virtual Geog Environm, Nanjing 210023, Jiangsu, Peoples R China; [Jiang, Sheng; Tang, Guoan; Liu, Kai] State Key Lab Cultivat Base Geog Environm Evolut, Nanjing 210023, Jiangsu, Peoples R China; [Jiang, Sheng; Tang, Guoan; Liu, Kai] Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing 210023, Jiangsu, Peoples R China	Nanjing Normal University	Tang, G (corresponding author), Nanjing Normal Univ, Minist Educ, Key Lab Virtual Geog Environm, 1 Wenyuan Rd, Nanjing 210023, Jiangsu, Peoples R China.	tangguoan@njnu.edu.cn	Tang, Guo-An/W-3278-2017	Tang, Guoan/0000-0002-1443-6134	National Natural Science Foundation of China [41401440, 41471316, 41171320]; PAPD (Priority Academic Program Development of Jiangsu Higher Education Institutions)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PAPD (Priority Academic Program Development of Jiangsu Higher Education Institutions)	This research was supported by the National Natural Science Foundation of China (No. 41401440, No. 41471316, No. 41171320) and the PAPD (Priority Academic Program Development of Jiangsu Higher Education Institutions).	Argialas D.P., 2004, INT ARCH PHOTOGRAMME, V34; Fayuan YSTGL, 2011, GEOMATICS INFORM SCI, V3; Hessel R, 2003, CATENA, V54, P131, DOI 10.1016/S0341-8162(03)00061-4; Huang B.W., 1955, SCI B, V6, P15; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Jiang Z., 1988, MEMOIR NW I SOIL WAT, V7, P40; Liu PengJu, 2006, Journal of Beijing Forestry University, V28, P72; Luo L.X., 1956, ACTA GEOGR SIN, V22, P201; Lv G., 1998, SCI GEOGR SIN, V18, P567, DOI [10.13249/j.cnki.sgs.1998.06.567, DOI 10.13249/J.CNKI.SGS.1998.06.567]; MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; PARK DJ, 1995, PATTERN RECOGN, V28, P211, DOI 10.1016/0031-3203(94)00097-6; Qiu Y, 2010, J ARID ENVIRON, V74, P208, DOI 10.1016/j.jaridenv.2009.08.003; Shi H, 2000, J ARID ENVIRON, V45, P9, DOI 10.1006/jare.1999.0618; Shrivakshan G.T., 2012, INT J COMPUT SCI ISS, V9, P269, DOI DOI 10.13140/RG.2.1.5036.7123; Song XD, 2013, COMPUT GEOSCI-UK, V52, P11, DOI 10.1016/j.cageo.2012.08.014; Tang G, 2007, DEM BASED INVESTIGAT; Vincent L, 1993, IEEE T IMAGE PROCESS, V2, P176, DOI 10.1109/83.217222; Wang TC, 2014, SCI WORLD J, DOI 10.1155/2014/105826; Xie KQ, 2003, CATENA, V54, P161, DOI 10.1016/S0341-8162(03)00063-8; [朱红春 Zhu Hongchun], 2003, [水土保持通报, Bulletin of Soil and Water Conservation], V23, P43; Zhu TX, 2012, GEOMORPHOLOGY, V153, P144, DOI 10.1016/j.geomorph.2012.02.019	21	8	11	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123804	10.1371/journal.pone.0123804	http://dx.doi.org/10.1371/journal.pone.0123804			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910079	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800047
J	Wade, LJ; Bartolome, V; Mauleon, R; Vasant, VD; Prabakar, SM; Chelliah, M; Kameoka, E; Nagendra, K; Reddy, KRK; Varma, CMK; Patil, KG; Shrestha, R; Al-Shugeairy, Z; Al-Ogaidi, F; Munasinghe, M; Gowda, V; Semon, M; Suralta, RR; Shenoy, V; Vadez, V; Serraj, R; Shashidhar, HE; Yamauchi, A; Babu, RC; Price, A; McNally, KL; Henry, A				Wade, Len J.; Bartolome, Violeta; Mauleon, Ramil; Vasant, Vivek Deshmuck; Prabakar, Sumeet Mankar; Chelliah, Muthukumar; Kameoka, Emi; Nagendra, K.; Reddy, K. R. Kamalnath; Varma, C. Mohan Kumar; Patil, Kalmeshwar Gouda; Shrestha, Roshi; Al-Shugeairy, Zaniab; Al-Ogaidi, Faez; Munasinghe, Mayuri; Gowda, Veeresh; Semon, Mande; Suralta, Roel R.; Shenoy, Vinay; Vadez, Vincent; Serraj, Rachid; Shashidhar, H. E.; Yamauchi, Akira; Babu, Ranganathan Chandra; Price, Adam; McNally, Kenneth L.; Henry, Amelia			Environmental Response and Genomic Regions Correlated with Rice Root Growth and Yield under Drought in the OryzaSNP Panel across Multiple Study Systems	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SOIL-FILLED CHAMBERS; SATIVA L.; WATER-DEFICIT; GRAIN-YIELD; MORPHOLOGICAL TRAITS; PENETRATION ABILITY; ALUMINUM TOLERANCE; RESISTANCE TRAITS; PLANT-PRODUCTION	The rapid progress in rice genotyping must be matched by advances in phenotyping. A better understanding of genetic variation in rice for drought response, root traits, and practical methods for studying them are needed. In this study, the OryzaSNP set (20 diverse genotypes that have been genotyped for SNP markers) was phenotyped in a range of field and container studies to study the diversity of rice root growth and response to drought. Of the root traits measured across more than 20 root experiments, root dry weight showed the most stable genotypic performance across studies. The environment (E) component had the strongest effect on yield and root traits. We identified genomic regions correlated with root dry weight, percent deep roots, maximum root depth, and grain yield based on a correlation analysis with the phenotypes and aus, indica, or japonica introgression regions using the SNP data. Two genomic regions were identified as hot spots in which root traits and grain yield were co-located; on chromosome 1 (39.7-40.7 Mb) and on chromosome 8 (20.3-21.9 Mb). Across experiments, the soil type/growth medium showed more correlations with plant growth than the container dimensions. Although the correlations among studies and genetic co-location of root traits from a range of study systems points to their potential utility to represent responses in field studies, the best correlations were observed when the two setups had some similar properties. Due to the co-location of the identified genomic regions (from introgression block analysis) with QTL for a number of previously reported root and drought traits, these regions are good candidates for detailed characterization to contribute to understanding rice improvement for response to drought. This study also highlights the utility of characterizing a small set of 20 genotypes for root growth, drought response, and related genomic regions.	[Wade, Len J.] Charles Sturt Univ, Graham Ctr Agr Innovat, Wagga Wagga, NSW 2678, Australia; [Bartolome, Violeta; Mauleon, Ramil; Gowda, Veeresh; Serraj, Rachid; McNally, Kenneth L.; Henry, Amelia] Int Rice Res Inst, Manila 1301, Philippines; [Vasant, Vivek Deshmuck; Prabakar, Sumeet Mankar; Chelliah, Muthukumar; Babu, Ranganathan Chandra] Tamil Nadu Agr Univ, Ctr Plant Mol Biol & Biotechnol, Coimbatore 641003, Tamil Nadu, India; [Kameoka, Emi; Yamauchi, Akira] Nagoya Univ Chikusa, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Nagendra, K.; Reddy, K. R. Kamalnath; Varma, C. Mohan Kumar; Patil, Kalmeshwar Gouda; Shenoy, Vinay] Barwale Fdn, Hyderabad 500029, Andhra Pradesh, India; [Shrestha, Roshi; Al-Shugeairy, Zaniab; Al-Ogaidi, Faez; Munasinghe, Mayuri; Price, Adam] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 3UU, Scotland; [Semon, Mande] Africa Rice Ctr, IITA, Ibadan, Nigeria; [Suralta, Roel R.] Philippine Rice Res Inst, Science City Of Munoz 3119, Nueva Ecija, Philippines; [Vadez, Vincent] Int Crops Res Inst Semi Arid Trop, Patancheru 502324, Telangana, India; [Shashidhar, H. E.] Univ Agr Sci Gandhi Krishi Vignana Kendra GKVK, Coll Agr, Bangalore 560065, Karnataka, India	Charles Sturt University; CGIAR; International Rice Research Institute (IRRI); Tamil Nadu Agricultural University; Nagoya University; University of Aberdeen; CGIAR; Africa Rice Center; International Institute of Tropical Agriculture (IITA); Philippine Rice Research Institute; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); University of Agricultural Sciences Bangalore	Henry, A (corresponding author), Int Rice Res Inst, DAPO Box 7777, Manila 1301, Philippines.	a.henry@irri.org	Wade, Len J/A-8872-2008; McNally, Kenneth L./L-3970-2019; Mankar, Sumeet/AAT-6287-2020; Vadez, Vincent/GLU-8981-2022; Mauleon, Ramil/AAW-1697-2020; ALshugeairy, zainab Kareem/GXF-1895-2022; Vadez, Vincent/C-5310-2014	Wade, Len J/0000-0002-1321-4310; McNally, Kenneth L./0000-0002-9613-5537; Mankar, Sumeet/0000-0002-9603-121X; Mauleon, Ramil/0000-0001-8512-144X; ALshugeairy, zainab Kareem/0000-0002-0821-3110; Henry, Amelia/0000-0001-6255-5480	Generation Challenge Program (GCP) project, "Targeting Drought-Avoidance Root Traits to Enhance Rice Productivity under Water-Limited Environments" [G3008.06]	Generation Challenge Program (GCP) project, "Targeting Drought-Avoidance Root Traits to Enhance Rice Productivity under Water-Limited Environments"	This research was funded by the Generation Challenge Program (GCP) project G3008.06, "Targeting Drought-Avoidance Root Traits to Enhance Rice Productivity under Water-Limited Environments". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna TLB, 2008, FIELD CROP RES, V108, P117, DOI 10.1016/j.fcr.2008.04.003; Ali ML, 2000, THEOR APPL GENET, V101, P756, DOI 10.1007/s001220051541; Babu RC, 2001, PLANT BREEDING, V120, P233, DOI 10.1046/j.1439-0523.2001.00578.x; Babu RC, 2003, CROP SCI, V43, P1457, DOI 10.2135/cropsci2003.1457; Cairns JE, 2009, FIELD CROP RES, V114, P108, DOI 10.1016/j.fcr.2009.07.009; Cooper M, 1999, FIELD CROP RES, V64, P131, DOI 10.1016/S0378-4290(99)00056-8; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Courtois B, 2009, RICE, V2, P115, DOI 10.1007/s12284-009-9028-9; Gomez MS., 2006, AM, V2, P161, DOI [10.3844/ajbbsp.2006.161.169, DOI 10.3844/AJBBSP.2006.161.169]; Gomez SM, 2010, ACTA PHYSIOL PLANT, V32, P355, DOI 10.1007/s11738-009-0413-1; Gowda VRP, 2012, FUNCT PLANT BIOL, V39, P402, DOI 10.1071/FP12015; Gowda VRP, 2011, FIELD CROP RES, V122, P1, DOI 10.1016/j.fcr.2011.03.001; Hardy B., 2008, DROUGHT FRONTIERS RI, P3, DOI [10.3389/fphys.2012.00429, DOI 10.3389/FPHYS.2012.00429]; Henry A, 2011, FIELD CROP RES, V120, P205, DOI 10.1016/j.fcr.2010.10.003; *IRRI, 2007, CROPSTAT WIND VERS 7; Jahn CE, 2011, PLANT PHYSIOL, V155, P157, DOI 10.1104/pp.110.165654; Kamoshita A, 2002, THEOR APPL GENET, V104, P880, DOI 10.1007/s00122-001-0837-5; Kamoshita A, 2008, FIELD CROP RES, V109, P1, DOI 10.1016/j.fcr.2008.06.010; Kano-Nakata M, 2013, FIELD CROP RES, V144, P288, DOI 10.1016/j.fcr.2013.01.024; Kano-Nakatal M, 2011, PLANT PROD SCI, V14, P307, DOI 10.1626/pps.14.307; Khowaja FS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-276; Lafitte HR, 2001, FIELD CROP RES, V71, P57, DOI 10.1016/S0378-4290(01)00150-2; Lian XM, 2005, THEOR APPL GENET, V112, P85, DOI 10.1007/s00122-005-0108-y; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Nguyen BD, 2003, THEOR APPL GENET, V106, P583, DOI 10.1007/s00122-002-1072-4; Nguyen HT, 1997, CROP SCI, V37, P1426, DOI 10.2135/cropsci1997.0011183X003700050002x; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pasuquin EM, 2013, PLANT PROD SCI, V16, P217, DOI 10.1626/pps.16.217; Price AH, 2000, THEOR APPL GENET, V100, P49, DOI 10.1007/s001220050007; Price AH, 2002, J EXP BOT, V53, P989, DOI 10.1093/jexbot/53.371.989; Price AH, 2002, FIELD CROP RES, V76, P25, DOI 10.1016/S0378-4290(02)00010-2; Price AH, 2002, FIELD CROP RES, V76, P11, DOI 10.1016/S0378-4290(02)00012-6; R Core Team, 2021, R LANGUAGE ENV STAT; Ray JD, 1996, THEOR APPL GENET, V92, P627, DOI 10.1007/BF00226082; Salunkhe AS, 2011, MOL BIOTECHNOL, V49, P90, DOI 10.1007/s12033-011-9382-x; Samson BK, 2002, FIELD CROP RES, V76, P175, DOI 10.1016/S0378-4290(02)00038-2; SAS Institute Inc, 2012, SAS ONLINEDOC VERS 9; Serraj R, 2009, ADV AGRON, V103, P41, DOI 10.1016/S0065-2113(09)03002-8; Serraj R, 2011, PLANT PROD SCI, V14, P1, DOI 10.1626/pps.14.1; Shashidhar HE, 2013, PLANT BREEDING LAB F, P151; Shashidhar HE, 2012, METHODOLOGIES ROOT D; Shen L, 2001, THEOR APPL GENET, V103, P75, DOI 10.1007/s001220100538; Shrestha R, 2014, PLANT BIOLOGY, V16, P632, DOI 10.1111/plb.12096; Siopongco JDLC, 2005, PLANT PROD SCI, V8, P497, DOI 10.1626/pps.8.497; Srinivasan S, 2008, PLANT GROWTH REGUL, V56, P245, DOI 10.1007/s10725-008-9304-5; Suji KK, 2012, FIELD CROP RES, V137, P89, DOI 10.1016/j.fcr.2012.08.006; Venuprasad R, 2002, EUPHYTICA, V128, P293, DOI 10.1023/A:1021281428957; Vikram P, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-89; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wade Len J., 2000, Plant Production Science, V3, P173; Wade LJ, 1999, FIELD CROP RES, V64, P35, DOI 10.1016/S0378-4290(99)00049-0; Wu P, 2000, THEOR APPL GENET, V100, P1295, DOI 10.1007/s001220051438; Yadav R, 1997, THEOR APPL GENET, V94, P619, DOI 10.1007/s001220050459; Zhang WP, 2001, THEOR APPL GENET, V103, P118, DOI 10.1007/s001220100561; Zheng HG, 2000, GENOME, V43, P53, DOI 10.1139/gen-43-1-53	55	19	19	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124127	10.1371/journal.pone.0124127	http://dx.doi.org/10.1371/journal.pone.0124127			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909711	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800060
J	Xu, K; Li, SS; Yang, W; Li, K; Bai, YW; Xu, YY; Jin, J; Wang, YY; Bartlam, M				Xu, Kun; Li, Shanshan; Yang, Wen; Li, Kan; Bai, Yuwei; Xu, Yueyang; Jin, Jin; Wang, Yingying; Bartlam, Mark			Structural and Biochemical Analysis of Tyrosine Phosphatase Related to Biofilm Formation A (TpbA) from the Opportunistic Pathogen Pseudomonas aeruginosa PAO1	PLOS ONE			English	Article							SUBSTRATE; EXPRESSION; RESISTANCE; MECHANISM; VHZ	Biofilms are important for cell communication and growth in most bacteria, and are responsible for a number of human clinical infections and diseases. TpbA (PA3885) is a dual specific tyrosine phosphatase (DUSP) that negatively regulates biofilm formation in the opportunistic pathogen Pseudomonas aeruginosa PAO1 by converting extracellular quorum sensing signals into internal gene cascade reactions that result in reduced biofilm formation. We have determined the three-dimensional crystal structure of wild-type TpbA from Pseudomonas aeruginosa PAO1 in the phosphate-bound state and a TpbA (C132S) mutant with phosphotyrosine. Comparison between the phosphate-bound structure and the previously reported ligand-free TpbA structure reveals the extent of conformational changes that occur upon substrate binding. The largest changes occur in the functional loops that define the substrate binding site, including the PTP, general acid and alpha 4-alpha 5 loops. We further show that TpbA efficiently catalyzes the hydrolysis of two phosphotyrosine peptides derived from the periplasmic domain of TpbB (YfiN, PA1120), with a strong preference for dephosphorylating Tyr48 over Tyr62. This work adds to the small repertoire of DUSP structures in both the ligand-free and ligand-bound states, and provides a starting point for further study of the role of TpbA in biofilm formation.	[Xu, Kun; Li, Shanshan; Bartlam, Mark] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Xu, Kun; Li, Shanshan; Yang, Wen; Li, Kan; Bai, Yuwei; Xu, Yueyang; Bartlam, Mark] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Jin, Jin] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China; [Wang, Yingying] Nankai Univ, Coll Environm Sci & Engn, Key Lab Pollut Proc & Environm Criteria, Minist Educ, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University; Nankai University	Wang, YY (corresponding author), Nankai Univ, Coll Environm Sci & Engn, Key Lab Pollut Proc & Environm Criteria, Minist Educ, Tianjin 300071, Peoples R China.	wangyy@nankai.edu.cn; bartlam@nankai.edu.cn	YANG, WEN/A-1993-2014; wang, yingying/GRS-3058-2022; wang, yan/GSE-6489-2022	Xu, Yueyang/0000-0003-2375-9135; Bartlam, Mark/0000-0001-5173-5080	Ministry of Science & Technology 973 Project [2014CB560709]; Natural Science Foundation of China [31450110071]; Tianjin Municipal Science and Technology Commission [13JCYBJC20800, 12JCZDJC29700]	Ministry of Science & Technology 973 Project; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission	This work was supported by the Ministry of Science & Technology 973 Project (grant number 2014CB560709 to MB), the Natural Science Foundation of China (grant number 31450110071 to MB) and the Tianjin Municipal Science and Technology Commission (grant number 13JCYBJC20800 to MB and 12JCZDJC29700 to YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal R, 2008, J BIOL CHEM, V283, P8946, DOI 10.1074/jbc.M708945200; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Balasubramanian D, 2013, NUCLEIC ACIDS RES, V41, P1, DOI 10.1093/nar/gks1039; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; DENU JM, 1995, P NATL ACAD SCI USA, V92, P5910, DOI 10.1073/pnas.92.13.5910; Dickschat JS, 2010, NAT PROD REP, V27, P343, DOI 10.1039/b804469b; Diggle SP, 2006, INT J MED MICROBIOL, V296, P83, DOI 10.1016/j.ijmm.2006.01.038; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; Giardina G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081324; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Koveal D, 2013, J MOL BIOL, V425, P2219, DOI 10.1016/j.jmb.2013.03.023; Kuznetsov VI, 2012, BIOCHEMISTRY-US, V51, P9869, DOI 10.1021/bi300908y; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Nakhamchik A, 2008, APPL ENVIRON MICROB, V74, P4199, DOI 10.1128/AEM.00176-08; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Oberhardt MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07; OCHSNER UA, 1995, P NATL ACAD SCI USA, V92, P6424, DOI 10.1073/pnas.92.14.6424; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PASSADOR L, 1993, SCIENCE, V260, P1127, DOI 10.1126/science.8493556; Prince AS, 2002, NEW ENGL J MED, V347, P1110, DOI 10.1056/NEJMcibr021776; Pu MM, 2010, BIOCHEM BIOPH RES CO, V402, P351, DOI 10.1016/j.bbrc.2010.10.032; Rajan Sujatha, 2002, Semin Respir Infect, V17, P47, DOI 10.1053/srin.2002.31690; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Sakharkar MK, 2009, J MICROBIOL IMMUNOL, V42, P364; Schumacher MA, 2002, BIOCHEMISTRY-US, V41, P3009, DOI 10.1021/bi015799l; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Ueda A, 2010, ENV MICROBIOL REP, V2, P449, DOI 10.1111/j.1758-2229.2010.00171.x; Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483; Wang Wen-min, 2010, Zhejiang Da Xue Xue Bao Yi Xue Ban, V39, P103; Winstanley C, 2009, FEMS MICROBIOL LETT, V290, P1, DOI 10.1111/j.1574-6968.2008.01394.x; Xie LP, 2002, BIOCHEMISTRY-US, V41, P4032, DOI 10.1021/bi015904r; Yang W, 2010, ACTA CRYSTALLOGR F, V66, P1473, DOI 10.1107/S1744309110034317	39	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124330	10.1371/journal.pone.0124330	http://dx.doi.org/10.1371/journal.pone.0124330			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909591	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800077
J	Zamiri, R; Ahangar, HA; Kaushal, A; Zakaria, A; Zamiri, G; Tobaldi, D; Ferreira, JMF				Zamiri, Reza; Ahangar, Hossein Abbastabar; Kaushal, Ajay; Zakaria, Azmi; Zamiri, Golnoosh; Tobaldi, David; Ferreira, J. M. F.			Dielectrical Properties of CeO2 Nanoparticles at Different Temperatures	PLOS ONE			English	Article							CERIUM OXIDE NANOPARTICLES; PARTICLES; HYDROLYSIS; TRANSPORT	A template-free precipitation method was used as a simple and low cost method for preparation of CeO2 nanoparticles. The structure and morphology of the prepared nanoparticle samples were studied in detail using X-ray diffraction, Raman spectroscopy and Scanning Electron Microscopy (SEM) measurements. The whole powder pattern modelling (WPPM) method was applied on XRD data to accurately measure the crystalline domain size and their size distribution. The average crystalline domain diameter was found to be 5.2 nm, with a very narrow size distribution. UV-visible absorbance spectrum was used to calculate the optical energy band gap of the prepared CeO2 nanoparticles. The FT-IR spectrum of prepared CeO2 nanoparticles showed absorption bands at 400 cm(-1) to 450 cm(-1) regime, which correspond to CeO2 stretching vibration. The dielectric constant (er) and dielectric loss (tan delta) values of sintered CeO2 compact consolidated from prepared nanoparticles were measured at different temperatures in the range from 298 K (room temperature) to 623 K, and at different frequencies from 1 kHz to 1 MHz.	[Zamiri, Reza; Zakaria, Azmi; Zamiri, Golnoosh] Univ Putra Malaysia, Dept Phys, Fac Sci, Upm Serdang 43400, Selangor, Malaysia; [Zamiri, Reza; Kaushal, Ajay; Tobaldi, David; Ferreira, J. M. F.] Univ Aveiro, Dept Mat & Ceram Engn DEMaC, CICECO, P-3810193 Aveiro, Portugal; [Ahangar, Hossein Abbastabar] Islamic Azad Univ, Najafabad Branch, Dept Chem, Fac Sci, Esfahan, Iran	Universiti Putra Malaysia; Universidade de Aveiro; Islamic Azad University	Zamiri, R (corresponding author), Univ Putra Malaysia, Dept Phys, Fac Sci, Upm Serdang 43400, Selangor, Malaysia.	zamiri.r@gmail.com; azmizak@gmail.com	Zamiri, Golnoush/AAK-8009-2020; zamir, reza/D-4100-2016; Tobaldi, David Maria/H-9620-2019; Abbastabar, Hossein/AAE-4447-2021; Ahangar, Hossein Abbastabar/AAN-2224-2021	Zamiri, Golnoush/0000-0003-4223-5062; zamir, reza/0000-0002-1413-9797; Tobaldi, David Maria/0000-0002-0112-8570; Ahangar, Hossein Abbastabar/0000-0002-3716-2172; Ferreira, Jose/0000-0002-7520-2809	Foundation for Science and Technology of Portugal (FCT); Universiti Putra Malaysia Postdoctoral research fellow program [SFRH/BPD/76185/2011, NSR-8978]; Foundation for Science and Technology of Portugal (FCT) [SFRH/BPD/77598/2011]; ECO-SEE project (European Union's Seventh Framework Programme for research, technological development and demonstration) [609234]	Foundation for Science and Technology of Portugal (FCT)(Portuguese Foundation for Science and Technology); Universiti Putra Malaysia Postdoctoral research fellow program; Foundation for Science and Technology of Portugal (FCT)(Portuguese Foundation for Science and Technology); ECO-SEE project (European Union's Seventh Framework Programme for research, technological development and demonstration)	Reza Zamiri would like to thank the Foundation for Science and Technology of Portugal (FCT) and Universiti Putra Malaysia Postdoctoral research fellow program (Reza Zamiri) for the financial support under the grant references, SFRH/BPD/76185/2011 and NSR-8978 (G. P. D.). Ajay Kaushal thanks the financial support under the grant references SFRH/BPD/77598/2011 from the Foundation for Science and Technology of Portugal (FCT). David M. Tobaldi is grateful to the ECO-SEE project (funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 609234. Note: The views expressed are purely those of the authors and may not in any circumstances be regarded as stating an official position of the European Commission). The authors would also like to thank CICECO for the work at the University of Aveiro.	Abecassis-Wolfovich M, 2005, APPL CATAL B-ENVIRON, V59, P91, DOI 10.1016/j.apcatb.2005.01.001; Araujo VD, 2012, CRYSTENGCOMM, V14, P1150, DOI 10.1039/c1ce06188g; Aspinall HC, 2011, INORG CHEM, V50, P11644, DOI 10.1021/ic201593s; AYYUB P, 1995, PHYS REV B, V51, P6135, DOI 10.1103/PhysRevB.51.6135; Brandily-Anne ML, 2010, J NON-CRYST SOLIDS, V356, P2337, DOI 10.1016/j.jnoncrysol.2010.02.020; CAGLIOTI G, 1960, NUCL INSTRUM METHODS, V9, P195, DOI 10.1016/0029-554X(60)90101-4; Chen HI, 2005, CERAM INT, V31, P795, DOI 10.1016/j.ceramint.2004.09.006; CHU X, 1993, J AM CERAM SOC, V76, P2115, DOI 10.1111/j.1151-2916.1993.tb08344.x; Gleiter H, 2000, ACTA MATER, V48, P1, DOI 10.1016/S1359-6454(99)00285-2; Hirano M, 2000, J MATER CHEM, V10, P473, DOI 10.1039/a907510k; HSU WP, 1988, LANGMUIR, V4, P31, DOI 10.1021/la00079a005; Hu ZY, 2006, COMMUN SOIL SCI PLAN, V37, P1381, DOI 10.1080/00103620600628680; KIRK TJ, 1993, J ELECTROCHEM SOC, V140, P3494, DOI 10.1149/1.2221117; Klug H.P., 1974, XRAY DIFFRACTION PRO; Leoni M, 2006, Z KRISTALLOGR, P249; Lewis JA, 2000, J AM CERAM SOC, V83, P2341, DOI 10.1111/j.1151-2916.2000.tb01560.x; Lira-Cantu M, 2006, CHEM MATER, V18, P5684, DOI 10.1021/cm061429d; Masui T, 1997, CHEM MATER, V9, P2197, DOI 10.1021/cm970359v; Mokkelbost T, 2004, CHEM MATER, V16, P5489, DOI 10.1021/cm048583p; Niu JL, 2007, CARDIOVASC RES, V73, P549, DOI 10.1016/j.cardiores.2006.11.031; Pautrot-d'Alencon L, 2006, J SOL-GEL SCI TECHN, V39, P261, DOI 10.1007/s10971-006-7803-2; Phoka S, 2009, MATER CHEM PHYS, V115, P423, DOI 10.1016/j.matchemphys.2008.12.031; Phokha S, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-425; Rani, 2012, ADV SCI LETT, V5, P1, DOI [10.1166/asl.2012.3312, DOI 10.1166/ASL.2012.3312]; Riccardi CS, 2009, SOLID STATE IONICS, V180, P288, DOI 10.1016/j.ssi.2008.11.016; Samuel MS, 2011, PHYSICA B, V406, P3023, DOI 10.1016/j.physb.2011.04.070; Samuel MS, 2011, CURR APPL PHYS, V11, P1094, DOI 10.1016/j.cap.2011.02.002; Santha NL, 2004, J AM CERAM SOC, V87, P1233, DOI 10.1111/j.1151-2916.2004.tb07717_33.x; Scardi P, 2005, ACTA MATER, V53, P5229, DOI 10.1016/j.actamat.2005.08.002; Scardi P, 2004, DIFFRACTION ANALYSIS OF THE MICROSTRUCTURE OF MATERIALS, P51; Scardi P, 2002, ACTA CRYSTALLOGR A, V58, P190, DOI 10.1107/S0108767301021298; Schubert D, 2006, BIOCHEM BIOPH RES CO, V342, P86, DOI 10.1016/j.bbrc.2006.01.129; Sehgal A, 2005, LANGMUIR, V21, P9359, DOI 10.1021/la0513757; Tarnuzzer RW, 2005, NANO LETT, V5, P2573, DOI 10.1021/nl052024f; VERDON E, 1995, MATER LETT, V25, P127, DOI 10.1016/0167-577X(95)00161-1; WEBER WH, 1993, PHYS REV B, V48, P178, DOI 10.1103/PhysRevB.48.178; WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6; Wu NC, 2002, J AM CERAM SOC, V85, P2462, DOI 10.1111/j.1151-2916.2002.tb00481.x; Xu HR, 2002, J AM CERAM SOC, V85, P139; Zamiri R, 2014, CERAM INT, V40, P6031, DOI 10.1016/j.ceramint.2013.11.052; Zamiri R, 2014, CERAM INT, V40, P4471, DOI 10.1016/j.ceramint.2013.08.120; Zhang DS, 2007, INORG CHEM, V46, P2446, DOI 10.1021/ic061697d; ZHANG Y, 1995, APPL CATAL B-ENVIRON, V6, P325, DOI 10.1016/0926-3373(95)00041-0; ZHOU YC, 1995, J AM CERAM SOC, V78, P981, DOI 10.1111/j.1151-2916.1995.tb08425.x; Zong Y, 2010, MATER LETT, V64, P243, DOI 10.1016/j.matlet.2009.09.032	45	79	80	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122989	10.1371/journal.pone.0122989	http://dx.doi.org/10.1371/journal.pone.0122989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910071	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800026
J	Reimer, JJ; Vargas, R; Rivas, D; Gaxiola-Castro, G; Hernandez-Ayon, JM; Lara-Lara, R				Reimer, Janet J.; Vargas, Rodrigo; Rivas, David; Gaxiola-Castro, Gilberto; Martin Hernandez-Ayon, J.; Lara-Lara, Ruben			Sea Surface Temperature Influence on Terrestrial Gross Primary Production along the Southern California Current	PLOS ONE			English	Article							BAJA-CALIFORNIA; GREENHOUSE-GAS; COASTAL; VARIABILITY; WATER; EVOLUTION; MOISTURE; FUTURE; WINDS; FOG	Some land and ocean processes are related through connections (and synoptic-scale tele-connections) to the atmosphere. Synoptic-scale atmospheric (El Nino/Southern Oscillation [ENSO], Pacific Decadal Oscillation [PDO], and North Atlantic Oscillation [NAO]) decadal cycles are known to influence the global terrestrial carbon cycle. Potentially, smaller scale land-ocean connections influenced by coastal upwelling (changes in sea surface temperature) may be important for local-to-regional water-limited ecosystems where plants may benefit from air moisture transported from the ocean to terrestrial ecosystems. Here we use satellite-derived observations to test potential connections between changes in sea surface temperature (SST) in regions with strong coastal upwelling and terrestrial gross primary production (GPP) across the Baja California Peninsula. This region is characterized by an arid/semiarid climate along the southern California Current. We found that SST was correlated with the fraction of photosynthetic active radiation (fPAR; as a proxy for GPP) with lags ranging from 0 to 5 months. In contrast ENSO was not as strongly related with fPAR as SST in these coastal ecosystems. Our results show the importance of local-scale changes in SST during upwelling events, to explain the variability in GPP in coastal, water-limited ecosystems. The response of GPP to SST was spatially-dependent: colder SST in the northern areas increased GPP (likely by influencing fog formation), while warmer SST at the southern areas was associated to higher GPP (as SST is in phase with precipitation patterns). Interannual trends in fPAR are also spatially variable along the Baja California Peninsula with increasing secular trends in subtropical regions, decreasing trends in the most arid region, and no trend in the semi-arid regions. These findings suggest that studies and ecosystem process based models should consider the lateral influence of local-scale ocean processes that could influence coastal ecosystem productivity.	[Reimer, Janet J.; Vargas, Rodrigo] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19716 USA; [Reimer, Janet J.; Rivas, David; Gaxiola-Castro, Gilberto; Lara-Lara, Ruben] Ctr Invest Cient & Educ Super Ensenada, Dept Oceanog Biol, Ensenada, Baja California, Mexico; [Reimer, Janet J.] Programa Mexicano Carbono, Texcoco, Estado De Mexic, Mexico; [Martin Hernandez-Ayon, J.] Univ Autonoma Baja California, Inst Invest Oceanol, Ensenada, Baja California, Mexico	University of Delaware; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Universidad Autonoma de Baja California	Vargas, R (corresponding author), Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19716 USA.	rvargas@udel.edu	Rivas, David/B-3439-2017; Hernandez-Ayon, Jose Martin/AAV-9088-2021; Vargas, Rodrigo/C-4720-2008	Hernandez-Ayon, Jose Martin/0000-0001-6869-6225; Vargas, Rodrigo/0000-0001-6829-5333; Rivas, David/0000-0002-7855-4797	Mexican Carbon Program (Programa Mexicano del Carbono); Centro de Investigacion Cientifica y de Educacion Superior de Ensenada's (CICESE) [625118]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [CB-2009-128940-F]; CICESE's internal projects; CONACYT [CB 2009/129140]; NASA under Carbon Monitoring System [NNX13AQ06G]; USDA [2014-67003-22070]	Mexican Carbon Program (Programa Mexicano del Carbono); Centro de Investigacion Cientifica y de Educacion Superior de Ensenada's (CICESE); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CICESE's internal projects; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NASA under Carbon Monitoring System; USDA(United States Department of Agriculture (USDA))	The Mexican Carbon Program (Programa Mexicano del Carbono) provided a Postdoctoral scholarship to JJR for the elaboration of this work. JJR also thanks the University of Delaware for fostering a Visiting Scholar position which allowed for collaborations with RV in the early stages of this project. DR has been funded by Centro de Investigacion Cientifica y de Educacion Superior de Ensenada's (CICESE) budget through the internal project number 625118, and Consejo Nacional de Ciencia y Tecnologia (CONACYT) project CB-2009-128940-F. GGC and RLL have also been funded through CICESE's internal projects and CONACYT project CB 2009/129140. This work is part of the North American Carbon Program, and RV acknowledges support from NASA under Carbon Monitoring System (NNX13AQ06G) and USDA (2014-67003-22070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badan A., 2003, GEOFISICA INT, V42, P567; Bakun A, 2004, ECOL LETT, V7, P1015, DOI 10.1111/j.1461-0248.2004.00665.x; Bakun A, 2010, GLOBAL CHANGE BIOL, V16, P1213, DOI 10.1111/j.1365-2486.2009.02094.x; Bane JM, 2005, J GEOPHYS RES, V110; Carbone MS, 2013, GLOBAL CHANGE BIOL, V19, P484, DOI 10.1111/gcb.12054; Casey KS, 2001, J CLIMATE, V14, P3801, DOI 10.1175/1520-0442(2001)014<3801:GARSST>2.0.CO;2; Cavazos T, 2004, CLIM RES, V25, P229, DOI 10.3354/cr025229; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Di Lorenzo E, 2005, J PHYS OCEANOGR, V35, P336, DOI 10.1175/JPO-2690.1; Durazo R, 2002, PROG OCEANOGR, V54, P7, DOI 10.1016/S0079-6611(02)00041-1; Feng WM, 2014, EARTH PLANET SC LETT, V401, P47, DOI 10.1016/j.epsl.2014.05.046; Fischer DT, 2009, J BIOGEOGR, V36, P783, DOI 10.1111/j.1365-2699.2008.02025.x; Garcia-Oliva F., 1991, Geografiska Annaler, Series A, Physical Geography, V73A, P179; Garreaud R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000709; Gimeno L, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000389; Gimeno L, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043712; Goldstein AH, 2000, AGR FOREST METEOROL, V101, P113, DOI 10.1016/S0168-1923(99)00168-9; Houghton RA, 2003, TREATISE GEOCHEMISTR, V8, P473, DOI [DOI 10.1016/B0-08-043751-6/08168-8, 10.1016/B0-08-043751-6/08168-8]; Hsieh WW, 1992, FISH OCEANOGR, V1, P333, DOI DOI 10.1111/J.1365-2419.1992.TB00005.X; Knippertz P, 2010, J CLIMATE, V23, P987, DOI 10.1175/2009JCLI3333.1; Koracin D, 2005, BOUND-LAY METEOROL, V117, P447, DOI 10.1007/s10546-005-2772-5; Lewis J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002833; Linacre L, 2010, CONT SHELF RES, V30, P1730, DOI 10.1016/j.csr.2010.07.011; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Muenchow J, 2013, BIOTROPICA, V45, P557, DOI 10.1111/btp.12049; Nyquist H., 1928, T AM I ELECT ING, V47, P617, DOI [10.1109/T-AIEE.1928.5055024, DOI 10.1109/T-AIEE.1928.5055024]; Palacios DM, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002380; Pares-Sierra A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016716; Pavia EG, 1998, GEOPHYS RES LETT, V25, P3855, DOI 10.1029/1998GL900029; Pegau WS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014076; Piao SL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002848; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Schwinning S, 2001, J ECOL, V89, P464, DOI 10.1046/j.1365-2745.2001.00576.x; Snyder MA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017647; Tian YH, 2000, IEEE T GEOSCI REMOTE, V38, P2387, DOI 10.1109/36.868894; Tokinaga H, 2009, J GEOPHYS RES, V114; Trenberth K, 2005, SCIENCE, V308, P1753, DOI 10.1126/science.1112551; Turner Raymond M., 1965, CHANGING MILE ECOLOG; Vargas R, 2013, ECOSYSTEMS, V16, P749, DOI 10.1007/s10021-013-9648-1; Wharton S, 2009, GLOBAL CHANGE BIOL, V15, P2187, DOI 10.1111/j.1365-2486.2009.01952.x; Zaytsev O, 2003, J OCEANOGR, V59, P489, DOI 10.1023/A:1025544700632	41	7	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125177	10.1371/journal.pone.0125177	http://dx.doi.org/10.1371/journal.pone.0125177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923109	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600131
J	Yu, W; Chen, XJ; Yi, Q; Chen, Y; Zhang, Y				Yu, Wei; Chen, Xinjun; Yi, Qian; Chen, Yong; Zhang, Yang			Variability of Suitable Habitat of Western Winter-Spring Cohort for Neon Flying Squid in the Northwest Pacific under Anomalous Environments	PLOS ONE			English	Article							REMOTE-SENSING DATA; OMMASTREPHES-BARTRAMII; SUITABILITY INDEX; DOSIDICUS-GIGAS; FISHING GROUNDS; LIFE-HISTORY; TUNA; FISHERY; CATCH; IMPACTS	We developed a habitat suitability index (HSI) model to evaluate the variability of suitable habitat for neon flying squid (Ommastrephes bartramii) under anomalous environments in the Northwest Pacific Ocean. Commercial fisheries data from the Chinese squid-jigging vessels on the traditional fishing ground bounded by 35 degrees-45 degrees N and 150 degrees-175 degrees E from July to November during 1998-2009 were used for analyses, as well as the environmental variables including sea surface temperature (SST), chlorophyll-a (Chl-a) concentration, sea surface height anomaly (SSHA) and sea surface salinity (SSS). Two empirical HSI models (arithmeticmean model, AMM; geometric mean model, GMM) were established according to the frequency distribution of fishing efforts. The AMM model was found to perform better than the GMM model. The AMM-based HSI model was further validated by the fishery and environmental data in 2010. The predicted HSI values in 1998 (high catch), 2008 (average catch) and 2009 (low catch) indicated that the squid habitat quality was strongly associated with the ENSO-induced variability in the oceanic conditions on the fishing ground. The La Nina events in 1998 tended to yield warm SST and favorable range of Chl-a concentration and SSHA, resulting in high-quality habitats for O. bartramii. While the fishing ground in the El Nino year of 2009 experienced anomalous cool waters and unfavorable range of Chl-a concentration and SSHA, leading to relatively low-quality squid habitats. Our findings suggest that the La Nina event in 1998 tended to result in more favorable habitats for O. bartramii in the Northwest Pacific with the gravity centers of fishing efforts falling within the defined suitable habitat and yielding high squid catch; whereas the El Nino event in 2009 yielded less favorable habitat areas with the fishing effort distribution mismatching the suitable habitat and a dramatic decline of the catch of O. bartramii. This study might provide some potentially valuable insights into exploring the relationship between the underlying squid habitat and the inter-annual environmental change.	[Yu, Wei; Chen, Xinjun; Yi, Qian; Zhang, Yang] Shanghai Ocean Univ, Coll Marine Sci, Shanghai 201306, Peoples R China; [Chen, Xinjun; Yi, Qian] Shanghai Ocean Univ, Natl Engn Res Ctr Ocean Fisheries, Shanghai 201306, Peoples R China; [Chen, Xinjun; Yi, Qian] Shanghai Ocean Univ, Key Lab Sustainable Exploitat Ocean Fisheries Res, Minist Educ, Shanghai 201306, Peoples R China; [Chen, Yong] Univ Maine, Sch Marine Sci, Orono, ME 04469 USA; [Yu, Wei; Chen, Xinjun; Yi, Qian; Chen, Yong] Collaborat Innovat Ctr Distant Water Fisheries, Shanghai 201306, Peoples R China	Shanghai Ocean University; National Engineering Research Center for Oceanic Fisheries; Shanghai Ocean University; Shanghai Ocean University; University of Maine System; University of Maine Orono	Chen, XJ (corresponding author), Shanghai Ocean Univ, Coll Marine Sci, Shanghai 201306, Peoples R China.	xjchen@shou.edu.cn			National High-Tech R&D Program (863 Program) of China [2012AA092303]; Project of Shanghai Science and Technology Innovation [12231203900]; Industrialization Program of National Development and Reform Commission [2159999]; National Key Technologies R&D Program of China [2013BAD13B00]; Shanghai Universities First-Class Disciplines Project (Fisheries A); Funding Program for Outstanding Dissertations in Shanghai Ocean University; Shanghai Ocean University International Center for Marine Studies	National High-Tech R&D Program (863 Program) of China(National High Technology Research and Development Program of China); Project of Shanghai Science and Technology Innovation; Industrialization Program of National Development and Reform Commission; National Key Technologies R&D Program of China(National Key Technology R&D Program); Shanghai Universities First-Class Disciplines Project (Fisheries A); Funding Program for Outstanding Dissertations in Shanghai Ocean University; Shanghai Ocean University International Center for Marine Studies	This study was financially supported by the National High-Tech R&D Program (863 Program) of China (2012AA092303), the Project of Shanghai Science and Technology Innovation (12231203900), the Industrialization Program of National Development and Reform Commission (2159999), the National Key Technologies R&D Program of China (2013BAD13B00), the Shanghai Universities First-Class Disciplines Project (Fisheries A), and the Funding Program for Outstanding Dissertations in Shanghai Ocean University. Y. Chen's involvement is supported by the Shanghai Ocean University International Center for Marine Studies.	Anderson CIH, 2001, FISH RES, V54, P133, DOI 10.1016/S0165-7836(01)00378-2; Arguelles J, 2001, FISH RES, V54, P51, DOI 10.1016/S0165-7836(01)00380-0; Bertrand A, 2002, CAN J FISH AQUAT SCI, V59, P1002, DOI 10.1139/F02-073; Bovee K, 1988, P WORKSH DEV EV HAB, P11; Cao J, 2009, MAR ECOL PROG SER, V381, P119, DOI 10.3354/meps07969; Chang YJ, 2013, ICES J MAR SCI, V70, P1000, DOI 10.1093/icesjms/fss190; Chen Chih-Shin, 1999, Acta Zoologica Taiwanica, V10, P135; Chen X.J., 1997, J SHANGHAI FISH U, V6, P285; Chen X. J., 2009, CEPHALOPOD WORLD, P60; Chen X. J., 2005, PERIODICAL OCEAN U C, V35, P101; Chen XJ, 2007, ICES J MAR SCI, V64, P1152, DOI 10.1093/icesjms/fsm103; Chen Xin-Jun, 2013, Zhongguo Haiyang Daxue Xuebao, V43, P29; Chen Xin-jun, 2005, Shanghai Shuichan Daxue Xuebao, V14, P168; Chen Xin-Jun, 2009, Oceanologia et Limnologia Sinica, V40, P707; Chen XJ, 2008, FISH RES, V92, P221, DOI 10.1016/j.fishres.2008.01.011; Chen XJ, 2014, ACTA OCEANOL SIN, V33, P45, DOI 10.1007/s13131-014-0452-3; Chen XJ, 2011, CHIN J OCEANOL LIMN, V29, P493, DOI 10.1007/s00343-011-0058-y; Chen XJ, 2010, FISH B-NOAA, V108, P1; Chen XJ, 2009, J OCEANOGR, V65, P93, DOI 10.1007/s10872-009-0009-9; Chen XJ, 2004, FISHERIES RESOURCES, P121; Chen XJ, 2012, PERIODICAL OCEAN U C, V42, P052; [程家骅 Cheng Jiahua], 2003, [中国水产科学, Journal of Fishery Sciences of China], V10, P507; [樊伟 Fan Wei], 2004, [高技术通讯, High Technology Letters], V14, P84; Fan W, 2009, CHIN J OCEANOL LIMN, V27, P408, DOI 10.1007/s00343-009-9107-1; [冯波 FENG Bo], 2007, [水产学报, Journal of Fisheries of China], V31, P805; Gillenwater D, 2006, ECOL ENG, V28, P311, DOI 10.1016/j.ecoleng.2006.08.003; Gong CX, 2012, J OCEAN U CHINA, V11, P241, DOI 10.1007/s11802-012-1898-6; Gore JA, 1996, REGUL RIVER, V12, P459; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Ichii T, 2009, MAR ECOL PROG SER, V378, P1, DOI 10.3354/meps07873; Lee PF, 2005, ZOOL STUD, V44, P260; Lehodey P, 1997, NATURE, V389, P715, DOI 10.1038/39575; Li G, 2014, INT J REMOTE SENS, V35, P4399, DOI 10.1080/01431161.2014.916057; Maddock I, 1999, FRESHWATER BIOL, V41, P373, DOI 10.1046/j.1365-2427.1999.00437.x; Mohri Masahiko, 1999, Journal of National Fisheries University, V47, P43; MURATA M, 1990, MAR BEHAV PHYSIOL, V18, P19, DOI 10.1080/10236249009378779; Murata M., 1998, INT S LARG PEL SQUID, P13; Murphy EJ, 1999, EVOL ECOL, V13, P517, DOI 10.1023/A:1006783902331; Nigmatullin CM, 2001, FISH RES, V54, P9, DOI 10.1016/S0165-7836(01)00371-X; Nishikawa H, 2014, FISH OCEANOGR, V23, P289, DOI 10.1111/fog.12064; Rodhouse PG, 2001, FISH RES, V54, P3, DOI 10.1016/S0165-7836(01)00370-8; Roper CFE, 1984, FAO FISH SYNOP; Seki Michael P., 1993, International North Pacific Fisheries Commission Bulletin, V53, P207; Su NJ, 2011, ICES J MAR SCI, V68, P1072, DOI 10.1093/icesjms/fsr028; Swain DP, 2003, CAN J FISH AQUAT SCI, V60, P897, DOI 10.1139/F03-076; TANG FH, 2011, OCEAN TECHNOLOGY, V30, P7; Terrel JW, 1984, P WORKSH FISH HAB SU, P6; Tian SQ, 2009, CHIN J OCEANOL LIMN, V27, P729, DOI 10.1007/s00343-009-9199-7; Tian SQ, 2009, FISH RES, V95, P181, DOI 10.1016/j.fishres.2008.08.012; Vinagre C, 2006, FISH RES, V82, P140, DOI 10.1016/j.fishres.2006.07.011; Waluda CM, 2006, FISH RES, V79, P56, DOI 10.1016/j.fishres.2006.02.017; Wang WY, 2010, INT J REMOTE SENS, V31, P4515, DOI 10.1080/01431161.2010.485139; Xu Bing, 2012, Journal of Fisheries of China, V36, P696; Yamagata T., 1985, J OCEANOGR SOC JAPAN, V41, P274, DOI DOI 10.1007/BF02109276; Yatsu A, 1997, FISH RES, V29, P257, DOI 10.1016/S0165-7836(96)00541-3; Yatsu A, 1998, INT S LARG PEL SQUID, P31; Yen KW, 2012, INT J REMOTE SENS, V33, P7507, DOI 10.1080/01431161.2012.685973; Yu W, 2012, J GUANGDONG OCEAN U, V32, P74; Zainuddin M, 2006, DEEP-SEA RES PT II, V53, P419, DOI 10.1016/j.dsr2.2006.01.007	59	31	51	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122997	10.1371/journal.pone.0122997	http://dx.doi.org/10.1371/journal.pone.0122997			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923519	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600027
J	Zhang, GM; Bao, CY; Wan, FN; Cao, DL; Qin, XJ; Zhang, HL; Zhu, Y; Dai, B; Shi, GH; Ye, DW				Zhang, Gui-Ming; Bao, Chun-Yang; Wan, Fang-Ning; Cao, Da-Long; Qin, Xiao-Jian; Zhang, Hai-Liang; Zhu, Yao; Dai, Bo; Shi, Guo-Hai; Ye, Ding-Wei			MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer	PLOS ONE			English	Article							SELF-RENEWAL; STEM-CELLS; REPRESSION	Micro (mi) RNAs are important regulators involved in various physical and pathological processes, including cancer. The miRNA-302 family has been documented as playing a critical role in carcinogenesis. In this study, we investigated the role of miRNA-302a in prostate cancer (PCa). MiRNA-302a expression was detected in 44 PCa tissues and 10 normal prostate tissues, and their clinicopathological significance was analyzed. Cell proliferation and cell cycle analysis were performed on PCa cells that stably expressed miRNA-302a. The target gene of miRNA-302a and the downstream pathway were further investigated. Compared with normal prostate tissues, miRNA-302a expression was downregulated in PCa tissues, and was even lower in PCa tissues with a Gleason score >= 8. Overexpression of miRNA-302a induced G1/S cell cycle arrest in PCa cells, and suppressed PCa cell proliferation both in vitro and in vivo. Furthermore, miRNA-302a inhibits AKT expression by directly binding to its 3' untranslated region, resulting in subsequent alterations of the AKT-GSK3 beta-cyclin D1 and AKT-p27(Kip1) pathway. These results reveal miRNA-302a as a tumor suppressor in PCa, suggesting that miRNA-302a may be used as a potential target for therapeutic intervention in PCa.	[Zhang, Gui-Ming; Wan, Fang-Ning; Cao, Da-Long; Qin, Xiao-Jian; Zhang, Hai-Liang; Zhu, Yao; Dai, Bo; Shi, Guo-Hai; Ye, Ding-Wei] Fudan Univ, Shanghai Canc Ctr, Dept Urol, Shanghai 200433, Peoples R China; [Zhang, Gui-Ming; Wan, Fang-Ning] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Bao, Chun-Yang] Shanghai Jiao Tong Univ, Ren Ji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University	Shi, GH (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Urol, Shanghai 200433, Peoples R China.	guohaishi@126.com; dwyeli@163.com	Zhang, Hailiang/AAF-4937-2020		National Natural Science Foundation of China [NSFC 81202003]; Science Foundation of Shanghai Municipal Commission of Health and Family Planning [2010145]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Shanghai Municipal Commission of Health and Family Planning	This study was supported by grants from National Natural Science Foundation of China (Grant No. NSFC 81202003) (http://www.nsfc.gov.cn/) and Science Foundation of Shanghai Municipal Commission of Health and Family Planning (Grant No. 2010145) (http://www.wsjsw.gov.cn/wsj/) to GHS.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bourguignon LYW, 2012, J BIOL CHEM, V287, P32800, DOI 10.1074/jbc.M111.308528; Cai N, 2013, RNA, V19, P85, DOI 10.1261/rna.035295.112; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Fareh M, 2012, CELL DEATH DIFFER, V19, P232, DOI 10.1038/cdd.2011.89; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; He J., 2012, CHINESE CANC REGISTR; Hu SJ, 2013, STEM CELLS, V31, P259, DOI 10.1002/stem.1278; Huang JX, 2012, ONCOL LETT, V4, P607, DOI 10.3892/ol.2012.814; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Liang ZX, 2013, PHARM RES-DORDR, V30, P1008, DOI 10.1007/s11095-012-0936-9; Lin SL, 2010, CANCER RES, V70, P9473, DOI 10.1158/0008-5472.CAN-10-2746; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Toker A, 2014, ADV BIOL REGUL; Wang LM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-448; Zhu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032170	22	49	50	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124410	10.1371/journal.pone.0124410	http://dx.doi.org/10.1371/journal.pone.0124410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922934	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600082
J	Coumou, J; Wagemakers, A; Trentelman, JJ; Nijhof, AM; Hovius, JW				Coumou, Jeroen; Wagemakers, Alex; Trentelman, Jos J.; Nijhof, Ard M.; Hovius, Joppe W.			Vaccination against Bm86 Homologues in Rabbits Does Not Impair Ixodes ricinus Feeding or Oviposition	PLOS ONE			English	Article							TICK-BORNE DISEASES; BOOPHILUS-MICROPLUS; CATTLE; INFESTATIONS; ANTIGEN; EFFICACY; TRANSMISSION; ANTIBODIES; PROTEINS; BINDING	Human tick-borne diseases that are transmitted by Ixodes ricinus, such as Lyme borreliosis and tick borne encephalitis, are on the rise in Europe. Diminishing I. ricinus populations in nature can reduce tick exposure to humans, and one way to do so is by developing an anti-vector vaccine against tick antigens. Currently, there is only one anti-vector vaccine available against ticks, which is a veterinary vaccine based on the tick antigen Bm86 in the gut of Rhipicephalus microplus. Bm86 vaccine formulations cause a reduction in the number of Rhipicephalus microplus ticks that successfully feed, i.e. lower engorgement weights and a decrease in the number of oviposited eggs. Furthermore, Bm86 vaccines reduce transmission of bovine Babesia spp. Previously two conserved Bm86 homologues in I. ricinus ticks, designated as Ir86-1 and Ir86-2, were described. Here we investigated the effect of a vaccine against recombinant Ir86-1, Ir86-2 or a combination of both on Ixodes ricinus feeding. Recombinant Ixodes ricinus Bm86 homologues were expressed in a Drosophila expression system and rabbits were immunized with rIr86-1, rIr86-2, a combination of both or ovalbumin as a control. Each animal was infested with 50 female adults and 50 male adults Ixodes ricinus and tick mortality, engorgement weights and egg mass were analyzed. Although serum IgG titers against rIr86 proteins were elicited, no effect was found on tick feeding between the rIr86 vaccinated animals and ovalbumin vaccinated animals. We conclude that vaccination against Bm86 homologues in Ixodes ricinus is not an effective approach to control Ixodes ricinus populations, despite the clear effects of Bm86 vaccination against Rhipicephalus microplus.	[Coumou, Jeroen; Wagemakers, Alex; Trentelman, Jos J.; Hovius, Joppe W.] Univ Amsterdam, Acad Med Ctr Amsterdam, Ctr Expt & Mol Med, Amsterdam, Netherlands; [Nijhof, Ard M.] Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany; [Hovius, Joppe W.] Univ Amsterdam, Acad Med Ctr Amsterdam, Amsterdam Multidisciplinary Lyme Borreliosis Ctr, Amsterdam, Netherlands; [Hovius, Joppe W.] Univ Amsterdam, Acad Med Ctr Amsterdam, Dept Infect Dis, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Free University of Berlin; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Coumou, J (corresponding author), Univ Amsterdam, Acad Med Ctr Amsterdam, Ctr Expt & Mol Med, Amsterdam, Netherlands.	j.coumou@amc.uva.nl	Hovius, Joppe/GZL-6894-2022	Hovius, Joppe/0000-0003-0066-2437; Wagemakers, Alex/0000-0001-9632-7830; Nijhof, Ard/0000-0001-7373-2243	VENI from Netherlands Organization for Health Research and Development (ZonMw) [91611065]; European Union [602272]	VENI from Netherlands Organization for Health Research and Development (ZonMw); European Union(European Commission)	Funding: JWH is a recipient of a VENI stipend (91611065) from the Netherlands Organization for Health Research and Development (ZonMw). This work was supported by funding from the European Union's Seventh Programme for research, technological development and demonstration under grant agreement No. 602272 (project ANTIDotE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azhahianambi P, 2009, PARASITE IMMUNOL, V31, P111, DOI 10.1111/j.1365-3024.2008.01082.x; Canales M, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-29; Dai JF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001205; Dai JF, 2009, CELL HOST MICROBE, V6, P482, DOI 10.1016/j.chom.2009.10.006; de la Fuente Jose, 2007, Animal Health Research Reviews, V8, P23, DOI 10.1017/S1466252307001193; de la Fuente J, 2008, FRONT BIOSCI-LANDMRK, V13, P6938, DOI 10.2741/3200; De Vos S, 2001, EXP APPL ACAROL, V25, P245, DOI 10.1023/A:1010609007009; Galai Y, 2012, VACCINE, V30, P7084, DOI 10.1016/j.vaccine.2012.09.051; GOUGH JM, 1993, J PARASITOL, V79, P900, DOI 10.2307/3283728; Hajdusek O, 2010, VACCINE, V28, P2993, DOI 10.1016/j.vaccine.2010.02.008; Hofhuis A, 2010, INFECTIEZIEKTEN B, V3, P84; Labuda M, 2006, PLOS PATHOG, V2, P251, DOI 10.1371/journal.ppat.0020027; Lindgren E, 2012, SCIENCE, V336, P418, DOI 10.1126/science.1215735; Narasimhan S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000451; Nijhof AM, 2010, INT J PARASITOL, V40, P1587, DOI 10.1016/j.ijpara.2010.06.003; Odongo D, 2007, VACCINE, V25, P1287, DOI 10.1016/j.vaccine.2006.09.085; Pages F, 2014, VECTOR-BORNE ZOONOT, V14, P85, DOI 10.1089/vbz.2013.1410; Rodriguez-Valle M, 2012, VACCINE, V30, P3453, DOI 10.1016/j.vaccine.2012.03.020; Schuijt TJ, 2011, TRENDS PARASITOL, V27, P40, DOI 10.1016/j.pt.2010.06.006; Schuijt TJ, 2011, CELL HOST MICROBE, V10, P136, DOI 10.1016/j.chom.2011.06.010; Schuijt TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015926; Sprong H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-77; Trager W, 1939, J PARASITOL, V7, P15; WILLADSEN P, 1989, J IMMUNOL, V143, P1346	24	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123495	10.1371/journal.pone.0123495	http://dx.doi.org/10.1371/journal.pone.0123495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919587	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659400028
J	Rutanga, C; Lowrance, DW; Oeltmann, JE; Mutembayire, G; Willis, M; Uwizeye, CB; Hinda, R; Bassirou, C; Gutreuter, S; Gasana, M				Rutanga, Claude; Lowrance, David W.; Oeltmann, John E.; Mutembayire, Grace; Willis, Matt; Uwizeye, Claude Bernard; Hinda, Ruton; Bassirou, Chitou; Gutreuter, Steve; Gasana, Michel			Latent Tuberculosis Infection and Associated Factors among Health Care Workers in Kigali, Rwanda	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MULTIDRUG-RESISTANT; RISK-FACTORS; 2 HOSPITALS; PREVALENCE; OUTBREAK; DISEASE; STAFF	Introduction Data are limited regarding tuberculosis (TB) and latent TB infection prevalence in Rwandan health facilities. Methods We conducted a cross-sectional survey among healthcare workers (HCWs) in Kigali during 2010. We purposively selected the public referral hospital, both district hospitals, and randomly selected 7 of 17 health centers. School workers (SWs) from the nearest willing public schools served as a local reference group. We tested for latent TB infection (LTBI) using tuberculin skin testing (TST) and asked about past TB disease. We assessed risk of LTBI and past history of TB disease associated with hospital employment. Among HCWs, we assessed risk associated with facility type (district hospital, referral hospital, health center), work setting (inpatient, outpatient), and occupation. Results Age, gender, and HIV status was similar between the enrolled 1,131 HCWs and 381 SWs. LTBI was more prevalent among HCWs (62%) than SWs (39%). Adjusted odds of a positive TST result were 2.71 (95% CI 2.01-3.67) times greater among HCWs than SWs. Among HCWs, there was no detectable difference between prevalence of LTBI according to facility type, work setting, or occupation. Conclusion HCWs are at greater risk of LTBI, regardless of facility type, work setting, or occupation. The current status of TB infection control practices should be evaluated in the entire workforce in all Rwandan healthcare facilities.	[Rutanga, Claude; Mutembayire, Grace; Gasana, Michel] Rwanda Biomed Ctr, Div TB & Other Resp Communicable Dis, Kigali, Rwanda; [Lowrance, David W.; Uwizeye, Claude Bernard; Bassirou, Chitou] Ctr Dis Control & Prevent, Div Global HIV AIDS, Kigali, Rwanda; [Oeltmann, John E.; Willis, Matt] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Hinda, Ruton] Rwanda Biomed Ctr, Sexually Transmitted Infect, Div HIV AIDS, Kigali, Rwanda; [Hinda, Ruton] Rwanda Biomed Ctr, Other Blood Borne Dis, Kigali, Rwanda; [Gutreuter, Steve] Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA USA	Rwanda Biomedical Center; Centers for Disease Control & Prevention - USA; Rwanda Biomedical Center; Rwanda Biomedical Center; Centers for Disease Control & Prevention - USA	Rutanga, C (corresponding author), Rwanda Biomed Ctr, Div TB & Other Resp Communicable Dis, Kigali, Rwanda.	rutanga75@yahoo.fr	Gutreuter, Steve/ABC-7980-2020	Gutreuter, Steve/0000-0002-0733-2900; UWIZEYE, CLAUDE BERNARD/0000-0002-3858-6567	US Centres for Disease Control and Prevention [5U2GPS000643-03]	US Centres for Disease Control and Prevention	Implementaion of this study was supported with funding from the US Centres for Disease Control and Prevention under the cooperative agreement between the Department of Health and Human Services/National Centre for HIV, Viral hepatitis, STDs and TB prevention, and the Rwanda Treatment/Research on AIDS Centre, on the grant number: 5U2GPS000643-03. The Centres for Disease Control and Prevention played a role in the study design, data analysis which was performed anonymously, decision to publish and preparation of the manuscript.	Alonso-Echanove J, 2001, CLIN INFECT DIS, V33, P589, DOI 10.1086/321892; American Thoracic Society Centers for Disease Control and Prevention, 2000, 49RR6 CTR DIS CONTR; [Anonymous], 2010, RWAND DEM HLTH SURV; [Anonymous], 2009, TB HIV FACTS 2009; Arnadottir T, 1996, TUBERCLE LUNG DIS, V77, P1, DOI 10.1016/S0962-8479(96)90127-6; Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Bock NN, 2007, J INFECT DIS, V196, pS108, DOI 10.1086/518661; Cain KR, 2007, INT J TUBERC LUNG D, V11, P1008; CDC, TUB SKIN TEST; Do AN, 1999, INT J TUBERC LUNG D, V3, P377; Drobniewski F, 2007, PLOS MED, V4, P273, DOI 10.1371/journal.pmed.0040055; Galgalo T, 2008, INT J TUBERC LUNG D, V12, P949; Garcia-Garcia MD, 2001, INFECT CONT HOSP EP, V22, P88, DOI 10.1086/501869; Granich R, 2010, CLIN INFECT DIS, V50, pS215, DOI 10.1086/651494; He GX, 2012, INT J TUBERC LUNG D, V16, P1485, DOI 10.5588/ijtld.12.0193; He GX, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-313; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kassim S, 2000, INT J TUBERC LUNG D, V4, P321; Kayanja HK, 2005, INT J TUBERC LUNG D, V9, P686; Kenyon TA, 1997, ANN INTERN MED, V127, P32, DOI 10.7326/0003-4819-127-1-199707010-00006; Keskiner R, 2004, INFECT CONT HOSP EP, V25, P1067, DOI 10.1086/502345; Lien Luu Thi, 2009, PLoS One, V4, pe6798, DOI 10.1371/journal.pone.0006798; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Moro ML, 1998, AIDS, V12, P1095, DOI 10.1097/00002030-199809000-00017; Moss AR, 1997, INT J TUBERC LUNG D, V1, P115; Naidoo S, 2006, INT J TUBERC LUNG D, V10, P676; O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008; Powell K, 2011, INT J TUBERC LUNG D, V15, P1643, DOI 10.5588/ijtld.11.0207; Rafiza S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-19; Sherman HA, 2011, INT J TUBERC LUNG D, V15, P1050, DOI 10.5588/ijtld.10.0344; Wahome E, 2013, PUBLIC HEALTH ACTION, V3, P323, DOI 10.5588/pha.13.0054; *WHO, 2009, GLOB TUB CONTR SHORT; World Health Organization, 2014, TUB COUNTR PROF RWAN	34	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124485	10.1371/journal.pone.0124485	http://dx.doi.org/10.1371/journal.pone.0124485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919759	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400052
J	Tabak, RG; Hipp, JA; Marx, CM; Brownson, RC				Tabak, Rachel G.; Hipp, J. Aaron; Marx, Christine M.; Brownson, Ross C.			Workplace Social and Organizational Environments and Healthy-Weight Behaviors	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; WORKSITE HEALTH; OBESITY; OVERWEIGHT; CLIMATE; IPAQ; ASSOCIATION; PERCEPTIONS; RELIABILITY; MORTALITY	Background The workplace is an important setting for health promotion including nutrition and physical activity behaviors to prevent obesity. This paper explores the relationship between workplace social environment and cultural factors and diet and physical activity (PA) behaviors and obesity among employees. Methods Between 2012 and 2013, telephone interviews were conducted with participants residing in four Missouri metropolitan areas. Questions included demographic characteristics, workplace socio/organizational factors related to activity and diet, and individual diet and PA behaviors, and obesity. Multivariate logistic regression was used to examine associations between the workplace socio/organizational environment and nutrition, PA, and obesity. Results There were differences in reported health behaviors and socio/organizational environment by gender, race, age, income, and worksite size. For example, agreement with the statement the 'company values my health' was highest among Whites, older employees, and higher income workers. As worksite size increased, the frequency of reporting seeing co-workers doing several types of healthy behaviors (eat fruits and vegetables, doing PA, and doing PA on breaks at work) increased. In adjusted analyses, employees agreeing the company values my health were more likely to engage in higher PA levels (aOR=1.54, 95% CI: 1.09-2.16) and less likely to be obese (aOR=0.73, 95% CI: 0.54-0.98). Seeing co-workers eating fruits and vegetables was associated with increased reporting of eating at least one vegetable per day (aOR=1.43, 95% CI: 1.06-1.91) and seeing co-workers being active was associated with higher PA levels (aOR 1.56, 95% CI: 1.19-2.05). Conclusions This research suggests that social/organizational characteristics of the workplace environment, particularly feeling the company values the workers' health and to seeing co-workers engaging in healthy behaviors, may be related to nutrition and PA behaviors and obesity. These findings point to the potential for intervention targets including environment and policy changes.	[Tabak, Rachel G.; Hipp, J. Aaron; Brownson, Ross C.] Washington Univ, Brown Sch, Prevent Res Ctr St Louis, St Louis, MO 63130 USA; [Marx, Christine M.; Brownson, Ross C.] Washington Univ, Sch Med, Div Publ Hlth Sci, St Louis, MO USA; [Brownson, Ross C.] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Tabak, RG (corresponding author), Washington Univ, Brown Sch, Prevent Res Ctr St Louis, St Louis, MO 63130 USA.	rtabak@wustl.edu	Hipp, J. Aaron/AAF-9869-2021	Hipp, J. Aaron/0000-0002-2394-7112	Transdisciplinary Research on Energetics and Cancer (TREC) Center at Washington University in St. Louis; National Cancer Institute at National Institutes of Health (NIH) [U54 CA155496]; Washington University; Siteman Cancer Center; Centers for Disease Control and Prevention [U48/DP001903]; NIH/NIDDK Washington University Center for Diabetes Translation Research (WU-CDTR) [P30DK092950]; NATIONAL CANCER INSTITUTE [U54CA155496] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP001903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092950] Funding Source: NIH RePORTER	Transdisciplinary Research on Energetics and Cancer (TREC) Center at Washington University in St. Louis; National Cancer Institute at National Institutes of Health (NIH); Washington University; Siteman Cancer Center; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIH/NIDDK Washington University Center for Diabetes Translation Research (WU-CDTR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Transdisciplinary Research on Energetics and Cancer (TREC) Center at Washington University in St. Louis. The TREC Center is funded by the National Cancer Institute at National Institutes of Health (NIH) (U54 CA155496), (http://www.nih.gov/), Washington University and the Siteman Cancer Center (http:// www.siteman.wustl.edu/) (RGT, JAH, CMM, RCB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This article is a product of a Prevention Research Center and was also supported by Cooperative Agreement Number U48/DP001903 from the Centers for Disease Control and Prevention (http://www.cdc.gov/) (RGT, AJH, RCB). This publication was also supported by NIH/NIDDK P30DK092950 Washington University Center for Diabetes Translation Research (WU-CDTR) (http://cdtr.wustl.edu/) (RGT and RCB). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the WU-CDTR, National Institute of Diabetes and Digestive Kidney Diseases or NIH. The authors thank the Health and Behavioral Risk Research Center (HBRRC) at the University of Missouri-Columbia School of Medicine for their assistance in implementing the sampling frame and for data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlakha D, 2015, AM J PREV MED, V48, P104, DOI 10.1016/j.amepre.2014.08.023; [Anonymous], 2011, WIRELESS SUBSTITUTIO; [Anonymous], PHYS ACT GUID ADV CO; Basen-Engquist K, 1998, PREV MED, V27, P111, DOI 10.1006/pmed.1997.0253; Blanck H. M., 2007, Morbidity and Mortality Weekly Report, V56, P213; BRAY GA, 1987, ANN NY ACAD SCI, V499, P14, DOI 10.1111/j.1749-6632.1987.tb36194.x; California Department of Public Health, 2012, CHECK FOR HLTH; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Centers for Disease Control and Prevention (CDC), 2011, BEH RISK FACT SURV S; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Ervin R.B., 2013, NCHS DATA BRIEF, V122, P1, DOI DOI 10.1089/152460902753668448; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Frank LD, 2010, BRIT J SPORT MED, V44, P924, DOI 10.1136/bjsm.2009.058701; Fryer Cheryl D, 2013, NCHS Data Brief, P1; Fugas CS, 2011, J OCCUP HEALTH PSYCH, V16, P67, DOI 10.1037/a0021731; Grimm KA, 2012, J ACAD NUTR DIET, V112, P2014, DOI 10.1016/j.jand.2012.08.030; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Harris CD, 2013, MMWR-MORBID MORTAL W, V62, P326; Harris JR, 2014, ANNU REV PUBLIC HEAL; Heinen L, 2009, MILBANK Q, V87, P101, DOI 10.1111/j.1468-0009.2009.00549.x; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hiza HAB, 2013, J ACAD NUTR DIET, V113, P297, DOI 10.1016/j.jand.2012.08.011; Hoehner CM, 2013, J PUBLIC HEALTH MAN, V19, pS105, DOI 10.1097/PHH.0b013e3182849f21; Institute of Medicine, 2003, FUT PUBL HLTH 21 CEN, P60; Kimmons Joel, 2009, Medscape J Med, V11, P26; Kruger J., 2007, Morbidity and Mortality Weekly Report, V56, P301; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Lemon SC, 2009, AM J HEALTH BEHAV, V33, P299; Lewis M.A., 2002, HLTH BEHAV HLTH ED T, Vthird, P240; Linnan L, 2007, AM J HEALTH PROMOT, V21, P521, DOI 10.4278/0890-1171-21.6.521; Lucove JC, 2007, AM J HEALTH PROMOT, V21, P196, DOI 10.4278/0890-1171-21.3.196; McNeill LH, 2006, SOC SCI MED, V63, P1011, DOI 10.1016/j.socscimed.2006.03.012; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Quintiliani L., 2008, WORKPLACE SETTING IN; RIBISL KM, 1993, J OCCUP ENVIRON MED, V35, P812, DOI 10.1097/00043764-199308000-00019; Rzewnicki R, 2003, PUBLIC HEALTH NUTR, V6, P299, DOI 10.1079/PHN2002427; Sallis JF, 2008, HLTH BEHAV HLTH ED, P465, DOI DOI 10.7326/0003-4819-116-4-350_; Schmitz MKH, 2000, MED CLIN N AM, V84, P491, DOI 10.1016/S0025-7125(05)70233-9; Sliter KA, 2013, J OCCUP HEALTH PSYCH, V18, P350, DOI 10.1037/a0033132; Smith-McLallen Aaron, 2008, Psychol Health Med, V13, P389, DOI 10.1080/13548500701842933; Sorensen G, 2004, PREV MED, V39, pS94, DOI 10.1016/j.ypmed.2003.12.020; Stokols D, 2003, AM J HEALTH PROMOT, V18, P4, DOI 10.4278/0890-1171-18.1.4; TREC Coordination Center-Fred Hutchinson Cancer Research Center, 2015, TRANSD RES EN CANC; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wilson MG, 2004, J OCCUP ORGAN PSYCH, V77, P565, DOI 10.1348/0963179042596522; Yang L, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140286; Yun D, 2011, HEALTH COMMUN, V26, P275, DOI 10.1080/10410236.2010.549814	49	24	24	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125424	10.1371/journal.pone.0125424	http://dx.doi.org/10.1371/journal.pone.0125424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SE	25919659	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659400084
J	Talib, WH; Saleh, S				Talib, Wamidh H.; Saleh, Suhair			Propionibacterium acnes Augments Antitumor, Anti-Angiogenesis and Immunomodulatory Effects of Melatonin on Breast Cancer Implanted in Mice	PLOS ONE			English	Article							TUMOR-SPECIFIC IMMUNITY; CORYNEBACTERIUM-PARVUM; T-CELLS; IN-VIVO; BACTERIOLYTIC THERAPY; RECEPTOR EXPRESSION; COMBINATION; CHEMOTHERAPY; MECHANISMS; PROLIFERATION	Breast cancer is one of the most invasive cancers with high mortality. The immune stimulating Propionibacterium acnes is a Gram positive bacterium that has the ability to cause inflammation and activate Th1-type cytokine immune response. Antitumor response was associated with the inflammation induced by P. acnes, but the antitumor effect of this bacterium was not evaluated in combination with other agents. The aim of this study was to test the antitumor potential of a combination of melatonin and P. acnes against breast cancer implanted in mice. Balb/C mice were transplanted with EMT6/P cell line and in vivo antitumor effect was assessed for P. acnes, melatonin, and a combination of melatonin and P. acnes. Tumor and organs sections were examined using hematoxylin/eosin staining protocol, and TUNEL colorimetric assay was used to detect apoptosis. The expression of vascular endothelial growth factor (VEGF) was measured in tumor sections and serum levels of INF-gamma, and IL-4 were measured to evaluate the immune system function. To evaluate the toxicity of our combination, AST and ALT levels were measured in the serum of treated mice. The combination of melatonin and P. acnes has high efficiency in targeting breast cancer in mice. Forty percent of treated mice were completely cured using this combination and the combination inhibited metastasis of cancer cells to other organs. The combination therapy reduced angiogenesis, exhibited no toxicity, induced apoptosis, and stimulates strong Th1-type cytokine antitumor immune response. The combination of melatonin and P. acnes represents a promising option to treat breast cancer. However, carful preclinical and clinical evaluation is needed before considering this combination for human therapy.	[Talib, Wamidh H.] Appl Sci Univ, Dept Clin Pharm & Therapeut, Amman, Jordan; [Saleh, Suhair] Appl Sci Univ, Dept Pharmaceut Sci & Pharmaceut, Amman, Jordan	Applied Science University - Jordan; Applied Science University - Jordan	Talib, WH (corresponding author), Appl Sci Univ, Dept Clin Pharm & Therapeut, Amman, Jordan.	w_talib@asu.edu.jo	Talib, Wamidh H./H-9831-2017	Talib, Wamidh H./0000-0003-1942-8982	Applied Science University [DRGS-2012-2013-14]	Applied Science University	The full financial support granted to this research project (Grant NO. DRGS-2012-2013-14) was provided by Applied Science University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2004, P NATL ACAD SCI USA, V101, P15172, DOI 10.1073/pnas.0406242101; Al-Ghamdi MS, 2003, AM J CHINESE MED, V31, P721, DOI 10.1142/S0192415X03001399; Alvarez-Garcia V, 2013, MICROVASC RES, V87, P25, DOI 10.1016/j.mvr.2013.02.008; Apte SH, 2010, J IMMUNOL, V185, P998, DOI 10.4049/jimmunol.0903372; Bennett IC, 2000, BREAST, V9, P247, DOI 10.1054/brst.2000.0208; CONLEY FK, 1990, J NATL CANCER I, V82, P1340, DOI 10.1093/jnci/82.16.1340; Dang LH, 2001, P NATL ACAD SCI USA, V98, P15155, DOI 10.1073/pnas.251543698; Di Bella G, 2013, INT J MOL SCI, V14, P2410, DOI 10.3390/ijms14022410; Diener-West M, 2004, J CLIN ONCOL, V22, P2438, DOI 10.1200/jco.2004.08.194; Drott JB, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-126; DYE ES, 1981, J EXP MED, V154, P609, DOI 10.1084/jem.154.3.609; El All HSA, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-4; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FISHER B, 1990, CANCER-AM CANCER SOC, V66, P220, DOI 10.1002/1097-0142(19900715)66:2<220::AID-CNCR2820660205>3.0.CO;2-6; GarciaMaurino S, 1997, J IMMUNOL, V159, P574; Giannoulia-Karantana A, 2006, NEUROIMMUNOMODULAT, V13, P133, DOI 10.1159/000097258; Jardim-Perassi BV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085311; Kitagawa H, 2011, EXP DERMATOL, V20, P157, DOI 10.1111/j.1600-0625.2010.01180.x; Kumaraguruparan R, 2007, MOL CARCINOGEN, V46, P797, DOI 10.1002/mc.20309; Kurokawa I, 2009, EXP DERMATOL, V18, P821, DOI 10.1111/j.1600-0625.2009.00890.x; Lee CH, 2008, CLIN CANCER RES, V14, P1905, DOI 10.1158/1078-0432.CCR-07-2050; LICHTENSTEIN AK, 1984, CANCER RES, V44, P5118; Lomholt HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012277; Miller SC, 2006, INT J EXP PATHOL, V87, P81, DOI 10.1111/j.0959-9673.2006.00474.x; MILLS CD, 1981, J EXP MED, V154, P621, DOI 10.1084/jem.154.3.621; MITCHESON HD, 1980, BRIT J CANCER, V41, P407, DOI 10.1038/bjc.1980.64; MOORE K, 1983, BRIT J CANCER, V47, P797, DOI 10.1038/bjc.1983.133; Morioka H, 2003, CLIN CANCER RES, V9, P1211; NISSENMEYER R, 1989, ACTA ONCOL, V28, P903, DOI 10.3109/02841868909092329; OJO E, 1979, CELL IMMUNOL, V45, P182, DOI 10.1016/0008-8749(79)90374-5; OLIVOTTO M, 1974, INT J CANCER, V13, P478, DOI 10.1002/ijc.2910130406; Olsson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051434; Olsson J, 2012, APMIS, V120, P778, DOI 10.1111/j.1600-0463.2012.02905.x; Sahin K, 2011, NUTR CANCER, V63, P1279, DOI 10.1080/01635581.2011.606955; Seaton A, 2008, CARCINOGENESIS, V29, P1148, DOI 10.1093/carcin/bgn109; Souter RG, 1982, BRIT J CANCER, V44, P496; Steiner H, 2003, AM J PATHOL, V162, P655, DOI 10.1016/S0002-9440(10)63859-X; Talib Wamidh H, 2013, Sci Pharm, V81, P519, DOI 10.3797/scipharm.1211-15; Talib WH, 2012, J CANCER RES THER, V8, P417, DOI 10.4103/0973-1482.103523; Tchaptchet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039155; Tsuda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029020; TUTTLE RL, 1976, J RETICULOENDOTH SOC, V20, P209; Vermeulen PB, 2001, J PATHOL, V195, P336, DOI 10.1002/path.966; Walker RA, 1997, CANCER METAST REV, V16, P5, DOI 10.1023/A:1005740222307; Wang JS, 2013, J PINEAL RES, V54, P406, DOI 10.1111/jpi.12035; Xiao Y, 1990, Hua Xi Yi Ke Da Xue Xue Bao, V21, P318; Yamamoto M, 2009, ONCOL REP, V22, P337, DOI 10.3892/or_00000442	47	36	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124384	10.1371/journal.pone.0124384	http://dx.doi.org/10.1371/journal.pone.0124384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919398	gold, Green Submitted, Green Published			2022-12-27	WOS:000353659400048
J	Zhang, Y; Yang, HQ; Fang, F; Song, LL; Jiao, YY; Wang, H; Peng, XL; Zheng, YP; Wang, J; He, JS; Hung, T				Zhang, Ying; Yang, Hai-Qiang; Fang, Fang; Song, Lin-Lin; Jiao, Yue-Ying; Wang, He; Peng, Xiang-Lei; Zheng, Yan-Peng; Wang, Jun; He, Jin-Sheng; Hung, Tao			Single Chain Variable Fragment Against A beta Expressed in Baculovirus Inhibits Abeta Fibril Elongation and Promotes its Disaggregation	PLOS ONE			English	Article							MOUSE MODELS; FV; IMMUNOTHERAPY; IMMUNIZATION; OLIGOMERS; DISEASE	Alzheimer's disease (AD) is the most common form of age-related dementia, and the most urgent problem is that it is currently incurable. Amyloid-beta (A beta) peptide is believed to play a major role in the pathogenesis of AD. We previously reported that an A beta N-terminal amino acid targeting monoclonal antibody (MAb), A8, inhibits A beta fibril formation and has potential as an immunotherapy for AD based on a mouse model. To further study the underlying mechanisms, we tested our hypothesis that the single chain fragment variable (scFv) without the Fc fragment is capable of regulating either A beta aggregation or disaggregation in vitro. Here, a model of cell-free A beta "on-pathway" aggregation was established and identified using PCR, Western blot, ELISA, transmission electron microscopy (TEM) and thioflavin T (ThT) binding analyses. His-tagged A8 scFvs was cloned and solubly expressed in baculovirus. Our data demonstrated that the Ni-NTA agarose affinity-purified A8 scFv inhibited the forward reaction of "on-pathway" aggregation and A beta fibril maturation. The effect of A8 scFv on A beta fibrillogenesis was markedly more significant when administered at the start of the A beta folding reaction. Furthermore, the results also showed that pre-formed A beta fibrils could be disaggregated via incubation with purified A8 scFv, which suggested that A8 scFv is involved in the reverse reaction of A beta aggregation. Therefore, A8 scFv was capable of both inhibiting fibrillogenesis and disaggregating matured fibrils. Our present study provides valuable insight into the regulators of ultrastructural dynamics of cell-free "on-pathway" A beta aggregation and will assist in the development of therapeutic strategies for AD.	[Zhang, Ying; Yang, Hai-Qiang; Fang, Fang; Song, Lin-Lin; Jiao, Yue-Ying; Wang, He; Peng, Xiang-Lei; Zheng, Yan-Peng; Wang, Jun; He, Jin-Sheng; Hung, Tao] Beijing Jiaotong Univ, Coll Life Sci & Bioengn, Beijing, Peoples R China; [Hung, Tao] China CDC, Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Beijing Jiaotong University; Chinese Center for Disease Control & Prevention	Zhang, Y (corresponding author), Beijing Jiaotong Univ, Coll Life Sci & Bioengn, Beijing, Peoples R China.	yingzhang@bjtu.edu.cn	HE, Jin-Sheng/G-4585-2011; yang, zheng/HGC-7753-2022	HE, Jin-Sheng/0000-0002-6592-0540; 	National Natural Science Foundation of China [81100809, 81271417]; Beijing Natural Science Foundation [7152090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn) (81100809 and 81271417) and the Beijing Natural Science Foundation (http://www.bjnsf.org/) (7152090) to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDZYK WD, 1990, J BIOL CHEM, V265, P18615; Blennow K, 2014, NEUROPSYCHOPHARMACOL, V39, P189, DOI 10.1038/npp.2013.154; Cattepoel S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018296; CHAUDHARY VK, 1989, NATURE, V339, P394, DOI 10.1038/339394a0; Donofrio G, 2005, J VIROL, V79, P8330, DOI 10.1128/JVI.79.13.8330-8338.2005; Drachman DA, 2014, ALZHEIMERS DEMENT; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hurtado DE, 2012, J NEUROSCI, V32, P7392, DOI 10.1523/JNEUROSCI.0889-12.2012; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Joseph-Mathurin N, 2013, NEUROBIOL AGING, V34, P2613, DOI 10.1016/j.neurobiolaging.2013.05.013; Lashuel HA, 2002, J BIOL CHEM, V277, P42881, DOI 10.1074/jbc.M206593200; Laske C, 2014, NEW ENGL J MED, V370, P1459, DOI 10.1056/NEJMc1402193; Morgan D, 2011, J INTERN MED, V269, P54, DOI 10.1111/j.1365-2796.2010.02315.x; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Roychaudhuri R, 2013, J MOL BIOL; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tang TC, 2014, STRUCTURE, V22, P387, DOI 10.1016/j.str.2013.12.012; Upadhaya AR, 2012, NEUROBIOL AGING, V33, P2641, DOI 10.1016/j.neurobiolaging.2011.12.032; Wang X, 2010, LETTERS BIOTECHNOLOG, V21, P192; Wang YJ, 2014, NAT REV NEUROL, V10, P188, DOI 10.1038/nrneurol.2014.44; Weatherill EE, 2012, PROTEIN ENG DES SEL, V25, P321, DOI 10.1093/protein/gzs021; WHITLOW M, 1994, PROTEIN ENG, V7, P1017, DOI 10.1093/protein/7.8.1017; Wilcock DM, 2011, ASN NEURO, V3, DOI 10.1042/AN20110018; Younan ND, 2013, FASEB J, V27, P1847, DOI 10.1096/fj.12-222588; Zhang Y, 2011, J ALZHEIMERS DIS, V23, P551, DOI 10.3233/JAD-2010-091195; Zhang Y, 2009, HYBRIDOMA, V28, P349, DOI 10.1089/hyb.2009.0015	30	4	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124736	10.1371/journal.pone.0124736	http://dx.doi.org/10.1371/journal.pone.0124736			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919299	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659400059
J	Guzman-Puyol, S; Benitez, JJ; Dominguez, E; Bayer, IS; Cingolani, R; Athanassiou, A; Heredia, A; Heredia-Guerrero, JA				Guzman-Puyol, Susana; Jesus Benitez, Jose; Dominguez, Eva; Bayer, Ilker Sefik; Cingolani, Roberto; Athanassiou, Athanassia; Heredia, Antonio; Heredia-Guerrero, Jose Alejandro			Pectin-Lipid Self-Assembly: Influence on the Formation of Polyhydroxy Fatty Acids Nanoparticles	PLOS ONE			English	Article							PYROLYTIC-GRAPHITE SURFACE; FRUIT CUTICLE; PLANT BIOPOLYESTER; VESICLES; CHAINS	Nanoparticles, named cutinsomes, have been prepared from aleuritic (9,10,16-trihidroxipalmitic) acid and tomato fruit cutin monomers (a mixture of mainly 9(10), 16-dihydroxypalmitic acid (85%, w/w) and 16-hydroxyhexadecanoic acid (7.5%, w/w)) with pectin in aqueous solution. The process of formation of the nanoparticles of aleuritic acid plus pectin has been monitored by UV-Vis spectrophotometry, while their chemical and morphological characterization was analyzed by ATR-FTIR, TEM, and non-contact AFM. The structure of these nanoparticles can be described as a lipid core with a pectin shell. Pectin facilitated the formation of nanoparticles, by inducing their aggregation in branched chains and favoring the condensation between lipid monomers. Also, pectin determined the self-assembly of cutinsomes on highly ordered pyrolytic graphite (HOPG) surfaces, causing their opening and forming interconnected structures. In the case of cutin monomers, the nanoparticles are fused, and the condensation of the hydroxy fatty acids is strongly affected by the presence of the polysaccharide. The interaction of pectin with polyhydroxylated fatty acids could be related to an initial step in the formation of the plant biopolyester cutin.	[Guzman-Puyol, Susana; Bayer, Ilker Sefik; Athanassiou, Athanassia; Heredia-Guerrero, Jose Alejandro] Fdn Ist Italiano Tecnol IIT, Nanophys, Smart Mat, I-16163 Genoa, Italy; [Jesus Benitez, Jose] Ctr Mixto CSIC Univ Sevilla, ICMS, E-41092 Seville, Spain; [Dominguez, Eva] Univ Malaga CSIC, IHSM Mayora, E-29750 Malaga, Spain; [Cingolani, Roberto] Fdn Ist Italiano Tecnol IIT, I-16163 Genoa, Italy; [Heredia, Antonio] Univ Malaga, UMA CSIC, IHSM La Mayora, Dept Biol Mol & Bioquim, E-29071 Malaga, Spain	Istituto Italiano di Tecnologia - IIT; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Ciencia de Materiales de Sevilla (ICMS-CSIC); University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Istituto Italiano di Tecnologia - IIT; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM)	Heredia-Guerrero, JA (corresponding author), Fdn Ist Italiano Tecnol IIT, Nanophys, Smart Mat, Via Morego 30, I-16163 Genoa, Italy.	jose.guerrero@iit.it	Domínguez, Eva/D-6137-2014; Guzman-Puyol, Susana/W-4155-2017; Heredia-Guerrero, José Alejandro/H-8822-2012; ATHANASSIOU, ATHANASSIA/B-4197-2018; Heredia, Antonio/AAR-2209-2021; Heredia, Antonio/H-4366-2015; Benitez, Jose J/K-5662-2014; Puyol, Susana Guzman/AAG-8919-2019	Domínguez, Eva/0000-0003-4129-9849; Guzman-Puyol, Susana/0000-0001-5658-5181; Heredia-Guerrero, José Alejandro/0000-0002-8251-7577; ATHANASSIOU, ATHANASSIA/0000-0002-6533-3231; Heredia, Antonio/0000-0001-9051-6876; Benitez, Jose J/0000-0002-3222-0564; Puyol, Susana Guzman/0000-0001-5658-5181; Bayer, Ilker S./0000-0002-7951-8851	Marie Curie Intra-European Fellowship (BIOPROTO project); EU	Marie Curie Intra-European Fellowship (BIOPROTO project); EU(European Commission)	Jose A. Heredia-Guerrero is supported by a Marie Curie Intra-European Fellowship (BIOPROTO project), financed by the EU's Seventh Framework Programme for Research (FP7).	Apel CL, 2002, BBA-BIOMEMBRANES, V1559, P1, DOI 10.1016/S0005-2736(01)00400-X; Beniitez JJ, 2004, BBA-GEN SUBJECTS, V1674, P1, DOI 10.1016/j.bbagen.2004.06.012; Benitez JJ, 2014, J APPL POLY IN PRESS, DOI 10.1002./APP.41328; D'Angeli S, 2013, NEW PHYTOL, V197, P123, DOI 10.1111/j.1469-8137.2012.04372.x; Dominguez E, 2010, MOL BIOSYST, V6, P948, DOI 10.1039/b927186d; Frey-Wyssling A, 1965, ULTRASTRUCTURAL PLAN; Heredia A, 2003, BBA-GEN SUBJECTS, V1620, P1, DOI 10.1016/S0304-4165(02)00510-X; Heredia A, 2009, BIOINTERPHASES, V4, pP1, DOI 10.1116/1.3063816; Heredia-Guerrero JA, 2011, SOFT MATTER, V7, P4357, DOI 10.1039/c0sm01545h; Heredia-Guerrero JA, 2008, BIOESSAYS, V30, P273, DOI 10.1002/bies.20716; Heredia-Guerrero JA, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00305; Heredia-Guerrero JA, 2010, CHEM PHYS LIPIDS, V163, P329, DOI 10.1016/j.chemphyslip.2010.01.006; Heredia-Guerrero JA, 2009, POLYMER, V50, P5633, DOI 10.1016/j.polymer.2009.10.018; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Kwiatkowska M, 2014, PROTOPLASMA, V251, P1151, DOI 10.1007/s00709-014-0623-2; Lara I, 2014, POSTHARVEST BIOL TEC, V87, P103, DOI 10.1016/j.postharvbio.2013.08.012; LUQUE P, 1995, ARCH BIOCHEM BIOPHYS, V317, P417, DOI 10.1006/abbi.1995.1183; Martin LBB, 2014, J EXP BOT, V65, P4639, DOI 10.1093/jxb/eru301; Parsons EP, 2013, PHYSIOL PLANTARUM, V149, P160, DOI 10.1111/ppl.12035; PETRACEK PD, 1995, PLANT PHYSIOL, V109, P675, DOI 10.1104/pp.109.2.675; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Riederer M., 2006, BIOL PLANT CUTICLE; Tsubaki S, 2008, J AGR FOOD CHEM, V56, P11293, DOI 10.1021/jf802253s; Vilela C, 2014, POLYM CHEM-UK, V5, P3119, DOI 10.1039/c3py01213a; Yeats TH, 2013, PLANT PHYSIOL, V163, P5, DOI 10.1104/pp.113.222737; Yeats TH, 2012, NAT CHEM BIOL, V8, P609, DOI [10.1038/NCHEMBIO.960, 10.1038/nchembio.960]; Yokota S, 2007, CARBOHYD RES, V342, P2593, DOI 10.1016/j.carres.2007.08.018; Yokota S, 2007, BIOMACROMOLECULES, V8, P3848, DOI 10.1021/bm700819f	28	16	16	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124639	10.1371/journal.pone.0124639	http://dx.doi.org/10.1371/journal.pone.0124639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915490	Green Published, gold			2022-12-27	WOS:000353659100058
J	Kim, H; Bakshi, A; Kim, J				Kim, Hana; Bakshi, Arundhati; Kim, Joomyeong			Retrotransposon-Derived Promoter of Mammalian Aebp2	PLOS ONE			English	Article							DNA METHYLATION; CYTOSINE METHYLATION; EVOLUTION; POLYCOMB; PRIMATES; GENES	Variable DNA methylation in promoter regions has been implicated in altering transcriptional regulation. The current study analyzed the evolutionary origin and DNA methylation pattern of one of the promoters of Aebp2. According to the results, the first promoter of Aebp2 has been derived from retrotransposons independently in the primate and rodent lineages. DNA methylation analyses revealed that this promoter is unmethylated in sperm, methylated in mature oocytes, and partially methylated at embryonic day 10.5 (78.3%) and 14.5 (58.3%). This promoter also shows variable levels of DNA methylation among adult organs, ranging from the highest in spleen (similar to 80%) to the lowest in tail (similar to 50%). The results from the F1 hybrid of interspecific crossing further indicated that both alleles are equally methylated without any allele bias, also supported by its biallelic expression. Therefore, the partial methylation observed among somatic tissues is an outcome of the genome-wide resetting of DNA methylation during the implantation stage, but not of the inherited allelic methylation pattern preset during gametogenesis. Taken together, mammalian Aebp2 has adopted retrotransposons as its promoter, which displays partial DNA methylation pattern of allelic-or nonallelic origin during the different stages of development.	[Kim, Hana; Bakshi, Arundhati; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Bakshi, Arundhati/0000-0001-8483-1597	National Institute of Health [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES019118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066225, R01GM097074] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institute of Health (J.K. R01-GM066225 and R01-GM097074). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Bunch PO, 1991, BIOL REPROD, V44, P672; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; CATZEFLIS FM, 1993, MAMMAL PHYLOGENY : PLACENTALS, P159; Do Kim J, 2009, NUCLEIC ACIDS RES, V37, P5656, DOI 10.1093/nar/gkp613; EPPIG JJ, 1993, METHOD ENZYMOL, V225, P77; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Hogan B, 1994, MANIPULATING MOUSE E, DOI [10.1007/978-1-60327-019-9_13, DOI 10.1007/978-1-60327-019-9_13]; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Kim H, 2015, GENOMICS, V105, P108, DOI 10.1016/j.ygeno.2014.11.007; Kim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025174; Kim H, 2009, NUCLEIC ACIDS RES, V37, P2940, DOI 10.1093/nar/gkp149; Kim J, 2012, ILAR J, V53, P232, DOI 10.1093/ilar.53.3-4.232; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; LI WH, 1981, NATURE, V292, P237, DOI 10.1038/292237a0; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schroeder DI, 2011, GENOME RES, V21, P1583, DOI 10.1101/gr.119131.110; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330; Smallwood SA, 2012, TRENDS GENET, V28, P33, DOI 10.1016/j.tig.2011.09.004; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Whitelaw NC, 2006, HUM MOL GENET, V15, pR131, DOI 10.1093/hmg/ddl200; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	30	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0126966	10.1371/journal.pone.0126966	http://dx.doi.org/10.1371/journal.pone.0126966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915901	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100159
J	Wang, JS; Zheng, JN; Tang, TY; Zhu, F; Yao, YH; Xu, J; Wang, AZ; Zhang, LZ				Wang, Jianshe; Zheng, Junnian; Tang, Tianyou; Zhu, Feng; Yao, Yuanhu; Xu, Jing; Wang, Andrew Z.; Zhang, Longzhen			A Randomized Pilot Trial Comparing Position Emission Tomography (PET)-Guided Dose Escalation Radiotherapy to Conventional Radiotherapy in Chemoradiotherapy Treatment of Locally Advanced Nasopharyngeal Carcinoma	PLOS ONE			English	Article							FDG-PET; RADIATION-THERAPY; CHEMOTHERAPY; CANCER; BOOST; HEAD	Background This pilot trial is designed to determine whether PET/CT-guided radiotherapy dose escalation can improve local control while minimizing toxicity for the treatment of locally advanced nasopharyngeal carcinoma. Methods 67 patients were randomized into the three treatment arms: conventional chemoradiotherapy (group A), CT-guided dose escalation chemoradiotherapy (group B) and PET/CT-guided dose escalation chemoradiotherapy (group C). Radiotherapy was delivered using the simultaneous modulated accelerated radiation therapy (SMART) technique in the dose-escalation treatment arms. Patients received concurrent and adjuvant chemotherapy. Results The use of PET/CT significantly changed the treatment volume delineation of the gross tumor volume. 3-year local progression-free (LPF) survival rates of three groups were 83.3%, 90.9% and 100%, respectively. The 3-year regional progression-free survival (RPFS) rates were 95.8%, 95.5% and 100%, respectively. The 3-year disease free survival (DFS) rates were 79.2%, 86.4% and 95.2%, respectively. The 3-year overall survival (OS) rates were 83.3%, 90.9% and 95.2%, respectively. The 3-year disease-free survival (DFS) rates were 79.2%, 86.4% and 95.2%, respectively. No patient had grade 4 late toxicity. Conclusions PET/CT-guided dose escalation radiotherapy is well-tolerated and appears to be superior to conventional chemoradiotherapy for locally advanced NPC.	[Wang, Jianshe; Zheng, Junnian; Tang, Tianyou; Yao, Yuanhu; Xu, Jing; Wang, Andrew Z.; Zhang, Longzhen] Xuzhou Med Coll, Affiliated Hosp, Dept Radiat Oncol, Xuzhou, Jiangsu, Peoples R China; [Wang, Jianshe; Zheng, Junnian; Tang, Tianyou; Yao, Yuanhu; Xu, Jing; Wang, Andrew Z.; Zhang, Longzhen] Xuzhou Med Coll, Inst Canc, Xuzhou, Jiangsu, Peoples R China; [Wang, Andrew Z.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC USA; [Zhu, Feng] Xuzhou Cent Hosp, PET CT Ctr, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; University of North Carolina; University of North Carolina Chapel Hill	Zhang, LZ (corresponding author), Xuzhou Med Coll, Affiliated Hosp, Dept Radiat Oncol, Xuzhou, Jiangsu, Peoples R China.	jsxzzlz@126.com	Wang, Andrew/AAU-7549-2020	Wang, Andrew/0000-0002-9781-4494; zhang, longzhen/0000-0002-5786-1560	National Natural Science Foundation of China [81071831]; Jiangsu Provincial Health Bureau issues [H201021]; Xuzhou City Science and Technology Bureau issues [XF10C082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Health Bureau issues; Xuzhou City Science and Technology Bureau issues	This study was supported by grants from the National Natural Science Foundation of China (No. 81071831), Jiangsu Provincial Health Bureau issues (No. H201021) and Xuzhou City Science and Technology Bureau issues (No. XF10C082). The funders had no role in study design, data and analysis, decision to publish, or preparation of the manuscript, collection and analysis, decision to publish, or preparation of the manuscript.	Bakst RL, 2011, INT J RADIAT ONCOL, V80, P148, DOI 10.1016/j.ijrobp.2010.01.026; Butler EB, 1999, INT J RADIAT ONCOL, V45, P21, DOI 10.1016/S0360-3016(99)00101-7; Hara W, 2008, INT J RADIAT ONCOL, V71, P393, DOI 10.1016/j.ijrobp.2007.10.027; Hung GU, 2011, CLIN NUCL MED, V36, P447, DOI 10.1097/RLU.0b013e31821738b8; LOWE VJ, 1994, J NUCL MED, V35, P1771; Madani I, 2007, INT J RADIAT ONCOL, V68, P126, DOI 10.1016/j.ijrobp.2006.12.070; MARKS JE, 1982, CANCER-AM CANCER SOC, V50, P1042, DOI 10.1002/1097-0142(19820915)50:6<1042::AID-CNCR2820500604>3.0.CO;2-Y; Paulino AC, 2004, INT J RADIAT ONCOL, V59, P4, DOI 10.1016/j.ijrobp.2003.10.045; Spratt DE, 2012, ONCOTARGETS THER, V5, P297, DOI 10.2147/OTT.S28032; Teo PML, 2006, RADIOTHER ONCOL, V79, P27, DOI 10.1016/j.radonc.2006.03.012; Teo PML, 2000, INT J RADIAT ONCOL, V46, P445, DOI 10.1016/S0360-3016(99)00326-0; Tomitaka E, 2011, JPN J CLIN ONCOL, V41, P503, DOI 10.1093/jjco/hyq236; Wee J, 2005, J CLIN ONCOL, V23, P6730, DOI 10.1200/JCO.2005.16.790; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Xiao WW, 2011, CANCER-AM CANCER SOC, V117, P1874, DOI 10.1002/cncr.25754	15	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124018	10.1371/journal.pone.0124018	http://dx.doi.org/10.1371/journal.pone.0124018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915944	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100034
J	Gong, WP; Wang, PC; Xiong, XL; Jiao, J; Yang, XM; Wen, BH				Gong, Wenping; Wang, Pengcheng; Xiong, Xiaolu; Jiao, Jun; Yang, Xiaomei; Wen, Bohai			Chloroform-Methanol Residue of Coxiella burnetii Markedly Potentiated the Specific Immunoprotection Elicited by a Recombinant Protein Fragment rOmpB-4 Derived from Outer Membrane Protein B of Rickettsia rickettsii in C3H/HeN Mice	PLOS ONE			English	Article							MOUNTAIN-SPOTTED-FEVER; PROTECTIVE IMMUNITY; ANTIVIRAL IMMUNITY; ENDOTHELIAL-CELLS; NITRIC-OXIDE; INFECTION; PHASE; VACCINE; ACTIVATION; ANTIBODIES	The obligate intracellular bacteria, Rickettsia rickettsii and Coxiella burnetii, are the potential agents of bio-warfare/bio-terrorism. Here C3H/HeN mice were immunized with a recombinant protein fragment rOmp-4 derived from outer membrane protein B, a major protective antigen of R. rickettsii, combined with chloroform-methanol residue (CMR) extracted from phase I C. burnetii organisms, a safer Q fever vaccine. These immunized mice had significantly higher levels of IgG1 and IgG2a to rOmpB-4 and interferon-gamma .(IFN-gamma.)and tumor necrosis factor-alpha (TNF-alpha), two crucial cytokines in resisting intracellular bacterial infection, as well as significantly lower rickettsial loads and slighter pathological lesions in organs after challenge with R. rickettsii, compared with mice immunized with rOmpB-4 or CMR alone. Additionally, after challenge with C. burnetii, the coxiella loads in the organs of these mice were significantly lower than those of mice immunized with rOmpB-4 alone. Our results prove that CMR could markedly potentiate enhance the rOmpB-4-specific immunoprotection by promoting specific and non-specific immunoresponses and the immunization with the protective antigen of R. rickettsii combined with CMR of C. burnetii could confer effective protection against infection of R. rickettsii or C. burnetii.	[Gong, Wenping; Wang, Pengcheng; Xiong, Xiaolu; Jiao, Jun; Yang, Xiaomei; Wen, Bohai] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Wang, Pengcheng] PLA, Hosp 105, Dept Clin Lab, Hefei, Anhui, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Xiong, XL (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	xiongxiaolu624@sohu.com; wenbohai@yahoo.com	Jiao, Jun/ABE-7519-2021; Gong, Wenping/B-8183-2018	Gong, Wenping/0000-0002-0333-890X	National Natural Science Foundation of China [31470894, 81371767, 31170161]; Natural Science and Technology Major Project of China [2013ZX10004803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science and Technology Major Project of China	This work was supported by the National Natural Science Foundation of China grants 31470894, 81371767 and 31170161, the Natural Science and Technology Major Project of China (grant 2013ZX10004803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeykoon A, 2014, J BIOL CHEM, V289, P7691, DOI 10.1074/jbc.M113.535567; ACKLAND JR, 1994, MED J AUSTRALIA, V160, P704, DOI 10.5694/j.1326-5377.1994.tb125909.x; BACA OG, 1983, MICROBIOL REV, V47, P127, DOI 10.1128/MMBR.47.2.127-149.1983; Balraj P, 2008, FEMS MICROBIOL LETT, V286, P257, DOI 10.1111/j.1574-6968.2008.01283.x; Benenson AS., 1959, Q FEVER VACCINE EFFI; Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004; Chan YGY, 2009, CELL MICROBIOL, V11, P629, DOI 10.1111/j.1462-5822.2008.01279.x; Chan YGY, 2011, INFECT IMMUN, V79, P2303, DOI 10.1128/IAI.01324-10; Chao CC, 2008, CLIN VACCINE IMMUNOL, V15, P684, DOI 10.1128/CVI.00281-07; CLARK IA, 1979, INFECT IMMUN, V24, P319, DOI 10.1128/IAI.24.2.319-325.1979; DAMROW TA, 1985, INFECT IMMUN, V47, P149, DOI 10.1128/IAI.47.1.149-156.1985; de Cremoux R, 2012, FEMS IMMUNOL MED MIC, V64, P104, DOI 10.1111/j.1574-695X.2011.00892.x; Duan CS, 2011, AM J TROP MED HYG, V85, P504, DOI 10.4269/ajtmh.2011.10-0660; DUPONT HL, 1973, J INFECT DIS, V128, P340, DOI 10.1093/infdis/128.3.340; Feng HM, 2004, INFECT IMMUN, V72, P2222, DOI 10.1128/IAI.72.4.2222-2228.2004; FORTIER AH, 1992, INFECT IMMUN, V60, P817, DOI 10.1128/IAI.60.3.817-825.1992; FRIES LF, 1993, INFECT IMMUN, V61, P1251, DOI 10.1128/IAI.61.4.1251-1258.1993; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; HANSON BA, 1983, INFECT IMMUN, V42, P341, DOI 10.1128/IAI.42.1.341-349.1983; HARRELL GT, 1949, ARCH INTERN MED, V83, P331, DOI 10.1001/archinte.1949.00220320085007; HORNEY LF, 1988, SOUTHERN MED J, V81, P915, DOI 10.1097/00007611-198807000-00028; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Kampschreur LM, 2013, EMERG INFECT DIS, V19, P768, DOI 10.3201/eid1905.120353; KELLY MT, 1977, CELL IMMUNOL, V28, P198, DOI 10.1016/S0008-8749(77)80020-8; KELLY MT, 1976, CANCER IMMUNOL IMMUN, V1, P187, DOI 10.1007/BF00205464; KIPPS TJ, 1985, J EXP MED, V161, P1, DOI 10.1084/jem.161.1.1; Kokkini S, 2013, INT J INFECT DIS, V17, pE977, DOI 10.1016/j.ijid.2013.04.010; KOSTER FT, 1985, J IMMUNOL, V135, P1067; Kwak Wooseok, 2013, Osong Public Health Res Perspect, V4, P34, DOI 10.1016/j.phrp.2012.12.006; LEENEN PJM, 1994, J IMMUNOL, V153, P5141; Li QF, 2005, ANN NY ACAD SCI, V1063, P130, DOI 10.1196/annals.1355.021; Maassen CBM, 2003, VACCINE, V21, P2751, DOI 10.1016/S0264-410X(03)00220-2; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; NEUBERGER MS, 1981, EUR J IMMUNOL, V11, P1012, DOI 10.1002/eji.1830111212; Niu Dong-sheng, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P526; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; PARKER R. R., 1941, AMER JOUR TROP MED, V21, P369; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Qi Y, 2013, VACCINE, V31, P5643, DOI 10.1016/j.vaccine.2013.09.064; Rolph MS, 2004, VIROLOGY, V326, P1, DOI 10.1016/j.virol.2004.04.049; Rothoeft T, 2003, IMMUNOLOGY, V110, P430, DOI 10.1111/j.1365-2567.2003.01758.x; SILVERMAN DJ, 1986, J INFECT DIS, V153, P694, DOI 10.1093/infdis/153.4.694; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Uchiyama T, 2006, MICROBES INFECT, V8, P801, DOI 10.1016/j.micinf.2005.10.003; Varghees S, 2002, INFECT IMMUN, V70, P6741, DOI 10.1128/IAI.70.12.6741-6750.2002; Waag DM, 2008, CLIN VACCINE IMMUNOL, V15, P1505, DOI 10.1128/CVI.00119-08; WAAG DM, 1990, ANN NY ACAD SCI, V590, P203, DOI 10.1111/j.1749-6632.1990.tb42221.x; Waag DM, 2002, VACCINE, V20, P2623, DOI 10.1016/S0264-410X(02)00176-7; WALKER DH, 1980, HUM PATHOL, V11, P263, DOI 10.1016/S0046-8177(80)80008-6; WEINBERG EH, 1969, J BACTERIOL, V98, P398, DOI 10.1128/JB.98.2.398-402.1969; Wilhelmsen CL, 2000, COMPARATIVE MED, V50, P374; WILLIAMS JC, 1982, INFECT IMMUN, V35, P1091, DOI 10.1128/IAI.35.3.1091-1102.1982; WILLIAMS JC, 1992, ANN NY ACAD SCI, V653, P88, DOI 10.1111/j.1749-6632.1992.tb19633.x; Woods ME, 2008, J CLIN IMMUNOL, V28, P174, DOI 10.1007/s10875-007-9140-9; Xiong XL, 2012, VACCINE, V30, P6809, DOI 10.1016/j.vaccine.2012.09.017; ZVILICH M, 1995, ANTIVIR RES, V27, P389, DOI 10.1016/0166-3542(95)00022-E	58	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124664	10.1371/journal.pone.0124664	http://dx.doi.org/10.1371/journal.pone.0124664			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909586	gold, Green Submitted, Green Published			2022-12-27	WOS:000353376800097
J	Nghiem, N; Blakely, T; Cobiac, LJ; Pearson, AL; Wilson, N				Nghiem, Nhung; Blakely, Tony; Cobiac, Linda J.; Pearson, Amber L.; Wilson, Nick			Health and Economic Impacts of Eight Different Dietary Salt Reduction Interventions	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SODIUM-INTAKE; COST-EFFECTIVENESS; BLOOD-PRESSURE; GLOBAL BURDEN; NEW-ZEALAND; MORTALITY; INEQUALITIES; POLICY; TRADE	Background Given the high importance of dietary sodium (salt) as a global disease risk factor, our objective was to compare the impact of eight sodium reduction interventions, including feasible and more theoretical ones, to assist prioritisation. Methods Epidemiological modelling and cost-utility analysis were performed using a Markov macro-simulation model. The setting was New Zealand (NZ) (2.3 million citizens, aged 35+ years) which has detailed individual-level administrative cost data. Results Of the most feasible interventions, the largest health gains were from (in descending order): (i) mandatory 25% reduction in sodium levels in all processed foods; (ii) the package of interventions performed in the United Kingdom (UK); (iii) mandatory 25% reduction in sodium levels in bread, processed meats and sauces; (iv) media campaign (as per a previous UK one); (v) voluntary food labelling as currently used in NZ; (vi) dietary counselling as currently used in NZ. Even larger health gains came from the more theoretical options of a "sinking lid" on the amount of food salt released to the national market to achieve an average adult intake of 2300 mg sodium/day (211,000 QALYs gained, 95% uncertainty interval: 170,000 255,000), and from a salt tax. All the interventions produced net cost savings (except counselling -albeit still cost-effective). Cost savings were especially large with the sinking lid (NZ$ 1.1 billion, US$ 0.7 billion). Also the salt tax would raise revenue (up to NZ$ 452 million/year). Health gain per person was greater for Maori (indigenous population) men and women compared to non-Maori. Conclusions This study substantially expands on the range of previously modelled salt reduction interventions and suggests that some of these might achieve major health gains and major cost savings (particularly the regulatory interventions). They could also reduce ethnic inequalities in health.	[Nghiem, Nhung; Blakely, Tony; Cobiac, Linda J.; Pearson, Amber L.; Wilson, Nick] Univ Otago, Dept Publ Hlth, Wellington, Wellington Sout, New Zealand; [Cobiac, Linda J.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	University of Otago; University of Queensland	Wilson, N (corresponding author), Univ Otago, Dept Publ Hlth, Wellington, Wellington Sout, New Zealand.	nick.wilson@otago.ac.nz		Nghiem, Nhung/0000-0003-0078-4549; Blakely, Tony/0000-0002-6995-4369	Health Research Council of New Zealand [10/248]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by the Health Research Council of New Zealand (10/248). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; [Anonymous], 2012, CHOOS INT AR COST EF; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Baltussen RM., 2003, MAKING CHOICES HLTH; Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Basu S, 2014, AM J PUBLIC HEALTH, V104, P2432, DOI 10.2105/AJPH.2014.302170; Bayer R, 2012, HEALTH AFFAIR, V31, P2738, DOI 10.1377/hlthaff.2012.0554; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Blakely T, 2012, 3 U OT DEP PUBL HLTH; Blakely T, 2014, NZ MED J, V127, P1; Blakely T., 2015, BODE3 PROGRAMME; Blakely T, 2008, BRIT MED J, V336, P371, DOI 10.1136/bmj.39455.596181.25; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Chang HY, 2006, AM J CLIN NUTR, V83, P1289, DOI 10.1093/ajcn/83.6.1289; Cobiac LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041842; Cobiac LJ, 2010, HEART, V96, P1920, DOI 10.1136/hrt.2010.199240; Collins M, 2014, VALUE HEALTH, V17, P517, DOI 10.1016/j.jval.2014.03.1722; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Cook NR, 2014, CIRCULATION, V129, P981, DOI 10.1161/CIRCULATIONAHA.113.006032; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Eatwell, 2012, D2 3 EVALUATION COST; Forshee RA, 2008, NUTR REV, V66, P280, DOI 10.1111/j.1753-4887.2008.00033.x; Goodman Richard A, 2006, MMWR Suppl, V55, P29; He FJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004937.pub2; He FJ, 2013, J HUM HYPERTENS; Hofman KJ, 2013, LANCET GLOB HEALTH, V1, pE66, DOI 10.1016/S2214-109X(13)70019-6; Institute of Medicine, 2013, SOD INT POP ASS EV; Kivimaki M, 2008, LANCET, V372, P1648, DOI 10.1016/S0140-6736(08)61688-8; Landsburg S, 2010, PRICE THEORY APPL EC; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; LAW MR, 1991, BMJ-BRIT MED J, V302, P811, DOI 10.1136/bmj.302.6780.811; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewis KH, 2011, NEW ENGL J MED, V365, P1561, DOI 10.1056/NEJMp1105128; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McLean R, 2011, MUCH SALT ARE WE EAT; McLean RM, 2011, NEW ZEAL MED J, V124, P68; McLean RM, 2013, NZ MED J, V126, P1; McLeod M, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-15; Merino J, 2015, AM J CLIN NUTR, V101, P440, DOI 10.3945/ajcn.114.096750; Ministry of Health, 2013, WAYS MEANS REP METH; Moulton AD, 2009, AM J PUBLIC HEALTH, V99, P17, DOI 10.2105/AJPH.2007.130278; National Institute for Clinical Excellence (NICE), 2010, NICE PUBL HLTH GUID, P25; Neal B, 2013, CURR HYPERTENS REP, V15, P687, DOI 10.1007/s11906-013-0389-5; Nghiem N, 2014, VALIDATION ISSUES RE; O'Donnell M, 2014, NEW ENGL J MED, V371, P2137, DOI 10.1056/NEJMc1412113; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; OECD, 2013, NEW INT COMP GDP CON; OECD, 2014, DOES NZ COMP; Pietinen P, 2010, PUBLIC HEALTH NUTR, V13, P901, DOI 10.1017/S1368980010001072; Rees K., 2013, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002128.PUB4; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212; van Baal PHM, 2008, PLOS MED, V5, P242, DOI 10.1371/journal.pmed.0050029; van Baal PHM, 2007, HEALTH POLICY, V82, P142, DOI 10.1016/j.healthpol.2006.09.004; van Baal PHM, 2011, HEALTH ECON, V20, P432, DOI 10.1002/hec.1599; WHO, 2012, GUID SOD INT AD CHIL; Wilson N, 2014, TECHNICAL REPORT; Wilson N, 2014, BACKGROUND REPORT BO; Wilson N, 2014, NEW ZEAL MED J, V127, P85; Wilson N, 2012, B WORLD HEALTH ORGAN, V90, P532, DOI 10.2471/BLT.11.097584	61	55	57	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123915	10.1371/journal.pone.0123915	http://dx.doi.org/10.1371/journal.pone.0123915			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG6AH	25910259	Green Published, gold			2022-12-27	WOS:000353376800050
J	Menger, DJ; Omusula, P; Holdinga, M; Homan, T; Carreira, AS; Vandendaele, P; Derycke, JL; Mweresa, CK; Mukabana, WR; van Loon, JJA; Takken, W				Menger, David J.; Omusula, Philemon; Holdinga, Maarten; Homan, Tobias; Carreira, Ana S.; Vandendaele, Patrice; Derycke, Jean-Luc; Mweresa, Collins K.; Mukabana, Wolfgang Richard; van Loon, Joop J. A.; Takken, Willem			Field Evaluation of a Push-Pull System to Reduce Malaria Transmission	PLOS ONE			English	Article							LASTING INSECTICIDAL NETS; ANOPHELES-GAMBIAE COMPLEX; SPATIAL REPELLENCY; MOSQUITOS DIPTERA; CARBON-DIOXIDE; TRAP CATCHES; HOUSE ENTRY; FUNESTUS; CULICIDAE; VECTORS	Malaria continues to place a disease burden on millions of people throughout the tropics, especially in sub-Saharan Africa. Although efforts to control mosquito populations and reduce human-vector contact, such as long-lasting insecticidal nets and indoor residual spraying, have led to significant decreases in malaria incidence, further progress is now threatened by the widespread development of physiological and behavioural insecticide-resistance as well as changes in the composition of vector populations. A mosquito-directed push-pull system based on the simultaneous use of attractive and repellent volatiles offers a complementary tool to existing vector-control methods. In this study, the combination of a trap baited with a five-compound attractant and a strip of net-fabric impregnated with micro-encapsulated repellent and placed in the eaves of houses, was tested in a malaria-endemic village in western Kenya. Using the repellent delta-undecalactone, mosquito house entry was reduced by more than 50%, while the traps caught high numbers of outdoor flying mosquitoes. Model simulations predict that, assuming area-wide coverage, the addition of such a push-pull system to existing prevention efforts will result in up to 20-fold reductions in the entomological inoculation rate. Reductions of such magnitude are also predicted when mosquitoes exhibit a high resistance against insecticides. We conclude that a push-pull system based on non-toxic volatiles provides an important addition to existing strategies for malaria prevention.	[Menger, David J.; Holdinga, Maarten; Homan, Tobias; Mweresa, Collins K.; van Loon, Joop J. A.; Takken, Willem] Wageningen Univ, Entomol Lab, NL-6700 EH Wageningen, Netherlands; [Omusula, Philemon; Mweresa, Collins K.; Mukabana, Wolfgang Richard] Int Ctr Insect Physiol & Ecol, Gpo Nairobi, Kenya; [Carreira, Ana S.] Univ Coimbra, Dept Chem Engn, CIEPQPF, P-3030790 Coimbra, Portugal; [Carreira, Ana S.] Devan Micropolis, P-4470605 Maia, Portugal; [Vandendaele, Patrice] Devan Chem NV, B-9600 Ronse, Belgium; [Derycke, Jean-Luc] Utexbel NV, B-9600 Ronse, Belgium; [Mukabana, Wolfgang Richard] Univ Nairobi, Sch Biol Sci, Gpo Nairobi, Kenya	Wageningen University & Research; International Centre of Insect Physiology & Ecology (ICIPE); Universidade de Coimbra; University of Nairobi	Menger, DJ (corresponding author), Wageningen Univ, Entomol Lab, POB 8031, NL-6700 EH Wageningen, Netherlands.	david.menger@wur.nl	van Loon, Joop J.A./B-3744-2009	van Loon, Joop J.A./0000-0002-4260-0501	European Union [NMP2-2009-228639]; Foundation for the National Institutes of Health [121]; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BDE/51601/2011]	European Union(European Commission); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	The laboratory work was funded by the European Union through NMP2-2009-228639, FP7, NOBUG project; the fieldwork was funded by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH#121). Ana S. Carreira gratefully acknowledges the Fundacao para a Ciencia e Tecnologia, Portugal, for the financial support under the PhD grant (SFRH/BDE/51601/2011), which includes the encapsulation work. Devan Chemicals and Utexbel provided support in the form of salaries	Baker, 2000, EVALUATING IMPACT DE; Besansky NJ, 2004, TRENDS PARASITOL, V20, P249, DOI 10.1016/j.pt.2004.03.007; Campos E, 2013, EUR POLYM J, V49, P2005, DOI 10.1016/j.eurpolymj.2013.04.033; Chaiyasat P, 2013, ENRGY PROCED, V34, P656, DOI 10.1016/j.egypro.2013.06.797; Cohuet A, 2003, AM J TROP MED HYG, V69, P200, DOI 10.4269/ajtmh.2003.69.200; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Costantini C, 1998, B ENTOMOL RES, V88, P503, DOI 10.1017/S000748530002602X; Dabire RK, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-127; DAY JF, 1994, AM J TROP MED HYG, V50, P126, DOI 10.4269/ajtmh.1994.50.126; Hiscox A, 2012, MALARIA J, V11, pO45; Hiscox A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-257; Jawara M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008167; Kampango A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-99; Kawada H, 2008, J AM MOSQUITO CONTR, V24, P404, DOI 10.2987/5743.1; Khan Z, 2011, INT J AGR SUSTAIN, V9, P162, DOI 10.3763/ijas.2010.0558; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kline DL, 2006, J AM MOSQUITO CONTR, V22, P490, DOI 10.2987/8756-971X(2006)22[490:TATTFA]2.0.CO;2; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Koureas M, 2012, TOXICOL LETT, V210, P155, DOI 10.1016/j.toxlet.2011.10.007; LIN F M, 1970, Journal of Food Science, V35, P538, DOI 10.1111/j.1365-2621.1970.tb04802.x; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; LINDSAY SW, 1988, T ROY SOC TROP MED H, V82, P645, DOI 10.1016/0035-9203(88)90546-9; LINES JD, 1991, B ENTOMOL RES, V81, P77, DOI 10.1017/S0007485300053268; Lwetoijera DW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-331; Mahajan SS, 2004, J DAIRY SCI, V87, P4057, DOI 10.3168/jds.S0022-0302(04)73547-X; Maia MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084875; Maia MF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S11; Maxwell CA, 1998, MED VET ENTOMOL, V12, P325, DOI 10.1046/j.1365-2915.1998.00108.x; Menger DJ, 2014, MED VET ENTOMOL, V28, P407, DOI 10.1111/mve.12061; Menger DJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-119; Specos MMM, 2010, T ROY SOC TROP MED H, V104, P653, DOI 10.1016/j.trstmh.2010.06.004; Mnyone LL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-87; Moiroux N, 2012, J INFECT DIS, V206, P1622, DOI 10.1093/infdis/jis565; Mukabana WR, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-202; Mukabana WR, 2012, J CHEM ECOL, V38, P235, DOI 10.1007/s10886-012-0088-8; Mweresa CK, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-376; Mweresa CK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-160; N'Guessan R, 2008, T ROY SOC TROP MED H, V102, P259, DOI 10.1016/j.trstmh.2007.10.012; Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39; Ogoma SB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-54; Okumu F, 2010, J MED ENTOMOL, V47, P274, DOI 10.1603/ME09114; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Qiu YT, 2007, J MED ENTOMOL, V44, P970, DOI 10.1603/0022-2585(2007)44[970:AOMTBW]2.0.CO;2; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; Russell TL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-56; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Senhorini GA, 2012, MAT SCI ENG C-MATER, V32, P1121, DOI 10.1016/j.msec.2012.02.027; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; SNOW WF, 1987, MED VET ENTOMOL, V1, P9, DOI 10.1111/j.1365-2915.1987.tb00318.x; Sougoufara S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-125; Spitzen J, 2008, PHYSIOL ENTOMOL, V33, P116, DOI 10.1111/j.1365-3032.2008.00612.x; Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wischke C, 2008, INT J PHARMACEUT, V364, P298, DOI 10.1016/j.ijpharm.2008.04.042	58	34	35	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123415	10.1371/journal.pone.0123415	http://dx.doi.org/10.1371/journal.pone.0123415			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923114	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600047
J	Raquin, V; Moro, CV; Saucereau, Y; Tran, FH; Potier, P; Mavingui, P				Raquin, Vincent; Moro, Claire Valiente; Saucereau, Yoann; Tran, Florence-Helene; Potier, Patrick; Mavingui, Patrick			Native Wolbachia from Aedes albopictus Blocks Chikungunya Virus Infection In Cellulo	PLOS ONE			English	Article							DENGUE VIRUS; VECTOR COMPETENCE; AEGYPTI MOSQUITOS; HOST MICRORNAS; STRAIN WMEL; REPLICATION; PIPIENTIS; LINE; TRANSMISSION; TEMPERATURE	Wolbachia, a widespread endosymbiont of terrestrial arthropods, can protect its host against viral and parasitic infections, a phenotype called "pathogen blocking". However, in some cases Wolbachia may have no effect or even enhance pathogen infection, depending on the host-Wolbachia-pathogen combination. The tiger mosquito Aedes albopictus is naturally infected by two strains of Wolbachia, wAlbA and wAlbB, and is a competent vector for different arboviruses such as dengue virus (DENV) and chikungunya virus (CHIKV). Interestingly, it was shown in some cases that Ae. albopictus native Wolbachia strains are able to inhibit DENV transmission by limiting viral replication in salivary glands, but no such impact was measured on CHIKV replication in vivo. To better understand the Wolbachia/CHIKV/Ae. albopictus interaction, we generated a cellular model using Ae. albopictus derived C6/36 cells that we infected with the wAlbB strain. Our results indicate that CHIKV infection is negatively impacted at both RNA replication and virus assembly/secretion steps in presence of wAlbB. Using FISH, we observed CHIKV and wAlbB in the same mosquito cells, indicating that the virus is still able to enter the cell in the presence of the bacterium. Further work is needed to decipher molecular pathways involved in Wolbachia-CHIKV interaction at the cellular level, but this cellular model can be a useful tool to study the mechanism behind virus blocking phenotype induced by Wolbachia. More broadly, this put into question the ecological role of Wolbachia symbiont in Ae. albopictus, but also the ability of the CHIKV to counteract Wolbachia's antiviral potential in vivo.	[Raquin, Vincent; Moro, Claire Valiente; Saucereau, Yoann; Tran, Florence-Helene; Potier, Patrick; Mavingui, Patrick] Univ Lyon 1, CNRS, INRA USC1190, UMR5557 Ecol Microbienne,VetAgro Sup, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Raquin, V (corresponding author), Inst Pasteur, Genomes & Genet Dept, Insects Viruses Interact Grp, Paris, France.	vincent.raquin@gmail.com; patrick.mavingui@univ-lyon1.fr		valiente moro, claire/0000-0002-7193-405X; RAQUIN, Vincent/0000-0001-6814-4199	Agence Nationale de la Recherche (ANR) [ANR-2010-BLAN-170101]; Fondation pour la Recherche et la Biodiversite (FRB) [FRBCD-AOOI-07-12]; Action Concertee InterPasteurienne (ACIP) [A-10-2009]; ERA-Net BiodivERsA network; ANR France [ANR-13-EBID-0007-01]; FWF Austria [FWF I-1437]; DFG Germany [DFG KL 2087/6-1]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche et la Biodiversite (FRB); Action Concertee InterPasteurienne (ACIP); ERA-Net BiodivERsA network; ANR France(French National Research Agency (ANR)); FWF Austria(Austrian Science Fund (FWF)); DFG Germany(German Research Foundation (DFG))	This work was partially funded by the Agence Nationale de la Recherche (ANR, http://www.agence-nationale-recherche.fr/) grant ANR-2010-BLAN-170101 (ImmunSymbArt), the Fondation pour la Recherche et la Biodiversite (FRB, http://www.fondationbiodiversite.fr/) grant FRBCD-AOOI-07-12, the Action Concertee InterPasteurienne (ACIP) grant A-10-2009 and the ERA-Net BiodivERsA network (http://www.biodiversa.org/) with the national funders ANR France (ANR-13-EBID-0007-01), FWF Austria (FWF I-1437), and DFG Germany (DFG KL 2087/6-1), part of the 2012-2013 BiodivERsA call for research proposals.	Angelini R, 2007, Euro Surveill, V12; Baldridge GD, 2014, MOL MICROBIOL, V94, P537, DOI 10.1111/mmi.12768; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4; Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459; Carrington LB, 2013, AM J TROP MED HYG, V88, P689, DOI 10.4269/ajtmh.12-0488; Christodoulou M, 2011, LANCET INFECT DIS, V11, P84, DOI 10.1016/S1473-3099(11)70017-2; Darby AC, 2014, ISME J, V8, P925, DOI 10.1038/ismej.2013.192; David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; Fallon AM, 2013, IN VITRO CELL DEV-AN, V49, P66, DOI 10.1007/s11626-012-9571-3; Fallon AM, 2009, IN VITRO CELL DEV-AN, V45, P460, DOI 10.1007/s11626-009-9193-6; Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621; Fenollar F, 2003, J CLIN MICROBIOL, V41, P5434, DOI 10.1128/JCM.41.12.5434-5441.2003; Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; Hughes GL, 2014, P NATL ACAD SCI USA, V111, P12498, DOI 10.1073/pnas.1408888111; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001296; Hussain M, 2013, RNA BIOL, V10, P1868, DOI 10.4161/rna.27392; Hussain M, 2013, J VIROL, V87, P851, DOI 10.1128/JVI.01837-12; Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108; Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Khoo CCH, 2013, B ENTOMOL RES, V103, P251, DOI 10.1017/S0007485312000648; Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006; Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754; McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Mousson L, 2010, MOL ECOL, V19, P1953, DOI 10.1111/j.1365-294X.2010.04606.x; Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989; Murdock CC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03932; ONeill SL, 1997, INSECT MOL BIOL, V6, P33, DOI 10.1046/j.1365-2583.1997.00157.x; Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12; Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003; Ponlawat A, 2005, J MED ENTOMOL, V42, P821, DOI 10.1603/0022-2585(2005)042[0821:ISOAAA]2.0.CO;2; Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398; Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548; Raquin V, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-243; Richards SL, 2012, J MED ENTOMOL, V49, P1502, DOI 10.1603/ME12054; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Slatko BE, 2014, MOL BIOCHEM PARASIT, V195, P88, DOI 10.1016/j.molbiopara.2014.07.004; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892; Venard CMP, 2011, LETT APPL MICROBIOL, V52, P168, DOI 10.1111/j.1472-765X.2010.02986.x; Voronin D, 2010, J APPL MICROBIOL, V108, P2133, DOI 10.1111/j.1365-2672.2009.04621.x; Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; [WHO WHO], WHO ABOUT VECTOR BOR; WHO, WHO CHIKUNGUNYA FRAN; Zele F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2837; Zhang GM, 2014, INSECT BIOCHEM MOLEC, V53, P81, DOI 10.1016/j.ibmb.2014.08.003; Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110; Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x; Zouache K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006388; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	73	28	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125066	10.1371/journal.pone.0125066	http://dx.doi.org/10.1371/journal.pone.0125066			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923352	gold, Green Published			2022-12-27	WOS:000353711600121
J	Sonani, RR; Gupta, GD; Madamwar, D; Kumar, V				Sonani, Ravi Raghav; Gupta, Gagan Deep; Madamwar, Datta; Kumar, Vinay			Crystal Structure of Allophycocyanin from Marine Cyanobacterium Phormidium sp A09DM	PLOS ONE			English	Article							ENERGY-TRANSFER; PURIFICATION; PHYCOCYANIN; PHYCOBILISOMES; ANGSTROM; PHYCOERYTHRIN; VISUALIZATION; ARCHITECTURE; ANTIOXIDANT; COMPONENTS	Isolated phycobilisome (PBS) sub-assemblies have been widely subjected to X-ray crystallography analysis to obtain greater insights into the structure-function relationship of this light harvesting complex. Allophycocyanin (APC) is the phycobiliprotein always found in the PBS core complex. Phycocyanobilin (PCB) chromophores, covalently bound to conserved Cys residues of alpha- and beta-subunits of APC, are responsible for solar energy absorption from phycocyanin and for transfer to photosynthetic apparatus. In the known APC structures, heterodimers of alpha- and beta-subunits (known as alpha beta monomers) assemble as trimer or hexamer. We here for the first time report the crystal structure of APC isolated from a marine cyanobacterium (Phormidium sp. A09DM). The crystal structure has been refined against all the observed data to the resolution of 2.51 angstrom to R-work (R-free) of 0.158 (0.229) with good stereochemistry of the atomic model. The Phormidium protein exists as a trimer of alpha beta monomers in solution and in crystal lattice. The overall tertiary structures of alpha- and beta-subunits, and trimeric quaternary fold of the Phormidium protein resemble the other known APC structures. Also, configuration and conformation of the two covalently bound PCB chromophores in the marine APC are same as those observed in fresh water cyanobacteria and marine red algae. More hydrophobic residues, however, constitute the environment of the chromophore bound to alpha-subunit of the Phormidium protein, owing mainly to amino acid substitutions in the marine protein.	[Sonani, Ravi Raghav; Madamwar, Datta] Sardar Patel Univ, BRD Sch Biosci, Vallabh Vidyanagar 388120, Gujarat, India; [Gupta, Gagan Deep; Kumar, Vinay] Bhabha Atom Res Ctr, Div Solid State Phys, Prot Crystallog Sect, Mumbai 400085, Maharashtra, India	Sardar Patel University; Bhabha Atomic Research Center (BARC)	Madamwar, D (corresponding author), Sardar Patel Univ, BRD Sch Biosci, Vadtal Rd,Satellite Campus, Vallabh Vidyanagar 388120, Gujarat, India.	datta_madamwar@yahoo.com; vinay@barc.gov.in	Sonani, Ravi/Q-5096-2019	Sonani, Ravi/0000-0002-6212-2869; Gupta, Gagan Deep/0000-0003-2549-3190				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; Adir N., 2008, PHOTOSYNTHETIC PROTE, P243, DOI DOI 10.1002/9783527623464.CH11; Anderson LK, 1998, MOL MICROBIOL, V30, P467, DOI 10.1046/j.1365-2958.1998.01081.x; BENNETT A, 1973, J CELL BIOL, V58, P419, DOI 10.1083/jcb.58.2.419; BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; Bibby TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004601; BREJC K, 1995, J MOL BIOL, V249, P424, DOI 10.1006/jmbi.1995.0307; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; David L, 2011, J MOL BIOL, V405, P201, DOI 10.1016/j.jmb.2010.10.036; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GANTT E, 1973, BIOCHIM BIOPHYS ACTA, V292, P858, DOI 10.1016/0005-2728(73)90036-4; GARFIN DE, 1990, METHOD ENZYMOL, V182, P425; GLAZER AN, 1989, J BIOL CHEM, V264, P1; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; HUBER R, 1989, EMBO J, V8, P2125, DOI 10.1002/j.1460-2075.1989.tb08337.x; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Liu HJ, 2013, SCIENCE, V342, P1104, DOI 10.1126/science.1242321; Liu JY, 1999, J BIOL CHEM, V274, P16945, DOI 10.1074/jbc.274.24.16945; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUNDELL DJ, 1981, J BIOL CHEM, V256, P3580; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; MacColl R, 2004, BBA-BIOENERGETICS, V1657, P73, DOI 10.1016/j.bbabio.2004.04.005; Marx A, 2014, PHOTOSYNTH RES, V121, P87, DOI 10.1007/s11120-014-9996-5; Marx A, 2013, BBA-BIOENERGETICS, V1827, P311, DOI 10.1016/j.bbabio.2012.11.006; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGregor A, 2008, J MOL BIOL, V384, P406, DOI 10.1016/j.jmb.2008.09.018; MURAKAMI A, 1981, J BIOCHEM-TOKYO, V89, P79, DOI 10.1093/oxfordjournals.jbchem.a133205; Murray JW, 2007, ACTA CRYSTALLOGR F, V63, P998, DOI 10.1107/S1744309107050920; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Parmar A, 2011, BIORESOURCE TECHNOL, V102, P1795, DOI 10.1016/j.biortech.2010.09.025; Parmar A, 2010, J PHYCOL, V46, P285, DOI 10.1111/j.1529-8817.2009.00798.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quintana N, 2011, APPL MICROBIOL BIOT, V91, P471, DOI 10.1007/s00253-011-3394-0; Reuter W, 1999, P NATL ACAD SCI USA, V96, P1363, DOI 10.1073/pnas.96.4.1363; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh NK, 2012, PROCESS BIOCHEM, V47, P2472, DOI 10.1016/j.procbio.2012.10.009; Singh NK, 2009, BIORESOURCE TECHNOL, V100, P1663, DOI 10.1016/j.biortech.2008.09.021; Sonani RR, 2014, PROCESS BIOCHEM, V49, P1757, DOI 10.1016/j.procbio.2014.06.022; Sonani RR, 2014, AGE, V36, DOI 10.1007/s11357-014-9717-1; Soni B, 2008, BIORESOURCE TECHNOL, V99, P188, DOI 10.1016/j.biortech.2006.11.010; Soni B, 2006, PROCESS BIOCHEM, V41, P2017, DOI 10.1016/j.procbio.2006.04.018; Su HN, 2010, J APPL PHYCOL, V22, P65, DOI 10.1007/s10811-009-9427-8; SWANSON RV, 1990, J MOL BIOL, V214, P787, DOI 10.1016/0022-2836(90)90293-U; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Watanabe M, 2013, PHOTOSYNTH RES, V116, P265, DOI 10.1007/s11120-013-9905-3; Waterbury JB, 1981, PROKARYOTES, P221, DOI DOI 10.1007/978-3-662-13187-9_9; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Work VH, 2012, CURR OPIN BIOTECH, V23, P290, DOI 10.1016/j.copbio.2011.11.022	52	23	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124580	10.1371/journal.pone.0124580	http://dx.doi.org/10.1371/journal.pone.0124580			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923120	Green Published, gold			2022-12-27	WOS:000353711600095
J	van der Geest, KSM; Abdulahad, WH; Horst, G; Lorencetti, PG; Bijzet, J; Arends, S; van der Heiden, M; Buisman, AM; Kroesen, BJ; Brouwer, E; Boots, AMH				van der Geest, Kornelis S. M.; Abdulahad, Wayel H.; Horst, Gerda; Lorencetti, Pedro G.; Bijzet, Johan; Arends, Suzanne; van der Heiden, Marieke; Buisman, Anne-Marie; Kroesen, Bart-Jan; Brouwer, Elisabeth; Boots, Annemieke M. H.			Quantifying Distribution of Flow Cytometric TCR-V beta Usage with Economic Statistics	PLOS ONE			English	Article							T-CELL REPERTOIRE; DIVERSITY; NAIVE; CLONALITY; CD4(+); AGE	Measuring changes of the T cell receptor (TCR) repertoire is important to many fields of medicine. Flow cytometry is a popular technique to study the TCR repertoire, as it quickly provides insight into the TCR-V beta usage among well-defined populations of T cells. However, the interpretation of the flow cytometric data remains difficult, and subtle TCR repertoire changes may go undetected. Here, we introduce a novel means for analyzing the flow cytometric data on TCR-V beta usage. By applying economic statistics, we calculated the Gini-TCR skewing index from the flow cytometric TCR-V beta analysis. The Gini-TCR skewing index, which is a direct measure of TCR-V beta distribution among T cells, allowed us to track subtle changes of the TCR repertoire among distinct populations of T cells. Application of the Gini-TCR skewing index to the flow cytometric TCR-V beta analysis will greatly help to gain better understanding of the TCR repertoire in health and disease.	[van der Geest, Kornelis S. M.; Abdulahad, Wayel H.; Horst, Gerda; Lorencetti, Pedro G.; Bijzet, Johan; Arends, Suzanne; van der Heiden, Marieke; Brouwer, Elisabeth; Boots, Annemieke M. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [van der Heiden, Marieke; Buisman, Anne-Marie] Natl Inst Publ Hlth & Environm, Ctr Immunol Infect Dis & Vaccines, NL-3720 BA Bilthoven, Netherlands; [Kroesen, Bart-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands	University of Groningen; Netherlands National Institute for Public Health & the Environment; University of Groningen	van der Geest, KSM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands.	k.s.m.van.der.geest@umcg.nl	Arends, Suzanne/M-5436-2015; Brouwer, Elisabeth/AAL-9029-2020; Brouwer, Elisabeth/A-3198-2015	Arends, Suzanne/0000-0002-4422-7640; Brouwer, Elisabeth/0000-0002-5652-4423; Brouwer, Elisabeth/0000-0002-5652-4423; /0000-0003-3109-4487; van der Geest, Kornelis/0000-0003-2798-6765	MSD; Foundation 'De Drie Lichten' [19/11 GJF/mk]; Foundation 'Jan Kornelis de Cock' [2012-22]; National Institute of Public Health [SOR230426/01]	MSD; Foundation 'De Drie Lichten'; Foundation 'Jan Kornelis de Cock'; National Institute of Public Health	This study was supported by unrestricted grants from NV Organon (now MSD) to AMHB, Foundation 'De Drie Lichten' (project no. 19/11 GJF/mk) to KvdG, Foundation 'Jan Kornelis de Cock' to KvdG (project no. 2012-22), and by strategic research funding of the National Institute of Public Health (SOR230426/01) to A-MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum PD, 2012, BLOOD, V119, P3469, DOI 10.1182/blood-2011-11-395384; Bellu LG, 2005, INEQUALITY ANAL GINI; Britanova OV, 2014, J IMMUNOL, V192, P2689, DOI 10.4049/jimmunol.1302064; Ceriani L, 2012, J ECON INEQUAL, V10, P421, DOI 10.1007/s10888-011-9188-x; De Rosa SC, 2001, NAT MED, V7, P245, DOI 10.1038/84701; GASTWIRT.JL, 1972, REV ECON STAT, V54, P306, DOI 10.2307/1937992; Gorochov G, 1998, NAT MED, V4, P215, DOI 10.1038/nm0298-215; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Klarenbeek PL, 2010, IMMUNOL LETT, V133, P42, DOI 10.1016/j.imlet.2010.06.011; Kohler S, 2005, EUR J IMMUNOL, V35, P1987, DOI 10.1002/eji.200526181; Langerak AW, 2001, BLOOD, V98, P165, DOI 10.1182/blood.V98.1.165; Laydon DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003646; Manuel M, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19545; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Miles JJ, 2011, IMMUNOL CELL BIOL, V89, P375, DOI 10.1038/icb.2010.139; Qi Q, 2014, P NATL ACAD SCI USA, V111, P13139, DOI 10.1073/pnas.1409155111; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Thomas PG, 2013, P NATL ACAD SCI USA, V110, P1839, DOI 10.1073/pnas.1222149110; van Heijst JWJ, 2013, NAT MED, V19, P372, DOI 10.1038/nm.3100; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647	22	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125373	10.1371/journal.pone.0125373	http://dx.doi.org/10.1371/journal.pone.0125373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923356	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600145
J	Blatny, M; Millova, K; Jelinek, M; Osecka, T				Blatny, Marek; Millova, Katarna; Jelinek, Martin; Osecka, Terezie			Personality Predictors of Successful Development: Toddler Temperament and Adolescent Personality Traits Predict Well-Being and Career Stability in Middle Adulthood	PLOS ONE			English	Article							HIGHER-ORDER FACTORS; LONG-TERM UNEMPLOYMENT; BIG 5; SELF-ESTEEM; AGE 3; CHILDHOOD PERSONALITY; LIFE SATISFACTION; HISTORY CALENDAR; YOUNG ADULTHOOD; 5-FACTOR MODEL	The aim of the study was to predict both adaptive psychological functioning (well-being) and adaptive social functioning (career stability) in middle adulthood based on behaviors observed in toddlerhood and personality traits measured in adolescence. 83 people participated in an ongoing longitudinal study started in 1961 (58% women). Based on children's behavior in toddlerhood, three temperamental dimensions were identified -positive affectivity, negative affectivity and disinhibition. In adolescence, extraversion and neuroticism were measured at the age of 16 years. Various aspects of well-being were used as indicators of adaptive psychological functioning in adulthood: life satisfaction, self-esteem and self-efficacy. Career stability was used as an indicator of adaptive social functioning. Job careers of respondents were characterized as stable, unstable or changeable. Extraversion measured at the age of 16 proved to be the best predictor of well-being indicators; in case of self-efficacy it was also childhood disinhibition. Extraversion in adolescence, childhood disinhibition and negative affectivity predicted career stability. Findings are discussed in the context of a theoretical framework of higher order factors of the Big Five personality constructs, stability and plasticity.	[Blatny, Marek; Millova, Katarna; Osecka, Terezie] Acad Sci Czech Republ, Inst Psychol, Dept Personal & Social Psychol, Brno, Czech Republic; [Jelinek, Martin] Acad Sci Czech Republ, Inst Psychol, Dept Res Methodol, Brno, Czech Republic	Czech Academy of Sciences; Institute of Psychology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Psychology of the Czech Academy of Sciences	Blatny, M (corresponding author), Acad Sci Czech Republ, Inst Psychol, Dept Personal & Social Psychol, Brno, Czech Republic.	blatny@psu.cas.cz	Jelinek, Martin/K-7863-2013; Millová, Katarína/AAB-3505-2021; Millová, Katarína/H-9491-2014; Blatny, Marek/H-4293-2014	Jelinek, Martin/0000-0003-2639-5453; Millová, Katarína/0000-0003-3429-4652; Blatny, Marek/0000-0001-9831-0637	Czech Science Foundation [P407-10-2410]; Czech Republic's support for long-term strategic development of research organization [RVO: 68081740]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Republic's support for long-term strategic development of research organization	This work was supported by the Czech Science Foundation (Grant No. P407-10-2410) and Czech Republic's support for long-term strategic development of research organization (RVO: 68081740). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri G, 2012, PERS INDIV DIFFER, V53, P779, DOI 10.1016/j.paid.2012.05.037; Argyle M, 1991, SUBJECTIVE WELL BEIN, P77; Arrindell WA, 1999, PERS INDIV DIFFER, V26, P815, DOI 10.1016/S0191-8869(98)00180-9; Asendorpf JB, 2008, DEV PSYCHOL, V44, P997, DOI 10.1037/0012-1649.44.4.997; Baltes M.M., 2003, UNDERSTANDING HUMAN, P81, DOI DOI 10.1007/978-1-4615-0357-6_5; Baltes P.B., 2006, HDB CHILD PSYCHOL, P569, DOI [10.1002/9780470147658.chpsy0111, DOI 10.1002/9780470147658.CHPSY0111]; Baltes PB, 1999, ANNU REV PSYCHOL, V50, P471, DOI 10.1146/annurev.psych.50.1.471; Bates JE., 2012, HDB TEMPERAMENT, P425; Belli RF, 1998, MEMORY, V6, P383, DOI 10.1080/741942610; Blatny M, 2001, CESK PSYCHOL, V45, P385; Blatny M, 2004, STUD PSYCHOL, V46, P97; Blatny M, 2007, PERS INDIV DIFFER, V43, P2127, DOI 10.1016/j.paid.2007.06.024; Blickle G, 1996, EUR J PERSONALITY, V10, P337; Boehm JK, 2008, J CAREER ASSESSMENT, V16, P101, DOI 10.1177/1069072707308140; Botwin MD, 1997, J PERS, V65, P107, DOI 10.1111/j.1467-6494.1997.tb00531.x; Bradburn N.M., 1969, STRUCTURE PSYCHOL WE, DOI DOI 10.1037/T10756-000; Brandtstodter J., 2006, HDB CHILD PSYCHOL, P516, DOI DOI 10.1002/9780470147658.CHPSY0110; Buss A. H., 1991, EXPLORATIONS TEMPERA, P43, DOI DOI 10.1007/978-1-4899-0643-4_4; Butkovic A, 2012, J HAPPINESS STUD, V13, P455, DOI 10.1007/s10902-011-9273-7; Card David, 1999, HDB LABOR EC, V3B, P2809, DOI DOI 10.1016/S1573-4463(99)30028-6; Carless SA, 2011, J VOCAT BEHAV, V78, P80, DOI 10.1016/j.jvb.2010.09.002; Caspi A, 1996, INT J METHOD PSYCH, V6, P101, DOI 10.1002/(SICI)1234-988X(199607)6:2<101::AID-MPR156>3.3.CO;2-E; Caspi A, 2000, J PERS SOC PSYCHOL, V78, P158, DOI 10.1037/0022-3514.78.1.158; Caspi A, 2003, J PERS, V71, P495, DOI 10.1111/1467-6494.7104001; CASPI A, 1995, CHILD DEV, V66, P486, DOI 10.2307/1131592; Cellar DF, 2004, PSYCHOL REP, V94, P1437, DOI 10.2466/PR0.94.3.1437-1441; Chipperfield JG, 2001, J GERONTOL B-PSYCHOL, V56, pP176, DOI 10.1093/geronb/56.3.P176; Clark AE, 2003, J LABOR ECON, V21, P323, DOI 10.1086/345560; CLARK AE, 1994, ECON J, V104, P648, DOI 10.2307/2234639; Clark LA, 2005, J ABNORM PSYCHOL, V114, P505, DOI 10.1037/0021-843X.114.4.505; Connor-Smith JK, 2007, J PERS SOC PSYCHOL, V93, P1080, DOI 10.1037/0022-3514.93.6.1080; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; Costa PT, 2007, REVISED NEO PERSONAL; Czech Statistical Office, 2008, LAB MARK AN 2000 200, P36; DeNeve KM, 1998, PSYCHOL BULL, V124, P197, DOI 10.1037/0033-2909.124.2.197; Denissen JJA, 2008, J PERS, V76, P67, DOI 10.1111/j.1467-6494.2007.00480.x; DeYoung CG, 2002, PERS INDIV DIFFER, V33, P533, DOI 10.1016/S0191-8869(01)00171-4; DeYoung CG, 2008, J ABNORM PSYCHOL, V117, P947, DOI 10.1037/a0013742; DeYoung CG, 2006, J PERS SOC PSYCHOL, V91, P1138, DOI 10.1037/0022-3514.91.6.1138; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Digman JM, 1997, J PERS SOC PSYCHOL, V73, P1246, DOI 10.1037/0022-3514.73.6.1246; Dubow EF, 2006, DEV PSYCHOL, V42, P937, DOI 10.1037/0012-1649.42.5.937; Eid M, 2008, SCI SUBJECTIVE WELL; Elder GH, 1998, CHILD DEV, V69, P1, DOI 10.2307/1132065; EMMONS RA, 1985, PERS SOC PSYCHOL B, V11, P89, DOI 10.1177/0146167285111008; Erdle S, 2009, J RES PERS, V43, P921, DOI 10.1016/j.jrp.2009.04.012; Erikson E. H., 2002, DETSTVI SPOLECNOST; Eysenck H.J., 1959, MANUAL MAUDSLEY PERS; Eysenck H.J., 1964, MANUAL EYSENCK PERSO, DOI DOI 10.1007/SPRINGERREFERENCE_184643; Feldt T, 2005, EUR PSYCHOL, V10, P298, DOI 10.1027/1016-9040.10.4.298; Fischer P, 2008, AGGRESSIVE BEHAV, V34, P34, DOI 10.1002/ab.20218; Freedman D, 1988, Sociol Methodol, V18, P37, DOI 10.2307/271044; Freund AM, 2002, J PERS SOC PSYCHOL, V82, P642, DOI 10.1037//0022-3514.82.4.642; Gale CR, 2013, J RES PERS, V47, P687, DOI 10.1016/j.jrp.2013.06.005; Goldsmith H.H., TEMPERAMENT PERSONAL, V20 0 0, P1; Gomez V, 2009, J RES PERS, V43, P345, DOI 10.1016/j.jrp.2008.12.014; GOTTFREDSON GD, 1993, J COUNS PSYCHOL, V40, P518, DOI 10.1037/0022-0167.40.4.518; Gray J. A., 1991, EXPLORATIONS TEMPERA, P105, DOI [DOI 10.1007/978-1-4899-0643-4_8, 10.1007/978-1-4899-0643-4_8, 10.1007/978-1-4899-0643-4]; Gray J. A., 1981, MODEL PERSONALITY, P246, DOI [10.1007/978-3-642-67783-0_8, DOI 10.1007/978-3-642-67783-0_8]; GRAY JA, 1970, BEHAV RES THER, V8, P249, DOI 10.1016/0005-7967(70)90069-0; Grishakova M, 2008, QUALITATIVE SOCIOLOG, V4, P106; Grob A, 1996, J PERS SOC PSYCHOL, V71, P785, DOI 10.1037/0022-3514.71.4.785; Halverson CF, 2001, TEMPERAMENT IN CONTEXT, P61; HAMILTON VL, 1993, J PERS SOC PSYCHOL, V65, P234, DOI 10.1037/0022-3514.65.2.234; Hartman RO, 2007, J CAREER ASSESSMENT, V15, P145, DOI 10.1177/1069072706298011; Hayes N, 2003, PERS INDIV DIFFER, V34, P723, DOI 10.1016/S0191-8869(02)00057-0; HELSON R, 1987, J PERS SOC PSYCHOL, V53, P531, DOI 10.1037/0022-3514.53.3.531; Hill PL, 2012, SOC PSYCHOL PERS SCI, V3, P698, DOI 10.1177/1948550611433888; Hirsh JB, 2009, J PERS, V77, P1085, DOI 10.1111/j.1467-6494.2009.00575.x; Hrebickova M., 2001, NEO 5 FACTOR PERSONA; Huppert FA, 2005, SCI WELL BEING; Jokela M, 2010, EUR J PERSONALITY, V24, P151, DOI 10.1002/per.749; Judge TA, 1999, PERS PSYCHOL, V52, P621, DOI 10.1111/j.1744-6570.1999.tb00174.x; KALIMO R, 1991, J OCCUP PSYCHOL, V64, P97, DOI 10.1111/j.2044-8325.1991.tb00546.x; Klicperova M, 1997, J COMMUNITY APPL SOC, V7, P39, DOI 10.1002/(SICI)1099-1298(199702)7:1<39::AID-CASP398>3.0.CO;2-1; Kokko K, 1998, J ADULT DEV, V5, P205, DOI 10.1023/A:1021450208639; Kokko K, 2000, DEV PSYCHOL, V36, P463, DOI 10.1037/0012-1649.36.4.463; Kokko K, 2003, INT J BEHAV DEV, V27, P134, DOI 10.1080/01650250244000137; Kokko K, 2008, J SOC ISSUES, V64, P59, DOI 10.1111/j.1540-4560.2008.00548.x; Kokko K, 2013, J RES PERS, V47, P748, DOI 10.1016/j.jrp.2013.07.002; KREBS V., 2007, SOCIALNI POLITIKA; Levinson D., 1978, SEASON MANS LIFE; Lucas R. E., 2008, SCI SUBJECTIVE WELL, P171; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; MacDonald K., 2012, HDB TEMPERAMENT, P273; Magnusson D., 1990, STRAIGHT DEVIOUS PAT, P101; McAdams DP, 2006, AM PSYCHOL, V61, P204, DOI 10.1037/0003-066X.61.3.204; McCrae RR, 2000, J PERS SOC PSYCHOL, V78, P173, DOI 10.1037/0022-3514.78.1.173; MCCRAE RR, 1991, PERS SOC PSYCHOL B, V17, P227, DOI 10.1177/014616729101700217; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; Mickiewicz T, 2010, EC I CHANGE; Newman DL, 1997, DEV PSYCHOL, V33, P206, DOI 10.1037/0012-1649.33.2.206; Ng TWH, 2014, HUM RELAT, V67, P71, DOI 10.1177/0018726713486946; Ozer DJ, 2006, ANNU REV PSYCHOL, V57, P401, DOI 10.1146/annurev.psych.57.102904.190127; Pavot W., 2011, WILEY BLACKWELL HDB, P699; Peng YS, 2012, PSYCHOL MARKET, V29, P519, DOI 10.1002/mar.20539; Prior M, 2001, AUST NZ J PSYCHIAT, V35, P297, DOI 10.1046/j.1440-1614.2001.00903.x; Pulkkinen L, 1999, J VOCAT BEHAV, V54, P37, DOI 10.1006/jvbe.1998.1653; Pulkkinen L, 2002, J ADULT DEV, V9, P251, DOI 10.1023/A:1020234926608; Pulkkinen L., 2002, PATHS SUCCESSFUL DEV, P1; Pulkkinen L, 2006, SOC INDIC RES, V77, P171, DOI 10.1007/s11205-005-5558-8; Pulkkinen L, 2011, INT J BEHAV DEV, V35, P475, DOI 10.1177/0165025411422993; Roberts K., 2001, INT J SOCIOLOGY SOCI, V21, P118, DOI DOI 10.1108/01443330110789466; Robins RW, 2005, CURR DIR PSYCHOL SCI, V14, P158, DOI 10.1111/j.0963-7214.2005.00353.x; RONKA A, 1995, J PERS SOC PSYCHOL, V69, P381; Ronka A, 2000, INT J BEHAV DEV, V24, P442; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Rothbart M.K., 2011, BECOMING WHO WE ARE; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; Ryan RM, 2008, J HAPPINESS STUD, V9, P139, DOI 10.1007/s10902-006-9023-4; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Schieman S, 2001, J HEALTH SOC BEHAV, V42, P80, DOI 10.2307/3090228; Schwarzer R., 1993, MEASUREMENT PERCEIVE; Shallcross AJ, 2013, J PERS SOC PSYCHOL, V104, P734, DOI 10.1037/a0031180; Shiner R.L., 2012, HDB TEMPERAMENT, P497; Shiner RL, 2012, DEV PSYCHOPATHOL, V24, P507, DOI 10.1017/S0954579412000120; Shiner RL, 2003, J PERS, V71, P1145, DOI 10.1111/1467-6494.7106010; Silbereisen R. K., 2005, HIST INFLUENCES LIVE, P148; Silbereisen R. K., 2010, SOCIAL CHANGE HUMAN, P125; Silbereisen RK, 2008, RES HUM DEV, V5, P244, DOI 10.1080/15427600802494005; Silbereisen RK, 2010, SOCIAL CHANGE AND HU; Simsek OF, 2014, J PERS ASSESS, V96, P226, DOI 10.1080/00223891.2013.836527; Simsek OF, 2012, J RES PERS, V46, P442, DOI 10.1016/j.jrp.2012.04.005; Sivanathan N., 2004, POSITIVE PSYCHOL PRA, DOI DOI 10.1002/9780470939338.CH15; Slobodskaya HR, 2011, EUR J PERSONALITY, V25, P453, DOI 10.1002/per.810; Slutske WS, 2012, PSYCHOL SCI, V23, P510, DOI 10.1177/0956797611429708; Specht J, 2011, J PERS SOC PSYCHOL, V101, P862, DOI 10.1037/a0024950; Steel P, 2008, PSYCHOL BULL, V134, P138, DOI 10.1037/0033-2909.134.1.138; Sterns H.L., 2001, HDB MIDLIFE DEV, P447; Swider BW, 2010, J VOCAT BEHAV, V76, P487, DOI 10.1016/j.jvb.2010.01.003; Thoms P, 1996, J ORGAN BEHAV, V17, P349, DOI 10.1002/(SICI)1099-1379(199607)17:4<349::AID-JOB756>3.0.CO;2-3; Titma M, 2002, SOC EC, V24, P297, DOI DOI 10.1556/S0CEC.24.2002.3.1; Trzesniewski KH, 2003, J PERS SOC PSYCHOL, V84, P205, DOI 10.1037//0022-3514.84.1.205; Vonkomer J., 1979, EYSENCK PERSONALITY; Wang Z, 2013, EUR J PERSONALITY, V27, P96, DOI 10.1002/per.1886; WATERMAN AS, 1993, J PERS SOC PSYCHOL, V64, P678, DOI 10.1037/0022-3514.64.4.678; Watson D, 2002, J PERS SOC PSYCHOL, V83, P185, DOI 10.1037//0022-3514.83.1.185; Wille B, 2012, J VOCAT BEHAV, V81, P307, DOI 10.1016/j.jvb.2012.06.004; Wille B, 2010, J VOCAT BEHAV, V76, P547, DOI 10.1016/j.jvb.2010.01.007; Wilt J, 2011, J RES PERS, V45, P613, DOI 10.1016/j.jrp.2011.08.010; Wortman J, 2012, PSYCHOL AGING, V27, P867, DOI 10.1037/a0029322	145	14	14	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0126032	10.1371/journal.pone.0126032	http://dx.doi.org/10.1371/journal.pone.0126032			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SE	25919394	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659400092
J	Pinho, R; Garcia, V; Feldman, MW				Pinho, Ricardo; Garcia, Victor; Feldman, Marcus W.			Phenotype Accessibility and Noise in Random Threshold Gene Regulatory Networks	PLOS ONE			English	Article							EVO-DEVO; EVOLUTION; EXPRESSION; ROBUSTNESS; SYSTEMS; STOCHASTICITY; CONSEQUENCES; TOPOLOGY	Evolution requires phenotypic variation in a population of organisms for selection to function. Gene regulatory processes involved in organismal development affect the phenotypic diversity of organisms. Since only a fraction of all possible phenotypes are predicted to be accessed by the end of development, organisms may evolve strategies to use environmental cues and noise-like fluctuations to produce additional phenotypic diversity, and hence to enhance the speed of adaptation. We used a generic model of organismal development -gene regulatory networks-to investigate how different levels of noise on gene expression states (i.e. phenotypes) may affect access to new, unique phenotypes, thereby affecting phenotypic diversity. We studied additional strategies that organisms might adopt to attain larger phenotypic diversity: either by augmenting their genome or the number of gene expression states. This was done for different types of gene regulatory networks that allow for distinct levels of regulatory influence on gene expression or are more likely to give rise to stable phenotypes. We found that if gene expression is binary, increasing noise levels generally decreases phenotype accessibility for all network types studied. If more gene expression states are considered, noise can moderately enhance the speed of discovery if three or four gene expression states are allowed, and if there are enough distinct regulatory networks in the population. These results were independent of the network types analyzed, and were robust to different implementations of noise. Hence, for noise to increase the number of accessible phenotypes in gene regulatory networks, very specific conditions need to be satisfied. If the number of distinct regulatory networks involved in organismal development is large enough, and the acquisition of more genes or fine tuning of their expression states proves costly to the organism, noise can be useful in allowing access to more unique phenotypes.	[Pinho, Ricardo; Feldman, Marcus W.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Pinho, Ricardo] Inst Gulbenkian Ciencias, PhD Program Computat Biol, Oeiras, Portugal; [Garcia, Victor] ETH, Inst Integrat Biol, Zurich, Switzerland	Stanford University; Instituto Gulbenkian de Ciencia; Swiss Federal Institutes of Technology Domain; ETH Zurich	Pinho, R (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	pinho.ricardo@gmail.com	Garcia, Victor/H-4403-2019; Pinho, Ricardo/G-2643-2012; Pinho, Ricardo/GQH-3657-2022	Pinho, Ricardo/0000-0003-3116-4553; Pinho, Ricardo/0000-0003-3116-4553	Fundacao Calouste Gulbenkian; Siemens SA; Fundacao para a Ciencia e Tecnologia [SFRH/BD/33531/2008]; Stanford Center for Computational, Evolutionary and Human Genomics; National Institutes of Health [GM28016]; Swiss National Science Foundation [P1EZP3_148648]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028016] Funding Source: NIH RePORTER	Fundacao Calouste Gulbenkian(European Commission); Siemens SA; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Stanford Center for Computational, Evolutionary and Human Genomics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: The Ph.D. Program in Computational Biology is sponsored by Fundacao Calouste Gulbenkian, Siemens SA, and Fundacao para a Ciencia e Tecnologia (fellowship SFRH/BD/33531/2008). This work was supported in part by The Stanford Center for Computational, Evolutionary and Human Genomics, and by National Institutes of Health grant no. GM28016. V.G. gratefully acknowledges the funding of the Swiss National Science Foundation, grant number P1EZP3_148648. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Babu MM, 2003, NUCLEIC ACIDS RES, V31, P1234, DOI 10.1093/nar/gkg210; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Borenstein E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000202; Bornholdt S, 2001, BIOL CHEM, V382, P1289, DOI 10.1515/BC.2001.161; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Brent R. P., 1980, BIT (Nordisk Tidskrift for Informationsbehandling), V20, P176, DOI 10.1007/BF01933190; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Crauel H., 1997, Journal of Dynamics and Differential Equations, V9, P307, DOI 10.1007/BF02219225; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fontana W, 2002, BIOESSAYS, V24, P1164, DOI 10.1002/bies.10190; GILBERT SF, 1994, DEV BIOL; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Gray F., 1953, U. S. Patent, Patent No. [2,632,058, 2632058, 2 632 058]; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Jaeger J, 2012, J EXP ZOOL PART B, V318B, P591, DOI 10.1002/jez.b.22468; Jenkins DJ, 2010, J MOL EVOL, V70, P215, DOI 10.1007/s00239-010-9323-5; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kaneko K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000434; Kim M, 2010, BIOINFORMATICS, V26, P486, DOI 10.1093/bioinformatics/btp685; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; KURTEN KE, 1988, J PHYS A-MATH GEN, V21, pL615, DOI 10.1088/0305-4470/21/11/009; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Masel J, 2004, J EVOLUTION BIOL, V17, P1106, DOI 10.1111/j.1420-9101.2004.00739.x; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Pinho R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034285; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Rossi FMV, 2000, MOL CELL, V6, P723, DOI 10.1016/S1097-2765(00)00070-8; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Shmulevich I, 2002, BIOINFORMATICS, V18, P1319, DOI 10.1093/bioinformatics/18.10.1319; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Thomas P, 2014, P NATL ACAD SCI USA, V111, P6994, DOI 10.1073/pnas.1400049111; Viney M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1104; Waddington C H, 1957, STRATEGY GENES DISCU; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; Wagner A, 1996, EVOLUTION, V50, P1008, DOI 10.1111/j.1558-5646.1996.tb02342.x; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Whitacre JM, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-20; Whitacre JM, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-6; Zhang ZH, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.58	55	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0119972	10.1371/journal.pone.0119972	http://dx.doi.org/10.1371/journal.pone.0119972			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919290	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659400002
J	Wang, Y; Wang, Z; Chen, MP; Fan, N; Yang, J; Liu, L; Wang, Y; Liu, XY				Wang, Yun; Wang, Zhi; Chen, Mengping; Fan, Ning; Yang, Jie; Liu, Lu; Wang, Ying; Liu, Xuyang			Mutational Analysis of the TYR and OCA2 Genes in Four Chinese Families with Oculocutaneous Albinism	PLOS ONE			English	Article							PINK-EYED DILUTION; TYROSINASE GENE; P-GENE; IDENTIFICATION; PHENOTYPE; DIAGNOSIS; SEQUENCE; TYPE-1; MAPS	Background Oculocutaneous albinism (OCA) is an autosomal recessive disorder. The most common type OCA1 and OCA2 are caused by homozygous or compound heterozygous mutations in the tyrosinase gene (TYR) and OCA2 gene, respectively. Objective The purpose of this study was to evaluate the molecular basis of oculocutaneous albinism in four Chinese families. Patients and Methods Four non-consanguineous OCA families were included in the study. The TYR and OCA2 genes of all individuals were amplified by polymerase chain reaction (PCR), sequenced and compared with a reference database. Results Four patients with a diagnosis of oculocutaneous albinism, presented with milky skin, white or light brown hair and nystagmus. Genetic analyses demonstrated that patient A was compound heterozygous for c.1037-7T. A, c.1037-10_11delTT and c.1114delG mutations in the TYR gene; patient B was heterozygous for c.593C>T and c.1426A>G mutations in the OCA2 gene, patients C and D were compound heterozygous mutations in the TYR gene (c.549_550delGT and c.896G>A, c.832C>T and c.985T>C, respectively). The heterozygous c.549_550delGT and c.1114delG alleles in the TYR gene were two novel mutations. Interestingly, heterozygous members in these pedigrees who carried c.1114delG mutations in the TYR gene or c.1426A>G mutations in the OCA2 gene presented with blond or brown hair and pale skin, but no ocular disorders when they were born; the skin of these patients accumulated pigment over time and with sun exposure. Conclusion This study expands the mutation spectrum of oculocutaneous albinism. It is the first time, to the best of our knowledge, to report that c.549_550delGT and c.1114delG mutations in the TYR gene were associated with OCA. The two mutations (c.1114delG in the TYR gene and c.1426A>G in the OCA2 gene) may be responsible for partial clinical manifestations of OCA.	[Wang, Yun; Fan, Ning; Liu, Lu; Wang, Ying; Liu, Xuyang] Jinan Univ, Shenzhen Eye Hosp, Shenzhen Key Lab Ophthalmol, Shenzhen, Peoples R China; [Wang, Zhi; Yang, Jie] Nanchang Univ, Inst Translat Med, Nanchang, Peoples R China; [Chen, Mengping] Second Peoples Hosp Zhengzhou, Dept Ophthalmol, Zhengzhou, Peoples R China	Jinan University; Nanchang University	Liu, XY (corresponding author), Jinan Univ, Shenzhen Eye Hosp, Shenzhen Key Lab Ophthalmol, Shenzhen, Peoples R China.	xliu1213@126.com			National Natural Science Foundation of China (NSFC) [81170851, 81270995, 81200688, 81371009]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (NSFC 81170851, 81270995, 81200688 and 81371009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brilliant MH, 2001, PIGM CELL RES, V14, P86, DOI 10.1034/j.1600-0749.2001.140203.x; BRILLIANT MH, 1994, PIGM CELL RES, V7, P398, DOI 10.1111/j.1600-0749.1994.tb00068.x; GERSHONIBARUCH R, 1994, AM J HUM GENET, V54, P586; Gong Y, 1994, Yi Chuan Xue Bao, V21, P169; Goto M, 2004, J DERMATOL SCI, V35, P215, DOI 10.1016/j.jdermsci.2004.06.007; Gronskov K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-43; Gronskov K, 2013, AM J HUM GENET, V92, P415, DOI 10.1016/j.ajhg.2013.01.006; HERMANSKY F, 1959, BLOOD, V14, P162, DOI 10.1182/blood.V14.2.162.162; Introne W, 1999, MOL GENET METAB, V68, P283, DOI 10.1006/mgme.1999.2927; Jeffery G, 1997, DEV BRAIN RES, V99, P95, DOI 10.1016/S0165-3806(96)00211-8; Kausar T, 2013, CLIN GENET, V84, P91, DOI 10.1111/cge.12019; KING RA, 1985, AM J MED GENET, V20, P49, DOI 10.1002/ajmg.1320200108; King RA, 2003, HUM GENET, V113, P502, DOI 10.1007/s00439-003-0998-1; Lee ST, 1997, JPN J HUM GENET, V42, P499, DOI 10.1007/BF02767026; LEE ST, 1995, GENOMICS, V26, P354, DOI 10.1016/0888-7543(95)80220-G; LERNER AB, 1950, J BIOL CHEM, V187, P793; Levin AV, 2011, J AAPOS, V15, P59, DOI 10.1016/j.jaapos.2010.10.012; Li HY, 2007, PRENATAL DIAG, V27, P502, DOI 10.1002/pd.1713; Matsunaga J, 1999, DERMATOLOGY, V199, P124, DOI 10.1159/000018218; Matsunaga J, 1998, DERMATOLOGY, V196, P189, DOI 10.1159/000017897; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Montoliu L, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12167; Park SK, 1997, MOL CELLS, V7, P187; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; ROSEMBLAT S, 1994, P NATL ACAD SCI USA, V91, P12071, DOI 10.1073/pnas.91.25.12071; Rundshagen U, 2004, HUM MUTAT, V23, P106, DOI 10.1002/humu.10311; Simeonov DR, 2013, HUM MUTAT, V34, P827, DOI 10.1002/humu.22315; Sundaresan P, 2004, MOL VIS, V10, P1005; Suzuki T, 2003, J INVEST DERMATOL, V120, P781, DOI 10.1046/j.1523-1747.2003.12127.x; TRIPATHI RK, 1992, AM J MED GENET, V43, P865, DOI 10.1002/ajmg.1320430523; TRIPATHI RK, 1993, AM J HUM GENET, V53, P1173; Wang Y, 2009, J DERMATOL SCI, V53, P80, DOI 10.1016/j.jdermsci.2008.07.002; Wei AH, 2013, J INVEST DERMATOL, V133, P1834, DOI 10.1038/jid.2013.49; Wei AH, 2013, CHINESE MED J-PEKING, V126, P226, DOI 10.3760/cma.j.issn.0366-6999.20121104; Wei AH, 2010, J INVEST DERMATOL, V130, P716, DOI 10.1038/jid.2009.339; Zahed L, 2005, J HUM GENET, V50, P317, DOI 10.1007/s10038-005-0257-5	36	4	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125651	10.1371/journal.pone.0125651	http://dx.doi.org/10.1371/journal.pone.0125651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919014	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400087
J	Anderson, JS; Smithson, T; Mansky, CF; Meyer, T; Clack, J				Anderson, Jason S.; Smithson, Tim; Mansky, Chris F.; Meyer, Taran; Clack, Jennifer			A Diverse Tetrapod Fauna at the Base of 'Romer's Gap'	PLOS ONE			English	Article							EARLY EVOLUTION; EAST KIRKTON; STEM TETRAPOD; CARBONIFEROUS TETRAPOD; ACANTHOSTEGA-GUNNARI; PRIMITIVE TETRAPOD; OSSINODUS-PUERI; AXIAL SKELETON; PECTORAL FIN; ORIGIN	The lack of fossil tetrapod bearing deposits in the earliest Carboniferous ('Romer's Gap') has provoked some recent discussions regarding the proximal cause, with three explanations being offered: environmental, taphonomic, and collection failure. One of the few, and earliest, windows into this time is the locality of Blue Beach exposed in the Tournaisian deposits at Horton Bluff lying along the Avon River near Hantsport, Nova Scotia, Canada. This locality has long been known but, because the fossils were deposited in high energy settings they are almost always disarticulated, so the fauna has not been described in detail. Recent intensive collection has revealed a diverse assemblage of material, including for the first time associated elements, which permits an evaluation of the faunal constituents at the locality. Although not diagnosable to a fine taxonomic level, sufficient apomorphies are present to identify representatives from numerous clades known from more complete specimens elsewhere. The evidence suggests a diverse fauna was present, including whatch-eeriids and embolomeres. A single humerus previously had been attributed to a colosteid, but there is some uncertainty with this identification. Additional elements suggest the presence of taxa otherwise only known from the late Devonian. Depositional biases at the locality favor tetrapod fossils from larger individuals, but indirect evidence from trackways and tantalizing isolated bones evidences the presence of small taxa that remain to be discovered. The fossils from Blue Beach demonstrate that when windows into the fauna of 'Romer's Gap' are found a rich diversity of tetrapods will be shown to be present, contra arguments that suggested this hiatus in the fossil record was due to extrinsic factors such as atmospheric oxygen levels. They also show that the early tetrapod fauna is not easily divisible into Devonian and Carboniferous faunas, suggesting that some tetrapods passed through the end Devonian extinction event unaffected.	[Anderson, Jason S.] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada; [Smithson, Tim; Clack, Jennifer] Univ Cambridge, Museum Zool, Cambridge, England; [Mansky, Chris F.] Blue Beach Fossil Museum, Hantsport, NS, Canada; [Meyer, Taran] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Cambridge; University of Calgary	Anderson, JS (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada.	janders@ucalgary.ca			Natural Environment Research Council [NE/J022713/1]; Natural Sciences and Engineering Research Council [327756-2011]; NERC [NE/J022713/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council Grant NE/J022713/1 (http://www.nerc.ac.uk/) to JC, and the Natural Sciences and Engineering Research Council Discovery Grant 327756-2011 (http://www.nserc-crsng.gc.ca/index_eng.asp) to JSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg PE, 2005, NATURE, V437, P137, DOI 10.1038/nature03893; Algeo TJ, 2007, PALAEOGEOGR PALAEOCL, V256, P130, DOI 10.1016/j.palaeo.2007.02.029; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P391; [Anonymous], 1988, PHYLOGENY CLASSIFICA; Bishop PJ, 2014, ALCHERINGA, V38, P209, DOI 10.1080/03115518.2014.861320; Boisvert CA, 2005, NATURE, V438, P1145, DOI 10.1038/nature04119; Boisvert CA, 2008, NATURE, V456, P636, DOI 10.1038/nature07339; Boisvert CA, 2009, ACTA ZOOL-STOCKHOLM, V90, P297, DOI 10.1111/j.1463-6395.2008.00389.x; Bolt JR, 2010, J PALEONTOL, V84, P1135, DOI 10.1666/10-020.1; Bolt JR, 2001, J PALEONTOL, V75, P1016, DOI 10.1666/0022-3360(2001)075<1016:TMOTPT>2.0.CO;2; Brazeau MD, 2006, NATURE, V439, P318, DOI 10.1038/nature04196; Brazeau MD, 2005, CAN J EARTH SCI, V42, P1481, DOI 10.1139/E05-041; Carroll RL., 2009, RISE AMPHIBIANS 365; Carroll RL, 1972, 24 INT GEOL C, P113; Clack J. A., 2012, GAINING GROUND ORIGI; Clack J. A., 1993, DECIPHERING NATURAL, P39; CLACK JA, 1994, T ROY SOC EDIN-EARTH, V84, P369; Clack JA, 2003, NATURE, V425, P65, DOI 10.1038/nature01904; Clack JA, 1998, ZOOL J LINN SOC-LOND, V122, P61, DOI 10.1006/zjls.1997.0114; Clack JA, 2002, T ROY SOC EDIN-EARTH, V93, P17, DOI 10.1017/S0263593300000304; Clack JA, 2001, T ROY SOC EDIN-EARTH, V92, P75, DOI 10.1017/S0263593300000055; Clack JA., 2005, J SYST PALAEONTOL, V2, P311, DOI [10.1017/S1477201904001506, DOI 10.1017/S1477201904001506]; Clack JA, 2007, INTEGR COMP BIOL, V47, P510, DOI 10.1093/icb/icm055; Clack Jennifer A., 2012, Fieldiana-Life and Earth Sciences, V5, P17; Clack Jennifer A., 2000, Amphibian Biology, V4, P1030; Clack Jennifer A., 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P359; COATES MI, 1991, NATURE, V352, P234, DOI 10.1038/352234a0; COATES MI, 1990, NATURE, V347, P66, DOI 10.1038/347066a0; Coates Michael I., 2007, P15; Coates Michael I., 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P373; Cohn MJ, 2002, BIOESSAYS, V24, P460, DOI 10.1002/bies.10088; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Daeschler EB, 2009, ACTA ZOOL-STOCKHOLM, V90, P306, DOI 10.1111/j.1463-6395.2008.00361.x; Davis MC, 2004, J VERTEBR PALEONTOL, V24, P26, DOI 10.1671/1920-3; GODFREY SJ, 1989, PHILOS T ROY SOC B, V323, P75, DOI 10.1098/rstb.1989.0002; Graham JB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4022; Hall B.K., 2007, FINS LIMBS EVOLUTION; Holmes R., 1980, Systematics Association Special Volume Series, P351; Jarvik Erik, 1996, Fossils and Strata, V40, P1; Kawano SM, 2013, INTEGR COMP BIOL, V53, P283, DOI 10.1093/icb/ict051; Kutschera Ulrich, 2013, Evolution Education and Outreach, V6, P1; Larsson Hans C.E., 2007, P150; LEBEDEV OA, 1995, ZOOL J LINN SOC-LOND, V114, P307, DOI 10.1006/zjls.1995.0027; LOMBARD RE, 1995, PALAEONTOLOGY, V38, P471; Lucas S.G., 2010, GEOL SOC AM ABSTR, V45, P641; Mabee PM, 2002, J EXP ZOOL, V294, P77, DOI 10.1002/JEZ.10076; Mansky Chris F., 2013, Bulletin of the New Mexico Museum of Natural History and Science, P244; MARTEL AT, 1993, CAN J EARTH SCI, V30, P1091, DOI 10.1139/e93-092; McGhee G. R., 2013, INVASION LAND FAILED, DOI 10.7312/MCGH16056/PDF; MILNER AC, 1994, T ROY SOC EDIN-EARTH, V84, P363; MILNER AR, 1994, T ROY SOC EDIN-EARTH, V84, P331; Parker K, 2005, J VERTEBR PALEONTOL, V25, P46, DOI 10.1671/0272-4634(2005)025[0046:SRSPEF]2.0.CO;2; Pierce SE, 2013, INTEGR COMP BIOL, V53, P209, DOI 10.1093/icb/ict022; Pierce SE, 2012, NATURE, V486, P523, DOI 10.1038/nature11124; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; ROMER AS, 1956, P AM PHILOS SOC, V100, P157; Sallan LC, 2010, P NATL ACAD SCI USA, V107, P10131, DOI 10.1073/pnas.0914000107; San Mauro D, 2010, MOL PHYLOGENET EVOL, V56, P554, DOI 10.1016/j.ympev.2010.04.019; Scott AC, 2006, P NATL ACAD SCI USA, V103, P10861, DOI 10.1073/pnas.0604090103; SHUBIN N, 1995, EVOL BIOL, V28, P39; Shubin NH, 2014, P NATL ACAD SCI USA, V111, P893, DOI 10.1073/pnas.1322559111; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; Smithson TR, 2013, CR PALEVOL, V12, P405, DOI 10.1016/j.crpv.2013.06.006; Smithson TR, 2012, P NATL ACAD SCI USA, V109, P4532, DOI 10.1073/pnas.1117332109; SMITHSON TR, 1985, ZOOL J LINN SOC-LOND, V85, P317, DOI 10.1111/j.1096-3642.1985.tb01517.x; SMITHSON TR, 1994, T ROY SOC EDIN-EARTH, V84, P383, DOI 10.1017/S0263593300006192; SMITHSON TR, 1994, T ROY SOC EDIN-EARTH, V84, P377; Standen EM, 2014, NATURE, V513, P54, DOI 10.1038/nature13708; Sues HD, 2013, ATL GEOL, V49, P90, DOI 10.4138/atlgeol.2013.004; Wagner Gunter P., 2007, P49; Ward P, 2006, P NATL ACAD SCI USA, V103, P16818, DOI 10.1073/pnas.0607824103; Warren A, 2004, PALAEONTOLOGY, V47, P151, DOI 10.1111/j.0031-0239.2004.00353.x; Warren A, 2007, J VERTEBR PALEONTOL, V27, P850, DOI 10.1671/0272-4634(2007)27[850:NDOOPA]2.0.CO;2; Zhang P, 2005, SYST BIOL, V54, P391, DOI 10.1080/10635150590945278; Zheng YC, 2011, MOL BIOL EVOL, V28, P2521, DOI 10.1093/molbev/msr072	75	38	39	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125446	10.1371/journal.pone.0125446	http://dx.doi.org/10.1371/journal.pone.0125446			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915639	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100129
J	Chaplin, A; Parra, P; Serra, F; Palou, A				Chaplin, Alice; Parra, Pilar; Serra, Francisca; Palou, Andreu			Conjugated Linoleic Acid Supplementation under a High-Fat Diet Modulates Stomach Protein Expression and Intestinal Microbiota in Adult Mice	PLOS ONE			English	Article							REDUCES BODY-FAT; GROWTH-HORMONE SECRETAGOGUE; GUT MICROBIOTA; GASTRIC LEPTIN; WEIGHT-GAIN; FOOD-INTAKE; AKKERMANSIA-MUCINIPHILA; GHRELIN SECRETION; GLUCAGON RECEPTOR; ENERGY-METABOLISM	The gastrointestinal tract constitutes a physiological interface integrating nutrient and microbiota-host metabolism. Conjugated linoleic acids (CLA) have been reported to contribute to decreased body weight and fat accretion. The modulation by dietary CLA of stomach proteins related to energy homeostasis or microbiota may be involved, although this has not been previously analysed. This is examined in the present study, which aims to underline the potential mechanisms of CLA which contribute to body weight regulation. Adult mice were fed either a normal fat (NF, 12% kJ content as fat) or a high-fat (HF, 43% kJ content as fat) diet. In the latter case, half of the animals received daily oral supplementation of CLA. Expression and content of stomach proteins and specific bacterial populations from caecum were analysed. CLA supplementation was associated with an increase in stomach protein expression, and exerted a prebiotic action on both Bacteroidetes/Prevotella and Akkermansia muciniphila. However, CLA supplementation was not able to override the negative effects of HF diet on Bifidobacterium spp., which was decreased in both HF and HF+CLA groups. Our data show that CLA are able to modulate stomach protein expression and exert a prebiotic effect on specific gut bacterial species.	[Serra, Francisca] Univ Balearic Isl, Lab Mol Biol Nutr & Biotechnol, Palma De Mallorca, Spain; CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Palma De Mallorca, Spain	Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Serra, F (corresponding author), Univ Balearic Isl, Lab Mol Biol Nutr & Biotechnol, Palma De Mallorca, Spain.	francisca.serra@uib.es	Chaplin, Alice/R-5067-2019; Palou, Andreu/K-9881-2014; Serra, Francisca/B-8641-2008	Palou, Andreu/0000-0002-0295-4452; Serra, Francisca/0000-0002-8307-9732; Chaplin, Alice/0000-0003-0685-4237	EU [BIOCLAIMS FP7-244995]; Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion, CIBERobn; "Direccio General d'Universitats, Recerca i Transferencia del Coneixement" of Regional Government (CAIB); FEDER funds (EU); Conselleria d'Educacio, Cultura i Universitats, Govern de les Illes Balears; European Social Fund;  [AGL2012-33692]	EU(European Commission); Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion, CIBERobn; "Direccio General d'Universitats, Recerca i Transferencia del Coneixement" of Regional Government (CAIB); FEDER funds (EU)(European Commission); Conselleria d'Educacio, Cultura i Universitats, Govern de les Illes Balears; European Social Fund(European Social Fund (ESF)); 	This work was supported by the grant AGL2012-33692 and the EU-funded project (BIOCLAIMS FP7-244995). The authors' group receives financial support from Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion, CIBERobn. Authors belong to the Nutrigenomics-group, awarded as "Group of Excellence" of CAIB and supported by "Direccio General d'Universitats, Recerca i Transferencia del Coneixement" of Regional Government (CAIB) and FEDER funds (EU). AC is supported by a PhD fellowship by Conselleria d'Educacio, Cultura i Universitats, Govern de les Illes Balears, a project which is cofinanced by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012; Bednarek MA, 2000, J MED CHEM, V43, P4370, DOI 10.1021/jm0001727; Blankson H, 2000, J NUTR, V130, P2943, DOI 10.1093/jn/130.12.2943; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brownawell AM, 2012, J NUTR, V142, P962, DOI 10.3945/jn.112.158147; Cammisotto P, 2012, ANAT CELL BIOL, V45, P1, DOI 10.5115/acb.2012.45.1.1; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2009, CURR OPIN PHARMACOL, V9, P737, DOI 10.1016/j.coph.2009.06.016; Cinti S, 2001, GUT, V49, P155, DOI 10.1136/gut.49.1.155; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Derrien M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00166; dos Santos VM, 2010, CURR OPIN BIOTECH, V21, P539, DOI 10.1016/j.copbio.2010.08.003; Dunphy JL, 1998, MOL CELL ENDOCRINOL, V141, P179, DOI 10.1016/S0303-7207(98)00096-3; Erdmann J, 2003, REGUL PEPTIDES, V116, P101, DOI 10.1016/S0167-0115(03)00195-2; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Cano PG, 2013, OBESITY, V21, P2310, DOI 10.1002/oby.20330; Gaullier JM, 2007, BRIT J NUTR, V97, P550, DOI 10.1017/S0007114507381324; Greenman Y, 2004, CLIN ENDOCRINOL, V60, P382, DOI 10.1111/j.1365-2265.2004.01993.x; Guinane CM, 2013, THER ADV GASTROENTER, V6, P295, DOI 10.1177/1756283X13482996; Hernandez E, 2013, GUT MICROBES, V4, P306, DOI 10.4161/gmic.25321; Kanaya N, 2010, NUTR RES, V30, P714, DOI 10.1016/j.nutres.2010.09.001; Katayama T, 2007, BIOCHEM BIOPH RES CO, V357, P865, DOI 10.1016/j.bbrc.2007.04.001; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kumar U, 2010, RESULTS PROBL CELL D, V50, P137, DOI 10.1007/400_2009_29; Laraichi S, 2013, LIPIDS, V48, P817, DOI 10.1007/s11745-013-3798-y; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lukovac S, 2014, MBIO, V5, DOI 10.1128/mBio.01438-14; McKee KK, 1997, GENOMICS, V46, P426, DOI 10.1006/geno.1997.5069; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Nadal I, 2009, INT J OBESITY, V33, P758, DOI 10.1038/ijo.2008.260; Neary MT, 2009, PHARMACOL THERAPEUT, V124, P44, DOI 10.1016/j.pharmthera.2009.06.005; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Nogueiras R, 2003, FEBS LETT, V548, P21, DOI 10.1016/S0014-5793(03)00708-7; Nogueiras R, 2007, ENDOCRINOLOGY, V148, P21, DOI 10.1210/en.2006-0915; Oliver P, 2002, DEV DYNAM, V223, P148, DOI 10.1002/dvdy.1233; Palou A, 2009, APPETITE, V52, P249, DOI 10.1016/j.appet.2008.09.013; Park Y, 2007, J FOOD SCI, V72, pS612, DOI 10.1111/j.1750-3841.2007.00477.x; Park Y, 1997, LIPIDS, V32, P853, DOI 10.1007/s11745-997-0109-x; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Parnell JA, 2012, BRIT J NUTR, V107, P601, DOI 10.1017/S0007114511003163; Parra Pilar, 2010, Nutr Metab (Lond), V7, P5, DOI 10.1186/1743-7075-7-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sakata I, 2009, AM J PHYSIOL-ENDOC M, V297, pE134, DOI 10.1152/ajpendo.90859.2008; Sanchez J, 2007, GENES NUTR, V2, P135, DOI 10.1007/s12263-007-0033-6; Sanchez J, 2004, ENDOCRINOLOGY, V145, P5049, DOI 10.1210/en.2004-0493; Sanchez J, 2004, PFLUG ARCH EUR J PHY, V448, P500, DOI 10.1007/s00424-004-1283-4; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; Scarpace PJ, 2009, AM J PHYSIOL-REG I, V296, pR493, DOI 10.1152/ajpregu.90669.2008; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Smedman A, 2001, LIPIDS, V36, P773, DOI 10.1007/s11745-001-0784-7; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Sonoyama K, 2010, BRIT J NUTR, V103, P218, DOI 10.1017/S0007114509991589; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Takahashi Y, 2002, COMP BIOCHEM PHYS B, V133, P395, DOI 10.1016/S1096-4959(02)00164-1; Thom E, 2001, J INT MED RES, V29, P392, DOI 10.1177/147323000102900503; Trigueros L, 2013, CRIT REV FOOD SCI, V53, P929, DOI 10.1080/10408398.2011.574215; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wadden D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045748; West DB, 1998, AM J PHYSIOL-REG I, V275, pR667; West DB, 2000, J NUTR, V130, P2471, DOI 10.1093/jn/130.10.2471; Zabala A, 2006, NUTRITION, V22, P528, DOI 10.1016/j.nut.2005.10.005; Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Zhao Z, 2008, J ENDOCRINOL, V196, P529, DOI 10.1677/JOE-07-0300	71	44	46	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125091	10.1371/journal.pone.0125091	http://dx.doi.org/10.1371/journal.pone.0125091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915857	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100096
J	Fontenete, S; Leite, M; Guimaraes, N; Madureira, P; Ferreira, RM; Figueiredo, C; Wengel, J; Azevedo, NF				Fontenete, Silvia; Leite, Marina; Guimaraes, Nuno; Madureira, Pedro; Ferreira, Rui Manuel; Figueiredo, Ceu; Wengel, Jesper; Azevedo, Nuno Filipe			Towards Fluorescence In Vivo Hybridization (FIVH) Detection of H. pylori in Gastric Mucosa Using Advanced LNA Probes	PLOS ONE			English	Article							ANTISENSE PHOSPHOROTHIOATE OLIGONUCLEOTIDES; CONFOCAL LASER ENDOMICROSCOPY; NUCLEIC-ACID PROBE; HELICOBACTER-PYLORI; SITU HYBRIDIZATION; RIBOSOMAL-RNA; CHEMICAL-MODIFICATION; CLARITHROMYCIN RESISTANCE; ESCHERICHIA-COLI; EPITHELIAL-CELLS	In recent years, there have been several attempts to improve the diagnosis of infection caused by Helicobacter pylori. Fluorescence in situ hybridization (FISH) is a commonly used technique to detect H. pylori infection but it requires biopsies from the stomach. Thus, the development of an in vivo FISH-based method (FIVH) that directly detects and allows the visualization of the bacterium within the human body would significantly reduce the time of analysis, allowing the diagnosis to be performed during endoscopy. In a previous study we designed and synthesized a phosphorothioate locked nucleic acid (LNA)/2' O-methyl RNA (2'OMe) probe using standard phosphoramidite chemistry and FISH hybridization was then successfully performed both on adhered and suspended bacteria at 37 degrees C. In this work we simplified, shortened and adapted FISH to work at gastric pH values, meaning that the hybridization step now takes only 30 minutes and, in addition to the buffer, uses only urea and probe at non-toxic concentrations. Importantly, the sensitivity and specificity of the FISH method was maintained in the range of conditions tested, even at low stringency conditions (e.g., low pH). In conclusion, this methodology is a promising approach that might be used in vivo in the future in combination with a confocal laser endomicroscope for H. pylori visualization.	[Fontenete, Silvia; Guimaraes, Nuno; Azevedo, Nuno Filipe] Univ Porto, Fac Engn, Lab Proc Engn Environm Biotechnol & Energy, LEPABE, P-4100 Oporto, Portugal; [Fontenete, Silvia; Leite, Marina; Guimaraes, Nuno; Madureira, Pedro; Ferreira, Rui Manuel; Figueiredo, Ceu] Univ Porto, Inst Invest Inovacao Saude, P-4100 Oporto, Portugal; [Fontenete, Silvia; Leite, Marina; Guimaraes, Nuno; Ferreira, Rui Manuel; Figueiredo, Ceu; Wengel, Jesper] Univ Porto, Inst Mol Pathol & Immunol, IPATIMUP, P-4100 Oporto, Portugal; [Fontenete, Silvia; Guimaraes, Nuno] Univ Southern Denmark, Dept Phys Chem & Pharm, Nucle Acid Ctr, Odense M, Denmark; [Fontenete, Silvia; Madureira, Pedro] Univ Porto, Inst Biomed Sci Abel Salazar, ICBAS, P-4100 Oporto, Portugal; [Madureira, Pedro] Inst Mol Biol & Cell Biol, IBMC, Oporto, Portugal; [Figueiredo, Ceu] Univ Porto, Fac Med, FMUP, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; University of Southern Denmark; Universidade do Porto; Universidade do Porto; Universidade do Porto	Fontenete, S (corresponding author), Univ Porto, Fac Engn, Lab Proc Engn Environm Biotechnol & Energy, LEPABE, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	sfontenete@fe.up.pt	Ferreira, Rui M./J-6915-2013; Figueiredo, Ceu/B-8776-2008; Madureira, Pedro/D-2174-2013; Leite, Carla Marina Gonçalves/J-5976-2013; Guimaraes, Nuno/H-3270-2019; Fontenete, Sílvia/Q-1936-2018	Ferreira, Rui M./0000-0003-0961-2356; Figueiredo, Ceu/0000-0001-5247-840X; Madureira, Pedro/0000-0003-4078-800X; Leite, Carla Marina Gonçalves/0000-0003-4286-0247; Guimaraes, Nuno/0000-0002-7623-3877; Fontenete, Sílvia/0000-0003-1972-6349; Azevedo, Nuno/0000-0001-5864-3250; Wengel, Jesper/0000-0001-9835-1009	Fundacao de Ciencia e Tecnologia [PIC/IC/82815/2007]; Ministerio da Ciencia, Tecnologia e Ensino Superior [SFRH/BD/72999/2010, SFRH/BPD/33420/2008, SFRH/BPD/78846/2011]; Nucleic Acid Center, University of Southern Denmark; FEDER (Operational Programme for Competitiveness Factors - COMPETE, ON.2 - O Novo Norte - North Portugal Regional Operational Programme) [NORTE-07-0124-FEDER- 000022]	Fundacao de Ciencia e Tecnologia; Ministerio da Ciencia, Tecnologia e Ensino Superior; Nucleic Acid Center, University of Southern Denmark; FEDER (Operational Programme for Competitiveness Factors - COMPETE, ON.2 - O Novo Norte - North Portugal Regional Operational Programme)	This work was supported by Fundacao de Ciencia e Tecnologia [DNA mimics Research Project PIC/IC/82815/2007], Ministerio da Ciencia, Tecnologia e Ensino Superior, PhD grant [SFRH/BD/72999/2010 to SF], Post-Doctoral fellowship [SFRH/BPD/33420/2008 to ML and grant SFRH/BPD/78846/2011 to NG], Nucleic Acid Center, University of Southern Denmark and FEDER (Operational Programme for Competitiveness Factors - COMPETE, ON.2 - O Novo Norte - North Portugal Regional Operational Programme, reference NORTE-07-0124-FEDER- 000022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida C, 2010, APPL ENVIRON MICROB, V76, P4476, DOI 10.1128/AEM.01678-09; Amieva MR, 2002, CELL MICROBIOL, V4, P677, DOI 10.1046/j.1462-5822.2002.00222.x; Anjum MF, 1997, EUR J OPER RES, V101, P65, DOI 10.1016/S0377-2217(96)00232-9; Backert S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-28; Behlke MA, 2008, OLIGONUCLEOTIDES, V18, P305, DOI 10.1089/oli.2008.0164; Bergman JJGHM, 2005, GUT, V54, pI38, DOI 10.1136/gut.2004.041590; Bouvier T, 2003, FEMS MICROBIOL ECOL, V44, P3, DOI 10.1016/S0168-6496(02)00461-0; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Bucker R, 2012, SCI REP-UK, V2, DOI 10.1038/srep00994; Burdick AD, 2014, NUCLEIC ACIDS RES, V42, P4882, DOI 10.1093/nar/gku142; Celli JP, 2009, P NATL ACAD SCI USA, V106, P14321, DOI 10.1073/pnas.0903438106; Cerqueira L, 2013, J CLIN MICROBIOL, V51, P1887, DOI 10.1128/JCM.00302-13; Chu YT, 2010, INFECT IMMUN, V78, P4157, DOI 10.1128/IAI.00524-10; Chung HJ, 2011, ACS NANO, V5, P8834, DOI 10.1021/nn2029692; Crinelli R, 2002, NUCLEIC ACIDS RES, V30, P2435, DOI 10.1093/nar/30.11.2435; Crinelli R, 2004, CURR DRUG TARGETS, V5, P745, DOI 10.2174/1389450043345083; de Groot A, 2010, CONTACT DERMATITIS, V63, P117, DOI 10.1111/j.1600-0536.2010.01714.x; Dubois A, 2007, CELL MICROBIOL, V9, P1108, DOI 10.1111/j.1462-5822.2007.00921.x; Ezzat K, 2012, J CONTROL RELEASE, V162, P1, DOI 10.1016/j.jconrel.2012.06.006; Ferreira RM, 2012, J CLIN MICROBIOL, V50, P3983, DOI 10.1128/JCM.02087-12; FIMMEL CJ, 1985, GASTROENTEROLOGY, V88, P1842, DOI 10.1016/0016-5085(85)90009-5; Finotto S, 2001, J ALLERGY CLIN IMMUN, V107, P279, DOI 10.1067/mai.2001.113049; Fontenete S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081230; FORMAN D, 1995, ALIMENT PHARM THER, V9, P71; Fuchs BM, 1998, APPL ENVIRON MICROB, V64, P4973; Gozzetti A, 2000, SEMIN HEMATOL, V37, P320, DOI 10.1016/S0037-1963(00)90013-1; Guga P, 2011, CHEM BIODIVERS, V8, P1642, DOI 10.1002/cbdv.201100130; Guimaraes N, 2007, J CLIN MICROBIOL, V45, P3089, DOI 10.1128/JCM.00858-07; Hagedorn PH, 2013, NUCLEIC ACID THER, V23, P302, DOI 10.1089/nat.2013.0436; Heemskerk HA, 2009, J GENE MED, V11, P257, DOI 10.1002/jgm.1288; Hildebrandt-Eriksen ES, 2012, NUCLEIC ACID THER, V22, P152, DOI 10.1089/nat.2011.0332; Hildner KM, 2007, J IMMUNOL, V178, P3427, DOI 10.4049/jimmunol.178.6.3427; Karstensen JG, 2014, WORLD J GASTROENTERO, V20, P7794, DOI 10.3748/wjg.v20.i24.7794; Kenzaka T, 1998, MICROBIOL-UK, V144, P2085, DOI 10.1099/00221287-144-8-2085; Khan AA, 2012, BBA-REV CANCER, V1826, P331, DOI 10.1016/j.bbcan.2012.05.005; Kiesslich Ralf, 2005, Clin Gastroenterol Hepatol, V3, pS58, DOI 10.1016/S1542-3565(05)00252-1; Kurreck J, 2002, NUCLEIC ACIDS RES, V30, P1911, DOI 10.1093/nar/30.9.1911; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lawson TS, 2012, LETT APPL MICROBIOL, V54, P263, DOI 10.1111/j.1472-765X.2011.03197.x; Lennox KA, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.46; Levin AA, 1999, BBA-GENE STRUCT EXPR, V1489, P69, DOI 10.1016/S0167-4781(99)00140-2; Lian SQ, 2013, LUMINESCENCE, V28, P967, DOI 10.1002/bio.2469; Magalhaes A, 2010, BRAZ J MED BIOL RES, V43, P611, DOI 10.1590/S0100-879X2010007500049; Majlessi M, 1998, NUCLEIC ACIDS RES, V26, P2224, DOI 10.1093/nar/26.9.2224; Markey FB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093488; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Matthiesen Steen H, 2012, PLoS One, V7, pe40675, DOI 10.1371/journal.pone.0040675; McNulty CAM, 2011, HELICOBACTER, V16, P10, DOI 10.1111/j.1523-5378.2011.00875.x; MEINKOTH J, 1984, ANAL BIOCHEM, V138, P267, DOI 10.1016/0003-2697(84)90808-X; Moralli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004483; Myers RH., 2016, RESPONSE SURFACE MET; Neumann H, 2010, GASTROENTEROLOGY, V139, P388, DOI 10.1053/j.gastro.2010.06.029; NOACH LA, 1994, J CLIN PATHOL, V47, P699, DOI 10.1136/jcp.47.8.699; Okamoto A, 2011, CHEM SOC REV, V40, P5815, DOI 10.1039/c1cs15025a; Olfat FO, 2002, J INFECT DIS, V186, P423, DOI 10.1086/341459; Pernthaler J, 2001, METHOD MICROBIOL, V30, P207, DOI 10.1016/S0580-9517(01)30046-6; Rickard A., 2003, BIOFILM COMMUNITIES, P105; Santos RS, 2014, J BIOTECHNOL, V187, P16, DOI 10.1016/j.jbiotec.2014.06.023; Schreiber S, 2005, INFECT IMMUN, V73, P1584, DOI 10.1128/IAI.73.3.1584-1589.2005; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Seidel CAM, 1996, J PHYS CHEM-US, V100, P5541, DOI 10.1021/jp951507c; Shaffer SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075120; Shukla R, 2011, WORLD J GASTRO ENDOS, V3, P183, DOI 10.4253/wjge.v3.i10.183; Soe MJ, 2011, J HISTOCHEM CYTOCHEM, V59, P661, DOI 10.1369/0022155411409411; Stanton R, 2012, NUCLEIC ACID THER, V22, P344, DOI 10.1089/nat.2012.0366; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Sun Z, 2011, BIOCHEM BIOPH RES CO, V409, P430, DOI 10.1016/j.bbrc.2011.05.016; Swayze EE, 2007, NUCLEIC ACIDS RES, V35, P687, DOI 10.1093/nar/gkl1071; Tang YZ, 2005, APPL ENVIRON MICROB, V71, P8157, DOI 10.1128/AEM.71.12.8157-8164.2005; Vinette KMB, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-5; Wadstrom T, 1997, J PHYSIOL PHARMACOL, V48, P325; Wahlestedt C, 2000, P NATL ACAD SCI USA, V97, P5633, DOI 10.1073/pnas.97.10.5633; WESSENDORF MW, 1992, HISTOCHEMISTRY, V98, P81, DOI 10.1007/BF00716998; WETMUR JG, 1976, ANNU REV BIOPHYS BIO, V5, P337, DOI 10.1146/annurev.bb.05.060176.002005; Wong Kee Song Louis-Michel, 2005, Best Pract Res Clin Gastroenterol, V19, P833, DOI 10.1016/j.bpg.2005.04.006; Yilmaz O, 2007, WORLD J GASTROENTERO, V13, P671, DOI 10.3748/wjg.v13.i5.671; You Y, 2011, BIOPOLYMERS, V95, P472, DOI 10.1002/bip.21615; Zhang DY, 2012, NAT CHEM, V4, P208, DOI [10.1038/NCHEM.1246, 10.1038/nchem.1246]	78	28	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125494	10.1371/journal.pone.0125494	http://dx.doi.org/10.1371/journal.pone.0125494			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915865	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100131
J	Horn, P; Baars, T; Kahlert, P; Heiss, C; Westenfeld, R; Kelm, M; Erbel, R; Heusch, G; Kleinbongard, P				Horn, Patrick; Baars, Theodor; Kahlert, Philipp; Heiss, Christian; Westenfeld, Ralf; Kelm, Malte; Erbel, Raimund; Heusch, Gerd; Kleinbongard, Petra			Release of Intracoronary Microparticles during Stent Implantation into Stable Atherosclerotic Lesions under Protection with an Aspiration Device	PLOS ONE			English	Article							TRANSLUMINAL CORONARY ANGIOPLASTY; ELEVATION MYOCARDIAL-INFARCTION; SAPHENOUS-VEIN GRAFTS; TISSUE FACTOR; CIRCULATING MICROPARTICLES; ENDOTHELIAL MICROPARTICLES; MICROVASCULAR OBSTRUCTION; PLATELET MICROPARTICLES; DISEASE; ARTERY	Objective Stent implantation into atherosclerotic coronary vessels impacts on downstream microvascular function and induces the release of particulate debris and soluble substances, which differs qualitatively and quantitatively between native right coronary arteries (RCAs) and saphenous vein grafts on right coronary arteries (SVG-RCAs). We have now quantified the release of microparticles (MPs) during stent implantation into stable atherosclerotic lesions and compared the release between RCAs and SVG-RCAs. Methods In symptomatic, male patients with stable angina and a stenosis in their RCA or SVG-RCA, respectively (n = 14/14), plaque volume and composition were analyzed using intravascular ultrasound before stent implantation. Coronary aspirate was retrieved during stent implantation with a distal occlusion/aspiration device and divided into particulate debris and plasma. Particulate debris was weighed. Platelet-derived MPs (PMPs) were distinguished by flow cytometry as CD41(+), endothelium-derived MPs (EMPs) as CD144(+), CD62E(+) and CD31(+)/CD41(-), leukocyte-derived MPs as CD45(+), and erythrocyte-derived MPs as CD235(+). Results In patients with comparable plaque volume and composition in RCAs and SVG-RCAs, intra-coronary PMPs and EMPs were increased after stent implantation into their RCAs and SVG-RCAs (CD41(+): 2729.6 +/- 645.6 vs. 4208.7 +/- 679.4 and 2355.9 +/- 503.9 vs. 3285.8 +/- 733.2 nr/mu L; CD144(+): 451.5 +/- 87.9 vs. 861.7 +/- 147.0 and 444.6 +/- 74.8 vs. 726.5 +/- 136.4 nr/mu L;CD62E(+): 1404.1 +/- 247.7 vs. 1844.3 +/- 378.6 and 1084.6 +/- 211.0 vs. 1783.8 +/- 384.3 nr/mu L, P<0.05), but not different between RCAs and SVG-RCAs. Conclusion Stenting in stable atherosclerotic lesions is associated with a substantial release not only of PMPs, but also of EMPs in RCAs and SVG-RCAs. Their release does not differ between RCAs and SVG-RCAs.	[Horn, Patrick; Heiss, Christian; Westenfeld, Ralf; Kelm, Malte] Univ Duesseldorf, Fac Med, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany; [Baars, Theodor; Heusch, Gerd; Kleinbongard, Petra] Univ Essen Gesamthsch, Sch Med, West German Heart & Vasc Ctr Essen, Inst Pathophysiol, Essen, Germany; [Baars, Theodor; Kahlert, Philipp; Erbel, Raimund] Univ Essen Gesamthsch, Sch Med, West German Heart & Vasc Ctr Essen, Clin Cardiol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Kleinbongard, P (corresponding author), Univ Essen Gesamthsch, Sch Med, West German Heart & Vasc Ctr Essen, Inst Pathophysiol, Essen, Germany.	petra.kleinbongard@uk-essen.de	Heiss, Christian/AAL-8582-2020; Heusch, Gerd/ABE-6675-2020	Heiss, Christian/0000-0002-3212-8995; Kelm, Malte/0000-0003-0060-1052	Heinz-Horst Deichmann Foundation	Heinz-Horst Deichmann Foundation	This work was supported by the Heinz-Horst Deichmann Foundation. The FACS facility was provided by Susanne-Bunnenberg Foundation at the Duesseldorf Heart Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baars T, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-12; Baars T, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0303-3; Bernal-Mizrachi L, 2003, AM HEART J, V145, P962, DOI 10.1016/S0002-8703(03)00103-0; Bose D, 2008, BASIC RES CARDIOL, V103, P587, DOI 10.1007/s00395-008-0745-9; Bonderman D, 2002, BLOOD, V99, P2794, DOI 10.1182/blood.V99.8.2794; Bonello L, 2006, J THROMB HAEMOST, V4, P979, DOI 10.1111/j.1538-7836.2006.01858.x; Boulanger CM, 2001, CIRCULATION, V104, P2649, DOI 10.1161/hc4701.100516; Brodsky SV, 2004, AM J PHYSIOL-HEART C, V286, pH1910, DOI 10.1152/ajpheart.01172.2003; Burnier L, 2009, THROMB HAEMOSTASIS, V101, P439, DOI 10.1160/TH08-08-0521; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Craft JA, 2004, BLOOD COAGUL FIBRIN, V15, P475, DOI 10.1097/00001721-200408000-00006; Empana JP, 2015, EUR HEART J-ACUTE CA, V4, P28, DOI 10.1177/2048872614538404; Erdbrugger U, 2014, CYTOM PART A, V85A, P756, DOI 10.1002/cyto.a.22494; Franca CN, 2012, CIRC J, V76, P729, DOI 10.1253/circj.CJ-11-1145; George FD, 2008, THROMB RES, V122, pS55, DOI 10.1016/S0049-3848(08)70020-3; Hamilos M, 2011, J THROMB THROMBOLYS, V32, P64, DOI 10.1007/s11239-011-0557-x; Haude M, 1996, CIRCULATION, V94, P286, DOI 10.1161/01.CIR.94.3.286; Heusch G, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0380-y; Heusch G, 2009, CIRCULATION, V120, P1822, DOI 10.1161/CIRCULATIONAHA.109.888784; Horn P, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.003764; Horstman LL, 1999, CRIT REV ONCOL HEMAT, V30, P111, DOI 10.1016/S1040-8428(98)00044-4; Jimenez JJ, 2003, THROMB RES, V109, P175, DOI 10.1016/S0049-3848(03)00064-1; Jung F, 2002, PATHOPHYSIOL HAEMO T, V32, P121, DOI 10.1159/000065213; Jy W, 2005, J THROMB HAEMOST, V3, P1301, DOI 10.1111/j.1538-7836.2005.01384.x; Kleinbongard P, 2013, AM J PHYSIOL-HEART C, V305, pH1222, DOI 10.1152/ajpheart.00358.2013; Kleinbongard P, 2012, J MOL CELL CARDIOL, V52, P890, DOI 10.1016/j.yjmcc.2011.06.022; Kleinbongard P, 2011, BASIC RES CARDIOL, V106, P681, DOI 10.1007/s00395-011-0177-9; Kleinbongard P, 2011, CIRC RES, V108, P344, DOI 10.1161/CIRCRESAHA.110.235713; Leborgne L, 2003, AM HEART J, V146, P501, DOI 10.1016/S0002-8703(03)00309-0; Leineweber M, 2006, J AM COLL CARDIOL, V47, P981, DOI 10.1016/j.jacc.2005.10.053; Leroyer AS, 2007, J AM COLL CARDIOL, V49, P772, DOI 10.1016/j.jacc.2006.10.053; Mahemuti A, 2009, J THROMB THROMBOLYS, V28, P333, DOI 10.1007/s11239-008-0266-2; Mallat Z, 1999, CIRCULATION, V99, P348, DOI 10.1161/01.CIR.99.3.348; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Min PK, 2013, ATHEROSCLEROSIS, V227, P323, DOI 10.1016/j.atherosclerosis.2013.01.032; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Mizuno O, 2001, CARDIOLOGY, V95, P84, DOI 10.1159/000047351; Moons AHM, 2002, CARDIOVASC RES, V53, P313, DOI 10.1016/S0008-6363(01)00452-7; Morel O, 2009, ATHEROSCLEROSIS, V204, P636, DOI 10.1016/j.atherosclerosis.2008.10.039; Motwani JG, 1998, CIRCULATION, V97, P916, DOI 10.1161/01.CIR.97.9.916; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; Pfister SL, 2004, HYPERTENSION, V43, P428, DOI 10.1161/01.HYP.0000110906.77479.91; Porto I, 2012, EUR HEART J, V33, P2928, DOI 10.1093/eurheartj/ehs065; Pregowski J, 2005, J AM COLL CARDIOL, V45, P1974, DOI 10.1016/j.jacc.2005.02.078; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Rautou PE, 2011, CIRC RES, V108, P335, DOI 10.1161/CIRCRESAHA.110.237420; Shantsila E, 2010, J THROMB HAEMOST, V8, P2358, DOI 10.1111/j.1538-7836.2010.04007.x; Sluijter JPG, 2014, CARDIOVASC RES, V102, P302, DOI 10.1093/cvr/cvu022; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Tutar E, 2003, CIRCULATION, V108, P1581, DOI 10.1161/01.CIR.0000091082.75419.9F; Viera AJ, 2012, J AM SOC HYPERTENS, V6, P243, DOI 10.1016/j.jash.2012.06.003; Vion AC, 2013, CIRC RES, V112, P1323, DOI 10.1161/CIRCRESAHA.112.300818; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]; Zhang YJ, 2013, THROMB HAEMOSTASIS, V110, P331, DOI 10.1160/TH12-11-0853; Zwicker JI, 2011, ARTERIOSCL THROM VAS, V31, P728, DOI 10.1161/ATVBAHA.109.200964	55	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124904	10.1371/journal.pone.0124904	http://dx.doi.org/10.1371/journal.pone.0124904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915510	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100079
J	Osanai, T; Pasupuleti, V; Deshpande, A; Thota, P; Roman, Y; Hernandez, AV; Uchino, K				Osanai, Toshiya; Pasupuleti, Vinay; Deshpande, Abhishek; Thota, Priyaleela; Roman, Yuani; Hernandez, Adrian V.; Uchino, Ken			Acute Endovascular Reperfusion Therapy in Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							INTRAARTERIAL UROKINASE; MECHANICAL THROMBECTOMY; RECANALIZATION; THROMBOLYSIS; PROUROKINASE; PROACT	Background Randomized controlled trials (RCTs) of endovascular therapy for acute ischemic stroke have had inconsistent results. We evaluated the efficacy and safety of endovascular therapy in published RCTs. Methods We performed a systematic review of RCTs of endovascular therapy with thrombolytic or mechanical reperfusion compared with interventions without endovascular therapy. Primary outcome was the frequency of good functional outcome (modified Rankin scale (mRS) of 0-2 at 90 days) and secondary outcomes were mortality at 90 days and symptomatic intracranial hemorrhage (sICH). Random-effects meta-analysis was performed and the Cochrane risk of bias assessment was used to evaluate quality of evidence. Results Ten studies involving 1,612 subjects were included. Endovascular therapy was not significantly associated with good functional outcome (Relative Risk [RR] = 1.17; 95% CI, 0.97 to 1.42; p=0.10 and Absolute Risk Difference [ARD] = 7%; 95% CI -0.1% to 14%; p=0.05); heterogeneity was moderate among studies (I-2=30%). Mortality was unchanged with endovascular therapy (RR=0.92; 95% CI, 0.75 to 1.13; p=0.45) and there was no difference in sICH (RR=1.20; 95% CI, 0.79 to 1.82; p=0.39). The quality of evidence was low for all outcomes and the recommendation is weak for the use of endovascular therapy as per GRADE methodology. Conclusions Intra-arterial therapy did not show significant increase in good outcomes and no changes in either mortality or sICH in patients with acute ischemic stroke. We need further RCTs with better design and quality to evaluate the true efficacy of endovascular therapy.	[Osanai, Toshiya; Uchino, Ken] Cleveland Clin, Cerebrovasc Ctr, Cleveland, OH 44106 USA; [Pasupuleti, Vinay; Thota, Priyaleela] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Deshpande, Abhishek] Cleveland Clin, Ctr Value Based Care Res, Inst Med, Cleveland, OH 44106 USA; [Roman, Yuani] Inst Nacl Salud, UNAGESP, Lima, Peru; [Hernandez, Adrian V.] Univ Peruana Ciencias Aplicadas UPC, Sch Med, Lima, Peru; [Hernandez, Adrian V.] Cleveland Clin, Lerner Res Inst, Dept Quantitat Hlth Sci, Hlth Outcomes & Clin Epidemiol Sect, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Instituto Nacional de Salud - Peru; Universidad Peruana de Ciencias Aplicadas (UPC); Cleveland Clinic Foundation	Uchino, K (corresponding author), Cleveland Clin, Cerebrovasc Ctr, Cleveland, OH 44106 USA.	uchinok@ccf.org	Osanai, Toshiya/AAF-3011-2020; Hernandez, Adrian V./ABD-4616-2021; Uchino, Ken/ABC-1611-2021; Pasupuleti, Vinay/G-1316-2013; Osanai, Toshiya/AAE-4945-2022; Deshpande, Abhishek/A-7695-2012	Hernandez, Adrian V./0000-0002-9999-4003; Uchino, Ken/0000-0001-9468-4172; Deshpande, Abhishek/0000-0001-5522-2995				Baker WL, 2011, ANN INTERN MED, V154, P243, DOI 10.7326/0003-4819-154-4-201102150-00306; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Campbell BC, 2013, NEW ENGL J MED, V368, P2431, DOI [10.1056/NEJMc1304759, 10.1056/NEJMoa1213701]; Ciccone A, 2010, J NEUROINTERV SURG, V2, P74, DOI 10.1136/jnis.2009.001388; del Zoppo GJ, 1998, STROKE, V29, P4, DOI 10.1161/01.STR.29.1.4; Demchuk AM, 2014, RADIOLOGY, V273, P202, DOI 10.1148/radiol.14132649; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ducrocq X, 2005, J NEURORADIOLOGY, V32, P26, DOI 10.1016/S0150-9861(05)83018-4; Fields JD, 2011, J NEUROINTERV SURG, V3, P151, DOI 10.1136/jnis.2010.002766; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Keris V, 2001, AM J NEURORADIOL, V22, P352; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Langer D, 2009, STROKE, V40, P2761, DOI 10.1161/STROKEAHA.108.544957; Lee M, 2010, STROKE, V41, P932, DOI 10.1161/STROKEAHA.109.574335; Macleod MR, 2005, CEREBROVASC DIS, V20, P12, DOI 10.1159/000086121; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nam J, 2015, INT J STROKE, V10, P13, DOI 10.1111/j.1747-4949.2012.00914.x; Ogawa A, 2007, STROKE, V38, P2633, DOI 10.1161/STROKEAHA.107.488551; Qureshi AI, 2004, LANCET, V363, P804, DOI 10.1016/S0140-6736(04)15697-3; Rha JH, 2007, STROKE, V38, P967, DOI 10.1161/01.STR.0000258112.14918.24; Smith WS, 2008, STROKE, V39, P1205, DOI 10.1161/STROKEAHA.107.497115; Smith WS, 2006, AM J NEURORADIOL, V27, P1177; Tomsick T, 1996, AM J NEURORADIOL, V17, P79	24	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0122806	10.1371/journal.pone.0122806	http://dx.doi.org/10.1371/journal.pone.0122806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915905	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100012
J	Ganjali, M; Baghfalaki, T; Berridge, D				Ganjali, Mojtaba; Baghfalaki, Taban; Berridge, Damon			Robust Modeling of Differential Gene Expression Data Using Normal/Independent Distributions: A Bayesian Approach	PLOS ONE			English	Article							INFERENCE; IDENTIFICATION; MICROARRAYS	In this paper, the problem of identifying differentially expressed genes under different conditions using gene expression microarray data, in the presence of outliers, is discussed. For this purpose, the robust modeling of gene expression data using some powerful distributions known as normal/independent distributions is considered. These distributions include the Student's t and normal distributions which have been used previously, but also include extensions such as the slash, the contaminated normal and the Laplace distributions. The purpose of this paper is to identify differentially expressed genes by considering these distributional assumptions instead of the normal distribution. A Bayesian approach using the Markov Chain Monte Carlo method is adopted for parameter estimation. Two publicly available gene expression data sets are analyzed using the proposed approach. The use of the robust models for detecting differentially expressed genes is investigated. This investigation shows that the choice of model for differentiating gene expression data is very important. This is due to the small number of replicates for each gene and the existence of outlying data. Comparison of the performance of these models is made using different statistical criteria and the ROC curve. The method is illustrated using some simulation studies. We demonstrate the flexibility of these robust models in identifying differentially expressed genes.	[Ganjali, Mojtaba; Baghfalaki, Taban] Inst Res Fundamental Sci IPM, Sch Biol Sci, Tehran, Iran; [Ganjali, Mojtaba] Shahid Beheshti Univ, Fac Math Sci, Dept Stat, Tehran, Iran; [Baghfalaki, Taban] Tarbiat Modares Univ, Fac Math Sci, Dept Stat, Tehran, Iran; [Berridge, Damon] Swansea Univ, Coll Med, Farr Inst CIPHER, Swansea, W Glam, Wales	Shahid Beheshti University; Tarbiat Modares University; Swansea University	Ganjali, M (corresponding author), Inst Res Fundamental Sci IPM, Sch Biol Sci, Tehran, Iran.	m-ganjali@sbu.ac.ir	Baghfalaki, Taban/R-7017-2019	Berridge, Damon/0000-0002-5442-6686	Computer Science department of Institute for Research in Fundamental Sciences (IPM); Iranian National Science Foundation [INSF BS1392201]; Medical Research Council [MR/K006525/1] Funding Source: researchfish; MRC [MR/K006525/1] Funding Source: UKRI	Computer Science department of Institute for Research in Fundamental Sciences (IPM); Iranian National Science Foundation(Iran National Science Foundation (INSF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research presented in this study was carried out on the High Performance Computing Cluster supported by the Computer Science department of Institute for Research in Fundamental Sciences (IPM). The authors would like to thank the Iranian National Science Foundation (INSF BS1392201) for their support.	Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Bhowmick D, 2006, BIOSTATISTICS, V7, P630, DOI 10.1093/biostatistics/kxj032; Casella G., 2002, STAT INFERENCE, V2nd; Chen Y, 1997, J Biomed Opt, V2, P364, DOI 10.1117/12.281504; Chu G, 2002, SAM SIGNIFICANT ANAL; Dudoit S, 2002, STAT SINICA, V12, P111; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gottardo R, 2006, BIOMETRICS, V62, P10, DOI 10.1111/j.1541-0420.2005.00397.x; Gottardo R, 2003, 438 U WASH STAT DEP; Gottardo R, 2008, BIOMETRICS, V64, P468, DOI 10.1111/j.1541-0420.2007.00899.x; Haye Alexandre, 2012, BMC Res Notes, V5, P46, DOI 10.1186/1756-0500-5-46; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Ibrahim JG, 2002, J AM STAT ASSOC, V97, P88, DOI 10.1198/016214502753479257; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Lachos VH, 2010, STAT SINICA, V20, P303; Lange K., 1993, J COMPUT GRAPH STAT, V2, P175, DOI DOI 10.2307/1390698; Mallick BK, 2009, BAYESIAN ANAL GENE E; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Posekany A, 2011, BIOINFORMATICS, V27, P807, DOI 10.1093/bioinformatics/btr018; Subramaniam S, 2012, NAT IMMUNOL, V13, P199, DOI 10.1038/ni.2244; Tadesse MG, 2003, BIOMETRICS, V59, P542, DOI 10.1111/1541-0420.00064; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Zhang SP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-230	26	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123791	10.1371/journal.pone.0123791	http://dx.doi.org/10.1371/journal.pone.0123791			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910040	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800046
J	Kirrane, MJ; de Guzman, LI; Holloway, B; Frake, AM; Rinderer, TE; Whelan, PM				Kirrane, Maria J.; de Guzman, Lilia I.; Holloway, Beth; Frake, Amanda M.; Rinderer, Thomas E.; Whelan, Padraig M.			Phenotypic and Genetic Analyses of the Varroa Sensitive Hygienic Trait in Russian Honey Bee (Hymenoptera: Apidae) Colonies	PLOS ONE			English	Article							DESTRUCTOR MESOSTIGMATA VARROIDAE; APIS-CERANA FABR; MITE REPRODUCTION; INFESTATION RATE; JACOBSONI OUD; BEHAVIOR; RESISTANCE; MELLIFERA; BROOD; RESPONSES	Varroa destructorcontinues to threaten colonies of European honey bees. General hygiene, and more specific Varroa Sensitive Hygiene (VSH), provide resistance towards the Varroa mite in a number of stocks. In this study, 32 Russian (RHB) and 14 Italian honey bee colonies were assessed for the VSH trait using two different assays. Firstly, colonies were assessed using the standard VSH behavioural assay of the change in infestation of a highly infested donor comb after a one-week exposure. Secondly, the same colonies were assessed using an "actual brood removal assay" that measured the removal of brood in a section created within the donor combs as a potential alternative measure of hygiene towards Varroa-infested brood. All colonies were then analysed for the recently discovered VSH quantitative trait locus (QTL) to determine whether the genetic mechanisms were similar across different stocks. Based on the two assays, RHB colonies were consistently more hygienic toward Varroa-infested brood than Italian honey bee colonies. The actual number of brood cells removed in the defined section was negatively correlated with the Varroa infestations of the colonies (r(2) = 0.25). Only two (percentages of brood removed and reproductive foundress Varroa) out of nine phenotypic parameters showed significant associations with genotype distributions. However, the allele associated with each parameter was the opposite of that determined by VSH mapping. In this study, RHB colonies showed high levels of hygienic behaviour towards Varroa - infested brood. The genetic mechanisms are similar to those of the VSH stock, though the opposite allele associates in RHB, indicating a stable recombination event before the selection of the VSH stock. The measurement of brood removal is a simple, reliable alternative method of measuring hygienic behaviour towards Varroa mites, at least in RHB stock.	[Kirrane, Maria J.; Whelan, Padraig M.] Natl Univ Ireland Univ Coll Cork, Sch Biol Earth & Environm Sci BEES, Cork, Ireland; [Kirrane, Maria J.; Whelan, Padraig M.] Natl Univ Ireland Univ Coll Cork, ERI, Cork, Ireland; [de Guzman, Lilia I.; Holloway, Beth; Frake, Amanda M.; Rinderer, Thomas E.] USDA ARS, Honey Bee Breeding Genet & Physiol Lab, Baton Rouge, LA 70820 USA	University College Cork; University College Cork; United States Department of Agriculture (USDA)	Kirrane, MJ (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Biol Earth & Environm Sci BEES, Cork, Ireland.	s105692474@student.ucc.ie			Irish Research Council, Government of Ireland	Irish Research Council, Government of Ireland	MJK is funded by the Irish Research Council, Government of Ireland Postgraduate Scholarship Scheme (www.research.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumeier P, 2001, APIDOLOGIE, V32, P253, DOI 10.1051/apido:2001127; BOECKING O, 1991, APIDOLOGIE, V22, P237, DOI 10.1051/apido:19910308; Buchler R, 2010, APIDOLOGIE, V41, P393, DOI 10.1051/apido/2010011; Danka JR, 2009, J APICULT RES, V48, P156; Danka RG, 2012, J APICULT RES, V52, P69; Danka RG, 2011, J ECON ENTOMOL, V104, P745, DOI 10.1603/EC10401; de Guzman LI, 2008, J APICULT RES, V47, P216, DOI 10.1080/00218839.2008.11101462; de Guzman LI, 2008, EXP APPL ACAROL, V44, P227, DOI 10.1007/s10493-008-9142-1; De Guzman LI, 2007, ANN ENTOMOL SOC AM, V100, P187, DOI 10.1603/0013-8746(2007)100[187:GOVDAV]2.0.CO;2; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Donze G, 1996, ECOL ENTOMOL, V21, P17, DOI 10.1111/j.1365-2311.1996.tb00261.x; Frey E, 2013, J INVERTEBR PATHOL, V113, P56, DOI 10.1016/j.jip.2013.01.007; Gramacho KP, 2003, BEHAV ECOL SOCIOBIOL, V54, P472, DOI 10.1007/s00265-003-0643-y; Harbo JR, 2009, J APICULT RES, V48, P156, DOI 10.3896/IBRA.1.48.3.02; Harbo JR, 1999, J ECON ENTOMOL, V92, P261, DOI 10.1093/jee/92.2.261; Harbo JR, 2005, J APICULT RES, V44, P21, DOI 10.1080/00218839.2005.11101141; Harbo JR, 2001, J ECON ENTOMOL, V94, P1319, DOI 10.1603/0022-0493-94.6.1319; Harris JW, 2007, J APICULT RES, V46, P134, DOI 10.1080/00218839.2007.11101383; Harris JW, 2012, ANN ENTOMOL SOC AM, V105, P512, DOI 10.1603/AN11188; Holloway B, 2013, J APICULT RES, V52, P134, DOI 10.3896/IBRA.1.52.3.04; Ibrahim A, 2006, APIDOLOGIE, V37, P31, DOI 10.1051/apido:2005052; Ibrahim A, 2007, APIDOLOGIE, V38, P67, DOI 10.1051/apido:2006065; Kavinseksan B, 2004, AM BEE J, V144, P870; Kirrane MJ, 2011, J ECON ENTOMOL, V104, P1146, DOI 10.1603/EC11035; Lapidge KL, 2002, NATURWISSENSCHAFTEN, V89, P565, DOI 10.1007/s00114-002-0371-6; Le Conte Y, 2011, INSECT MOL BIOL, V20, P399, DOI 10.1111/j.1365-2583.2011.01074.x; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Masterman R, 2001, J COMP PHYSIOL A, V187, P441, DOI 10.1007/s003590100216; Oxley PR, 2010, MOL ECOL, V19, P1452, DOI 10.1111/j.1365-294X.2010.04569.x; PENG YS, 1987, J INVERTEBR PATHOL, V49, P54, DOI 10.1016/0022-2011(87)90125-X; R Core Team, 2013, LANG ENV STAT COMP, DOI [DOI 10.3758/S13428-013-0330-5, 10.3758/s13428-013-0330-5]; RATH W, 1990, APIDOLOGIE, V21, P311, DOI 10.1051/apido:19900406; Rinderer TE, 2001, APIDOLOGIE, V32, P381, DOI 10.1051/apido:2001138; Rinderer TE, 2000, AM BEE J, V140, P305; ROTHENBUHLER WC, 1964, AM ZOOL, V4, P111; Schoning C, 2012, J EXP BIOL, V215, P264, DOI 10.1242/jeb.062562; Spivak M, 1996, APIDOLOGIE, V27, P245, DOI 10.1051/apido:19960407; Spivak M, 2001, J ECON ENTOMOL, V94, P326, DOI 10.1603/0022-0493-94.2.326; STEINER J, 1994, INVERTEBR REPROD DEV, V25, P175, DOI 10.1080/07924259.1994.9672384; Tarpy DR, 2007, J ECON ENTOMOL, V100, P258, DOI 10.1603/0022-0493(2007)100[258:COPMIR]2.0.CO;2; Tsuruda JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048276; Vandame R, 2002, APIDOLOGIE, V33, P433, DOI 10.1051/apido:2002025; Villa JD, 2009, J APICULT RES, V48, P162, DOI 10.3896/IBRA.1.48.3.03; Villegas AJ, 2006, J APICULT RES, V45, P203, DOI 10.1080/00218839.2006.11101348; Ward K, 2008, J ECON ENTOMOL, V101, P654, DOI 10.1603/0022-0493(2008)101[654:CPOTMS]2.0.CO;2	45	18	18	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0116672	10.1371/journal.pone.0116672	http://dx.doi.org/10.1371/journal.pone.0116672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909856	Green Published, gold			2022-12-27	WOS:000353376800002
J	Laube, M; Bossmann, M; Thome, UH				Laube, Mandy; Bossmann, Miriam; Thome, Ulrich H.			Glucocorticoids Distinctively Modulate the CFTR Channel with Possible Implications in Lung Development and Transition into Extrauterine Life	PLOS ONE			English	Article							CONGENITAL DIAPHRAGMATIC-HERNIA; CONDUCTANCE REGULATOR CFTR; EPITHELIAL FLUID CLEARANCE; CYSTIC-FIBROSIS GENE; HUMAN FETAL TISSUES; BICARBONATE SECRETION; CELL-PROLIFERATION; SODIUM-TRANSPORT; NA+ CHANNEL; KINASE SGK1	During fetal development, the lung is filled with fluid that is secreted by an active Cl-transport promoting lung growth. The basolateral Na+, K+, 2Cl(-) cotransporter (NKCC1) participates in Cl-secretion. The apical Cl-channels responsible for secretion are unknown but studies suggest an involvement of the cystic fibrosis transmembrane conductance regulator (CFTR). CFTR is developmentally regulated with a high expression in early fetal development and a decline in late gestation. Perinatal lung transition is triggered by hormones that stimulate alveolar Na+ channels resulting in fluid absorption. Little is known on how hormones affect pulmonary Cl-channels. Since the rise of fetal cortisol levels correlates with the decrease in fetal CFTR expression, a causal relation may be assumed. The aim of this study was to analyze the influence of glucocorticoids on pulmonary Cl-channels. Alveolar cells from fetal and adult rats, A549 cells, bronchial Calu-3 and 16HBE14o-cells, and primary rat airway cells were studied with real-time quantitative PCR and Ussing chambers. In fetal and adult alveolar cells, glucocorticoids strongly reduced Cftr expression and channel activity, which was prevented by mifepristone. In bronchial and primary airway cells CFTR mRNA expression was also reduced, whereas channel activity was increased which was prevented by LY-294002 in Calu-3 cells. Therefore, glucocorticoids strongly reduce CFTR expression while their effect on CFTR activity depends on the physiological function of the cells. Another apical Cl-channel, anoctamin 1 showed a glucocorticoid-induced reduction of mRNA expression in alveolar cells and an increase in bronchial cells. Furthermore, voltage- gated chloride channel 5 and anoctamine 6 mRNA expression were increased in alveolar cells. NKCCl expression was reduced by glucocorticoids in alveolar and bronchial cells alike. The results demonstrate that glucocorticoids differentially modulate pulmonary Clchannels and are likely causing the decline of CFTR during late gestation in preparation for perinatal lung transition.	[Laube, Mandy; Bossmann, Miriam; Thome, Ulrich H.] Univ Leipzig, Ctr Pediat Res Leipzig, Hosp Children & Adolescents, Div Neonatol, D-04109 Leipzig, Germany	Leipzig University	Laube, M (corresponding author), Univ Leipzig, Ctr Pediat Res Leipzig, Hosp Children & Adolescents, Div Neonatol, D-04109 Leipzig, Germany.	Mandy.Laube@medizin.uni-leipzig.de		Laube, Mandy/0000-0002-7180-2858	medical faculty of Leipzig University; German Research Foundation (DFG); Leipzig University within the program of Open Access Publishing	medical faculty of Leipzig University; German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University within the program of Open Access Publishing	The study was supported by a research grant of the medical faculty of Leipzig University to ML. The authors acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCORN D, 1977, J ANAT, V123, P649; BARKER PM, 1995, AM J PHYSIOL-LUNG C, V268, pL270, DOI 10.1152/ajplung.1995.268.2.L270; Blackburn S.T., 2012, MATERNAL FETAL NEONA, V4; Bland RD, 2001, AM J PHYSIOL-LUNG C, V280, pL602, DOI 10.1152/ajplung.2001.280.4.L602; Bomberger JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089599; Bourbon JR, 2006, AM J PHYSIOL-LUNG C, V291, pL1, DOI 10.1152/ajplung.00091.2006; Broackes-Carter FC, 2002, HUM MOL GENET, V11, P125, DOI 10.1093/hmg/11.2.125; Cadepond F, 1997, ANNU REV MED, V48, P129; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; CASSIN S, 1986, P SOC EXP BIOL MED, V181, P427; CLARKE LL, 1992, AM J PHYSIOL, V263, pL519, DOI 10.1152/ajplung.1992.263.5.L519; Cohen JC, 2006, DEV DYNAM, V235, P2736, DOI 10.1002/dvdy.20912; Cohen JC, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-2; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; ENGELHARDT JF, 1994, J CLIN INVEST, V93, P737, DOI 10.1172/JCI117028; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Farrell PM, 2003, PEDIATR PULM, V36, P230, DOI 10.1002/ppul.10336; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Finley N, 1998, J CLIN INVEST, V101, P972, DOI 10.1172/JCI1478; Folkesson HG, 2000, J APPL PHYSIOL, V88, P416, DOI 10.1152/jappl.2000.88.2.416; Gappa M, 2001, PEDIATR PULM, V32, P228, DOI 10.1002/ppul.1113; Garnett JP, 2011, J BIOL CHEM, V286, P41069, DOI 10.1074/jbc.M111.266734; GEORGE DK, 1987, AM REV RESPIR DIS, V136, P947, DOI 10.1164/ajrccm/136.4.947; Harding R, 1996, J APPL PHYSIOL, V81, P209, DOI 10.1152/jappl.1996.81.1.209; Hudak JJ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-34; Hug MJ, 2003, NEWS PHYSIOL SCI, V18, P38, DOI 10.1152/nips.01412.2002; JASSAL D, 1991, IN VITRO CELL DEV B, V27, P625; KINDLER PM, 1993, ACTA ENDOCRINOL-COP, V129, P169, DOI 10.1530/acta.0.1290169; KITTERMAN JA, 1979, J APPL PHYSIOL, V47, P985, DOI 10.1152/jappl.1979.47.5.985; KOTAS RV, 1971, J APPL PHYSIOL, V30, P358, DOI 10.1152/jappl.1971.30.3.358; Kunzelmann K, 2012, INT J BIOCHEM CELL B, V44, P1897, DOI 10.1016/j.biocel.2012.06.011; Kunzelmann K, 2011, PFLUG ARCH EUR J PHY, V462, P195, DOI 10.1007/s00424-011-0975-9; Larson JE, 2006, AM J PHYSIOL-LUNG C, V291, pL4, DOI 10.1152/ajplung.00372.2005; Larson JE, 2000, AM J PHYSIOL-LUNG C, V279, pL333, DOI 10.1152/ajplung.2000.279.2.L333; Manwani N, 2010, AM J RESP CELL MOL, V43, P599, DOI 10.1165/rcmb.2009-0263OC; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Miklavc P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010982; Mustafa SB, 2004, AM J PHYSIOL-LUNG C, V286, pL73, DOI 10.1152/ajplung.00342.2002; OLVER RE, 1974, J PHYSIOL-LONDON, V241, P327, DOI 10.1113/jphysiol.1974.sp010659; ORNOY A, 1987, AM J MED GENET, V28, P935, DOI 10.1002/ajmg.1320280420; Oshika E, 1998, PEDIATR RES, V43, P305, DOI 10.1203/00006450-199803000-00001; Prota LFM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047405; Reddy MM, 2003, NATURE, V423, P756, DOI 10.1038/nature01694; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Rubenstein RC, 2011, AM J PHYSIOL-LUNG C, V300, pL88, DOI 10.1152/ajplung.00142.2010; Sakamoto H, 1996, J BIOL CHEM, V271, P10210, DOI 10.1074/jbc.271.17.10210; Sato JD, 2007, CELL PHYSIOL BIOCHEM, V20, P91, DOI 10.1159/000104157; Schmidt C, 2014, LUNG, V192, P935, DOI 10.1007/s00408-014-9640-3; Sharp JK, 2002, CLIN REV ALLERG IMMU, V23, P59, DOI 10.1385/CRIAI:23:1:059; Shcheynikov N, 2004, J BIOL CHEM, V279, P21857, DOI 10.1074/jbc.M313323200; SMITH BT, 1974, J CLIN INVEST, V53, P1518, DOI 10.1172/JCI107702; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Tang L, 2009, J CYST FIBROS, V8, P115, DOI 10.1016/j.jcf.2008.10.004; TEBBUTT SJ, 1995, P NATL ACAD SCI USA, V92, P2293, DOI 10.1073/pnas.92.6.2293; Thome UH, 2003, AM J PHYSIOL-LUNG C, V284, pL376, DOI 10.1152/ajplung.00218.2002; TIZZANO EF, 1993, HUM MOL GENET, V2, P219, DOI 10.1093/hmg/2.3.219; TREZISE AEO, 1993, HUM MOL GENET, V2, P213, DOI 10.1093/hmg/2.3.213; Tuo BG, 2009, AM J PHYSIOL-CELL PH, V297, pC503, DOI 10.1152/ajpcell.00460.2008; von Wangenheim KH, 1998, J THEOR BIOL, V193, P663, DOI 10.1006/jtbi.1998.0731; Wagner CA, 2001, CELL PHYSIOL BIOCHEM, V11, P209, DOI 10.1159/000051935; Yigit E, 2013, NUCLEIC ACIDS RES, V41, P2857, DOI 10.1093/nar/gks1462	63	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124833	10.1371/journal.pone.0124833	http://dx.doi.org/10.1371/journal.pone.0124833			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910246	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000353376800109
J	Braga, VAVN; Couto, GK; Lazzarin, MC; Rossoni, LV; Medeiros, A				Braga, Viviane A. V. N.; Couto, Gisele K.; Lazzarin, Mariana C.; Rossoni, Luciana V.; Medeiros, Alessandra			Aerobic Exercise Training Prevents the Onset of Endothelial Dysfunction via Increased Nitric Oxide Bioavailability and Reduced Reactive Oxygen Species in an Experimental Model of Menopause	PLOS ONE			English	Article							OXIDATIVE STRESS; ESTROGEN; OVARIECTOMY; EXPRESSION; MUSCLE; RATS; HYPERTENSION; MICROVESSELS; RELAXATION; DILATION	Objective Previous studies have shown that estrogen deficiency, arising in postmenopause, promotes endothelial dysfunction. This study evaluated the effects of aerobic exercise training on endothelial dependent vasodilation of aorta in ovariectomized rats, specifically investigating the role of nitric oxide (NO) and reactive oxygen species (ROS). Methods Female Wistar rats ovariectomized (OVX - n= 20) or with intact ovary (SHAM - n= 20) remained sedentary (OVX and SHAM) or performed aerobic exercise training on a treadmill 5 times a week for a period of 8 weeks (OVX-TRA and SHAM-TRA). In the thoracic aorta the endothelium-dependent and - independent vasodilation was assessed by acetylcholine (ACh) and sodium nitroprusside (SNP), respectively. Certain aortic rings were incubated with L-NAME to assess the NO modulation on the ACh-induced vasodilation. The fluorescence to dihydroethidium in aortic slices and plasma nitrite/nitrate concentrations were measured to evaluate ROS and NO bioavailability, respectively. Results ACh-induced vasodilation was reduced in OVX rats as compared SHAM (Rmax: SHAM: 86 +/-3.3 vs. OVX: 57+/-3.0%, p<0.01). Training prevented this response in OVX-TRA (Rmax: OVX-TRA: 88+/-2.0%, p<0.01), while did not change it in SHAM-TRA (Rmax: SHAM-TRA: 80+/-2.2%, p<0.01). The L-NAME incubation abolished the differences in ACh-induced relaxation among groups. SNP-induced vasodilation was not different among groups. OVX reduced nitrite/nitrate plasma concentrations and increased ROS in aortic slices, training as effective to restore these parameters to the SHAM levels. Conclusions Exercise training, even in estrogen deficiency conditions, is able to improve endothelial dependent vasodilation in rat aorta via enhanced NO bioavailability and reduced ROS levels.	[Braga, Viviane A. V. N.; Lazzarin, Mariana C.; Medeiros, Alessandra] Univ Fed Sao Paulo, Dept Biosci, Sao Paulo, Brazil; [Couto, Gisele K.; Rossoni, Luciana V.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Medeiros, A (corresponding author), Univ Fed Sao Paulo, Dept Biosci, Sao Paulo, Brazil.	a.medeiros@unifesp.br	Medeiros, Alessandra/E-8132-2012; Lazzarin, Mariana C/C-7187-2017; Rossoni, Luciana Venturini/AFR-0021-2022; deng, qiongxia/A-3206-2017; Rossoni, Luciana Venturini/C-7226-2012	Medeiros, Alessandra/0000-0002-7962-7185; Lazzarin, Mariana C/0000-0003-2858-5453; Rossoni, Luciana Venturini/0000-0002-0944-9483	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2012/17709-0, 2010/50048-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP# 2012/17709-0 (V.A.V.N.B) and FAPESP# 2010/50048-1 (L.V.R and A.M.). L.V.R. is research fellow at Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2005, CIRCULATION, V111, P555, DOI 10.1161/01.CIR.0000154560.88933.7E; [Anonymous], 2010, REV BRASILEIRA HIPER, V13, P6; [Anonymous], 2013, ARQUIVO BRASILEIRO C, V101, P4; Babaei Parvin, 2010, Menopause Int, V16, P100, DOI 10.1258/mi.2010.010028; Bauersachs J, 1999, CIRCULATION, V100, P292, DOI 10.1161/01.CIR.100.3.292; BROOKS GA, 1978, J APPL PHYSIOL, V45, P1009, DOI 10.1152/jappl.1978.45.6.1009; Claudio ERG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064806; Cornelissen VA, 2005, HYPERTENSION, V46, P667, DOI 10.1161/01.HYP.0000184225.05629.51; Dantas APV, 1999, HYPERTENSION, V34, P914, DOI 10.1161/01.HYP.34.4.914; Davel AP, 2011, BRAZ J MED BIOL RES, V44, P920, DOI [10.1590/S0100-879X2011007500104, 10.1590/S0100-879X2011000900014]; Davel APC, 2006, BRIT J PHARMACOL, V148, P629, DOI 10.1038/sj.bjp.0706749; Dong JH, 2013, KIDNEY INT, V84, P54, DOI 10.1038/ki.2013.12; Dugan SA, 2010, OBESITY, V18, P1260, DOI 10.1038/oby.2009.396; Endlich PW, 2013, PEPTIDES, V47, P29, DOI 10.1016/j.peptides.2013.06.002; Figard H, 2006, APPL PHYSIOL NUTR ME, V31, P621, DOI 10.1139/H06-070; Fleming I, 2010, PFLUG ARCH EUR J PHY, V459, P793, DOI 10.1007/s00424-009-0767-7; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Camporez JPG, 2011, J PHYSIOL-LONDON, V589, P2585, DOI 10.1113/jphysiol.2011.206078; GAVA NS, 1995, HYPERTENSION, V26, P1129, DOI 10.1161/01.HYP.26.6.1129; Goto C, 2003, CIRCULATION, V108, P530, DOI 10.1161/01.CIR.0000080893.55729.28; Graham DA, 2004, J APPL PHYSIOL, V96, P2088, DOI 10.1152/japplphysiol.01252.2003; Guidry MA, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2006.03.010; Inoue N, 1996, CIRC RES, V79, P32, DOI 10.1161/01.RES.79.1.32; Irigoyen MC, 2005, HYPERTENSION, V46, P998, DOI 10.1161/01.HYP.0000176238.90688.6b; Ito K, 2006, HYPERTENSION, V48, P651, DOI 10.1161/01.HYP.0000238125.21656.9e; KOLLER A, 1995, CIRC RES, V76, P544, DOI 10.1161/01.RES.76.4.544; Lejskova M, 2012, PHYSIOL RES, V61, P587, DOI 10.33549/physiolres.932313; Li HG, 2014, ATHEROSCLEROSIS, V237, P208, DOI 10.1016/j.atherosclerosis.2014.09.001; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Martorell A, 2009, CARDIOVASC RES, V84, P300, DOI 10.1093/cvr/cvp214; Masson GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094927; Maturana MA, 2007, CLINICS, V62, P77, DOI 10.1590/S1807-59322007000100012; McCormick KM, 2004, J MUSCLE RES CELL M, V25, P21, DOI 10.1023/B:JURE.0000021398.78327.39; Melton SA, 2000, APPETITE, V35, P1, DOI 10.1006/appe.2000.0338; Moraes-Silva IC, 2010, CLIN EXP PHARMACOL P, V37, pe114, DOI 10.1111/j.1440-1681.2009.05333.x; Moreau KL, 2012, J CLIN ENDOCR METAB, V97, P4692, DOI 10.1210/jc.2012-2244; National Research Council Committee for the Update of the Guide for the C Use of Laboratory A, 2011, NATL ACAD COLLECTION; Nickenig G, 1998, CIRCULATION, V97, P2197, DOI 10.1161/01.CIR.97.22.2197; Niebauer J, 1996, J AM COLL CARDIOL, V28, P1652, DOI 10.1016/S0735-1097(96)00393-2; Park JH, 2008, ACTA PHYSIOL, V193, P47, DOI 10.1111/j.1748-1716.2007.01799.x; Park JK, 2013, J WOMENS HEALTH, V22, P587, DOI 10.1089/jwh.2012.4035; PESCATELLO LS, 1991, CIRCULATION, V83, P1557, DOI 10.1161/01.CIR.83.5.1557; Pierce GL, 2011, CLIN SCI, V120, P13, DOI 10.1042/CS20100174; Pighon A, 2009, CLIMACTERIC, V12, P153, DOI 10.1080/13697130802447074; Roque FR, 2013, BRIT J PHARMACOL, V168, P686, DOI 10.1111/j.1476-5381.2012.02224.x; Veras-Silva AS, 1997, AM J PHYSIOL-HEART C, V273, pH2627, DOI 10.1152/ajpheart.1997.273.6.H2627; Wang D, 2014, HYPERTENSION, V63, P1063, DOI 10.1161/HYPERTENSIONAHA.113.02284; Wassmann S, 2001, CIRCULATION, V103, P435; Widder J, 2003, HYPERTENSION, V42, P991, DOI 10.1161/01.HYP.0000098661.37637.89; Yung LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017437; Zanchi NE, 2006, REV BRAS EDUC FIS ES, V20, p239 a 47	51	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125388	10.1371/journal.pone.0125388	http://dx.doi.org/10.1371/journal.pone.0125388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923465	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600146
J	Mattison, SM; Brown, MJ; Floyd, B; Feldman, MW				Mattison, Siobhan M.; Brown, Melissa J.; Floyd, Bruce; Feldman, Marcus W.			Adoption Does Not Increase the Risk of Mortality among Taiwanese Girls in a Longitudinal Analysis	PLOS ONE			English	Article							GENETIC FATHERS; PATERNAL CARE; CHILD-ABUSE; KINSHIP; EVOLUTION; MARRIAGE; TRENDS	Adopted children often experience health and well-being disadvantages compared to biological children remaining in their natal households. The degree of genetic relatedness is thought to mediate the level of parental investment in children, leading to poorer outcomes of biologically unrelated children. We explore whether mortality is related to adoption in a historical Taiwanese population where adoption rarely occurred among kin. Using Cox proportional hazards models in which adoption is included as a time-dependent covariate, we show that adoption of girls does not increase the risk of mortality, as previously suggested; in fact, it is either protective or neutral with respect to mortality. These results suggest that socio-structural variables may produce positive outcomes for adopted children, even compared to biological children who remain in the care of their parents.	[Mattison, Siobhan M.] Boston Univ, Dept Biol & Womens, Gender & Sexual Studies Program, Boston, MA 02215 USA; [Mattison, Siobhan M.; Floyd, Bruce] Univ Auckland, Auckland Ctr, Dept Anthropol, Auckland 1142, New Zealand; [Brown, Melissa J.] Harvard Yenching Inst, Cambridge, MA 02138 USA; [Brown, Melissa J.] Univ Minnesota Twin Cities, Minnesota Populat Ctr, Minneapolis, MN 55455 USA; [Feldman, Marcus W.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Feldman, Marcus W.] Stanford Univ, Morrison Inst Populat & Resource Studies, Stanford, CA 94305 USA	Boston University; University of Auckland; Harvard University; University of Minnesota System; University of Minnesota Twin Cities; Stanford University; Stanford University	Mattison, SM (corresponding author), Boston Univ, Dept Biol & Womens, Gender & Sexual Studies Program, 5 Cummington Mall, Boston, MA 02215 USA.	smattiso@bu.edu		Floyd, Bruce/0000-0002-6092-0787; Mattison, Siobhan/0000-0002-9537-5459	Andrew W. Mellon Foundation, John E. Sawyer Seminar on the Comparative Study of Cultures; Morrison Institute for Population and Resource Studies; Center for East Asian Studies at Stanford University; University of Auckland Faculty Research Development Fund	Andrew W. Mellon Foundation, John E. Sawyer Seminar on the Comparative Study of Cultures; Morrison Institute for Population and Resource Studies; Center for East Asian Studies at Stanford University; University of Auckland Faculty Research Development Fund	Andrew W. Mellon Foundation, John E. Sawyer Seminar on the Comparative Study of Cultures (http://www.mellon.org/grant_programs/programs/higher-education-and-scholarship/john-e-sawyer-seminars-on-the-comparative-study-of-cultures/) to MJB and MWF, which supported a postdoctoral fellowship to SMM. Additional support has been provided by the Morrison Institute for Population and Resource Studies and the Center for East Asian Studies at Stanford University, and the University of Auckland Faculty Research Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KG, 1999, EVOL HUM BEHAV, V20, P433, DOI 10.1016/S1090-5138(99)00022-7; Anderson KG, 1999, EVOL HUM BEHAV, V20, P405, DOI 10.1016/S1090-5138(99)00023-9; ANDERTON DL, 1990, DEMOGRAPHY, V27, P397, DOI 10.2307/2061375; [Anonymous], 1972, WOMEN FAMILY RURAL T; Avital E, 1998, ANIM BEHAV, V55, P1451, DOI 10.1006/anbe.1998.0729; Barclay, 1954, COLONIAL DEV POPULAT; Berger LM, 2008, J MARRIAGE FAM, V70, P625, DOI 10.1111/j.1741-3737.2008.00510.x; Borders LD, 1998, FAM RELAT, V47, P237, DOI 10.2307/584972; Brown M, 2004, IS TAIWAN CHINESE IM; Brown MJ, 2009, P NATL ACAD SCI USA, V106, P22139, DOI 10.1073/pnas.0907520106; Case A, 2001, EVOL HUM BEHAV, V22, P269, DOI 10.1016/S1090-5138(01)00069-1; CHUANG YC, 1995, J ASIAN STUD, V54, P781; Cuddeback GS, 2004, CHILD YOUTH SERV REV, V26, P623, DOI 10.1016/j.childyouth.2004.01.014; DALY M, 1985, ETHOL SOCIOBIOL, V6, P197, DOI 10.1016/0162-3095(85)90012-3; Daly M, 2001, ANN ZOOL FENN, V38, P287; DALY M, 1980, J MARRIAGE FAM, V42, P277, DOI 10.2307/351225; Daly M, 2011, HUM NATURE-INT BIOS, V22, P350, DOI 10.1007/s12110-011-9116-6; Engelen T, 2011, DEATH OPPOSITE ENDS; FREEDMAN R, 1963, POP STUD-J DEMOG, V16, P219; GATES H, 1989, SIGNS, V14, P799, DOI 10.1086/494545; Gibson K, 2009, EVOL HUM BEHAV, V30, P184, DOI 10.1016/j.evolhumbehav.2009.01.001; GOODY J, 1969, COMP STUD SOC HIST, V11, P55, DOI 10.1017/S0010417500005156; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Henderson S H, 1999, Monogr Soc Res Child Dev, V64, P79, DOI 10.1111/1540-5834.00048; Herring D. J., 2009, CAPITAL U LAW REV, V38, P291; Hofferth SL, 2003, J MARRIAGE FAM, V65, P213, DOI 10.1111/j.1741-3737.2003.00213.x; Howell S, 2009, ANNU REV ANTHROPOL, V38, P149, DOI 10.1146/annurev.anthro.37.081407.085115; Ihara Y, 2004, THEOR POPUL BIOL, V65, P105, DOI 10.1016/j.tpb.2003.07.003; Jones JH, 2010, HUMAN EVOLUTIONARY B; Lawler MJ, 2008, CHILD YOUTH SERV REV, V30, P1131, DOI 10.1016/j.childyouth.2008.02.007; Liu JT, 2008, ANAL BIOCHEM, V375, P90, DOI 10.1016/j.ab.2008.01.004; Olds KB, 2006, ECON HUM BIOL, V4, P206, DOI 10.1016/j.ehb.2005.12.002; Palacios J, 2010, INT J BEHAV DEV, V34, P270, DOI 10.1177/0165025410362837; Pasternak B, 1985, FAMILY POPULATION E; PENNINGTON R, 1991, ETHOL SOCIOBIOL, V12, P83, DOI 10.1016/0162-3095(91)90015-I; R Core Team, 2021, R LANGUAGE ENV STAT; Sahlins M. D., 1976, USE ABUSE BIOL ANTHR; Scelza BA, 2014, HUM NATURE-INT BIOS, V25, P448, DOI 10.1007/s12110-014-9211-6; Schnettler S, 2011, J FAM RES, V23; Shenk MK, 2011, HUM NATURE-INT BIOS, V22, P1, DOI 10.1007/s12110-011-9105-9; Shepherd John R., 2011, DEATH OPPOSITE ENDS, P45; Sheppard P, 2014, EVOL HUM BEHAV; Silk J B, 1990, Hum Nat, V1, P25, DOI 10.1007/BF02692145; SILK JB, 1987, ETHOS, V15, P320, DOI 10.1525/eth.1987.15.3.02a00040; SILK JB, 1980, AM ANTHROPOL, V82, P799, DOI 10.1525/aa.1980.82.4.02a00050; Silk JB., 1987, CULTURAL ANTHR, V2, P39, DOI [10.1525/can.1987.2.1.02a00050, DOI 10.1525/CAN.1987.2.1.02A00050]; Skinner G. W., 1997, ANTHR DEMOGRAPHY NEW, P53; TERRELL J, 1994, AM ANTHROPOL, V96, P155, DOI 10.1525/aa.1994.96.1.02a00130; Therneau T.M., 2000, MODELING SURVIVAL DA; TUAN CH, 1958, POP STUD-J DEMOG, V12, P40, DOI 10.2307/2172211; Volk AA, 2011, OXFORD HDB EVOLUTION, P113; WALTNER A, 1984, MOD CHINA, V10, P441, DOI 10.1177/009770048401000404; Wang F, 1998, HIST FAMILY, V3, P411, DOI [10.1016/S1081-602X(99)80255-3, DOI 10.1016/S1081-602X(99)80255-3]; Watson James L., 1980, ASIAN AFRICAN SYSTEM, P223; WATSON JL, 1975, MAN, V10, P293, DOI 10.2307/2800500; Wegar K, 2000, FAM RELAT, V49, P363, DOI 10.1111/j.1741-3729.2000.00363.x; WILSON MI, 1980, J BIOSOC SCI, V12, P333, DOI 10.1017/S0021932000012876; Wolf AP, 2003, CURR ANTHROPOL, V44, pS31, DOI 10.1086/377668; WOLF AP, 1968, AM ANTHROPOL, V70, P864, DOI 10.1525/aa.1968.70.5.02a00040; Wolf AP, 2005, INBREEDING INCEST IN, pviii; Wolf AP, 1995, SEXUAL ATTRACTION CH, pxxiii; Wolf Arthur P., 1980, MARRIAGE ADOPTION CH; Wolf Margery, 1968, HOUSE LIM STUDY CHIN; Yu G, 2011, DEATH OPPOSITE ENDS, P317	64	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122867	10.1371/journal.pone.0122867	http://dx.doi.org/10.1371/journal.pone.0122867			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923106	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600023
J	Shao, MY; Sun, YN; Zhou, SG				Shao, Mingyu; Sun, Yanni; Zhou, Shuigeng			Identifying TF-MiRNA Regulatory Relationships Using Multiple Features	PLOS ONE			English	Article							CHIP-SEQ DATA; GENOME BROWSER DATABASE; CHROMATIN-IMMUNOPRECIPITATION; TRANSCRIPTION FACTOR; MICRORNA GENES; PROFILES; NETWORKS; TOOLS; RNA	MicroRNAs are known to play important roles in the transcriptional and post-transcriptional regulation of gene expression. While intensive research has been conducted to identify miRNAs and their target genes in various genomes, there is only limited knowledge about how microRNAs are regulated. In this study, we construct a pipeline that can infer the regulatory relationships between transcription factors and microRNAs from ChIP-Seq data with high confidence. In particular, after identifying candidate peaks from ChIP-Seq data, we formulate the inference as a PU learning (learning from only positive and unlabeled examples) problem. Multiple features including the statistical significance of the peaks, the location of the peaks, the transcription factor binding site motifs, and the evolutionary conservation are derived from peaks for training and prediction. To further improve the accuracy of our inference, we also apply a mean reciprocal rank (MRR)-based method to the candidate peaks. We apply our pipeline to infer TF-miRNA regulatory relationships in mouse embryonic stem cells. The experimental results show that our approach provides very specific findings of TF-miRNA regulatory relationships.	[Shao, Mingyu; Zhou, Shuigeng] Fudan Univ, Sch Comp Sci, Shanghai 200433, Peoples R China; [Shao, Mingyu; Zhou, Shuigeng] Fudan Univ, Shanghai Key Lab Intelligent Informat Proc, Shanghai 200433, Peoples R China; [Shao, Mingyu; Sun, Yanni] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA	Fudan University; Fudan University; Michigan State University	Sun, YN (corresponding author), Michigan State Univ, Dept Comp Sci & Engn, 428 S Shaw Lane, E Lansing, MI 48824 USA.	yannisun@msu.edu; sgzhou@fudan.edu.cn	SUN, Yanni/AHC-4163-2022; Sun, Yanni/AAZ-7373-2021	SUN, Yanni/0000-0003-1373-8023; 	Fudan University Graduate School, National Natural Science and Foundation of China (NSFC) [61272380]; NSF CAREER [DBI-0953738]; National Natural Science Foundation of China (NSFC) [61272380]	Fudan University Graduate School, National Natural Science and Foundation of China (NSFC); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	MS was supported by the exchange program fund of doctoral student under the Fudan University Graduate School, National Natural Science and Foundation of China (NSFC) under grant no. 61272380. YS was supported by NSF CAREER grant DBI-0953738. SZ was supported by National Natural Science Foundation of China (NSFC) under grant no. 61272380.	Aparicio O, 2005, CURRENT PROTOCOLS MO, P21; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bing L, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P179, DOI 10.1109/icdm.2003.1250918; Bisognin A, 2012, NUCLEIC ACIDS RES, V40, pW13, DOI 10.1093/nar/gks460; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Brill E., 2001, TREC; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Cerulo L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-228; Chang LW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-84; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Elkan C., 2008, PROC ACM SIGKDD INT, P213, DOI DOI 10.1145/1401890.1401920; Friard O, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-435; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Gordon A.H., 2010, FASTX TOOLKIT; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Ji XH, 2008, CURR TOP MICROBIOL, V320, P99; Joachims T, 1999, MACHINE LEARNING, PROCEEDINGS, P200; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; Kurubanjerdjit N, 2013, COMPUT BIOL MED, DOI [10.1016/j.compbiomed.2013.08.010, DOI 10.1016/J.C0MPBI0MED.2013.08.010]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Bechec A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-67; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liang K, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-199; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mendoza MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070153; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Mitchell T.M, 2003, MACH LEARN; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Natarajan N., 2011, TR1137 U TEX AUST DE; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Shao M, 2013, BRIEFINGS BIOINFORMA; Shao Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r16; Sun GN, 2013, METHODS MOL BIOL, V1038, P193, DOI 10.1007/978-1-62703-514-9_12; Toedling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032724; Vapnik V., 2013, NATURE STAT LAERNING; Vega VB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005241; Vert J.-P., 2010, ARXIV10100772; Voorhees E.M., 2000, P 2 INT C LANGUAGE R, P77; Yang JH, 2013, NUCLEIC ACIDS RES, V41, pD177, DOI 10.1093/nar/gks1060; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	49	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125156	10.1371/journal.pone.0125156	http://dx.doi.org/10.1371/journal.pone.0125156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922940	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600130
J	Velez-Juarbe, J; Wood, AR; De Gracia, C; Hendy, AJW				Velez-Juarbe, Jorge; Wood, Aaron R.; De Gracia, Carlos; Hendy, Austin J. W.			Evolutionary Patterns among Living and Fossil Kogiid Sperm Whales: Evidence from the Neogene of Central America	PLOS ONE			English	Article							LATE MIOCENE; SEXUAL SELECTION; MARINE MAMMALS; CETACEA; ODONTOCETI; PLIOCENE; BREVICEPS; PHYSETEROIDEA; PANAMA; SKULL	Kogiids are known by two living species, the pygmy and dwarf sperm whale (Kogia breviceps and K. sima). Both are relatively rare, and as their names suggest, they are closely related to the sperm whale, all being characterized by the presence of a spermaceti organ. However, this organ is much reduced in kogiids and may have become functionally different. Here we describe a fossil kogiid from the late Miocene of Panama and we explore the evolutionary history of the group with special attention to this evolutionary reduction. The fossil consists of cranial material from the late Tortonian (similar to 7.5 Ma) Pina facies of the Chagres Formation in Panama. Detailed comparison with other fossil and extant kogiids and the results of a phylogenetic analysis place the Panamanian kogiid, herein named Nanokogia isthmia gen. et sp. nov., as a taxon most closely related to Praekogia cedrosensis from the Messinian (similar to 6 Ma) of Baja California and to Kogia spp. Furthermore our results show that reduction of the spermaceti organ has occurred iteratively in kogiids, once in Thalassocetus antwerpiensis in the early-middle Miocene, and more recently in Kogia spp. Additionally, we estimate the divergence between extant species of Kogia at around the late Pliocene, later than previously predicted by molecular estimates. Finally, comparison of Nanokogia with the coeval Scaphokogia cochlearis from Peru shows that these two species display a greater morphological disparity between them than that observed between the extant members of the group. We hypothesize that this reflects differences in feeding ecologies of the two species, with Nanokogia being more similar to extant Kogia. Nanokogia shows that kogiids have been part of the Neotropical marine mammal communities at least since the late Miocene, and gives us insight into the evolutionary history and origins of one of the rarest groups of living whales.	[Velez-Juarbe, Jorge] Nat Hist Museum Los Angeles Cty, Dept Mammal, Los Angeles, CA 90007 USA; [Velez-Juarbe, Jorge] Calif State Univ Fullerton, Dept Geol Sci, John D Cooper Archaeol & Paleontol Ctr, Fullerton, CA 92634 USA; [Wood, Aaron R.] Iowa State Univ, Dept Geol & Atmospher Sci, Ames, IA USA; [De Gracia, Carlos] Smithsonian Trop Res Inst, Balboa, Panama; [Hendy, Austin J. W.] Nat Hist Museum Los Angeles Cty, Dept Invertebrate Paleontol, Los Angeles, CA USA	California State University System; California State University Fullerton; Iowa State University; Smithsonian Institution; Smithsonian Tropical Research Institute	Velez-Juarbe, J (corresponding author), Nat Hist Museum Los Angeles Cty, Dept Mammal, Los Angeles, CA 90007 USA.	jvelezjuar@nhm.org	Hendy, Austin J/C-1279-2013	Hendy, Austin J/0000-0002-9818-1158; De Gracia, Carlos/0000-0003-0637-3302	National Science Foundation Partnerships for International Research and Education [0966884]; National Science Foundation Earth Sciences Postdoctoral Fellowship [1249920]; Secretaria Nacional de Ciencia, Tecnologia en Innovacion [APY-NI10-016A]; Direct For Biological Sciences [1203222] Funding Source: National Science Foundation	National Science Foundation Partnerships for International Research and Education(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Science Foundation Earth Sciences Postdoctoral Fellowship; Secretaria Nacional de Ciencia, Tecnologia en Innovacion; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this project was provided by National Science Foundation Partnerships for International Research and Education grant #0966884 to JVJ, ARW, CDG, and AJWH; National Science Foundation Earth Sciences Postdoctoral Fellowship grant #1249920 to JVJ; and Secretaria Nacional de Ciencia, Tecnologia en Innovacion grant #APY-NI10-016A to CDG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel O., 1905, MEMOIRES MUSEE ROYAL, V3, P1; Barnes L.G., 1973, Contributions Sci, VNo. 247, P1; Barnes L. G., 1984, PALEOBIOS, V42, P1; Barnes Lawrence G., 2008, Natural History Museum of Los Angeles County Science Series, P99; Benham W. B., 1901, Proceedings of the Zoological Society of London, Vii, P107; Bianucci G, 1999, RIV ITAL PALEONTOL S, V105, P445, DOI 10.13130/2039-4942/5385; Bianucci G, 2006, ZOOL J LINN SOC-LOND, V148, P103, DOI 10.1111/j.1096-3642.2006.00228.x; Blainville H. M. de., 1838, ANN FRANCAISES ETRAN, V2, P335; Bloodworth Brian E., 2008, Mammalian Species, P1, DOI 10.1644/819.1; Brisson AD., 1762, LUGDUM BATARORUM APU; Caldwell D.K., 1989, P235; Carrier DR, 2002, J EXP BIOL, V205, P1755; Clarke MR, 2003, J MAR BIOL ASSOC UK, V83, P241, DOI 10.1017/S0025315403007045h; Cohen KM, 2013, EPISODES, V36, P199, DOI 10.18814/epiiugs/2013/v36i3/002; Collins LS, 1996, GEOLOGY, V24, P687, DOI 10.1130/0091-7613(1996)024<0687:TLMPIS>2.3.CO;2; Cranford TW, 1999, MAR MAMMAL SCI, V15, P1133, DOI 10.1111/j.1748-7692.1999.tb00882.x; Cranford TW, 1996, J MORPHOL, V228, P223; De Gracia C, 2012, GEOL SOC AM ABS, V44, P164; de Muizon C, 1988, TRAVAUX I FRANCAIS E, V42, P1, DOI DOI 10.1179/ACB.2002.068; Dines JP, 2014, EVOLUTION, V68, P3296, DOI 10.1111/evo.12516; Ehret DJ, 2012, PALAEONTOLOGY, V55, P1139, DOI 10.1111/j.1475-4983.2012.01201.x; FIERSTINE HL, 1978, COPEIA, P1; FITCH JE, 1968, J FISH RES BOARD CAN, V25, P2561, DOI 10.1139/f68-227; Fitzgerald Erich M. G., 2005, Memoirs of Museum Victoria, V62, P67; Flower W. H., 1867, T ZOOLOGICAL SOC LON, V6, P87, DOI DOI 10.1111/J.1096-3642.1867.TB00572.X; FRASER F. C., 1960, BULL BRIT MUS [NAT HIST] ZOOL, V7, P1; Gill T, 1871, AM NAT, V4, P725, DOI DOI 10.1086/270684; Gray J.E., 1821, LONDON MED REPOSITOR, V15, P296; Gray JE, 1846, ZOOLOGY VOYAGE H M 3, V1, P13; Hendy A JW, J GEOL IN PRESS; Huggenberger S., 2014, J MAR BIOL ASS UK; Kernan JD, 1918, B AM MUS NAT HIST, V38, P0231; Lambert O, 2008, CR PALEVOL, V7, P361, DOI 10.1016/j.crpv.2008.06.002; Lambert O, 2013, J VERTEBR PALEONTOL, V33, P709, DOI 10.1080/02724634.2013.743405; Lambert O, 2010, NATURE, V466, P105, DOI 10.1038/nature09067; Lambert O, 2008, BULL INST R SC N B-S, V78, P277; Laurito Cesar A., 2011, Revista Geologica de America Central, V44, P153; Lindberg DR, 2007, LETHAIA, V40, P335, DOI 10.1111/j.1502-3931.2007.00032.x; Linnaeus C., 1758, SYSTEMA NATURAE REGN, DOI [10.5962/bhl.title.542, DOI 10.5962/BHL.TITLE.542]; Lucas SG, 2009, REV GEOL AM CEN, V41, P14; Luo ZX, 1996, J VERTEBR PALEONTOL, V16, P328, DOI 10.1080/02724634.1996.10011320; McAlpine D., 2002, ENCY MARINE MAMMALS, P1007; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; Mead James G., 2009, Smithsonian Contributions to Zoology, P1; Morgan Gary S., 1994, Proceedings of the San Diego Society of Natural History, V29, P239; Owen R., 1866, Transactions of the Zoological Society, Vvi, P17; Perrin WF., 1975, B SCRIPPS I OCEANOGR, V21; PILLERI G, 1987, CETACEA ITALIAN PLIO; Pyenson ND, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3316; Pyenson ND, 2011, J MAMM EVOL, V18, P269, DOI 10.1007/s10914-011-9170-1; Schulte H.vonW, 1918, B AM MUS NAT HIST, V38, P7; Schulte HV, 1917, B AM MUS NAT HIST, V37, P361; Schwarzhans Werner, 2013, Palaeo Ichthyologica, V13, P83; Staudinger MD, 2014, MAR MAMMAL SCI, V30, P626, DOI 10.1111/mms.12064; Swofford DL, 2002, PAUP V 40B10; Uhen MD, 2010, J S AM EARTH SCI, V30, P167, DOI 10.1016/j.jsames.2010.08.002; Valerio Ana L., 2012, Revista Geologica de America Central, V46, P151; Velez-Juarbe J, 2013, J VERT PAL PROGR ABS, P231; Vigil Dioselina I, 2014, Rev. Geol. Amér. Central, P213; Werth AJ, 2006, J MAMMAL, V87, P579, DOI 10.1644/05-MAMM-A-279R1.1; Whitmore Frank C. Jr, 2008, Virginia Museum of Natural History Special Publication, V14, P181; Willis PM, 1998, CAN FIELD NAT, V112, P114	62	30	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123909	10.1371/journal.pone.0123909	http://dx.doi.org/10.1371/journal.pone.0123909			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923213	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600060
J	Xu, YY; Evaristo, C; Alegre, ML; Gurbuxani, S; Kee, BL				Xu, Yiying; Evaristo, Cesar; Alegre, Maria-Luisa; Gurbuxani, Sandeep; Kee, Barbara L.			Analysis of Gzmb(Cre) as a Model System for Gene Deletion in the Natural Killer Cell Lineage	PLOS ONE			English	Article							KAPPA-B ACTIVITY; TRANSGENIC MICE; NK CELLS; IN-VIVO; ACTIVATION; MEMORY; CYTOTOXICITY; EXPRESSION; RECEPTOR; NKP46	The analysis of gene function in mature and activated natural killer cells has been hampered by the lack of model systems for Cre-mediated recombination in these cells. Here we have investigated the utility of Gzmb(Cre) for recombination of loxp sequences in these cells predicated on the observation that Gzmb mRNA is highly expressed in mature and activated natural killer cells. Using two different reporter strains we determined that gene function could be investigated in mature natural killer cells after Gzmb(Cre) mediated recombination in vitro in conditions that lead to natural killer cell activation such as in the cytokine combination of interleukin 2 and interleukin 12. We demonstrated the utility of this model by creating Gzmb(Cre); Rosa26(IKKbca) mice in which Cre-mediated recombination resulted in expression of constitutively active IKK beta, which results in activation of the NF kappa B transcription factor. In vivo and in vitro activation of IKK beta in natural killer cells revealed that constitutive activation of this pathway leads to natural killer cell hyper-activation and altered morphology. As a caveat to the use of Gzmb(Cre) we found that this transgene can lead to recombination in all hematopoietic cells the extent of which varies with the particular loxp flanked allele under investigation. We conclude that Gzmb(Cre) can be used under some conditions to investigate gene function in mature and activated natural killer cells.	[Xu, Yiying; Alegre, Maria-Luisa; Kee, Barbara L.] Univ Chicago, Comm Mol Pathogenesis & Mol Med, Chicago, IL 60637 USA; [Evaristo, Cesar; Alegre, Maria-Luisa; Kee, Barbara L.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Kee, Barbara L.] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Gurbuxani, Sandeep; Kee, Barbara L.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Evaristo, Cesar; Alegre, Maria-Luisa] Univ Chicago, Dept Med, Sect Rhuematol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Kee, BL (corresponding author), Univ Chicago, Comm Mol Pathogenesis & Mol Med, Chicago, IL 60637 USA.	bkee@bsd.uchicago.edu	Evaristo, Cesar/O-8430-2016	Evaristo, Cesar/0000-0002-2281-1045; Kee, Barbara/0000-0001-7014-1982	National Institute of Allergy and Infectious Diseases [R01 AI106352]; National Institute of Diabetes and Digestive and Diseases [T32 DK007074]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007074] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Diseases; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the National Institute of Allergy and Infectious Diseases (R01 AI106352 to B. L. K.) and a training grant from the National Institute of Diabetes and Digestive and Diseases (T32 DK007074 to Y. X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biassoni R, 1999, EUR J IMMUNOL, V29, P1014, DOI 10.1002/(SICI)1521-4141(199903)29:03<1014::AID-IMMU1014>3.0.CO;2-O; Brady J, 2010, J IMMUNOL, V185, P6679, DOI 10.4049/jimmunol.0903354; Campbell KS, 2013, J ALLERGY CLIN IMMUN, V132, P536, DOI 10.1016/j.jaci.2013.07.006; Cooper MA, 2010, IMMUNOL REV, V235, P297, DOI 10.1111/j.0105-2896.2010.00891.x; Eckelhart E, 2010, BLOOD, V117, P1565, DOI 10.1182/blood-2010-06-291633; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Hand TW, 2010, P NATL ACAD SCI USA, V107, P16601, DOI 10.1073/pnas.1003457107; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Klinger M, 2010, J IMMUNOL, V184, P6170, DOI 10.4049/jimmunol.1000089; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LANIER LL, 1988, J EXP MED, V167, P1572, DOI 10.1084/jem.167.5.1572; Lewis AE, 2013, DEV BIOL, V379, P229, DOI 10.1016/j.ydbio.2013.04.026; Marcais A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00450; Matthaei KI, 2007, J PHYSIOL-LONDON, V582, P481, DOI 10.1113/jphysiol.2007.134908; Min-Oo G, 2013, TRENDS IMMUNOL, V34, P251, DOI 10.1016/j.it.2013.02.005; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Orange JS, 2013, J ALLERGY CLIN IMMUN, V132, P515, DOI 10.1016/j.jaci.2013.07.020; Orange JS, 2002, J CLIN INVEST, V109, P1501, DOI 10.1172/JCI200214858; Pandey R, 2007, J IMMUNOL, V179, P7385, DOI 10.4049/jimmunol.179.11.7385; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Rajasekaran K, 2013, NAT IMMUNOL, V14, P1127, DOI 10.1038/ni.2708; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Samson SI, 2004, BLOOD, V103, P4573, DOI 10.1182/blood-2003-08-2975; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sun JC, EMBO J, V33, P1295; Sun MY, 2014, J COMP NEUROL, V522, P1191, DOI 10.1002/cne.23497; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125211	10.1371/journal.pone.0125211	http://dx.doi.org/10.1371/journal.pone.0125211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923440	gold, Green Submitted, Green Published			2022-12-27	WOS:000353711600134
J	Zuber, Z; Jurecka, A; Rozdzynska-Swiatkowska, A; Migas-Majoch, A; Lembas, A; Kiec-Wilk, B; Tylki-Szymanska, A				Zuber, Zbigniew; Jurecka, Agnieszka; Rozdzynska-Swiatkowska, Agnieszka; Migas-Majoch, Agata; Lembas, Agnieszka; Kiec-Wilk, Beata; Tylki-Szymanska, Anna			Ultrasonographic Features of Hip Joints in Mucopolysaccharidoses Type I and II	PLOS ONE			English	Article							CONVENTIONAL RADIOGRAPHY; DISEASE; BONE; INVOLVEMENT; ARTHRITIS; MECHANISM; VI	Objectives The primary aim of this study was to assess the ultrasonographic features of hip joints in patients with mucopolysaccharidosis (MPS) type I and II in comparison with healthy population. The secondary aims were to correlate these features with clinical measures and to evaluate the utility of ultrasound in the diagnosis of MPS disease. Materials and Methods Sixteen MPS I (n = 3) and II (n = 13) patients were enrolled in the present study and underwent clinical and radiological evaluation, and bilateral high-resolution ultrasonography (US) of hip joints. The distance from the femoral neck to joint capsule (synovial joint space, SJS), joint effusion, synovial hyperthrophy, and local pathological vascularization were evaluated. The results were compared to the healthy population and correlated with clinical and radiological measures. Results 1. There was a difference in US SJS between children with MPS disease and the normative value for healthy population (7mm). Mean values of SJS were 15.81 +/- 4.08 cm (right hip joints) and 15.69 +/- 4.19 cm (left joints). 2. No inflammatory joint abnormalities were detected in MPS patients. 3. There was a clear correlation between US SJS and patients' age and height, while no clear correlation was observed between SJS and disease severity. Conclusions 1. Patients with MPS I and II present specific features in hip joint ultrasonography. 2. The data suggests that ultrasonography might be effective in the evaluation of hip joint involvement in patients with MPS and might present a valuable tool in facilitating the diagnosis and follow up of the disease.	[Zuber, Zbigniew; Migas-Majoch, Agata] St Louis Reg Childrens Hosp, Dept Pediat, Krakow, Poland; [Jurecka, Agnieszka; Tylki-Szymanska, Anna] Childrens Mem Hlth Inst, Dept Pediat Nutr & Metab Dis, Warsaw, Poland; [Jurecka, Agnieszka] Univ Gdansk, Dept Genet, PL-80952 Gdansk, Poland; [Rozdzynska-Swiatkowska, Agnieszka] Childrens Mem Hlth Inst, Anthropol Lab, Warsaw, Poland; [Lembas, Agnieszka] Childrens Mem Hlth Inst, Dept Radiol, Warsaw, Poland; [Kiec-Wilk, Beata] Jagiellonian Univ, Coll Med, Dept Metab Dis, Krakow, Poland	Children's Memorial Health Institute; Fahrenheit Universities; University of Gdansk; Children's Memorial Health Institute; Children's Memorial Health Institute; Jagiellonian University; Collegium Medicum Jagiellonian University	Jurecka, A (corresponding author), Childrens Mem Hlth Inst, Dept Pediat Nutr & Metab Dis, Warsaw, Poland.	ajurecka@gmail.com		Tylki-Szymanska, Anna/0000-0002-8935-1768; Zuber, Zbigniew/0000-0001-9581-0601; Rozdzynska-Swiatkowska, Agnieszka/0000-0001-6936-5989				Backhaus M, 1999, ARTHRITIS RHEUM-US, V42, P1232, DOI 10.1002/1529-0131(199906)42:6<1232::AID-ANR21>3.0.CO;2-3; Beck M, 2010, J PEDIATR REHAB MED, V3, P39, DOI 10.3233/PRM-2010-0100; Brands MMMG, 2013, MOL GENET METAB, V109, P70, DOI 10.1016/j.ymgme.2013.02.013; Ciechomska Anna, 2005, Reumatologia (Warsaw), V43, P301; Clarke LA, 2009, PEDIATRICS, V123, P229, DOI 10.1542/peds.2007-3847; Coppa GV, 2011, RHEUMATOLOGY, V50, pV1, DOI 10.1093/rheumatology/ker391; D'Agostino MA., 2010, ESSENTIAL APPL MUSCU; Dougados M, 2010, ANN RHEUM DIS, V69, P828, DOI 10.1136/ard.2009.115493; EBERHARDT K, 1995, ANN RHEUM DIS, V54, P45, DOI 10.1136/ard.54.1.45; EICH GF, 1994, PEDIATR RADIOL, V24, P558, DOI 10.1007/BF02012732; Fedrizzi MS, 1997, J RHEUMATOL, V24, P1820; Hinek A, 2000, AM J PATHOL, V156, P925, DOI 10.1016/S0002-9440(10)64961-9; Jakubowski W, 2011, STANDARDY BADAN ULTR; Jeka Slawomir, 2009, Reumatologia (Warsaw), V47, P339; Lampe C, 2013, RHEUM DIS CLIN N AM, V39, P431, DOI 10.1016/j.rdc.2013.03.004; Naredo E, 2006, ANN RHEUM DIS, V65, P14, DOI 10.1136/ard.2005.037382; Naredo E, 2009, ANN RHEUM DIS, V68, P1322, DOI 10.1136/ard.2008.090738; Neufeld EF, ONLINE METABOLIC MOL; Oussoren E, 2011, BBA-MOL BASIS DIS, V1812, P1542, DOI 10.1016/j.bbadis.2011.07.013; Pastores GM, 2005, CURR OPIN RHEUMATOL, V17, P70, DOI 10.1097/01.bor.0000147283.40529.13; ROUBICEK M, 1985, AM J MED GENET, V20, P471, DOI 10.1002/ajmg.1320200308; Simonaro CM, 2008, AM J PATHOL, V172, P112, DOI 10.2353/ajpath.2008.070564; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073/pnas.0912937107; Simonaro CM, 2005, PEDIATR RES, V57, P701, DOI 10.1203/01.PDR.0000156510.96253.5A; Simonaro CM, 2001, LAB INVEST, V81, P1319, DOI 10.1038/labinvest.3780345	25	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123792	10.1371/journal.pone.0123792	http://dx.doi.org/10.1371/journal.pone.0123792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922936	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600058
J	Hsieh, JL; Nguyen, TQ; Matte, T; Ito, K				Hsieh, Jennifer L.; Nguyen, Trang Quyen; Matte, Thomas; Ito, Kazuhiko			Drinking Water Turbidity and Emergency Department Visits for Gastrointestinal Illness in New York City, 2002-2009	PLOS ONE			English	Article							SYNDROMIC SURVEILLANCE; ASSOCIATION; MILWAUKEE; MORTALITY; RAINFALL; OUTBREAK	Background Studies have examined whether there is a relationship between drinking water turbidity and gastrointestinal (GI) illness indicators, and results have varied possibly due to differences in methods and study settings. Objectives As part of a water security improvement project we conducted a retrospective analysis of the relationship between drinking water turbidity and GI illness in New York City (NYC) based on emergency department chief complaint syndromic data that are available in near-real-time. Methods We used a Poisson time-series model to estimate the relationship of turbidity measured at distribution system and source water sites to diarrhea emergency department (ED) visits in NYC during 2002-2009. The analysis assessed age groups and was stratified by season and adjusted for sub-seasonal temporal trends, year-to-year variation, ambient temperature, day-of-week, and holidays. Results Seasonal variation unrelated to turbidity dominated (similar to 90% deviance) the variation of daily diarrhea ED visits, with an additional 0.4% deviance explained with turbidity. Small yet significant multi-day lagged associations were found between NYC turbidity and diarrhea ED visits in the spring only, with approximately 5% excess risk per inter-quartile-range of NYC turbidity peaking at a 6 day lag. This association was strongest among those aged 0-4 years and was explained by the variation in source water turbidity. Conclusions Integrated analysis of turbidity and syndromic surveillance data, as part of overall drinking water surveillance, may be useful for enhanced situational awareness of possible risk factors that can contribute to GI illness. Elucidating the causes of turbidity-GI illness associations including seasonal and regional variations would be necessary to further inform surveillance needs.	[Hsieh, Jennifer L.; Nguyen, Trang Quyen] New York City Dept Hlth & Mental Hyg, Bur Communicable Dis, New York, NY 10013 USA; [Nguyen, Trang Quyen] San Francisco Dept Hlth, Populat Hlth Div, Appl Res Community Hlth Epidemiol & Surveillance, San Francisco, CA USA; [Matte, Thomas; Ito, Kazuhiko] New York City Dept Hlth & Mental Hyg, Bur Environm Surveillance & Policy, New York, NY USA	New York City Department of Health & Mental Hygiene; New York City Department of Health & Mental Hygiene	Hsieh, JL (corresponding author), New York City Dept Hlth & Mental Hyg, Bur Communicable Dis, New York, NY 10013 USA.	jhsieh@health.nyc.gov			Environmental Protection Agency Water Security Initiative grant [H1-83380501]	Environmental Protection Agency Water Security Initiative grant	This work was supported by the Environmental Protection Agency Water Security Initiative grant #H1-83380501 (http://water.epa.gov/infrastructure/watersecurity/lawsregs/initiative.cfm). The EPA approved funding for the NYC Water Security Initiative, including funds to conduct a study of water quality and health outcomes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramini J, 2000, Can Commun Dis Rep, V26, P211; Department of Environmental Protection NYC, 2015, DRINK WAT SUPPL QUAL; Drayna P, 2010, ENVIRON HEALTH PERSP, V118, P1439, DOI 10.1289/ehp.0901671; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gilbert Marie-Line, 2006, Journal of Water and Health, V4, P225, DOI 10.2166/wh.2006.0019; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Hrudey ES, 2008, TURBIDITY MICROBIAL; Hrudey SE, 2002, CAN J PUBLIC HEALTH, V93, P332, DOI 10.1007/BF03404562; Ito K, 2011, ENVIRON HEALTH PERSP, V119, P467, DOI 10.1289/ehp.1002667; Jagai JS, 2012, INT J ENV RES PUB HE, V9, P1771, DOI 10.3390/ijerph9051771; Kistemann T, 2002, APPL ENVIRON MICROB, V68, P2188, DOI 10.1128/AEM.68.5.2188-2197.2002; LeChevallier Mark W., 2003, Journal of Water and Health, V1, P3; Lim G., 2002, INVESTIGATING RELATI; MACKENZIE WR, 1994, NEW ENGL J MED, V331, P161, DOI 10.1056/NEJM199407213310304; Mann AG, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-256; Marx MA, 2006, AM J PUBLIC HEALTH, V96, P547, DOI 10.2105/AJPH.2004.061358; Morris RD, 1998, EPIDEMIOLOGY, V9, P264, DOI 10.1097/00001648-199805000-00009; Payment P, 1999, CAN J MICROBIOL, V45, P709, DOI 10.1139/cjm-45-8-709; Schwartz J, 2000, J EPIDEMIOL COMMUN H, V54, P45, DOI 10.1136/jech.54.1.45; Schwartz J, 1997, EPIDEMIOLOGY, V8, P615, DOI 10.1097/00001648-199710000-00001; SHUMWAY RH, 1988, ENVIRON RES, V45, P224, DOI 10.1016/S0013-9351(88)80049-5; Sitzenfrei R, 2011, WATER SCI TECHNOL, V64, P1885, DOI 10.2166/wst.2011.813; Tinker SC, 2010, J EXPO SCI ENV EPID, V20, P19, DOI 10.1038/jes.2008.68; Venables WN., 2002, MODERN APPL STAT S 4; Zeger SL, 1999, EPIDEMIOLOGY, V10, P171, DOI 10.1097/00001648-199903000-00015	25	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125071	10.1371/journal.pone.0125071	http://dx.doi.org/10.1371/journal.pone.0125071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919375	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659400070
J	Obermajer, T; Lipoglavsek, L; Tompa, G; Treven, P; Lorbeg, PM; Matijasic, BB; Rogelj, I				Obermajer, Tanja; Lipoglavsek, Luka; Tompa, Gorazd; Treven, Primoz; Lorbeg, Petra Mohar; Matijasic, Bojana Bogovic; Rogelj, Irena			Colostrum of Healthy Slovenian Mothers: Microbiota Composition and Bacteriocin Gene Prevalence	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; LACTIC-ACID BACTERIA; REAL-TIME PCR; HUMAN-MILK; INTESTINAL MICROBIOTA; BREAST-MILK; TUF GENE; IDENTIFICATION; DIVERSITY; POPULATIONS	Microbial communities inhabiting the breast milk microenvironment are essential in supporting mammary gland health in lactating women and in providing gut-colonizing bacterial 'inoculum' for their infants' gastro-intestinal development. Bacterial DNA was extracted from colostrum samples of 45 healthy Slovenian mothers. Characteristics of the communities in the samples were assessed by polymerase chain reaction (PCR) coupled with denaturing gradient gel electrophoresis (DGGE) and by quantitative real-time PCR (qPCR). PCR screening for the prevalence of bacteriocin genes was performed on DNA of culturable and total colostrum bacteria. DGGE profiling revealed the presence of Staphylococcus and Gemella in most of the samples and exposed 4 clusters based on the abundance of 3 bands: Staphylococcus epidermidis/Gemella, Streptococcus oralis/pneumonia and Streptococcus salivarius. Bacilli represented the largest proportion of the communities. High prevalence in samples at relatively low quantities was confirmed by qPCR for enterobacteria (100%), Clostridia (95.6%), Bacteroides-Prevotella group (62.2%) and bifidobacteria (53.3%). Bacterial quantities (genome equivalents ml(-1)) varied greatly among the samples; Staphylococcus epidermidis and staphylococci varied in the range of 4 logs, streptococci and all bacteria varied in the range of 2 logs, and other researched groups varied in the range of 1 log. The quantity of most bacterial groups was correlated with the amount of all bacteria. The majority of the genus Staphylococcus was represented by the species Staphylococcus epidermidis (on average 61%), and their abundances were linearly correlated. Determinants of salivaricin A, salivaricin B, streptin and cytolysin were found in single samples. This work provides knowledge on the colostrum microbial community composition of healthy lactating Slovenian mothers and reports bacteriocin gene prevalence.	[Obermajer, Tanja; Tompa, Gorazd; Treven, Primoz; Lorbeg, Petra Mohar; Matijasic, Bojana Bogovic; Rogelj, Irena] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Inst Dairy Sci & Probiot, Domzale, Slovenia; [Lipoglavsek, Luka] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia	University of Ljubljana; University of Ljubljana	Obermajer, T (corresponding author), Univ Ljubljana, Biotech Fac, Dept Anim Sci, Inst Dairy Sci & Probiot, Domzale, Slovenia.	tanja.obermajer@bf.uni-lj.si	Matijašić, Bojana Bogovič/ABI-8319-2020; Matijasic, Bojana Bogovic/J-2885-2012; Treven, Primož/AAN-4721-2020	Matijašić, Bojana Bogovič/0000-0003-0666-6981; Treven, Primož/0000-0002-4235-4304	Slovenian Research Agency-ARRS [J4-3606, P4-0097]	Slovenian Research Agency-ARRS(Slovenian Research Agency - Slovenia)	Funding: This work was performed in the frame of the research project "The Role of Human Milk in Development of Breast Fed Child's Intestinal Microbiota." The project was fully supported by Slovenian Research Agency-ARRS (Contract No. J4-3606; P4-0097), https://www.arrs.gov.si/en/agencija/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Bernhard AE, 2000, APPL ENVIRON MICROB, V66, P1587, DOI 10.1128/AEM.66.4.1587-1594.2000; Cabrera-Rubio R, 2013, AM J CLIN NUTR, V97, P656, DOI 10.3945/ajcn.112.054262; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Chen HC, 2008, J FOOD DRUG ANAL, V16, P44; Collado MC, 2009, LETT APPL MICROBIOL, V48, P523, DOI 10.1111/j.1472-765X.2009.02567.x; Contreras GA, 2011, J MAMMARY GLAND BIOL, V16, P339, DOI 10.1007/s10911-011-9234-0; Delgado S, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-51; Dobson A, 2012, APPL ENVIRON MICROB, V78, P1, DOI 10.1128/AEM.05576-11; Donangelo C.M., 2003, ENCY FOOD SCI NUTR, Vsecond, P3449, DOI [10.1016/B0-12-227055-X/01356-0, DOI 10.1016/B0-12-227055-X/01356-0]; Fernandez L, 2013, PHARMACOL RES, V69, P1, DOI 10.1016/j.phrs.2012.09.001; Fiedler T, 2013, APPL ENVIRON MICROB, V79, P1265, DOI 10.1128/AEM.03350-12; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Hugon P, 2013, J CLIN MICROBIOL, V51, P3286, DOI 10.1128/JCM.00473-13; Hunt KM, 2012, APPL ENVIRON MICROB, V78, P4763, DOI 10.1128/AEM.00477-12; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Jeurink PV, 2013, BENEF MICROBES, V4, P17, DOI 10.3920/BM2012.0040; Jimenez E, 2008, RES MICROBIOL, V159, P595, DOI 10.1016/j.resmic.2008.09.001; Jimenez E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-143; Jost T, 2014, ENVIRON MICROBIOL, V16, P2891, DOI 10.1111/1462-2920.12238; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Lakshminarayanan B, 2013, J APPL MICROBIOL, V114, P886, DOI 10.1111/jam.12085; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Maldonado A, 2004, J BACTERIOL, V186, P1556, DOI 10.1128/JB.186.5.1556-1564.2004; Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028; Martin R, 2007, RES MICROBIOL, V158, P31, DOI 10.1016/j.resmic.2006.11.004; Martin V, 2012, J BACTERIOL, V194, P4466, DOI 10.1128/JB.00896-12; Martineau F, 2001, J CLIN MICROBIOL, V39, P2541, DOI 10.1128/JCM.39.7.2541-2547.2001; Matamoros S, 2013, TRENDS MICROBIOL, V21, P167, DOI 10.1016/j.tim.2012.12.001; Matijasic BB, 2014, EUR J NUTR, V53, P1051, DOI 10.1007/s00394-013-0607-6; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Mehanna N. S. H., 2013, Middle East Journal of Scientific Research, V14, P354; Mori Hiroshi, 2014, DNA Res, V21, P217, DOI 10.1093/dnares/dst052; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Ozgun D., 2011, J MED GENET GENOMICS, V3, P46; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quigley L, 2013, FEMS MICROBIOL REV, V37, P664, DOI 10.1111/1574-6976.12030; Ren DW, 2014, MICROB ECOL, V68, P146, DOI 10.1007/s00248-013-0315-z; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; SELA S, 1989, J BACTERIOL, V171, P581, DOI 10.1128/jb.171.1.581-584.1989; Songjinda P, 2007, BIOSCI BIOTECH BIOCH, V71, P2338, DOI 10.1271/bbb.70154; Trmcic A, 2008, J DAIRY SCI, V91, P4535, DOI 10.3168/jds.2008-1396; Urbaniak C, 2012, WOMENS HEALTH, V8, P385, DOI [10.2217/WHE.12.23, 10.2217/whe.12.23]; Van Dyke MI, 2002, APPL ENVIRON MICROB, V68, P2049, DOI 10.1128/AEM.68.4.2049-2053.2002; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward TL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-116; Xuan CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083744	51	25	26	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123324	10.1371/journal.pone.0123324	http://dx.doi.org/10.1371/journal.pone.0123324			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919457	Green Published, gold			2022-12-27	WOS:000353659400027
J	Bashir, T; Patgaonkar, M; Kumar, CS; Pasi, A; Reddy, KVR				Bashir, Tahir; Patgaonkar, Mandar; Kumar, Selvaa C.; Pasi, Achhelal; Reddy, Kudumula Venkata Rami			HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIMICROBIAL PEPTIDES; HUMAN DEFENSINS; FUSION INHIBITOR; PROTEIN; HEMOGLOBIN; ENFUVIRTIDE; GLYCOPROTEIN; INFLAMMATION; REPLICATION	Human Immunodeficiency Virus (HIV-1) poses a serious threat to the developing world and sexual transmission continues to be the major source of new infections. Therefore, the development of molecules, which prevent new HIV-1 infections, is highly warranted. In the present study, a panel of human hemoglobin (Hb)-alpha subunit derived peptides and their analogues, with an ability to bind gp120, were designed in-silico and their anti-HIV-1 activity was evaluated. Of these peptides, HbAHP-25, an analogue of Hb-alpha derived peptide, demonstrated significant anti-HIV-1 activity. HbAHP-25 was found to be active against CCR5-tropic HIV-1 strains (ADA5 and BaL) and CXCR4-tropic HIV-1 strains (IIIB and NL4-3). Surface plasmon resonance (SPR) and ELISA revealed direct interaction between HbAHP-25 and HIV-1 envelope protein, gp120. The peptide prevented binding of CD4 to gp120 and blocked subsequent steps leading to entry and/or fusion or both. Anti-HIV activity of HbAHP-25 appeared to be specific as it failed to inhibit the entry of HIV-1 pseudotyped virus (HIV-1 VSV). Further, HbAHP-25 was found to be non-cytotoxic to TZM-bl cells, VK2/E6E7 cells, CEM-GFP cells and PBMCs, even at higher concentrations. Moreover, HbAHP-25 retained its anti-HIV activity in presence of seminal plasma and vaginal fluid. In brief, the study identified HbAHP-25, a novel anti-HIV peptide, which directly interacts with gp120 and thus has a potential to inhibit early stages of HIV-1 infection.	[Bashir, Tahir; Pasi, Achhelal; Reddy, Kudumula Venkata Rami] Indian Council Med Res, Natl Inst Res Reprod Hlth, Div Mol Immunol & Microbiol, Bombay, Maharashtra, India; [Patgaonkar, Mandar] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Kumar, Selvaa C.] DY Patil Univ, Sch Biotechnol & Bioinformat, Dept Bioinformat, Navi Mumbai, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Tata Institute of Fundamental Research (TIFR)	Reddy, KVR (corresponding author), Indian Council Med Res, Natl Inst Res Reprod Hlth, Div Mol Immunol & Microbiol, Bombay, Maharashtra, India.	reddyk@nirrh.res.in	Dar, Tahir/AAR-8854-2021	Dar, Tahir/0000-0001-5191-8346				Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; Akari H, 1999, J GEN VIROL, V80, P2945, DOI 10.1099/0022-1317-80-11-2945; Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Cai LF, 2011, CURR TOP MED CHEM, V11, P2959, DOI 10.2174/156802611798808497; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034947; Cole AM, 2005, PROTEIN PEPTIDE LETT, V12, P41, DOI 10.2174/0929866053406101; Cornelia L, 2003, J CHROMATOGR B, V791, P345; Dassen H, 2008, HUM REPROD, V23, P635, DOI 10.1093/humrep/dem430; Deng LX, 2009, HUM REPROD, V24, P211, DOI 10.1093/humrep/den318; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Du RJ, 2010, EMBO J, V29, P632, DOI 10.1038/emboj.2009.380; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; Ghosh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011366; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Hugo AA, 2012, J APPL MICROBIOL, V113, P1491, DOI 10.1111/j.1365-2672.2012.05433.x; Klibanov OM, 2010, CURR OPIN INVEST DR, V11, P940; Kong L, 2015, PROTEINS, V83, P590, DOI 10.1002/prot.24747; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lackman-Smith C, 2008, ANTIMICROB AGENTS CH, V52, P1768, DOI 10.1128/AAC.01328-07; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Liu S, 2004, PROTEINS, V56, P93, DOI 10.1002/prot.20019; Lu WY, 2013, BIOCHEM BIOPH RES CO, V436, P557, DOI 10.1016/j.bbrc.2013.06.015; Mak P, 2004, PEPTIDES, V25, P1839, DOI 10.1016/j.peptides.2004.06.015; Mak P, 2008, FRONT BIOSCI-LANDMRK, V13, P6859, DOI 10.2741/3194; Mak P, 2007, AM J REPROD IMMUNOL, V57, P81, DOI 10.1111/j.1600-0897.2006.00456.x; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; MCNEELY TB, 1995, J CLIN INVEST, V96, P456, DOI 10.1172/JCI118056; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; Neurath AR, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-150; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Patgaonkar M, 2011, VET IMMUNOL IMMUNOP, V139, P176, DOI 10.1016/j.vetimm.2010.10.012; Patgaonkar MS, 2011, CLIN VACCINE IMMUNOL, V18, P1632, DOI 10.1128/CVI.00411-10; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rapista A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-45; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Seidel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009737; Sundaresan Sigamani, 2008, Protein Pept Lett, V15, P318; UNAIDS, 2013, REP GLOB AIDS EP; VanCompernolle SE, 2005, J VIROL, V79, P11598, DOI 10.1128/JVI.79.18.11598-11606.2005; Wachinger M, 1998, J GEN VIROL, V79, P731, DOI 10.1099/0022-1317-79-4-731; Wang GS, 2008, ANTIMICROB AGENTS CH, V52, P3438, DOI 10.1128/AAC.00452-08; Wang N, 2010, INT J EPIDEMIOL, V39, pII21, DOI 10.1093/ije/dyq209; Wang W, 2004, J IMMUNOL, V173, P515, DOI 10.4049/jimmunol.173.1.515; Wicherek L, 2007, EUR J OBSTET GYN R B, V131, P97, DOI 10.1016/j.ejogrb.2006.03.012; Yang QE, 2005, J VIROL, V79, P6122, DOI 10.1128/JVI.79.10.6122-6133.2005	52	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124839	10.1371/journal.pone.0124839	http://dx.doi.org/10.1371/journal.pone.0124839			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915507	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100072
J	Bruno, N; Bertamini, M; Protti, F				Bruno, Nicola; Bertamini, Marco; Protti, Federica			Selfie and the City: A World-Wide, Large, and Ecologically Valid Database Reveals a Two-Pronged Side Bias in Naive Self-Portraits	PLOS ONE			English	Article							LATERALITY	Self-portraits are more likely to show the artist's right than left cheek. This phenomenon may have a psychobiological basis: Self-portraitists often copy their subject from mirrors and, if they prefer to present their left cheek (more expressive due to right-lateralization of emotions) to the mirror, this would result in a right-cheek bias in the painting. We tested this hypothesis using SelfieCity (3200 selfies posted on Instagram from December 4 through 12, 2013 from New York, Sao Paulo, Berlin, Moskow, and Bangkok), which includes two selfie-taking styles: a "standard" (photograph of selfie-taker) and a "mirror" (photograph of mirror reflection of selfie-taker) style. We show that the first style reveals a left cheek bias, whereas the second reveals a right cheek bias. Thus side biases observed in a world-wide, large, and ecologically valid database of naive self-portraits provide strong support for a role of psychobiological factors in the artistic composition of self-portraits.	[Bruno, Nicola] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; [Bertamini, Marco] Univ Liverpool, Sch Psychol, Liverpool L69 3BX, Merseyside, England; [Protti, Federica] Univ Suor Orsola Benincasa, Naples, Italy	University of Parma; University of Liverpool; Suor Orsola Benincasa University Naples	Bruno, N (corresponding author), Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy.	nicola.bruno@unipr.it	Bertamini, Marco/C-2495-2011; Bertamini, Marco/H-2752-2019	Bertamini, Marco/0000-0001-8617-6864; Bertamini, Marco/0000-0001-8617-6864	Economic and Social Research Council (ESRC) [ES/K000187/1]; Economic and Social Research Council [ES/K000187/1] Funding Source: researchfish; ESRC [ES/K000187/1] Funding Source: UKRI	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported in part by a grant from the Economic and Social Research Council (ESRC Ref. ES/K000187/1) to Marco Bertamini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruno N, 2014, ART PERCEPT, V2, P45, DOI 10.1163/22134913-00002027; Bruno N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055141; EKMAN P, 1981, PSYCHOPHYSIOLOGY, V18, P101, DOI 10.1111/j.1469-8986.1981.tb02919.x; Humphrey NK., 1973, NEW SCI, V59, P437; LABAR M, 1973, NATURE, V245, P338, DOI 10.1038/245338a0; Latto R, 1996, EMPIR STUD ARTS, VArts14, P89, DOI DOI 10.2190/198M-911X-PR9G-U18E; Lindell AK, 2013, LATERALITY, V18, P319, DOI 10.1080/1357650X.2012.673622; MCMANUS IC, 1973, NATURE, V243, P271, DOI 10.1038/243271a0; Nicholls MER, 2000, SIDE BIAS: A NEUROPSYCHOLOGICAL PERSPECTIVE, P313; Nicholls MER, 1999, P ROY SOC B-BIOL SCI, V266, P1517, DOI 10.1098/rspb.1999.0809; Powell WR, 2009, LATERALITY, V14, P545, DOI 10.1080/13576500802680336; Rogers L.J., 2013, DIVIDED BRAINS BIOL; Tifentale A., 2014, SELFIECITY EXPLORING	13	29	29	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124999	10.1371/journal.pone.0124999	http://dx.doi.org/10.1371/journal.pone.0124999			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915767	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100088
J	Cesca, F; Bregant, E; Peterlin, B; Zadel, M; de Wittenau, GD; Siciliano, G; Ceravolo, R; Petrozzi, L; Pauletto, G; Verriello, L; Bergonzi, P; Damante, G; Barillari, G; Lucci, B; Curcio, F; Lonigro, IR				Cesca, Federica; Bregant, Elisa; Peterlin, Borut; Zadel, Maja; de Wittenau, Giorgia Dubsky; Siciliano, Gabriele; Ceravolo, Roberto; Petrozzi, Lucia; Pauletto, Giada; Verriello, Lorenzo; Bergonzi, Paolo; Damante, Giuseppe; Barillari, Giovanni; Lucci, Bruno; Curcio, Francesco; Lonigro, Incoronata Renata			Evaluating the SERCA2 and VEGF mRNAs as Potential Molecular Biomarkers of the Onset and Progression in Huntington's Disease	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RECEPTOR-MEDIATED EXCITOTOXICITY; GENE-EXPRESSION PROFILE; TRANSGENIC MOUSE MODEL; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; IN-VITRO; CALCIUM; BLOOD; TRANSPORT	Abnormalities of intracellular Ca2+ homeostasis and signalling as well as the down-regulation of neurotrophic factors in several areas of the central nervous system and in peripheral tissues are hallmarks of Huntington's disease (HD). As there is no therapy for this hereditary, neurodegenerative fatal disease, further effort should be made to slow the progression of neurodegeneration in patients through the definition of early therapeutic interventions. For this purpose, molecular biomarker(s) for monitoring disease onset and/or progression and response to treatment need to be identified. In the attempt to contribute to the research of peripheral candidate biomarkers in HD, we adopted a multiplex real-time PCR approach to analyse the mRNA level of targeted genes involved in the control of cellular calcium homeostasis and in neuroprotection. For this purpose we recruited a total of 110 subjects possessing the HD mutation at different clinical stages of the disease and 54 sex-and age-matched controls. This study provides evidence of reduced transcript levels of sarco-endoplasmic reticulum-associated ATP2A2 calcium pump (SERCA2) and vascular endothelial growth factor (VEGF) in peripheral blood mononuclear cells (PBMCs) of manifest and pre-manifest HD subjects. Our results provide a potentially new candidate molecular biomarker for monitoring the progression of this disease and contribute to understanding some early events that might have a role in triggering cellular dysfunctions in HD.	[Cesca, Federica; de Wittenau, Giorgia Dubsky; Curcio, Francesco; Lonigro, Incoronata Renata] Univ Udine, Dipartimento Sci Med & Biol, I-33100 Udine, Italy; [Bregant, Elisa; Damante, Giuseppe] Univ Udine, Azienda Osped, SOC Ist Genet, I-33100 Udine, Italy; [Peterlin, Borut; Zadel, Maja] Univ Med Ctr, Clin Inst Med Genet, Ljubljana, Slovenia; [Zadel, Maja] Community Hlth Ctr Ljubljana, Ljubljana, Slovenia; [Siciliano, Gabriele; Ceravolo, Roberto; Petrozzi, Lucia] Univ Pisa, Dipartimento Med Clin & Sperimentale, Pisa, Italy; [Pauletto, Giada; Verriello, Lorenzo; Bergonzi, Paolo] Univ Udine, Clin Neurol Azienda Osped, I-33100 Udine, Italy; [Barillari, Giovanni] Univ Udine, Azienda Osped, Med Trasfus, I-33100 Udine, Italy; [Lucci, Bruno] Azienda Osped, Neurol, Pordenone, Italy; [Curcio, Francesco; Lonigro, Incoronata Renata] Univ Udine, Azienda Osped, SOC Ist Patol Clin, I-33100 Udine, Italy	University of Udine; University of Udine; University Medical Centre Ljubljana; University of Pisa; University of Udine; University of Udine; University of Udine	Lonigro, IR (corresponding author), Univ Udine, Dipartimento Sci Med & Biol, I-33100 Udine, Italy.	renata.lonigro@uniud.it	Damante, Giuseppe/AAC-5200-2022; ceravolo, roberto/AAB-1293-2019; Peterlin, Borut/C-6086-2011; Curcio, Francesco/K-4669-2014; Lonigro, Incoronata/AAE-5996-2020; ceravolo, roberto/K-6831-2016; Siciliano, Gabriele/K-7259-2016	ceravolo, roberto/0000-0003-1412-9406; Peterlin, Borut/0000-0001-7824-4978; ceravolo, roberto/0000-0003-1412-9406; CURCIO, Francesco/0000-0002-9070-4807; Damante, Giuseppe/0000-0003-2312-4009; Siciliano, Gabriele/0000-0002-6142-2384; Barillari, Giovanni/0000-0002-0706-8839	SNO (Societa dei Neurologi, Neurochirurghi e Neuroradiologi degli Ospedali Italiani) on legacy "Gobessi"	SNO (Societa dei Neurologi, Neurochirurghi e Neuroradiologi degli Ospedali Italiani) on legacy "Gobessi"	This work was funded by SNO (Societa dei Neurologi, Neurochirurghi e Neuroradiologi degli Ospedali Italiani) on legacy "Gobessi". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JH, 2000, ONCOGENE, V19, P4621, DOI 10.1038/sj.onc.1203814; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; BESSE S, 1993, AM J PHYSIOL, V265, pH183, DOI 10.1152/ajpheart.1993.265.1.H183; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Boyle PJ, 1995, NEW ENGL J MED, V333, P1726, DOI 10.1056/NEJM199512283332602; Chang KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046492; Choi KC, 2011, J PHYSIOL PHARMACOL, V62, P499; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Czeredys M, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00042; Dantz D, 2002, J CLIN ENDOCR METAB, V87, P835, DOI 10.1210/jc.87.2.835; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Diamanti D, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-28; Ellison SM, 2013, MOL THER, V21, P1862, DOI 10.1038/mt.2013.132; Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; Fan MMY, 2007, J NEUROSCI, V27, P3768, DOI 10.1523/JNEUROSCI.4356-06.2007; Gora-Kupilas K, 2005, FOLIA NEUROPATHOL, V43, P31; Guo KK, 2006, AGING CELL, V5, P259, DOI 10.1111/j.1474-9726.2006.00215.x; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Heng MY, 2009, J NEUROSCI, V29, P3200, DOI 10.1523/JNEUROSCI.5599-08.2009; Issa R, 1999, LAB INVEST, V79, P417; Jin K, 2001, NEUROSCIENCE, V108, P351, DOI 10.1016/S0306-4522(01)00154-3; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Krzyszton-Russjan J, 2013, J BIOENERG BIOMEMBR, V45, P71, DOI 10.1007/s10863-012-9479-3; KUMAGAI AK, 1995, DIABETES, V44, P1399, DOI 10.2337/diabetes.44.12.1399; Lakatta Edward G, 2002, Heart Lung Circ, V11, P76, DOI 10.1046/j.1444-2892.2002.00126.x; Li SH, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-19; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Losekoot M, 2013, EUR J HUM GENET, V21, P480, DOI 10.1038/ejhg.2012.200; Lovrecic L, 2009, MOVEMENT DISORD, V24, P2277, DOI 10.1002/mds.22477; MacDonald Marcy E, 2003, Sci STKE, V2003, ppe48; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marchina E, 2014, J NEUROL SCI, V337, P42, DOI 10.1016/j.jns.2013.11.014; Marian MJ, 2007, CELL CALCIUM, V41, P87, DOI 10.1016/j.ceca.2006.05.003; Nishie A, 1999, CLIN CANCER RES, V5, P1107; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; PEKALA P, 1990, J BIOL CHEM, V265, P18051; Prasad V, 2007, ANN NY ACAD SCI, V1099, P276, DOI 10.1196/annals.1387.029; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Roze E, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00055; Runne H, 2007, P NATL ACAD SCI USA, V104, P14424, DOI 10.1073/pnas.0703652104; Sanchez-Lopez F, 2012, NEUROL RES, V34, P721, DOI 10.1179/1743132812Y.0000000073; Shehadeh J, 2006, NEUROBIOL DIS, V21, P392, DOI 10.1016/j.nbd.2005.08.001; Sone H, 2000, INVEST OPHTH VIS SCI, V41, P1876; Song C, 2003, J BIOL CHEM, V278, P33364, DOI 10.1074/jbc.M304240200; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Sun Y, 2001, J BIOL CHEM, V276, P24713, DOI 10.1074/jbc.M103501200; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Tang TS, 2005, P NATL ACAD SCI USA, V102, P2602, DOI 10.1073/pnas.0409402102; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Trushina E, 2003, P NATL ACAD SCI USA, V100, P12171, DOI 10.1073/pnas.2034961100; Volm M, 1999, ANTICANCER RES, V19, P1669; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; WARNER JP, 1993, MOL CELL PROBE, V7, P235, DOI 10.1006/mcpr.1993.1034; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zhu YH, 2003, FASEB J, V17, P186, DOI 10.1096/fj.02-0515com	62	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125259	10.1371/journal.pone.0125259	http://dx.doi.org/10.1371/journal.pone.0125259			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915065	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100112
J	Louis, J; Schaal, K; Bieuzen, F; Le Meur, Y; Filliard, JR; Volondat, M; Brisswalter, J; Hausswirth, C				Louis, Julien; Schaal, Karine; Bieuzen, Francois; Le Meur, Yann; Filliard, Jean-Robert; Volondat, Marielle; Brisswalter, Jeanick; Hausswirth, Christophe			Head Exposure to Cold during Whole-Body Cryostimulation: Influence on Thermal Response and Autonomic Modulation	PLOS ONE			English	Article							WATER FACE IMMERSION; RATE-VARIABILITY; DORSAL HEAD; EXERCISE; PERFORMANCE; REFLEX; STIMULATION; PREDICTOR; PRESSURE; DESIGN	Recent research on whole-body cryotherapy has hypothesized a major responsibility of head cooling in the physiological changes classically reported after a cryostimulation session. The aim of this experiment was to verify this hypothesis by studying the influence of exposing the head to cold during whole-body cryostimulation sessions, on the thermal response and the autonomic nervous system (ANS). Over five consecutive days, two groups of 10 participants performed one whole-body cryostimulation session daily, in one of two different systems; one exposing the whole-body to cold (whole-body cryostimulation, WBC), and the other exposing the whole-body except the head (partial-body cryostimulation, PBC). 10 participants constituted a control group (CON) not receiving any cryostimulation. In order to isolate the head-cooling effect on recorded variables, it was ensured that the WBC and PBC systems induced the same decrease in skin temperature for all body regions (mean decrease over the 5 exposures: -8.6 degrees C +/- 1.3 degrees C and -8.3 +/- 0.7 degrees C for WBC and PBC, respectively), which persisted up to 20-min after the sessions (P20). The WBC sessions caused an almost certain decrease in tympanic temperature from Pre to P20 (-0.28 +/- 0.11 degrees C), while it only decreased at P20 (-0.14 +/- 0.05 degrees C) after PBC sessions. Heart rate almost certainly decreased after PBC (-8.6%) and WBC (-12.3%) sessions. Resting vagal-related heart rate variability indices (the root-mean square difference of successive normal RR intervals, RMSSD, and high frequency band, HF) were very likely to almost certainly increased after PBC (RMSSD:+49.1%, HF:+123.3%) and WBC (RMSSD:+38.8%, HF:+70.3%). Plasma norepinephrine concentration was likely increased in similar proportions after PBC and WBC, but only after the first session. Both cryostimulation techniques stimulated the ANS with a predominance of parasympathetic tone activation from the first to the fifth session and in slightly greater proportion with WBC than PBC. The main result of this study indicates that the head exposure to cold during whole-body cryostimulation may not be the main factor responsible for the effects of cryostimulation on the ANS.	[Louis, Julien; Schaal, Karine; Bieuzen, Francois; Le Meur, Yann; Hausswirth, Christophe] French Natl Inst Sport Expertise & Performance IN, Res Dept, Sport Expertise & Performance SEP Lab, Paris, France; [Schaal, Karine] Univ Calif Davis, Sports Med Program, Sports Performance Lab, Sacramento, CA 95817 USA; [Filliard, Jean-Robert; Volondat, Marielle] French Natl Inst Sport Expertise & Performance IN, Dept Med, Paris, France; [Brisswalter, Jeanick] Univ Nice Sophia Antipolis, Lab Human Motr Educ Sport & Hlth, F-06189 Nice, France	University of California System; University of California Davis; Sanofi-Aventis; Sanofi France; UDICE-French Research Universities; Universite Cote d'Azur	Louis, J (corresponding author), French Natl Inst Sport Expertise & Performance IN, Res Dept, Sport Expertise & Performance SEP Lab, Paris, France.	julien.louis@insep.fr	Louis, Julien/AAI-4392-2021; Bieuzen, Francois/F-8162-2013	Louis, Julien/0000-0002-9109-0958; Schaal, Karine/0000-0001-9215-9665; Bieuzen, Francois/0000-0002-9690-9168				Al Haddad H, 2011, INT J SPORTS MED, V32, P598, DOI 10.1055/s-0031-1275356; Al Haddad H, 2010, EUR J APPL PHYSIOL, V108, P599, DOI 10.1007/s00421-009-1253-9; Anderson LJ, 2012, NUTR RES, V32, P479, DOI 10.1016/j.nutres.2012.05.009; Buch AN, 2002, EXP PHYSIOL, V87, P423, DOI 10.1111/j.1469-445X.2002.tb00055.x; Buchheit M, 2009, AM J PHYSIOL-HEART C, V296, pH421, DOI 10.1152/ajpheart.01017.2008; Camm AJ, 1996, CIRCULATION, V93, P1043; Cholewka A, 2012, SKIN RES TECHNOL, V18, P180, DOI 10.1111/j.1600-0846.2011.00550.x; Chudecka M, 2014, AVIAT SPACE ENVIR MD, V85, P1170, DOI 10.3357/ASEM.3678.2014; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Communal C, 1999, CIRCULATION, V100, P2210, DOI 10.1161/01.CIR.100.22.2210; Costello JT, 2012, SCAND J MED SCI SPOR, V22, P190, DOI 10.1111/j.1600-0838.2011.01292.x; Costello JT, 2013, COCHRANE LIB; ECKBERG DL, 1984, J PHYSIOL-LONDON, V347, P75, DOI 10.1113/jphysiol.1984.sp015054; Giesbrecht GG, 2005, J APPL PHYSIOL, V99, P1958, DOI 10.1152/japplphysiol.00052.2005; Hausswirth C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072658; Hausswirth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027749; HAYWARD JS, 1984, RESUSCITATION, V11, P21, DOI 10.1016/0300-9572(84)90031-5; HEISTAD DD, 1968, J APPL PHYSIOL, V25, P542, DOI 10.1152/jappl.1968.25.5.542; Hopkins W.G., 2006, SPORTSCIENCE, V10, P46; Hopkins WG, 1999, MED SCI SPORT EXER, V31, P472, DOI 10.1097/00005768-199903000-00018; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; HURWITZ BE, 1986, PHYSIOL BEHAV, V36, P287, DOI 10.1016/0031-9384(86)90018-1; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; KAWAKAMI Y, 1967, J APPL PHYSIOL, V23, P964, DOI 10.1152/jappl.1967.23.6.964; Khurana RK, 2006, CLIN AUTON RES, V16, P202, DOI 10.1007/s10286-006-0332-9; Khurana RK, 1997, HEADACHE, V37, P522, DOI 10.1046/j.1526-4610.1997.3708522.x; Kinoshita T, 2006, CIRC J, V70, P773, DOI 10.1253/circj.70.773; Larsen PD, 2010, RESP PHYSIOL NEUROBI, V174, P111, DOI 10.1016/j.resp.2010.04.021; Lockhart TL, 2005, AVIAT SPACE ENVIR MD, V76, P954; Lubkowska A, 2010, INT J OCCUP MED ENV, V23, P367, DOI 10.2478/v10001-010-0037-0; MANN DL, 1992, CIRCULATION, V85, P790, DOI 10.1161/01.CIR.85.2.790; Paton JFR, 2005, BRAIN RES REV, V49, P555, DOI 10.1016/j.brainresrev.2005.02.005; Pournot H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022748; Pretorius T, 2006, J APPL PHYSIOL, V101, P669, DOI 10.1152/japplphysiol.01241.2005; Pump B, 2001, AM J PHYSIOL-HEART C, V280, pH2607, DOI 10.1152/ajpheart.2001.280.6.H2607; Ring EFJ, 2015, INFRARED IMAGING: A CASEBOOK IN CLINICAL MEDICINE, DOI 10.1088/978-0-7503-1143-4ch1; Schaal K, 2013, APPL PHYSIOL NUTR ME, V38, P126, DOI 10.1139/apnm-2012-0155; SCHUITEMA K, 1988, ACTA PHYSIOL SCAND, V132, P119, DOI 10.1111/j.1748-1716.1988.tb08306.x; Shibahara N, 1996, J AUTONOM NERV SYST, V61, P109, DOI 10.1016/S0165-1838(96)00065-3; Stanley J, 2013, EUR J APPL PHYSIOL, V113, P371, DOI 10.1007/s00421-012-2445-2; Stanley J, 2012, EUR J APPL PHYSIOL, V112, P951, DOI 10.1007/s00421-011-2052-7; Udo T, 2013, J STUD ALCOHOL DRUGS, V74, P787, DOI 10.15288/jsad.2013.74.787; Utter AC, 2010, MED SCI SPORT EXER, V42, P361, DOI 10.1249/MSS.0b013e3181b2e8b4; Vaile J, 2011, BRIT J SPORT MED, V45, P825, DOI 10.1136/bjsm.2009.067272; Westerlund T, 2006, J THERM BIOL, V31, P342, DOI 10.1016/j.jtherbio.2006.01.004	46	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124776	10.1371/journal.pone.0124776	http://dx.doi.org/10.1371/journal.pone.0124776			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915642	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659100066
J	Tachi, T; Teramachi, H; Tanaka, K; Asano, S; Osawa, T; Kawashima, A; Yasuda, M; Mizui, T; Nakada, T; Noguchi, Y; Tsuchiya, T; Goto, C				Tachi, Tomoya; Teramachi, Hitomi; Tanaka, Kazuhide; Asano, Shoko; Osawa, Tomohiro; Kawashima, Azusa; Yasuda, Masahiro; Mizui, Takashi; Nakada, Takumi; Noguchi, Yoshihiro; Tsuchiya, Teruo; Goto, Chitoshi			The Impact of Outpatient Chemotherapy-Related Adverse Events on the Quality of Life of Breast Cancer Patients	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; DIAGNOSIS; EQ-5D; WOMEN	The objective of our study was to clarify the impact of adverse events associated with the initial course of outpatient chemotherapy on the quality of life of breast cancer patients. We conducted a survey to assess the quality of life in 48 breast cancer patients before and after receiving their first course of outpatient chemotherapy at Gifu Municipal Hospital. Patients completed the European Quality of Life 5 Dimensions and Quality of Life Questionnaire for Cancer Patients Treated with Anticancer Drugs before and after 1 course of outpatient chemotherapy. European Quality of Life 5 Dimensions utility value and Quality of Life Questionnaire for Cancer Patients Treated with Anticancer Drugs total score decreased significantly after chemotherapy (p<0.001 and p = 0.018, respectively). The mean scores for the activity, physical condition, and psychological condition subscales of the Quality of Life Questionnaire for Cancer Patients Treated with Anticancer Drugs decreased significantly after chemotherapy (p = 0.003, p<0.001, and p = 0.032, respectively), whereas the social relationships score increased significantly (p<0.001). Furthermore, in the evaluation of quality of life according to individual adverse events, the decrease in quality of life after chemotherapy in terms of the European Quality of Life 5 Dimensions utility value and the Quality of Life Questionnaire for Cancer Patients Treated with Anticancer Drugs total score was greater in anorexic patients than in non-anorexic patients (p = 0.009 and p<0.001, respectively). This suggests that anorexia greatly reduces quality of life. Our findings reveal that anticancer drug-related adverse events, particularly anorexia, reduce overall quality of life following the first course of outpatient chemotherapy in current breast cancer patients. These findings are extremely useful and important in understanding the impact of anticancer drug-related adverse events on quality of life.	[Tachi, Tomoya; Teramachi, Hitomi; Asano, Shoko; Noguchi, Yoshihiro] Gifu Pharmaceut Univ, Lab Clin Pharm, Gifu, Japan; [Tachi, Tomoya; Tanaka, Kazuhide; Osawa, Tomohiro; Kawashima, Azusa; Yasuda, Masahiro; Mizui, Takashi; Goto, Chitoshi] Gifu Municipal Hosp, Dept Pharm, Gifu, Japan; [Nakada, Takumi] Gifu Municipal Hosp, Dept Breast Surg, Gifu, Japan; [Tsuchiya, Teruo] Community Hlth Support & Res Ctr, Gifu, Japan	Gifu Pharmaceutical University; Gifu Municipal Hospital; Gifu Municipal Hospital	Teramachi, H (corresponding author), Gifu Pharmaceut Univ, Lab Clin Pharm, Gifu, Japan.	teramachih@gifu-pu.ac.jp	Tachi, Tomoya/AAM-8441-2020; Noguchi, Yoshihiro/ABI-5618-2020	Tachi, Tomoya/0000-0002-5380-0218; Noguchi, Yoshihiro/0000-0002-9110-9604; Osawa, Tomohiro/0000-0003-3984-6911; Yasuda, Masahiro/0000-0003-4119-0149				Ando N, 2009, SUPPORT CARE CANCER, V17, P1361, DOI 10.1007/s00520-009-0593-7; Arndt V, 2006, CANCER-AM CANCER SOC, V107, P2496, DOI 10.1002/cncr.22274; AYRES A, 1994, J PSYCHOSOM RES, V38, P393, DOI 10.1016/0022-3999(94)90100-7; Dorval M, 1998, CANCER, V83, P2130, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2130::AID-CNCR11>3.0.CO;2-8; Fallowfield LJ, 2006, J CLIN ONCOL, V24, P910, DOI 10.1200/JCO.2005.03.3654; Fernandez-Ortega P, 2012, SUPPORT CARE CANCER, V20, P3141, DOI 10.1007/s00520-012-1448-1; Fujii T, 2006, JPN J PHARM HLTH CAR, V32, P946, DOI DOI 10.5649/JJPHCS.32.946; Group EQ, 1990, HLTH POLICY, V16, P199, DOI DOI 10.1016/0168-8510(90)90421-9; Hashizume K, 2013, PALLIATIVE CARE RES, V8, P232; Hjerl K, 2003, PSYCHOSOMATICS, V44, P24, DOI 10.1176/appi.psy.44.1.24; Institute NC, 2010, COMM TERM CRIT ADV E, P1; Ishiura Yoshihisa, 2009, Gan To Kagaku Ryoho, V36, P2565; Iwamitsu Y, 2005, PSYCHOSOMATICS, V46, P19, DOI 10.1176/appi.psy.46.1.19; Janni W, 2001, ANN SURG ONCOL, V8, P542, DOI 10.1007/s10434-001-0542-2; Khanna R, 2013, VALUE HEALTH, V16, P778, DOI 10.1016/j.jval.2013.04.007; Kim DH, 2010, J KOREAN MED SCI, V25, P1140, DOI 10.3346/jkms.2010.25.8.1140; Kitada N, 2006, JPN J PHARM HLTH CAR, V32, P835, DOI DOI 10.5649/jjphcs.32.835; Kuroda Y, 2010, JPN J GEN HOSP PSYCH, V22, P27; Miyake T., 2008, JPN J PHARM HEALTH C, V34, P268, DOI [10.5649/jjphcs.34.268, DOI 10.5649/JJPHCS.34.268]; Okamoto T., 2004, JPN J REHABIL MED, V41, P678, DOI [10.2490/jjrm1963.41.678, DOI 10.2490/JJRM1963.41.678]; Park BW, 2011, J BREAST CANCER, V14, P112, DOI 10.4048/jbc.2011.14.2.112; Sakamaki H, 2006, VALUE HEALTH, V9, P47, DOI 10.1111/j.1524-4733.2006.00080.x; Shimozuma, 1994, Breast Cancer, V1, P123, DOI 10.1007/BF02967042; Shimozuma, 1995, Breast Cancer, V2, P35, DOI 10.1007/BF02966894; Shimozuma K, 2000, SURG TODAY, V30, P255, DOI 10.1007/s005950050055; SHIMOZUMA K, 1995, SURG TODAY, V25, P874, DOI 10.1007/BF00311752; Taira N, 2014, BREAST CANCER RES TR, V145, P155, DOI 10.1007/s10549-014-2935-5; Toume M, 2007, NURS J KAGAWA U, V11, P37	28	39	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124169	10.1371/journal.pone.0124169	http://dx.doi.org/10.1371/journal.pone.0124169			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915539	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100037
J	Vilos, C; Velasquez, LA; Rodas, PI; Zepeda, K; Bong, SJ; Herrera, N; Cantin, M; Simon, F; Constandil, L				Vilos, Cristian; Velasquez, Luis A.; Rodas, Paula I.; Zepeda, Katherine; Bong, Soung-Jae; Herrera, Natalia; Cantin, Mario; Simon, Felipe; Constandil, Luis			Preclinical Development and In Vivo Efficacy of Ceftiofur-PLGA Microparticles	PLOS ONE			English	Article							INJECTABLE MICROENCAPSULATED VITAMIN-B-12; VITRO; MICROSPHERES; NANOPARTICLES; DESFUROYLCEFTIOFUR; ENCAPSULATION; METABOLITES; PLASMA; MICRO; SERUM	Drug delivery systems based on polymeric microparticles represent an interesting field of development for the treatment of several infectious diseases for humans and animals. In this work, we developed PLGA microparticles loaded with ceftiofur (PLGA-cef), a third-generation cephalosporin that is used exclusively used in animals. PLGA-cef was prepared by the double emulsion w/o/w method, and exhibited a diameter in the range of 1.5-2.2 mu m, and a negative zeta potential in the range of -35 to -55 mV. The loading yield of PLGA-cef was similar to 7% and encapsulation efficiency was approximately 40%. The pharmacokinetic study demonstrated a sustained release profile of ceftiofur for 20 days. PLGA-cef administrated in a single dose was more effective than ceftiofur non-encapsulated in rats challenged with S. Typhimurium. The in vivo toxicological evaluation showed that PLGA-cef did not affect the blood biochemical, hematological and hemostasis parameters. Overall, the PLGA-cef showed slow in vivo release profile, high antibacterial efficacy, and low toxicity. The results obtained supports the safe application of PLGA-cef as sustained release platform in the veterinary industry.	[Vilos, Cristian; Velasquez, Luis A.; Rodas, Paula I.; Zepeda, Katherine; Bong, Soung-Jae; Herrera, Natalia] Univ Andres Bello, Ctr Integrat Med & Innovat Sci, Fac Med, Santiago, Chile; [Vilos, Cristian; Velasquez, Luis A.; Constandil, Luis] Univ Santiago Chile, Ctr Desarrollo Nanociencia & Nanotecnol CEDENNA, Santiago, Chile; [Constandil, Luis] Univ Santiago Chile, Neurobiol Lab, Dept Biol, Fac Quim & Biol, Santiago, Chile; [Cantin, Mario] Univ La Frontera, Dept Integral Dent, CIMA, Fac Dent, Temuco, Chile; [Cantin, Mario] Univ Autonoma Chile, Biomed Sci Res Ctr, Temuco, Chile; [Simon, Felipe] Univ Andres Bello, Lab Fisiopatol Integrat, Dept Ciencias Biol, Fac Ciencias Biol, Santiago, Chile; [Simon, Felipe] Univ Andres Bello, Fac Med, Santiago, Chile	Universidad Andres Bello; Universidad de Santiago de Chile; Universidad de Santiago de Chile; Universidad de La Frontera; Universidad Autonoma de Chile; Universidad Andres Bello; Universidad Andres Bello	Constandil, L (corresponding author), Univ Santiago Chile, Ctr Desarrollo Nanociencia & Nanotecnol CEDENNA, Santiago, Chile.	luis.constandil@usach.cl	Ortiz, Cristian Vilos/F-9162-2014; Rodas, Paula I./I-3631-2013; Cantin, Mario/L-9054-2013	Ortiz, Cristian Vilos/0000-0001-5619-3348; Rodas, Paula I./0000-0002-8071-1229; Cantin, Mario/0000-0002-1749-8672; Velasquez, Luis/0000-0002-9479-1792; Simon, Felipe/0000-0002-2653-9798	CONICYT under BASAL Grant [FB0807]; FONDECYT [1120952]; Becas-Chile fellowship CONICYT-Chile; Vicerrectoria de Investigacion, Desarrollo e Innovacion, from Universidad de Santiago de Chile [021540CC_APOYOQ1];  [TPI06]	CONICYT under BASAL Grant; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Becas-Chile fellowship CONICYT-Chile; Vicerrectoria de Investigacion, Desarrollo e Innovacion, from Universidad de Santiago de Chile; 	The authors acknowledge the financial support of CONICYT under BASAL Grant FB0807 and FONDECYT 1120952. CV acknowledges the support of the Grant TPI06 and Becas-Chile fellowship CONICYT-Chile. http://cedenna.cl/en http://www.conicyt.cl http://www.fondecyt.cl. L.C. acknowledges the support of Vicerrectoria de Investigacion, Desarrollo e Innovacion, from Universidad de Santiago de Chile, Code Number 021540CC_APOYOQ1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna L, 2011, INT J MORPHOL, V29, P403, DOI 10.4067/S0717-95022011000200016; Arnold MM, 2007, J CONTROL RELEASE, V121, P100, DOI 10.1016/j.jconrel.2007.05.039; Bronstad A, 2011, LAB ANIMAL, V40, P22, DOI 10.1038/laban0111-22; Coimbra PA, 2008, J MICROENCAPSUL, V25, P170, DOI [10.1080/02652040701814140, 10.1080/02652040701814140 ]; DeMerlis CC, 2003, FOOD CHEM TOXICOL, V41, P319, DOI 10.1016/S0278-6915(02)00258-2; Grace ND, 2000, NEW ZEAL VET J, V48, P70, DOI 10.1080/00480169.2000.36162; Grace ND, 1999, NEW ZEAL VET J, V47, P3, DOI 10.1080/00480169.1999.36099; Hejazi R, 2002, INT J PHARM, V235, P87, DOI 10.1016/S0378-5173(01)00985-1; Hornish Rex E., 2002, Current Topics in Medicinal Chemistry, V2, P717, DOI 10.2174/1568026023393679; Hrkach J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003651; JAGLAN PS, 1989, J AGR FOOD CHEM, V37, P1112, DOI 10.1021/jf00088a066; JAGLAN PS, 1994, J VET PHARMACOL THER, V17, P24, DOI 10.1111/j.1365-2885.1994.tb00517.x; JAGLAN PS, 1990, J ASSOC OFF ANA CHEM, V73, P26; Jovanovic I, 2008, MICROSC RES TECHNIQ, V71, P86, DOI 10.1002/jemt.20529; Kamaly N, 2013, P NATL ACAD SCI USA, V110, P6506, DOI 10.1073/pnas.1303377110; Kamaly N, 2012, CHEM SOC REV, V41, P2971, DOI 10.1039/c2cs15344k; Lee JH, 2000, INT J PHARM, V196, P75, DOI 10.1016/S0378-5173(99)00440-8; Luzardo-Alvarez A, 2005, J CONTROL RELEASE, V109, P62, DOI 10.1016/j.jconrel.2005.09.015; Miller JA, 1999, J ECON ENTOMOL, V92, P1142, DOI 10.1093/jee/92.5.1142; Min YJ, 2008, NAT MATER, V7, P527, DOI 10.1038/nmat2206; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Nicolete R, 2011, INT IMMUNOPHARMACOL, V11, P1557, DOI 10.1016/j.intimp.2011.05.014; Patel J, 2012, J MICROENCAPSUL, V29, P398, DOI 10.3109/02652048.2012.655329; Prior S, 2000, INT J PHARM, V196, P115, DOI 10.1016/S0378-5173(99)00448-2; Ribeiro-Costa RM, 2004, J MICROENCAPSUL, V21, P371, DOI 10.1080/02652040410001673919; Roy P, 2010, INT J NANOMED, V5, P1113, DOI 10.2147/IJN.S14787; Salmon SA, 1996, J VET DIAGN INVEST, V8, P332, DOI 10.1177/104063879600800309; Shi X, 2014, COLLOIDS SURF B; Tang S, 2010, J VET PHARMACOL THER, V33, P238, DOI 10.1111/j.1365-2885.2009.01126.x; Vilos C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/672760; Vilos C, 2012, ELECTRON J BIOTECHN, V15, P13; Vilos C, 2014, DRUG DES DEV THER, V8, P651, DOI 10.2147/DDDT.S60444; Weidmann A, 2008, OPEN OPHTHALMOL J, V2, P112, DOI 10.2174/1874364100802010112	33	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123335	10.1371/journal.pone.0123335	http://dx.doi.org/10.1371/journal.pone.0123335			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915043	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100021
J	Zhou, YY; Zhang, LY; Pan, H; Wang, BS; Yan, F; Fang, XD; Munnee, K; Tang, ZG				Zhou, Yueying; Zhang, Leiyi; Pan, Hao; Wang, Baisheng; Yan, Fei; Fang, Xiaodan; Munnee, Krishna; Tang, Zhangui			Bmi1 Essentially Mediates Podocalyxin-Enhanced Cisplatin Chemoresistance in Oral Tongue Squamous Cell Carcinoma	PLOS ONE			English	Article							CANCER-CELLS; EXPRESSION; BREAST; PROLIFERATION; METASTASIS; STATISTICS; INHIBITOR; EZRIN	Oral tongue squamous cell carcinoma (OTSCC) is one of the most common head and neck cancers. Innate or acquired resistance to cisplatin, a standard chemotherapy agent for OTSCC, is common in patients with OTSCC. Understanding the molecular basis for cisplatin chemoresistance in OTSCC cells may serve as a basis for identification of novel therapeutic targets. Podocalyxin (PODXL) has been found critical for malignant progression in a variety of cancers. Bmi1 has recently been found to induce cell apoptosis and cisplatin chemosensitivity in OTSCC cells. In this study, we explored the interaction between PODXL and Bmi1 in OTSCC cells, and assessed its impact on OTSCC cell chemoresistance to cisplatin. PODXL and/or Bmi1 were stably overexpressed or knocked down in SCC-4 and Tca8113 human OTSCC cells. Overexpression of PODXL in both cell lines markedly elevated the expression level of Bmi1 and the half maximal inhibitory concentration (IC50) of cisplain and reduced cisplatin-induced cell apoptosis, which was abolished by knockdown of Bmi1 or a selective focal adhesion kinase (FAK) inhibitor. On the other hand, knockdown of PODXL significantly decreased the Bmi1 expression level and cisplatin IC50 and increased cisplatin-induced cell apoptosis, which was completely reversed by overexpression of Bmi1. While overexpression and knockdown of PODXL respectively increased and decreased the FAK activity, Bmi1 showed no significant effect on the FAK activity in OTSCC cells. In addition, overexpression of PODXL markedly elevated the stability of Bmi1 mRNA, which was abolished by a selective FAK inhibitor. In conclusion, this study provides the first evidence that PODXL up-regulates the expression level of Bmi1 in OTSCC cells by increasing the stability of Bmi1 mRNA through a FAK-dependent mechanism; this effect leads to enhanced cisplatin chemoresistance in OTSCC cells. This study adds new insights into the molecular mechanisms underlying OTSCC chemoresistance.	[Zhou, Yueying; Wang, Baisheng; Munnee, Krishna] Cent S Univ, Xiangya Hosp, Dept Stomatol, Changsha, Hunan, Peoples R China; [Zhang, Leiyi] Cent S Univ, Xiangya Hosp 2, Dept Minimal Invas Surg, Changsha, Hunan, Peoples R China; [Pan, Hao; Fang, Xiaodan; Tang, Zhangui] Cent S Univ, Xiangya Stomatol Hosp, Dept Maxillofacial Surg, Changsha, Hunan, Peoples R China; [Yan, Fei] Cent S Univ, Xiangya Stomatol Hosp, Dept Prosthodont, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Tang, ZG (corresponding author), Cent S Univ, Xiangya Stomatol Hosp, Dept Maxillofacial Surg, Changsha, Hunan, Peoples R China.	tangzhangui@aliyun.com			Nature Sciences Foundation of Qinghai Province [2013-z-908]; Science and Technology Bureau of Hunan Province [2013-FJ-4078]	Nature Sciences Foundation of Qinghai Province; Science and Technology Bureau of Hunan Province	This work was supported by The Nature Sciences Foundation of Qinghai Province (grant no. 2013-z-908) and The Science and Technology Bureau of Hunan Province (grant no. 2013-FJ-4078).	Byun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037917; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Choi K., 2009, JOURNAL OF PHYSICS, V42, P1; Ding XQ, 2011, ONCOL RES, V19, P303, DOI 10.3727/096504011X13079697132790; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; He QT, 2015, INT J BIOL SCI, V11, P1, DOI 10.7150/ijbs.10405; Hsu YH, 2010, AM J PATHOL, V176, P3050, DOI 10.2353/ajpath.2010.090539; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kelley TW, 2005, AM J CLIN PATHOL, V124, P134, DOI 10.1309/7BHLAHHU0N4MHT7Q; Kurio N, 2012, ORAL ONCOL, V48, P1159, DOI 10.1016/j.oraloncology.2012.05.019; Li ZW, 2014, LAB INVEST, V94, P1431, DOI 10.1038/labinvest.2014.123; Lin CW, 2014, CARCINOGENESIS, V35, P2425, DOI 10.1093/carcin/bgu139; Lin CW, 2014, INT J ONCOL, V45, P710, DOI 10.3892/ijo.2014.2427; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; Price KAR, 2012, CURR TREAT OPTION ON, V13, P35, DOI 10.1007/s11864-011-0176-y; Riccioni R, 2006, BLOOD CELL MOL DIS, V37, P218, DOI 10.1016/j.bcmd.2006.09.001; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Sizemore S, 2007, CANCER RES, V67, P6183, DOI 10.1158/0008-5472.CAN-06-3575; Smith LL, 2011, CELL STEM CELL, V8, P649, DOI 10.1016/j.stem.2011.05.004; Somasiri A, 2004, CANCER RES, V64, P5068, DOI 10.1158/0008-5472.CAN-04-0240; Su Hsing-Hao, 2006, J Chin Med Assoc, V69, P478; Wang H, 2007, J NEUROSCI, V27, P10703, DOI 10.1523/JNEUROSCI.3102-07.2007; WINGO PA, 1995, CA-CANCER J CLIN, V45, P8, DOI 10.3322/canjclin.45.1.8; WOLF GT, 1991, NEW ENGL J MED, V324, P1685, DOI 10.1056/nejm199106133242402; Wu H, 2013, EXP THER MED, V5, P1025, DOI 10.3892/etm.2013.957; Xia J, 2009, J ORAL PATHOL MED, V38, P524, DOI 10.1111/j.1600-0714.2008.00728.x; Xing Y, 2013, EXP CELL RES, V319, P2058, DOI 10.1016/j.yexcr.2013.05.014; Yasuoka H, 2008, J CLIN PATHOL, V61, P1228, DOI 10.1136/jcp.2008.059956; Yu ZW, 2010, ORAL ONCOL, V46, P317, DOI 10.1016/j.oraloncology.2010.02.002	30	12	13	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123208	10.1371/journal.pone.0123208	http://dx.doi.org/10.1371/journal.pone.0123208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915207	gold, Green Submitted, Green Published			2022-12-27	WOS:000353659100015
J	Clifton, MC; Dranow, DM; Leed, A; Fulroth, B; Fairman, JW; Abendroth, J; Atkins, KA; Wallace, E; Fan, DZ; Xu, GP; Ni, ZJ; Daniels, D; Van Drie, J; Wei, G; Burgin, AB; Golub, TR; Hubbard, BK; Serrano-Wu, MH				Clifton, Matthew C.; Dranow, David M.; Leed, Alison; Fulroth, Ben; Fairman, James W.; Abendroth, Jan; Atkins, Kateri A.; Wallace, Ellen; Fan, Dazhong; Xu, Guoping; Ni, Z. J.; Daniels, Doug; Van Drie, John; Wei, Guo; Burgin, Alex B.; Golub, Todd R.; Hubbard, Brian K.; Serrano-Wu, Michael H.			A Maltose-Binding Protein Fusion Construct Yields a Robust Crystallography Platform for MCL1	PLOS ONE			English	Article							INHIBITORS; CANCER; POTENT; ACTIVATION; DISCOVERY; APOPTOSIS; SURVIVAL	Crystallization of a maltose-binding protein MCL1 fusion has yielded a robust crystallography platform that generated the first apo MCL1 crystal structure, as well as five ligandbound structures. The ability to obtain fragment-bound structures advances structurebased drug design efforts that, despite considerable effort, had previously been intractable by crystallography. In the ligand-independent crystal form we identify inhibitor binding modes not observed in earlier crystallographic systems. This MBP-MCL1 construct dramatically improves the structural understanding of well-validated MCL1 ligands, and will likely catalyze the structure-based optimization of high affinity MCL1 inhibitors.	[Leed, Alison; Fulroth, Ben; Daniels, Doug; Wei, Guo; Burgin, Alex B.; Golub, Todd R.; Hubbard, Brian K.; Serrano-Wu, Michael H.] Broad Inst, Cambridge, MA USA; [Golub, Todd R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Clifton, Matthew C.; Dranow, David M.; Fairman, James W.; Abendroth, Jan; Atkins, Kateri A.; Wallace, Ellen] Beryllium, Bedford, MA 01730 USA; [Fan, Dazhong; Xu, Guoping; Ni, Z. J.] Acme Biosci, Palo Alto, CA USA; [Van Drie, John] Van Drie Res, N Andover, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Clifton, MC (corresponding author), Beryllium, Bedford, MA 01730 USA.	mclifton@be4.com; swu@broadinstitute.org		Daniels, Douglas/0000-0003-0238-9403	Carlos Slim Health Institute; Robertson Foundation; Van Drie Research	Carlos Slim Health Institute; Robertson Foundation; Van Drie Research	This study was funded by the Broad Institute with generous support from the Carlos Slim Health Institute and the Robertson Foundation. AL, BF, D. Daniels, GW, AB, TRG, BKH, and MSW are employees of the Broad Institute and received funding for this study in the form of a salary. MCC, D. Dranow, JWF, JA, KAA, and EW are employees of Beryllium and received funding for this study in the form of a salary. DF, ZN, and GX are employees of Acme Bioscience and received funding for this study in the form of a salary. JVD is the sole proprietor of Van Drie Research and received funding for this study in the form of a salary. The Broad Institute, Beryllium, Acme, and Van Drie Research played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Abulwerdi F, 2014, MOL CANCER THER, V13, P565, DOI 10.1158/1535-7163.MCT-12-0767; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belmar J, 2015, PHARMACOL THERAPEUT, V145, P76, DOI 10.1016/j.pharmthera.2014.08.003; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Friberg A, 2013, J MED CHEM, V56, P15, DOI 10.1021/jm301448p; Gavathiotis E, 2012, NAT CHEM BIOL, V8, P639, DOI [10.1038/NCHEMBIO.995, 10.1038/nchembio.995]; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kelly GL, 2011, ADV CANCER RES, V111, P39, DOI 10.1016/B978-0-12-385524-4.00002-7; Leshchiner ES, 2013, P NATL ACAD SCI USA, V110, pE986, DOI 10.1073/pnas.1214313110; Liu GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096521; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527; Petros AM, 2014, BIOORG MED CHEM LETT, V24, P1484, DOI 10.1016/j.bmcl.2014.02.010; Richard DJ, 2013, BIOORGAN MED CHEM, V21, P6642, DOI 10.1016/j.bmc.2013.08.017; Rogers JM, 2014, P NATL ACAD SCI USA, V111, P15420, DOI 10.1073/pnas.1409122111; Rudin CM, 2012, CLIN CANCER RES, V18, P3163, DOI 10.1158/1078-0432.CCR-11-3090; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Wang X, 2013, GENE DEV, V27, P1351, DOI 10.1101/gad.215855.113; Wei G, 2012, CANCER CELL, V21, P547, DOI 10.1016/j.ccr.2012.02.028; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885	32	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125010	10.1371/journal.pone.0125010	http://dx.doi.org/10.1371/journal.pone.0125010			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909780	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800121
J	Dalgaard, LS; Norgaard, M; Jespersen, B; Jensen-Fangel, S; Ostergaard, LJ; Schonheyder, HC; Sogaard, OS				Dalgaard, Lars Skov; Norgaard, Mette; Jespersen, Bente; Jensen-Fangel, Soren; Ostergaard, Lars Jorgen; Schonheyder, Henrik Carl; Sogaard, Ole Schmeltz			Risk and Prognosis of Bloodstream Infections among Patients on Chronic Hemodialysis: A Population-Based Cohort Study	PLOS ONE			English	Article							AUREUS NASAL CARRIAGE; DIALYSIS PATIENTS; CLINICAL-SIGNIFICANCE; BACTEREMIA; SEPTICEMIA; CULTURES; QUALITY; SURVEILLANCE; PROPHYLAXIS; FUNGEMIA	Background and Objectives Infections are common complications among patients on chronic hemodialysis. This population-based cohort study aims to estimate risk and case fatality of bloodstream infection among chronic hemodialysis patients. Methods In this population-based cohort study we identified residents with end-stage renal disease in Central and North Jutland, Denmark who had hemodialysis as first renal replacement therapy (hemodialysis patients) during 1995-2010. For each hemodialysis patient, we sampled 19 persons from the general population matched on age, gender, and municipality. Information on positive blood cultures was obtained from regional microbiology databases. All persons were observed from cohort entry until first episode of bloodstream infection, emigration, death, or end of hemodialysis treatment, whichever came first. Incidence-rates and incidence-rate ratios were computed and risk factors for bloodstream infection assessed by Poisson regression. Case fatality was compared by Cox regression. Results Among 1792 hemodialysis patients and 33 618 matched population controls, we identified 461 and 1126 first episodes of bloodstream infection, respectively. Incidence rates of first episode of bloodstream infection were 13.7 (95% confidence interval (CI), 12.5-15.0) per 100 person-years among hemodialysis patients and 0.53 (95% CI, 0.50-0.56) per 100 person-years among population controls. In hemodialysis patients, the most common causative microorganisms were Staphylococcus aureus (43.8%) and Escherichia coli (12.6%). The 30-day case fatality was similar among hemodialysis patients and population controls 16% (95% CI, 13%-20%) vs. 18% (95% CI, 15%-20%). Conclusions Hemodialysis patients have extraordinary high risk of bloodstream infection while short-term case fatality following is similar to that of population controls.	[Dalgaard, Lars Skov; Jensen-Fangel, Soren; Ostergaard, Lars Jorgen; Sogaard, Ole Schmeltz] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark; [Norgaard, Mette] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Jespersen, Bente] Aarhus Univ Hosp, Dept Nephrol, DK-8000 Aarhus, Denmark; [Schonheyder, Henrik Carl] Aalborg Univ Hosp, Dept Clin Microbiol, Aalborg, Denmark; [Schonheyder, Henrik Carl] Aalborg Univ, Dept Clin Med, Aalborg, Denmark	Aarhus University; Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital; Aalborg University	Dalgaard, LS (corresponding author), Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark.	lars.dalgaard@clin.au.dk	Søgaard, Ole Schmeltz/AEP-7968-2022; Søgaard, Ole S/P-6058-2016; Ostergaard, Lars/AAA-3020-2020	Søgaard, Ole Schmeltz/0000-0001-9107-2023; Ostergaard, Lars/0000-0003-2459-0511; Ostergaard, Lars/0000-0002-7619-605X; Jespersen, Bente/0000-0001-7196-2870; Skov Dalgaard, Lars/0000-0002-4398-6821	Faculty of Health Science, University of Aarhus, Denmark	Faculty of Health Science, University of Aarhus, Denmark	LD is supported by a PhD grant from the Faculty of Health Science, University of Aarhus, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KC, 2001, CLIN NEPHROL, V56, P124; Allon M, 2003, J AM SOC NEPHROL, V14, P1863, DOI 10.1097/01.ASN.0000074237.78764.D1; BOELAERT JR, 1993, NEPHROL DIAL TRANSPL, V8, P235; CHOW JW, 1989, ARCH INTERN MED, V149, P1258, DOI 10.1001/archinte.149.6.1258; CHURCHILL DN, 1992, AM J KIDNEY DIS, V19, P214, DOI 10.1016/S0272-6386(13)80002-9; Foley RN, 2004, J AM SOC NEPHROL, V15, P1038, DOI 10.1097/01.ASN.0000119144.95922.C4; Foley RN, 2007, INFECT DIS CLIN N AM, V21, P659, DOI 10.1016/j.idc.2007.06.005; Gradel KO, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-139; Hoen B, 1998, J AM SOC NEPHROL, V9, P869; Hommel K, 2010, NEPHROL DIAL TRANSPL, V25, P947, DOI 10.1093/ndt/gfp571; Ishani A, 2005, KIDNEY INT, V68, P311, DOI 10.1111/j.1523-1755.2005.00414.x; Johnson DW, 2002, NEPHROL DIAL TRANSPL, V17, P1802, DOI 10.1093/ndt/17.10.1802; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen KM, 1998, INFECT CONT HOSP EP, V19, P175; Nephrology DSo, 2010, DAN NEPHR REG ANN RE; Nephrology DSo, 2012, DAN NEPHR REG ANN RE; Ollendorf DA, 2002, VALUE HEALTH, V5, P79, DOI 10.1046/j.1524-4733.2002.52013.x; Powe NR, 1999, KIDNEY INT, V55, P1081, DOI 10.1046/j.1523-1755.1999.0550031081.x; Prevention CfDCa, BLOODSTR INF EV CENT; Rosenblum A, 2014, AM J KIDNEY DIS, V63, P259, DOI 10.1053/j.ajkd.2013.08.019; Sesso R, 1998, J AM SOC NEPHROL, V9, P1085; Tacconelli E, 2003, CLIN INFECT DIS, V37, P1629, DOI 10.1086/379715; Taylor G, 2004, AM J INFECT CONTROL, V32, P155, DOI 10.1016/j.ajic.2003.05.007; Thomson PC, 2007, QJM-INT J MED, V100, P415, DOI 10.1093/qjmed/hcm040; Tokars JI, 2004, CLIN INFECT DIS, V39, P333, DOI 10.1086/421941; U.S. Renal Data System, 2013, USRDS 2013 ANN DAT R; Vaziri ND, 2012, J RENAL NUTR, V22, P149, DOI 10.1053/j.jrn.2011.10.020; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584; WEINSTEIN MP, 1983, REV INFECT DIS, V5, P35, DOI 10.1093/clinids/5.1.35; YU VL, 1986, NEW ENGL J MED, V315, P91, DOI 10.1056/NEJM198607103150204	30	31	33	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124547	10.1371/journal.pone.0124547	http://dx.doi.org/10.1371/journal.pone.0124547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910221	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800088
J	Dong, Y; Gao, GR; Fan, HY; Li, SX; Li, XH; Liu, W				Dong, Ying; Gao, Guirong; Fan, Hongyan; Li, Shengxian; Li, Xuhang; Liu, Wei			Activation of the Liver X Receptor by Agonist TO901317 Improves Hepatic Insulin Resistance via Suppressing Reactive Oxygen Species and JNK Pathway	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; FREE FATTY-ACIDS; CELL DYSFUNCTION; SKELETAL-MUSCLE; IN-VITRO; BETA; LXR; LIPOGENESIS; INHIBITION; EXPRESSION	Activation of Liver X receptors (LXRs), key transcriptional regulators of glucose metabolism, normalizes glycemia and improves insulin sensitivity in rodent models with insulin resistance. However, the molecular mechanism is unclear. This study is aimed to elucidate the mechanism of LXRs-mediated liver glucose metabolic regulation in vitro and in vivo. Db/db mice were used as an in vivo model of diabetes; palmitate (PA)-stimulated HepG2 cells were used as an in vitro cell model with impairment of insulin signaling. TO901317 (TO) was chosen as the LXRs agonist. We demonstrated that TO treatment for 14 days potently improved the hepatic glucose metabolism in db/db mice, including fasting blood glucose, fasting insulin level, and HOMA-IR. TO had no effect on the glucose metabolism in normal WT mice. TO-mediated activation of hepatic LXRs led to strong inhibition of ROS production accompanied by inactivation of JNK pathway and re-activation of Akt pathway. TO also suppressed the expression of gluconeogenic genes such as PEPCK and G-6-pase in db/db mice, but not in WT mice. In HepG2 cells, TO almost completely restored PA-induced Akt inactivation, and suppressed PA-stimulated ROS production and JNK activation. Interestingly, basal level of ROS was also inhibited by TO in HepG2 cells. TO significantly inhibited PA-stimulated expressions of gluconeogenic genes. Finally, we found that anti-oxidative genes, such as Nrf2, were up-regulated after LXRs activation by TO. These results strongly support the notion that activation of LXRs is critical in suppression of liver gluconeogenesis and improvement of insulin sensitivity in diabetic individuals. At molecular levels, the mode of action appears to be as fellows: under diabetic condition, ROS production is increased, JNK is activated, and Akt activity is inhibited; TO-mediated LXR activation potently inhibits ROS production, increases anti-oxidative gene expressions, suppresses JNK activation, and restores Akt activity. Our data provide new evidence to support LXRs as promising therapeutic targets for anti-diabetic drug development.	[Dong, Ying; Gao, Guirong; Fan, Hongyan; Li, Shengxian; Liu, Wei] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Endocrinol, Shanghai 200030, Peoples R China; [Dong, Ying; Li, Xuhang] Johns Hopkins Univ, Sch Med, Dept Med, GI Div, Baltimore, MD 21205 USA	Shanghai Jiao Tong University; Johns Hopkins University	Li, XH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, GI Div, Baltimore, MD 21205 USA.	sue_liuwei@163.com; xuhang@jhmi.edu	Li, Shengxian/AFT-2979-2022		Foundation of Science and Technology Commission of Shanghai Grand [124119a5700]; National Institute of Health [PO1 DK72084]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072084] Funding Source: NIH RePORTER	Foundation of Science and Technology Commission of Shanghai Grand; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was support by Foundation of Science and Technology Commission of Shanghai Grand 124119a5700 and National Institute of Health Grant PO1 DK72084. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer A, 2014, AM J PHYSIOL-ENDOC M, V306, pE494, DOI 10.1152/ajpendo.00410.2013; Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31; Barazzoni R, 2012, DIABETOLOGIA, V55, P773, DOI 10.1007/s00125-011-2396-x; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Diaz-Flores M, 2013, CAN J PHYSIOL PHARM, V91, P855, DOI 10.1139/cjpp-2012-0341; Evans JL, 2005, ANTIOXID REDOX SIGN, V7, P1040, DOI 10.1089/ars.2005.7.1040; Faulds MH, 2010, CURR OPIN PHARMACOL, V10, P692, DOI 10.1016/j.coph.2010.07.003; Gao MM, 2013, AAPS J, V15, P258, DOI 10.1208/s12248-012-9429-3; Gong HBA, 2009, J BIOL CHEM, V284, P30113, DOI 10.1074/jbc.M109.047753; Grefhorst A, 2005, AM J PHYSIOL-ENDOC M, V289, pE829, DOI 10.1152/ajpendo.00165.2005; Grefhorst A, 2005, AM J PHYSIOL-GASTR L, V289, pG592, DOI 10.1152/ajpgi.00063.2005; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hassing HC, 2012, HEPATOLOGY, V55, P1746, DOI 10.1002/hep.25580; He Q, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0149-0; He Q, 2014, CIRC-HEART FAIL, V7, P1032, DOI 10.1161/CIRCHEARTFAILURE.114.001260; Hessvik NP, 2010, AM J PHYSIOL-ENDOC M, V298, pE602, DOI 10.1152/ajpendo.00553.2009; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hokayem M, 2013, DIABETES CARE, V36, P1454, DOI 10.2337/dc12-1652; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Jiang SN, 2011, AM J PHYSIOL-GASTR L, V301, pG454, DOI 10.1152/ajpgi.00148.2011; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Lam TKT, 2003, AM J PHYSIOL-ENDOC M, V284, pE281, DOI 10.1152/ajpendo.00332.2002; Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107; Le Lay S, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/908539; Li XX, 2012, MICROCIRCULATION, V19, P547, DOI 10.1111/j.1549-8719.2012.00186.x; Liu S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06894; Liu YJ, 2006, ENDOCRINOLOGY, V147, P5061, DOI 10.1210/en.2006-0243; Matsuda M, 2013, OBES RES CLIN PRACT, V7, pE330, DOI 10.1016/j.orcp.2013.05.004; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; Muurling M, 2004, J LIPID RES, V45, P9, DOI 10.1194/jlr.M300240-JLR200; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; Nielsen F, 1997, CLIN CHEM, V43, P1209; Pereira S, 2014, AM J PHYSIOL-ENDOC M, V307, pE34, DOI 10.1152/ajpendo.00436.2013; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shi DM, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-173; Sorrentino SA, 2007, CIRCULATION, V116, P163, DOI 10.1161/CIRCULATIONAHA.106.684381; Steffensen KR, 2013, EXPERT OPIN THER TAR, V17, P977, DOI 10.1517/14728222.2013.806490; Steffensen KR, 2003, BIOCHEM BIOPH RES CO, V310, P589, DOI 10.1016/j.bbrc.2003.08.139; Stulnig TM, 2002, MOL PHARMACOL, V62, P1299, DOI 10.1124/mol.62.6.1299; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Venteclef N, 2014, BIOCHEM J, V459, pE1, DOI 10.1042/BJ20140211; Wang ZB, 2012, J PHARM PHARMACOL, V64, P293, DOI 10.1111/j.2042-7158.2011.01402.x; Wilding JPH, 2007, DIABETIC MED, V24, P934, DOI 10.1111/j.1464-5491.2007.02186.x; Wojcicka Grazyna, 2007, Postepy Hig Med Dosw (Online), V61, P736; Yamashita Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097419; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Yu Z, 2011, DIABETOLOGIA, V54, P922, DOI 10.1007/s00125-010-2001-8	54	17	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124778	10.1371/journal.pone.0124778	http://dx.doi.org/10.1371/journal.pone.0124778			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909991	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800105
J	Gao, XJ; Tian, F; Wang, XY; Zhao, J; Wan, X; Zhang, L; Wu, C; Li, N; Li, JS				Gao, Xuejin; Tian, Feng; Wang, Xinying; Zhao, Jie; Wan, Xiao; Zhang, Li; Wu, Chao; Li, Ning; Li, Jieshou			Leucine Supplementation Improves Acquired Growth Hormone Resistance in Rats with Protein-Energy Malnutrition	PLOS ONE			English	Article							I IGF-I; BINDING PROTEIN; SOMATOMEDIN-C; RESTRICTED RATS; LIVER; AXIS; REDUCTION; CHILDREN; CELLS; ACID	Background Protein-energy malnutrition (PEM) can lead to growth hormone (GH) resistance. Leucine supplementation diets have been shown to increase protein synthesis in muscles. Our study aimed at investigating if long-term leucine supplementation could modulate GH-insulin-like growth factor (IGF)-1 system function and mammalian target of rapamycin (mTOR)related signal transduction in skeletal muscles in a rat model of severe malnutrition. Methodology/Principal Findings Male Sprague-Dawley rats (n = 50; weight, 302 +/- 5 g) were divided into 5 treatment groups, including 2 control groups (a normal control group that was fed chow and ad libitum water [CON, n = 10] and a malnourished control group [MC, n = 10] that was fed a 50% chow diet). After undergoing a weight loss stage for 4 weeks, rats received either the chow diet (MC-CON, n = 10), the chow diet supplemented with low-dose leucine (MC-L, n = 10), or the chow diet supplemented with high-dose leucine (MC-H, n = 10) for 2 weeks. The muscle masses of the gastrocnemius, soleus, and extensor digitorum longus were significantly reduced in the MC group. Re-feeding increased muscle mass, especially in the MC-L and MC-H groups. In the MC group, serum IGF-1, IGF-binding protein (IGFBP)-3, and hepatic growth hormone receptor (GHR) levels were significantly decreased and phosphorylation of the downstream anabolic signaling effectors protein kinase B (Akt), mTOR, and ribosomal protein S6 kinase 1 (S6K1) were significantly lower than in other groups. However, serum IGF-1 and IGF binding protein (IGFBP)-3 concentrations and hepatic growth hormone receptor (GHR) levels were significantly higher in the MC-L and MC-H groups than in the MC-CON group, and serum IGFBP-1 levels was significantly reduced in the MC-L and MC-H groups. These changes were consistent with those observed for hepatic mRNA expression levels. Phosphorylation of the downstream anabolic signaling effectors Akt, mTOR, and S6K1 were also significantly higher in the MC-L and MC-H groups than in the MC-CON group. Conclusion/Significance Our data are the first to demonstrate that long-term supplementation with leucine improved acquired growth hormone resistance in rats with protein-energy malnutrition. Leucine might promote skeletal muscle protein synthesis by regulating downstream anabolic signaling transduction.	[Gao, Xuejin; Wang, Xinying] Southern Med Univ, Res Inst Gen Surg, Jinling Hosp, Guangzhou, Guangdong, Peoples R China; [Tian, Feng; Wang, Xinying; Wan, Xiao; Zhang, Li; Wu, Chao; Li, Ning; Li, Jieshou] Nanjing Univ, Sch Med, Res Inst Gen Surg, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Zhao, Jie] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China	Southern Medical University - China; Nanjing University; Nanjing University	Wang, XY (corresponding author), Southern Med Univ, Res Inst Gen Surg, Jinling Hosp, Guangzhou, Guangdong, Peoples R China.	wxinying@263.net	Li, jie/GXG-4583-2022; Wu, Chao/H-3195-2019		National Natural Science Foundation in China [81470797]	National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC))	The authors' research project is sponsored by the National Natural Science Foundation in China (81470797). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argente J, 1997, HORM RES, V48, P16, DOI 10.1159/000191306; Balage M, 2010, CURR OPIN CLIN NUTR, V13, P265, DOI 10.1097/MCO.0b013e328336f6b8; Banks MD, 2010, CLIN NUTR, V29, P180, DOI 10.1016/j.clnu.2009.08.006; Boisclair YR, 2001, J ENDOCRINOL, V170, P63, DOI 10.1677/joe.0.1700063; Borelli P, 2009, BRAZ J MED BIOL RES, V42, P523, DOI 10.1590/S0100-879X2009000600008; Caregaro L, 2001, CLIN NUTR, V20, P251, DOI 10.1054/clnu.2001.0397; Casperson SL, 2012, CLIN NUTR, V31, P512, DOI 10.1016/j.clnu.2012.01.005; Chandra RK, 1997, AM J CLIN NUTR, V66, P460; CLEMMONS DR, 1981, J CLIN ENDOCR METAB, V53, P1247, DOI 10.1210/jcem-53-6-1247; Favaro A, 2000, PSYCHOSOM MED, V62, P535, DOI 10.1097/00006842-200007000-00012; HOCHBERG Z, 1992, METABOLISM, V41, P106, DOI 10.1016/0026-0495(92)90198-J; HUMBEL RE, 1990, EUR J BIOCHEM, V190, P445, DOI 10.1111/j.1432-1033.1990.tb15595.x; Iizaka S, 2010, CLIN NUTR, V29, P47, DOI 10.1016/j.clnu.2009.05.018; ISLEY WL, 1984, JPEN-PARENTER ENTER, V8, P407, DOI 10.1177/0148607184008004407; Kagansky N, 2005, AM J CLIN NUTR, V82, P784, DOI 10.1093/ajcn/82.4.784; KETELSLEGERS JM, 1995, METABOLISM, V44, P50, DOI 10.1016/0026-0495(95)90221-X; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; LEMOZY S, 1994, ENDOCRINOLOGY, V135, P617, DOI 10.1210/en.135.2.617; Magne H, 2013, NUTR METABOLISM C S1, V1, pS51; Galdeano CM, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-64; MCWHIRTER JP, 1994, BRIT MED J, V308, P945, DOI 10.1136/bmj.308.6934.945; OSTER MH, 1995, J CLIN INVEST, V95, P2258, DOI 10.1172/JCI117916; Pedrosa RG, 2013, APPL PHYSIOL NUTR ME, V38, P694, DOI 10.1139/apnm-2012-0440; Pedrosa RG, 2010, APPL PHYSIOL NUTR ME, V35, P180, DOI 10.1139/H09-132; Sanchez FF, 2011, BRAZ J MED BIOL RES, V44, P453, DOI 10.1590/S0100-879X2011007500024; Shuto Y, 1999, J CLIN ENDOCR METAB, V84, P2320, DOI 10.1210/jc.84.7.2320; Skipworth RJE, 2006, SURG-J R COLL SURG E, V4, P273, DOI 10.1016/S1479-666X(06)80004-1; SMITH WJ, 1995, J CLIN ENDOCR METAB, V80, P443, DOI 10.1210/jc.80.2.443; STRAUS DS, 1990, MOL ENDOCRINOL, V4, P91, DOI 10.1210/mend-4-1-91; STRAUS DS, 1993, ENDOCRINOLOGY, V132, P1090, DOI 10.1210/en.132.3.1090; UNTERMAN TG, 1985, AM J MED, V78, P228, DOI 10.1016/0002-9343(85)90431-0; World Health Organization. WHO, 2002, PROM PROP FEED INF Y; Xia XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077823	33	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125023	10.1371/journal.pone.0125023	http://dx.doi.org/10.1371/journal.pone.0125023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909895	gold, Green Submitted, Green Published			2022-12-27	WOS:000353376800123
J	Rizal, G; Karki, S; Garcia, R; Larazo, N; Alcasid, M; Quick, WP				Rizal, Govinda; Karki, Shanta; Garcia, Richard; Larazo, Nikki; Alcasid, Michael; Quick, William Paul			The Use of Maleic Hydrazide for Effective Hybridization of Setaria viridis	PLOS ONE			English	Article							FOXTAIL MILLET; VICIA-FABA; MODEL; EMASCULATION; GERMINATION; INDUCTION; ITALICA; SYSTEMS; GROWTH	An efficient method for crossing green foxtail (Setaria viridis) is currently lacking. S. viridis is considered to be the new model plant for the study of C4 system in monocots and so an effective crossing protocol is urgently needed. S. viridis is a small grass with C4-NADP (ME) type of photosynthesis and has the advantage of having small genome of about 515 Mb, small plant stature, short life cycle, multiple tillers, and profuse seed set, and hence is an ideal model species for research. The objectives of this project were to develop efficient methods of emasculation and pollination, and to speed up generation advancement. We assessed the response of S. viridis flowers to hot water treatment (48 degrees C) and to different concentrations of gibberellic acid, abscisic acid, maleic hydrazide (MH), and kinetin. We found that 500 mu M of MH was effective in the emasculation of S. viridis, whilst still retaining the receptivity of the stigma to pollination. We also report effective ways to accelerate the breeding cycle of S. viridis for research through the germination of mature as well as immature seeds in optimized culture media. We believe these findings will be of great interest to researchers using Setaria.	[Rizal, Govinda; Karki, Shanta; Garcia, Richard; Larazo, Nikki; Alcasid, Michael; Quick, William Paul] C4 Rice Ctr, Int Rice Res Inst, Los Banos, Laguna, Philippines; [Quick, William Paul] Univ Sheffield, Sheffield, S Yorkshire, England	CGIAR; International Rice Research Institute (IRRI); University of Sheffield	Quick, WP (corresponding author), C4 Rice Ctr, Int Rice Res Inst, Los Banos, Laguna, Philippines.	w.p.quick@irri.org	Karki, Shanta/AAO-2373-2021	Garcia, Richard/0000-0002-8311-0365; Rizal, Govinda/0000-0002-6245-1996	Bill & Melinda Gates Foundation; UK AID; C4 Rice Consortium; International Rice Research Institute	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); UK AID(CGIAR); C4 Rice Consortium; International Rice Research Institute(CGIAR)	This work was supported by the Bill & Melinda Gates Foundation, the UK AID, the C4 Rice Consortium; and the International Rice Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R. N, 1968, GERMINATION ESTABLIS; BASSIRI A, 1972, CAN J PLANT SCI, V52, P846, DOI 10.4141/cjps72-141; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Chahal G.S., 2002, PRINCIPLES PROCEDURE; Coffman W. R., 1979, International Rice Research Newsletter, V4, P2; Coffman W. R., 1980, HYBRIDIZATION CROP P, P511; DEMARCO A, 1992, MUTAT RES, V279, P9, DOI 10.1016/0165-1218(92)90260-7; EVANS HJ, 1964, GENETICS, V49, P17; Faehnrich B, 2012, J APPL BOT FOOD QUAL, V85, P73; GRANT WF, 1994, MUTAT RES-FUND MOL M, V310, P187, DOI 10.1016/0027-5107(94)90113-9; Herrera R., 1974, P 5 SCI M, P12; House LR, 1985, GUIDE SORGHUM BREEDI; Jiang H, 2013, JOVE-J VIS EXP, DOI 10.3791/50527; Kalidasu G, 2009, J HORT FOREST, V1, P126; KIHLMAN BA, 1975, MUTAT RES, V31, P401, DOI 10.1016/0165-1161(75)90050-3; Lata C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113092; LI H. W., 1935, JOUR AMER SOC AGRON, V27, P963; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Lyakhovkin A. G., 1976, Byul. nauch.-tekhn. inform. VNII risa, P9; Mackill D.J., 1996, RAINFED LOWLAND RICE; MANTHEY DR, 1987, WEED TECHNOL, V1, P302, DOI 10.1017/S0890037X0002978X; Ponnampalam R, 1983, Regul Toxicol Pharmacol, V3, P38, DOI 10.1016/0273-2300(83)90048-X; Ribas G, 1996, MUTAGENESIS, V11, P221, DOI 10.1093/mutage/11.3.221; Rizal G, 2013, J BOT; SAVAGE D. A., 1935, Journal of the American Society of Agronomy, V27, P774; Sebastian J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095109; SWIETLINSKA Z, 1978, MUTAT RES, V55, P15, DOI 10.1016/0165-1110(78)90010-6; Tong L, 2008, PLANT PROD SCI, V11, P132, DOI 10.1626/pps.11.132; TYSDAL H. M., 1940, JOUR AMER SOC AGRON, V32, P405; VANDENBORN WH, 1971, CAN J PLANT SCI, V51, P53; Vollmann J, 2009, SERIES HDB PLANT BRE, V4; Wang T, 2010, WEED RES, V50, P228, DOI 10.1111/j.1365-3180.2010.00774.x; Wang YJ, 2007, ADVANCES IN BUCKWHEAT RESEARCH, P100; Wang ZM, 1998, THEOR APPL GENET, V96, P31, DOI 10.1007/s001220050705; Zhao G, 2014, CLIN MICROBIOL INFEC, V20, pO776, DOI 10.1111/1469-0691.12571	36	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125092	10.1371/journal.pone.0125092	http://dx.doi.org/10.1371/journal.pone.0125092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910193	Green Accepted, gold, Green Published			2022-12-27	WOS:000353376800128
J	Shao, P; Ou, JJ; Peng, M; Zhao, JP; Chen, JD; Wu, RR				Shao, Ping; Ou, Jianjun; Peng, Mei; Zhao, Jingping; Chen, Jindong; Wu, Renrong			Effects of Clozapine and other Atypical Antipsychotics on Infants Development Who Were Exposed to as Fetus: A Post-Hoc Analysis	PLOS ONE			English	Article							PREGNANCY; SCHIZOPHRENIA; RELAPSE; THERAPY; DRUGS; WOMEN; COST	Objective To investigate the developmental effects of clozapine and other atypical antipsychotics on infants who were exposed to as fetus. Method The developmental progress of 33 infants who were exposed to clozapine as fetus was compared to 30 infants who were exposed to risperidone, olanzapine or quetiapine as fetus by assessing Apgar scoring, birth weight at birth, body weight, height, and the Bayley Scales of Infant and Toddler Development, Third Edition (BSID-III) at months 2, 6 and 12 of age. Five subscale scores of BSID-III including cognitive, language, motor, social-emotional, and adaptive behavior were also compared. Student's t test and Chi-square analysis were used as appropriate. Repeated measurements were evaluated by analysis of covariance. Results Of the 63 infants, 58 (92.1%) completed a 12-month study period. At the age of 2 and 6 months, mean adaptive behavior scores of BSID-III were significantly lower in clozapine-exposed infants than infants who exposed to other atypical antipsychotic at 2 and 6 months of age. More clozapine-exposed infants had delayed development (defined as the subscale score of <85) for adaptive behavior at 2 and 6 months of age. There was no difference between the two groups for cognitive, language, motor, social and emotional at 2, 6 and 12 months of age. More infants who were exposed to clozapine as fetus (25 of 33, 75.8%) had disturbed sleep and a labile state than those who were exposed to other atypical antipsychotics (8 of 30, 26.7%) during 2 months of age (P<0.001). Conclusion These results suggest that clozapine has more adaptive behavior effects on infants who were exposed to as a fetus than other atypical antipsychotics at 2 and 6 months of age.	[Shao, Ping; Ou, Jianjun; Zhao, Jingping; Chen, Jindong; Wu, Renrong] Cent South Univ, Xiangya Hosp 2, Inst Mental Hlth, Changsha 410011, Hunan, Peoples R China; [Shao, Ping] Brains Hosp Hunan Prov, Changsha 410007, Hunan, Peoples R China; [Peng, Mei] Cent South Univ, Xiangya Hosp 2, Dept Obstet, Changsha 410011, Hunan, Peoples R China	Central South University; Central South University	Wu, RR (corresponding author), Cent South Univ, Xiangya Hosp 2, Inst Mental Hlth, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China.	chenjd269@163.com; wurenrong2013@163.com	zhao, jing/B-3868-2019		National Natural Science Foundation of China [81371481]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81371481 to RRW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderson GD, 2005, CLIN PHARMACOKINET, V44, P989, DOI 10.2165/00003088-200544100-00001; Bayley N., 2005, BAYLEY SCALES INFANT; Duran A, 2008, J PSYCHOPHARMACOL, V22, P111, DOI 10.1177/0269881107079171; First M. B., 1997, STRUCTURED CLIN INTE; Gentile S, 2008, J CLIN PSYCHIAT, V69, P666, DOI 10.4088/JCP.v69n0421; Gilad O, 2011, BREASTFEED MED, V6, P55, DOI 10.1089/bfm.2010.0027; Gupta N, 2004, CAN J PSYCHIAT, V49, P865, DOI 10.1177/070674370404901213; Hong JY, 2009, PROG NEURO-PSYCHOPH, V33, P835, DOI 10.1016/j.pnpbp.2009.03.034; Lin HC, 2010, SCHIZOPHR RES, V116, P55, DOI 10.1016/j.schres.2009.10.011; Lindenmayer JP, 2009, J CLIN PSYCHIAT, V70, P990, DOI 10.4088/JCP.08m04221; McKenna K, 2005, J CLIN PSYCHIAT, V66, P444, DOI 10.4088/JCP.v66n0406; Mendhekar DN, 2007, J NEUROPSYCH CLIN N, V19, P196, DOI 10.1176/appi.neuropsych.19.2.196; Msall ME, 2010, ARCH PEDIAT ADOL MED, V164, P391, DOI 10.1001/archpediatrics.2010.25; MUCKLOW JC, 1986, CLIN OBSTET GYNAECOL, V13, P161; Newport DJ, 2007, AM J PSYCHIAT, V164, P1214, DOI 10.1176/appi.ajp.2007.06111886; Nguyen HN, 2003, ENCEPHALE, V29, P119; Peng M, 2013, PSYCHOPHARMACOLOGY, V228, P577, DOI 10.1007/s00213-013-3060-6; Robertson CMT, 2010, ARCH PEDIAT ADOL MED, V164, P1072, DOI 10.1001/archpediatrics.2010.199; WEIDEN PJ, 1995, SCHIZOPHRENIA BULL, V21, P419, DOI 10.1093/schbul/21.3.419; Wunderink L, 2007, J CLIN PSYCHIAT, V68, P654, DOI 10.4088/JCP.v68n0502	21	22	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123373	10.1371/journal.pone.0123373	http://dx.doi.org/10.1371/journal.pone.0123373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909513	Green Submitted, gold, Green Published			2022-12-27	WOS:000353376800036
J	Siebers, N; Martius, C; Eckhardt, KU; Garcia, MVB; Leinweber, P; Amelung, W				Siebers, Nina; Martius, Christopher; Eckhardt, Kai-Uwe; Garcia, Marcos V. B.; Leinweber, Peter; Amelung, Wulf			Origin and Alteration of Organic Matter in Termite Mounds from Different Feeding Guilds of the Amazon Rainforests	PLOS ONE			English	Article							DENSITY FRACTIONS; PHOSPHORUS FORMS; TROPICAL FORESTS; MURAMIC ACID; AMINO-SUGARS; BEECH LITTER; SOIL; LIGNIN; CARBON; NITROGEN	The impact of termites on nutrient cycling and tropical soil formation depends on their feeding habits and related material transformation. The identification of food sources, however, is difficult, because they are variable and changed by termite activity and nest construction. Here, we related the sources and alteration of organic matter in nests from seven different termite genera and feeding habits in the Terra Firme rainforests to the properties of potential food sources soil, wood, and microepiphytes. Chemical analyses comprised isotopic composition of C and N, cellulosic (CPS), non-cellulosic (NCPS), and N-containing saccharides, and molecular composition screening using pyrolysis-field ionization mass spectrometry (Py-FIMS). The isotopic analysis revealed higher soil delta C-13 (-27.4%) and delta N-15 (6.6%) values in nests of wood feeding Nasutitermes and Cornitermes than in wood samples (delta C-13 = -29.1 parts per thousand, delta N-15 = 3.4 parts per thousand), reflecting stable-isotope enrichment with organic matter alterations during or after nest construction. This result was confirmed by elevated NCPS: CPS ratios, indicating a preferential cellulose decomposition in the nests. High portions of muramic acid (MurAc) pointed to the participation of bacteria in the transformation processes. Non-metric multidimensional scaling (MDS) revealed increasing geophagy in the sequence Termes < Embiratermes < Anoplotermes and increasing xylophagy for Cornitermes < Nasutitermes., and that the nest material of Constrictotermes was similar to the microepiphytes sample, confirming the report that Constrictotermes belongs to the microepiphyte-feeders. We therewith document that nest chemistry of rainforest termites shows variations and evidence of modification by microbial processes, but nevertheless it primarily reflects the trophic niches of the constructors.	[Siebers, Nina; Amelung, Wulf] Univ Bonn, Inst Crop Sci & Resource Conservat INRES, Soil Sci & Soil Ecol, D-53115 Bonn, Germany; [Martius, Christopher; Garcia, Marcos V. B.] Univ Bonn, Ctr Dev Res ZEF, D-53113 Bonn, Germany; [Eckhardt, Kai-Uwe; Leinweber, Peter] Univ Rostock, Soil Sci, D-18051 Rostock, Germany; [Garcia, Marcos V. B.] Embrapa Amazonia Ocidental, BR-69010970 Manaus, Amazonas, Brazil	University of Bonn; University of Bonn; University of Rostock; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Siebers, N (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat INRES, Soil Sci & Soil Ecol, Nussallee 13, D-53115 Bonn, Germany.	n.siebers@fz-juelich.de	Amelung, Wulf/H-2136-2013	Amelung, Wulf/0000-0002-4920-4667; Martius, Christopher/0000-0002-6884-0298; Siebers, Nina/0000-0002-6431-0046	German Research Foundation	German Research Foundation(German Research Foundation (DFG))	The work had been funded by the German Research Foundation.	Amelung W, 1997, SOIL SCI SOC AM J, V61, P115, DOI 10.2136/sssaj1997.03615995006100010018x; Amelung W, 2008, ADV AGRON, V100, P155, DOI 10.1016/S0065-2113(08)00606-8; Amelung W, 2002, SOIL BIOL BIOCHEM, V34, P367, DOI 10.1016/S0038-0717(01)00192-4; Amelung W, 1999, SOIL SCI SOC AM J, V63, P86, DOI 10.2136/sssaj1999.03615995006300010014x; Amelung W., 2001, ASSESSMENT METHODS S, P233, DOI [10.1201/9781482278644-27, DOI 10.1201/9781482278644-27]; Araujo R. L., 1970, P527; Bandowe BAM, 2009, SOIL BIOL BIOCHEM, V41, P630, DOI 10.1016/j.soilbio.2008.12.029; BENZINGPURDIE L, 1984, SOIL SCI SOC AM J, V48, P219, DOI 10.2136/sssaj1984.03615995004800010040x; Bezerra-Gusmao MA, 2011, APPL SOIL ECOL, V47, P1, DOI 10.1016/j.apsoil.2010.11.003; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P363; Bourguignon T, 2009, SOIL BIOL BIOCHEM, V41, P2038, DOI 10.1016/j.soilbio.2009.07.005; BOUTTON TW, 1983, OECOLOGIA, V59, P1, DOI 10.1007/BF00388065; Brauman A, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P233; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; BURNEY C M, 1977, Marine Chemistry, V5, P15, DOI 10.1016/0304-4203(77)90012-3; CHESHIRE MV, 1966, J SOIL SCI, V17, P372, DOI 10.1111/j.1365-2389.1966.tb01480.x; COCHRAN TW, 1978, CARBOHYD RES, V61, P529, DOI 10.1016/S0008-6215(00)84511-5; DELIGNE J, 1966, CR ACAD SCI D NAT, V263, P1323; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Ding XL, 2010, J SOIL SEDIMENT, V10, P758, DOI 10.1007/s11368-009-0132-7; EISNER T, 1976, BEHAV ECOL SOCIOBIOL, V1, P83, DOI 10.1007/BF00299954; Fabritius H, 2011, TOP GEOBIOL, V34, P35, DOI 10.1007/978-90-481-9684-5_2; Fall S, 2004, MICROB ECOL, V48, P191, DOI 10.1007/s00248-003-1047-2; Glaser B, 2004, SOIL BIOL BIOCHEM, V36, P399, DOI 10.1016/j.soilbio.2003.10.013; Griffiths BS, 2013, SOIL BIOL BIOCHEM, V57, P957, DOI 10.1016/j.soilbio.2012.08.012; GUGGENBERGER G, 1994, EUR J SOIL SCI, V45, P449, DOI 10.1111/j.1365-2389.1994.tb00530.x; HEDGES JI, 1982, ANAL CHEM, V54, P174, DOI 10.1021/ac00239a007; Kiersch K, 2012, THERMOCHIM ACTA, V537, P36, DOI 10.1016/j.tca.2012.02.034; KOGEL I, 1986, SOIL BIOL BIOCHEM, V18, P589, DOI 10.1016/0038-0717(86)90080-5; KOGEL I, 1985, SOIL BIOL BIOCHEM, V17, P637, DOI 10.1016/0038-0717(85)90040-9; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lee K. E., 1971, TERMITES AND SOILS; Leinweber P., 2009, BIOPHYSICOCHEMICAL P, P539, DOI DOI 10.1002/9780470494950.CH14; Leinweber P, 2013, ADV AGRON, V119; Martius C, 2000, SOCIOBIOLOGY, V35, P379; MARTIUS C, 1994, PEDOBIOLOGIA, V38, P407; Miltner A, 1998, SOIL BIOL BIOCHEM, V30, P1, DOI 10.1016/S0038-0717(97)00092-8; Nadelhoffer K., 1994, STABLE ISOTOPES ECOL, P22; Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z; Ometto JPHB, 2006, BIOGEOCHEMISTRY, V79, P251, DOI 10.1007/s10533-006-9008-8; Parsons J. W., 1981, Soil biochemistry. Volume 5, P197; R Core Team, 2021, R LANGUAGE ENV STAT; Rodionov A, 2001, GEODERMA, V102, P299, DOI 10.1016/S0016-7061(01)00038-6; Roth PJ, 2011, GLOBAL CHANGE BIOL, V17, P3405, DOI 10.1111/j.1365-2486.2011.02500.x; Ruckamp D, 2012, GEODERMA, V170, P239, DOI 10.1016/j.geoderma.2011.10.004; Ruckamp D, 2010, GEODERMA, V155, P269, DOI 10.1016/j.geoderma.2009.12.010; SCHNITZER M, 1992, SOIL SCI SOC AM J, V56, P1811, DOI 10.2136/sssaj1992.03615995005600060027x; Schulten HR, 1999, EUR J SOIL SCI, V50, P237, DOI 10.1046/j.1365-2389.1999.00241.x; Schulten HR, 1998, IUPAC S ANAL PHYS CH, V4, P281; Sleaford F, 1996, ECOL ENTOMOL, V21, P279, DOI 10.1111/j.1365-2311.1996.tb01245.x; Sleutel S, 2008, BIOGEOCHEMISTRY, V89, P253, DOI 10.1007/s10533-008-9217-4; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Solomon D, 2002, SOIL SCI SOC AM J, V66, P68, DOI 10.2136/sssaj2002.0068; SOWDEN FJ, 1977, CAN J SOIL SCI, V57, P445, DOI 10.4141/cjss77-050; Spain AV, 1996, SOIL BIOL BIOCHEM, V28, P1585, DOI 10.1016/S0038-0717(96)00260-X; SPSS: IBM Corp, 2012, IBM SPSS STAT WIND V; Sradnick A, 2014, GEODERMA, V226, P79, DOI 10.1016/j.geoderma.2014.03.005; Stevenson F.J., 1982, NITROGEN AGR SOILS, P101; Tayasu I, 2002, SOIL BIOL BIOCHEM, V34, P297, DOI 10.1016/S0038-0717(01)00181-X; Tayasu I, 1998, FUNCT ECOL, V12, P536, DOI 10.1046/j.1365-2435.1998.00220.x; Tayasu I, 1997, ECOL ENTOMOL, V22, P343, DOI 10.1046/j.1365-2311.1997.00070.x; UZAKI M, 1983, J CHROMATOGR, V260, P487, DOI 10.1016/0021-9673(83)80058-2; VARMA A, 1994, FEMS MICROBIOL REV, V15, P9, DOI 10.1111/j.1574-6976.1994.tb00120.x; Wilcke W, 2003, ORG GEOCHEM, V34, P1405, DOI 10.1016/S0146-6380(03)00137-2; Wood T.G., 1978, International Biological Programme, P245; Yamada A, 2005, ECOL RES, V20, P453, DOI 10.1007/s11284-005-0062-9; Zhang XD, 1996, SOIL BIOL BIOCHEM, V28, P1201, DOI 10.1016/0038-0717(96)00117-4; ZIEGLER F, 1991, Z PFLANZ BODENKUNDE, V154, P377, DOI 10.1002/jpln.19911540511	68	7	7	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123790	10.1371/journal.pone.0123790	http://dx.doi.org/10.1371/journal.pone.0123790			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909987	Green Published, gold			2022-12-27	WOS:000353376800045
J	van der Hoeven, R; Cruz, MR; Chavez, V; Garsin, DA				van der Hoeven, Ransome; Cruz, Melissa R.; Chavez, Violeta; Garsin, Danielle A.			Localization of the Dual Oxidase BLI-3 and Characterization of Its NADPH Oxidase Domain during Infection of Caenorhabditis elegans	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; PHAGOCYTE OXIDASE; NOX/DUOX FAMILY; CROSS-LINKING; REVEALS; HOST; DUOX; EPITHELIUM; VIRULENCE; FAECALIS	Dual oxidases (DUOX) are enzymes that contain an NADPH oxidase domain that produces hydrogen peroxide (H2O2) and a peroxidase domain that can utilize H2O2 to carry out a variety of reactions. The model organism Caenorhabditis elegans produces the DUOX, BLI-3, which has roles in both cuticle development and in protection against infection. In previous work, we demonstrated that while certain peroxidases were protective against the human bacterial pathogen Enterococcus faecalis, the peroxidase domain of BLI-3 was not, leading to the postulate that the NADPH oxidase domain is the basis for BLI-3's protective effects. In this work, we show that a strain carrying a mutation in the NADPH oxidase domain of BLI-3, bli-3(im10), is more susceptible to E. faecalis and the human fungal pathogen Candida albicans. Additionally, less H2O2 is produced in response to pathogen using both an established Amplex Red assay and a strain of C. albicans, WT-OXYellow, which acts as a biosensor of reactive oxygen species (ROS). Finally, a C. elegans line containing a BLI-3:: mCherry transgene was generated. Previous work suggested that BLI-3 is produced in the hypodermis and the intestine. Expression of the transgene was observed in both these tissues, and additionally in the pharynx. The amount and pattern of localization of BLI-3 did not change in response to pathogen exposure.	[van der Hoeven, Ransome; Cruz, Melissa R.; Chavez, Violeta; Garsin, Danielle A.] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Garsin, DA (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	Danielle.A.Garsin@uth.tmc.edu		van der Hoeven, Ransome/0000-0001-9686-832X; Cruz, Melissa/0000-0003-2399-3343	National Institutes of Health [R01AI076406]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076406, R01AI110432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by R01AI076406 to D.A.G and its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerssens J, 2008, CLIN GASTROENTEROL H, V6, P194, DOI 10.1016/j.cgh.2007.11.012; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; BRENNER S, 1974, GENETICS, V77, P71; Brothers KM, 2011, EUKARYOT CELL, V10, P932, DOI 10.1128/EC.05005-11; Chavez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587; Chavez V, 2009, INFECT IMMUN, V77, P4983, DOI 10.1128/IAI.00627-09; Cruz MR, 2013, INFECT IMMUN, V81, P189, DOI 10.1128/IAI.00914-12; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Engelmann I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019055; Enjalbert B, 2007, INFECT IMMUN, V75, P2143, DOI 10.1128/IAI.01680-06; Flores MV, 2010, BIOCHEM BIOPH RES CO, V400, P164, DOI 10.1016/j.bbrc.2010.08.037; FONZI WA, 1993, GENETICS, V134, P717; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Hope IA., 1999, C ELEGANS PRACTICAL; Jain C, 2009, EUKARYOT CELL, V8, P1218, DOI 10.1128/EC.00367-08; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Mango Susan E, 2007, WormBook, P1; Moribe H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002957; Nagai K, 2008, ANTIOXID REDOX SIGN, V10, P705, DOI 10.1089/ars.2007.1941; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Thein MC, 2009, J BIOL CHEM, V284, P17549, DOI 10.1074/jbc.M900831200; Tiller GR, 2014, GENETICS, V197, P515, DOI 10.1534/genetics.113.160606; Tiller GR, 2014, SKPO 1 PEROXIDASE FU; van der Hoeven R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002453; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194	34	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124091	10.1371/journal.pone.0124091	http://dx.doi.org/10.1371/journal.pone.0124091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909649	Green Submitted, gold, Green Published			2022-12-27	WOS:000353376800059
J	Zanni, R; Galvez-Llompart, M; Morell, C; Rodriguez-Henche, N; Diaz-Laviada, I; Recio-Iglesias, MC; Garcia-Domenech, R; Galvez, J				Zanni, Riccardo; Galvez-Llompart, Maria; Morell, Cecilia; Rodriguez-Henche, Nieves; Diaz-Laviada, Ines; Carmen Recio-Iglesias, Maria; Garcia-Domenech, Ramon; Galvez, Jorge			Novel Cancer Chemotherapy Hits by Molecular Topology: Dual Akt and Beta-Catenin Inhibitors	PLOS ONE			English	Article							NF-KAPPA-B; MELANOMA CELL-GROWTH; WNT/BETA-CATENIN; SIGNALING PATHWAY; HUMAN COLON; DOWN-REGULATION; PROTEIN-KINASE; UP-REGULATION; HUMAN PROSTATE; IN-VITRO	Background and Purpose Colorectal and prostate cancers are two of the most common types and cause of a high rate of deaths worldwide. Therefore, any strategy to stop or at least slacken the development and progression of malignant cells is an important therapeutic choice. The aim of the present work is the identification of novel cancer chemotherapy agents. Nowadays, many different drug discovery approaches are available, but this paper focuses on Molecular Topology, which has already demonstrated its extraordinary efficacy in this field, particularly in the identification of new hit and lead compounds against cancer. This methodology uses the graph theoretical formalism to numerically characterize molecular structures through the so called topological indices. Once obtained a specific framework, it allows the construction of complex mathematical models that can be used to predict physical, chemical or biological properties of compounds. In addition, Molecular Topology is highly efficient in selecting and designing new hit and lead drugs. According to the aforementioned, Molecular Topology has been applied here for the construction of specific Akt/mTOR and beta-catenin inhibition mathematical models in order to identify and select novel antitumor agents. Experimental Approach Based on the results obtained by the selected mathematical models, six novel potential inhibitors of the Akt/mTOR and beta-catenin pathways were identified. These compounds were then tested in vitro to confirm their biological activity. Conclusion and Implications Five of the selected compounds, CAS no 256378-54-8 (Inhibitor no 1), 663203-38-1 (Inhibitor no 2), 247079-73-8 (Inhibitor no 3), 689769-86-6 (Inhibitor no 4) and 431925-096 (Inhibitor no 6) gave positive responses and resulted to be active for Akt/mTOR and/or beta-catenin inhibition. This study confirms once again the Molecular Topology's reliability and efficacy to find out novel drugs in the field of cancer.	[Zanni, Riccardo; Galvez-Llompart, Maria; Garcia-Domenech, Ramon; Galvez, Jorge] Univ Valencia, Sch Pharm, Dept Phys Chem, Valencia, Spain; [Morell, Cecilia; Rodriguez-Henche, Nieves; Diaz-Laviada, Ines] Univ Alcala, Sch Med, Biochem & Mol Biol Unit, Dept Syst Biol, Alcala De Henares, Spain; [Zanni, Riccardo; Galvez-Llompart, Maria; Carmen Recio-Iglesias, Maria] Univ Valencia, Sch Pharm, Dept Pharmacol, Valencia, Spain	University of Valencia; Universidad de Alcala; University of Valencia	Galvez, J (corresponding author), Univ Valencia, Sch Pharm, Dept Phys Chem, Valencia, Spain.	jorge.galvez@uv.es	Diaz-Laviada, Ines/I-2838-2015; Galvez-Llompart, Maria/ABH-4751-2020; Galvez, Jorge/P-6466-2014; Rodriguez-Henche, Nieves/K-6828-2017; Garcia-Domenech, Ramon/R-5909-2018	Diaz-Laviada, Ines/0000-0001-9704-4373; Galvez-Llompart, Maria/0000-0002-0718-4143; Galvez, Jorge/0000-0003-0928-8437; Rodriguez-Henche, Nieves/0000-0001-9798-359X; Morell Pucci, Maria Cecilia/0000-0002-9759-855X; Garcia-Domenech, Ramon/0000-0003-1137-0587; Zanni, Riccardo/0000-0002-3388-3730; MCarmen, Recio/0000-0002-0933-2306	Spanish Minneco [BFU2012-31444]; Comunidad de Madrid [S2010/BMD-2308]; Junta de Castilla-La Mancha [POII-2014-011-P]; Fundacion Tatiana Perez de Guzman [2013-001]; Valencia University (Especials Accions Grant) [UV-INV-AE13-139455]; University of Valencia (Atraction of Talent Grant) [UV-INV-PDOC11-39853]	Spanish Minneco; Comunidad de Madrid(Comunidad de Madrid); Junta de Castilla-La Mancha; Fundacion Tatiana Perez de Guzman; Valencia University (Especials Accions Grant); University of Valencia (Atraction of Talent Grant)	IDL is supported by grants from Spanish Minneco (grant BFU2012-31444), Comunidad de Madrid (grant S2010/BMD-2308) Junta de Castilla-La Mancha (grant POII-2014-011-P), Fundacion Tatiana Perez de Guzman (grant 2013-001). MCR is supported by Valencia University (Especials Accions Grant UV-INV-AE13-139455). MGL is supported by University of Valencia (Atraction of Talent Grant UV-INV-PDOC11-39853). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitha P, 2013, EUR J NUTR, V52, P75, DOI 10.1007/s00394-011-0288-y; [Anonymous], 2009, CHEMDRAW ULTR VERS 1; [Anonymous], SPECS DAT; Antony L, 2014, PROSTATE, V74, P1118, DOI 10.1002/pros.22828; Arensman MD, 2014, ONCOGENE, V33, P899, DOI 10.1038/onc.2013.23; Baba Y, 2011, CANCER-AM CANCER SOC, V117, P1399, DOI 10.1002/cncr.25630; Bajer MM, 2014, BIOCHEM PHARMACOL, V88, P313, DOI 10.1016/j.bcp.2014.01.034; Bao-ying H, 2012, CHINESE J INTEGRATED, V32, P965; Baskar AA, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-24; Behari J, 2007, J HEPATOL, V46, P849, DOI 10.1016/j.jhep.2006.11.017; Bilir B, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-280; Blum CA, 2001, CARCINOGENESIS, V22, P315, DOI 10.1093/carcin/22.2.315; Bokmann S, 2003, EUR J CANCER PREV, V12, P469, DOI [10.1097/01.cej.0000102800.33147.d9, 10.1097/00008469-200312000-00005]; Brown JB, 2010, GASTROENTEROLOGY, V138, P595, DOI 10.1053/j.gastro.2009.10.038; Buitrago CG, 2012, J CELL BIOCHEM, V113, P1170, DOI 10.1002/jcb.23444; Caboni L, 2014, J CHEM INF MODEL, V54, P2953, DOI 10.1021/ci500324f; Canter RJ, 2005, ANN SURG ONCOL, V12, P733, DOI 10.1245/ASO.2005.10.005; Chen RH, 2000, J BIOL CHEM, V275, P17894, DOI 10.1074/jbc.M905336199; Chen WY, 2014, INT IMMUNOPHARMACOL, V22, P409, DOI 10.1016/j.intimp.2014.07.026; Cheng B, 2012, INT J PHOTOENERGY, V2012, DOI 10.1155/2012/797968; Chinni SR, 2001, ONCOGENE, V20, P2927, DOI 10.1038/sj.onc.1204365; Choi H, 2010, BIOCHEM BIOPH RES CO, V391, P915, DOI 10.1016/j.bbrc.2009.11.164; Choi J, 2014, J MED FOOD, V17, P842, DOI 10.1089/jmf.2013.0159; Choo EJ, 2011, BIOL PHARM BULL, V34, P41, DOI 10.1248/bpb.34.41; Crowell JA, 2007, MOL CANCER THER, V6, P2139, DOI 10.1158/1535-7163.MCT-07-0120; Cui L, 2014, J PHARM PHARMACOL, V66, P1615, DOI 10.1111/jphp.12283; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Deeb D, 2014, INT J ONCOL, V44, P1707, DOI 10.3892/ijo.2014.2325; Dehnhardt CM, 2010, J MED CHEM, V53, P897, DOI 10.1021/jm901370m; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Dihlmann S, 2003, MOL CANCER THER, V2, P509; Duart MJ, 2002, INT J PHARMACEUT, V246, P111, DOI 10.1016/S0378-5173(02)00352-6; Eagle D, 2012, ONCOLOGY-NY, V26, P918; Edlind MP, 2014, ASIAN J ANDROL, V16, P378, DOI 10.4103/1008-682X.122876; Esmaeili MA, 2014, S AFR J BOT, V93, P37, DOI 10.1016/j.sajb.2014.03.010; Fila C, 2008, J BIOL CHEM, V283, P21714, DOI 10.1074/jbc.M710264200; Fu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102535; FURNIVAL GM, 1971, TECHNOMETRICS, V13, P403, DOI 10.2307/1266801; Galvez J, 1996, BIOORG MED CHEM LETT, V6, P2301, DOI 10.1016/0960-894X(96)00418-0; Galvez J, 2000, J MOL STRUC-THEOCHEM, V504, P241, DOI 10.1016/S0166-1280(00)00365-1; Galvez J, 1996, J MOL GRAPH MODEL, V14, P272, DOI 10.1016/S0263-7855(96)00081-1; Galvez J, 2010, QSPR QSAR STUDIES DE, P63; Galvez J, 2004, US patent, Patent No. [US20040266732, 20040266732]; Galvez Jorge, 2013, Drug Discov Today Technol, V10, pe475, DOI 10.1016/j.ddtec.2013.05.001; Galvez J, 2012, CURR COMPUT-AID DRUG, V8, P196, DOI 10.2174/157340912801619094; Galvez J, 2012, EXPERT OPIN DRUG DIS, V7, P133, DOI 10.1517/17460441.2012.652083; Galvez J, 2011, COMB CHEM HIGH T SCR, V14, P279, DOI 1386-2073/11 $58.00+.00; Galvez J, 2010, CURR COMPUT-AID DRUG, V6, P252; Galvez-Llompart M, 2013, MOL DIVERS, V17, P573, DOI 10.1007/s11030-013-9458-6; Galvez-Llompart M, 2013, MED CHEM RES, V22, P3466, DOI 10.1007/s00044-012-0361-y; Galvez-Llompart M, 2011, MOL DIVERS, V15, P917, DOI 10.1007/s11030-011-9323-4; Galvez-Llompart M, 2010, LETT DRUG DES DISCOV, V7, P438, DOI 10.2174/157018010791306597; Gao N, 2003, BIOCHEM BIOPH RES CO, V310, P1124, DOI 10.1016/j.bbrc.2003.09.132; Garcia-Domenech R, 2008, CHEM REV, V108, P1127, DOI 10.1021/cr0780006; Garcia-Domenech R, 2013, EXPERT OPIN DRUG DIS, V8, P933, DOI 10.1517/17460441.2013.800043; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Gardner SH, 2004, BRIT J CANCER, V91, P153, DOI 10.1038/sj.bjc.6601901; Greenspan EJ, 2011, CANCER PREV RES, V4, P161, DOI 10.1158/1940-6207.CAPR-10-0021; Haegele L, 2003, MOL CELL NEUROSCI, V24, P696, DOI 10.1016/S1044-7431(03)00232-X; Hallett RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033976; Han AJ, 2008, EUR J PHARMACOL, V583, P26, DOI 10.1016/j.ejphar.2007.12.034; Hara A, 2005, ONCOL REP, V14, P345; Haug U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088407; [侯丽颖 Hou Liying], 2013, [癌变·畸变·突变, Carcinogenesis, Teratogenesis and Mutagenesis], V25, P343; Hu C, 2008, BIOORGAN MED CHEM, V16, P7888, DOI 10.1016/j.bmc.2008.07.076; Huang MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092161; Hwang TL, 2010, BIOCHEM PHARMACOL, V80, P1190, DOI 10.1016/j.bcp.2010.06.028; Jasinski P, 2008, INVEST NEW DRUG, V26, P223, DOI 10.1007/s10637-007-9096-x; Jasinski P, 2011, INVEST NEW DRUG, V29, P846, DOI 10.1007/s10637-010-9432-4; Jayasooriya RGPT, 2014, TOXICOL IN VITRO, V28, P751, DOI 10.1016/j.tiv.2014.02.015; Jeon SJ, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-17; Jia D, 2015, CELL DEATH DIFFER, V22, P298, DOI 10.1038/cdd.2014.145; Jiang S, 2012, ZHONGHUA SHENJINGKE, V45, P500; Jin KS, 2014, FOOD CHEM TOXICOL, V68, P38, DOI 10.1016/j.fct.2014.03.001; Jin X, 2004, BRIT J CANCER, V91, P1808, DOI 10.1038/sj.bjc.6602214; Johnson SM, 2010, J AM COLL SURGEONS, V210, P767, DOI 10.1016/j.jamcollsurg.2009.12.008; Joo YN, 2014, INT J ONCOL, V44, P187, DOI 10.3892/ijo.2013.2178; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kaur J, 2010, AM J BIOMED SCI, V2, P63; Kawabata K, 2006, FEBS LETT, V580, P5288, DOI 10.1016/j.febslet.2006.08.072; Kaza N, 2014, THESIS; Kim JH, 2014, FOOD CHEM TOXICOL, V67, P87, DOI 10.1016/j.fct.2014.02.019; Kim MB, 2014, BIOCHEM BIOPH RES CO, V445, P433, DOI 10.1016/j.bbrc.2014.02.017; KLECKA WR, 1980, SAGE U PAPER SERIES; Krech T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-287; Kwak DH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/413906; Lambert JR, 2007, BIOCHEM BIOPH RES CO, V361, P189, DOI 10.1016/j.bbrc.2007.07.012; Lee E, 2013, P NATL ACAD SCI USA, V110, P15710, DOI 10.1073/pnas.1218168110; Lee H, 2011, LIFE SCI, V88, P294, DOI 10.1016/j.lfs.2010.12.004; Lee IA, 2014, WORLD J GASTROENTERO, V20, P1127, DOI 10.3748/wjg.v20.i5.1127; Lee MA, 2013, BIOORG MED CHEM LETT, V23, P5511, DOI 10.1016/j.bmcl.2013.08.065; Lee SY, 2013, CANCER PREV RES, V6, P1356, DOI 10.1158/1940-6207.CAPR-13-0241; Lee YM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/210604; Leow PC, 2010, INVEST NEW DRUG, V28, P766, DOI 10.1007/s10637-009-9311-z; Li HZ, 2013, TOXICOL LETT, V220, P219, DOI 10.1016/j.toxlet.2013.05.006; Li J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-241; Li J, 2013, CELL REP, V5, P1650, DOI 10.1016/j.celrep.2013.11.037; Li L, 2011, ASIAN PAC J CANCER P, V12, P3293; Li QH, 2012, ARCH GERONTOL GERIAT, V55, P749, DOI 10.1016/j.archger.2012.06.013; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; Liagre B, 2007, INT J MOL MED, V20, P451; [林碧华 Lin Bihua], 2014, [中国药学杂志, Chinese Pharmaceutical Journal], V49, P837; Liu J, 2014, MOL MED REP, V9, P1289, DOI 10.3892/mmr.2014.1928; Liu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036237; Liu Y, 2014, CN patent, Patent No. [CN104055779, 104055779]; Liu YL, 2013, ONCOL REP, V30, P1723, DOI 10.3892/or.2013.2658; Llacer MT, 2006, INTERNET ELECT J MOL, V5, P306; Llompart J, 2006, US patent, Patent No. [US20060014770, 20060014770]; Llompart J, 2004, US patent, Patent No. [US20040059000, 20040059000]; Lopez ME, 2013, IJCCE, V3, P64; Lu DS, 2005, P NATL ACAD SCI USA, V102, P18567, DOI 10.1073/pnas.0509316102; Lu WY, 2012, CELL SIGNAL, V24, P2291, DOI 10.1016/j.cellsig.2012.07.009; Lu WZ, 2012, LIFE SCI, V91, P279, DOI 10.1016/j.lfs.2012.07.032; Ma L, 2013, FEBS J, V280, P2027, DOI 10.1111/febs.12226; Maier TJ, 2005, FASEB J, V19, P1353, DOI 10.1096/fj.04-3274fje; Makhov PB, 2012, MOL CANCER THER, V11, P1510, DOI 10.1158/1535-7163.MCT-11-0907; Mao JM, 2013, DIABETES, V62, P3736, DOI 10.2337/db13-0035; Mao YJ, 2014, J HETEROCYCLIC CHEM, V51, P594, DOI 10.1002/jhet.1111; Matsuzaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076808; McGuire TF, 2001, J BIOL CHEM, V276, P26365, DOI 10.1074/jbc.M010101200; Merhi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025963; Merla R, 2007, AM J PHYSIOL-HEART C, V293, pH1918, DOI 10.1152/ajpheart.00416.2007; Meropol NJ, 2009, J CLIN ONCOL, V27, P3868, DOI 10.1200/JCO.2009.23.1183; Meuillet EJ, 2010, MOL CANCER THER, V9, P706, DOI 10.1158/1535-7163.MCT-09-0985; Do MT, 2013, FOOD CHEM, V141, P2591, DOI 10.1016/j.foodchem.2013.04.125; Mojsin M, 2014, FOOD FUNCT, V5, P2564, DOI [10.1039/c4fo00484a, 10.1039/C4FO00484A]; Mologni L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051449; Morikawa K, 2008, J AGR FOOD CHEM, V56, P11030, DOI 10.1021/jf801965n; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muche S, 2014, ANTICANCER RES, V34, P4677; Nozawa H, 2007, CANCER LETT, V251, P105, DOI 10.1016/j.canlet.2006.11.008; Oh JH, 2009, INT IMMUNOPHARMACOL, V9, P614, DOI 10.1016/j.intimp.2009.02.002; Olivier-Van Stichelen Stephanie, 2012, Am J Physiol Endocrinol Metab, V302, pE417, DOI 10.1152/ajpendo.00390.2011; Ou X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095393, 10.1371/journal.pone.0101587]; Pandey MK, 2014, EXP HEMATOL, V42, P883, DOI 10.1016/j.exphem.2014.07.261; Pang XF, 2011, MOL CANCER THER, V10, P795, DOI 10.1158/1535-7163.MCT-10-0936; Panno ML, 2010, FEBS LETT, V584, P2321, DOI 10.1016/j.febslet.2010.04.001; Park HS, 2012, FOOD CHEM TOXICOL, V50, P2407, DOI 10.1016/j.fct.2012.04.034; Park S, 2013, BIOL PHARM BULL, V36, P1040, DOI 10.1248/bpb.b13-00158; Piazza GA, 2010, PHARMACEUTICALS, V3, P1652, DOI 10.3390/ph3051652; Pradhan A, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119016; Prinz H, 2011, J MED CHEM, V54, P4247, DOI 10.1021/jm200436t; Raina K, 2013, AUTOPHAGY, V9, P697, DOI 10.4161/auto.23960; Raju J, 2007, CANCER LETT, V255, P194, DOI 10.1016/j.canlet.2007.04.011; Roy HK, 2005, CANCER LETT, V217, P161, DOI 10.1016/j.canlet.2004.07.042; Saifo MS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-310; Saini MK, 2014, BIOMED PHARMACOTHER, V68, P537, DOI 10.1016/j.biopha.2014.03.007; Saiprasad G, 2014, EUR J CANCER, V50, P2489, DOI 10.1016/j.ejca.2014.06.013; Scalo JF, 2014, EXPERT REV PHARM OUT, V14, P35, DOI 10.1586/14737167.2014.864561; Scartabelli T, 2008, NEUROPHARMACOLOGY, V55, P509, DOI 10.1016/j.neuropharm.2008.06.019; Seo BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095588; Shan BE, 2009, CANCER INVEST, V27, P604, DOI 10.1080/07357900802337191; Shanmugam MK, 2012, CANCER LETT, V320, P158, DOI 10.1016/j.canlet.2012.02.037; Singh T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060749; Song NR, 2014, FOOD CHEM, V142, P66, DOI 10.1016/j.foodchem.2013.07.002; StatSoft I, STAT DAT AN SOFTW SY; Stein U, 2012, BRIT J CANCER, V106, P1395, DOI 10.1038/bjc.2012.81; Su TR, 2013, INT J MOL SCI, V14, P20443, DOI 10.3390/ijms141020443; Su Y, 2009, CARCINOGENESIS, V30, P331, DOI 10.1093/carcin/bgn279; Suh N, 2011, CANCER PREV RES, V4, P1895, DOI 10.1158/1940-6207.CAPR-11-0222; Sundram V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035368; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Suzuki M, 2006, PHARM BIOL, V44, P178, DOI 10.1080/13880200600686491; Syed DN, 2014, BIOCHEM PHARMACOL, V89, P349, DOI 10.1016/j.bcp.2014.03.007; Syed DN, 2011, J INVEST DERMATOL, V131, P1291, DOI 10.1038/jid.2011.6; Tabernero J, 2011, ANN ONCOL, V2011, P22; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Thamilselvan V, 2011, INT J CANCER, V129, P2916, DOI 10.1002/ijc.25949; Tinsley Heather N, 2013, Recent Results Cancer Res, V191, P105, DOI 10.1007/978-3-642-30331-9_6; Dung TTM, 2014, INT IMMUNOPHARMACOL, V20, P37, DOI 10.1016/j.intimp.2014.02.019; Todeschini R., 2006, DRAGON WINDOWS SOFTW; Todeschini R, 2008, HDB MOL DESCRIPTORS, DOI [10.1002/9783527613106.oth2, DOI 10.1002/9783527613106.OTH2]; Toulany M, 2013, CANC BIOL THERAPY, V15, P0; Vanella L, 2013, ONCOL REP, V30, P2804, DOI 10.3892/or.2013.2757; Vara D, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.141; Vara D, 2011, CELL DEATH DIFFER, V18, P1099, DOI 10.1038/cdd.2011.32; Villagra S, 2000, MOLECULES, V5, P330, DOI 10.3390/50300330; Wang C, 2015, EXP CELL RES, V331, P115, DOI 10.1016/j.yexcr.2014.10.023; Wang D, 2011, ASIAN PAC J CANCER P, V12, P2581; Wang G, 2012, SHIYONG YIXUE ZAZHI, V28, P1756; Wang HY, 2014, INT J MED SCI, V11, P841, DOI 10.7150/ijms.8128; Wang J, 2011, CELL MOL BIOL NOISY, V57; Wang N, 2014, CARCINOGENESIS, V35, P2544, DOI 10.1093/carcin/bgu187; Wang S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-81; Wang Y, 2013, ZHONGGUO SHIYAN FANG, V19, P167; Wang Y, 2011, CAN J PHYSIOL PHARM, V89, P345, DOI [10.1139/Y11-024, 10.1139/y11-024]; Watson SA, 2001, LANCET, V357, P572, DOI 10.1016/S0140-6736(00)04074-5; Way TD, 2014, EUR J CANCER, V50, P366, DOI 10.1016/j.ejca.2013.09.025; Wei W, 2010, INT J CANCER, V126, P2426, DOI 10.1002/ijc.24810; Wolle D, 2014, CANCER MED-US, V3, P1146, DOI 10.1002/cam4.314; Woo KJ, 2004, BIOCHEM BIOPH RES CO, V325, P1215, DOI 10.1016/j.bbrc.2004.09.225; Xia JJ, 2010, J INT MED RES, V38, P1294, DOI 10.1177/147323001003800411; Xiao D, 2006, NUTR CANCER, V55, P94, DOI 10.1207/s15327914nc5501_12; Xiaonan W, 2011, J CANC THER, P2011; Xie Rong-Hui, 2014, Zhong Yao Cai, V37, P465; Xiong NA, 2010, BIOL BLOOD MARROW TR, V16, P1519, DOI 10.1016/j.bbmt.2010.06.004; Xu H, 2013, INFLAMMATION, V36, P216, DOI 10.1007/s10753-012-9537-3; Yabroff K. Robin, 2013, Journal of the National Cancer Institute Monographs, P62, DOI 10.1093/jncimonographs/lgt001; Yadav VR, 2012, BRIT J PHARMACOL, V165, P741, DOI 10.1111/j.1476-5381.2011.01603.x; Yang Y, 2014, FOOD CHEM TOXICOL, V74, P14, DOI 10.1016/j.fct.2014.08.013; Yardy GW, 2005, PROSTATE CANCER P D, V8, P119, DOI 10.1038/sj.pcan.4500794; Yoon SO, 2006, MOL CANCER THER, V5, P2666, DOI 10.1158/1535-7163.MCT-06-0321; Yoshimitsu T, 2009, ORG LETT, V11, P3402, DOI 10.1021/ol9012684; YuJun H, 2009, CHINESE J DIGESTIVE, V8, P294; Zeller J, 2013, BIOORG MED CHEM LETT, V23, P5814, DOI 10.1016/j.bmcl.2013.08.111; Zhang XD, 2004, MOL CANCER THER, V3, P187; ZHAO S, 2010, B ACAD MILITARY MED, V5	207	12	12	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124244	10.1371/journal.pone.0124244	http://dx.doi.org/10.1371/journal.pone.0124244			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910265	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800070
J	Scott, IM; Pound, N				Scott, Isabel M.; Pound, Nicholas			Menstrual Cycle Phase Does Not Predict Political Conservatism	PLOS ONE			English	Article							DISGUST SENSITIVITY; PSYCHOLOGY; CONCEPTION; SINGLE; WOMEN	Recent authors have reported a relationship between women's fertility status, as indexed by menstrual cycle phase, and conservatism in moral, social and political values. We conducted a survey to test for the existence of a relationship between menstrual cycle day and conservatism. 2213 women reporting regular menstrual cycles provided data about their political views. Of these women, 2208 provided information about their cycle date, 1260 provided additional evidence of reliability in self-reported cycle date, and of these, 750 also indicated an absence of hormonal disruptors such as recent hormonal contraception use, breastfeeding or pregnancy. Cycle day was used to estimate day-specific fertility rate (probability of conception); political conservatism was measured via direct self-report and via responses to the "Moral Foundations" questionnaire. We also recorded relationship status, which has been reported to interact with menstrual cycle phase in determining political preferences. We found no evidence of a relationship between estimated cyclical fertility changes and conservatism, and no evidence of an interaction between relationship status and cyclical fertility in determining political attitudes. Our findings were robust to multiple inclusion/exclusion criteria and to different methods of estimating fertility and measuring conservatism. In summary, the relationship between cycle-linked reproductive parameters and conservatism may be weaker or less reliable than previously thought.	[Scott, Isabel M.; Pound, Nicholas] Brunel Univ London, Div Psychol, Dept Life Sci, Uxbridge UB8 3PH, Middx, England	Brunel University	Scott, IM (corresponding author), Brunel Univ London, Div Psychol, Dept Life Sci, Uxbridge UB8 3PH, Middx, England.	isabel.scott@brunel.ac.uk	Pound, Nicholas/B-5453-2008	Pound, Nicholas/0000-0003-2170-9943	Brunel University	Brunel University	No specific funding was provided for this research. Participant payments were financed by a lecturer start-up fund provided by Brunel University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chandler J, 2014, BEHAV RES METHODS, V46, P112, DOI 10.3758/s13428-013-0365-7; Dreher JC, 2007, P NATL ACAD SCI USA, V104, P2465, DOI 10.1073/pnas.0605569104; Durante KM, 2014, PSYCHOL SCI, V25, P1150, DOI 10.1177/0956797614524422; Durante KM, 2013, PSYCHOL SCI, V24, P1007, DOI 10.1177/0956797612466416; Farage MA, 2008, ARCH GYNECOL OBSTET, V278, P299, DOI 10.1007/s00404-008-0708-2; Faraji- Rad A, 2013, J CONSUMER PSYCHOL; Fehring RJ, 2006, JOGNN-J OBST GYN NEO, V35, P376, DOI 10.1111/j.1552-6909.2006.00051.x; Fessler DMT, 2003, EVOL HUM BEHAV, V24, P406, DOI 10.1016/S1090-5138(03)00054-0; Fleischman DS, 2011, HORM BEHAV, V59, P271, DOI 10.1016/j.yhbeh.2010.11.014; Gangestad SW, 2008, P ROY SOC B-BIOL SCI, V275, P991, DOI 10.1098/rspb.2007.1425; Gangestad SW, 2002, ANN REV SEX RES, V12, P145; Gelman A., 2013, J MANAGE; Gildersleeve K, DO WOMENS MATE PREFE; Gildersleeve K, 2013, SEX ROLES, V69, P516, DOI 10.1007/s11199-013-0273-4; Graham J, 2011, J PERS SOC PSYCHOL; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Guillermo CJ, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-19; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Harris CR, 2014, PSYCHOL SCI, V25, P1147, DOI 10.1177/0956797613520236; Harris CR, 2013, SEX ROLES, V69, P507, DOI 10.1007/s11199-012-0229-0; Inbar Y, 2012, SOC PSYCHOL PERS SCI, V3, P537, DOI 10.1177/1948550611429024; Inbar Y, 2009, COGNITION EMOTION, V23, P714, DOI 10.1080/02699930802110007; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jones BC, 2008, ARCH SEX BEHAV, V37, P78, DOI 10.1007/s10508-007-9268-y; Nosek BA, 2012, PERSPECT PSYCHOL SCI, V7, P615, DOI 10.1177/1745691612459058; Saad G, 2012, J CONSUM PSYCHOL, V22, P102, DOI 10.1016/j.jcps.2011.10.001; Sacher J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00374; Scott IML, 2013, BEHAV ECOL, V24, P579, DOI 10.1093/beheco/ars092; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Sommer B., 1992, COGNITION MENSTRUAL, P39, DOI [10.1007/978-1-4613-9148-7_2, DOI 10.1007/978-1-4613-9148-7_2]; Tybur JM, 2013, PSYCHOL REV, V120, P65, DOI 10.1037/a0030778; Tybur JM, 2010, EVOL PSYCHOL-US, V8, P599, DOI 10.1177/147470491000800406; Vitzthum VJ, 2008, ANNU REV ANTHROPOL, V37, P53, DOI 10.1146/annurev.anthro.37.081407.085112; Wegienka G, 2005, J WOMENS HEALTH, V14, P248, DOI 10.1089/jwh.2005.14.248; Wideman L, 2013, SPORTS HEALTH, V5, P143, DOI 10.1177/1941738112469930; Wilcox AJ, 2001, CONTRACEPTION, V63, P211, DOI 10.1016/S0010-7824(01)00191-3; Wilcox AJ, 2000, BRIT MED J, V321, P1259, DOI 10.1136/bmj.321.7271.1259; Wood W, 2014, EMOT REV, V6, P229, DOI 10.1177/1754073914523073; ZAADSTRA BM, 1993, BRIT MED J, V306, P484, DOI 10.1136/bmj.306.6876.484	39	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0112042	10.1371/journal.pone.0112042	http://dx.doi.org/10.1371/journal.pone.0112042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923332	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600001
J	Simcic, M; Smetko, A; Solkner, J; Seichter, D; Gorjanc, G; Kompan, D; Medugorac, I				Simcic, Mojca; Smetko, Anamarija; Soelkner, Johann; Seichter, Doris; Gorjanc, Gregor; Kompan, Dragomir; Medugorac, Ivica			Recovery of Native Genetic Background in Admixed Populations Using Haplotypes, Phenotypes, and Pedigree Information - Using Cika Cattle as a Case Breed	PLOS ONE			English	Article							MOLECULAR COANCESTRY; CONSERVATION VALUE; DIVERSITY; INFERENCE; MICROSATELLITE; ASSOCIATION; DENSITY; ORIGIN; SHEEP; TREES	The aim of this study was to obtain unbiased estimates of the diversity parameters, the population history, and the degree of admixture in Cika cattle which represents the local admixed breeds at risk of extinction undergoing challenging conservation programs. Genetic analyses were performed on the genome-wide Single Nucleotide Polymorphism(SNP) Illumina Bovine SNP50 array data of 76 Cika animals and 531 animals from 14 reference populations. To obtain unbiased estimates we used short haplotypes spanning four markers instead of single SNPs to avoid an ascertainment bias of the BovineSNP50 array. Genome-wide haplotypes combined with partial pedigree and type trait classification show the potential to improve identification of purebred animals with a low degree of admixture. Phylogenetic analyses demonstrated unique genetic identity of Cika animals. Genetic distance matrix presented by rooted Neighbour-Net suggested long and broad phylogenetic connection between Cika and Pinzgauer. Unsupervised clustering performed by the admixture analysis and two-dimensional presentation of the genetic distances between individuals also suggest Cika is a distinct breed despite being similar in appearance to Pinzgauer. Animals identified as the most purebred could be used as a nucleus for a recovery of the native genetic background in the current admixed population. The results show that local well-adapted strains, which have never been intensively managed and differentiated into specific breeds, exhibit large haplotype diversity. They suggest a conservation and recovery approach that does not rely exclusively on the search for the original native genetic background but rather on the identification and removal of common introgressed haplotypes would be more powerful. Successful implementation of such an approach should be based on combining phenotype, pedigree, and genome-wide haplotype data of the breed of interest and a spectrum of reference breeds which potentially have had direct or indirect historical contribution to the genetic makeup of the breed of interest.	[Simcic, Mojca; Gorjanc, Gregor; Kompan, Dragomir] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia; [Smetko, Anamarija; Soelkner, Johann] Univ Nat Resources & Life Sci Vienna, Dept Sustainable Agr Syst, Div Livestock Sci, Vienna, Austria; [Seichter, Doris] Tierzuchtforsch eV Munchen, Grub, Germany; [Medugorac, Ivica] Univ Munich, Fac Vet Med, Chair Anim Genet & Husb, Munich, Germany	University of Ljubljana; University of Natural Resources & Life Sciences, Vienna; University of Munich	Medugorac, I (corresponding author), Univ Munich, Fac Vet Med, Chair Anim Genet & Husb, Munich, Germany.	ivica.medjugorac@gen.vetmed.uni-muenchen.de	Gorjanc, Gregor/D-3684-2014	Gorjanc, Gregor/0000-0001-8008-2787; Solkner, Johann/0000-0002-1517-5829; Seichter, Doris/0000-0002-0325-1134; Medugorac, Ivica/0000-0002-6891-3039	Program for animal genetic resources conservation - Ministry of Agriculture and the Environment of Slovenia; Slovene human resources development and scholarship fund [11012-45/2012-5]; German Research Foundation (DFG, Bonn, Germany) [ME3404/2-1]; Bavarian State Ministry of Food, Agriculture and Forestry [L/a-7406-917]; Ministry of Science, Education and Sports, Croatia [178-0790466-0398]; Croatian Reproduction Centres	Program for animal genetic resources conservation - Ministry of Agriculture and the Environment of Slovenia; Slovene human resources development and scholarship fund; German Research Foundation (DFG, Bonn, Germany)(German Research Foundation (DFG)); Bavarian State Ministry of Food, Agriculture and Forestry; Ministry of Science, Education and Sports, Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Croatian Reproduction Centres	This research was partly supported by the Program for animal genetic resources conservation financed by Ministry of Agriculture and the Environment of Slovenia. M. Simcic received a scholarship from Slovene human resources development and scholarship fund (Nr. 11012-45/2012-5). Genotyping of RH, FGV, DFV, BBV, OBV and IMB cattle breeds was financially supported by the German Research Foundation (DFG, Bonn, Germany), project ME3404/2-1. Genotyping of the MWF cattle breed was financially supported by the Bavarian State Ministry of Food, Agriculture and Forestry, project L/a-7406-917. Sampling and DNA preparation of HRB, HRI and HRP were supported by the Ministry of Science, Education and Sports, Croatia (Project 178-0790466-0398) as well as Croatian Reproduction Centres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Amador C, 2014, EVOL APPL, V7, P227, DOI 10.1111/eva.12113; Amador C, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-13; Amador C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049409; Amador C, 2011, CONSERV GENET, V12, P1565, DOI 10.1007/s10592-011-0255-4; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cinkulov M, 2008, J ANIM BREED GENET, V125, P417, DOI 10.1111/j.1439-0388.2008.00742.x; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Cymbron T, 2005, P ROY SOC B-BIOL SCI, V272, P1837, DOI 10.1098/rspb.2005.3138; Decker J. E., 2013, DRYAD DIGIT REPOS, DOI DOI 10.5061/DRYAD.TH092; Decker JE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004254; Decker JE, 2009, P NATL ACAD SCI USA, V106, P18644, DOI 10.1073/pnas.0904691106; Durkin K, 2012, NATURE, V482, P81, DOI 10.1038/nature10757; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Falush D, 2003, GENETICS, V164, P1567; FELIUS M, 2007, CATTLE BREEDS ENCY; Ferencakovic M, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-42; Fernandez J, 2012, LIVEST SCI, V149, P282, DOI 10.1016/j.livsci.2012.07.019; Frkonja A, 2012, ANIM GENET, V43, P696, DOI 10.1111/j.1365-2052.2012.02345.x; Gandini GC, 2003, J ANIM BREED GENET, V120, P1, DOI 10.1046/j.1439-0388.2003.00365.x; Gautier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013038; Gautier M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-550; Gomez-Romano F, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-38; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jeretina J, 2004, 100 LET DELA SELEKCI, P79; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Lohmueller KE, 2009, GENETICS, V182, P217, DOI 10.1534/genetics.108.099275; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Maxa J, 2012, J DAIRY SCI, V95, P5357, DOI 10.3168/jds.2011-4673; Medugorac I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039477; Medugorac I, 2011, ECOL EVOL, V1, P408, DOI 10.1002/ece3.39; Medugorac I, 2009, MOL ECOL, V18, P3394, DOI 10.1111/j.1365-294X.2009.04286.x; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nei M., 1987, MOL EVOLUTIONARY GEN; Neuditschko M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048375; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Neto LRP, 2010, ANIM PROD SCI, V50, P792, DOI 10.1071/AN10073; Powell JE, 2010, NAT REV GENET, V11, P800, DOI 10.1038/nrg2865; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2018, R LANG ENV STAT COMP; Ramljak J, 2011, J ANIM BREED GENET, V128, P73, DOI 10.1111/j.1439-0388.2010.00905.x; Rothammer S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-908; Sambraus HH, 1999, GEFAHRDETE NUTZTIERR; Simcic M, 2013, J ANIM BREED GENET, V130, P487, DOI 10.1111/jbg.12034; Taberlet P, 2008, MOL ECOL, V17, P275, DOI 10.1111/j.1365-294X.2007.03475.x; Veit-Kensch CE, 2007, GENET SEL EVOL, V39, P447, DOI 10.1051/gse:2007014; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zan Lotric M, 2012, THESIS U LJUBLJANA	55	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123253	10.1371/journal.pone.0123253	http://dx.doi.org/10.1371/journal.pone.0123253			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923207	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600036
J	Lee, WC				Lee, Wen-Chung			Excess Relative Risk as an Effect Measure in Case-Control Studies of Rare Diseases	PLOS ONE			English	Article							SUFFICIENT CAUSE INTERACTIONS; ATOMIC-BOMB SURVIVORS; CANCER INCIDENCE; MODELS	Epidemiologists often use ratio-type indices (rate ratio, risk ratio and odds ratio) to quantify the association between exposure and disease. By comparison, less attention has been paid to effect measures on a difference scale (excess rate or excess risk). The excess relative risk (ERR) used primarily by radiation epidemiologists is of peculiar interest here, in that it involves both difference and ratio operations. The ERR index (but not the difference-type indices) is estimable in case-control studies. Using the theory of sufficient component cause model, the author shows that when there is no mechanistic interaction (no synergism in the sufficient cause sense) between the exposure under study and the stratifying variable, the ERR index (but not the ratio-type indices) in a rare-disease case-control setting should remain constant across strata and can therefore be regarded as a common effect parameter. By exploiting this homogeneity property, the related attributable fraction indices can also be estimated with greater precision. The author demonstrates the methodology (SAS codes provided) using a case-control dataset, and shows that ERR preserves the logical properties of the ratio-type indices. In light of the many desirable properties of the ERR index, the author advocates its use as an effect measure in case-control studies of rare diseases.	[Lee, Wen-Chung] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan; [Lee, Wen-Chung] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Lee, WC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan.	wenchung@ntu.edu.tw		Lee, Wen-Chung/0000-0003-3171-7672	Ministry of Science and Technology, Taiwan [NSC 102-2628-B-002-036-MY3]; National Taiwan University, Taiwan [NTU-CESRP-102R7622-8]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University, Taiwan(National Taiwan University)	Funding: This paper is partly supported by grants from the Ministry of Science and Technology, Taiwan (NSC 102-2628-B-002-036-MY3) and the National Taiwan University, Taiwan (NTU-CESRP-102R7622-8). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	HOGUE CJR, 1983, AM J EPIDEMIOL, V118, P396, DOI 10.1093/oxfordjournals.aje.a113646; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Langholz B, 2010, AM J EPIDEMIOL, V171, P377, DOI 10.1093/aje/kwp403; Lee WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086374; Lee WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067424; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Richardson DB, 2008, AM J EPIDEMIOL, V168, P1333, DOI 10.1093/aje/kwn278; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schlesselman JJ, 1982, CASE CONTROL STUDIES; SHAPIRO S, 1979, LANCET, V1, P743; Suissa S, 1999, AM J EPIDEMIOL, V150, P279; THOMPSON DE, 1994, RADIAT RES, V137, pS17, DOI 10.2307/3578892; Vanderweele TJ, 2008, BIOMETRIKA, V95, P49, DOI 10.1093/biomet/asm090; VanderWeele TJ, 2007, EPIDEMIOLOGY, V18, P329, DOI 10.1097/01.ede.0000260218.66432.88; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P6, DOI 10.1097/EDE.0b013e31818f69e7	15	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0121141	10.1371/journal.pone.0121141	http://dx.doi.org/10.1371/journal.pone.0121141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919483	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659400005
J	Barrera-Moreno, OA; Ciros-Perez, J; Ortega-Mayagoitia, E; Alcantara-Rodriguez, JA; Piedra-Ibarra, E				Alfredo Barrera-Moreno, Omar; Ciros-Perez, Jorge; Ortega-Mayagoitia, Elizabeth; Arturo Alcantara-Rodriguez, Jose; Piedra-Ibarra, Elias			From Local Adaptation to Ecological Speciation in Copepod Populations from Neighboring Lakes	PLOS ONE			English	Article							FRESH-WATER; REPRODUCTIVE ISOLATION; SALINITY TOLERANCE; GENETIC-STRUCTURE; CRATER LAKES; WALKER LAKE; EVOLUTION; DIVERGENCE; DNA; SYSTEMATICS	Continental copepods have been derived from several independent invasive events from the sea, but the subsequent evolutionary processes that account for the current diversity in lacustrine environments are virtually unknown. Salinity is highly variable among lakes and constitutes a source of divergent selection driving potential reproductive isolation. We studied four populations of the calanoid copepod Leptodiaptomus cf. sicilis inhabiting four neighboring lakes with a common history (since the Late Pleistocene) located in the Oriental Basin, Mexico; one lake is shallow and varies in salinity periodically (1.4-10 g L-1), while three are deep and permanent, with constant salinity (0.5, 1.1 and 6.5 g L-1, respectively). We hypothesized that (1) these populations belong to a different species than L. sicilis sensu stricto and (2) are experiencing ecologically based divergence due to salinity differences. We assessed morphological and molecular (mtDNA) COI variation, as well as fitness differences and tests of reproductive isolation. Although relationships of the Mexican populations with L. sicilis s.s. could not be elucidated, we identified a clear pattern of divergent selection driven by salinity conditions. The four populations can still be considered a single biological species (sexual recognition and hybridization are still possible in laboratory conditions), but they have diverged into at least three different phenotypes: two locally adapted, specialized in the lakes of constant salinity (saline vs. freshwater), and an intermediate generalist phenotype inhabiting the temporary lake with fluctuating salinity. The specialized phenotypes are poorly suited as migrants, so prezygotic isolation due to immigrant inviability is highly probable. This implication was supported by molecular evidence that showed restricted gene flow, persistence of founder events, and a pattern of allopatric fragmentation. This study showed how ecologically based divergent selection may explain diversification patterns in lacustrine copepods.	[Alfredo Barrera-Moreno, Omar] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Programa Doctorado Ciencias Mar & Limnol, Tlalnepantla, Estado De Mexic, Mexico; [Ciros-Perez, Jorge; Ortega-Mayagoitia, Elizabeth] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Proyecto Invest Limnol Trop, Tlalnepantla, Estado De Mexic, Mexico; [Arturo Alcantara-Rodriguez, Jose] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Programa Doctorado Ciencias Biol, Tlalnepantla, Estado De Mexic, Mexico; [Piedra-Ibarra, Elias] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, UBIPRO, Lab Fisiol Vegetal, Tlalnepantla, Estado De Mexic, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Ciros-Perez, J (corresponding author), Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Proyecto Invest Limnol Trop, Tlalnepantla, Estado De Mexic, Mexico.	jorge.ciros@gmail.com	Ciros, Jorge/G-5958-2018; Ortega-Mayagoitia, Elizabeth/AAF-8441-2020; Alcántara, Arturo/AAZ-6228-2020	Ciros, Jorge/0000-0002-4292-7539; Ortega-Mayagoitia, Elizabeth/0000-0002-8892-1888; Alcantara-Rodriguez, Jose Arturo/0000-0002-2536-4615	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico [PAPIIT IN-222709, IN-217513]; Programa de Apoyo a los Profesores de Carrera para la Formacion de Grupos de Investigacion - FES Iztacala, UNAM (PAPCA); Consejo Nacional de Ciencia y Tecnologia (CONACYT)	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico; Programa de Apoyo a los Profesores de Carrera para la Formacion de Grupos de Investigacion - FES Iztacala, UNAM (PAPCA)(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (PAPIIT IN-222709 and IN-217513; http://dgapa.unam.mx/html/papiit/papit.html) to JCP and EOM, Programa de Apoyo a los Profesores de Carrera para la Formacion de Grupos de Investigacion - FES Iztacala, UNAM (PAPCA 2007-2008; http://www.iztacala.unam.mx/spcc/spcc_papca.php) to EOM and JCP. OABM thanks the scholarship granted by Consejo Nacional de Ciencia y Tecnologia (CONACYT; http://www.conacyt.mx/) to support his PhD research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz SJ, 2007, BIOL J LINN SOC, V90, P279, DOI 10.1111/j.1095-8312.2007.00723.x; Alcocer J., 1999, Aquatic Ecosystem Health & Management, V1, P291, DOI 10.1080/14634989808656925; Alcocer J, 2014, J LIMNOL, V73, P223, DOI 10.4081/jlimnol.2014.783; Aliberti M. A., 2013, IMAGE BASED KEY ZOOP; Andersen R. A., 2005, ALGAL CULTURING TECH; Gutierrez-Aguirre MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085019; Armienta MA, 2008, J VOLCANOL GEOTH RES, V178, P249, DOI 10.1016/j.jvolgeores.2008.06.019; Alcantara-Rodriguez JA, 2012, FRESHWATER BIOL, V57, P728, DOI 10.1111/j.1365-2427.2012.02738.x; Balcer M. D., 1984, ZOOPLANKTON GREAT LA; Berdan EL, 2012, J ZOOL, V287, P283, DOI 10.1111/j.1469-7998.2012.00914.x; Beutel MW, 2001, HYDROBIOLOGIA, V466, P91, DOI 10.1023/A:1014569521381; Bloom DD, 2013, EVOLUTION, V67, P2040, DOI 10.1111/evo.12074; Bloom DD, 2009, COPEIA, P408, DOI 10.1643/CI-07-151; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Boxshall GA, 2000, ADV ECOL RES, V31, P61, DOI 10.1016/S0065-2504(00)31007-8; Boxshall GA, 2008, HYDROBIOLOGIA, V595, P195, DOI 10.1007/s10750-007-9014-4; BYRON ER, 1982, ECOLOGY, V63, P1871, DOI 10.2307/1940127; Campillo S, 2009, J EVOLUTION BIOL, V22, P2542, DOI 10.1111/j.1420-9101.2009.01871.x; Carrasco-Nunez G, 2007, J VOLCANOL GEOTH RES, V159, P179, DOI 10.1016/j.jvolgeores.2006.07.001; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cohuo-Duran S, 2014, REV BIOL TROP, V62, P15, DOI 10.15517/rbt.v62i1.11796; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Conner J. K., 2004, PRIMER ECOLOGICAL GE; COOPER JJ, 1984, HYDROBIOLOGIA, V118, P275, DOI 10.1007/BF00046625; De los Rios-Escalanta Patricio, 2011, International Journal of Aquatic Science, V2, P80; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; DeClerck S, 2001, FRESHWATER BIOL, V46, P187, DOI 10.1046/j.1365-2427.2001.00632.x; Derry AM, 2003, LIMNOL OCEANOGR, V48, P675, DOI 10.4319/lo.2003.48.2.0675; DEXTER DM, 1993, HYDROBIOLOGIA, V267, P203, DOI 10.1007/BF00018802; Dobzhansky T., 1935, PHILOS SCI, V2, P344, DOI DOI 10.1086/286379; Dussart BH, 2001, INTRO COPEPODA; Dytham C., 2011, CHOOSING USING STAT; Elias-Gutierrez M, 1999, J PLANKTON RES, V21, P603, DOI 10.1093/plankt/21.4.603; Elias-Gutierrez M, 2008, ZOOTAXA, P1; Ellison CK, 2008, EVOLUTION, V62, P631, DOI 10.1111/j.1558-5646.2007.00305.x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Escobar-Briones E, 2002, HYDROBIOLOGIA, V477, P93, DOI 10.1023/A:1021013132626; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fuller RC, 2007, J EVOLUTION BIOL, V20, P1962, DOI 10.1111/j.1420-9101.2007.01368.x; GALAT DL, 1981, HYDROBIOLOGIA, V81-2, P281, DOI 10.1007/BF00048722; Haag CR, 2006, HEREDITY, V96, P150, DOI 10.1038/sj.hdy.6800774; HAGIWARA A, 1989, HYDROBIOLOGIA, V186, P415, DOI 10.1007/BF00048940; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hansson LA, 2004, ECOLOGY, V85, P1005, DOI 10.1890/02-0525; Herrick CL, 1884, FINAL REPORT CRUSTAC; HERZIG A, 1980, HOLARCTIC ECOL, V3, P50; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karanovic T, 2012, INVERTEBR SYST, V26, P115, DOI 10.1071/IS11027; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kingsolver JG, 2002, TRENDS ECOL EVOL, V17, P540, DOI 10.1016/S0169-5347(02)02641-1; Kiorboe T, 2011, J PLANKTON RES, V33, P677, DOI 10.1093/plankt/fbq159; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Lampert W, 2007, LIMNOECOLOGY, V2ed; Lee CE, 2012, J EVOLUTION BIOL, V25, P625, DOI 10.1111/j.1420-9101.2012.02459.x; Lee CE, 2011, EVOLUTION, V65, P2229, DOI 10.1111/j.1558-5646.2011.01308.x; Lee CE, 2000, EVOLUTION, V54, P2014, DOI 10.1111/j.0014-3820.2000.tb01245.x; Lee CE, 2002, PHYSIOL BIOCHEM ZOOL, V75, P335, DOI 10.1086/343138; Lee MSY, 2003, J EVOLUTION BIOL, V16, P179, DOI 10.1046/j.1420-9101.2003.00520.x; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Lesko LT, 2003, CALANOID COPEPODS LA; Lowe CD, 2005, MAR BIOL, V146, P923, DOI 10.1007/s00227-004-1501-9; Macek M, 2002, LAGOS PRESAS MEXICO, P199; Marrone F, 2013, MOL PHYLOGENET EVOL, V66, P190, DOI 10.1016/j.ympev.2012.09.016; Marsh C.D., 1907, T WIS ACAD SCI ARTS, V15, P381; Matute DR, 2013, J EVOLUTION BIOL, V26, P2299, DOI 10.1111/jeb.12246; Mayr E, 1942, SYSTEMATICS ORIGIN S; McCullagh P, 1989, GEN LINEAR MODELS; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; Montiel-Martinez A, 2008, J PLANKTON RES, V30, P1079, DOI 10.1093/plankt/fbn067; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nosil P, 2005, EVOLUTION, V59, P705; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; Oliva MG, 2006, DIATOM RES, V21, P81; Oliva MG, 2001, HYDROBIOLOGIA, V466, P299, DOI 10.1023/A:1014578024049; Ortega-Mayagoitia E, 2011, J PLANKTON RES, V33, P1574, DOI 10.1093/plankt/fbr045; Panchal M, 2007, BIOINFORMATICS, V23, P509, DOI 10.1093/bioinformatics/btl614; Peralta L, 2002, HYDROBIOLOGIA, V467, P109, DOI 10.1023/A:1014913503577; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Posada D, 2000, MOL ECOL, V9, P487, DOI 10.1046/j.1365-294x.2000.00887.x; Posada D, 1999, GEODIS INFERENCE KEY; Purcell KM, 2012, J EVOLUTION BIOL, V25, P2623, DOI 10.1111/jeb.12016; Rhode SC, 2001, NATURE, V412, P69, DOI 10.1038/35083567; RIDGWAY MS, 1984, CAN J ZOOL, V62, P1813, DOI 10.1139/z84-264; ROBERTSON A, 1981, Journal of Great Lakes Research, V7, P382; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Runge J.A., 2000, P401, DOI 10.1016/B978-012327645-2/50010-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANTER B, 1994, J PLANKTON RES, V16, P171, DOI 10.1093/plankt/16.2.171; Schacht FW, 1897, B ILLINOIS STATE LAB, V5, P97; Seidel RA, 2010, J N AM BENTHOL SOC, V29, P1161, DOI 10.1899/09-098.1; Sereda SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090010; Sokal RR., 2011, BIOMETRY; Suarez-Morales E, 2005, INT REV HYDROBIOL, V90, P71, DOI 10.1002/iroh.200410742; Suarez-Morales E, 2000, J LIMNOL, V59, P5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Team R Core, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; TEMPLETON AR, 1987, GENETICS, V117, P343; Ting JH, 2000, MAR BIOL, V137, P31, DOI 10.1007/s002270000320; Tobler M, 2008, EVOLUTION, V62, P2643, DOI 10.1111/j.1558-5646.2008.00466.x; Torke B, 2001, HYDROBIOLOGIA, V453, P351, DOI 10.1023/A:1013185916287; USEPA United States Environmental Protection Agency USEPA, 2002, METH MEAS AC TOX EFF; Vaillant JJ, 2013, ECOL EVOL, V3, P3083, DOI 10.1002/ece3.697; Via S, 2000, EVOLUTION, V54, P1626, DOI 10.1111/j.0014-3820.2000.tb00707.x; Williams WD, 1998, HYDROBIOLOGIA, V381, P191, DOI 10.1023/A:1003287826503; Williamson Craig E., 2001, P915, DOI 10.1016/B978-012690647-9/50023-5; Wilson M.S., 1959, WARDS WHIPPLES FRESH, P735; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534; [No title captured]; [No title captured]; [No title captured]; [No title captured]	116	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125524	10.1371/journal.pone.0125524	http://dx.doi.org/10.1371/journal.pone.0125524			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915059	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659100133
J	Chen, HG; Zhou, X; Zhao, Y; Gong, XJ; He, Y; Ma, FW; Zhou, M; Zhao, C; Niu, Y; Deng, J				Chen, Huaguo; Zhou, Xin; Zhao, Yang; Gong, Xiao-Jian; He, Yan; Ma, Feng-Wei; Zhou, Mei; Zhao, Chao; Niu, Yi; Deng, Jie			HPLC-DAD-ELSD Combined Pharmacodynamics and Serum Medicinal Chemistry for Quality Assessment of Huangqi Granule	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; RADIX-ASTRAGALI; PHOTODIODE-ARRAY; IN-VIVO; IV; ISOFLAVONOIDS; RATS; SAPONINS; EXTRACTION; EXPRESSION	Objective To more scientifically and reasonably control the quality of Huangqi Granules, preliminary studies on the pharmacodynamics and serum pharmacochemistry of this medicine were performed. DPPH and MTT experiments showed that water extracts of Huangqi Granules had good antioxidant activity and increased immunity. Timed blood samples collected 5 min, 15 min, and 30 min after oral administration of a set amount of Huangqi Granules were collected and tested using UPLC-ESI-MS/MS. As a result, calycosin-7-O-beta-D-glucoside, ononin, calycosin, astragaloside IV, and formononetin were found to exist in rat blood after dosing, indicating that the five chemical compounds might have pharmacological activity, and based on this result, they were designated biomarkers for quality control of Huangqi Granules. Consequently, a simple, rapid and efficient method was developed in the present study for the simultaneous determination of the five characteristic compounds in Huangqi Granules using HPLC-DAD-ELSD. Materials and Methods The separation was performed using an Agilent Hypersil ODS column (4.6 x 250 mm, 5 mu m) at 30 degrees C. The mobile phase was composed of water (solvent A) and acetonitrile (solvent B) with a flow rate of 1 mL/min. The drift tube temperature of the ELSD system was set to 85 degrees C, and the nitrogen pressure was 3.5 bar. Results All five characteristic compounds had good linear behavior with r2 values greater than 0.9972. The recoveries varied from 96.31% to 101.22%. Subsequently, the developed method was applied to evaluate the quality of Huangqi Granules from different batches, and hierarchical clustering analysis (HCA) was used to analyze the classification of the samples based on the values of the five compounds. Conclusion The established HPLC method combined with HCA proved to be effective to evaluate the quality of Huangqi Granules.	[Chen, Huaguo; Zhou, Xin; Zhao, Yang; Gong, Xiao-Jian; He, Yan; Ma, Feng-Wei; Zhou, Mei; Zhao, Chao] Guizhou Engn Lab Qual Control & Evaluat Technol M, Guiyang, Guizhou, Peoples R China; [Chen, Huaguo; Zhou, Xin; Zhao, Yang; Gong, Xiao-Jian; He, Yan; Ma, Feng-Wei; Zhou, Mei; Zhao, Chao] Guizhou Normal Univ, Res Ctr Qual Control Nat Med, Guiyang, Guizhou, Peoples R China; [Chen, Huaguo; Zhou, Xin; Zhao, Yang; Gong, Xiao-Jian; He, Yan; Ma, Feng-Wei; Zhou, Mei; Zhao, Chao] Guizhou Normal Univ, Key Lab Informat Syst Mountainous Areas & Protect, Guiyang, Guizhou, Peoples R China; [Niu, Yi; Deng, Jie] Han Fang Pharmaceut Co Ltd Guizhou Prov, Guiyang, Guizhou, Peoples R China	Guizhou Normal University; Guizhou Normal University	Zhou, X (corresponding author), Guizhou Engn Lab Qual Control & Evaluat Technol M, Guiyang, Guizhou, Peoples R China.	642452984@qq.com			Natural Science Research Project from the Department of Education of the Guizhou Province [2011 026]; Science and Technology Plan Projects of Guiyang [2011 204-24]; Guizhou Provincial Special Program on Research and Development of Science and Technology Industry on Modernization of TCMs [ZY 2011 3013, KY 2012 005, 2011040]	Natural Science Research Project from the Department of Education of the Guizhou Province; Science and Technology Plan Projects of Guiyang; Guizhou Provincial Special Program on Research and Development of Science and Technology Industry on Modernization of TCMs	Natural Science Research Project from the Department of Education of the Guizhou Province (No. 2011 026), Science and Technology Plan Projects of Guiyang (No. 2011 204-24), Guizhou Provincial Special Program on Research and Development of Science and Technology Industry on Modernization of TCMs (No. ZY 2011 3013) were used to fund study design and manuscript preparation, project (No. KY 2012 005) was used for data collection and project (No. 2011040) provided funds for sample analysis.	Bahorun T, 2004, J SCI FOOD AGR, V84, P1553, DOI 10.1002/jsfa.1820; Committee NP, 2010, PHARMACOPOEIA PEOPLE; Deschamps FS, 2002, ANALYST, V127, P35, DOI 10.1039/b108810f; Gui SY, 2006, J ETHNOPHARMACOL, V103, P154, DOI 10.1016/j.jep.2005.07.025; GUIOCHON G, 1988, J LIQ CHROMATOGR, V11, P2547, DOI 10.1080/01483918808076746; Huang XL, 2009, TALANTA, V78, P1129, DOI 10.1016/j.talanta.2009.01.029; Juan YC, 2011, EVID-BASED COMPL ALT, V2011, DOI DOI 10.1155/2011/349807; Li ZP, 2002, ACTA PHARMACOL SIN, V23, P898; Liang XR, 2013, PHARMACOGN MAG, V9, P238, DOI 10.4103/0973-1296.113277; Lin YW, 2008, PROCESS BIOCHEM, V43, P244, DOI 10.1016/j.procbio.2007.11.020; Liu RR, 2006, PLANT CELL REP, V25, P705, DOI 10.1007/s00299-005-0072-7; Luo YM, 2004, NEUROSCI LETT, V363, P218, DOI 10.1016/j.neulet.2004.03.036; Ouyang Z, 2012, PHARMACOGN MAG, V8, P256, DOI 10.4103/0973-1296.103648; Qi LW, 2006, J CHROMATOGR A, V1134, P162, DOI 10.1016/j.chroma.2006.08.085; Sinclair S, 1998, Altern Med Rev, V3, P338; Song JZ, 2008, J PHARMACEUT BIOMED, V47, P399, DOI 10.1016/j.jpba.2007.12.036; Song JZ, 2007, J SEP SCI, V30, P819, DOI 10.1002/jssc.200600340; Wang D, 2006, J SEP SCI, V29, P2012, DOI 10.1002/jssc.200500486; Wang SG, 2009, BIOL PHARM BULL, V32, P132, DOI 10.1248/bpb.32.132; Wu T, 2005, FITOTERAPIA, V76, P157, DOI 10.1016/j.fitote.2004.11.006; Xiao HB, 2004, J CHROMATOGR A, V1032, P117, DOI 10.1016/j.chroma.2003.09.032; Yong-Chun J., 2012, PHARMACOGN MAG, V8, P42; Yu JX, 2006, CAN J PHYSIOL PHARM, V84, P579, DOI 10.1139/Y06-015; Yu QT, 2007, J SEP SCI, V30, P1292, DOI 10.1002/jssc.200600422; Zhang WD, 2006, PLANTA MED, V72, P4, DOI 10.1055/s-2005-873126; Zhang WJ, 2003, THROMB HAEMOSTASIS, V90, P904, DOI 10.1160/TH03-03-0136	26	41	46	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123176	10.1371/journal.pone.0123176	http://dx.doi.org/10.1371/journal.pone.0123176			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915040	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100014
J	Fan, PH; Li, XJ; Su, WH; Kong, W; Kong, XG; Wang, ZX; Wang, YC; Jiang, CL; Gao, F				Fan, Peihu; Li, Xiaojun; Su, Weiheng; Kong, Wei; Kong, Xianggui; Wang, Zhenxin; Wang, Youchun; Jiang, Chunlai; Gao, Feng			Enhanced Sensitivity for Detection of HIV-1 p24 Antigen by a Novel Nuclease-Linked Fluorescence Oligonucleotide Assay	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ULTRASENSITIVE ENZYME-IMMUNOASSAY; IMMUNOSORBENT-ASSAY; INFECTION; ELISA; NANOPARTICLE; DIAGNOSIS; ANTIBODY; VIREMIA; PROTEINS	The relatively high detection limit of the Enzyme-linked immunosorbent assay (ELISA) prevents its application for detection of low concentrations of antigens. To increase the sensitivity for detection of HIV-1 p24 antigen, we developed a highly sensitive nuclease-linked fluorescence oligonucleotide assay (NLFOA). Two major improvements were incorporated in NLFOA to amplify antibody-antigen interaction signals and reduce the signal/noise ratio; a large number of nuclease molecules coupled to the gold nanoparticle/streptavidin complex and fluorescent signals generated from fluorescent-labeled oligonucleotides by the nuclease. The detection limit of p24 by NLFOA was 1 pg/mL, which was 10-fold more sensitive than the conventional ELISA (10 pg/mL). The specificity was 100% and the coefficient of variation (CV) was 7.8% at low p24 concentration (1.5 pg/mL) with various concentrations of spiked p24 in HIV-1 negative sera. Thus, NLFOA is highly sensitive, specific, reproducible and user-friendly. The more sensitive detection of low p24 concentrations in HIV-1-infected individuals by NLFOA could allow detection of HIV-1 infections that are missed by the conventional ELISA at the window period during acute infection to further reduce the risk for HIV-1 infection due to the undetected HIV-1 in the blood products. Moreover, NLFOA can be easily applied to more sensitive detection of other antigens.	[Fan, Peihu; Li, Xiaojun; Su, Weiheng; Kong, Wei; Jiang, Chunlai; Gao, Feng] Jilin Univ, Sch Life Sci, Changchun 130023, Jilin, Peoples R China; [Fan, Peihu; Li, Xiaojun; Su, Weiheng; Kong, Wei; Jiang, Chunlai; Gao, Feng] Jilin Univ, Natl Engn Lab Acquired Immune Deficiency Syndrome, Changchun 130023, Jilin, Peoples R China; [Kong, Wei; Jiang, Chunlai] Jilin Univ, Key Lab Mol Enzymol & Engn, Changchun 130023, Jilin, Peoples R China; [Kong, Xianggui] Chinese Acad Sci, Changchun Inst Opt Fine Mech & Phys, State Key Lab Luminescence & Applicat, Changchun, Jilin, Peoples R China; [Wang, Zhenxin] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Wang, Youchun] Natl Inst Food & Drug Control, Div Human Immunodeficiency Virus Acquired Immune, Beijing, Peoples R China	Jilin University; Jilin University; Jilin University; Chinese Academy of Sciences; Changchun Institute of Optics, Fine Mechanics & Physics, CAS; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; National Institute of Food & Drug Control - China	Jiang, CL (corresponding author), Jilin Univ, Sch Life Sci, Changchun 130023, Jilin, Peoples R China.	jiangcl@jlu.edu.cn; feng0215@gmail.com		wang, zhen xin/0000-0002-1908-9848	National Science and Technology Major Project [2012ZX10001009]	National Science and Technology Major Project	This work was supported by the National Science and Technology Major Project (2012ZX10001009) to KW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agasti SS, 2010, ADV DRUG DELIVER REV, V62, P316, DOI 10.1016/j.addr.2009.11.004; ALLAIN JP, 1986, LANCET, V2, P1233; Ambrosi A, 2007, ANAL CHEM, V79, P5232, DOI 10.1021/ac070357m; Ambrosi A, 2010, ANAL CHEM, V82, P1151, DOI 10.1021/ac902492c; CAO Y, 1987, BLOOD, V70, P575; CARTHEW P, 1981, LAB ANIM, V15, P69, DOI 10.1258/002367781780958504; CHARGELEGUE D, 1992, J VIROL METHODS, V38, P323, DOI 10.1016/0166-0934(92)90077-Q; Chirra HD, 2011, ACTA BIOMATER, V7, P2865, DOI 10.1016/j.actbio.2011.01.003; CLARK SJ, 1991, NEW ENGL J MED, V324, P954, DOI 10.1056/NEJM199104043241404; Cohen GM, 2007, AIDS, V21, pS81, DOI 10.1097/01.aids.0000279710.47298.5c; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Cohen MS, 2010, J INFECT DIS, V202, pS270, DOI 10.1086/655651; Crowther J., 2008, MOL BIOMETHODS HDB, P657; CROWTHER JR, 1990, BIOLOGICALS, V18, P331, DOI 10.1016/1045-1056(90)90038-2; DAAR ES, 1991, NEW ENGL J MED, V324, P961, DOI 10.1056/NEJM199104043241405; de la Rica R, 2012, NAT NANOTECHNOL, V7, P821, DOI [10.1038/nnano.2012.186, 10.1038/NNANO.2012.186]; Dong HH, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-180; DOWBENKO DJ, 1985, P NATL ACAD SCI USA, V82, P7748, DOI 10.1073/pnas.82.22.7748; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Fox J, 2011, SEX TRANSM INFECT, V87, P178, DOI 10.1136/sti.2010.042564; Fransen K, 1997, J MED VIROL, V53, P31, DOI 10.1002/(SICI)1096-9071(199709)53:1&lt;31::AID-JMV6&gt;3.0.CO;2-R; Gan SD, 2013, J INVEST DERMATOL, V133, pE10, DOI 10.1038/jid.2013.287; Hashida S, 1995, Biotechnol Annu Rev, V1, P403; HASHIDA S, 1995, J CLIN MICROBIOL, V33, P298, DOI 10.1128/JCM.33.2.298-303.1995; Hashida S, 1996, J CLIN LAB ANAL, V10, P302, DOI 10.1002/(SICI)1098-2825(1996)10:5<302::AID-JCLA11>3.0.CO;2-0; HORSBURGH CR, 1989, LANCET, V2, P637; Hutchinson AB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000342; ISHIKAWA E, 1990, CLIN CHIM ACTA, V194, P51, DOI 10.1016/0009-8981(90)90303-A; Ke RQ, 2010, ANAL BIOCHEM, V406, P8, DOI 10.1016/j.ab.2010.06.039; Laperche S, 2012, J INFECT DIS, V206, P1946, DOI 10.1093/infdis/jis616; Lequin RM, 2005, CLIN CHEM, V51, P2415, DOI 10.1373/clinchem.2005.051532; Li YY, 2007, CLIN CHEM, V53, P1061, DOI 10.1373/clinchem.2006.082271; Lindback S, 2000, AIDS, V14, P2333, DOI 10.1097/00002030-200010200-00014; Liu MY, 2010, ANALYST, V135, P327, DOI 10.1039/b916629g; Long EF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027625; Maritz J, 2011, J CLIN MICROBIOL, V49, P1704, DOI 10.1128/JCM.02497-10; Meng Y, 2005, ANAL BIOCHEM, V345, P227, DOI 10.1016/j.ab.2005.07.026; Nadal D, 1999, J INFECT DIS, V180, P1089, DOI 10.1086/315012; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; SCHARPE SL, 1976, CLIN CHEM, V22, P733; Schupbach J, 2003, JAIDS-J ACQ IMM DEF, V33, P292, DOI 10.1097/00126334-200307010-00002; SHEKARCHI IC, 1985, J CLIN MICROBIOL, V21, P92, DOI 10.1128/JCM.21.1.92-96.1985; Sutthent R, 2003, J CLIN MICROBIOL, V41, P1016, DOI 10.1128/JCM.41.3.1016-1022.2003; Tang SX, 2010, CLIN VACCINE IMMUNOL, V17, P1244, DOI 10.1128/CVI.00066-10; Tang SX, 2010, J INFECT DIS, V201, pS59, DOI 10.1086/650386; YOLKEN RH, 1979, J CLIN MICROBIOL, V10, P317, DOI 10.1128/JCM.10.3.317-321.1979; YOLKEN RH, 1982, J CLIN MICROBIOL, V15, P757, DOI 10.1128/JCM.15.5.757-760.1982; ZAAIJER HL, 1992, LANCET, V340, P770, DOI 10.1016/0140-6736(92)92303-W; Zhou F, 2012, ANALYST, V137, P1779, DOI 10.1039/c2an16257a; Zhou F, 2011, LANGMUIR, V27, P2155, DOI 10.1021/la1049937	51	10	10	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125701	10.1371/journal.pone.0125701	http://dx.doi.org/10.1371/journal.pone.0125701			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915630	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100143
J	IJzerman, H; Janssen, JA; Coan, JA				IJzerman, Hans; Janssen, Janneke A.; Coan, James A.			Maintaining Warm, Trusting Relationships with Brands: Increased Temperature Perceptions after Thinking of Communal Brands	PLOS ONE			English	Article							EXPERIENCING PHYSICAL WARMTH; UNIVERSAL DIMENSIONS; SOCIAL PROXIMITY; ATTACHMENT; REPLICATION; COMPETENCE; EMOTION; ECONOMY; AGENCY; MOTOR	Classical theories on interpersonal relations have long suggested that social interactions are influenced by sensation, such as the experience of warmth. Past empirical work now confirms that perceived differences in temperature impact how people form thoughts about relationships. The present work first integrates our knowledge database on brand research with this idea of "grounded social cognition". It then leverages a large sample (total N = 2,552) toward elucidating links between estimates of temperature and positive versus negative evaluations of communal brands. In five studies, the authors have found that thinking about positively (vs. negatively) perceived communal brands leads to heightened temperature estimates. A meta-analysis of the five studies shows a small but consistent effect in this noisy environment, r = .11, 95% CI,.05,.18. Exploratory analyses in Studies 1a and b further suggest that temperature perceptions mediate the (significant) relationship between perceived communality and willingness to purchase from the brand. The authors discuss implications for theory and practice and consider the effects from a Social Baseline Perspective.	[IJzerman, Hans] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Janssen, Janneke A.] Tilburg Univ, Dept Social Psychol, Sch Social & Behav Sci, NL-5000 LE Tilburg, Netherlands; [Coan, James A.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA	Vrije Universiteit Amsterdam; Tilburg University; University of Virginia	IJzerman, H (corresponding author), Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.	h.ijzerman@gmail.com		IJzerman, Hans/0000-0002-0990-2276	Netherlands Organization for Scientific Research (NWO) [016.145.049]; National Institute of Mental Health [NIMH R01MH080725, NIMH R01-MH066902]; National Science Foundation [NSF DMS-1209118, NSF BCS-1261499]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080725, R01MH066902] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The paper was partially supported by a Veni grant of the Netherlands Organization for Scientific Research (NWO; www.nwo.nl) (016.145.049) awarded to HIJ. JAC received funding from the National Institute of Mental Health (NIMH R01MH080725, NIMH R01-MH066902) and the National Science Foundation (NSF DMS-1209118, NSF BCS-1261499). The research was embedded in HIJ and JAC research program, whose salaries are paid for by their institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaker J, J CONSUM RES, V3, P1; Aaker JL, 1997, J MARKETING RES, V34, P347, DOI 10.2307/3151897; Abele AE, 2014, ACCEPTED IN ADV EXP; Abele AE, 2007, J PERS SOC PSYCHOL, V93, P751, DOI 10.1037/0022-3514.93.5.751; Ahuvia AC, 2001, THESIS; Bakan D., 1966, THE DUALITY OF HUMAN; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Beckes L, 2014, TOWARD A RADICALLY E; Beckes L, 2011, SOC PERSONAL PSYCHOL, V5, P976, DOI 10.1111/j.1751-9004.2011.00400.x; Bhalla M, 1999, J EXP PSYCHOL HUMAN, V25, P1076, DOI 10.1037/0096-1523.25.4.1076; Blanken I, 2014, SOC PSYCHOL-GERMANY, V45, P232, DOI 10.1027/1864-9335/a000189; Bowlby J., 1969, ATTACHMENT AND LOSS; Brandt MJ, 2014, J EXP SOC PSYCHOL, V50, P217, DOI 10.1016/j.jesp.2013.10.005; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; Cuddy AJC, 2008, ADV EXP SOC PSYCHOL, V40, P61, DOI 10.1016/S0065-2601(07)00002-0; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fay AJ, 2012, J EXP SOC PSYCHOL, V48, P1369, DOI 10.1016/j.jesp.2012.05.017; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Foroni F, 2009, PSYCHOL SCI, V20, P974, DOI 10.1111/j.1467-9280.2009.02400.x; Fournier S, 1998, J CONSUM RES, V24, P343, DOI 10.1086/209515; Hafner M, 2011, PERS SOC PSYCHOL B, V37, P1551, DOI 10.1177/0146167211415629; HARNAD S, 1990, PHYSICA D, V42, P335, DOI 10.1016/0167-2789(90)90087-6; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; IJzerman H, 2014, ACTA PSYCHOL, V148, P136, DOI 10.1016/j.actpsy.2014.01.013; Ijzerman H, 2013, EUR J PERSONALITY, V27, P128; IJzerman H, 2013, SOC PSYCHOL-GERMANY, V44, P160, DOI 10.1027/1864-9335/a000142; Ijzerman H, 2012, ACTA PSYCHOL, V140, P283, DOI 10.1016/j.actpsy.2012.05.002; Ijzerman H, 2011, EUR J SOC PSYCHOL, V41, P456, DOI 10.1002/ejsp.806; IJzerman H, 2011, PSYCHOL BULL, V137, P355, DOI 10.1037/a0022373; Ijzerman H, 2010, J EXP SOC PSYCHOL, V46, P867, DOI 10.1016/j.jesp.2010.07.015; IJzerman H, 2009, PSYCHOL SCI, V20, P1214, DOI 10.1111/j.1467-9280.2009.02434.x; Judd CM, 2005, J PERS SOC PSYCHOL, V89, P899, DOI 10.1037/0022-3514.89.6.899; LeBel EP, 2013, PSYCHOL SCI, V24, P2128, DOI 10.1177/0956797613486983; Lynott D, 2014, SOC PSYCHOL-GERMANY, V45, P216, DOI 10.1027/1864-9335/a000187; OSF, 2014, RELATIONSHIPS WITH B; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Proffitt DR, 2001, PSYCHOL SCI, V12, P418, DOI 10.1111/1467-9280.00377; Richins ML, 1997, J CONSUM RES, V24, P127, DOI 10.1086/209499; Schilder JD, 2014, PHYSICAL WARMTH AND; Schimmack U, 2012, PSYCHOL METHODS, V17, P551, DOI 10.1037/a0029487; Schnall S, 2010, PERCEPTION, V39, P464, DOI 10.1068/p6445; SEARLE JR, 1980, BEHAV BRAIN SCI, V3, P417, DOI 10.1017/S0140525X00006038; Shimp T.A., 1988, ADV CONSUM RES, V15, P163; Simmons JP, 2015, LIFE AFTER P HACKING; Simmons JP, 2013, A 21 WORD SOLUTION; Slater JS, 2001, ADV CONSUM RES, V28, P362; STERNBERG RJ, 1986, PSYCHOL REV, V93, P119, DOI 10.1037/0033-295X.93.2.119; Sung YJ, 2010, PSYCHOL MARKET, V27, P639, DOI 10.1002/mar.20349; Szymkow A, 2012, SOC PSYCHOL, V44, P168; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; Wojciszke B, 2008, EUR J SOC PSYCHOL, V38, P1139, DOI 10.1002/ejsp.549; Yoon C, 2006, J CONSUM RES, V33, P31, DOI 10.1086/504132; Zhong CB, 2008, PSYCHOL SCI, V19, P838, DOI 10.1111/j.1467-9280.2008.02165.x	57	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125194	10.1371/journal.pone.0125194	http://dx.doi.org/10.1371/journal.pone.0125194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915686	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100108
J	Lee, MS; Kim, JH; Lee, JS; Yun, SJ; Kim, WJ; Ahn, H; Park, J				Lee, Myung-Shin; Kim, Joo Heon; Lee, Ji-Su; Yun, Seok Joong; Kim, Wun-Jae; Ahn, Hanjong; Park, Jinsung			Prognostic Significance of CREB-Binding Protein and CD81 Expression in Primary High Grade Non-Muscle Invasive Bladder Cancer: Identification of Novel Biomarkers for Bladder Cancer Using Antibody Microarray	PLOS ONE			English	Article							MOLECULAR PATHWAYS; CELL-CARCINOMA; PROGRESSION; METASTASIS; RECURRENCE; PREDICTION; ARRAYS; P300; CBP	High-grade (HG) bladder cancers (BCs) are genetically unstable and have an unpredictable course. The identification of prognostic factors in HG non-muscle invasive BC (NMIBC) is crucial for improving patients' quality of life and preventing BC-specific mortality. Here, we used an antibody microarray (AbM) to identify novel candidate biomarkers in primary HG NMIBC and validated the prognostic significance of the candidate biomarkers. Three pairs of tissue samples from primary HG NMIBC and normal urothelium were analyzed using an AbM kit containing 656 antibodies, and differentially expressed proteins were identified. Among the 42 upregulated and 14 downregulated proteins with statistical significance in BC tissues, CREB-binding protein and CD81 were selected as representative upregulated and downregulated candidate biomarkers, respectively. We then validated the expression of these candidate biomarkers in primary human urothelial cells and BC cell lines by western blotting and immunofluorescence assays, and the results were consistent with the AbM expression profiles. Additionally, Kaplan-Meier survival using immunohistochemical data from an independent primary HG NMIBC cohort comprising 113 patients showed that expression of the 2 biomarkers was significantly associated with recurrence-free and progression-free survival. In multivariate analysis, the 2 biomarkers remained significant predictors for recurrence-free survival. Taken together, our findings suggest that expression of CREB-binding protein and CD81 in BC tissue specimens may have prognostic value in patients with primary HG NMIBC.	[Lee, Myung-Shin; Lee, Ji-Su] Eulji Univ, Sch Med, Dept Microbiol, Taejon, South Korea; [Kim, Joo Heon] Eulji Univ, Sch Med, Dept Pathol, Taejon, South Korea; [Yun, Seok Joong; Kim, Wun-Jae] Chungbuk Natl Univ, Coll Med, Dept Urol, Cheongju, South Korea; [Ahn, Hanjong] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Urol, Seoul, South Korea; [Park, Jinsung] Eulji Univ, Eulji Univ Hosp, Sch Med, Dept Urol, Taejon, South Korea	Eulji University; Eulji University; Chungbuk National University; University of Ulsan; Asan Medical Center; Eulji University	Park, J (corresponding author), Eulji Univ, Eulji Univ Hosp, Sch Med, Dept Urol, Taejon, South Korea.	jspark.uro@gmail.com	Lee, Myung-Shin/AAB-8407-2020	Lee, Myung-Shin/0000-0001-9145-6190	National Research Foundation of Korea (NRF) - Korean Government (MSIP) [2012010299, 2013024817, 2014013993]	National Research Foundation of Korea (NRF) - Korean Government (MSIP)(National Research Foundation of Korea)	This study was supported by a National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIP) (Nos. 2012010299, 2013024817, and 2014013993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Boorjian SA, 2009, ENDOCR-RELAT CANCER, V16, P123, DOI 10.1677/ERC-08-0124; Castillo-Martin M, 2010, UROL ONCOL-SEMIN ORI, V28, P401, DOI 10.1016/j.urolonc.2009.04.019; ECKNER R, 1994, COLD SPRING HARB SYM, V59, P85, DOI 10.1101/SQB.1994.059.01.012; Feng JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096671; Gabriel U, 2007, ANTICANCER RES, V27, P3163; Gao YN, 2014, INT J CLIN EXP PATHO, V7, P760; Hoque MO, 2003, CANCER RES, V63, P2216; Imao T, 1999, J UROLOGY, V161, P692, DOI 10.1016/S0022-5347(01)61997-9; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones TD, 2005, CLIN CANCER RES, V11, P6512, DOI 10.1158/1078-0432.CCR-05-0891; Kim JH, 2008, CLIN CANCER RES, V14, P2326, DOI 10.1158/1078-0432.CCR-07-4457; Kim June-Bum, 2014, Korean J Pediatr, V57, P1, DOI 10.3345/kjp.2014.57.1.1; Kopf E, 2007, INT J BIOCHEM CELL B, V39, P1305, DOI 10.1016/j.biocel.2007.04.029; Lee MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004412; Linden M, 2013, BJU INT, V112, P407, DOI 10.1111/j.1464-410X.2012.11653.x; Mazzocca A, 2008, GASTROENTEROLOGY, V135, P244, DOI 10.1053/j.gastro.2008.03.024; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Moon KM, 2012, INT J MOL SCI, V13, P1239, DOI 10.3390/ijms13011239; Park J, 2013, UROL ONCOL-SEMIN ORI, V31, P849, DOI 10.1016/j.urolonc.2011.06.004; Park J, 2009, WORLD J UROL, V27, P277, DOI 10.1007/s00345-008-0350-4; Sanchez-Carbayo M, 2006, AM J PATHOL, V168, P93, DOI 10.2353/ajpath.2006.050601; Shariat SF, 2008, CURR OPIN UROL, V18, P1, DOI 10.1097/MOU.0b013e3282f1c5c1; Simon R, 2002, ONCOGENE, V21, P2476, DOI 10.1038/sj.onc.1205304; Sobin LHGM., 2010, INT UNION CANC TNM C; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; SPRUCK CH, 1994, CANCER RES, V54, P784; Srinivasan H, 2014, PROTEOMICS, V14, P1333, DOI 10.1002/pmic.201300320; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Tejera E, 2013, MOL BIOL CELL, V24, P261, DOI 10.1091/mbc.E12-09-0642; Thomas F, 2012, CANCER-AM CANCER SOC, V118, P5525, DOI 10.1002/cncr.27587; van Rhijn BWG, 2003, J CLIN ONCOL, V21, P1912, DOI 10.1200/JCO.2003.05.073; White A, 1998, ONCOGENE, V16, P3143, DOI 10.1038/sj.onc.1201852; Yoo TH, 2013, CELL ONCOL, V36, P141, DOI 10.1007/s13402-012-0119-z	35	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125405	10.1371/journal.pone.0125405	http://dx.doi.org/10.1371/journal.pone.0125405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915404	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659100127
J	Orosz, A; Csajbok, E; Czekus, C; Gavaller, H; Magony, S; Valkusz, Z; Varkonyi, TT; Nemes, A; Baczko, I; Forster, T; Wittmann, T; Papp, JG; Varro, A; Lengyel, C				Orosz, Andrea; Csajbok, Eva; Czekus, Csilla; Gavaller, Henriette; Magony, Sandor; Valkusz, Zsuzsanna; Varkonyi, Tamas T.; Nemes, Attila; Baczko, Istvan; Forster, Tamas; Wittmann, Tibor; Papp, Julius Gy.; Varro, Andras; Lengyel, Csaba			Increased Short-Term Beat-To-Beat Variability of QT Interval in Patients with Acromegaly	PLOS ONE			English	Article							COMPLETE ATRIOVENTRICULAR-BLOCK; HEART-RATE-VARIABILITY; SUDDEN CARDIAC DEATH; DOWN-REGULATION; VENTRICULAR-ARRHYTHMIAS; LATE POTENTIALS; FAILING CANINE; BLOOD-PRESSURE; RISK-FACTORS; DE-POINTES	Cardiovascular diseases, including ventricular arrhythmias are responsible for increased mortality in patients with acromegaly. Acromegaly may cause repolarization abnormalities such as QT prolongation and impairment of repolarization reserve enhancing liability to arrhythmia. The aim of this study was to determine the short-term beat-to-beat QT variability in patients with acromegaly. Thirty acromegalic patients (23 women and 7 men, mean age +/- SD: 55.7 +/- 10.4 years) were compared with age-and sex-matched volunteers (mean age 51.3 +/- 7.6 years). Cardiac repolarization parameters including frequency corrected QT interval, PQ and QRS intervals, duration of terminal part of T waves (T-peak-T-end) and short-term variability of QT interval were evaluated. All acromegalic patients and controls underwent transthoracic echocardiographic examination. Autonomic function was assessed by means of five standard cardiovascular reflex tests. Comparison of the two groups revealed no significant differences in the conventional ECG parameters of repolarization (QT: 401.1 +/- 30.6 ms vs 389.3 +/- 16.5 ms, corrected QT interval: 430.1 +/- 18.6 ms vs 425.6 +/- 17.3 ms, QT dispersion: 38.2 +/- 13.2 ms vs 36.6 +/- 10.2 ms; acromegaly vs control, respectively). However, short-term beat-to-beat QT variability was significantly increased in acromegalic patients (4.23 +/- 1.03 ms vs 3.02 +/- 0.80, P<0.0001). There were significant differences between the two groups in the echocardiographic dimensions (left ventricular end diastolic diameter: 52.6 +/- 5.4 mm vs 48.0 +/- 3.9 mm, left ventricular end systolic diameter: 32.3 +/- 5.2 mm vs 29.1 +/- 4.4 mm, interventricular septum: 11.1 +/- 2.2 mm vs 8.8 +/- 0.7 mm, posterior wall of left ventricle: 10.8 +/- 1.4 mm vs 8.9 +/- 0.7 mm, P<0.05, respectively). Short-term beat-to-beat QT variability was elevated in patients with acromegaly in spite of unchanged conventional parameters of ventricular repolarization. This enhanced temporal QT variability may be an early indicator of increased liability to arrhythmia.	[Orosz, Andrea; Baczko, Istvan; Papp, Julius Gy.; Varro, Andras; Lengyel, Csaba] Univ Szeged, Fac Med, Dept Pharmacol & Pharmacotherapy, Szeged, Hungary; [Csajbok, Eva; Czekus, Csilla; Magony, Sandor; Valkusz, Zsuzsanna; Varkonyi, Tamas T.; Wittmann, Tibor; Lengyel, Csaba] Univ Szeged, Fac Med, Dept Internal Med 1, Szeged, Hungary; [Gavaller, Henriette; Nemes, Attila; Forster, Tamas] Univ Szeged, Fac Med, Dept Internal Med 2, Szeged, Hungary; [Gavaller, Henriette; Nemes, Attila; Forster, Tamas] Univ Szeged, Fac Med, Ctr Cardiol, Szeged, Hungary; [Papp, Julius Gy.; Varro, Andras] Hungarian Acad Sci, MTA SZTE Res Grp Cardiovasc Pharmacol, Szeged, Hungary	Szeged University; Szeged University; Szeged University; Szeged University; Hungarian Academy of Sciences	Lengyel, C (corresponding author), Univ Szeged, Fac Med, Dept Pharmacol & Pharmacotherapy, Szeged, Hungary.	lecs.in1st@gmail.com	Varro, Andras/M-2647-2016; Forster, Tamas/AAV-9037-2020; Dagdelen, Selcuk/A-9432-2017; Baczko, István/I-7752-2019	Dagdelen, Selcuk/0000-0002-0513-1750; Baczko, István/0000-0002-9588-0797; Nemes, Attila/0000-0002-7570-6214; Orosz, Andrea/0000-0002-0750-4741; Csajbok, Eva/0000-0002-7089-5431	Hungarian Research Fund [OTKA NK-104331, CNK-77855]; National Development Agency; European Social Fund [TAMOP-4.2.2A-11/1/KONV-2012-0073, TAMOP-4.2.2./B-10/1-2010-0012, GOP-1.1.1-11-2011-00812-0035]; National Research, Development and Innovation Office [PIAC_13-1-2013-0201]; Hungarian National Office for Research and Technology [TECH_08_A1_CARDIO 08]; Hungarian Academy of Sciences; HU-RO Cross-Border Cooperation Programmes [HURO/0901/137-HU-RO_TRANSMED]	Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency; European Social Fund(European Social Fund (ESF)); National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Hungarian National Office for Research and Technology(National Office for Research and Technology); Hungarian Academy of Sciences(Hungarian Academy of Sciences); HU-RO Cross-Border Cooperation Programmes	This work was supported by grants from the Hungarian Research Fund [OTKA NK-104331, CNK-77855], the National Development Agency and co-financed by the European Social Fund [TAMOP-4.2.2A-11/1/KONV-2012-0073, TAMOP-4.2.2./B-10/1-2010-0012; GOP-1.1.1-11-2011-00812-0035], the National Research, Development and Innovation Office [PIAC_13-1-2013-0201], Hungarian National Office for Research and Technology (TECH_08_A1_CARDIO 08), the Hungarian Academy of Sciences (Janos Bolyai Research Scholarship to AN, IB, CsL), and by the HU-RO Cross-Border Cooperation Programmes (HURO/0901/137-HU-RO_TRANSMED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auriemma RS, 2013, EUR J ENDOCRINOL, V168, P15, DOI 10.1530/EJE-12-0596; Baykan M, 2008, ECHOCARDIOGR-J CARD, V25, P374, DOI 10.1111/j.1540-8175.2007.00615.x; Berg C, 2010, J CLIN ENDOCR METAB, V95, P3648, DOI 10.1210/jc.2009-2570; Berger RD, 1997, CIRCULATION, V96, P1557, DOI 10.1161/01.CIR.96.5.1557; Bihan H, 2004, J CLIN ENDOCR METAB, V89, P5308, DOI 10.1210/jc.2004-0821; Bogazzi F, 2007, J CLIN ENDOCR METAB, V92, P4271, DOI 10.1210/jc.2007-1213; Bohlooly-Y M, 2001, ENDOCRINOLOGY, V142, P3317, DOI 10.1210/en.142.8.3317; Bollano E, 2000, ENDOCRINOLOGY, V141, P2229, DOI 10.1210/en.141.6.2229; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Cabo C, 2003, AM J PHYSIOL-HEART C, V284, pH372, DOI 10.1152/ajpheart.00512.2002; Chemla D, 2014, J CLIN ENDOCR METAB, V99, P2925, DOI 10.1210/jc.2013-4288; Ciulla M, 1999, J HYPERTENS, V17, P1965, DOI 10.1097/00004872-199917121-00028; Clayton RN, 2003, ENDOCR REV, V24, P272, DOI 10.1210/er.2003-0009; Colao A, 2004, EUR J ENDOCRINOL, V151, pS93, DOI 10.1530/eje.0.151S093; Comunello A, 2015, PITUITARY, V18, P525, DOI 10.1007/s11102-014-0605-6; Dassie F, 2012, EUR J ENDOCRINOL, V166, P199, DOI 10.1530/EJE-11-0835; Dural M, 2014, PITUITARY, V17, P163, DOI 10.1007/s11102-013-0482-4; Fatti LM, 2006, CLIN ENDOCRINOL, V65, P626, DOI 10.1111/j.1365-2265.2006.02639.x; Haigney MC, 2004, J AM COLL CARDIOL, V44, P1481, DOI 10.1016/j.jacc.2004.06.063; Hanton G., 2008, Journal of Pharmacological and Toxicological Methods, V57, P194, DOI 10.1016/j.vascn.2008.03.001; Herrmann BL, 2001, CLIN ENDOCRINOL, V55, P201, DOI 10.1046/j.1365-2265.2001.01319.x; Hinterseer M, 2008, EUR HEART J, V29, P185, DOI 10.1093/eurheartj/ehm586; Hinterseer M, 2010, AM J CARDIOL, V106, P216, DOI 10.1016/j.amjcard.2010.02.033; Hinterseer M, 2009, AM J CARDIOL, V103, P1244, DOI 10.1016/j.amjcard.2009.01.011; JANSE MJ, 1989, PHYSIOL REV, V69, P1049, DOI 10.1152/physrev.1989.69.4.1049; Jiang M, 2000, CARDIOVASC RES, V48, P34, DOI 10.1016/S0008-6363(00)00159-0; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; KAHALY G, 1992, EUR HEART J, V13, P51, DOI 10.1093/oxfordjournals.eurheartj.a060047; Lahiri MK, 2008, J AM COLL CARDIOL, V51, P1725, DOI 10.1016/j.jacc.2008.01.038; Lengyel C, 2007, BRIT J PHARMACOL, V151, P941, DOI 10.1038/sj.bjp.0707297; Lengyel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018751; Li GR, 2002, AM J PHYSIOL-HEART C, V283, pH1031, DOI 10.1152/ajpheart.00105.2002; LIE JT, 1980, AM HEART J, V100, P41, DOI 10.1016/0002-8703(80)90277-X; LUE WM, 1992, CIRCULATION, V85, P1175, DOI 10.1161/01.CIR.85.3.1175; Maffei P, 2005, INT J CARDIOL, V104, P197, DOI 10.1016/j.ijcard.2004.12.010; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; Mohamed A L, 1999, Med J Malaysia, V54, P338; Murabayashi T, 2002, J ELECTROCARDIOL, V35, P19, DOI 10.1054/jelc.2002.30250; Nabauer M, 1998, CARDIOVASC RES, V37, P324, DOI 10.1016/S0008-6363(97)00274-5; Nemes A, 2008, INT J CARDIOL, V124, P121, DOI 10.1016/j.ijcard.2006.11.196; Oosterhoff P, 2011, HEART RHYTHM, V8, P1584, DOI 10.1016/j.hrthm.2011.04.033; Pinto JMB, 1998, J CARDIOVASC ELECTR, V9, P299, DOI 10.1111/j.1540-8167.1998.tb00915.x; Resmini E, 2006, J CLIN ENDOCR METAB, V91, P115, DOI 10.1210/jc.2005-1506; Rhee SS, 2011, REV ESP CARDIOL, V64, P220, DOI 10.1016/j.recesp.2010.10.015; Roden DM, 1998, PACE, V21, P1029, DOI 10.1111/j.1540-8159.1998.tb00148.x; RODRIGUES EA, 1989, BRIT HEART J, V62, P185; ROSSI L, 1977, CHEST, V72, P495, DOI 10.1378/chest.72.4.495; Seegers J, 2012, EUROPACE, V14, P416, DOI 10.1093/europace/eur352; Seravalle G, 2012, CLIN ENDOCRINOL, V77, P262, DOI 10.1111/j.1365-2265.2012.04335.x; Shen MJ, 2014, CIRC RES, V114, P1004, DOI 10.1161/CIRCRESAHA.113.302549; Spinelli L, 2003, J CLIN ENDOCR METAB, V88, P4105, DOI 10.1210/jc.2003-030462; Stengl M, 2006, CARDIOVASC RES, V72, P90, DOI 10.1016/j.cardiores.2006.07.015; Suyama K, 2000, ENDOCR J, V47, pS73, DOI 10.1507/endocrj.47.SupplMarch_S73; Thomsen MB, 2007, BRIT J PHARMACOL, V151, P909, DOI 10.1038/sj.bjp.0707299; Thomsen MB, 2004, CIRCULATION, V110, P2453, DOI 10.1161/01.CIR.0000145162.64183.C8; Thomsen MB, 2005, BASIC RES CARDIOL, V100, P279, DOI 10.1007/s00395-005-0519-6; Valdivia CR, 2005, J MOL CELL CARDIOL, V38, P475, DOI 10.1016/j.yjmcc.2004.12.012; van Eck HJR, 2009, COMPUT CARDIOL, V36, P585; Varkevisser R, 2012, HEART RHYTHM, V9, P1718, DOI 10.1016/j.hrthm.2012.05.016; Varro A, 2000, J PHYSIOL-LONDON, V523, P67, DOI 10.1111/j.1469-7793.2000.00067.x; Varro A, 2011, BRIT J PHARMACOL, V164, P14, DOI 10.1111/j.1476-5381.2011.01367.x; Varro A, 2010, PFLUG ARCH EUR J PHY, V460, P31, DOI 10.1007/s00424-010-0798-0; Volders PGA, 1998, CIRCULATION, V98, P1136, DOI 10.1161/01.CIR.98.11.1136; Volders PGA, 1999, CIRCULATION, V100, P2455, DOI 10.1161/01.CIR.100.24.2455; Vos MA, 1998, CIRCULATION, V98, P1125, DOI 10.1161/01.CIR.98.11.1125; Zicha S, 2004, J PHYSIOL-LONDON, V561, P735, DOI 10.1113/jphysiol.2004.075861	66	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125639	10.1371/journal.pone.0125639	http://dx.doi.org/10.1371/journal.pone.0125639			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915951	Green Accepted, Green Published, gold			2022-12-27	WOS:000353659100139
J	Rajah, T; Chow, SC				Rajah, Tanuja; Chow, Sek Chuen			Suppression of Human T Cell Proliferation Mediated by the Cathepsin B Inhibitor, z-FA-FMK Is Due to Oxidative Stress	PLOS ONE			English	Article							Z-VAD-FMK; GLUTATHIONE DEPLETION; INTRACELLULAR GLUTATHIONE; LYMPHOCYTE-ACTIVATION; CASPASE ACTIVATION; HOMOCYSTEINE SULFOXIMINE; BUTHIONINE SULFOXIMINE; FLUOROMETHYL KETONES; INDUCED APOPTOSIS; JOINT DISEASES	The cathepsin B inhibitor, benzyloxycarbonyl-phenylalanine-alanine-fluoromethyl ketone (z-FA-FMK) readily inhibits anti-CD3-induced human T cell proliferation, whereas the analogue benzyloxycarbonyl-phenylalanine-alanine-diazomethyl ketone (z-FA-DMK) had no effect. In contrast, benzyloxycarbonyl-phenylalanine-alanine-chloromethyl ketone (z-FA-CMK) was toxic. The inhibition of T cell proliferation mediated by z-FA-FMK requires not only the FMK moiety, but also the benzyloxycarbonyl group at the N-terminal, suggesting some degree of specificity in z-FA-FMK-induced inhibition of primary T cell proliferation. We showed that z-FA-FMK treatment leads to a decrease in intracellular glutathione (GSH) with a concomitant increase in reactive oxygen species (ROS) levels in activated T cells. The inhibition of anti-CD3-induced T cell proliferation mediated by z-FA-FMK was abolished by the presence of low molecular weight thiols such as GSH, N-acetylcysteine (NAC) and L-cysteine, whereas D-cysteine which cannot be metabolised to GSH has no effect. The inhibition of anti-CD3-induced up-regulation of CD25 and CD69 expression mediated by z-FA-FMK was also attenuated in the presence of exogenous GSH. Similar to cell proliferation, GSH, NAC and L-cysteine but not D-cysteine, completely restored the processing of caspase-8 and caspase-3 to their respective subunits in z-FA-FMK-treated activated T cells. Our collective results demonstrated that the inhibition of T cell activation and proliferation mediated by z-FA-FMK is due to oxidative stress via the depletion of GSH.	[Rajah, Tanuja; Chow, Sek Chuen] Monash Univ, Sch Sci, Bandar Sunway 46150, Selangor Darul, Malaysia	Monash University; Monash University Sunway	Chow, SC (corresponding author), Monash Univ, Sch Sci, Sunway Campus, Bandar Sunway 46150, Selangor Darul, Malaysia.	chow.sek.chuen@monash.edu			Monash University Malaysia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER	Monash University Malaysia(Monash University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was funded by Monash University Malaysia student grant.	AHMED NK, 1992, BIOCHEM PHARMACOL, V44, P1201, DOI 10.1016/0006-2952(92)90385-V; Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; ANGLIKER H, 1987, BIOCHEM J, V241, P871, DOI 10.1042/bj2410871; Aoshiba K, 2001, AM J PHYSIOL-LUNG C, V281, pL1392, DOI 10.1152/ajplung.2001.281.6.L1392; Apostolova N, 2010, BRIT J PHARMACOL, V160, P2069, DOI 10.1111/j.1476-5381.2010.00866.x; Bidere N, 2002, J BIOL CHEM, V277, P32339, DOI 10.1074/jbc.M205153200; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Cai Hua, 2007, V139, P293; Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; CHAPLIN DD, 1978, CELL IMMUNOL, V36, P303, DOI 10.1016/0008-8749(78)90274-5; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; D'Agostino DP, 2007, J NEUROPHYSIOL, V98, P1030, DOI 10.1152/jn.01003.2006; Deas O, 1998, J IMMUNOL, V161, P3375; ESSER RE, 1994, ARTHRITIS RHEUM, V37, P236, DOI 10.1002/art.1780370213; FIDELUS RK, 1987, EXP CELL RES, V170, P269, DOI 10.1016/0014-4827(87)90305-3; GABRIJELCIC D, 1990, J CLIN CHEM CLIN BIO, V28, P149; GMUNDER H, 1990, CELL IMMUNOL, V129, P32, DOI 10.1016/0008-8749(90)90184-S; GMUNDER H, 1991, CELL IMMUNOL, V138, P229, DOI 10.1016/0008-8749(91)90147-4; GRIFFITH OW, 1979, J BIOL CHEM, V254, P1205; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; HIDAKA T, 1990, ARCH TOXICOL, V64, P103, DOI 10.1007/BF01974394; Hung LF, 2010, MECH AGEING DEV, V131, P682, DOI 10.1016/j.mad.2010.09.005; KETTNER C, 1981, METHOD ENZYMOL, V80, P826; Koenig A, 2008, CELL DEATH DIFFER, V15, P1701, DOI 10.1038/cdd.2008.100; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lawrence CP, 2012, TOXICOL APPL PHARM, V265, P103, DOI 10.1016/j.taap.2012.09.002; Lawrence CP, 2006, J IMMUNOL, V177, P3827, DOI 10.4049/jimmunol.177.6.3827; LENARCIC B, 1988, BIOL CHEM H-S, V369, P257; Liow KY, 2013, TOXICOL APPL PHARM, V272, P559, DOI 10.1016/j.taap.2013.07.022; McColl KS, 1998, MOL CELL ENDOCRINOL, V139, P229, DOI 10.1016/S0303-7207(98)00051-3; MESSINA JP, 1989, J IMMUNOL, V143, P1974; Osseni RA, 1999, TOXICOL IN VITRO, V13, P683, DOI 10.1016/S0887-2333(99)00050-8; Otto HH, 1997, CHEM REV, V97, P133, DOI 10.1021/cr950025u; Paulsen M, 2008, EUR J IMMUNOL, V38, P1979, DOI 10.1002/eji.200838211; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; POWERS JC, 1977, CHEM BIOCH AMINO ACI, V4, P65; Rajah T, 2014, TOXICOL APPL PHARM, V278, P100, DOI 10.1016/j.taap.2014.04.014; RASNICK D, 1985, ANAL BIOCHEM, V149, P461, DOI 10.1016/0003-2697(85)90598-6; RAUBER P, 1986, BIOCHEM J, V239, P633, DOI 10.1042/bj2390633; Reliene R, 2006, CARCINOGENESIS, V27, P240, DOI 10.1093/carcin/bgi222; RONZIO RA, 1969, BIOCHEMISTRY-US, V8, P1066, DOI 10.1021/bi00831a038; Roozendaal R, 2002, IMMUNOLOGY, V107, P334, DOI 10.1046/j.1365-2567.2002.01502.x; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Sarin A, 1996, J EXP MED, V184, P2445, DOI 10.1084/jem.184.6.2445; Schotte P, 2001, J BIOL CHEM, V276, P21153, DOI 10.1074/jbc.M102239200; Stridh H, 1998, FEBS LETT, V429, P351, DOI 10.1016/S0014-5793(98)00630-9; Sun HL, 2009, CLIN CANCER RES, V15, P4904, DOI 10.1158/1078-0432.CCR-09-0269; SUTHANTHIRAN M, 1990, P NATL ACAD SCI USA, V87, P3343, DOI 10.1073/pnas.87.9.3343; VANNOORDEN CJF, 1988, J RHEUMATOL, V15, P1525; Vaziri ND, 2000, HYPERTENSION, V36, P142, DOI 10.1161/01.HYP.36.1.142; WALSH AC, 1995, TOXICOL APPL PHARM, V133, P249, DOI 10.1006/taap.1995.1149; WEBER CA, 1990, AM J PHYSIOL, V258, pL308, DOI 10.1152/ajplung.1990.258.6.L308; YIM CY, 1994, J IMMUNOL, V152, P5796; Zapata JM, 1998, J BIOL CHEM, V273, P6916, DOI 10.1074/jbc.273.12.6916	54	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123711	10.1371/journal.pone.0123711	http://dx.doi.org/10.1371/journal.pone.0123711			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915766	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100025
J	Wu, SC; Chen, WTL; Muo, CH; Sung, FC				Wu, Shih-Chi; Chen, William Tzu-Liang; Muo, Chih-Hsin; Sung, Fung-Chang			Appendicitis as an Early Manifestation of Subsequent Malignancy: An Asian Population Study	PLOS ONE			English	Article							CANCER-RISK; LARGE-BOWEL; APPENDECTOMY; LEUKEMIA; BIOFILMS; INVASION; COLON; RATS; DMH	Background & Aims Cancer risk after appendectomy in patients with appendicitis remains unclear. This study examined the role of appendicitis as an early manifestation harbingering the distant malignancy. Methods From the insurance claims data of Taiwan, we identified a cohort of 130,374 patients newly received appendectomy from 2000-2009, without cancer diagnosis. A comparison cohort of 260,746 persons without appendectomy and cancer was selected from the same database, frequency matched by age, sex, comorbidity and index year. We monitored subsequent cancers with a 12-month follow-up. Results Over all, 1406 and 616 cancer cases were identified in the appendectomy cohort and comparisons, respectively, with all cancers incidence rate 4.64-fold higher in the appendectomy cohort (9.06 vs. 1.96 per 1000 person-months). Digestive and female genital organs harbored 80.9% of cancer cases in the appendectomy cohort. The Cox model measured site-specific hazard ratio (HR) was the highest for female genital cancers (23.3), followed by cancers of colorectum (14.7), small intestine (10.1), pancreas (7.40), lymphoma (5.89) and urinary system (4.50), all significant at 0.001 level. The HR of all cancers decreased from 13.7 within 3 months after appendectomy to 1.37 in 7-12 months after the surgery. In general, relative to the comparison cohort, younger appendectomy patients tended to have a higher HR than older patients. Conclusions The high incident cancers identified soon after appendectomy suggest the acute appendicitis is the early sign of distant metastatic malignancy. The risk of colorectal cancer, female genital cancer and haemopoietic malignancy deserve attention.	[Wu, Shih-Chi] China Med Univ Hosp, Trauma & Emergency Ctr, Taichung 404, Taiwan; [Wu, Shih-Chi; Chen, William Tzu-Liang; Muo, Chih-Hsin] China Med Univ, Coll Med, Taichung 404, Taiwan; [Chen, William Tzu-Liang] China Med Univ Hosp, Dept Surg, Div Colorectal Surg, Taichung 404, Taiwan; [Muo, Chih-Hsin; Sung, Fung-Chang] China Med Univ & Hosp, Management Off Hlth Data, Taichung 404, Taiwan; [Sung, Fung-Chang] China Med Univ, Coll Med, Inst Clin Med Sci, Taichung 404, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Sung, FC (corresponding author), China Med Univ, Inst Clin Med Sci, 91 Hsueh Shih Rd, Taichung 404, Taiwan.	fcsung1008@yahoo.com	Chen, William Tzu-Liang/ABA-5673-2021		Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039-006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; National Sciences Council, Executive Yuan [NSC 100-2621-M-039-001]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; National Sciences Council, Executive Yuan	The study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM104010092), NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039-006), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, Katsuzo and Kiyo Aoshima Memorial Funds, Japan and the National Sciences Council, Executive Yuan (NSC 100-2621-M-039-001). The funding agencies had no role in study design, data management and analyses, and results interpretation and publication of this study.	ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; Azzali G, 2003, IMMUNOL REV, V195, P178, DOI 10.1034/j.1600-065X.2003.00072.x; BIERMAN HR, 1968, CANCER, V21, P109, DOI 10.1002/1097-0142(196801)21:1<109::AID-CNCR2820210117>3.0.CO;2-#; Bollinger RR, 2007, J THEOR BIOL, V249, P826, DOI 10.1016/j.jtbi.2007.08.032; Bollinger RR, 2007, GUT, V56, P1481; Cope JU, 2003, PEDIATRICS, V111, P1343, DOI 10.1542/peds.111.6.1343; Gross L, 1996, CANCER, V19, P849; Hueman MT, 2009, ANN SURG ONCOL, V16, P2101, DOI 10.1245/s10434-009-0538-x; HYAMS L, 1968, J CHRON DIS, V21, P391, DOI 10.1016/0021-9681(68)90003-9; Karachiwala H, 2012, J CANCER RES THER, V8, P132, DOI 10.4103/0973-1482.95194; Lai HW, 2006, J GASTROEN HEPATOL, V21, P1693, DOI 10.1111/j.1440-1746.2006.04426.x; Laurin M, 2011, ANAT REC, V294, P567, DOI 10.1002/ar.21357; Lin CY, 2005, INT J CLIN PRACT, V59, P89, DOI 10.1111/j.1368-504X.2005.00360.x; McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653; McIntosh GH, 1999, NUTR CANCER, V35, P153, DOI 10.1207/S15327914NC352_9; Mellemkjaer L, 1998, CANCER CAUSE CONTROL, V9, P183, DOI 10.1023/A:1008834311514; Muller G, 1997, J CANCER RES CLIN, V123, P560, DOI 10.1007/s004320050105; Poruk KE, 2013, ANN SURG, V257, P17, DOI 10.1097/SLA.0b013e31825ffbfb; Rappaport H, 1967, ATLAS TUMOR PATHOL, P241; Ratanarapee Samrerng, 2010, Journal of the Medical Association of Thailand, V93, P1327; Rauenzahn S, 2013, CASE REP HEMATOL, V2013, DOI 10.1155/2013/815365; ROBINSON E, 1968, BRIT J CANCER, V22, P250, DOI 10.1038/bjc.1968.32; Rowland IR, 1996, NUTR CANCER, V26, P37, DOI 10.1080/01635589609514461; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Swidsinski A, 2012, SAUDI J GASTROENTERO, V18, P55, DOI 10.4103/1319-3767.91734; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Toubai T, 2003, ACTA HAEMATOL-BASEL, V109, P199, DOI 10.1159/000070971; Tsimberidou AM, 2006, CANCER-AM CANCER SOC, V107, P1294, DOI 10.1002/cncr.22121; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wen CP, 2005, TOB CONTROL, V14, pI51, DOI 10.1136/tc.2004.008011	31	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0122725	10.1371/journal.pone.0122725	http://dx.doi.org/10.1371/journal.pone.0122725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915658	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100010
J	Chae, DH; Clouston, S; Hatzenbuehler, ML; Kramer, MR; Cooper, HLF; Wilson, SM; Stephens-Davidowitz, SI; Gold, RS; Link, BG				Chae, David H.; Clouston, Sean; Hatzenbuehler, Mark L.; Kramer, Michael R.; Cooper, Hannah L. F.; Wilson, Sacoby M.; Stephens-Davidowitz, Seth I.; Gold, Robert S.; Link, Bruce G.			Association between an Internet-Based Measure of Area Racism and Black Mortality	PLOS ONE			English	Article							RESIDENTIAL SEGREGATION; RACIAL/ETHNIC DISCRIMINATION; HEALTH CONSEQUENCES; AFRICAN-AMERICANS; DISPARITIES; STRESS; INFLAMMATION; EXPERIENCES; REACTIVITY; PATTERNS	Racial disparities in health are well-documented and represent a significant public health concern in the US. Racism-related factors contribute to poorer health and higher mortality rates among Blacks compared to other racial groups. However, methods to measure racism and monitor its associations with health at the population-level have remained elusive. In this study, we investigated the utility of a previously developed Internet search-based proxy of area racism as a predictor of Black mortality rates. Area racism was the proportion of Google searches containing the "N-word" in 196 designated market areas (DMAs). Negative binomial regression models were specified taking into account individual age, sex, year of death, and Census region and adjusted to the 2000 US standard population to examine the association between area racism and Black mortality rates, which were derived from death certificates and mid-year population counts collated by the National Center for Health Statistics (2004-2009). DMAs characterized by a one standard deviation greater level of area racism were associated with an 8.2% increase in the all-cause Black mortality rate, equivalent to over 30,000 deaths annually. The magnitude of this effect was attenuated to 5.7% after adjustment for DMA-level demographic and Black socioeconomic covariates. A model controlling for the White mortality rate was used to further adjust for unmeasured confounders that influence mortality overall in a geographic area, and to examine Black-White disparities in the mortality rate. Area racism remained significantly associated with the all-cause Black mortality rate (mortality rate ratio = 1.036; 95% confidence interval = 1.015, 1.057; p = 0.001). Models further examining cause-specific Black mortality rates revealed significant associations with heart disease, cancer, and stroke. These findings are congruent with studies documenting the deleterious impact of racism on health among Blacks. Our study contributes to evidence that racism shapes patterns in mortality and generates racial disparities in health.	[Chae, David H.; Gold, Robert S.] Univ Maryland, Dept Epidemiol & Biostat, Sch Publ Hlth, College Pk, MD 20742 USA; [Clouston, Sean] SUNY Stony Brook, Hlth Sci Ctr, Dept Prevent Med, Stony Brook, NY 11794 USA; [Hatzenbuehler, Mark L.; Link, Bruce G.] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY USA; [Kramer, Michael R.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Cooper, Hannah L. F.] Emory Univ, Rollins Sch Publ Hlth, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA; [Wilson, Sacoby M.] Univ Maryland, Maryland Inst Appl Environm Hlth, Sch Publ Hlth, College Pk, MD 20742 USA; [Stephens-Davidowitz, Seth I.] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA	University System of Maryland; University of Maryland College Park; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Columbia University; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; University System of Maryland; University of Maryland College Park; Harvard University	Chae, DH (corresponding author), Univ Maryland, Dept Epidemiol & Biostat, Sch Publ Hlth, College Pk, MD 20742 USA.	hdchae@umd.edu	Kramer, Michael R/A-3195-2013; Link, Bruce/AAO-9094-2021; Clouston, Sean/L-4653-2013	Kramer, Michael R/0000-0002-6372-6170; Clouston, Sean/0000-0002-6124-0329	National Institute on Aging of the National Institutes of Health [K01AG041787]; Robert Wood Johnson Foundation; Google, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG041787] Funding Source: NIH RePORTER	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Google, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	DHC was supported by the National Institute on Aging of the National Institutes of Health under Award Number K01AG041787. BGL was supported by grants from the Robert Wood Johnson Foundation during the course of the study. SIS-D received funding in the form of salary from Google, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Robert Wood Johnson Foundation.	[Anonymous], 2012, CD ROM SER, V20; Bertrand M., 2003, ARE EMILY GREG MORE; Bobo L, 1996, SOC FORCES, V74, P883, DOI 10.2307/2580385; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; Chae DH, 2014, AM J PREV MED, V46, P103, DOI 10.1016/j.amepre.2013.10.020; Chae DH, 2012, PSYCHOSOM MED, V74, P961, DOI 10.1097/PSY.0b013e3182733665; Chae DH, 2011, DU BOIS REV, V8, P63, DOI 10.1017/S1742058X11000166; Chae DH, 2010, SOC SCI MED, V71, P1182, DOI 10.1016/j.socscimed.2010.05.045; Cheng WS, 2008, DIABETES CARE, V31, P279, DOI 10.2337/dc07-1327; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Clark R, 1999, AM PSYCHOL, V54, P805, DOI 10.1037/0003-066X.54.10.805; Cooper DE, 2009, TLS-TIMES LIT SUPPL, P22; COOPER R, 1981, INT J HEALTH SERV, V11, P511, DOI 10.2190/WJEP-VB83-GAUT-XEJR; Cunningham TJ, 2012, SOC SCI MED, V75, P922, DOI 10.1016/j.socscimed.2012.04.027; Darity WA, 2003, AM J PUBLIC HEALTH, V93, P226, DOI 10.2105/AJPH.93.2.226; Dinwiddie GY, 2013, SOC SCI MED, V80, P67, DOI 10.1016/j.socscimed.2012.11.024; Dovidio JF, 2000, PSYCHOL SCI, V11, P315, DOI 10.1111/1467-9280.00262; Duncan DT, 2013, J URBAN HEALTH, V90, P618, DOI 10.1007/s11524-012-9770-y; Duru OK, 2012, J NATL MED ASSOC, V104, P89, DOI 10.1016/S0027-9684(15)30120-6; Friedman EM, 2009, BRAIN BEHAV IMMUN, V23, P684, DOI 10.1016/j.bbi.2009.01.002; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Gelman A, 2007, J AM STAT ASSOC, V102, P813, DOI 10.1198/016214506000001040; Geronimus AT, 2006, AM J PUBLIC HEALTH, V96, P826, DOI 10.2105/AJPH.2004.060749; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Hansel A, 2010, NEUROSCI BIOBEHAV R, V35, P115, DOI 10.1016/j.neubiorev.2009.12.012; Hayanga AJ, 2013, JAMA SURG, V148, P37, DOI 10.1001/jamasurgery.2013.408; Kau JB, 2012, J REAL ESTATE FINANC, V45, P289, DOI 10.1007/s11146-011-9330-3; Krieger N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027636; LAVEIST TA, 1993, MILBANK Q, V71, P41, DOI 10.2307/3350274; Lewis TT, 2006, PSYCHOSOM MED, V68, P362, DOI 10.1097/01.psy.0000221360.94700.16; Lewis TT, 2010, BRAIN BEHAV IMMUN, V24, P438, DOI 10.1016/j.bbi.2009.11.011; Malat J, 2011, ETHNIC DIS, V21, P349; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; Merritt MM, 2006, HEALTH PSYCHOL, V25, P364, DOI 10.1037/0278-6133.25.3.364; Murphy SL, 2013, NATL VITAL STAT REPO; National Research Council, 2003, UNEQUAL TREATMENT CO; National Research Council, 2004, MEAS RAC DISCR; Paradies Y, 2006, INT J EPIDEMIOL, V35, P888, DOI 10.1093/ije/dyl056; Pittman CT, 2011, J BLACK STUD, V42, P1106, DOI 10.1177/0021934711401737; Richman LS, 2008, ANN BEHAV MED, V35, P105, DOI 10.1007/s12160-007-9013-8; Scheitle CP, 2011, SOC SCI QUART, V92, P285, DOI 10.1111/j.1540-6237.2011.00768.x; Stephens-Davidowitz S, 2014, J PUBLIC ECON, V118, P26, DOI 10.1016/j.jpubeco.2014.04.010; Szanton SL, 2012, INT J BEHAV MED, V19, P489, DOI 10.1007/s12529-011-9188-z; US Census Bureau, 2012, SUMM FIL 2004 2009 A; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Williams DR, 2003, AM J PUBLIC HEALTH, V93, P200, DOI 10.2105/AJPH.93.2.200; WILLIAMS DR, 1997, J HLTH PSYCHOL, V0002; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7; WILLIAMS DR, 1995, ANNU REV SOCIOL, V21, P349, DOI 10.1146/annurev.so.21.080195.002025; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x	50	107	108	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122963	10.1371/journal.pone.0122963	http://dx.doi.org/10.1371/journal.pone.0122963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG6AH	25909964	Green Published, gold			2022-12-27	WOS:000353376800024
J	Jung, K; Cho, JY; Soh, YJ; Lee, J; Shin, SW; Jang, S; Jung, E; Kim, MH; Lee, J				Jung, Kwangseon; Cho, Jae Youl; Soh, Young-Jin; Lee, Jienny; Shin, Seoung Woo; Jang, Sunghee; Jung, Eunsun; Kim, Min Hee; Lee, Jongsung			Antagonizing Effects of Aspartic Acid against Ultraviolet A-Induced Downregulation of the Stemness of Human Adipose Tissue-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							ACTIVATION; RADIATION; HYPOXIA	Ultraviolet A (UVA) irradiation is responsible for a variety of changes in cell biology. The purpose of this study was to investigate effects of aspartic acid on UVA irradiation-induced damages in the stemness properties of human adipose tissue-derived mesenchymal stem cells (hAMSCs). Furthermore, we elucidated the UVA-antagonizing mechanisms of aspartic acid. The results of this study showed that aspartic acid attenuated the UVA-induced reduction of the proliferative potential and stemness of hAMSCs, as evidenced by increased proliferative activity in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and upregulation of stemness-related genes OCT4, NANOG, and SOX2 in response to the aspartic acid treatment. UVA-induced reduction in the mRNA level of hypoxiainducible factor (HIF)-1 alpha was also significantly recovered by aspartic acid. In addition, the antagonizing effects of aspartic acid against the UVA effects were found to be mediated by reduced production of PGE2 through the inhibition of JNK and p42/44 MAPK. Taken together, these findings show that aspartic acid improves reduced stemness of hAMSCs induced by UVA and its effects are mediated by upregulation of HIF-1 alpha via the inhibition of PGE2-cAMP signaling. In addition, aspartic acid may be used as an antagonizing agent to mitigate the effects of UVA.	[Jung, Kwangseon; Lee, Jongsung] Eulji Univ, Dept Convergence Biomed Sci & Engn, Songnam, Gyunggi Do, South Korea; [Jung, Kwangseon] Skincure Life Sci Inst, Songnam, Gyunggi Do, South Korea; [Cho, Jae Youl] Sungkyunkwan Univ, Dept Genet Engn, Suwon, Gyeonggi Do, South Korea; [Lee, Jienny] Anim & Plant Quarantine Agcy, Div Viral Dis, Anyang Si, Gyeonggi Do, South Korea; [Shin, Seoung Woo; Jung, Eunsun] Biospectr Life Sci Inst, Songnam, Gyunggi Do, South Korea; [Jang, Sunghee; Lee, Jongsung] Eulji Univ, Grad Sch, Dept Senior Healthcare, Plus Program BK21, Songnam, Gyunggi Do, South Korea; [Kim, Min Hee] Eulji Univ, Dept Phys Therapy, Coll Hlth Sci, Songnam, Gyunggi Do, South Korea; [Soh, Young-Jin] Eulji Univ, Coll Hlth Sci, Dept Dermatol Hlth Management, Songnam, Gyunggi Do, South Korea	Eulji University; Sungkyunkwan University (SKKU); Animal & Plant Quarantine Agency; Eulji University; Eulji University; Eulji University	Lee, J (corresponding author), Eulji Univ, Dept Convergence Biomed Sci & Engn, Songnam, Gyunggi Do, South Korea.	jslee@eulji.ac.kr		Shin, Seoungwoo/0000-0001-5354-7286	Korean Health Technology R & D Project, Ministry of Health and Welfare, Republic of Korea [HN13C0072]; Skincure Life Science Institute	Korean Health Technology R & D Project, Ministry of Health and Welfare, Republic of Korea; Skincure Life Science Institute	This study was supported by a grant from the Korean Health Technology R & D Project, Ministry of Health and Welfare, Republic of Korea (Grant Number: HN13C0072). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Kwangseon Jung is employed by Skincure Life Science Institute. Skincure Life Science Institute provided support in the form of salary for author KJ, but did not have any additional role in the study	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Canino C, 2012, ONCOGENE, V31, P3148, DOI 10.1038/onc.2011.485; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Halliday GM, 2008, PHOTOCHEM PHOTOBIOL, V84, P35, DOI 10.1111/j.1751-1097.2007.00212.x; HORN TD, 1994, J AM ACAD DERMATOL, V31, P735, DOI 10.1016/S0190-9622(94)70234-9; Lee J, 2007, BIOCHEM PHARMACOL, V74, P960, DOI 10.1016/j.bcp.2007.06.007; Lee J, 2012, J CELL BIOCHEM, V113, P3681, DOI 10.1002/jcb.24241; Lee J, 2010, J BIOL CHEM, V285, P32647, DOI 10.1074/jbc.M110.135830; Mitani H, 1999, PHOTOCHEM PHOTOBIOL, V69, P41, DOI 10.1562/0031-8655(1999)069<0041:AOHMSE>2.3.CO;2; Moreno-Manzano V, 2010, J BIOL CHEM, V285, P1333, DOI 10.1074/jbc.M109.008326; Nadler JV, 2011, NEUROCHEM RES, V36, P668, DOI 10.1007/s11064-010-0291-3; Rycerz K, 2013, FOLIA NEUROPATHOL, V51, P10, DOI 10.5114/fn.2013.34191; Sakata D, 2010, J PHARMACOL SCI, V112, P1, DOI 10.1254/jphs.09R03CP; Situm M, 2010, COLLEGIUM ANTROPOL, V34, P9; Sunderkotter C, 2006, RHEUMATOLOGY, V45, P52, DOI 10.1093/rheumatology/kel293; Torii S, 2009, J BIOCHEM, V146, P839, DOI 10.1093/jb/mvp129	17	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124417	10.1371/journal.pone.0124417	http://dx.doi.org/10.1371/journal.pone.0124417			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909857	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800082
J	Lim, YW; Meyer, NP; Shah, AS; Budde, MD; Stemper, BD; Olsen, CM				Lim, Yi Wei; Meyer, Nathan P.; Shah, Alok S.; Budde, Matthew D.; Stemper, Brian D.; Olsen, Christopher M.			Voluntary Alcohol Intake following Blast Exposure in a Rat Model of Mild Traumatic Brain Injury	PLOS ONE			English	Article							SUBSTANCE-ABUSE; ETHANOL-CONSUMPTION; PREFRONTAL CORTEX; ANIMAL-MODELS; DRINKING; OVERPRESSURE; PREFERENCE; RESISTANT; ADDICTION; BEHAVIOR	Alcoholism is a frequent comorbidity following mild traumatic brain injury (mTBI), even in patients without a previous history of alcohol dependence. Despite this correlational relationship, the extent to which the neurological effects of mTBI contribute to the development of alcoholism is unknown. In this study, we used a rodent blast exposure model to investigate the relationship between mTBI and voluntary alcohol drinking in alcohol naive rats. We have previously demonstrated in Sprague Dawley rats that blast exposure leads to microstructural abnormalities in the medial prefrontal cortex (mPFC) and other brain regions that progress from four to thirty days. The mPFC is a brain region implicated in alcoholism and drug addiction, although the impact of mTBI on drug reward and addiction using controlled models remains largely unexplored. Alcohol naive Sprague Dawley rats were subjected to a blast model of mTBI (or sham conditions) and then tested in several common measures of voluntary alcohol intake. In a seven-week intermittent two-bottle choice alcohol drinking test, sham and blast exposed rats had comparable levels of alcohol intake. In a short access test session at the conclusion of the two-bottle test, blast rats fell into a bimodal distribution, and among high intake rats, blast treated animals had significantly elevated intake compared to shams. We found no effect of blast when rats were tested for an alcohol deprivation effect or compulsive drinking in a quinine adulteration test. Throughout the experiment, alcohol drinking was modest in both groups, consistent with other studies using Sprague Dawley rats. In conclusion, blast exposure had a minimal impact on overall alcohol intake in Sprague Dawley rats, although intake was increased in a subpopulation of blast animals in a short access session following intermittent access exposure.	[Lim, Yi Wei; Meyer, Nathan P.; Budde, Matthew D.; Stemper, Brian D.; Olsen, Christopher M.] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA; [Lim, Yi Wei; Meyer, Nathan P.; Olsen, Christopher M.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Shah, Alok S.; Budde, Matthew D.; Stemper, Brian D.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Shah, Alok S.; Budde, Matthew D.; Stemper, Brian D.] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Olsen, CM (corresponding author), Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA.	colsen@mcw.edu	Stemper, Brian/AAX-7611-2020; Olsen, Christopher/G-9595-2013	Olsen, Christopher/0000-0003-2700-0310	Neuroscience Research Center at the Medical College of Wisconsin; Research and Education Initiative Fund , a component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin; United States (U.S.) Department of Veterans Affairs [I01 RX000380]; Veterans Health Administration, Rehabilitation Research and Development Service Program, and Veterans Affairs Medical Research; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA039276] Funding Source: NIH RePORTER	Neuroscience Research Center at the Medical College of Wisconsin; Research and Education Initiative Fund , a component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin; United States (U.S.) Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Health Administration, Rehabilitation Research and Development Service Program, and Veterans Affairs Medical Research; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Neuroscience Research Center at the Medical College of Wisconsin (CMO), the Research and Education Initiative Fund, a component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin (CMO), Merit Review Award I01 RX000380 from the United States (U.S.) Department of Veterans Affairs (MDB), Veterans Health Administration, Rehabilitation Research and Development Service Program, and Veterans Affairs Medical Research (BDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy K, 2010, INT REV NEUROBIOL, V91, P289, DOI 10.1016/S0074-7742(10)91009-X; Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; AMIT Z, 1970, PSYCHOPHARMACOLOGIA, V17, P367, DOI 10.1007/BF00403808; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Beck A, 2012, ARCH GEN PSYCHIAT, V69, P842, DOI 10.1001/archgenpsychiatry.2011.2026; Becker HC, 2013, CURR TOP BEHAV NEURO, V13, P355, DOI 10.1007/7854_2012_203; Bito-Onon JJ, 2011, ADDICT BIOL, V16, P440, DOI 10.1111/j.1369-1600.2010.00309.x; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Camicella S, 2009, ALCOHOL, V43, P35, DOI 10.1016/j.alcohol.2008.12.001; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Control NcfIPa, 2003, REP C MILD TRAUM BRA; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Edwards S, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.70; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fein G, 2002, ALCOHOL CLIN EXP RES, V26, P558, DOI 10.1111/j.1530-0277.2002.tb02574.x; Fetzner MG, 2011, DEPRESS ANXIETY, V28, P632, DOI 10.1002/da.20852; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Heltemes KJ, 2011, MIL MED, V176, P147, DOI 10.7205/MILMED-D-10-00191; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Holmes A, 2012, NAT NEUROSCI, V15, P1359, DOI 10.1038/nn.3204; Hopf FW, 2010, ALCOHOL CLIN EXP RES, V34, P1565, DOI 10.1111/j.1530-0277.2010.01241.x; KHANNA JM, 1990, ALCOHOL, V7, P429, DOI 10.1016/0741-8329(90)90027-A; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Li J, 2011, BRAIN RES BULL, V86, P428, DOI 10.1016/j.brainresbull.2011.08.013; LINSEMAN MA, 1987, PSYCHOPHARMACOLOGY, V92, P254; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lowing JL, 2014, J NEUROTRAUMA; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; McBride WJ, 1998, CRIT REV NEUROBIOL, V12, P339, DOI 10.1615/CritRevNeurobiol.v12.i4.40; Moorman DE, 2009, ALCOHOL, V43, P379, DOI 10.1016/j.alcohol.2009.07.002; Naqvi NH, 2010, BRAIN STRUCT FUNCT, V214, P435, DOI 10.1007/s00429-010-0268-7; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Samson HH, 2003, INT REV NEUROBIOL, V54, P109; Seif T, 2013, NAT NEUROSCI, V16, P1094, DOI 10.1038/nn.3445; Shah Ms Alok S, 2012, Biomed Sci Instrum, V48, P393; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; SINCLAIR JD, 1968, Q J STUD ALCOHOL, V29, P863; Stemper B.D., 2014, ANN BIOMED ENG; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Teng SX, 2014, BRAIN BEHAV IMMUN; Tiffany ST, 2000, ADDICTION, V95, pS145, DOI 10.1046/j.1360-0443.95.8s2.3.x; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Vengeliene V, 2014, ALCOHOL, V48, P313, DOI 10.1016/j.alcohol.2014.03.002; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034; Yoneyama N, 2008, ALCOHOL, V42, P149, DOI 10.1016/j.alcohol.2007.12.006; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	66	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125130	10.1371/journal.pone.0125130	http://dx.doi.org/10.1371/journal.pone.0125130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910266	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800130
J	Dewji, NN; Singer, SJ; Masliah, E; Rockenstein, E; Kim, M; Harber, M; Horwood, T				Dewji, Nazneen N.; Singer, S. Jonathan; Masliah, Eliezer; Rockenstein, Edward; Kim, Mihyun; Harber, Martha; Horwood, Taylor			Peptides of Presenilin-1 Bind the Amyloid Precursor Protein Ectodomain and Offer a Novel and Specific Therapeutic Approach to Reduce beta-Amyloid in Alzheimer's Disease	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; MEMBRANE TOPOLOGY; DOMAIN; SURFACE; APP; ACTIVATION; EXPRESSION; DEPOSITION; RELEASE; PATHWAY	beta-Amyloid (A beta) accumulation in the brain is widely accepted to be critical to the development of Alzheimer's disease (AD). Current efforts at reducing toxic A beta 40 or 42 have largely focused on modulating.-secretase activity to produce shorter, less toxic A beta, while attempting to spare other secretase functions. In this paper we provide data that offer the potential for a new approach for the treatment of AD. The method is based on our previous findings that the production of A beta from the interaction between the beta-amyloid precursor protein (APP) and Presenilin (PS), as part of the gamma-secretase complex, in cell culture is largely inhibited if the entire water-soluble NH2-terminal domain of PS is first added to the culture. Here we demonstrate that two small, non-overlapping water-soluble peptides from the PS-1 NH2-terminal domain can substantially and specifically inhibit the production of total A beta as well as A beta 40 and 42 in vitro and in vivo in the brains of APP transgenic mice. These results suggest that the inhibitory activity of the entire amino terminal domain of PS-1 on A beta production is largely focused in a few smaller sequences within that domain. Using biolayer interferometry and confocal microscopy we provide evidence that peptides effective in reducing A beta give a strong, specific and biologically relevant binding with the purified ectodomain of APP 695. Finally, we demonstrate that the reduction of A beta by the peptides does not affect the catalytic activities of beta- or gamma-secretase, or the level of APP. P4 and P8 are the first reported protein site-specific small peptides to reduce A beta production in model systems of AD. These peptides and their derivatives offer new potential drug candidates for the treatment of AD.	[Dewji, Nazneen N.; Kim, Mihyun] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Masliah, Eliezer; Rockenstein, Edward] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Singer, S. Jonathan] Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; [Dewji, Nazneen N.; Singer, S. Jonathan; Kim, Mihyun] Cenna Biosci Inc, La Jolla, CA 92037 USA; [Harber, Martha] Pall Corp, ForteBio, Menlo Pk, CA 94025 USA; [Horwood, Taylor] Univ Calif San Diego, Dept Neurosci Imaging Core, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Pall Corporation; University of California System; University of California San Diego	Dewji, NN (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	ndewji@ucsd.edu			National Institutes of Health [5RO1NS055161, 5RO1AG17888, 1R43AG043278, AG18440, AG022074, AG011385, AG03197, NS057096]; Alzheimer's Drug Discovery Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096, R01NS055161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131, R01AG011385, R37AG011385, R01AG017888, R37AG018440, R44AG043278, R01AG018440, P01AG022074, R43AG043278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Drug Discovery Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by National Institutes of Health grants 5RO1NS055161, 5RO1AG17888, 1R43AG043278 and Alzheimer's Drug Discovery Foundation to NND, and National Institutes of Health grants AG18440, AG022074, AG011385, AG03197, NS057096 to EM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Dahms SO, 2010, P NATL ACAD SCI USA, V107, P5381, DOI 10.1073/pnas.0911326107; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dewji NN, 2006, P NATL ACAD SCI USA, V103, P1540, DOI 10.1073/pnas.0509899103; Dewji NN, 2005, CELL MOL LIFE SCI, V62, P1109, DOI 10.1007/s00018-005-4566-9; Dewji NN, 2004, P NATL ACAD SCI USA, V101, P1057, DOI 10.1073/pnas.0307290101; Dewji NN, 1996, P NATL ACAD SCI USA, V93, P12575, DOI 10.1073/pnas.93.22.12575; Dewji NN, 1997, P NATL ACAD SCI USA, V94, P9926, DOI 10.1073/pnas.94.18.9926; Dewji NN, 1996, SCIENCE, V271, P159, DOI 10.1126/science.271.5246.159; Doan A, 1996, NEURON, V17, P1023, DOI 10.1016/S0896-6273(00)80232-9; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gralle M, 2006, J MOL BIOL, V357, P493, DOI 10.1016/j.jmb.2005.12.053; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Keselman HJ, 1998, REV EDUC RES, V68, P350, DOI 10.2307/1170601; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Lee S, 2011, BIOCHEMISTRY-US, V50, P5453, DOI 10.1021/bi101846x; Lehmann S, 1997, J BIOL CHEM, V272, P12047, DOI 10.1074/jbc.272.18.12047; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Li XJ, 1996, NEURON, V17, P1015, DOI 10.1016/S0896-6273(00)80231-7; Lleo A, 2006, ANNU REV MED, V57, P513, DOI 10.1146/annurev.med.57.121304.131442; Lleo A, 2011, CURR TOP MED CHEM, V11, P1513, DOI 10.2174/156802611795861004; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nakai T, 1999, J BIOL CHEM, V274, P23647, DOI 10.1074/jbc.274.33.23647; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; O'Reilly DR, 1992, BACULOVIRUS EXPRESSI, P150; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Oh YS, 2005, AM J PHYSIOL-CELL PH, V289, pC576, DOI 10.1152/ajpcell.00636.2004; Pradier L, 1999, NEUROBIOL DIS, V6, P43, DOI 10.1006/nbdi.1998.0212; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Ray WJ, 1999, P NATL ACAD SCI USA, V96, P3263, DOI 10.1073/pnas.96.6.3263; Rich RL, 2009, ANAL BIOCHEM, V386, P194, DOI 10.1016/j.ab.2008.11.021; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Schwarzman AL, 1999, P NATL ACAD SCI USA, V96, P7932, DOI 10.1073/pnas.96.14.7932; So Pauline Pl, 2012, Am J Neurodegener Dis, V1, P75; Takagi S, 2010, J NEUROSCI, V30, P15943, DOI 10.1523/JNEUROSCI.3318-10.2010; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Verheijen JH, 2006, CLIN CHEM, V52, P1168, DOI 10.1373/clinchem.2006.066720; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; Waragai M, 1997, BIOCHEM BIOPH RES CO, V239, P480, DOI 10.1006/bbrc.1997.7488; Weidemann A, 1997, NAT MED, V3, P328, DOI 10.1038/nm0397-328; Zage PE, 2012, PEDIATR BLOOD CANCER, V58, P682, DOI 10.1002/pbc.23202; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	55	6	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122451	10.1371/journal.pone.0122451	http://dx.doi.org/10.1371/journal.pone.0122451			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923432	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600014
J	Qadeer, E; Fatima, R; Fielding, K; Qazi, F; Moore, D; Khan, MS				Qadeer, Ejaz; Fatima, Razia; Fielding, Katherine; Qazi, Fahad; Moore, David; Khan, Mishal S.			Good Quality Locally Procured Drugs Can Be as Effective as Internationally Quality Assured Drugs in Treating Multi-Drug Resistant Tuberculosis	PLOS ONE			English	Article							ACID-FAST BACILLI; PULMONARY TUBERCULOSIS; CULTURE CONVERSION; PREDICTORS; OUTCOMES; SPUTUM	Background Owing toGiven the high costs of drugs to treat multi-drug resistant tuberculosis (MDR-TB), the Green Light Committee (GLC) initiative enables TB programs to procure quality-assured drugs at reduced prices. Despite price reductions, internationally quality assured (IQA) drugs can be more expensive than locally procured drugs. There is little evidence to inform decision-makers about whether IQA drugs are more effective than local drugs. This is the first study to compare outcomes between MDR-TB patients treated using IQA, and locally procured drugs in the same hospitals during the same time period. Methods/Findings A retrospective cohort study was conducted in three hospitals across Pakistan. Data on baseline characteristics and treatment outcomes during the first six months of treatment were extracted from hospital records of adult culture-positive pulmonary MDR-TB patients starting treatment between January 2011 and June 2012. Two cohorts were defined: patients receiving IQA drugs, and patients receiving locally procured non-IQA drugs. Data were analysed using Kaplan-Meier curves and Cox proportional hazards regression. The primary outcome compared between cohorts was time to culture conversion. Of 231 patients, 90 were in the IQA and 141 in the non-IQA cohorts. Baseline characteristics were similar except for higher frequency of quinolone resistance in the IQA cohort. Overall, 193 patients (84%) culture converted. Culture conversion was not faster in the IQA cohort; the median time was 81 and 68 days in the IQA and non-IQA cohorts, respectively. Unadjusted and adjusted hazard ratios for culture conversion in IQA verses non-IQA cohorts were 0.82 (95%-CI, 0.62-1.10) and 0.95 (95%-CI, 0.66-1.36) respectively. Conclusions Use of good quality, locally procured drugs can be effective in treating MDR-TB, may involve lower costs than using IQA drugs and could strengthen developing country drug quality assurance systems. This may be a suitable alternative in lieu of or whilst awaiting arrival of internationally procured medicines.	[Qadeer, Ejaz; Fatima, Razia] Natl TB Control Program Pakistan, Islamabad, Pakistan; [Fielding, Katherine; Moore, David; Khan, Mishal S.] London Sch Hyg & Trop Med, London WC1, England; [Qazi, Fahad] Res Alliance Advocacy & Dev, Karachi, Pakistan	University of London; London School of Hygiene & Tropical Medicine	Khan, MS (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	mishal.khan@lshtm.ac.uk			Global Fund To Fight AIDS, Tuberculosis and Malaria (GFATM); Medical Research Council [MR/K012126/1] Funding Source: researchfish	Global Fund To Fight AIDS, Tuberculosis and Malaria (GFATM); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by operational research funds made available to the Pakistan National TB Program by the Global Fund To Fight AIDS, Tuberculosis and Malaria (GFATM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Moamary MS, 1999, CHEST, V116, P726, DOI 10.1378/chest.116.3.726; Almuzaini T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002923; [Anonymous], 2013, GLOB TUB REP; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Gupta R, 2000, P M CAMBR US 5 6 JUL; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kurbatova EV, 2012, TUBERCULOSIS, V92, P397, DOI 10.1016/j.tube.2012.06.003; Lee JS, 2008, J KOREAN MED SCI, V23, P767, DOI 10.3346/jkms.2008.23.5.767; Mpagama SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062034; Qazi F, 2011, INT J TUBERC LUNG D, V15, P1556, DOI 10.5588/ijtld.10.0679; WHO, 2011, NEW GLOB FRAM SUPP E; Yew WW, 2000, CHEST, V117, P744, DOI 10.1378/chest.118.3.744	13	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0126099	10.1371/journal.pone.0126099	http://dx.doi.org/10.1371/journal.pone.0126099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923538	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000353711600171
J	Wissuwa, M; Kondo, K; Fukuda, T; Mori, A; Rose, MT; Pariasca-Tanaka, J; Kretzschmar, T; Haefele, SM; Rose, TJ				Wissuwa, Matthias; Kondo, Katsuhiko; Fukuda, Takuya; Mori, Asako; Rose, Michael T.; Pariasca-Tanaka, Juan; Kretzschmar, Tobias; Haefele, Stephan M.; Rose, Terry J.			Unmasking Novel Loci for Internal Phosphorus Utilization Efficiency in Rice Germplasm through Genome-Wide Association Analysis	PLOS ONE			English	Article							COMPLEX TRAITS; ORYZA-SATIVA; DEFICIENCY; PLANT; DEPRIVATION; TOLERANCE; SEQUENCE; IMPROVE; CROPS	Depletion of non-renewable rock phosphate reserves and phosphorus (P) fertilizer price increases has renewed interest in breeding P-efficient varieties. Internal P utilization efficiency (PUE) is of prime interest because there has been no progress to date in breeding for high PUE. We characterized the genotypic variation for PUE present within the rice gene pool by using a hydroponic system that assured equal plant P uptake, followed by mapping of loci controlling PUE via Genome-Wide Association Studies (GWAS). Loci associated with PUE were mapped on chromosomes 1, 4, 11 and 12. The highest PUE was associated with a minor indica-specific haplotype on chromosome 1 and a rare aus-specific haplotype on chromosome 11. Comparative variant and expression analysis for genes contained within the chromosome 1 haplotype identified high priority candidate genes. Differences in coding regions and expression patterns between genotypes of contrasting haplotypes, suggested functional alterations for two predicted nucleic acid-interacting proteins that are likely causative for the observed differences in PUE. The loci reported here are the first identified for PUE in any crop that is not confounded by differential P uptake among genotypes. Importantly, modern rice varieties lacked haplotypes associated with superior PUE, and would thus benefit from targeted introgressions of these loci from traditional donors to improve plant growth in phosphorus-limited cropping systems.	[Wissuwa, Matthias; Kondo, Katsuhiko; Fukuda, Takuya; Mori, Asako; Rose, Michael T.; Pariasca-Tanaka, Juan; Rose, Terry J.] Japan Int Res Ctr Agr Sci, Crop Livestock & Environm Div, Tsukuba, Ibaraki, Japan; [Rose, Michael T.] Monash Univ, Sch Chem, Clayton, Vic, Australia; [Kretzschmar, Tobias] IRRI, Los Banos, Philippines; [Haefele, Stephan M.] ACPFG, Glen Osmond, SA, Australia; [Rose, Terry J.] So Cross Univ, Ctr Plant Sci, Lismore, NSW 2480, Australia	Japan International Research Center for Agricultural Sciences; Monash University; CGIAR; International Rice Research Institute (IRRI); Southern Cross University	Wissuwa, M (corresponding author), Japan Int Res Ctr Agr Sci, Crop Livestock & Environm Div, Tsukuba, Ibaraki, Japan.	mcwissuwa@gmail.com	Rose, Michael/P-2161-2016; Haefele, Stephan M/E-1256-2017; kretzschmar, tobias/AAH-3739-2021	Rose, Michael/0000-0001-6457-145X; Haefele, Stephan M/0000-0003-0389-8373; kretzschmar, tobias/0000-0002-8227-0746; Wissuwa, Matthias/0000-0003-3505-9398; Rose, Terry/0000-0001-5386-6818	Japan Society for the Promotion of Science (JSPS)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Financial support for this work was provided by the Japan Society for the Promotion of Science (JSPS), https://www.jsps.go.jp/english/, in the form of postdoctoral fellowships to TJR and MTR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brown RL, 2003, BIOCHEM BIOPH RES CO, V306, P394, DOI 10.1016/S0006-291X(03)00982-3; Calderon-Vazquez C, 2011, PLANT PHYSIOL, V156, P1067, DOI 10.1104/pp.111.174987; Chin JH, 2011, PLANT PHYSIOL, V156, P1202, DOI 10.1104/pp.111.175471; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; GOURLEY CJP, 1994, PLANT SOIL, V158, P29, DOI 10.1007/BF00007914; Hammond JP, 2004, ANN BOT-LONDON, V94, P323, DOI 10.1093/aob/mch156; Heuer S, 2009, PLANT BIOTECHNOL J, V7, P456, DOI 10.1111/j.1467-7652.2009.00415.x; Hofmann A, 2000, EMBO J, V19, P6207, DOI 10.1093/emboj/19.22.6207; Ismail AM, 2007, PLANT MOL BIOL, V65, P547, DOI 10.1007/s11103-007-9215-2; Kim HJ, 1999, MOL CELL BIOL, V19, P6323; Manske GGB, 2002, EUPHYTICA, V125, P113, DOI 10.1023/A:1015760600750; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Oono Y, 2013, PLANT MOL BIOL, V83, P523, DOI 10.1007/s11103-013-0106-4; Pariasca-Tanaka J, 2009, RICE, V2, P167, DOI 10.1007/s12284-009-9032-0; Plaxton WC, 2011, PLANT PHYSIOL, V156, P1006, DOI 10.1104/pp.111.175281; Richardson AE, 2011, PLANT SOIL, V349, P121, DOI 10.1007/s11104-011-0950-4; Rose TJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00073; Rose TJ, 2012, ADV AGRON, V116, P185, DOI 10.1016/B978-0-12-394277-7.00005-1; Sharpley AN, 2001, PLANT SOIL, V237, P287, DOI 10.1023/A:1013335814593; Shen JB, 2011, PLANT PHYSIOL, V156, P997, DOI 10.1104/pp.111.175232; Shenoy VV, 2005, BIOTECHNOL ADV, V23, P501, DOI 10.1016/j.biotechadv.2005.01.004; SIDDIQI MY, 1981, J PLANT NUTR, V4, P289, DOI 10.1080/01904168109362919; Steen I, 1998, PHOSP POTAS, V217, P25; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sulpice R, 2014, PLANT CELL ENVIRON, V37, P1276, DOI 10.1111/pce.12240; Veneklaas EJ, 2012, NEW PHYTOL, V195, P306, DOI 10.1111/j.1469-8137.2012.04190.x; Wang XR, 2010, PLANT SCI, V179, P302, DOI 10.1016/j.plantsci.2010.06.007; Wissuwa M, 1998, THEOR APPL GENET, V97, P777, DOI 10.1007/s001220050955; Wissuwa M, 2009, PLANT SOIL, V321, P409, DOI 10.1007/s11104-008-9693-2; Yoshida S, 1971, INT RICE RES I; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zheng LQ, 2009, PLANT PHYSIOL, V151, P262, DOI 10.1104/pp.109.141051	35	50	51	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124215	10.1371/journal.pone.0124215	http://dx.doi.org/10.1371/journal.pone.0124215			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923470	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600074
J	Zhang, JJ; O'Reilly, KM; Perry, GLW; Taylor, GA; Dennis, TE				Zhang, Jingjing; O'Reilly, Kathleen M.; Perry, George L. W.; Taylor, Graeme A.; Dennis, Todd E.			Extending the Functionality of Behavioural Change-Point Analysis with k-Means Clustering: A Case Study with the Little Penguin (Eudyptula minor)	PLOS ONE			English	Article							ANIMAL MOVEMENT DATA; FORAGING BEHAVIOR; LARGE HERBIVORES; TELEMETRY DATA; RANDOM-WALKS; MODELS; SPACE; ISLAND; SELECTION; STATES	We present a simple framework for classifying mutually exclusive behavioural states within the geospatial lifelines of animals. This method involves use of three sequentially applied statistical procedures: (1) behavioural change point analysis to partition movement trajectories into discrete bouts of same-state behaviours, based on abrupt changes in the spatiotemporal autocorrelation structure of movement parameters; (2) hierarchical multivariate cluster analysis to determine the number of different behavioural states; and (3) k-means clustering to classify inferred bouts of same-state location observations into behavioural modes. We demonstrate application of the method by analysing synthetic trajectories of known 'artificial behaviours' comprised of different correlated random walks, as well as real foraging trajectories of little penguins (Eudyptula minor) obtained by global-positioning-system telemetry. Our results show that the modelling procedure correctly classified 92.5% of all individual location observations in the synthetic trajectories, demonstrating reasonable ability to successfully discriminate behavioural modes. Most individual little penguins were found to exhibit three unique behavioural states (resting, commuting/active searching, area-restricted foraging), with variation in the timing and locations of observations apparently related to ambient light, bathymetry, and proximity to coastlines and river mouths. Addition of k-means clustering extends the utility of behavioural change point analysis, by providing a simple means through which the behaviours inferred for the location observations comprising individual movement trajectories can be objectively classified.	[Zhang, Jingjing; Perry, George L. W.; Dennis, Todd E.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [O'Reilly, Kathleen M.] Univ Portland, Dept Biol, Portland, OR 97203 USA; [Perry, George L. W.] Univ Auckland, Sch Environm, Auckland 1, New Zealand; [Taylor, Graeme A.] Dept Conservat, Wellington, New Zealand	University of Auckland; University of Portland; University of Auckland	Dennis, TE (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	t.dennis@auckland.ac.nz		Perry, George/0000-0001-9672-9135; Zhang, Jingjing/0000-0001-8809-3405	Fulbright Senior Scholar Award; Center for Biodiversity and Biosecurity, the University of Auckland	Fulbright Senior Scholar Award; Center for Biodiversity and Biosecurity, the University of Auckland	KO was supported by a Fulbright Senior Scholar Award. JZ received a research grant from the Center for Biodiversity and Biosecurity, the University of Auckland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PJAL, 2010, ZOOLOGIA-CURITIBA, V27, P674, DOI 10.1590/S1984-46702010000500002; Ares JO, 2010, ECOL MODEL, V221, P2323, DOI 10.1016/j.ecolmodel.2010.06.012; Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bilmes J. A., 1998, INT COMPUTER SCI I, V4, P126, DOI DOI 10.1080/0042098032000136147; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Bull L, 2000, NEW ZEAL J ZOOL, V27, P291, DOI 10.1080/03014223.2000.9518237; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cannell BL, 1998, IBIS, V140, P467, DOI 10.1111/j.1474-919X.1998.tb04608.x; Chiaradia A., 1999, THESIS U TASMANIA; Dalziel BD, 2010, AM NAT, V175, P762, DOI 10.1086/652521; Dean B, 2012, J R SOC INTERFACE, V10, DOI [10.1098/rsif.2012.0570(78), DOI 10.1098/RSIF.2012.0570(78)]; Dominoni DM, 2014, J ANIM ECOL, V83, P681, DOI 10.1111/1365-2656.12150; Edren SMC, 2010, ECOGRAPHY, V33, P698, DOI 10.1111/j.1600-0587.2009.05901.x; ERSI, 2013, ARCMAP; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fleming C, 2014, METHODS ECOLOGY EVOL; GALES R, 1990, J ZOOL, V220, P61, DOI 10.1111/j.1469-7998.1990.tb04294.x; Guilford T, 2004, J THEOR BIOL, V227, P25, DOI 10.1016/j.jtbi.2003.07.003; Guilford TC, 2008, IBIS, V150, P462, DOI 10.1111/j.1474-919X.2008.00805.x; Gurarie E, 2013, RCPT D RCPP L PACKAG; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Hanks EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022795; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hennig C., 2010, FPC FLEXIBLE PROCEDU, V2, P0; Johnson DS, 2008, BIOMETRICS, V64, P968, DOI 10.1111/j.1541-0420.2007.00943.x; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Kinsky F, 1976, SUBSPECIFIC REVISION; KLOMP NI, 1991, EMU, V91, P190, DOI 10.1071/MU9910190; Knell AS, 2012, THEOR ECOL-NETH, V5, P325, DOI 10.1007/s12080-011-0130-4; Kranstauber B, 2012, J ANIM ECOL, V81, P738, DOI 10.1111/j.1365-2656.2012.01955.x; KRZANOWSKI WJ, 1988, BIOMETRICS, V44, P23, DOI 10.2307/2531893; Macqueen J., 1967, P 5 BERK S MATH STAT, P281; Maechler M, 2014, CLUSTER CLUSTER ANAL; Marchant S, 1990, HDB AUSTR NZ ANTARCT, V1, p[125, 246]; Mattern T, 2001, THESIS O OTAGO; McClintock BT, 2012, ECOL MONOGR, V82, P335, DOI 10.1890/11-0326.1; Merrill E, 2010, PHILOS T R SOC B, V365, P2279, DOI 10.1098/rstb.2010.0077; Miller LA, 2012, INTEGR COMP BIOL, V52, P553, DOI 10.1093/icb/ics115; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Nams VO, 2014, ECOL LETT, V17, P1228, DOI 10.1111/ele.12328; Owen-Smith N, 2012, WILDLIFE RES, V39, P452, DOI 10.1071/WR12062; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Petersen SL, 2006, IBIS, V148, P14, DOI 10.1111/j.1474-919X.2006.00459.x; Postlethwaite CM, 2013, J THEOR BIOL, V317, P175, DOI 10.1016/j.jtbi.2012.10.007; Ropert-Coudert Y, 2006, MAR BIOL, V149, P139, DOI 10.1007/s00227-005-0188-x; Schwager M, 2007, COMPUT ELECTRON AGR, V56, P46, DOI 10.1016/j.compag.2007.01.002; *STATSOFT I, 2009, STAT DAT AN SOFTW SY; Team R Core, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Tremblay Y, 2007, J EXP BIOL, V210, P935, DOI 10.1242/jeb.02710; Tryon R. C., 1939, CLUSTER ANAL; Van Moorter B, 2010, J WILDLIFE MANAGE, V74, P588, DOI 10.2193/2009-155; Wilensky U., 1999, NETLOGO; Wilson RP, 1997, WILDLIFE SOC B, V25, P101; Wilson RP, 1990, FORAGING ECOLOGY BRE, P181	55	19	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122811	10.1371/journal.pone.0122811	http://dx.doi.org/10.1371/journal.pone.0122811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922935	gold, Green Published, Green Submitted			2022-12-27	WOS:000353711600022
J	Abehsera, S; Glazer, L; Tynyakov, J; Plaschkes, I; Chalifa-Caspi, V; Khalaila, I; Aflalo, ED; Sagi, A				Abehsera, Shai; Glazer, Lilah; Tynyakov, Jenny; Plaschkes, Inbar; Chalifa-Caspi, Vered; Khalaila, Isam; Aflalo, Eliahu D.; Sagi, Amir			Binary Gene Expression Patterning of the Molt Cycle: The Case of Chitin Metabolism	PLOS ONE			English	Article							SKELETAL STRUCTURES; CALCIUM-TRANSPORT; GASTROLITH DISK; CRAYFISH; DEPOSITION; ENZYMES; CALCIFICATION; CRUSTACEANS; ANNOTATION; PROTEINS	In crustaceans, like all arthropods, growth is accompanied by a molting cycle. This cycle comprises major physiological events in which mineralized chitinous structures are built and degraded. These events are in turn governed by genes whose patterns of expression are presumably linked to the molting cycle. To study these genes we performed next generation sequencing and constructed a molt-related transcriptomic library from two exoskeletal-forming tissues of the crayfish Cherax quadricarinatus, namely the gastrolith and the mandible cuticle-forming epithelium. To simplify the study of such a complex process as molting, a novel approach, binary patterning of gene expression, was employed. This approach revealed that key genes involved in the synthesis and breakdown of chitin exhibit a molt-related pattern in the gastrolith-forming epithelium. On the other hand, the same genes in the mandible cuticle-forming epithelium showed a molt-independent pattern of expression. Genes related to the metabolism of glucosamine-6-phosphate, a chitin precursor synthesized from simple sugars, showed a molt-related pattern of expression in both tissues. The binary patterning approach unfolds typical patterns of gene expression during the molt cycle of a crustacean. The use of such a simplifying integrative tool for assessing gene patterning seems appropriate for the study of complex biological processes.	[Abehsera, Shai; Glazer, Lilah; Aflalo, Eliahu D.; Sagi, Amir] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Abehsera, Shai; Glazer, Lilah; Tynyakov, Jenny; Plaschkes, Inbar; Chalifa-Caspi, Vered; Aflalo, Eliahu D.; Sagi, Amir] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Khalaila, Isam] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University	Abehsera, S (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	abehsera@post.bgu.ac.il	khalaila, Isam/F-1498-2012	khalaila, Isam/0000-0003-3250-5778; Chalifa-Caspi, Vered/0000-0001-6030-5816; Sagi, Amir/0000-0002-4229-1059; Aflalo, Eli/0000-0003-1385-2387	Israel Science Foundation [102/09, 613/13]; National Institute for Biotechnology in the Negev	Israel Science Foundation(Israel Science Foundation); National Institute for Biotechnology in the Negev	Funding: This study was supported in part by grants from the Israel Science Foundation (Grant 102/09 and 613/13) (http://www.isf.org.il) and the National Institute for Biotechnology in the Negev (in.bgu.ac.il/en/nibn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BUCHHOLZ F, 1989, POLAR BIOL, V9, P311, DOI 10.1007/BF00287429; Chang ES, 1995, J EXP MAR BIOL ECOL, V193, P1, DOI 10.1016/0022-0981(95)00106-9; COMB DG, 1958, J BIOL CHEM, V232, P807; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Correlo VM, 2005, MACROMOL MATER ENG, V290, P1157, DOI 10.1002/mame.200500163; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Dennis JW., 2014, HDB GLYCOSYLTRANSFER, P1481; Dixit R, 2008, INSECT BIOCHEM MOLEC, V38, P440, DOI 10.1016/j.ibmb.2007.12.002; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drach P, 1939, MUE CYCLE INTERMUE C; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Glazer L, 2013, J EXP BIOL, V216, P1898, DOI 10.1242/jeb.080945; Glazer L, 2010, J BIOL CHEM, V285, P12831, DOI 10.1074/jbc.M109.071068; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; GWINN JF, 1973, COMP BIOCHEM PHYSIOL, V45, P769, DOI 10.1016/0305-0491(73)90138-7; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Hoell IA, 2010, BIOTECHNOL GENET ENG, V27, P331, DOI 10.1080/02648725.2010.10648156; HOHNKE LA, 1971, COMP BIOCHEM PHYSIOL, V40, P757, DOI 10.1016/0305-0491(71)90151-9; HORNUNG DE, 1971, COMP BIOCHEM PHYSIOL, V40, P341, DOI 10.1016/0305-0491(71)90219-7; Huang QS, 2010, FISH SHELLFISH IMMUN, V29, P75, DOI 10.1016/j.fsi.2010.02.014; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kuballa Anna, 2007, Bulletin of Fisheries Research Agency, P53; Lowenstam HA, 1989, BIOMINERALIZATION; Luquet G, 2004, CR PALEVOL, V3, P515, DOI 10.1016/j.crpv.2004.07.015; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Milewski S, 2002, BBA-PROTEIN STRUCT M, V1597, P173, DOI 10.1016/S0167-4838(02)00318-7; Nagasawa Hiromichi, 2012, Front Biosci (Elite Ed), V4, P711; OBRIEN JJ, 1991, BIOL BULL, V181, P427, DOI 10.2307/1542363; PAHLIC M, 1978, COMP BIOCHEM PHYS B, V60, P281, DOI 10.1016/0305-0491(78)90102-5; Rocha J, 2012, AQUACULTURE, V330, P111, DOI 10.1016/j.aquaculture.2011.12.024; ROER R, 1984, AM ZOOL, V24, P893; Shechter A, 2008, P NATL ACAD SCI USA, V105, P7129, DOI 10.1073/pnas.0800193105; Shechter A, 2008, BIOL BULL-US, V214, P122, DOI 10.2307/25066669; Shechter A, 2007, J EXP BIOL, V210, P3525, DOI 10.1242/jeb.006791; SKINNER D M, 1985, P43; STEVENSON JR, 1972, AM ZOOL, V12, P373; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TRAVIS DF, 1963, ACTA HISTOCHEM, V15, P251; TRAVIS DF, 1960, BIOL BULL, V118, P137, DOI 10.2307/1539064; UENO M, 1980, J EXP ZOOL, V213, P161, DOI 10.1002/jez.1402130202; UENO M, 1984, HISTOCHEMISTRY, V80, P213, DOI 10.1007/BF00495768; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Yudkovski Y, 2010, COMP BIOCHEM PHYS D, V5, P171, DOI 10.1016/j.cbd.2010.03.010; Zou E, 1999, MAR BIOL, V133, P97, DOI 10.1007/s002270050447	47	21	21	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0122602	10.1371/journal.pone.0122602	http://dx.doi.org/10.1371/journal.pone.0122602			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919476	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400016
J	Ambridge, B; Bidgood, A; Twomey, KE; Pine, JM; Rowland, CF; Freudenthal, D				Ambridge, Ben; Bidgood, Amy; Twomey, Katherine E.; Pine, Julian M.; Rowland, Caroline F.; Freudenthal, Daniel			Preemption versus Entrenchment: Towards a Construction-General Solution to the Problem of the Retreat from Verb Argument Structure Overgeneralization	PLOS ONE			English	Article							NEGATIVE EVIDENCE; GRAMMATICALITY JUDGMENT; ERRORS; SEMANTICS; STATISTICS; CHILDRENS; TRANSITIVITY	Participants aged 5;2-6;8, 9;2-10;6 and 18;1-22;2 (72 at each age) rated verb argument structure overgeneralization errors (e.g., *Daddy giggled the baby) using a five-point scale. The study was designed to investigate the feasibility of two proposed construction-general solutions to the question of how children retreat from, or avoid, such errors. No support was found for the prediction of the preemption hypothesis that the greater the frequency of the verb in the single most nearly synonymous construction (for this example, the periphrastic causative; e.g., Daddy made the baby giggle), the lower the acceptability of the error. Support was found, however, for the prediction of the entrenchment hypothesis that the greater the overall frequency of the verb, regardless of construction, the lower the acceptability of the error, at least for the two older groups. Thus while entrenchment appears to be a robust solution to the problem of the retreat from error, and one that generalizes across different error types, we did not find evidence that this is the case for preemption. The implication is that the solution to the retreat from error lies not with specialized mechanisms, but rather in a probabilistic process of construction competition.	[Ambridge, Ben; Bidgood, Amy; Pine, Julian M.; Rowland, Caroline F.; Freudenthal, Daniel] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Twomey, Katherine E.] Univ Lancaster, Lancaster, England; [Ambridge, Ben; Bidgood, Amy; Twomey, Katherine E.; Pine, Julian M.; Rowland, Caroline F.] ESRC Int Ctr Language & Commun Dev LuCiD, Manchester, Lancs, England; [Ambridge, Ben; Bidgood, Amy; Twomey, Katherine E.; Pine, Julian M.; Rowland, Caroline F.] ESRC Int Ctr Language & Commun Dev LuCiD, Liverpool, Merseyside, England; [Ambridge, Ben; Bidgood, Amy; Twomey, Katherine E.; Pine, Julian M.; Rowland, Caroline F.] ESRC Int Ctr Language & Commun Dev LuCiD, Lancaster, England	University of Liverpool; Lancaster University; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC)	Ambridge, B (corresponding author), Univ Liverpool, Liverpool L69 3BX, Merseyside, England.	Ben.Ambridge@Liverpool.ac.uk	Twomey, Katherine/Q-3410-2017; Rowland, Caroline/U-5257-2018	Twomey, Katherine/0000-0002-5077-2741; Ambridge, Ben/0000-0003-2389-8477; Rowland, Caroline/0000-0002-8675-8669; Bidgood, Amy/0000-0002-9719-4256	Leverhulme Trust [RPG-158]; Economic and Social Research Council (LuCiD: International Centre for Language and Communicative Development) [ES/L008955/1]; ESRC [ES/L008955/1] Funding Source: UKRI; Economic and Social Research Council [ES/L008955/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); Economic and Social Research Council (LuCiD: International Centre for Language and Communicative Development); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Funding: This research was funded by a Leverhulme Trust Grant (RPG-158) to BA, CFR and JMP and by a Grant from the Economic and Social Research Council (LuCiD: International Centre for Language and Communicative Development; [ES/L008955/1]) to CFR, JMP and BA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambridge B, PREPRINT; Ambridge B, 2008, COGNITION, V106, P87, DOI 10.1016/j.cognition.2006.12.015; Ambridge B, 2015, BLACKW HBK LINGUIST, P478; Ambridge B, 2014, LANG COGN NEUROSCI, V29, P218, DOI 10.1080/01690965.2012.738300; Ambridge B, 2013, COGNITIVE SCI, V37, P508, DOI 10.1111/cogs.12018; Ambridge B, 2012, LANGUAGE, V88, P45, DOI 10.1353/lan.2012.0000; Ambridge B, 2012, COGNITION, V123, P260, DOI 10.1016/j.cognition.2012.01.002; Ambridge B, 2011, COGN LINGUIST, V22, P303, DOI 10.1515/COGL.2011.012; Ambridge B, 2009, COGNITIVE SCI, V33, P1301, DOI 10.1111/j.1551-6709.2009.01055.x; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BAKER CL, 1979, LINGUIST INQ, V10, P533; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates M, 2012, LME4 LINEAR MIXED EF; Bidgood A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097634; Blything RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110009; Bowerman Melissa., 1988, EXPLAINING LANGUAGE, P73; Boyd JK, 2011, LANGUAGE, V87, P55, DOI 10.1353/lan.2011.0012; Braine M. D., 1971, ONTOGENESIS GRAMMAR, P153; Braine MartinD.S., 1995, NAMES THINGS YOUNG C, P352; Brooks PJ, 2002, J CHILD LANG, V29, P759, DOI 10.1017/S0305000902005287; Brooks PJ, 1999, CHILD DEV, V70, P1325, DOI 10.1111/1467-8624.00097; Brooks PJ, 1999, LANGUAGE, V75, P720, DOI 10.2307/417731; CHOMSKY N, 1959, LANGUAGE, V35, P26, DOI 10.2307/411334; Chouinard MM, 2003, J CHILD LANG, V30, P637, DOI 10.1017/S0305000903005701; CLARK EV, 1979, LANGUAGE, V55, P767, DOI 10.2307/412745; CLARK EV, 1988, J CHILD LANG, V15, P317, DOI 10.1017/S0305000900012393; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; Goldberg AdeleE., 1995, CONSTRUCTIONS CONSTR; Langacker Ronald, 1987, FDN COGNITIVE GRAMMA, V1; Pinker Steven., 1989, LEARNABILITY COGNITI; Skinner B. F., 1957, VERBAL BEHAV; Stefanowitsch A, 2008, COGN LINGUIST, V19, P513, DOI 10.1515/COGL.2008.020; Theakston AL, 2004, COGNITIVE DEV, V19, P15, DOI 10.1016/j.cogdev.2003.08.001; van Heuven WJB, 2014, Q J EXP PSYCHOL, V67, P1176, DOI 10.1080/17470218.2013.850521	34	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123723	10.1371/journal.pone.0123723	http://dx.doi.org/10.1371/journal.pone.0123723			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CG9SE	25919003	Green Published, Green Accepted, gold			2022-12-27	WOS:000353659400032
J	Deng, QL; Odhiambo, JF; Farooq, U; Lam, T; Dunn, SM; Ametaj, BN				Deng, Qilan; Odhiambo, John F.; Farooq, Umar; Lam, Tran; Dunn, Suzanna M.; Ametaj, Burim N.			Intravaginal Lactic Acid Bacteria Modulated Local and Systemic Immune Responses and Lowered the Incidence of Uterine Infections in Periparturient Dairy Cows	PLOS ONE			English	Article							LACTOBACILLUS-RHAMNOSUS GR-1; LIPOPOLYSACCHARIDE-BINDING; REPRODUCTIVE-PERFORMANCE; FERMENTUM RC-14; VAGINAL FLORA; POSTPARTUM; PROTEIN; ABSORPTION; PROBIOTICS; MASTITIS	The objective of this investigation was to evaluate whether intravaginal infusion of a lactic acid bacteria (LAB) cocktail around parturition could influence the immune response, incidence rate of uterine infections, and the overall health status of periparturient dairy cows. One hundred pregnant Holstein dairy cows were assigned to 1 of the 3 experimental groups as follows: 1) one dose of LAB on wk -2 and -1, and one dose of carrier (sterile skim milk) on wk +1 relative to the expected day of parturition (TRT1); 2) one dose of LAB on wk -2, -1, and +1 (TRT2), and 3) one dose of carrier on wk -2, -1, and +1 (CTR). The LAB were a lyophilized culture mixture composed of Lactobacillus sakei FUA3089, Pediococcus acidilactici FUA3138, and Pediococcus acidilactici FUA3140 with a cell count of 108-109 cfu/dose. Blood samples and vaginal mucus were collected once a week from wk -2 to +3 and analyzed for content of serum total immunoglobulin G (IgG), lipopolysaccharide-binding protein (LBP), serum amyloid A (SAA), haptoglobin (Hp), tumor necrosis factor (TNF), interleukin (IL)-1, IL-6, and vaginal mucus secretory IgA (sIgA). Clinical observations including rectal temperature, vaginal discharges, retained placenta, displaced abomasum, and laminitis were monitored from wk -2 to +8 relative to calving. Results showed that intravaginal LAB lowered the incidence of metritis and total uterine infections. Intravaginal LAB also were associated with lower concentrations of systemic LBP, an overall tendency for lower SAA, and greater vaginal mucus sIgA. No differences were observed for serum concentrations of Hp, TNF, IL-1, IL-6 and total IgG among the treatment groups. Administration with LAB had no effect on the incidence rates of other transition cow diseases. Overall intravaginal LAB lowered uterine infections and improved local and systemic immune responses in the treated transition dairy cows.	[Deng, Qilan; Odhiambo, John F.; Farooq, Umar; Lam, Tran; Dunn, Suzanna M.; Ametaj, Burim N.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada	University of Alberta	Ametaj, BN (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada.	burim.ametaj@ualberta.ca	odhiambo, john/AAC-2444-2020	odhiambo, john/0000-0002-1005-3486; Ametaj, Burim/0000-0003-0957-9373	Alberta Livestock and Meat Agency Ltd. (ALMA); Alberta Milk; Natural Sciences and Engineering Research Council of Canada (NSERC)	Alberta Livestock and Meat Agency Ltd. (ALMA); Alberta Milk; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors acknowledge the financial support of the funding agencies including Alberta Livestock and Meat Agency Ltd. (ALMA), Alberta Milk, and Natural Sciences and Engineering Research Council of Canada (NSERC) for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ametaj BN, 2014, RES VET SCI, V96, P365, DOI 10.1016/j.rvsc.2014.02.007; Ametaj BN, 2011, ACUTE PHASE PROTEINS AS EARLY NON-SPECIFIC BIOMARKERS OF HUMAN AND VETERINARY DISEASES, P299; Azawi OI, 2008, ANIM REPROD SCI, V105, P187, DOI 10.1016/j.anireprosci.2008.01.010; Boullier S, 2009, J IMMUNOL, V183, P5879, DOI 10.4049/jimmunol.0901838; Burton JL, 2001, ACTA VET SCAND, V42, P407; BURTON NR, 1995, VET REC, V136, P90, DOI 10.1136/vr.136.4.90; Chan JPW, 2010, VET CLIN PATH, V39, P72, DOI 10.1111/j.1939-165X.2009.00182.x; Cross ML, 2002, FEMS IMMUNOL MED MIC, V34, P245, DOI 10.1111/j.1574-695X.2002.tb00632.x; Falagas ME, 2006, DRUGS, V66, P1253, DOI 10.2165/00003495-200666090-00007; Galdeano CM, 2006, CLIN VACCINE IMMUNOL, V13, P219, DOI 10.1128/CVI.13.2.219-226.2006; Gardiner GE, 2002, CLIN DIAGN LAB IMMUN, V9, P92, DOI 10.1128/CDLI.9.1.92-96.2002; Government of Canada, 2013, CULL REPL RAT DAIR H; Hammon DS, 2006, VET IMMUNOL IMMUNOP, V113, P21, DOI 10.1016/j.vetimm.2006.03.022; Herr M, 2011, THERIOGENOLOGY, V75, P377, DOI 10.1016/j.theriogenology.2010.09.009; HILTON E, 1995, J CLIN MICROBIOL, V33, P1433, DOI 10.1128/JCM.33.5.1433-1433.1995; HUSSAIN AM, 1989, J VET MED B, V36, P641, DOI 10.1111/j.1439-0450.1989.tb00657.x; KAILA M, 1992, PEDIATR RES, V32, P141, DOI 10.1203/00006450-199208000-00002; Kasimanickam RK, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-103; Kim IH, 2005, J REPROD DEVELOP, V51, P757, DOI 10.1262/jrd.17036; Kitchens RL, 2003, J LIPID RES, V44, P2339, DOI 10.1194/jlr.M300228-JLR200; Kucharski J, 2008, POL J VET SCI, V11, P9; Kutteh WH, 1996, CLIN EXP IMMUNOL, V104, P538, DOI 10.1046/j.1365-2249.1996.36742.x; Laugerette F, 2011, BIOCHIMIE, V93, P39, DOI 10.1016/j.biochi.2010.04.016; Lewis GS, 1997, J DAIRY SCI, V80, P984, DOI 10.3168/jds.S0022-0302(97)76024-7; Madsen K, 2006, J CLIN GASTROENTEROL, V40, P232, DOI 10.1097/00004836-200603000-00014; MAITRA SK, 1981, HEPATOLOGY, V1, P401, DOI 10.1002/hep.1840010506; Mateus L, 2002, REPROD DOMEST ANIM, V37, P31, DOI 10.1046/j.1439-0531.2002.00317.x; MATHISON J, 1993, J CLIN INVEST, V92, P2053, DOI 10.1172/JCI116801; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Munford RS, 2005, J ENDOTOXIN RES, V11, P69, DOI 10.1179/096805105X35161; Olsson J, 1996, BRIT J OBSTET GYNAEC, V103, P558, DOI 10.1111/j.1471-0528.1996.tb09806.x; Reid G, 2003, FEMS IMMUNOL MED MIC, V35, P131, DOI 10.1016/S0928-8244(02)00465-0; Reid G, 2003, POSTGRAD MED J, V79, P428, DOI 10.1136/pmj.79.934.428; Reid G, 2001, FEMS IMMUNOL MED MIC, V32, P37, DOI 10.1111/j.1574-695X.2001.tb00531.x; REID G, 1994, LANCET, V344, P1229, DOI 10.1016/S0140-6736(94)90543-6; RIGHTER HF, 1975, CAN VET J, V16, P10; RUSSELL MW, 1999, MUCOSAL IMMUNOLOGY, P225; Schukken YH, 2003, VET RES, V34, P579, DOI 10.1051/vetres:2003028; Shao BM, 2012, INNATE IMMUN-LONDON, V18, P825, DOI 10.1177/1753425912442431; Sharma N, 2011, ASIAN AUSTRAL J ANIM, V24, P429, DOI 10.5713/ajas.2011.10233; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Sheldon IM, 2006, THERIOGENOLOGY, V65, P1516, DOI 10.1016/j.theriogenology.2005.08.021; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712; Wang Y, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-19; Williams EJ, 2007, THERIOGENOLOGY, V68, P549, DOI 10.1016/j.theriogenology.2007.04.056; WURFEL MM, 1994, J EXP MED, V180, P1025, DOI 10.1084/jem.180.3.1025; Zeng R, 2009, J DAIRY SCI, V92, P980, DOI 10.3168/jds.2008-1636; Zerbe H, 1996, THERIOGENOLOGY, V46, P1339, DOI 10.1016/S0093-691X(96)00314-7	48	20	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124167	10.1371/journal.pone.0124167	http://dx.doi.org/10.1371/journal.pone.0124167			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919010	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400043
J	Steck, SE; Arab, L; Zhang, HM; Bensen, JT; Fontham, ETH; Johnson, CS; Mohler, JL; Smith, GJ; Su, JL; Trump, DL; Woloszynska-Read, A				Steck, Susan E.; Arab, Lenore; Zhang, Hongmei; Bensen, Jeannette T.; Fontham, Elizabeth T. H.; Johnson, Candace S.; Mohler, James L.; Smith, Gary J.; Su, Joseph L.; Trump, Donald L.; Woloszynska-Read, Anna			Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaP	PLOS ONE			English	Article							SERUM VITAMIN-D; D-BINDING-PROTEIN; UNITED-STATES; RACIAL-DIFFERENCES; SUBSEQUENT RISK; D INSUFFICIENCY; BREAST-CANCER; PREVENTION; 1,25-DIHYDROXYVITAMIN-D; ADULTS	Background African Americans (AAs) have lower circulating 25-hydroxyvitamin D3 [25(OH) D3] concentrations and higher prostate cancer (CaP) aggressiveness than other racial/ethnic groups. The purpose of the current study was to examine the relationship between plasma 25(OH) D3, African ancestry and CaP aggressiveness among AAs and European Americans (EAs). Methods Plasma 25(OH) D3 was measured using LC-MS/MS (Liquid Chromatography Tandem Mass Spectrometry) in 537 AA and 663 EA newly-diagnosed CaP patients from the North Carolina-Louisiana Prostate Cancer Project (PCaP) classified as having either 'high' or 'low' aggressive disease based on clinical stage, Gleason grade and prostate specific antigen at diagnosis. Mean plasma 25(OH) D3 concentrations were compared by proportion of African ancestry. Logistic regression was used to calculate multivariable adjusted odds ratios (OR) and 95% confidence intervals (95% CI) for high aggressive CaP by tertile of plasma 25(OH) D3. Results AAs with highest percent African ancestry (>95%) had the lowest mean plasma 25(OH)D3 concentrations. Overall, plasma 25(OH) D3 was associated positively with aggressiveness among AA men, an association that was modified by calcium intake (ORT3vs.T1: 2.23, 95% CI: 1.26-3.95 among men with low calcium intake, and ORT3vs.T1: 0.19, 95% CI: 0.05-0.70 among men with high calcium intake). Among EAs, the point estimates of the ORs were <1.0 for the upper tertiles with CIs that included the null. Conclusions Among AAs, plasma 25(OH)D3 was associated positively with CaP aggressiveness among men with low calcium intake and inversely among men with high calcium intake. The clinical significance of circulating concentrations of 25(OH)D3 and interactions with calcium intake in the AA population warrants further study.	[Steck, Susan E.] Univ S Carolina, Arnold Sch Publ Hlth, Canc Prevent & Control Program, Ctr Res Nutr & Hlth Dispar,Dept Epidemiol & Biost, Columbia, SC 29208 USA; [Arab, Lenore] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Zhang, Hongmei] Univ Memphis, Memphis, TN 38152 USA; [Bensen, Jeannette T.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Fontham, Elizabeth T. H.] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, New Orleans, LA USA; [Johnson, Candace S.; Mohler, James L.; Smith, Gary J.; Trump, Donald L.; Woloszynska-Read, Anna] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Su, Joseph L.] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Memphis; University of North Carolina; University of North Carolina Chapel Hill; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Roswell Park Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Woloszynska-Read, A (corresponding author), Roswell Pk Canc Inst, Buffalo, NY 14263 USA.	anna.woloszynska-read@roswellpark.org	Steck, Susan E/G-5736-2013; Facility, Biospecimen Processing/AAC-7837-2022	Steck, Susan E/0000-0002-3201-9537; 	United States Department of Defense [11-1-0568, W81WH11-1-0308PCa]; National Institutes of Health [CA067267, CA137650, CA016056]; NATIONAL CANCER INSTITUTE [R01CA067267, R21CA137650, P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	United States Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	United States Department of Defense 11-1-0568 http://cdmrp.army.mil/default.shtml SES, CSJ; United States Department of Defense W81WH11-1-0308PCa http://cdmrp.army.mil/default.shtml AWR; National Institutes of Health CA067267, CA137650 and CA016056 http://www.nih.gov DLT and CSJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2008, JNCI-J NATL CANCER I, V100, P796, DOI 10.1093/jnci/djn152; Ahonen MH, 2000, CANCER CAUSE CONTROL, V11, P847, DOI 10.1023/A:1008923802001; Albanes D, 2011, CANCER EPIDEM BIOMAR, V20, P1850, DOI 10.1158/1055-9965.EPI-11-0403; Amrein K, 2014, J CLIN ENDOCR METAB; [Anonymous], 2011, DIETARY REFERENCE IN; Arab L, 2003, J AM DIET ASSOC, V103, P1008, DOI 10.1016/S0002-8223(03)00474-7; Arab L, 2010, FASEB J, V24, P325322; ARNAUD J, 1993, HUM GENET, V92, P183; Barnett CM, 2010, CANC CAUSES CONTROL; BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954, DOI 10.1210/jcem-63-4-954; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; Brandstedt J, 2012, CANCER CAUSE CONTROL, V23, P1377, DOI 10.1007/s10552-012-9948-3; BRAUN A, 1992, HUM GENET, V89, P401; BRAUN MM, 1995, CANCER CAUSE CONTROL, V6, P235, DOI 10.1007/BF00051795; Chandler PD, 2014, CANC EPIDEMIOL BIOMA; Chen TC, 2003, TRENDS ENDOCRIN MET, V14, P423, DOI 10.1016/j.tem.2003.09.004; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; CONSTANS J, 1985, AM J PHYS ANTHROPOL, V68, P107, DOI 10.1002/ajpa.1330680110; CORDER EH, 1995, CANCER EPIDEM BIOMAR, V4, P655; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Egan KM, 2008, CANCER CAUSE CONTROL, V19, P527, DOI 10.1007/s10552-008-9115-z; Engelman CD, 2008, J CLIN ENDOCR METAB, V93, P3381, DOI 10.1210/jc.2007-2702; Faupel-Badger JM, 2007, CANCER EPIDEM BIOMAR, V16, P2784, DOI 10.1158/1055-9965.EPI-07-0672; Freedman DM, 2013, AM J EPIDEMIOL, V177, P180, DOI 10.1093/aje/kws223; Gann PH, 1996, CANCER EPIDEM BIOMAR, V5, P121; Getzenberg RH, 1997, UROLOGY, V50, P999, DOI 10.1016/S0090-4295(97)00408-1; Gilbert R, 2012, INT J CANCER, V131, P1187, DOI 10.1002/ijc.27327; Gilbert R, 2011, CANCER CAUSE CONTROL, V22, P319, DOI 10.1007/s10552-010-9706-3; Giovannucci E, 2009, ANN EPIDEMIOL, V19, P84, DOI 10.1016/j.annepidem.2007.12.002; Grant WB, 2008, J NATL MED ASSOC, V100, P1040, DOI 10.1016/S0027-9684(15)31441-3; Gupta D, 2009, PROSTATE CANCER P D, V12, P215, DOI 10.1038/pcan.2009.7; Hebert JR, 2009, CANCER-AM CANCER SOC, V115, P2539, DOI 10.1002/cncr.24270; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Hollis BW, 2008, AM J CLIN NUTR, V88, p507S, DOI 10.1093/ajcn/88.2.507S; Jacobs ET, 2004, J STEROID BIOCHEM, V89-90, P533, DOI 10.1016/j.jsbmb.2004.03.063; Johnson CS, 2002, CANCER METAST REV, V21, P147, DOI 10.1023/A:1020836226594; Krishnan AV, 2003, J CELL BIOCHEM, V88, P363, DOI 10.1002/jcb.10334; Kristal AR, 2014, CANCER EPIDEM BIOMAR, V23, P1494, DOI 10.1158/1055-9965.EPI-14-0115; Li HJ, 2007, PLOS MED, V4, P562, DOI 10.1371/journal.pmed.0040103; Looker AC, 2002, BONE, V30, P771, DOI 10.1016/S8756-3282(02)00692-0; Michaelsson K, 2010, AM J CLIN NUTR, V92, P841, DOI 10.3945/ajcn.2010.29749; Moore CE, 2005, J NUTR, V135, P2478, DOI 10.1093/jn/135.10.2478; Moreno J, 2005, J STEROID BIOCHEM, V97, P31, DOI 10.1016/j.jsbmb.2005.06.012; Murphy AB, 2014, CLIN CANCER RES, V20, P2289, DOI 10.1158/1078-0432.CCR-13-3085; Murphy AB, 2012, AM J MENS HEALTH, V6, P420, DOI 10.1177/1557988312437240; Nomura AMY, 1998, CANCER CAUSE CONTROL, V9, P425, DOI 10.1023/A:1008875819232; Ordonez-Mena JM, 2013, CANCER EPIDEM BIOMAR, V22, P905, DOI 10.1158/1055-9965.EPI-12-1332; Park SY, 2010, EUR J CANCER, V46, P932, DOI 10.1016/j.ejca.2009.12.030; Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440; Platz EA, 2004, CANCER CAUSE CONTROL, V15, P255, DOI 10.1023/B:CACO.0000024245.24880.8a; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Schenk JM, 2014, CANCER EPIDEM BIOMAR, V23, P1484, DOI 10.1158/1055-9965.EPI-13-1340; Schroeder JC, 2006, PROSTATE, V66, P1162, DOI 10.1002/pros.20449; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Shui IM, 2012, JNCI-J NATL CANCER I, V104, P690, DOI 10.1093/jnci/djs189; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Signorello LB, 2010, CANCER EPIDEM BIOMAR, V19, P2325, DOI 10.1158/1055-9965.EPI-10-0482; Sucheston LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030950; Taksler GB, 2013, CANCER-AM CANCER SOC, V119, P3195, DOI 10.1002/cncr.28127; Travis RC, 2009, AM J EPIDEMIOL, V169, P1223, DOI 10.1093/aje/kwp022; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; Yao S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3162; Yin L, 2009, CANCER EPIDEMIOL, V33, P435, DOI 10.1016/j.canep.2009.10.014; Zadshir Ashraf, 2005, Ethn Dis, V15, pS5	64	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125151	10.1371/journal.pone.0125151	http://dx.doi.org/10.1371/journal.pone.0125151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919866	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400074
J	Hiratsuka, M; Yamashita, H; Akai, F; Hosono, H; Hishinuma, E; Hirasawa, N; Mori, T				Hiratsuka, Masahiro; Yamashita, Hiroshi; Akai, Fumika; Hosono, Hiroki; Hishinuma, Eiji; Hirasawa, Noriyasu; Mori, Takahiro			Genetic Polymorphisms of Dihydropyrimidinase in a Japanese Patient with Capecitabine-Induced Toxicity	PLOS ONE			English	Article							SEVERE 5-FLUOROURACIL TOXICITY; DEHYDROGENASE GENE; DEFICIENCY; MUTATIONS; IDENTIFICATION; CANCER	Dihydropyrimidinase (DHP) is the second enzyme in the catabolic pathway of uracil, thymine, and chemotherapeutic fluoropyrimidine agents such as 5-fluorouracil (5-FU). Thus, DHP deficiency might be associated with 5-FU toxicity during fluoropyrimidine chemotherapy. We performed genetic analyses of the family of a patient with advanced colon cancer who underwent radical colectomy followed by treatment with 5-FU prodrug capecitabine and developed severe toxicity attributable to a lack of DHP. We measured urinary uracil and dihydrouracil, and genotyped DPYS in the patient and her family. We also measured the allele frequency of DPYS polymorphisms in 391 unrelated Japanese subjects. The patient had compound heterozygous missense and nonsense polymorphisms comprising c.1001A>G (p.Gln334Arg) in exon 6 and c.1393C>T (p.Arg465Ter) in exon 8, which are known to result in a DHP enzyme with little or no activity. The urinary dihydrouracil/uracil ratio in the patient was 17.08, while the mean +/- SD urinary dihydrouracil/uracil ratio in family members who were heterozygous or homozygous for wild-type DPYS was 0.25 +/- 0.06. In unrelated subjects, 8 of 391 individuals were heterozygous for the c.1001A>G mutation, while the c.1393C>T mutation was not identified. This is the first report of a DHP-deficient patient with DPYS compound heterozygous polymorphisms who was treated with a fluoropyrimidine, and our findings suggest that polymorphisms in the DPYS gene are pharmacogenomic markers associated with severe 5-FU toxicity in Japanese patients.	[Hiratsuka, Masahiro; Akai, Fumika; Hosono, Hiroki; Hishinuma, Eiji; Hirasawa, Noriyasu] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi 980, Japan; [Yamashita, Hiroshi] Iwate Prefectural Chubu Hosp, Dept Surg, Kitakami, Iwate, Japan; [Mori, Takahiro] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Hiratsuka, M (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi 980, Japan.	mhira@m.tohoku.ac.jp	Hiratsuka, Masahiro/AAO-8082-2020	Hiratsuka, Masahiro/0000-0002-3767-7686; Hirasawa, Noriyasu/0000-0002-8062-4838; Mori, Takahiro/0000-0001-7324-8574	Smoking Research Foundation	Smoking Research Foundation	This work was supported in part by a grant from the Smoking Research Foundation.	Assmann B, 1997, J INHERIT METAB DIS, V20, P681, DOI 10.1023/A:1005374426168; DURAN M, 1990, LANCET, V336, P817, DOI 10.1016/0140-6736(90)93288-Z; DURAN M, 1991, J INHERIT METAB DIS, V14, P367, DOI 10.1007/BF01811705; Fidlerova J, 2010, CANCER CHEMOTH PHARM, V65, P661, DOI 10.1007/s00280-009-1071-0; Fischer J, 2003, GENET TEST, V7, P97, DOI 10.1089/109065703322146777; Hamajima N, 1998, AM J HUM GENET, V63, P717, DOI 10.1086/302022; Hayashi K, 1996, CLIN CANCER RES, V2, P1937; HENDERSON MJ, 1993, J INHERIT METAB DIS, V16, P574, DOI 10.1007/BF00711685; Kouwaki M, 1998, CLIN CANCER RES, V4, P2999; Loganayagam A, 2013, BRIT J CANCER, V108, P2505, DOI 10.1038/bjc.2013.262; OHBA S, 1994, ADV EXP MED BIOL, V370, P383; Pan XY, 2011, CURR MED CHEM, V18, P4538, DOI 10.2174/092986711797287584; Putman CWMM, 1997, NEUROPEDIATRICS, V28, P106, DOI 10.1055/s-2007-973681; Schwab M, 2008, J CLIN ONCOL, V26, P2131, DOI 10.1200/JCO.2006.10.4182; Sobin LH, 2010, TNM CLASSIFICATION M, V20, P309; Sumi S, 1996, J INHERIT METAB DIS, V19, P701, DOI 10.1007/BF01799851; Sumi S, 1998, AM J MED GENET, V78, P336, DOI 10.1002/(SICI)1096-8628(19980724)78:4<336::AID-AJMG6>3.0.CO;2-J; Twelves C, 2005, NEW ENGL J MED, V352, P2696, DOI 10.1056/NEJMoa043116; van Kuilenburg ABP, 2004, NUCLEOS NUCLEOT NUCL, V23, P1371, DOI 10.1081/NCN-200027624; Van Kuilenburg ABP, 2005, BIOL CHEM, V386, P319, DOI 10.1515/BC.2005.038; van Kuilenburg ABP, 2003, CLIN CANCER RES, V9, P4363; van Kuilenburg ABP, 2002, BIOCHEM J, V364, P157, DOI 10.1042/bj3640157; van Kuilenburg ABP, 2001, CLIN CANCER RES, V7, P1149; van Kuilenburg ABP, 2007, MOL GENET METAB, V91, P157, DOI 10.1016/j.ymgme.2007.02.008; van Kuilenburg ABP, 2010, BBA-MOL BASIS DIS, V1802, P639, DOI 10.1016/j.bbadis.2010.03.013; Wei XX, 1998, GENOMICS, V51, P391, DOI 10.1006/geno.1998.5379	26	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124818	10.1371/journal.pone.0124818	http://dx.doi.org/10.1371/journal.pone.0124818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915935	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100069
J	Kale, MS; Federman, AD; Krauskopf, K; Wolf, M; O'Conor, R; Martynenko, M; Leventhal, H; Wisnivesky, JP				Kale, Minal S.; Federman, Alex D.; Krauskopf, Katherine; Wolf, Michael; O'Conor, Rachel; Martynenko, Melissa; Leventhal, Howard; Wisnivesky, Juan P.			The Association of Health Literacy with Illness and Medication Beliefs among Patients with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							SELF-MANAGEMENT; ADHERENCE; ASTHMA; COPD; NONADHERENCE; PERCEPTIONS; VALIDATION; MORTALITY; PATTERNS; OUTCOMES	Background Low health literacy is associated with low adherence to self-management in many chronic diseases. Additionally, health beliefs are thought to be determinants of self-management behaviors. In this study we sought to determine the association, if any, of health literacy and health beliefs among elderly individuals with COPD. Methods We enrolled a cohort of patients with COPD from two academic urban settings in New York, NY and Chicago, IL. Health literacy was measured using the Short Test of Functional Health Literacy in Adults. Using the framework of the Self-Regulation Model, illness and medication beliefs were measured with the Brief Illness Perception Questionnaire (B-IPQ) and Beliefs about Medications Questionnaire (BMQ). Unadjusted analyses, with corresponding Cohen's d effect sizes, and multiple logistic regression were used to assess the relationships between HL and illness and medication beliefs. Results We enrolled 235 participants, 29% of whom had low health literacy. Patients with low health literacy were more likely to belong to a racial minority group (p<0.001), not be married (p = 0.006), and to have lower income (p<0.001) or education (p<0.001). In unadjusted analyses, patients with low health literacy were less likely to believe they will always have COPD (p = 0.003, Cohen's d = 0.42), and were more likely to be concerned about their illness ((p = 0.04, Cohen's d = 0.17). In analyses adjusted for sociodemographic factors and other health beliefs, patients with low health literacy were less likely to believe that they will always have COPD (odds ratio [OR]: 0.78, 95% confidence interval [CI]: 0.65-0.94). In addition, the association of low health literacy with expressed concern about medications remained significant (OR: 1.20, 95% CI: 1.05-1.37) though the association of low health literacy with belief in the necessity of medications was no longer significant (OR: 0.92, 95% CI: 0.82-1.04). Conclusions In this cohort of urban individuals with COPD, low health literacy was prevalent, and associated with illness beliefs that predict decreased adherence. Our results suggest that targeted strategies to address low health literacy and related illness and medications beliefs might improve COPD medication adherence and other self-management behaviors.	[Kale, Minal S.; Federman, Alex D.; Krauskopf, Katherine; Martynenko, Melissa; Wisnivesky, Juan P.] Icahn Sch Med Mt Sinai, Div Gen Internal Med, New York, NY 10029 USA; [Wolf, Michael; O'Conor, Rachel] Northwestern Univ, Feinberg Sch Med, Div Gen Internal Med, Chicago, IL 60611 USA; [Leventhal, Howard] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, New Brunswick, NJ 08903 USA; [Wisnivesky, Juan P.] Icahn Sch Med Mt Sinai, Div Pulm Crit Care & Sleep Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Northwestern University; Feinberg School of Medicine; Rutgers State University New Brunswick; Icahn School of Medicine at Mount Sinai	Kale, MS (corresponding author), Icahn Sch Med Mt Sinai, Div Gen Internal Med, New York, NY 10029 USA.	minal.kale@mountsinai.org	Wolf, Michael/V-3351-2018	Wolf, Michael/0000-0002-4342-6517	National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HL105385]; National Cancer Institute of the National Institutes of Health [K07CA187071]; NATIONAL CANCER INSTITUTE [K07CA187071] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105385] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number R01HL105385. Minal Kale was supported by a grant from the National Cancer Institute of the National Institutes of Health under Award Number K07CA187071 during the writing of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams P., 1996, VITAL HLTH STAT, V10, P1; [Anonymous], GLOBAL STRATEGY FOR; Baker DW, 2007, ARCH INTERN MED, V167, P1503, DOI 10.1001/archinte.167.14.1503; Baker DW, 1999, PATIENT EDUC COUNS, V38, P33, DOI 10.1016/S0738-3991(98)00116-5; Bennett IM, 2009, ANN FAM MED, V7, P204, DOI 10.1370/afm.940; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Cameron H., 2003, SELF REGULATION HLTH; Chapman KR, 2006, EUR RESPIR J, V27, P188, DOI 10.1183/09031936.06.00024505; Cho YI, 2008, SOC SCI MED, V66, P1809, DOI 10.1016/j.socscimed.2008.01.003; Cohen J, 1988, STAT POWER ANAL BEHA, Vxxi; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; DOLCE JJ, 1991, CHEST, V99, P837, DOI 10.1378/chest.99.4.837; DOMPELING E, 1992, FAM PRACT, V9, P161, DOI 10.1093/fampra/9.2.161; Effing T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002990.pub2; Eisner MD, 2005, CHEST, V127, P1890, DOI 10.1378/chest.127.6.1890; Federman AD, 2013, PATIENT EDUC COUNS, V92, P273, DOI 10.1016/j.pec.2013.02.013; Federman AD, 2010, J ASTHMA, V47, P620, DOI 10.3109/02770901003702816; George J, 2005, CHEST, V128, P3198, DOI 10.1378/chest.128.5.3198; Halm EA, 2006, CHEST, V129, P573, DOI 10.1378/chest.129.3.573; Halpin David M G, 2006, Proc Am Thorac Soc, V3, P619, DOI 10.1513/pats.200603-093SS; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Institute of Medicine, 2004, HLTH LITERACY PRESCR; JAMES PNE, 1985, POSTGRAD MED J, V61, P7, DOI 10.1136/pgmj.61.711.7; Kaptein AA, 2008, J ASTHMA, V45, P625, DOI 10.1080/02770900802127048; Kaptein AA, 2010, CURR OPIN ALLERGY CL, V10, P194, DOI 10.1097/ACI.0b013e32833950c1; Khdour MR, 2012, EUR J CLIN PHARMACOL, V68, P1365, DOI 10.1007/s00228-012-1279-5; Mann DM, 2009, J BEHAV MED, V32, P278, DOI 10.1007/s10865-009-9202-y; Menckeberg TT, 2008, J PSYCHOSOM RES, V64, P47, DOI 10.1016/j.jpsychores.2007.07.016; Mooss A, 2013, HEALTH EDUC J, V72, P292, DOI 10.1177/0017896912442952; Nurss JR, 2003, TEST FUNCTIONAL HLTH; Omachi TA, 2013, J GEN INTERN MED, V28, P74, DOI 10.1007/s11606-012-2177-3; Paasche-Orlow MK, 2007, AM J HEALTH BEHAV, V31, pS19; Tordera MP, 2009, ARCH BRONCONEUMOL, V45, P218, DOI 10.1016/j.arbres.2008.06.006; Rand CS, 2005, EUR RESPIR REV, V14, P97, DOI 10.1183/09059180.05.00009604; Shoemaker SJ, 2014, PATIENT EDUC COUNS, V96, P395, DOI 10.1016/j.pec.2014.05.027; Sofianou A, 2013, J GEN INTERN MED, V28, P67, DOI 10.1007/s11606-012-2160-z; TAYLOR DR, 1984, BRIT J CLIN PHARMACO, V17, P15, DOI 10.1111/j.1365-2125.1984.tb04992.x; THOMPSON J, 1994, CHEST, V105, P715, DOI 10.1378/chest.105.3.715; White S, 2008, AM J HEALTH BEHAV, V32, P227; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166; Wolf MS, 2005, ARCH INTERN MED, V165, P1946, DOI 10.1001/archinte.165.17.1946	42	68	71	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123937	10.1371/journal.pone.0123937	http://dx.doi.org/10.1371/journal.pone.0123937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915420	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100029
J	Kim, JK; Kim, JM; Song, BH; Yun, SI; Yun, GN; Byun, SJ; Lee, YM				Kim, Jin-Kyoung; Kim, Jeong-Min; Song, Byung-Hak; Yun, Sang-Im; Yun, Gil-Nam; Byun, Sung-June; Lee, Young-Min			Profiling of Viral Proteins Expressed from the Genomic RNA of Japanese Encephalitis Virus Using a Panel of 15 Region-Specific Polyclonal Rabbit Antisera: Implications for Viral Gene Expression	PLOS ONE			English	Article							YELLOW-FEVER VIRUS; WEST-NILE-VIRUS; DENGUE VIRUS; CORE PROTEIN; NONSTRUCTURAL PROTEIN; NUCLEAR-LOCALIZATION; FLAVIVIRUS KUNJIN; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; FUNCTIONAL IMPORTANCE	Japanese encephalitis virus (JEV), a mosquito-borne flavivirus, is closely related to West Nile (WN), yellow fever (YF), and dengue (DEN) viruses. Its plus-strand genomic RNA carries a single open reading frame encoding a polyprotein that is cleaved into three structural (C, prM/M, and E) and at least seven nonstructural (NS1/NS1', NS2A, NS2B, NS3, NS4A, NS4B, and NS5) proteins, based on previous work with WNV, YFV, and DENV. Here, we aimed to profile experimentally all the viral proteins found in JEV-infected cells. We generated a collection of 15 JEV-specific polyclonal antisera covering all parts of the viral proteincoding regions, by immunizing rabbits with 14 bacterially expressed glutathione-Stransferase fusion proteins (for all nine viral proteins except NS2B) or with a chemically synthesized oligopeptide (for NS2B). In total lysates of JEV-infected BHK-21 cells, immunoblotting with these antisera revealed: (i) three mature structural proteins (similar to 12-kDa C, similar to 8-kDa M, and similar to 53-kDa E), a precursor of M (similar to 24-kDa prM) and three other M-related proteins (similar to 10-14 kDa); (ii) the predicted similar to 45-kDa NS1 and its frameshift product, similar to 58-kDa NS1', with no evidence of the predicted similar to 25-kDa NS2A; (iii) the predicted but hardly detectable similar to 14-kDa NS2B and an unexpected but predominant similar to 12-kDa NS2B-related protein; (iv) the predicted similar to 69-kDa NS3 plus two major cleavage products (similar to 34-kDa NS3(N-term) and similar to 35-kDa NS3(C-term)), together with at least nine minor proteins of similar to 016-52 kDa; (v) the predicted similar to 14kDa NS4A; (vi) two NS4B-related proteins (similar to 27-kDa NS4B and similar to 25-kDa NS4B'); and (vii) the predicted similar to 103-kDa NS5 plus at least three other NS5-related proteins (similar to 15 kDa, similar to 27 kDa, and similar to 90 kDa). Combining these data with confocal microscopic imaging of the proteins' intracellular localization, our study is the first to provide a solid foundation for the study of JEV gene expression, which is crucial for elucidating the regulatory mechanisms of JEV genome replication and pathobiology.	[Kim, Jin-Kyoung; Song, Byung-Hak; Yun, Sang-Im; Lee, Young-Min] Utah State Univ, Coll Agr & Appl Sci, Dept Anim Dairy & Vet Sci, Utah Sci Technol & Res, Logan, UT 84322 USA; [Kim, Jeong-Min; Yun, Gil-Nam] Chungbuk Natl Univ, Coll Med, Dept Microbiol, Cheongju, South Korea; [Byun, Sung-June] Korea Natl Inst Anim Sci, Anim Biotechnol Div, Suwon, South Korea	Utah System of Higher Education; Utah State University; Chungbuk National University; National Institute of Animal Science, Republic of Korea	Lee, YM (corresponding author), Utah State Univ, Coll Agr & Appl Sci, Dept Anim Dairy & Vet Sci, Utah Sci Technol & Res, Logan, UT 84322 USA.	youngmin.lee@usu.edu			Utah Science Technology and Research [A25454]; Utah Agricultural Experiment Station [UTA01102]; Basic Science Research Program of the National Research Foundation - Ministry of Education, Science, and Technology of Korea [2009-0069679]; Chungbuk National University	Utah Science Technology and Research; Utah Agricultural Experiment Station; Basic Science Research Program of the National Research Foundation - Ministry of Education, Science, and Technology of Korea; Chungbuk National University	This work was supported by funding from the Utah Science Technology and Research (A25454), the Utah Agricultural Experiment Station (UTA01102), and the Basic Science Research Program (2009-0069679) of the National Research Foundation by the Ministry of Education, Science, and Technology of Korea. This research was approved as journal paper number UAES #8752. YML was supported in part by a grant from Chungbuk National University in 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P331; ARIAS CF, 1993, VIROLOGY, V193, P888, DOI 10.1006/viro.1993.1198; Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09; Beasley DWC, 2008, EXPERT OPIN BIOL TH, V8, P95, DOI 10.1517/14712598.8.1.95; Bhattachan A, 2009, EMERG INFECT DIS, V15, P1691, DOI 10.3201/eid1510.081641; Blitvich BJ, 1999, VIRUS RES, V60, P67, DOI 10.1016/S0168-1702(99)00003-9; Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013; Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200; BUCKLEY A, 1992, J GEN VIROL, V73, P1125, DOI 10.1099/0022-1317-73-5-1125; BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999; Burke DS, 1988, ARBOVIRUSES EPIDEMIO, V3, P63; Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; CASTLE E, 1986, VIROLOGY, V149, P10, DOI 10.1016/0042-6822(86)90082-6; CASTLE E, 1985, VIROLOGY, V145, P227, DOI 10.1016/0042-6822(85)90156-4; CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991; CHAMBERS TJ, 1989, VIROLOGY, V169, P100, DOI 10.1016/0042-6822(89)90045-7; CHAMBERS TJ, 1990, VIROLOGY, V177, P159, DOI 10.1016/0042-6822(90)90470-C; Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715; Diamond MS, 2009, J INTERF CYTOK RES, V29, P521, DOI 10.1089/jir.2009.0069; Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Elshuber S, 2005, J VIROL, V79, P11813, DOI 10.1128/JVI.79.18.11813-11823.2005; Elshuber S, 2003, J GEN VIROL, V84, P183, DOI 10.1099/vir.0.18723-0; Endy TP, 2002, CURR TOP MICROBIOL, V267, P11; Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311; FALGOUT B, 1989, J VIROL, V63, P1852, DOI 10.1128/JVI.63.5.1852-1860.1989; FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993; FALGOUT B, 1995, J VIROL, V69, P7232, DOI 10.1128/JVI.69.11.7232-7243.1995; Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14; Fischer Marc, 2010, Morbidity and Mortality Weekly Report, V59, P1; Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739; Geiss BJ, 2009, FUTURE MED CHEM, V1, P327, DOI 10.4155/FMC.09.27; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X; Gubler D.J., 2007, FIELDS VIROLOGY, VVolume 1; Halstead Scott B, 2003, Adv Virus Res, V61, P103, DOI 10.1016/S0065-3527(03)61003-1; Halstead SB, 2011, EXPERT REV VACCINES, V10, P355, DOI [10.1586/ERV.11.7, 10.1586/erv.11.7]; Hanna JN, 1999, MED J AUSTRALIA, V170, P533, DOI 10.5694/j.1326-5377.1999.tb127878.x; Hanna JN, 1996, MED J AUSTRALIA, V165, P256, DOI 10.5694/j.1326-5377.1996.tb124960.x; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; HORI H, 1990, J VIROL, V64, P4573, DOI 10.1128/JVI.64.9.4573-4577.1990; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709; Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735; Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08; Junjhon J, 2010, J VIROL, V84, P8353, DOI 10.1128/JVI.00696-10; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Kaufmann B, 2011, MICROBES INFECT, V13, P1, DOI 10.1016/j.micinf.2010.09.005; Kim JM, 2008, J VIROL, V82, P7846, DOI 10.1128/JVI.00789-08; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kumar R, 2006, CLIN INFECT DIS, V43, P123, DOI 10.1086/505121; Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002; Kuwayama M, 2005, EMERG INFECT DIS, V11, P471; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; LIN C, 1993, J VIROL, V67, P2327, DOI 10.1128/JVI.67.4.2327-2335.1993; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003; LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218; Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002; Lowry PW, 1998, AM J TROP MED HYG, V58, P324, DOI 10.4269/ajtmh.1998.58.324; Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Mackenzie JS, 2007, PERSP MED V, V16, P201, DOI 10.1016/S0168-7069(06)16010-3; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Mackenzie JS, 2002, CURR TOP MICROBIOL, V267, P1; Mackenzie JS, 2002, CURR TOP MICROBIOL, V267, P49; MAKINO Y, 1989, J GEN VIROL, V70, P1417, DOI 10.1099/0022-1317-70-6-1417; Markoff L, 2003, ADV VIRUS RES, V59, P177, DOI 10.1016/S0065-3527(03)59006-6; MASON PW, 1989, VIROLOGY, V169, P354, DOI 10.1016/0042-6822(89)90161-X; MASON PW, 1987, VIROLOGY, V158, P361, DOI 10.1016/0042-6822(87)90208-X; Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09; Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200; Monath TP, 2002, CURR TOP MICROBIOL, V267, P105; Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005; Mori Y, 2007, J VIROL, V81, P8477, DOI 10.1128/JVI.00477-07; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; NESTOROWICZ A, 1994, VIROLOGY, V199, P114, DOI 10.1006/viro.1994.1103; Paranjape SM, 2010, CURR TOP MICROBIOL, V338, P15, DOI 10.1007/978-3-642-02215-9_2; Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07; PAUL WS, 1993, J INFECT DIS, V167, P1053, DOI 10.1093/infdis/167.5.1053; Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069; Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001; Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011; Pijlman GP, 2006, J VIROL, V80, P11255, DOI 10.1128/JVI.01559-06; PREUGSCHAT F, 1991, VIROLOGY, V185, P689, DOI 10.1016/0042-6822(91)90540-R; PUGACHEV KV, 1992, FEBS LETT, V297, P67, DOI 10.1016/0014-5793(92)80329-F; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Rayamajhi A, 2006, ANN TROP PAEDIATR, V26, P293, DOI 10.1179/146532806X152818; RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707; Robertson C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066168; Robertson SJ, 2009, IMMUNOL RES, V43, P172, DOI 10.1007/s12026-008-8065-6; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; ROSEN L, 1986, ANNU REV MICROBIOL, V40, P395, DOI 10.1146/annurev.mi.40.100186.002143; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; SCHIMENTI KJ, 1992, CYTOMETRY, V13, P48, DOI 10.1002/cyto.990130109; Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160; Solomon T, 2004, ARCH VIROL, P161; Solomon T, 2002, CURR TOP MICROBIOL, V267, P171; Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; Song BH, 2008, RNA, V14, P1791, DOI 10.1261/rna.993608; Song BH, 2012, J MICROBIOL, V50, P698, DOI 10.1007/s12275-012-2336-6; SPEIGHT G, 1988, J GEN VIROL, V69, P23, DOI 10.1099/0022-1317-69-1-23; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4; Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998; SUMIYOSHI H, 1987, VIROLOGY, V161, P497, DOI 10.1016/0042-6822(87)90144-9; TADANO M, 1989, J GEN VIROL, V70, P1409, DOI 10.1099/0022-1317-70-6-1409; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Teo KF, 1997, J GEN VIROL, V78, P337, DOI 10.1099/0022-1317-78-2-337; Thiel H-J, 2005, VIRUS TAXONOMY, P981; Tiwari S, 2012, BRAZ J INFECT DIS, V16, P564, DOI 10.1016/j.bjid.2012.10.004; Tsai Theodore F., 2000, Vaccine, V18, P1, DOI 10.1016/S0264-410X(00)00037-2; Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x; Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05; van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510; VAUGHN DW, 1992, EPIDEMIOL REV, V14, P197, DOI 10.1093/oxfordjournals.epirev.a036087; Verma R, 2012, HUM VACC IMMUNOTHER, V8, P491, DOI 10.4161/hv.18925; Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016; Wang SH, 2002, J GEN VIROL, V83, P3093, DOI 10.1099/0022-1317-83-12-3093; Watt G, 2003, AM J TROP MED HYG, V68, P704, DOI 10.4269/ajtmh.2003.68.704; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; WENGLER G, 1991, VIROLOGY, V184, P707, DOI 10.1016/0042-6822(91)90440-M; WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587; WENGLER G, 1985, VIROLOGY, V147, P264, DOI 10.1016/0042-6822(85)90129-1; Westaway EG, 1997, VIROLOGY, V234, P31, DOI 10.1006/viro.1997.8629; Westaway EG, 2002, CURR TOP MICROBIOL, V267, P323; Wilder-Smith A, 2010, CURR OPIN INFECT DIS, V23, P426, DOI 10.1097/QCO.0b013e32833c1d01; Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12; Xu YH, 1996, PEDIATR INFECT DIS J, V15, P1018, DOI 10.1097/00006454-199611000-00017; YAMSHCHIKOV VF, 1994, J VIROL, V68, P5765, DOI 10.1128/JVI.68.9.5765-5771.1994; Ye Q, 2012, J GEN VIROL, V93, P1959, DOI 10.1099/vir.0.043844-0; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Yun S. I., 2006, MOL BIOL FLAVIVIRUS, P225; Yun SI, 2014, HUM VACC IMMUNOTHER, V10, P263, DOI 10.4161/hv.26902; Yun SI, 2009, J VIROL, V83, P7909, DOI 10.1128/JVI.02541-08; Yun SI, 2003, VIRUS RES, V96, P129, DOI 10.1016/S0168-1702(03)00181-3; Yun SI, 2003, J VIROL, V77, P6450, DOI 10.1128/JVI.77.11.6450-6465.2003; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270; Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07; Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0	150	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124318	10.1371/journal.pone.0124318	http://dx.doi.org/10.1371/journal.pone.0124318			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915765	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100046
J	Li, YL; Yu, GP; Li, QX; Wang, WL; Shen, XQ; Liu, H; Liu, RJ				Li, Yunlong; Yu, Guopeng; Li, Qiaoxing; Wang, Weilu; Shen, Xiangqian; Liu, Hua; Liu, Ruijiang			Construction of a BALB/c-Nu Mouse Model of Invasive Bladder Carcinoma and Preliminary Studies on the Treatment of Bladder Tumors through Internal Iliac Arterial Infusion of Albumin-Bound Arsenic Trioxide (As2O3)	PLOS ONE			English	Article							CANCER	To establish a BALB/c-nu mouse model of invasive bladder carcinoma and to investigate the feasibility, efficacy, and side effects of treating the mouse xenografts with internal iliac arterial infusion of albumin-bound arsenic trioxide (As2O3). Bladder tumors were established by intravesicular injection. Color Doppler were used to monitor tumor growth. Albumin-bound As2O3 and bovine serum albumin (BSA) nanoparticles were synthesized by cross-linking. BALB/c-nu mice were randomly divided into four treatment groups: 1) normal saline, 2) BSA nanoparticles, 3) As2O3 injections, and 4) albumin-bound As2O3. In an attempt to replicate the treatment of bladder cancer in humans using internal iliac arterial infusion, the drugs were injected into the mouse abdominal aorta. Tumor xenografts were established successfully. Mice treated with As2O3 injections and with albumin-bound As2O3 had significantly smaller bladders (36.59% and 37.82% smaller, respectively) than mice given normal saline injections (P < 0.01). Mice receiving As2O3 injections had lower white blood cell (WBC) and platelet counts compared with mice receiving normal saline injections only (P < 0.05). However, mice treated with albumin-bound As2O3 did not experience a significant decrease in WBC or platelet counts compared with control mice. A model of intra-arterial bladder cancer treatment was successfully established in BALB/c-nu mice. In this model, albumin-bound As2O3 appeared to be an effective method for treating bladder tumors, with less severe hematologic side effects compared with As2O3 alone. The infusion of albumin-bound As2O3 through the internal iliac artery is a promising method of bladder cancer therapy.	[Li, Yunlong; Li, Qiaoxing; Wang, Weilu; Liu, Hua] Jiangsu Univ, Affiliated Kunshan Hosp, Dept Urol, Suzhou 215300, Peoples R China; [Yu, Guopeng] Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200040, Peoples R China; [Yu, Guopeng] Fudan Univ, Fudan Inst Urol, Shanghai 200040, Peoples R China; [Liu, Hua] Jiangsu Univ, Affiliated Kunshan Hosp, Dept Neurosurg, Suzhou 215300, Peoples R China; [Shen, Xiangqian; Liu, Ruijiang] Jiangsu Univ, Sch Mat Sci & Engn, Zhenjiang 212013, Peoples R China	Jiangsu University; Fudan University; Fudan University; Jiangsu University; Jiangsu University	Liu, H (corresponding author), Jiangsu Univ, Affiliated Kunshan Hosp, Dept Urol, Suzhou 215300, Peoples R China.	urologymed@sina.com; luckystar_lrj@ujs.edu.cn	Liu, Ruijiang/F-5213-2019	Liu, Ruijiang/0000-0002-0716-832X	Jiangsu province clinical medicine science and technology special funds [BL2014056]; Kunshan social development science and technology plan projects [KS1335];  [30700836]	Jiangsu province clinical medicine science and technology special funds; Kunshan social development science and technology plan projects; 	This research was partially supported by Grants-in-Aid for Chinese National Natural Science (30700836). This research was partially supported by Jiangsu province clinical medicine science and technology special funds (BL2014056) and Kunshan social development science and technology plan projects (KS1335).	Ahn RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058491; Ai ZL, 2006, CLIN MED J CHINA, V13, P429; Chen GC, 2002, ANTICANCER RES, V22, P633; Chen G, 2012, INT J ONCOL, V40, P139, DOI 10.3892/ijo.2011.1210; Du CW, 2002, CHINESE J CANC PREVE, V9, P350; Feng Chun-qiong, 2002, Ai Zheng, V21, P1386; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang PC, 2000, FOREIGN MED SCI UROL, V20, P226; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji XY, 2006, CHINESE J CLIN MED, V13, P949; Kchour G, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-91; Leu L, 2009, AM J HEALTH-SYST PH, V66, P1913, DOI 10.2146/ajhp080342; [李凌 Li Ling], 2002, [中华实验外科杂志, Chinese Journal of Experimental Surgery], V19, P78; Li Y, 2014, LEUKEMIA LYMPHOMA, V55, P1366, DOI 10.3109/10428194.2013.829573; Liu HB, 2000, CHINA PHARM, V11, P155; Maeda H, 2013, ADV DRUG DELIVER REV, V65, P71, DOI 10.1016/j.addr.2012.10.002; Orntoft TF, 2011, LANCET ONCOL, V12, P111, DOI 10.1016/S1470-2045(11)70001-8; Qu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032215; Rink M, 2012, EUR UROL, V62, P1204, DOI 10.1016/j.eururo.2012.08.057; Shah JB, 2004, CURR OPIN UROL, V14, P287, DOI 10.1097/00042307-200409000-00007; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; [孙昊 Sun Hao], 2010, [介入放射学杂志, Journal of Interventional Radiology], V19, P454; The Ministry of Science and Technology of the People's Republic of China, 2006, GUID SUGG CAR US LAB; Tong QS, 2000, J CLIN UROLOGY, V15, P72; Ulbrich K, 2011, INT J PHARMACEUT, V406, P128, DOI 10.1016/j.ijpharm.2010.12.023; Waxman S, 2001, ONCOLOGIST, V6, P3, DOI 10.1634/theoncologist.6-suppl_2-3; Weizer AZ, 2011, WORLD J UROL, V29, P59, DOI 10.1007/s00345-010-0617-4; Yang Shen-Min, 2007, Ai Zheng, V26, P341; Zhang XH, 2013, LEUKEMIA RES, V37, P1719, DOI 10.1016/j.leukres.2013.09.019; Zhang Y, 2011, CHINA MODERN MEIDCIN, V18, P59; [周洁 Zhou Ji], 2005, [中国新药杂志, Chinese Journal New Drugs], V14, P54; Zhu J, 2004, J CLIN UROLOGY, V19, P83	32	1	1	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124959	10.1371/journal.pone.0124959	http://dx.doi.org/10.1371/journal.pone.0124959			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915411	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100085
J	Pan, HP; Yang, XW; Siegfried, BD; Zhou, XG				Pan, Huipeng; Yang, Xiaowei; Siegfried, Blair D.; Zhou, Xuguo			A Comprehensive Selection of Reference Genes for RT-qPCR Analysis in a Predatory Lady Beetle, Hippodamia convergens (Coleoptera: Coccinellidae)	PLOS ONE			English	Article							REAL-TIME PCR; HOUSEKEEPING GENES; TRANSGENIC CROPS; NORMALIZATION; GUIDELINES	Reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) is a reliable, rapid, and reproducible technique for measuring and evaluating changes in gene expression. To facilitate gene expression studies and obtain more accurate RT-qPCR data, normalization relative to stable reference genes is required. In this study, expression profiles of seven candidate reference genes, including beta-actin (Actin), elongation factor 1 a (EF1A), glyceralde hyde-3-phosphate dehydro-genase (GAPDH), cyclophilins A (CypA), vacuolartype H+-ATPase (ATPase), 28S ribosomal RNA (28S), and 18S ribosomal RNA (18S) from Hippodamia convergens were investigated. H. convergens is an abundant predatory species in the New World, and has been widely used as a biological control agent against sapsucking insect pests, primarily aphids. A total of four analytical methods, geNorm, Normfinder, BestKeeper, and the Delta Ct method, were employed to evaluate the performance of these seven genes as endogenous controls under diverse experimental conditions. Additionally, RefFinder, a comprehensive evaluation platform integrating the four above mentioned algorithms, ranked the overall stability of these candidate genes. A suite of reference genes were specifically recommended for each experimental condition. Among them, 28S, EF1A, and CypA were the best reference genes across different development stages; GAPDH, 28S, and CypA were most stable in different tissues. GAPDH and CypA were most stable in female and male adults and photoperiod conditions, 28S and EF1A were most stable under a range of temperatures, Actin and CypA were most stable under dietary RNAi condition. This work establishes a standardized RT-qPCR analysis in H. convergens. Additionally, this study lays a foundation for functional genomics research in H. convergens and sheds light on the ecological risk assessment of RNAi-based biopesticides on this non-target biological control agent.	[Pan, Huipeng; Yang, Xiaowei; Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA; [Yang, Xiaowei] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Siegfried, Blair D.] Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA	University of Kentucky; Cornell University; University of Nebraska System; University of Nebraska Lincoln	Zhou, XG (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	xuguozhou@uky.edu			University of Kentucky; USDA BRAG [3048108827]	University of Kentucky; USDA BRAG	This research was supported by a start-up fund from the University of Kentucky to XGZ, a grant from USDA BRAG grant (Award Agreement No.: 3048108827) to XGZ and BDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dreistadt SH, 1996, ENVIRON ENTOMOL, V25, P688, DOI 10.1093/ee/25.3.688; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Haug G. W., 1938, Annals of the Entomological Society of America, V31, P240, DOI 10.1093/aesa/31.2.240; Hodek I, 2012, ECOLOGY BEHAV LADYBI, DOI DOI 10.1002/9781118223208; Kupferschmidt K, 2013, SCIENCE, V341, P732, DOI 10.1126/science.341.6147.732; Li RM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053006, 10.1371/journal.pone.0058597]; Liang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087514; Lin JT, 2012, DEV GENES EVOL, V222, P369, DOI 10.1007/s00427-012-0420-x; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Lundgren JG, 2013, BIOSCIENCE, V63, P657, DOI 10.1525/bio.2013.63.8.8; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Obrycki JJ, 1998, ANNU REV ENTOMOL, V43, P295, DOI 10.1146/annurev.ento.43.1.295; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Raupp Michael J., 1994, Journal of Arboriculture, V20, P241; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Shi Xiao-Qin, 2013, BMC Res Notes, V6, P93, DOI 10.1186/1756-0500-6-93; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Strube C, 2008, GENE, V425, P36, DOI 10.1016/j.gene.2008.08.001; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Thomas KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088653; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veazey KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027592; Yang CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110454; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084730	34	68	72	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125868	10.1371/journal.pone.0125868	http://dx.doi.org/10.1371/journal.pone.0125868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915640	Green Published, gold			2022-12-27	WOS:000353659100150
J	Zhong, QY; Gelaye, B; Zaslavsky, AM; Fann, JR; Rondon, MB; Sanchez, SE; Williams, MA				Zhong, Qiu-Yue; Gelaye, Bizu; Zaslavsky, Alan M.; Fann, Jesse R.; Rondon, Marta B.; Sanchez, Sixto E.; Williams, Michelle A.			Diagnostic Validity of the Generalized Anxiety Disorder-7 (GAD-7) among Pregnant Women	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; WORLD-HEALTH-ORGANIZATION; PARTIAL CREDIT MODEL; PRIMARY-CARE; SPANISH VERSION; INTERVIEW CIDI; DEPRESSION; RISK; PREVALENCE; VALIDATION	Objective Generalized anxiety disorder (GAD) during pregnancy is associated with several adverse maternal and perinatal outcomes. A reliable and valid screening tool for GAD should lead to earlier detection and treatment. Among pregnant Peruvian women, a brief screening tool, the GAD-7, has not been validated. This study aims to evaluate the reliability and validity of the GAD-7. Methods Of 2,978 women who attended their first perinatal care visit and had the GAD-7 screening, 946 had a Composite International Diagnostic Interview (CIDI). The Cronbach's alpha was calculated to examine the reliability. We assessed the criterion validity by calculating operating characteristics. The construct validity was evaluated using factor analysis and association with health status on the CIDI. The cross-cultural validity was explored using the Rasch Rating Scale Model (RSM). Results The reliability of the GAD-7 was good (Cronbach's alpha = 0.89). A cutoff score of 7 or higher, maximizing the Youden Index, yielded a sensitivity of 73.3% and a specificity of 67.3%. One-factor structure of the GAD-7 was confirmed by exploratory and confirmatory factor analysis. Concurrent validity was supported by the evidence that higher GAD-7 scores were associated with poor self-rated physical and mental health. The Rasch RSM further confirmed the cross-cultural validity of the GAD-7. Conclusion The results suggest that the Spanish-language version of the GAD-7 may be used as a screening tool for pregnant Peruvian women. The GAD-7 has good reliability, factorial validity, and concurrent validity. The optimal cutoff score obtained by maximizing the Youden Index should be considered cautiously; women who screened positive may require further investigation to confirm GAD diagnosis.	[Zhong, Qiu-Yue; Gelaye, Bizu; Williams, Michelle A.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Zaslavsky, Alan M.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Rondon, Marta B.] Cayetano Heredia Peruvian Univ, Dept Med, Lima, Peru; [Sanchez, Sixto E.] Univ Peruana Ciencias Aplicadas, Lima, Peru; [Sanchez, Sixto E.] Asociac Civil PROESA, Lima, Peru	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Universidad Peruana Cayetano Heredia; Universidad Peruana de Ciencias Aplicadas (UPC)	Zhong, QY (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	qyzhong@mail.harvard.edu		Sanchez, Sixto/0000-0003-0354-0523; Rondon, Marta/0000-0001-8459-6785; Gelaye, Bizu/0000-0001-7934-548X	Eunice Kennedy Shriver Institute of Child Health and Human Development at the National Institutes of Health (NIH) [R01-HD-059835]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059835] Funding Source: NIH RePORTER	Eunice Kennedy Shriver Institute of Child Health and Human Development at the National Institutes of Health (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by an award from the Eunice Kennedy Shriver Institute of Child Health and Human Development (R01-HD-059835) at the National Institutes of Health (NIH). The NIH had no further role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Abbey CK, 2013, MED DECIS MAKING, V33, P510, DOI 10.1177/0272989X12470756; ACOG Committee on Practice Bulletins--Obstetrics, 2008, Obstet Gynecol, V111, P1001, DOI 10.1097/AOG.0b013e31816fd910; Adams RJ, 2012, EDUC PSYCHOL MEAS, V72, P547, DOI 10.1177/0013164411432166; Adewuya AO, 2006, ARCH WOMEN MENT HLTH, V9, P325, DOI 10.1007/s00737-006-0157-5; Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; Andrich D, 2005, RASCH MODEL EXPLAINE; Andrich D., 1978, APPL PSYCH MEAS, V2, P581, DOI [DOI 10.1177/014662167800200413, 10.1177/014662167800200413]; Austin M-P, 2004, Arch Womens Ment Health, V7, P1, DOI 10.1007/s00737-003-0034-4; Baker F., 2001, BASICS ITEM RESPONSE; Bar-Shai M, PSYCHOSOMATICS; BEGG CB, 1983, BIOMETRICS, V39, P207, DOI 10.2307/2530820; Bond TG, 2013, APPL RASCH MODEL FUN, DOI [10.1186/1471-2377-13-78, DOI 10.1186/1471-2377-13-78]; Brown T.A., 2015, CONFIRMATORY FACTOR, V2nd ed., DOI DOI 10.5860/CHOICE.44-2769; BURSTEIN I, 1974, AM J OBSTET GYNECOL, V118, P195, DOI 10.1016/0002-9378(74)90549-3; de Paz NC, 2011, J AFFECT DISORDERS, V130, P280, DOI 10.1016/j.jad.2010.07.024; Delgadillo J, 2012, DRUG ALCOHOL DEPEN, V125, P37, DOI 10.1016/j.drugalcdep.2012.03.011; Ding XX, 2014, J AFFECT DISORDERS, V159, P103, DOI 10.1016/j.jad.2014.02.027; Donker T, 2011, PSYCHIAT RES, V188, P58, DOI 10.1016/j.psychres.2011.01.016; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Forkmann T, 2013, J AFFECT DISORD; Garcia-Campayo Javier, 2012, Health Qual Life Outcomes, V10, P114, DOI 10.1186/1477-7525-10-114; Garcia-Campayo J, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-8; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gelaye B, 2013, INT J PSYCHIAT MED, V46, P387, DOI 10.2190/PM.46.4.e; Huizink AC, 2004, EARLY HUM DEV, V79, P81, DOI 10.1016/j.earlhumdev.2004.04.014; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kertz S, 2013, CLIN PSYCHOL PSYCHOT, V20, P456, DOI 10.1002/cpp.1802; Kessler R. C., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P511; Kessler R.C., 1998, INT J METHODS PSYCHI, V7, P171, DOI [10.1002/mpr.47, DOI 10.1002/MPR.47]; Kessler RC, 2005, PSYCHOL MED, V35, P1073, DOI 10.1017/S0033291705004538; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2004, INT J METH PSYCH RES, V13, P122, DOI 10.1002/mpr.169; KRAEMER HC, 1992, EVALUATING MED TESTS; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Lamoureux EL, 2009, OPTOMETRY VISION SCI, V86, P139, DOI 10.1097/OPX.0b013e318194eb47; Li YL, 2012, STAT MED, V31, P2010, DOI 10.1002/sim.4475; Lowe B, 2008, GEN HOSP PSYCHIAT, V30, P191, DOI 10.1016/j.genhosppsych.2008.01.001; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; McFall RM, 1999, ANNU REV PSYCHOL, V50, P215, DOI 10.1146/annurev.psych.50.1.215; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mulder EJH, 2002, EARLY HUM DEV, V70, P3, DOI 10.1016/S0378-3782(02)00075-0; MURAKI E, 1992, APPL PSYCH MEAS, V16, P159, DOI 10.1177/014662169201600206; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Orr ST, 2007, PSYCHOSOM MED, V69, P566, DOI 10.1097/PSY.0b013e3180cac25d; Pepe M. S., 2003, STAT EVALUATION MED; Perales MT, 2009, VIOLENCE AGAINST WOM, V15, P224, DOI 10.1177/1077801208329387; Pompili M, 2012, SUICIDE GLOBAL PERSP; Portman ME, 2011, PSYCHIAT ANN, V41, P79, DOI 10.3928/00485713-20110203-06; Qiu CF, 2009, AM J HYPERTENS, V22, P397, DOI 10.1038/ajh.2008.366; Rasch G., 1960, PROBABILISTIC MODELS; Rollman BL, 2005, ARCH GEN PSYCHIAT, V62, P1332, DOI 10.1001/archpsyc.62.12.1332; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Roy-Byrne P, 2010, JAMA-J AM MED ASSOC, V303, P1921, DOI 10.1001/jama.2010.608; Rubertsson C, 2014, ARCH WOMEN MENT HLTH, P1; Ruiz MA, 2011, J AFFECT DISORDERS, V128, P277, DOI 10.1016/j.jad.2010.07.010; Shear MK, 1995, PSYCHOPHARMACOL BULL, V31, P693; Sidik SM, 2012, J PRIM HEALTH CARE, V4, P5; Simpson W, 2014, CAN J PSYCHIAT, V59, P434, DOI 10.1177/070674371405900806; Smits N, 2007, INT J METH PSYCH RES, V16, P219, DOI 10.1002/mpr.230; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sutter-Dallay AL, 2004, EUR PSYCHIAT, V19, P459, DOI 10.1016/j.eurpsy.2004.09.025; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Tijdink J, 2014, QUAL LIFE RES, P1, DOI [10.1007/s11136-014-0769-6, DOI 10.1007/S11136-014-0769-6]; Van den Bergh B, 1990, J PRENAT PERINAT PSY, V5; Vythilingum Bavanisha, 2008, Curr Psychiatry Rep, V10, P331, DOI 10.1007/s11920-008-0053-y; Wetzel E, 2014, REVERSED THRESHOLDS; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhong QY, 2014, J AFFECT DISORDERS, V158, P148, DOI 10.1016/j.jad.2014.02.012	72	115	124	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125096	10.1371/journal.pone.0125096	http://dx.doi.org/10.1371/journal.pone.0125096			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915929	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100097
J	Albano, G; Moor, M; Dolder, S; Siegrist, M; Wagner, CA; Biber, J; Hernando, N; Hofstetter, W; Bonny, O; Fuster, DG				Albano, Giuseppe; Moor, Matthias; Dolder, Silvia; Siegrist, Mark; Wagner, Carsten A.; Biber, Juerg; Hernando, Nati; Hofstetter, Willy; Bonny, Olivier; Fuster, Daniel G.			Sodium-Dependent Phosphate Transporters in Osteoclast Differentiation and Function	PLOS ONE			English	Article							BASAL GANGLIA CALCIFICATION; BONE-RESORBING OSTEOCLASTS; INORGANIC-PHOSPHATE; IN-VITRO; MICE; CALCIUM; CELLS; RESORPTION; HOMEOSTASIS; METABOLISM	Osteoclasts are multinucleated bone degrading cells. Phosphate is an important constituent of mineralized bone and released in significant quantities during bone resorption. Molecular contributors to phosphate transport during the resorptive activity of osteoclasts have been controversially discussed. This study aimed at deciphering the role of sodium-dependent phosphate transporters during osteoclast differentiation and bone resorption. Our studies reveal RANKL-induced differential expression of sodium-dependent phosphate transport protein IIa (NaPi-IIa) transcript and protein during osteoclast development, but no expression of the closely related NaPi-IIb and NaPi-IIc SLC34 family isoforms. In vitro studies employing NaPi-IIa-deficient osteoclast precursors and mature osteoclasts reveal that NaPi-IIa is dispensable for bone resorption and osteoclast differentiation. These results are supported by the analysis of structural bone parameters by high-resolution microcomputed tomography that yielded no differences between adult NaPi-IIa WT and KO mice. By contrast, both type III sodium-dependent phosphate transporters Pit-1 and Pit-2 were abundantly expressed throughout osteoclast differentiation, indicating that they are the relevant sodium-dependent phosphate transporters in osteoclasts and osteoclast precursors. We conclude that phosphate transporters of the SLC34 family have no role in osteoclast differentiation and function and propose that Pit-dependent phosphate transport could be pivotal for bone resorption and should be addressed in further studies.	[Albano, Giuseppe; Fuster, Daniel G.] Univ Hosp Bern, Div Nephrol Hypertens & Clin Pharmacol, CH-3010 Bern, Switzerland; [Albano, Giuseppe; Fuster, Daniel G.] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Albano, Giuseppe; Dolder, Silvia; Siegrist, Mark; Hofstetter, Willy; Fuster, Daniel G.] Univ Bern, NCCR Transcure, Bern, Switzerland; [Moor, Matthias; Bonny, Olivier] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland; [Dolder, Silvia; Siegrist, Mark; Hofstetter, Willy] Univ Bern, Dept Clin Res, Grp Bone Biol & Orthopaed Res, Bern, Switzerland; [Wagner, Carsten A.; Biber, Juerg; Hernando, Nati] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Albano, Giuseppe; Moor, Matthias; Dolder, Silvia; Siegrist, Mark; Wagner, Carsten A.; Biber, Juerg; Hernando, Nati; Hofstetter, Willy; Bonny, Olivier; Fuster, Daniel G.] Univ Zurich, NCCR Kidney CH, Zurich, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Lausanne; University of Bern; University of Zurich; University of Zurich	Fuster, DG (corresponding author), Univ Hosp Bern, Div Nephrol Hypertens & Clin Pharmacol, CH-3010 Bern, Switzerland.	Daniel.Fuster@ibmm.unibe.ch	Fuster, Daniel G/AAA-7079-2021; Moor, Matthias/W-1627-2019	Fuster, Daniel G/0000-0001-7220-1803; Hofstetter, Wilhelm/0000-0003-0126-8423; bonny, olivier/0000-0003-4123-4279; Moor, Matthias/0000-0002-7717-651X	Swiss National Science Foundation [3100A0_135503, 3100A0_152829, PP00P3-133648]; Swiss National Science Foundation NCCR Trancure; Swiss National Science Foundation NCCR Kidney	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation NCCR Trancure; Swiss National Science Foundation NCCR Kidney	Swiss National Science Foundation NCCR Trancure to DF, WH. Swiss National Science Foundation NCCR Kidney. CH to DF, JB, CW, NH, OB. Swiss National Science Foundation grants # 3100A0_135503 and 3100A0_152829 to DF. Prof. Max Cloetta Foundation grant to DF. Swiss National Science Foundation grant # PP00P3-133648 to OB.	Balga R, 2006, BONE, V39, P325, DOI 10.1016/j.bone.2006.02.056; Battini JL, 1999, P NATL ACAD SCI USA, V96, P1385, DOI 10.1073/pnas.96.4.1385; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Beck L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009148; Beck L, 2009, J BIOL CHEM, V284, P31363, DOI 10.1074/jbc.M109.053132; Berger CEM, 2001, J BONE MINER RES, V16, P2092, DOI 10.1359/jbmr.2001.16.11.2092; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Bourgeois S, 2013, PFLUG ARCH EUR J PHY, V465, P1557, DOI 10.1007/s00424-013-1298-9; Bourgine A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065979; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chavkin NW, 2015, EXP CELL RES; Choy J, 2014, BONE, V69, P80, DOI 10.1016/j.bone.2014.09.013; Crouthamel MH, 2013, ARTERIOSCL THROM VAS, V33, P2625, DOI 10.1161/ATVBAHA.113.302249; Datta HK, 2003, J ENDOCRINOL, V176, P1, DOI 10.1677/joe.0.1760001; Dolder S, 2006, J BONE MINER RES, V21, P647, DOI 10.1359/JBMR.060111; Egermann M, 2009, J ORTHOP RES; Forster IC, 2013, MOL ASPECTS MED, V34, P386, DOI 10.1016/j.mam.2012.07.007; Fuster DG, 2008, J AM SOC NEPHROL, V19, P1547, DOI 10.1681/ASN.2007111245; Giovannini D, 2013, CELL REP, V3, P1866, DOI 10.1016/j.celrep.2013.05.035; Gupta A, 1997, J CLIN INVEST, V100, P538, DOI 10.1172/JCI119563; Gupta A, 1996, KIDNEY INT, V49, P968, DOI 10.1038/ki.1996.137; Gupta A, 2001, BONE, V29, P467, DOI 10.1016/S8756-3282(01)00601-9; Hilfiker H, 1998, P NATL ACAD SCI USA, V95, P14564, DOI 10.1073/pnas.95.24.14564; Ito M, 2005, AM J PHYSIOL-CELL PH, V288, pC921, DOI 10.1152/ajpcell.00412.2004; Ito M, 2007, AM J PHYSIOL-CELL PH, V292, pC526, DOI 10.1152/ajpcell.00357.2006; Jensen N, 2013, J MOL NEUROSCI, V51, P994, DOI 10.1007/s12031-013-0085-6; Khadeer MA, 2003, AM J PHYSIOL-CELL PH, V284, pC1633, DOI 10.1152/ajpcell.00580.2002; Miyazaki T, 2010, DENT MATER J, V29, P403, DOI 10.4012/dmj.2009-132; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Myakala K, 2014, AM J PHYSIOL-RENAL, V306, pF833, DOI 10.1152/ajprenal.00133.2013; Nesbitt SA, 1997, SCIENCE, V276, P266, DOI 10.1126/science.276.5310.266; Nowik M, 2008, PFLUG ARCH EUR J PHY, V457, P539, DOI 10.1007/s00424-008-0530-5; Onishi T, 2007, J DENT RES, V86, P158, DOI 10.1177/154405910708600210; Picard N, 2010, PFLUG ARCH EUR J PHY, V460, P677, DOI 10.1007/s00424-010-0841-1; Salo J, 1997, SCIENCE, V276, P270, DOI 10.1126/science.276.5310.270; Segawa H, 2009, AM J PHYSIOL-RENAL, V297, pF671, DOI 10.1152/ajprenal.00156.2009; Segawa H, 2009, J AM SOC NEPHROL, V20, P104, DOI 10.1681/ASN.2008020177; Sharma P, 2010, BIOCHEM BIOPH RES CO, V399, P129, DOI 10.1016/j.bbrc.2010.07.022; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; Wang C, 2012, NAT GENET, V44, P254, DOI 10.1038/ng.1077	40	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125104	10.1371/journal.pone.0125104	http://dx.doi.org/10.1371/journal.pone.0125104			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910236	Green Published, gold, Green Accepted			2022-12-27	WOS:000353376800129
J	Ruiz-Lafuente, N; Alcaraz-Garcia, MJ; Sebastian-Ruiz, S; Garcia-Serna, AM; Gomez-Espuch, J; Moraleda, JM; Minguela, A; Garcia-Alonso, AM; Parrado, A				Ruiz-Lafuente, Natalia; Alcaraz-Garcia, Maria-Jose; Sebastian-Ruiz, Silvia; Garcia-Serna, Azahara-Maria; Gomez-Espuch, Joaquin; Moraleda, Jose-Maria; Minguela, Alfredo; Garcia-Alonso, Ana-Maria; Parrado, Antonio			IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							KAPPA-B ACTIVITY; CLL PATIENTS; MICRORNA EXPRESSION; CELL-PROLIFERATION; ACTIVATION; APOPTOSIS; RESISTANCE; CANCER; DELETION; SUBSETS	Interleukin 4 (IL-4) induces B-cell differentiation and survival of chronic lymphocytic leukemia (CLL) cells. MicroRNAs (miRNAs) regulate mRNA and protein expression, and several miRNAs, deregulated in CLL, might play roles as oncogenes or tumor suppressors. We have studied the miRNA profile of CLL, and its response to IL-4, by oligonucleotide microarrays, resulting in the detection of a set of 129 mature miRNAs consistently expressed in CLL, which included 41 differentially expressed compared to normal B cells (NBC), and 6 significantly underexpressed in ZAP-70 positive patients. IL-4 stimulation brought about upregulation of the 5p and 3p mature variants of the miR-21 gene, which maps immediately downstream to the VMP1 gene, and of the mature forms generated from the miR-362 (3p and 5p), miR-500a (3p), miR-502 (3p), and miR-532 (3p and 5p) genes, which map within the third intron of the CLCN5 gene. Both genes are in turn regulated by IL-4, suggesting that these miRNAs were regulated by IL-4 as passengers from their carrier genes. Their levels of up-regulation by IL-4 significantly correlated with cytoprotection. MiR-21 has been reported to be leukemogenic, associated to bad prognosis in CLL, and the miRNA more frequently overexpressed in human cancer. Up-regulation by IL-4 of miR-21 and the miRNAs hosted in the CLCN5 locus may contribute to evasion of apoptosis of CLL cells. These findings indicate that the IL-4 pathway and the miRNAs induced by IL-4 are promising targets for the development of novel therapies in CLL.	[Ruiz-Lafuente, Natalia; Alcaraz-Garcia, Maria-Jose; Sebastian-Ruiz, Silvia; Garcia-Serna, Azahara-Maria; Minguela, Alfredo; Garcia-Alonso, Ana-Maria; Parrado, Antonio] Univ Virgen Arrixaca, Hosp Clin, Serv Inmunol, Murcia, Spain; [Gomez-Espuch, Joaquin; Moraleda, Jose-Maria] Univ Virgen Arrixaca, Hosp Clin, Serv Hematol & Hemoterapia, Murcia, Spain; [Garcia-Serna, Azahara-Maria; Moraleda, Jose-Maria] Univ Murcia, Murcia, Spain; [Minguela, Alfredo; Garcia-Alonso, Ana-Maria] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Murcia, Spain; [Ruiz-Lafuente, Natalia; Alcaraz-Garcia, Maria-Jose; Sebastian-Ruiz, Silvia; Garcia-Serna, Azahara-Maria; Gomez-Espuch, Joaquin; Moraleda, Jose-Maria; Minguela, Alfredo; Garcia-Alonso, Ana-Maria; Parrado, Antonio] Inst Murciano Invest Biosanitaria Virgen Arrixaca, Murcia, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Clinico Universitario Virgen de la Arrixaca	Parrado, A (corresponding author), Univ Virgen Arrixaca, Hosp Clin, Serv Inmunol, Murcia, Spain.	antonio.parrado@carm.es	García, Maria Jose Alcaraz/ABH-2338-2020; Ruiz-Lafuente, Natalia/R-5449-2019; Moraleda, José María/AAB-4119-2020; Minguela, Alfredo/Q-9783-2019; Parrado, Antonio/K-9591-2014	Ruiz-Lafuente, Natalia/0000-0003-4628-7038; Minguela, Alfredo/0000-0003-2472-5893; Parrado, Antonio/0000-0002-7660-018X; Alcaraz/0000-0002-1057-0299; Garcia-Serna, Azahara M/0000-0001-7828-3213	Plan Nacional de I+D+I, Programa de Promocion de la Investigacion Biomedica y en Ciencias de la Salud del Ministerio de Sanidad y Consumo [PI07/0135]; Plan Nacional de I+D+I, Accion Estrategica en Salud [PI10/01226]; European Regional Development Funds; II PCTRM, Fundacion Seneca, Agencia de Ciencia y Tecnologia de la Region de Murcia [08721/PI/08]; ISCIII Spanish Cell Therapy Network (Tercel) [RD06/0010/0023]; CIBERehd scientific program	Plan Nacional de I+D+I, Programa de Promocion de la Investigacion Biomedica y en Ciencias de la Salud del Ministerio de Sanidad y Consumo; Plan Nacional de I+D+I, Accion Estrategica en Salud; European Regional Development Funds(European Commission); II PCTRM, Fundacion Seneca, Agencia de Ciencia y Tecnologia de la Region de Murcia; ISCIII Spanish Cell Therapy Network (Tercel); CIBERehd scientific program	This work was supported by grants from Plan Nacional de I+D+I 2004-2007, Programa de Promocion de la Investigacion Biomedica y en Ciencias de la Salud del Ministerio de Sanidad y Consumo (PI07/0135 to AP) and Plan Nacional de I +D+I 2008-2011, Accion Estrategica en Salud (PI10/01226 to AP) (Instituto de Salud Carlos III (ISCIII) co-financed with European Regional Development Funds, "Una manera de hacer Europa"), II PCTRM 2007-2010, Fundacion Seneca, Agencia de Ciencia y Tecnologia de la Region de Murcia (08721/PI/08 to AP), ISCIII Spanish Cell Therapy Network (Tercel; RD06/0010/0023 to JMM), and the CIBERehd scientific program to AM and AMGA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer C, 2012, CANCER RES, V72, P3775, DOI 10.1158/0008-5472.CAN-12-0803; Bhattacharya N, 2015, INT J CANCER, V136, P65, DOI 10.1002/ijc.28974; Bomben R, 2012, LEUKEMIA, V26, P1584, DOI 10.1038/leu.2012.44; Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chiorazzi N, 2012, HEMATOL-AM SOC HEMAT, P76, DOI 10.1182/asheducation-2012.1.76; Christensen LL, 2013, INT J CANCER, V133, P67, DOI 10.1002/ijc.28010; Coscia M, 2011, LEUKEMIA, V25, P828, DOI 10.1038/leu.2011.12; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Cuni S, 2004, LEUKEMIA, V18, P1391, DOI 10.1038/sj.leu.2403398; DANCESCU M, 1992, J EXP MED, V176, P1319, DOI 10.1084/jem.176.5.1319; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Dijkstra MK, 2009, LEUKEMIA, V23, P625, DOI 10.1038/leu.2008.264; Douglas RS, 1997, BLOOD, V89, P941, DOI 10.1182/blood.V89.3.941; Rodriguez AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048485; Ferracin M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-123; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Furman RR, 2000, J IMMUNOL, V164, P2200, DOI 10.4049/jimmunol.164.4.2200; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Lawrie CH, 2009, BRIT J HAEMATOL, V147, P398, DOI 10.1111/j.1365-2141.2009.07857.x; LI S, 2011, PLOS GENET, V7, P16956, DOI DOI 10.1371/JOURNAL.PONE.0016956; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Marton S, 2008, LEUKEMIA, V22, P330, DOI 10.1038/sj.leu.2405022; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mraz M, 2009, LEUKEMIA, V23, P1159, DOI 10.1038/leu.2008.377; Negrini M, 2014, CLIN CANCER RES, V20, P4141, DOI 10.1158/1078-0432.CCR-13-2497; Okada H, 2003, CYTOKINE HDB, VI, P227; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; Papakonstantinou N, 2013, MOL MED, V19, P115, DOI 10.2119/molmed.2013.00005; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; Ribas J, 2012, NUCLEIC ACIDS RES, V40, P6821, DOI 10.1093/nar/gks308; Rossi S, 2010, BLOOD, V116, P945, DOI 10.1182/blood-2010-01-263889; Ruiz-Lafuente N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109533; Sandhu SK, 2013, P NATL ACAD SCI USA, V110, P18208, DOI 10.1073/pnas.1315365110; Santanam U, 2010, P NATL ACAD SCI USA, V107, P12210, DOI 10.1073/pnas.1007186107; Smonskey MT, 2012, AM J CLIN PATHOL, V137, P641, DOI 10.1309/AJCPP31FSSRQTTAQ; Song FJ, 2009, CLIN CANCER RES, V15, P6292, DOI 10.1158/1078-0432.CCR-09-0826; Stamatopoulos B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012780; Steele AJ, 2010, BLOOD, V116, P4569, DOI 10.1182/blood-2009-09-245811; Thapa DR, 2012, AIDS, V26, P1177, DOI 10.1097/QAD.0b013e3283543e0e; Thieu VT, 2007, J LEUKOCYTE BIOL, V82, P370, DOI 10.1189/jlb.1106707; Vargova K, 2011, BLOOD, V117, P3816, DOI 10.1182/blood-2010-05-285064; Wang WJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-819; Xia JT, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-33; Yamamoto Y, 2009, BIOMARKERS, V14, P529, DOI 10.3109/13547500903150771; Zamorano J, 2001, INT IMMUNOL, V13, P1479, DOI 10.1093/intimm/13.12.1479; Zenz T, 2009, BLOOD, V113, P3801, DOI 10.1182/blood-2008-08-172254; Zhai H, 2013, ONCOGENE, V32, P1570, DOI 10.1038/onc.2012.167; Zhu DX, 2012, CARCINOGENESIS, V33, P1294, DOI 10.1093/carcin/bgs179	49	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124936	10.1371/journal.pone.0124936	http://dx.doi.org/10.1371/journal.pone.0124936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909590	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800117
J	Cerino, A; Bremer, CM; Glebe, D; Mondelli, MU				Cerino, Antonella; Bremer, Corinna M.; Glebe, Dieter; Mondelli, Mario U.			A Human Monoclonal Antibody against Hepatitis B Surface Antigen with Potent Neutralizing Activity	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; IMMUNE GLOBULIN; CELL EPITOPE; VIRUS HBV; VACCINATION; INFECTION	We describe the production and characterization of human monoclonal antibodies (mAb) specific for the major hepatitis B virus (HBV) S protein. The mAbs, two IgG1 kappa and one IgG1 lambda, were secreted by B-cell clones obtained from peripheral blood mononuclear cells (PBMC) of one person convalescent from acute hepatitis B and one vaccinated individual. The former recognized a denaturation-insensitive epitope within the p24 protein whereas the latter recognized a denaturation-sensitive, conformational epitope located within the HBsAg common "a" determinant. This mAb, denominated ADRI-2F3, displayed a very high protective titer of over 43,000 IU/mg mAb and showed an extremely potent neutralizing activity in the in vitro model of HBV infection using primary hepatocytes from Tupaia belangeri as target. Recombinant variable heavy and light domain sequences derived from mAb ADRI-2F3 were cloned into eukaryotic expression vectors and showed identical fine specificity and 1 log(10) higher titer than the original IgG1 lambda. It is envisaged that such mAb will be able to efficiently prevent HBV reinfection after liver transplantation for end-stage chronic HBV infection or infection after needle-stick exposure, providing an unlimited source of valuable protective anti-HBs antibody.	[Cerino, Antonella; Mondelli, Mario U.] Fdn IRCCS Policlin San Matteo, Dept Infect Dis, Res Labs, Pavia, Italy; [Bremer, Corinna M.; Glebe, Dieter] Univ Giessen, German Ctr Infect Res, Natl Reference Ctr Hepatitis B & D Viruses, Inst Med Virol, D-35390 Giessen, Germany; [Mondelli, Mario U.] Univ Pavia, Dept Internal Med & Therapeut, I-27100 Pavia, Italy	IRCCS Fondazione San Matteo; German Center for Infection Research; Justus Liebig University Giessen; University of Pavia	Mondelli, MU (corresponding author), Fdn IRCCS Policlin San Matteo, Dept Infect Dis, Res Labs, Pavia, Italy.	mario.mondelli@unipv.it	Mondelli, Mario U/J-5375-2016	Mondelli, Mario U/0000-0003-1811-3153; Bremer, Corinna Mareen/0000-0003-4811-785X				Allain JP, 2012, BIOLOGICALS, V40, P180, DOI 10.1016/j.biologicals.2011.09.014; Bremer CM, 2011, J HEPATOL, V55, P29, DOI 10.1016/j.jhep.2010.10.019; CERINO A, 1993, J IMMUNOL, V151, P7005; CERINO A, 1991, J IMMUNOL, V147, P2692; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; DAVENPORT FM, 1953, J EXP MED, V98, P641, DOI 10.1084/jem.98.6.641; Eren R, 2000, HEPATOLOGY, V32, P588, DOI 10.1053/jhep.2000.9632; Fox AN, 2012, J HEPATOL, V56, P1189, DOI 10.1016/j.jhep.2011.08.026; Ishigami M, 2014, LIVER TRANSPLANT, V20, P1211, DOI 10.1002/lt.23935; Kim SH, 2008, ANTIVIR RES, V79, P188, DOI 10.1016/j.antiviral.2008.03.006; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; MONDELL MU, 1994, J VIROL, V68, P4829, DOI 10.1128/JVI.68.8.4829-4836.1994; Mondelli Mario U., 1998, V19, P451; Romano L, 2015, HUM VACC IMMUNOTHER, V11, P53, DOI 10.4161/hv.34306; SAMUEL D, 1993, NEW ENGL J MED, V329, P1842, DOI 10.1056/NEJM199312163292503; Schilling R, 2003, J VIROL, V77, P8882, DOI 10.1128/JVI.77.16.8882-8892.2003; Shin YW, 2007, ANTIVIR RES, V75, P113, DOI 10.1016/j.antiviral.2007.01.005; Shouval D, 2000, HEPATOLOGY, V32, P1189, DOI 10.1053/jhep.2000.19789; Tajiri K, 2010, ANTIVIR RES, V87, P40, DOI 10.1016/j.antiviral.2010.04.006; Terrault NA, 1998, HEPATOLOGY, V28, P555, DOI 10.1002/hep.510280237; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; UEDA K, 1991, J VIROL, V65, P3521, DOI 10.1128/JVI.65.7.3521-3529.1991; Walter E, 1996, HEPATOLOGY, V24, P1, DOI 10.1002/hep.510240101; WHO, HEP B WHO FACT SHEET	24	22	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125704	10.1371/journal.pone.0125704	http://dx.doi.org/10.1371/journal.pone.0125704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923526	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600159
J	Liu, YM; Xu, YY; Fang, F; Zhang, JT; Guo, L; Weng, Z				Liu, Yumeng; Xu, Yunyun; Fang, Fang; Zhang, Jianting; Guo, Liang; Weng, Zhen			Therapeutic Efficacy of Stem Cell-based Therapy in Peripheral Arterial Disease: A Meta-Analysis	PLOS ONE			English	Article							CRITICAL LIMB ISCHEMIA; MARROW MONONUCLEAR-CELL; AUTOLOGOUS TRANSPLANTATION; ANGIOGENESIS; PLACEBO; FOOT	Several cell-based therapies for peripheral arterial disease (PAD) have been studied in multiple clinical trials; however, the outcome of this treatment remains controversial. The aim of this study was to perform a meta-analysis of the clinical trials on stem cell-based therapy after PAD. We searched for clinical trials that investigated the effect of stem cell-based therapy on patients with PAD and were published between January 2000 and October 2014. The outcomes of interest comprised all-cause mortality, amputation rate, ulcer healing, and ankle-brachial index (ABI). In addition, pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to assess the safety and efficacy of the stem cell-based therapies for PAD. Thirteen studies were retrieved from 261 citations for the analysis, and in total, 527 patients (mean age: 64.2 years; median follow up: 6 months) were included in the analysis. After synthesizing data, the meta-analysis showed significant improvement in the amputation rate (OR=0.33, 95% CI=0.22-0.51; P<0.001), ulcer healing (OR=6.11, 95% CI=3.04-12.28; P<0.001), and ABI (SMD=0.65, 95% CI=0.33-0.97; P<0.001) for the stem cell-based therapy group compared with the controls. Moreover, significant improvement in the amputation rate, ulcer healing, and ABI were also found based on the time point and stem cell source. In addition, no significant difference was found in the all-cause mortality (OR=0.80, 95% CI=0.39-1.641; P=0.546) between the stem cell-based therapy and control groups. Therefore, according to the results of our meta-analysis, stem cell-based therapy is safe and shows a beneficial outcome for patients with PAD, especially in the short term.	[Liu, Yumeng; Guo, Liang] Soochow Univ, Affiliated Hosp 1, Dept Radiol, Suzhou, Jiangsu, Peoples R China; [Xu, Yunyun; Fang, Fang] Soochow Univ, Childrens Hosp, Inst Pediat, Suzhou, Jiangsu, Peoples R China; [Zhang, Jianting; Weng, Zhen] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Div Nanobiomed, Key Lab Nanobio Interface, Suzhou, Jiangsu, Peoples R China; [Zhang, Jianting; Weng, Zhen] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, I Lab, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Chinese Academy of Sciences; Suzhou Institute of Nano-Tech & Nano-Bionics, CAS; Chinese Academy of Sciences; Suzhou Institute of Nano-Tech & Nano-Bionics, CAS	Guo, L (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Radiol, Suzhou, Jiangsu, Peoples R China.	guoliangsuda@126.com; zweng2014@sinano.ac.cn			Natural Science Foundation of Jiangsu Providence, China [BK20140388]	Natural Science Foundation of Jiangsu Providence, China	This study was funded by the Natural Science Foundation of Jiangsu Providence, China (Grant No. BK20140388 to ZW).	Behar T, 2013, J Mal Vasc, V38, P22, DOI 10.1016/j.jmv.2012.10.005; Benoit E, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-165; Chen HX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06222; Cobellis G, 2008, BONE MARROW TRANSPL, V42, P667, DOI 10.1038/bmt.2008.228; Diehm C, 2004, ATHEROSCLEROSIS, V172, P95, DOI 10.1016/S0021-9150(03)00204-1; Dubsky M, 2013, DIABETES-METAB RES, V29, P369, DOI 10.1002/dmrr.2399; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fadini GP, 2010, ATHEROSCLEROSIS, V209, P10, DOI 10.1016/j.atherosclerosis.2009.08.033; Gao Wei, 2011, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V25, P610; Gupta NK, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-013-0447-2; Gupta PK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-143; Heidrich H, 2004, VASA-J VASCULAR DIS, V33, P63, DOI 10.1024/0301-1526.33.2.63; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Huang PP, 2005, DIABETES CARE, V28, P2155, DOI 10.2337/diacare.28.9.2155; Lasala GP, 2012, J THORAC CARDIOV SUR, V144, P377, DOI 10.1016/j.jtcvs.2011.08.053; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lau JF, 2011, NAT REV CARDIOL, V8, P405, DOI 10.1038/nrcardio.2011.66; Li M, 2013, EXP CLIN TRANSPLANT, V11, P435, DOI 10.6002/ect.2012.0129; Lu DB, 2011, DIABETES RES CLIN PR, V92, P26, DOI 10.1016/j.diabres.2010.12.010; Mohammadzadeh L, 2013, EXP CLIN ENDOCR DIAB, V121, P48, DOI 10.1055/s-0032-1311646; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Ozturk A, 2012, J DIABETES COMPLICAT, V26, P29, DOI 10.1016/j.jdiacomp.2011.11.007; Powell RJ, 2011, J VASC SURG, V54, P1032, DOI 10.1016/j.jvs.2011.04.006; Prochazka V, 2010, CELL TRANSPLANT, V19, P1413, DOI 10.3727/096368910X514170; Raval Z, 2013, CIRC RES, V112, P1288, DOI 10.1161/CIRCRESAHA.113.300565; Szabo GV, 2013, CYTOTHERAPY, V15, P1245, DOI 10.1016/j.jcyt.2013.05.017; Walter DH, 2011, CIRC-CARDIOVASC INTE, V4, P26, DOI 10.1161/CIRCINTERVENTIONS.110.958348; Wang ZX, 2014, J ATHEROSCLER THROMB, V21, P1183	28	17	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125032	10.1371/journal.pone.0125032	http://dx.doi.org/10.1371/journal.pone.0125032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923119	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600119
J	Neukam, K; Munteanu, DI; Rivero-Juarez, A; Lutz, T; Fehr, J; Mandorfer, M; Bhagani, S; Lopez-Cortes, LF; Haberl, A; Stoeckle, M; Marquez, M; Scholten, S; de los Santos-Gil, I; Mauss, S; Rivero, A; Collado, A; Delgado, M; Rockstroh, JK; Pineda, JA				Neukam, Karin; Munteanu, Daniela I.; Rivero-Juarez, Antonio; Lutz, Thomas; Fehr, Jan; Mandorfer, Mattias; Bhagani, Sanjay; Lopez-Cortes, Luis F.; Haberl, Annette; Stoeckle, Marcel; Marquez, Manuel; Scholten, Stefan; de los Santos-Gil, Ignacio; Mauss, Stefan; Rivero, Antonio; Collado, Antonio; Delgado, Marcial; Rockstroh, Juergen K.; Pineda, Juan A.			Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy	PLOS ONE			English	Article							GENOTYPE 1 INFECTION; SUSTAINED VIROLOGICAL RESPONSE; INTERFERON PLUS RIBAVIRIN; PEGYLATED INTERFERON; PHASE-2 TRIAL; CIRRHOSIS; FIBROSIS; HIV/HCV; COHORT	Background and Aims Clinical trials of therapy against chronic hepatitis C virus (HCV) infection including boceprevir (BOC) or telaprevir (TVR) plus pegylated interferon and ribavirin (PR) have reported considerably higher response rates than those achieved with PR alone. This study sought to evaluate the efficacy and safety of triple therapy including BOC or TVR in combination with PR in HIV/HCV-coinfected patients under real-life conditions. Methods In a multicentre study conducted in 24 sites throughout five European countries, all HIV/HCV-coinfected patients who initiated a combination of BOC or TVR plus PR and who had at least 60 weeks of follow-up, were analyzed. Sustained virologic response 12 weeks after the scheduled end of therapy date (SVR12) and the rate of discontinuations due to adverse events (AE) were evaluated. Results Of the 159 subjects included, 127 (79.9%) were male, 45 (34.4%) were treatment-naive for PR and 60 (45.4%) showed cirrhosis. SVR12 was observed in 31/46 (67.4%) patients treated with BOC and 69/113 (61.1%) patients treated with TVR. Overall discontinuations due to AE rates were 8.7% for BOC and 8% for TVR. Grade 3 or 4 hematological abnormalities were frequently observed; anemia 7%, thrombocytopenia 17.2% and neutropenia 16.4%. Conclusion The efficacy and safety of triple therapy including BOC or TVR plus PR under real-life conditions of use in the HIV/HCV-coinfected population was similar to what is observed in clinical trials. Hematological side effects are frequent but manageable.	[Neukam, Karin; Pineda, Juan A.] Valme Univ Hosp, Unit Infect Dis & Microbiol, Seville, Spain; [Neukam, Karin; Pineda, Juan A.] Seville Inst Biomed IBiS, Seville, Spain; [Munteanu, Daniela I.; Rockstroh, Juergen K.] Bonn Univ Hosp, Dept Med 1, Bonn, Germany; [Munteanu, Daniela I.] Matei Bals Natl Inst Infect Dis, Bucharest, Romania; [Rivero-Juarez, Antonio; Rivero, Antonio] Reina Sofia Univ Hosp, Maimonides Inst Biomed Invest Cordoba IMIBIC, Infect Dis Unit, Cordoba, Spain; [Lutz, Thomas] Infektiologikum Frankfurt, Frankfurt, Germany; [Fehr, Jan] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Mandorfer, Mattias] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria; [Mandorfer, Mattias] Vienna HIV & Liver Study Grp, Vienna, Austria; [Bhagani, Sanjay] Royal Free London NHS Fdn Trust, Dept Infect Dis HIV Med, London, England; [Lopez-Cortes, Luis F.] Virgen del Rocio Univ Hosp, Infect Dis Microbiol & Prevent Med, Seville, Spain; [Lopez-Cortes, Luis F.] Seville Inst Biomed IBiS, Seville, Spain; [Haberl, Annette] Frankfurt Univ Hosp, Dept Med 2, Frankfurt, Germany; [Stoeckle, Marcel] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [Marquez, Manuel] Virgen de la Victoria Univ Hosp, Infect Dis Unit, Malaga, Spain; [Scholten, Stefan] Praxis Hohenstaufenring, Cologne, Germany; [de los Santos-Gil, Ignacio] La Princesa Univ Hosp, Infect Dis Unit, Madrid, Spain; [Mauss, Stefan] Ctr HIV & Hepatogastroenterol, Dusseldorf, Germany; [Collado, Antonio] Torrecardenas Univ Hosp, Infect Dis Unit, Almeria, Spain; [Delgado, Marcial] Carlos Haya Reg Univ Hosp, Infect Dis Unit, Malaga, Spain	Hospital Valme; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); University of Bonn; National Institute for Infectious Diseases "Matei Bals"; University of Zurich; University Zurich Hospital; Medical University of Vienna; University of London; University College London; Royal Free London NHS Foundation Trust; Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Basel; Hospital Virgen de la Victoria; Hospital Carlos Haya	Neukam, K (corresponding author), Valme Univ Hosp, Unit Infect Dis & Microbiol, Seville, Spain.	karin.neukam@gmail.com	Lopez.Cortes, Luis Fernando/W-8323-2019; Pineda, Juan A./AAO-9312-2021; Fehr, Jan S/V-7499-2017; IBIS, VIH/O-8856-2015; Neukam, Karin/D-9415-2018; Rivero-Juarez, Antonio/E-4528-2019; Mandorfer, Mattias/H-7603-2019; Rivero, Antonio/ABE-5294-2020	Lopez.Cortes, Luis Fernando/0000-0002-3804-3458; Pineda, Juan A./0000-0002-3751-0296; Fehr, Jan S/0000-0003-1113-9895; Neukam, Karin/0000-0003-3875-1013; Rivero-Juarez, Antonio/0000-0002-5813-6889; Mandorfer, Mattias/0000-0003-2330-0017; Bhagani, Sanjay/0000-0003-2557-4337; Rivero, Antonio/0000-0001-5005-8268; Marquez, Manuel/0000-0002-7901-6966; Rivero Roman, Antonio/0000-0002-8643-4250; De Los Santos Gil, Ignacio/0000-0001-7073-5211	RIS-HEP07 Study Group [RD12/0017/0012]; Ministerio de Sanidad y Servicios Sociales [EC11-304]; Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia [PI-0492-2012]; Swiss National Science Foundation [134277]; Swiss National Science Foundation (SHCS) [688]; Instituto de Salud Carlos III [CP13/00187, Programa-I3SNS]; Fundacion Progreso y Salud of the Junta de Andalucia [RH-0024-2013]	RIS-HEP07 Study Group; Ministerio de Sanidad y Servicios Sociales; Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation (SHCS)(Swiss National Science Foundation (SNSF)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Progreso y Salud of the Junta de Andalucia	This work was supported by the RD12/0017/0012 (RIS-HEP07 Study Group), the Ministerio de Sanidad y Servicios Sociales (grant number EC11-304), the Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia (grant number PI-0492-2012) and the framework of the Swiss HIV Cohort Study, supported by the Swiss National Science Foundation (grant number 134277 and SHCS project number 688). K.N. is the recipient of a Miguel Servet research grant from the Instituto de Salud Carlos III (grant number CP13/00187). D.M. is a participant in the European AIDS Clinical Society Exchange Medical Programme. A.R.-J. is the recipient of a post-doctoral extension grant of the Fundacion Progreso y Salud of the Junta de Andalucia (grant number RH-0024-2013). J.A.P is the recipient of an intensification grant from the Instituto de Salud Carlos III (grant number Programa-I3SNS).	Akiyama Matthew J, 2013, Hawaii J Med Public Health, V72, P6; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Colombo M, 2014, GUT, V63, P1150, DOI 10.1136/gutjnl-2013-305667; Cotte L, 2014, CLIN INFECT DIS, V59, P1768, DOI 10.1093/cid/ciu659; Di Bisceglie A, 2013, PROGRAM AND ABSTRACT; European AIDS Clinical Society, CLINICAL MANAGEMENT; European AIDS Clinical Society (EACS), CLINICAL MANAGEMENT; European Association for the Study of the Liver (EASL), 2014, EASL RECOMMENDATIONS; Gheorghe L, 2014, J GASTROINTEST LIVER, V23, P45; Hare CB, 2013, GLOBAL ANTIVIRAL JOU, V9; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; Ioannou GN, 2014, CLIN GASTROENTEROL H, V12, P1371, DOI 10.1016/j.cgh.2013.12.011; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Lacombe K, 2013, AIDS, V27, P1356, DOI 10.1097/QAD.0b013e32836138d0; Limketkai BN, 2012, JAMA-J AM MED ASSOC, V308, P370, DOI 10.1001/jama.2012.7844; Mandorfer M, 2015, J INFECT DIS, V211, P729, DOI 10.1093/infdis/jiu516; Martel-Laferriere V, 2013, PROGRAM AND ABSTRACT; Mira JA, 2013, CLIN INFECT DIS, V56, P1646, DOI 10.1093/cid/cit103; Mira JA, 2012, AIDS, V26, P1721, DOI 10.1097/QAD.0b013e3283568884; Montes M, 2013, PROGRAM AND ABSTRACT; Pineda JA, 2007, J ANTIMICROB CHEMOTH, V60, P1347, DOI 10.1093/jac/dkm373; Pineda JA, 2009, CLIN INFECT DIS, V49, P1274, DOI 10.1086/605676; Poizot-Martin I, 2014, PROGRAM AND ABSTRACT; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Sulkowski M, 2013, LANCET INFECT DIS, V13, P597, DOI 10.1016/S1473-3099(13)70149-X; Sulkowski MS, 2013, ANN INTERN MED, V159, P86, DOI 10.7326/0003-4819-159-2-201307160-00654; U.S. Food and Drug Administration, OLYSIO SIMEPREVIR FO; US Food and Drug Administration, APPROVAL OF SOVALDI; Vergara S, 2007, CLIN INFECT DIS, V45, P969, DOI 10.1086/521857; Vierling JM, 2014, J HEPATOL, V61, P200, DOI 10.1016/j.jhep.2014.03.022; von Wichmann MA, 2013, PROGRAM AND ABSTRACT; Werner CR, 2014, J VIRAL HEPATITIS, V21, P333, DOI 10.1111/jvh.12145; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zinkernagel AS, 2006, ANTIVIR THER, V11, P131	35	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125080	10.1371/journal.pone.0125080	http://dx.doi.org/10.1371/journal.pone.0125080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923540	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600123
J	Chang, SS; Hu, HY				Chang, Shen-Shong; Hu, Hsiao-Yun			Long-Term Use of Steroids Protects from the Development of Symptomatic Diverticulitis Requiring Hospitalization in the Asian Population	PLOS ONE			English	Article							COMPLICATED DIVERTICULITIS; DISEASE; COLON; EPIDEMIOLOGY; HEALTH; IMPACT	Objective The pathophysiology of diverticulitis is poorly understood. Factors such as physical inactivity, constipation, obesity, smoking, and the use of nonsteroidal antiinflammatory drugs (NSAIDs) have been associated with an increased risk of diverticular disease. To evaluate whether patients exhibiting long-term steroid use are at increased risk of colonic diverticulitis. Method We conducted a population-based, nested case-control study. Data were retrospectively collected from the National Health Insurance Research Database. The study cohort comprised patients diagnosed with diverticulitis, identified using inpatient discharge records using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes (562.11 and 562.13), and those who were administered one or more prescriptions for corticosteroids for systemic use. Control patients were matched to cases by age, sex, NSAID use, laxative drug use, and index date. We enrolled 690 patients with colonic diverticulitis and 2760 in the control group. The adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using conditional logistic regression. Results Compared with steroid nonusers, the adjusted ORs were 0.60 (95% CI = 0.35-1.06) and 0.80 (95% CI = 0.64-1.008) in current steroid users and previous steroid users, respectively. In addition, the adjusted ORs were 0.55 (95% CI = 0.31-0.98), 0.57 (95% CI = 0.31-0.98), and 0.44 (95% CI = 0.22-0.86) for steroid use duration more than half time by an exposure period of 90 days, 180 days, and 365 days before the claim date of colonic diverticulitis, respectively. Conclusions The results indicated that long-term steroid use within one year is associated with lower risk of colonic diverticulitis.	[Chang, Shen-Shong] Taipei City Hosp, Yang Ming Branch, Div Gastroenterol, Taipei, Taiwan; [Chang, Shen-Shong] Taipei City Hosp, Yang Ming Branch, Dept Internal Med, Taipei, Taiwan; [Chang, Shen-Shong] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Hu, Hsiao-Yun] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Hu, Hsiao-Yun] Natl Yang Ming Univ, Dept Publ Hlth, Taipei 112, Taiwan; [Hu, Hsiao-Yun] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	Taipei City Hospital; Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital	Hu, HY (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	hyhu@ym.edu.tw						ALMY TP, 1980, NEW ENGL J MED, V302, P324, DOI 10.1056/NEJM198002073020605; [Anonymous], [No title captured]; Bose KP, 2013, J CLIN GASTROENTEROL, V47, P160, DOI 10.1097/MCG.0b013e318259e71c; Chapman J, 2005, ANN SURG, V242, P576, DOI 10.1097/01.sla.0000184843.89836.35; Cheng SH, 1997, JAMA-J AM MED ASSOC, V278, P89, DOI 10.1001/jama.278.2.89; Delvaux M, 2003, ALIMENT PHARM THERAP, V18, P71, DOI 10.1046/j.0953-0673.2003.01720.x; Humes DJ, 2011, GUT, V60, P219, DOI 10.1136/gut.2010.217281; Jacobs DO, 2007, NEW ENGL J MED, V357, P2057, DOI 10.1056/NEJMcp073228; Laine L, 2008, GASTROENTEROLOGY, V135, P1517, DOI 10.1053/j.gastro.2008.07.067; Lanas A, 2006, DIGESTION, V73, P136, DOI 10.1159/000089789; Lanas A, 2009, GASTROENTEROL CLIN N, V38, P333, DOI 10.1016/j.gtc.2009.03.007; Morris CR, 2002, POSTGRAD MED J, V78, P654, DOI 10.1136/pmj.78.925.654; PARKS TG, 1968, POSTGRAD MED J, V44, P680, DOI 10.1136/pgmj.44.515.680; SLACK WW, 1962, BRIT J SURG, V50, P185, DOI 10.1002/bjs.18005022012; Stollman NH, 1999, J CLIN GASTROENTEROL, V29, P241, DOI 10.1097/00004836-199910000-00004; Strate LL, 2012, AM J GASTROENTEROL, V107, P1486, DOI 10.1038/ajg.2012.194; Strate LL, 2011, GASTROENTEROLOGY, V140, P1427, DOI 10.1053/j.gastro.2011.02.004; von Rahden BHA, 2012, COLORECTAL DIS, V14, P1276, DOI 10.1111/j.1463-1318.2012.02967.x	18	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124598	10.1371/journal.pone.0124598	http://dx.doi.org/10.1371/journal.pone.0124598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919040	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400056
J	Fukuzaki, Y; Shin, H; Kawai, HD; Yamanoha, B; Kogure, S				Fukuzaki, Yumi; Shin, Hyeryun; Kawai, Hideki D.; Yamanoha, Banri; Kogure, Shinichi			532 nm Low-Power Laser Irradiation Facilitates the Migration of GABAergic Neural Stem/Progenitor Cells in Mouse Neocortex	PLOS ONE			English	Article							STEM-CELLS; PROLIFERATION; THERAPY; PATHWAY; DIFFERENTIATION; NEURONS; PHOTOBIOMODULATION; PRECURSORS; EXPRESSION; INDUCTION	Background and Objective Accumulating evidence has shown that low-power laser irradiation (LLI) affects cell proliferation and survival, but little is known about LLI effects on neural stem/progenitor cells (NSPCs). Here we investigate whether transcranial 532 nm LLI affects NSPCs in adult murine neocortex and in neurospheres from embryonic mice. Study Design/Materials and Methods We applied 532 nm LLI (Nd:YVO4, CW, 60 mW) on neocortical surface via cranium in adult mice and on cultured cells from embryonic mouse brains in vitro to investigate the proliferation and migration of NSPCs and Akt expression using immunohistochemical assays and Western blotting techniques. Results In vivo experiments demonstrated that 532 nm LLI significantly facilitated the migration of GABAergic NSPCs that were induced to proliferate in layer 1 by mild ischemia. In vitro experiments using GABAergic NSPCs derived from embryonic day 14 ganglionic eminence demonstrated that 532 nm LLI for 60 min promoted the migration of GAD67-immunopositive NSPCs with a significant increase of Akt expression. Meanwhile, the LLI induced proliferation, but not migration, of NSPCs that give rise to excitatory neurons. Conclusion It is concluded that 532 nm LLI promoted the migration of GABAergic NSPCs into deeper layers of the neocortex in vivo by elevating Akt expression.	[Fukuzaki, Yumi; Shin, Hyeryun; Kawai, Hideki D.; Kogure, Shinichi] Soka Univ, Grad Sch Engn, Dept Bioinformat, Hachioji, Tokyo, Japan; [Yamanoha, Banri] Soka Univ, Fac Engn, Dept Environm Engn Symbiosis, Hachioji, Tokyo, Japan	Soka University; Soka University	Kogure, S (corresponding author), Soka Univ, Grad Sch Engn, Dept Bioinformat, Hachioji, Tokyo, Japan.	kogure@soka.ac.jp		Kawai, Hideki/0000-0003-2113-6866	Soka University; JSPS KAKENHI [26.8139]	Soka University; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: The authors have received Faculty Research Fees (total: 1,600,000 Yen) from Soka University in 2013 and 2014 and Grant-in-Aid for JSPS Fellows (total: 1,000,000 Yen) from JSPS KAKENHI Grant Number 26.8139 in 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang FY, 2012, LASER MED SCI, V27, P935, DOI 10.1007/s10103-011-1009-8; Anwer AG, 2012, LASER SURG MED, V44, P769, DOI 10.1002/lsm.22083; Arsenijevic Y, 1998, J NEUROSCI, V18, P2118; Bjordal JM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-75; Brosseau L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002049.pub2; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; da Silva JP, 2010, PHOTOMED LASER SURG, V28, P17, DOI 10.1089/pho.2008.2372; Fournier NM, 2012, NEUROPHARMACOLOGY, V63, P642, DOI 10.1016/j.neuropharm.2012.04.033; Fukuzaki Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070737; Gao XJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-4; Gresner P, 2005, J PHOTOCH PHOTOBIO B, V79, P43, DOI 10.1016/j.jphotobiol.2004.11.018; Guillemot F, 2007, PROG NEUROBIOL, V83, P37, DOI 10.1016/j.pneurobio.2007.02.009; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Huang D, 2008, CHINESE GERMAN J CLI, V7, P227, DOI [10.1007/s10330-007-0185-2, DOI 10.1007/S10330-007-0185-2]; Jamtvedt G, 2008, PHYS THER, V88, P123, DOI 10.2522/ptj.20070043; KARU T, 1989, HEALTH PHYS, V56, P691, DOI 10.1097/00004032-198905000-00015; Karu T, 2003, BIOMEDICAL PHOTONICS, V48; Karu T, 2013, PHOTOMED LASER SURG, V31, P189, DOI 10.1089/pho.2013.3510; Kassak P, 2005, GEN PHYSIOL BIOPHYS, V24, P209; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Liang JG, 2012, FREE RADICAL BIO MED, V53, P1459, DOI 10.1016/j.freeradbiomed.2012.08.003; MESTER E, 1968, ACTA CHIR HUNG, V9, P349; Moore P, 2005, LASER SURG MED, V36, P8, DOI 10.1002/lsm.20117; Murayama H, 2012, LASER MED SCI, V27, P87, DOI 10.1007/s10103-011-0924-z; Novoselova EG, 2006, PHOTODERMATOL PHOTO, V22, P33, DOI 10.1111/j.1600-0781.2006.00191.x; Ohira K, 2010, NAT NEUROSCI, V13, P173, DOI 10.1038/nn.2473; Oishi K, 2009, P NATL ACAD SCI USA, V106, P13064, DOI 10.1073/pnas.0808400106; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Pozas E, 2005, NEURON, V45, P701, DOI 10.1016/j.neuron.2005.01.043; Reddy GK, 2001, WOUND REPAIR REGEN, V9, P248, DOI 10.1046/j.1524-475x.2001.00248.x; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rojas JC, 2013, BIOCHEM PHARMACOL, V86, P447, DOI 10.1016/j.bcp.2013.06.012; Rojas JC, 2011, EYE BRAIN, V3, P49, DOI 10.2147/EB.S21391; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Sinor AD, 2004, J NEUROSCI, V24, P8531, DOI 10.1523/JNEUROSCI.1470-04.2004; Souza BR, 2011, J NEUROSCI, V31, P5512, DOI 10.1523/JNEUROSCI.5548-10.2011; Staiger JF, 2000, NEUROSCIENCE, V99, P7, DOI 10.1016/S0306-4522(00)00166-4; Te Alexis E, 2006, Rev Urol, V8 Suppl 3, pS24; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; van den Ameele J, 2014, TRENDS NEUROSCI, V37, P334, DOI 10.1016/j.tins.2014.03.005; Vinck EM, 2003, LASER MED SCI, V18, P95, DOI 10.1007/s10103-003-0262-x; Webb C, 1998, LASER SURG MED, V22, P294, DOI 10.1002/(SICI)1096-9101(1998)22:5<294::AID-LSM6>3.3.CO;2-J; Yip KK, 2011, NEUROSCIENCE, V190, P301, DOI 10.1016/j.neuroscience.2011.06.022; Zhang LL, 2009, J CELL PHYSIOL, V219, P553, DOI 10.1002/jcp.21697; Zhang Q, 2014, J CEREBR BLOOD F MET, V34, P1391, DOI 10.1038/jcbfm.2014.95	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123833	10.1371/journal.pone.0123833	http://dx.doi.org/10.1371/journal.pone.0123833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919297	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400036
J	Kamiya, K; Sakabe, JI; Yamaguchi, H; Suzuki, T; Yatagai, T; Aoshima, M; Ito, T; Tokura, Y				Kamiya, Koji; Sakabe, Jun-Ichi; Yamaguchi, Hayato; Suzuki, Takahiro; Yatagai, Tsuyoshi; Aoshima, Masahiro; Ito, Taisuke; Tokura, Yoshiki			Gross Cystic Disease Fluid Protein 15 in Stratum Corneum Is a Potential Marker of Decreased Eccrine Sweating for Atopic Dermatitis	PLOS ONE			English	Article							PROLACTIN-INDUCIBLE PROTEIN; SKIN BARRIER FUNCTION; GCDFP-15 EXPRESSION; ANTIMICROBIAL PEPTIDES; CHOLINERGIC URTICARIA	It is well known that eccrine sweating is attenuated in patients with atopic dermatitis (AD). We have reported by using proteome analysis that gross cystic disease fluid protein 15 (GCDFP15), a substance secreted from eccrine sweat glands, is decreased in tape-stripped stratum corneum (SC) samples from AD patients. The aim of this study was to evaluate GCDFP15 production by eccrine glands with SC samples and to assess sweating in AD. SC samples were obtained from 51 healthy control (HC) and 51 AD individuals. Sweat samples were from 18 HC and 12 AD subjects. GCDFP15 was quantified by ELISA. By immunohistochemistry, the expression of GCDFP15 in eccrine glands was examined in normal and AD skin specimens. To identify GCDFP15-producing cells, double immunofluorescence staining for GCDFP15 and S100 protein was performed in frozen sections. To address the mechanism underlying the decreased eccrine sweating in AD patients, we examined the expression of cholinergic receptor M3 (CHRM3), a receptor for acetylcholine-induced sweating, in eccrine sweat glands. The amounts of GCDFP15 in the SC extracts were significantly lower in AD than HC (P < 0.0001). The sweat samples from AD patients also had lower levels of GCDFP15 concentration (P < 0.05). Immunohistochemistry showed positive GCDFP15 staining in the eccrine gland secretory cells and the ductal and acrosyringial lumen in normal skin, but AD lacked clear staining. Immunofluorescence staining revealed that GCDFP15 was co-expressed with S100 protein, suggesting that the clear cell of eccrine glands produces GCDFP15. Finally, we found that the expression of CHRM3 was depressed in AD, suggesting contribution to the low sweating. The SC of AD patients contains a low amount of GCDFP15 due to both low sweating and low GCDFP15 concentration in the sweat. GCDFP15 in SC is a potential marker for dysregulated sweating in AD.	[Kamiya, Koji; Sakabe, Jun-Ichi; Yamaguchi, Hayato; Suzuki, Takahiro; Yatagai, Tsuyoshi; Aoshima, Masahiro; Ito, Taisuke; Tokura, Yoshiki] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine	Kamiya, K (corresponding author), Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan.	m01023kk@jichi.ac.jp		Sakabe, Jun-Ichi/0000-0002-8237-0472				Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Dainichi T, 2014, J DERMATOL SCI, V76, P81, DOI 10.1016/j.jdermsci.2014.08.010; Darb-Esfahani S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-546; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Eishi K, 2002, BRIT J DERMATOL, V147, P683, DOI 10.1046/j.1365-2133.2002.04765.x; Gallo A, 2013, J Genet Syndr Gene Ther, V4, DOI 10.4172/2157-7412.1000140; Gallo RL, 1998, J INVEST DERMATOL, V111, P739, DOI 10.1046/j.1523-1747.1998.00361.x; Hino R, 2010, CANCER-AM CANCER SOC, V116, P1757, DOI 10.1002/cncr.24899; Jung M, 2014, J DERMATOL SCI, V76, P231, DOI 10.1016/j.jdermsci.2014.09.004; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; Kijima A, 2012, ALLERGOL INT, V61, P469, DOI 10.2332/allergolint.12-OA-0429; Kitaba Shun, 2011, Allergology International, V60, P387, DOI 10.2332/allergolint.10-CR-0265; Loos S, 1999, INT J MOL MED, V4, P135; Matsui S, 2014, J INVEST DERMATOL, V134, P326, DOI 10.1038/jid.2013.323; Mori T, 2010, BRIT J DERMATOL, V162, P83, DOI 10.1111/j.1365-2133.2009.09440.x; Murota H, 2015, J DERMATOL SCI, V77, P3, DOI 10.1016/j.jdermsci.2014.08.011; MYAL Y, 1991, MOL CELL ENDOCRINOL, V80, P165, DOI 10.1016/0303-7207(91)90153-J; Nistor A, 2009, ORAL MICROBIOL IMMUN, V24, P510, DOI 10.1111/j.1399-302X.2009.00543.x; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Priyadarsini S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113310; Saga K, 2001, J INVEST DERM SYMP P, V6, P49, DOI 10.1046/j.0022-202x.2001.00005.x; Sakabe J, 2014, J ALLERGY CLIN IMMUN, V134, P957, DOI 10.1016/j.jaci.2014.07.054; Sawada Y, 2014, J INVEST DERMATOL, V134, P276, DOI 10.1038/jid.2013.244; Sawada Y, 2010, J INVEST DERMATOL, V130, P2683, DOI 10.1038/jid.2010.188; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Schittek Birgit, 2008, Infectious Disorders - Drug Targets, V8, P135; Schroder JM, 1999, CELL MOL LIFE SCI, V56, P32, DOI 10.1007/s000180050004; Shibasaki Manabu, 2010, Front Biosci (Schol Ed), V2, P685; Striebel JM, 2008, AM J SURG PATHOL, V32, P426, DOI 10.1097/PAS.0b013e318157a5a6; Takahashi A, 2013, ALLERGOL INT, V62, P473, DOI 10.2332/allergolint.13-OA-0547; TOKURA Y, 1986, J CUTAN PATHOL, V13, P102, DOI 10.1111/j.1600-0560.1986.tb01509.x; Tokura Y, 2010, J DERMATOL SCI, V58, P1, DOI 10.1016/j.jdermsci.2010.02.008; Tomar AK, 2012, BIOMARKERS, V17, P545, DOI 10.3109/1354750X.2012.699555; Viacava P, 1998, VIRCHOWS ARCH, V432, P255, DOI 10.1007/s004280050163	34	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125082	10.1371/journal.pone.0125082	http://dx.doi.org/10.1371/journal.pone.0125082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919462	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659400071
J	Neely, BA; Ferrante, JA; Chaves, JM; Soper, JL; Almeida, JS; Arthur, JM; Gulland, FMD; Janech, MG				Neely, Benjamin A.; Ferrante, Jason A.; Chaves, J. Mauro; Soper, Jennifer L.; Almeida, Jonas S.; Arthur, John M.; Gulland, Frances M. D.; Janech, Michael G.			Proteomic Analysis of Plasma from California Sea Lions (Zalophus californianus) Reveals Apolipoprotein E as a Candidate Biomarker of Chronic Domoic Acid Toxicosis	PLOS ONE			English	Article							TOXICITY; NMDA; GLYCOSYLATION; PATHOLOGY; EPILEPSY; MODEL; MICE	Domoic acid toxicosis (DAT) in California sea lions (Zalophus californianus) is caused by exposure to the marine biotoxin domoic acid and has been linked to massive stranding events and mortality. Diagnosis is based on clinical signs in addition to the presence of domoic acid in body fluids. Chronic DAT further is characterized by reoccurring seizures progressing to status epilepticus. Diagnosis of chronic DAT is often slow and problematic, and minimally invasive tests for DAT have been the focus of numerous recent biomarker studies. The goal of this study was to retrospectively profile plasma proteins in a population of sea lions with chronic DAT and those without DAT using two dimensional gel electrophoresis to discover whether individual, multiple, or combinations of protein and clinical data could be utilized to identify sea lions with DAT. Using a training set of 32 sea lion sera, 20 proteins and their isoforms were identified that were significantly different between the two groups (p<0.05). Interestingly, 11 apolipoprotein E (ApoE) charge forms were decreased in DAT samples, indicating that ApoE charge form distributions may be important in the progression of DAT. In order to develop a classifier of chronic DAT, an independent blinded test set of 20 sea lions, seven with chronic DAT, was used to validate models utilizing ApoE charge forms and eosinophil counts. The resulting support vector machine had high sensitivity (85.7% with 92.3% negative predictive value) and high specificity (92.3% with 85.7% positive predictive value). These results suggest that ApoE and eosinophil counts along with machine learning can perform as a robust and accurate tool to diagnose chronic DAT. Although this analysis is specifically focused on blood biomarkers and routine clinical data, the results demonstrate promise for future studies combining additional variables in multidimensional space to create robust classifiers.	[Neely, Benjamin A.; Ferrante, Jason A.; Chaves, J. Mauro; Arthur, John M.; Janech, Michael G.] Med Univ S Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA; [Ferrante, Jason A.; Janech, Michael G.] Coll Charleston, Grice Marine Lab, Charleston, SC 29401 USA; [Soper, Jennifer L.; Gulland, Frances M. D.] Marine Mammal Ctr, Sausalito, CA USA; [Almeida, Jonas S.] SUNY Stony Brook, Dept Biomed Informat, Long Isl City, NY USA; [Arthur, John M.; Janech, Michael G.] Ralph H Johnson VA Med Ctr, Res Serv, Charleston, SC USA	Medical University of South Carolina; College of Charleston; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Janech, MG (corresponding author), Med Univ S Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA.	janechmg@musc.edu	janech, michael/AAA-1011-2019; Almeida, Jonas/C-9093-2009; Chaves, Jose Mauro/GNH-4323-2022; Neely, Benjamin/AGR-8303-2022	Almeida, Jonas/0000-0002-7883-7922; Chaves, Jose Mauro/0000-0001-7416-4356; Ferrante, Jason/0000-0003-3453-4636; Neely, Benjamin/0000-0001-6120-7695; Arthur, John/0000-0003-4342-4762	Office of Naval Research [N00014-08-1-0341]	Office of Naval Research(Office of Naval Research)	Funding: Funding for this work, and for BAN JAF JMC JLS JSA JMA FMDG MGJ, was provided by the Office of Naval Research (N00014-08-1-0341). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Berman FW, 2002, BRAIN RES, V924, P20, DOI 10.1016/S0006-8993(01)03221-8; Buckmaster PS, 2014, J COMP NEUROL, V522, P1691, DOI 10.1002/cne.23509; CENDES F, 1995, ANN NEUROL, V37, P123, DOI 10.1002/ana.410370125; Chua CC, 2010, J NEUROCHEM, V112, P1619, DOI 10.1111/j.1471-4159.2010.06586.x; Cook P, 2011, BIOL LETTERS, V7, P536, DOI 10.1098/rsbl.2011.0127; DAVIS RW, 1991, J LIPID RES, V32, P1013; Ferrante JA, 2010, DISCOVERY BLOOD PROT; Funk JA, 2014, J AM SOC NEPHROL, V25, P1187, DOI 10.1681/ASN.2013080836; Fuquay JM, 2012, PHYSIOL BEHAV, V105, P315, DOI 10.1016/j.physbeh.2011.08.013; Goldstein T, 2008, P ROY SOC B-BIOL SCI, V275, P267, DOI 10.1098/rspb.2007.1221; Greig Denise J., 2005, Aquatic Mammals, V31, P11, DOI 10.1578/AM.31.1.2005.11; Gulland FMD, 2002, VET REC, V150, P475; Gulland FMD, 2012, JAVMA-J AM VET MED A, V241, P943, DOI 10.2460/javma.241.7.943; Hampson David R., 1998, Natural Toxins, V6, P153, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<153::AID-NT16>3.0.CO;2-1; Larm JA, 1997, NEUROCHEM INT, V31, P677, DOI 10.1016/S0197-0186(97)00030-2; Lee Y, 2010, MOL CELL PROTEOMICS, V9, P1968, DOI 10.1074/mcp.M900430-MCP200; Lefebvre KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036213; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Muha N, 2011, TOXICON, V57, P168, DOI 10.1016/j.toxicon.2010.07.018; Neely BA, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-18; Pepe M. S., 2003, STAT EVALUATION MED; PERL TM, 1990, NEW ENGL J MED, V322, P1775, DOI 10.1056/NEJM199006213222504; Pulido OM, 2008, MAR DRUGS, V6, P180, DOI 10.3390/md20080010; Raber J, 2000, J NEUROSCI, V20, P2064; Ramsdell JS, 2014, MAR DRUGS, V12, P1185, DOI 10.3390/md12031185; Ramsey Una P., 1998, Natural Toxins, V6, P137, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<137::AID-NT28>3.3.CO;2-C; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Schwacke LH, 2010, ENVIRON RES, V110, P548, DOI 10.1016/j.envres.2010.05.003; Silvagni PA, 2005, VET PATHOL, V42, P184, DOI 10.1354/vp.42-2-184; Tasker RAR, 2005, AMINO ACIDS, V28, P193, DOI 10.1007/s00726-005-0167-z; Tasker RAR, 1998, NEUROTOXICOLOGY, V19, P593; Thomton JD, 2007, J WILDLIFE DIS, V43, P258, DOI 10.7589/0090-3558-43.2.258; Thorngate FE, 2002, J LIPID RES, V43, P1920, DOI 10.1194/jlr.M200205-JLR200; TRUELOVE J, 1994, B ENVIRON CONTAM TOX, V52, P479; Twiner MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017394; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Walz P. M., 1994, Natural Toxins, V2, P271, DOI 10.1002/nt.2620020505; Zabka TS, 2009, VET PATHOL, V46, P105, DOI 10.1354/vp.46-1-105	39	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123295	10.1371/journal.pone.0123295	http://dx.doi.org/10.1371/journal.pone.0123295			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919366	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400026
J	Ogasawara, S; Chiba, T; Ooka, Y; Kanogawa, N; Motoyama, T; Suzuki, E; Tawada, A; Azemoto, R; Shinozaki, M; Yoshikawa, M; Yokosuka, O				Ogasawara, Sadahisa; Chiba, Tetsuhiro; Ooka, Yoshihiko; Kanogawa, Naoya; Motoyama, Tenyu; Suzuki, Eiichiro; Tawada, Akinobu; Azemoto, Ryosaku; Shinozaki, Masami; Yoshikawa, Masaharu; Yokosuka, Osamu			A Prognostic Score for Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Transarterial Chemoembolization	PLOS ONE			English	Article							SUBCLASSIFICATION; MANAGEMENT; SURVIVAL	Background Intermediate-stage hepatocellular carcinoma (HCC), defined according to the Barcelona Clinic Liver Cancer (BCLC) staging system, is a heterogeneous condition with variable clinical benefits from transarterial chemoembolization (TACE). This study aimed to develop a simple validated prognostic score based on the predictive factors for survival in patients with intermediate-stage HCC treated with TACE. Methods Three-hundred and fifty patients with intermediate-stage HCC undergoing initial TACE at Chiba University Hospital (training cohort; n = 187) and two affiliated hospitals (validation cohort; n = 163) were included. Following variables were entered into univariate and multivariate Cox regression models to develop a points-based clinical scoring system: gender, age, etiology, pretreatment, Child-Pugh score, aspartate aminotransferase, creatinine, Creactive protein, alfa-fetoprotein, size of the largest lesion, and number and location of lesions. Results The number of lesions and the Child-Pugh score were identified as independent prognostic factors in the training cohort. The development of a 0-7-point prognostic score, named the Chiba HCC in intermediate-stage prognostic (CHIP) score, was based on the sum of three subscale scores (Child-Pugh score = 0, 1, 2, or 3, respectively, number of lesions = 0, 2, or 3, respectively, HCV-RNA positivity = 0 or 1, respectively). The generated scores were then differentiated into five groups (0-2 points, 3 points, 4 points, 5 points, and 6-7 points) by the median survival time (65.2, 29.2, 24.3, 13.1, and 8.4 months, respectively; p < 0.0001). These results were confirmed in the external validation cohort (p < 0.0001). Conclusions The CHIP score is easy-to-use and may assist in finding an appropriate treatment strategy for intermediate-stage HCC.	[Ogasawara, Sadahisa; Chiba, Tetsuhiro; Ooka, Yoshihiko; Kanogawa, Naoya; Motoyama, Tenyu; Suzuki, Eiichiro; Tawada, Akinobu; Yoshikawa, Masaharu; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan; [Azemoto, Ryosaku] Kimitsu Chuo Hosp, Dept Gastroenterol, Chiba, Japan; [Shinozaki, Masami] Numazu City Hosp, Dept Gastroenterol, Shizuoka, Japan	Chiba University	Chiba, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan.	techiba@faculty.chiba-u.jp	Ogasawara, Sadahisa/GRF-7061-2022	Ogasawara, Sadahisa/0000-0002-6540-9064	Dainippon Sumitomo Pharma Co, Ltd (Osaka, Japan); Nippon Kayaku Co, Ltd (Tokyo, Japan)	Dainippon Sumitomo Pharma Co, Ltd (Osaka, Japan); Nippon Kayaku Co, Ltd (Tokyo, Japan)	Prof. Osamu Yokosuka received grant support (scholarship contribution) from Dainippon Sumitomo Pharma Co, Ltd (Osaka, Japan) and Nippon Kayaku Co, Ltd (Tokyo, Japan). The remaining authors disclose no conflicts. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Bolondi L, 2012, SEMIN LIVER DIS, V32, P348, DOI 10.1055/s-0032-1329906; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Dumortier J, 2006, DIGEST LIVER DIS, V38, P125, DOI 10.1016/j.did.2005.10.025; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao HJ, 2014, LIVER INT, V34, P612, DOI 10.1111/liv.12307; Golfieri R, 2011, HEPATOLOGY, V53, P1580, DOI 10.1002/hep.24246; Ha Y, 2014, J GASTROEN HEPATOL, V29, P787, DOI 10.1111/jgh.12452; Kadalayil L, 2013, ANN ONCOL, V24, P2565, DOI 10.1093/annonc/mdt247; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Marelli L, 2007, CARDIOVASC INTER RAD, V30, P6, DOI 10.1007/s00270-006-0062-3; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Poon RTP, 2003, ANN SURG, V237, P376, DOI 10.1097/00000658-200303000-00012; Sieghart W, 2013, HEPATOLOGY, V57, P2261, DOI 10.1002/hep.26256; Takayasu K, 2012, J HEPATOL, V56, P886, DOI 10.1016/j.jhep.2011.10.021; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; Wang JH, 2015, J GASTROEN HEPATOL, V30, P358, DOI 10.1111/jgh.12686; Xiao J, 2014, INT J CLIN EXP PATHO, V7, P1114; Yamakado K, 2014, JPN J RADIOL, V32, P260, DOI 10.1007/s11604-014-0298-9	21	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125244	10.1371/journal.pone.0125244	http://dx.doi.org/10.1371/journal.pone.0125244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919025	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400077
J	Song, ZY; Yamasaki, R; Kawano, Y; Sato, S; Masaki, K; Yoshimura, S; Matsuse, D; Murai, H; Matsushita, T; Kira, J				Song, Zi-Ye; Yamasaki, Ryo; Kawano, Yuji; Sato, Shinya; Masaki, Katsuhisa; Yoshimura, Satoshi; Matsuse, Dai; Murai, Hiroyuki; Matsushita, Takuya; Kira, Jun-ichi			Peripheral Blood T Cell Dynamics Predict Relapse in Multiple Sclerosis Patients on Fingolimod	PLOS ONE			English	Article							1-PHOSPHATE RECEPTOR MODULATOR; JAPANESE PATIENTS; CONTROLLED-TRIAL; FTY720 THERAPY; CENTRAL MEMORY; SUBSETS; LESIONS; PROFILES; TH17	Background Fingolimod efficiently reduces multiple sclerosis (MS) relapse by inhibiting lymphocyte egress from lymph nodes through down-modulation of sphingosine 1-phosphate (S1P) receptors. We aimed to clarify the alterations in peripheral blood T cell subsets associated with MS relapse on fingolimod. Methods/Principal Findings Blood samples successively collected from 23 relapsing-remitting MS patients before and during fingolimod therapy (0.5 mg/day) for 12 months and 18 healthy controls (HCs) were analysed for T cell subsets by flow cytometry. In MS patients, the percentages of central memory T (CCR7(+)CD45RO(+)) cells (TCM) and naive T (CCR7(+)CD45RO(-)) cells decreased significantly, while those of effector memory T (CCR7-CD45RA-) and suppressor precursor T (CD28-) cells increased in both CD4(+)T and CD8(+)T cells from 2 weeks to 12 months during fingolimod therapy. The percentages of regulatory T (CD4(+)CD25(high)CD127(low)) cells in CD4(+)T cells and CCR7(-)CD45RA(+)T cells in CD8(+)T cells also increased significantly. Eight relapsed patients demonstrated greater percentages of CD4(+)TCM than 15 non-relapsed patients at 3 and 6 months (p=0.0051 and p=0.0088, respectively). The IL17-, IL9-, and IL4-producing CD4(+)T cell percentages were significantly higher at pre-treatment in MS patients compared with HCs (p<0.01 for all), while the IL17-producing CD4(+)T cell percentages tended to show a transient increase at 2 weeks of fingolimod therapy (p(corr)=0.0834). Conclusions The CD4(+)TCM percentages at 2 weeks to 12 months during fingolimod therapy are related to relapse.	[Song, Zi-Ye; Kawano, Yuji; Sato, Shinya; Masaki, Katsuhisa; Yoshimura, Satoshi; Matsuse, Dai; Murai, Hiroyuki; Matsushita, Takuya; Kira, Jun-ichi] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 812, Japan; [Yamasaki, Ryo] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol Therapeut, Fukuoka 812, Japan	Kyushu University; Kyushu University	Kira, J (corresponding author), Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 812, Japan.	kira@neuro.med.kyushu-u.ac.jp			Health and Labour Sciences Research Grants on Intractable Diseases from the Ministry of Health, Labour and Welfare, Japan [H24-Nanchitou (Nan)-Ippan-055, H23-Nanchi-Ippan-017]; Ministry of Education, Culture, Sports, Science and Technology, Japan [25293204, 25670423, 25117012]; Bayer Schering Pharma; Biogen Idec; Novartis Pharma; Mitsubishi Tanabe Pharma; Ministry of Health, Labour and Welfare of Japan; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Kaibara Morikazu Medical Science Promotion Foundation, Japan; Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan; Pfizer Japan; Japan Blood Products Organization; Grants-in-Aid for Scientific Research [25670423] Funding Source: KAKEN	Health and Labour Sciences Research Grants on Intractable Diseases from the Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bayer Schering Pharma(Bayer AG); Biogen Idec(Biogen); Novartis Pharma; Mitsubishi Tanabe Pharma(Mitsubishi Tanabe Pharma Corporation); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kaibara Morikazu Medical Science Promotion Foundation, Japan(Kaibara Morikazu Medical Science Promotion Foundation); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Pfizer Japan(Pfizer); Japan Blood Products Organization; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Health and Labour Sciences Research Grants on Intractable Diseases (H24-Nanchitou (Nan)-Ippan-055 and H23-Nanchi-Ippan-017) from the Ministry of Health, Labour and Welfare, Japan, and by a Grant-in-Aid for Scientific Research B (No. 25293204), a Grant-in-Aid for Exploratory Research (No. 25670423), and a Grant-in-Aid for Scientific Research on Innovative Areas (No. 25117012) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Ryo Yamasaki has received research support from Bayer Schering Pharma, Biogen Idec, Novartis Pharma, and Mitsubishi Tanabe Pharma. Takuya Matsushita has received speaker honoraria from Bayer Schering Pharma, Biogen Idec, and Pfizer and receives research support from Bayer Schering Pharma, Biogen Idec, Novartis Pharma, Mitsubishi Tanabe Pharma, the Ministry of Health, Labour and Welfare of Japan, the Japan Science and Technology Agency, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Kaibara Morikazu Medical Science Promotion Foundation, Japan. Junichi Kira has received honoraria from Biogen Idec Japan, Novartis Pharma Japan, and Mitsubishi Tanabe Pharma Corporation. He is funded by a Research Grant for Nervous and Mental Disorders from the Ministry of Health, Labour and Welfare, Japan, and grants from the Japan Science and Technology Agency, the Ministry of Education, Culture, Sports, Science and Technology, Japan, Pfizer Japan, and the Japan Blood Products Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiba K, 2011, INT IMMUNOPHARMACOL, V11, P366, DOI 10.1016/j.intimp.2010.10.005; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; CRUCIAN B, 1995, CLIN DIAGN LAB IMMUN, V2, P249, DOI 10.1128/CDLI.2.2.249-252.1995; CUI YW, 2014, CLIN EXP NEUROIMMUNO, V5, P92; Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652; Ishizu T, 2005, BRAIN, V128, P988, DOI 10.1093/brain/awh453; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Jander S, 2012, MULT SCLER J, V18, P1650, DOI 10.1177/1352458512463768; Kataoka H, 2005, CELL MOL IMMUNOL, V2, P439; Killestein J, 2001, MULT SCLER, V7, P145, DOI 10.1191/135245801678438357; Kira J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-21; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Liu H, 2008, J IMMUNOL, V180, P7948, DOI 10.4049/jimmunol.180.12.7948; Matsuoka T, 2007, BRAIN, V130, P1206, DOI 10.1093/brain/awm027; Matsushita T, 2009, MULT SCLER J, V15, P834, DOI 10.1177/1352458509104595; Matsushita T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061835; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Mehling M, 2008, NEUROLOGY, V71, P1261, DOI 10.1212/01.wnl.0000327609.57688.ea; Mehling M, 2010, NEUROLOGY, V75, P403, DOI 10.1212/WNL.0b013e3181ebdd64; Min JH, 2012, MULT SCLER J, V18, P113, DOI 10.1177/1352458511431973; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Ochi H, 2001, J NEUROIMMUNOL, V119, P297, DOI 10.1016/S0165-5728(01)00393-9; Ochi HF, 2004, J NEUROL SCI, V222, P65, DOI 10.1016/j.jns.2004.04.012; PANITCH HS, 1987, LANCET, V1, P893; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER S, 1981, J NEUROL, V225, P219, DOI 10.1007/BF00313751; Putheti P, 2003, J NEUROIMMUNOL, V144, P125, DOI 10.1016/j.jneuroim.2003.08.001; Saida T, 2012, MULT SCLER J, V18, P1269, DOI 10.1177/1352458511435984; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Salvadori M, 2006, AM J TRANSPLANT, V6, P2912, DOI 10.1111/j.1600-6143.2006.01552.x; Sato DK, 2014, J NEUROIMMUNOL, V268, P95, DOI 10.1016/j.jneuroim.2014.01.008; Soliven B, 2011, NEUROLOGY, V76, pS9, DOI 10.1212/WNL.0b013e31820d9507; Tanaka M, 2008, NEUROLOGY, V71, P974, DOI 10.1212/01.wnl.0000326589.57128.c3; Visser F, 2012, NEUROLOGY, V79, P2000, DOI 10.1212/WNL.0b013e3182735cb3; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53; Yoshimura S, 2013, J NEUROL NEUROSUR PS, V84, P29, DOI 10.1136/jnnp-2012-302925	36	54	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124923	10.1371/journal.pone.0124923	http://dx.doi.org/10.1371/journal.pone.0124923			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919001	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400065
J	Amemiya, T; Nakamura, T; Yamamoto, T; Kinoshita, S; Kanamura, N				Amemiya, Takeshi; Nakamura, Takahiro; Yamamoto, Toshiro; Kinoshita, Shigeru; Kanamura, Narisato			Autologous Transplantation of Oral Mucosal Epithelial Cell Sheets Cultured on an Amniotic Membrane Substrate for Intraoral Mucosal Defects	PLOS ONE			English	Article							SURFACE RECONSTRUCTION; BASEMENT-MEMBRANE; KERATIN PROTEINS; LOCALIZATION; EQUIVALENT; CORNEAL; SERUM; IV	The human amniotic membrane (AM) is a thin intrauterine placental membrane that is highly biocompatible and possesses anti-inflammatory and anti-scarring properties. Using AM, we developed a novel method for cultivating oral mucosal epithelial cell sheets. We investigated the autologous transplantation of oral mucosal epithelial cells cultured on AM in patients undergoing oral surgeries. We obtained specimens of AM from women undergoing cesarean sections. This study included five patients without any history of a medical disorder who underwent autologous cultured oral epithelial transplantation following oral surgical procedures. Using oral mucosal biopsy specimens obtained from these patients, we cultured oral epithelial cells on an AM carrier. We transplanted the resultant cell sheets onto the oral mucosal defects. Patients were followed-up for at least 12 months after transplantation. After 2-3 weeks of being cultured on AM, epithelial cells were well differentiated and had stratified into five to seven layers. Immunohistochemistry revealed that the cultured cells expressed highly specific mucosal epithelial cell markers and basement membrane proteins. After the surgical procedures, no infection, bleeding, rejection, or sheet detachment occurred at the reconstructed sites, at which new oral mucous membranes were evident. No recurrence was observed in the long-term follow-up, and the postoperative course was excellent. Our results suggest that AM-cultured oral mucosal epithelial cell sheets represent a useful biomaterial and feasible method for oral mucosal reconstruction. However, our primary clinical study only evaluated their effects on a limited number of small oral mucosal defects.	[Amemiya, Takeshi; Yamamoto, Toshiro; Kanamura, Narisato] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dent Med, Kyoto, Japan; [Nakamura, Takahiro; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Ophthalmol, Kyoto, Japan; [Nakamura, Takahiro] Doshisha Univ, Fac Life & Med Sci, Res Ctr Inflammat & Regenerat Med, Kyoto 602, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Doshisha University	Amemiya, T (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dent Med, Kyoto, Japan.	amemiya@koto.kpu-m.ac.jp			Japan Society for the Promotion of Science [21592535]; Kyoto Prefectural University of Medicine; Grants-in-Aid for Scientific Research [15K11261, 25861966] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kyoto Prefectural University of Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work supported by a Grant-in-Aid for Scientific Research (No. 21592535) from the Japan Society for the Promotion of Science (NK), and a Grant for Advanced Medical Treatment in Kyoto Prefectural University of Medicine (NK). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2014, ORAL DIS, V20, P582, DOI 10.1111/odi.12176; Amemiya T, 2004, J ORAL TISSUE ENG, V1, P89; Amemiya T, 2010, JPN J CONSERV DENT, V53, P214; Amemiya T, 2003, J JPN ASS REGENERATI, V1, P25; Amemiya T, 2010, BIO-MED MATER ENG, V20, P37, DOI 10.3233/BME-2010-0613; Amemyia T., 2010, INFLAMM REGEN, V30, P176, DOI [10.2492/inflammregen.30.176, DOI 10.2492/INFLAMMREGEN.30.176]; Black AF, 2005, TISSUE ENG, V11, P723, DOI 10.1089/ten.2005.11.723; CLAUSEN H, 1986, J ORAL PATHOL MED, V15, P36, DOI 10.1111/j.1600-0714.1986.tb00561.x; COLOCHO G, 1974, ARCH SURG-CHICAGO, V109, P370; COOPER D, 1986, J BIOL CHEM, V261, P4646; Cooper LJ, 2005, CORNEA, V24, P722, DOI 10.1097/01.ico.0000154237.49112.29; Feghali-Assaly M, 1997, EUR J ORAL SCI, V105, P599, DOI 10.1111/j.1600-0722.1997.tb00224.x; Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018; Izumi K, 2003, INT J ORAL MAX SURG, V32, P188, DOI 10.1054/ijom.2002.0365; JUHL M, 1989, SCAND J DENT RES, V97, P159; Kanamura, 2008, J ORAL TISSUE ENG, V6, P106; Kesting MR, 2014, ORAL MAXILLOFAC SURG, V18, P153, DOI 10.1007/s10006-012-0382-1; Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173; MALAK TM, 1993, PLACENTA, V14, P385, DOI 10.1016/S0143-4004(05)80460-6; Maragou P, 1999, ORAL DIS, V5, P20; Modesti A, 1989, Prog Clin Biol Res, V296, P459; Moharamzadeh K, 2007, J DENT RES, V86, P115, DOI 10.1177/154405910708600203; Nakamura T, 2006, INVEST OPHTH VIS SCI, V47, P909, DOI 10.1167/iovs.05-1188; Nakamura T, 2003, INVEST OPHTH VIS SCI, V44, P106, DOI 10.1167/iovs.02-0195; Nakamura T, 2004, BRIT J OPHTHALMOL, V88, P1280, DOI 10.1136/bjo.2003.038497; Nakamura T, 2011, BRIT J OPHTHALMOL, V95, P942, DOI 10.1136/bjo.2010.188714; NANAEV AK, 1991, PLACENTA, V12, P573, DOI 10.1016/0143-4004(91)90493-Y; Nishiyama T, 2000, J DERMATOL SCI, V24, pS51, DOI 10.1016/S0923-1811(00)00142-0; ROSDY M, 1990, J INVEST DERMATOL, V95, P409, DOI 10.1111/1523-1747.ep12555510; ROSDY M, 1993, BRIT J DERMATOL, V129, P227, DOI 10.1111/j.1365-2133.1993.tb11839.x; Samandari MH, 2004, ORAL SURG ORAL MED O, V97, P574, DOI 10.1016/j.tripleo.2003.10.031; SHABANA AHM, 1991, ARCH ORAL BIOL, V36, P747, DOI 10.1016/0003-9969(91)90041-R; STEPP MA, 1990, P NATL ACAD SCI USA, V87, P8970, DOI 10.1073/pnas.87.22.8970; TALMI YP, 1991, PLACENTA, V12, P285, DOI 10.1016/0143-4004(91)90010-D; TRELFORD JD, 1979, AM J OBSTET GYNECOL, V134, P833, DOI 10.1016/0002-9378(79)90957-8; Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431; Yamamoto T, 2007, J ORAL TISSUE ENG, V5, P54	37	13	15	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125391	10.1371/journal.pone.0125391	http://dx.doi.org/10.1371/journal.pone.0125391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915046	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659100126
J	Gessler, F; Dutzmann, S; Quick, J; Tizi, K; Voigt, MA; Mutlak, H; Vatter, H; Seifert, V; Senft, C				Gessler, Florian; Duetzmann, Stephan; Quick, Johanna; Tizi, Karima; Voigt, Melanie Alexandra; Mutlak, Haitham; Vatter, Hartmut; Seifert, Volker; Senft, Christian			Is Postoperative Imaging Mandatory after Meningioma Removal? Results of a Prospective Study	PLOS ONE			English	Article							RECURRENCE; SURGERY; TUMORS	Background Routine postoperative imaging (PI) following surgery for intracranial meningiomas is common practice in most neurosurgical departments. The purpose of this study was to determine the role of routine PI and its impact on clinical decision making after resection of meningioma. Methods Patient and tumor characteristics, details of radiographic scans, symptoms and alteration of treatment courses were prospectively collected for patients undergoing removal of a supratentorial meningioma of the convexity, falx, tentorium, or lateral sphenoid wing at the authors' institution between January 1st, 2010 and March 31st, 2012. Patients with infratentorial manifestations or meningiomas of the skull base known to be surgically difficult (e.g. olfactory groove, petroclival, medial sphenoid wing) were not included. Maximum tumor diameter was divided into groups of < 3cm (small), 3 to 6 cm (medium), and > 6 cm (large). Results 206 patients with meningiomas were operated between January 2010 and March 2012. Of these, 113 patients met the inclusion criteria and were analyzed in this study. 83 patients (73.5%) did not present new neurological deficits, whereas 30 patients (26.5%) became clinically symptomatic. Symptomatic patients had a change in treatment after PI in 21 cases (70%), while PI was without consequence in 9 patients (30%). PI did not result in a change of treatment in all asymptomatic patients (p<0.001) irrespective of tumor size (p<0.001) or localization (p<0.001). Conclusions PI is mandatory for clinically symptomatic patients but it is safe to waive it in clinically asymptomatic patients, even if the meningioma was large in size.	[Gessler, Florian; Duetzmann, Stephan; Quick, Johanna; Tizi, Karima; Mutlak, Haitham; Vatter, Hartmut; Seifert, Volker; Senft, Christian] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dept Neurosurg, D-60528 Frankfurt, Germany; [Voigt, Melanie Alexandra] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Inst Neuroradiol, D-60528 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Gessler, F (corresponding author), Univ Cambridge, Dept Clin Neurosci, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, England.	f.gessler@med.uni-frankfurt.de	Senft, Christian/F-4252-2010	Senft, Christian/0000-0003-1288-6913				ALBERT FK, 1994, NEUROSURGERY, V34, P45, DOI 10.1097/00006123-199401000-00008; Binning M, 2007, J NEUROSURG, V107, P43, DOI 10.3171/PED-07/07/043; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Dutzmann S, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12219; HODGSON TJ, 1995, J NEUROL NEUROSUR PS, V59, P545, DOI 10.1136/jnnp.59.5.545; Hoover Jason M, 2011, Surg Neurol Int, V2, P142, DOI 10.4103/2152-7806.85983; Hussain SA, 2001, BRIT J NEUROSURG, V15, P116; Ildan F, 2007, SKULL BASE-INTERD AP, V17, P157, DOI 10.1055/s-2007-970554; Jiang ZY, 2013, OTOLARYNG HEAD NECK, V149, P786, DOI 10.1177/0194599813502311; Jung JM, 2012, CHILD NERV SYST, V28, P673, DOI 10.1007/s00381-012-1716-x; Kim EH, 2011, ACTA NEUROCHIR, V153, P1487, DOI 10.1007/s00701-011-1046-x; LONGSTRETH WT, 1993, CANCER, V72, P639, DOI 10.1002/1097-0142(19930801)72:3<639::AID-CNCR2820720304>3.0.CO;2-P; Mettler Fred A. Jr., 2000, Journal of Radiological Protection, V20, P353, DOI 10.1088/0952-4746/20/4/301; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Schulder M, 2003, ACTA NEUROCHIR SUPPL, V85, P79; SIMPSON D, 1957, J NEUROL NEUROSUR PS, V20, P22, DOI 10.1136/jnnp.20.1.22; Solheim O, 2009, ACTA NEUROCHIR, V151, P1143, DOI 10.1007/s00701-009-0395-1; Sughrue ME, 2013, J NEUROSURG, V119, P86, DOI 10.3171/2012.12.JNS11539; Terlecki RP, 2011, UROLOGY, V78, P450, DOI 10.1016/j.urology.2011.01.071; Tomasello F, 2012, WORLD NEUROSURG, V77, P631, DOI 10.1016/j.wneu.2011.11.012; Valdes PA, 2011, J NEUROSURG, V115, P11, DOI 10.3171/2011.2.JNS101451; van den Bergh B, 2011, INT J ORAL MAX SURG, V40, P1373, DOI 10.1016/j.ijom.2011.08.008; Vassilyadi M, 2010, J NEUROSURG-PEDIATR, V6, P468, DOI 10.3171/2010.8.PEDS09557	23	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124534	10.1371/journal.pone.0124534	http://dx.doi.org/10.1371/journal.pone.0124534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915782	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100053
J	Liang, JG; Liu, L; Cheung, M; Lee, MP; Wang, HB; Li, CH; Chan, CC; Nishiura, K; Tang, X; Tan, ZW; Peng, J; Cheung, KW; Yam, WC; Chen, ZW				Liang, Jianguo; Liu, Li; Cheung, Mandy; Lee, Man-Po; Wang, Haibo; Li, Chun-ho; Chan, Chun-Chung; Nishiura, Kenji; Tang, Xian; Tan, Zhiwu; Peng, Jie; Cheung, Ka-Wai; Yam, Wing-Cheong; Chen, Zhiwei			Community-Based HIV-1 Early Diagnosis and Risk Behavior Analysis of Men Having Sex with Men in Hong Kong	PLOS ONE			English	Article							REAL-TIME PCR; DRIED BLOOD SPOTS; PROVIRAL DNA; INFECTION; QUANTIFICATION; PREVENTION; CHINA; CELLS; TRANSMISSION; PREVALENCE	The increasing prevalence of HIV-1 among men having sex with men (MSM) calls for an investigation of HIV-1 prevalence and incidence in MSM by early diagnosis to assist with early preventive interventions in Hong Kong. The participants were recruited randomly from MSM communities within a one-year period. Rapid HIV Test (RHT) and real-time dried blood spot (DBS)-based quantitative polymerase chain reaction (DBS-qPCR) were used for the early diagnosis of 474 participants. Risk behavior analysis was performed by studying information obtained from the participants during the study period. The HIV-1 prevalence and incident rates in the studied MSM population were 4.01%(19/474) and 1.47% (7/474), respectively. Three infected participants were found at the acute phase of infection by DBS-qPCR. Only 46.4%(220/474) MSM were using condoms regularly for anal sex. HIV infection significantly correlated with unprotected receptive anal sex and syphilis infection. An increased number of infections was found among foreign MSM in Hong Kong. This study is the first to use DBS-qPCR to identify acutely infected individuals in a community setting and to provide both the prevalence and incident rates of HIV-1 infection among MSM in Hong Kong. The risk analysis provided evidence that behavior intervention strengthening is necessary to fight against the increasing HIV-1 epidemic among MSM in Hong Kong and surrounding regions in Asia.	[Liang, Jianguo; Liu, Li; Wang, Haibo; Nishiura, Kenji; Tang, Xian; Tan, Zhiwu; Peng, Jie; Cheung, Ka-Wai; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immun, AIDS Inst, Pokfulam, Hong Kong, Peoples R China; [Liang, Jianguo; Liu, Li; Wang, Haibo; Nishiura, Kenji; Tang, Xian; Tan, Zhiwu; Peng, Jie; Cheung, Ka-Wai; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immun, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China; [Cheung, Mandy; Li, Chun-ho; Chan, Chun-Chung] AIDS Concern, Chaiwan, Hong Kong, Peoples R China; [Lee, Man-Po] Queen Elizabeth Hosp Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Yam, Wing-Cheong] Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Liu, L (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immun, AIDS Inst, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	liuli71@hkucc.hku.hk; zchenai@hku.hk	Liu, Li/ABA-8315-2020; Chen, Zhiwei/B-7793-2019	Liu, Li/0000-0003-2566-7357; Chen, Zhiwei/0000-0002-4511-2888; Nishiura, Kenji/0000-0002-9573-6808	Hong Kong AIDS Trust [MSS166R, MSS 183R]; University Development Fund (HKU UDF); Li Ka Shing Faculty of Medicine Matching Fund (LKSFM); National Science and Technology Major Project [2012ZX10001-009]; AIDS Trust Fund [MSS 227R]	Hong Kong AIDS Trust; University Development Fund (HKU UDF); Li Ka Shing Faculty of Medicine Matching Fund (LKSFM); National Science and Technology Major Project; AIDS Trust Fund	The authors thank Hong Kong AIDS Trust Fund for financial support MSS166R (to LL) and MSS 183R (to ZC). This work was partially supported by University Development Fund (HKU UDF) and Li Ka Shing Faculty of Medicine Matching Fund (LKSFM) matching fund to AIDS Institute and by the National Science and Technology Major Project 2012ZX10001-009. The authors thank K.H. Wong for providing patient PBMC samples. The authors thank D.D. Ho and K.Y. Yuen for scientific advice. AIDS Trust Fund, MSS 227R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CDC, HIV TEST BAS CONS; Chen J.J., 2011, MODEL SIMUL ENG, V2011, P1, DOI DOI 10.1371/J0URNAL.P0NE.0025286; Chen J, 2010, RADIAT PROT DOSIM, V142, P1, DOI 10.1093/rpd/ncq205; Chiminqgi M, 2007, CLIN CHEM LAB MED, V45, P993, DOI 10.1515/CCLM.2007.191; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Curran K, 2012, CURR HIV-AIDS REP, V9, P160, DOI 10.1007/s11904-012-0114-z; De Crignis E, 2010, J VIROL METHODS, V165, P51, DOI 10.1016/j.jviromet.2009.12.017; Defoort JP, 2000, J CLIN MICROBIOL, V38, P1066, DOI 10.1128/JCM.38.3.1066-1071.2000; Desire N, 2001, J CLIN MICROBIOL, V39, P1303, DOI 10.1128/JCM.39.4.1303-1310.2001; DH, 2012, HIV PREV RISK BEH SU; Gibellini D, 2004, J CLIN VIROL, V29, P282, DOI 10.1016/S1386-6532(03)00169-0; HAENDLER B, 1990, EUR J BIOCHEM, V190, P477, DOI 10.1111/j.1432-1033.1990.tb15598.x; He JQ, 2008, EUR RESPIR J, V32, P755, DOI 10.1183/09031936.00129107; HORSBURGH CR, 1989, LANCET, V2, P637; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kabamba-Mukadi B, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-15; Kahle EM, 2013, JAIDS-J ACQ IMM DEF, V62, P339, DOI 10.1097/QAI.0b013e31827e622d; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lau JTF, 2004, SEX TRANSM INFECT, V80, P459, DOI 10.1136/sti.2003.008854; Lau JTF, 2004, SEX TRANSM DIS, V31, P568, DOI 10.1097/01.olq.0000137905.94154.0a; Lau JTF, 2002, ARCH SEX BEHAV, V31, P367, DOI 10.1023/A:1016280411280; Lee EM SS, REPORT ASSESSMENT RE; Lee SS, 2009, AIDS, V23, P1753, DOI 10.1097/QAD.0b013e32832dc025; Leung TWC, 2008, AIDS RES HUM RETROV, V24, P903, DOI 10.1089/aid.2007.0272; Ling AE, 2000, JAMA-J AM MED ASSOC, V284, P210, DOI 10.1001/jama.284.2.210; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Luo MQ, 2009, JAIDS-J ACQ IMM DEF, V50, P1, DOI 10.1097/QAI.0b013e31818ffcdc; McKirnan DJ, 2010, J CONSULT CLIN PSYCH, V78, P952, DOI 10.1037/a0020759; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mehta N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005819; Ngo-Giang-Huong N, 2008, JAIDS-J ACQ IMM DEF, V49, P465, DOI 10.1097/QAI.0b013e31818e2531; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palombi L, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000279708.09180.f5; Rienzo M, 2013, CLIN TRANSL ONCOL, V15, P211, DOI 10.1007/s12094-012-0904-1; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Su R, 2003, AIDS, V17, P2515, DOI 10.1097/00002030-200311210-00015; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443	37	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125715	10.1371/journal.pone.0125715	http://dx.doi.org/10.1371/journal.pone.0125715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915755	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100144
J	Silva-Sanchez, A; Meza-Perez, S; Flores-Langarica, A; Donis-Maturano, L; Estrada-Garcia, I; Calderon-Amador, J; Hernandez-Pando, R; Idoyaga, J; Steinman, RM; Flores-Romo, L				Silva-Sanchez, Aaron; Meza-Perez, Selene; Flores-Langarica, Adriana; Donis-Maturano, Luis; Estrada-Garcia, Iris; Calderon-Amador, Juana; Hernandez-Pando, Rogelio; Idoyaga, Juliana; Steinman, Ralph M.; Flores-Romo, Leopoldo			ESAT-6 Targeting to DEC205+Antigen Presenting Cells Induces Specific-T Cell Responses against ESAT-6 and Reduces Pulmonary Infection with Virulent Mycobacterium tuberculosis	PLOS ONE			English	Article							DENDRITIC CELLS; IN-VIVO; ANTIGEN PRESENTATION; LYMPH-NODES; PHAGOSOME MATURATION; IMMUNE-RESPONSES; RECEPTOR DEC-205; CUTTING EDGE; BOVIS BCG; MICE	Airways infection with Mycobacterium tuberculosis (Mtb) is contained mostly by T cell responses, however, Mtb has developed evasion mechanisms which affect antigen presenting cell (APC) maturation/recruitment delaying the onset of Ag-specific T cell responses. Hypothetically, bypassing the natural infection routes by delivering antigens directly to APCs may overcome the pathogen's naturally evolved evasion mechanisms, thus facilitating the induction of protective immune responses. We generated a murine monoclonal fusion antibody (alpha-DEC-ESAT) to deliver Early Secretory Antigen Target (ESAT)-6 directly to DEC205(+) APCs and to assess its in vivo effects on protection associated responses (IFN-gamma production, in vivo CTL killing, and pulmonary mycobacterial load). Treatment with alpha-DEC-ESAT alone induced ESAT-6-specific IFN-gamma producing CD4(+) T cells and prime-boost immunization prior to Mtb infection resulted in early influx (d14 post-infection) and increased IFN-gamma(+) production by specific T cells in the lungs, compared to scarce IFN-gamma production in control mice. In vivo CTL killing was quantified in relevant tissues upon transferring target cells loaded with mycobacterial antigens. During infection, alpha-DEC-ESAT-treated mice showed increased target cell killing in the lungs, where histology revealed cellular infiltrate and considerably reduced bacterial burden. Targeting the mycobacterial antigen ESAT-6 to DEC205(+) APCs before infection expands specific T cell clones responsible for early T cell responses (IFN-gamma production and CTL activity) and substantially reduces lung bacterial burden. Delivering mycobacterial antigens directly to APCs provides a unique approach to study in vivo the role of APCs and specific T cell responses to assess their potential anti-mycobacterial functions.	[Silva-Sanchez, Aaron; Meza-Perez, Selene; Donis-Maturano, Luis; Calderon-Amador, Juana; Flores-Romo, Leopoldo] CINVESTAV, IPN, Dept Cell Biol, Mexico City 14000, DF, Mexico; [Silva-Sanchez, Aaron; Meza-Perez, Selene; Estrada-Garcia, Iris] ENCB IPN, Dept Immunol, Mexico City, DF, Mexico; [Flores-Langarica, Adriana; Idoyaga, Juliana; Steinman, Ralph M.] Rockefeller Univ, Physiol & Cell Biol, New York, NY 10021 USA; [Hernandez-Pando, Rogelio] Dept Pathol INNSZ, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Rockefeller University	Flores-Romo, L (corresponding author), CINVESTAV, IPN, Dept Cell Biol, Mexico City 14000, DF, Mexico.	leflores@cinvestav.mx	Meza-Perez, Selene/AAX-2300-2021; Silva-Sanchez, Aaron/AAI-8572-2021	Meza-Perez, Selene/0000-0001-7881-6964; Silva-Sanchez, Aaron/0000-0002-1882-2534; Donis Maturano, Luis/0000-0001-8430-5669; Flores-Langarica, Adriana/0000-0003-2183-4437; Hernandez-Pando, Rogelio/0000-0003-1292-3833	National Council for Science and Technology of Mexico, CONACyT; National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [AI13013]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) [5K99AR062595]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI013013, R01AI013013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR062595] Funding Source: NIH RePORTER	National Council for Science and Technology of Mexico, CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was in part funded by the National Council for Science and Technology of Mexico, CONACyT (LFR, RHP and IEG). RMS was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) grant AI13013. JI is supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) grant 5K99AR062595.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Anand PK, 2005, FEMS MICROBIOL LETT, V250, P137, DOI 10.1016/j.femsle.2005.06.056; Baena A, 2009, TISSUE ANTIGENS, V74, P189, DOI 10.1111/j.1399-0039.2009.01301.x; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Bodnar KA, 2001, INFECT IMMUN, V69, P800, DOI 10.1128/IAI.69.2.800-809.2001; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Brandt L, 2000, INFECT IMMUN, V68, P791, DOI 10.1128/IAI.68.2.791-795.2000; Brusasca PN, 2003, COMPARATIVE MED, V53, P165; Brusasca PN, 2001, SCAND J IMMUNOL, V54, P448, DOI 10.1046/j.1365-3083.2001.00975.x; Cardona DP-J, 2012, UNDERSTANDING TUBERC; Casadevall A, 2008, ANNU REV MICROBIOL, V62, P19, DOI 10.1146/annurev.micro.61.080706.093305; Cohn L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00255; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DENIS M, 1991, CELL IMMUNOL, V132, P150, DOI 10.1016/0008-8749(91)90014-3; Derrick SC, 2013, VACCINE, V31, P4641, DOI 10.1016/j.vaccine.2013.07.032; Djelouadji Z, 2011, LANCET INFECT DIS, V11, P641, DOI 10.1016/S1473-3099(11)70093-7; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Einarsdottir T, 2009, INFECT IMMUN, V77, P4621, DOI 10.1128/IAI.00415-09; Gallegos AM, 2008, J EXP MED, V205, P2359, DOI 10.1084/jem.20080353; Garcia-Romo GS, 2013, IMMUNOBIOLOGY, V218, P393, DOI 10.1016/j.imbio.2012.05.022; Garcia-Romo GS, 2004, IMMUNOLOGY, V112, P661, DOI 10.1046/j.1365-2567.2004.01904.x; Gueirard P, 2003, INFECT IMMUN, V71, P4137, DOI 10.1128/IAI.71.7.4137-4143.2003; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; HERNANDEZPANDO R, 1994, IMMUNOLOGY, V82, P591; HernandezPando R, 1997, IMMUNOLOGY, V90, P607, DOI 10.1046/j.1365-2567.1997.00193.x; HernandezPando R, 1996, IMMUNOLOGY, V89, P26; Idoyaga J, 2008, J IMMUNOL, V180, P3647, DOI 10.4049/jimmunol.180.6.3647; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Jung YJ, 2008, IMMUNOLOGY, V124, P514, DOI 10.1111/j.1365-2567.2007.02803.x; Kamath A, 2006, J IMMUNOL, V177, P6361, DOI 10.4049/jimmunol.177.9.6361; Kastenmuller W, 2014, NAT REV IMMUNOL, V14, P705, DOI 10.1038/nri3727; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Mendez-Samperio P, 2008, J INFECTION, V57, P374, DOI 10.1016/j.jinf.2008.08.010; Nchinda G, 2008, J CLIN INVEST, V118, P1427, DOI 10.1172/JCI34224; NORTH RJ, 1995, J INFECT DIS, V172, P1550, DOI 10.1093/infdis/172.6.1550; Pedroza-Gonzalez A, 2004, INT J EXP PATHOL, V85, P135, DOI 10.1111/j.0959-9673.2004.00381.x; Pieters J, 2001, MICROBES INFECT, V3, P249, DOI 10.1016/S1286-4579(01)01376-4; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Quintero-Macias L, 2010, SCAND J IMMUNOL, V71, P20, DOI 10.1111/j.1365-3083.2009.02335.x; Quintero-Macias L, 2012, IMMUNOL INVEST, V41, P51, DOI 10.3109/08820139.2011.580408; Rajasagi NK, 2009, J VIROL, V83, P5256, DOI 10.1128/JVI.01997-08; Ravn P, 1999, J INFECT DIS, V179, P637, DOI 10.1086/314640; Sendide K, 2004, INFECT IMMUN, V72, P4200, DOI 10.1128/IAI.72.7.4200-4209.2004; Serbina NV, 2001, J IMMUNOL, V167, P6991, DOI 10.4049/jimmunol.167.12.6991; Stylianou E, 2011, VACCINE, V29, P2279, DOI 10.1016/j.vaccine.2011.01.030; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Tascon RE, 1998, INFECT IMMUN, V66, P830, DOI 10.1128/IAI.66.2.830-834.1998; Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307; von GC, 2009, SWISSMEDWKLY, V139, P186; Wang H, 2000, P NATL ACAD SCI USA, V97, P847, DOI 10.1073/pnas.97.2.847; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Xu J, 2007, MOL MICROBIOL, V66, P787, DOI 10.1111/j.1365-2958.2007.05959.x; Yang EZ, 2014, MICROB PATHOGENESIS, V69-70, P53, DOI 10.1016/j.micpath.2014.03.011	63	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124828	10.1371/journal.pone.0124828	http://dx.doi.org/10.1371/journal.pone.0124828			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915045	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100070
J	Soulas, C; Autissier, PJ; Burdo, TH; Piatak, M; Lifson, JD; Williams, KC				Soulas, Caroline; Autissier, Patrick J.; Burdo, Tricia H.; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Williams, Kenneth C.			Distinct Phenotype, Longitudinal Changes of Numbers and Cell-Associated Virus in Blood Dendritic Cells in SIV-Infected CD8-Lymphocyte Depleted Macaques	PLOS ONE			English	Article							PREFERENTIALLY HARBORS HIV-1; CD16(+) MONOCYTE SUBSET; PERIPHERAL-BLOOD; RHESUS MACAQUES; LYMPH-NODES; T-CELLS; IN-VIVO; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; FLOW-CYTOMETRY	Loss of circulating CD123+ plasmacytoid dendritic cells (pDCs) during HIV infection is well established. However, changes of myeloid DCs (mDCs) are ambiguous since they are studied as a homogeneous CD11c+ population despite phenotypic and functional heterogeneity. Heterogeneity of CD11c+ mDCs in primates is poorly described in HIV and SIV infection. Using multiparametric flow cytometry, we monitored longitudinally cell number and cell-associated virus of CD123+ pDCs and non-overlapping subsets of CD1c+ and CD16+ mDCs in SIV-infected CD8-depleted rhesus macaques. The numbers of all three DC subsets were significantly decreased by 8 days post-infection. Whereas CD123+ pDCs were persistently depleted, numbers of CD1c+ and CD16+ mDCs rebounded. Numbers of CD1c+ mDCs significantly increased by 3 weeks post-infection while numbers of CD16+ mDCs remained closer to pre-infection levels. We found similar changes in the numbers of all three DC subsets in CD8 depleted animals as we found in animals that were SIV infected animals that were not CD8 lymphocyte depleted. CD16+ mDCs and CD123+ pDCs but not CD1c+ mDCs were significantly decreased terminally with AIDS. All DC subsets harbored SIV RNA as early as 8 days and then throughout infection. However, SIV DNA was only detected in CD123+ pDCs and only at 40 days post-infection consistent with SIV RNA, at least in mDCs, being surface-bound. Altogether our data demonstrate that SIV infection differently affects CD1c+ and CD16+ mDCs where CD16+ but not CD1c+ mDCs are depleted and might be differentially regulated in terminal AIDS. Finally, our data underline the importance of studying CD1c+ and CD16+ mDCs as discrete populations, and not as total CD11c+ mDCs.	[Soulas, Caroline; Autissier, Patrick J.; Burdo, Tricia H.; Williams, Kenneth C.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] Leidos Biomed Res Inc, Frederick Natl Lab, AIDS & Canc Virus Program, Frederick, MD 21702 USA	Boston College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Williams, KC (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	williauy@bc.edu			National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NIH [R01NS40237, R01NS37654, U19MH081835, R01NS06897]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040101, U24AI126683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH081835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082116, R01NS040237, R01NS037654] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010976] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project has been funded in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This work was also supported by NIH grants R01NS40237, R01NS37654, U19MH081835, and R01NS06897 to K.C.W. Nonhuman Primate Reagent Resource (RR016001, AI040101) provided the in vivo CD8 T lymphocyte depletion antibodies used in these studies. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autissier P, 2010, J IMMUNOL METHODS, V360, P119, DOI 10.1016/j.jim.2010.06.017; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barratt-Boyes SM, 2010, J MED PRIMATOL, V39, P235, DOI 10.1111/j.1600-0684.2010.00428.x; Brown KN, 2007, J IMMUNOL, V178, P6958, DOI 10.4049/jimmunol.178.11.6958; Brown KN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000413; Burdo TH, 2013, AIDS, V27, P1387, DOI 10.1097/QAD.0b013e32836010bd; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; CAMERON PU, 1992, CLIN EXP IMMUNOL, V88, P226, DOI 10.1111/j.1365-2249.1992.tb03066.x; Centlivre M, 2011, J LEUKOCYTE BIOL, V89, P785, DOI 10.1189/jlb.0410231; Cline AN, 2005, J MED PRIMATOL, V34, P303; Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Felts RL, 2010, P NATL ACAD SCI USA, V107, P13336, DOI 10.1073/pnas.1003040107; Fitzgerald-Bocarsly P, 2010, J LEUKOCYTE BIOL, V87, P609, DOI 10.1189/jlb.0909635; Izquierdo-Useros N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004146; Jaworowski A, 2007, J INFECT DIS, V196, P38, DOI 10.1086/518443; Jones GJ, 2001, AIDS, V15, P1657, DOI 10.1097/00002030-200109070-00008; Koopman G, 2004, HUM IMMUNOL, V65, P303, DOI 10.1016/j.humimm.2004.01.013; Lindstedt M, 2005, J IMMUNOL, V175, P4839, DOI 10.4049/jimmunol.175.8.4839; MACATONIA SE, 1990, IMMUNOLOGY, V71, P38; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Malleret B, 2008, BLOOD, V112, P4598, DOI 10.1182/blood-2008-06-162651; Nascimbeni M, 2009, BLOOD, V113, P6112, DOI 10.1182/blood-2008-07-170803; Otero M, 2003, AIDS RES HUM RETROV, V19, P1097, DOI 10.1089/088922203771881194; Patterson S, 1998, J GEN VIROL, V79, P247, DOI 10.1099/0022-1317-79-2-247; Pereyra F, 2012, AIDS, V26, P2409, DOI 10.1097/QAD.0b013e32835a9950; Piccioli D, 2007, BLOOD, V109, P5371, DOI 10.1182/blood-2006-08-038422; Pichyangkul S, 2001, J IMMUNOL METHODS, V252, P15, DOI 10.1016/S0022-1759(01)00327-1; Schmidt B, 2006, J CLIN IMMUNOL, V26, P55, DOI 10.1007/s10875-006-8401-3; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; Subramanian S, 2012, JAMA-J AM MED ASSOC, V308, P379, DOI 10.1001/jama.2012.6698; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; Venneti S, 2008, AM J PATHOL, V172, P1603, DOI 10.2353/ajpath.2008.070967; WEISSMAN D, 1995, P NATL ACAD SCI USA, V92, P826, DOI 10.1073/pnas.92.3.826; Wijewardana V, 2014, IMMUNOLOGY, V143, P146, DOI 10.1111/imm.12295; Wijewardana V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001235; Williams K, 2005, J CLIN INVEST, V115, P2534, DOI 10.1172/JCI22953; Wonderlich ER, 2013, J IMMUNOL, V190, P2188, DOI 10.4049/jimmunol.1201645	40	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0119764	10.1371/journal.pone.0119764	http://dx.doi.org/10.1371/journal.pone.0119764			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915601	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100003
J	Al-Subari, K; Al-Baddai, S; Tome, AM; Volberg, G; Hammwohner, R; Lang, EW				Al-Subari, Karema; Al-Baddai, Saad; Tome, Ana Maria; Volberg, Gregor; Hammwoehner, Rainer; Lang, Elmar W.			Ensemble Empirical Mode Decomposition Analysis of EEG Data Collected during a Contour Integration Task	PLOS ONE			English	Article							COMMUNICATION; DYNAMICS; CLOSURE; BAND	We discuss a data-driven analysis of EEG data recorded during a combined EEG/fMRI study of visual processing during a contour integration task. The analysis is based on an ensemble empirical mode decomposition (EEMD) and discusses characteristic features of event related modes (ERMs) resulting from the decomposition. We identify clear differences in certain ERMs in response to contour vs noncontour Gabor stimuli mainly for response amplitudes peaking around 100 [ms] (called P100) and 200 [ms] (called N200) after stimulus onset, respectively. We observe early P100 and N200 responses at electrodes located in the occipital area of the brain, while late P100 and N200 responses appear at electrodes located in frontal brain areas. Signals at electrodes in central brain areas show bimodal early/late response signatures in certain ERMs. Head topographies clearly localize statistically significant response differences to both stimulus conditions. Our findings provide an independent proof of recent models which suggest that contour integration depends on distributed network activity within the brain.	[Al-Subari, Karema; Al-Baddai, Saad; Lang, Elmar W.] Univ Regensburg, Inst Biophys, Dept Biol, D-93053 Regensburg, Germany; [Al-Subari, Karema; Al-Baddai, Saad; Hammwoehner, Rainer] Univ Regensburg, Inst Informat Sci, Dept Linguist Literature & Culture, D-93053 Regensburg, Germany; [Tome, Ana Maria] Univ Aveiro, Inst Elect Engn & Elect, Dept Elect Engn Telecommun & Informat, P-3800 Aveiro, Portugal; [Volberg, Gregor] Univ Regensburg, Inst Expt Psychol, Dept Psychol Pedag & Sport, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg; Universidade de Aveiro; University of Regensburg	Lang, EW (corresponding author), Univ Regensburg, Inst Biophys, Dept Biol, D-93053 Regensburg, Germany.	elmar.lang@ur.de		Volberg, Gregor/0000-0002-4427-2409; Tome, Ana Maria/0000-0002-1210-0266	DAAD	DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	DAAD (Acciones Conjuntas (Integradas) Hispano-Alemanas). DAAD (Accoes Integradas Luso-Alemas and FCT Cooperacao Transnacional). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftanas LI, 2001, NEUROSCI LETT, V303, P115, DOI 10.1016/S0304-3940(01)01703-7; Al-Baddai S, 2014, BIOMED SIGNAL PROCES, V13, P218, DOI 10.1016/j.bspc.2014.04.011; Aru J, 2012, NEUROSCI BIOBEHAV R, V36, P737, DOI 10.1016/j.neubiorev.2011.12.003; Attoh-Okine N, 2008, EURASIP J ADV SIGNAL; Claessens PME, 2008, J VISION, V8, DOI 10.1167/8.7.33; Claessens PM, 2005, PERCEPT PSYCHOPHYS, V67, P1446, DOI 10.3758/BF03193649; Dakin SC, 2009, J VISION, V9, DOI 10.1167/9.2.13; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eriksson J, 2008, J COGNITIVE NEUROSCI, V20, P1777, DOI 10.1162/jocn.2008.20064; Faltermeier R, 2011, ADV DATA SCI ADAPT, V3, P509, DOI 10.1142/S1793536911000891; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gilad A, 2013, NEURON, V78, P389, DOI 10.1016/j.neuron.2013.02.013; Hanslmayr S, 2013, CURR BIOL, V23, P2273, DOI 10.1016/j.cub.2013.09.020; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Imamoglu F, 2014, NEUROIMAGE, V102, P688, DOI 10.1016/j.neuroimage.2014.08.045; Keil A, 1999, J NEUROSCI, V19, P7152, DOI 10.1523/JNEUROSCI.19-16-07152.1999; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; KOVACS I, 1993, P NATL ACAD SCI USA, V90, P7495, DOI 10.1073/pnas.90.16.7495; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lang EW, 2011, EXPLORATORY MATRIX F, P26, DOI DOI 10.2174/97816080521891110101; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; LEHMANN D, 1984, PROG NEUROBIOL, V23, P227, DOI 10.1016/0301-0082(84)90003-0; Li W, 2002, J NEUROPHYSIOL, V88, P2846, DOI 10.1152/jn.00289.2002; Luck SJ, 2012, OXFORD HDB EVENT REL; Machilsen B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025151; Machilsen B, 2009, J VISION, V9, DOI 10.1167/9.12.11; Mathes B, 2006, BRAIN RES, V1114, P98, DOI 10.1016/j.brainres.2006.07.068; May KA, 2007, J VISION, V7, DOI 10.1167/7.13.9; Mijovic B, 2014, NEUROIMAGE, V88, P10, DOI 10.1016/j.neuroimage.2013.11.032; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Niazy RK, 2005, NEUROIMAGE, V28, P720, DOI 10.1016/j.neuroimage.2005.06.067; Novitskiy N, 2011, NEUROIMAGE, V54, P824, DOI 10.1016/j.neuroimage.2010.09.041; Pettet MW, 1998, VISION RES, V38, P865, DOI 10.1016/S0042-6989(97)00238-1; Shpaner M, 2013, NEUROIMAGE, V69, P146, DOI 10.1016/j.neuroimage.2012.11.023; Tarokh L, 2009, BEHAV BRAIN RES, V196, P55, DOI 10.1016/j.bbr.2008.07.026; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Volberg G, 2014, EXP PSYCHOL, V61, P331, DOI 10.1027/1618-3169/a000252; Volberg G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00264; Volberg G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054085; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P339, DOI 10.1142/S1793536909000187; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Zeiler A, 2013, NEURAL PROCESS LETT, V37, P21, DOI 10.1007/s11063-012-9270-9	45	26	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0119489	10.1371/journal.pone.0119489	http://dx.doi.org/10.1371/journal.pone.0119489			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910061	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800006
J	Dunkley, BT; Sedge, PA; Doesburg, SM; Grodecki, RJ; Jetly, R; Shek, PN; Taylor, MJ; Pang, EW				Dunkley, Benjamin T.; Sedge, Paul A.; Doesburg, Sam M.; Grodecki, Richard J.; Jetly, Rakesh; Shek, Pang N.; Taylor, Margot J.; Pang, Elizabeth W.			Theta, Mental Flexibility, and Post-Traumatic Stress Disorder: Connecting in the Parietal Cortex	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; CEREBRAL-BLOOD-FLOW; VIETNAM VETERANS; FUNCTIONAL CONNECTIVITY; CORTICAL MECHANISMS; NEURAL ACTIVITY; ATTENTION; MEMORY; OSCILLATIONS; SYNCHRONIZATION	Post-traumatic stress disorder (PTSD) is a mental health injury characterised by re-experiencing, avoidance, numbing and hyperarousal. Whilst the aetiology of the disorder is relatively well understood, there is debate about the prevalence of cognitive sequelae that manifest in PTSD. In particular, there are conflicting reports about deficits in executive function and mental flexibility. Even less is known about the neural changes that underlie such deficits. Here, we used magnetoencephalography to study differences in functional connectivity during a mental flexibility task in combat-related PTSD (all males, mean age = 37.4, n = 18) versus a military control (all males, mean age = 33.05, n = 19) group. We observed large-scale increases in theta connectivity in the PTSD group compared to controls. The PTSD group performance was compromised in the more attentionally-demanding task and this was characterised by 'late-stage' theta hyperconnectivity, concentrated in network connections involving right parietal cortex. Furthermore, we observed significant correlations with the connectivity strength in this region with a number of cognitive-behavioural outcomes, including measures of attention, depression and anxiety. These findings suggest atypical coordination of neural synchronisation in large scale networks contributes to deficits in mental flexibility for PTSD populations in timed, attentionally-demanding tasks, and this propensity toward network hyperconnectivity may play a more general role in the cognitive sequelae evident in this disorder.	[Dunkley, Benjamin T.; Doesburg, Sam M.; Taylor, Margot J.] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON M5G 1X8, Canada; [Dunkley, Benjamin T.; Doesburg, Sam M.; Taylor, Margot J.; Pang, Elizabeth W.] Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; [Sedge, Paul A.; Jetly, Rakesh] Canadian Forces Hlth Serv, Directorate Mental Hlth, Ottawa, ON, Canada; [Doesburg, Sam M.; Taylor, Margot J.] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Doesburg, Sam M.; Taylor, Margot J.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Grodecki, Richard J.] Canadian Forces Environm Med Estab, Toronto, ON, Canada; [Shek, Pang N.] Def Res & Dev Canada, Toronto, ON, Canada; [Pang, Elizabeth W.] Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Defence Research & Development Canada; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Dunkley, BT (corresponding author), Hosp Sick Children, Dept Diagnost Imaging, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	ben.dunkley@sickkids.ca		Dunkley, Benjamin Thomas/0000-0001-6173-1171	Defence Research and Development Canada (DRDC) [W7719-135182/001/TOR]; Canadian Forces Health Services	Defence Research and Development Canada (DRDC); Canadian Forces Health Services	This work was supported by funding from Defence Research and Development Canada (DRDC) (Contract #: W7719-135182/001/TOR; http://www.drdc-rddc.gc.ca/en/index.page) and the Canadian Forces Health Services (http://www.forces.gc.ca/en/caf-community-health-services/index.page) to MJTand EWP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Beckham JC, 1998, J TRAUMA STRESS, V11, P811, DOI 10.1023/A:1024409903617; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Boulos D, 2013, CAN MED ASSOC J, V185, pE545, DOI 10.1503/cmaj.122120; Caplan JB, 2003, J NEUROSCI, V23, P4726; Crowell TA, 2002, CLIN NEUROPSYCHOL, V16, P310, DOI 10.1076/clin.16.3.310.13851; Dalgleish T, 2003, J CLIN CHILD ADOLESC, V32, P10, DOI 10.1207/S15374424JCCP3201_02; Dunkley BT, 2014, NEUROIMAGE-CLIN, V5, P377, DOI 10.1016/j.nicl.2014.07.017; Engdahl B, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066005; Fox MT, 2003, J NEUROSCI, V23, P676, DOI 10.1523/JNEUROSCI.23-02-00676.2003; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Garber BG, 2012, CAN J PSYCHIAT, V57, P736, DOI 10.1177/070674371205701205; Georgopoulos AP, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016011; Gold AL, 2011, PSYCHOL MED, V41, P2563, DOI 10.1017/S0033291711000730; James LM, 2013, JAMA PSYCHIAT, V70, P410, DOI 10.1001/jamapsychiatry.2013.878; Jenkins MA, 2000, CLIN NEUROPSYCHOL, V14, P7, DOI 10.1076/1385-4046(200002)14:1;1-8;FT007; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kimble MO, 2010, J ANXIETY DISORD, V24, P293, DOI 10.1016/j.janxdis.2009.12.006; Kolassa IT, 2010, BIOL PSYCHIAT, V67, P304, DOI 10.1016/j.biopsych.2009.10.009; Kolassa IT, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-56; Konishi S, 2002, P NATL ACAD SCI USA, V99, P7803, DOI 10.1073/pnas.122644899; Konishi S, 1998, NAT NEUROSCI, V1, P80, DOI 10.1038/283; LaGarde G, 2010, PSYCHIAT RES, V177, P144, DOI 10.1016/j.psychres.2009.02.002; Leber AB, 2008, P NATL ACAD SCI USA, V105, P13592, DOI 10.1073/pnas.0805423105; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Lie CH, 2006, NEUROIMAGE, V30, P1038, DOI 10.1016/j.neuroimage.2005.10.031; Lindauer RJL, 2006, BIOL PSYCHIAT, V59, P171, DOI 10.1016/j.biopsych.2005.06.033; Liu TS, 2003, CEREB CORTEX, V13, P1334, DOI 10.1093/cercor/bhg080; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; Marmar CR, 2006, ANN NY ACAD SCI, V1071, P1, DOI 10.1196/annals.1364.001; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Muthukumaraswamy SD, 2013, NEUROPSYCHOPHARMACOL, V1, P1, DOI DOI 10.3389/FNHUM; Neuner F, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-34; Oh A, 2014, BRAIN COGNITION, V86, P90, DOI 10.1016/j.bandc.2014.02.006; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Quraan MA, 2010, NEUROIMAGE, V49, P2387, DOI 10.1016/j.neuroimage.2009.10.012; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Rogers RD, 2000, J COGNITIVE NEUROSCI, V12, P142, DOI 10.1162/089892900561931; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Samuelson KW, 2006, NEUROPSYCHOLOGY, V20, P716, DOI 10.1037/0894-4105.20.6.716; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Sauseng P, 2007, EUR J NEUROSCI, V25, P587, DOI 10.1111/j.1460-9568.2006.05286.x; Sauseng P, 2006, EXP BRAIN RES, V170, P295, DOI 10.1007/s00221-005-0211-y; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Shin LM, 2011, AM J PSYCHIAT, V168, P979, DOI 10.1176/appi.ajp.2011.09121812; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Shomstein S, 2003, SOC NEUR ABSTR, V29, P873; Shucard JL, 2008, BIOL PSYCHOL, V79, P223, DOI 10.1016/j.biopsycho.2008.05.005; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Tewarie P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069318; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wu J, 2010, NEUROSCI LETT; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013; Zalesky A, 2012, NEUROIMAGE, V60, P1055, DOI 10.1016/j.neuroimage.2012.01.068; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041	69	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123541	10.1371/journal.pone.0123541	http://dx.doi.org/10.1371/journal.pone.0123541			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909654	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800039
J	Lai, KMV; Gong, GC; Atanasio, A; Rojas, J; Quispe, J; Posca, J; White, D; Huang, M; Fedorova, D; Grant, C; Miloscio, L; Droguett, G; Poueymirou, WT; Auerbach, W; Yancopoulos, GD; Frendewey, D; Rinn, J; Valenzuela, DM				Lai, Ka-Man Venus; Gong, Guochun; Atanasio, Amanda; Rojas, Jose; Quispe, Joseph; Posca, Julita; White, Derek; Huang, Mei; Fedorova, Daria; Grant, Craig; Miloscio, Lawrence; Droguett, Gustavo; Poueymirou, William T.; Auerbach, Wojtek; Yancopoulos, George D.; Frendewey, David; Rinn, John; Valenzuela, David M.			Diverse Phenotypes and Specific Transcription Patterns in Twenty Mouse Lines with Ablated LincRNAs	PLOS ONE			English	Article							LONG NONCODING RNA; HUMAN-CELLS; ES CELLS; MICE; GENE; EXPRESSION; DISRUPTION; DELETION; GENOME; LANDSCAPE	In a survey of 20 knockout mouse lines designed to examine the biological functions of large intergenic non-coding RNAs (lincRNAs), we have found a variety of phenotypes, ranging from perinatal lethality to defects associated with premature aging and morphological and functional abnormalities in the lungs, skeleton, and muscle. Each mutant allele carried a lacZ reporter whose expression profile highlighted a wide spectrum of spatiotemporal and tissue-specific transcription patterns in embryos and adults that informed our phenotypic analyses and will serve as a guide for future investigations of these genes. Our study shows that lincRNAs are a new class of encoded molecules that, like proteins, serve essential and important functional roles in embryonic development, physiology, and homeostasis of a broad array of tissues and organs in mammals.	[Lai, Ka-Man Venus; Gong, Guochun; Atanasio, Amanda; Rojas, Jose; Quispe, Joseph; Posca, Julita; White, Derek; Huang, Mei; Fedorova, Daria; Grant, Craig; Miloscio, Lawrence; Droguett, Gustavo; Poueymirou, William T.; Auerbach, Wojtek; Yancopoulos, George D.; Frendewey, David; Valenzuela, David M.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Rinn, John] Regeneron Pharmaceut Inc, VelociGene, Tarrytown, NY 10591 USA; [Rinn, John] Broad Inst MIT & Harvard, Cambridge, MA USA	Harvard University; Regeneron; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Frendewey, D (corresponding author), Regeneron Pharmaceut Inc, VelociGene, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	david.valenzuela@regeneron.com; john_rinn@harvard.edu		Rinn, John/0000-0002-7231-7539	Regeneron Pharmaceuticals, Inc.	Regeneron Pharmaceuticals, Inc.(Regeneron)	Regeneron Pharmaceuticals, Inc., provided support in the form of salaries for the authors; Ka-Man Venus Lai, Guochun Gong, Amanda Atanasio, Jose Rojas, Joseph Quispe, Julita Posca, Derek White, Mei Huang, Daria Fedorova, Craig Grant, Lawrence Miloscio, Gustavo Droguett, William T. Poueymirou, Wojtek Auerbach, George D. Yancopoulos, David Frendewey and David M. Valenzuela, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; Bishop NB, 2011, AM J RESP CRIT CARE, V184, P172, DOI 10.1164/rccm.201010-1697CI; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Capecchi MR, 2001, NAT MED, V7, P1086, DOI 10.1038/nm1001-1086; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; DeChiara TM, 2010, METHOD ENZYMOL, V476, P285, DOI 10.1016/S0076-6879(10)76016-X; DeChiara Thomas M., 2009, V530, P311, DOI 10.1007/978-1-59745-471-1_16; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Evans MJ, 2001, NAT MED, V7, P1081, DOI 10.1038/nm1001-1081; Frendewey D, 2010, METHOD ENZYMOL, V476, P295, DOI 10.1016/S0076-6879(10)76017-1; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hostikka SL, 1998, MECH DEVELOP, V70, P133, DOI 10.1016/S0925-4773(97)00182-2; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Li LJ, 2013, CELL REP, V5, P3, DOI 10.1016/j.celrep.2013.09.003; Lu PF, 2008, DEVELOPMENT, V135, P1395, DOI 10.1242/dev.018945; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Marin-Bejar O, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r104; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mohammad F, 2010, DEVELOPMENT, V137, P2493, DOI 10.1242/dev.048181; Nagy A., 2003, MANIPULATING MOUSE E; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; Prosser HM, 2011, NAT BIOTECHNOL, V29, P843, DOI 10.1038/nbt.1929; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Sado T, 2001, DEVELOPMENT, V128, P1275; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Schorderet P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002071; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Smithies O, 2001, NAT MED, V7, P1083, DOI 10.1038/nm1001-1083; Szafranski P, 2013, GENOME RES, V23, P23, DOI 10.1101/gr.141887.112; Takahashi N, 2009, HUM MOL GENET, V18, P1879, DOI 10.1093/hmg/ddp108; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003	42	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125522	10.1371/journal.pone.0125522	http://dx.doi.org/10.1371/journal.pone.0125522			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909911	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800143
J	Pfannmuller, A; Wagner, D; Sieber, C; Schonig, B; Boeckstaens, M; Marini, AM; Tudzynski, B				Pfannmueller, Andreas; Wagner, Dominik; Sieber, Christian; Schoenig, Birgit; Boeckstaens, Melanie; Marini, Anna Maria; Tudzynski, Bettina			The General Amino Acid Permease FfGap1 of Fusarium fujikuroi Is Sorted to the Vacuole in a Nitrogen-Dependent, but Npr1 Kinase-Independent Manner	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GIBBERELLA-FUJIKUROI; UPTAKE SYSTEMS; TRANSCRIPTION FACTORS; PSEUDOHYPHAL GROWTH; YEAST AMMONIUM; GAP1 PERMEASE; HIGH-AFFINITY; PROTEIN; EXPRESSION	The rice pathogenic fungus Fusarium fujikuroiis well known for the production of a broad spectrum of secondary metabolites (SMs) such as gibberellic acids (GAs), mycotoxins and pigments. The biosynthesis of most of these SMs strictly depends on nitrogen availability and of the activity of permeases of nitrogen sources, e.g. the ammonium and amino acid permeases. One of the three ammonium permeases, MepB, was recently shown to act not only as a transporter but also as a nitrogen sensor affecting the production of nitrogen-repressed SMs. Here we describe the identification of a general amino acid permease, FfGap1, among the 99 putative amino acid permeases (AAPs) in the genome of F. fujikuroi. FfGap1 is able to fully restore growth of the yeast gap1 Delta mutant on several amino acids including citrulline and tryptophane. In S. cerevisiae, Gap1 activity is regulated by shuttling between the plasma membrane (nitrogen limiting conditions) and the vacuole (nitrogen sufficiency), which we also show for FfGap1. In yeast, the Npr1 serine/threonine kinase stabilizes the Gap1 position at the plasma membrane. Here, we identified and characterized three NPR1-homologous genes, encoding the putative protein kinases FfNpr1-1, FfNpr1-2 and FfNpr1-3 with significant similarity to yeast Npr1. Complementation of the yeast npr1 Delta mutant with each of the three F. fujikuroi NPR1homologues, resulted in partial restoration of ammonium, arginine and proline uptake by FfNPR1-1 while none of the three kinases affect growth on different nitrogen sources and nitrogen-dependent sorting of FfGap1 in F. fujikuroi. However, exchange of the putative ubiquitin-target lysine 9 (K9A) and 15 (K15A) residues of FfGap1 resulted in extended localization to the plasma membrane and increased protein stability independently of nitrogen availability. These data suggest a similar regulation of FfGap1 by nitrogen-dependent ubiquitination, but differences regarding the role of FusariumNpr1 homologues compared to yeast.	[Pfannmueller, Andreas; Wagner, Dominik; Schoenig, Birgit; Tudzynski, Bettina] Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48149 Munster, Germany; [Boeckstaens, Melanie; Marini, Anna Maria] Univ Libre Bruxelles, Inst Biol & Med Mol, Lab Biol Transport Membranaire, Gosselies, Belgium; [Sieber, Christian] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany	University of Munster; Universite Libre de Bruxelles; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Tudzynski, B (corresponding author), Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48149 Munster, Germany.	tudzynsb@uni-muenster.de		Boeckstaens, Melanie/0000-0003-1629-7403; Sieber, Christian/0000-0002-9560-0281	DFG Deutsche Forschungsgemeinschaft (DFG) [TU101-7, TU101-12]; F.R.S.M. [3.4633.09]; Mandat d'Impulsion Scientifique (M.I.S.) from the Belgian Fund for Scientific Research (F.R.S.-FNRS) [F.4.521.10.F]; ARC convention [AUWB-2012-12/17]; Jean Brachet Foundation; Alice et David Van Buuren Foundation	DFG Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); F.R.S.M.(Fonds de la Recherche Scientifique - FNRS); Mandat d'Impulsion Scientifique (M.I.S.) from the Belgian Fund for Scientific Research (F.R.S.-FNRS); ARC convention(Australian Research Council); Jean Brachet Foundation; Alice et David Van Buuren Foundation	This study was funded by DFG Deutsche Forschungsgemeinschaft (DFG), TU101-7, TU101-12, by F.R.S.M. (3.4633.09) and Mandat d'Impulsion Scientifique (M.I.S.) (F.4.521.10.F) from the Belgian Fund for Scientific Research (F.R.S.-FNRS), an ARC convention (AUWB-2012-12/17), and the Jean Brachet and the Alice et David Van Buuren Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreasson C, 2004, YEAST, V21, P193, DOI 10.1002/yea.1052; Apostolaki A, 2012, MOL MICROBIOL, V84, P530, DOI 10.1111/j.1365-2958.2012.08042.x; Biswas K, 2005, MOL MICROBIOL, V56, P649, DOI 10.1111/j.1365-2958.2005.04576.x; Biswas S, 2003, MICROBIOL-SGM, V149, P2597, DOI 10.1099/mic.0.26215-0; Bluhm BH, 2008, MOL PLANT PATHOL, V9, P203, DOI 10.1111/J.1364-3703.2007.00458.X; Boeckstaens M, 2008, J BIOL CHEM, V283, P21362, DOI 10.1074/jbc.M801467200; Boeckstaens M, 2007, MOL MICROBIOL, V64, P534, DOI 10.1111/j.1365-2958.2007.05681.x; Boeckstaens M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4101; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Coffman JA, 1996, MOL CELL BIOL, V16, P847; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; DARKEN MA, 1959, APPL MICROBIOL, V7, P301, DOI 10.1128/AEM.7.5.301-303.1959; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; DUBOIS E, 1979, MOL GEN GENET, V175, P67, DOI 10.1007/BF00267857; Feller A, 2006, J BIOL CHEM, V281, P28546, DOI 10.1074/jbc.M605551200; Forsberg H, 2001, CURR GENET, V40, P91, DOI 10.1007/s002940100244; Gander S, 2008, RAPID COMMUN MASS SP, V22, P3743, DOI 10.1002/rcm.3790; GEISSMAN TA, 1966, PHYTOCHEMISTRY, V5, P933, DOI 10.1016/S0031-9422(00)82790-9; GRENSON M, 1983, EUR J BIOCHEM, V133, P141, DOI 10.1111/j.1432-1033.1983.tb07439.x; GRENSON M, 1970, J BACTERIOL, V103, P770, DOI 10.1128/JB.103.3.770-777.1970; GRENSON M, 1982, EUR J BIOCHEM, V121, P643, DOI 10.1111/j.1432-1033.1982.tb05834.x; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; JAUNIAUX JC, 1990, EUR J BIOCHEM, V190, P39, DOI 10.1111/j.1432-1033.1990.tb15542.x; JAUNIAUX JC, 1987, EUR J BIOCHEM, V164, P601, DOI 10.1111/j.1432-1033.1987.tb11169.x; Kraidlova L, 2011, EUKARYOT CELL, V10, P1219, DOI 10.1128/EC.05026-11; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; Malonek S, 2004, J BIOL CHEM, V279, P25075, DOI 10.1074/jbc.M308517200; Margelis S, 2001, J BACTERIOL, V183, P5826, DOI 10.1128/JB.183.20.5826-5833.2001; Margolis-Clark E, 2001, FUNGAL GENET BIOL, V33, P127, DOI 10.1006/fgbi.2001.1273; Marini AM, 2000, MOL MICROBIOL, V38, P552, DOI 10.1046/j.1365-2958.2000.02151.x; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Merhi A, 2012, MOL CELL BIOL, V32, P4510, DOI 10.1128/MCB.00463-12; Michielse CB, 2014, MOL MICROBIOL, V91, P472, DOI 10.1111/mmi.12472; Mihlan M, 2003, MOL MICROBIOL, V47, P975, DOI 10.1046/j.1365-2958.2003.03326.x; Nakase M, 2012, MICROBIOL-SGM, V158, P659, DOI 10.1099/mic.0.053389-0; Neuhauser B, 2011, EUKARYOT CELL, V10, P332, DOI 10.1128/EC.00293-10; Niehaus EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103336; Niehaus EM, 2014, APPL MICROBIOL BIOT, V98, P1749, DOI 10.1007/s00253-013-5453-1; Niehaus EM, 2013, CHEM BIOL, V20, P1055, DOI 10.1016/j.chembiol.2013.07.004; Poggeler S, 2003, CURR GENET, V43, P54, DOI 10.1007/s00294-003-0370-y; Regenberg B, 1998, CURR GENET, V33, P171, DOI 10.1007/s002940050324; Regenberg B, 2000, YEAST, V16, P1111, DOI 10.1002/1097-0061(20000915)16:12<1111::AID-YEA611>3.0.CO;2-3; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Risinger AL, 2006, MOL BIOL CELL, V17, P4411, DOI 10.1091/mbc.E06-06-0506; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Rubio-Texeira M, 2006, MOL BIOL CELL, V17, P3031, DOI 10.1091/mbc.E05-07-0669; Rubio-Texeira M, 2012, NAT CHEM BIOL, V8, P400, DOI [10.1038/NCHEMBIO.910, 10.1038/nchembio.910]; Rutherford JC, 2008, MOL BIOL CELL, V19, P3028, DOI 10.1091/mbc.E08-01-0033; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Scherens B, 2006, FEMS YEAST RES, V6, P777, DOI 10.1111/j.1567-1364.2006.00060.x; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Schonig B, 2008, EUKARYOT CELL, V7, P1831, DOI 10.1128/EC.00130-08; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; Sherman F, 1986, LAB COURSE MANUAL ME; Shoji JY, 2006, EUKARYOT CELL, V5, P411, DOI 10.1128/EC.5.2.411-421.2006; Siegmund U, 2015, MOL MICROBIOL, V95, P988, DOI 10.1111/mmi.12869; Soetens O, 2001, J BIOL CHEM, V276, P43939; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Springael JY, 1999, J CELL SCI, V112, P1375; Staben C, 1989, FUNGAL GENET NEWSL, V36, P79, DOI DOI 10.4148/1941-4765.1519; Stanbrough M, 1996, J BACTERIOL, V178, P2465, DOI 10.1128/jb.178.8.2465-2468.1996; STANBROUGH M, 1995, P NATL ACAD SCI USA, V92, P9450, DOI 10.1073/pnas.92.21.9450; Studt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058185; Studt L, 2012, APPL ENVIRON MICROB, V78, P4468, DOI 10.1128/AEM.00823-12; Teichert S, 2008, EUKARYOT CELL, V7, P187, DOI 10.1128/EC.00351-07; Thevelein JM, 2005, BIOCHEM SOC T, V33, P253, DOI 10.1042/BST0330253; Trip H, 2004, APPL ENVIRON MICROB, V70, P4775, DOI 10.1128/AEM.70.8.4775-4783.2004; Tudzynski B, 1996, MICROBIOL-SGM, V142, P533, DOI 10.1099/13500872-142-3-533; Tudzynski B, 1999, MOL GEN GENET, V261, P106, DOI 10.1007/s004380050950; Van Zeebroeck G, 2014, MOL MICROBIOL, V93, P213, DOI 10.1111/mmi.12654; Van Zeebroeck G, 2009, NAT CHEM BIOL, V5, P45, DOI 10.1038/nchembio.132; VANDENBOL M, 1990, MOL GEN GENET, V222, P393, DOI 10.1007/BF00633845; VANDENBOL M, 1987, EUR J BIOCHEM, V164, P607, DOI 10.1111/j.1432-1033.1987.tb11170.x; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wagner D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080740; Wiemann P, 2013, FUSARIUM: GENOMICS, MOLECULAR AND CELLULAR BIOLOGY, P111; Wiemann P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003475; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107	88	9	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125487	10.1371/journal.pone.0125487	http://dx.doi.org/10.1371/journal.pone.0125487			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909858	Green Submitted, gold, Green Published			2022-12-27	WOS:000353376800142
J	Johnson, J; Borres, MP; Nordvall, L; Lidholm, J; Janson, C; Alving, K; Malinovschi, A				Johnson, Jennifer; Borres, Magnus P.; Nordvall, Lennart; Lidholm, Jonas; Janson, Christer; Alving, Kjell; Malinovschi, Andrei			Perceived Food Hypersensitivity Relates to Poor Asthma Control and Quality of Life in Young Non-Atopic Asthmatics	PLOS ONE			English	Article							GENERAL-POPULATION; IGE SENSITIZATION; NATIONAL-HEALTH; RISK-FACTORS; ALLERGY; CHILDREN; PREVALENCE; SYMPTOMS; MORBIDITY; ADULTS	Background The relationship between perceived food hypersensitivity in asthmatics, food allergen sensitization, asthma control and asthma-related quality of life has not been studied. Objective Our aim was to study the prevalence of perceived food hypersensitivity in a cohort of young asthmatics, its relation to food allergen sensitization, and any correlation to asthma control and asthma-related quality of life. Methods Perceived food hypersensitivity, as well as IgE sensitization to common food allergens, levels of exhaled nitric oxide (FeNO), and blood eosinophil counts (B-Eos) were assessed in 408 subjects (211 women) with asthma, aged (mean +/- SEM) 20.4 +/- 0.3 years. Subjects filled out the Asthma Control Test (ACT) and the Mini Asthma Quality of Life Questionnaire (Mini-AQLQ). Inflammation was assessed by means of FeNO and B-Eos. Results Fifty-three per cent of subjects reported food hypersensitivity. A corresponding food allergen sensitization was found in 68% of these subjects. Non-atopic subjects with perceived food hypersensitivity (n = 31) had lower ACT (19 (15 - 22) vs. 21 (20 - 23), p < 0.001) and Mini-AQLQ - scores (5.3 (4.3 - 6.1) vs. 6.1 (5.5 - 6.5), p < 0.001) than subjects with no food hypersensitivity (n = 190), despite lower levels of FeNO and B-Eos (p < 0.05). Conclusions and Clinical Relevance Food hypersensitivity was commonly reported among young asthmatics. In a majority of cases, a corresponding food allergen sensitization was found. A novel and clinically important finding was that non-atopic subjects with perceived food hypersensitivity were characterized by poorer asthma control and asthma-related quality of life.	[Johnson, Jennifer; Borres, Magnus P.; Nordvall, Lennart; Alving, Kjell] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Borres, Magnus P.; Lidholm, Jonas] Thermo Fisher Sci, Uppsala, Sweden; [Janson, Christer] Uppsala Univ, Dept Med Sci Resp Med & Allergol, Uppsala, Sweden; [Malinovschi, Andrei] Uppsala Univ, Dept Med Sci, Clin Physiol, Uppsala, Sweden	Uppsala University; Thermo Fisher Scientific; Uppsala University; Uppsala University	Johnson, J (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	Jennifer.Johnson@kbh.uu.se	Alving, Kjell/M-4579-2014	Alving, Kjell/0000-0003-0784-0443; Lidholm, Jonas/0000-0002-7779-3411	Bror Hjerpstedts Foundation; Uppsala University Hospital; Swedish Heart and Lung Foundation; Swedish Governmental Agency for Innovation Systems (VINNOVA, SAMBIO program) [2007-00084]; Thermo Fisher Scientific	Bror Hjerpstedts Foundation; Uppsala University Hospital; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Governmental Agency for Innovation Systems (VINNOVA, SAMBIO program); Thermo Fisher Scientific	Andrei Malinovschi had research grants/support from Bror Hjerpstedts Foundation, Uppsala University Hospital and Swedish Heart and Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The MIDAS study was financially supported within the framework of an academy/industry collaboration initiated by the Swedish Governmental Agency for Innovation Systems (VINNOVA, SAMBIO program, grant number 2007-00084), where Aerocrine AB and Thermo Fisher Scientific, Immunodiagnostics were partners and co-financed the program. Thermo Fisher Scientific provided support in the form of salaries for authors MPB and JL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altman DR, 1996, J ALLERGY CLIN IMMUN, V97, P1247, DOI 10.1016/S0091-6749(96)70192-6; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P912; Axelsson M, 2009, RESP MED, V103, P1033, DOI 10.1016/j.rmed.2009.01.013; Berns SH, 2007, J ASTHMA, V44, P377, DOI 10.1080/02770900701364031; Bjornsson E, 1996, ANN ALLERG ASTHMA IM, V77, P327; Emilsson OI, 2013, EUR RESPIR J, V41, P1347, DOI 10.1183/09031936.00052512; Friedlander JL, 2013, J ALLER CL IMM-PRACT, V1, P479, DOI 10.1016/j.jaip.2013.06.007; Gergen PJ, 2009, J ALLERGY CLIN IMMUN, V124, P447, DOI 10.1016/j.jaci.2009.06.011; Hagmolen of ten Have W, 2005, J ASTHMA, V42, P419; Heijkenskjold-Rentzhog C, 2014, ALLERGY, V69, P1102, DOI 10.1111/all.12430; HIRSCHWEHR R, 1992, J ALLERGY CLIN IMMUN, V90, P927, DOI 10.1016/0091-6749(92)90465-E; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; Jyonouchi Harumi, 2008, Inflammation & Allergy Drug Targets, V7, P173, DOI 10.2174/187152808785748119; Keet CA, 2014, ANN ALLERG ASTHMA IM, V112, P222, DOI 10.1016/j.anai.2013.12.007; Kulkarni N, 2012, PEDIAT ALLERG IMM-UK, V23, P28, DOI 10.1111/j.1399-3038.2011.01226.x; Liu AH, 2010, J ALLERGY CLIN IMMUN, V126, P798, DOI 10.1016/j.jaci.2010.07.026; McGowan EC, 2013, J ALLERGY CLIN IMMUN, V132, P1216, DOI 10.1016/j.jaci.2013.07.018; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Nguyen BP, 1996, ANN ALLERG ASTHMA IM, V77, P209, DOI 10.1016/S1081-1206(10)63257-7; Ostblom E, 2008, ALLERGY, V63, P211, DOI 10.1111/j.1398-9995.2007.01559.x; Ostblom E, 2008, ACTA PAEDIATR, V97, P85, DOI 10.1111/j.1651-2227.2007.00556.x; Osterballe M, 2005, PEDIAT ALLERG IMM-UK, V16, P567, DOI 10.1111/j.1399-3038.2005.00251.x; Patelis A, 2014, ALLERGY, V69, P380, DOI 10.1111/all.12345; Patelis A, 2012, J ALLERGY CLIN IMMUN, V130, P397, DOI 10.1016/j.jaci.2012.03.046; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pereira B, 2005, J ALLERGY CLIN IMMUN, V116, P884, DOI 10.1016/j.jaci.2005.05.047; Put C, 1999, EUR RESPIR J, V13, P751, DOI 10.1034/j.1399-3003.1999.13d09.x; Roberts G, 2003, J ALLERGY CLIN IMMUN, V112, P168, DOI 10.1067/mai.2003.1569; Roberts Graham, 2003, Paediatr Respir Rev, V4, P205, DOI 10.1016/S1526-0542(03)00058-7; Roehr CC, 2004, CLIN EXP ALLERGY, V34, P1534, DOI 10.1111/j.1365-2222.2004.02080.x; RUBINFELD AR, 1976, LANCET, V1, P882; Schafer T, 2001, ALLERGY, V56, P1172, DOI 10.1034/j.1398-9995.2001.00196.x; Sicherer SH, 2001, ANN ALLERG ASTHMA IM, V87, P461, DOI 10.1016/S1081-1206(10)62258-2; Simpson AB, 2007, PEDIATR PULM, V42, P489, DOI 10.1002/ppul.20605; Simpson AB, 2010, J PEDIATR-US, V156, P777, DOI 10.1016/j.jpeds.2009.11.080; Sundbom F, 2013, ALLERGY, V68, P213, DOI 10.1111/all.12079; Tariq SM, 2000, PEDIATR ALLERGY IMMU, V11, P162, DOI 10.1034/j.1399-3038.2000.00077.x; Van De Ven MO, 2011, J PSYCHOSOM RES, V71, P166, DOI [10.1016/j.jpsychores.2011.03.002, DOI 10.1016/J.JPSYCHORES.2011.03.002]; Vuorisalo T, 2012, PERSPECT BIOL MED, V55, P163, DOI 10.1353/pbm.2012.0016; Wang JL, 2005, J ALLERGY CLIN IMMUN, V115, P1076, DOI 10.1016/j.jaci.2005.02.014; Wood RA, 2003, PEDIATRICS, V111, P1631; Woods RK, 2001, EUR J CLIN NUTR, V55, P298, DOI 10.1038/sj.ejcn.1601159	42	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124675	10.1371/journal.pone.0124675	http://dx.doi.org/10.1371/journal.pone.0124675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923451	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600098
J	Maldonado-Aguayo, W; Chavez-Mardones, J; Goncalves, AT; Gallardo-Escarate, C				Maldonado-Aguayo, Waleska; Chavez-Mardones, Jacqueline; Teresa Goncalves, Ana; Gallardo-Escarate, Cristian			Cathepsin Gene Family Reveals Transcriptome Patterns Related to the Infective Stages of the Salmon Louse Caligus rogercresseyi	PLOS ONE			English	Article							CYSTEINE PROTEASE; ASPARTIC PROTEASE; LEPEOPHTHEIRUS-SALMONIS; FASCIOLA-HEPATICA; MOLECULAR-CLONING; FUNCTIONAL-ANALYSIS; HUMAN HEMOGLOBIN; HARD TICK; PROTEINASES; DEGRADATION	Cathepsins are proteases involved in the ability of parasites to overcome and/or modulate host defenses so as to complete their own lifecycle. However, the mechanisms underlying this ability of cathepsins are still poorly understood. One excellent model for identifying and exploring the molecular functions of cathepsins is the marine ectoparasitic copepod Caligus rogercresseyi that currently affects the Chilean salmon industry. Using high-throughput transcriptome sequencing, 56 cathepsin-like sequences were found distributed in five cysteine protease groups (B, F, L, Z, and S) as well as in an aspartic protease group (D). Ontogenic transcriptome analysis evidenced that L cathepsins were the most abundant during the lifecycle, while cathepsins B and K were mostly expressed in the larval stages and adult females, thus suggesting participation in the molting processes and embryonic development, respectively. Interestingly, a variety of cathepsins from groups Z, L, D, B, K, and S were upregulated in the infective stage of copepodid, corroborating the complexity of the processes involved in the parasitic success of this copepod. Putative functional roles of cathepsins were conjectured based on the differential expressions found and on roles previously described in other phylogenetically related species. Moreover, 140 single nucleotide polymorphisms (SNP) were identified in transcripts annotated for cysteine and aspartic proteases located into untranslated regions, or the coding region. This study reports for the first time the presence of cathepsin-like genes and differential expressions throughout a copepod lifecycle. The identification of cathepsins together with functional validations represents a valuable strategy for pinpointing target molecules that could be used in the development of new delousing drugs or vaccines against C. rogercresseyi.	[Maldonado-Aguayo, Waleska; Chavez-Mardones, Jacqueline; Teresa Goncalves, Ana; Gallardo-Escarate, Cristian] Univ Concepcion, Interdisciplinary Ctr Sustainable Aquaculture Res, Lab Biotechnol & Aquat Genom, Concepcion, Chile	Universidad de Concepcion	Gallardo-Escarate, C (corresponding author), Univ Concepcion, Interdisciplinary Ctr Sustainable Aquaculture Res, Lab Biotechnol & Aquat Genom, Concepcion, Chile.	crisgallardo@udec.cl	Gonçalves, Ana Teresa/ABB-3248-2021; Gallardo-Escárate, Cristian/AAE-8980-2022	Gonçalves, Ana Teresa/0000-0002-5443-7182; Gallardo-Escárate, Cristian/0000-0002-7094-6702	FONDAP project [1510027]; CORFO	FONDAP project(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); CORFO	This study was funded by FONDAP project 1510027 (CONICYT-Chile) and CORFO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000298; BILLINGSLEY PF, 1988, INT J INSECT MORPHOL, V17, P295, DOI 10.1016/0020-7322(88)90010-4; Boldbaatar D, 2006, INSECT BIOCHEM MOLEC, V36, P25, DOI 10.1016/j.ibmb.2005.10.003; Bravo S, 2012, AQUACULTURE, V364, P61, DOI 10.1016/j.aquaculture.2012.07.036; Brindley PJ, 2001, MOL BIOCHEM PARASIT, V112, P103, DOI 10.1016/S0166-6851(00)00351-0; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Carmona E, 1996, BIOCHEMISTRY-US, V35, P8149, DOI 10.1021/bi952736s; Cho WL, 1999, J BIOL CHEM, V274, P13311, DOI 10.1074/jbc.274.19.13311; Colbert JD, 2009, EUR J IMMUNOL, V39, P2955, DOI 10.1002/eji.200939650; Connors BM, 2011, BEHAV ECOL, V22, P588, DOI 10.1093/beheco/arr024; Conus S, 2010, SWISS MEDICAL WEEKLY, P1; Cordova M, 2001, MOL BIOCHEM PARASIT, V116, P109, DOI 10.1016/S0166-6851(01)00309-7; Costello MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3385, DOI 10.1098/rspb.2009.0771; Cunningham E, 2010, AQUACULTURE, V310, P38, DOI 10.1016/j.aquaculture.2010.10.013; Dalton JP, 1996, INFECT IMMUN, V64, P5066, DOI 10.1128/IAI.64.12.5066-5074.1996; Dalton JP, 2003, INT J PARASITOL, V33, P1173, DOI 10.1016/S0020-7519(03)00171-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fast MD, 2007, PARASITE IMMUNOL, V29, P179, DOI 10.1111/j.1365-3024.2007.00932.x; Firth KJ, 2000, J PARASITOL, V86, P1199, DOI 10.1645/0022-3395(2000)086[1199:COPITS]2.0.CO;2; Ford L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000377; Gallardo-Escarate C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092239; Ghoneim H, 1995, INT J PARASITOL, V25, P1515, DOI 10.1016/0020-7519(95)00079-8; GOLDBERG DE, 1991, J EXP MED, V173, P961, DOI 10.1084/jem.173.4.961; Gonzalez L, 2003, AQUACULTURE, V220, P101, DOI 10.1016/S0044-8486(02)00512-4; Gui ZZ, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-49; Hamilton KA, 2003, INT J PARASITOL, V33, P773, DOI 10.1016/S0020-7519(03)00089-4; Harrop SA, 1996, BIOCHEM BIOPH RES CO, V227, P294, DOI 10.1006/bbrc.1996.1503; Hashmi S, 2002, J BIOL CHEM, V277, P3477, DOI 10.1074/jbc.M106117200; Hashmi S, 2004, J BIOL CHEM, V279, P6035, DOI 10.1074/jbc.M312346200; Helgesen KO, 2014, JOURNAL OF FISH DISE; Jousson O, 2007, FEMS MICROBIOL LETT, V269, P77, DOI 10.1111/j.1574-6968.2006.00611.x; KABATA Z, 1974, J FISH RES BOARD CAN, V31, P1583, DOI 10.1139/f74-199; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kang JM, 2010, MOL BIOCHEM PARASIT, V170, P7, DOI 10.1016/j.molbiopara.2009.11.006; Kelley GO, 2003, EXP PARASITOL, V105, P201, DOI 10.1016/j.exppara.2003.12.004; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Li XP, 2013, FISH SHELLFISH IMMUN, V35, P1604, DOI 10.1016/j.fsi.2013.09.004; Liao PY, 2010, BIOCHEM ENG J, V49, P149, DOI 10.1016/j.bej.2009.12.021; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logullo C, 1998, PARASITOLOGY, V116, P525, DOI 10.1017/S0031182098002698; Lutgens E, 2006, CIRCULATION, V113, P98, DOI 10.1161/CIRCULATIONAHA.105.561449; Malagon D, 2010, PARASITOL INT, V59, P89, DOI 10.1016/j.parint.2009.11.001; Maldonado-Aguayo W, 2014, MAR GENOM, V15, P55, DOI 10.1016/j.margen.2014.04.006; McCarthy E, 2012, AQUACULTURE, V356, P264, DOI 10.1016/j.aquaculture.2012.05.007; MEDINA M, 1988, ARCH BIOCHEM BIOPHYS, V263, P355, DOI 10.1016/0003-9861(88)90646-7; Mendiola J, 2001, Rev Cubana Med Trop, V53, P145; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; O'Brien TC, 2008, J BIOL CHEM, V283, P28934, DOI 10.1074/jbc.M805824200; Oelckers K, 2014, AQUACULTURE, V420, P126, DOI 10.1016/j.aquaculture.2013.10.016; Que XC, 2000, CLIN MICROBIOL REV, V13, P196, DOI 10.1128/CMR.13.2.196-206.2000; Redmond DL, 2006, INT J PARASITOL, V36, P277, DOI 10.1016/j.ijpara.2005.10.011; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Rojo L, 2010, MAR BIOTECHNOL, V12, P696, DOI 10.1007/s10126-010-9257-3; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; SAKANARI JA, 1990, J PARASITOL, V76, P625, DOI 10.2307/3282971; Sojka D, 2011, ADV EXP MED BIOL, V712, P177, DOI 10.1007/978-1-4419-8414-2_11; TANG J, 1987, J CELL BIOCHEM, V33, P53, DOI 10.1002/jcb.240330106; Tort J, 1999, ADV PARASIT, V43, P161, DOI 10.1016/S0065-308X(08)60243-2; Tveiten H, 2010, J FISH BIOL, V76, P2318, DOI 10.1111/j.1095-8649.2010.02636.x; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Wang J, 2013, J INSECT PHYSIOL, V59, P953, DOI 10.1016/j.jinsphys.2013.07.003; Wang XM, 2008, AQUACULTURE, V282, P41, DOI 10.1016/j.aquaculture.2008.06.014; Williamson AL, 2003, J INFECT DIS, V187, P484, DOI 10.1086/367708; Williamson AL, 2003, TRENDS PARASITOL, V19, P417, DOI 10.1016/S1471-4922(03)00189-2; Yamashima T, 2013, PROG NEUROBIOL, V105, P1, DOI 10.1016/j.pneurobio.2013.02.004	66	11	11	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123954	10.1371/journal.pone.0123954	http://dx.doi.org/10.1371/journal.pone.0123954			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923525	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600063
J	Bhat, SV; Booth, SC; McGrath, SGK; Dahms, TES				Bhat, Supriya V.; Booth, Sean C.; McGrath, Seamus G. K.; Dahms, Tanya E. S.			Rhizobium leguminosarum bv. viciae 3841 Adapts to 2,4-Dichlorophenoxyacetic Acid with "Auxin-Like" Morphological Changes, Cell Envelope Remodeling and Upregulation of Central Metabolic Pathways	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; ROOT-NODULE DEVELOPMENT; ESCHERICHIA-COLI; OXIDATIVE STRESS; AZOSPIRILLUM-BRASILENSE; NITROGEN-FIXATION; PROTEOME ANALYSIS; PHOSPHOTRANSFERASE SYSTEM; CHLOROPHENOXY HERBICIDES; LYSINE ACETYLATION	There is a growing need to characterize the effects of environmental stressors at the molecular level on model organisms with the ever increasing number and variety of anthropogenic chemical pollutants. The herbicide 2,4-dichlorophenoxyacetic acid (2,4-D), as one of the most widely applied pesticides in the world, is one such example. This herbicide is known to have non-targeted undesirable effects on humans, animals and soil microbes, but specific molecular targets at sublethal levels are unknown. In this study, we have used Rhizobium leguminosarum bv. viciae 3841 (Rlv) as a nitrogen fixing, beneficial model soil organism to characterize the effects of 2,4-D. Using metabolomics and advanced microscopy we determined specific target pathways in the Rlv metabolic network and consequent changes to its phenotype, surface ultrastructure, and physical properties during sublethal 2,4-D exposure. Auxin and 2,4-D, its structural analogue, showed common morphological changes in vitro-which were similar to bacteroids isolated from plant nodules, implying that these changes are related to bacteroid differentiation required for nitrogen fixation. Rlv showed remarkable adaptation capabilities in response to the herbicide, with changes to integral pathways of cellular metabolism and the potential to assimilate 2,4-D with consequent changes to its physical and structural properties. This study identifies biomarkers of 2,4-D in Rlv and offers valuable insights into the mode-of-action of 2,4-D in soil bacteria.	[Bhat, Supriya V.; McGrath, Seamus G. K.; Dahms, Tanya E. S.] Univ Regina, Dept Chem & Biochem, Regina, SK S4S 0A2, Canada; [Booth, Sean C.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Regina; University of Calgary	Dahms, TES (corresponding author), Univ Regina, Dept Chem & Biochem, 3737 Wascana Pkwy, Regina, SK S4S 0A2, Canada.	tanya.dahms@uregina.ca	Booth, Sean Cameron/H-6480-2019	Booth, Sean Cameron/0000-0003-2552-5324	National Science and Engineering Research Council of Canada [228206-2012]; Canada Foundation for Innovation Leaders Opportunity Fund [29962]	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation)	Funding: This work was supported by the National Science and Engineering Research Council of Canada Discovery Grant (228206-2012) to TESD, and the Canada Foundation for Innovation Leaders Opportunity Fund (29962) to TESD.	AKAO S, 1991, PLANT SOIL, V138, P207, DOI 10.1007/BF00012247; Pereira SIA, 2006, APPL SOIL ECOL, V33, P286, DOI 10.1016/j.apsoil.2005.10.002; ARIAS RN, 1993, TOXICOL LETT, V68, P267, DOI 10.1016/0378-4274(93)90017-R; Balague C, 2001, ENVIRON TOXICOL, V16, P43, DOI 10.1002/1522-7278(2001)16:1<43::AID-TOX50>3.0.CO;2-R; Balague CE, 2002, TOXICOLOGY, V177, P143, DOI 10.1016/S0300-483X(02)00161-0; BALAJEE S, 1990, XENOBIOTICA, V20, P607, DOI 10.3109/00498259009046876; Benndorf D, 2002, MICROBIOL-SGM, V148, P2883, DOI 10.1099/00221287-148-9-2883; Benndorf D, 2001, FEMS MICROBIOL LETT, V200, P247, DOI 10.1111/j.1574-6968.2001.tb10723.x; Benndorf D, 2006, PROTEOMICS, V6, P3319, DOI 10.1002/pmic.200500781; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Bernal V, 2014, NEW BIOTECHNOL, V31, P586, DOI 10.1016/j.nbt.2014.03.002; Bhat S., 2012, VISCOELASTICITY THEO, P123; Bhat VS, 2015, CHEMOSPHERE IN PRESS; Boivin A, 2005, ENVIRON POLLUT, V138, P92, DOI 10.1016/j.envpol.2005.02.016; Booth SC, 2011, J PROTEOME RES, V10, P3190, DOI 10.1021/pr2002353; Bukowska B, 2006, POL J ENVIRON STUD, V15, P365; Buss DS, 2008, PESTIC BIOCHEM PHYS, V90, P141, DOI 10.1016/j.pestbp.2007.12.001; Camerini S, 2008, ARCH MICROBIOL, V190, P67, DOI 10.1007/s00203-008-0365-7; Castro S, 1996, TOXICOL LETT, V84, P33, DOI 10.1016/0378-4274(95)03462-5; Chagoyen M, 2011, BIOINFORMATICS, V27, P730, DOI 10.1093/bioinformatics/btr001; Chavez FP, 2004, APPL ENVIRON MICROB, V70, P3064, DOI 10.1128/AEM.70.5.3064-3072.2004; Cherepenko Y, 2005, CELL BIOL INT, V29, P3, DOI 10.1016/j.cellbi.2004.11.006; Chinalia A.F., 2007, TERR AQUAT ENV TOXIC, V1, P24; Cho YS, 2000, CURR MICROBIOL, V41, P33, DOI 10.1007/s002840010087; Corticeiro SC, 2006, ENZYME MICROB TECH, V40, P132, DOI 10.1016/j.enzmictec.2005.10.053; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; DEPERETTI AF, 1992, ARCH ENVIRON CON TOX, V23, P301, DOI 10.1007/BF00216237; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dong J, 2011, MICROBIOL-SGM, V157, P3049, DOI 10.1099/mic.0.051045-0; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; EBERBACH PL, 1989, PLANT SOIL, V119, P15, DOI 10.1007/BF02370265; Elanchezhian R, 1997, J AGRON CROP SCI, V178, P129, DOI 10.1111/j.1439-037X.1997.tb00480.x; FABRA A, 1993, TOXICOLOGY, V83, P19, DOI 10.1016/0300-483X(93)90088-A; Fabra A, 1997, B ENVIRON CONTAM TOX, V59, P645, DOI 10.1007/s001289900528; Fanous A, 2007, CHEMOSPHERE, V69, P25, DOI 10.1016/j.chemosphere.2007.04.075; Fox JE, 2007, P NATL ACAD SCI USA, V104, P10282, DOI 10.1073/pnas.0611710104; Gabor E, 2011, EUR J CELL BIOL, V90, P711, DOI 10.1016/j.ejcb.2011.04.002; GAGE DJ, 1993, J BACTERIOL, V175, P7105, DOI 10.1128/jb.175.21.7105-7108.1993; Grossmann K, 2010, PEST MANAG SCI, V66, P113, DOI 10.1002/ps.1860; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Gupta VK, 2012, BIOPHYS J, V103, P137, DOI 10.1016/j.bpj.2012.05.044; Hausinger RP, 1995, ENVIRON HEALTH PERSP, V103, P37, DOI 10.2307/3432476; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Houot L, 2008, J BACTERIOL, V190, P311, DOI 10.1128/JB.01410-07; Hrydziuszko O, 2012, METABOLOMICS, V8, pS161, DOI 10.1007/s11306-011-0366-4; Janczarek M, 2011, INT J MOL SCI, V12, P7898, DOI 10.3390/ijms12117898; Jenal U, 2003, CURR OPIN MICROBIOL, V6, P163, DOI 10.1016/S1369-5274(03)00029-8; Jofre E, 1996, TOXICOLOGY, V107, P9, DOI 10.1016/0300-483X(95)03196-M; Johnson L, 2012, J BACTERIOL, V194, P813, DOI 10.1128/JB.05230-11; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; KATUPITIYA S, 1995, SOIL BIOL BIOCHEM, V27, P447, DOI 10.1016/0038-0717(95)98617-W; Kelley KB, 2006, WEED SCI, V54, P220; Keum YS, 2008, APPL MICROBIOL BIOT, V80, P863, DOI 10.1007/s00253-008-1581-4; Kitagawa W, NOVEL 2 4 DICHLOROPH, P0131; Kurland NE, 2012, MICRON, V43, P116, DOI 10.1016/j.micron.2011.07.017; Lambert LA, 1997, J BACTERIOL, V179, P7595, DOI 10.1128/jb.179.23.7595-7599.1997; Lemuth K, 2008, APPL ENVIRON MICROB, V74, P7002, DOI 10.1128/AEM.01327-08; Lin DC, 2007, J BIOMECH ENG-T ASME, V129, P904, DOI 10.1115/1.2800826; Loffhagen N, 2003, ARCH ENVIRON CON TOX, V45, P317, DOI 10.1007/s00244-003-2142-6; LUPI CG, 1995, APPL ENVIRON MICROB, V61, P2863, DOI 10.1128/AEM.61.8.2863-2872.1995; Martinez P, 2007, ARCH MICROBIOL, V188, P289, DOI 10.1007/s00203-007-0247-4; Mazzoli R, 2011, MOL BIOSYST, V7, P598, DOI 10.1039/c0mb00112k; Moore MN, 2004, MUTAT RES-FUND MOL M, V552, P247, DOI 10.1016/j.mrfmmm.2004.06.028; Muller DJ, 2011, TRENDS CELL BIOL, V21, P461, DOI 10.1016/j.tcb.2011.04.008; MYLONA P, 1995, PLANT CELL, V7, P869, DOI 10.1105/tpc.7.7.869; Nan XL, 2013, P NATL ACAD SCI USA, V110, P18519, DOI 10.1073/pnas.1318188110; Pacios-Bras C, 2003, PLANT MOL BIOL, V52, P1169, DOI 10.1023/B:PLAN.0000004308.78057.f5; Palanisami S, 2009, PESTIC BIOCHEM PHYS, V94, P68, DOI 10.1016/j.pestbp.2009.03.003; Paul BC, 2011, EUKARYOT CELL, V10, P646, DOI 10.1128/EC.00304-10; Pazmino DM, 2012, PLANT SIGNAL BEHAV, V7, P425, DOI 10.4161/psb.19124; Perez JM, 2008, J BIOL CHEM, V283, P7346, DOI 10.1074/jbc.M708846200; Pii Y, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-21; Ramirez-Trujillo JA, 2007, J BACTERIOL, V189, P5875, DOI 10.1128/JB.00385-07; Remans R, 2008, PLANT SOIL, V312, P25, DOI 10.1007/s11104-008-9606-4; Rinaudi LV, 2010, FEMS MICROBIOL LETT, V304, P1, DOI 10.1111/j.1574-6968.2009.01840.x; RIVAROLA V, 1992, TOXICOLOGY, V73, P71, DOI 10.1016/0300-483X(92)90171-A; Roberts Mary F., 2006, V39, P103; Santos PM, 2004, PROTEOMICS, V4, P2640, DOI 10.1002/pmic.200300793; Schneider BL, 2013, MOL MICROBIOL, V88, P537, DOI 10.1111/mmi.12207; Semchyshyn H, 2005, CELL BIOL INT, V29, P898, DOI 10.1016/j.cellbi.2005.08.002; Seo JS, 2013, BIODEGRADATION, V24, P795, DOI 10.1007/s10532-013-9629-2; Simoes T, 2003, APPL ENVIRON MICROB, V69, P4019, DOI 10.1128/AEM.69.7.4019-4028.2003; Skorupska A, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-7; Suwa Y, 1996, APPL ENVIRON MICROB, V62, P2464, DOI 10.1128/AEM.62.7.2464-2469.1996; Teixeira MC, 2005, PROTEOMICS, V5, P1889, DOI 10.1002/pmic.200401085; Teixeira MC, 2004, BIOCHEM BIOPH RES CO, V324, P1101, DOI 10.1016/j.bbrc.2004.09.158; Tkachenko AG, 2012, RES MICROBIOL, V163, P83, DOI 10.1016/j.resmic.2011.10.009; Viegas CA, 2005, BIOCHEM BIOPH RES CO, V330, P271, DOI 10.1016/j.bbrc.2005.02.158; Wang JX, 2013, J PROTEOME RES, V12, P5302, DOI 10.1021/pr400640u; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Wishart DS, 2009, BIOANALYSIS, V1, P1579, DOI 10.4155/BIO.09.138; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34; Yu BJ, 2008, J MICROBIOL BIOTECHN, V18, P1529; Zabaloy MC, 2010, APPL SOIL ECOL, V46, P240, DOI 10.1016/j.apsoil.2010.08.006; Zhang WW, 2010, MICROBIOL-SGM, V156, P287, DOI 10.1099/mic.0.034793-0	98	8	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123813	10.1371/journal.pone.0123813	http://dx.doi.org/10.1371/journal.pone.0123813			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919284	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659400035
J	Larson, MA; Nalbantoglu, U; Sayood, K; Zentz, EB; Bartling, AM; Francesconi, SC; Fey, PD; Dempsey, MP; Hinrichs, SH				Larson, Marilynn A.; Nalbantoglu, Ufuk; Sayood, Khalid; Zentz, Emily B.; Bartling, Amanda M.; Francesconi, Stephen C.; Fey, Paul D.; Dempsey, Michael P.; Hinrichs, Steven H.			Francisella tularensis Subtype A.II Genomic Plasticity in Comparison with Subtype A.I	PLOS ONE			English	Article							VI SECRETION SYSTEM; BACTERIAL GENOMES; PATHOGENICITY ISLAND; MOLECULAR EPIDEMIOLOGY; SUBSPECIES TULARENSIS; INVERTED REPEATS; SCHU S4; SEQUENCE; GENES; IDENTIFICATION	Although Francisella tularensis is considered a monomorphic intracellular pathogen, molecular genotyping and virulence studies have demonstrated important differences within the tularensis subspecies (type A). To evaluate genetic variation within type A strains, sequencing and assembly of a new subtype A.II genome was achieved for comparison to other completed F. tularensis type A genomes. In contrast with the F. tularensis A.I strains (SCHU S4, FSC198, NE061598, and TI0902), substantial genomic variation was observed between the newly sequenced F. tularensis A.II strain (WY-00W4114) and the only other publically available A.II strain (WY96-3418). Genome differences between WY-00W4114 and WY96-3418 included three major chromosomal translocations, 1580 indels, and 286 nucleotide substitutions of which 159 were observed in predicted open reading frames and 127 were located in intergenic regions. The majority of WY-00W4114 nucleotide deletions occurred in intergenic regions, whereas most of the insertions and substitutions occurred in predicted genes. Of the nucleotide substitutions, 48 (30%) were synonymous and 111 (70%) were nonsynonymous. WY-00W4114 and WY96-3418 nucleotide polymorphisms were predominantly G/C to A/T allelic mutations, with WY-00W4114 having more A+T enrichment. In addition, the A.II genomes contained a considerably higher number of intact genes and longer repetitive sequences, including transposon remnants than the A.I genomes. Together these findings support the premise that F. tularensis A.II may have a fitness advantage compared to the A.I subtype due to the higher abundance of functional genes and repeated chromosomal sequences. A better understanding of the selective forces driving F. tularensis genetic diversity and plasticity is needed.	[Larson, Marilynn A.; Bartling, Amanda M.; Fey, Paul D.; Hinrichs, Steven H.] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68182 USA; [Nalbantoglu, Ufuk; Sayood, Khalid] Univ Nebraska, Dept Elect Engn, Lincoln, NE 68588 USA; [Zentz, Emily B.] OpGen Inc, Gaithersburg, MD USA; [Francesconi, Stephen C.] Naval Med Res Ctr, Ft Detrick, MD USA; [Dempsey, Michael P.] US Air Force, Sch Aerosp Med, Wright Patterson AFB, OH 45433 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln; Naval Medical Research Center (NMRC); United States Department of Defense; United States Air Force	Larson, MA (corresponding author), Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68182 USA.	malarson@unmc.edu	Nalbantoglu, Ufuk/AAA-8033-2022; Nalbantoglu, Ozkan Ufuk/AAK-5238-2021; Dempsey, Michael/GSM-7774-2022	Nalbantoglu, Ozkan Ufuk/0000-0002-2278-7786; Larson, Marilynn/0000-0002-0633-0313	U.S. Army Space and Missile Defense Command [W9113M-07-1-0004]; OpGen, Inc.	U.S. Army Space and Missile Defense Command; OpGen, Inc.	This work was supported in part by the U.S. Army Space and Missile Defense Command, 64 Thomas Johnson Drive, Frederick, MD 21702 (W9113M-07-1-0004) to the University of Nebraska Medical Center (SHH). There were no additional funding sources for this project. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. OpGen, Inc. provided support in the form of salaries for author EBZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Balbi KJ, 2009, MOL BIOL EVOL, V26, P345, DOI 10.1093/molbev/msn252; Beckstrom-Sternberg SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000947; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bhattacharjee Y, 2011, SCIENCE, V332, P1491, DOI 10.1126/science.332.6037.1491; Birdsell DN, 2014, EMERG INFECT DIS, V20, P861, DOI 10.3201/eid2005.131559; Broms JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034639; Broms JE, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00136; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Centers for Disease Control and Prevention DoHaHS, 2012, FED REGISTER, V77, P61083; CHANDLER M, 1993, MOL MICROBIOL, V7, P497, DOI 10.1111/j.1365-2958.1993.tb01140.x; Chaudhuri RR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000352; Dai S, 2010, FRONT MICROBIOL, V1, P1, DOI [10.3389/fmicb.2010.00001, DOI 10.3389/FMICB.2010.00001]; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dempsey MP, 2006, J BACTERIOL, V188, P5904, DOI 10.1128/JB.00437-06; Esnault E, 2007, PLOS GENET, V3, P2486, DOI 10.1371/journal.pgen.0030226; Fraser-Liggett CM, 2005, GENOME RES, V15, P1603, DOI 10.1101/gr.3724205; HESSELBROCK W, 1945, J BACTERIOL, V49, P209, DOI 10.1128/JB.49.3.209-231.1945; Ho BT, 2014, CELL HOST MICROBE, V15, P9, DOI 10.1016/j.chom.2013.11.008; HOLLIDAY R, 1993, MUTAT RES, V285, P61, DOI 10.1016/0027-5107(93)90052-H; Huber B, 2010, INT J SYST EVOL MICR, V60, P1887, DOI 10.1099/ijs.0.015941-0; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Johansson A, 2010, INT J SYST EVOL MICR, V60, P1717, DOI 10.1099/ijs.0.022830-0; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; Larson MA, 2011, J CLIN MICROBIOL, V49, P2786, DOI 10.1128/JCM.00033-11; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Larsson P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000472; Lin CT, 2001, NUCLEIC ACIDS RES, V29, P3529, DOI 10.1093/nar/29.17.3529; Marin A, 2008, J THEOR BIOL, V253, P508, DOI 10.1016/j.jtbi.2008.04.004; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Modise T, 2012, J BACTERIOL, V194, P2775, DOI 10.1128/JB.00152-12; Mohapatra NP, 2007, INFECT IMMUN, V75, P3305, DOI 10.1128/IAI.00351-07; Molins CR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-67; Molins CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010205; Nalbantoglu U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009007; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Ochman H, 2003, MOL BIOL EVOL, V20, P2091, DOI 10.1093/molbev/msg229; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Rocha EPC, 2003, GENOME RES, V13, P1123, DOI 10.1101/gr.966203; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Shao HG, 2001, GENETICS, V159, P1103; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Song JZ, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-17; US Department of Health and Human Services (Public Health Service) Centers for Disease Control and Prevention and National Institutes of Health, 2007, BIOSAFETY MICROBIOLO, V5th; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Zhao GY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000262	52	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124906	10.1371/journal.pone.0124906	http://dx.doi.org/10.1371/journal.pone.0124906			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25918839	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659400064
J	Han, SW; Alonso, JM; Rojas-Pierce, M				Han, Sang Won; Alonso, Jose M.; Rojas-Pierce, Marcela			REGULATOR OF BULB BIOGENESIS1 (RBB1) Is Involved in Vacuole Bulb Formation in Arabidopsis	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ROOT HAIR-CELLS; TRANSVACUOLAR STRAND; PLANT VILLIN; MEMBRANE; DYNAMICS; TONOPLAST; SNARE; BROWSER; COMPLEX	Vacuoles are dynamic compartments with constant fluctuations and transient structures such as trans-vacuolar strands and bulbs. Bulbs are highly dynamic spherical structures inside vacuoles that are formed by multiple layers of membranes and are continuous with the main tonoplast. We recently carried out a screen for mutants with abnormal trafficking to the vacuole or aberrant vacuole morphology. We characterized regulator of bulb biogenesis1-1 (rbb1-1), a mutant in Arabidopsis that contains increased numbers of bulbs when compared to the parental control. rbb1-1 mutants also contain fewer transvacuolar strands than the parental control, and we propose the hypothesis that the formation of transvacuolar strands and bulbs is functionally related. We propose that the bulbs may function transiently to accommodate membranes and proteins when transvacuolar strands fail to elongate. We show that RBB1 corresponds to a very large protein of unknown function that is specific to plants, is present in the cytosol, and may associate with cellular membranes. RBB1 is involved in the regulation of vacuole morphology and may be involved in the establishment or stability of trans-vacuolar strands and bulbs.	[Han, Sang Won; Alonso, Jose M.; Rojas-Pierce, Marcela] N Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Rojas-Pierce, M (corresponding author), N Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA.	mrojasp@ncsu.edu	Alonso, Jose M/K-6826-2014	Alonso, Jose M/0000-0001-7087-1571	National Science Foundation [MCB-1244354]; North Carolina State University; Div Of Molecular and Cellular Bioscience [1244354] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); North Carolina State University; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation grant MCB-1244354 (http://www.nsf.gov) to M.R.P. and North Carolina State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bassham Diane C, 2008, Arabidopsis Book, V6, pe0116, DOI 10.1199/tab.0116; Beebo A, 2009, PLANT MOL BIOL, V70, P193, DOI 10.1007/s11103-009-9465-2; Bottanelli F, 2011, PLANT CELL, V23, P3007, DOI 10.1105/tpc.111.085480; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Daxinger L, 2008, TRENDS PLANT SCI, V13, P4, DOI 10.1016/j.tplants.2007.10.007; Ebine K, 2008, PLANT CELL, V20, P3006, DOI 10.1105/tpc.107.057711; Escobara NM, 2003, PLANT CELL, V15, P1507, DOI 10.1105/tpc.013284; Gattolin S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-133; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; Goda H, 2008, PLANT J, V55, P526, DOI [10.1111/j.1365-313X.2008.03510.x, 10.1111/j.0960-7412.2008.03510.x]; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grefen C, 2010, PLANT J, V64, P355, DOI 10.1111/j.1365-313X.2010.04322.x; Gulledge AA, 2012, AM J BOT, V99, P219, DOI 10.3732/ajb.1100355; Hicks GR, 2004, PLANT PHYSIOL, V134, P1227, DOI 10.1104/pp.103.037382; Higaki T, 2006, PLANT CELL PHYSIOL, V47, P839, DOI 10.1093/pcp/pcj056; Hoffmann A, 2004, PROTOPLASMA, V224, P201, DOI 10.1007/s00709-004-0068-0; Hunter PR, 2007, PLANT PHYSIOL, V145, P1371, DOI 10.1104/pp.107.103945; Jaillais Y, 2008, PLANT J, V53, P237, DOI 10.1111/j.1365-313X.2007.03338.x; Kato T, 2002, PLANT CELL, V14, P33, DOI 10.1105/tpc.010215; Kutsuna N, 2002, PLANT CELL PHYSIOL, V43, P965, DOI 10.1093/pcp/pcf138; Laxmi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001510; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Maitrejean M, 2011, PLANT SIGNAL BEHAV, V6, P1809, DOI 10.4161/psb.6.11.17867; Maitrejean M, 2011, PLANT PHYSIOL, V156, P1783, DOI 10.1104/pp.111.177816; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Muntz K, 2007, J EXP BOT, V58, P2391, DOI 10.1093/jxb/erm089; Nebenfuhr A, 1999, PLANT PHYSIOL, V121, P1127, DOI 10.1104/pp.121.4.1127; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Novakova P, 2014, P NATL ACAD SCI USA, V111, P2818, DOI 10.1073/pnas.1324264111; Pagny S, 2000, PLANT CELL, V12, P739, DOI 10.1105/tpc.12.5.739; Rivera-Serrano EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044735; Ruthardt N, 2005, PROTOPLASMA, V225, P205, DOI 10.1007/s00709-005-0093-7; Saito C, 2002, PLANT J, V29, P245, DOI 10.1046/j.0960-7412.2001.01189.x; Saito C, 2011, PLANT J, V68, P64, DOI 10.1111/j.1365-313X.2011.04665.x; Sanderfoot AA, 2001, MOL BIOL CELL, V12, P3733, DOI 10.1091/mbc.12.12.3733; Segami S, 2014, PLANT CELL, V26, P3416, DOI 10.1105/tpc.114.127571; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; STAIGER CJ, 1994, CURR BIOL, V4, P215, DOI 10.1016/S0960-9822(00)00050-6; Szymanski DB, 2009, CURR BIOL, V19, pR800, DOI 10.1016/j.cub.2009.07.056; Tominaga M, 2000, PLANTA, V210, P836, DOI 10.1007/s004250050687; Tominaga M, 1998, PLANT CELL PHYSIOL, V39, P1342, DOI 10.1093/oxfordjournals.pcp.a029340; Uemura T, 2002, GENES CELLS, V7, P743, DOI 10.1046/j.1365-2443.2002.00550.x; van der Honing HS, 2010, NEW PHYTOL, V185, P90, DOI 10.1111/j.1469-8137.2009.03017.x; Vermeer JEM, 2006, PLANT J, V47, P687, DOI 10.1111/j.1365-313X.2006.02830.x; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xiang L, 2013, FEBS J, V280, P979, DOI 10.1111/febs.12092; Yokota E, 2003, PLANT CELL PHYSIOL, V44, P1088, DOI 10.1093/pcp/pcg132; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zheng JM, 2014, MOL PLANT, V7, P1026, DOI 10.1093/mp/ssu019; Zhou RR, 2011, PLANT J, V66, P712, DOI 10.1111/j.1365-313X.2011.04524.x; Zouhar J, 2009, CURR OPIN PLANT BIOL, V12, P677, DOI 10.1016/j.pbi.2009.08.004	53	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125621	10.1371/journal.pone.0125621	http://dx.doi.org/10.1371/journal.pone.0125621			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915922	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100138
J	Martin, JW; Cushman, F				Martin, Justin W.; Cushman, Fiery			To Punish or to Leave: Distinct Cognitive Processes Underlie Partner Control and Partner Choice Behaviors	PLOS ONE			English	Article							3RD-PARTY PUNISHMENT; OUTCOME BIAS; EVOLUTION; COOPERATION; FAIRNESS; RECIPROCITY; ALTRUISM; MORALITY; DESERTS; MOTIVES	When a cooperative partner defects, at least two types of response are available: Punishment, aimed at modifying behavior, and ostracism, aimed at avoiding further social interaction with the partner. These options, termed partner control and partner choice, have been distinguished at behavioral and evolutionary levels. However, little work has compared their cognitive bases. Do these disparate behaviors depend on common processes of moral evaluation? Specifically, we assess whether they show identical patterns of dependence on two key dimensions of moral evaluation: A person's intentions, and the outcomes that they cause. We address this issue in a "trembling hand" economic game. In this game, an allocator divides a monetary stake between themselves and a responder based on a stochastic mechanism. This allows for dissociations between the allocator's intent and the actual outcome. Responders were either given the opportunity to punish or reward the allocator (partner control) or to switch to a different partner for a subsequent round of play (partner choice). Our results suggest that partner control and partner choice behaviors are supported by distinct underlying cognitive processes: Partner control exhibits greater sensitivity to the outcomes a partner causes, while partner choice is influenced almost exclusively by a partner's intentions. This cognitive dissociation can be understood in light of the unique adaptive functions of partner control and partner choice.	[Martin, Justin W.; Cushman, Fiery] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA	Harvard University	Martin, JW (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	justinmartin@g.harvard.edu	Martin, Justin/J-3819-2019	Martin, Justin/0000-0001-6100-8581	National Science Foundation [1228380, DGE1144152]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by National Science Foundation Award No. 1228380 to FC and by National Science Foundation Graduate Research Fellowship Grant No. DGE1144152 to JWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALICKE MD, 1989, J EXP SOC PSYCHOL, V25, P362, DOI 10.1016/0022-1031(89)90028-0; Balliet D, 2013, PERSPECT PSYCHOL SCI, V8, P363, DOI 10.1177/1745691613488533; BARON J, 1988, J PERS SOC PSYCHOL, V54, P569, DOI 10.1037/0022-3514.54.4.569; Baumard N, 2013, BEHAV BRAIN SCI, V36, P59, DOI 10.1017/S0140525X11002202; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Bowles S, 2008, SCIENCE, V320, P1605, DOI 10.1126/science.1152110; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; BULL JJ, 1991, J THEOR BIOL, V149, P63, DOI 10.1016/S0022-5193(05)80072-4; Carlsmith KM, 2008, ADV EXP SOC PSYCHOL, V40, P193, DOI 10.1016/S0065-2601(07)00004-4; Carlsmith KM, 2002, J PERS SOC PSYCHOL, V83, P284, DOI [10.1037/0022-3514.83.2.284, 10.1037//0022-3514.83.2.284]; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Cushman F, 2008, COGNITION, V108, P353, DOI 10.1016/j.cognition.2008.03.006; Cushman F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006699; Darley JM, 2000, LAW HUMAN BEHAV, V24, P659, DOI 10.1023/A:1005552203727; Dreber A, 2014, J ECON BEHAV ORGAN, V98, P41, DOI 10.1016/j.jebo.2013.12.007; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; FINCHAM FD, 1985, J EXP SOC PSYCHOL, V21, P178, DOI 10.1016/0022-1031(85)90014-9; Frank R. H., 1988, PASSIONS REASON STRA; Frey BS, 1997, AM ECON REV, V87, P746; Gerstenberg T, 2010, P 32 ANN M COGN SCI; Gino F, 2009, NO HARM NO FOUL OUTC; Guglielmo S, 2009, INQUIRY, V52, P449, DOI 10.1080/00201740903302600; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Krasnow MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045662; Lergetporer P, 2014, P NATL ACAD SCI USA, V111, P6916, DOI 10.1073/pnas.1320451111; Malle BF, 2014, PSYCHOL INQ, V25, P147, DOI 10.1080/1047840X.2014.877340; Martin J. W., 2015, BLACKWELL COMPANION; Mathew S, 2011, P NATL ACAD SCI USA, V108, P11375, DOI 10.1073/pnas.1105604108; Mazzocco PJ, 2004, BASIC APPL SOC PSYCH, V26, P131, DOI 10.1207/s15324834basp2602&3_3; Nagel T, 1979, MORTAL QUESTIONS; Nobes G, 2009, J EXP CHILD PSYCHOL, V104, P382, DOI 10.1016/j.jecp.2009.08.001; NOE R, 1991, ETHOLOGY, V87, P97; Piaget J., 1965, PSYCHOANALYTIC REV; Rand DG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4677; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Rand DG, 2014, ITS THOUGHT COUNTS R; Richerson PJ, 2003, DAHL WS ENV, P357; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Santos MD, 2012, J THEOR BIOL, V315, P81, DOI 10.1016/j.jtbi.2012.09.001; StataCorp, 2013, STATA STAT SOFTW REL; Titmuss R., 1970, GIFT RELATIONSHIP HU; Tostain M, 2008, EUR J SOC PSYCHOL, V38, P272, DOI 10.1002/ejsp.404; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; WALSTER E, 1966, J PERS SOC PSYCHOL, V3, P73, DOI 10.1037/h0022733; Weiner B., 1985, ANATOMY RESPONSIBILI, P1; Williams B, 1981, MORAL LUCK; Young L, 2007, P NATL ACAD SCI USA, V104, P8235, DOI 10.1073/pnas.0701408104; Young L, 2010, REV PHILOS PSYCHOL, V1, P333, DOI 10.1007/s13164-010-0027-y	54	26	26	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125193	10.1371/journal.pone.0125193	http://dx.doi.org/10.1371/journal.pone.0125193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915550	Green Published, gold			2022-12-27	WOS:000353659100107
J	Srijaruskul, K; Charoenlap, N; Namchaiw, P; Chattrakarn, S; Giengkam, S; Mongkolsuk, S; Vattanaviboon, P				Srijaruskul, Kriangsuk; Charoenlap, Nisanart; Namchaiw, Poommaree; Chattrakarn, Sorayut; Giengkam, Suparat; Mongkolsuk, Skorn; Vattanaviboon, Paiboon			Regulation by SoxR of mfsA, Which Encodes a Major Facilitator Protein Involved in Paraquat Resistance in Stenotrophomonas maltophilia	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; AGROBACTERIUM-TUMEFACIENS; ACINETOBACTER-BAUMANNII; EFFLUX PUMP; DISINFECTANT RESISTANCE; STREPTOMYCES-COELICOLOR; MULTIDRUG-RESISTANCE; FUNCTIONAL-ANALYSIS; GENE-REGULATION; SUPERFAMILY	Stenotrophomonas maltophilia MfsA (Smlt1083) is an efflux pump in the major facilitator superfamily (MFS). Deletion of mfsA renders the strain more susceptible to paraquat, but no alteration in the susceptibility levels of other oxidants is observed. The expression of mfsA is inducible upon challenge with redox cycling/superoxide-generating drug (paraquat, menadione and plumbagin) treatments and is directly regulated by SoxR, which is a transcription regulator and sensor of superoxide-generating agents. Analysis of mfsA expression patterns in wild-type and a soxR mutant suggests that oxidized SoxR functions as a transcription activator of the gene. soxR (smlt1084) is located in a head-to-head fashion with mfsA, and these genes share the -10 motif of their promoter sequences. Purified SoxR specifically binds to the putative mfsA promoter motifs that contain a region that is highly homologous to the consensus SoxR binding site, and mutation of the SoxR binding site abolishes binding of purified SoxR protein. The SoxR box is located between the putative -35 and -10 promoter motifs of mfsA; and this position is typical for a promoter in which SoxR acts as a transcriptional activator. At the soxR promoter, the SoxR binding site covers the transcription start site of the soxR transcript; thus, binding of SoxR auto-represses its own transcription. Taken together, our results reveal for the first time that mfsA is a novel member of the SoxR regulon and that SoxR binds and directly regulates its expression.	[Srijaruskul, Kriangsuk; Charoenlap, Nisanart; Namchaiw, Poommaree; Mongkolsuk, Skorn; Vattanaviboon, Paiboon] Chulabhorn Res Inst, Biotechnol Lab, Bangkok 10210, Thailand; [Srijaruskul, Kriangsuk; Chattrakarn, Sorayut; Giengkam, Suparat; Vattanaviboon, Paiboon] Chulabhorn Grad Inst, Program Appl Biol Sci Environm Hlth, Bangkok 10210, Thailand; [Mongkolsuk, Skorn] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand; [Mongkolsuk, Skorn] Mahidol Univ, Ctr Emerging Bacterial Infect, Fac Sci, Bangkok 10400, Thailand; [Mongkolsuk, Skorn] Ctr Excellence Environm Hlth & Toxicol, Bangkok, Thailand	Chulabhorn Research Institute; Chulabhorn Graduate Institute; Mahidol University; Mahidol University	Vattanaviboon, P (corresponding author), Chulabhorn Res Inst, Biotechnol Lab, Lak Si, Bangkok 10210, Thailand.	paiboon@cri.or.th	Namchaiw, Poommaree/ABC-5389-2020; Vattanaviboon, Paiboon/V-1380-2019; Namchaiw, Poommaree/AAO-3663-2020	Namchaiw, Poommaree/0000-0003-0275-6234; Scheu nee Giengkam, Suparat/0000-0003-0747-4316	Chulabhorn Research Institute; Mahidol University; Center of Excellence on Environmental Health and Toxicology (EHT), Ministry of Education, Thailand [EHT-R-1/2556-1]; Chulabhorn Graduate Institute	Chulabhorn Research Institute; Mahidol University; Center of Excellence on Environmental Health and Toxicology (EHT), Ministry of Education, Thailand; Chulabhorn Graduate Institute	This work was supported by grants from the Chulabhorn Research Institute, Mahidol University, and the Center of Excellence on Environmental Health and Toxicology (EHT), Ministry of Education, Thailand (EHT-R-1/2556-1). Authors KS, SC, and SG were supported by scholarships from the Chulabhorn Graduate Institute.	Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Dela Cruz R, 2010, J BACTERIOL, V192, P6428, DOI 10.1128/JB.00916-10; Eiamphungporn W, 2006, J BACTERIOL, V188, P8669, DOI 10.1128/JB.00856-06; Falagas ME, 2009, FUTURE MICROBIOL, V4, P1103, DOI 10.2217/FMB.09.84; Godreuil S, 2003, ANTIMICROB AGENTS CH, V47, P704, DOI 10.1128/AAC.47.2.704-708.2003; Ha UW, 1999, INFECT IMMUN, V67, P5324, DOI 10.1128/IAI.67.10.5324-5331.1999; HIDALGO E, 1994, EMBO J, V13, P138, DOI 10.1002/j.1460-2075.1994.tb06243.x; Hidalgo E, 1998, EMBO J, V17, P2629, DOI 10.1093/emboj/17.9.2629; Hidalgo E, 1997, EMBO J, V16, P1056, DOI 10.1093/emboj/16.5.1056; Hidalgo E, 1997, TRENDS BIOCHEM SCI, V22, P207, DOI 10.1016/S0968-0004(97)01068-2; HINRICHS W, 1994, SCIENCE, V264, P418, DOI 10.1126/science.8153629; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Jittawuttipoka T, 2010, ARCH MICROBIOL, V192, P331, DOI 10.1007/s00203-010-0558-8; Jittawuttipoka T, 2009, FEMS MICROBIOL LETT, V298, P111, DOI 10.1111/j.1574-6968.2009.01707.x; Josephy P.D., 2006, MOL TOXICOLOGY, V2nd ed., P333; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kobayashi K, 2004, J BIOCHEM, V136, P607, DOI 10.1093/jb/mvh168; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; LEVY SB, 1992, ANTIMICROB AGENTS CH, V36, P695, DOI 10.1128/AAC.36.4.695; Ma YQ, 2000, MICROBIOL-UK, V146, P345, DOI 10.1099/00221287-146-2-345; Mahavihakanont A, 2012, J BACTERIOL, V194, P209, DOI 10.1128/JB.05603-11; Marx CJ, 2002, BIOTECHNIQUES, V33, P1062, DOI 10.2144/02335rr01; Palma M, 2005, INFECT IMMUN, V73, P2958, DOI 10.1128/IAI.73.5.2958-2966.2005; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0; Prapagdee B, 2004, FEMS MICROBIOL LETT, V232, P217, DOI 10.1016/S0378-1097(04)00075-8; Rajamohan G, 2010, J ANTIMICROB CHEMOTH, V65, P1919, DOI 10.1093/jac/dkq195; Roca I, 2009, ANTIMICROB AGENTS CH, V53, P4013, DOI 10.1128/AAC.00584-09; Saenkham P, 2007, J BACTERIOL, V189, P8807, DOI 10.1128/JB.00960-07; Saidijam M, 2006, CURR DRUG TARGETS, V7, P793, DOI 10.2174/138945006777709575; Sambrook J., 2001, MOL CLONING LAB MANU; Santiviago CA, 2002, MOL MICROBIOL, V46, P687, DOI 10.1046/j.1365-2958.2002.03204.x; Sheplock R, 2013, MOL MICROBIOL, V87, P368, DOI 10.1111/mmi.12101; Shin JH, 2011, J BACTERIOL, V193, P75, DOI 10.1128/JB.00965-10; Singh AK, 2013, MOL MICROBIOL, V90, P983, DOI 10.1111/mmi.12410; Somprasong N, 2012, J BACTERIOL, V194, P3904, DOI 10.1128/JB.00347-12; TENNENT JM, 1989, J GEN MICROBIOL, V135, P1; Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509; Ward A, 2001, J MOL MICROB BIOTECH, V3, P193; Watanabe S, 2008, P NATL ACAD SCI USA, V105, P4121, DOI 10.1073/pnas.0709188105; Wu Ping-Sheng, 2006, Journal of Microbiology Immunology and Infection, V39, P144	43	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123699	10.1371/journal.pone.0123699	http://dx.doi.org/10.1371/journal.pone.0123699			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915643	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659100024
J	Wang, HT; Zhou, YM; Chen, Y; Wang, QX; Jiang, LF; Luo, YQ				Wang, Huatian; Zhou, Yumei; Chen, Yang; Wang, Quanxi; Jiang, Lifen; Luo, Yiqi			Allelopathic Potential of Invasive Plantago virginica on Four Lawn Species	PLOS ONE			English	Article							LONICERA-MAACKII; ACTIVATED CARBON; PHRAGMITES-AUSTRALIS; RESTORATION TOOL; ECONOMIC COSTS; IMPACTS; ASIATICA; WEAPONS; GROWTH; SOIL	Plantago virginica L. has invaded many lawn ecosystems in the Eastern part of China. The invasion has incurred an economic cost to remove them. In order to prevent the invasion, it is critical to understand the invasive mechanisms of this species. However, few studies have been conducted on the allelopathic mechanisms of its invasion. In this study, we examined allelopathic effects of P. virginica on germination of seeds and growth of seedlings of four widely used lawn species. We found extensive allelopathic potential of P. virginica on other lawn species, which varied with species and developmental stage. While most effects of the extracts of P. virginica were inhibitory, some variables in some species were promoted by the addition of the extracts. The extracts of P. virginica significantly inhibited seed germination of Agrostis matsumurae. While the overall differences in seed germination rate of Poa annua were significant among treatments, difference between control and any of the treatments was not significant. The height of seedlings of A. matsumurae and Cynodon dactylon was significantly lower under the treatments of adding extracts of P. virginica. In contrast, growth of seedlings of Festuca elata and P. annua did not show significant differences among treatments. The root length of A. matsumurae, C. dactylon and P. annua was suppressed by the extracts of P. virginica whereas root length of F. elata was not affected. Aboveground biomass of A. matsumurae and F. elata was significantly higher than control, except for F. elata at the concentration of 50mg/mL, whereas aboveground biomass of C. dactylon and P. annua was reduced at higher concentrations of the extracts. Except for A. matsumurae, root biomass of the other three lawn species declined under the treatments with the extracts of P. virginica. Our results revealed that P. virginica had allelopathic potential on four lawn species and supported the theory of "novel weapons hypothesis". Invasion by P. virginica in lawn can be moderated by selecting those species that are not affected or promotionally affected by it.	[Wang, Huatian; Wang, Quanxi] Shanghai Normal Univ, Shanghai, Peoples R China; [Wang, Huatian; Zhou, Yumei; Chen, Yang] Shanghai Inst Technol, Shanghai, Peoples R China; [Jiang, Lifen; Luo, Yiqi] Univ Oklahoma, Norman, OK 73019 USA	Shanghai Normal University; Shanghai Institute of Technology; University of Oklahoma System; University of Oklahoma - Norman	Wang, QX (corresponding author), Shanghai Normal Univ, Shanghai, Peoples R China.	wangqx@shnu.edu.cn	Zhou, Yu/HHN-3071-2022		Shanghai Municipal Education Commission	Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This research was funded by the grants Visiting Scholarship for Young Teachers of Shanghai Universities from Shanghai Municipal Education Commission. HW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnum Kimberly, 2013, International Journal of Plant Biology, V4, P8, DOI 10.4081/pb.2013.e2; Bauer JT, 2012, PLANT ECOL, V213, P1907, DOI 10.1007/s11258-012-0036-2; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Callaway RM, 2008, ECOLOGY, V89, P1043, DOI 10.1890/07-0370.1; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Chen Xiang, 2011, Bulletin of Botanical Research, V31, P680; Chen Xiang, 2011, Guangxi Zhiwu / Guihaia, V31, P495; Cipollini D, 2008, J CHEM ECOL, V34, P144, DOI 10.1007/s10886-008-9426-2; Cipollini KA, 2008, AM MIDL NAT, V160, P117, DOI 10.1674/0003-0031(2008)160[117:SAABEO]2.0.CO;2; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; Czarnota MA, 2003, J CHEM ECOL, V29, P2073, DOI 10.1023/A:1025634402071; Daehler CC, 2001, BIOTIC HOMOGENIZATION, P81; Duponnois R, 2011, SOIL BIOL BIOCHEM, V43, P2160, DOI 10.1016/j.soilbio.2011.06.020; Editorial Committee of flora of Chinese, 2002, FLOR CHIN; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Gaertner M, 2009, PROG PHYS GEOG, V33, P319, DOI 10.1177/0309133309341607; Guo S., 1996, ACTA ECOLOGICA SINIC, V16, P302; Guo ShuiLiang, 2004, Acta Phytoecologica Sinica, V28, P787; [郭水良 Guo Shuiliang], 2003, [植物研究, Bulletin of Botanical Research], V23, P464; Guo SL, 2002, J ZHEJIANG NORMAL U, V25, P49; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Holmes TP, 2009, ANN NY ACAD SCI, V1162, P18, DOI 10.1111/j.1749-6632.2009.04446.x; Hu JL, 2013, FOOD CHEM, V138, P2338, DOI 10.1016/j.foodchem.2012.12.016; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Inderjit, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002536; Inderjit, 2003, CRIT REV PLANT SCI, V22, P221, DOI 10.1080/713610857; Kettunen M., 2009, TECHNICAL SUPPORT EU; Kulmatiski A, 2006, RESTOR ECOL, V14, P251, DOI 10.1111/j.1526-100X.2006.00127.x; Kulmatiski A, 2011, RESTOR ECOL, V19, P102, DOI 10.1111/j.1526-100X.2009.00632.x; Lau JA, 2008, NEW PHYTOL, V178, P412, DOI 10.1111/j.1469-8137.2007.02360.x; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Li Yun, 2008, Shengtaixue Zazhi, V27, P514; Lind EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010429; Liu Y, 2011, WEED BIOL MANAG, V11, P160, DOI 10.1111/j.1445-6664.2011.00416.x; Lorenzo P, 2013, SOIL BIOL BIOCHEM, V57, P156, DOI 10.1016/j.soilbio.2012.08.018; Lorenzo P, 2010, APPL SOIL ECOL, V44, P245, DOI 10.1016/j.apsoil.2010.01.001; Lu X, 2011, J NANYANG NORMAL U, V10, P58; Murai Y, 2009, BIOCHEM SYST ECOL, V37, P378, DOI 10.1016/j.bse.2009.07.005; National Pharmacopoeia Committee, 2005, PHARM PEOPL REP CH 2; NISHIBE S, 1995, PHYTOCHEMISTRY, V38, P741, DOI 10.1016/0031-9422(94)00299-9; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pisula NL, 2010, J TORREY BOT SOC, V137, P81, DOI 10.3159/09-RA-040.1; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Ren MX, 2009, WEED RES, V49, P449, DOI 10.1111/j.1365-3180.2009.00723.x; Rice EL, 1984, ALLELOPATHY; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Shuiliang Guo, 1995, WEED SCI, V2, P4; Silliman BR, 2004, CONSERV BIOL, V18, P1424, DOI 10.1111/j.1523-1739.2004.00112.x; Silva FML, 2014, J CHEM ECOL, V40, P276, DOI 10.1007/s10886-014-0390-8; Simmons ME, 2012, RESTOR ECOL, V20, P369, DOI 10.1111/j.1526-100X.2011.00778.x; Thorpe AS, 2009, J ECOL, V97, P641, DOI 10.1111/j.1365-2745.2009.01520.x; Uddin MN, 2014, AM J BOT, V101, P479, DOI 10.3732/ajb.1400021; Vidotto F, 2013, CROP PROT, V54, P161, DOI 10.1016/j.cropro.2013.08.009; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Wang Y, 2012, J ECOL, V100, P894, DOI 10.1111/j.1365-2745.2012.01980.x; Wang Y, 2011, ECOL APPL, V21, P729, DOI 10.1890/09-2406.1; Weiher E, 2007, RESTOR ECOL, V15, P340, DOI 10.1111/j.1526-100X.2007.00221.x; Weisshuhn K, 2009, BASIC APPL ECOL, V10, P500, DOI 10.1016/j.baae.2008.10.009; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Willis CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008878; Xu HG, 2006, BIOL INVASIONS, V8, P1495, DOI 10.1007/s10530-005-5841-2; [杨少华 YANG Shaohua], 2008, [草业科学, Pratacultural Science], V25, P103; Ye CL, 2011, CARBOHYD POLYM, V84, P495, DOI 10.1016/j.carbpol.2010.12.014; Yin JY, 2012, CARBOHYD POLYM, V88, P1395, DOI 10.1016/j.carbpol.2012.02.025; Yin JY, 2012, CARBOHYD POLYM, V87, P2416, DOI 10.1016/j.carbpol.2011.11.009; Yuan YG, 2013, J PLANT ECOL, V6, P253, DOI 10.1093/jpe/rts033; Zhang Wan-ling, 2013, Shengtaixue Zazhi, V32, P2959	73	4	5	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125433	10.1371/journal.pone.0125433	http://dx.doi.org/10.1371/journal.pone.0125433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915515	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100128
J	Yan, Y; Zhou, YQ; Liang, CH				Yan, Yin; Zhou, Yi Qun; Liang, Cheng Hua			Evaluation of Phosphate Fertilizers for the Immobilization of Cd in Contaminated Soils	PLOS ONE			English	Article							SEQUENTIAL EXTRACTION PROCEDURE; IN-SITU REMEDIATION; INDUSTRIAL FERTILIZERS; LEAD IMMOBILIZATION; POLLUTED SOILS; AVAILABILITY; AMENDMENTS; ADSORPTION; METALS; ZN	A laboratory investigation was conducted to evaluate the efficiency of four phosphate fertilizers, including diammonium phosphate (DAP), potassium phosphate monobasic (MPP), calcium superphosphateon (SSP), and calcium phosphate tribasic (TCP), in terms of the toxicity and bioavailability of Cd in contaminated soils. The efficiency of immobilization was evaluated on the basis of two criteria: (a) the reduction of extractable Cd concentration below the TCLP regulatory level and (b) the Cd changes associated with specific operational soil fractions on the basis of sequential extraction data. Results showed that after 50 d immobilization, the extractable concentrations of Cd in DAP, MPP, SSP, and TCP treated soils decreased from 42.64 mg/kg (in the control) to 23.86, 21.86, 33.89, and 35.59 mg/kg, respectively, with immobilization efficiency in the order of MPP > DAP > SSP > TCP. Results from the assessment of Cd speciation via the sequential extraction procedure revealed that the soluble exchangeable fraction of Cd in soils treated with phosphate fertilizers, especially TCP, was considerably reduced. In addition, the reduction was correspondingly related to the increase in the more stable forms of Cd, that is, the metal bound to manganese oxides and the metal bound to crystalline iron oxides. Treatment efficiency increased as the phosphate dose (according to the molar ratio of PO4/Cd) increased. Immobilization was the most effective under the molar ratio of PO4/Cd at 4: 1.	[Yan, Yin; Zhou, Yi Qun; Liang, Cheng Hua] Shenyang Agr Univ, Dept Land & Environm, Shenyang 110161, Liaoning, Peoples R China	Shenyang Agricultural University	Liang, CH (corresponding author), Shenyang Agr Univ, Dept Land & Environm, Shenyang 110161, Liaoning, Peoples R China.	liang110161@163.com			National Natural Science Foundation of China [31171997]; Department Of Agriculture in China; China Environmental Protection Foundation [CEPF2012-123-1-4]; Innovative Graduate Training Program of Shenyang Agricultural University of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department Of Agriculture in China; China Environmental Protection Foundation; Innovative Graduate Training Program of Shenyang Agricultural University of China	Funding for this study was provided by the National Natural Science Foundation of China (grant No. 31171997; http://isisn.nsfc.gov.cn) to C.H. Liang; the Department Of Agriculture in China (www.agri.gov.cn) to C.H. Liang; the China Environmental Protection Foundation ( No. CEPF2012-123-1-4; www.cepfln.com) to Y. Yin; and the Innovative Graduate Training Program of Shenyang Agricultural University of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RA, 2003, CHEMOSPHERE, V53, P1077, DOI 10.1016/S0045-6535(03)00572-1; Abumaizar RJ, 1999, J HAZARD MATER, V70, P71, DOI 10.1016/S0304-3894(99)00149-1; Adriano D.C., 2001, TRACE ELEMENTS TERRE, DOI 10.1007/978-0-387-21510-5; Alloway B.J., 1995, HEAVY METALS SOILS B; Bao SD., 2000, ANAL SOIL AGROCHEMIS, V3rd ed., P25; BOLLAND MDA, 1977, AUST J SOIL RES, V15, P279, DOI 10.1071/SR9770279; Brown S, 2005, ENVIRON POLLUT, V138, P34, DOI 10.1016/j.envpol.2005.02.020; Cao RX, 2003, ENVIRON POLLUT, V122, P19, DOI 10.1016/S0269-7491(02)00283-X; Doong RA, 1998, WATER SCI TECHNOL, V37, P65, DOI 10.1016/S0273-1223(98)00235-2; Garcia-Sanchez A, 1999, SCI TOTAL ENVIRON, V242, P179, DOI 10.1016/S0048-9697(99)00383-6; Hamon RE, 2002, ENVIRON SCI TECHNOL, V36, P3991, DOI 10.1021/es025558g; Kumpiene J, 2008, WASTE MANAGE, V28, P215, DOI 10.1016/j.wasman.2006.12.012; MA QY, 1993, ENVIRON SCI TECHNOL, V27, P1803, DOI 10.1021/es00046a007; OTTEN A, 1997, SITU SOIL REMEDIATIO; RUBY MV, 1994, ENVIRON SCI TECHNOL, V28, P646, DOI 10.1021/es00053a018; Scullion J, 2006, NATURWISSENSCHAFTEN, V93, P51, DOI 10.1007/s00114-005-0079-5; Soil Survey Staff, 1999, KEYS SOIL TAX; Soylak M, 1997, J TRACE MICROPROBE T, V15, P197; Soylak M, 2002, INT J ENVIRON AN CH, V82, P197, DOI 10.1080/03067310290007796; Sungur A, 2014, CHEM SPEC BIOAVAILAB, V26, P219, DOI 10.3184/095422914X14147781158674; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Unsal YE, 2014, J AOAC INT, V97, P1034, DOI 10.5740/jaoacint.13-002; XU YP, 1994, J CONTAM HYDROL, V15, P187, DOI 10.1016/0169-7722(94)90024-8	23	22	22	6	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124022	10.1371/journal.pone.0124022	http://dx.doi.org/10.1371/journal.pone.0124022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915051	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100035
J	Ye, JH; Pao, LH				Ye, Jia-Hung; Pao, Li-Heng			Using Visualized Matrix Effects to Develop and Improve LC-MS/MS Bioanalytical Methods, Taking TRAM-34 as an Example	PLOS ONE			English	Article							KCA3.1 POTASSIUM CHANNELS; HUMAN-PLASMA; MASS-SPECTROMETRY; ION SUPPRESSION; MONITORING PHOSPHOLIPIDS; LC/MS/MS ANALYSES; RENAL FIBROSIS; ESI; EXTRACTION; SECRETION	Matrix effects (MEs) continue to be an obstacle in the development of the LC-MS/MS method, with phospholipids being the major cause of MEs. Changing the mobile phase has been a common strategy to reduce MEs; however, the underlying mechanism is unclear. "Insource multiple-reaction monitoring" (IS-MRM) for glycerophosphocholines (PCs) has been commonly applied in many bioanalytical methods. "Visualized MEs" is a suitable term to describe the application of IS-MRM to visualize the elution pattern of phospholipids. We selected a real case to discuss the relationship of MEs and phospholipids in different mobile phases by quantitative, qualitative, and visualized MEs in LC-MS/MS bioanalysis. The application of visualized MEs not only predicts the ion-suppression zone but also helps in selecting an appropriate (1) mobile phase, (2) column, (3) needle wash solvent for the residue of analyte and phospholipids, and (4) evaluates the clean-up efficiency of sample preparation. The TRAM-34 LC-MS/MS method, improved by using visualized MEs, was shown to be a precise and accurate analytical method. All data indicated that the use of visualized MEs indeed provided useful information about the LC-MS/MS method development and improvement. In this study, an integrative approach for the qualitative, quantitative, and visualized MEs was used to decipher the complexity of MEs.	[Ye, Jia-Hung] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Pao, Li-Heng] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan; [Pao, Li-Heng] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan; [Pao, Li-Heng] Chang Gung Univ Sci & Technol, Grad Inst Hlth Ind Technol, Taoyuan, Taiwan	National Defense Medical Center; National Defense Medical Center; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology	Pao, LH (corresponding author), Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan.	paolhaa@gmail.com			Chang Gung Memorial Hospital [CMRPF1D0111]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	Funding for this work came from the Chang Gung Memorial Hospital CMRPF1D0111, (Chang-Gung Medical Research Project, CMRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Albaqumi M, 2008, KIDNEY INT, V74, P740, DOI 10.1038/ki.2008.246; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Bonfiglio R, 1999, RAPID COMMUN MASS SP, V13, P1175, DOI 10.1002/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>3.3.CO;2-S; Chambers E, 2007, J CHROMATOGR B, V852, P22, DOI 10.1016/j.jchromb.2006.12.030; Ghosh C, 2012, J CHROMATOGR B, V893, P193, DOI 10.1016/j.jchromb.2012.03.012; Grgic I, 2005, ARTERIOSCL THROM VAS, V25, P704, DOI 10.1161/01.ATV.0000156399.12787.5c; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Ismaiel OA, 2007, J CHROMATOGR B, V859, P84, DOI 10.1016/j.jchromb.2007.09.007; Ismaiel OA, 2010, J CHROMATOGR B, V878, P3303, DOI 10.1016/j.jchromb.2010.10.012; Ismaiel OA, 2008, J CHROMATOGR B, V875, P333, DOI 10.1016/j.jchromb.2008.08.032; Jager H, 2004, MOL PHARMACOL, V65, P630, DOI 10.1124/mol.65.3.630; Jiang H, 2012, J CHROMATOGR B, V891, P71, DOI 10.1016/j.jchromb.2012.02.031; Little JL, 2006, J CHROMATOGR B, V833, P219, DOI 10.1016/j.jchromb.2006.02.011; Matuszewski BK, 1998, ANAL CHEM, V70, P882, DOI 10.1021/ac971078+; Mene P, 2010, NEPHROL DIAL TRANSPL, V25, P353, DOI 10.1093/ndt/gfp634; MYHER JJ, 1989, LIPIDS, V24, P408, DOI 10.1007/BF02535148; Peters FT, 2012, ANAL BIOANAL CHEM, V403, P2155, DOI 10.1007/s00216-012-6035-2; Pucci V, 2009, J PHARMACEUT BIOMED, V50, P867, DOI 10.1016/j.jpba.2009.05.037; Schmidt J, 2010, CELL RES, V20, P1224, DOI 10.1038/cr.2010.121; Shen JX, 2005, J PHARMACEUT BIOMED, V37, P359, DOI 10.1016/j.jpba.2004.10.035; Trufelli H, 2011, MASS SPECTROM REV, V30, P491, DOI 10.1002/mas.20298; Xia YQ, 2009, RAPID COMMUN MASS SP, V23, P2125, DOI 10.1002/rcm.4121; Ye JH, 2014, CHROMATOGRAPHIA, V77, P695, DOI 10.1007/s10337-014-2674-0	23	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0118818	10.1371/journal.pone.0118818	http://dx.doi.org/10.1371/journal.pone.0118818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909956	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800004
J	Hardman, CA; Ferriday, D; Kyle, L; Rogers, PJ; Brunstrom, JM				Hardman, Charlotte A.; Ferriday, Danielle; Kyle, Lesley; Rogers, Peter J.; Brunstrom, Jeffrey M.			So Many Brands and Varieties to Choose from: Does This Compromise the Control of Food Intake in Humans?	PLOS ONE			English	Article							HIGH-INTENSITY SWEETENERS; CALORIC COMPENSATION; EXPECTED SATIETY; LOSS AVERSION; CHANGES EXPECTATIONS; SELF-REGULATION; PROSPECT-THEORY; PORTION-SIZE; SNACK FOODS; WEIGHT-GAIN	The recent rise in obesity is widely attributed to changes in the dietary environment (e.g., increased availability of energy-dense foods and larger portion sizes). However, a critical feature of our "obesogenic environment" may have been overlooked - the dramatic increase in "dietary variability" (the tendency for specific mass-produced foods to be available in numerous varieties that differ in energy content). In this study we tested the hypothesis that dietary variability compromises the control of food intake in humans. Specifically, we examined the effects of dietary variability in pepperoni pizza on two key outcome variables; i) compensation for calories in pepperoni pizza and ii) expectations about the satiating properties of pepperoni pizza (expected satiation). We reasoned that dietary variability might generate uncertainty about the postingestive effects of a food. An internet-based questionnaire was completed by 199 adults. This revealed substantial variation in exposure to different varieties of pepperoni pizza. In a follow-up study (n=66; 65% female), high pizza variability was associated with i) poorer compensation for calories in pepperoni pizza and ii) lower expected satiation for pepperoni pizza. Furthermore, the effect of uncertainty on caloric compensation was moderated by individual differences in decision making (loss aversion). For the first time, these findings highlight a process by which dietary variability may compromise food-intake control in humans. This is important because it exposes a new feature of Western diets (processed foods in particular) that might contribute to overeating and obesity.	[Hardman, Charlotte A.] Univ Liverpool, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England; [Ferriday, Danielle; Kyle, Lesley; Rogers, Peter J.; Brunstrom, Jeffrey M.] Univ Bristol, Sch Expt Psychol, Nutr & Behav Unit, Bristol, Avon, England	University of Liverpool; University of Bristol	Brunstrom, JM (corresponding author), Univ Bristol, Sch Expt Psychol, Nutr & Behav Unit, Bristol, Avon, England.	Jeff.Brunstrom@bristol.ac.uk	Brunstrom, Jeffrey M/C-7892-2009; Brunstrom, Jeff/AAS-3433-2021	Brunstrom, Jeffrey M/0000-0003-4657-7799; Brunstrom, Jeff/0000-0003-4657-7799; Ferriday, Dani/0000-0003-2665-0055	Biotechnology and Biological Sciences Research Council (United Kingdom) [BB/I012370/1]; European Union [607310]; BBSRC [BB/I012370/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I012370/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by a grant from the Biotechnology and Biological Sciences Research Council (United Kingdom), grant number: BB/I012370/1. JMB and PJR's research is supported by the European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 607310 (Nudge-it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almiron-Roig E, 2013, NUTR REV, V71, P458, DOI 10.1111/nure.12048; Anderson LR, 2008, J HEALTH ECON, V27, P1260, DOI 10.1016/j.jhealeco.2008.05.011; Barkley-Levenson EE, 2013, DEV COGN NEUROS-NETH, V3, P72, DOI 10.1016/j.dcn.2012.09.007; BIRCH LL, 1986, APPETITE, V7, P323, DOI 10.1016/S0195-6663(86)80001-0; BIRCH LL, 1985, LEARN MOTIV, V16, P341, DOI 10.1016/0023-9690(85)90020-7; Brunstrom JM, 2008, APPETITE, V51, P604, DOI 10.1016/j.appet.2008.04.017; Brunstrom JM, 2007, APPETITE, V49, P268, DOI 10.1016/j.appet.2006.11.007; Brunstrom JM, 2011, P NUTR SOC, V70, P155, DOI 10.1017/S002966511000491X; Brunstrom JM, 2010, APPETITE, V54, P587, DOI 10.1016/j.appet.2010.01.015; Brunstrom JM, 2009, OBESITY, V17, P1884, DOI 10.1038/oby.2009.201; Brunstrom JM, 2009, APPETITE, V52, P108, DOI 10.1016/j.appet.2008.09.002; Brunstrom JM, 2005, PHYSIOL BEHAV, V85, P57, DOI 10.1016/j.physbeh.2005.04.004; Cecil JE, 2005, AM J CLIN NUTR, V82, P302, DOI 10.1093/ajcn/82.2.302; Chen MK, 2006, J POLIT ECON, V114, P517, DOI 10.1086/503550; Davidson TL, 2005, OBES RES, V13, P537, DOI 10.1038/oby.2005.57; Davidson TL, 2004, INT J OBESITY, V28, P933, DOI 10.1038/sj.ijo.0802660; De Martino B, 2010, P NATL ACAD SCI USA, V107, P3788, DOI 10.1073/pnas.0910230107; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; Fay SH, 2011, APPETITE, V56, P284, DOI 10.1016/j.appet.2011.01.006; Gallo A. E., 1997, FoodReview, V20, P33; Hardman CA, 2011, AM J CLIN NUTR, V94, P1196, DOI 10.3945/ajcn.111.016873; HEATHERTON TF, 1988, J ABNORM PSYCHOL, V97, P19, DOI 10.1037/0021-843X.97.1.19; Hinton EC, 2013, APPETITE, V63, P31, DOI 10.1016/j.appet.2012.12.008; JOHNSON SL, 1994, PEDIATRICS, V94, P653; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; LOOY H, 1992, PHYSIOL BEHAV, V52, P219, DOI 10.1016/0031-9384(92)90261-Y; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; McCrickerd K., 2012, FLAVOUR SCI RECENT D, V1, P20, DOI [DOI 10.1186/2044-7248-1-20, 10.1186/2044-7248-1-20]; Oldham-Cooper RE, 2011, AM J CLIN NUTR, V93, P308, DOI 10.3945/ajcn.110.004580; PRENTICE AM, 1995, BRIT MED J, V311, P437, DOI 10.1136/bmj.311.7002.437; Ruel M.T., 2002, IS DIETARY DIVERSITY; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; Steiner JE, 2001, NEUROSCI BIOBEHAV R, V25, P53, DOI 10.1016/S0149-7634(00)00051-8; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Swithers SE, 2006, INT J OBESITY, V30, P1685, DOI 10.1038/sj.ijo.0803329; Swithers SE, 2008, BEHAV NEUROSCI, V122, P161, DOI 10.1037/0735-7044.122.1.161; Swithers SE, 2012, BEHAV BRAIN RES, V233, P1, DOI 10.1016/j.bbr.2012.04.024; Swithers SE, 2011, BEHAV NEUROSCI, V125, P512, DOI 10.1037/a0024404; Swithers SE, 2010, PHYSIOL BEHAV, V100, P55, DOI 10.1016/j.physbeh.2009.12.021; Swithers SE, 2009, BEHAV NEUROSCI, V123, P772, DOI 10.1037/a0016139; Teff KL, 2011, PHYSIOL BEHAV, V103, P44, DOI 10.1016/j.physbeh.2011.01.012; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; Van Praag BMS, 2003, RISK AVERSION SUBJEC; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wells JCK, 2011, EUR J CLIN NUTR, V65, P1173, DOI 10.1038/ejcn.2011.132; Wilkinson LL, 2012, APPETITE, V59, P933, DOI 10.1016/j.appet.2012.09.007; Wolf AM, 1998, OBES RES, V6, P97, DOI 10.1002/j.1550-8528.1998.tb00322.x; WOODS SC, 1991, PSYCHOL REV, V98, P488, DOI 10.1037/0033-295X.98.4.488; Yeomans MR, 2014, BRIT J NUTR, V111, P1137, DOI 10.1017/S0007114513003474; Yeomans MR, 2011, AM J CLIN NUTR, V94, P1410, DOI 10.3945/ajcn.111.011650; Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246	54	25	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125869	10.1371/journal.pone.0125869	http://dx.doi.org/10.1371/journal.pone.0125869			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923118	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600167
J	Nakanishi, T; Hasegawa, Y; Mimura, R; Wakayama, T; Uetoko, Y; Komori, H; Akanuma, S; Hosoya, K; Tamai, I				Nakanishi, Takeo; Hasegawa, Yoshitaka; Mimura, Reo; Wakayama, Tomohiko; Uetoko, Yuka; Komori, Hisakazu; Akanuma, Shin-ichi; Hosoya, Ken-ichi; Tamai, Ikumi			Prostaglandin Transporter (PGT/SLCO2A1) Protects the Lung from Bleomycin-Induced Fibrosis	PLOS ONE			English	Article							INDUCED PULMONARY-FIBROSIS; GROWTH-FACTOR-BETA; KINASE C-DELTA; ALVEOLAR MACROPHAGES; CLEARANCE SYSTEM; GENE-EXPRESSION; IN-VIVO; FIBROBLAST; COLLAGEN; CELLS	Prostaglandin (PG) E-2 exhibits an anti-fibrotic effect in the lung in response to inflammatory reactions and is a high-affinity substrate of PG transporter (SLCO2A1). The present study aimed to evaluate the pathophysiological relevance of SLCO2A1 to bleomycin (BLM)-induced pulmonary fibrosis in mice. Immunohistochemical analysis indicated that Slco2a1 protein was expressed in airway and alveolar type I (ATI) and II (ATII) epithelial cells, and electron-microscopic immunohistochemistry further demonstrated cell surface expression of Slco2a1 in ATI cells in wild type (WT) C57BL/6 mice. PGE(2) uptake activity was abrogated in ATI-like cells from Slco2a1-deficient (Slco2a1(-/-)) mice, which was clearly observed in the cells from WT mice. Furthermore, the PGE(2) concentrations in lung tissues were lower in Slco2a1(-/-)than in WT mice. The pathological relevance of SLCO2A1 was further studied in mouse BLM-induced pulmonary fibrosis models. BLM (1 mg/kg) or vehicle (phosphate buffered saline) was intratracheally injected into WT and Slco2a1(-/-)mice, and BLM-induced fibrosis was evaluated on day 14. BLM induced more severe fibrosis in Slco2a1(-/-)than in WT mice, as indicated by thickened interstitial connective tissue and enhanced collagen deposition. PGE2 levels were higher in bronchoalveolar lavage fluid, but lower in lung tissues of Slco2a1(-/-)mice. Transcriptional upregulation of TGF-beta 1 was associated with enhanced gene transcriptions of downstream targets including plasminogen activator inhitor-1. Furthermore, Western blot analysis demonstrated a significant activation of protein kinase C (PKC) delta along with a modest activation of Smad3 in lung from Slco2a1(-/-)mice, suggesting a role of PKC delta associated with TGF-beta signaling in aggravated fibrosis in BLM-treated Slco2a1(-/-)mice. In conclusion, pulmonary PGE2 disposition is largely regulated by SLCO2A1, demonstrating that SLCO2A1 plays a critical role in protecting the lung from BLM-induced fibrosis.	[Nakanishi, Takeo; Hasegawa, Yoshitaka; Mimura, Reo; Uetoko, Yuka; Komori, Hisakazu; Tamai, Ikumi] Kanazawa Univ, Fac Pharmaceut Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 920, Japan; [Wakayama, Tomohiko] Kanazawa Univ, Fac Med, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan; [Akanuma, Shin-ichi; Hosoya, Ken-ichi] Toyama Univ, Dept Pharmaceut, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan	Kanazawa University; Kanazawa University; University of Toyama	Tamai, I (corresponding author), Kanazawa Univ, Fac Pharmaceut Sci, Inst Med Pharmaceut & Hlth Sci, 13-1 Takara Machi, Kanazawa, Ishikawa 920, Japan.	tamai@p.kanazawa-u.ac.jp	Komori, Hisakazu/AAQ-2590-2020; Nakanishi, Takeo/C-3891-2015; TAMAI, Ikumi/D-8412-2015	Nakanishi, Takeo/0000-0002-6561-7138; Komori, Hisakazu/0000-0002-5159-0069	Ono Pharmaceutical Co., Ltd.	Ono Pharmaceutical Co., Ltd.(Ono Pharmaceutical Co Ltd)	This study was supported by a grant from Ono Pharmaceutical Co., Ltd. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; Bao Y, 2002, AM J PHYSIOL-RENAL, V282, pF1103, DOI 10.1152/ajprenal.00152.2001; BAUM BJ, 1980, J BIOL CHEM, V255, P2843; Bleasby K, 2006, XENOBIOTICA, V36, P963, DOI 10.1080/00498250600861751; Bonner JC, 2002, AM J PATHOL, V161, P459, DOI 10.1016/S0002-9440(10)64202-2; BOROK Z, 1991, AM REV RESPIR DIS, V144, P1080, DOI 10.1164/ajrccm/144.5.1080; Bozyk PD, 2011, AM J RESP CELL MOL, V45, P445, DOI 10.1165/rcmb.2011-0025RT; Card JW, 2007, AM J RESP CELL MOL, V37, P300, DOI 10.1165/rcmb.2007-0057OC; CASEY ML, 1983, BIOCHEM BIOPH RES CO, V114, P1056, DOI 10.1016/0006-291X(83)90669-1; CHANDLER DB, 1990, CLIN CHEST MED, V11, P21; Chang HY, 2010, CIRCULATION, V121, P529, DOI 10.1161/CIRCULATIONAHA.109.862946; Chaudhary NI, 2006, AM J RESP CRIT CARE, V173, P769, DOI 10.1164/rccm.200505-717OC; Chuang PC, 2006, MOL CELL BIOL, V26, P8281, DOI 10.1128/MCB.00941-06; DENHOLM EM, 1990, J LEUKOCYTE BIOL, V48, P519, DOI 10.1002/jlb.48.6.519; Diggle CP, 2012, HUM MUTAT, V33, P1175, DOI 10.1002/humu.22111; Finetti F, 2008, J BIOL CHEM, V283, P2139, DOI 10.1074/jbc.M703090200; Gonzalez AM, 1996, PEDIATR RES, V39, P375, DOI 10.1203/00006450-199603000-00001; HEMPEL SL, 1994, J BIOL CHEM, V269, P32979; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Ikehata M, 2008, PHARM RES-DORDR, V25, P913, DOI 10.1007/s11095-007-9426-x; Jackson TA, 2001, MOL ENDOCRINOL, V15, P1517, DOI 10.1210/me.15.9.1517; Jimenez SA, 2001, J CLIN INVEST, V108, P1395, DOI 10.1172/JCI200112347; Johnson MD, 2002, P NATL ACAD SCI USA, V99, P1966, DOI 10.1073/pnas.042689399; KANAI N, 1995, SCIENCE, V268, P866, DOI 10.1126/science.7754369; Keerthisingam CB, 2001, AM J PATHOL, V158, P1411, DOI 10.1016/S0002-9440(10)64092-8; KING SL, 1994, J BIOL CHEM, V269, P13156; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Kraft ME, 2010, INVEST OPHTH VIS SCI, V51, P2504, DOI 10.1167/iovs.09-4290; Kucich U, 2000, ARCH BIOCHEM BIOPHYS, V374, P313, DOI 10.1006/abbi.1999.1625; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovgren AK, 2006, AM J PHYSIOL-LUNG C, V291, pL144, DOI 10.1152/ajplung.00492.2005; Lu R, 1996, J CLIN INVEST, V98, P1142, DOI 10.1172/JCI118897; Luzina IG, 2006, AM J RESP CELL MOL, V35, P298, DOI 10.1165/rcmb.2006-0033OC; Maher TM, 2010, AM J RESP CRIT CARE, V182, P73, DOI 10.1164/rccm.200905-0674OC; Mandery K, 2010, J PHARMACOL EXP THER, V332, P345, DOI 10.1124/jpet.109.154518; McCoy JM, 2002, J CLIN INVEST, V110, P651, DOI 10.1172/JCI200215528; Moore BB, 2005, J IMMUNOL, V174, P5644, DOI 10.4049/jimmunol.174.9.5644; Nakanishi T, 2013, J PHARM SCI-US, V102, P3373, DOI 10.1002/jps.23603; Nakanishi T, 2010, METHODS MOL BIOL, V637, P105, DOI 10.1007/978-1-60761-700-6_5; Nomura T, 2004, MOL PHARMACOL, V65, P973, DOI 10.1124/mol.65.4.973; Oga T, 2009, NAT MED, V15, P1426, DOI 10.1038/nm.2066; OZAKI T, 1987, J APPL PHYSIOL, V62, P219, DOI 10.1152/jappl.1987.62.1.219; PHELPS DS, 1991, EXP LUNG RES, V17, P985, DOI 10.3109/01902149109064330; PIPER PJ, 1970, NATURE, V225, P600, DOI 10.1038/225600a0; Pucci ML, 1999, AM J PHYSIOL-REG I, V277, pR734, DOI 10.1152/ajpregu.1999.277.3.R734; Richards RJ, 1987, LUNG, V165, P3; Sakai Yoshitada, 2001, Kobe Journal of Medical Sciences, V47, P35; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seifert W, 2012, HUM MUTAT, V33, P660, DOI 10.1002/humu.22042; Sheller JR, 2000, J APPL PHYSIOL, V88, P2214, DOI 10.1152/jappl.2000.88.6.2214; Shirasaka Y, 2013, J ENDOCRINOL, V217, P265, DOI 10.1530/JOE-12-0339; Sleijfer S, 2001, CHEST, V120, P617, DOI 10.1378/chest.120.2.617; Tachikawa M, 2012, J PHARMACOL EXP THER, V343, P608, DOI 10.1124/jpet.112.197012; Tachikawa M, 2012, J NEUROCHEM, V123, P750, DOI 10.1111/jnc.12018; Topper JN, 1998, CIRCULATION, V98, P2396, DOI 10.1161/01.CIR.98.22.2396; Wakayama T, 2003, BIOL REPROD, V68, P1755, DOI 10.1095/biolreprod.102.012344; WARDLAW AJ, 1989, J ALLERGY CLIN IMMUN, V84, P19, DOI 10.1016/0091-6749(89)90173-5; Zhou BY, 2007, AM J PHYSIOL-CELL PH, V292, pC1280, DOI 10.1152/ajpcell.00070.2006	58	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123895	10.1371/journal.pone.0123895	http://dx.doi.org/10.1371/journal.pone.0123895			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923111	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600059
J	Ramazi, P; Hessel, J; Cao, M				Ramazi, Pouria; Hessel, Jop; Cao, Ming			How Feeling Betrayed Affects Cooperation	PLOS ONE			English	Article							PRISONERS-DILEMMA; SNOWDRIFT GAME; PUBLIC-GOODS; PUNISHMENT; EVOLUTION; BEHAVIOR	For a population of interacting self-interested agents, we study how the average cooperation level is affected by some individuals' feelings of being betrayed and guilt. We quantify these feelings as adjusted payoffs in asymmetric games, where for different emotions, the payoff matrix takes the structure of that of either a prisoner's dilemma or a snowdrift game. Then we analyze the evolution of cooperation in a well-mixed population of agents, each of whom is associated with such a payoff matrix. At each time-step, an agent is randomly chosen from the population to update her strategy based on the myopic best-response update rule. According to the simulations, decreasing the feeling of being betrayed in a portion of agents does not necessarily increase the level of cooperation in the population. However, this resistance of the population against low-betrayal-level agents is effective only up to some extend that is explicitly determined by the payoff matrices and the number of agents associated with these matrices. Two other models are also considered where the betrayal factor of an agent fluctuates as a function of the number of cooperators and defectors that she encounters. Unstable behaviors are observed for the level of cooperation in these cases; however, we show that one can tune the parameters in the function to make the whole population become cooperative or defective.	[Ramazi, Pouria; Hessel, Jop; Cao, Ming] Univ Groningen, Fac Math & Nat Sci, Engn & TEchnol Inst Groningen ENTEG, Groningen, Netherlands	University of Groningen	Ramazi, P (corresponding author), Univ Groningen, Fac Math & Nat Sci, Engn & TEchnol Inst Groningen ENTEG, Groningen, Netherlands.	p.ramazi@rug.nl	Cao, Ming/B-6808-2013	Cao, Ming/0000-0001-5472-562X	European Research Council [ERC-StG-307207]; EU INTERREG program under the SMARTBOT project	European Research Council(European Research Council (ERC)European Commission); EU INTERREG program under the SMARTBOT project	The work was supported in part by the European Research Council (ERC-StG-307207) and the EU INTERREG program under the auspices of the SMARTBOT project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alos-Ferrer C., 2003, INT GAME THEORY REV, V5, P263, DOI DOI 10.1142/S0219198903001057; ANDREONI J, 1993, ECON J, V103, P570, DOI 10.2307/2234532; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Boone C, 1999, J ECON PSYCHOL, V20, P343, DOI 10.1016/S0167-4870(99)00012-4; Bowles S, 2002, ECON J, V112, pF419, DOI 10.1111/1468-0297.00077; Brosig J, 2002, J ECON BEHAV ORGAN, V47, P275, DOI 10.1016/S0167-2681(01)00211-6; Chan NWH, 2013, PHYSICA A, V392, P168, DOI 10.1016/j.physa.2012.07.078; Colman AM, 2013, GAME THEORY ITS APPL; Cook Karen, 2001, TRUST SOC; Cooper R, 1996, GAME ECON BEHAV, V12, P187, DOI 10.1006/game.1996.0013; Dijkstra J, 2013, SOC NETWORKS, V35, P573, DOI 10.1016/j.socnet.2013.08.005; Du WB, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/60004; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Jin Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04095; KANDORI M, 1995, J ECON THEORY, V65, P383, DOI 10.1006/jeth.1995.1014; MATSUMOTO D, 1986, DEV PSYCHOL, V22, P663, DOI 10.1037/0012-1649.22.5.663; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Ramazi P, 2014, IEEE DECIS CONTR P, P4515, DOI 10.1109/CDC.2014.7040094; Riehl JR, 2014, IEEE DECIS CONTR P, P2877, DOI 10.1109/CDC.2014.7039831; Roca CP, 2009, EUR PHYS J B, V71, P587, DOI 10.1140/epjb/e2009-00189-0; Roth A.E., 1995, HDB EXPT EC; SCHUSTER P, 1983, J THEOR BIOL, V100, P533, DOI 10.1016/0022-5193(83)90445-9; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Waldeck R, 2013, JASSS-J ARTIF SOC S, V16, DOI 10.18564/jasss.2363; Wang C, 2012, CHIN CONT DECIS CONF, P164, DOI 10.1109/CCDC.2012.6242927; Wang Z, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052813; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Weibull J W, 1997, EVOLUTIONARY GAME TH; Winter F, 2012, SOC FORCES, V90, P919, DOI 10.1093/sf/sor028; Xia CY, 2012, PHYSICA A, V391, P6440, DOI 10.1016/j.physa.2012.07.065; Zhang JJ, 2012, FRONT PHYS-BEIJING, V7, P366, DOI 10.1007/s11467-011-0208-x	36	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122205	10.1371/journal.pone.0122205	http://dx.doi.org/10.1371/journal.pone.0122205			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25922933	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600010
J	Subramaniam, R; Hillberry, Z; Chen, H; Feng, Y; Fletcher, K; Neuenschwander, P; Shams, H				Subramaniam, Renuka; Hillberry, Zachary; Chen, Han; Feng, Yan; Fletcher, Kalyn; Neuenschwander, Pierre; Shams, Homayoun			Delivery of GM-CSF to Protect against Influenza Pneumonia	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; PULMONARY ALVEOLAR PROTEINOSIS; GRANULOCYTE-MACROPHAGE; RHGM-CSF; PEGYLATED INTERFERONS; DENDRITIC CELLS; DEFICIENT MICE; MURINE MODEL; LUNG; RESPONSES	Background Since adaptive immunity is thought to be central to immunity against influenza A virus (IAV) pneumonias, preventive strategies have focused primarily on vaccines. However, vaccine efficacy has been variable, in part because of antigenic shift and drift in circulating influenza viruses. Recent studies have highlighted the importance of innate immunity in protecting against influenza. Methods Granulocyte-macrophage colony stimulating factor (GM-CSF) contributes to maturation of mononuclear phagocytes, enhancing their capacity for phagocytosis and cytokine production. Results Overexpression of granulocyte macrophage-colony stimulating factor (GM-CSF) in the lung of transgenic mice provides remarkable protection against IAV, which depends on alveolar macrophages (AM). In this study, we report that pulmonary delivery of GM-CSF to wild type young and aged mice abrogated mortality from IAV. Conclusion We also demonstrate that protection is species specific and human GM-CSF do not protect the mice nor stimulates mouse immunity. We also show that IAV-induced lung injury is the culprit for side-effects of GM-CSF in treating mice after IAV infection, and introduce a novel strategy to deliver the GM-CSF to and retain it in the alveolar space even after IAV infection.	[Subramaniam, Renuka; Hillberry, Zachary; Chen, Han; Feng, Yan; Fletcher, Kalyn; Shams, Homayoun] Univ Texas Hlth Sci Ctr Tyler, Ctr Pulm & Infect Dis Control, Tyler, TX 75708 USA; [Neuenschwander, Pierre] Univ Texas Hlth Sci Ctr Tyler, Biomed Res, Tyler, TX USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Shams, H (corresponding author), Univ Texas Hlth Sci Ctr Tyler, Ctr Pulm & Infect Dis Control, 11937 US Highway 271, Tyler, TX 75708 USA.	homayoun.shams@uthct.edu			Flight Attendant Medical Research Institute [092015, 123020]	Flight Attendant Medical Research Institute	The authors have no additional financial interests. This work was in part supported by grants to H. Shams from the Flight Attendant Medical Research Institute (092015-Clinical Innovator Award and 123020-Clinical Innovator Award). H. Shams is the inventor of two pending patents filed by the Board of Regents, The University of Texas System, for use of GM-CSF to prevent influenza and its secondary bacterial pneumonia.	Aghemo A, 2010, NAT REV GASTRO HEPAT, V7, P485, DOI 10.1038/nrgastro.2010.101; CANTRELL MA, 1985, P NATL ACAD SCI USA, V82, P6250, DOI 10.1073/pnas.82.18.6250; Cates EC, 2003, J ALLERGY CLIN IMMUN, V111, P1076, DOI 10.1067/mai.2003.1460; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; Craxi A, 2003, ANTIVIR RES, V60, P87, DOI 10.1016/j.antiviral.2003.08.015; Daro E, 2000, J IMMUNOL, V165, P49, DOI 10.4049/jimmunol.165.1.49; DIEDERICHS K, 1991, SCIENCE, V254, P1779, DOI 10.1126/science.1837174; Frasca D, 2014, CURR OPIN IMMUNOL, V29, P112, DOI 10.1016/j.coi.2014.05.008; Frasca D, 2010, VACCINE, V28, P8077, DOI 10.1016/j.vaccine.2010.10.023; Ghoneim HE, 2013, J IMMUNOL, V191, P1250, DOI 10.4049/jimmunol.1300014; Guo JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034681; Herold S, 2014, AM J RESP CRIT CARE, V189, P609, DOI 10.1164/rccm.201311-2041LE; Hofer M, 2005, PHYSIOL RES, V54, P207, DOI 10.33549/physiolres.930606; Huang FF, 2011, AM J RESP CRIT CARE, V184, P259, DOI 10.1164/rccm.201012-2036OC; Huang H, 2010, CYTOKINE, V51, P151, DOI 10.1016/j.cyto.2010.04.001; Huffman JA, 1996, J CLIN INVEST, V97, P649, DOI 10.1172/JCI118461; Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632; Jevsevar S, 2010, BIOTECHNOL J, V5, P113, DOI 10.1002/biot.200900218; KAUSHANSKY K, 1988, J CLIN INVEST, V81, P92, DOI 10.1172/JCI113316; KAUSHANSKY K, 1989, P NATL ACAD SCI USA, V86, P1213, DOI 10.1073/pnas.86.4.1213; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Liu WM, 2011, HUM VACCINES, V7, P94, DOI 10.4161/hv.7.0.14568; McClure B, 2001, BLOOD, V98, P3165, DOI 10.1182/blood.V98.10.3165; METCALF D, 1986, BLOOD, V67, P257; MIYATAKE S, 1985, EMBO J, V4, P2561, DOI 10.1002/j.1460-2075.1985.tb03971.x; Nishijima I, 1997, HUMAN GRANULOCYTE MA; Paine R, 2000, J IMMUNOL, V164, P2602, DOI 10.4049/jimmunol.164.5.2602; Paine R, 2012, CRIT CARE MED, V40, P90, DOI 10.1097/CCM.0b013e31822d7bf0; Reed JA, 1999, AM J PHYSIOL-LUNG C, V276, pL556, DOI 10.1152/ajplung.1999.276.4.L556; Reed JAH, 1997, AM J PHYSIOL-LUNG C, V273, pL715, DOI 10.1152/ajplung.1997.273.4.L715; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; SHANAFELT AB, 1989, P NATL ACAD SCI USA, V86, P4872, DOI 10.1073/pnas.86.13.4872; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Su YC, 2008, J IMMUNOL, V180, P2600, DOI 10.4049/jimmunol.180.4.2600; Subramaniam R, 2014, J INFECT DIS, V209, P1827, DOI 10.1093/infdis/jit830; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; Tazawa R, 2005, AM J RESP CRIT CARE, V171, P1142, DOI 10.1164/rccm.200406-716OC; Tazawa R, 2014, CHEST, V145, P729, DOI 10.1378/chest.13-0603; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Trilla A, 2008, CLIN INFECT DIS, V47, P668, DOI 10.1086/590567; Tuvim MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004176; Unkel B, 2012, J CLIN INVEST, V122, P3652, DOI 10.1172/JCI62139; Xue RY, 2012, TRANSGENIC RES, V21, P101, DOI 10.1007/s11248-011-9513-y; Yamashita N, 2002, CELL IMMUNOL, V219, P92, DOI 10.1016/S0008-8749(02)00565-8; Yu CH, 2011, BIOL RES NURS, V13, P32, DOI 10.1177/1099800410378160; Zhang YZ, 2006, EUR J PHARM SCI, V28, P212, DOI 10.1016/j.ejps.2006.02.014	46	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124593	10.1371/journal.pone.0124593	http://dx.doi.org/10.1371/journal.pone.0124593			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923215	Green Published, gold, Green Submitted			2022-12-27	WOS:000353711600096
J	Tsukahara, K; Sawada, H; Kohno, Y; Matsuura, T; Mori, IC; Terao, T; Ioki, M; Tamaoki, M				Tsukahara, Keita; Sawada, Hiroko; Kohno, Yoshihisa; Matsuura, Takakazu; Mori, Izumi C.; Terao, Tomio; Ioki, Motohide; Tamaoki, Masanori			Ozone-Induced Rice Grain Yield Loss Is Triggered via a Change in Panicle Morphology That Is Controlled by ABERRANT PANICLE ORGANIZATION 1 Gene	PLOS ONE			English	Article							SPIKELET DEVELOPMENT; QUANTITATIVE TRAITS; ABSCISIC-ACID; STRESS; QTL; DISSECTION; MECHANISMS; TOLERANCE; CULTIVARS; RESPONSES	Rice grain yield is predicted to decrease in the future because of an increase in tropospheric ozone concentration. However, the underlying mechanisms are unclear. Here, we investigated the responses to ozone of two rice (Oryza Sativa L.) cultivars, Sasanishiki and Habataki. Sasanishiki showed ozone-induced leaf injury, but no grain yield loss. By contrast, Habataki showed grain yield loss with minimal leaf injury. A QTL associated with grain yield loss caused by ozone was identified in Sasanishiki/Habataki chromosome segment substitution lines and included the ABERRANT PANICLE ORGANIZATION 1 (APO1) gene. The Habataki allele of the APO1 locus in a near-isogenic line also resulted in grain yield loss upon ozone exposure, suggesting APO1 involvement in ozone-induced yield loss. Only a few differences in the APO1 amino acid sequences were detected between the cultivars, but the APO1 transcript level was oppositely regulated by ozone exposure: i.e., it increased in Sasanishiki and decreased in Habataki. Interestingly, the levels of some phytohormones (jasmonic acid, jasmonoyl-L-isoleucine, and abscisic acid) known to be involved in attenuation of ozone-induced leaf injury tended to decrease in Sasanishiki but to increase in Habataki upon ozone exposure. These data indicate that ozone-induced grain yield loss in Habataki is caused by a reduction in the APO1 transcript level through an increase in the levels of phytohormones that reduce leaf damage.	[Tsukahara, Keita; Sawada, Hiroko; Ioki, Motohide; Tamaoki, Masanori] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst, Tsukuba, Ibaraki 3058506, Japan; [Tsukahara, Keita; Tamaoki, Masanori] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Kohno, Yoshihisa] Cent Res Inst Elect Power Ind, Abiko, Chiba 2701194, Japan; [Matsuura, Takakazu; Mori, Izumi C.] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan; [Terao, Tomio] Natl Agr & Food Res Org, NARO Agr Res Ctr, Hokuriku Res Ctr, Crop Dev Div, Joetsu, Niigata 9430193, Japan	National Institute for Environmental Studies - Japan; University of Tsukuba; Central Research Institute of Electric Power Industry - Japan; Okayama University; National Agriculture & Food Research Organization - Japan	Tamaoki, M (corresponding author), Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst, Tsukuba, Ibaraki 3058506, Japan.	mtamaoki@nies.go.jp		Sawada, Hiroko/0000-0002-3232-710X; Mori, Izumi/0000-0002-2235-0779	Global Environment Research Fund of the Ministry of the Environment, Japan [A-0806]; Japan Advanced Plant Science Network	Global Environment Research Fund of the Ministry of the Environment, Japan; Japan Advanced Plant Science Network	This work was supported by the Global Environment Research Fund (A-0806) of the Ministry of the Environment, Japan to YK and MT (http://www.env.go.jp/policy/kenkyu/suishin/english/index.html), and by the Japan Advanced Plant Science Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2010, ENVIRON POLLUT, V158, P2970, DOI 10.1016/j.envpol.2010.05.026; Ando T, 2008, THEOR APPL GENET, V116, P881, DOI 10.1007/s00122-008-0722-6; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Ashmore M, 2006, NEW PHYTOL, V170, P201, DOI 10.1111/j.1469-8137.2006.01709.x; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cai Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4476; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Frei M, 2008, J EXP BOT, V59, P3741, DOI 10.1093/jxb/ern222; GUPTA AS, 1991, PLANT PHYSIOL, V96, P650, DOI 10.1104/pp.96.2.650; Haldane JBS, 1919, J GENET, V8, P299; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Hoeberichts FA, 2003, BIOESSAYS, V25, P47, DOI 10.1002/bies.10175; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iehisa JCM, 2014, J PLANT PHYSIOL, V171, P25, DOI 10.1016/j.jplph.2013.10.001; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Ikeda K, 2007, PLANT J, V51, P1030, DOI 10.1111/j.1365-313X.2007.03200.x; KANGASJARVI J, 1994, PLANT CELL ENVIRON, V17, P783, DOI 10.1111/j.1365-3040.1994.tb00173.x; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim EH, 2009, PLANT SIGNAL BEHAV, V4, P348, DOI 10.4161/psb.4.4.8199; Kim EH, 2009, PLANT PHYSIOL, V149, P1751, DOI 10.1104/pp.108.134684; KRUPA SV, 1988, ENVIRON POLLUT, V50, P101, DOI 10.1016/0269-7491(88)90187-X; Laloi C, 2004, CURR OPIN PLANT BIOL, V7, P323, DOI 10.1016/j.pbi.2004.03.005; LANDER ES, 1989, GENETICS, V121, P185; Lin DI, 2001, PLANT GROWTH REGUL, V35, P295, DOI 10.1023/A:1014427505353; Overmyer K, 2003, TRENDS PLANT SCI, V8, P335, DOI 10.1016/S1360-1385(03)00135-3; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Pell EJ, 1997, PHYSIOL PLANTARUM, V100, P264, DOI 10.1034/j.1399-3054.1997.1000207.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rao MV, 2001, PLANTA, V213, P682, DOI 10.1007/s004250100618; Sandermann H, 1998, TRENDS PLANT SCI, V3, P47, DOI 10.1016/S1360-1385(97)01162-X; Sawada H, 2009, PLANT BIOLOGY, V11, P70, DOI 10.1111/j.1438-8677.2009.00233.x; Sharma YK, 1997, FREE RADICAL BIO MED, V23, P480, DOI 10.1016/S0891-5849(97)00108-1; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Spartz AK, 2008, GENE DEV, V22, P2139, DOI 10.1101/gad.1693208; Terao T, 2010, THEOR APPL GENET, V120, P875, DOI 10.1007/s00122-009-1218-8; Tsukahara K, 2013, ENVIRON EXP BOT, V88, P100, DOI 10.1016/j.envexpbot.2011.12.012; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yang JC, 2004, PLANT CELL ENVIRON, V27, P1055, DOI 10.1111/j.1365-3040.2004.01210.x	43	27	31	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123308	10.1371/journal.pone.0123308	http://dx.doi.org/10.1371/journal.pone.0123308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923431	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600038
J	Banga, S; Coursen, JD; Portugal, S; Tran, TM; Hancox, L; Ongoiba, A; Traore, B; Doumbo, OK; Huang, CY; Harty, JT; Crompton, PD				Banga, Simran; Coursen, Jill D.; Portugal, Silvia; Tran, Tuan M.; Hancox, Lisa; Ongoiba, Aissata; Traore, Boubacar; Doumbo, Ogobara K.; Huang, Chiung-Yu; Harty, John T.; Crompton, Peter D.			Impact of Acute Malaria on Pre-Existing Antibodies to Viral and Vaccine Antigens in Mice and Humans	PLOS ONE			English	Article							MEMORY B-CELLS; PLASMODIUM-FALCIPARUM; CHILDREN; ACTIVATION; RESPONSES; DURATION; IMMUNITY	Vaccine-induced immunity depends on long-lived plasma cells (LLPCs) that maintain antibody levels. A recent mouse study showed that Plasmodium chaubaudi infection reduced pre-existing influenza-specific antibodies-raising concerns that malaria may compromise pre-existing vaccine responses. We extended these findings to P. yoelii infection, observing decreases in antibodies to model antigens in inbred mice and to influenza in outbred mice, associated with LLPC depletion and increased susceptibility to influenza rechallenge. We investigated the implications of these findings in Malian children by measuring vaccine-specific IgG (tetanus, measles, hepatitis B) before and after the malaria-free 6-month dry season, 10 days after the first malaria episode of the malaria season, and after the subsequent dry season. On average, vaccine-specific IgG did not decrease following acute malaria. However, in some children malaria was associated with an accelerated decline in vaccine-specific IgG, underscoring the need to further investigate the impact of malaria on pre-existing vaccine-specific antibodies.	[Banga, Simran; Hancox, Lisa; Harty, John T.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Coursen, Jill D.; Portugal, Silvia; Tran, Tuan M.; Crompton, Peter D.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Ongoiba, Aissata; Traore, Boubacar; Doumbo, Ogobara K.] Univ Sci Tech & Technol Bamako, Mali Int Ctr Excellence Res, Bamako, Mali; [Huang, Chiung-Yu] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Div Biostat & Bioinformat, Baltimore, MD USA; [Harty, John T.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Harty, John T.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA	University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Science & Technology of Bamako; Johns Hopkins University; Johns Hopkins Medicine; University of Iowa; University of Iowa	Harty, JT (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	john-harty@uiowa.edu; pcrompton@niaid.nih.gov	Banga, Simran/L-8806-2013; Crompton, Peter/N-1130-2016; Tran, Tuan M./H-9439-2019	Tran, Tuan M./0000-0002-1928-861X; Hancox, Lisa/0000-0003-1940-2619; Harty, John/0000-0001-7266-2802; Portugal, Silvia/0000-0003-4567-9101	National Institutes of Health (NIH) [AI085515, AI095178, AI100527]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085515, R01AI100527, R01AI095178, ZIAAI001155] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Malaria work in the JTH laboratory is supported by National Institutes of Health (NIH) grants (AI085515, AI095178, AI100527). The PDC laboratory and study in Mali is supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Amanna IJ, 2012, HUM IMMUNOL, V73, P1082, DOI 10.1016/j.humimm.2012.07.328; Amanna IJ, 2010, IMMUNOL REV, V236, P125, DOI 10.1111/j.1600-065X.2010.00912.x; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; BIN D, 1991, B WORLD HEALTH ORGAN, V69, P415; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Centers for Disease C Prevention. Global routine vaccination coverage, 2011, MMWR-MORBID MORTAL W, V61, P883; CHEN RT, 1990, J INFECT DIS, V162, P1036, DOI 10.1093/infdis/162.5.1036; Crompton PD, 2008, J INFECT DIS, V198, P1265, DOI 10.1086/592224; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Donati D, 2006, J IMMUNOL, V177, P3035, DOI 10.4049/jimmunol.177.5.3035; GREENWOOD BM, 1972, LANCET, V1, P169; Hepatitis B, 2009, WKLY EPIDEMIOL REC, V84, P405; Illingworth J, 2013, J IMMUNOL, V190, P1038, DOI 10.4049/jimmunol.1202438; Jack AD, 1999, J INFECT DIS, V179, P489, DOI 10.1086/314578; KEJA K, 1988, World Health Statistics Quarterly, V41, P59; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Minta D K, 2012, Bull Soc Pathol Exot, V105, P58, DOI 10.1007/s13149-011-0204-y; Nduati E, 2011, J INFECT DIS, V204, P962, DOI 10.1093/infdis/jir438; Ng DHL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003843; Okwo-Bele JM, 2011, VACCINE, V29, pD74, DOI 10.1016/j.vaccine.2012.01.080; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Portugal S, 2013, J IMMUNOL, V190, P3039, DOI 10.4049/jimmunol.1203067; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Rogers NJ, 2000, INFECT IMMUN, V68, P3455, DOI 10.1128/IAI.68.6.3455-3462.2000; Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Tetanus vaccine, 2006, HLTH SECTION SECRETA, V81, P198; Tran TM, 2013, CLIN INFECT DIS, V57, P40, DOI 10.1093/cid/cit174; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, IMM SUMM, P106; Wolters K. L., 1942, ZEITSCHR HYG U INJEKTIONSKRANKH, V124, P326, DOI 10.1007/BF02178438	35	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125090	10.1371/journal.pone.0125090	http://dx.doi.org/10.1371/journal.pone.0125090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919588	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659400072
J	Chen, PL; Li, YC; Toback, FG				Chen, Peili; Li, Yan Chun; Toback, F. Gary			AMP-18 Targets p21 to Maintain Epithelial Homeostasis	PLOS ONE			English	Article							SODIUM-INDUCED COLITIS; INFLAMMATORY-BOWEL-DISEASE; CELL-CYCLE INHIBITORS; VITAMIN-D-RECEPTOR; BARRIER FUNCTION; TNF-ALPHA; INTESTINAL BARRIER; CROHNS-DISEASE; APOPTOSIS; PROLIFERATION	Dysregulated homeostasis of epithelial cells resulting in disruption of mucosal barrier function is an important pathogenic mechanism in inflammatory bowel diseases (IBD). We have characterized a novel gastric protein, Antrum Mucosal Protein (AMP)-18, that has pleiotropic properties; it is mitogenic, anti-apoptotic and can stimulate formation of tight junctions. A 21-mer synthetic peptide derived from AMP-18 exhibits the same biological functions as the full-length protein and is an effective therapeutic agent in mouse models of IBD. In this study we set out to characterize therapeutic mechanisms and identify molecular targets by which AMP-18 maintains and restores disrupted epithelial homeostasis in cultured intestinal epithelial cells and a mouse model of IBD. Tumor necrosis factor (TNF)-alpha, a pro-inflammatory cytokine known to mediate gastrointestinal (GI) mucosal injury in IBD, was used to induce intestinal epithelial cell injury, and study the effects of AMP-18 on apoptosis and the cell cycle. An apoptosis array used to search for targets of AMP-18 in cells exposed to TNF-alpha identified the cyclin-dependent kinase inhibitor p21(WAF1/CIP1). Treatment with AMP-18 blunted increases in p21 expression and apoptosis, while reversing disturbed cell cycle kinetics induced by TNF-alpha. AMP-18 appears to act through PI3K/AKT pathways to increase p21 phosphorylation, thereby reducing its nuclear accumulation to overcome the antiproliferative effects of TNF-alpha. In vitamin D receptor-deficient mice with TNBS-induced IBD, the observed increase in p21 expression in colonic epithelial cells was suppressed by treatment with AMP peptide. The results indicate that AMP-18 can maintain and/or restore the homeostatic balance between proliferation and apoptosis in intestinal epithelial cells to protect and repair mucosal barrier homeostasis and function, suggesting a therapeutic role in IBD.	[Chen, Peili; Li, Yan Chun; Toback, F. Gary] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Chen, PL (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	pchen@medicine.bsd.uchicago.edu; gtoback@medicine.bsd.uchicago.edu			National Cancer Institute [CA 176032]; CA 180087; NATIONAL CANCER INSTITUTE [R01CA180087, R21CA176032] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CA 180087; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants from the National Cancer Institute: CA 176032 to F. G. Toback; CA 180087 to YC Li (www.cancer.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2000, GASTROENTEROLOGY, V119, P1524, DOI 10.1053/gast.2000.20232; Arai N, 1999, MODERN PATHOL, V12, P604; Araki Y, 2010, ONCOL REP, V24, P869, DOI 10.3892/or_00000932; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Butzner JD, 1996, GUT, V38, P568, DOI 10.1136/gut.38.4.568; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Chen PL, 2012, INFLAMM BOWEL DIS, V18, P1749, DOI 10.1002/ibd.22886; Chen PL, 2011, ORAL ONCOL, V47, P831, DOI 10.1016/j.oraloncology.2011.06.012; Chen Y, 2012, BIOINFORMATICS, V28, P1, DOI 10.1093/bioinformatics/btr619; COOPER HS, 1993, LAB INVEST, V69, P238; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Edelblum KL, 2009, CURR OPIN PHARMACOL, V9, P715, DOI 10.1016/j.coph.2009.06.022; Edelblum KL, 2006, INFLAMM BOWEL DIS, V12, P413, DOI 10.1097/01.MIB.0000217334.30689.3e; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Gartel AL, 2005, LEUKEMIA RES, V29, P1237, DOI 10.1016/j.leukres.2005.04.023; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Ghanem L, 2005, LEUKEMIA RES, V29, P1315, DOI 10.1016/j.leukres.2005.03.018; Gitter AH, 2000, FASEB J, V14, P1749, DOI 10.1096/fj.99-0898com; Goretsky T, 2012, AM J PATHOL, V181, P1306, DOI 10.1016/j.ajpath.2012.06.016; HALL PA, 1994, J CELL SCI, V107, P3569; Ioachim EE, 2004, INT J COLORECTAL DIS, V19, P325, DOI 10.1007/s00384-003-0571-3; Iwamoto M, 1996, J PATHOL, V180, P152; Joo YE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004562; Kong J, 2008, AM J PHYSIOL-GASTR L, V294, pG208, DOI 10.1152/ajpgi.00398.2007; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Liu SX, 2003, DRUG RESIST UPDATE, V6, P183, DOI 10.1016/S1368-7646(03)00044-X; Liu WC, 2013, J CLIN INVEST, V123, P3983, DOI 10.1172/JCI65842; Manapov F, 2005, GUT, V54, P814, DOI 10.1136/gut.2003.036491; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Marini M, 2003, P NATL ACAD SCI USA, V100, P8366, DOI 10.1073/pnas.1432897100; Martin TE, 2003, AM J PHYSIOL-GASTR L, V285, pG332, DOI 10.1152/ajpgi.00453.2002; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Miller JP, 2007, CELL CYCLE, V6, P2932, DOI 10.4161/cc.6.23.5042; Pavelic SK, 2008, CANCER GENE THER, V15, P576, DOI 10.1038/cgt.2008.28; Rutgeerts P, 2004, GASTROENTEROLOGY, V126, P1593, DOI 10.1053/j.gastro.2004.02.070; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Schmitz H, 1999, GASTROENTEROLOGY, V116, P301, DOI 10.1016/S0016-5085(99)70126-5; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Sipos F, 2005, DIS COLON RECTUM, V48, P775, DOI 10.1007/s10350-004-0831-5; Strater J, 1997, GASTROENTEROLOGY, V113, P160, DOI 10.1016/S0016-5085(97)70091-X; Toback FG, 2003, AM J PHYSIOL-GASTR L, V285, pG344, DOI 10.1152/ajpgi.00455.2002; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Vetuschi A, 2002, DIGEST DIS SCI, V47, P1447, DOI 10.1023/A:1015931128583; Vidal A, 2000, GENE, V247, P1, DOI 10.1016/S0378-1119(00)00092-5; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Walsh-Reitz MM, 2005, AM J PHYSIOL-GASTR L, V289, pG163, DOI 10.1152/ajpgi.00013.2005; Wang Y, 2006, J CLIN INVEST, V116, P1535, DOI 10.1172/JCI25442; Wu SP, 2010, AM J PATHOL, V177, P686, DOI 10.2353/ajpath.2010.090998; Wu XY, 2012, INT J RADIAT ONCOL, V83, pE409, DOI 10.1016/j.ijrobp.2012.01.006; Xing R, 2012, GUT, V61, P43, DOI 10.1136/gut.2010.230623; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yoon JH, 2013, J CELL BIOCHEM, V114, P1800, DOI 10.1002/jcb.24524; Yoon JH, 2011, J CANCER RES CLIN, V137, P1697, DOI 10.1007/s00432-011-1051-8; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632; Zhang YD, 2007, MOL CANCER RES, V5, P909, DOI 10.1158/1541-7786.MCR-06-0388; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	62	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125490	10.1371/journal.pone.0125490	http://dx.doi.org/10.1371/journal.pone.0125490			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919700	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400085
J	Luo, XY; Fan, Y; Park, IW; He, JJ				Luo, Xiaoyu; Fan, Yan; Park, In-Woo; He, Johnny J.			Exosomes Are Unlikely Involved in Intercellular Nef Transfer	PLOS ONE			English	Article							VIRUS TYPE-1 NEF; HEPATITIS-C VIRUS; CD4(+) T-CELLS; HIV-1 NEF; DOWN-REGULATION; IN-VITRO; TUNNELING NANOTUBES; ACCESSORY PROTEINS; INFECTED-CELLS; IMMUNODEFICIENCY	HIV-1 Nef is an important pathogenic factor for HIV/AIDS pathogenesis. Several recent studies including ours have demonstrated that Nef can be transferred to neighboring cells and alters the function of these cells. However, how the intercellular Nef transfer occurs is in dispute. In the current study, we attempted to address this important issue using several complementary strategies, a panel of exosomal markers, and human CD4+ T lymphocyte cell line Jurkat and a commonly used cell line 293T. First, we showed that Nef was transferred from Nef-expressing or HIV-infected Jurkat to naive Jurkat and other non-Jurkat cells and that the transfer required the membrane targeting function of Nef and was cell density-dependent. Then, we showed that Nef transfer was cell-cell contact-dependent, as exposure to culture supernatants or exosomes from HIV-infected Jurkat or Nef-expressing Jurkat and 293T led to little Nef detection in the target cells Jurkat. Thirdly, we demonstrated that Nef was only detected to be associated with HIV virions but not with acetylcholinesterase (AChE+) exosomes from HIV-infected Jurkat and not in the exosomes from Nef-expressing Jurkat. In comparison, when it was over-expressed in 293T, Nef was detected in detergent-insoluble AChE+/CD81(low)/TSG101(low) exosomes, but not in detergent-soluble AChE-/CD81(high)/TSG101(high) exosomes. Lastly, microscopic imaging showed no significant Nef detection in exosomal vesicle-like structures in and out 293T. Taken together, these results show that exosomes are unlikely involved in intercellular Nef transfer. In addition, this study reveals existence of two types of exosomes: AChE+/CD81(low)/TSG101(low) exosomes and AChE-/CD81(high)/TSG101(high) exosomes.	[Luo, Xiaoyu; Fan, Yan; Park, In-Woo; He, Johnny J.] Univ N Texas, Hlth Sci Ctr, Grad Sch Biomed Sci, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center	He, JJ (corresponding author), Univ N Texas, Hlth Sci Ctr, Grad Sch Biomed Sci, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA.	johnny.he@unthsc.edu	Fan, Yan/F-5107-2018	Luo, Xiaoyu/0000-0001-6059-0434	National Institutes of Health [NIH/NINDS R01NS065785, NIH/NIMH R01MH092673]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants NIH/NINDS R01NS065785 and NIH/NIMH R01MH092673 (to JJH) from National Institutes of Health.	Ahmed KA, 2008, CELL MOL IMMUNOL, V5, P261, DOI 10.1038/cmi.2008.32; Ahmed KA, 2011, J CELL MOL MED, V15, P1458, DOI 10.1111/j.1582-4934.2010.01008.x; AMEISEN JC, 1989, AIDS RES HUM RETROV, V5, P279, DOI 10.1089/aid.1989.5.279; Arenaccio C, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-46; Aucher A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/907371; Bentham M, 2006, J GEN VIROL, V87, P563, DOI 10.1099/vir.0.81200-0; Blanco J, 2004, J BIOL CHEM, V279, P51305, DOI 10.1074/jbc.M408547200; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Campbell Tamika D, 2008, Ethn Dis, V18, pS2; Cantin R, 2008, J IMMUNOL METHODS, V338, P21, DOI 10.1016/j.jim.2008.07.007; Caumartin J, 2006, TRANSPL IMMUNOL, V17, P20, DOI 10.1016/j.trim.2006.09.032; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Choi DS, 2014, MASS SPECTROMETRY RE; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Cocucci E, 2011, CURR BIOL, V21, pR940, DOI 10.1016/j.cub.2011.10.011; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Costin JM, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-100; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Das SR, 2005, INDIAN J MED RES, V121, P315; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; de Carvalho JV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113691; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; DERONDE A, 1992, VIROLOGY, V188, P391, DOI 10.1016/0042-6822(92)90772-H; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Fackler OT, 1996, VIRUS RES, V46, P105, DOI 10.1016/S0168-1702(96)01389-5; Foster JL, 2007, ADV PHARMACOL, V55, P389, DOI 10.1016/S1054-3589(07)55011-8; Fritzsching B, 2002, J IMMUNOL, V169, P5531, DOI 10.4049/jimmunol.169.10.5531; Fujii Y, 1996, J GEN VIROL, V77, P2943, DOI 10.1099/0022-1317-77-12-2943; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Gerlach H, 2010, NAT CHEM BIOL, V6, P46, DOI [10.1038/NCHEMBIO.268, 10.1038/nchembio.268]; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Green LA, 2009, J BIOL CHEM, V284, P13363, DOI 10.1074/jbc.M806631200; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Gulizia RJ, 1997, J VIROL, V71, P4161, DOI 10.1128/JVI.71.5.4161-4164.1997; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; James CO, 2004, J VIROL, V78, P3099, DOI 10.1128/JVI.78.6.3099-3109.2004; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; KAMINCHIK J, 1994, AIDS RES HUM RETROV, V10, P1003, DOI 10.1089/aid.1994.10.1003; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Khan IH, 1998, J VIROL, V72, P5820, DOI 10.1128/JVI.72.7.5820-5830.1998; Kimura S, 2012, EXP CELL RES, V318, P1699, DOI 10.1016/j.yexcr.2012.05.013; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Krogstad Paul, 2003, Semin Pediatr Infect Dis, V14, P258, DOI 10.1053/j.spid.2003.09.007; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Liu Y, 2002, J BIOL CHEM, V277, P23854, DOI 10.1074/jbc.M200773200; Liu ZQ, 2014, BIOCHEM BIOPH RES CO, V455, P218, DOI 10.1016/j.bbrc.2014.10.146; Liu ZQ, 2013, J VIROL, V87, P8545, DOI 10.1128/JVI.01062-13; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mangino G, 2007, J VIROL, V81, P2777, DOI 10.1128/JVI.01640-06; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mignot G, 2006, J CELL MOL MED, V10, P376, DOI 10.1111/j.1582-4934.2006.tb00406.x; Morita D, 2011, J IMMUNOL, V187, P608, DOI 10.4049/jimmunol.1101216; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895; Ohno Hiroshi, 2010, Commun Integr Biol, V3, P231; OVOD V, 1992, AIDS, V6, P25, DOI 10.1097/00002030-199201000-00003; Pandori MW, 1996, J VIROL, V70, P4283, DOI 10.1128/JVI.70.7.4283-4290.1996; Park IW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099545; Park IW, 2013, ARCH VIROL, V158, P845, DOI 10.1007/s00705-012-1560-z; Park IW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-234; Park IW, 2009, J LEUKOCYTE BIOL, V86, P1171, DOI 10.1189/jlb.0409261; Parolini I, 1996, BLOOD, V87, P3783, DOI 10.1182/blood.V87.9.3783.bloodjournal8793783; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Puigdomenech I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-89; Qi ML, 2008, VIROLOGY, V373, P287, DOI 10.1016/j.virol.2007.12.001; Quaranta MG, 2003, FASEB J, V17, P2025, DOI 10.1096/fj.03-0272com; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Salvi R, 1998, J VIROL, V72, P3646, DOI 10.1128/JVI.72.5.3646-3657.1998; Shelton MN, 2012, J VIROL, V86, P406, DOI 10.1128/JVI.05720-11; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; Sierra S, 2005, J CLIN VIROL, V34, P233, DOI 10.1016/j.jcv.2005.09.004; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; Szilluweit R, 2009, BIOPHYS J, V96, P3242, DOI 10.1016/j.bpj.2008.12.3947; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; TRONO D, 1995, CELL, V82, P189, DOI 10.1016/0092-8674(95)90306-2; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Welker R, 1998, J VIROL, V72, P8833, DOI 10.1128/JVI.72.11.8833-8840.1998; Welker R, 1996, VIROLOGY, V219, P228, DOI 10.1006/viro.1996.0240; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; ZAZOPOULOS E, 1993, J VIROL, V67, P1676, DOI 10.1128/JVI.67.3.1676-1680.1993	93	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124436	10.1371/journal.pone.0124436	http://dx.doi.org/10.1371/journal.pone.0124436			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919665	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659400051
J	Akacem, LD; Simpkin, CT; Carskadon, MA; Wright, KP; Jenni, OG; Achermann, P; LeBourgeois, MK				Akacem, Lameese D.; Simpkin, Charles T.; Carskadon, Mary A.; Wright, Kenneth P., Jr.; Jenni, Oskar G.; Achermann, Peter; LeBourgeois, Monique K.			The Timing of the Circadian Clock and Sleep Differ between Napping and Non-Napping Toddlers	PLOS ONE			English	Article							NOCTURNAL SLEEP; PHASE-SHIFT; LIGHT; MELATONIN; PATTERNS; CHILDREN; RHYTHM; NAPS; KINDERGARTEN; PHYSIOLOGY	The timing of the internal circadian clock shows large inter-individual variability across the lifespan. Although the sleep-wakefulness pattern of most toddlers includes an afternoon nap, the association between napping and circadian phase in early childhood remains unexplored. This study examined differences in circadian phase and sleep between napping and non-napping toddlers. Data were collected on 20 toddlers (34.2 +/- 2.0 months; 12 females; 15 nappers). Children followed their habitual napping and non-napping sleep schedules (monitored with actigraphy) for 5 days before an in-home salivary dim light melatonin onset (DLMO) assessment. On average, napping children fell asleep during their nap opportunities on 3.6 +/- 1.2 of the 5 days before the DLMO assessment. For these napping children, melatonin onset time was 38 min later (p = 0.044; d = 0.93), actigraphically-estimated bedtime was 43 min later (p = 0.014; d = 1.24), sleep onset time was 59 min later (p = 0.006; d = 1.46), and sleep onset latency was 16 min longer (p = 0.030; d = 1.03) than those not napping. Midsleep and wake time did not differ by napping status. No difference was observed in the bedtime, sleep onset, or midsleep phase relationships with DLMO; however, the wake time phase difference was 47 min smaller for napping toddlers (p = 0.029; d = 1.23). On average, nappers had 69 min shorter nighttime sleep durations (p = 0.006; d = 1.47) and spent 49 min less time in bed (p = 0.019; d = 1.16) than non-nappers. Number of days napping was correlated with melatonin onset time (r = 0.49;p = 0.014). Our findings indicate that napping influences individual variability in melatonin onset time in early childhood. The delayed bedtimes of napping toddlers likely permits light exposure later in the evening, thereby delaying the timing of the clock and sleep. Whether the early developmental trajectory of circadian phase involves an advance associated with the decline in napping is a question necessitating longitudinal data as children transition from a biphasic to monophasic sleep-wakefulness pattern.	[Akacem, Lameese D.; Simpkin, Charles T.; LeBourgeois, Monique K.] Univ Colorado, Dept Integrat Physiol, Sleep & Dev Lab, Boulder, CO 80309 USA; [Simpkin, Charles T.] Rocky Vista Univ, Coll Osteopath Med, Parker, CO USA; [Carskadon, Mary A.] Brown Univ, Warren Alpert Med Sch, Sleep & Chronobiol Lab, EP Bradley Hosp,Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Carskadon, Mary A.] Univ S Australia, Sch Psychol Social Work & Social Policy, Ctr Sleep Res, Adelaide, SA 5001, Australia; [Wright, Kenneth P., Jr.] Univ Colorado, Dept Integrat Physiol, Sleep & Chronobiol Lab, Boulder, CO 80309 USA; [Jenni, Oskar G.] Univ Childrens Hosp Zurich, Child Dev Ctr, Zurich, Switzerland; [Achermann, Peter] Univ Zurich, Inst Pharmacol & Toxicol, Sect Chronobiol & Sleep Res, Zurich, Switzerland	University of Colorado System; University of Colorado Boulder; Brown University; University of South Australia; University of Colorado System; University of Colorado Boulder; University Children's Hospital Zurich; University of Zurich	LeBourgeois, MK (corresponding author), Univ Colorado, Dept Integrat Physiol, Sleep & Dev Lab, Boulder, CO 80309 USA.	monique.lebourgeois@colorado.edu	Jenni, Oskar/AAG-4391-2019; Achermann, Peter/N-1215-2014	Jenni, Oskar/0000-0002-4561-6277; Achermann, Peter/0000-0002-0208-3511	National Institutes of Health [K01-MH074643, R01-MH08566]; Howard Hughes Medical Institute through the Biological Sciences Initiative at the University of Colorado Boulder; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH074643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute through the Biological Sciences Initiative at the University of Colorado Boulder; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	K01-MH074643 and R01-MH08566 were awarded to MKL from the National Institutes of Health (http://www.nih.gov/). LDA and CTS received grants from the Howard Hughes Medical Institute through the Biological Sciences Initiative at the University of Colorado Boulder (http://bsi.colotado.edu/)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebo C, 2005, SLEEP, V28, P1568, DOI 10.1093/sleep/28.12.1568; Achermann P, 2003, FRONT BIOSCI-LANDMRK, V8, pS683, DOI 10.2741/1064; BELTRAMINI AU, 1983, PEDIATRICS, V71, P153; Berger RH, 2012, J SLEEP RES, V21, P235, DOI 10.1111/j.1365-2869.2011.00962.x; Borbely A A, 1982, Hum Neurobiol, V1, P195; Bruni O, 2000, CLIN NEUROPHYSIOLO S, V53, P358; Burgess Helen J, 2003, Behav Sleep Med, V1, P102, DOI 10.1207/S15402010BSM0102_3; Burgess HJ, 2005, J SLEEP RES, V14, P229, DOI 10.1111/j.1365-2869.2005.00470.x; Burgess HJ, 2004, NEUROSCI LETT, V356, P115, DOI 10.1016/j.neulet.2003.11.032; Buxton OM, 2000, AM J PHYSIOL-REG I, V278, pR373, DOI 10.1152/ajpregu.2000.278.2.R373; Cairns A, 2013, BEHAV SLEEP MED, V12, P1, DOI [10.1080/15402002.2012.720315, DOI 10.1080/15402002.2012.720315]; Cajochen C, 2007, SLEEP MED REV, V11, P453, DOI 10.1016/j.smrv.2007.07.009; Cajochen C, 2011, J APPL PHYSIOL, V110, P1432, DOI 10.1152/japplphysiol.00165.2011; Carskadon MA, 2004, ANN NY ACAD SCI, V1021, P276, DOI 10.1196/annals.1308.032; Chang A, 2012, SLEEP, V35, pA205; Cohen J.E., 1988, STAT POWER ANAL BEHA; Common Sense Media, 2013, ZER 8 CHILDR MED US; Craven HJ, 2012, SLEEP, V35, pA127; Crosby B, 2005, PEDIATRICS, V115, P225, DOI 10.1542/peds.2004-0815D; Crowley SJ, 2007, SLEEP MED, V8, P602, DOI 10.1016/j.sleep.2006.12.002; Crowley SJ, 2006, SLEEP, V29, P1632, DOI 10.1093/sleep/29.12.1632; Crowley SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112199; CZEISLER CA, 1995, CIBA F SYMP, V183, P254; Dahl R E, 1996, Semin Pediatr Neurol, V3, P44, DOI 10.1016/S1071-9091(96)80028-3; Dales RJ, 1941, PEDAGOG SEMIN J GEN, V58, P161; Daniel LC, 2005, SLEEP, V28, pA102; Gooneratne NS, 2003, J PINEAL RES, V34, P88, DOI 10.1034/j.1600-079X.2003.02945.x; Hartman VA, 2011, SLEEP, V34, pA272; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Jenni OG, 2006, CURR OPIN PSYCHIATR, V19, P282, DOI 10.1097/01.yco.0000218599.32969.03; Jenni OG, 2005, PEDIATRICS S, V115, P204; Kawinska A, 2005, J BIOL RHYTHM, V20, P451, DOI 10.1177/0748730405280248; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; KOCH P, 1984, ACTA PAEDIATR SCAND, V73, P667, DOI 10.1111/j.1651-2227.1984.tb09993.x; Komada Y, 2012, SLEEP MED, V13, P107, DOI 10.1016/j.sleep.2011.10.017; Kurdziel L, 2013, P NATL ACAD SCI USA, V110, P17267, DOI 10.1073/pnas.1306418110; Lassonde J, 2013, SLEEP, V36, pA342; LeBourgeois MK, 2013, MIND BRAIN EDUC, V7, P234, DOI 10.1111/mbe.12032; LeBourgeois MK, 2013, J BIOL RHYTHM, V28, P322, DOI 10.1177/0748730413506543; LOZOFF B, 1985, PEDIATRICS, V75, P477; Martin SK, 2002, CHRONOBIOL INT, V19, P695, DOI 10.1081/CBI-120006080; Mason TBA, 2005, J PEDIATR-US, V147, P388, DOI 10.1016/j.jpeds.2005.06.042; Miller AL, 2014, J SLEEP RES; Pierpoint LA, 2014, SLEEP, V37, pA10; Sakashita Y, 1995, JAPANESE J MED PSYCH, V4, P27; Simpkin CT, 2014, J SLEEP RES, V23, P397, DOI 10.1111/jsr.12142; Thorleifsdottir B, 2002, J PSYCHOSOM RES, V53, P529, DOI 10.1016/S0022-3999(02)00444-0; Tikotzky L, 2001, J CLIN CHILD PSYCHOL, V30, P581, DOI 10.1207/S15374424JCCP3004_13; U.S. Department of Health and Human Services Website, 2008, WORK MOTH CHILD CAR; van der Lely S, 2015, J ADOLESCENT HEALTH, V56, P113, DOI 10.1016/j.jadohealth.2014.08.002; Ward TM, 2008, J PEDIATR PSYCHOL, V33, P666, DOI 10.1093/jpepsy/jsm102; WEISSBLUTH M, 1995, SLEEP, V18, P82, DOI 10.1093/sleep/18.2.82; Werth E, 1996, AM J PHYSIOL-REG I, V271, pR501, DOI 10.1152/ajpregu.1996.271.3.R501; Wood B, 2013, APPL ERGON, V44, P237, DOI 10.1016/j.apergo.2012.07.008; Wright KP, 2013, CURR BIOL, V23, P1554, DOI 10.1016/j.cub.2013.06.039	55	30	32	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125181	10.1371/journal.pone.0125181	http://dx.doi.org/10.1371/journal.pone.0125181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915066	Green Published, gold, Green Accepted			2022-12-27	WOS:000353659100105
J	Li, N; Peng, W; Shi, JQ; Wang, XF; Liu, GH; Wang, HZ				Li, Na; Peng, Wei; Shi, Jiaqin; Wang, Xinfa; Liu, Guihua; Wang, Hanzhong			The Natural Variation of Seed Weight Is Mainly Controlled by Maternal Genotype in Rapeseed (Brassica napus L.)	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; GENETIC-STRUCTURE; CELL ELONGATION; SIZE; ASSOCIATION; LINKAGE; TRAITS; MARKER; GROWTH; YIELD	Seed weight is a very important and complex trait in rapeseed (Brassica napus L.). The seed weight of rapeseed shows great variation in its natural germplasm resources; however, the morphological, cytological and genetic causes of this variation have remained unclear. In the present study, nine highly pure inbred rapeseed lines with large seed weight variation and different genetic backgrounds were selected for morphological, cytological and genetic studies on seed weight. The results showed the following: (1) Seed weight showed an extremely significant correlation and coordinated variation with seed size (including seed diameter, seed surface area and seed volume), but it showed no significant correlation with bulk density, which suggests that seed weight is determined by size rather than bulk density. (2) Seed weight showed a higher correlation with the cell numbers of seed coats and cotyledons than the cell sizes of seed coats and cotyledons, which suggests that cell number is more tightly correlated with final seed weight. (3) Seed weight was mainly controlled by the maternal genotype, with little or no xenia and cytoplasmic effects. This is the first report on the morphological and cytological causes of seed weight natural variation in rapeseed. We concluded that the natural variation of seed weight is mainly controlled by maternal genotype. This finding lays a foundation for genetic and breeding studies of seed weight in rapeseed and opens a new field of research on the regulation of seed traits in plants.	[Li, Na; Peng, Wei; Shi, Jiaqin; Wang, Xinfa; Liu, Guihua; Wang, Hanzhong] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan 430062, Hubei Province, Peoples R China; [Peng, Wei] Hubei Univ, Coll Life Sci, Wuhan 430062, Hubei Province, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Hubei University	Shi, JQ (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan 430062, Hubei Province, Peoples R China.	shijiaqin@caas.cn		Li, Na/0000-0001-5311-2418	National High Technology Research and Development Program of China [2012AA101107, 2011AA10A104]; National Science Foundation of China [31101181]; Rapeseed Industry Technology System [CARS-13]; Hubei Agricultural Science and Technology Innovation Center of China; Core Research Budget of the Non-profit Governmental Research Institution [1610172014001]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Rapeseed Industry Technology System; Hubei Agricultural Science and Technology Innovation Center of China; Core Research Budget of the Non-profit Governmental Research Institution	This work was supported by the National High Technology Research and Development Program (2012AA101107 and 2011AA10A104) of China, GHL; the National Science Foundation (31101181) of China, JQS; the Rapeseed Industry Technology System (CARS-13), HZW; the Hubei Agricultural Science and Technology Innovation Center of China, JQS; Core Research Budget of the Non-profit Governmental Research Institution (1610172014001), XFW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski NM, 2009, P NATL ACAD SCI USA, V106, P20115, DOI 10.1073/pnas.0907024106; Ali N, 2003, PAK J BOT, V35, P167; Alonso-Blanco C, 1999, P NATL ACAD SCI USA, V96, P4710, DOI 10.1073/pnas.96.8.4710; Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; BODNARYK RP, 1991, CAN J PLANT SCI, V71, P397, DOI 10.4141/cjps91-055; Cheng XM, 2009, THEOR APPL GENET, V118, P1121, DOI 10.1007/s00122-009-0967-8; Cong Z, 1996, THESIS CHINA AGR U; Culcuoglu E, 2002, ENERG SOURCE, V24, P329, DOI 10.1080/00908310252888709; Fang WJ, 2012, PLANT J, V70, P929, DOI 10.1111/j.1365-313X.2012.04907.x; Garcia D, 2005, PLANT CELL, V17, P52, DOI 10.1105/tpc.104.027136; GROCHOWSKI L, 1995, ACTA SOC BOT POL, V64, P175, DOI 10.5586/asbp.1995.025; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HARLAN JR, 1973, EVOLUTION, V27, P311, DOI [10.2307/2406971, 10.1111/j.1558-5646.1973.tb00676.x]; Hu ZY, 2009, PLANT CELL REP, V28, P541, DOI 10.1007/s00299-008-0654-2; Jofuku KD, 2005, P NATL ACAD SCI USA, V102, P3117, DOI 10.1073/pnas.0409893102; Lemontey C, 2000, J EXP BOT, V51, P167, DOI 10.1093/jexbot/51.343.167; Li HT, 2013, THEOR APPL GENET, V126, P937, DOI 10.1007/s00122-012-2027-z; Li N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-114; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lowe AJ, 2004, THEOR APPL GENET, V108, P1103, DOI 10.1007/s00122-003-1522-7; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; MILLET E, 1984, J CEREAL SCI, V2, P31, DOI 10.1016/S0733-5210(84)80005-3; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Ohto M, 2005, P NATL ACAD SCI USA, V102, P3123, DOI 10.1073/pnas.0409858102; Ohto MA, 2009, SEX PLANT REPROD, V22, P277, DOI 10.1007/s00497-009-0116-1; Piquemal J, 2005, THEOR APPL GENET, V111, P1514, DOI 10.1007/s00122-005-0080-6; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Sadras VO, 2007, FIELD CROP RES, V100, P125, DOI 10.1016/j.fcr.2006.07.004; SAS Institute Inc, 2000, C SAS STAT US GUID V; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Shi JQ, 2014, DNA RES, V21, P53, DOI 10.1093/dnares/dst040; STANLEY DW, 1976, CAN I FOOD SC TECH J, V9, P54, DOI 10.1016/S0315-5463(76)73612-5; Sundaresan V, 2005, P NATL ACAD SCI USA, V102, P17887, DOI 10.1073/pnas.0509021102; Tsuge T, 1996, DEVELOPMENT, V122, P1589; TSUKAYA H, 1993, DEVELOPMENT, V118, P751; Wang XF, 2010, EUPHYTICA, V173, P17, DOI 10.1007/s10681-009-0062-x; Xiao YJ, 2012, THEOR APPL GENET, V125, P437, DOI 10.1007/s00122-012-1843-5; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xu J, 2001, CHINESE J RICE SCI, V16, P6; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZHU J, 1994, THEOR APPL GENET, V89, P153, DOI 10.1007/BF00225135; Zhu Jun, 1996, Acta Genetica Sinica, V23, P56	42	15	17	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125360	10.1371/journal.pone.0125360	http://dx.doi.org/10.1371/journal.pone.0125360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915862	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659100124
J	Naclerio, F; Larumbe-Zabala, E; Cooper, R; Allgrove, J; Earnest, CP				Naclerio, Fernando; Larumbe-Zabala, Eneko; Cooper, Robert; Allgrove, Judith; Earnest, Conrad P.			A Multi-Ingredient Containing Carbohydrate, Proteins L-Glutamine and L-Carnitine Attenuates Fatigue Perception with No Effect on Performance, Muscle Damage or Immunity in Soccer Players	PLOS ONE			English	Article							INTERMITTENT SPRINT PERFORMANCE; EXERCISE; RECOVERY; MATCH; SUPPLEMENTATION; COINGESTION; INGESTION; RESPONSES; MARKERS; STRESS	We investigated the effects of ingesting a multi-ingredient (53g carbohydrate, 14.5g whey protein, 5g glutamine, 1.5g L-carnitine-L-tartrate) supplement, carbohydrate only, or placebo on intermittent performance, perception of fatigue, immunity, and functional and metabolic markers of recovery. Sixteen amateur soccer players ingested their respective treatments before, during and after performing a 90-min intermittent repeated sprint test. Primary outcomes included time for a 90-min intermittent repeated sprint test (IRS) followed by eleven 15 m sprints. Measurements included creatine kinase, myoglobin, interleukine-6, Neutrophil; Lymphocytes and Monocyte before (pre), immediately after (post), 1h and 24h after exercise testing period. Overall, time for the IRS and 15 m sprints was not different between treatments. However, the perception of fatigue was attenuated (P<0.001) for the multi-ingredient (15.9 +/- 1.4) vs. placebo (17.8 +/- 1.4) but not for the carbohydrate (17.0 +/- 1.9) condition. Several changes in immune/inflammatory indices were noted as creatine kinase peaked at 24h while Interleukin-6 and myoglobin increased both immediately after and at 1h compared with baseline (P<0.05) for all three conditions. However, Myoglobin (P<0.05) was lower 1h post-exercise for the multi-ingredient (241.8 +/- 142.6 ng.ml(-1)) and CHO (265.4 +/- 187.8 ng.ml(-1)) vs. placebo (518.6 +/- 255.2 ng.ml(-1)). Carbohydrate also elicited lower neutrophil concentrations vs. multi-ingredient (3.9 +/- 1.5 10(9)/L vs. 4.9 +/- 1.8 10(9)/L, P = 0.016) and a reduced (P<0.05) monocytes count (0.36 +/- 0.09 10(9)/L) compared to both multi-ingredient (0.42 +/- 0.09 10(9)/L) and placebo (0.42 +/- 0.12 10(9)/L). In conclusion, multi-ingredient and carbohydrate supplements did not improve intermittent performance, inflammatory or immune function. However, both treatments did attenuate serum myoglobin, while only carbohydrate blunted post-exercise leukocytosis.	[Naclerio, Fernando; Cooper, Robert] Univ Greenwich, Ctr Sport Sci & Human Performance, Medway, England; [Larumbe-Zabala, Eneko] Texas Tech Univ, Hlth Sci Ctr, Clin Res Inst, Lubbock, TX 79430 USA; [Allgrove, Judith] Univ Kingston, Fac Sci Engn & Comp, London, England; [Earnest, Conrad P.] Woodbolt Int, Res, College Stn, TX USA; [Earnest, Conrad P.] Texas A&M Univ, College Stn, TX USA	University of Greenwich; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Kingston University; Texas A&M University System; Texas A&M University College Station	Naclerio, F (corresponding author), Univ Greenwich, Ctr Sport Sci & Human Performance, Medway, England.	f.j.naclerio@gre.ac.uk	Larumbe-Zabala, Eneko/I-1648-2013; Naclerio, Fernando/G-4407-2013; Earnest, Conrad P./M-6849-2017; Larumbe-Zabala, Eneko/I-7519-2019	Larumbe-Zabala, Eneko/0000-0002-8949-0602; Naclerio, Fernando/0000-0001-7405-4894; Earnest, Conrad P./0000-0002-6546-1268; Larumbe-Zabala, Eneko/0000-0002-8949-0602	Maxinutrition GlaxoSmithKline	Maxinutrition GlaxoSmithKline(GlaxoSmithKline)	Maxinutrition GlaxoSmithKline provided joint funding for the development of the project. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghannam AF, 2011, APPL PHYSIOL NUTR ME, V36, P748, DOI [10.1139/h11-097, 10.1139/H11-097]; Ascensao A, 2008, CLIN BIOCHEM, V41, P841, DOI 10.1016/j.clinbiochem.2008.04.008; Bassini-Cameron A, 2008, BRIT J SPORT MED, V42, P260, DOI 10.1136/bjsm.2007.040378; Betts J, 2007, J SPORT SCI, V25, P1449, DOI 10.1080/02640410701213459; Bianco A, 2011, J INT SOC SPORT NUTR, V8, DOI 10.1186/1550-2783-8-25; Bishop DJ, 2012, CLIN EXP PHARMACOL P, V39, P836, DOI 10.1111/j.1440-1681.2012.05735.x; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brancaccio P, 2010, CLIN CHEM LAB MED, V48, P757, DOI 10.1515/CCLM.2010.179; Castell LM, 1996, EUR J APPL PHYSIOL O, V73, P488, DOI 10.1007/BF00334429; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cooper R, 2014, EUR J SPORT SCI, V14, P353, DOI 10.1080/17461391.2013.813972; Darvishi L, 2013, INT J PREVENTIVE MED, V4, pS68; Edwards AM, 2009, SPORTS MED, V39, P1, DOI 10.2165/00007256-200939010-00001; Erdman KA, 2007, CLIN J SPORT MED, V17, P458, DOI 10.1097/JSM.0b013e31815aed33; Gleeson M, 2006, ADV SPORT EXERCISE S, P115; Highton J, 2013, J SPORT SCI, V31, P361, DOI 10.1080/02640414.2012.735370; Howatson G, 2008, SPORTS MED, V38, P483, DOI 10.2165/00007256-200838060-00004; Ivy JL, 2002, J APPL PHYSIOL, V93, P1337, DOI 10.1152/japplphysiol.00394.2002; Kirksey B, 1999, J STRENGTH COND RES, V13, P148; Kreider RB, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-7; Krustrup P, 2006, MED SCI SPORT EXER, V38, P1165, DOI 10.1249/01.mss.0000222845.89262.cd; Lancaster GI, 2006, ADV SPORT EXERCISE S, P205; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; Magalhaes J, 2010, EUR J APPL PHYSIOL, V108, P39, DOI 10.1007/s00421-009-1161-z; Maughan RJ, 2011, J SPORT SCI, V29, pS57, DOI 10.1080/02640414.2011.587446; McLellan TM, 2014, SPORTS MED, V44, P535, DOI 10.1007/s40279-013-0133-y; Moreira A, 2007, EUR J CLIN NUTR, V61, P443, DOI 10.1038/sj.ejcn.1602549; Naclerio F, 2014, APPL PHYSIOL NUTR ME, V39, P1151, DOI 10.1139/apnm-2013-0556; Nedelec M, 2013, SPORTS MED, V43, P9, DOI 10.1007/s40279-012-0002-0; Nedelec M, 2012, SPORTS MED, V42, P997, DOI 10.2165/11635270-000000000-00000; Nicholas CW, 2000, J SPORT SCI, V18, P97, DOI 10.1080/026404100365162; Nicol C, 2006, SPORTS MED, V36, P977, DOI 10.2165/00007256-200636110-00004; Nieman DC, 2006, J SPORT SCI, V24, P763, DOI 10.1080/02640410500482982; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2011, J EXP BIOL, V214, P337, DOI 10.1242/jeb.048074; Rebouche CJ, 2004, ANN NY ACAD SCI, P1033; Sasaki E, 2013, LUMINESCENCE, V28, P442, DOI 10.1002/bio.2474; Saunders MJ, 2007, INT J SPORT NUTR EXE, V17, pS87, DOI 10.1123/ijsnem.17.s1.s87; Spencer M, 2005, SPORTS MED, V35, P1025, DOI 10.2165/00007256-200535120-00003; Spiering BA, 2007, J STRENGTH COND RES, V21, P259, DOI 10.1519/00124278-200702000-00046; Thiago Gomes H, 2012, SKELETAL MUSCLE MYOG, P105; Tipton KD, 2004, J SPORT SCI, V22, P65, DOI 10.1080/0264041031000140554; Volek JS, 2002, AM J PHYSIOL-ENDOC M, V282, pE474, DOI 10.1152/ajpendo.00277.2001; Wall BT, 2011, J PHYSIOL-LONDON, V589, P963, DOI 10.1113/jphysiol.2010.201343; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64; Williams C, 2006, J SPORT SCI, V24, P687, DOI 10.1080/02640410500482628	46	20	20	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125188	10.1371/journal.pone.0125188	http://dx.doi.org/10.1371/journal.pone.0125188			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915424	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100106
J	Uddin, S; Khan, A; Baur, LA				Uddin, Shahadat; Khan, Arif; Baur, Louise A.			A Framework to Explore the Knowledge Structure of Multidisciplinary Research Fields	PLOS ONE			English	Article							GOOGLE-SCHOLAR; OBESITY; NETWORKS; SCIENCE; SYSTEM; SCOPUS; WEB	Understanding emerging areas of a multidisciplinary research field is crucial for researchers, policymakers and other stakeholders. For them a knowledge structure based on longitudinal bibliographic data can be an effective instrument. But with the vast amount of available online information it is often hard to understand the knowledge structure for data. In this paper, we present a novel approach for retrieving online bibliographic data and propose a framework for exploring knowledge structure. We also present several longitudinal analyses to interpret and visualize the last 20 years of published obesity research data.	[Uddin, Shahadat; Khan, Arif] Univ Sydney, Complex Syst Res Grp, Project Management Program, Sydney, NSW 2006, Australia; [Baur, Louise A.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Baur, Louise A.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Khan, A (corresponding author), Univ Sydney, Complex Syst Res Grp, Project Management Program, Sydney, NSW 2006, Australia.	arif.khan@sydney.edu.au	Uddin, Shahadat/E-1963-2011; Baur, Louise/AAE-3413-2021	Uddin, Shahadat/0000-0003-0091-6919; Baur, Louise/0000-0002-4521-9482; Khan, Arif/0000-0002-5793-933X				Abbasi A, 2011, SCIENTOMETRICS, V89, P687, DOI 10.1007/s11192-011-0463-1; Allen K, 1973, ENCY LIB INFORM SCI; BURNETT MM, 1994, J VISUAL LANG COMPUT, V5, P287, DOI 10.1006/jvlc.1994.1015; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Choi J, 2011, INFORM MANAGE-AMSTER, V48, P371, DOI 10.1016/j.im.2011.09.004; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cummins S, 2006, INT J EPIDEMIOL, V35, P100, DOI 10.1093/ije/dyi276; Ding Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071416; Diseases TNIoDaDaK, 2011, ADV EM OPP DIAB RES, P140; Eom YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024926; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Guo HN, 2011, SCIENTOMETRICS, V89, P421, DOI 10.1007/s11192-011-0433-7; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Hussain F., 2004, J KNOWLEDGE MANAGEME, V5, P1; Iyer H, 1995, KNOWL ORGAN, V22, P141; Jacso P, 2005, ONLINE INFORM REV, V29, P208, DOI 10.1108/14684520510598066; Kalaitzidakis P, 2003, J EUR ECON ASSOC, V1, P1346, DOI 10.1162/154247603322752566; Kaur J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043235; Kulkarni AV, 2009, JAMA-J AM MED ASSOC, V302, P1092, DOI 10.1001/jama.2009.1307; Molsa J, 2004, COMMUNICATION; Mons B, 2011, NAT GENET, V43, P281, DOI 10.1038/ng0411-281; Organization WH, 2010, WHO FOR TECHN M GEN; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; SMALL H, 1973, J AM SOC INFORM SCI, V24, P265, DOI 10.1002/asi.4630240406; Snijders TA, 2005, MODELS LONGITUDINAL, P215; Song M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084639; Speier C, 1999, DECISION SCI, V30, P337, DOI 10.1111/j.1540-5915.1999.tb01613.x; Su HN, 2010, SCIENTOMETRICS, V85, P65, DOI 10.1007/s11192-010-0259-8; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Uddin S, 2013, SOC COMP SOCIALCOM 2; Uddin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057546; Uddin S, 2012, SCIENTOMETRICS, V90, P687, DOI 10.1007/s11192-011-0511-x; United States National Library of Medicine, 2014, MED USNLO MESH BROWS, DOI [10.1155/2014/920985, DOI 10.1155/2014/920985]; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; WHO, 2014, OB OV; Wu BH, 2012, ASIA PAC J TOUR RES, V17, P355, DOI 10.1080/10941665.2011.628330; Yu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101214; Zaiane OR, 2009, LECT NOTES ARTIF INT, V5439, P59; Zhang ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005686	42	21	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123537	10.1371/journal.pone.0123537	http://dx.doi.org/10.1371/journal.pone.0123537			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915521	Green Published, gold			2022-12-27	WOS:000353659100023
J	Wadewitz, P; Hammerschmidt, K; Battaglia, D; Witt, A; Wolf, F; Fischer, J				Wadewitz, Philip; Hammerschmidt, Kurt; Battaglia, Demian; Witt, Annette; Wolf, Fred; Fischer, Julia			Characterizing Vocal Repertoires-Hard vs. Soft Classification Approaches	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; ACOUSTIC STRUCTURE; BABOONS; CALLS; COMMUNICATION; FEATURES; MONKEYS; URSINUS; VOCALIZATIONS; RESPONSES	To understand the proximate and ultimate causes that shape acoustic communication in animals, objective characterizations of the vocal repertoire of a given species are critical, as they provide the foundation for comparative analyses among individuals, populations and taxa. Progress in this field has been hampered by a lack of standard in methodology, however. One problem is that researchers may settle on different variables to characterize the calls, which may impact on the classification of calls. More important, there is no agreement how to best characterize the overall structure of the repertoire in terms of the amount of gradation within and between call types. Here, we address these challenges by examining 912 calls recorded from wild chacma baboons (Papio ursinus). We extracted 118 acoustic variables from spectrograms, from which we constructed different sets of acoustic features, containing 9, 38, and 118 variables; as well 19 factors derived from principal component analysis. We compared and validated the resulting classifications of k-means and hierarchical clustering. Datasets with a higher number of acoustic features lead to better clustering results than datasets with only a few features. The use of factors in the cluster analysis resulted in an extremely poor resolution of emerging call types. Another important finding is that none of the applied clustering methods gave strong support to a specific cluster solution. Instead, the cluster analysis revealed that within distinct call types, subtypes may exist. Because hard clustering methods are not well suited to capture such gradation within call types, we applied a fuzzy clustering algorithm. We found that this algorithm provides a detailed and quantitative description of the gradation within and between chacma baboon call types. In conclusion, we suggest that fuzzy clustering should be used in future studies to analyze the graded structure of vocal repertoires. Moreover, the use of factor analyses to reduce the number of acoustic variables should be discouraged.	[Wadewitz, Philip; Hammerschmidt, Kurt; Fischer, Julia] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Wadewitz, Philip; Battaglia, Demian; Witt, Annette; Wolf, Fred] Max Planck Inst Dynam & Self Org, Theoret Neurophys, Gottingen, Germany; [Wadewitz, Philip; Battaglia, Demian; Witt, Annette; Wolf, Fred; Fischer, Julia] Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Battaglia, Demian] Inst Syst Neurosci, Theoret Neurosci Grp, Marseille, France	Deutsches Primatenzentrum (DPZ); Max Planck Society	Wadewitz, P (corresponding author), German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany.	pwadewitz@dpz.eu	Battaglia, Demian/C-1281-2017; Fischer, Julia/B-6674-2008	Battaglia, Demian/0000-0003-2021-7920; Fischer, Julia/0000-0002-5807-0074; Wolf, Fred/0000-0002-7068-3762	German Federal Ministry of Education and Research (BMBF) via the Bernstein Center for Computational Neuroscience (BCCN) Gottingen [01GQ1005C]	German Federal Ministry of Education and Research (BMBF) via the Bernstein Center for Computational Neuroscience (BCCN) Gottingen(Federal Ministry of Education & Research (BMBF))	The authors acknowledge financial support by the German Federal Ministry of Education and Research (BMBF) via the Bernstein Center for Computational Neuroscience (BCCN) Gottingen under Grant No. 01GQ1005C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, ANIM BEHAV, V72, P643, DOI 10.1016/j.anbehav.2005.11.017; Battaglia D, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00013; BEZDEK JC, 1974, J MATH BIOL, V1, P57, DOI 10.1007/BF02339490; Boersma P., 2001, GLOT INT, V5, P341; Bouchet H, 2012, J COMP PSYCHOL, V126, P45, DOI 10.1037/a0025018; DEWAAL FBM, 1988, BEHAVIOUR, V106, P183, DOI 10.1163/156853988X00269; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; EQUIHUA M, 1990, J ECOL, V78, P519, DOI 10.2307/2261127; Fischer J, 2000, P ROY SOC B-BIOL SCI, V267, P2317, DOI 10.1098/rspb.2000.1285; Fischer J, 2002, J ACOUST SOC AM, V111, P1465, DOI 10.1121/1.1433807; Fischer J, 2001, ANIM BEHAV, V61, P925, DOI 10.1006/anbe.2000.1687; FISCHER J, 1995, ETHOLOGY, V101, P51, DOI 10.1111/j.1439-0310.1995.tb00345.x; Fischer J, 2001, ETHOLOGY, V107, P33, DOI 10.1046/j.1439-0310.2001.00630.x; FITCH WT, 1995, AM J PRIMATOL, V37, P191, DOI 10.1002/ajp.1350370303; FORREST TG, 1994, AM ZOOL, V34, P644; Fuller JL, 2014, AM J PRIMATOL, V76, P203, DOI 10.1002/ajp.22223; Green S, 1975, PRIMATE BEHAV, P1, DOI DOI 10.1016/B978-0-12-534004-5.50006-3; Gros-Louis JJ, 2008, INT J PRIMATOL, V29, P641, DOI 10.1007/s10764-008-9263-8; Gustison ML, 2012, PHILOS T R SOC B, V367, P1847, DOI 10.1098/rstb.2011.0218; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hammerschmidt K, 1998, ETHOLOGY, V104, P203; Hammerschmidt K, 1995, INDIVIDUAL DIFFERENC; Keenan S, 2013, ANIM BEHAV, V85, P109, DOI 10.1016/j.anbehav.2012.10.014; Kershenbaum A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077671; Kitchen DM, 2005, ANIM COGN, V8, P1, DOI 10.1007/s10071-004-0222-2; Laiolo P, 2000, J ORNITHOL; Maciej P, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-58; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; MARLER P, 1970, FOLIA PRIMATOL, V13, P81, DOI 10.1159/000155312; Marler P., 1976, GROWING POINTS ETHOL, P239; Marler P., 1975, ROLE SPEECH LANG, V11; McComb K, 2005, BIOL LETTERS, V1, P381, DOI 10.1098/rsbl.2005.0366; MCKUSICK VA, 1969, PERSPECT BIOL MED, V12, P298; Mizutani E, 1997, NEURO FUZZY SOFT COM, DOI DOI 10.1109/TAC.1997.633847; Owren MJ, 1997, J ACOUST SOC AM, V101, P2951, DOI 10.1121/1.418523; Padgham M, 2004, J ACOUST SOC AM, V115, P402, DOI 10.1121/1.1629304; Papworth S, 2008, BIOL LETTERS, V4, P472, DOI 10.1098/rsbl.2008.0299; Rendall D, 2000, J COMP PSYCHOL, V114, P36, DOI 10.1037/0735-7036.114.1.36; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; ROWELL T. E., 1962, PROC ZOOL SOC LONDON, V138, P279; Shulezhko TS, 2008, RUSS J MAR BIOL+, V34, P118, DOI 10.1134/S1063074008020053; Silk JB, 1999, BEHAVIOUR, V136, P679, DOI 10.1163/156853999501522; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tomasello M, 2002, COGNITIVE ANIMAL, P293; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WASER PM, 1986, AM J PRIMATOL, V10, P135, DOI 10.1002/ajp.1350100205; WINTER P, 1966, EXP BRAIN RES, V1, P359; Xu D., 2008, APPL FUZZY LOGIC BIO; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zadeh LA, 2008, INFORM SCIENCES, V178, P2751, DOI 10.1016/j.ins.2008.02.012	51	41	41	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125785	10.1371/journal.pone.0125785	http://dx.doi.org/10.1371/journal.pone.0125785			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915039	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100147
J	Zheng, K; Zhang, SS; Wang, CJ; Zhao, WX; Shen, H				Zheng, Kai; Zhang, Shengsheng; Wang, Chuijie; Zhao, Wenxia; Shen, Hong			Health-Related Quality of Life in Chinese Patients with Mild and Moderately Active Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SWEDISH PATIENTS; CROHNS-DISEASE; QUESTIONNAIRE; TRANSLATION; VALIDATION; INFLIXIMAB; EFFICACY; THERAPY; VERSION	Background Ulcerative colitis (UC) impairs the health-related quality of life (HRQOL). The difference in HRQOL between patients with mild and moderately active UC is not well-defined. Few studies have been conducted to explore the factors that influence HRQOL in Chinese patients. Our study aims were to (1) compare HRQOL of mildly active UC patients with moderate patients; (2) explore the factors that influence HRQOL in Chinese patients with UC; and (3) analyze demographic and disease characteristics of UC in China. Methods A total of 110 mild and 114 moderate patients with UC were enrolled. The demographic and disease characteristics were recorded. HRQOL was measured by the Chinese version of the inflammatory bowel disease questionnaire (IBDQ) between mild and moderate patients, male and female patients, and different disease distributions. Stepwise regression analysis was used to assess factors influencing the IBDQ score. Results Patients with moderate UC had significantly lower IBDQ total scores compared to patients with mild UC (P=0.001). The IBDQ total score had a negative correlation with the Mayo score (r=-0.263, P<0.001). Stepwise regression analysis showed that the disease activity index and gender had an influence on the IBDQ total score (P<0.05). The female patients had a lower score than the male patients (P<0.05), especially in the emotional function domain (P=0.002). Different disease distributions were not statistically significant in the IBDQ total score (P=0.183). Conclusions UC has a negative influence on HRQOL. HRQOL in patients with moderate UC was lower than HRQOL in patients with mild UC, as measured by the IBDQ. UC disease activity has a negative correlation with HRQOL. Gender and the disease activity index are important factors involved in the impairment of HRQOL in Chinese patients with UC. Chinese females may benefit from increased psychological care as part of UC therapy.	[Zheng, Kai; Shen, Hong] Nanjing Univ Chinese Med, Affiliated Hosp, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Zhang, Shengsheng] Beijing Hosp Chinese Med, Dept Gastroenterol, Beijing, Peoples R China; [Wang, Chuijie] Liaoning Univ Chinese Med, Affiliated Hosp, Dept Gastroenterol, Shenyang, Liaoning, Peoples R China; [Zhao, Wenxia] Henan Univ Chinese Med, Affiliated Hosp 1, Dept Gastroenterol, Zhengzhou, Henan, Peoples R China	Nanjing University of Chinese Medicine; Henan University of Traditional Chinese Medicine	Shen, H (corresponding author), Nanjing Univ Chinese Med, Affiliated Hosp, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China.	jiangsutcm@163.com			National ministry of science and technology - National Key Technology Research and Development Program of China [2006BAI04A14]; National Natural Science Foundation of China [81403343]	National ministry of science and technology - National Key Technology Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by National ministry of science and technology, supported by the National Key Technology Research and Development Program of China (grant number 2006BAI04A14), and supported by National Natural Science Foundation of China (grant number 81403343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernklev T, 2004, SCAND J GASTROENTERO, V39, P365, DOI 10.1080/00365520310008386; Bernklev T, 2002, SCAND J GASTROENTERO, V37, P1164, DOI 10.1080/003655202760373371; Casellas F, 2002, QUAL LIFE RES, V11, P775, DOI 10.1023/A:1020841601110; Casellas F, 2004, AM J GASTROENTEROL, V99, P457, DOI 10.1111/j.1572-0241.2004.04071.x; Casellas F, 2001, EUR J GASTROEN HEPAT, V13, P567, DOI 10.1097/00042737-200105000-00017; Cheung WY, 2000, J CLIN EPIDEMIOL, V53, P297, DOI 10.1016/S0895-4356(99)00152-3; CHINESE COOPERATIVE GROUP FOR THE STUDY ON IBD, 2008, J Dig Dis, V9, P52, DOI 10.1111/j.1443-9573.2007.00320.x; Ciccocioppo R, 2011, DIGEST LIVER DIS, V43, P535, DOI 10.1016/j.dld.2010.12.014; Feagan BG, 2007, AM J GASTROENTEROL, V102, P794, DOI 10.1111/j.1572-0241.2007.01094.x; Guthrie E, 2002, AM J GASTROENTEROL, V97, P1994, DOI 10.1111/j.1572-0241.2002.05842.x; GUYATT G, 1989, GASTROENTEROLOGY, V96, P804, DOI 10.1016/0016-5085(89)90905-0; Haapamaki J, 2011, J PAEDIATR CHILD H, V47, P832, DOI 10.1111/j.1440-1754.2011.02034.x; Haapamaki J, 2009, QUAL LIFE RES, V18, P961, DOI 10.1007/s11136-009-9514-y; Hjortswang H, 1998, AM J GASTROENTEROL, V93, P2203, DOI 10.1111/j.1572-0241.1998.00537.x; Hjortswang H, 2003, EUR J GASTROEN HEPAT, V15, P1011, DOI 10.1097/00042737-200309000-00012; Hjortswang H, 2001, SCAND J GASTROENTERO, V36, P77; Irvine EJ, 1997, AM J GASTROENTEROL, V92, pS18; IRVINE EJ, 1994, GASTROENTEROLOGY, V106, P287, DOI 10.1016/0016-5085(94)90585-1; Jiang XL, 2002, WORLD J GASTROENTERO, V8, P158, DOI 10.3748/wjg.v8.i1.158; Kim WH, 1999, INT J COLORECTAL DIS, V14, P52, DOI 10.1007/s003840050183; Kornbluth A, 2004, AM J GASTROENTEROL, V99, P1371, DOI 10.1111/j.1572-0241.2004.40036.x; Kuriyama M, 2008, EUR J GASTROEN HEPAT, V20, P634, DOI 10.1097/MEG.0b013e3282f5e9c9; Li XJ, 2012, WORLD J GASTROENTERO, V18, P2561, DOI 10.3748/wjg.v18.i20.2561; Loftus EV, 2002, GASTROENTEROL CLIN N, V31, P1, DOI 10.1016/S0889-8553(01)00002-4; Loopez-Vivancos J, 1999, DIGESTION, V60, P274, DOI 10.1159/000007670; Malik BA, 2013, INT J COLORECTAL DIS, V28, P325, DOI 10.1007/s00384-012-1561-0; Qin OY, 2006, J GASTROEN HEPATOL, V21, P1772, DOI 10.1111/j.1440-1746.2006.04674.x; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sandborn WJ, 2014, GASTROENTEROLOGY, V146, P85, DOI 10.1053/j.gastro.2013.05.048; Suzuki Y, 2013, J CROHNS COLITIS, V7, P239, DOI 10.1016/j.crohns.2012.06.006; Zahn A, 2006, INFLAMM BOWEL DIS, V12, P1058, DOI 10.1097/01.mib.0000234134.35713.d2; Zhou YX, 2010, J CLIN NURS, V19, P79, DOI 10.1111/j.1365-2702.2009.03020.x	32	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124211	10.1371/journal.pone.0124211	http://dx.doi.org/10.1371/journal.pone.0124211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915777	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659100039
J	Gay, MS; Li, Y; Xiong, FX; Lin, T; Zhang, LB				Gay, Maresha S.; Li, Yong; Xiong, Fuxia; Lin, Thant; Zhang, Lubo			Dexamethasone Treatment of Newborn Rats Decreases Cardiomyocyte Endowment in the Developing Heart through Epigenetic Modifications	PLOS ONE			English	Article							CELL-CYCLE CONTROL; GLUCOCORTICOID-RECEPTOR; DNA METHYLATION; CARDIAC MYOCYTES; VENTRICULAR MYOCYTES; MYOCARDIAL-CELLS; HYPERTROPHY; GROWTH; TRANSITION; MATURATION	The potential adverse effect of synthetic glucocorticoid, dexamethasone therapy on the developing heart remains unknown. The present study investigated the effects of dexamethasone on cardiomyocyte proliferation and binucleation in the developing heart of newborn rats and evaluated DNA methylation as a potential mechanism. Dexamethasone was administered intraperitoneally in a three day tapered dose on postnatal day 1 (P1), 2 and 3 to rat pups in the absence or presence of a glucocorticoid receptor antagonist Ru486, given 30 minutes prior to dexamethasone. Cardiomyocytes from P4, P7 or P14 animals were analyzed for proliferation, binucleation and cell number. Dexamethasone treatment significantly increased the percentage of binucleated cardiomyocytes in the hearts of P4 pups, decreased myocyte proliferation in P4 and P7 pups, reduced cardiomyocyte number and increased the heart to body weight ratio in P14 pups. Ru486 abrogated the effects of dexamethasone. In addition, 5-aza-2'-deoxycytidine (5-AZA) blocked the effects of dexamethasone on binucleation in P4 animals and proliferation at P7, leading to recovered cardiomyocyte number in P14 hearts. 5-AZA alone promoted cardiomyocyte proliferation at P7 and resulted in a higher number of cardiomyocytes in P14 hearts. Dexamethasone significantly decreased cyclin D2, but not p27 expression in P4 hearts. 5-AZA inhibited global DNA methylation and blocked dexamethasone-mediated down-regulation of cyclin D2 in the heart of P4 pups. The findings suggest that dexamethasone acting on glucocorticoid receptors inhibits proliferation and stimulates premature terminal differentiation of cardiomyocytes in the developing heart via increased DNA methylation in a gene specific manner.	[Gay, Maresha S.; Li, Yong; Xiong, Fuxia; Zhang, Lubo] Dept Basic Sci, Div Pharmacol, Ctr Perinatal Biol, Loma Linda, CA 92350 USA; [Lin, Thant] Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA 92350 USA	Loma Linda University	Zhang, LB (corresponding author), Dept Basic Sci, Div Pharmacol, Ctr Perinatal Biol, Loma Linda, CA 92350 USA.	lzhang@llu.edu		Zhang, Lubo/0000-0002-9386-8938	NIH [HL118861]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118861] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH HL118861.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Bal MP, 2008, J APPL PHYSIOL, V104, P446, DOI 10.1152/japplphysiol.00951.2007; Bal MP, 2009, PEDIATR RES, V66, P74, DOI 10.1203/PDR.0b013e3181a283a0; Barrington K J, 2001, BMC Pediatr, V1, P1, DOI 10.1186/1471-2431-1-1; Bird AD, 2007, J PHYSIOL-LONDON, V585, P187, DOI 10.1113/jphysiol.2007.136796; Brooks G, 1997, J MOL CELL CARDIOL, V29, P2261, DOI 10.1006/jmcc.1997.0471; Brown SE, 2007, EPIGENETICS-US, V2, P54, DOI 10.4161/epi.2.1.3880; CAPASSO JM, 1992, CIRC RES, V71, P1379, DOI 10.1161/01.RES.71.6.1379; Chang KH, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-18; CLUBB FJ, 1984, LAB INVEST, V50, P571; Corstius HB, 2005, PEDIATR RES, V57, P796, DOI 10.1203/01.PDR.0000157726.65492.CD; Crochemore C, 2002, FASEB J, V16, DOI 10.1096/fj.01-0577com; Crudo A, 2013, ENDOCRINOLOGY, V154, P4170, DOI 10.1210/en.2013-1484; Crudo A, 2012, ENDOCRINOLOGY, V153, P3269, DOI 10.1210/en.2011-2160; De Vries WB, 2002, PEDIATR RES, V52, P900, DOI 10.1203/01.PDR.0000036281.74804.27; Garland JS, 1999, PEDIATRICS, V104, P91, DOI 10.1542/peds.104.1.91; Gilsbach R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6288; Giraud GD, 2006, ENDOCRINOLOGY, V147, P3643, DOI 10.1210/en.2006-0061; GOYA L, 1993, MOL ENDOCRINOL, V7, P1121, DOI 10.1210/me.7.9.1121; Grange T, 2001, ONCOGENE, V20, P3028, DOI 10.1038/sj.onc.1204327; Horky M, 1997, PHYSIOL RES, V46, P233; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Jobe AH, 2010, PEDIATR NEONATOL, V51, P7, DOI 10.1016/S1875-9572(10)60003-4; Kamphuis PJGH, 2007, PEDIATR RES, V61, P72, DOI 10.1203/01.pdr.0000249980.95264.dd; Kim MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093407; Kou CYC, 2010, BIOCHEM BIOPH RES CO, V400, P278, DOI 10.1016/j.bbrc.2010.08.064; LaMear NS, 1997, BIOL NEONATE, V72, P175; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037030; Lister K, 2006, CARDIOVASC RES, V70, P555, DOI 10.1016/j.cardiores.2006.02.010; Matsuda Y, 1999, GASTROENTEROLOGY, V116, P394, DOI 10.1016/S0016-5085(99)70137-X; MCGILL CJ, 1995, CARDIOVASC RES, V30, P557, DOI 10.1016/S0008-6363(95)00113-1; Nagai T, 2001, J MOL CELL CARDIOL, V33, P1769, DOI 10.1006/jmcc.2001.1449; Oakley RH, 2013, P NATL ACAD SCI USA, V110, P17035, DOI 10.1073/pnas.1302546110; Ortiz LA, 2003, HYPERTENSION, V41, P328, DOI 10.1161/01.HYP.0000049763.51269.51; Paradis AN, 2014, DRUG DISCOV TODAY, V19, P602, DOI 10.1016/j.drudis.2013.10.019; Patterson AJ, 2010, CIRC RES, V107, P365, DOI 10.1161/CIRCRESAHA.110.221259; Poolman RA, 1998, J MOL CELL CARDIOL, V30, P2121, DOI 10.1006/jmcc.1998.0808; Porrello ER, 2010, NEONATOLOGY, V97, P257, DOI 10.1159/000253757; Qin Xue CD, 2012, CARDIOVASC RES, V89, P300; Rog-Zielinska EA, 2013, HUM MOL GENET, V22, P3269, DOI 10.1093/hmg/ddt182; Rudolph AM, 1999, PEDIATR RES, V46, P141, DOI 10.1203/00006450-199908000-00002; Sato A, 1996, AM J PHYSIOL-ENDOC M, V271, pE827, DOI 10.1152/ajpendo.1996.271.5.E827; Sharma D, 2013, MOL ENDOCRINOL, V27, P1142, DOI 10.1210/me.2013-1079; Smith E, 2000, J BIOL CHEM, V275, P19992, DOI 10.1074/jbc.M001758200; Torres A, 1997, PEDIATR RES, V42, P139, DOI 10.1203/00006450-199708000-00001; VANYUSHI.BF, 1973, GERONTOLOGY, V19, P138, DOI 10.1159/000211967; WERNER JC, 1992, J PEDIATR-US, V120, P286, DOI 10.1016/S0022-3476(05)80446-9; Whitehurst RM, 1999, J MOL CELL CARDIOL, V31, P1551, DOI 10.1006/jmcc.1999.0990; Xiao YJ, 2000, J PHARMACOL EXP THER, V292, P8	50	30	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125033	10.1371/journal.pone.0125033	http://dx.doi.org/10.1371/journal.pone.0125033			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923220	Green Submitted, gold, Green Published			2022-12-27	WOS:000353711600120
J	Ma, J; Guo, CY; Guo, CW; Sun, Y; Liao, T; Beattie, U; Lopez, FJ; Chen, DF; Lashkari, K				Ma, Jie; Guo, Chenying; Guo, Caiwei; Sun, Yu; Liao, Tiffany; Beattie, Ursula; Lopez, Francisco J.; Chen, Dong Feng; Lashkari, Kameran			Transplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retinal Ganglion Cell Survival	PLOS ONE			English	Article							GROWTH-FACTOR-I; PLURIPOTENT STEM-CELLS; NECROSIS-FACTOR-ALPHA; MOUSE MODEL; TRANSGENIC MICE; POSTNATAL-DEVELOPMENT; INTRAOCULAR-PRESSURE; VENTRICULAR MYOCYTES; BINDING PROTEIN-2; INSULIN-RECEPTOR	We have previously characterized human neuronal progenitor cells (hNP) that can adopt a retinal ganglion cell (RGC)-like morphology within the RGC and nerve fiber layers of the retina. In an effort to determine whether hNPs could be used a candidate cells for targeted delivery of neurotrophic factors (NTFs), we evaluated whether hNPs transfected with an vector that expresses IGF-1 in the form of a fusion protein with tdTomato (TD), would increase RGC survival in vitro and confer neuroprotective effects in a mouse model of glaucoma. RGCs co-cultured with hNP(IGF-TD) cells displayed enhanced survival, and increased neurite extension and branching as compared to hNP(TD) or untransfected hNP cells. Application of various IGF-1 signaling blockers or IGF-1 receptor antagonists abrogated these effects. In vivo, using a model of glaucoma we showed that IOP elevation led to reductions in retinal RGC count. In this model, evaluation of retinal flatmounts and optic nerve cross sections indicated that only hNP(IGF-TD) cells effectively reduced RGC death and showed a trend to improve optic nerve axonal loss. RT-PCR analysis of retina lysates over time showed that the neurotrophic effects of IGF-1 were also attributed to down-regulation of inflammatory and to some extent, angiogenic pathways. This study shows that neuronal progenitor cells that hone into the RGC and nerve fiber layers may be used as vehicles for local production and delivery of a desired NTF. Transplantation of hNP(IGF-TD) cells improves RGC survival in vitro and protects against RGC loss in a rodent model of glaucoma. Our findings have provided experimental evidence and form the basis for applying cell-based strategies for local delivery of NTFs into the retina. Application of cell-based delivery may be extended to other disease conditions beyond glaucoma.	[Ma, Jie; Guo, Chenying; Guo, Caiwei; Sun, Yu; Liao, Tiffany; Beattie, Ursula; Chen, Dong Feng; Lashkari, Kameran] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst,Dept Ophthalmol, Boston, MA 02114 USA; [Lopez, Francisco J.] GlaxoSmithKline, Ophthalmol DPU RD Alternat Discovery & Dev, King Of Prussia, PA 19406 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; GlaxoSmithKline	Lashkari, K (corresponding author), Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst,Dept Ophthalmol, Boston, MA 02114 USA.	kameran_lashkari@meei.harvard.edu	Chen, Dong/AAJ-2444-2020	Chen, Dong/0000-0001-6283-8843; Beattie, Ursula/0000-0002-7131-3712; Guo, Caiwei/0000-0002-9975-9732; Lashkari, Kameran/0000-0003-3855-0246	Canary Charitable Foundation, New York, NY	Canary Charitable Foundation, New York, NY	This work was funded from an unrestricted grant from Canary Charitable Foundation, New York, NY to KL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BATCHELOR DC, 1995, J MOL ENDOCRINOL, V15, P105, DOI 10.1677/jme.0.0150105; BEHRINGER RR, 1990, ENDOCRINOLOGY, V127, P1033, DOI 10.1210/endo-127-3-1033; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; BIENZLE D, 1994, P NATL ACAD SCI USA, V91, P350, DOI 10.1073/pnas.91.1.350; BONDY CA, 1993, ANN NY ACAD SCI, V692, P33; Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337; Boyd ZS, 2003, INVEST OPHTH VIS SCI, V44, P5206, DOI 10.1167/iovs.03-0534; Burren CP, 1996, INVEST OPHTH VIS SCI, V37, P1459; Chen GC, 2012, CELL TRANSPLANT, V21, P2621, DOI 10.3727/096368912X647153; Chen HH, 2011, INVEST OPHTH VIS SCI, V52, P36, DOI 10.1167/iovs.09-5115; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Dana M Reza, 2006, Semin Ophthalmol, V21, P19, DOI 10.1080/08820530500509358; Danias J, 1996, CURRENT EYE RES, V9, P379; DICICCOBLOOM E, 1988, P NATL ACAD SCI USA, V85, P4066, DOI 10.1073/pnas.85.11.4066; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Douglas AD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1615; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Dupraz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054462; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; EPSTEIN RJ, 1987, CORNEA, V6, P250, DOI 10.1097/00003226-198706040-00004; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Galvan V, 2003, J BIOL CHEM, V278, P13325, DOI 10.1074/jbc.M211398200; Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723; GRANT M, 1986, DIABETES, V35, P416, DOI 10.2337/diabetes.35.4.416; GULER HP, 1989, ACTA ENDOCRINOL-COP, V121, P753, DOI 10.1530/acta.0.1210753; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Gutierrez-Aranda I, 2010, STEM CELLS, V28, P1568, DOI 10.1002/stem.471; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Heck S, 1999, J BIOL CHEM, V274, P9828, DOI 10.1074/jbc.274.14.9828; Hintz KK, 2002, DIABETES RES CLIN PR, V55, P89, DOI 10.1016/S0168-8227(01)00323-0; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P2051, DOI 10.1167/iovs.09-4509; Kermer P, 2000, J NEUROSCI, V20, P722, DOI 10.1523/JNEUROSCI.20-02-00722.2000; Knappskog S, 2007, J BIOTECHNOL, V128, P705, DOI 10.1016/j.jbiotec.2006.11.026; Kondo T, 2003, J CLIN INVEST, V111, P1835, DOI 10.1172/JCI200317455; Kwon J, 2009, CANCER RES, V69, P1350, DOI 10.1158/0008-5472.CAN-08-1328; Laron Z, 1999, BIODRUGS, V11, P55, DOI 10.2165/00063030-199911010-00006; Lenkowski JR, 2014, PROG RETIN EYE RES, V40, P94, DOI 10.1016/j.preteyeres.2013.12.007; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu XJ, 2001, J BIOL CHEM, V276, P32419, DOI 10.1074/jbc.C100299200; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082061; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Mead B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109305; Mead B, 2013, INVEST OPHTH VIS SCI, V54, P7544, DOI 10.1167/iovs.13-13045; MEYERSCHWICKERATH R, 1993, J CLIN INVEST, V92, P2620, DOI 10.1172/JCI116877; O'Driscoll C, 2006, EXP EYE RES, V83, P1482, DOI 10.1016/j.exer.2006.08.007; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; Pearson RA, 2014, BIOTECHNOL ADV, V32, P485, DOI 10.1016/j.biotechadv.2014.01.001; Peraldi P, 1996, J BIOL CHEM, V271, P13018, DOI 10.1074/jbc.271.22.13018; PIETRZKOWSKI Z, 1992, CANCER RES, V52, P6447; Popken GJ, 2004, EUR J NEUROSCI, V19, P2056, DOI 10.1111/j.0953-816X.2004.03320.x; Ren J, 2003, CARDIOVASC RES, V57, P738, DOI 10.1016/S0008-6363(02)00788-5; Ruecker O, 2008, MOL GENET GENOMICS, V280, P153, DOI 10.1007/s00438-008-0352-3; Seigel G, 2000, MOL VIS, V6, P157; Smith LEH, 1997, SCIENCE, V276, P1706, DOI 10.1126/science.276.5319.1706; Suzuki K, 2004, CIRCULATION, V110, pII219, DOI 10.1161/01.CIR.0000138388.55416.06; Tezel G, 2000, J NEUROSCI, V20, P8693; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Venters HD, 2000, ANN NY ACAD SCI, V917, P210; WHITE MF, 1988, J BIOL CHEM, V263, P2969; Wilkins A, 2001, GLIA, V36, P48, DOI 10.1002/glia.1094; XU LC, 1995, P NATL ACAD SCI USA, V92, P4372, DOI 10.1073/pnas.92.10.4372; Yang Q, 2012, INVEST OPHTH VIS SCI, V53, P3733, DOI 10.1167/iovs.12-9814; Ye P, 1997, ENDOCRINOLOGY, V138, P5466, DOI 10.1210/en.138.12.5466; YE P, 1995, J NEUROSCI, V15, P7344; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhou XH, 2005, J BIOL CHEM, V280, P31240, DOI 10.1074/jbc.M502641200	71	28	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125695	10.1371/journal.pone.0125695	http://dx.doi.org/10.1371/journal.pone.0125695			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923430	Green Submitted, Green Published, gold			2022-12-27	WOS:000353711600158
J	Ma, DC; Yoon, AJ; Faull, KF; Desharnais, R; Zemanick, ET; Porter, E				Ma, Daniel C.; Yoon, Alexander J.; Faull, Kym F.; Desharnais, Robert; Zemanick, Edith T.; Porter, Edith			Cholesteryl Esters Are Elevated in the Lipid Fraction of Bronchoalveolar Lavage Fluid Collected from Pediatric Cystic Fibrosis Patients	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; FATTY-ACID DEFICIENCY; PSEUDOMONAS-AERUGINOSA; LIPOPROTEIN ABNORMALITIES; CHRONIC RHINOSINUSITIS; PULMONARY-FUNCTION; PEPTIDE LL-37; INFLAMMATION; SPUTUM; LUNG	Background Host-derived lipids including cholesteryl esters (CEs) such as cholesteryl linoleate have emerged as important antibacterial effectors of innate immunity in the airways and cholesteryl linoleate has been found elevated in the context of inflammation. Cystic fibrosis (CF) patients suffer from chronic infection and severe inflammation in the airways. Here, we identified and quantified CEs in bronchoalveolar lavage fluid (BALF) from CF patients and non-CF disease controls, and tested whether CE concentrations are linked to the disease. Materials and Methods CEs in BALF from 6 pediatric subjects with CF and 7 pediatric subjects with non-CF chronic lung disease were quantified by mass spectral analysis using liquid chromatography coupled with tandem mass spectrometry and multiple reaction monitoring. BALFs were also examined for total lipid, total protein, albumin, and, as a marker for inflammation, human neutrophil peptide (HNP) 1-3 concentrations. Statistical analysis was conducted after log 10 transformation of the data. Results Total lipid/protein ratio was reduced in CF BALF (p = 0.018) but the concentrations of CEs, including cholesteryl linoleate, were elevated in the total lipid fraction in CF BALF compared to non-CF disease controls (p < 0.050). In addition, the concentrations of CEs and HNP1-3 correlated with one another (p < 0.050). Conclusions The data suggests that the lipid composition of BALF is altered in CF with less total lipid relative to protein but with increased CE concentrations in the lipid fraction, likely contributed by inflammation. Future longitudinal studies may reveal the suitability of CEs as a novel biomarker for CF disease activity which may provide new information on the lipid mediated pathophysiology of the disease.	[Ma, Daniel C.; Desharnais, Robert; Porter, Edith] Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA; [Yoon, Alexander J.; Faull, Kym F.] Univ Calif Los Angeles, David Geffen Sch Med, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA; [Zemanick, Edith T.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA	California State University System; California State University Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Colorado System; University of Colorado Anschutz Medical Campus	Porter, E (corresponding author), Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA.	eporter@calstatela.edu	Zemanick, Edith/D-5260-2017; Ma, Daniel/AAG-1890-2021; Zemanick, Edith T/ABF-9455-2020	Zemanick, Edith/0000-0002-7507-9337; Ma, Daniel/0000-0002-2957-4687; Zemanick, Edith T/0000-0002-7507-9337; Desharnais, Robert/0000-0003-2874-6835	Cystic Fibrosis Foundation [PORTER12I0, ZEMANI11A0]; NIH [1SC1GM096916, K23HL114883]; NSF/DMS [1225529]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL114883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM096916] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1225529] Funding Source: National Science Foundation	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF/DMS(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This study has been supported by the Cystic Fibrosis Foundation (http://www.cff.org; PORTER12I0, ZEMANI11A0), NIH (http://www.nih. gov; 1SC1GM096916 to EP, K23HL114883 to EZ), and NSF/DMS (http://www.nsf.gov; 1225529 to RD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2014, J CYST FIBROS, V13, P139, DOI 10.1016/j.jcf.2013.09.007; Asmis R, 1997, J CHROMATOGR B, V691, P59, DOI 10.1016/S0378-4347(96)00436-7; Beisswenger Christoph, 2005, V86, P55, DOI 10.1159/000086651; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Booton R, 2014, CHEST, V146, P193, DOI 10.1378/chest.13-2736; Bucki R, 2007, EUR RESPIR J, V29, P624, DOI 10.1183/09031936.00080806; Cannon CL, 2003, AM J RESP CELL MOL, V29, P188, DOI 10.1165/rcmb.4898; Chen CH, 2011, J MICROBIOL BIOTECHN, V21, P391, DOI 10.4014/jmb.1011.11014; Chen Christiane I-U, 2004, J Cyst Fibros, V3, P45, DOI 10.1016/j.jcf.2003.12.008; Colombo C, 2011, INT J IMMUNOPATH PH, V24, P423, DOI 10.1177/039463201102400215; Do TQ, 2008, J IMMUNOL, V181, P4177, DOI 10.4049/jimmunol.181.6.4177; Dooring G, 2009, CELL MICROBIOL, V11, P208, DOI 10.1111/j.1462-5822.2008.01271.x; Eickmeier O, 2010, CYTOKINE, V50, P152, DOI 10.1016/j.cyto.2010.02.004; Fischer BM, 2013, AM J PHYSIOL-LUNG C, V304, pL394, DOI 10.1152/ajplung.00091.2012; Gifford AM, 2014, CURR OPIN HEMATOL, V21, P16, DOI 10.1097/MOH.0000000000000009; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Kimura K, 2004, J MICROBIOL METH, V56, P331, DOI 10.1016/j.mimet.2003.10.018; Konstan Michael W, 2009, J Cyst Fibros, V8 Suppl 1, pS15, DOI 10.1016/S1569-1993(09)60006-0; Lee JT, 2014, INT FORUM ALLERGY RH, V4, P893, DOI 10.1002/alr.21404; Lee JT, 2010, AM J RHINOL ALLERGY, V24, P99, DOI 10.2500/ajra.2010.24.3444; LEVY E, 1993, AM J CLIN NUTR, V57, P573, DOI 10.1093/ajcn/57.4.573; LEVY E, 1989, J LIPID RES, V30, P1197; Martinez JG, 2009, BIOCHEM J, V419, P193, DOI 10.1042/BJ20081505; May GL, 1997, J LIPID RES, V38, P1562; Mayer-Hamblett Nicole, 2007, Proc Am Thorac Soc, V4, P370, DOI 10.1513/pats.200703-040BR; Megiorni F, 2013, J CYST FIBROS, V12, P797, DOI 10.1016/j.jcf.2013.03.007; Meyer KC, 2000, CHEST, V118, P164, DOI 10.1378/chest.118.1.164; Mickle JE, 2000, MED CLIN N AM, V84, P597, DOI 10.1016/S0025-7125(05)70243-1; Ollero M, 2011, J LIPID RES, V52, P1011, DOI 10.1194/jlr.P013722; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Pier GB, 2000, P NATL ACAD SCI USA, V97, P8822, DOI 10.1073/pnas.97.16.8822; Porter E, 2005, INFECT IMMUN, V73, P4823, DOI 10.1128/IAI.73.8.4823-4833.2005; Rosenfeld Margaret, 2007, Proc Am Thorac Soc, V4, P299, DOI 10.1513/pats.200611-178HT; Sagel SD, 2012, AM J RESP CRIT CARE, V186, P857, DOI 10.1164/rccm.201203-0507OC; Sagel SD, 2009, PEDIATR PULM, V44, P402, DOI 10.1002/ppul.21028; Schluchter MD, 2002, STAT MED, V21, P1271, DOI 10.1002/sim.1104; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; SLOMIANY A, 1982, BIOCHIM BIOPHYS ACTA, V710, P106, DOI 10.1016/0005-2760(82)90196-5; Sly PD, 2013, NEW ENGL J MED, V368, P1963, DOI 10.1056/NEJMoa1301725; Solomon GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072398; Sousa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047708; Suzuki T, 2008, INT J BIOCHEM CELL B, V40, P1348, DOI 10.1016/j.biocel.2008.01.003; Taggart CC, 2003, J IMMUNOL, V171, P931, DOI 10.4049/jimmunol.171.2.931; Tollin M, 2005, CELL MOL LIFE SCI, V62, P2390, DOI 10.1007/s00018-005-5260-7; Uda S, 2013, J LIPID RES, V54, P3158, DOI 10.1194/jlr.M042663; Wattiez R, 2005, J CHROMATOGR B, V815, P169, DOI 10.1016/j.jchromb.2004.10.029	47	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125326	10.1371/journal.pone.0125326	http://dx.doi.org/10.1371/journal.pone.0125326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919295	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659400080
J	Mumford, JA; Poline, JB; Poldrack, RA				Mumford, Jeanette A.; Poline, Jean-Baptiste; Poldrack, Russell A.			Orthogonalization of Regressors in fMRI Models	PLOS ONE			English	Article								The occurrence of collinearity in fMRI-based GLMs (general linear models) may reduce power or produce unreliable parameter estimates. It is commonly believed that orthogonalizing collinear regressors in the model will solve this problem, and some software packages apply automatic orthogonalization. However, the effects of orthogonalization on the interpretation of the resulting parameter estimates is widely unappreciated or misunderstood. Here we discuss the nature and causes of collinearity in fMRI models, with a focus on the appropriate uses of orthogonalization. Special attention is given to how the two popular fMRI data analysis software packages, SPM and FSL, handle orthogonalization, and pitfalls that may be encountered in their usage. Strategies are discussed for reducing collinearity in fMRI designs and addressing their effects when they occur.	[Mumford, Jeanette A.] Univ Wisconsin, Waisman Ctr, Ctr Investigating Hlth Minds, Madison, WI 53705 USA; [Poline, Jean-Baptiste] Univ Calif Berkeley, Brain Imaging Ctr, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Poldrack, Russell A.] Stanford Univ, Dept Psychol, Palo Alto, CA 94304 USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Berkeley; Stanford University	Mumford, JA (corresponding author), Univ Wisconsin, Waisman Ctr, Ctr Investigating Hlth Minds, Madison, WI 53705 USA.	jeanette.mumford@gmail.com		Poldrack, Russell/0000-0001-6755-0259				Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Mumford JA, 2006, IEEE ENG MED BIOL, V25, P42, DOI 10.1109/MEMB.2006.1607668; Neter J, APPL LINEAR STAT MOD; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Pernet CR, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00001; Poline J, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P126, DOI 10.1016/B978-012372560-8/50009-7	7	141	142	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0126255	10.1371/journal.pone.0126255	http://dx.doi.org/10.1371/journal.pone.0126255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919488	gold, Green Published			2022-12-27	WOS:000353659400093
J	Sugie, K; Sugie, M; Taoka, T; Tonomura, Y; Kumazawa, A; Izumi, T; Kichikawa, K; Ueno, S				Sugie, Kazuma; Sugie, Miho; Taoka, Toshio; Tonomura, Yasuyo; Kumazawa, Aya; Izumi, Tesseki; Kichikawa, Kimihiko; Ueno, Satoshi			Characteristic MRI Findings of upper Limb Muscle Involvement in Myotonic Dystrophy Type 1	PLOS ONE			English	Article							SKELETAL-MUSCLE; DEGENERATION	The objective of our study was to evaluate the relation between muscle MRI findings and upper limb weakness with grip myotonia in patients with myotonic dystrophy type 1 (DM1). Seventeen patients with DM1 were evaluated by manual muscle strength testing and muscle MRI of the upper limbs. Many DM1 patients presenting with decreased grasping power frequently showed high intensity signals in the flexor digitorum profundus (FDP) muscles on T1-weighted imaging. Patients presenting with upper limb weakness frequently also showed high intensity signals in the flexor pollicis longus, abductor pollicis longus, and extensor pollicis muscles. Disturbances of the distal muscles of the upper limbs were predominant in all DM1 patients. Some DM1 patients with a prolonged disease duration showed involvement of not only distal muscles but also proximal muscles in the upper limbs. Muscle involvement of the upper limbs on MRI strongly correlated positively with the disease duration or the numbers of CTG repeats. To our knowledge, this is the first study to provide a detailed description of the distribution and severity of affected muscles of the upper limbs on MRI in patients with DM1. We conclude that muscle MRI findings are very useful for identifying affected muscles and predicting the risk of muscle weakness in the upper limbs of DM1 patients.	[Sugie, Kazuma; Sugie, Miho; Tonomura, Yasuyo; Kumazawa, Aya; Izumi, Tesseki; Ueno, Satoshi] Nara Med Univ, Sch Med, Dept Neurol, Nara, Japan; [Sugie, Miho] Nara Prefectural Rehabil Ctr, Dept Neurol, Nara, Japan; [Taoka, Toshio; Kichikawa, Kimihiko] Nara Med Univ, Sch Med, Dept Radiol, Nara, Japan	Nara Medical University; Nara Medical University	Sugie, K (corresponding author), Nara Med Univ, Sch Med, Dept Neurol, Nara, Japan.	ksugie@naramed-u.ac.jp	Taoka, Toshiaki/A-1637-2016	Taoka, Toshiaki/0000-0001-9227-0240				Andersen G, 2013, MUSCLE NERVE, V47, P409, DOI 10.1002/mus.23535; [Anonymous], [No title captured]; Bachmann G, 1996, NEURORADIOLOGY, V38, P629, DOI 10.1007/s002340050322; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BROOKE MH, 1983, MUSCLE NERVE, V6, P204, DOI 10.1002/mus.880060307; Cote C, 2011, CAN J NEUROL SCI, V38, P112, DOI 10.1017/S0317167100011148; EDWARDS RHT, 1980, BRIT MED BULL, V36, P159, DOI 10.1093/oxfordjournals.bmb.a071632; Fischer D, 2008, NEUROLOGY, V71, P758, DOI 10.1212/01.wnl.0000324927.28817.9b; FUJINO H, 1991, MUSCLE NERVE, V14, P716, DOI 10.1002/mus.880140805; Hamano T, 2010, EUR NEUROL, V63, P144, DOI 10.1159/000280763; Hiba B, 2012, J MAGN RESON IMAGING, V35, P678, DOI 10.1002/jmri.22849; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Kornblum C, 2006, J NEUROL, V253, P753, DOI 10.1007/s00415-006-0111-5; Kornblum C, 2010, ACTA NEUROL SCAND, V121, P131, DOI 10.1111/j.1600-0404.2009.01228.x; SCHREIBER A, 1987, PEDIATR RADIOL, V17, P495, DOI 10.1007/BF02388288; Sekul EA, 1997, NEUROLOGY, V48, P863, DOI 10.1212/WNL.48.4.863; Turner C, 2010, J NEUROL NEUROSUR PS, V81, P358, DOI 10.1136/jnnp.2008.158261	17	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125051	10.1371/journal.pone.0125051	http://dx.doi.org/10.1371/journal.pone.0125051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919300	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400069
J	Antony, C; Mehto, S; Tiwari, BK; Singh, Y; Natarajan, K				Antony, Cecil; Mehto, Subhash; Tiwari, Brijendra K.; Singh, Yogendra; Natarajan, Krishnamurthy			Regulation of L-type Voltage Gated Calcium Channel CACNA1S in Macrophages upon Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							DENDRITIC CELLS; T-CELLS; PROTECTIVE IMMUNITY; ACTIVATION; PROTEIN; RESPONSES; APOPTOSIS; SURVIVAL; DIFFERENTIATION; MODULATION	We demonstrated earlier the inhibitory role played by Voltage Gated Calcium Channels (VGCCs) in regulating Mycobacterium tuberculosis (M. tb) survival and pathogenesis. In this report, we investigated mechanisms and key players that regulate the surface expression of VGCC-CACNA1S by Rv2463 and Mycobacterium tuberculosis infection in macrophages. Our earlier work identified Rv2463 to be expressed at early times post infection in macrophages that induced suppressor responses to dendritic cells and macrophages. Our results in this study demonstrate a role of MyD88 independent TLR pathway in mediating CACNA1S expression. Dissecting the role for second messengers, we show that calcium homeostasis plays a key role in CACNA1S expression during Mycobacterium tuberculosis infection. Using siRNAs against molecular sensors of calcium regulation, we show an involvement of ER associated Stromal Interaction Molecules 1 and 2 (STIM1 and STIM2), and transcription factor pCREB, towards CACNA1S expression that also involved the MyD88 independent pathway. Interestingly, reactive oxygen species played a negative role in Mycobacterium tuberculosis mediated CACNA1S expression. Further, a cross-regulation of ROS and pCREB was noted that governed CACNA1S expression. Characterizing the mechanisms governing CACNA1S expression would improve our understanding of the regulation of VGCC expression and its role in Mycobacterium tuberculosis pathogenesis during Mycobacterium tuberculosis infection.	[Antony, Cecil; Mehto, Subhash; Natarajan, Krishnamurthy] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Infect Dis Immunol, Delhi 110007, India; [Tiwari, Brijendra K.; Singh, Yogendra] CSIR, Inst Genom & Integrat Biol, Delhi 110007, India	University of Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Antony, C (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Infect Dis Immunol, Delhi 110007, India.	cecilantony.f@gmail.com; knatarajan@acbr.du.ac.in	Tiwari, Brijesh Kumar/K-6227-2013; Antony, Cecil/AFE-5951-2022; Antony, Cecil/O-7733-2017	Tiwari, Brijesh Kumar/0000-0002-4834-6831; Mehto, Subhash/0000-0002-5351-7850; Antony, Cecil/0000-0001-7622-4586	Department of Biotechnology, Ministry of Science and Technology, Government of India; ICMR Senior Research Fellowship	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); ICMR Senior Research Fellowship	This work was supported by grants to KN and YS from the Department of Biotechnology, Ministry of Science and Technology, Government of India, and CA is a recipient of the ICMR Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Azenabor AA, 2003, MED MICROBIOL IMMUN, V192, P99, DOI 10.1007/s00430-002-0164-8; Badou A, 1997, J BIOL CHEM, V272, P32411, DOI 10.1074/jbc.272.51.32411; Badou A, 2006, P NATL ACAD SCI USA, V103, P15529, DOI 10.1073/pnas.0607262103; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; Balkhi MY, 2004, J LEUKOCYTE BIOL, V75, P874, DOI 10.1189/jlb.1003476; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Carmona J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067277; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; DOUGHERTY RW, 1986, J BIOL CHEM, V261, P4097; Faries MB, 2001, BLOOD, V98, P2489, DOI 10.1182/blood.V98.8.2489; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Foote S, 1999, NAT GENET, V21, P345, DOI 10.1038/7663; Grafton G, 2003, BIOCHEM PHARMACOL, V66, P2001, DOI 10.1016/j.bcp.2003.07.005; Gupta D, 2010, J IMMUNOL, V184, P5444, DOI 10.4049/jimmunol.0903283; Gupta S, 2013, AM J RESP CRIT CARE, V188, P600, DOI 10.1164/rccm.201304-0650OC; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005305; Harris TH, 2007, INFECT IMMUN, V75, P2366, DOI 10.1128/IAI.01649-06; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; JACONI MEE, 1990, J CELL BIOL, V110, P1555, DOI 10.1083/jcb.110.5.1555; Jassal MS, 2010, CLIN INFECT DIS, V50, pS156, DOI 10.1086/651486; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Jha MK, 2009, NAT IMMUNOL, V10, P1275, DOI 10.1038/ni.1793; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Latchumanan VK, 2002, J IMMUNOL, V169, P6856, DOI 10.4049/jimmunol.169.12.6856; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liu WL, 2011, CURR OPIN INFECT DIS, V24, P254, DOI 10.1097/QCO.0b013e3283463e5b; Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811; Matza D, 2008, IMMUNITY, V28, P64, DOI 10.1016/j.immuni.2007.11.020; Matza D, 2009, IMMUNOL REV, V231, P257, DOI 10.1111/j.1600-065X.2009.00805.x; Mellstrom B, 2008, PHYSIOL REV, V88, P421, DOI 10.1152/physrev.00041.2005; MORRIS SA, 1988, MOL BIOCHEM PARASIT, V29, P213, DOI 10.1016/0166-6851(88)90076-X; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; Nagabhushanam V, 2003, J IMMUNOL, V171, P4750, DOI 10.4049/jimmunol.171.9.4750; Natarajan K, 2003, J INFECT DIS, V187, P914, DOI 10.1086/368173; Nejatbakhsh N, 2011, ACTA PHARMACOL SIN, V32, P741, DOI 10.1038/aps.2011.64; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Pennini ME, 2006, J IMMUNOL, V176, P4323, DOI 10.4049/jimmunol.176.7.4323; PETERSEN OH, 1994, ANNU REV PHYSIOL, V56, P297, DOI 10.1146/annurev.ph.56.030194.001501; Podinovskaia M, 2013, CELL MICROBIOL, V15, P843, DOI 10.1111/cmi.12092; Poggi A, 1998, J BIOL CHEM, V273, P7205, DOI 10.1074/jbc.273.13.7205; ROSALES C, 1992, J BIOL CHEM, V267, P1443; Salam N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002869; Savignac M, 2001, FASEB J, V15, P1577, DOI 10.1096/fj.00-0733fje; Selvakumar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096427; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Singhal A, 2007, INFECT IMMUN, V75, P2500, DOI 10.1128/IAI.01743-06; Singhal J, 2012, J BIOL CHEM, V287, P11108, DOI 10.1074/jbc.M111.300319; Sinha A, 2006, J IMMUNOL, V177, P468, DOI 10.4049/jimmunol.177.1.468; Stokes L, 2004, J BIOL CHEM, V279, P19566, DOI 10.1074/jbc.M401481200; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; Wadsworth SJ, 1999, INFECT IMMUN, V67, P1770; Wieland H, 2006, FEMS IMMUNOL MED MIC, V47, P296, DOI 10.1111/j.1574-695X.2006.00092.x; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Zheng ZL, 2002, J PHYSIOL-LONDON, V540, P397, DOI 10.1113/jphysiol.2001.013464; Zocchi MR, 1998, J IMMUNOL, V161, P2938	64	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124263	10.1371/journal.pone.0124263	http://dx.doi.org/10.1371/journal.pone.0124263			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915405	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659100043
J	Arntzen, MO; Karlskas, IL; Skaugen, M; Eijsink, VGH; Mathiesen, G				Arntzen, Magnus Overlie; Karlskas, Ingrid Lea; Skaugen, Morten; Eijsink, Vincent G. H.; Mathiesen, Geir			Proteomic Investigation of the Response of Enterococcus faecalis V583 when Cultivated in Urine	PLOS ONE			English	Article							VIRULENCE-RELATED GENES; STREPTOCOCCUS-SANGUIS; NUCLEOTIDE-SEQUENCE; SURFACE-PROTEINS; SIGNAL PEPTIDES; STRESS-RESPONSE; IDENTIFICATION; EXPRESSION; BINDING; VANCOMYCIN	Enterococcus faecalis is a robust bacterium, which is able to survive in and adapt to hostile environments such as the urinary tract and bladder. In this label-free quantitative proteomic study based on MaxQuant LFQ algorithms, we identified 127 proteins present in the secretome of the clinical vancomycin-resistant isolate E. faecalis V583 and we compared proteins secreted in the initial phase of cultivation in urine with the secretome during cultivation in standard laboratory medium, 2xYT. Of the 54 identified proteins predicted to be secreted, six were exclusively found after cultivation in urine including the virulence factor EfaA ("endocarditis specific antigen") and its homologue EF0577 ("adhesion lipoprotein"). These two proteins are both involved in manganese transport, known to be an important determinant of colonization and infection, and may additionally function as adhesins. Other detected urine-specific proteins are involved in peptide transport (EF0063 and EF3106) and protease inhibition (EF3054). In addition, we found an uncharacterized protein (EF0764), which had not previously been linked to the adaptation of V583 to a urine environment, and which is unique to E. faecalis. Proteins found in both environments included a histone-like protein, EF1550, that was up-regulated during cultivation in urine and that has a homologue in streptococci (HlpA) known to be involved in bacterial adhesion to host cells. Up-regulated secreted proteins included autolysins. These results from secretome analyses are largely compatible with previously published data from transcriptomics studies. All in all, the present data indicate that transport, in particular metal transport, adhesion, cell wall remodelling and the unknown function carried out by the unique EF0764 are important for enterococcal adaptation to the urine environment. These results provide a basis for a more targeted exploration of novel proteins involved in the adaptability and pathogenicity of E. faecalis.	[Arntzen, Magnus Overlie; Karlskas, Ingrid Lea; Skaugen, Morten; Eijsink, Vincent G. H.; Mathiesen, Geir] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway	Norwegian University of Life Sciences	Arntzen, MO (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway.	magnus.arntzen@nmbu.no	Arntzen, Magnus Ø/N-6983-2016	Arntzen, Magnus Ø/0000-0002-1803-727X	FUGE programme of the Norwegian Research Council [183627, 183637]	FUGE programme of the Norwegian Research Council	This work was funded by the FUGE programme of the Norwegian Research Council, grant numbers 183627 & 183637. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakra A, 2005, ANTIMICROB AGENTS CH, V49, P2246, DOI 10.1128/AAC.49.6.2246-2259.2005; Abranches J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064875; Abrantes MC, 2013, INFECT IMMUN, V81, P935, DOI 10.1128/IAI.06377-11; Abrantes MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026519; Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Benachour A, 2009, CAN J MICROBIOL, V55, P967, DOI [10.1139/W09-052, 10.1139/w09-052]; Bohle LA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-135; Bohle LA, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-37; Boleij A, 2009, INFECT IMMUN, V77, P5519, DOI 10.1128/IAI.00384-09; Bravetti AL, 2009, ANTIMICROB AGENTS CH, V53, P1667, DOI 10.1128/AAC.00692-08; Carlos AR, 2010, J APPL MICROBIOL, V108, P1563, DOI 10.1111/j.1365-2672.2009.04551.x; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deb Roy S, 2014, ENTEROCOCCI COMMENSA; Dundar H, 2015, J BACTERIOL, V197, P2112, DOI 10.1128/JB.02513-14; Eirich J, 2011, J AM CHEM SOC, V133, P12144, DOI 10.1021/ja2039979; FACHONKALWEIT S, 1985, INFECT IMMUN, V48, P617, DOI 10.1128/IAI.48.3.617-624.1985; FENNO JC, 1989, INFECT IMMUN, V57, P3527, DOI 10.1128/IAI.57.11.3527-3533.1989; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; GANESHKUMAR N, 1991, INFECT IMMUN, V59, P1093, DOI 10.1128/IAI.59.3.1093-1099.1991; GANESHKUMAR N, 1988, INFECT IMMUN, V56, P1150, DOI 10.1128/IAI.56.5.1150-1157.1988; Giard JC, 2001, ELECTROPHORESIS, V22, P2947, DOI 10.1002/1522-2683(200108)22:14&lt;2947::AID-ELPS2947&gt;3.0.CO;2-K; Guedon E, 2005, MICROBIOL-SGM, V151, P3895, DOI 10.1099/mic.0.28186-0; Guiton PS, 2009, INFECT IMMUN, V77, P3626, DOI 10.1128/IAI.00219-09; GUZMAN CA, 1989, INFECT IMMUN, V57, P1834; Hanin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011879; Heim S, 2002, J BACTERIOL, V184, P6739, DOI 10.1128/JB.184.23.6739-6745.2002; Horsley H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083637; Huang CJ, 2011, APPL MICROBIOL BIOT, V90, P235, DOI 10.1007/s00253-011-3118-5; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Komeil D, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-35; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; La Carbona S, 2007, MOL MICROBIOL, V66, P1148, DOI 10.1111/j.1365-2958.2007.05987.x; Lindenstrauss AG, 2013, ARCH MICROBIOL, V195, P121, DOI 10.1007/s00203-012-0857-3; Low YL, 2003, J MED MICROBIOL, V52, P113, DOI 10.1099/jmm.0.05039-0; LOWE AM, 1995, INFECT IMMUN, V63, P703, DOI 10.1128/IAI.63.2.703-706.1995; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Maddalo G, 2011, PROTEOMICS, V11, P3935, DOI 10.1002/pmic.201100103; Mesnage S, 2008, J BIOL CHEM, V283, P19845, DOI 10.1074/jbc.M802323200; Murray BE, 1998, EMERG INFECT DIS, V4, P37, DOI 10.3201/eid0401.980106; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pakotiprapha D, 2012, NAT STRUCT MOL BIOL, V19, P291, DOI 10.1038/nsmb.2240; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Peppoloni S, 2011, MICROBIOL-SGM, V157, P1816, DOI 10.1099/mic.0.047381-0; Pessione A, 2012, PROTEOMICS, V12, P431, DOI 10.1002/pmic.201100468; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Qin X, 2001, J BACTERIOL, V183, P3372, DOI 10.1128/JB.183.11.3372-3382.2001; Reffuveille F, 2011, MICROBIOL-SGM, V157, P3001, DOI 10.1099/mic.0.053314-0; RUHFEL RE, 1993, J BACTERIOL, V175, P5253, DOI 10.1128/JB.175.16.5253-5259.1993; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Shankar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033450; Shepard BD, 2002, INFECT IMMUN, V70, P4344, DOI 10.1128/IAI.70.8.4344-4352.2002; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Singh KV, 1998, FEMS IMMUNOL MED MIC, V21, P323, DOI 10.1016/S0928-8244(98)00087-X; Solheim M, 2007, APPL ENVIRON MICROB, V73, P5767, DOI 10.1128/AEM.00651-07; Solheim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094571; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stenz L, 2011, FEMS IMMUNOL MED MIC, V62, P123, DOI 10.1111/j.1574-695X.2011.00812.x; Stinson MW, 1998, INFECT IMMUN, V66, P259, DOI 10.1128/IAI.66.1.259-265.1998; Taboada B, 2012, NUCLEIC ACIDS RES, V40, pD627, DOI 10.1093/nar/gkr1020; Vebo HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012489; Vebo HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007660; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang XS, 2010, J PROTEOME RES, V9, P1772, DOI 10.1021/pr901216e; Wisniewski JR, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.44; Yeats C, 2004, TRENDS BIOCHEM SCI, V29, P169, DOI 10.1016/j.tibs.2004.02.004; Zhang LP, 1999, INFECT IMMUN, V67, P6473	68	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0126694	10.1371/journal.pone.0126694	http://dx.doi.org/10.1371/journal.pone.0126694			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915650	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000353659100157
J	Grbesa, I; Pajares, MJ; Martinez-Terroba, E; Agorreta, J; Mikecin, AM; Larrayoz, M; Idoate, MA; Gall-Troselj, K; Pio, R; Montuenga, LM				Grbesa, Ivana; Pajares, Maria J.; Martinez-Terroba, Elena; Agorreta, Jackeline; Mikecin, Ana-Matea; Larrayoz, Marta; Idoate, Miguel A.; Gall-Troselj, Koraljka; Pio, Ruben; Montuenga, Luis M.			Expression of Sirtuin 1 and 2 Is Associated with Poor Prognosis in Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							REGULATES SIRT1; P53; DEACETYLASE; SENESCENCE; CARCINOMA; GROWTH; ADENOCARCINOMA; INHIBITION; KNOCKDOWN; APOPTOSIS	Background Sirtuin 1 (SIRT1) and sirtuin 2 (SIRT2) are NAD+-dependent protein deacetylases involved in the regulation of key cancer-associated genes. In this study we evaluated the relevance of these deacetylases in lung cancer biology. Material and Methods Protein levels of SIRT1 and SIRT2 were determined in non-small cell lung cancer (NSCLC) cell lines and primary tumors from 105 patients. Changes in proliferation were assessed after SIRT1 and SIRT2 downregulation in lung cancer cell lines using siRNA-mediated technology or tenovin-1, a SIRT1 and SIRT2 inhibitor. Results High SIRT1 and SIRT2 protein levels were found in NSCLC cell lines compared with nontumor lung epithelial cells. The expression of SIRT1 and SIRT2 proteins was also significantly higher in lung primary tumors than in normal tissue (P<0.001 for both sirtuins). Stronger nuclear SIRT1 staining was observed in adenocarcinomas than in squamous cell carcinomas (P=0.033). Interestingly, in NSCLC patients, high SIRT1 and SIRT2 expression levels were associated with shorter recurrence-free survival (P=0.04 and P=0.007, respectively). Moreover, the combination of high SIRT1 and SIRT2 expression was an independent prognostic factor for shorter recurrence-free survival (P=0.002) and overall survival (P=0.022). In vitro studies showed that SIRT1 and/or SIRT2 downregulation significantly decreased proliferation of NSCLC. Conclusions Our results support the hypothesis that SIRT1 and SIRT2 have a protumorigenic role in lung cancer, promoting cell proliferation. Moreover, the expression of these proteins is associated with poor prognosis in NSCLC patients and may help to identify those NSCLC patients with high risk of recurrence that could benefit from adjuvant therapy after resection.	[Grbesa, Ivana; Pajares, Maria J.; Martinez-Terroba, Elena; Agorreta, Jackeline; Larrayoz, Marta; Pio, Ruben; Montuenga, Luis M.] Univ Navarra, Ctr Appl Med Res CIMA, Program Solid Tumors & Biomarkers, Biomarkers Lab, Pamplona 31008, Spain; [Grbesa, Ivana] Rudjer Boskovic Inst, Div Mol Med, Grp Translat Med, Zagreb 10000, Croatia; [Pajares, Maria J.; Martinez-Terroba, Elena; Agorreta, Jackeline; Montuenga, Luis M.] Univ Navarra, Sch Med, Dept Histol & Pathol, Pamplona 31008, Spain; [Pajares, Maria J.; Agorreta, Jackeline; Idoate, Miguel A.; Pio, Ruben; Montuenga, Luis M.] Navarras Hlth Res Inst IDISNA, Pamplona, Spain; [Mikecin, Ana-Matea] Rudjer Boskovic Inst, Div Mol Med, Lab Expt Therapy, Zagreb 10000, Croatia; [Idoate, Miguel A.] Univ Hosp, Dept Pathol, Pamplona 31008, Spain; [Idoate, Miguel A.] Univ Navarra, Fac Med, Pamplona 31008, Spain; [Gall-Troselj, Koraljka] Rudjer Boskovic Inst, Div Mol Med, Lab Epigen, Zagreb 10000, Croatia; [Pio, Ruben] Univ Navarra, Sch Sci, Dept Biochem & Genet, Pamplona 31008, Spain	University of Navarra; Rudjer Boskovic Institute; University of Navarra; University of Navarra; Rudjer Boskovic Institute; University of Navarra	Pajares, MJ (corresponding author), Univ Navarra, Ctr Appl Med Res CIMA, Program Solid Tumors & Biomarkers, Biomarkers Lab, Pamplona 31008, Spain.	mpajares@unav.es	Larrayoz, Marta/F-9456-2016; Pio, Ruben/F-5353-2017; Idoate, Miguel-Ángel/D-8502-2019; Grbesa, Ivana/AAT-4455-2020; Agorreta, Jackeline/N-2393-2018; Montuenga, Luis M/AAF-7783-2020; Gall Troselj, Koraljka/B-5866-2017	Larrayoz, Marta/0000-0001-6097-8244; Pio, Ruben/0000-0002-6831-6111; Idoate, Miguel-Ángel/0000-0002-1596-1192; Agorreta, Jackeline/0000-0003-4503-9884; Montuenga, Luis M/0000-0002-8739-1387; Gall Troselj, Koraljka/0000-0001-7501-7614; Grbesa, Ivana/0000-0002-4579-9149	CIMA; Spanish Ministries of Health/Economy and Competitivity; Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional(FEDER) [ISCIII: RTICC RD12/0036/0040, FIS-PI 10/00166 PI 11/00618, PI13/00806, PI14/01686]; AECC Scientific Foundation [GCB14-2170]; Seventh Framework Programme project [CURELUNG HEALTH-F2-2010-258677]; Croatian Science Foundation [O-190-2011]; Croatian Ministry of Science, Education and Sport [098-0982464-2511]	CIMA(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Spanish Ministries of Health/Economy and Competitivity; Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional(FEDER); AECC Scientific Foundation; Seventh Framework Programme project; Croatian Science Foundation; Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia)	This work was supported by CIMA, the Spanish Ministries of Health/Economy and Competitivity and *Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional(FEDER)* (ISCIII: RTICC RD12/0036/0040, FIS-PI 10/00166 PI 11/00618,PI13/00806 and PI14/01686), and AECC Scientific Foundation (GCB14-2170) and a Seventh Framework Programme project (CURELUNG HEALTH-F2-2010-258677). IG was financed by Croatian Science Foundation (Brain Gain-Postdoc program, O-190-2011) and Croatian Ministry of Science, Education and Sport (098-0982464-2511). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Bosch-Presegue Laia, 2011, Genes Cancer, V2, P648, DOI 10.1177/1947601911417862; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Chen HC, 2012, ANN SURG ONCOL, V19, P2011, DOI 10.1245/s10434-011-2159-4; Chen J, 2013, HEPATOLOGY, V57, P2287, DOI 10.1002/hep.26278; Chen J, 2011, CANCER RES, V71, P4138, DOI 10.1158/0008-5472.CAN-10-4274; Fong Y, 2014, SCI WORLD J, DOI 10.1155/2014/937051; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Herranz D, 2013, ONCOGENE, V32, P4052, DOI 10.1038/onc.2012.407; Hirai S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102831; Hoffmann G, 2014, J BIOL CHEM, V289, P5208, DOI 10.1074/jbc.M113.487736; Holloway KR, 2013, MOL ENDOCRINOL, V27, P480, DOI 10.1210/me.2012-1347; Holloway KR, 2010, P NATL ACAD SCI USA, V107, P9216, DOI 10.1073/pnas.0911325107; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Jang KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045119; Jung-Hynes B, 2009, CELL CYCLE, V8, P1478, DOI 10.4161/cc.8.10.8408; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Lejeune A, 2001, CHEM BIOL, V8, P831, DOI 10.1016/S1074-5521(01)00053-9; Li LT, 2012, J ADV CERAM, V1, P1, DOI 10.1007/s40145-012-0001-5; Li ZM, 2013, LUNG CANCER, V82, P9, DOI 10.1016/j.lungcan.2013.05.013; Lima RT, 2013, ANTI-CANCER AGENT ME, V13, P414; Liu GB, 2012, J CELL MOL MED, V16, P1618, DOI 10.1111/j.1582-4934.2011.01401.x; Liu PY, 2013, CELL DEATH DIFFER, V20, P503, DOI 10.1038/cdd.2012.147; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nguewa PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-103; Noh SJ, 2013, PATHOL RES PRACT, V209, P365, DOI 10.1016/j.prp.2013.03.011; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Pajares MJ, 2012, J CLIN ONCOL, V30, P1129, DOI 10.1200/JCO.2011.37.4231; Peters CJ, 2010, GASTROENTEROLOGY, V139, P1995, DOI 10.1053/j.gastro.2010.05.080; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Revollo JR, 2013, TRENDS BIOCHEM SCI, V38, P160, DOI 10.1016/j.tibs.2012.12.004; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Shin DH, 2014, CANCER RES, V74, P298, DOI 10.1158/0008-5472.CAN-13-2620; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Simmons GE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098861; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Sun LN, 2013, JNCI-J NATL CANCER I, V105, P887, DOI 10.1093/jnci/djt118; Sun YN, 2007, LUNG CANCER, V58, P21, DOI 10.1016/j.lungcan.2007.05.013; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Travis W, 2004, WHO CLASSIFICATION T; Tseng RC, 2009, NEOPLASIA, V11, P763, DOI 10.1593/neo.09470; Wu MQ, 2012, MED ONCOL, V29, P3240, DOI 10.1007/s12032-012-0260-6; Yuan HF, 2013, ONCOTARGETS THER, V6, P1399, DOI 10.2147/OTT.S37750; Zhang T, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-351; Zhao G, 2011, GENE THER, V18, P920, DOI 10.1038/gt.2011.81	50	54	58	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124670	10.1371/journal.pone.0124670	http://dx.doi.org/10.1371/journal.pone.0124670			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915617	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100059
J	Johnston, D; Gerbing, R; Alonzo, T; Aplenc, R; Nagarajan, R; Schulte, F; Cullen, P; Sung, L				Johnston, Donna; Gerbing, Robert; Alonzo, Todd; Aplenc, Richard; Nagarajan, Rajaram; Schulte, Fiona; Cullen, Patricia; Sung, Lillian			Patient-Reported Outcome Coordinator Did Not Improve Quality of Life Assessment Response Rates: A Report from the Children's Oncology Group	PLOS ONE			English	Article							GENERIC CORE SCALES; MULTIDIMENSIONAL FATIGUE SCALE; PARENTING STRESS; CANCER; RELIABILITY; PEDSQL(TM); VALIDITY; RECOMMENDATIONS; TRIALS	Purpose Health related quality of life (HRQL) assessments during therapy for pediatric cancer provide valuable information to better understand the patient experience. Our objective was to determine the impact of a patient-reported outcome (PRO) coordinator on HRQL questionnaire completion rates during a pediatric acute myeloid leukemia (AML) trial. Methods AAML1031 is a multicenter Children's Oncology Group therapeutic trial for de novo AML with a secondary aim to assess HRQL of children and adolescents treated with chemotherapy and hematopoietic stem cell transplantation (HSCT). Parents/guardians are the primary respondents and four questionnaires are administered at eight time points. The questionnaires are the PedsQL 4.0 Generic Core Scales, PedsQL 3.0 Acute Cancer Module, PedsQL Multidimensional Fatigue Scale, and the Pediatric Inventory for Parents. To improve response rates, a central PRO coordinator was instituted and reminded sites about upcoming and delinquent questionnaires. The proportion of HRQL questionnaires completed were compared prior to, and following institution of the PRO coordinator. This analysis evaluated the first five assessment time points. Results There were 231 families who consented to participate in the HRQL aim. Overall response rates for all questionnaires were 73-83%. At time point 1, within 14 days of chemotherapy initiation, post-PRO coordinator completion rates were significantly higher for three of four questionnaires. However, the effect was not sustained and at time point 4, one month following last chemotherapy or HSCT, completion rates were significantly lower post-PRO coordinator for all four questionnaires. Conclusion Addition of a central PRO coordinator did not result in sustained improvement in HRQL questionnaire completion rates. Efforts to improve response rates must consider other strategies.	[Johnston, Donna] Childrens Hosp Eastern Ontario, Div Hematol Oncol, Ottawa, ON K1H 8L1, Canada; [Gerbing, Robert] Childrens Oncol Grp, Monrovia, CA USA; [Alonzo, Todd] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Aplenc, Richard] Childrens Hosp Philadelphia, Pediat Oncol Stem Cell Transplant, Philadelphia, PA 19104 USA; [Nagarajan, Rajaram] Cincinnati Childrens Hosp Med Ctr, Div Oncol, Cincinnati, OH 45229 USA; [Schulte, Fiona] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Schulte, Fiona] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Cullen, Patricia] Regis Univ, Loretto Hts Sch Nursing, Denver, CO USA; [Sung, Lillian] Hosp Sick Children, Div Haematol Oncol, Toronto, ON M5G 1X8, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; Children's Oncology Group (COG); University of Southern California; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Cincinnati Children's Hospital Medical Center; University of Calgary; University of Calgary; Regis University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Johnston, D (corresponding author), Childrens Hosp Eastern Ontario, Div Hematol Oncol, Ottawa, ON K1H 8L1, Canada.	djohnston@cheo.on.ca	Schulte, Fiona/AAK-7619-2020	Schulte, Fiona/0000-0002-3076-9676	COG Statistics and Data Center [1U10CA180899-01]; COG NCTN Network Group Operations Center [1U10CA180886-01]; NATIONAL CANCER INSTITUTE [U10CA180886, UG1CA189955, U10CA180899] Funding Source: NIH RePORTER	COG Statistics and Data Center; COG NCTN Network Group Operations Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following grants: COG Statistics and Data Center Grant 1U10CA180899-01 and COG NCTN Network Group Operations Center 1U10CA180886-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks BA, 2008, J PEDIAT HEMATOL ONC, V30, P292, DOI 10.1097/MPH.0b013e3181647bda; Bennett AV, 2012, CA-CANCER J CLIN, V62, P336; BLUMENSTEIN BA, 1995, CONTROL CLIN TRIALS, V16, pS4; Buchanan DR, 2007, CANCER, V110, P1621, DOI 10.1002/cncr.22893; Carter A, 2008, CANCER EPIDEM BIOMAR, V17, P1665, DOI 10.1158/1055-9965.EPI-07-2862; Coons SJ, 2009, VALUE HEALTH, V12, P419, DOI 10.1111/j.1524-4733.2008.00470.x; de Vries MAG, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-103; Johnston DL, 2012, PLOS ONE, V8; Klaassen RJ, 2010, CANCER-AM CANCER SOC, V116, P1608, DOI 10.1002/cncr.24883; Lipscomb J, 2007, J CLIN ONCOL, V25, P5133, DOI 10.1200/JCO.2007.12.4644; Minasian LM, 2007, J CLIN ONCOL, V25, P5128, DOI 10.1200/JCO.2007.12.6672; O'Mara Ann M, 2010, Semin Oncol Nurs, V26, P68, DOI 10.1016/j.soncn.2009.11.009; Russell KMW, 2006, CANCER-AM CANCER SOC, V106, P2267, DOI 10.1002/cncr.21871; Streisand R, 2003, CHILD HEALTH CARE, V32, P245, DOI 10.1207/S15326888CHC3204_1; Streisand R, 2001, J PEDIATR PSYCHOL, V26, P155, DOI 10.1093/jpepsy/26.3.155; Sung LL, 2011, INT J CANCER, V128, P1213, DOI 10.1002/ijc.25433; Tremolada M, 2011, SUPPORT CARE CANCER, V19, P591, DOI 10.1007/s00520-010-0854-5; VanHoff D, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-154; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 2004, J RHEUMATOL, V31, P2494; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Varni JW, 2002, J BEHAV MED, V25, P175, DOI 10.1023/A:1014836921812	22	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125290	10.1371/journal.pone.0125290	http://dx.doi.org/10.1371/journal.pone.0125290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915772	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100116
J	Kalota, A; Selak, MA; Garcia-Cid, LA; Carroll, M				Kalota, Anna; Selak, Mary A.; Garcia-Cid, Laura A.; Carroll, Martin			Eltrombopag Modulates Reactive Oxygen Species and Decreases Acute Myeloid Leukemia Cell Survival	PLOS ONE			English	Article							THROMBOPOIETIN RECEPTOR AGONIST; CHRONIC IMMUNE THROMBOCYTOPENIA; DAMAGE; EXPRESSION	Previous studies have demonstrated that the small molecule thrombopoietin (TPO) mimetic, eltrombopag (E), induces apoptosis in acute myeloid leukemia (AML) cells. Here, we sought to define the mechanism of the anti-leukemic effect of eltrombopag. Our studies demonstrate that, at a concentration of 5 mu M E in 2% serum, E induces apoptosis in leukemia cells by triggering PARP cleavage and activation of caspase cascades within 2-6 hours. The induction of apoptotic enzymes is critically dependent on drug concentration and the concentration of serum. This effect is not associated with an alteration in mitochondrial potential but is associated with a rapid decrease in a reactive oxygen species (ROS) in particular hydrogen peroxide (H2O2). Interestingly, E also decreases mitochondrial maximal and spare respiratory capacities suggesting an induced mitochondrial dysfunction that may not be readily apparent under basal conditions but becomes manifest only under stress. Co-treatment of MOLM14 AML cells with E plus Tempol or H2O2 provides a partial rescue of cell toxicity. Ferric ammonioum citrate (FAC) also antagonized the E induced toxicity, by inducing notable increase in ROS level. Overall, we propose that E dramatically decreases ROS levels leading to a disruption of AML intracellular metabolism and rapid cell death.	[Kalota, Anna; Garcia-Cid, Laura A.; Carroll, Martin] Univ Penn, Div Hematol & Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Selak, Mary A.] Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Carroll, M (corresponding author), Univ Penn, Div Hematol & Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA.	carroll2@mail.med.upenn.edu			Veterans Affairs Administration [1I01BX000918-01]; National Institute of Health [1R01CA149566-01A1]; National Institutes of Health [1-R21-CA-153018-01]; GlaxoSmithKline, Collegeville, PA; NATIONAL CANCER INSTITUTE [R21CA153018, R01CA149566] Funding Source: NIH RePORTER	Veterans Affairs Administration(US Department of Veterans Affairs); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline, Collegeville, PA(GlaxoSmithKline); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by: Veterans Affairs Administration (1I01BX000918-01), National Institute of Health (1R01CA149566-01A1) and National Institutes of Health (1-R21-CA-153018-01), and in part with research funds provided by GlaxoSmithKline, Collegeville, PA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; Bussel JB, 2007, NEW ENGL J MED, V357, P2237, DOI 10.1056/NEJMoa073275; Cardamone D, 2013, ARCH PATHOL LAB MED, V137, P1175, DOI 10.5858/arpa.2012-0716-LE; Cheng G, 2011, LANCET, V377, P393, DOI 10.1016/S0140-6736(10)60959-2; Clerkin JS, 2008, CANCER LETT, V266, P30, DOI 10.1016/j.canlet.2008.02.029; Deng YL, 2011, DRUG METAB DISPOS, V39, P1734, DOI 10.1124/dmd.111.040170; DIZDAROGLU M, 1991, ARCH BIOCHEM BIOPHYS, V285, P317, DOI 10.1016/0003-9861(91)90366-Q; Erickson-Miller CL, 2009, STEM CELLS, V27, P424, DOI 10.1634/stemcells.2008-0366; Fathi AT, 2012, LEUKEMIA RES, V36, P224, DOI 10.1016/j.leukres.2011.07.011; Frey Noelle V., 2012, ASH M; HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6; Hole PS, 2010, BLOOD, V115, P1238, DOI 10.1182/blood-2009-06-222869; Jenkins JM, 2007, BLOOD, V109, P4739, DOI 10.1182/blood-2006-11-057968; Kalota A, 2006, NUCLEIC ACIDS RES, V34, P451, DOI 10.1093/nar/gkj455; Kalota A, 2010, BLOOD, V115, P89, DOI 10.1182/blood-2009-06-227751; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maraldi T, 2009, FREE RADICAL RES, V43, P1111, DOI 10.1080/10715760903186132; Molineux G, 2010, BRIT J HAEMATOL, V150, P9, DOI 10.1111/j.1365-2141.2010.08140.x; Naughton R, 2009, LEUKEMIA, V23, P1432, DOI 10.1038/leu.2009.49; NIo H., 2013, ELTROMBOPAG ELDERLY; Roth M, 2012, BLOOD, V120, P386, DOI 10.1182/blood-2011-12-399667; Scotland S, 2013, LEUKEMIA, V27, P2129, DOI 10.1038/leu.2013.107; Sugita M, 2013, LEUKEMIA, V27, P1207, DOI 10.1038/leu.2012.310; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Will B, 2009, BLOOD, V114, P3899, DOI 10.1182/blood-2009-04-219493; Zhou FL, 2010, J BIOL CHEM, V285, P15010, DOI 10.1074/jbc.M110.103713	26	31	31	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0126691	10.1371/journal.pone.0126691	http://dx.doi.org/10.1371/journal.pone.0126691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915523	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659100156
J	Kuehl, MN; Rodriguez, H; Burkhardt, BR; Alman, AC				Kuehl, Melanie N.; Rodriguez, Henry; Burkhardt, Brant R.; Alman, Amy C.			Tumor Necrosis Factor-alpha, Matrix-Metalloproteinases 8 and 9 Levels in the Saliva Are Associated with Increased Hemoglobin A1c in Type 1 Diabetes Subjects	PLOS ONE			English	Article							PERIODONTAL TREATMENT; GLYCEMIC CONTROL; COTININE LEVELS; PEPTIDOME; MELLITUS; HOST; BIOMARKERS; DISEASE	Background Type 1 diabetes (T1D) is an autoimmune disease resulting in the targeted destruction of pancreatic beta-cells and permanent loss of insulin production. Proper glucose management results in better clinical outcomes for T1D and provides a strong rationale to identify non-invasive biomarkers indicative or predictive of glycemic control. Therefore, we investigated the association of salivary inflammation with HbA(1c) in a T1D cohort. Methods Unstimulated saliva was collected from 144 subjects with T1D at the USF Diabetes Center. BMI, duration of diabetes, and HbA(1c) were recorded during clinical visit. Levels of interleukin (IL)-1 beta, -6, -8, -10, IFN-gamma, TNF-alpha, MMP-3, -8, and -9 were measured using multiplexing immunoassay analysis. To account for smoking status, salivary cotinine levels were also determined. Results Multiple linear (HbA(1c)) and logistic (self-reported gingival condition) regression analyses were performed to examine the relationships between the Principal Component Analysis (PCA) components and HbA(1c) and gingival condition (adjusted for age, duration of diabetes, BMI, and sex; model for HbA(1c) also adjusted for gingival condition and model for gingival condition also adjusted for HbA(1c)). PCA components 1 (MMP-8 and MMP-9) and 3 (TNF-alpha) were significantly associated with HbA(1c) (beta = 0.28 +/- 0.14, p = 0.045; beta = 0.31 +/- 0.14, p = 0.029), while PCA component 2 (IL-6, IL-1 beta, and IL-8) was significantly associated with gingival condition (OR 1.60 95% CI 1.09-2.34, p = 0.016). In general, increased salivary inflammatory burden is associated with decreased glycemic control and self-reported gingival condition. Conclusions The saliva may represent a useful reservoir of novel noninvasive inflammatory biomarkers predictive of the progression and control of T1D.	[Kuehl, Melanie N.; Burkhardt, Brant R.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Rodriguez, Henry; Burkhardt, Brant R.] Univ S Florida, Coll Med, Ctr Diabet, Tampa, FL USA; [Alman, Amy C.] Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Biostat, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Burkhardt, BR (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	bburkhardt@usf.edu			USF College of Public Health	USF College of Public Health	This study was supported by the USF College of Public Health, New Investigator Award (to ACA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajita M, 2013, DIABETES METAB SYND, V7, P61, DOI 10.1016/j.dsx.2013.03.001; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Bencharit S, 2013, MOL BIOSYST, V9, P2785, DOI 10.1039/c3mb70196d; Binnie V, 2004, ORAL DIS, V10, P287, DOI 10.1111/j.1601-0825.2004.01018.x; Cabras T, 2010, MOL CELL PROTEOMICS, V9, P2099, DOI 10.1074/mcp.M110.001057; Caseiro A, 2013, J PROTEOME RES, V12, P1700, DOI 10.1021/pr3010343; Caseiro A, 2012, BIOMED CHROMATOGR, V26, P571, DOI 10.1002/bmc.1677; Dakovic D, 2013, J CLIN PEDIATR DENT, V37, P377, DOI 10.17796/jcpd.37.4.l135531h4542gj66; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; EDGAR WM, 1992, BRIT DENT J, V172, P305, DOI 10.1038/sj.bdj.4807861; Eke PI, 2010, J DENT RES, V89, P1208, DOI 10.1177/0022034510377793; Engebretson SP, 2004, J PERIODONTOL, V75, P1203, DOI 10.1902/jop.2004.75.9.1203; Engebretson S, 2013, J PERIODONTOL, V84, pS153, DOI [10.1902/jop.2013.1340017, 10.1111/jcpe.12084]; Engebretson SP, 2006, J CLIN PERIODONTOL, V33, P784, DOI 10.1111/j.1600-051X.2006.00984.x; Engebretson SP, 2013, JAMA-J AM MED ASSOC, V310, P2523, DOI 10.1001/jama.2013.282431; Etter JF, 2000, AM J EPIDEMIOL, V151, P251; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Gilbert GH, 2007, J PERIODONTOL, V78, P1429, DOI 10.1902/jop.2007.060199; Gursoy UK, 2013, J CLIN PERIODONTOL, V40, P18, DOI 10.1111/jcpe.12020; Gursoy UK, 2011, DIS MARKERS, V30, P299, DOI [10.3233/DMA-2011-0788, 10.1155/2011/621484]; Kaufman E, 2002, CRIT REV ORAL BIOL M, V13, P197, DOI 10.1177/154411130201300209; Mealey BL, 2006, J AM DENT ASSOC, V137, p26S, DOI 10.14219/jada.archive.2006.0404; Miller CS, 2010, BIOMARK MED, V4, P171, DOI 10.2217/BMM.09.68; Miller CS, 2006, J AM DENT ASSOC, V137, P322, DOI 10.14219/jada.archive.2006.0181; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Rathnayake N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061356; Sgolastra F, 2013, J PERIODONTOL, V84, P958, DOI 10.1902/jop.2012.120377; Teeuw WJ, 2010, DIABETES CARE, V33, P421, DOI 10.2337/dc09-1378; Wang X., 2014, PLOS ONE, V9; Yoon AJ, 2012, J CLIN PERIODONTOL, V39, P434, DOI 10.1111/j.1600-051X.2012.01866.x	31	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125320	10.1371/journal.pone.0125320	http://dx.doi.org/10.1371/journal.pone.0125320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915398	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659100120
J	Marini, E; Buffa, R; Contreras, M; Magris, M; Hidalgo, G; Sanchez, W; Ortiz, V; Urbaez, M; Cabras, S; Blaser, MJ; Dominguez-Bello, MG				Marini, Elisabetta; Buffa, Roberto; Contreras, Monica; Magris, Magda; Hidalgo, Glida; Sanchez, Wilmer; Ortiz, Vanessa; Urbaez, Maryluz; Cabras, Stefano; Blaser, Martin J.; Dominguez-Bello, Maria G.			Effect of Influenza-Induced Fever on Human Bioimpedance Values	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; NUTRITIONAL-STATUS; VECTOR	Background and Aims Bioelectrical impedance analysis (BIA) is a widely used technique to assess body composition and nutritional status. While bioelectrical values are affected by diverse variables, there has been little research on validation of BIA in acute illness, especially to understand prognostic significance. Here we report the use of BIA in acute febrile states induced by influenza. Methods Bioimpedance studies were conducted during an H1N1 influenza A outbreak in Venezuelan Amerindian villages from the Amazonas. Measurements were performed on 52 subjects between 1 and 40 years of age, and 7 children were re-examined after starting Oseltamivir treatment. Bioelectrical Impedance Vector Analysis (BIVA) and permutation tests were applied. Results For the entire sample, febrile individuals showed a tendency toward greater reactance (p=0.058) and phase angle (p=0.037) than afebrile individuals, while resistance and impedance were similar in the two groups. Individuals with repeated measurements showed significant differences in bioimpedance values associated with fever, including increased reactance (p<0.001) and phase angle (p=0.007), and decreased resistance (p=0.007) and impedance (p<0.001). Conclusions There are bioelectrical variations induced by influenza that can be related to dehydration, with lower extracellular to intracellular water ratio in febrile individuals, or a direct thermal effect. Caution is recommended when interpreting bioimpedance results in febrile states.	[Marini, Elisabetta; Buffa, Roberto; Cabras, Stefano] Univ Cagliari, Cagliari, Italy; [Contreras, Monica; Urbaez, Maryluz] Venezuelan Inst Sci Res IVIC, Caracas, Venezuela; [Magris, Magda; Hidalgo, Glida] Amazon Ctr Res & Control Trop Dis CAICET, Puerto Ayacucho, Amazonas, Venezuela; [Hidalgo, Glida; Sanchez, Wilmer] Fdn Ctr Studies Growth & Dev Venezuelan Populat, Caracas, Venezuela; [Ortiz, Vanessa] Popular Minist Hlth, Caracas, Venezuela; [Cabras, Stefano] Univ Carlos III Madrid, Madrid, Spain; [Blaser, Martin J.; Dominguez-Bello, Maria G.] NYU, Sch Med, New York, NY 10012 USA; [Dominguez-Bello, Maria G.] Univ Puerto Rico, San Juan, PR 00936 USA	University of Cagliari; Venezuelan Institute Science Research; Universidad Carlos III de Madrid; New York University; University of Puerto Rico	Dominguez-Bello, MG (corresponding author), NYU, Sch Med, New York, NY 10012 USA.	maria.dominguez-bello@nyumc.org	Cabras, Stefano/AAA-2477-2019	Cabras, Stefano/0000-0001-6690-8378; BUFFA, Roberto/0000-0001-7082-859X; Marini, Elisabetta/0000-0001-8779-8745; Contreras Valero, Monica/0000-0003-4729-9559	University of Cagliari; Diane Belfer Program for Human Microbial Ecology	University of Cagliari; Diane Belfer Program for Human Microbial Ecology	The study was partially supported by the C&D and Emch Research Funds and visiting Professor program of University of Cagliari (to MGDB) and by the Diane Belfer Program for Human Microbial Ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buffa R, 2009, J TROP PEDIATRICS, V55, P406, DOI 10.1093/tropej/fmp032; CHERTOW GM, 1995, J AM SOC NEPHROL, V6, P75; De Palo T, 2000, NUTRITION, V16, P417, DOI 10.1016/S0899-9007(00)00269-0; Hidalgo G, 2014, AM J HUM BIOL, V26, P710, DOI 10.1002/ajhb.22567; Jacobs JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042328; Klassen P, 2000, ANN NY ACAD SCI, V904, P163, DOI 10.1111/j.1749-6632.2000.tb06442.x; Kushner RF, 1996, AM J CLIN NUTR, V64, P423, DOI 10.1093/ajcn/64.3.423S; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Marini E, 2007, AM J TROP MED HYG, V76, P534, DOI 10.4269/ajtmh.2007.76.534; NIH, 1996, AM J CLIN NUTR, V64, pS524; PICCOLI A, 1995, AM J CLIN NUTR, V61, P269, DOI 10.1093/ajcn/61.2.269; PICCOLI A, 1994, KIDNEY INT, V46, P534, DOI 10.1038/ki.1994.305; World Health Organization, 2010, EV PAND H1NI 2009	13	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125301	10.1371/journal.pone.0125301	http://dx.doi.org/10.1371/journal.pone.0125301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915945	gold, Green Published			2022-12-27	WOS:000353659100118
J	Panenka, WJ; Lange, RT; Bouix, S; Shewchuk, JR; Heran, MKS; Brubacher, JR; Eckbo, R; Shenton, ME; Iverson, GL				Panenka, William J.; Lange, Rael T.; Bouix, Sylvain; Shewchuk, Jason R.; Heran, Manraj K. S.; Brubacher, Jeffrey R.; Eckbo, Ryan; Shenton, Martha E.; Iverson, Grant L.			Neuropsychological Outcome and Diffusion Tensor Imaging in Complicated versus Uncomplicated Mild Traumatic Brain Injury	PLOS ONE			English	Article							POST-CONCUSSION SYNDROME; COMPUTED-TOMOGRAPHY; HEAD-INJURY; AXONAL INJURY; MODERATE; CT; PREDICTION; ASSOCIATION; SYMPTOMS; CHILDREN	This study examined whether intracranial neuroimaging abnormalities in those with mild traumatic brain injury (MTBI) (i.e., "complicated" MTBIs) are associated with worse subacute outcomes as measured by cognitive testing, symptom ratings, and/or diffusion tensor imaging (DTI). We hypothesized that (i) as a group, participants with complicated MTBIs would report greater symptoms and have worse neurocognitive outcomes than those with uncomplicated MTBI, and (ii) as a group, participants with complicated MTBIs would show more Diffusion Tensor Imaging (DTI) abnormalities. Participants were 62 adults with MTBIs (31 complicated and 31 uncomplicated) who completed neurocognitive testing, symptom ratings, and DTI on a 3T MRI scanner approximately 6-8 weeks post injury. There were no statistically significant differences between groups on symptom ratings or on a broad range of neuropsychological tests. When comparing the groups using tract-based spatial statistics for DTI, no significant difference was found for axial diffusivity or mean diffusivity. However, several brain regions demonstrated increased radial diffusivity (purported to measure myelin integrity), and decreased fractional anisotropy in the complicated group compared with the uncomplicated group. Finally, when we extended the DTI analysis, using a multivariate atlas based approach, to 32 orthopedic trauma controls (TC), the findings did not reveal significantly more areas of abnormal DTI signal in the complicated vs. uncomplicated groups, although both MTBI groups had a greater number of areas with increased radial diffusivity compared with the trauma controls. This study illustrates that macrostructural neuroimaging changes following MTBI are associated with measurable changes in DTI signal. Of note, however, the division of MTBI into complicated and uncomplicated subtypes did not predict worse clinical outcome at 6-8 weeks post injury.	[Panenka, William J.; Lange, Rael T.; Iverson, Grant L.] Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Bouix, Sylvain; Eckbo, Ryan; Shenton, Martha E.] Harvard Univ, Sch Med, Brigham Womens Hosp, Psychiat Neuroimaging Lab, Boston, MA USA; [Shewchuk, Jason R.; Heran, Manraj K. S.] Univ British Columbia, Dept Radiol, Vancouver, BC V5Z 1M9, Canada; [Brubacher, Jeffrey R.] Univ British Columbia, Dept Emergency Med, Vancouver, BC V5Z 1M9, Canada; [Shenton, Martha E.] VA Boston Healthcare Syst, Brockton, MA USA; [Iverson, Grant L.] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA	University of British Columbia; Walter Reed National Military Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of British Columbia; University of British Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Harvard University; Massachusetts General Hospital	Panenka, WJ (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada.	wpanenka@mail.ubc.ca	Shenton, Martha/V-8780-2019	Bouix, Sylvain/0000-0003-1326-6054; Brubacher, Jeffrey/0000-0002-4866-4231; Panenka, William/0000-0001-7143-6512; Iverson, Grant/0000-0001-7348-9570	Canadian Institute of Health Research [200903MOP-200377-BSB-CAAA-161276]; INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium - Department of Defense Psychological Health/Traumatic Brain Injury Research Program [X81XWH-07-CC-CSDoD]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium - Department of Defense Psychological Health/Traumatic Brain Injury Research Program	Primary funding for this study was provided by the Canadian Institute of Health Research (200903MOP-200377-BSB-CAAA-161276); provided to RTL as PI). MES and GLI note that this work was supported in part by the INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium funded by the Department of Defense Psychological Health/Traumatic Brain Injury Research Program (X81XWH-07-CC-CSDoD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00010]; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bay Esther H, 2009, Res Theory Nurs Pract, V23, P42; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Beck A., 1993, BECK ANXIETY INVENTO; Beck AT., 1996, MANUAL BECK DEPRESSI; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dagher JH, 2013, BRAIN INJURY, V27, P189, DOI 10.3109/02699052.2012.729288; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gering DT, 2001, J MAGN RESON IMAGING, V13, P967, DOI 10.1002/jmri.1139; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Hiekkanen H, 2009, BRAIN INJURY, V23, P396, DOI 10.1080/02699050902926259; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1999, CLIN NEUROPSYCHOL, V13, P437, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT437; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Iverson GL, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Iverson GL, 2011, BRAIN INJURY, V25, P1325, DOI 10.3109/02699052.2011.608409; Kaddurah-Daouk R, 2007, MOL PSYCHIATR, V12, P934, DOI 10.1038/sj.mp.4002000; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kumar RG, 2014, AM J PHYS MED REHAB, V93, P687, DOI 10.1097/PHM.0000000000000077; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Landman BA, 2007, NEUROIMAGE, V36, P1123, DOI 10.1016/j.neuroimage.2007.02.056; Lange RT, 2014, J NEUROTRAUM, V31, P198, DOI 10.1089/neu.2013.2866; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mori A, 2005, MRI ATLAS HUMAN WHIT; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Pandor A, 2012, J NEUROTRAUM, V29, P707, DOI 10.1089/neu.2011.1967; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Stern R. A., 2003, NEUROPSYCHOLOGICAL A; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; Tombaugh T.N., 1996, TEST MEMORY MALINGER; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Waljas M, 2013, J NEUROTRAUMA; White T, 2003, NAB DEMOGRAPHICALLY; WHO, 2018, INT STAT CLASS DIS R; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc	85	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0122746	10.1371/journal.pone.0122746	http://dx.doi.org/10.1371/journal.pone.0122746			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915776	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100011
J	Pelisch, N; Dan, T; Ichimura, A; Sekiguchi, H; Vaughan, DE; de Strihou, CV; Miyata, T				Pelisch, Nicolas; Dan, Takashi; Ichimura, Atsuhiko; Sekiguchi, Hiroki; Vaughan, Douglas E.; de Strihou, Charles van Ypersele; Miyata, Toshio			Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NEUROTROPHIC FACTOR; RECEPTOR MODULATOR; POTENTIAL ROLE; FINGOLIMOD; NEURODEGENERATION; FIBRINOLYSIS; INFLAMMATION	Multiple sclerosis (MS) is characterized by inflammatory demyelination and deposition of fibrinogen in the central nervous system (CNS). Elevated levels of a critical inhibitor of the mammalian fibrinolitic system, plasminogen activator inhibitor 1 (PAI-1) have been demonstrated in human and animal models of MS. In experimental studies that resemble neuroinflammatory disease, PAI-1 deficient mice display preserved neurological structure and function compared to wild type mice, suggesting a link between the fibrinolytic pathway and MS. We previously identified a series of PAI-1 inhibitors on the basis of the 3-dimensional structure of PAI-1 and on virtual screening. These compounds have been reported to provide a number of in vitro and in vivo benefits but none was tested in CNS disease models because of their limited capacity to penetrate the blood-brain barrier (BBB). The existing candidates were therefore optimized to obtain CNS-penetrant compounds. We performed an in vitro screening using a model of BBB and were able to identify a novel, low molecular PAI-1 inhibitor, TM5484, with the highest penetration ratio among all other candidates. Next, we tested the effects on inflammation and demyelination in an experimental allergic encephalomyelitis mice model. Results were compared to either fingolimod or 6a-methylprednisolone. Oral administration of TM5484 from the onset of signs, ameliorates paralysis, attenuated demyelination, and axonal degeneration in the spinal cord of mice. Furthermore, it modulated the expression of brain-derived neurotrophic factor, which plays a protective role in neurons against various pathological insults, and choline acetyltransferase, a marker of neuronal density. Taken together, these results demonstrate the potential benefits of a novel PAI-1 inhibitor, TM5484, in the treatment of MS.	[Pelisch, Nicolas; Dan, Takashi; Ichimura, Atsuhiko; Sekiguchi, Hiroki; Miyata, Toshio] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Dept Mol Med & Therapy, Sendai, Miyagi 980, Japan; [Vaughan, Douglas E.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [de Strihou, Charles van Ypersele] Clin Univ St Luc, Serv Nephrol, B-1200 Brussels, Belgium	Tohoku University; Northwestern University; Feinberg School of Medicine; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Pelisch, N (corresponding author), Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Dept Mol Med & Therapy, Sendai, Miyagi 980, Japan.	n.pelisch@med.tohoku.ac.jp	Miyata, Toshio/A-4872-2010	Ichimura, Atsuhiko/0000-0003-0366-5211	Ministry of Health, Labour and Welfare of Japan; Japan Science and Technology Agency; National Institute of Biomedical Innovation	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	The authors' work is supported in part by grants from the Ministry of Health, Labour and Welfare of Japan (Initiative to facilitate development of innovative drug, medical devices, and cellular and tissue-based products), from the Japan Science and Technology Agency (Adaptable & Seamless Technology Transfer Program through Target-driven Research and Development) and from the National Institute of Biomedical Innovation (Advanced Research for Medical Products Mining Progamme).	Aharoni R, 2011, J AUTOIMMUN, V37, P228, DOI 10.1016/j.jaut.2011.06.003; Akenami FOT, 1997, J CLIN PATHOL, V50, P157, DOI 10.1136/jcp.50.2.157; Boe AE, 2013, CIRCULATION, V128, P2318, DOI 10.1161/CIRCULATIONAHA.113.003192; Chan J, 2008, AUTOIMMUNITY, V41, P405, DOI 10.1080/08916930802011258; Chiba K, 2011, INT IMMUNOPHARMACOL, V11, P366, DOI 10.1016/j.intimp.2010.10.005; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Deogracias R, 2012, P NATL ACAD SCI USA, V109, P14230, DOI 10.1073/pnas.1206093109; Doi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061988; East E, 2008, NEUROPATH APPL NEURO, V34, P216, DOI 10.1111/j.1365-2990.2007.00889.x; East E, 2005, AM J PATHOL, V167, P545, DOI 10.1016/S0002-9440(10)62996-3; Glynn D, 2003, HUM MOL GENET, V12, P2431, DOI 10.1093/hmg/ddg249; Gur-Wahnon D, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-124; Gveric D, 2003, BRAIN, V126, P1590, DOI 10.1093/brain/awg167; Gveric D, 2001, BRAIN, V124, P1978, DOI 10.1093/brain/124.10.1978; Ichimura A, 2013, ARTERIOSCL THROM VAS, V33, P935, DOI 10.1161/ATVBAHA.113.301224; Izuhara Y, 2008, ARTERIOSCL THROM VAS, V28, P672, DOI 10.1161/ATVBAHA.107.157479; Izuhara Y, 2010, J CEREBR BLOOD F MET, V30, P904, DOI 10.1038/jcbfm.2009.272; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Loskutoff DJ, 1999, APMIS, V107, P54, DOI 10.1111/j.1699-0463.1999.tb01526.x; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Luhder F, 2013, ARCH IMMUNOL THER EX, V61, P95, DOI 10.1007/s00005-012-0211-0; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Neumann H, 2003, CURR OPIN NEUROL, V16, P267, DOI 10.1097/00019052-200306000-00004; Neumann H, 2002, TRENDS NEUROSCI, V25, P313, DOI 10.1016/S0166-2236(02)02154-9; Norinder U, 2002, ADV DRUG DELIVER REV, V54, P291, DOI 10.1016/S0169-409X(02)00005-4; Oh J, 2013, CNS DRUGS, V27, P591, DOI 10.1007/s40263-013-0080-z; Pelletier D, 2012, NEW ENGL J MED, V366, P339, DOI 10.1056/NEJMct1101691; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; Rossi S, 2014, MULT SCLER J, V20, P304, DOI 10.1177/1352458513498128; Shin T, 2012, ANAT CELL BIOL, V45, P141, DOI 10.5115/acb.2012.45.3.141; Soulika AM, 2009, J NEUROSCI, V29, P14965, DOI 10.1523/JNEUROSCI.3794-09.2009; Thone J, 2012, AM J PATHOL, V180, P267, DOI 10.1016/j.ajpath.2011.09.037; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; van Horssen J, 2005, J NEUROPATH EXP NEUR, V64, P722, DOI 10.1097/01.jnen.0000173894.09553.13; van Horssen J, 2006, NEUROBIOL DIS, V24, P484, DOI 10.1016/j.nbd.2006.08.005; Wager TT, 2010, ACS CHEM NEUROSCI, V1, P420, DOI 10.1021/cn100007x; Wiendl H, 2009, NEUROLOGY, V72, P1008, DOI 10.1212/01.wnl.0000344417.42972.54	37	27	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124510	10.1371/journal.pone.0124510	http://dx.doi.org/10.1371/journal.pone.0124510			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915660	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100052
J	Dingwell, JB; Cusumano, JP				Dingwell, Jonathan B.; Cusumano, Joseph P.			Identifying Stride-To-Stride Control Strategies in Human Treadmill Walking	PLOS ONE			English	Article							LOCAL DYNAMIC STABILITY; LONG-RANGE CORRELATIONS; CAPTURABILITY-BASED ANALYSIS; CENTRAL PATTERN GENERATORS; OPTIMAL FEEDBACK-CONTROL; FOOT PLACEMENT; LEGGED LOCOMOTION; KINEMATIC VARIABILITY; VISUAL GUIDANCE; OPTIC FLOW	Variability is ubiquitous in human movement, arising from internal and external noise, inherent biological redundancy, and from the neurophysiological control actions that help regulate movement fluctuations. Increased walking variability can lead to increased energetic cost and/or increased fall risk. Conversely, biological noise may be beneficial, even necessary, to enhance motor performance. Indeed, encouraging more variability actually facilitates greater improvements in some forms of locomotor rehabilitation. Thus, it is critical to identify the fundamental principles humans use to regulate stride-to-stride fluctuations in walking. This study sought to determine how humans regulate stride-to-stride fluctuations in stepping movements during treadmill walking. We developed computational models based on pre-defined goal functions to compare if subjects, from each stride to the next, tried to maintain the same speed as the treadmill, or instead stay in the same position on the treadmill. Both strategies predicted average behaviors empirically indistinguishable from each other and from that of humans. These strategies, however, predicted very different strideto- stride fluctuation dynamics. Comparisons to experimental data showed that human stepping movements were generally well-predicted by the speed-control model, but not by the position-control model. Human subjects also exhibited no indications they corrected deviations in absolute position only intermittently: i.e., closer to the boundaries of the treadmill. Thus, humans clearly do not adopt a control strategy whose primary goal is to maintain some constant absolute position on the treadmill. Instead, humans appear to regulate their stepping movements in a way most consistent with a strategy whose primary goal is to try to maintain the same speed as the treadmill at each consecutive stride. These findings have important implications both for understanding how biological systems regulate walking in general and for being able to harness these mechanisms to develop more effective rehabilitation interventions to improve locomotor performance.	[Dingwell, Jonathan B.] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA; [Cusumano, Joseph P.] Penn State Univ, Dept Engn Sci & Mech, University Pk, PA 16802 USA	University of Texas System; University of Texas Austin; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Dingwell, JB (corresponding author), Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA.	jdingwell@austin.utexas.edu		Dingwell, Jonathan/0000-0001-6990-4153	Whitaker Biomedical Engineering Foundation grant [RG-02-0354]; National Institutes of Health [R01-HD059844]; National Science Foundation [0625764]; Congressionally Directed Medical Research Programs [W81XWH-11-2-0222]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059844] Funding Source: NIH RePORTER	Whitaker Biomedical Engineering Foundation grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Congressionally Directed Medical Research Programs(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding provided in part by the Whitaker Biomedical Engineering Foundation grant # RG-02-0354 (to JBD), the National Institutes of Health (http://www.nih.gov/) grant # R01-HD059844 (to JBD), the National Science Foundation (http://www.nsf.gov) grant # 0625764 (to JPC), and the Congressionally Directed Medical Research Programs (https://cdmrp.org/) contract #W81XWH-11-2-0222 (to JBD and JPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson FC, 2001, J BIOMECH ENG-T ASME, V123, P381, DOI 10.1115/1.1392310; ARSENAULT AB, 1986, ERGONOMICS, V29, P665, DOI 10.1080/00140138608968301; Bach DR, 2012, NAT REV NEUROSCI, V13, P572, DOI 10.1038/nrn3289; Bertram JEA, 2001, J THEOR BIOL, V209, P445, DOI 10.1006/jtbi.2001.2279; Bollens B, 2010, GAIT POSTURE, V32, P369, DOI 10.1016/j.gaitpost.2010.06.011; Bruggeman H, 2007, CURR BIOL, V17, P2035, DOI 10.1016/j.cub.2007.10.059; Byl K, 2009, INT J ROBOT RES, V28, P1040, DOI 10.1177/0278364909340446; Collins SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073597; Crenshaw JR, 2012, J BIOMECH, V45, P129, DOI 10.1016/j.jbiomech.2011.09.022; Cusumano JP, 2013, HUM MOVEMENT SCI, V32, P899, DOI 10.1016/j.humov.2013.07.019; Cusumano JP, 2006, BIOL CYBERN, V94, P367, DOI 10.1007/s00422-006-0052-1; Marc-Andre C, 2007, J BIOMECH, V40, P2857, DOI 10.1016/j.jbiomech.2007.03.012; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Dingwell JB, 2006, J BIOMECH, V39, P444, DOI 10.1016/j.jbiomech.2004.12.014; Dingwell JB, 2001, J BIOMECH ENG-T ASME, V123, P27, DOI 10.1115/1.1336798; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; Dingwell JB, 2010, DATA DO HUMANS OPTIM; Dingwell JB, 2013, J NEUROPHYSIOL, V109, P225, DOI 10.1152/jn.00951.2011; Dingwell JB, 2010, GAIT POSTURE, V32, P348, DOI 10.1016/j.gaitpost.2010.06.004; Dingwell JB, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000856; Duschau-Wicke A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-43; Engelbrecht SE, 2001, J MATH PSYCHOL, V45, P497, DOI 10.1006/jmps.2000.1295; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Forner Cordero A, 2003, GAIT POSTURE, V18, P47, DOI 10.1016/S0966-6362(02)00160-1; Franchak JM, 2010, VISION RES, V50, P2766, DOI 10.1016/j.visres.2010.09.024; Full RJ, 1999, J EXP BIOL, V202, P3325; Gates DH, 2012, GAIT POSTURE, V35, P36, DOI 10.1016/j.gaitpost.2011.08.001; Geyer H, 2006, P R SOC B, V273, P2861, DOI 10.1098/rspb.2006.3637; Golubitsky M, 1999, NATURE, V401, P693, DOI 10.1038/44416; GUBINA F, 1974, IEEE T BIO-MED ENG, VBM21, P102, DOI 10.1109/TBME.1974.324294; Guckenheimer J, 2013, APPL MATH SCI, V42; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hollands MA, 2002, EXP BRAIN RES, V143, P221, DOI 10.1007/s00221-001-0983-7; Ijspeert AJ, 2008, NEURAL NETWORKS, V21, P642, DOI 10.1016/j.neunet.2008.03.014; Kang HG, 2008, J BIOMECH, V41, P2899, DOI 10.1016/j.jbiomech.2008.08.002; Kang HG, 2008, GAIT POSTURE, V27, P572, DOI 10.1016/j.gaitpost.2007.07.009; Koolen T, 2012, INT J ROBOT RES, V31, P1094, DOI 10.1177/0278364912452673; Krishnan C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077370; Kuo AD, 1999, INT J ROBOT RES, V18, P917, DOI 10.1177/02783649922066655; Kuo AD, 2001, J BIOMECH ENG-T ASME, V123, P264, DOI 10.1115/1.1372322; Lewek MD, 2009, PHYS THER, V89, P829, DOI 10.2522/ptj.20080180; Luenberg D.G., 2008, LINEAR NONLINEAR PRO; Lyon I, 2005, EXP BRAIN RES, V161, P193, DOI 10.1007/s00221-004-2058-z; Lyon IN, 1997, EXP BRAIN RES, V115, P345, DOI 10.1007/PL00005703; Manoonpong P, 2007, PLOS COMPUT BIOL, V3, P1305, DOI 10.1371/journal.pcbi.0030134; Maraun D, 2004, NONLINEAR PROC GEOPH, V11, P495, DOI 10.5194/npg-11-495-2004; Marigold DS, 2007, NEUROSCIENCE, V144, P302, DOI 10.1016/j.neuroscience.2006.09.006; Marigold DS, 2008, EXERC SPORT SCI REV, V36, P145, DOI 10.1097/JES.0b013e31817bff72; Matthis JS, 2014, J EXP PSYCHOL HUMAN, V40, P106, DOI 10.1037/a0033101; Matthis JS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0700; McAndrew PM, 2011, J BIOMECH, V44, P644, DOI 10.1016/j.jbiomech.2010.11.007; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; Moraes R, 2007, J NEUROPHYSIOL, V98, P1928, DOI 10.1152/jn.00044.2006; O'Connor SM, 2012, GAIT POSTURE, V36, P102, DOI 10.1016/j.gaitpost.2012.01.014; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; PAILHOUS J, 1992, BEHAV BRAIN RES, V47, P181, DOI 10.1016/S0166-4328(05)80124-X; Patla AE, 2006, NEUROSCI LETT, V397, P110, DOI 10.1016/j.neulet.2005.12.016; Patla AE, 2003, EXP BRAIN RES, V148, P133, DOI 10.1007/s00221-002-1246-y; Patla AE, 1999, EXP BRAIN RES, V129, P629, DOI 10.1007/s002210050932; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; Potocanac Z, 2014, EXP BRAIN RES, V232, P3579, DOI 10.1007/s00221-014-4038-2; Pratt J, 2012, INT J ROBOT RES, V31, P1117, DOI 10.1177/0278364912452762; Racz K, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00155; REDFERN MS, 1994, J BIOMECH, V27, P1339, DOI 10.1016/0021-9290(94)90043-4; Reynolds RF, 2005, J PHYSIOL-LONDON, V569, P677, DOI 10.1113/jphysiol.2005.095869; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Rosenblatt NJ, 2010, GAIT POSTURE, V31, P380, DOI 10.1016/j.gaitpost.2010.01.002; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Sethna JP, 2006, STAT MECH ENTROPY OR; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; Su JLS, 2007, J BIOMECH ENG-T ASME, V129, P802, DOI 10.1115/1.2800760; Terrier P, 2005, HUM MOVEMENT SCI, V24, P97, DOI 10.1016/j.humov.2005.03.002; Terrier P, 2012, HUM MOVEMENT SCI, V31, P1585, DOI 10.1016/j.humov.2012.05.004; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Toebes MJP, 2012, GAIT POSTURE, V36, P527, DOI 10.1016/j.gaitpost.2012.05.016; TOWNSEND MA, 1985, J BIOMECH, V18, P21, DOI 10.1016/0021-9290(85)90042-9; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; van Beers RJ, 2013, J NEUROPHYSIOL, V109, P969, DOI 10.1152/jn.00706.2012; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; VANINGENSCHENAU GJ, 1980, MED SCI SPORT EXER, V12, P257; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; Wang Y, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0405; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; White SC, 1998, MED SCI SPORT EXER, V30, P1537, DOI 10.1097/00005768-199810000-00011; Wisse M, 2005, IEEE T ROBOT, V21, P393, DOI 10.1109/TRO.2004.838030; Ziegler MD, 2010, J NEUROSCI, V30, P10720, DOI 10.1523/JNEUROSCI.1938-10.2010	91	46	46	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124879	10.1371/journal.pone.0124879	http://dx.doi.org/10.1371/journal.pone.0124879			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910253	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800110
J	Drewnowska, JM; Zambrzycka, M; Kalska-Szostko, B; Fiedoruk, K; Swiecicka, I				Drewnowska, Justyna M.; Zambrzycka, Monika; Kalska-Szostko, Beata; Fiedoruk, Krzysztof; Swiecicka, Izabela			Melanin-Like Pigment Synthesis by Soil Bacillus weihenstephanensis Isolates from Northeastern Poland	PLOS ONE			English	Article							CRYPTOCOCCUS-NEOFORMANS; VIBRIO-CHOLERAE; THURINGIENSIS; DIVERSITY; CEREUS; SUSCEPTIBILITY; PURIFICATION; LACCASE; STRAIN; GENE	Although melanin is known for protecting living organisms from harmful physical and chemical factors, its synthesis is rarely observed among endospore-forming Bacillus cereus sensu lato. Here, for the first time, we reported that psychrotolerant Bacillus weihenstephanensis from Northeastern Poland can produce melanin-like pigment. We assessed physicochemical properties of the pigment and the mechanism of its synthesis in relation to Bacillus weihenstephanensis genotypic and phenotypic characteristics. Electron paramagnetic resonance (EPR) spectroscopy displayed a stable free radical signal of the pigment from environmental isolates which are consistent with the commercial melanin. Fourier transform infrared spectroscopy (FT-IR) and physicochemical tests indicated the phenolic character of the pigment. Several biochemical tests showed that melanin-like pigment synthesis by Bacillus weihenstephanensis was associated with laccase activity. The presence of the gene encoding laccase was confirmed by the next generation whole genome sequencing of one Bacillus weihenstephanensis strain. Biochemical (API 20E and 50CHB tests) and genetic (Multi-locus Sequence Typing, 16S rRNA sequencing, and Pulsed-Field Gel Electrophoresis) characterization of the isolates revealed their close relation to the psychrotrophic Bacillus weihenstephanensis DSMZ 11821 reference strain. The ability to synthesize melanin-like pigment by soil Bacillus weihenstephanensis isolates and their psychrotrophic character seemed to be a local adaptation to a specific niche. Detailed genetic and biochemical analyses of melanin-positive environmental Bacillus weihenstephanensis strains shed some light on the evolution and ecological adaptation of these bacteria. Moreover, our study raised new biotechnological possibilities for the use of water-soluble melanin-like pigment naturally produced by Bacillus weihenstephanensis as an alternative to commercial non-soluble pigment.	[Drewnowska, Justyna M.; Zambrzycka, Monika; Swiecicka, Izabela] Univ Bialystok, Inst Biol, Dept Microbiol, Bialystok, Poland; [Kalska-Szostko, Beata] Univ Bialystok, Inst Chem, Dept Physicochem Anal, Bialystok, Poland; [Fiedoruk, Krzysztof] Med Univ Bialystok, Dept Microbiol, Bialystok, Poland; [Swiecicka, Izabela] Univ Bialystok, Appl Microbiol Lab, Bialystok, Poland	University of Bialystok; University of Bialystok; Medical University of Bialystok; University of Bialystok	Swiecicka, I (corresponding author), Univ Bialystok, Inst Biol, Dept Microbiol, Bialystok, Poland.	izabelas@uwb.edu.pl	Drewnowska, Justyna M/K-2076-2016; Fiedoruk, Krzysztof/R-5460-2018	Drewnowska, Justyna M/0000-0002-2004-8824; Fiedoruk, Krzysztof/0000-0001-7343-8837; Kalska-Szostko, Beata/0000-0002-6353-243X; Swiecicka, Izabela/0000-0002-2750-9451	National Science Centre of Poland grant [UMO-2013/09/N/NZ8/03209]; European Union, Operational Program Development of Eastern Poland [POPW.01.03.00-20-034/09-00]	National Science Centre of Poland grant(National Science Centre, Poland); European Union, Operational Program Development of Eastern Poland	This work was supported by the National Science Centre of Poland (https://www.ncn.gov.pl/?language=en) grant UMO-2013/09/N/NZ8/03209 to JMD. FT-IR was performed in the Center of Synthesis and Analysis BioNanoTechno of University of Bialystok funded by the European Union as a part of the Operational Program Development of Eastern Poland 2007-2013 (project POPW.01.03.00-20-034/09-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriouel H, 2011, FEMS MICROBIOL REV, V35, P201, DOI 10.1111/j.1574-6976.2010.00244.x; Aghajanyan AE, 2005, PIGM CELL RES, V18, P130, DOI 10.1111/j.1600-0749.2005.00211.x; Amal AM, 2011, RES J CHEM SCI, V1, P22, DOI DOI 10.1017/CB09781107415324.004; Banerjee D, 2014, LETT APPL MICROBIOL, V58, P25, DOI 10.1111/lam.12151; Bargabus RL, 2002, PHYSIOL MOL PLANT P, V61, P289, DOI 10.1006/pmpp.2003.0443; Bartoszewicz M, 2009, J APPL MICROBIOL, V106, P1967, DOI 10.1111/j.1365-2672.2009.04166.x; Belotte D, 2003, EVOLUTION, V57, P27, DOI 10.1111/j.0014-3820.2003.tb00213.x; Ceuppens S, 2013, FEMS MICROBIOL ECOL, V84, P433, DOI 10.1111/1574-6941.12110; Chatfield CH, 2007, INFECT IMMUN, V75, P4062, DOI 10.1128/IAI.00489-07; Chen YH, 2004, J GEN APPL MICROBIOL, V50, P183, DOI 10.2323/jgam.50.183; Coates J., 2000, ENCY ANAL CHEM, P10815, DOI DOI 10.1002/9780470027318.A5606; Crickmore N, 2006, J APPL MICROBIOL, V101, P616, DOI 10.1111/j.1365-2672.2006.02936.x; Cunha MML, 2005, MICROSC RES TECHNIQ, V68, P377, DOI 10.1002/jemt.20260; Drewnowska JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080175; Eisenman HC, 2007, MICROBIOL-SGM, V153, P3954, DOI 10.1099/mic.0.2007/011049-0; FAVA F, 1993, CHEMOSPHERE, V27, P825, DOI 10.1016/0045-6535(93)90014-V; Funa N, 2005, J BACTERIOL, V187, P8149, DOI 10.1128/JB.187.23.8149-8155.2005; Garcia-Rivera J, 2001, MED MYCOL, V39, P353, DOI 10.1080/mmy.39.4.353.357; Geng J, 2008, J EUR ACAD DERMATOL, V22, P852, DOI 10.1111/j.1468-3083.2007.02574.x; Guinebretiere MH, 2013, INT J SYST EVOL MICR, V63, P31, DOI 10.1099/ijs.0.030627-0; HOTI SL, 1993, J GEN MICROBIOL, V139, P2365, DOI 10.1099/00221287-139-10-2365; Ibarra JE, 2003, APPL ENVIRON MICROB, V69, P5269, DOI 10.1128/AEM.69.9.5269-5274.2003; Jacobson ES, 2000, CLIN MICROBIOL REV, V13, P708, DOI 10.1128/CMR.13.4.708-717.2000; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Jimenez G, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01080-13; Kannan P., 2009, J SCI RES, V1, P655, DOI DOI 10.3329/jsr.v1i3.2005; Kolczynski-Szafraniec U, 1992, CURR TOP BIOPHYS, V16, P77; KOTOB SI, 1995, APPL ENVIRON MICROB, V61, P1620, DOI 10.1128/AEM.61.4.1620-1622.1995; Kumar CG, 2013, LETT APPL MICROBIOL, V57, P295, DOI 10.1111/lam.12111; Lechner S, 1998, INT J SYST BACTERIOL, V48, P1373, DOI 10.1099/00207713-48-4-1373; Liang TW, 2013, CARBOHYD POLYM, V92, P2141, DOI 10.1016/j.carbpol.2012.11.097; Liu FX, 2013, ANN MICROBIOL, V63, P1131, DOI 10.1007/s13213-012-0570-0; Liu N, 2004, LETT APPL MICROBIOL, V39, P407, DOI 10.1111/j.1472-765X.2004.01599.x; Logan NA, 2012, J APPL MICROBIOL, V112, P417, DOI 10.1111/j.1365-2672.2011.05204.x; Magarelli M., 2010, Revista CES Medicina Veterinaria y Zootecnia, V5, P18; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Minussi RC, 2007, AFR J BIOTECHNOL, V6, P1248; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Moeller R, 2005, FEMS MICROBIOL ECOL, V51, P231, DOI 10.1016/j.femsec.2004.08.008; NAIR S, 1992, WATER RES, V26, P431, DOI 10.1016/0043-1354(92)90042-3; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Pinero S, 2007, J MOL MICROB BIOTECH, V13, P35, DOI 10.1159/000103595; Plonka PM, 2006, ACTA BIOCHIM POL, V53, P429, DOI 10.18388/abp.2006_3314; Raymond B, 2012, SCIENCE, V337, P85, DOI 10.1126/science.1218196; Rivera AMG, 2003, FEMS MICROBIOL LETT, V223, P61, DOI 10.1016/S0378-1097(03)00347-1; Rosas AL, 1997, FEMS MICROBIOL LETT, V153, P265, DOI 10.1016/S0378-1097(97)00239-5; Ruan L, 2002, LETT APPL MICROBIOL, V34, P244, DOI 10.1046/j.1472-765x.2002.01049.x; Sajjan S, 2010, J MICROBIOL BIOTECHN, V20, P1513, DOI 10.4014/jmb.1002.02006; Schmaler-Ripcke J, 2009, APPL ENVIRON MICROB, V75, P493, DOI 10.1128/AEM.02077-08; Singh S, 2013, BIOINFORMATION, V9, P94, DOI 10.6026/97320630009094; Solano F, 2001, FEMS MICROBIOL LETT, V204, P175, DOI 10.1111/j.1574-6968.2001.tb10882.x; Swiecicka I, 2006, FEMS MICROBIOL ECOL, V56, P132, DOI 10.1111/j.1574-6941.2006.00063.x; Swiecicka I, 2003, J APPL MICROBIOL, V94, P60, DOI 10.1046/j.1365-2672.2003.01790.x; Swiecicka I, 2008, BIOCONTROL SCI TECHN, V18, P221, DOI 10.1080/09583150801942334; Swiecicka I, 2013, FEMS MICROBIOL ECOL, V85, P262, DOI 10.1111/1574-6941.12116; Tada M, 2010, J CLIN BIOCHEM NUTR, V46, P224, DOI 10.3164/jcbn.09-84; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang RB, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-109; Youngchim S, 2011, MICROBIOL-SGM, V157, P2348, DOI 10.1099/mic.0.047928-0; Zdybel M, 2015, J APPL BIOMED, V13, P131, DOI 10.1016/j.jab.2015.01.002; Zdybel M, 2013, NUKLEONIKA, V58, P407	61	39	40	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125428	10.1371/journal.pone.0125428	http://dx.doi.org/10.1371/journal.pone.0125428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909751	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800140
J	Jansen, FM; Prins, RG; Etman, A; van der Ploeg, HP; de Vries, SI; van Lenthe, FJ; Pierik, FH				Jansen, F. Marijke; Prins, Rick G.; Etman, Astrid; van der Ploeg, Hidde P.; de Vries, Sanne I.; van Lenthe, Frank J.; Pierik, Frank H.			Physical Activity in Non-Frail and Frail Older Adults	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; EXERCISE; DECLINE; HEALTH	Introduction Physical activity (PA) is important for healthy ageing. Better insight into objectively measured PA levels in older adults is needed, since most previous studies employed self-report measures for PA assessment, which are associated with overestimation of PA. Aim This study aimed to provide insight in objectively measured indoor and outdoor PA of older adults, and in PA differences by frailty levels. Methods Data were collected among non-frail (N = 74) and frail (N = 10) subjects, aged 65 to 89 years. PA, measured for seven days with accelerometers and GPS-devices, was categorized into three levels of intensity (sedentary, light, and moderate-to-vigorous PA). Results Older adults spent most time in sedentary and light PA. Subjects spent 84.7%, 15.1% and 0.2% per day in sedentary, light and moderate-to-vigorous PA respectively. On average, older adults spent 9.8 (SD 23.7) minutes per week in moderate-to-vigorous activity, and 747.0 (SD 389.6) minutes per week in light activity. None of the subjects met the WHO recommendations of 150 weekly minutes of moderate-to-vigorous PA. Age-, sex- and health status-adjusted results revealed no differences in PA between non-frail and frail older adults. Subjects spent significantly more sedentary time at home, than not at home. Non-frail subjects spent significantly more time not at home during moderate-to-vigorous activities, than at home. Conclusions Objective assessment of PA in older adults revealed that most PA was of light intensity, and time spent in moderate-to-vigorous PA was very low. None of the older adults met the World Health Organization recommendations for PA. These levels of MVPA are much lower than generally reported based on self-reported PA. Future studies should employ objective methods, and age specific thresholds for healthy PA levels in older adults are needed. These results emphasize the need for effective strategies for healthy PA levels for the growing proportion of older adults.	[Jansen, F. Marijke; Pierik, Frank H.] TNO, Dept Urban Environm & Safety, Utrecht, Netherlands; [Prins, Rick G.; Etman, Astrid; van Lenthe, Frank J.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [van der Ploeg, Hidde P.] VU Univ Med Ctr Amsterdam, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [de Vries, Sanne I.] TNO, Dept Hlth Living, Leiden, Netherlands; [de Vries, Sanne I.] Hague Univ Appl Sci, Hlth Lifestyle Supporting Environm, The Hague, Netherlands; [Jansen, F. Marijke] Univ Utrecht, Human Geog & Planning, Utrecht, Netherlands	Netherlands Organization Applied Science Research; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Netherlands Organization Applied Science Research; Utrecht University	Pierik, FH (corresponding author), TNO, Dept Urban Environm & Safety, Utrecht, Netherlands.	frank.pierik@tno.nl	de Vries, Sanne/ABH-4704-2020; van der Ploeg, Hidde P/B-2599-2013; van der Ploeg, Hidde/ABD-6402-2021	van der Ploeg, Hidde P/0000-0002-3719-5249; De Vries, Sanne/0000-0002-9032-883X	Netherlands Organisation for Health Research and Development [60-61900-98-451]; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MR/K023187/1, MC_UU_12015/6] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_UU_12015/6, MR/K023187/1] Funding Source: researchfish	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by The Netherlands Organisation for Health Research and Development (funding number: 60-61900-98-451). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acree LS, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-37; Aoyagi Y, 2013, ARCH GERONTOL GERIAT, V56, P327, DOI 10.1016/j.archger.2012.11.006; Asmus-Szepesi KJE, 2013, AGE AGEING, V42, P803, DOI 10.1093/ageing/aft126; Barreto PD, 2013, J PHYS ACT HEALTH, V10, P359, DOI 10.1123/jpah.10.3.359; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Catellier DJ, 2005, MED SCI SPORT EXER, V37, pS555, DOI 10.1249/01.mss.0000185651.59486.4e; Chodzko-Zajko WJ, 2009, MED SCI SPORT EXER, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; de Vos AJBM, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-7; Etman A, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-7; Evenson KR, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110109; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fruianu M., 2009, CYCLING NETHERLANDS; Fuzeki E, 2013, PUBLIC HLTH FORUM, V21, DOI DOI 10.1016/J.PHF.2013.03.002; Gorman E, 2014, EUR REV AGING PHYS A, V11, P35, DOI 10.1007/s11556-013-0132-x; Hart TL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-62; Hoogerduijn JG, 2012, AGE AGEING, V41, P381, DOI 10.1093/ageing/afs015; Kerr J, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-89; Lally F, 2007, POSTGRAD MED J, V83, P16, DOI 10.1136/pgmj.2006.048587; Maas J, 2013, NEIGHBOURHOOD STRUCT, P153; Manini TM, 2006, JAMA-J AM MED ASSOC, V296, P171, DOI 10.1001/jama.296.2.171; Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011; Ministry of Transport Public Works and Water Management, 2010, MOB NED 2009; Park Soyoung, 2012, J Prev Med Public Health, V45, P21, DOI 10.3961/jpmph.2012.45.1.21; Prins RG, 2014, HEALTH PLACE, V27, P127, DOI 10.1016/j.healthplace.2014.01.012; Santos DA, 2012, EXP GERONTOL, V47, P908, DOI 10.1016/j.exger.2012.07.011; Sterkenburg RP, 2012, TNO060UT201201287; Strath SJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-40; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Suzuki T, 2010, TELEMED J E-HEALTH, V16, P686, DOI 10.1089/tmj.2009.0175; Taraldsen K, 2012, MATURITAS, V71, P13, DOI 10.1016/j.maturitas.2011.11.003; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Watkinson C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-68; Wendel-Vos, 2013, HOEVEEL MENSEN ZIJN; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2011, WHO PUBL	38	33	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123168	10.1371/journal.pone.0123168	http://dx.doi.org/10.1371/journal.pone.0123168			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910249	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800029
J	Lei, W; Ni, H; Herington, J; Reese, J; Paria, BC				Lei, Wei; Ni, Hua; Herington, Jennifer; Reese, Jeff; Paria, Bibhash C.			Alkaline Phosphatase Protects Lipopolysaccharide-Induced Early Pregnancy Defects in Mice	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; UTERINE EPITHELIAL-CELLS; MONOPHOSPHORYL-LIPID-A; ACUTE KIDNEY INJURY; PRETERM LABOR; MOUSE UTERUS; BACTERIAL-ENDOTOXIN; VACCINE ADJUVANT; INNATE IMMUNITY; IN-VIVO	Excessive cytokine inflammatory response due to chronic or superphysiological level of microbial infection during pregnancy leads to pregnancy complications such as early pregnancy defects/loss and preterm birth. Bacterial toxin lipopolysaccharide (LPS), long recognized as a potent proinflammatory mediator, has been identified as a risk factor for pregnancy complications. Alkaline phosphatase (AP) isozymes have been shown to detoxify LPS by dephosphorylation. In this study, we examined the role of alkaline phosphatase (AP) in mitigating LPS-induced early pregnancy complications in mice. We found that 1) the uterus prior to implantation and implantation sites following embryo implantation produce LPS recognition and dephosphorylation molecules TLR4 and tissue non-specific AP (TNAP) isozyme, respectively; 2) uterine TNAP isozyme dephosphorylates LPS at its sites of production; 3) while LPS administration following embryo implantation elicits proinflammatory cytokine mRNA levels at the embryo implantation sites (EISs) and causes early pregnancy loss, dephosphorylated LPS neither triggers proinflammatory cytokine mRNA levels at the EISs nor induces pregnancy complications; 4) AP isozyme supplementation to accelerate LPS detoxification attenuates LPS-induced pregnancy complications following embryo implantation. These findings suggest that a LPS dephosphorylation strategy using AP isozyme may have a unique therapeutic potential to mitigate LPS- or Gram-negative bacteria-induced pregnancy complications in at-risk women.	[Lei, Wei; Herington, Jennifer; Reese, Jeff; Paria, Bibhash C.] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Neonatol, Nashville, TN 37232 USA; [Ni, Hua] Northeast Agr Univ, Coll Life Sci, Harbin, Peoples R China	Vanderbilt University; Northeast Agricultural University - China	Paria, BC (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Div Neonatol, Nashville, TN 37232 USA.	bc.paria@vanderbilt.edu	Lei, Wei/N-7611-2013	Lei, Wei/0000-0002-8342-8859; Reese, Jeff/0000-0001-8751-6146	National Institutes of Health [HD044741]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044741, R01HD081121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health grant HD044741.	Aisemberg J, 2010, NEUROIMMUNOMODULAT, V17, P150, DOI 10.1159/000258710; Ashdown H, 2006, MOL PSYCHIATR, V11, P47, DOI 10.1038/sj.mp.4001748; Austin KJ, 2003, ENDOCRINOLOGY, V144, P3107, DOI 10.1210/en.2002-0031; Bentala H, 2002, SHOCK, V18, P561, DOI 10.1097/00024382-200212000-00013; Beumer C, 2003, J PHARMACOL EXP THER, V307, P737, DOI 10.1124/jpet.103.056606; Bucci M, 1995, CELL BIOL INT, V19, P921, DOI 10.1006/cbir.1995.1030; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; CHAN JRA, 1986, J BIOL CHEM, V261, P7635; Chen KT, 2010, AM J PHYSIOL-GASTR L, V299, pG467, DOI 10.1152/ajpgi.00364.2009; Clark DA, 2004, AM J REPROD IMMUNOL, V52, P370, DOI 10.1111/j.1600-0897.2004.00237.x; Cronin JG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092718; Deb K, 2004, REPRODUCTION, V128, P87, DOI 10.1530/rep.1.00110; Deb Kaushik, 2005, Infect Dis Obstet Gynecol, V13, P125, DOI 10.1080/10647440500147885; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Hajishafiha M, 2011, INT J WOMENS HEALTH, V3, P329, DOI 10.2147/IJWH.S24424; HALL CL, 1983, P NATL ACAD SCI-BIOL, V80, P6671, DOI 10.1073/pnas.80.21.6671; HASE S, 1977, EUR J BIOCHEM, V75, P23, DOI 10.1111/j.1432-1033.1977.tb11500.x; Haziot A, 1995, Prog Clin Biol Res, V392, P349; Hirsch E, 2005, J SOC GYNECOL INVEST, V12, P145, DOI 10.1016/j.jsgi.2005.01.007; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huck O, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/164654; Ie S, 2002, OBSTET GYNECOL SURV, V57, P39, DOI 10.1097/00006254-200201000-00022; Jaiswal MK, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108068; Jaiswal YK, 2009, FERTIL STERIL, V91, P2095, DOI 10.1016/j.fertnstert.2008.04.050; JOHANSSON S, 1994, ANAT EMBRYOL, V190, P287; JONES DJ, 1974, LIFE SCI, V14, P1577, DOI 10.1016/0024-3205(74)90168-4; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kohmura Y, 2000, MICROBIOL IMMUNOL, V44, P897, DOI 10.1111/j.1348-0421.2000.tb02581.x; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Koyama I, 2002, CLIN BIOCHEM, V35, P455, DOI 10.1016/S0009-9120(02)00330-2; Kozlenkov A, 2004, J BONE MINER RES, V19, P1862, DOI 10.1359/JBMR.040608; Krikun G, 2007, HISTOL HISTOPATHOL, V22, P847, DOI 10.14670/HH-22.847; Kurien BT, 1997, ANAL BIOCHEM, V245, P123, DOI 10.1006/abio.1996.9971; Lei W, 2013, REPRODUCTION, V146, P419, DOI 10.1530/REP-13-0153; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lin JH, 1997, PHARMACOL REV, V49, P403; Liska D J, 1998, Altern Med Rev, V3, P187; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Matsuguchi T, 2000, BLOOD, V95, P1378, DOI 10.1182/blood.V95.4.1378.004k08_1378_1385; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; MURDOCH RN, 1978, J REPROD FERTIL, V54, P293, DOI 10.1530/jrf.0.0540293; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; NARISAWA S, 1992, DEVELOPMENT, V116, P159; Narisawa S, 2007, AM J PHYSIOL-GASTR L, V293, pG1068, DOI 10.1152/ajpgi.00073.2007; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Ogando DG, 2003, REPRODUCTION, V125, P95, DOI 10.1530/rep.0.1250095; Ojogun N, 2009, J INFECT DIS, V200, P1685, DOI 10.1086/646616; Pan HY, 2006, ENDOCRINOLOGY, V147, P4904, DOI 10.1210/en.2006-0140; Pararas MV, 2006, EUR J CLIN MICROBIOL, V25, P562, DOI 10.1007/s10096-006-0190-3; Paria BC, 1999, DEV BIOL, V208, P488, DOI 10.1006/dbio.1999.9206; Peters E, 2014, AM J KIDNEY DIS, V63, P1038, DOI 10.1053/j.ajkd.2013.11.027; Peters E, 2013, J PHARMACOL EXP THER, V344, P2, DOI 10.1124/jpet.112.198226; Poelstra K, 1997, LAB INVEST, V76, P319; Poelstra K, 1997, AM J PATHOL, V151, P1163; POLLARD JW, 1990, J REPROD FERTIL, V89, P735; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; ROMERO R, 1994, ANN NY ACAD SCI, V734, P414, DOI 10.1111/j.1749-6632.1994.tb21771.x; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Sheldon IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012906; Simcox R, 2007, AUST NZ J OBSTET GYN, V47, P368, DOI 10.1111/j.1479-828X.2007.00759.x; Soboll G, 2006, BIOL REPROD, V75, P131, DOI 10.1095/biolreprod.106.050690; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; van Veen SQ, 2005, INFECT IMMUN, V73, P4309, DOI 10.1128/IAI.73.7.4309-4314.2005; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wang XH, 2004, J CELL SCI, V117, P53, DOI 10.1242/jcs.00826; Wang XH, 2002, DEVELOPMENT, V129, P4125; Whitehouse JS, 2010, J SURG RES, V163, P79, DOI 10.1016/j.jss.2010.04.048; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239	71	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123243	10.1371/journal.pone.0123243	http://dx.doi.org/10.1371/journal.pone.0123243			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910276	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800030
J	Browne, JL; van Nievelt, SW; Srofenyoh, EK; Grobbee, DE; Klipstein-Grobusch, K				Browne, Joyce L.; van Nievelt, Sabine W.; Srofenyoh, Emmanuel K.; Grobbee, Diederick E.; Klipstein-Grobusch, Kerstin			Criteria-Based Audit of Quality of Care to Women with Severe Pre-Eclampsia and Eclampsia in a Referral Hospital in Accra, Ghana	PLOS ONE			English	Article							MISS; MANAGEMENT	Objectives Severe pre-eclampsia and eclampsia are one of the major causes of maternal mortality globally. Reducing maternal morbidity and mortality demands optimizing quality of care. Criteria-based audits are a tool to define, assess and improve quality of care. The aim of this study was to determine applicability of a criteria-based audit to assess quality of care delivered to women with severe hypertensive disorders in pregnancy, and to assess adherence to protocols and quality of care provided at a regional hospital in Accra, Ghana. Methods Checklists for management of severe preeclampsia, hypertensive emergency and eclampsia were developed in an audit cycle based on nine existing key clinical care protocols. Fifty cases were audited to assess quality of care, defined as adherence to protocols. Analysis was stratified for complicated cases, defined as (imminent) eclampsia, perinatal mortality and/or one or more WHO maternal near miss C-criteria. Results Mean adherence to the nine protocols ranged from 15-85%. Protocols for 'plan for delivery' and 'magnesium sulphate administration' were best adhered to (85%), followed by adherence to protocols for 'eclampsia' (64%), 'severe pre-eclampsia at admission' (60%), 'severe pre-eclampsia ward follow-up' (53%) and 'hypertensive emergency' (53%). Protocols for monitoring were least adhered to (15%). No difference was observed for severe disease. Increased awareness, protocol-based training of staff, and clear task assignment were identified as contributors to better adherence. Conclusion A criteria-based audit is an effective tool to determine quality of care, identify gaps in standard of care, and allow for monitoring and evaluation in a health facility, ultimately resulting in improved quality of care provided and reduced maternal morbidity and mortality. In our audit, good adherence was observed for plan for delivery and treatment with magnesium sulphate. Substandard adherence to a number of protocols was identified, and points towards opportunities for targeted improvement strategies.	[Browne, Joyce L.; van Nievelt, Sabine W.; Grobbee, Diederick E.; Klipstein-Grobusch, Kerstin] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands; [Srofenyoh, Emmanuel K.] Ghana Hlth Serv, Ridge Reg Hosp, Greater Accra Region, Accra, Ghana; [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Div Epidemiol & Biostat, Johannesburg, South Africa	Utrecht University; Utrecht University Medical Center; Ghana Health Service; University of Witwatersrand	Browne, JL (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands.	J.L.Browne@umcutrecht.nl	Klipstein-Grobusch, Kerstin/F-5555-2016	Klipstein-Grobusch, Kerstin/0000-0002-5462-9889				Abalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005; Andersgaard AB, 2006, ACTA OBSTET GYN SCAN, V85, P929, DOI 10.1080/00016340600607149; [Anonymous], ACC PROGR HLTH REL M; [Anonymous], 2012, UN SYSTEM TASK TEAM; Baldwin KJ, 2001, HYPERTENS PREGNANCY, V20, P257, DOI 10.1081/PRG-100107828; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Crombie I K, 1993, Qual Health Care, V2, P47, DOI 10.1136/qshc.2.1.47; De Brouwere V., 2013, CONDUCT MATERNAL DEA; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Edson W, 2007, INT J GYNECOL OBSTET, V97, P209, DOI 10.1016/j.ijgo.2007.02.018; Engmann C, 2010, INT ANESTHESIOL CLIN, V48, P109, DOI 10.1097/AIA.0b013e3181dd4f13; Filippi V, 2005, ACTA OBSTET GYN SCAN, V84, P11, DOI 10.1111/j.0001-6349.2005.00636.x; Gao Y, 2010, INT J GYNECOL OBSTET, V110, P181, DOI 10.1016/j.ijgo.2010.05.001; Ghana Ministry of Health, 2010, STAND TREATM GUID; Hunyinbo K I, 2008, Afr J Reprod Health, V12, P59; IBM Corp, 2011, IBM SPSS STAT WIND V; Jabir M, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-11; Kidanto HL, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-134; Lauritsen J, COMPREHENSIVE TOOL V; Liabsuetrakul T, 2008, INT J GYNECOL OBSTET, V103, P166, DOI 10.1016/j.ijgo.2008.06.016; Lori JR, 2012, MIDWIFERY, V28, P67, DOI 10.1016/j.midw.2010.12.001; Nelissen EJT, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-141; Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001; Penney G, 2011, SCOTTISH CONFIDENTIA; Pirkle CM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-118; Safe Motherhood Services, 2007, GHAN NAT SAF MOTH SE; Srofenyoh E, 2012, INT J GYNECOL OBSTET, V116, P17, DOI 10.1016/j.ijgo.2011.08.010; Talungchit P, 2013, INT J GYNECOLOGY OBS; Tuncalp O, 2012, BJOG-INT J OBSTET GY, V119, P653, DOI 10.1111/j.1471-0528.2012.03294.x; van den Akker T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054805; Wagaarachchi PT, 2001, INT J GYNECOL OBSTET, V74, P119, DOI 10.1016/S0020-7292(01)00427-1; Weeks AD, 2005, INT J GYNECOL OBSTET, V91, P292, DOI 10.1016/j.ijgo.2005.07.022; WHO UNICEF, 2013, TRENDS MAT MORT 1990; World Health Organization, 2004, NUMB REV MAT DEATHS; World Health Organization, 2011, WHO REC PREV TREATM; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; World Health Organization (WHO), 2011, EV QUAL CAR SEV PREG	37	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125749	10.1371/journal.pone.0125749	http://dx.doi.org/10.1371/journal.pone.0125749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923663	Green Published, Green Submitted, gold			2022-12-27	WOS:000353711600160
J	Tian, LX; Pan, YX; Metzner, W; Zhang, JS; Zhang, BF				Tian, Lan-Xiang; Pan, Yong-Xin; Metzner, Walter; Zhang, Jin-Shuo; Zhang, Bing-Fang			Bats Respond to Very Weak Magnetic Fields	PLOS ONE			English	Article							MOUSE-EARED BAT; BIOGENIC MAGNETITE; MAGNETORECEPTION; ORIENTATION; NAVIGATION; INTENSITY; ALIGNMENT; ANIMALS; COMPASS; REVERSALS	How animals, including mammals, can respond to and utilize the direction and intensity of the Earth's magnetic field for orientation and navigation is contentious. In this study, we experimentally tested whether the Chinese Noctule, Nyctalus plancyi (Vespertilionidae) can sense magnetic field strengths that were even lower than those of the present-day geomagnetic field. Such field strengths occurred during geomagnetic excursions or polarity reversals and thus may have played an important role in the evolution of a magnetic sense. We found that in a present-day local geomagnetic field, the bats showed a clear preference for positioning themselves at the magnetic north. As the field intensity decreased to only 1/5th of the natural intensity (i.e., 10 mu T; the lowest field strength tested here), the bats still responded by positioning themselves at the magnetic north. When the field polarity was artificially reversed, the bats still preferred the new magnetic north, even at the lowest field strength tested (10 mu T), despite the fact that the artificial field orientation was opposite to the natural geomagnetic field (P<0.05). Hence, N. plancyi is able to detect the direction of a magnetic field even at 1/5th of the present-day field strength. This high sensitivity to magnetic fields may explain how magnetic orientation could have evolved in bats even as the Earth's magnetic field strength varied and the polarity reversed tens of times over the past fifty million years.	[Tian, Lan-Xiang; Pan, Yong-Xin; Zhang, Bing-Fang] Chinese Acad Sci, Inst Geol & Geophys, Biogeomagnetism Grp, PGL,Key Lab Earth & Planetary Phys, Beijing, Peoples R China; [Tian, Lan-Xiang; Pan, Yong-Xin; Zhang, Bing-Fang] Chinese Acad Sci, France China Biomineralizat & Nanostruct Lab, Beijing, Peoples R China; [Metzner, Walter] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA; [Zhang, Jin-Shuo] Chinese Acad Sci, Inst Zool, Natl Zool Museum, Beijing, Peoples R China; [Zhang, Bing-Fang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Chinese Academy of Sciences; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Pan, YX (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Biogeomagnetism Grp, PGL,Key Lab Earth & Planetary Phys, Beijing, Peoples R China.	yxpan@mail.iggcas.ac.cn	Pan, Yongxin/B-4302-2008	Pan, Yongxin/0000-0002-4227-3061	Chinese Academy of Sciences Cross-disciplinary Collaborative Teams Program for Science, Technology and Innovation; CAS [KZCX2-YW-T10]; National Natural Science Foundation of China [41374074, 41330104]	Chinese Academy of Sciences Cross-disciplinary Collaborative Teams Program for Science, Technology and Innovation; CAS(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Chinese Academy of Sciences Cross-disciplinary Collaborative Teams Program for Science, Technology and Innovation, the CAS project (KZCX2-YW-T10) and National Natural Science Foundation of China grants (41374074, 41330104).	Altringham JD, 1996, BATS BIOL BEHAV; Begall S, 2011, J COMP PHYSIOL A, V197, P1127, DOI 10.1007/s00359-011-0674-1; Begall S, 2008, P NATL ACAD SCI USA, V105, P13451, DOI 10.1073/pnas.0803650105; Begall S, 2013, MAMM BIOL, V78, P10, DOI 10.1016/j.mambio.2012.05.005; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Boles LC, 2003, NATURE, V421, P60, DOI 10.1038/nature01226; Cai SH, 2014, EARTH PLANET SC LETT, V392, P217, DOI 10.1016/j.epsl.2014.02.030; Cain SD, 2005, INTEGR COMP BIOL, V45, P539, DOI 10.1093/icb/45.3.539; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Channell JET, 2009, EARTH PLANET SC LETT, V283, P14, DOI 10.1016/j.epsl.2009.03.012; Davila AF, 2005, BIOPHYS J, V89, P56, DOI 10.1529/biophysj.104.049346; Diebel CE, 2000, NATURE, V406, P299, DOI 10.1038/35018561; Finlay CC, 2010, GEOPHYS J INT, V183, P1216, DOI 10.1111/j.1365-246X.2010.04804.x; FIRESTER AH, 1966, REV SCI INSTRUM, V37, P1264, DOI 10.1063/1.1720478; Greif S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5488; Gubbins D, 1999, GEOPHYS J INT, V137, pF1, DOI 10.1046/j.1365-246x.1999.00810.x; Hart V, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-80; Holland RA, 2006, NATURE, V444, P702, DOI 10.1038/444702b; Holland RA, 2010, P NATL ACAD SCI USA, V107, P6941, DOI 10.1073/pnas.0912477107; Holland RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001676; Juarez MT, 1998, NATURE, V394, P878, DOI 10.1038/29746; Kirschvink JL, 2001, CURR OPIN NEUROBIOL, V11, P462, DOI 10.1016/S0959-4388(00)00235-X; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; Li T T, 2004, TRIAXIAL SQUARE HELM; Lohmann KJ, 2012, CURR OPIN NEUROBIOL, V22, P336, DOI 10.1016/j.conb.2011.11.005; MANN S, 1988, J EXP BIOL, V140, P35; Merlin C, 2012, CURR OPIN NEUROBIOL, V22, P353, DOI 10.1016/j.conb.2011.11.009; Mora CV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072869; Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077; Oliveriusova L, 2012, J EXP BIOL, V215, P3649, DOI 10.1242/jeb.069625; Olson P, 2014, EARTH PLANET SC LETT, V388, P9, DOI 10.1016/j.epsl.2013.11.038; Putman NF, 2011, CURR BIOL, V21, P463, DOI 10.1016/j.cub.2011.01.057; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Shi Hongyan, 2001, Acta Theriologica Sinica, V21, P210; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Tian LX, 2010, BIOELECTROMAGNETICS, V31, P499, DOI 10.1002/bem.20590; Vacha M, 2006, J EXP BIOL, V209, P3882, DOI 10.1242/jeb.02456; Valet JP, 2005, NATURE, V435, P802, DOI 10.1038/nature03674; VALET JP, 1993, NATURE, V366, P234, DOI 10.1038/366234a0; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; Wang YN, 2007, P R SOC B, V274, P2901, DOI 10.1098/rspb.2007.0904; Wegner RE, 2006, J EXP BIOL, V209, P4747, DOI 10.1242/jeb.02573; Wiltschko R, 2013, J COMP PHYSIOL A, V199, P89, DOI 10.1007/s00359-012-0769-3; Wiltschko R., 1995, TIEROSYCHOL; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Winklhofer M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0853; Zhu RX, 2000, J GEOPHYS RES-SOL EA, V105, P8305, DOI 10.1029/1999JB900448	47	8	9	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123205	10.1371/journal.pone.0123205	http://dx.doi.org/10.1371/journal.pone.0123205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922944	Green Submitted, gold, Green Published			2022-12-27	WOS:000353711600034
J	Mahadevan, C; Jaleel, A; Deb, L; Thomas, G; Sakuntala, M				Mahadevan, Chidambareswaren; Jaleel, Abdul; Deb, Lokesh; Thomas, George; Sakuntala, Manjula			Development of an Efficient Virus Induced Gene Silencing Strategy in the Non-Model Wild Ginger-Zingiber zerumbet and Investigation of Associated Proteome Changes	PLOS ONE			English	Article							STRIPE-MOSAIC-VIRUS; CHLOROPLAST PHOSPHOGLYCERATE KINASE; NICOTIANA-BENTHAMIANA; INFECTION; PROTEINS; PLANTS; BIOSYNTHESIS; RESISTANCE; SEPARATION; SYSTEM	Zingiber zerumbet (Zingiberaceae) is a wild, tropical medicinal herb that shows a high degree of resistance to diseases affecting cultivated ginger. Barley stripe mosaic virus (BSMV) silencing vectors containing an endogenous phytoene desaturase (PDS) gene fragment were agroinfiltrated into young leaves of Z. zerumbet under controlled growth conditions to effect virus-induced gene silencing (VIGS). Infiltrated leaves as well as newly emerged leaves and tillers showed visual signs of PDS silencing after 30 days. Replication and systemic movement of the viral vectors in silenced plants were confirmed by RT-PCR. Real-time quantitative PCR analysis verified significant down-regulation of PDS transcripts in the silenced tissues. Label-free proteomic analysis was conducted in leaves with established PDS transcript down regulation and buffer-infiltrated (mock) leaves. A total of 474 proteins were obtained, which were up-regulated, down-regulated or modulated de novo during VIGS. Most of these proteins were localized to the chloroplast, as revealed by UniprotKB analysis, and among the up-regulated proteins there were abiotic stress responsive, photosynthetic, metabolic and membrane proteins. Moreover, the demonstration of viral proteins together with host proteins proved successful viral infection. We report for the first time the establishment of a high-throughput gene functional analysis platform using BSMV-mediated VIGS in Z. zerumbet, as well as proteomic changes associated with VIGS.	[Mahadevan, Chidambareswaren; Thomas, George; Sakuntala, Manjula] Rajiv Gandhi Ctr Biotechnol, Div Plant Mol Biol, Thiruvananthapuram 695014, Kerala, India; [Jaleel, Abdul] Rajiv Gandhi Ctr Biotechnol, Prote Core Facil, Thiruvananthapuram 695014, Kerala, India; [Deb, Lokesh] Inst Bioresources & Sustainable Dev, Imphal 795001, Manipur, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Department of Biotechnology (DBT) India; Institute of Bioresources & Sustainable Development (IBSD)	Thomas, G (corresponding author), Rajiv Gandhi Ctr Biotechnol, Div Plant Mol Biol, Thiruvananthapuram 695014, Kerala, India.	gthomas@rgcb.res.in; smanjula@rgcb.res.in	Mahadevan, Chidambareswaren/AAT-3947-2020; Deb, Lokesh/N-6226-2019	Mahadevan, Chidambareswaren/0000-0001-8410-8286; , ABDUL JALEEL/0000-0003-2536-9093	Department of Biotechnology, Government of India;  [BT/PR11168/NDB/51/185/2008]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); 	This study was funded by The Department of Biotechnology, Government of India, URL http://dbtindia.nic.in. Funds received by CM, LD, GT and MS, grant number BT/PR11168/NDB/51/185/2008.	Armstrong GA, 1996, FASEB J, V10, P228, DOI 10.1096/fasebj.10.2.8641556; Bai SL, 2011, J EXP BOT, V62, P4561, DOI 10.1093/jxb/err163; Benedito Vagner A, 2004, Genet Mol Res, V3, P323; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruun-Rasmussen M, 2007, MOL PLANT MICROBE IN, V20, P1323, DOI 10.1094/MPMI-20-11-1323; Cakir C, 2010, CROP SCI, V50, pS77, DOI 10.2135/cropsci2009.10.0567; Carrington JC, 1996, PLANT CELL, V8, P1669, DOI 10.1105/tpc.8.10.1669; Cheng SF, 2013, PLANT PHYSIOL, V163, P1598, DOI 10.1104/pp.113.229666; Cruz SS, 1999, TRENDS MICROBIOL, V7, P237, DOI 10.1016/S0966-842X(99)01508-5; Dai JR, 1997, NAT PROD LETT, V10, P115, DOI 10.1080/10575639708043725; Eichelmann H, 2004, PLANT BIOLOGY, V6, P307, DOI 10.1055/s-2004-820874; Fantini E, 2013, PLANT PHYSIOL, V163, P986, DOI 10.1104/pp.113.224733; Gilar M, 2005, J SEP SCI, V28, P1694, DOI 10.1002/jssc.200500116; Glaser E, 2004, MOLECULAR BIOLOGY AND BIOTECHNOLOGY OF PLANT ORGANELLES: CHLOROPLASTS AND MITOCHONDRIA, P385, DOI 10.1007/978-1-4020-3166-3_14; Havelda Z, 2008, PLANT J, V55, P278, DOI 10.1111/j.1365-313X.2008.03501.x; Isaacson T, 2006, NAT PROTOC, V1, P769, DOI 10.1038/nprot.2006.102; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Kavitha PG, 2008, J BIOSCIENCES, V33, P81, DOI 10.1007/s12038-008-0002-2; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; Laliberte JF, 2010, ANNU REV PHYTOPATHOL, V48, P69, DOI 10.1146/annurev-phyto-073009-114239; Lee WS, 2012, PLANT PHYSIOL, V160, P582, DOI 10.1104/pp.112.203489; Levin Y, 2011, PROTEOMICS, V11, P3273, DOI 10.1002/pmic.201000661; Lin JW, 2007, NUCLEIC ACIDS RES, V35, P424, DOI 10.1093/nar/gkl1061; LIN NS, 1984, J GEN VIROL, V65, P2217, DOI 10.1099/0022-1317-65-12-2217; Lu R, 2003, METHODS, V30, P296, DOI 10.1016/S1046-2023(03)00037-9; Maxwell KL, 2007, MICROBIOL MOL BIOL R, V71, P398, DOI 10.1128/MMBR.00042-06; McGregor CE, 2009, J AM SOC HORTIC SCI, V134, P658, DOI 10.21273/JASHS.134.6.658; MCMORROW EM, 1990, PLANT PHYSIOL, V93, P374, DOI 10.1104/pp.93.2.374; Mininno M, 2012, J BIOL CHEM, V287, P21034, DOI 10.1074/jbc.M112.359976; Nair RA, 2013, GENE, V516, P58, DOI 10.1016/j.gene.2012.12.011; Niehl A, 2013, J PROTEOME RES, V12, P2491, DOI 10.1021/pr3010698; PETTY ITD, 1990, EMBO J, V9, P3453, DOI 10.1002/j.1460-2075.1990.tb07553.x; Renner T, 2009, MOL PLANT, V2, P1084, DOI 10.1093/mp/ssp033; Romero I, 2011, J PLANT PHYSIOL, V168, P1129, DOI 10.1016/j.jplph.2010.12.020; Salzman RA, 1999, PLANT MOL BIOL REP, V17, P11, DOI 10.1023/A:1007520314478; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Senthil-Kumar M, 2007, NEW PHYTOL, V176, P782, DOI 10.1111/j.1469-8137.2007.02225.x; Senthil-Kumar M, 2011, TRENDS PLANT SCI, V16, P656, DOI 10.1016/j.tplants.2011.08.006; Shin M, 2004, PHOTOSYNTH RES, V80, P307, DOI 10.1023/B:PRES.0000030456.96329.f9; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Sobhan PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059350; Spetea C, 2012, FEBS LETT, V586, P2946, DOI 10.1016/j.febslet.2012.07.005; Torrance L, 2006, J GEN VIROL, V87, P2403, DOI 10.1099/vir.0.81975-0; Tournier B, 2006, PLANT J, V47, P383, DOI 10.1111/j.1365-313X.2006.02796.x; Weigel Detlef, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4666; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wiener MC, 2004, ANAL CHEM, V76, P6085, DOI 10.1021/ac0493875; Yuan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026468	48	10	10	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124518	10.1371/journal.pone.0124518	http://dx.doi.org/10.1371/journal.pone.0124518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25918840	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400053
J	Tan, HL; Xie, QJ; Xiang, XOE; Li, JQ; Zheng, SN; Xu, XY; Guo, HL; Ye, WX				Tan, Helin; Xie, Qingjun; Xiang, Xiaoe; Li, Jianqiao; Zheng, Suning; Xu, Xinying; Guo, Haolun; Ye, Wenxue			Dynamic Metabolic Profiles and Tissue-Specific Source Effects on the Metabolome of Developing Seeds of Brassica napus	PLOS ONE			English	Article							FATTY-ACID BIOSYNTHESIS; OIL CONTENT; LIPID-METABOLISM; GENE-EXPRESSION; ACETYL-COENZYME; PHOTOSYNTHESIS; ACCUMULATION; CANOLA; CARBOXYLASE; WRINKLED1	Canola (Brassica napus) is one of several important oil-producing crops, and the physiological processes, enzymes, and genes involved in oil synthesis in canola seeds have been well characterized. However, relatively little is known about the dynamic metabolic changes that occur during oil accumulation in seeds, as well as the mechanistic origins of metabolic changes. To explore the metabolic changes that occur during oil accumulation, we isolated metabolites from both seed and silique wall and identified and characterized them by using gas chromatography coupled with mass spectrometry (GC-MS). The results showed that a total of 443 metabolites were identified from four developmental stages. Dozens of these metabolites were differentially expressed during seed ripening, including 20 known to be involved in seed development. To investigate the contribution of tissue-specific carbon sources to the biosynthesis of these metabolites, we examined the metabolic changes of silique walls and seeds under three treatments: leaf-detachment (Ld), phloem-peeling (Pe), and selective silique darkening (Sd). Our study demonstrated that the oil content was independent of leaf photosynthesis and phloem transport during oil accumulation, but required the metabolic influx from the silique wall. Notably, Sd treatment resulted in seed senescence, which eventually led to a severe reduction of the oil content. Sd treatment also caused a significant accumulation of fatty acids (FA), organic acids and amino acids. Furthermore, an unexpected accumulation of sugar derivatives and organic acid was observed in the Pe- and Sd-treated seeds. Consistent with this, the expression of a subset of genes involved in FA metabolism, sugar and oil storage was significantly altered in Pe and Sd treated seeds. Taken together, our studies suggest the metabolite profiles of canola seeds dynamically varied during the course of oil accumulation, which may provide a new insight into the mechanisms of the oil accumulation at the metabolite level.	[Tan, Helin; Li, Jianqiao; Xu, Xinying; Guo, Haolun; Ye, Wenxue] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China; [Xie, Qingjun] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou 510642, Guangdong, Peoples R China; [Xiang, Xiaoe] Nanjing Agr Univ, Anim Sci Natl Teaching Demonstrat Ctr, Nanjing 210095, Jiangsu, Peoples R China; [Zheng, Suning] Chinese Acad Agr Sci, Supervis & Testing Ctr Vegetable Qual, Inst Vegetables & Flowers, Minist Agr, Beijing 100081, Peoples R China	Nanjing Agricultural University; South China Agricultural University; Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs	Tan, HL (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China.	hltan@njau.edu.cn	Xie, Qingjun/A-4199-2017	Xie, Qingjun/0000-0002-6372-3260	Natural Science Foundation of Jiangsu province [BK2012767]; Fundamental Research Funds for the Central Universities [KYZ201301]	Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was supported by the Natural Science Foundation of Jiangsu province (BK2012767), the Fundamental Research Funds for the Central Universities (KYZ201301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokanthan PS, 1997, PHYSIOL PLANTARUM, V101, P353, DOI 10.1034/j.1399-3054.1997.1010215.x; Bates PD, 2011, PLANT J, V68, P387, DOI 10.1111/j.1365-313X.2011.04693.x; Baud S, 2007, PLANT J, V50, P825, DOI 10.1111/j.1365-313X.2007.03092.x; Baud S, 2009, PLANT J, V60, P933, DOI 10.1111/j.1365-313X.2009.04011.x; Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; Bennett EJ, 2011, NEW PHYTOL, V190, P838, DOI 10.1111/j.1469-8137.2011.03714.x; Biermann U, 2011, ANGEW CHEM INT EDIT, V50, P3854, DOI 10.1002/anie.201002767; BROWSE J, 1985, PLANTA, V166, P74, DOI 10.1007/BF00397388; Clauss K, 2011, PLANT PHYSIOL, V155, P1127, DOI 10.1104/pp.110.169821; de Sousa CAF, 2003, ENVIRON EXP BOT, V50, P1, DOI 10.1016/S0098-8472(02)00108-9; Ding WH, 2003, RAPID COMMUN MASS SP, V17, P56, DOI 10.1002/rcm.819; Eastmond P, 1996, J EXP BOT, V47, P1763, DOI 10.1093/jxb/47.11.1763; Fritschi FB, 2007, PHOTOSYNTHETICA, V45, P92, DOI 10.1007/s11099-007-0014-4; Harwood JL, 1996, BBA-LIPID LIPID MET, V1301, P7, DOI 10.1016/0005-2760(95)00242-1; Hill LM, 2003, PLANT PHYSIOL, V131, P228, DOI 10.1104/pp.010868; Hsieh R J, 1989, Adv Food Nutr Res, V33, P233, DOI 10.1016/S1043-4526(08)60129-1; Hua W, 2012, PLANT J, V69, P432, DOI 10.1111/j.1365-313X.2011.04802.x; HUANG LS, 1990, PHYTOCHEMISTRY, V29, P1441, DOI 10.1016/0031-9422(90)80097-Z; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; Jessica P., 2010, THESIS U MANITOBA; Jiang JJ, 2013, J INTEGR PLANT BIOL, V55, P537, DOI 10.1111/jipb.12039; King SP, 1997, PLANT PHYSIOL, V114, P153, DOI 10.1104/pp.114.1.153; LEWIS GJ, 1994, AUST J EXP AGR, V34, P93, DOI 10.1071/EA9940093; Maeo K, 2009, PLANT J, V60, P476, DOI 10.1111/j.1365-313X.2009.03967.x; Masaki T, 2005, PLANT CELL PHYSIOL, V46, P547, DOI 10.1093/pcp/pci072; Millar AA, 2000, TRENDS PLANT SCI, V5, P95, DOI 10.1016/S1360-1385(00)01566-1; Mu JY, 2008, PLANT PHYSIOL, V148, P1042, DOI 10.1104/pp.108.126342; Napier JA, 2014, CURR OPIN PLANT BIOL, V19, P68, DOI 10.1016/j.pbi.2014.04.001; Nesi N, 2008, CR BIOL, V331, P763, DOI 10.1016/j.crvi.2008.07.018; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Ohlrogge JB, 1997, ANNU REV PLANT PHYS, V48, P109, DOI 10.1146/annurev.arplant.48.1.109; PECHAN PA, 1985, J EXP BOT, V36, P458, DOI 10.1093/jxb/36.3.458; Porterfield DM, 1999, CAN J BOT, V77, P1439, DOI 10.1139/cjb-77-10-1439; Puthur JT, 2013, J PLANT PHYSIOL, V170, P1131, DOI 10.1016/j.jplph.2013.04.011; Roesler K, 1997, PLANT PHYSIOL, V113, P75, DOI 10.1104/pp.113.1.75; Ruuska SA, 2004, PLANT PHYSIOL, V136, P2700, DOI 10.1104/pp.104.047977; Ruuska SA, 2002, PLANT CELL, V14, P1191, DOI 10.1105/tpc.000877; SHORROSH BS, 1995, PLANT PHYSIOL, V108, P805, DOI 10.1104/pp.108.2.805; Siloto RMP, 2006, PLANT CELL, V18, P1961, DOI 10.1105/tpc.106.041269; SINGAL HR, 1987, PLANT PHYSIOL, V83, P1043, DOI 10.1104/pp.83.4.1043; SLABAS AR, 1992, PLANT MOL BIOL, V19, P169, DOI 10.1007/BF00015613; Tan HL, 2011, PLANT PHYSIOL, V156, P1577, DOI 10.1104/pp.111.175000; Ting JTL, 1996, PLANTA, V199, P158, DOI 10.1007/BF00196892; TZEN JTC, 1993, PLANT PHYSIOL, V101, P267, DOI 10.1104/pp.101.1.267; TZEN JTC, 1992, J BIOL CHEM, V267, P15626; Vigeolas H, 2003, PLANT PHYSIOL, V133, P2048, DOI 10.1104/pp.103.031963; Voelker T, 2001, ANNU REV PLANT PHYS, V52, P335, DOI 10.1146/annurev.arplant.52.1.335; Watanabe M, 2013, PLANT PHYSIOL, V162, P1290, DOI 10.1104/pp.113.217380; Weselake RJ, 2009, BIOTECHNOL ADV, V27, P866, DOI 10.1016/j.biotechadv.2009.07.001; Wu XL, 2014, J INTEGR PLANT BIOL, V56, P582, DOI 10.1111/jipb.12158; Yu CY, 2013, J APPL GENET, V54, P135, DOI 10.1007/s13353-012-0132-y; Zou JT, 1997, PLANT CELL, V9, P909, DOI 10.1105/tpc.9.6.909	52	27	30	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124794	10.1371/journal.pone.0124794	http://dx.doi.org/10.1371/journal.pone.0124794			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919591	Green Published, Green Submitted, gold			2022-12-27	WOS:000353659400062
J	Abud, MJ; Hall, B; Helmers, C				Abud, Maria Jose; Hall, Bronwyn; Helmers, Christian			An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile	PLOS ONE			English	Article							PROTECTION	We analyze the patent filing strategies of foreign pharmaceutical companies in Chile distinguishing between "primary" (active ingredient) and "secondary" patents (patents on modified compounds, formulations, dosages, particular medical uses, etc.). There is prior evidence that secondary patents are used by pharmaceutical originator companies in the U.S. and Europe to extend patent protection on drugs in length and breadth. Using a novel dataset that comprises all drugs registered in Chile between 1991 and 2010 as well as the corresponding patents and trademarks, we find evidence that foreign originator companies pursue similar strategies in Chile. We find a primary to secondary patents ratio of 1:4 at the drug-level, which is comparable to the available evidence for Europe; most secondary patents are filed over several years following the original primary patent and after the protected active ingredient has obtained market approval in Chile. This points toward effective patent term extensions through secondary patents. Secondary patents dominate "older" therapeutic classes like anti-ulcer and anti-depressants. In contrast, newer areas like anti-virals and anti-neoplastics (anti-cancer) have a much larger share of primary patents.	[Abud, Maria Jose] Columbia Univ, Sch Int & Publ Affairs, New York, NY USA; [Hall, Bronwyn] Univ Calif Berkeley, Dept Econ, Berkeley, CA 94720 USA; [Hall, Bronwyn] Maastricht Univ, UNU MERIT, NL-6200 MD Maastricht, Netherlands; [Helmers, Christian] Santa Clara Univ, Dept Econ, Santa Clara, CA 95053 USA	Columbia University; University of California System; University of California Berkeley; Maastricht University; Santa Clara University	Helmers, C (corresponding author), Santa Clara Univ, Dept Econ, Santa Clara, CA 95053 USA.	chelmers@scu.edu		Hall, Bronwyn/0000-0002-3802-5567	World Intellectual Property Organization; United Nations University-MERIT; Santa Clara University	World Intellectual Property Organization; United Nations University-MERIT; Santa Clara University	This study was supported by the World Intellectual Property Organization to MA, BH, and CH (WIPO, http://www.wipo.int); United Nations University-MERIT to BH; and Santa Clara University to CH. WIPO's chief economist, Carsten Fink, provided advice in the study design and data collection, and manuscript.	Abud M.J., 2013, 11 WIPO; Amin T, 2012, HEALTH AFFAIR, V31, P2286, DOI 10.1377/hlthaff.2012.0107; Arora A, 2011, LOCATION BIOPHARMACE; Burdon M, 2003, INT J MED MARKETING, V3; Chaudhuri S, 2006, AM ECON REV, V96, P1477, DOI 10.1257/aer.96.5.1477; European Commission, 2009, PHARM SECT INQ FIN R; Goldberg PK, 2010, J EUR ECON ASSOC, V8, P326, DOI 10.1111/j.1542-4774.2010.tb00506.x; Hemphill CS, 2012, J HEALTH ECON, V31, P327, DOI 10.1016/j.jhealeco.2012.01.004; Hutchins M, 2003, J GENERIC MED, V1, P57, DOI DOI 10.1057/PALGRAVE.JGM.4940018; Hutchins M, 2003, J MED MARKETING DEVI, V3, P212; Kapczynski A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049470; Sternitzke C, 2013, RES POLICY, V42, P542, DOI 10.1016/j.respol.2012.11.003	12	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124257	10.1371/journal.pone.0124257	http://dx.doi.org/10.1371/journal.pone.0124257			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915050	Green Published, gold			2022-12-27	WOS:000353659100042
J	Jiang, LG; Zhang, QY; Ren, H; Ma, S; Lu, CJ; Liu, B; Liu, J; Liang, J; Li, MY; Zhu, RZ				Jiang, Lianggui; Zhang, Qingyu; Ren, Hao; Ma, Sheng; Lu, CaiJie; Liu, Bin; Liu, Jie; Liang, Jian; Li, Mingyi; Zhu, Runzhi			Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/BcI-2 Pathway in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							CANCER CELLS; CISPLATIN; PACLITAXEL; CHEMOTHERAPY; INHIBITION; ACTIVATION	Chemotherapy is an effective weapon in the battle against cancer. Nedaplatin (NDP) is an improved platinum-containing drug with lower cytotoxicity than other similar drugs. However, the repeated use of NDP results in substantial hepatocyte damage as well as drug resistance in hepatocellular carcinoma (HCC) cases. Therefore, the development of effective chemotherapy strategies that enhance tumor sensitivity to chemotherapeutics and reduce the secondary damage to liver cells is urgently needed. Dihydromyricetin (DHM), a natural flavonoid compound, has been shown to have antitumor activity with no obvious toxicity to normal cells in vitro and in vivo. In this study, DHM and NDP were combined to treat liver cancer cells; we found that DHM functions as a protector of normal cells compared with the use of NDP alone. In addition, the synergy of DHM with NDP enhanced the effect of NDP on the induction of HCC cell apoptosis. We found that the combination caused clear changes in the level of reactive oxygen species (ROS). Furthermore, we demonstrated that the combination of DHM and NDP activated the p53/BcI-2 signaling pathway, which resulted in mitochondrial dysfunction and induced cell death and growth inhibition in HCC cells.	[Jiang, Lianggui; Zhang, Qingyu; Ren, Hao; Ma, Sheng; Lu, CaiJie; Liu, Bin; Liu, Jie; Li, Mingyi; Zhu, Runzhi] Guangdong Med Coll, Affiliated Hosp, Zhanjiang Key Lab Hepatobiliary Dis, Lab Hepatobiliary Surg, Zhanjiang, Peoples R China; [Liang, Jian] Guangdong Med Coll, Affiliated Hosp, Dept Gastroenterol, Zhanjiang, Peoples R China	Guangdong Medical University; Guangdong Medical University	Li, MY (corresponding author), Guangdong Med Coll, Affiliated Hosp, Zhanjiang Key Lab Hepatobiliary Dis, Lab Hepatobiliary Surg, Zhanjiang, Peoples R China.	limingyi63@163.com; hepatolab@163.com			Guangdong Medical College Youth Fund [Q2012017]; Outstanding master's thesis cultivation project of Guangdong Medical College [2014-12#]; Key Laboratory of Zhanjiang project [2013A402-4]; competitive projects of Zhanjiang [2013-17#, 2013-10#]; National Natural Science Funds [81041099]; Guangdong Province Natural Science Funds [S2011010003750]	Guangdong Medical College Youth Fund; Outstanding master's thesis cultivation project of Guangdong Medical College; Key Laboratory of Zhanjiang project; competitive projects of Zhanjiang; National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Funds	This study was supported by The Guangdong Medical College Youth Fund (Q2012017, QYZ received this funding); Outstanding master's thesis cultivation project of Guangdong Medical College (2014-12#, LGJ received this funding); Key Laboratory of Zhanjiang project (2013A402-4, MYL received this funding); competitive projects of Zhanjiang, secondary financial support project (2013-17# and -10#, RZZ and JL (RZZ and Jian Liang received this funding); The National Natural Science Funds 81041099 and Guangdong Province Natural Science Funds S2011010003750 (MYL received these fundings). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunner TB, 2011, RADIAT ONCOL, V6, pe88; Chu DJ, 2014, GENET MOL RES, V13, P2796, DOI 10.4238/2014.April.14.8; Deng LT, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-71; Fukui Tadahisa, 2011, Nihon Shokakibyo Gakkai Zasshi, V108, P813; Gamarra-Luques CD, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-45; Gamarra-Luques CD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-200; Hirata K, 2014, JPN J CLIN ONCOL, V44, P556, DOI 10.1093/jjco/hyu048; Huang H, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2461912.2461913; Kubala M, 2014, BIOMED PAP, V158, P194, DOI 10.5507/bp.2014.018; Li CH, 2014, ASIAN PAC J CANCER P, V15, P731, DOI 10.7314/APJCP.2014.15.2.731; Nedaplatin Ota K., 1996, CANC CHEMOTH, V23, P379; Nishioka K, 2014, JPN J CLIN ONCOL, V44, P28, DOI 10.1093/jjco/hyt182; Sato D, 2013, CHEMOTHERAPY, V59, P314, DOI 10.1159/000357469; Shaili Evyenia, 2014, Science Progress, V97, P20, DOI 10.3184/003685014X13904811808460; Shen Y, 2012, J NEUROSCI, V32, P390, DOI 10.1523/JNEUROSCI.4639-11.2012; Sims JT, 2009, BIOCHEM PHARMACOL, V78, P249, DOI 10.1016/j.bcp.2009.04.007; Srinivasan KN, 2014, CASE REP ONCOL MED, V2014, DOI 10.1155/2014/940591; Takamoto Daiji, 2014, Hinyokika Kiyo, V60, P95; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055599; Xia J, 2014, FOOD CHEM TOXICOL, V66, P7, DOI 10.1016/j.fct.2014.01.014; Zaidi Y, 2014, METALLOMICS, V6, P1469, DOI 10.1039/c4mt00035h; Zhang QY, 2014, SCI REP-UK, V4, DOI 10.1038/srep04628	22	34	39	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124994	10.1371/journal.pone.0124994	http://dx.doi.org/10.1371/journal.pone.0124994			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915649	Green Published, gold, Green Submitted			2022-12-27	WOS:000353659100087
J	Kim, JH; Holman, DJ; Goodreau, SM				Kim, Jun-Hong; Holman, Darryl J.; Goodreau, Steven M.			Using Social Network Methods to Test for Assortment of Prosociality among Korean High School Students	PLOS ONE			English	Article							GROUP SELECTION; COOPERATION; BEHAVIOR; EVOLUTION; FEATHER; BIRDS	Assortative interaction among altruistic individuals is a necessary condition for the evolution of cooperation. The requirement for assortment holds regardless of whether a meta-population is subdivided into distinct and isolated subgroups or has ephemeral boundaries with a high migration rate. The assumption, however, is rarely tested directly. In this paper, we develop a method to test for assortment of prosociality in network-structured data. The method is applied to a friendship network collected from 238 Korean students attending the same high school. A mixing matrix was used to explore the presence of assortative friendship among more prosocial individuals. An exponential random graph model of network structure that accounts for additional observed relational propensities (higher-than-expected number of people nominating no friends) and sampling constraints (upper bound on friendship nominations) found that individual prosociality predicted friendship propensity, and that individuals with higher prosocial scores had a higher probability of befriending other more prosocial individuals. The results reveal that a considerable level of assortment of prosociality characterizes this population.	[Kim, Jun-Hong] Seoul Natl Univ, Inst Cross Cultural Studies, Seoul, South Korea; [Holman, Darryl J.; Goodreau, Steven M.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Holman, Darryl J.; Goodreau, Steven M.] Univ Washington, Ctr Stat & Social Sci, Seattle, WA 98195 USA; [Holman, Darryl J.; Goodreau, Steven M.] Univ Washington, Ctr Studies Demog & Ecol, Seattle, WA 98195 USA	Seoul National University (SNU); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kim, JH (corresponding author), Seoul Natl Univ, Inst Cross Cultural Studies, Seoul, South Korea.	junhongkim@snu.ac.kr	Goodreau, Steven/P-2366-2017	Kim, Junhong/0000-0002-6143-8810	NSF [BCS-1154447]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068395, R24HD042828] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The support for the field research was provided by the Department of Anthropology, University of Washington (J.K.) and an NSF Doctoral Dissertation Improvement Grant (J.K., BCS-1154447). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, J STAT SOFTW; Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Barr Abigail, 2010, WHOM CAN WE TRUST HO, P65; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; Converse Jean M., 1986, SURVEY QUESTIONS HAN, V63; Fehl K, 2011, ECOL LETT, V14, P546, DOI 10.1111/j.1461-0248.2011.01615.x; Fletcher JA, 2009, P ROY SOC B-BIOL SCI, V276, P13, DOI 10.1098/rspb.2008.0829; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; FRANK O, 1986, J AM STAT ASSOC, V81, P832, DOI 10.2307/2289017; Frank SA., 1998, FOUNDATIONS OF SOCIA; Godfrey-Smith P, 2009, AM NAT, V174, P906, DOI 10.1086/646605; Goodreau SM, 2009, DEMOGRAPHY, V46, P103, DOI 10.1353/dem.0.0045; Hamilton W. D., 1975, BIOSOCIAL ANTHR, P133; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Henrich J, 2004, J ECON BEHAV ORGAN, V53, P3, DOI 10.1016/S0167-2681(03)00094-5; Hruschka D., 2010, FRIENDSHIP DEVELOPME; Kerr B, 2004, TRENDS ECOL EVOL, V19, P135, DOI 10.1016/j.tree.2003.10.004; Kerr B, 2002, BIOL PHILOS, V17, P477, DOI 10.1023/A:1020504900646; McElreath R, 2007, MATHEMATICAL MODELS; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; Richerson P. J., 2005, NOT BY GENES ALONE H; Robins G, 2009, SOC NETWORKS, V31, P105, DOI 10.1016/j.socnet.2008.10.006; Schulz W, 2010, ICCS 2009 INTERNATIO; Silk JB, 2003, DAHL WS ENV, P37; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; Wasserman S, 1996, PSYCHOMETRIKA, V61, P401, DOI 10.1007/BF02294547; Wasserman S., 1994, SOCIAL NETWORK ANALY; Wilson DS, 2009, EVOL HUM BEHAV, V30, P190, DOI 10.1016/j.evolhumbehav.2008.12.002; Wilson DS, 1997, AM NAT, V149, P336, DOI 10.1086/285993	31	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125333	10.1371/journal.pone.0125333	http://dx.doi.org/10.1371/journal.pone.0125333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915508	Green Submitted, Green Published, gold			2022-12-27	WOS:000353659100121
J	Lin, M; Yang, LY; Xie, DD; Chen, JT; Nguba, SMM; Ehapo, CS; Zhan, XF; Eyi, JUM; Matesa, RA; Obono, MMO; Yang, H; Yang, HT; Cheng, JD				Lin, Min; Yang, Li Ye; Xie, Dong De; Chen, Jiang Tao; Nguba, Santiago-m Monte; Ehapo, Carlos Sala; Zhan, Xiao Fen; Eyi, Juan Urbano Monsuy; Matesa, Rocio Apicante; Obono, Maximo Miko Ondo; Yang, Hui; Yang, Hui Tian; Cheng, Ji Dong			G6PD Deficiency and Hemoglobinopathies: Molecular Epidemiological Characteristics and Healthy Effects on Malaria Endemic Bioko Island, Equatorial Guinea	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; NIGERIAN POPULATION; WEST-AFRICA; DEHYDROGENASE; HAEMOGLOBIN; DISORDERS; REGION	Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency and hemoglobinopathies were the inherited conditions found mostly in African. However, few epidemiological data of these disorders was reported in Equatorial Guinea (EQG). This study aimed to assess the prevalence and healthy effects of G6PD deficiency and hemoglobinopathies among the people on malaria endemic Bioko Island, EQG. Materials and Methods Blood samples from 4,144 unrelated subjects were analyzed for G6PD deficieny by fluorescence spot test (FST), high-resolution melting assay and PCR-DNA sequencing. In addition, 1,186 samples were randomly selected from the 4,144 subjects for detection of hemoglobin S (HbS), HbC, and alpha-thalassemia deletion by complete blood count, PCR-DNA sequencing and reverse dot blot (RDB). Results The prevalence of malaria and anemia was 12.6%(522/4,144) and 32.8% (389/1,186), respectively. Overall, 8.7% subjects (359/4,144) were G6PD-deficient by FST, including 9.0% (249/2,758) males and 7.9%(110/1,386) females. Among the 359 G6PD-deficient individuals molecularly studied, the G6PD A(-)(G202A/A376G) were detected in 356 cases (99.2%), G6PD Betica (T968C/A376G) in 3 cases. Among the 1,186 subjects, 201 cases were HbS heterozygotes, 35 cases were HbC heterozygotes, and 2 cases were HbCS double heterozygotes; 452 cases showed heterozygous alpha-thalassemia 3.7 kb deletion (-alpha(3.7) kb deletion) and 85 homozygous -alpha(3.7) kb deletion. The overall allele frequencies were HbS 17.1% ( 203/1186); HbC, 3.1%( 37/1186); and -alpha(3.7) kb deletion 52.4% (622/1186), respectively. Conclusions High G6PD deficiency in this population indicate that diagnosis and management of G6PD deficiency is necessary on Bioko Island. Obligatory newborn screening, prenatal screening and counseling for these genetic disorders, especially HbS, are needed on the island.	[Lin, Min; Cheng, Ji Dong] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Internal Med, Shantou, Guangdong, Peoples R China; [Lin, Min; Yang, Li Ye; Zhan, Xiao Fen; Yang, Hui; Yang, Hui Tian] Southern Med Univ, Chaozhou Cent Hosp, Cent Lab, Chaozhou, Guangdong, Peoples R China; [Xie, Dong De; Chen, Jiang Tao] Chinese Med Aid Team Republ Equatorial Guinea, Guangzhou, Guangdong, Peoples R China; [Nguba, Santiago-m Monte] Malabo Reg Hosp, Med Lab, Malabo, Equat Guinea; [Ehapo, Carlos Sala; Eyi, Juan Urbano Monsuy; Matesa, Rocio Apicante; Obono, Maximo Miko Ondo] Malabo Reg Hosp, Cent Blood Transfus Serv, Malabo, Equat Guinea	Shantou University; Southern Medical University - China	Cheng, JD (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Internal Med, Shantou, Guangdong, Peoples R China.	Jidongcheng36@hotmail.com			China Postdoctoral Science Foundation [2013M542195]; Medical Science Fund of Guangdong Province [A2013780]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Medical Science Fund of Guangdong Province	This work was partially supported by China Postdoctoral Science Foundation (contract/grant number 2013M542195 to Min Lin) and Medical Science Fund of Guangdong Province (contract/grant number A2013780 to Jiang-Tao Chen). The funders had no role in study design and data analysis, decision to publish, or reparation of the manuscript.	Ademowo O G, 2002, East Afr Med J, V79, P42; Ashley EA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-418; Aygun B, 2012, PEDIATR BLOOD CANCER, V59, P386, DOI 10.1002/pbc.24175; Bouanga JC, 1998, HUM HERED, V48, P192, DOI 10.1159/000022801; Burchard GD, 2001, ACTA TROP, V80, P103, DOI 10.1016/S0001-706X(01)00157-7; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Carter N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-241; Charle P, 2013, AM J TROP MED HYG, V88, P1087, DOI 10.4269/ajtmh.12-0290; Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8; DUFLO B, 1979, B SOC PATHOL EXOT, V72, P258; Ewusie JE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-626; Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339; Jiang J, 2014, GENET MOL RES, V13, P4272, DOI 10.4238/2014.June.9.13; Kaplan M, 2011, SEMIN PERINATOL, V35, P155, DOI 10.1053/j.semperi.2011.02.010; Kashmoola MA, 2015, INDIAN J HEMATOL BLO, V31, P133, DOI 10.1007/s12288-014-0368-2; Kleinschmidt I, 2006, AM J TROP MED HYG, V74, P972, DOI 10.4269/ajtmh.2006.74.972; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Lin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101505; Lin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055024; LUZZATTO L, 1968, NATURE, V219, P1041, DOI 10.1038/2191041a0; Luzzatto L, 2014, BRIT J HAEMATOL, V164, P469, DOI 10.1111/bjh.12665; Maiga B, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-270; May J, 2000, TROP MED INT HEALTH, V5, P119, DOI 10.1046/j.1365-3156.2000.00529.x; Meissner PE, 2005, BRIT J HAEMATOL, V131, P395, DOI 10.1111/j.1365-2141.2005.05778.x; Millimono TS, 2012, HEMOGLOBIN, V36, P25, DOI 10.3109/03630269.2011.600491; MODICA RE, 1970, T ROY SOC TROP MED H, V64, P730, DOI 10.1016/0035-9203(70)90014-3; Overgaard HJ, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-253; Pan MC, 2013, MOL BIOL REP, V40, P3073, DOI 10.1007/s11033-012-2381-6; Rehman AM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-154; Rohner F, 2013, FOOD NUTR BULL, V34, pS17, DOI 10.1177/15648265130342S104; Smith-Whitley K, 2014, BLOOD, V124, P3538, DOI 10.1182/blood-2014-07-577619; Spolarics Z, 2001, CRIT CARE MED, V29, P728, DOI 10.1097/00003246-200104000-00005; Taylor SM, 2014, CURR OPIN HEMATOL, V21, P193, DOI 10.1097/MOH.0000000000000039; Taylor SM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003327; Tsang BL, 2014, AM J TROP MED HYG, V90, P955, DOI 10.4269/ajtmh.13-0496; von Seidlein L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-112; Williams O, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068800, 10.1371/journal.pone.0080616, 10.1371/journal.pone.0081098, 10.1371/journal.pone.0079344]; Yang H, 2015, INT J LAB HEMATOL, V37, P410, DOI 10.1111/ijlh.12303; Yue L, 2014, MOL MED REP, V9, P2479, DOI 10.3892/mmr.2014.2130	39	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123991	10.1371/journal.pone.0123991	http://dx.doi.org/10.1371/journal.pone.0123991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915902	Green Submitted, gold, Green Published			2022-12-27	WOS:000353659100033
J	Zuo, JJ; Wu, F; Liu, YH; Xiao, J; Xu, M; Yu, QP; Xia, MH; He, XJ; Zou, SG; Tan, HZ; Feng, DY				Zuo, Jianjun; Wu, Fan; Liu, Yihua; Xiao, Juan; Xu, Mei; Yu, Qinping; Xia, Minhao; He, Xiaojun; Zou, Shigeng; Tan, Huize; Feng, Dingyuan			MicroRNA Transcriptome Profile Analysis in Porcine Muscle and the Effect of miR-143 on the MYH7 Gene and Protein	PLOS ONE			English	Article							HEAVY-CHAIN ISOFORMS; FIBER-TYPE; MEAT QUALITY; LARGE WHITE; EXPRESSION; REGULATOR; GROWTH; ALPHA; MEF2; BIOGENESIS	Porcine skeletal muscle fibres are classified based on their different physiological and biochemical properties. Muscle fibre phenotype is regulated by several independent signalling pathways, including the mitogen-activated protein kinase (MAPK), nuclear factor of activated T cells (NFAT), myocyte enhancer factor 2 (MEF2) and peroxisome proliferator-activated receptor (PPAR) signalling pathways. MicroRNAs are non-coding small RNAs that regulate many biological processes. However, their function in muscle fibre type regulation remains unclear. The aim of our study was to identify miRNAs that regulate muscle fibre type during porcine growth to help understand the miRNA regulation mechanism of fibre differentiation. We performed Solexa/Illumina deep sequencing for the microRNAome during 3 muscle growth stages (63, 98 and 161 d). In this study, 271 mature miRNAs and 243 pre-miRNAs were identified. We detected 472 novel miRNAs in the muscle samples. Among the mature miRNAs, there are 23 highest expression miRNAs (over 10000 RPM), account for 85.3% of the total counts of mature miRNAs., including 10 (43.5%) muscle-related miRNAs (ssc-miR133a-3p, ssc-miR-486, ssc-miR-1, ssc-miR-143-3p, ssc-miR-30a-5p, ssc-miR-181a, ssc-miR-148a-3p, ssc-miR-92a, ssc-miR-21, ssc-miR-126-5p). Particularly, both ssc-miR-1 and ssc-miR-133 belong to the MyomiRs, which control muscle myosin content, myofibre identity and muscle performance. The involvement of these miRNAs in muscle fibre phenotype provides new insight into the mechanism of muscle fibre regulation underlying muscle development. Furthermore, we performed cell transfection experiment. Overexpression/inhibition of ssc-miR-143-3p in porcine skeletal muscle satellite cell induced an/a increase/reduction of the slow muscle fibre gene and protein (MYH7), indicating that miR-143 activity regulated muscle fibre differentiate in skeletal muscle. And it regulate MYH7 through the HDAC4-MEF2 pathway.	[Zuo, Jianjun; Wu, Fan; Liu, Yihua; Xiao, Juan; Xu, Mei; Yu, Qinping; Xia, Minhao; He, Xiaojun; Feng, Dingyuan] South China Agr Univ, Coll Anim Sci, Guangzhou 510642, Guangdong, Peoples R China; [Zou, Shigeng; Tan, Huize] WENs Grp, Prod Technol Dept, Xinxing 527400, Peoples R China	South China Agricultural University	Zuo, JJ (corresponding author), South China Agr Univ, Coll Anim Sci, Guangzhou 510642, Guangdong, Peoples R China.	zuojianjun2000@163.com; puramber@163.com; fengdingyuan2000@163.com			National Basic Research Program of China (973 project) [2012CB12470]; WENs Group	National Basic Research Program of China (973 project)(National Basic Research Program of China); WENs Group	This work was supported by the National Basic Research Program of China (973 project; project number 2012CB12470). (http://www.973.gov.cn/English/Index.aspx) Co-authors Shigeng Zou and Huizhe Tan are employed by WENs Group. WENs Group provided support in the form of salaries for authors SZ and HT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar HN, 2010, HUM REPROD UPDATE, V16, P725, DOI 10.1093/humupd/dmq016; ASHMORE CR, 1972, J ANIM SCI, V34, P37; BEATTY CH, 1963, AM J PHYSIOL, V204, P939, DOI 10.1152/ajplegacy.1963.204.5.939; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen L, 2014, CURR MOL MED, V14, P370, DOI 10.2174/1566524014666140228100250; Chen ZM, 2012, DEVELOPMENT, V139, P3543, DOI 10.1242/dev.082719; Dalkilic I, 2006, MOL CELL BIOL, V26, P6522, DOI 10.1128/MCB.00243-06; Ehlers ML, 2014, CELL REP, V8, P1639, DOI 10.1016/j.celrep.2014.08.035; el Azzouzi H, 2013, CELL METAB, V18, P341, DOI 10.1016/j.cmet.2013.08.009; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fazius F, 2012, MOL MICROBIOL, V86, P1508, DOI 10.1111/mmi.12076; Gea J, 2000, AM J RESP CRIT CARE, V161, P1274, DOI 10.1164/ajrccm.161.4.99040103; Golding JP, 2007, EXP CELL RES, V313, P341, DOI 10.1016/j.yexcr.2006.10.019; HANDEL SE, 1987, J ANAT, V152, P107; Jiang HB, 2004, DEV DYNAM, V231, P292, DOI 10.1002/dvdy.20137; Jin WW, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-90; Joo ST, 2013, MEAT SCI, V95, P828, DOI 10.1016/j.meatsci.2013.04.044; Jordan T, 2005, J CELL SCI, V118, P2295, DOI 10.1242/jcs.02341; Klont RE, 1998, MEAT SCI, V49, pS219; Krawczynski K, 2012, REPROD DOMEST ANIM, V47, P545; Larzul C, 1997, J ANIM SCI, V75, P3126; Lebrasseur NK, 2003, AM J PHYSIOL-CELL PH, V284, pC1149, DOI 10.1152/ajpcell.00487.2002; Lefaucheur L, 2004, J ANIM SCI, V82, P1931; Lefaucheur L, 2002, J HISTOCHEM CYTOCHEM, V50, P719, DOI 10.1177/002215540205000513; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024883; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Murgia M, 2000, NAT CELL BIOL, V2, P142, DOI 10.1038/35004013; Muroya S, 2013, J ANIM SCI, V91, P90, DOI 10.2527/jas.2012-5371; NACHLAS MM, 1957, J HISTOCHEM CYTOCHEM, V5, P420, DOI 10.1177/5.4.420; Pette D, 2001, HISTOCHEM CELL BIOL, V115, P359, DOI 10.1007/s004180100268; Qin LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072418; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Takawa M, 2012, CANCER RES, V72, P3217, DOI 10.1158/0008-5472.CAN-11-3701; Valdez G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093140; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang L, 2012, ACTA PHYSIOL, V204, P525, DOI 10.1111/j.1748-1716.2011.02354.x; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wegner J, 2000, J ANIM SCI, V78, P1485; Wells L, 1996, EMBO J, V15, P4454, DOI 10.1002/j.1460-2075.1996.tb00822.x; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wimmers K, 2008, J ANIM SCI, V86, P795, DOI 10.2527/jas.2006-521; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	51	18	21	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124873	10.1371/journal.pone.0124873	http://dx.doi.org/10.1371/journal.pone.0124873			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915937	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659100076
J	Gupta, J; Dominic, EA; Fink, JC; Ojo, AO; Barrows, IR; Reilly, MP; Townsend, RR; Joffe, MM; Rosas, SE; Wolman, M; Patel, SS; Keane, MG; Feldman, HI; Kusek, JW; Raj, DS				Gupta, Jayanta; Dominic, Elizabeth A.; Fink, Jeffrey C.; Ojo, Akinlolu O.; Barrows, Ian R.; Reilly, Muredach P.; Townsend, Raymond R.; Joffe, Marshall M.; Rosas, Sylvia E.; Wolman, Melanie; Patel, Samir S.; Keane, Martin G.; Feldman, Harold I.; Kusek, John W.; Raj, Dominic S.		CRIC Study Investigators	Association between Inflammation and Cardiac Geometry in Chronic Kidney Disease: Findings from the CRIC Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NECROSIS-FACTOR-ALPHA; LEFT-VENTRICULAR HYPERTROPHY; CARDIOVASCULAR MORTALITY; PROGNOSTIC VALUE; HEART-FAILURE; INTERLEUKIN-6; CYTOKINES; MASS; RECOMMENDATIONS	Background Left ventricular hypertrophy (LVH) and myocardial contractile dysfunction are independent predictors of mortality in patients with chronic kidney disease (CKD). The association between inflammatory biomarkers and cardiac geometry has not yet been studied in a large cohort of CKD patients with a wide range of kidney function. Methods Plasma levels of interleukin (IL)-1 beta, IL-1 receptor antagonist (IL-1RA), IL-6, tumor necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta, high-sensitivity C-Reactive protein (hs-CRP), fibrinogen and serum albumin were measured in 3,939 Chronic Renal Insufficiency Cohort study participants. Echocardiography was performed according to the recommendations of the American Society of Echocardiography and interpreted at a centralized core laboratory. Results LVH, systolic dysfunction and diastolic dysfunction were present in 52.3%, 11.8% and 76.3% of the study subjects, respectively. In logistic regression analysis adjusted for age, sex, race/ethnicity, diabetic status, current smoking status, systolic blood pressure, urinary albumin-creatinine ratio and estimated glomerular filtration rate, hs-CRP (OR 1.26 [95% CI 1.16, 1.37], p< 0.001), IL-1RA (1.23 [1.13, 1.34], p< 0.0001), IL-6 (1.25 [1.14, 1.36], p< 0.001) and TNF-alpha (1.14 [1.04, 1.25], p = 0.004) were associated with LVH. The odds for systolic dysfunction were greater for subjects with elevated levels of hs-CRP (1.32 [1.18, 1.48], p< 0.001) and IL-6 (1.34 [1.21, 1.49], p< 0.001). Only hs-CRP was associated with diastolic dysfunction (1.14 [1.04, 1.26], p = 0.005). Conclusion In patients with CKD, elevated plasma levels of hs-CRP and IL-6 are associated with LVH and systolic dysfunction.	[Gupta, Jayanta] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, El Paso, TX USA; [Dominic, Elizabeth A.; Barrows, Ian R.] George Washington Univ, Sch Med, Washington, DC USA; [Fink, Jeffrey C.] Univ Maryland, Sch Med, Div Nephrol, Baltimore, MD 21201 USA; [Ojo, Akinlolu O.] Univ Michigan, Div Nephrol, Ann Arbor, MI 48109 USA; [Reilly, Muredach P.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Townsend, Raymond R.; Feldman, Harold I.] Univ Penn, Renal & Electrolyte Div, Philadelphia, PA 19104 USA; [Joffe, Marshall M.; Wolman, Melanie; Feldman, Harold I.] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Rosas, Sylvia E.] Harvard Univ, Sch Med, Joslyn Diabet Ctr, Boston, MA USA; [Patel, Samir S.; Raj, Dominic S.] George Washington Univ, Div Renal Dis & Hypertens, Washington, DC 20052 USA; [Keane, Martin G.] Temple Univ, Dept Med, Philadelphia, PA 19122 USA; [Kusek, John W.] NIDDK, Div Kidney Urol & Hematol Dis, Bethesda, MD 20892 USA	Texas Tech University System; Texas Tech University; George Washington University; University System of Maryland; University of Maryland Baltimore; University of Michigan System; University of Michigan; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Harvard Medical School; George Washington University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Raj, DS (corresponding author), George Washington Univ, Div Renal Dis & Hypertens, Washington, DC 20052 USA.	draj@mfa.gwu.edu	; Keane, Martin/A-1072-2007	Reilly, Muredach/0000-0002-3035-9386; Keane, Martin/0000-0002-6567-3826; Fink, Jeffrey/0000-0002-5622-5052	National Institutes of Health [1R01DK073665-01A1, 1U01DK099924-01, 1U01DK099914-01]; National Institute of Diabetes and Digestive and Kidney Diseases [U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, U01DK060902]; University of Pennsylvania CTRC CTSA [UL1 RR-024134]; Johns Hopkins University [UL1 RR-025005]; University of Maryland [GCRC M01 RR-16500]; Clinical and Translational Science Collaborative of Cleveland; National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health and NIH roadmap for Medical Research [UL1TR000439]; Michigan Institute for Clinical and Health Research (MICHR) [UL1RR024986]; University of Illinois at Chicago CTSA [UL1RR029879]; Tulane University Translational Research in Hypertension and Renal Biology [P30GM103337]; Kaiser Permanente Northern California NIH/NCRR UCSF-CTSI [UL1 RR-024131]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439, UL1TR000433] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134, UL1RR029879, M01RR016500, UL1RR025005, UL1RR024986, UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK099924, U01DK061021, U01DK060990, U01DK060980, U01DK060963, U01DK099914, U01DK060902, U01DK061022, R01DK073665, U01DK060984, U01DK061028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Pennsylvania CTRC CTSA; Johns Hopkins University(Johns Hopkins University); University of Maryland; Clinical and Translational Science Collaborative of Cleveland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health and NIH roadmap for Medical Research; Michigan Institute for Clinical and Health Research (MICHR); University of Illinois at Chicago CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Tulane University Translational Research in Hypertension and Renal Biology; Kaiser Permanente Northern California NIH/NCRR UCSF-CTSI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr. Raj is supported by the National Institutes of Health Grants 1R01DK073665-01A1, 1U01DK099924-01 and 1U01DK099914-01. Funding for the CRIC Study was obtained under a cooperative agreement from National Institute of Diabetes and Digestive and Kidney Diseases (U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, and U01DK060902). In addition, this work was supported in part by: the University of Pennsylvania CTRC CTSA UL1 RR-024134, Johns Hopkins University UL1 RR-025005, University of Maryland GCRC M01 RR-16500, Clinical and Translational Science Collaborative of Cleveland, UL1TR000439 from the National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health and NIH roadmap for Medical Research, Michigan Institute for Clinical and Health Research (MICHR) UL1RR024986, University of Illinois at Chicago CTSA UL1RR029879, Tulane University Translational Research in Hypertension and Renal Biology P30GM103337, Kaiser Permanente Northern California NIH/NCRR UCSF-CTSI UL1 RR-024131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bursi F, 2006, JAMA-J AM MED ASSOC, V296, P2209, DOI 10.1001/jama.296.18.2209; deGoma EM, 2012, ATHEROSCLEROSIS, V224, P274, DOI 10.1016/j.atherosclerosis.2012.07.017; den Elzen WPJ, 2006, NEPHROL DIAL TRANSPL, V21, P1588, DOI 10.1093/ndt/gfk092; DESIMONE G, 1995, J AM COLL CARDIOL, V25, P1056, DOI 10.1016/0735-1097(94)00540-7; Eckardt KU, 2009, J AM SOC NEPHROL, V20, P2651, DOI 10.1681/ASN.2009060631; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; Feldman HI, 2003, J AM SOC NEPHROL, V14, pS148, DOI 10.1097/01.ASN.0000070149.78399.CE; FOLEY RN, 1995, J AM SOC NEPHROL, V5, P2024; Foley RN, 1996, J AM SOC NEPHROL, V7, P728; Fox ER, 2005, STROKE, V36, P546, DOI 10.1161/01.STR.0000154893.68957.55; Fredj S, 2005, J CELL PHYSIOL, V204, P428, DOI 10.1002/jcp.20307; GULICK T, 1989, P NATL ACAD SCI USA, V86, P6753, DOI 10.1073/pnas.86.17.6753; Gupta J, 2012, CLIN J AM SOC NEPHRO, V7, P1938, DOI 10.2215/CJN.03500412; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; Krown KA, 1996, J CLIN INVEST, V98, P2854, DOI 10.1172/JCI119114; Kurdi M, 2005, MOL CELL BIOCHEM, V269, P95, DOI 10.1007/s11010-005-3085-1; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Mann DL, 2003, ANNU REV PHYSIOL, V65, P81, DOI 10.1146/annurev.physiol.65.092101.142249; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; Menon V, 2005, KIDNEY INT, V68, P766, DOI 10.1111/j.1523-1755.2005.00455.x; Meuwese CL, 2011, NEPHROL DIAL TRANSPL, V26, P1313, DOI 10.1093/ndt/gfq557; Middleton RJ, 2001, J AM SOC NEPHROL, V12, P1079, DOI 10.1681/ASN.V1251079; Monfared A, 2013, INT UROL NEPHROL, V45, P1679, DOI 10.1007/s11255-012-0375-x; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Navarro SL, 2012, CANCER EPIDEM BIOMAR, V21, P1167, DOI 10.1158/1055-9965.EPI-12-0110; Oral H, 1997, J BIOL CHEM, V272, P4836, DOI 10.1074/jbc.272.8.4836; Park M, 2012, J AM SOC NEPHROL, V23, P1725, DOI 10.1681/ASN.2012020145; Raj DSC, 2005, KIDNEY INT, V68, P2338, DOI 10.1111/j.1523-1755.2005.00695.x; Rao M, 2005, AM J KIDNEY DIS, V45, P324, DOI 10.1053/j.ajkd.2004.09.018; Rogacev KS, 2011, EUR HEART J, V32, P84, DOI 10.1093/eurheartj/ehq371; Salles GF, 2007, HYPERTENSION, V50, P723, DOI 10.1161/HYPERTENSIONAHA.107.093120; Sano M, 2000, J BIOL CHEM, V275, P29717, DOI 10.1074/jbc.M003128200; Snaedal S, 2009, AM J KIDNEY DIS, V53, P1024, DOI 10.1053/j.ajkd.2009.02.008; Wing MR, 2014, OBESITY, V22, P1359, DOI 10.1002/oby.20692; Wollert K C, 2001, Heart Fail Rev, V6, P95; Wu CK, 2011, CRIT CARE MED, V39, P984, DOI 10.1097/CCM.0b013e31820a91b9; Yokoyama T, 1997, CIRCULATION, V95, P1247; Zoccali C, 2004, KIDNEY INT, V65, P1492, DOI 10.1111/j.1523-1755.2004.00530.x; Zoccali C, 2006, J AM SOC NEPHROL, V17, pS169, DOI 10.1681/ASN.2006080910	41	43	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124772	10.1371/journal.pone.0124772	http://dx.doi.org/10.1371/journal.pone.0124772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909952	gold, Green Submitted, Green Published			2022-12-27	WOS:000353376800104
J	Habib, SM; Abrahams, AC; Korte, MR; Zietse, R; de Vogel, LL; Boer, WH; Dendooven, A; Clahsen-van Groningen, MC; Betjes, MGH				Habib, Sayed M.; Abrahams, Alferso C.; Korte, Mario R.; Zietse, Robert; de Vogel, Lisette L.; Boer, Walther H.; Dendooven, Amelie; Clahsen-van Groningen, Marian C.; Betjes, Michiel G. H.			CD4-Positive T Cells and M2 Macrophages Dominate the Peritoneal Infiltrate of Patients with Encapsulating Peritoneal Sclerosis	PLOS ONE			English	Article							CAPD TREATMENT; DUTCH EPS; INFLAMMATION; DIALYSIS; FIBROSIS; DIAGNOSIS; PARADIGM; MODELS	Background Encapsulating peritoneal sclerosis (EPS) is a severe complication of peritoneal dialysis (PD). Previously, it has been shown that infiltrating CD4-positive T cells and M2 macrophages are associated with several fibrotic conditions. Therefore, the characteristics of the peritoneal cell infiltrate in EPS may be of interest to understand EPS pathogenesis. In this study, we aim to elucidate the composition of the peritoneal cell infiltrate in EPS patients and relate the findings to clinical outcome. Study Design, Setting, and Participants We studied peritoneal membrane biopsies of 23 EPS patients and compared them to biopsies of 15 PD patients without EPS. The cellular infiltrate was characterized by immunohistochemistry to detect T cells(CD3-positive), CD4-positive (CD4+) and CD8-positive T cell subsets, B cells(CD20-positive), granulocytes(CD15-positive), macrophages(CD68-positive), M1(CD80-positive), and M2(CD163-positive) macrophages. Tissues were analysed using digital image analysis. Kaplan-Meier survival analysis was performed to investigate the survival in the different staining groups. Results The cellular infiltrate in EPS biopsies was dominated by mononuclear cells. For both CD3 and CD68, the median percentage of area stained was higher in biopsies of EPS as opposed to non-EPS patients (p<0.001). EPS biopsies showed a higher percentage of area stained for CD4 (1.29%(0.61-3.20)) compared to CD8 (0.71%(0.46-1.01), p = 0.04), while in the non-EPS group these cells were almost equally represented (respectively 0.28% (0.05-0.83) versus 0.22%(0.17-0.43), p = 0.97). The percentage of area stained for both CD80 and CD163 was higher in EPS than in non-EPS biopsies (p<0.001), with CD163+ cells being the most abundant phenotype. Virtually no CD20-positive and CD15-positive cells were present in biopsies of a subgroup of EPS patients. No relation was found between the composition of the mononuclear cell infiltrate and clinical outcome. Conclusions A characteristic mononuclear cell infiltrate consisting of CD4+ and CD163+ cells dominates the peritoneum of EPS patients. These findings suggest a role for both CD4+ T cells and M2 macrophages in the pathogenesis of EPS.	[Habib, Sayed M.; Zietse, Robert; Betjes, Michiel G. H.] Erasmus MC, Dept Internal Med, Div Nephrol & Transplantat, Rotterdam, Netherlands; [Abrahams, Alferso C.; Boer, Walther H.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands; [Korte, Mario R.] Albert Schweitzer Hosp, Dept Internal Med, Div Nephrol, Dordrecht, Netherlands; [Clahsen-van Groningen, Marian C.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Dendooven, Amelie] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Albert Schweitzer Ziekenhuis; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center	Habib, SM (corresponding author), Erasmus MC, Dept Internal Med, Div Nephrol & Transplantat, Rotterdam, Netherlands.	s.m.habib@erasmusmc.nl	Dendooven, Amélie/AAC-1192-2021; Groningen, Marian Clahsen-van/J-8250-2015	Groningen, Marian Clahsen-van/0000-0003-0565-9560; boer, walther/0000-0001-5048-2755; Dendooven, Amelie/0000-0002-9900-7952; Betjes, Michiel/0000-0001-9435-6208				Ahmad S, 2010, EUR J CLIN INVEST, V40, P1067, DOI 10.1111/j.1365-2362.2010.02353.x; Bellon T, 2011, NEPHROL DIAL TRANSPL, V26, P2995, DOI 10.1093/ndt/gfq771; BETJES MGH, 1993, KIDNEY INT, V43, P641, DOI 10.1038/ki.1993.93; Chung DR, 2002, J EXP MED, V195, P1471, DOI 10.1084/jem.20020028; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Groningen MCRV, 2006, J AM SOC NEPHROL, V17, P881, DOI 10.1681/ASN.2005080891; Grzegorzewska A E, 2001, Adv Perit Dial, V17, P10; Grzegorzewska AE, 2000, PERITON DIALYSIS INT, V20, P577; Habib SM, 2011, NETH J MED, V69, P500; Habib SM, 2013, AM J NEPHROL, V37, P223, DOI 10.1159/000348267; Habib SM, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-203; Hoff CM, 2005, PERITON DIALYSIS INT, V25, pS57; Honda K, 2005, PERITON DIALYSIS INT, V25, pS19; Honda Kazuho, 2003, Adv Perit Dial, V19, P169; Kawaguchi Y, 2000, PERITON DIALYSIS INT, V20, pS43; Kawamura K, 2009, PATHOL INT, V59, P300, DOI 10.1111/j.1440-1827.2009.02369.x; Korte MR, 2009, NETH J MED, V67, P359; Korte MR, 2011, NAT REV NEPHROL, V7, P528, DOI 10.1038/nrneph.2011.93; Korte MR, 2011, PERITON DIALYSIS INT, V31, P269, DOI 10.3747/pdi.2010.00167; Latus J, 2013, PERITON DIALYSIS INT, V33, P495, DOI 10.3747/pdi.2012.00019; Levine S, 1996, PERITON DIALYSIS INT, V16, P613; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakamoto H, 2005, PERITON DIALYSIS INT, V25, pS30; O'Reilly S, 2012, RHEUMATOLOGY, V51, P1540, DOI 10.1093/rheumatology/kes090; Park SH, 2008, PERITON DIALYSIS INT, V28, pS21; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Rey-Giraud F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042656; Sampimon DE, 2010, PERITON DIALYSIS INT, V30, P163, DOI 10.3747/pdi.2009.00022; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Zampell JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049940	34	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0120174	10.1371/journal.pone.0120174	http://dx.doi.org/10.1371/journal.pone.0120174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910222	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800008
J	Hall, BJ; Saltzman, LY; Canetti, D; Hobfoll, SE				Hall, Brian J.; Saltzman, Leia Y.; Canetti, Daphna; Hobfoll, Stevan E.			A Longitudinal Investigation of the Relationship between Posttraumatic Stress Symptoms and Posttraumatic Growth in a Cohort of Israeli Jews and Palestinians during Ongoing Violence	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; ADMINISTERED PTSD SCALE; MENTAL-HEALTH SYMPTOMS; EVENT CENTRALITY; REPEATED ACTS; TERRORISM; ARABS; RESILIENCE; EXPOSURE; SEPTEMBER-11	Objectives Meta-analytic evidence based on cross-sectional investigations between posttraumatic growth (PTG) and posttraumatic stress disorder (PTSD) demonstrates that the two concepts are positively related and that ethnic minorities report greater PTG. Few longitudinal studies have quantified this relationship so the evidence is limited regarding the potential benefit PTG may have on post-traumatic adjustment and whether differences between ethnic groups exist. Methods The current study attempts to fill a substantial gap in the literature by exploring the relationship between PTG and PTSD symptom clusters longitudinally using a nationally representative cohort of 1613 Israelis and Palestinian Citizens of Israel (PCI) interviewed via telephone on three measurement occasions during one year. Latent cross-lagged structural models estimated the relationship between PTG and each PTSD symptom cluster, derived from confirmatory factor analysis, representing latent and statistically invariant PTSD symptom factors, best representing PTSD for both ethnic groups. Results PTG was not associated with less PTSD symptom severity in any of the four PTSD clusters, for Jews and PCI. In contrast, PTSD symptom severity assessed earlier was related to later reported PTG in both groups. Conclusions This study demonstrates that PTSD symptoms contribute to greater reported PTG, but that PTG does not provide a salutatory benefit by reducing symptoms of PTSD.	[Hall, Brian J.] Univ Macau, Dept Psychol, Macau, Peoples R China; [Hall, Brian J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Saltzman, Leia Y.] Boston Coll, Sch Social Work, Boston, MA USA; [Canetti, Daphna] Univ Haifa, Sch Polit Sci, IL-31999 Haifa, Israel; [Hobfoll, Stevan E.] Rush Univ, Med Ctr, Dept Behav Sci, Chicago, IL 60612 USA	University of Macau; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Boston College; University of Haifa; Rush University	Hall, BJ (corresponding author), Univ Macau, Dept Psychol, Macau, Peoples R China.	brianhall@umac.mo	Saltzman, Leia/Y-8568-2018; Hall, Brian J./B-7694-2016	Saltzman, Leia/0000-0002-2027-6982; Hall, Brian J./0000-0001-9358-2377	National Institute of Mental Health [RO1MH073687]; Ohio Board of Regents; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073687] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ohio Board of Regents; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was made possible in part by a grant from the National Institute of Mental Health (RO1MH073687) and the Ohio Board of Regents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai AL, 2005, J INTERPERS VIOLENCE, V20, P523, DOI 10.1177/0886260504272896; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bleich A, 2003, JAMA-J AM MED ASSOC, V290, P612, DOI 10.1001/jama.290.5.612; Boals A, 2010, J LOSS TRAUMA, V15, P518, DOI 10.1080/15325024.2010.519271; Bonanno GA, 2005, CURR DIR PSYCHOL SCI, V14, P135, DOI 10.1111/j.0963-7214.2005.00347.x; Bonanno GA, 2011, ANNU REV CLIN PSYCHO, V7, P511, DOI 10.1146/annurev-clinpsy-032210-104526; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cordova MJ, 2007, J CLIN PSYCHOL MED S, V14, P308, DOI 10.1007/s10880-007-9083-6; Dekel R, 2009, HEALTH SOC WORK, V34, P87, DOI 10.1093/hsw/34.2.87; Dekel S, 2012, PSYCHOL TRAUMA-US, V4, P94, DOI 10.1037/a0021865; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1007/BF00974317; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Hall BJ, 2008, J TRAUMA STRESS, V21, P22, DOI 10.1002/jts.20301; Hall BJ, 2010, J NERV MENT DIS, V198, P180, DOI 10.1097/NMD.0b013e3181d1411b; Hall BJ, 2009, J SOC CLIN PSYCHOL, V28, P993, DOI 10.1521/jscp.2009.28.8.993; Heath NM, 2013, PSYCHOL TRAUMA-US, V5, P366, DOI 10.1037/a0028367; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Hinton DE, 2011, DEPRESS ANXIETY, V28, P783, DOI 10.1002/da.20753; HOBFOLL SE, 1993, J COMMUNITY PSYCHOL, V21, P128, DOI 10.1002/1520-6629(199304)21:2<128::AID-JCOP2290210206>3.0.CO;2-5; Hobfoll SE, 2006, J CONSULT CLIN PSYCH, V74, P207, DOI 10.1037/0022-006X.74.2.207; Hobfoll SE, 2008, J TRAUMA STRESS, V21, P9, DOI 10.1002/jts.20307; Hobfoll SE, 2007, APPL PSYCHOL-INT REV, V56, P345, DOI 10.1111/j.1464-0597.2007.00292.x; Hobfoll SE, 2011, PSYCHOL ASSESSMENT, V23, P599, DOI 10.1037/a0022817; Hobfoll SE, 2011, SOC SCI MED, V72, P1400, DOI 10.1016/j.socscimed.2011.02.022; Hobfoll SE, 2009, J CONSULT CLIN PSYCH, V77, P138, DOI 10.1037/a0014360; Johnson RJ, 2009, PSYCHOL TRAUMA-US, V1, P291, DOI 10.1037/a0017586; King DW, 2009, PSYCHOL TRAUMA-US, V1, P173, DOI 10.1037/a0016990; King DW, 1998, PSYCHOL ASSESSMENT, V10, P90, DOI 10.1037/1040-3590.10.2.90; Lancaster SL, 2013, J AGGRESS MALTREAT T, V22, P379, DOI 10.1080/10926771.2013.775983; Lowe SR, 2013, J CONSULT CLIN PSYCH, V81, P877, DOI 10.1037/a0033252; Palmieri PA, 2007, J ABNORM PSYCHOL, V116, P329, DOI 10.1037/0021-843X.116.2.329; Schuettler D, 2011, J LOSS TRAUMA, V16, P180, DOI 10.1080/15325024.2010.519273; Shakespeare-Finch J, 2014, J ANXIETY DISORD, V28, P223, DOI 10.1016/j.janxdis.2013.10.005; Smith SK, 2014, PSYCHO-ONCOLOGY, V23, P315, DOI 10.1002/pon.3419; Splevins K, 2010, J LOSS TRAUMA, V15, P259, DOI 10.1080/15325020903382111; Tedeschi R.G., 1995, TRAUMA TRANSFORMATIO, DOI [10.4135/9781483326931, DOI 10.4135/9781483326931]; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Tracy M, 2008, ANN EPIDEMIOL, V18, P447, DOI 10.1016/j.annepidem.2007.12.004; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	42	27	28	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124782	10.1371/journal.pone.0124782	http://dx.doi.org/10.1371/journal.pone.0124782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG6AH	25910043	Green Published, gold			2022-12-27	WOS:000353376800106
J	Kovacs, M; Kiss, A; Gonczi, M; Miskolczi, G; Seprenyi, G; Kaszaki, J; Kohr, MJ; Murphy, E; Vegh, A				Kovacs, Maria; Kiss, Attila; Gonczi, Mrton; Miskolczi, Gottfried; Seprenyi, Gyorgy; Kaszaki, Jozsef; Kohr, Mark J.; Murphy, Elizabeth; Vegh, Agnes			Effect of Sodium Nitrite on Ischaemia and Reperfusion-Induced Arrhythmias in Anaesthetized Dogs: Is Protein S-Nitrosylation Involved?	PLOS ONE			English	Article							MYOCARDIAL-ISCHEMIA; INORGANIC NITRATE; CARDIOVASCULAR HEALTH; RYANODINE RECEPTOR; GAP-JUNCTIONS; EMERGING ROLE; L-ARGININE; IN-VIVO; OXIDE; PROTECTION	Background and Purpose To provide evidence for the protective role of inorganic nitrite against acute ischaemia and reperfusion-induced ventricular arrhythmias in a large animal model. Experimental Approach Dogs, anaesthetized with chloralose and urethane, were administered intravenously with sodium nitrite (0.2 mu molkg(-1)min(-1)) in two protocols. In protocol 1 nitrite was infused 10 min prior to and during a 25 min occlusion of the left anterior descending (LAD) coronary artery (NaNO2-PO; n = 14), whereas in protocol 2 the infusion was started 10 min prior to reperfusion of the occluded vessel (NaNO2-PR; n = 12). Control dogs (n = 15) were infused with saline and subjected to the same period of ischaemia and reperfusion. Severities of ischaemia and ventricular arrhythmias, as well as changes in plasma nitrate/nitrite (NOx) levels in the coronary sinus blood, were assessed throughout the experiment. Myocardial superoxide and nitrotyrosine (NT) levels were determined during reperfusion. Changes in protein S-nitrosylation (SNO) and S-glutathionylation were also examined. Key Results Compared with controls, sodium nitrite administered either pre-occlusion or pre-reperfusion markedly suppressed the number and severity of ventricular arrhythmias during occlusion and increased survival (0% vs. 50 and 92%) upon reperfusion. There were also significant decreases in superoxide and NT levels in the nitrite treated dogs. Compared with controls, increased SNO was found only in NaNO2-PR dogs, whereas S-glutathionylation occurred primarily in NaNO2-PO dogs. Conclusions Intravenous infusion of nitrite profoundly reduced the severity of ventricular arrhythmias resulting from acute ischaemia and reperfusion in anaesthetized dogs. This effect, among several others, may result from an NO-mediated reduction in oxidative stress, perhaps through protein SNO and/or S-glutathionylation.	[Kovacs, Maria; Kiss, Attila; Gonczi, Mrton; Miskolczi, Gottfried; Vegh, Agnes] Univ Szeged, Dept Pharmacol & Pharmacotherapy, Fac Med, Szeged, Hungary; [Seprenyi, Gyorgy] Univ Szeged, Dept Med Biol, Fac Med, Szeged, Hungary; [Kaszaki, Jozsef] Univ Szeged, Inst Surg Res, Albert Szent Gyorgyi Med Ctr, Szeged, Hungary; [Kohr, Mark J.; Murphy, Elizabeth] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA	Szeged University; Szeged University; Szeged University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Vegh, A (corresponding author), Univ Szeged, Dept Pharmacol & Pharmacotherapy, Fac Med, Szeged, Hungary.	vegh.agnes@med.u-szeged.hu	Kiss, Attila/ABF-3583-2021	Kiss, Attila/0000-0003-4652-1998; Dr. Seprenyi, Gyorgy/0000-0002-1318-860X	Hungarian Scientific Research Foundation (OTKA) [K75281, K105252]; MTA Postdoctoral Research Programme; National Institutes of Health Intramural Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL114721, ZIAHL006059, F32HL096142] Funding Source: NIH RePORTER	Hungarian Scientific Research Foundation (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); MTA Postdoctoral Research Programme; National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Hungarian Scientific Research Foundation (OTKA; Project number K75281 and K105252) and the MTA Postdoctoral Research Programme. This work was also supported, in part, by the National Institutes of Health Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar FG, 2011, PHARMACOL THERAPEUT, V131, P287, DOI 10.1016/j.pharmthera.2011.04.005; Babai L, 2002, CLIN SCI, V102, P435, DOI 10.1042/CS20010296; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Bryan NS, 2006, FREE RADICAL BIO MED, V41, P691, DOI 10.1016/j.freeradbiomed.2006.05.019; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; Burwell LS, 2008, ANTIOXID REDOX SIGN, V10, P579, DOI 10.1089/ars.2007.1845; BUSSMANN WD, 1984, AM HEART J, V107, P940, DOI 10.1016/0002-8703(84)90832-9; Calvert JW, 2011, CARDIOVASC RES, V89, P499, DOI 10.1093/cvr/cvq307; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; CLANCY RM, 1992, J CLIN INVEST, V90, P1116, DOI 10.1172/JCI115929; Davis KL, 2001, ANNU REV PHARMACOL, V41, P203, DOI 10.1146/annurev.pharmtox.41.1.203; Dejam A, 2004, BLOOD CELL MOL DIS, V32, P423, DOI 10.1016/j.bcmd.2004.02.002; Dezfulian C, 2007, CARDIOVASC RES, V75, P327, DOI 10.1016/j.cardiores.2007.05.001; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Foster DB, 2009, J BIOENERG BIOMEMBR, V41, P159, DOI 10.1007/s10863-009-9217-7; Gilchrist M, 2011, CARDIOVASC RES, V89, P492, DOI 10.1093/cvr/cvq309; Gonczi M, 2012, CLIN SCI, V123, P39, DOI 10.1042/CS20110501; Gonczi M, 2009, BRIT J PHARMACOL, V156, P786, DOI 10.1111/j.1476-5381.2008.00089.x; Gonzalez DR, 2007, P NATL ACAD SCI USA, V104, P20612, DOI 10.1073/pnas.0706796104; Gonzalez DR, 2009, J CARDIOVASC PHARM, V54, P188, DOI 10.1097/FJC.0b013e3181b72c9f; Gonzalez FM, 2008, CIRCULATION, V117, P2986, DOI 10.1161/CIRCULATIONAHA.107.748814; Gyorgy K, 2000, CARDIOVASC DRUG THER, V14, P481, DOI 10.1023/A:1007832921391; HOELZER M, 1981, J CARDIOVASC PHARM, V3, P917, DOI 10.1097/00005344-198109000-00001; Inserte J, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005975; Iwase H, 2007, FREE RADICAL BIO MED, V43, P590, DOI 10.1016/j.freeradbiomed.2007.05.017; Kevil CG, 2011, FREE RADICAL BIO MED, V51, P576, DOI 10.1016/j.freeradbiomed.2011.04.042; Kevil CG, 2011, CARDIOVASC RES, V89, P489, DOI 10.1093/cvr/cvq409; Kis A, 1999, J MOL CELL CARDIOL, V31, P1229, DOI 10.1006/jmcc.1999.0955; Kis A, 1999, BRIT J PHARMACOL, V127, P1545, DOI 10.1038/sj.bjp.0702695; Kiss A, 2011, MEETING ON APPROACHI; Kiss A, 2010, J MOL CELL CARDIOL, V48, pS162; Kiss A, 2010, BRIT J PHARMACOL, V160, P1263, DOI 10.1111/j.1476-5381.2010.00774.x; Kohr MJ, 2011, CIRC RES, V108, P418, DOI 10.1161/CIRCRESAHA.110.232173; Korge P, 2008, CIRC RES, V103, P873, DOI 10.1161/CIRCRESAHA.108.180869; Lefer DJ, 2009, ARCH PHARM RES, V32, P1127, DOI 10.1007/s12272-009-1804-y; Lefer DJ, 2006, AM J PHYSIOL-RENAL, V290, pF777, DOI 10.1152/ajprenal.00470.2005; Lima B, 2010, CIRC RES, V106, P633, DOI 10.1161/CIRCRESAHA.109.207381; LOHMANN SM, 1991, BASIC RES CARDIOL, V86, P503, DOI 10.1007/BF02190700; Lundberg JO, 2004, FREE RADICAL BIO MED, V37, P395, DOI 10.1016/j.freeradbiomed.2004.04.027; Lundberg JO, 2011, CARDIOVASC RES, V89, P525, DOI 10.1093/cvr/cvq325; Miller MR, 2007, BRIT J PHARMACOL, V151, P305, DOI 10.1038/sj.bjp.0707224; MURAD F, 1986, J CLIN INVEST, V78, P1, DOI 10.1172/JCI112536; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Parratt Jr, 1997, ENDOTHEL CELL RES S, V2, P237; Pimentel D, 2012, ANTIOXID REDOX SIGN, V16, P524, DOI 10.1089/ars.2011.4336; Raat NJH, 2009, ADV DRUG DELIVER REV, V61, P339, DOI 10.1016/j.addr.2009.02.002; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Stoyanovsky D, 1997, CELL CALCIUM, V21, P19, DOI 10.1016/S0143-4160(97)90093-2; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Sun JH, 2006, ANTIOXID REDOX SIGN, V8, P1693, DOI 10.1089/ars.2006.8.1693; Tamargo J, 2010, CARDIOVASC RES, V87, P593, DOI 10.1093/cvr/cvq214; Tripathi P, 2009, INDIAN J BIOCHEM BIO, V46, P498; VEGH A, 1992, CARDIOVASC RES, V26, P487, DOI 10.1093/cvr/26.5.487; VEGH A, 1994, BRIT J PHARMACOL, V113, P1081, DOI 10.1111/j.1476-5381.1994.tb17104.x; VEGH A, 1992, BRIT J PHARMACOL, V107, P648, DOI 10.1111/j.1476-5381.1992.tb14501.x; Vegh A, 1996, EUR J PHARMACOL, V305, P163, DOI 10.1016/0014-2999(96)00166-5; VEGH A, 1992, BRIT J PHARMACOL, V107, P910, DOI 10.1111/j.1476-5381.1992.tb13384.x; WALKER MJA, 1988, CARDIOVASC RES, V22, P447, DOI 10.1093/cvr/22.7.447; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; West MB, 2006, FASEB J, V20, P1715, DOI 10.1096/fj.06-5843fje; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804	62	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122243	10.1371/journal.pone.0122243	http://dx.doi.org/10.1371/journal.pone.0122243			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909651	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000353376800019
J	Minkwitz, S; Fassbender, M; Kronbach, Z; Wildemann, B				Minkwitz, Susann; Fassbender, Mirja; Kronbach, Zienab; Wildemann, Britt			Longitudinal Analysis of Osteogenic and Angiogenic Signaling Factors in Healing Models Mimicking Atrophic and Hypertrophic Non-Unions in Rats	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; GROWTH-FACTOR; RELEASE KINETICS; NONUNION; CLASSIFICATION; EXPRESSION; FUMAGILLIN; VASCULARITY; INHIBITION; GENTAMICIN	Impaired bone healing can have devastating consequences for the patient. Clinically relevant animal models are necessary to understand the pathology of impaired bone healing. In this study, two impaired healing models, a hypertrophic and an atrophic non-union, were compared to physiological bone healing in rats. The aim was to provide detailed information about differences in gene expression, vascularization and histology during the healing process. The change from a closed fracture (healing control group) to an open osteotomy (hypertrophy group) led to prolonged healing with reduced mineralized bridging after 42 days. RT-PCR data revealed higher gene expression of most tested osteogenic and angiogenic factors in the hypertrophy group at day 14. After 42 days a significant reduction of gene expression was seen for Bmp4 and Bambi in this group. The inhibition of angiogenesis by Fumagillin (atrophy group) decreased the formation of new blood vessels and led to a non-healing situation with diminished chondrogenesis. RT-PCR results showed an attempt towards overcoming the early perturbance by significant up regulation of the angiogenic regulators Vegfa, Angiopoietin 2 and Fgf1 at day 7 and a further continuous increase of Fgf1, -2 and Angiopoietin 2 over time. However mu CT angiograms showed incomplete recovery after 42 days. Furthermore, lower expression values were detected for the Bmps at day 14 and 21. The Bmp antagonists Dan and Twsg1 tended to be higher expressed in the atrophy group at day 42. In conclusion, the investigated animal models are suitable models to mimic human fracture healing complications and can be used for longitudinal studies. Analyzing osteogenic and angiogenic signaling patterns, clear changes in expression were identified between these three healing models, revealing the importance of a coordinated interplay of different factors to allow successful bone healing.	[Minkwitz, Susann; Fassbender, Mirja; Kronbach, Zienab; Wildemann, Britt] Charite, Berlin Brandenburg Ctr Regenerat Therapies, Julius Wolff Inst, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wildemann, B (corresponding author), Charite, Berlin Brandenburg Ctr Regenerat Therapies, Julius Wolff Inst, Augustenburger Pl 1, D-13353 Berlin, Germany.	Britt.Wildemann@charite.de	Minkwitz, Susann/G-6183-2017; Wildemann, Britt/G-7732-2012	Minkwitz, Susann/0000-0003-4331-1450; Wildemann, Britt/0000-0002-8365-1188	Oskar-Helene-Heim foundation (Oskar-Helene Medizinpreis); Elsa-Neumann foundation; Bundesministerium fur Bildung und Forschung (BMBF) [FKZ 1315848A]; Berlin-Brandenburg Center for Regenerative Therapies (BCRT)	Oskar-Helene-Heim foundation (Oskar-Helene Medizinpreis); Elsa-Neumann foundation; Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Berlin-Brandenburg Center for Regenerative Therapies (BCRT)	This study was supported by the Oskar-Helene-Heim foundation (Oskar-Helene Medizinpreis 2011) and the Elsa-Neumann foundation, and partially by the Bundesministerium fur Bildung und Forschung (BMBF, FKZ 1315848A) and the Berlin-Brandenburg Center for Regenerative Therapies (BCRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215; Beamer B., 2010, HSS J, V6, P85, DOI [10. 1007/s11420-009- 9129-4, DOI 10.1007/S11420-009-9129-4, 10.1007/s11420-009-9129-4]; Brownlow HC, 2002, INJURY, V33, P145, DOI 10.1016/S0020-1383(01)00153-X; Calori GM, 2008, INJURY, V39, pS59, DOI 10.1016/S0020-1383(08)70016-0; Cruess RL, 1985, TXB SMALL ANIMAL ORT; Dai J, 2007, J DENT RES, V86, P937, DOI 10.1177/154405910708601006; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; DICKSON K, 1994, CLIN ORTHOP RELAT R, P189; Fajardo M, 2009, CLIN ORTHOP RELAT R, V467, P3071, DOI 10.1007/s11999-009-0981-9; Fassbender M, 2011, EUR CELLS MATER, V22, P1; Frolke JPM, 2007, INJURY, V38, pS19, DOI 10.1016/S0020-1383(07)80005-2; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Guimaraes JM, 2013, J ORTHOP RES, V31, P1971, DOI 10.1002/jor.22455; Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1; Heckman J D, 1997, Bull Hosp Jt Dis, V56, P63; Heinke J, 2013, J CELL SCI, V126, P3082, DOI 10.1242/jcs.122333; Holstein JH, 2008, BRIT J PHARMACOL, V154, P1055, DOI 10.1038/bjp.2008.167; Horner A, 2001, BONE, V28, P65, DOI 10.1016/S8756-3282(00)00422-1; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; Kaya M, 2001, Sarcoma, V5, P197, DOI 10.1080/13577140120099182; Kloen P, 2003, BONE, V33, P362, DOI 10.1016/S8756-3282(03)00191-1; Kloen P, 2012, BONE, V51, P59, DOI 10.1016/j.bone.2012.03.032; Knippenberg M, 2006, BIOCHEM BIOPH RES CO, V342, P902, DOI 10.1016/j.bbrc.2006.02.052; Kratzel C, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-135; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Lienau J, 2009, J ORTHOP RES, V27, P1133, DOI 10.1002/jor.20870; Liu SP, 1998, SCIENCE, V282, P1324, DOI 10.1126/science.282.5392.1324; Ma L, 2010, J BONE MINER RES, V25, P1305, DOI 10.1002/jbmr.19; Malik MHA, 2004, J BONE JOINT SURG BR, V86B, P556, DOI 10.1302/0301-620X.86B4.14097; Marsell R, 2009, INJURY, V40, P4; Marsh DR, 1999, BRIT MED BULL, V55, P856, DOI 10.1258/0007142991902673; Mehta M, 2012, EUR CELLS MATER, V24, P358, DOI 10.22203/eCM.v024a26; Montjovent MO, 2013, BONE, V53, P79, DOI 10.1016/j.bone.2012.11.027; Niikura T, 2006, J ORTHOP RES, V24, P1463, DOI 10.1002/jor.20182; Pountos I, 2013, INJURY, V44, P1725, DOI 10.1016/j.injury.2013.09.009; Reed AAC, 2003, J BONE JOINT SURG BR, V85B, P604, DOI 10.1302/0301-620X.85B4.12944; Reed AAC, 2002, J ORTHOP RES, V20, P593, DOI 10.1016/S0736-0266(01)00142-5; Schmidmaier G, 2001, J BIOMED MATER RES, V58, P449; Schmidmaier G, 2004, EUR J TRAUMA, V30, P35; Schwabe P, 2014, INT ORTHOP, V38, P2623, DOI 10.1007/s00264-014-2496-6; Sin N, 1997, P NATL ACAD SCI USA, V94, P6099, DOI 10.1073/pnas.94.12.6099; SKINNER SA, 1990, CANCER RES, V50, P2411; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Strobel C, 2011, J CONTROL RELEASE, V156, P37, DOI 10.1016/j.jconrel.2011.07.006; Strobel C, 2011, INT J ARTIF ORGANS, V34, P304, DOI 10.5301/IJAO.2011.6470; Tomlinson RE, 2013, BONE, V52, P212, DOI 10.1016/j.bone.2012.09.035; Tzioupis C, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(07)80003-9; Uhrig BA, 2013, BONE, V55, P410, DOI 10.1016/j.bone.2013.04.027; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Wang JY, 2000, J CELL BIOCHEM, V77, P465, DOI 10.1002/(SICI)1097-4644(20000601)77:3<465::AID-JCB11>3.3.CO;2-D; WEBER BG, 1982, Z ORTHOP GRENZGEB, V120, P528; Zelle BA, 2006, J ORTHOP TRAUMA, V20, P76, DOI 10.1097/01.bot.0000202997.45274.a1	53	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124217	10.1371/journal.pone.0124217	http://dx.doi.org/10.1371/journal.pone.0124217			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910190	Green Submitted, gold, Green Published			2022-12-27	WOS:000353376800068
J	Zhang, FJ; Dong, W; Huang, LL; Song, AP; Wang, HB; Fang, WM; Chen, FD; Teng, NJ				Zhang, Fengjiao; Dong, Wen; Huang, Lulu; Song, Aiping; Wang, Haibin; Fang, Weimin; Chen, Fadi; Teng, Nianjun			Identification of MicroRNAs and their Targets Associated with Embryo Abortion during Chrysanthemum Cross Breeding via High-Throughput Sequencing	PLOS ONE			English	Article							SMALL RNAS; FLORAL DEVELOPMENT; PISTIL DEVELOPMENT; ARABIDOPSIS; EXPRESSION; EMBRYOGENESIS; REPRESSION; MATURATION; BODENLOS; PATTERNS	Background MicroRNAs (miRNAs) are important regulators in plant development. They post-transcriptionally regulate gene expression during various biological and metabolic processes by binding to the 3'-untranslated region of target mRNAs to facilitate mRNA degradation or inhibit translation. Chrysanthemum (Chrysanthemum morifolium) is one of the most important ornamental flowers with increasing demand each year. However, embryo abortion is the main reason for chrysanthemum cross breeding failure. To date, there have been no experiments examining the expression of miRNAs associated with chrysanthemum embryo development. Therefore, we sequenced three small RNA libraries to identify miRNAs and their functions. Our results will provide molecular insights into chrysanthemum embryo abortion. Results Three small RNA libraries were built from normal chrysanthemum ovules at 12 days after pollination (DAP), and normal and abnormal chrysanthemum ovules at 18 DAP. We validated 228 miRNAs with significant changes in expression frequency during embryonic development. Comparative profiling revealed that 69 miRNAs exhibited significant differential expression between normal and abnormal embryos at 18 DAP. In addition, a total of 1037 miRNA target genes were predicted, and their annotations were defined by transcriptome data. Target genes associated with metabolic pathways were most highly represented according to the annotation. Moreover, 52 predicted target genes were identified to be associated with embryonic development, including 31 transcription factors and 21 additional genes. Gene ontology (GO) annotation also revealed that high-ranking miRNA target genes related to cellular processes and metabolic processes were involved in transcription regulation and the embryo developmental process. Conclusions The present study generated three miRNA libraries and gained information on miRNAs and their targets in the chrysanthemum embryo. These results enrich the growing database of new miRNAs and lay the foundation for the further understanding of miRNA biological function in the regulation of chrysanthemum embryo abortion.	[Zhang, Fengjiao; Huang, Lulu; Song, Aiping; Wang, Haibin; Fang, Weimin; Chen, Fadi; Teng, Nianjun] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Zhang, Fengjiao; Teng, Nianjun] Jiangsu Prov Engn Lab Modern Facil Agr Technol &, Nanjing, Jiangsu, Peoples R China; [Dong, Wen] China Rural Technol Dev Ctr, Beijing, Peoples R China	Nanjing Agricultural University	Teng, NJ (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	nianjunteng@163.com			National Natural Science Foundation of China [31171983, 31471901]; Programs for New Century Excellent Talents in Universities, Ministry of Education of China [NCET-11-0669]; Fundamental Research Funds for the Central Universities [KYZ201308]; fourth phase of Jiangsu ''333'' project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Programs for New Century Excellent Talents in Universities, Ministry of Education of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); fourth phase of Jiangsu ''333'' project	This study was supported by the National Natural Science Foundation of China (31171983, 31471901), the Programs for New Century Excellent Talents in Universities, Ministry of Education of China (NCET-11-0669), the Fundamental Research Funds for the Central Universities (KYZ201308), and the fourth phase of Jiangsu ''333'' project to NJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Agyi A, 2013, J PLANT BIOL, V56, P336, DOI 10.1007/s12374-013-0097-3; Anderson N.O., 2006, CHRYSANTHEMUM FLOWER, P389; Arathi HS, 1996, INT J PLANT SCI, V157, P49, DOI 10.1086/297319; Baroux C, 2002, ADV GENET, V46, P165; Baud Sebastien, 2008, Arabidopsis Book, V6, pe0113, DOI 10.1199/tab.0113; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Buxdorf K, 2010, PLANTA, V232, P1009, DOI 10.1007/s00425-010-1231-9; Chen J., 2001, CLASSIFICATION SYSTE; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; De Smet I, 2013, J EXP BOT, V64, P3009, DOI 10.1093/jxb/ert137; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Duarte GT, 2013, J EXP BOT, V64, P4301, DOI 10.1093/jxb/ert239; FRANZ RE, 1991, CROP SCI, V31, P1651, DOI 10.2135/cropsci1991.0011183X003100060054x; Gao ZH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-371; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Golden TA, 2002, PLANT PHYSIOL, V130, P808, DOI 10.1104/pp.003491; Grunewald W, 2013, EMBO REP, V14, P1136, DOI 10.1038/embor.2013.169; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Johri BM, 2001, REPROD BIOL PLANTS, P237; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lau S, 2012, ANNU REV PLANT BIOL, V63, P483, DOI 10.1146/annurev-arplant-042811-105507; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liang CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010698; Liang G, 2014, PLANT PHYSIOL, V164, P249, DOI 10.1104/pp.113.225144; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Mallory AC, 2008, CURR OPIN PLANT BIOL, V11, P560, DOI 10.1016/j.pbi.2008.06.008; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mallory AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000646; Masiero S, 2011, PLANT CELL, V23, P865, DOI 10.1105/tpc.110.081737; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Ndoutoumou PN, 2007, PLANT CELL TISS ORG, V88, P329, DOI 10.1007/s11240-006-9198-8; Nodine MD, 2010, GENE DEV, V24, P2678, DOI 10.1101/gad.1986710; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ru P, 2006, CELL RES, V16, P457, DOI 10.1038/sj.cr.7310057; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Seefried WF, 2014, PLANT PHYSIOL, V165, P670, DOI 10.1104/pp.114.240846; Song A, 2012, PLANT BIOLOGY, V14, P706, DOI 10.1111/j.1438-8677.2011.00560.x; Song AP, 2014, INT J MOL SCI, V15, P14442, DOI 10.3390/ijms150814442; Song AP, 2014, PLANT PHYSIOL BIOCH, V80, P114, DOI 10.1016/j.plaphy.2014.03.030; Sun CQ, 2010, EUPHYTICA, V174, P51, DOI 10.1007/s10681-009-0117-z; Sun CQ, 2010, EUPHYTICA, V171, P181, DOI 10.1007/s10681-009-0005-6; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Vashisht D, 2014, BIOCHEM SOC T, V42, P352, DOI 10.1042/BST20130252; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wang XC, 2009, CELL RES, V19, P224, DOI 10.1038/cr.2008.276; Willmann MR, 2011, PLANT PHYSIOL, V155, P1871, DOI 10.1104/pp.110.171355; Wu G, 2013, J GENET GENOMICS, V40, P217, DOI 10.1016/j.jgg.2013.04.002; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xie ZX, 2010, SEMIN CELL DEV BIOL, V21, P790, DOI 10.1016/j.semcdb.2010.03.012; Yamaguchi A, 2012, J PLANT RES, V125, P693, DOI 10.1007/s10265-012-0513-7; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Yin LL, 2012, PLANT CELL, V24, P1049, DOI 10.1105/tpc.111.094854; Zhai L, 2014, PLANT MOL BIOL REP, P1; Zhang FJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06536; Zhang JH, 2012, PLANTA, V236, P647, DOI 10.1007/s00425-012-1643-9; Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818	70	41	46	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124371	10.1371/journal.pone.0124371	http://dx.doi.org/10.1371/journal.pone.0124371			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909659	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800079
J	Kim, H; Suzuki, T; Kim, M; Kojima, N; Ota, N; Shimotoyodome, A; Hase, T; Hosoi, E; Yoshida, H				Kim, Hunkyung; Suzuki, Takao; Kim, Miji; Kojima, Narumi; Ota, Noriyasu; Shimotoyodome, Akira; Hase, Tadashi; Hosoi, Erika; Yoshida, Hideyo			Effects of Exercise and Milk Fat Globule Membrane (MFGM) Supplementation on Body Composition, Physical Function, and Hematological Parameters in Community-Dwelling Frail Japanese Women: A Randomized Double Blind, Placebo-Controlled, Follow-Up Trial	PLOS ONE			English	Article							GROWTH-FACTOR; RESISTANCE EXERCISE; OLDER-PEOPLE; WEIGHT-LOSS; BDNF; SARCOPENIA; MYOSTATIN; STRENGTH; MOBILITY; ADULTS	Objective To investigate the combined and separate effects of exercise and milk fat globule membrane (MFGM) supplementation on frailty, physical function, physical activity level, and hematological parameters in community-dwelling elderly Japanese women. Methods A total of 131 frail, elderly women over 75 years were randomly assigned to one of four groups: exercise and MFGM supplementation (Ex+MFGM), exercise and placebo (Ex+Plac), MFGM supplementation, or the placebo group. The exercise group attended a 60-minute training program twice a week for three months, and the MFGM group ingested 1g of the MFGM supplement in pill form, daily for 3 months. The primary outcome measure was change in frailty status based on Fried's frailty phenotype. Secondary outcome measures included body composition, physical function and hematological parameters, and interview survey components assessing lifestyle factors. Participants were followed for 4 months post-intervention. Results Significant groupxtime interactions were observed for usual walking speed (P = 0.005), timed up & go (P < 0.001), and insulin-like growth factor-binding protein 3/insulin-like growth factor 1 ratio (P = 0.013). The frailty components revealed that weight loss, exhaustion, low physical activity, and slow walking speed were reversed, but low muscle strength did not significantly changed. Frailty reversal rate was significantly higher in the Ex+MFGM (57.6%) than in the MFGM (28.1%) or placebo (30.3%) groups at post-intervention (chi(2) = 8.827, P = 0.032), and at the follow-up was also significantly greater in the Ex+MFGM (45.5%) and Ex+Plac (39.4%) groups compared with the placebo (15.2%) group (chi(2) = 8.607, P = 0.035). The exercise+MFGM group had the highest odds ratio (OR) for frailty reversal at post-intervention and follow-up (OR = 3.12, 95% confidence interval (CI) = 1.13-8.60; and OR = 4.67, 95% CI = 1.45-15.08, respectively). Conclusion This study suggests that interventions including exercise and nutrition can improve frailty status. Statistically significant additive effects of MFGM with exercise could not be confirmed in this population, and further investigation in larger samples is necessary.	[Kim, Hunkyung; Kim, Miji; Kojima, Narumi; Hosoi, Erika; Yoshida, Hideyo] Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Tokyo, Japan; [Suzuki, Takao] Natl Inst Longev Sci, Obu, Aichi, Japan; [Ota, Noriyasu; Shimotoyodome, Akira; Hase, Tadashi] Kao Corp, Biol Sci Labs, Hlth Sci, Ichikai, Tochigi, Japan	Tokyo Metropolitan Institute of Gerontology; KAO Corporation	Kim, H (corresponding author), Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Tokyo, Japan.	kimhk@tmig.or.jp	Kim, Heejin/HII-8568-2022; Lee, Sei Won/AAG-9977-2019	shimotoyodome, akira/0000-0001-7567-8316	Ministry of Health and Welfare of Japan; Japan Society for the Promotion of Science [22300243]	Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a research grant of the Ministry of Health and Welfare of Japan and a Grant-in-Aid for Scientific Research B of the Japan Society for the Promotion of Science (22300243). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors Noriyasu Ota, Akira Shimotoyodome and Tadashi Hase are employed by Kao Corporation. Kao Corporation provided support in the form of salaries for authors NO, AS and TH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bermon S, 1999, ACTA PHYSIOL SCAND, V165, P51; Borst SE, 2002, J AM GERIATR SOC, V50, P884, DOI 10.1046/j.1532-5415.2002.50215.x; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Cameron ID, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-65; Chan DCD, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-58; Clegg A, 2014, AGE AGEING; Coelho FM, 2012, ARCH GERONTOL GERIAT, V54, P415, DOI 10.1016/j.archger.2011.05.014; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; El-Loly Mohamed Mansour, 2011, Polish Journal of Food and Nutrition Sciences, V61, P7; Elliot TA, 2006, MED SCI SPORT EXER, V38, P667, DOI 10.1249/01.mss.0000210190.64458.25; Fallah N, 2011, J AM GERIATR SOC, V59, P524, DOI 10.1111/j.1532-5415.2011.03300.x; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gezen-Ak D, 2013, J ALZHEIMERS DIS, V37, P185, DOI 10.3233/JAD-130497; Hand BD, 2007, J APPL PHYSIOL, V103, P1678, DOI 10.1152/japplphysiol.00420.2007; Haramizu S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-339; Hittel DS, 2010, MED SCI SPORT EXER, V42, P2023, DOI 10.1249/MSS.0b013e3181e0b9a8; Josse AR, 2010, MED SCI SPORT EXER, V42, P1122, DOI 10.1249/MSS.0b013e3181c854f6; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Li CM, 2010, ARCH GERONTOL GERIAT, V50, pS39, DOI 10.1016/S0167-4943(10)70011-X; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Morley JE, 2011, J AM MED DIR ASSOC, V12, P403, DOI 10.1016/j.jamda.2011.04.014; Parkhouse WS, 2000, MECH AGEING DEV, V113, P75, DOI 10.1016/S0047-6374(99)00103-7; Raji MA, 2010, J GERONTOL A-BIOL, V65, P1228, DOI 10.1093/gerona/glq121; Rothman MD, 2008, J AM GERIATR SOC, V56, P2211, DOI 10.1111/j.1532-5415.2008.02008.x; Ryan AS, 2013, OBESITY, V21, P1350, DOI 10.1002/oby.20216; Shimada H, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00069; Syddall H, 2003, AGE AGEING, V32, P650, DOI 10.1093/ageing/afg111; Theou Olga, 2011, J Aging Res, V2011, P569194, DOI 10.4061/2011/569194; Tylavsky F, 2003, J APPL PHYSIOL, V94, P959, DOI 10.1152/japplphysiol.00732.2002; van Kan GA, 2010, CLIN GERIATR MED, V26, P275, DOI 10.1016/j.cger.2010.02.002; Vaughan S, 2014, AGE AGEING; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Walker KS, 2004, MED SCI SPORT EXER, V36, P787, DOI 10.1249/01.MSS.0000126384.04778.29; Wilkinson SB, 2007, AM J CLIN NUTR, V85, P1031, DOI 10.1093/ajcn/85.4.1031; Woods NF, 2005, J AM GERIATR SOC, V53, P1321, DOI 10.1111/j.1532-5415.2005.53405.x; Wu K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028520	39	128	145	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116256	10.1371/journal.pone.0116256	http://dx.doi.org/10.1371/journal.pone.0116256			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659147	Green Submitted, gold, Green Published			2022-12-27	WOS:000349444900033
J	Bachmann, D; Gockele, A; Ravenek, JM; Roscher, C; Strecker, T; Weigelt, A; Buchmann, N				Bachmann, Doerte; Gockele, Annette; Ravenek, Janneke M.; Roscher, Christiane; Strecker, Tanja; Weigelt, Alexandra; Buchmann, Nina			No Evidence of Complementary Water Use along a Plant Species Richness Gradient in Temperate Experimental Grasslands	PLOS ONE			English	Article							DIVERSITY-PRODUCTIVITY RELATIONSHIPS; BIODIVERSITY EXPERIMENTS; ECOSYSTEM PROCESSES; CURRENT KNOWLEDGE; STABLE ISOTOPES; COMMUNITIES; DEPTH; NITROGEN; PATTERNS; SPACE	Niche complementarity in resource use has been proposed as a key mechanism to explain the positive effects of increasing plant species richness on ecosystem processes, in particular on primary productivity. Since hardly any information is available for niche complementarity in water use, we tested the effects of plant diversity on spatial and temporal complementarity in water uptake in experimental grasslands by using stable water isotopes. We hypothesized that water uptake from deeper soil depths increases in more diverse compared to low diverse plant species mixtures. We labeled soil water in 8 cm (with O-18) and 28 cm depth (with H-2) three times during the 2011 growing season in 40 temperate grassland communities of varying species richness (2, 4, 8 and 16 species) and functional group number and composition (legumes, grasses, tall herbs, small herbs). Stable isotope analyses of xylem and soil water allowed identifying the preferential depth of water uptake. Higher enrichment in 18O of xylem water than in H-2 suggested that the main water uptake was in the upper soil layer. Furthermore, our results revealed no differences in root water uptake among communities with different species richness, different number of functional groups or with time. Thus, our results do not support the hypothesis of increased complementarity in water use in more diverse than in less diverse communities of temperate grassland species.	[Bachmann, Doerte; Buchmann, Nina] ETH, Inst Agr Sci, Zurich, Switzerland; [Gockele, Annette] Univ Freiburg, Fac Biol, Dept Geobot, D-79106 Freiburg, Germany; [Ravenek, Janneke M.] Radboud Univ Nijmegen, Dept Expt Plant Ecol, Inst Water & Wetland Res, NL-6525 ED Nijmegen, Netherlands; [Roscher, Christiane] Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Halle, Germany; [Strecker, Tanja] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Weigelt, Alexandra] Univ Leipzig, Dept Special Bot & Funct Biodivers, Inst Biol, D-04109 Leipzig, Germany; [Weigelt, Alexandra] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Freiburg; Radboud University Nijmegen; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Gottingen; Leipzig University	Bachmann, D (corresponding author), ETH, Inst Agr Sci, Zurich, Switzerland.	doerte.bachmann@usys.ethz.ch	Buchmann, Nina/E-6095-2011	Buchmann, Nina/0000-0003-0826-2980; Bachmann, Dorte/0000-0003-2171-3838; Segura, Diego Fernando/0000-0003-2927-9028; Fernandez, Patricia C./0000-0002-4360-6761; Juarez, Maria Laura/0000-0002-4563-5080; Vera, Maria Teresa/0000-0002-1446-6042; Ruiz, Maria Josefina/0000-0003-0773-2629	Swiss National Science Foundation [315230E-131194]; German Science Foundation [FOR 456/1451]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Science Foundation(German Research Foundation (DFG))	This study was financially supported by the Swiss National Science Foundation (315230E-131194, www.snf.ch) and the German Science Foundation (FOR 456/1451, www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2013, OECOLOGIA, V173, P223, DOI 10.1007/s00442-012-2589-0; ALLISON GB, 1983, EFFECT CLIMATE VEGET, P105; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barnard RL, 2006, RAPID COMMUN MASS SP, V20, P3799, DOI 10.1002/rcm.2778; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BERENDSE F, 1982, OECOLOGIA, V53, P50, DOI 10.1007/BF00377135; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bessler H, 2012, PLANT SOIL, V358, P301, DOI 10.1007/s11104-012-1181-z; Caldeira MC, 2001, ECOL LETT, V4, P439, DOI 10.1046/j.1461-0248.2001.00238.x; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; Clark I., 1997, ENV ISOTOPES HYDROLO; DANSGAARD W, 1964, TELLUS, V16, P436; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Dimitrakopoulos PG, 2004, ECOL LETT, V7, P574, DOI 10.1111/j.1461-0248.2004.00607.x; Dodd MB, 1998, OECOLOGIA, V117, P504, DOI 10.1007/s004420050686; EHLERINGER JR, 1992, PLANT CELL ENVIRON, V15, P1073, DOI 10.1111/j.1365-3040.1992.tb01657.x; EHLERINGER JR, 1991, OECOLOGIA, V88, P430, DOI 10.1007/BF00317589; Fargione J, 2005, OECOLOGIA, V143, P598, DOI 10.1007/s00442-005-0010-y; Fischer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098987; GORDON DR, 1992, AM J BOT, V79, P967, DOI 10.2307/2444905; Grieu P, 2001, PLANT SOIL, V230, P197, DOI 10.1023/A:1010363532118; Gubsch M, 2011, PLANT CELL ENVIRON, V34, P895, DOI 10.1111/j.1365-3040.2011.02287.x; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Hoekstra NJ, 2014, BIOGEOSCIENCES DISCU, V11, P4151, DOI DOI 10.5194/BGD-11-4151-2014; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Jobbagy EG, 2001, BIOGEOCHEMISTRY, V53, P51, DOI 10.1023/A:1010760720215; Kahmen A, 2006, ECOLOGY, V87, P1244, DOI 10.1890/0012-9658(2006)87[1244:NCFNAE]2.0.CO;2; Kulmatiski A, 2010, NEW PHYTOL, V188, P199, DOI 10.1111/j.1469-8137.2010.03338.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; Moreno-Gutierrez C, 2012, NEW PHYTOL, V196, P489, DOI 10.1111/j.1469-8137.2012.04276.x; Mueller KE, 2013, ECOLOGY, V94, P787, DOI 10.1890/12-1399.1; Muller-Westermeier G, 2000, BERICHTE DTSCH WETTE, V213; Nippert JB, 2007, OIKOS, V116, P1017, DOI [10.1111/j.2007.0030-1299.15630.x, 10.1111/j.0030-1299.2007.15630.x]; Oelmann Y, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003869; Ogle K, 2004, ECOLOGY, V85, P1967, DOI 10.1890/03-0346; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036760; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; Schlapfer F, 1999, ECOL APPL, V9, P893, DOI 10.1890/1051-0761(1999)009[0893:EEOBAC]2.0.CO;2; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Van Peer L, 2004, FUNCT ECOL, V18, P769, DOI 10.1111/j.0269-8463.2004.00901.x; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; Verheyen K, 2008, OECOLOGIA, V156, P351, DOI 10.1007/s00442-008-0998-x; Volaire F, 2014, EUR J AGRON, V52, P81, DOI 10.1016/j.eja.2013.10.002; von Felten S, 2008, J PLANT ECOL, V1, P33, DOI 10.1093/jpe/rtm006; von Felten S, 2009, ECOLOGY, V90, P1389, DOI 10.1890/08-0802.1; Werner RA, 1999, RAPID COMMUN MASS SP, V13, P1237, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1237::AID-RCM633>3.0.CO;2-C; WHITE JWC, 1985, GEOCHIM COSMOCHIM AC, V49, P237, DOI 10.1016/0016-7037(85)90207-8	57	54	57	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116367	10.1371/journal.pone.0116367	http://dx.doi.org/10.1371/journal.pone.0116367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25923584	Green Submitted, Green Published, gold			2022-12-27	WOS:000347928300011
J	Kim, HJ; Baek, S; Kim, HJ; Lee, JS; Oh, YM; Lee, SD; Lee, SW				Kim, Hyun Jung; Baek, Seunghee; Kim, Hee Jin; Lee, Jae Seung; Oh, Yeon-Mok; Lee, Sang-Do; Lee, Sei Won			The Impact of Smoking on Airflow Limitation in Subjects with History of Asthma and Inactive Tuberculosis	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CIGARETTE-SMOKING; GLOBAL BURDEN; LUNG-DISEASE; RISK; HYPERRESPONSIVENESS; INFLAMMATION; PREVALENCE; HEALTH; KOREA	Background Although smoking is the most important and modifiable cause of chronic obstructive pulmonary disease (COPD), other risk factors including asthma and tuberculosis (TB) are also associated. It is common for COPD patients to have more than one of these risk factors. The aims of this study were to determine the prevalence of airflow limitation (FEV1/FVC<0.7) according to the risk factors and to investigate their impact and interaction in airflow limitation. Methods From the Korean National Health and Nutrition Examination Survey between 2008 and 2012, we analyzed participants over 40 years of age by spirometry, chest radiograph and questionnaire about asthma and smoking history. Results Of 12,631 participants, 1,548 (12.3%) had airflow limitation. The prevalence of airflow limitation in smokers (>= 10 pack-year), asthmatics, and those with inactive TB was 23.9%, 32.1%, and 33.6%. The prevalence increased with the number of risk factors: 86.1% had airflow limitation if they had all three risk factors. Impacts of inactive TB and asthma on airflow limitation were equivalent to 47 and 69 pack-years of smoking, respectively. Airflow limitation resulted from lower levels of smoking in those with inactive TB and asthma. A potential interaction between smoking and inactive tuberculosis in the development of airflow limitation was identified (p = 0.054). Conclusions Asthma and inactive TB lesions increase susceptibility to smoking in the development of airflow limitation. People with these risk factors should be seen as a major target population for anti-smoking campaigns to prevent COPD.	[Kim, Hyun Jung; Lee, Jae Seung; Oh, Yeon-Mok; Lee, Sang-Do; Lee, Sei Won] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea; [Kim, Hyun Jung; Lee, Jae Seung; Oh, Yeon-Mok; Lee, Sang-Do; Lee, Sei Won] Univ Ulsan, Coll Med, Asan Med Ctr, Clin Res Ctr Chron Obstruct Airway Dis, Seoul, South Korea; [Kim, Hyun Jung] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Baek, Seunghee] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea; [Kim, Hee Jin] Korean Inst TB, Osong, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Kyungpook National University; University of Ulsan; Asan Medical Center	Lee, SW (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea.	iseiwon@gmail.com	Kim, Heejin/HII-8568-2022; Lee, Sei Won/AAG-9977-2019	shimotoyodome, akira/0000-0001-7567-8316	National Strategic Coordinating Center for Clinical Research, Ministry for Health & Welfare Affairs, Republic of Korea [HI10C2020]	National Strategic Coordinating Center for Clinical Research, Ministry for Health & Welfare Affairs, Republic of Korea	This study was supported by a grant of the National Strategic Coordinating Center for Clinical Research, Ministry for Health & Welfare Affairs, Republic of Korea (HI10C2020) to SWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1990, CATEGORICAL DATA ANA, pXV; ANDERSON DO, 1962, NEW ENGL J MED, V267, P787, DOI 10.1056/NEJM196210182671601; [Anonymous], 2009, LANCET, V374, P663, DOI 10.1016/S0140-6736(09)61535-X; Boulet LP, 2000, AM J RESP CRIT CARE, V162, P1308, DOI 10.1164/ajrccm.162.4.9910051; BURROWS B, 1977, AM REV RESPIR DIS, V115, P195; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; COX DR, 1984, INT STAT REV, V52, P1, DOI 10.2307/1403235; DAVIS RM, 1989, AM REV RESPIR DIS, V140, pS82, DOI 10.1164/ajrccm/140.3_Pt_2.S82; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Elkington PTG, 2006, THORAX, V61, P259, DOI 10.1136/thx.2005.051979; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Global Institute for Chronic Obstructive Lung Disease, 2013, GLOB STRAT DIAGN MAN; Hagstad S, 2014, CHEST, V145, P1298, DOI 10.1378/chest.13-1349; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; James AL, 2005, AM J RESP CRIT CARE, V171, P109, DOI 10.1164/rccm.200402-230OC; JEFFERY PK, 1992, AM REV RESPIR DIS, V145, P890, DOI 10.1164/ajrccm/145.4_Pt_1.890; Kim DS, 2005, AM J RESP CRIT CARE, V172, P842, DOI 10.1164/rccm.200502-259OC; Kim S, 2013, ALLERGY, V68, P1435, DOI 10.1111/all.12256; Lam KBH, 2010, CHEST, V137, P593, DOI 10.1378/chest.09-1435; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Lee SW, 2011, J KOREAN MED SCI, V26, P268, DOI 10.3346/jkms.2011.26.2.268; LUNDGREN R, 1988, EUR RESPIR J, V1, P883; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Menezes AMB, 2007, EUR RESPIR J, V30, P1180, DOI 10.1183/09031936.00083507; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Murray CJL, 2007, LANCET, V370, P109, DOI 10.1016/S0140-6736(07)61064-2; National Herat Lung and Blood Institue, 2004, MORB MORT CHARTB CAR; OSWALD NC, 1955, LANCET, V2, P843; Perret JL, 2013, AM J RESP CRIT CARE, V187, P42, DOI 10.1164/rccm.201205-0788OC; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Silva GE, 2004, CHEST, V126, P59, DOI 10.1378/chest.126.1.59; SNIDER GL, 1971, AM REV RESPIR DIS, V103, P625; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Soriano JB, 2003, CHEST, V124, P474, DOI 10.1378/chest.124.2.474; Straus SE, 2000, JAMA-J AM MED ASSOC, V283, P1853, DOI 10.1001/jama.283.14.1853; Tai A, 2014, THORAX, V69, P805, DOI 10.1136/thoraxjnl-2013-204815; The United States of America Department of State DoHcHS Centers for Disease Control and Preventionn, INSTR PAN PHYS COMPL; TOREN K, 1993, CHEST, V104, P600, DOI 10.1378/chest.104.2.600; Ward C, 2002, THORAX, V57, P309, DOI 10.1136/thorax.57.4.309; Yoo KH, 2011, RESPIROLOGY, V16, P659, DOI 10.1111/j.1440-1843.2011.01951.x	42	128	145	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125020	10.1371/journal.pone.0125020	http://dx.doi.org/10.1371/journal.pone.0125020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25659147	gold, Green Published, Green Submitted			2022-12-27	WOS:000353659100090
